PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kingston, D; Heaman, M; Brownell, M; Ekuma, O				Kingston, Dawn; Heaman, Maureen; Brownell, Marni; Ekuma, Okechukwu			Predictors of Childhood Anxiety: A Population-Based Cohort Study	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; HEALTH-CARE COSTS; MENTAL-HEALTH; AGE-CHILDREN; DISORDERS; ADOLESCENTS; PRETERM; DEPRESSION; MANAGEMENT; COMMUNITY	Background Few studies have explored predictors of early childhood anxiety. Objective To determine the prenatal, postnatal, and early life predictors of childhood anxiety by age 5. Methods Population-based, provincial administrative data (N = 19,316) from Manitoba, Canada were used to determine the association between demographic, obstetrical, psychosocial, medical, behavioral, and infant factors on childhood anxiety. Results Risk factors for childhood anxiety by age 5 included maternal psychological distress from birth to 12 months and 13 months to 5 years post-delivery and an infant 5-minute Apgar score of <= 7. Factors associated with decreased risk included maternal age < 20 years, multiparity, and preterm birth. Conclusion Identifying predictors of childhood anxiety is a key step to early detection and prevention. Maternal psychological distress is an early, modifiable risk factor. Future research should aim to disentangle early life influences on childhood anxiety occurring in the prenatal, postnatal, and early childhood periods.	[Kingston, Dawn] Univ Alberta, Fac Nursing & Med, Edmonton, AB, Canada; [Kingston, Dawn] Univ Alberta, Fac Psychiat, Edmonton, AB, Canada; [Kingston, Dawn] Univ Alberta, Fac Obstet & Gynecol, Edmonton, AB, Canada; [Heaman, Maureen; Brownell, Marni] Univ Manitoba, Fac Nursing, Winnipeg, MB, Canada; [Brownell, Marni; Ekuma, Okechukwu] Univ Manitoba, Fac Med, Manitoba Ctr Hlth Policy, Winnipeg, MB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Manitoba; University of Manitoba	Kingston, D (corresponding author), Univ Alberta, Fac Nursing & Med, Edmonton, AB, Canada.	dawn.kingston@ualberta.ca		Heaman, Maureen/0000-0002-8775-714X; Brownell, Marni/0000-0001-7673-4404	Canadian Institutes of Health Research (CIHR) Chair in Gender and Health [07/2008-06/2013]; Alberta Centre for Child, Family, and Community Research and CIHR; Government of Manitoba through the Manitoba Centre for Health Policy Population-Based Child Health Research Award; Manitoba Institute of Child Health [H2010:250]	Canadian Institutes of Health Research (CIHR) Chair in Gender and Health(Canadian Institutes of Health Research (CIHR)); Alberta Centre for Child, Family, and Community Research and CIHR; Government of Manitoba through the Manitoba Centre for Health Policy Population-Based Child Health Research Award; Manitoba Institute of Child Health	Dr. Heaman received career support from a Canadian Institutes of Health Research (CIHR) Chair in Gender and Health (07/2008-06/2013). Dr. Kingston's post-doctoral fellowship was funded through Dr. Heaman's Chair and she has since received career support from the Alberta Centre for Child, Family, and Community Research and CIHR (New Investigator Award). Dr. Brownell acknowledges the financial support of the Government of Manitoba through the Manitoba Centre for Health Policy Population-Based Child Health Research Award. The authors are grateful for funding received from the Manitoba Institute of Child Health to conduct this study (grant # H2010:250). The funder played no role in the design and conduct of the study, data collection or management, analysis, interpretation of data, preparation or review of the manuscript, approval of the manuscript, or decision to submit for publication. The results and conclusions are those of the authors and no official endorsement by the Manitoba Centre for Health Policy, funders or data providers is intended or should be inferred.	Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; Anhalt K., 2007, SCHOOL PSYCHOL QUART, V22, P16; Bales M, 2015, EUR PSYCHIAT, V30, DOI 10.1016/j.eurpsy.2014.11.004; Beesdo K, 2009, PSYCHIAT CLIN N AM, V32, P483, DOI 10.1016/j.psc.2009.06.002; Beesdo-Baum K, 2012, CHILD ADOL PSYCH CL, V21, P457, DOI 10.1016/j.chc.2012.05.001; Brownell M, 2008, MANITOBA CHILD HLTH; Brumariu LE, 2010, DEV PSYCHOPATHOL, V22, P177, DOI 10.1017/S0954579409990344; Creswell C, 2014, ARCH DIS CHILD, V99, P674, DOI 10.1136/archdischild-2013-303768; Earls MF, 2010, PEDIATRICS, V126, P1032, DOI 10.1542/peds.2010-2348; Fihrer I, 2009, J AFFECT DISORDERS, V119, P116, DOI 10.1016/j.jad.2009.03.001; Guyer B, 2009, ACAD PEDIATR, V9, P142, DOI 10.1016/j.acap.2008.12.007; Hodgkinson S, 2014, PEDIATRICS, V133, P114, DOI 10.1542/peds.2013-0927; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Indredavik MS, 2010, J DEV BEHAV PEDIATR, V31, P286, DOI 10.1097/DBP.0b013e3181d7b1d3; Joseph K S, 2007, BMC Pregnancy Childbirth, V7, P4, DOI 10.1186/1471-2393-7-4; Mian ND, 2014, CLIN CHILD FAM PSYCH, V17, P85, DOI 10.1007/s10567-013-0152-0; Monk C, 2012, DEV PSYCHOPATHOL, V24, P1361, DOI 10.1017/S0954579412000764; Mount KS, 2010, INFANT BEHAV DEV, V33, P567, DOI 10.1016/j.infbeh.2010.07.008; Muroff J, 2011, HANDBOOK OF CHILD AND ADOLESCENT ANXIETY DISORDERS, P457, DOI 10.1007/978-1-4419-7784-7_31; O'Connor TG, 2002, J AM ACAD CHILD PSY, V41, P1470, DOI 10.1097/00004583-200212000-00019; Pine DS, 2009, NEUROPSYCHOPHARMACOL, V34, P213, DOI 10.1038/npp.2008.113; Rapee RM, 2010, AM J PSYCHIAT, V167, P1518, DOI 10.1176/appi.ajp.2010.09111619; Robinson M, 2008, J CHILD PSYCHOL PSYC, V49, P1118, DOI 10.1111/j.1469-7610.2008.01955.x; Sciberras E, 2015, INT J SPEECH-LANG PA, V17, P41, DOI 10.3109/17549507.2014.898095; Singh GK, 2013, DEPRESS RES TREAT, V2013; Sommer KS, 2000, ADOLESCENCE, V35, P87; Waddell C, 2007, CAN J PUBLIC HEALTH, V98, P174, DOI 10.1007/BF03403707; Weeks M, 2009, J ANXIETY DISORD, V23, P965, DOI 10.1016/j.janxdis.2009.06.006; Westrupp EM, 2014, CHILD CARE HLTH DEV, V40, P259, DOI 10.1111/cch.12040; Westrupp EM, 2012, J AM ACAD CHILD PSY, V51, P313, DOI 10.1016/j.jaac.2011.12.004; Wichstrom L, 2013, J CHILD PSYCHOL PSYC, V54, P1327, DOI 10.1111/jcpp.12116; Wilmshurst L., 2005, ESSENTIALS CHILD PSY	32	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0129339	10.1371/journal.pone.0129339	http://dx.doi.org/10.1371/journal.pone.0129339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EW	26158268	Green Published, gold, Green Submitted			2022-12-27	WOS:000358161200007
J	Lee, JT; Hamid, F; Pati, S; Atun, R; Millett, C				Lee, John Tayu; Hamid, Fozia; Pati, Sanghamitra; Atun, Rifat; Millett, Christopher			Impact of Noncommunicable Disease Multimorbidity on Healthcare Utilisation and Out-Of-Pocket Expenditures in Middle-Income Countries: Cross Sectional Analysis	PLOS ONE			English	Article							MULTIPLE CHRONIC CONDITIONS; UNIVERSAL HEALTH; PREVALENCE; COVERAGE; POPULATION; PRIORITY; BURDEN	Background The burden of non-communicable disease (NCDs) has grown rapidly in low-and middle-income countries (LMICs), where populations are ageing, with rising prevalence of multimorbidity (more than two co-existing chronic conditions) that will significantly increase pressure on already stretched health systems. We assess the impact of NCD multimorbidity on healthcare utilisation and out-of-pocket expenditures in six middle-income countries: China, Ghana, India, Mexico, Russia and South Africa. Methods Secondary analyses of cross-sectional data from adult participants (>18 years) in the WHO Study on Global Ageing and Adult Health (SAGE) 2007-2010. We used multiple logistic regression to determine socio-demographic correlates of multimorbidity. Association between the number of NCDs and healthcare utilisation as well as out-of-pocket spending was assessed using logistic, negative binominal and log-linear models. Results The prevalence of multimorbidity in the adult population varied from 3.9% in Ghana to 33.6% in Russia. Number of visits to doctors in primary and secondary care rose substantially for persons with increasing numbers of co-existing NCDs. Multimorbidity was associated with more outpatient visits in China (coefficient for number of NCD = 0.56, 95% CI = 0.46, 0.66), a higher likelihood of being hospitalised in India (AOR = 1.59, 95% CI = 1.45, 1.75), higher out-of-pocket expenditures for outpatient visits in India and China, and higher expenditures for hospital visits in Russia. Medicines constituted the largest proportion of out-of-pocket expenditures in persons with multimorbidity (88.3% for outpatient, 55.9% for inpatient visit in China) in most countries. Conclusion Multimorbidity is associated with higher levels of healthcare utilisation and greater financial burden for individuals in middle-income countries. Our study supports the WHO call for universal health insurance and health service coverage in LMICs, particularly for vulnerable groups such as the elderly with multimorbidity.	[Lee, John Tayu; Hamid, Fozia; Millett, Christopher] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London, England; [Pati, Sanghamitra] Publ Hlth Fdn India, Indian Inst Publ Hlth, Bhubaneswar, Orissa, India; [Atun, Rifat] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Millett, Christopher] Publ Hlth Fdn India, Gurgaon, India	Imperial College London; Public Health Foundation of India; Harvard University; Harvard T.H. Chan School of Public Health; Public Health Foundation of India	Lee, JT (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London, England.	t.lee@imperial.ac.uk	Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983; Millett, Christopher/0000-0002-0793-9884; Lee, John Tayu/0000-0002-1551-4923	Higher Education Funding Council for England; National Institute for Health Research; Wellcome Trust [084674/Z/08/Z]; National Institute for Health Research [IPF-12-05] Funding Source: researchfish	Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	CM is funded by the Higher Education Funding Council for England and the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care scheme. The South Asia Network for Chronic Disease (CM) is supported by a Wellcome Trust strategic award 084674/Z/08/Z. Funding sources had no role in the design of the study, analysis, interpretation of the results or writing of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Akbari A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005471.pub2; [Anonymous], WHO GLOBAL HEALTH OB; Atun R., 2014, LANCET; Atun R, 2013, LANCET, V381, P690, DOI 10.1016/S0140-6736(13)60063-X; Atun R, 2012, LANCET, V380, P2044, DOI 10.1016/S0140-6736(12)61460-3; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Barton P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4044; Basu S, 2013, HYPERTENSION, V62, P18, DOI 10.1161/HYPERTENSIONAHA.113.01374; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Blank L, 2014, REFERRAL INTERVENTIO, V2014, pe765; Chandra A, 2010, AM ECON REV, V100, P193, DOI 10.1257/aer.100.1.193; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Ebrahim S, 2005, INT J EPIDEMIOL, V34, P961, DOI 10.1093/ije/dyi188; Ebrahim S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001377; FARRAR DE, 1967, REV ECON STAT, V49, P92, DOI 10.2307/1937887; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Frenk J, 2006, LANCET, V368, P1524, DOI 10.1016/S0140-6736(06)69564-0; Garcia-Diaz R, 2011, J HEALTH ECON, V30, P707, DOI 10.1016/j.jhealeco.2011.04.003; Glynn LG, 2011, FAM PRACT, V28, P516, DOI 10.1093/fampra/cmr013; Goldman DP, 2007, JAMA-J AM MED ASSOC, V298, P61, DOI 10.1001/jama.298.1.61; Goldman N, 2003, J CLIN EPIDEMIOL, V56, P148, DOI 10.1016/S0895-4356(02)00580-2; Guthrie B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6341; Hogerzeil HV, 2013, LANCET, V381, P680, DOI 10.1016/S0140-6736(12)62128-X; Hosseinpoor AR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-474; Howitt P, 2012, LANCET, V380, P507, DOI 10.1016/S0140-6736(12)61127-1; Hwang W, 2001, HEALTH AFFAIR, V20, P267, DOI 10.1377/hlthaff.20.6.267; Iezzoni LI, 2010, HEALTH SERV RES, V45, P1523, DOI 10.1111/j.1475-6773.2010.01145.x; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Kowal P, AGEING AND ADULT HEA; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Lagomarsino G, 2012, LANCET, V380, P933, DOI 10.1016/S0140-6736(12)61147-7; Lee JT, 2012, LANCET, V380, P1643, DOI 10.1016/S0140-6736(12)61941-2; Lehnert T, 2011, MED CARE RES REV, V68, P387, DOI 10.1177/1077558711399580; Li Y, 2012, B WORLD HEALTH ORGAN, V90, P664, DOI 10.2471/BLT.12.102178; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Maimaris W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001490; Marengoni A, 2008, AM J PUBLIC HEALTH, V98, P1198, DOI 10.2105/AJPH.2007.121137; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Moreno-Serra R, 2012, LANCET, V380, P917, DOI 10.1016/S0140-6736(12)61039-3; Moreno-Serra R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001087; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Niens LM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000333; Paez KA, 2009, HEALTH AFFAIR, V28, P15, DOI 10.1377/hlthaff.28.1.15; Payne RA, 2013, CAN MED ASSOC J, V185, pE221, DOI 10.1503/cmaj.121349; Raina P, 2002, HEALTH SERV RES, V37, P751, DOI 10.1111/1475-6773.00047; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Roland M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2510; Sachs JD, 2012, LANCET, V380, P944, DOI 10.1016/S0140-6736(12)61149-0; Salive ME, 2013, EPIDEMIOL REV, V35, P75, DOI 10.1093/epirev/mxs009; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Trivedi AN, 2010, NEW ENGL J MED, V362, P320, DOI 10.1056/NEJMsa0904533; Vellakkal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068219; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Ward BW, 2010, PREV CHRONIC DIS, V10, pE65, DOI DOI 10.5888/PCD10.120203; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; World Health Organization, WHO GLOBAL STATUS RE; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Yip W, 2009, SOC SCI MED, V68, P201, DOI 10.1016/j.socscimed.2008.09.066; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1	63	117	119	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0127199	10.1371/journal.pone.0127199	http://dx.doi.org/10.1371/journal.pone.0127199			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26154083	Green Published, gold			2022-12-27	WOS:000358159700003
J	Miao, CL; Bao, MH; Xing, AJ; Chen, SH; Wu, YT; Cai, J; Chen, YR; Yang, XC				Miao, Congliang; Bao, Minghui; Xing, Aijun; Chen, Shuohua; Wu, Yuntao; Cai, Jun; Chen, Youren; Yang, Xinchun			Cardiovascular Health Score and the Risk of Cardiovascular Diseases	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEYS; C-REACTIVE PROTEIN; NATIONAL-HEALTH; HEART-RATE; URIC-ACID; PREVALENCE; EVENTS; STROKE; ADULTS; DEATH	In 2010 the American Heart Association proposed a definition of ideal health behaviors and health factors to measure cardiovascular health, from which Huffman et al. created the Cardiovascular Health Score (CVH score) to estimate these metrics on an individual level. We performed a prospective cohort study among employees of the Kailuan Group Corporation, who underwent a physical examination in 2006-2007 to investigate the relationship between the CVH score and the risk of cardiovascular disease (CVD). A total of 91,598 individuals free of stroke and myocardial infarction at baseline were included in the final analysis. We calculated baseline CVH score for each metric (poor=0, intermediate=1, ideal=2 points; range=0-14 points for all seven metrics) and categorized them into three groups: inadequate (0-4 points), average (5-9 points), and optimum (10-14 points). Incidence of total number of CVD events, myocardial infarction, and stroke was analyzed among these three groups and each incremental point on the CVH score. During an average 6.81 years of follow-up, there were 3276 CVD events, 2579 strokes and 747 myocardial infarction occurred. After adjusting for several confounding factors, each better health category of the CVH score was associated with reduced odds of 47% for all CVD events, and each point higher on the CVH score was associated with reduced odds of 18%. Similar trends were detected in the risks for myocardial infarction and stroke. A higher CVH score is therefore a protective factor for CVD, myocardial infarction, and stroke.	[Miao, Congliang; Chen, Youren] Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Cardiol, Shantou, Guangdong, Peoples R China; [Bao, Minghui; Cai, Jun; Yang, Xinchun] Capital Med Univ, Chaoyang Hosp, Dept Cardiol, Beijing, Peoples R China; [Xing, Aijun; Chen, Shuohua; Wu, Yuntao] Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China	Shantou University; Capital Medical University; North China University of Science & Technology	Chen, YR (corresponding author), Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Cardiol, Shantou, Guangdong, Peoples R China.	13902779840@139.com; bmh891219@sina.com			National Natural Science Foundation of China [81270346]; Projects of Science and Technology Plans of Guangdong Province [2009B030801310]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Projects of Science and Technology Plans of Guangdong Province	This work is supported by grants from the National Natural Science Foundation of China (No. 81270346; URLs: (http://www.nsfc.gov.cn/); YX received the funding), and the Projects of Science and Technology Plans of Guangdong Province (No. 2009B030801310; URLs: (http://pro.gdstc.gov.cn/egrantweb/); CY received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, Stroke, V20, P1407; Bambs C, 2011, CIRCULATION, V123, P850, DOI 10.1161/CIRCULATIONAHA.110.980151; Chien KL, 2005, ATHEROSCLEROSIS, V183, P147, DOI 10.1016/j.atherosclerosis.2005.01.018; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Dong CH, 2012, CIRCULATION, V125, P2975, DOI 10.1161/CIRCULATIONAHA.111.081083; Du SF, 2014, AM J CLIN NUTR, V99, P334, DOI 10.3945/ajcn.113.059121; Fang J, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.005371; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Folsom AR, 2011, J AM COLL CARDIOL, V57, P1690, DOI 10.1016/j.jacc.2010.11.041; Ford ES, 2012, CIRCULATION, V125, P987, DOI 10.1161/CIRCULATIONAHA.111.049122; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Huffman MD, 2012, CIRCULATION, V125, P2595, DOI 10.1161/CIRCULATIONAHA.111.070722; Inoue T, 2012, CLIN EXP NEPHROL, V16, P938, DOI 10.1007/s10157-012-0641-3; Jacqueline I, 2013, J AM HEART ASSOC, V2, DOI [10.1161/JAHA.113.000058, DOI 10.1161/JAHA.113.000058]; Kochanek K, 2011, NATL VITAL STAT REP, V59, P1; Kulshreshtha A, 2013, STROKE, V44, P1909, DOI 10.1161/STROKEAHA.111.000352; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Mao QX, 2010, INT J EPIDEMIOL, V39, P1638, DOI 10.1093/ije/dyq119; Saito M, 2003, ATHEROSCLEROSIS, V167, P73, DOI 10.1016/S0021-9150(02)00380-5; Shay CM, 2012, CIRCULATION, V125, P45, DOI 10.1161/CIRCULATIONAHA.111.035733; Wu HY, 2013, INT J CARDIOL, V168, P760, DOI 10.1016/j.ijcard.2012.09.235; Wu SL, 2012, CIRC-CARDIOVASC QUAL, V5, P487, DOI 10.1161/CIRCOUTCOMES.111.963694; Wu SL, 2012, INT J CARDIOL, V157, P75, DOI 10.1016/j.ijcard.2010.12.019; Xanthakis V, 2014, CIRCULATION, V130, P1676, DOI 10.1161/CIRCULATIONAHA.114.009273; Zhang Q, 2013, STROKE, V44, P2451, DOI 10.1161/STROKEAHA.113.678839	26	33	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131537	10.1371/journal.pone.0131537	http://dx.doi.org/10.1371/journal.pone.0131537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154254	gold, Green Published, Green Submitted			2022-12-27	WOS:000358159700071
J	Zengin, E; Bickel, C; Schnabel, RB; Zeller, T; Lackner, KJ; Rupprecht, HJ; Blankenberg, S; Westermann, D				Zengin, Elvin; Bickel, Christoph; Schnabel, Renate B.; Zeller, Tanja; Lackner, Karl-J.; Rupprecht, Hans-J.; Blankenberg, Stefan; Westermann, Dirk		Christoph Sinning AtheroGene-Study	Risk Factors of Coronary Artery Disease in Secondary Prevention-Results from the AtheroGene-Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; HEART-DISEASE; MULTIFACTORIAL INTERVENTION; MYOCARDIAL-INFARCTION; LOWER TARGETS; MORTALITY; EVENTS; PREDICTION	Background Risk factors are important in cardiovascular (CV) medicine for risk stratification of patients. We aimed to compare the traditional risk factors to clinical variables for the prediction of secondary cardiovascular events. Methods and Results For this study, 3229 patients with known coronary artery disease (CAD) were included. We calculated whether the traditional risk factors, diabetes mellitus, increased LDL/HDL ratio, arterial hypertension and smoking alone and in combination with the clinical variables, ejection fraction, creatinine clearance, multi-vessel disease and CRP concentration predict the outcome cardiovascular death or non-fatal myocardial infarction (N = 432) during the mean follow-up time of 4.2 +/- 2.0 years. In this cohort diabetes mellitus was the risk factor with the strongest influence regarding occurrence of secondary events (hazard ratio; HR: 1.70, confidence interval; CI 95%: 1.36-2.11; P<0.0001), followed by LDL/HDL ratio and smoking. However, risk stratification is further improved by using additional clinical variables like ejection fraction (HR:3.30 CI 95%: 2.51-4.33; P>0.0001) or calculated creatinine clearence (Cockroft-Gault formula) (HR:2.26 CI 95%: 1.78-2.89; P<0.0001). Further ameliorating risk stratification from the clinical variables were CRP and multi-vessel disease. The most precise risk prediction was achieved when all clinical variables were added to the CV risk factors. Conclusion Diabetes mellitus has the strongest influence to predict secondary cardiovascular events in patients with known CAD. Risk stratification can further be improved by adding CV risk factors and clinical variables together. Control of risk factors is of paramount importance in patients with known CAD, while clinical variables can further enhance prediction of events.	[Zengin, Elvin; Schnabel, Renate B.; Zeller, Tanja; Blankenberg, Stefan; Westermann, Dirk; Christoph Sinning AtheroGene-Study] Univ Heart Ctr Hamburg, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Bickel, Christoph] Fed Armed Forces Cent Hosp Koblenz, Dept Med, Koblenz, Germany; [Lackner, Karl-J.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Clin Chem & Lab Med, D-55122 Mainz, Germany; [Rupprecht, Hans-J.] GPR Klinikum Ruesselsheim, Dept Med 2, Russelsheim, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz	Bickel, C (corresponding author), Fed Armed Forces Cent Hosp Koblenz, Dept Med, Koblenz, Germany.	cbickel@t-online.de	Westermann, Dirk/D-1344-2011; Schnabel, Renate B/ABE-6668-2021	Schnabel, Renate B/0000-0001-7170-9509; Westermann, Dirk/0000-0002-7542-1956; Zeller, Tanja/0000-0003-3379-2641	"Stiftung Rheinland-Pfalz fur Innovation," Ministry of Science and Education, Mainz [AZ 15202-386261/545]; MAIFOR grant of the Johannes Gutenberg-University Mainz, Germany; Fondation de France [2002004994]; French Ministry of Research [ACIIMPBIO 032619]; Institut National de la Sante et de la Recherche Medicale (Programme National de Recherches sur les Maladies Cardiovasculaires) [A04052DS]	"Stiftung Rheinland-Pfalz fur Innovation," Ministry of Science and Education, Mainz; MAIFOR grant of the Johannes Gutenberg-University Mainz, Germany; Fondation de France(Fondation de France); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Institut National de la Sante et de la Recherche Medicale (Programme National de Recherches sur les Maladies Cardiovasculaires)	The AtheroGene study is supported by a grant of the "Stiftung Rheinland-Pfalz fur Innovation," Ministry of Science and Education (AZ 15202-386261/545), Mainz, by the MAIFOR grant 2001 of the Johannes Gutenberg-University Mainz, Germany, and by grants from the Fondation de France (no. 2002004994), the French Ministry of Research (ACIIMPBIO 032619) and the Institut National de la Sante et de la Recherche Medicale (Programme National de Recherches sur les Maladies Cardiovasculaires A04052DS).	Bangalore S, 2011, CIRCULATION, V123, P2799, DOI 10.1161/CIRCULATIONAHA.110.016337; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Blankenberg S, 2006, CIRCULATION, V114, P201, DOI 10.1161/CIRCULATIONAHA.105.590927; Bowker TJ, 1996, HEART, V75, P334, DOI 10.1136/hrt.75.4.334; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Coresh J, 2006, CURR OPIN NEPHROL HY, V15, P276, DOI 10.1097/01.mnh.0000222695.84464.61; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Germano G, 2012, EUR HEART J, V33, P137; Giannuzzi P, 2008, ARCH INTERN MED, V168, P2194, DOI 10.1001/archinte.168.20.2194; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Howard BV, 2008, JAMA-J AM MED ASSOC, V299, P1678, DOI 10.1001/jama.299.14.1678; Kaplan RC, 2002, J CLIN EPIDEMIOL, V55, P654, DOI 10.1016/S0895-4356(02)00405-5; Keller T, 2009, EUR HEART J, V30, P314, DOI 10.1093/eurheartj/ehn598; Kotseva K, 2001, EUR HEART J, V22, P554, DOI 10.1053/euhj.2001.2610; Kotseva K, 2016, EUR J PREV CARDIOL, V23, P636, DOI 10.1177/2047487315569401; Kotseva K, 2009, EUR J CARDIOV PREV R, V16, P121, DOI 10.1097/HJR.0b013e3283294b1d; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Leander K, 2007, EUR J CARDIOV PREV R, V14, P532, DOI 10.1097/HJR.0b013e328012e3cc; Liu Jing, 2009, Zhonghua Yi Xue Za Zhi, V89, P1676; Mehta RH, 2008, EUR HEART J, V29, P3052, DOI 10.1093/eurheartj/ehn478; Mielniczuk LM, 2008, AM HEART J, V155, P725, DOI 10.1016/j.ahj.2007.11.031; Miura K, 2001, ARCH INTERN MED, V161, P1501, DOI 10.1001/archinte.161.12.1501; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Preis SR, 2009, CIRCULATION, V120, P212, DOI 10.1161/CIRCULATIONAHA.108.846519; Prugger C, 2008, EUR J EPIDEMIOL, V23, P731, DOI 10.1007/s10654-008-9291-x; Rosvall M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-189; Russell M, 2006, AM HEART J, V152, P867, DOI 10.1016/j.ahj.2006.05.021; Sabatine MS, 2007, CIRCULATION, V115, P1528, DOI 10.1161/CIRCULATIONAHA.106.649939; Sinning C, 2013, CLIN RES CARDIOL, V102, P495, DOI 10.1007/s00392-013-0555-4; The sixth report of the Joint National Committee, 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005; Turnbull F, 2003, LANCET, V362, P1527; Volzke H, 2007, INT J CARDIOL, V116, P46, DOI 10.1016/j.ijcard.2006.02.008; Wood D, 1997, EUR HEART J, V18, P1569; Wood D, 2001, ATHEROSCLEROSIS SUPP, V2, P3, DOI 10.1016/S1567-5688(00)00003-9; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	42	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131434	10.1371/journal.pone.0131434	http://dx.doi.org/10.1371/journal.pone.0131434			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154343	gold, Green Published, Green Submitted			2022-12-27	WOS:000358159700062
J	Barragan, S; Rueda, C; Fernandez, MA; Peddada, SD				Barragan, Sandra; Rueda, Cristina; Fernandez, Miguel A.; Peddada, Shyamal D.			Determination of Temporal Order among the Components of an Oscillatory System	PLOS ONE			English	Article							CYCLE-REGULATED GENES; CELL-CYCLE; CIRCADIAN CLOCK; FISSION YEAST; EXPRESSION; IDENTIFICATION; PREDICTION; NETWORK; FAMILY; BRAIN	Oscillatory systems in biology are tightly regulated process where the individual components (e.g. genes) express in an orderly manner by virtue of their functions. The temporal order among the components of an oscillatory system may potentially be disrupted for various reasons (e.g. environmental factors). As a result some components of the system may go out of order or even cease to participate in the oscillatory process. In this article, we develop a novel framework to evaluate whether the temporal order is unchanged in different populations (or experimental conditions). We also develop methodology to estimate the order among the components with a suitable notion of "confidence." Using publicly available data on S. pombe, S. cerevisiae and Homo sapiens we discover that the temporal order among the genes cdc18; mik1; hhf1; hta2; fkh2 and klp5 is evolutionarily conserved from yeast to humans.	[Barragan, Sandra; Rueda, Cristina; Fernandez, Miguel A.] Univ Valladolid, Dept Estadist & Invest Operat, Valladolid, Spain; [Peddada, Shyamal D.] NIEHS, Biostat Branch, NIH, Res Triangle Pk, NC 27709 USA	Universidad de Valladolid; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Peddada, SD (corresponding author), NIEHS, Biostat Branch, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	peddada@niehs.nih.gov	Fernández, Miguel/I-2874-2015	Fernández, Miguel/0000-0002-1272-8950; Peddada, Shyamal/0000-0002-5014-6513; Rueda Sabater, Cristina/0000-0001-9179-3154	Spanish Ministerio de Ciencia e Innovacion [MTM2012-37129]; Junta de Castilla y Leon, Consejeria de Educacion; European Social Fund within the Programa Operativo Castilla y Leon; Intramural Research Program of the National Institute of Environmental Health Sciences [Z01 ES101744-04]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101744, Z01ES101744] Funding Source: NIH RePORTER	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Castilla y Leon, Consejeria de Educacion(Junta de Castilla y Leon); European Social Fund within the Programa Operativo Castilla y Leon; Intramural Research Program of the National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The research of SB, MAF and CR was funded by the Spanish Ministerio de Ciencia e Innovacion grant (MTM2012-37129). SB was also funded by the Junta de Castilla y Leon, Consejeria de Educacion and the European Social Fund within the Programa Operativo Castilla y Leon 2007-2013. The research of SDP was supported by the Intramural Research Program of the National Institute of Environmental Health Sciences (Z01 ES101744-04).	Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Baayen C, 2012, J MOTOR BEHAV, V44, P351, DOI 10.1080/00222895.2012.709549; Bahler J, 2005, ANNU REV GENET, V39, P69, DOI 10.1146/annurev.genet.39.110304.095808; BARTHOLDI J, 1989, SOC CHOICE WELFARE, V6, P157, DOI 10.1007/BF00303169; Borda JC, 1781, MEMORIE ELECTIONS SC; Bushel PR, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-93; Caretta-Cartozo C, 2007, PLOS COMPUT BIOL, V3, P968, DOI 10.1371/journal.pcbi.0030103; Cermakian N, 2011, J BIOL RHYTHM, V26, P160, DOI 10.1177/0748730410395732; CHARTRAND G, 1993, J GRAPH THEOR, V17, P509, DOI 10.1002/jgt.3190170408; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu LH, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-56; Condorcet J.-A.-N.d.C, 1785, ESSAI APPL ANAL PROB; de Lichtenberg U, 2005, YEAST, V22, P1191, DOI 10.1002/yea.1302; de Lichtenberg U, 2005, BIOINFORMATICS, V21, P1164, DOI 10.1093/bioinformatics/bti093; DIACONIS P, 1977, J ROY STAT SOC B MET, V39, P262, DOI 10.1111/j.2517-6161.1977.tb01624.x; Dwork C., 2001, P 10 INT C WORLD WID, P613, DOI DOI 10.1145/371920.372165; Fernandez MA, 2012, NUCLEIC ACIDS RES, V40, P2823, DOI 10.1093/nar/gkr1077; Fisher NI, 1995, STAT ANAL CIRCULAR D; Forsburg SL, 1999, TRENDS GENET, V15, P340, DOI 10.1016/S0168-9525(99)01798-9; Forsburg Susan L, 2005, Gravit Space Biol Bull, V18, P3; Gauthier NP, 2008, NUCLEIC ACIDS RES, V36, pD854, DOI 10.1093/nar/gkm729; Grosheva I, 2001, J CELL SCI, V114, P695; Hahsler M, 2011, TRAVELING SALESPERSO; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Jensen LJ, 2006, NATURE, V443, P594, DOI 10.1038/nature05186; Karp RM, 1972, COMPLEXITY COMPUTER; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Lawler EL, 1985, TRAVELING SALEMAN PR; Lehmann R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-133; Liu DL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-87; Liu DL, 2004, P NATL ACAD SCI USA, V101, P7240, DOI 10.1073/pnas.0402285101; Mardia KV, 2000, DIRECTIONAL STAT; McDowall MD, 2009, NUCLEIC ACIDS RES, V37, pD651, DOI 10.1093/nar/gkn870; Moller-Levet CS, 2013, P NATL ACAD SCI USA, V110, pE1132, DOI 10.1073/pnas.1217154110; Oliva A, 2005, PLOS BIOL, V3, P1239, DOI 10.1371/journal.pbio.0030225; Papadimitriou C.H., 1998, COMBINATORIAL OPTIMI, VUnabridged edition; Peng X, 2005, MOL BIOL CELL, V16, P1026, DOI 10.1091/mbc.E04-04-0299; Pihur V, 2007, BIOINFORMATICS, V23, P1607, DOI 10.1093/bioinformatics/btm158; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Reinelt G., 1994, TRAVELING SALESMAN C; Roux AE, 2010, J GERONTOL A-BIOL, V65, P1, DOI 10.1093/gerona/glp152; Rueda C, 2009, J AM STAT ASSOC, V104, P338, DOI 10.1198/jasa.2009.0120; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; SARDET C, 1995, P NATL ACAD SCI USA, V92, P2403, DOI 10.1073/pnas.92.6.2403; Schalekamp F., 2009, P 11 WORKSH ALG ENG, P38, DOI DOI 10.1137/1.9781611972894.4; Scott MS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-239; Slavov N, 2012, MOL BIOL CELL, V23, P1986, DOI 10.1091/mbc.E11-11-0961; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stokes M., 2007, EVOLUTIONARY PSYCHOL, V5, P453; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Xiao EN, 1998, J CLIN ENDOCR METAB, V83, P2454, DOI 10.1210/jc.83.7.2454	54	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0124842	10.1371/journal.pone.0124842	http://dx.doi.org/10.1371/journal.pone.0124842			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151635	Green Published, Green Submitted, gold			2022-12-27	WOS:000358158900002
J	Fu, JJ; Chu, XT; Sun, YF; Miao, YJ; Xu, YF; Hu, TM				Fu, Juanjuan; Chu, Xitong; Sun, Yongfang; Miao, Yanjun; Xu, Yuefei; Hu, Tianming			Nitric Oxide Mediates 5-Aminolevulinic Acid-Induced Antioxidant Defense in Leaves of Elymus nutans Griseb. Exposed to Chilling Stress	PLOS ONE			English	Article							SPINACH SPINACIA-OLERACEA; INDUCED OXIDATIVE DAMAGE; MEMBRANE H+-ATPASE; HEAT-STRESS; HYDROGEN-PEROXIDE; ABSCISIC-ACID; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; ENZYME-ACTIVITY; SALICYLIC-ACID	Nitric oxide (NO) and 5-aminolevulinic acid (ALA) are both extremely important signalling molecules employed by plants to control many aspects of physiology. In the present study, the role of NO in ALA-induced antioxidant defense in leaves of two sources of Elymus nutans Griseb. (Damxung, DX and Zhengdao, ZD) was investigated. Chilling stress enhanced electrolyte leakage, accumulation of malondialdehyde (MDA), hydrogen peroxide (H2O2) and superoxide radical in two E. nutans, which were substantially alleviated by exogenous ALA and NO application. Pretreatment with NO scavenger PTIO or NOS inhibitor L-NNA alone and in combination with ALA induced enhancements in electrolyte leakage and the accumulation of MDA, H2O2 and superoxide radical in leaves of DX and ZD exposed to chilling stress, indicating that the inhibition of NO biosynthesis reduced the chilling resistance of E. nutans and the ALA-enhanced chilling resistance. Further analyses showed that ALA and NO enhanced antioxidant defense and activated plasma membrane (PM) H+-ATPase and decreased the accumulation of ROS induced by chilling stress. A pronounced increase in nitric oxide synthase (NOS) activity and NO release by exogenous ALA treatment was found in chilling-resistant DX plants exposed to chilling stress, while only a little increase was observed in chilling-sensitive ZD. Furthermore, inhibition of NO accumulation by PTIO or L-NNA blocked the protective effect of exogenous ALA, while both exogenous NO treatment and inhibition of endogenous NO accumulation did not induce ALA production. These results suggested that NO might be a downstream signal mediating ALA-induced chilling resistance in E. nutans.	[Fu, Juanjuan; Chu, Xitong; Sun, Yongfang; Xu, Yuefei; Hu, Tianming] Northwest A&F Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Yangling, Shaanxi, Peoples R China; [Miao, Yanjun] Tibet Agr & Anim Husb Coll, Coll Plant Sci, Linzhi 860000, Tibet, Peoples R China	Northwest A&F University - China; Tibet Agriculture & Animal Husbandry University	Xu, YF (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Yangling, Shaanxi, Peoples R China.	xuyuefei1980@163.com; hutianming@126.com		Fu, Juanjuan/0000-0001-8178-6698	National Natural Science Foundation of China [31402129]; Northwest A&F University Fundamental Research Special Fund [QN2011100]; Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period [2011BAD17B05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northwest A&F University Fundamental Research Special Fund; Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period	This work was supported by the National Natural Science Foundation of China (No. 31402129), Northwest A&F University Fundamental Research Special Fund (No. QN2011100), and Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period (No. 2011BAD17B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 1999, PHYSIOL PLANTARUM, V106, P35, DOI 10.1034/j.1399-3054.1999.106105.x; Akram NA, 2013, J PLANT GROWTH REGUL, V32, P663, DOI 10.1007/s00344-013-9325-9; Ali B, 2013, ECOTOX ENVIRON SAFE, V92, P271, DOI 10.1016/j.ecoenv.2013.02.006; Arasimowicz-Jelonek M, 2009, PLANT SCI, V177, P682, DOI 10.1016/j.plantsci.2009.09.007; Aroca R, 2001, PLANT SCI, V161, P719, DOI 10.1016/S0168-9452(01)00460-5; Bai XG, 2012, FREE RADICAL BIO MED, V53, P710, DOI 10.1016/j.freeradbiomed.2012.05.042; Balestrasse KB, 2010, PHYTOCHEMISTRY, V71, P2038, DOI 10.1016/j.phytochem.2010.07.012; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Bhyan SB, 2012, J PLANT PHYSIOL, V169, P137, DOI 10.1016/j.jplph.2011.08.004; Bindu RC, 1998, PLANT GROWTH REGUL, V26, P15, DOI 10.1023/A:1006098005335; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAKMAK I, 1992, PLANT PHYSIOL, V98, P1222, DOI 10.1104/pp.98.4.1222; Corpas FJ, 2009, NEW PHYTOL, V184, P9, DOI 10.1111/j.1469-8137.2009.02989.x; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Erdal S, 2011, BIOL TRACE ELEM RES, V143, P500, DOI 10.1007/s12011-010-8857-0; Fadzillah NM, 1996, PLANTA, V199, P552, DOI 10.1007/BF00195186; Farooq M, 2008, J AGRON CROP SCI, V194, P350, DOI 10.1111/j.1439-037X.2008.00322.x; Fu JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107152; HAMPP R, 1975, PHYSIOL PLANTARUM, V33, P53, DOI 10.1111/j.1399-3054.1975.tb03764.x; HAREL E, 1972, BIOCHEM BIOPH RES CO, V49, P364, DOI 10.1016/0006-291X(72)90419-6; HAYAT S, 2007, ROLE SALICYLIC ACID, P91; Janda T, 1999, PLANTA, V208, P175, DOI 10.1007/s004250050547; Janicka-Russak M, 2012, J PLANT RES, V125, P291, DOI 10.1007/s10265-011-0438-6; KAMPFENKEL K, 1995, ANAL BIOCHEM, V225, P165, DOI 10.1006/abio.1995.1127; Kang HM, 2002, PHYSIOL PLANTARUM, V115, P571, DOI 10.1034/j.1399-3054.2002.1150411.x; Khan MN, 2012, NITRIC OXIDE-BIOL CH, V27, P210, DOI 10.1016/j.niox.2012.07.005; Kim HS, 2013, J PLANT PHYSIOL, V170, P828, DOI 10.1016/j.jplph.2013.01.007; Kong WW, 2012, FUNGAL GENET BIOL, V49, P15, DOI 10.1016/j.fgb.2011.12.003; Korkmaz A, 2010, ENVIRON EXP BOT, V67, P495, DOI 10.1016/j.envexpbot.2009.07.009; Lamotte O, 2005, PLANTA, V221, P1, DOI 10.1007/s00425-005-1494-8; LAW MY, 1983, BIOCHEM J, V210, P899, DOI 10.1042/bj2100899; Liu D, 2011, J AGRON CROP SCI, V197, P284, DOI 10.1111/j.1439-037X.2011.00465.x; Liu YJ, 2011, J PLANT PHYSIOL, V168, P853, DOI 10.1016/j.jplph.2010.09.020; Liu ZJ, 2010, J PLANT GROWTH REGUL, V29, P171, DOI 10.1007/s00344-009-9121-8; Ma FF, 2012, J EXP BOT, V63, P4835, DOI 10.1093/jxb/ers161; Memon SA, 2009, ACTA PHYSIOL PLANT, V31, P51, DOI 10.1007/s11738-008-0198-7; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MURPHY ME, 1994, METHOD ENZYMOL, V233, P240; Naeem MS, 2011, ACTA PHYSIOL PLANT, V33, P517, DOI 10.1007/s11738-010-0575-x; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nishihara E, 2003, J PLANT PHYSIOL, V160, P1085, DOI 10.1078/0176-1617-00991; Nunez M, 2003, BIOL PLANTARUM, V47, P67, DOI 10.1023/A:1027380831429; PALMGREN MG, 1990, PLANT PHYSIOL, V92, P871, DOI 10.1104/pp.92.4.871; REBEIZ CA, 1984, ENZYME MICROB TECH, V6, P390, DOI 10.1016/0141-0229(84)90012-7; Santa-Cruz DM, 2010, PHYTOCHEMISTRY, V71, P1700, DOI 10.1016/j.phytochem.2010.07.009; Schaedle M, 1997, PLANT PHYSIOL, V59, P1011, DOI DOI 10.1104/PP.59.5.1011; Song LL, 2006, PLANT SCI, V171, P449, DOI 10.1016/j.plantsci.2006.05.002; Sun YP, 2009, PHOTOSYNTHETICA, V47, P347, DOI 10.1007/s11099-009-0055-y; Tartoura KAH, 2011, SCI HORTIC-AMSTERDAM, V130, P862, DOI 10.1016/j.scienta.2011.08.015; Vital SA, 2008, ENVIRON EXP BOT, V62, P60, DOI 10.1016/j.envexpbot.2007.07.006; Wendehenne D, 2001, TRENDS PLANT SCI, V6, P177, DOI 10.1016/S1360-1385(01)01893-3; Xu MJ, 2012, POSTHARVEST BIOL TEC, V65, P5, DOI 10.1016/j.postharvbio.2011.10.008; Xu S, 2006, ENVIRON EXP BOT, V56, P274, DOI 10.1016/j.envexpbot.2005.03.002; Xu YF, 2010, J PLANT PHYSIOL, V167, P512, DOI 10.1016/j.jplph.2009.10.010; Yu CW, 2003, FUNCT PLANT BIOL, V30, P955, DOI 10.1071/FP03091; Zhang AY, 2007, NEW PHYTOL, V175, P36, DOI 10.1111/j.1469-8137.2007.02071.x; Zhang AY, 2011, PLANT CELL PHYSIOL, V52, P181, DOI 10.1093/pcp/pcq187; Zhang J, 2012, BIOL PLANTARUM, V56, P780, DOI 10.1007/s10535-012-0136-9; Zhang LG, 2009, J PLANT BIOL, V52, P135, DOI 10.1007/s12374-009-9013-2; Zhang WF, 2008, J PLANT GROWTH REGUL, V27, P159, DOI 10.1007/s00344-008-9042-y; Zhang YK, 2009, SCI HORTIC-AMSTERDAM, V123, P217, DOI 10.1016/j.scienta.2009.08.015; Zhao L, 2008, J PLANT PHYSIOL, V165, P182, DOI 10.1016/j.jplph.2007.03.002; Zhou WJ, 1999, PLANT GROWTH REGUL, V27, P99, DOI 10.1023/A:1006165603300	63	12	15	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0130367	10.1371/journal.pone.0130367	http://dx.doi.org/10.1371/journal.pone.0130367			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151364	Green Published, Green Submitted, gold			2022-12-27	WOS:000358158900009
J	Xiao, NC; Cai, SS; Moritz, M; Garabed, R; Pomeroy, LW				Xiao, Ningchuan; Cai, Shanshan; Moritz, Mark; Garabed, Rebecca; Pomeroy, Laura W.			Spatial and Temporal Characteristics of Pastoral Mobility in the Far North Region, Cameroon: Data Analysis and Modeling	PLOS ONE			English	Article							MOUTH-DISEASE; SPACE-TIME; TRANSMISSION; MOVEMENTS; ACCESSIBILITY; EPIDEMIOLOGY; TRANSHUMANCE; OUTBREAKS; SPREAD; RISK	Modeling the movements of humans and animals is critical to understanding the transmission of infectious diseases in complex social and ecological systems. In this paper, we focus on the movements of pastoralists in the Far North Region of Cameroon, who follow an annual transhumance by moving between rainy and dry season pastures. Describing, summarizing, and modeling the transhumance movements in the region are important steps for understanding the role these movements may play in the transmission of infectious diseases affecting humans and animals. We collected data on this transhumance system for four years using a combination of surveys and GPS mapping. An analysis on the spatial and temporal characteristics of pastoral mobility suggests four transhumance modes, each with its own properties. Modes M1 and M2 represent the type of transhumance movements where pastoralists settle in a campsite for a relatively long period of time (>= 20 days) and then move around the area without specific directions within a seasonal grazing area. Modes M3 and M4 on the other hand are the situations when pastoralists stay in a campsite for a relatively short period of time (<20 days) when moving between seasonal grazing areas. These four modes are used to develop a spatial-temporal mobility (STM) model that can be used to estimate the probability of a mobile pastoralist residing at a location at any time. We compare the STM model with two reference models and the experiments suggest that the STM model can effectively capture and predict the space-time dynamics of pastoral mobility in our study area.	[Xiao, Ningchuan] Ohio State Univ, Dept Geog, Columbus, OH 43210 USA; [Cai, Shanshan] Nipissing Univ, Dept Geog, North Bay, ON, Canada; [Moritz, Mark] Ohio State Univ, Dept Anthropol, Columbus, OH 43210 USA; [Moritz, Mark] NIAS, Wassenaar, Netherlands; [Garabed, Rebecca; Pomeroy, Laura W.] Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nipissing University; University System of Ohio; Ohio State University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Advanced Study in the Humanities & Social Sciences (NIAS-KNAW); University System of Ohio; Ohio State University	Xiao, NC (corresponding author), Ohio State Univ, Dept Geog, Columbus, OH 43210 USA.	xiao.37@osu.edu	Moritz, Mark/X-4052-2019	Moritz, Mark/0000-0003-0644-0069; Garabed, Rebecca/0000-0002-8964-3576	National Science Foundation [BCS-0748594, DEB-1015908]; National Geographic Society [8306-07]; Ohio State University; Centre d'Appuia la Recherche et au Pastoralisme; Division Of Environmental Biology [1015908] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); Ohio State University(Ohio State University); Centre d'Appuia la Recherche et au Pastoralisme; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The research presented in this paper has been supported by the National Science Foundation (BCS-0748594, DEB-1015908), the National Geographic Society (8306-07), and the Ohio State University. We would like to thank pastoralists in Cameroon for participating in this study, the Centre d'Appuia la Recherche et au Pastoralisme for research support, and the Ministry of Scientific Research and Innovation, the Garoua Wildlife College, and the Higher Institute of the Sahel at the University of Maroua for granting research permission and research affiliation (2008-2013).	Adriansen HK, 2002, HUM ECOL, V30, P215, DOI 10.1023/A:1015692730088; Aidaros HA, 2002, REV SCI TECH OIE, V21, P451, DOI 10.20506/rst.21.3.1348; Anderson D. M., 2013, POSITIONING, V4, P115, DOI [10.4236/pos.2013.41012, DOI 10.4236/POS.2013.41012]; Aune K, 2012, J WILDLIFE MANAGE, V76, P253, DOI 10.1002/jwmg.274; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Barth F, 1961, NOMADS OF SOUTH PERS; Bassett TJ, 2007, HUM ECOL, V35, P33, DOI 10.1007/s10745-006-9067-4; Behnke RH, 2011, ANIMAL MIGRATION: A SYNTHESIS, P144; Boutrais J, 1996, HAUTES TERRES D ELEV; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Bronsvoort BMD, 2004, PREV VET MED, V66, P127, DOI 10.1016/j.prevetmed.2004.09.010; Brottem L, 2014, HUM ECOL, V42, P351, DOI 10.1007/s10745-014-9640-1; Brown CT, 2007, HUM ECOL, V35, P129, DOI 10.1007/s10745-006-9083-4; Butt B, 2010, J ARID ENVIRON, V74, P403, DOI 10.1016/j.jaridenv.2009.09.025; Chevalier V, 2004, MED VET ENTOMOL, V18, P247, DOI 10.1111/j.0269-283X.2004.00511.x; Cho Eunjoon, 2011, KDD, P1082, DOI [10.1145/2020408.2020579, DOI 10.1145/2020408.2020579]; Coppolillo PB, 2000, HUM ECOL, V28, P527, DOI 10.1023/A:1026435714109; COUGHENOUR MB, 1985, SCIENCE, V230, P619, DOI 10.1126/science.230.4726.619; Dalziel BD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0763; DEBOER WF, 1989, HUM ECOL, V17, P445, DOI 10.1007/BF00889500; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Downs JA, 2010, LECT NOTES COMPUT SC, V6292, P16, DOI 10.1007/978-3-642-15300-6_2; ELLIS JE, 1988, J RANGE MANAGE, V41, P450, DOI 10.2307/3899515; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Fraley C, 2012, MCLUST VERSION 4 FOR; Galaty J.G., 2013, DRYLAND AFRICA PASTO, P473; Giere RN, 2004, PHILOS SCI, V71, P742, DOI 10.1086/425063; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Hagerstrand T., 1970, PAPERS REGIONAL SCI, VXXIV, P6, DOI [DOI 10.1007/BF01936872, 10/bkqqfc]; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Jiang B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021136; Keeling M.J., 2008, MODELING INFECT DIS; Kwan MP, 2014, GEOGR ANAL, V46, P297, DOI 10.1111/gean.12040; Kwan MP, 1998, GEOGR ANAL, V30, P191, DOI 10.1111/j.1538-4632.1998.tb00396.x; LEVINS R, 1966, AM SCI, V54, P421; Macpherson CNL, 1995, PREV VET MED, V25, P213, DOI 10.1016/0167-5877(95)00539-0; Mazeri S, 2013, TROP ANIM HEALTH PRO, V45, P617, DOI 10.1007/s11250-012-0268-0; McCabe JT, 2004, CATTLE BRING US TO O; McLachlan G., 2000, WILEY SER PROB STAT; Merler S, 2010, P ROY SOC B-BIOL SCI, V277, P557, DOI 10.1098/rspb.2009.1605; Miller HJ, 2005, GEOGR ANAL, V37, P17, DOI 10.1111/j.1538-4632.2005.00575.x; MILLER HJ, 1991, INT J GEOGR INF SYST, V5, P287, DOI 10.1080/02693799108927856; Moritz M, 2014, CURR ANTHROPOL, V55, P115, DOI 10.1086/674717; Moritz M, 2013, HUM ECOL, V41, P351, DOI 10.1007/s10745-012-9550-z; Moritz M, 2010, HUM ECOL, V38, P775, DOI 10.1007/s10745-010-9361-z; Msami HM, 2001, TROP ANIM HEALTH PRO, V33, P21, DOI 10.1023/A:1010377325566; Papoulis A., 2002, PROBABILITY RANDOM V; Perry BD, 2007, VET REC, V160, P238, DOI 10.1136/vr.160.7.238; Peters P. E., 2004, Journal of Agrarian Change, V4, P269, DOI 10.1111/j.1471-0366.2004.00080.x; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Rebaudet S, 2013, J INFECT DIS, V208, pS46, DOI 10.1093/infdis/jit195; Rivas AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039778; Sawyer H, 2009, ECOL APPL, V19, P2016, DOI 10.1890/08-2034.1; Schareika N, 2003, KNOW TO MOVE MOVE TO; Scholte P, 2006, HUM ECOL, V34, P27, DOI 10.1007/s10745-005-9001-1; Seignobos C, 2000, ATLAS PROVINCE EXTRE; Spergser J, 2013, VET MICROBIOL, V164, P299, DOI 10.1016/j.vetmic.2013.02.007; Stenning Derrick, 1957, J ROYAL ANTHR I GREA, V87, P57, DOI DOI 10.2307/2843971; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Tottrup AP, 2012, P ROY SOC B-BIOL SCI, V279, P1008, DOI 10.1098/rspb.2011.1323; Vosloo W, 2002, REV SCI TECH OIE, V21, P437, DOI 10.20506/rst.21.3.1349; Wand MP., 1994, KERNEL SMOOTHING; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112608; Winter S, 2010, INT J GEOGR INF SCI, V24, P1349, DOI 10.1080/13658811003619150; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; WORTON BJ, 1987, ECOL MODEL, V38, P277, DOI 10.1016/0304-3800(87)90101-3; Zhou HX, 2000, ANN TROP MED PARASIT, V94, P715, DOI 10.1080/00034983.2000.11813595	69	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131697	10.1371/journal.pone.0131697	http://dx.doi.org/10.1371/journal.pone.0131697			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151750	Green Published, Green Submitted, gold			2022-12-27	WOS:000358158900023
J	Bradshaw, PL; Colville, JF; Linder, HP				Bradshaw, Peter L.; Colville, Jonathan F.; Linder, H. Peter			Optimising Regionalisation Techniques: Identifying Centres of Endemism in the Extraordinarily Endemic-Rich Cape Floristic Region	PLOS ONE			English	Article							PARSIMONY ANALYSIS; BIOGEOGRAPHICAL REGIONS; COMPOSITIONAL DISSIMILARITY; SPECIES RICHNESS; VASCULAR PLANTS; BETA-DIVERSITY; AREAS; PATTERNS; HISTORY; FLORA	We used a very large dataset (>40% of all species) from the endemic-rich Cape Floristic Region (CFR) to explore the impact of different weighting techniques, coefficients to calculate similarity among the cells, and clustering approaches on biogeographical regionalisation. The results were used to revise the biogeographical subdivision of the CFR. We show that weighted data (down-weighting widespread species), similarity calculated using Kulczinsky's second measure, and clustering using UPGMA resulted in the optimal classification. This maximized the number of endemic species, the number of centres recognized, and operational geographic units assigned to centres of endemism (CoEs). We developed a dendrogram branch order cut-off (BOC) method to locate the optimal cut-off points on the dendrogram to define candidate clusters. Kulczinsky's second measure dendrograms were combined using consensus, identifying areas of conflict which could be due to biotic element overlap or transitional areas. Post-clustering GIS manipulation substantially enhanced the endemic composition and geographic size of candidate CoEs. Although there was broad spatial congruence with previous phytogeographic studies, our techniques allowed for the recovery of additional phytogeographic detail not previously described for the CFR.	[Bradshaw, Peter L.] South African Natl Pk, Pk Planning & Dev Unit, Port Elizabeth, South Africa; [Bradshaw, Peter L.] Nelson Mandela Metropolitan Univ, Dept Bot, Port Elizabeth, South Africa; [Colville, Jonathan F.] South African Natl Biodivers Inst, Kirstenbosch Res Ctr, Cape Town, South Africa; [Colville, Jonathan F.] Univ Cape Town, Dept Stat Sci, Stat Ecol Environm & Conservat, ZA-7700 Rondebosch, South Africa; [Linder, H. Peter] Univ Zurich, Inst Systemat Bot, Zurich, Switzerland	Nelson Mandela University; South African National Biodiversity Institute; University of Cape Town; University of Zurich	Bradshaw, PL (corresponding author), South African Natl Pk, Pk Planning & Dev Unit, Port Elizabeth, South Africa.	peter.bradshaw@nmmu.ac.za	Linder, Hans Peter/F-5316-2010					Adnan M, 2014, GEOCOMPUTATION, P49; ANDERSON S, 1994, Q REV BIOL, V69, P451, DOI 10.1086/418743; Bolus H, 1886, OFFICIAL HDB CAPE GO; BORCHERT R, 1981, BOT GAZ, V142, P394, DOI 10.1086/337238; Born J, 2007, J BIOGEOGR, V34, P147, DOI 10.1111/j.1365-2699.2006.01595.x; Bradshaw P., 2009, ENDEMISM RICHNESS CA; Brooks DR, 2003, J BIOGEOGR, V30, P819, DOI 10.1046/j.1365-2699.2003.00848.x; Cabrera A, 1973, BIOGEOGRAFIA AM LATI, V13; Carine MA, 2009, J BIOGEOGR, V36, P593, DOI 10.1111/j.1365-2699.2008.02016.x; Casado MA, 1997, PLANT ECOL, V131, P193, DOI 10.1023/A:1009788022662; Cavieres LA, 2002, BIODIVERS CONSERV, V11, P1301, DOI 10.1023/A:1016001714358; Cowling R. M., 2005, Plant diversity and complexity patterns: local, regional and global dimensions. Proceedings of an International Symposium held at the Royal Danish Academy of Sciences and Letters in Copenhagen, Denmark, 25-28 May, 2003, P273; Cowling R.M., 1992, ECOLOGY FYNBOS NUTR, P62; COWLING RM, 1987, S AFR J SCI, V83, P106; COWLING RM, 1983, J BIOGEOGR, V10, P393, DOI 10.2307/2844748; Cowling RM, 2002, DIVERS DISTRIB, V8, P163, DOI 10.1046/j.1472-4642.2002.00143.x; COWLING RM, 1990, J VEG SCI, V1, P699, DOI 10.2307/3235578; Crisci JV, 2006, AUST SYST BOT, V19, P1, DOI 10.1071/SB05006; Crisp MD, 2001, J BIOGEOGR, V28, P183, DOI 10.1046/j.1365-2699.2001.00524.x; Croizat L, 1965, WEBBIA, V20, P573; CROVELLO TJ, 1981, TAXON, V30, P563, DOI 10.2307/1219938; Juarez HSD, 2009, BIOL J LINN SOC, V97, P373, DOI 10.1111/j.1095-8312.2009.01212.x; Drege JF, 1844, BESONDERE BEIGABE FL, V2; Ebach MC, 2012, ZOOTAXA, P1; Edwards D., 1971, MITTEILUNGEN BOT STA, V10, P501; Escalante T, 2009, BIOL J LINN SOC, V98, P468, DOI 10.1111/j.1095-8312.2009.01293.x; ESRI, 2013, ARCGIS DESKT 10 2; Exell AW, 1974, SERIE BOT, V1, P105; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Fattorini S, 2010, J BIOGEOGR, V37, P1061, DOI 10.1111/j.1365-2699.2009.02252.x; Fayle TM, 2010, ECOL MODEL, V221, P2237, DOI 10.1016/j.ecolmodel.2010.06.013; Finnie TJR, 2007, J BIOGEOGR, V34, P1848, DOI 10.1111/j.1365-2699.2007.01750.x; Furrer R, 2010, SPAM SPARSE MATRIX R; Garzon-Orduna IJ, 2008, J BIOGEOGR, V35, P903, DOI 10.1111/j.1365-2699.2007.01842.x; Germishuizen G., 2003, PLANTS SO AFRICA ANN; Giokas S, 2008, J BIOGEOGR, V35, P893, DOI 10.1111/j.1365-2699.2007.01840.x; GOLDBLATT P, 1978, ANN MO BOT GARD, V65, P369, DOI 10.2307/2398858; Gonzalez-Orozco CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092558; Gonzalez-Orozco CE, 2014, DIVERS DISTRIB, V20, P46, DOI 10.1111/ddi.12129; Gonzalez-Orozco CE, 2013, J BIOGEOGR, V40, P2156, DOI 10.1111/jbi.12153; Good R., 1974, GEOGRAPHY FLOWERING; Gotelli NJ, 2012, OIKOS, V121, P171, DOI 10.1111/j.1600-0706.2011.20301.x; Hand D., 2001, ADAP COMP MACH LEARN; HAROLD AS, 1994, SYST BIOL, V43, P261, DOI 10.2307/2413466; Hazel J, 1977, GEOLOGICAL SOC AM B, V81, P3237; Heikinheimo H, 2007, J BIOGEOGR, V34, P1053, DOI 10.1111/j.1365-2699.2006.01664.x; Hennig C, 2007, DESIGN DISSIMILARITY; Hilton-Taylor C, 1996, RED DATA LIST SO AFR; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; JANSON S, 1981, OECOLOGIA, V49, P371, DOI 10.1007/BF00347601; Jardine N., 1972, Taxonomy, phytogeography and evolution., P381; Jetz W, 2004, ECOL LETT, V7, P1180, DOI 10.1111/j.1461-0248.2004.00678.x; Jurasinski G., 2012, SIMBA COLLECTION FUN; Jurgens N, 1997, BIODIVERS CONSERV, V6, P495, DOI 10.1023/A:1018325026863; Kier G, 2001, BIODIVERS CONSERV, V10, P1513, DOI 10.1023/A:1011812528849; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; KRUGER FJ, 1980, VEGETATIO, V41, P85, DOI 10.1007/BF00121419; Laffan SW, 2013, J BIOGEOGR, V40, P570, DOI 10.1111/jbi.12001; Laffan SW, 2003, J BIOGEOGR, V30, P511, DOI 10.1046/j.1365-2699.2003.00875.x; Latimer AM, 2005, SCIENCE, V309, P1722, DOI 10.1126/science.1115576; Lawson BE, 2010, APPL VEG SCI, V13, P473, DOI 10.1111/j.1654-109X.2010.01085.x; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Levyns M.R., 1964, T ROY SOC S AFR, V37, P85, DOI [10.1080/00359196409519059, DOI 10.1080/00359196409519059]; Linder H. P., 2005, Plant diversity and complexity patterns: local, regional and global dimensions. Proceedings of an International Symposium held at the Royal Danish Academy of Sciences and Letters in Copenhagen, Denmark, 25-28 May, 2003, P229; Linder H. P., 1985, SPECIES SPECIATION, V4, P53; Linder HP, 2012, J BIOGEOGR, V39, P1189, DOI 10.1111/j.1365-2699.2012.02728.x; Linder HP, 2003, BIOL REV, V78, P597, DOI 10.1017/S1464793103006171; Linder HP, 2001, SYST BIOL, V50, P892, DOI 10.1080/106351501753462867; Linder HP, 1998, BOT J LINN SOC, V128, P319; Linder HP, 2001, J BIOGEOGR, V28, P169, DOI 10.1046/j.1365-2699.2001.00527.x; Lopez-Pujol J, 2011, J BIOGEOGR, V38, P1267, DOI 10.1111/j.1365-2699.2011.02504.x; Major J., 1988, ANAL BIOGEOGRAPHY, P117, DOI DOI 10.1007/978-94-009-0435-4; Manning J., 2012, PLANTS GREATER CAPE; Marloth R, 1908, WISSENSCHAFFLICHE ER, P1; Mast AR, 2003, SYST BIOL, V52, P271, DOI 10.1080/10635150390192799; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; Moline PM, 2006, J BIOGEOGR, V33, P47, DOI 10.1111/j.1365-2699.2005.01369.x; MORRONE JJ, 1994, SYST BIOL, V43, P438, DOI 10.2307/2413679; MORRONE JJ, 1995, ANNU REV ECOL SYST, V26, P373, DOI 10.1146/annurev.es.26.110195.002105; Morrone JJ, 2014, J BIOGEOGR, V41, P842, DOI 10.1111/jbi.12251; Mucina L., 2006, VEGETATION S AFRICA, P801; Murguia M, 2003, ANN BOT FENN, V40, P415; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nelson G., 1981, SYSTEMATICS BIOGEORA; Oksanen J., 2017, COMMUNITY ECOLOGY PA; OLIVER EGH, 1983, BOTHALIA, V14, P427, DOI DOI 10.4102/abc.v14i3/4.1189; Peng YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037726; PLATNICK NI, 1992, SYSTEMATICS, ECOLOGY, AND THE BIODIVERSITY CRISIS, P15; R Core Team, 2016, R FDN STAT COMP; Ramdhani S, 2008, J BIOGEOGR, V35, P2258, DOI 10.1111/j.1365-2699.2008.01982.x; RAUP DM, 1979, J PALEONTOL, V53, P1213; Rosen B.R., 1988, P23; Rosen B.R., 1988, P437; Rovito SM, 2004, J BIOGEOGR, V31, P1623, DOI 10.1111/j.1365-2699.2004.01100.x; Rueda M, 2010, J BIOGEOGR, V37, P2067, DOI 10.1111/j.1365-2699.2010.02388.x; Salvador S, 2004, PROC INT C TOOLS ART, P576; Santos CMD, 2005, J BIOGEOGR, V32, P1284, DOI 10.1111/j.1365-2699.2005.01269.x; Sfenthourakis S, 2006, GLOBAL ECOL BIOGEOGR, V15, P39, DOI 10.1111/j.1466-822x.2005.00192.x; SHI GR, 1993, PALAEOGEOGR PALAEOCL, V105, P199, DOI 10.1016/0031-0182(93)90084-V; SIMBERLOFF D, 1978, AM NAT, V112, P713, DOI 10.1086/283313; Simmons MT, 1996, BIODIVERS CONSERV, V5, P551, DOI 10.1007/BF00137609; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; SLINGSBY P, 1985, S AFR J BOT, V51, P30, DOI 10.1016/S0254-6299(16)31698-2; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; STEHLI FG, 1971, SYST ZOOL, V20, P115, DOI 10.2307/2412052; Strahler A.N., 1957, EOS T AM GEOPHYS UN, V38, P913, DOI [DOI 10.1029/TR038I006P00913, 10.1029/TR038i006p00913]; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Szumik CA, 2002, SYST BIOL, V51, P806, DOI 10.1080/10635150290102483; Szumik CA, 2004, SYST BIOL, V53, P968, DOI 10.1080/10635150490888859; Takhtajan AL., 1986, FLORISTIC REGIONS WO; Thuiller W, 2006, ECOGRAPHY, V29, P733, DOI 10.1111/j.0906-7590.2006.04674.x; Tribsch A, 2004, J BIOGEOGR, V31, P747, DOI 10.1111/j.1365-2699.2004.01065.x; Unmack PJ, 2001, J BIOGEOGR, V28, P1053, DOI 10.1046/j.1365-2699.2001.00615.x; van Wyk AE., 2001, REGIONS FLORISTIC EN; Villeger S, 2012, ECOL INDIC, V18, P552, DOI 10.1016/j.ecolind.2012.01.009; Weimarck H., 1941, LUNDS U ARSSKR, V37, P1, DOI DOI 10.1016/J.TREE.2012.10.002; White F., 1978, Monographiae Biologicae, V31, P463; White F., 1983, VEGETATION AFRICA DE, P356; WILLIAMS PH, 1994, P ROY SOC B-BIOL SCI, V256, P67, DOI 10.1098/rspb.1994.0050	120	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132538	10.1371/journal.pone.0132538	http://dx.doi.org/10.1371/journal.pone.0132538			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147438	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000358157600299
J	Fernandez-Bustamante, A; Agazio, A; Wilson, P; Elkins, N; Domaleski, L; He, QB; Baer, KA; Moss, AFD; Wischmeyer, PE; Repine, JE				Fernandez-Bustamante, Ana; Agazio, Amanda; Wilson, Paul; Elkins, Nancy; Domaleski, Luke; He, Qianbin; Baer, Kaily A.; Moss, Angela F. D.; Wischmeyer, Paul E.; Repine, John E.			Brief Glutamine Pretreatment Increases Alveolar Macrophage CD163/Heme Oxygenase-1/p38-MAPK Dephosphorylation Pathway and Decreases Capillary Damage but Not Neutrophil Recruitment in IL-1/LPS-Insufflated Rats	PLOS ONE			English	Article							ACUTE LUNG INJURY; SCAVENGER RECEPTOR CD163; HEME OXYGENASE-1; MURINE MACROPHAGES; EXPERIMENTAL-MODEL; PLASMA GLUTAMINE; EPITHELIAL-CELLS; ACTIVATION; EXPRESSION; INDUCTION	Background Glutamine (GLN) attenuates acute lung injury (ALI) but its effect on alveolar macrophages is unknown. We hypothesized that GLN pretreatment would induce the anti-inflammatory CD163/heme oxygenase (HO)-1/p38-MAPK dephosphorylation pathway in alveolar macrophages and reduce ALI in rats insufflated with interleukin-1 (IL-1) and lipopolysaccharide (LPS). Methods Male Sprague-Dawley rats were randomized to the following groups: GLN-IL-1/LPS-, GLN + IL-1/LPS-, GLN-IL-1/LPS+, and GLN+ IL-1/LPS+. GLN pretreatment was given via gavage (1g/kg L-alanyl-L-glutamine) daily for 2 days. ALI was subsequently induced by insufflating 50ng IL-1 followed by 5mg/kg E. coli LPS. After 24h, bronchoalveolar lavage (BAL) protein, lactate dehydrogenase (LDH) and neutrophil concentrations were analyzed. BAL alveolar macrophage CD163+ expression, HO-1 and p38-MAPK concentrations were measured, as well as alveolar macrophage tumor necrosis factor (TNF)-alpha and interleukin (IL)-10 concentrations. Histology and immunofluorescence studies were also performed. Results Following IL-1/LPS insufflation, GLN pretreated rats had significantly decreased BAL protein and LDH concentrations, but not BAL neutrophil counts, compared to non-GLN pretreated rats. The number of alveolar macrophages and the number of CD163+ macrophages were significantly increased in GLN pretreated IL-1/LPS-insufflated rats compared to non-GLN pretreated, IL-1/LPS-insufflated rats. GLN pretreatment before IL-1/LPS also significantly increased HO-1 concentrations and dephosphorylated p38-MAPK levels but not cytokine levels in alveolar macrophages. Immunofluorescence localized CD163 and HO-1 in alveolar macrophages. Conclusion Short- term GLN pretreatment activates the anti-inflammatory CD163/HO-1/p38-MAPK dephosphorylation pathway of alveolar macrophages and decreases capillary damage but not neutrophil recruitment in IL-1/LPS-insufflated rats.	[Fernandez-Bustamante, Ana; Agazio, Amanda; He, Qianbin; Wischmeyer, Paul E.] Univ Colorado SOM, Dept Anesthesiol, Aurora, CO 80045 USA; [Repine, John E.] Univ Colorado SOM, Dept Med, Aurora, CO USA; [Fernandez-Bustamante, Ana; Agazio, Amanda; Wilson, Paul; Elkins, Nancy; Domaleski, Luke; He, Qianbin; Baer, Kaily A.; Repine, John E.] Univ Colorado SOM, Webb Waring Ctr, Aurora, CO USA; [Moss, Angela F. D.] Univ Colorado SOM, Adult & Child Ctr Hlth Outcomes & Delivery Sci AC, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Fernandez-Bustamante, A (corresponding author), Univ Colorado SOM, Dept Anesthesiol, Aurora, CO 80045 USA.	Ana.Fernandez-Bustamante@ucdenver.edu		Fernandez-Bustamante, Ana/0000-0002-2996-7704; Agazio, Amanda/0000-0003-3344-7901	Foundation for Anesthesia Education and Research clinical/translational mentored research training grant [MRTG-CT_2/15/2012]; Department of Defense award [W81-XWH-11-2-0045]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	Foundation for Anesthesia Education and Research clinical/translational mentored research training grant; Department of Defense award(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	AFB (PI) and JER (mentor) received an award from the Foundation for Anesthesia Education and Research clinical/translational mentored research training grant (MRTG-CT_2/15/2012) (http://faer.org). This work was partially supported by the Department of Defense award W81-XWH-11-2-0045 (JER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akila P, 2012, CLIN CHIM ACTA, V413, P669, DOI 10.1016/j.cca.2012.01.028; An L, 2011, EUR J PHARMACOL, V661, P102, DOI 10.1016/j.ejphar.2011.04.032; Beck-Schimmer B, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-61; Bharucha AE, 2010, CLIN PHARMACOL THER, V87, P187, DOI 10.1038/clpt.2009.221; Boe DM, 2010, ALCOHOL CLIN EXP RES, V34, P1723, DOI 10.1111/j.1530-0277.2010.01259.x; Bordbar A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.21; BOWMAN CM, 1983, INFLAMMATION, V7, P331, DOI 10.1007/BF00916297; Chen HL, 2012, INFLAMMATION, V35, P1087, DOI 10.1007/s10753-011-9415-4; Chien CC, 2012, SHOCK, V38, P549, DOI 10.1097/SHK.0b013e31826b2826; D'Alessio FR, 2012, J IMMUNOL, V189, P2234, DOI 10.4049/jimmunol.1102606; de Oliveira GP, 2014, SHOCK, V41, P222, DOI 10.1097/SHK.0000000000000102; Fernandez-Bustamante A, 2013, INFLAMMATION, V36, P1030, DOI 10.1007/s10753-013-9635-x; Freitas A, 2006, BRIT J PHARMACOL, V149, P345, DOI 10.1038/sj.bjp.0706882; Furst P, 1997, NUTRITION, V13, P731, DOI 10.1016/S0899-9007(97)83035-3; FURST P, 1990, JPEN-PARENTER ENTER, V14, pS118, DOI 10.1177/014860719001400417; Galera SC, 2010, NUTRITION, V26, P375, DOI 10.1016/j.nut.2009.05.013; Geng GQ, 2011, INJURY, V42, P72, DOI 10.1016/j.injury.2009.09.027; Graversen JH, 2012, MOL THER, V20, P1550, DOI 10.1038/mt.2012.103; Hack V, 1997, AM J PHYSIOL-ENDOC M, V272, pE788, DOI 10.1152/ajpendo.1997.272.5.E788; Henderson RB, 2003, BLOOD, V102, P328, DOI 10.1182/blood-2002-10-3228; Heyland D, 2013, NEW ENGL J MED, V368, P1489, DOI 10.1056/NEJMoa1212722; Hou YC, 2013, J NUTR BIOCHEM, V24, P1555, DOI 10.1016/j.jnutbio.2013.01.004; Hu YM, 2014, SHOCK, V41, P115, DOI 10.1097/SHK.0000000000000086; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Ito Y, 2009, BIOGERONTOLOGY, V10, P173, DOI 10.1007/s10522-008-9164-4; Janssen WJ, 2011, AM J RESP CRIT CARE, V184, P547, DOI 10.1164/rccm.201011-1891OC; Johnston LK, 2012, AM J RESP CELL MOL, V47, P417, DOI 10.1165/rcmb.2012-0090OC; Kallweit AR, 2012, JPEN-PARENTER ENTER, V36, P551, DOI 10.1177/0148607112445579; Kwon WY, 2010, BRIT J NUTR, V103, P890, DOI 10.1017/S0007114509992509; Lee TS, 2003, J BIOL CHEM, V278, P19325, DOI 10.1074/jbc.M300498200; LEFF JA, 1994, AM J PHYSIOL, V266, pL2, DOI 10.1152/ajplung.1994.266.1.L2; Li WQ, 2013, INT IMMUNOPHARMACOL, V16, P248, DOI 10.1016/j.intimp.2013.02.022; Ma LY, 2012, NUTRITION, V28, P1186, DOI 10.1016/j.nut.2012.04.001; Marwood S, 2011, RESP PHYSIOL NEUROBI, V177, P41, DOI 10.1016/j.resp.2011.03.010; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murphy C, 1998, CLIN SCI, V95, P397, DOI 10.1042/CS19980194; Newsholme F, 1999, J NUTR BIOCHEM, V10, P316; NEWSHOLME P, 1986, BIOCHEM J, V239, P121, DOI 10.1042/bj2390121; Niederlechner S, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-88; PARRYBILLINGS M, 1992, ARCH SURG-CHICAGO, V127, P1237; PARRYBILLINGS M, 1990, LANCET, V336, P523, DOI 10.1016/0140-6736(90)92083-T; Peng CK, 2011, PULM PHARMACOL THER, V24, P153, DOI 10.1016/j.pupt.2010.07.002; Perng WC, 2010, CLIN EXP PHARMACOL P, V37, P56, DOI 10.1111/j.1440-1681.2009.05239.x; Philippidis P, 2004, CIRC RES, V94, P119, DOI 10.1161/01.RES.0000109414.78907.F9; Salman AE, 2014, J ANESTH, V28, P354, DOI 10.1007/s00540-013-1745-y; Schaer CA, 2006, CIRC RES, V99, P943, DOI 10.1161/01.RES.0000247067.34173.1b; Sheng WS, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-51; Shi Q, 2009, PHARMACOLOGY, V84, P1, DOI 10.1159/000220767; Silva G, 2006, J IMMUNOL, V177, P1894, DOI 10.4049/jimmunol.177.3.1894; Singleton KD, 2006, SHOCK, V25, P295, DOI 10.1097/01.shk.0000196548.10634.02; Sufit A, 2012, JPEN-PARENTER ENTER, V36, P556, DOI 10.1177/0148607112448823; THEPEN T, 1989, J EXP MED, V170, P499, DOI 10.1084/jem.170.2.499; Thomsen JH, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/523652; Van Gorp H, 2010, MOL IMMUNOL, V47, P1650, DOI 10.1016/j.molimm.2010.02.008; Wernerman J, 2011, ACTA ANAESTH SCAND, V55, P812, DOI 10.1111/j.1399-6576.2011.02453.x; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Wischmeyer PE, 2009, AM J PHYSIOL-LUNG C, V296, pL286, DOI 10.1152/ajplung.00003.2009; Yin H, 2011, INT IMMUNOPHARMACOL, V11, P2112, DOI 10.1016/j.intimp.2011.09.004; Yin H, 2010, MOL IMMUNOL, V47, P2443, DOI 10.1016/j.molimm.2010.06.013; Zhang F, 2009, NUTRITION, V25, P692, DOI 10.1016/j.nut.2008.11.032; Zhang SC, 2013, PHARMACOLOGY, V91, P59, DOI 10.1159/000343809; Zhang X, 2008, J PATHOL, V214, P161, DOI 10.1002/path.2284	63	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130764	10.1371/journal.pone.0130764	http://dx.doi.org/10.1371/journal.pone.0130764			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147379	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600046
J	Hilz, MJ; Intravooth, T; Moeller, S; Wang, RH; Lee, DH; Koehn, J; Linker, RA				Hilz, Max J.; Intravooth, Tassanai; Moeller, Sebastian; Wang, Ruihao; Lee, De-Hyung; Koehn, Julia; Linker, Ralf A.			Central Autonomic Dysfunction Delays Recovery of Fingolimod Induced Heart Rate Slowing	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; ORAL FINGOLIMOD; CARDIAC RATE; FTY720; TRIAL; RHYTHM	Background In multiple sclerosis (MS) patients, Fingolimod may induce prolonged heart-rate slowing which might be caused by MS-related central autonomic lesions. Objectives To evaluate whether MS-patients with prolonged heart-rate slowing (> six hours) upon Fingolimod show cardiovascular-autonomic dysfunction before Fingolimod-initiation. Methods Before Fingolimod-initiation, we recorded electrocardiographic RR-intervals (RRIs) and blood-pressure (BP) at rest, upon standing-up, during metronomic deep-breathing, Valsalva-maneuver, and "sustained-handgrip-exercise" in 21 patients with relapsing-remitting MS, and 20 healthy persons. We calculated sympathetic and parasympathetic cardiovascular parameters, including low-(LF) and high-frequency (HF) powers of RRI-and BP-oscillations, RRI-RMSSDs, RRI-and BP-changes during handgrip-exercise, parasympathetic heart-rate-slowing in relation to BP-overshoot after Valsalva-strain-release. We compared values of healthy persons and patients with and without prolonged heart-rate slowing after Fingolimod-initiation (ANOVA; significance: p<0.05). Results Upon Fingolimod-initiation, 7/21 patients had prolonged HR-slowing. Before Fingolimod, these patients had higher resting BP and higher BP increase during handgrip-exercise than had the other participants (p<0.05). They did not reduce parasympathetic HR-parameters upon standing-up. After Valsalva-strain-release, their parasympathetic HR-slowing in response to BP-overshoot was four times higher than in the other participants (p<0.05). Conclusions The autonomic cardiovascular dysfunction in MS-patients with delayed HR-re-acceleration upon Fingolimod-initiation suggests that MS-related central autonomic lesions compromise HR-re-acceleration upon Fingolimod.	[Hilz, Max J.; Intravooth, Tassanai; Moeller, Sebastian; Wang, Ruihao; Lee, De-Hyung; Koehn, Julia; Linker, Ralf A.] Univ Erlangen Nurnberg, Dept Neurol, Erlangen, Germany	University of Erlangen Nuremberg	Hilz, MJ (corresponding author), Univ Erlangen Nurnberg, Dept Neurol, Erlangen, Germany.	max.hilz@uk-erlangen.de	Linker, Ralf/AAD-8884-2020	Wang, Ruihao/0000-0003-4792-5572; Intravooth, Tassanai/0000-0002-6188-4503	Genzyme; Sanofi company; Novartis Pharma GmbH; Bayer HealthCare Pharmaceuticals; Biogen Idec; Merck Serono; TEVA Pharmaceutical Industries LTD; Roche	Genzyme(Sanofi-AventisGenzyme Corporation); Sanofi company; Novartis Pharma GmbH; Bayer HealthCare Pharmaceuticals(Bayer AGBayer Healthcare Pharmaceuticals); Biogen Idec(Biogen); Merck Serono(Merck & Company); TEVA Pharmaceutical Industries LTD(Teva Pharmaceutical Industries); Roche(Roche Holding)	The authors of this manuscript have read the journal's policy and have the following competing interests: Max. J. Hilz received speaker honoraria and research support from Genzyme, a Sanofi company, Novartis Pharma GmbH, and Bayer HealthCare Pharmaceuticals. Tassanai Intravooth received travel grants from Genzyme, a Sanofi company. De-Hyung Lee received travel grants or speaker honoraria from Bayer HealthCare Pharmaceuticals, Biogen Idec, Merck Serono, Novartis Pharma GmbH, and TEVA Pharmaceutical Industries LTD, as well as research support from Novartis Pharma GmbH. Julia Koehn received travel grants from Genzyme, a Sanofi company and Bayer HealthCare Pharmaceuticals. Ralf A. Linker received travel grants or speaker honoraria from Bayer HealthCare Pharmaceuticals, Biogen Idec, Merck Serono, Novartis Pharma GmbH, Roche, and TEVA Pharmaceutical Industries LTD, as well as research support from Novartis Pharma GmbH, Biogen Idec, and Merck Serono. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Benarroch E.E., 1997, CLIN AUTONOMIC DISOR, P17; Benarroch EE, 1993, CLIN AUTONOMIC DISOR, P209; Budde K, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341073; Camm AJ, 1996, CIRCULATION, V93, P1043; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Eckberg D, 1992, HUMAN BAROREFLEXES H; Faber H, 2013, MULT SCLER J, V19, P126, DOI 10.1177/1352458512447596; Fazekas F, 2012, WIEN MED WOCHENSCHR, V162, P354, DOI 10.1007/s10354-012-0123-y; Filippi M, 2012, LANCET NEUROL, V11, P349, DOI 10.1016/S1474-4422(12)70003-0; Gold R, 2014, J NEUROL, V261, P267, DOI 10.1007/s00415-013-7115-8; Hilz MJ, 2008, STROKE, V39, P2421, DOI 10.1161/STROKEAHA.108.518613; Hilz MJ, 2006, BRAIN, V129, P3343, DOI 10.1093/brain/awl299; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Hilz MJ, 2001, ANN NEUROL, V49, P575, DOI 10.1002/ana.1006; Hilz MJ., 2002, NEUROMUSCULAR FUNCTI, P1899; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kovarik JM, 2008, BRIT J CLIN PHARMACO, V66, P199, DOI 10.1111/j.1365-2125.2008.03199.x; Koyrakh L, 2005, AM J TRANSPLANT, V5, P529, DOI 10.1111/j.1600-6143.2005.00754.x; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Low PA, 2008, CLIN AUTONOMIC DISOR, P130; Marsolais D, 2009, NAT REV DRUG DISCOV, V8, P297, DOI 10.1038/nrd2356; MELCHER A, 1981, AM J PHYSIOL, V241, pH838, DOI 10.1152/ajpheart.1981.241.6.H838; Merkelbach S, 2006, J NEUROL, V253, P21, DOI 10.1007/s00415-005-1105-z; Nada A, 2013, AM HEART J, V165, P489, DOI 10.1016/j.ahj.2013.01.011; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rossi S, 2014, MULT SCLER, DOI 10.1177/1352458514538885; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Sanya EO, 2005, CLIN AUTON RES, V15, P213, DOI 10.1007/s10286-005-0274-7; Sbardella E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063250; Schmouder R, 2006, J CLIN PHARMACOL, V46, P895, DOI 10.1177/0091270006289853; Schmouder R, 2012, EUR J CLIN PHARMACOL, V68, P355, DOI 10.1007/s00228-011-1146-9; Singer BA, 2013, THER ADV NEUROL DISO, V6, P269, DOI 10.1177/1756285613491520; THOMAIDES TN, 1993, J NEUROL, V240, P139, DOI 10.1007/BF00857517; Vellinga MM, 2009, J MAGN RESON IMAGING, V29, P768, DOI 10.1002/jmri.21679; Ziemssen T, 2013, J NEURAL TRANSM, V120, pS27, DOI 10.1007/s00702-013-1054-5	36	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132139	10.1371/journal.pone.0132139	http://dx.doi.org/10.1371/journal.pone.0132139			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147106	Green Submitted, gold, Green Published			2022-12-27	WOS:000358157600205
J	Hu, WL; Swanson, BA; Heller, GZ				Hu, Wenli; Swanson, Brett A.; Heller, Gillian Z.			A Statistical Method for the Analysis of Speech Intelligibility Tests	PLOS ONE			English	Article							NOISE; THRESHOLD	Speech intelligibility tests are conducted on hearing-impaired people for the purpose of evaluating the performance of a hearing device under varying listening conditions and device settings or algorithms. The speech reception threshold (SRT) is typically defined as the signal-to-noise ratio (SNR) at which a subject scores 50% correct on a speech intelligibility test. An SRT is conventionally measured with an adaptive procedure, in which the SNR of successive sentences is adjusted based on the subject's scores on previous sentences. The SRT can be estimated as the mean of a subset of the SNR levels, or by fitting a psychometric function. A set of SRT results is typically analyzed with a repeated measures analysis of variance. We propose an alternative approach for analysis, a zero-and-one inflated beta regression model, in which an observation is a single sentence score rather than an SRT. A parametrization of the model is defined that allows efficient maximum likelihood estimation of the parameters. Fitted values from this model, when plotted against SNR, are analogous to a mean psychometric function in the traditional approach. Confidence intervals for the fitted value curves are obtained by parametric bootstrap. The proposed approach was applied retrospectively to data from two studies that assessed the speech perception of cochlear implant recipients using different sound processing algorithms under different listening conditions. The proposed approach yielded mean SRTs for each condition that were consistent with the traditional approach, but were more informative. It provided the mean psychometric curve of each condition, revealing differences in slope, i.e. differential performance at different parts of the SNR spectrum. Another advantage of the new method of analysis is that results are stated in terms of differences in percent correct scores, which is more interpretable than results from the traditional analysis.	[Hu, Wenli; Heller, Gillian Z.] Macquarie Univ, Dept Stat, Sydney, NSW 2109, Australia; [Swanson, Brett A.] Cochlear Ltd, Sydney, NSW, Australia	Macquarie University; Cochlear	Heller, GZ (corresponding author), Macquarie Univ, Dept Stat, Sydney, NSW 2109, Australia.	gillian.heller@mq.edu.au		Swanson, Brett/0000-0003-1732-2332; Heller, Gillian/0000-0003-1270-1499	Cochlear Ltd.	Cochlear Ltd.	The authors received no specific funding for this work. Cochlear Ltd., provided support in the form of a salary for author BAS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the "author contributions" section.	Bench J, 1979, Br J Audiol, V13, P108, DOI 10.3109/03005367909078884; Brand T, 2002, J ACOUST SOC AM, V111, P2801, DOI 10.1121/1.1479152; Davison AC, 1997, CAMBRIDGE SERIES STA; Dawson PW, 2013, EAR HEARING, V34, P592, DOI 10.1097/AUD.0b013e31828576fb; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Hersbach AA, 2013, J ACOUST SOC AM, V133, P2412, DOI 10.1121/1.4794391; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Ospina R, 2006, ZERO INFLATED BETA D; Ospina R, 2010, STAT PAP, V51, P111, DOI 10.1007/s00362-008-0125-4; PLOMP R, 1979, AUDIOLOGY, V18, P43; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544	13	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132409	10.1371/journal.pone.0132409	http://dx.doi.org/10.1371/journal.pone.0132409			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147290	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600261
J	Nichols, TC; Merricks, EP; Bellinger, DA; Raymer, RA; Yu, J; Lam, D; Koch, GG; Busby, WH; Clemmons, DR				Nichols, Timothy C.; Merricks, Elizabeth P.; Bellinger, Dwight A.; Raymer, Robin A.; Yu, Jing; Lam, Diana; Koch, Gary G.; Busby, Walker H., Jr.; Clemmons, David R.			Oxidized LDL and Fructosamine Associated with Severity of Coronary Artery Atherosclerosis in Insulin Resistant Pigs Fed a High Fat/High NaCl Diet	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; TYPE-2 DIABETES-MELLITUS; IMPAIRED GLUCOSE-TOLERANCE; ADIPOSE-TISSUE CELLULARITY; LOW-GRADE INFLAMMATION; VON-WILLEBRAND-FACTOR; METABOLIC-SYNDROME; OXIDATIVE STRESS; ACCELERATED ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE	Background Insulin-resistant subjects develop more severe and diffuse coronary artery atherosclerosis than insulin-sensitive controls but the mechanisms that mediate this atherosclerosis phenotype are unknown. Research Objective To determine the metabolic parameters that associate with the severity of coronary atherosclerosis in insulin resistant pigs fed a high fat/high NaCl diet. Key Methods The primary endpoint was severity of coronary atherosclerosis in adult pigs (Sus scrofa, n = 37) fed a high fat diet that also contained high NaCl (56% above recommended levels) for 1 year. Principal Findings Twenty pigs developed severe and diffuse distal coronary artery atherosclerosis (i.e., severe = intimal area as a percent medial area > 200% in at least 2 coronary artery cross sections and diffuse distal = intimal area as a percent medial area >= 150% over 3 sections separated by 2 cm in the distal half of the coronary artery). The other 17 pigs had substantially less coronary artery atherosclerosis. All 37 pigs had blood pressure in a range that would be considered hypertensive in humans and developed elevations in total and LDL and HDL cholesterol, weight gain, increased backfat, and increased insulin resistance (Bergman Si) without overt diabetes. Insulin resistance was not associated with atherosclerosis severity. Five additional pigs fed regular pig chow also developed increased insulin resistance but essentially no change in the other variables and little to no detectible coronary atherosclerosis. Most importantly, the 20 high fat/high NaCl diet -fed pigs with severe and diffuse distal coronary artery atherosclerosis had substantially greater increases (p<0.05) in oxidized LDL (oxLDL) and fructosamine consistent with increased protein glycation. Conclusion In pigs fed a high fat/high NaCl diet, glycated proteins are induced in the absence of overt diabetes and this degree of increase is associated with the development of severe and diffuse distal coronary artery atherosclerosis.	[Nichols, Timothy C.; Merricks, Elizabeth P.; Bellinger, Dwight A.; Raymer, Robin A.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Nichols, Timothy C.; Busby, Walker H., Jr.; Clemmons, David R.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Yu, Jing; Lam, Diana; Koch, Gary G.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Nichols, TC (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA.	tnichols@med.unc.edu			National Heart, Lung, and Blood institute of the National Institutes of Health [HL069364]; North Carolina Biotechnology Center (NCBC) [MRG1101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069364] Funding Source: NIH RePORTER	National Heart, Lung, and Blood institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); North Carolina Biotechnology Center (NCBC); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood institute of the National Institutes of Health (HL069364, DRC, TCN) and the North Carolina Biotechnology Center (NCBC MRG1101, TCN and DRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanji AO, 2002, CLIN CHIM ACTA, V317, P171, DOI 10.1016/S0009-8981(01)00792-6; ARMBRUSTER DA, 1987, CLIN CHEM, V33, P2153; Behme MT, 1996, J NUTR, V126, P1549, DOI 10.1093/jn/126.6.1549; Bellinger DA, 2006, ILAR J, V47, P243, DOI 10.1093/ilar.47.3.243; BERGMAN RN, 1985, ENDOCR REV, V6, P45, DOI 10.1210/edrv-6-1-45; BERGMAN RN, 1987, J CLIN INVEST, V79, P790, DOI 10.1172/JCI112886; Black MH, 2008, DIABETES, V57, P1048, DOI 10.2337/db07-0848; Bonnet F, 2006, J HYPERTENS, V24, P1157, DOI 10.1097/01.hjh.0000226206.03560.ac; Brodala N, 2005, ARTERIOSCLER THROMB, V25, P1456; BUHLINGER CA, 1978, GROWTH, V42, P225; Burke AP, 2004, ARTERIOSCL THROM VAS, V24, P1266, DOI 10.1161/01.ATV.0000131783.74034.97; Carson AP, 2014, DIABETES CARE; Chade AR, 2005, HYPERTENSION, V46, P772, DOI 10.1161/01.HYP.0000184250.37607.da; Chade AR, 2005, J AM SOC NEPHROL, V16, P1005, DOI 10.1681/ASN.2004080674; Christoffersen B, 2009, AM J PHYSIOL-REG I, V297, pR1195, DOI 10.1152/ajpregu.90851.2008; Council NR, 1998, NUTRIENT REQUIREMENT; Daghini E, 2006, AM J PHYSIOL-REG I, V290, pR609, DOI 10.1152/ajpregu.00436.2005; de Castro Simone H, 2005, Rev Diabet Stud, V2, P157; Dixon JL, 1999, ARTERIOSCL THROM VAS, V19, P2981, DOI 10.1161/01.ATV.19.12.2981; Dyson MC, 2006, COMPARATIVE MED, V56, P35; Edwards IJ, 1999, DIABETES RES CLIN PR, V46, P9, DOI 10.1016/S0168-8227(99)00074-1; Edwards IJ, 2002, METABOLISM, V51, P1223, DOI 10.1053/meta.2002.35177; Ersen BOC, 2007, COMPARATIVE MED, V57, P493; ETHERTON TD, 1980, GROWTH, V44, P182; ETHERTON TD, 1980, LIPIDS, V15, P823, DOI 10.1007/BF02534372; Fink LN, 2014, OBESITY, V22, P747, DOI 10.1002/oby.20615; Finn AV, 2005, J AM COLL CARDIOL, V45, P479, DOI 10.1016/j.jacc.2004.10.060; Flaherty JD, 2005, JAMA-J AM MED ASSOC, V293, P1501, DOI 10.1001/jama.293.12.1501; Fu RB, 2011, EUROPACE, V13, P31, DOI 10.1093/europace/euq346; Furusyo N, 2013, INT J CARDIOL, V167, P2066, DOI 10.1016/j.ijcard.2012.05.045; Gerrity RG, 2001, DIABETES, V50, P1654, DOI 10.2337/diabetes.50.7.1654; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Gokulakrishnan K, 2007, METABOLISM, V56, P245, DOI 10.1016/j.metabol.2006.10.002; Graner M, 2007, ANN MED, V39, P137, DOI 10.1080/07853890601083451; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Grunwald KAA, 1999, J LIPID RES, V40, P475; Hanssen NM, 2014, DIABETES; Hasler-Rapacz J, 1998, AM J MED GENET, V76, P379, DOI 10.1002/(SICI)1096-8628(19980413)76:5<379::AID-AJMG3>3.0.CO;2-I; HASLERRAPACZ JO, 1994, ARTERIOSCLER THROMB, V14, P923, DOI 10.1161/01.ATV.14.6.923; HAUSMAN GJ, 1983, J LIPID RES, V24, P223; Herdzik E, 2002, ACTA DIABETOL, V39, P15, DOI 10.1007/s005920200007; HIGGINS PJ, 1982, DIABETES, V31, P743, DOI 10.2337/diabetes.31.9.743; Ho RC, 2002, METABOLISM, V51, P1478, DOI 10.1053/meta.2002.35577; Holvoet P, 1998, ARTERIOSCL THROM VAS, V18, P415, DOI 10.1161/01.ATV.18.3.415; Howard BV, 1999, AM J CARDIOL, V84, p28J; Hussein OA, 2007, CLIN CHIM ACTA, V377, P114, DOI 10.1016/j.cca.2006.09.002; Inokuchi-Shimizu S, 2014, THE JOURNAL OF CLINI; Inoue I, 2006, METABOLISM, V55, P946, DOI 10.1016/j.metabol.2006.03.002; Ishigaki Y, 2008, CIRCULATION, V118, P75, DOI 10.1161/CIRCULATIONAHA.107.745174; Jais A, 2014, CELL, V158, P25, DOI 10.1016/j.cell.2014.04.043; Juutilainen A, 2004, DIABETES CARE, V27, P2898, DOI 10.2337/diacare.27.12.2898; Kalela A, 2000, EUR J CLIN INVEST, V30, P99; Karolkiewicz J, 2006, AGING MALE, V9, P159, DOI 10.1080/13685530600884309; Kilhovd BK, 2005, ARTERIOSCL THROM VAS, V25, P815, DOI 10.1161/01.ATV.0000158380.44231.fe; Knopp RH, 2006, AM J CLIN NUTR, V83, P1; Kohen-Avramoglu R, 2003, CLIN BIOCHEM, V36, P413, DOI 10.1016/S0009-9120(03)00038-9; Kohler KA, 2000, AM J KIDNEY DIS, V36, P903, DOI 10.1053/ajkd.2000.19080; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Kurella M, 2005, J AM SOC NEPHROL, V16, P2134, DOI 10.1681/ASN.2005010106; Laakso M, 2014, NAT REV ENDOCRINOL, V10, P293, DOI 10.1038/nrendo.2014.29; LABERLAIRD K, 1992, LAB ANIM SCI, V42, P579; Lau CL, 2003, AM J TRANSPLANT, V3, P1065, DOI 10.1034/j.1600-6143.2003.00190.x; LaVange LM, 2006, CIRCULATION, V114, P2528, DOI 10.1161/CIRCULATIONAHA.106.613638; Lee B, 2014, AM J PHYSIOL-ENDOC M, V306, pE1144, DOI 10.1152/ajpendo.00002.2014; Lee YS, 2014, CELL, V157, P1339, DOI 10.1016/j.cell.2014.05.012; Li JP, 2007, CIRC J, V71, P1067, DOI 10.1253/circj.71.1067; Lomax MA, 2013, J NUTR BIOCHEM, V24, P656, DOI 10.1016/j.jnutbio.2012.03.013; Lopes-Virella MF, 2011, DIABETES, V60, P582, DOI 10.2337/db10-0915; Lucove J, 2008, AM J KIDNEY DIS, V51, P21, DOI 10.1053/j.ajkd.2007.09.014; MCNAMARA JP, 1982, J ANIM SCI, V55, P1057, DOI 10.2527/jas1982.5551057x; Meigs JB, 2002, DIABETES CARE, V25, P1313, DOI 10.2337/diacare.25.8.1313; Meisinger C, 2005, CIRCULATION, V112, P651, DOI 10.1161/CIRCULATIONAHA.104.529297; Mesangeau D, 2000, CARDIOVASC RES, V45, P889, DOI 10.1016/S0008-6363(99)00406-X; Moreno PR, 2004, J AM COLL CARDIOL, V44, P2293, DOI 10.1016/j.jacc.2004.07.060; Moses AC, 1996, DIABETES, V45, P91, DOI 10.2337/diabetes.45.1.91; Negrean M, 2007, AM J CLIN NUTR, V85, P1236, DOI 10.1093/ajcn/85.5.1236; Nichols TC, 1999, CIRC RES, V85, P1040; NICHOLS TC, 1992, AM J PATHOL, V140, P403; Nilsson J, 2007, CURR PHARM DESIGN, V13, P1021, DOI 10.2174/138161207780487557; Nin JWM, 2009, DIABETOLOGIA, V52, P705, DOI 10.1007/s00125-009-1263-5; O'Connell T, 2002, J CLIN ENDOCR METAB, V87, P4356, DOI 10.1210/jc.2002-020343; Oh DY, 2014, NATURE MED; Okopien B., 2003, Research Communications in Molecular Pathology and Pharmacology, V113, P87; Otis CR, 2003, COMPARATIVE MED, V53, P53; Paniagua JA, 2005, DIABETIC MED, V22, P1647, DOI 10.1111/j.1464-5491.2005.01703.x; Patschan S, 2008, AM J PHYSIOL-HEART C, V294, pH1119, DOI 10.1152/ajpheart.00713.2007; Pinhas-Hamiel O, 2007, LANCET, V369, P1823, DOI 10.1016/S0140-6736(07)60821-6; Renard C, 2006, DIABETES METAB, V32, P15, DOI 10.1016/S1262-3636(07)70243-4; Sam S, 2008, METABOLISM, V57, P84, DOI 10.1016/j.metabol.2007.08.010; Schindhelm RK, 2007, DIABETES CARE, V30, P1789, DOI 10.2337/dc06-2585; Schwenke DC, 2003, DIABETES CARE, V26, P1449, DOI 10.2337/diacare.26.5.1449; Selvin E, 2014, LANCET DIABETES ENDO, V2, P279, DOI 10.1016/S2213-8587(13)70199-2; Serin O, 2007, HORM METAB RES, V39, P207, DOI 10.1055/s-2007-970419; Shin MJ, 2006, INT J OBESITY, V30, P1529, DOI 10.1038/sj.ijo.0803304; Sies H, 2005, J NUTR, V135, P969, DOI 10.1093/jn/135.5.969; Song SO, 2012, ATHEROSCLEROSIS, V225, P450, DOI 10.1016/j.atherosclerosis.2012.09.005; Song YM, 2013, ENDOCRINOLOGY, V154, P2626, DOI 10.1210/en.2013-1031; Sosenko JM, 2002, DIABETES CARE, V25, P1078, DOI 10.2337/diacare.25.6.1078; Spijkerman AMW, 2003, DIABETES CARE, V26, P2604, DOI 10.2337/diacare.26.9.2604; Springett R, 2001, PHYS MED BIOL, V46, P2209, DOI 10.1088/0031-9155/46/8/312; Suzuki LA, 2001, DIABETES, V50, P851, DOI 10.2337/diabetes.50.4.851; TASKINEN MR, 1995, CURR OPIN LIPIDOL, V6, P153, DOI 10.1097/00041433-199506000-00007; Thornalley Paul J, 2004, Diab Vasc Dis Res, V1, P21, DOI 10.3132/dvdr.2004.002; Thornalley PJ, 2003, ARCH BIOCHEM BIOPHYS, V419, P31, DOI 10.1016/j.abb.2003.08.013; Tushuizen ME, 2006, J THROMB HAEMOST, V4, P1003, DOI 10.1111/j.1538-7836.2006.01914.x; Veiraiah A, 2005, ANGIOLOGY, V56, P431, DOI 10.1177/000331970505600411; Verhamme P, 2002, CARDIOVASC RES, V56, P135, DOI 10.1016/S0008-6363(02)00515-1; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wahid ST, 2002, DIABETIC MED, V19, P543, DOI 10.1046/j.1464-5491.2002.00730.x; Weckbach S, 2009, INVEST RADIOL, P44; Yamagishi S, 2004, INT J CLIN PHARM RES, V24, P129; YEGIN A, 1995, INT J CLIN LAB RES, V25, P157, DOI 10.1007/BF02592559; Zhang H, 2014, ANN THORAC SURG, V97, P2073, DOI 10.1016/j.athoracsur.2014.02.047; Zhang LF, 2003, CIRCULATION, V108, P472, DOI 10.1161/01.CIR.0000080378.96063.23; Zhang YF, 2006, CLIN ENDOCRINOL, V64, P153, DOI 10.1111/j.1365-2265.2005.02440.x; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a; Zoungas S, 2014, NEW ENGL J MED, V371, P1392, DOI 10.1056/NEJMoa1407963	117	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132302	10.1371/journal.pone.0132302	http://dx.doi.org/10.1371/journal.pone.0132302			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147990	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600235
J	Ockenhouse, CF; Regules, J; Tosh, D; Cowden, J; Kathcart, A; Cummings, J; Paolino, K; Moon, J; Komisar, J; Kamau, E; Oliver, T; Chhoeu, A; Murphy, J; Lyke, K; Laurens, M; Birkett, A; Lee, C; Weltzin, R; Wille-Reece, U; Sedegah, M; Hendriks, J; Versteege, I; Pau, MG; Sadoff, J; Vanloubbeeck, Y; Lievens, M; Heerwegh, D; Moris, P; Mendoza, YG; Jongert, E; Cohen, J; Voss, G; Ballou, WR; Vekemans, J				Ockenhouse, Christian F.; Regules, Jason; Tosh, Donna; Cowden, Jessica; Kathcart, April; Cummings, James; Paolino, Kristopher; Moon, James; Komisar, Jack; Kamau, Edwin; Oliver, Thomas; Chhoeu, Austin; Murphy, Jitta; Lyke, Kirsten; Laurens, Matthew; Birkett, Ashley; Lee, Cynthia; Weltzin, Rich; Wille-Reece, Ulrike; Sedegah, Martha; Hendriks, Jenny; Versteege, Isabella; Pau, Maria Grazia; Sadoff, Jerold; Vanloubbeeck, Yannick; Lievens, Marc; Heerwegh, Dirk; Moris, Philippe; Mendoza, Yolanda Guerra; Jongert, Erik; Cohen, Joe; Voss, Gerald; Ballou, W. Ripley; Vekemans, Johan			Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naive Adults	PLOS ONE			English	Article							PHASE 2A TRIAL; FALCIPARUM-MALARIA; CIRCUMSPOROZOITE PROTEIN; IMMUNE-RESPONSES; DOUBLE-BLIND; FOLLOW-UP; RTS,S/AS02A; SAFETY; IMMUNOGENICITY; CANDIDATE	Methods In an observer blind, phase 2 trial, 55 adults were randomized to receive one dose of Ad35. CS. 01 vaccine followed by two doses of RTS,S/AS01 (ARR-group) or three doses of RTS, S/AS01 (RRR-group) at months 0, 1, 2 followed by controlled human malaria infection. Results ARR and RRR vaccine regimens were well tolerated. Efficacy of ARR and RRR groups after controlled human malaria infection was 44% (95% confidence interval 21%-60%) and 52% (25%-70%), respectively. The RRR-group had greater anti-CS specific IgG titers than did the ARR-group. There were higher numbers of CS-specific CD4 T-cells expressing > 2 cytokine/activation markers and more ex vivo IFN-gamma enzyme-linked immunospots in the ARR-group than the RRR-group. Protected subjects had higher CS-specific IgG titers than non-protected subjects (geometric mean titer, 120.8 vs 51.8 EU/ml, respectively; P = .001). Conclusions An increase in vaccine efficacy of ARR-group over RRR-group was not achieved. Future strategies to improve upon RTS, S-induced protection may need to utilize alternative highly immunogenic prime-boost regimens and/or additional target antigens.	[Ockenhouse, Christian F.; Regules, Jason; Tosh, Donna; Cowden, Jessica; Kathcart, April; Cummings, James; Paolino, Kristopher; Moon, James; Komisar, Jack; Kamau, Edwin; Oliver, Thomas; Chhoeu, Austin; Murphy, Jitta] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA; [Lyke, Kirsten; Laurens, Matthew] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Birkett, Ashley; Lee, Cynthia; Weltzin, Rich; Wille-Reece, Ulrike] PATH MVI, Washington, DC USA; [Sedegah, Martha] Naval Med Res Ctr, Silver Spring, MD USA; [Hendriks, Jenny; Versteege, Isabella; Pau, Maria Grazia; Sadoff, Jerold] Crucell Holland BV, Leiden, Netherlands; [Vanloubbeeck, Yannick; Lievens, Marc; Heerwegh, Dirk; Moris, Philippe; Mendoza, Yolanda Guerra; Jongert, Erik; Cohen, Joe; Voss, Gerald; Ballou, W. Ripley; Vekemans, Johan] GSK Vaccines, Rixensart, Belgium	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University System of Maryland; University of Maryland Baltimore; Naval Medical Research Center (NMRC); Johnson & Johnson; GlaxoSmithKline	Ockenhouse, CF (corresponding author), Walter Reed Army Inst Res, Silver Spring, MD 20910 USA.	cockenhouse@path.org	Moon, James E./B-6810-2011; Laurens, Matthew/E-7293-2013	Moon, James E./0000-0002-9274-4554; Laurens, Matthew/0000-0003-3874-581X	PATH Malaria Vaccine Initiative (Washington, D.C.); Military Infectious Diseases Research Program (Fort Detrick, MD); DMID [N01-AI05421]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI005421] Funding Source: NIH RePORTER	PATH Malaria Vaccine Initiative (Washington, D.C.); Military Infectious Diseases Research Program (Fort Detrick, MD); DMID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the PATH Malaria Vaccine Initiative (Washington, D.C.) and the Military Infectious Diseases Research Program (Fort Detrick, MD). The Ad35.CS.01 vaccine was manufactured by Crucell Holland BV., Leiden, The Netherlands, under DMID-supported contract N01-AI05421, NIAID, Bethesda, MD, USA. Crucell Holland BV. provided support in the form of salaries for authors AB, CL, RW, UWR, and contributed to project management, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; [Anonymous], PLOS MED; [Anonymous], 1997, NEW ENGL J MED, DOI DOI 10.1056/NEJM199701093360202; [Anonymous], STAT ART VACC RES DE; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Asante KP, 2011, LANCET INFECT DIS, V11, P741, DOI 10.1016/S1473-3099(11)70100-1; Bejon P, 2005, J INFECT DIS, V191, P619, DOI 10.1086/427243; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Clement F, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-384; Creech CB, 2013, HUM VACC IMMUNOTHER, V9, P2548, DOI 10.4161/hv.26038; Dunachie SJ, 2006, VACCINE, V24, P2850, DOI 10.1016/j.vaccine.2005.12.041; Garcon Nathalie, 2003, Expert Rev Vaccines, V2, P231, DOI 10.1586/14760584.2.2.231; Heppner DG, 2005, VACCINE, V23, P2243, DOI 10.1016/j.vaccine.2005.01.042; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Lalvani A, 1999, J INFECT DIS, V180, P1656, DOI 10.1086/315074; Lu S, 2009, CURR OPIN IMMUNOL, V21, P346, DOI 10.1016/j.coi.2009.05.016; Lumsden JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020775; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Ndungu FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052870; Olotu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025786; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; Olotu AI, 2010, J INFECT DIS, V201, P970, DOI 10.1086/651025; Ophorst OJAE, 2006, INFECT IMMUN, V74, P313, DOI 10.1128/IAI.74.1.313-320.2006; Ouedraogo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078679; Pinder M, 2004, CLIN EXP IMMUNOL, V135, P286, DOI 10.1111/j.1365-2249.2004.02371.x; Radosevic K, 2009, EXPERT REV VACCINES, V8, P577, DOI 10.1586/ERV.09.14; Regules JA, 2011, EXPERT REV VACCINES, V10, P589, DOI [10.1586/erv.11.57, 10.1586/ERV.11.57]; Rodriguez A, 2009, VACCINE, V27, P6226, DOI 10.1016/j.vaccine.2009.07.106; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; Sacarlal J, 2009, J INFECT DIS, V200, P329, DOI 10.1086/600119; Shott JP, 2008, VACCINE, V26, P2818, DOI 10.1016/j.vaccine.2008.03.080; Steketee RW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-299; Stewart VA, 2007, INFECT IMMUN, V75, P2283, DOI 10.1128/IAI.01879-06; Stewart VA, 2006, VACCINE, V24, P6483, DOI 10.1016/j.vaccine.2006.06.033; Stoute JA, 1998, J INFECT DIS, V178, P1139, DOI 10.1086/515657; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; White MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061395; World Health Organization, WORLD MALARIA REPORT	41	58	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131571	10.1371/journal.pone.0131571	http://dx.doi.org/10.1371/journal.pone.0131571			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148007	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600109
J	Ogawa, R; Nagao, K; Taniuchi, K; Tsuchiya, M; Kato, U; Hara, Y; Inaba, T; Kobayashi, T; Sasaki, Y; Akiyoshi, K; Watanabe-Takahashi, M; Nishikawa, K; Umeda, M				Ogawa, Rina; Nagao, Kohjiro; Taniuchi, Kentaro; Tsuchiya, Masaki; Kato, Utako; Hara, Yuji; Inaba, Takehiko; Kobayashi, Toshihide; Sasaki, Yoshihiro; Akiyoshi, Kazunari; Watanabe-Takahashi, Miho; Nishikawa, Kiyotaka; Umeda, Masato			Development of a Novel Tetravalent Synthetic Peptide That Binds to Phosphatidic Acid	PLOS ONE			English	Article							PHOSPHOLIPASE-D; MONOCLONAL-ANTIBODIES; MEMBRANE; CYTOKINESIS; PROTEINS; PHOSPHATIDYLETHANOLAMINE; REDISTRIBUTION; RECOGNITION; METABOLISM; BIOSENSOR	We employed a multivalent peptide-library screening technique to identify a peptide motif that binds to phosphatidic acid (PA), but not to other phospholipids such as phosphatidylcholine (PC), phosphatidylethanolamine (PE), and phosphatidylserine (PS). A tetravalent peptide with the sequence motif of MARWHRHHH, designated as PAB-TP (phosphatidic acid-binding tetravalent peptide), was shown to bind as low as 1 mol% of PA in the bilayer membrane composed of PC and cholesterol. Kinetic analysis of the interaction between PAB-TP and the membranes containing 10 mol% of PA showed that PAB-TP associated with PA with a low dissociation constant of K-D = 38 +/- 5 nM. Coexistence of cholesterol or PE with PA in the membrane enhanced the PAB-TP binding to PA by increasing the ionization of the phosphomonoester head group as well as by changing the microenvironment of PA molecules in the membrane. Amino acid replacement analysis demonstrated that the tryptophan residue at position 4 of PAB-TP was involved in the interaction with PA. Furthermore, a series of amino acid substitutions at positions 5 to 9 of PAB-TP revealed the involvement of consecutive histidine and arginine residues in recognition of the phosphomonoester head group of PA. Our results demonstrate that the recognition of PA by PABTP is achieved by a combination of hydrophobic, electrostatic and hydrogen-bond interactions, and that the tetravalent structure of PAB-TP contributes to the high affinity binding to PA in the membrane. The novel PA-binding tetravalent peptide PAB-TP will provide insight into the molecular mechanism underlying the recognition of PA by PA-binding proteins that are involved in various cellular events.	[Ogawa, Rina; Nagao, Kohjiro; Taniuchi, Kentaro; Tsuchiya, Masaki; Kato, Utako; Hara, Yuji; Umeda, Masato] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto, Japan; [Inaba, Takehiko; Kobayashi, Toshihide] RIKEN, Lipid Biol Lab, Wako, Saitama, Japan; [Sasaki, Yoshihiro; Akiyoshi, Kazunari] Kyoto Univ, Dept Polymer Chem, Grad Sch Engn, Kyoto, Japan; [Watanabe-Takahashi, Miho; Nishikawa, Kiyotaka] Doshisha Univ, Fac Life & Med Sci, Kyoto, Japan	Kyoto University; RIKEN; Kyoto University; Doshisha University	Umeda, M (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto, Japan.	umeda@sbchem.kyoto-u.ac.jp	KOBAYASHI, TOSHIHIDE/S-8313-2019	KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Inaba, Takehiko/0000-0002-8770-4662	Ministry of Education, Culture, Sports, Science and Technology, Japan [25293012, 25116714, 25670119, 15K13741]; Grants-in-Aid for Scientific Research [15H04846] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research, a Grant-in-Aid for Scientific Research on Innovative Areas, and Grant-in-Aid for Challenging Exploratory Research from The Ministry of Education, Culture, Sports, Science and Technology, Japan (scientific research grants 25293012, 25116714, 25670119 and 15K13741) [http://www.mext.go.jp/english/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwarawrah M, 2010, J PHYS CHEM B, V114, P7516, DOI 10.1021/jp101415g; BLUME A, 1992, BIOCHEMISTRY-US, V31, P4636, DOI 10.1021/bi00134a014; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Cockcroft S, 2009, BBA-MOL CELL BIOL L, V1791, P837, DOI 10.1016/j.bbalip.2009.08.003; Emoto K, 1996, P NATL ACAD SCI USA, V93, P12867, DOI 10.1073/pnas.93.23.12867; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; Fan JP, 2014, P NATL ACAD SCI USA, V111, P7636, DOI 10.1073/pnas.1403097111; Ghosh S, 2003, J BIOL CHEM, V278, P45690, DOI 10.1074/jbc.M302933200; Gottlin EB, 1998, P NATL ACAD SCI USA, V95, P9202, DOI 10.1073/pnas.95.16.9202; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Horchani H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113484; Jang JH, 2012, PROG LIPID RES, V51, P71, DOI 10.1016/j.plipres.2011.12.003; Kassas N, 2012, METHOD CELL BIOL, V108, P445, DOI 10.1016/B978-0-12-386487-1.00020-1; Kato U, 2013, J BIOL CHEM, V288, P4922, DOI 10.1074/jbc.M112.402701; Kobayashi S, 2013, FUNGAL GENET BIOL, V61, P100, DOI 10.1016/j.fgb.2013.09.008; Kooijman EE, 2008, BIOPHYS J, V94, P4320, DOI 10.1529/biophysj.107.121046; Kooijman EE, 2007, J BIOL CHEM, V282, P11356, DOI 10.1074/jbc.M609737200; Kooijman EE, 2009, BBA-MOL CELL BIOL L, V1791, P881, DOI 10.1016/j.bbalip.2009.04.001; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P17007, DOI 10.1021/bi0518794; Kraft CA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.299pl4; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Makino A, 2015, FASEB J, V29, P477, DOI 10.1096/fj.13-247585; MIYAZAWA A, 1988, MOL IMMUNOL, V25, P1025; Murate M, 2015, J CELL SCI, V128, P1627, DOI 10.1242/jcs.163105; Nagao K, 2014, BBA-MOL CELL BIOL L, V1841, P80, DOI 10.1016/j.bbalip.2013.10.005; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; NAM KS, 1990, BIOCHIM BIOPHYS ACTA, V1046, P89, DOI 10.1016/0005-2760(90)90098-I; Nishikawa K, 2006, FASEB J, V20, P2597, DOI 10.1096/fj.06-6572fje; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Nishioka T, 2010, J BIOL CHEM, V285, P35979, DOI 10.1074/jbc.M110.153007; Pleskot R, 2013, TRENDS PLANT SCI, V18, P496, DOI 10.1016/j.tplants.2013.04.005; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Toita S, 2010, BIOMACROMOLECULES, V11, P397, DOI 10.1021/bm901109z; UMEDA M, 1989, J IMMUNOL, V143, P2273; Watanabe-Takahashi M, 2010, INFECT IMMUN, V78, P177, DOI 10.1128/IAI.01022-09; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300; Yang CY, 2012, INT J BIOCHEM CELL B, V44, P1346, DOI 10.1016/j.biocel.2012.05.006; Yang JS, 2008, NAT CELL BIOL, V10, P1146, DOI 10.1038/ncb1774; Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026; YU L, 1991, P NATL ACAD SCI USA, V88, P9325, DOI 10.1073/pnas.88.20.9325	42	5	5	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131668	10.1371/journal.pone.0131668	http://dx.doi.org/10.1371/journal.pone.0131668			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147860	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600124
J	Shuai, B; Shen, L; Yang, YP; Ma, C; Zhu, R; Xu, XJ				Shuai, Bo; Shen, Lin; Yang, Yanping; Ma, Chen; Zhu, Rui; Xu, Xiaojuan			Assessment of the Impact of Zoledronic Acid on Ovariectomized Osteoporosis Model Using Micro-CT Scanning	PLOS ONE			English	Article							BONE-MINERAL DENSITY; WNT/BETA-CATENIN; BETA-CATENIN; RAT MODEL; TRABECULAR MICROARCHITECTURE; COMPUTED-TOMOGRAPHY; CORTICAL BONE; DENOSUMAB; ASSOCIATION; RECEPTOR	Purpose/Objective Prompted by preliminary findings, this study was conducted to investigate the impact of zoledronic acid on the cancellous bone microstructure and its effect on the level of beta-catenin in a mouse model of postmenopausal osteoporosis. Methods and Materials 96 8-week-old specific-pathogen-free C57BL/6 mice were randomly divided into 4 groups (24 per group): a sham group, an ovariectomized osteoporosis model group, an estradiol-treated group, and a zoledronic acid-treated group. Five months after surgery, the third lumbar vertebra and left femur of the animals were dissected and scanned using micro-computed tomography (micro-CT) to acquire three-dimensional imagery of their cancellous bone microstructure. The impact of ovariectomy, the effect of estradiol, and the effect of zoledronic acid intervention on cancellous bone microstructure, as well as on the expression of beta-catenin, were evaluated. Results The estradiol-treated and the zoledronic acid-treated group exhibited a significant increase in the bone volume fraction, trabecular number, trabecular thickness, bone surface to bone volume ratio (BS/BV), and beta-catenin expression, when compared with those of the control group (P <0.01). In contrast, the structure model index, trabecular separation, and BS/BV were significantly lower compared with those of the model group (P <0.01). No differences were observed in the above parameters between animals of the zoledronic acid-treated and the estradiol-treated group. Conclusion These results suggest that increased beta-catenin expression may be the mechanism underlying zoledronic acid-related improvement in the cancellous bone microstructure in ovariectomized mice. Our findings provide a scientific rationale for using zoledronic acid as a therapeutic intervention to prevent bone loss in post-menopausal women.	[Shuai, Bo; Shen, Lin; Yang, Yanping; Ma, Chen; Zhu, Rui; Xu, Xiaojuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Integrated Tradit Chinese & Western Med, Wuhan 430022, Peoples R China	Huazhong University of Science & Technology	Shen, L (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Integrated Tradit Chinese & Western Med, Wuhan 430022, Peoples R China.	18971511705@126.com		Shuai, Bo/0000-0002-9298-8129	National Natural Science Foundation of China [81403257, 81473492, 81072493]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Natural Science Foundation of China (Project Number: 81403257 to Bo Shuai, 81473492 to Lin Shen, and 81072493 to Ping Yan Yang) (http://www.nsfc.gov.cn/publish/portal0/tab117/).	Anastasilakis AD, 2013, J CLIN ENDOCR METAB, V98, P3206, DOI 10.1210/jc.2013-1402; Audran M, 2001, CALCIFIED TISSUE INT, V69, P214, DOI 10.1007/s00223-001-1058-2; Bolotin HH, 2001, J BONE MINER RES, V16, P799, DOI 10.1359/jbmr.2001.16.5.799; Brand L, 2013, INT J COLORECTAL DIS, V28, P1091, DOI 10.1007/s00384-013-1667-z; Chang KV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081124; Chen Q, 2014, CHIN J INTEGR MED, V20, P743, DOI 10.1007/s11655-014-1810-x; Contrera JF, 2004, REGUL TOXICOL PHARM, V40, P185, DOI 10.1016/j.yrtph.2004.08.004; Du LY, 2007, PHYS MED BIOL, V52, P7087, DOI 10.1088/0031-9155/52/23/021; Effendy NM, 2014, J X-RAY SCI TECHNOL, V22, P503, DOI 10.3233/XST-140441; HAHN M, 1992, BONE, V13, P327, DOI 10.1016/8756-3282(92)90078-B; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Ibrahim NI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115595; Ito M, 1998, BONE, V23, P163, DOI 10.1016/S8756-3282(98)00083-0; Khajuria DK, 2014, J ORTHOP SCI, V19, P646, DOI 10.1007/s00776-014-0557-8; Khajuria Deepak Kumar, 2014, Sci Pharm, V82, P357, DOI 10.3797/scipharm.1310-06; Kinney JH, 2000, J BONE MINER RES, V15, P1981, DOI 10.1359/jbmr.2000.15.10.1981; Knapp KM, 2015, J CLIN DENSITOM, V18, P209, DOI 10.1016/j.jocd.2014.06.001; Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200; Laib A, 2000, MED BIOL ENG COMPUT, V38, P326, DOI 10.1007/BF02347054; Legrand E, 2000, J BONE MINER RES, V15, P13, DOI 10.1359/jbmr.2000.15.1.13; Li FL, 2011, CHIN J INTEGR MED, V17, P261, DOI 10.1007/s11655-011-0703-5; Liedert A, 2010, BIOCHEM BIOPH RES CO, V394, P755, DOI 10.1016/j.bbrc.2010.03.065; Liu ZS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116194; Medical Advisory Secretariat, 2006, Ont Health Technol Assess Ser, V6, P1; Mittra E, 2005, J BIOMECH, V38, P1229, DOI 10.1016/j.jbiomech.2004.06.007; Neves AA, 2014, DENT MATER, V30, P799, DOI 10.1016/j.dental.2014.05.003; Park YS, 2014, IMAGNG SCI DENT, V44, P143, DOI 10.5624/isd.2014.44.2.143; Poole KES, 2015, J BONE MINER RES, V30, P46, DOI 10.1002/jbmr.2325; Ramli R, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/501858; Ruegsegger P, 1996, CALCIFIED TISSUE INT, V58, P24, DOI 10.1007/s002239900006; Scagliotti GV, 2012, J THORAC ONCOL, V7, P1823, DOI 10.1097/JTO.0b013e31826aec2b; Schreiber JJ, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.5.FOCUS1483; Shuai B, 2015, OSTEOPOROSIS INT, V26, P1063, DOI 10.1007/s00198-014-2992-y; Shuai Bo, 2014, Chinese Medicine, V5, P145; Shuai B, 2010, J RHEUMATOL, V37, P2151, DOI 10.3899/jrheum.100342; Silva BC, 2014, J BONE MINER RES, V29, P518, DOI 10.1002/jbmr.2176; Tai TW, 2014, BONE, V67, P166, DOI 10.1016/j.bone.2014.07.003; Tian J, 2015, J HUAZHONG U SCI-MED, V35, P212, DOI 10.1007/s11596-015-1413-6; Vasconcelos ACU, 2012, J ORAL PATHOL MED, V41, P702, DOI 10.1111/j.1600-0714.2012.01140.x; Vasquez Sergio X, 2013, Methods Mol Biol, V947, P223, DOI 10.1007/978-1-62703-131-8_18; Verborgt O, 2000, J BONE MINER RES, V15, P60, DOI 10.1359/jbmr.2000.15.1.60; Warden SJ, 2005, J BONE MINER RES, V20, P809, DOI 10.1359/JBMR.041222; Wurnig MC, 2014, NMR BIOMED, V27, P1159, DOI 10.1002/nbm.3169; Xu XJ, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/534352; Xu YX, 2012, CHIN J INTEGR MED, V18, P909, DOI 10.1007/s11655-012-1294-2	45	20	24	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132104	10.1371/journal.pone.0132104	http://dx.doi.org/10.1371/journal.pone.0132104			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148020	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600200
J	Zeng, QY; Fan, TT; Zhu, P; He, RQ; Bao, YX; Zheng, RY; Xu, HQ				Zeng, Qing-Yi; Fan, Tian-Tian; Zhu, Pan; He, Ru-Qian; Bao, Yi-Xin; Zheng, Rong-Yuan; Xu, Hui-Qin			Comparative Long-Term Effectiveness of a Monotherapy with Five Antiepileptic Drugs for Focal Epilepsy in Adult Patients: A Prospective Cohort Study	PLOS ONE			English	Article							TECHNOLOGY-ASSESSMENT SUBCOMMITTEE; QUALITY STANDARDS SUBCOMMITTEE; RETENTION RATES; AMERICAN ACADEMY; ILAE-COMMISSION; EFFICACY; TOLERABILITY; TOPIRAMATE; THERAPY; LAMOTRIGINE	Objective To evaluate and compare long-term effectiveness of five antiepileptic drugs (AEDs) for monotherapy of adult patients with focal epilepsy in routine clinical practice. Methods Adult patients with focal epilepsy, who were prescribed with carbamazepine (CBZ), valproate (VPA), lamotrigine (LTG), topiramate (TPM), or oxcarbazepine (OXC) as monotherapy, during the period from January 2004 to June 2012 registered in Wenzhou Epilepsy Follow Up Registry Database (WEFURD), were included in the study. Prospective long-term follow-up was conducted until June 2013. The endpoints were time to treatment failure, time to seizure remission, and time to first seizure. Results This study included 654 patients: CBZ (n=125), VPA (n=151), LTG (n=135), TPM (n=76), and OXC (n=167). The retention rates of CBZ, VPA, LTG, TPM, and OXC at the third year were 36.1%, 32.4%, 57.6%, 37.9%, and 41.8%, respectively. For time to treatment failure, LTG was significantly better than CBZ and VPA (LTG vs. CBZ, hazard ratio, [HR] 0.80 [95% confidence interval: 0.67-0.96], LTG vs. VPA, 0.53 [0.37-0.74]); TPM was worse than LTG (TPM vs. LTG, 1.77 [1.15-2.74]), and OXC was better than VPA (0.86 [0.78-0.96]). After initial target doses, the seizure remission rates of CBZ, VPA, LTG, TPM, and OXC were 63.0%, 77.0%, 83.6%, 67.9%, and 75.3%, respectively. LTG was significantly better than CBZ (1.44 [1.15-1.82]) and OXC (LTG vs. OXC, 0.76 [0.63-0.93]); OXC was less effective than LTG in preventing the first seizure (1.20 [1.02-1.40]). Conclusion LTG was the best, OXC was better than VPA only, while VPA was the worst. The others were equivalent for comparisons between five AEDs regarding the long-term treatment outcomes of monotherapy for adult patients with focal epilepsy in a clinical practice. For selecting AEDs for these patients among the first-line drugs, LTG is an appropriate first choice; others are reservation in the first-line but VPA is not.	[Zeng, Qing-Yi; Zhu, Pan; He, Ru-Qian; Bao, Yi-Xin; Zheng, Rong-Yuan; Xu, Hui-Qin] Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurol, Wenzhou, Zhejiang, Peoples R China; [Fan, Tian-Tian] First Hosp Zibo, Rehabil Ctr, Zibo, Shandong, Peoples R China	Wenzhou Medical University	Zheng, RY (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurol, Wenzhou, Zhejiang, Peoples R China.	zhengry2013@163.com; xuhuiqin1972@163.com	Zeng, Qingyi/U-7280-2017	Zeng, Qingyi/0000-0002-1291-9861	Wenzhou Medical Association	Wenzhou Medical Association	The study was funded by grants from Wenzhou Medical Association (RYZ). The funder had no role in the study design; in the collection, analysis and interpretation of data; in the writing of the manuscript; or in the decision to submit the paper for publication.	Andrew T, 2012, SEIZURE-EUR J EPILEP, V21, P610, DOI 10.1016/j.seizure.2012.06.013; [Anonymous], 1981, Epilepsia, V22, P489; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Ben-Menachem E, 2010, EPILEPSY BEHAV, V18, P24, DOI 10.1016/j.yebeh.2010.04.001; Bergin P, 2012, EPILEPSIA, V53, P1829, DOI 10.1111/j.1528-1167.2012.03636.x; BERKOVIC SF, 1997, EPILEPSIA S10, V38, P1; Bootsma HP, 2009, SEIZURE-EUR J EPILEP, V18, P327, DOI 10.1016/j.seizure.2008.11.006; Brodie MJ, 2012, NEUROLOGY, V78, P1548, DOI 10.1212/WNL.0b013e3182563b19; Brodie MJ, 1996, NEW ENGL J MED, V334, P168, DOI 10.1056/NEJM199601183340308; Chinese Medical Association, 2007, BOOK EP CHIN CLIN PR; Cho YJ, 2009, EPILEPSIA, V50, P1910, DOI 10.1111/j.1528-1167.2009.02177.x; Chung S, 2007, SEIZURE-EUR J EPILEP, V16, P296, DOI 10.1016/j.seizure.2007.01.004; Dichter MA, 1996, NEW ENGL J MED, V334, P1583, DOI 10.1056/NEJM199606133342407; Dreyer NA, 2009, JAMA-J AM MED ASSOC, V302, P790, DOI 10.1001/jama.2009.1092; French JA, 2004, NEUROLOGY, V62, P1252, DOI 10.1212/01.WNL.0000123693.82339.FC; French JA, 2004, NEUROLOGY, V62, P1261, DOI 10.1212/01.WNL.0000123695.22623.32; Gilliam FG, 2004, NEUROLOGY, V62, P23, DOI 10.1212/WNL.62.1.23; Glauser T, 2013, EPILEPSIA, V54, P551, DOI 10.1111/epi.12074; Hsieh FY, 2000, CONTROL CLIN TRIALS, V21, P552, DOI 10.1016/S0197-2456(00)00104-5; Hu YD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047982; Hu YD, 2011, SEIZURE-EUR J EPILEP, V20, P208, DOI 10.1016/j.seizure.2010.11.020; Hu YD, 2010, EPILEPSY RES, V90, P278, DOI 10.1016/j.eplepsyres.2010.06.004; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Lhatoo SD, 2000, EPILEPSIA, V41, P1592; Li J, 2012, CHINESE J PHARMACOEP, V21, P587; Marson AG, 2007, LANCET, V369, P1016, DOI 10.1016/S0140-6736(07)60461-9; Marson AG, 2007, LANCET, V369, P1000, DOI 10.1016/S0140-6736(07)60460-7; Mohanraj R, 2005, EPILEPSY BEHAV, V6, P382, DOI 10.1016/j.yebeh.2005.01.008; Mohanraj R, 2003, SEIZURE-EUR J EPILEP, V12, P413, DOI 10.1016/S1059-1311(03)00047-5; National Institute for Clinical Excellence, 2014, EP DIAGN MAN EP AD C; Patsalos PN, 2008, EPILEPSIA, V49, P1239, DOI 10.1111/j.1528-1167.2008.01561.x; Perucca E, 2001, CNS DRUGS, V15, P609, DOI 10.2165/00023210-200115080-00004; Perucca E, 1996, BAILLIERE CLIN NEUR, V5, P693; Sander JW, 2005, ACTA NEUROL SCAND, V112, P26, DOI 10.1111/j.1600-0404.2005.00505.x; Sander JW, 2004, EPILEPSIA, V45, P28, DOI 10.1111/j.0013-9580.2004.455005.x; Shorvon S, 2000, SEIZURE-EUR J EPILEP, V9, P75, DOI 10.1053/seiz.2000.0391; Shorvon SD, 2011, EPILEPSIA, V52, P1052, DOI 10.1111/j.1528-1167.2011.03041.x; Simister RJ, 2007, EPILEPSY BEHAV, V10, P336, DOI 10.1016/j.yebeh.2006.12.005; Tatum WO, 2001, EPILEPSIA, V42, P1134, DOI 10.1046/j.1528-1157.2001.41700.x; Tomson T, 2010, EPILEPSIA, V51, P909, DOI 10.1111/j.1528-1167.2010.02525.x; Vajda FJE, 2010, ACTA NEUROL SCAND, V121, P89, DOI 10.1111/j.1600-0404.2009.01260.x; Wieshmann UC, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002564; World Health Organization, 2014, EPILEPSY; Zaccara G, 2006, ACTA NEUROL SCAND, V114, P157, DOI 10.1111/j.1600-0404.2006.00705.x	44	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131566	10.1371/journal.pone.0131566	http://dx.doi.org/10.1371/journal.pone.0131566			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147937	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600107
J	Azerkan, F; Widmark, C; Sparen, P; Weiderpass, E; Tillgren, P; Faxelid, E				Azerkan, Fatima; Widmark, Catarina; Sparen, Par; Weiderpass, Elisabete; Tillgren, Per; Faxelid, Elisabeth			When Life Got in the Way: How Danish and Norwegian Immigrant Women in Sweden Reason about Cervical Screening and Why They Postpone Attendance	PLOS ONE			English	Article							QUALITATIVE CONTENT-ANALYSIS; PAP-SMEAR; HISPANIC WOMEN; CANCER; ACCULTURATION; PROGRAM; RISK; DISPARITIES; KNOWLEDGE; AGE	Introduction Danish and Norwegian immigrant women in Sweden have an increased risk of cervical cancer compared to Swedish-born women. In addition, Danish and Norwegian immigrant women follow the national recommendations for attendance at cervical screening to much lesser extent than Swedish-born women. The aim of this study was to explore how Danish and Norwegian immigrant women in Sweden reason about attending cervical screening, focusing on women's perceptions as to why they and their compatriots do not attend. Methods Eight focus group discussions (FGDs) were conducted with Danish and Norwegian immigrant women living in Stockholm. The women were between 26 and 66 years of age at the time of the FGDs, and were aged between <1 and 48 years old when they immigrated to Sweden. A FGD guide was used, which included questions related to cervical screening, and obstacles and motivators to attend cervical screening. The FGDs were tape recorded and transcribed, and the results analysed according to the principles of qualitative content analysis. Results The main theme was "Women have a comprehensive rationale for postponing cervical screening, yet do not view themselves as non-attenders". Investigation of women's rationale for non-attendance after being invited to cervical screening revealed some complex reasons related to immigration itself, including competing needs, organisational and structural factors and differences in mentality, but also reasons stemming from other factors. Postponing attendance at cervical screening was the category that linked all these factors as the reasons to why women did not attend to cervical screening according to the recommendations of the authorities. Conclusions The rationale used to postpone cervical screening, in combination with the fact that women do not consider themselves to be non-attenders, indicates that they have not actively taken a stance against cervical screening, and reveals an opportunity to motivate these women to attend.	[Azerkan, Fatima; Sparen, Par; Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Widmark, Catarina] Karolinska Univ Hosp, Dept Qual & Patient Safety, Stockholm, Sweden; [Widmark, Catarina] Karolinska Inst, Med Management Ctr, Dept Learning Informat Management & Eth, Stockholm, Sweden; [Weiderpass, Elisabete] Arctic Univ Norway, Univ Tromso, Fac Hlth Sci, Dept Community Med, Tromso, Norway; [Weiderpass, Elisabete] Canc Registry Norway, Dept Res, Oslo, Norway; [Weiderpass, Elisabete] Samfundet Folkhalsan, Helsinki, Finland; [Tillgren, Per] Malardalen Univ, Sch Hlth Care & Social Welf, Vasteras, Sweden; [Tillgren, Per] Karolinska Inst, Dept Publ Hlth Sci, Div Social Med, Stockholm, Sweden; [Faxelid, Elisabeth] Karolinska Inst, Dept PublicHlth Sci, Global Hlth IHCAR, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; UiT The Arctic University of Tromso; University of Oslo; Samfundet Folkhalsan; Malardalen University; Karolinska Institutet; Karolinska Institutet	Azerkan, F (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	fatimaazerkan@gmail.com	Weiderpass, Elisabete/AAP-2747-2021; Weiderpass, Elisabete/M-4029-2016	Weiderpass, Elisabete/0000-0003-2237-0128; Weiderpass, Elisabete/0000-0003-2237-0128; Sparen, Par/0000-0002-5184-8971	Swedish Research Council [K2010-70X-21418-01-3, 2008-4438, 521-2009-4410]; Swedish Council for Working Life and Social Research [2007-2029]; Health Care Sciences Postgraduate School, Karolinska Institutet [2/2005]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Health Care Sciences Postgraduate School, Karolinska Institutet	This work was supported by The Swedish Research Council, (grant number: K2010-70X-21418-01-3, http://www.vr.se/) to FA, EW. The Swedish Research Council, (grant number: 2008-4438, http://www.vr.se/); The Swedish Council for Working Life and Social Research, (grant number: 2007-2029, http://fas.se) to CW. The Swedish Research Council, (grant number 521-2009-4410, http://www.vr.se/); Health Care Sciences Postgraduate School, Karolinska Institutet, (grant number: "Karolinska Institutet FFU ordforandebeslut Nr 2/2005", www.ki.se) to FA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdipour H, 2008, WOMEN HEALTH, V47, P23, DOI 10.1080/03630240802132302; Anttila A, 2009, EUR J CANCER, V45, P2649, DOI 10.1016/j.ejca.2009.07.020; Anttila A, 2009, EUR J CANCER, V45, P2685, DOI 10.1016/j.ejca.2009.07.017; Arbyn M, 2009, EUR J CANCER, V45, P2671, DOI 10.1016/j.ejca.2009.07.016; Austin LT, 2002, WOMEN HEALTH ISS, V12, P122, DOI 10.1016/S1049-3867(02)00132-9; Azerkan F, 2008, INT J CANCER, V123, P2664, DOI 10.1002/ijc.23843; Azerkan F, 2012, INT J CANCER, V130, P937, DOI 10.1002/ijc.26084; Barbour R., 2007, DOING FOCUS GROUPS; Bergstrom R, 1999, BRIT J CANCER, V81, P159, DOI 10.1038/sj.bjc.6690666; Blomberg K, 2008, PSYCHO-ONCOLOGY, V17, P561, DOI 10.1002/pon.1270; Blomberg K, 2011, ACTA ONCOL, V50, P112, DOI 10.3109/0284186X.2010.528790; Blomberg K, 2011, CANCER NURS, V34, pE11, DOI 10.1097/NCC.0b013e3181f70f83; Brown DR, 2000, ANN EPIDEMIOL, V10, pS13, DOI 10.1016/S1047-2797(00)00197-6; Caplan Susan, 2007, Policy Polit Nurs Pract, V8, P93, DOI 10.1177/1527154407301751; Documet Patricia I, 2004, J Immigr Health, V6, P5, DOI 10.1023/B:JOIH.0000014638.87569.2e; Donnelly TT, 2007, NURS INQ, V14, P2, DOI 10.1111/j.1440-1800.2007.00347.x; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Gupta Abha, 2002, Health Care Women Int, V23, P123, DOI 10.1080/073993302753429004; GUSTAFSSON L, 1990, BRIT J CANCER, V61, P903, DOI 10.1038/bjc.1990.202; Hansen BT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-264; Harmon MP, 1996, WOMEN HEALTH, V24, P37; Idestrom M, 2002, ACTA OBSTET GYN SCAN, V81, P962, DOI 10.1034/j.1600-0412.2002.811011.x; Karwalajtys TL, 2010, CAN FAM PHYSICIAN, V56, pE130; Kaufert PA, 1997, J PSYCHOSOM OBST GYN, V18, P81, DOI 10.3109/01674829709085573; Krueger RA, 1994, FOCUS GROUPS PRACTIC, V2nd; Lum T, 2004, GERONTOLOGIST, V44, P391; MAHLCK CG, 1994, INT J GYNECOL OBSTET, V44, P267, DOI 10.1016/0020-7292(94)90177-5; Mandelblatt J S, 2000, J Am Med Womens Assoc (1972), V55, P210; Martin LM, 1996, AM J PREV MED, V12, P82, DOI 10.1016/S0749-3797(18)30349-0; Morgan D.L, 1996, FOCUS GROUPS QUALITA; Nordic Council of Ministers, 2011, NORD STAT YB, V49; Nygard JF, 2002, J MED SCREEN, V9, P86, DOI 10.1136/jms.9.2.86; Oscarsson MG, 2008, J PSYCHOSOM OBST GYN, V29, P23, DOI 10.1080/01674820701504619; Owusu GA, 2005, MATERN CHILD HLTH J, V9, P285, DOI 10.1007/s10995-005-0004-8; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pol Louis G, 2002, J Immigr Health, V4, P103, DOI 10.1023/A:1014502710289; Shin Hosung, 2005, J Immigr Health, V7, P65, DOI 10.1007/s10903-005-2638-4; Sigurdsson K, 1999, Laeknabladid, V85, P862; SIGURDSSON K, 1993, INT J CANCER, V54, P563, DOI 10.1002/ijc.2910540408; SUAREZ L, 1994, AM J PUBLIC HEALTH, V84, P742, DOI 10.2105/AJPH.84.5.742; Swedish Cervical Cancer Screening Register, 2008, CERV CANC SCR SWED 2; Swedish Government Inquiries, 2009, NAT CANC STRAT FUT S; Swedish Tax Agency, 2007, 717B SKV SWED TAX AG; von Euler-Chelpin M, 2011, SCAND J PUBLIC HEALT, V39, P158, DOI 10.1177/1403494811401479; WIDMARK C, 2008, INT J QUAL STUD HEAL, V3, P89, DOI DOI 10.3402/QHW.V3I2.4978; World Health Organization, 2005, B WHO BLT, V84, P81	48	21	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0107624	10.1371/journal.pone.0107624	http://dx.doi.org/10.1371/journal.pone.0107624			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EW	26158449	gold, Green Published, Green Submitted			2022-12-27	WOS:000358161200001
J	Benn, P; Curnow, KJ; Chapman, S; Michalopoulos, SN; Hornberger, J; Rabinowitz, M				Benn, Peter; Curnow, Kirsten J.; Chapman, Steven; Michalopoulos, Steven N.; Hornberger, John; Rabinowitz, Matthew			An Economic Analysis of Cell-Free DNA Non-Invasive Prenatal Testing in the US General Pregnancy Population	PLOS ONE			English	Article							COST-EFFECTIVENESS ANALYSIS; DOWN-SYNDROME; HIGH-RISK; STRATEGIES; SERUM; 1ST-TRIMESTER; ANEUPLOIDIES	Objective Analyze the economic value of replacing conventional fetal aneuploidy screening approaches with non-invasive prenatal testing (NIPT) in the general pregnancy population. Methods Using decision-analysis modeling, we compared conventional screening to NIPT with cellfree DNA (cfDNA) analysis in the annual US pregnancy population. Sensitivity and specificity for fetal aneuploidies, trisomy 21, trisomy 18, trisomy 13, and monosomy X, were estimated using published data and modeling of both first-and second trimester screening. Costs were assigned for each prenatal test component and for an affected birth. The overall cost to the healthcare system considered screening costs, the number of aneuploid cases detected, invasive procedures performed, procedure-related euploid losses, and affected pregnancies averted. Sensitivity analyses evaluated the effect of variation in parameters. Costs were reported in 2014 US Dollars. Results Replacing conventional screening with NIPT would reduce healthcare costs if it can be provided for $744 or less in the general pregnancy population. The most influential variables were timing of screening entry, screening costs, and pregnancy termination rates. Of the 13,176 affected pregnancies undergoing screening, NIPT detected 96.5% (12,717/13,176) of cases, compared with 85.9% (11,314/13,176) by conventional approaches. NIPT reduced invasive procedures by 60.0%, with NIPT and conventional methods resulting in 24,596 and 61,430 invasive procedures, respectively. The number of procedure-related euploid fetal losses was reduced by 73.5% (194/ 264) in the general screening population. Conclusion Based on our analysis, universal application of NIPT would increase fetal aneuploidy detection rates and can be economically justified. Offering this testing to all pregnant women is associated with substantial prenatal healthcare benefits.	[Benn, Peter] Univ Connecticut, Div Human Genet, Dept Genet & Genome Sci, Ctr Hlth, Farmington, CT 06030 USA; [Curnow, Kirsten J.] Illumina Inc, San Francisco, CA USA; [Chapman, Steven; Rabinowitz, Matthew] Natera Inc, San Carlos, CA USA; [Michalopoulos, Steven N.] Cedar Associates, Menlo Pk, CA USA; [Hornberger, John] Cedar Associates, Menlo Pk, CA USA; [Hornberger, John] Stanford Univ, Stanford, CA 94305 USA	University of Connecticut; Illumina; Stanford University	Benn, P (corresponding author), Univ Connecticut, Div Human Genet, Dept Genet & Genome Sci, Ctr Hlth, Farmington, CT 06030 USA.	benn@nso1.uchc.edu	Michalopoulos, Efstathios/AAA-4674-2020; Hornberger, John/M-4932-2019		Natera, Inc.	Natera, Inc.	This study was funded by Natera, Inc. (http://www.natera.com). Cedar Associates received research funding to develop the economic analysis and manuscript. Peter Benn, Steven Chapman, John Hornberger, and Matthew Rabinowitz were involved in the initial design of the study. All authors contributed to the analysis and the preparation of the manuscript.	ACOG Committee on Practice Bulletins, 2007, Obstet Gynecol, V109, P217; Agency for Healthcare Research and Quality, 2014, HEALTHC COST UT PROJ; American College of Obstetricians and Gynecologists Committee on Genetics, 2012, Obstet Gynecol, V120, P1532, DOI 10.1097/01.AOG.0000423819.85283.f4; Ayres AC, 2014, AUST NZ J OBSTET GYN, V54, P412, DOI 10.1111/ajo.12223; Benn P, 2005, PRENATAL DIAG, V25, P645, DOI 10.1002/pd.1215; Benn P, 2015, PRENATAL DIAG, V35, P725, DOI 10.1002/pd.4608; Benn P, 2014, J CLIN MED, V3, P537, DOI 10.3390/jcm3020537; Benn P, 2013, PRENATAL DIAG, V33, P622, DOI 10.1002/pd.4139; Beulen L, 2014, EUR J OBSTET GYN R B, V182, P53, DOI 10.1016/j.ejogrb.2014.08.028; Bianchi DW, 2014, NEW ENGL J MED, V370, P799, DOI 10.1056/NEJMoa1311037; Biggio JR, 2004, AM J OBSTET GYNECOL, V190, P721, DOI 10.1016/j.ajog.2003.09.028; Centers for Disease Control and Prevention, 2014, VIT STATS BIRTHS 201; Centers for Medicare and Medicaid Services, 2014, PHYS FEE SCHED 2014; Cuckle H, 2013, PRENATAL DIAG, V33, P636, DOI 10.1002/pd.4157; Dar P, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.08.006; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI DOI 10.1007/s00134-012-2769-8; Evans MI, 2015, ULTRASOUND OBST GYN, V45, P74, DOI 10.1002/uog.14693; Fairbrother G, 2016, J MATERN-FETAL NEO M, V29, P1160, DOI 10.3109/14767058.2015.1038703; Garfield SS, 2012, J MANAGED CARE MED, V15, P34; Gregg AR, 2013, GENET MED, V15, P395, DOI 10.1038/gim.2013.29; Martin JA, 2013, BIRTHS FINAL DATA 20; Morris S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093559; Neyt M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005922; Nicolaides KH, 2014, FETAL DIAGN THER, V35, P212, DOI 10.1159/000355655; Norton ME, 2015, NEW ENGL J MED, V372, P1589, DOI 10.1056/NEJMoa1407349; O'Leary P, 2013, AUST NZ J OBSTET GYN, V53, P425, DOI 10.1111/ajo.12136; Ohno M, 2013, PRENATAL DIAG, V33, P630, DOI 10.1002/pd.4156; Okun N, 2014, PRENATAL DIAG, V34, P350, DOI 10.1002/pd.4311; Palomaki GE, 2015, PRENATAL DIAG, V35, P289, DOI 10.1002/pd.4541; Palomaki GE, 2013, ARCH PATHOL LAB MED, V137, P921, DOI 10.5858/arpa.2012-0319-CP; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Pergament E, 2014, OBSTET GYNECOL, V124, P210, DOI 10.1097/AOG.0000000000000363; Rava RP, 2014, CLIN CHEM, V60, P243, DOI 10.1373/clinchem.2013.207951; Saenger P, 2001, J CLIN ENDOCR METAB, V86, P3061, DOI 10.1210/jc.86.7.3061; Shaffer BL, 2006, PRENATAL DIAG, V26, P667, DOI 10.1002/pd.1462; Song K, 2013, J MATERN-FETAL NEO M, V26, P1180, DOI 10.3109/14767058.2013.770464; Spencer K, 2002, PRENATAL DIAG, V22, P877, DOI 10.1002/pd.420; WAITZMAN NJ, 1994, INQUIRY-J HEALTH CAR, V31, P188; Wald NJ, 2003, J MED SCREEN, V10, P56, DOI 10.1258/096914103321824133; Walker BS, 2015, PRENATAL DIAG, V35, P440, DOI 10.1002/pd.4511; Wallerstein R, 2014, J PREGNANCY, V2014, DOI 10.1155/2014/962720; Zhang H, 2015, ULTRASOUND OBST GYN, V45, P530, DOI 10.1002/uog.14792	42	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0132313	10.1371/journal.pone.0132313	http://dx.doi.org/10.1371/journal.pone.0132313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158465	Green Published, Green Submitted, gold			2022-12-27	WOS:000358161200050
J	Hegg, JC; Giarrizzo, T; Kennedy, BP				Hegg, Jens C.; Giarrizzo, Tommaso; Kennedy, Brian P.			Diverse Early Life-History Strategies in Migratory Amazonian Catfish: Implications for Conservation and Management	PLOS ONE			English	Article							BRACHYPLATYSTOMA-ROUSSEAUXII; HYDROELECTRIC DEVELOPMENT; FISH; RIVER; CHALLENGES; ISOTOPES; BRAZIL; WATER; BIODIVERSITY; SR-87/SR-86	Animal migrations provide important ecological functions and can allow for increased biodiversity through habitat and niche diversification. However, aquatic migrations in general, and those of the world's largest fish in particular, are imperiled worldwide and are often poorly understood. Several species of large Amazonian catfish carry out some of the longest freshwater fish migrations in the world, travelling from the Amazon River estuary to the Andes foothills. These species are important apex predators in the main stem rivers of the Amazon Basin and make up the region's largest fishery. They are also the only species to utilize the entire Amazon Basin to complete their life cycle. Studies indicate both that the fisheries may be declining due to overfishing, and that the proposed and completed dams in their upstream range threaten spawning migrations. Despite this, surprisingly little is known about the details of these species' migrations, or their life history. Otolith microchemistry has been an effective method for quantifying and reconstructing fish migrations worldwide across multiple spatial scales and may provide a powerful tool to understand the movements of Amazonian migratory catfish. Our objective was to describe the migratory behaviors of the three most populous and commercially important migratory catfish species, Dourada (Brachyplatystoma rousseauxii), Piramutaba (Brachyplatystoma vaillantii), and Piraiba (Brachyplatystoma filamentosum). We collected fish from the mouth of the Amazon River and the Central Amazon and used strontium isotope signatures (Sr-87/Sr-86) recorded in their otoliths to determine the location of early rearing and subsequent. Fish location was determined through discriminant function classification, using water chemistry data from the literature as a training set. Where water chemistry data was unavailable, we successfully in predicted 87Sr/86Sr isotope values using a regression-based approach that related the geology of the upstream watershed to the Sr isotope ratio. Our results provide the first reported otolith microchemical reconstruction of Brachyplatystoma migratory movements in the Amazon Basin. Our results indicate that juveniles exhibit diverse rearing strategies, rearing in both upstream and estuary environments. This contrasts with the prevailing understanding that juveniles rear in the estuary before migrating upstream; however, it is supported by some fisheries data that has indicated the presence of alternate spawning and rearing life-histories. The presence of alternate juvenile rearing strategies may have important implications for conservation and management of the fisheries in the region.	[Hegg, Jens C.; Kennedy, Brian P.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA; [Giarrizzo, Tommaso] Fed Univ Para, UFPA, Lab Biol Pesqueira Manejo Recursos Aquat, BR-66059 Belem, PA, Brazil; [Kennedy, Brian P.] Univ Idaho, Dept Geol Sci, Moscow, ID 83843 USA; [Kennedy, Brian P.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA	Idaho; University of Idaho; Universidade Federal do Para; Idaho; University of Idaho; Idaho; University of Idaho	Hegg, JC (corresponding author), Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA.	hegg1432@vandals.uidaho.edu	Hegg, Jens/G-3380-2018; Giarrizzo, Tommaso/G-8482-2016	Hegg, Jens/0000-0003-0125-9287; Giarrizzo, Tommaso/0000-0002-5116-5206	CNPq [308278/2012-7]; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Giarrizzo received a productivity grant from CNPq (process: 308278/2012-7) and was funded by CAPES (PNPD and Pro-Amazonia: biodiversidade e sustentabilidade), which were used for sample permitting and collection. All other research activities were completed without specific funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cordoba EA, 2013, NEOTROP ICHTHYOL, V11, P637, DOI 10.1590/S1679-62252013000300017; Agudelo E, 2000, BAGRES AMAZONIA COLO; Allan JD, 2005, BIOSCIENCE, V55, P1041, DOI 10.1641/0006-3568(2005)055[1041:OOIW]2.0.CO;2; Alonso JC, 2002, PADRAO ESPACO TEMPOR; Queiroz Maria Mireide Andrade, 2009, Acta Amaz., V39, P943, DOI 10.1590/S0044-59672009000400022; Angelini R, 2006, AFR J AGR RES, V1, P151; Barnett-Johnson R, 2008, LIMNOL OCEANOGR, V53, P1633, DOI 10.4319/lo.2008.53.4.1633; Barthem R., 1997, CATFISH CONNECTION E; BARTHEM RB, 1991, BIOL CONSERV, V55, P339, DOI 10.1016/0006-3207(91)90037-A; Barthem Ronaldo Borges, 1995, P329; Bataille CP, 2012, CHEM GEOL, V304, P39, DOI 10.1016/j.chemgeo.2012.01.028; Batista JS, 2006, GENET MOL RES, V5, P723; Bauer S, 2014, SCIENCE, V344, P54, DOI 10.1126/science.1242552; Beechie T, 2006, BIOL CONSERV, V130, P560, DOI 10.1016/j.biocon.2006.01.019; Bouchez J, 2010, EARTH PLANET SC LETT, V290, P37, DOI 10.1016/j.epsl.2009.11.054; Bowlin MS, 2010, INTEGR COMP BIOL, V50, P261, DOI 10.1093/icb/icq013; Burke JL, 2004, LIFE HIST JUVENILE C; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Calcagno V, 2010, J STAT SOFTW, V34, P1; Carpenter SR, 2011, ANNU REV ENV RESOUR, V36, P75, DOI 10.1146/annurev-environ-021810-094524; Carvajal F, 2013, MADERA BASIN MONTPEL, V2; Cohen K.M., 2013, INT CHRONOSTRATIGRAP; Collins SM, 2013, T AM FISH SOC, V142, P1192, DOI 10.1080/00028487.2013.804005; Copeland T, 2009, CAN J FISH AQUAT SCI, V66, P1658, DOI 10.1139/F09-110; Crook DA, 2013, CAN J FISH AQUAT SCI, V70, P953, DOI 10.1139/cjfas-2012-0504; de Merona B, 2001, ENVIRON BIOL FISH, V60, P375, DOI 10.1023/A:1011033025706; Dudgeon D, 2011, J FISH BIOL, V79, P1487, DOI 10.1111/j.1095-8649.2011.03086.x; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; FabrU N.N., 2005, MANEJO PESCA GRANDES; Faure G., 2004, ISOTOPES PRINCIPLES; Fearnside PM, 2006, ENVIRON MANAGE, V38, P705, DOI 10.1007/s00267-005-0295-y; Fearnside PM, 2014, ENVIRON SCI POLICY, V38, P164, DOI 10.1016/j.envsci.2013.11.004; Finer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035126; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Forero J, 2013, WASHINGTON POST; Freeman MC, 2003, AM FISH S S, V35, P255; Gaillardet J, 1997, CHEM GEOL, V142, P141, DOI 10.1016/S0009-2541(97)00074-0; Garcez RCS, 2014, ECOL FRESHW FISH; Vasquez AG, 2009, J FISH BIOL, V75, P2527, DOI 10.1111/j.1095-8649.2009.02444.x; Godoy M.P, 1979, B FCAP, V11, P3; Hamann EJ, 2012, ECOLOGY, V93, P733, DOI 10.1890/11-1009.1; Hegg JC, 2013, CHEM GEOL, V360, P89, DOI 10.1016/j.chemgeo.2013.10.010; Hegg JC, 2013, OECOLOGIA, V172, P1017, DOI 10.1007/s00442-012-2564-9; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Hobbs JA, 2010, ENVIRON BIOL FISH, V89, P557, DOI 10.1007/s10641-010-9672-3; Hobson KA, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P273, DOI 10.1007/978-90-481-3354-3_13; Hogan Z, 2007, J FISH BIOL, V71, P818, DOI 10.1111/j.1095-8649.2007.01549.x; Hughes JM, 2014, MOL ECOL, V23, P1000, DOI 10.1111/mec.12661; JICA, 1998, FISH RES STUD AM TOC FISH RES STUD AM TOC; Jimenez EA, 2013, BRAZ J OCEANOGR, V61, P129, DOI 10.1590/S1679-87592013000200005; Junk WJ, 2011, WETLANDS, V31, P623, DOI 10.1007/s13157-011-0190-7; Kennedy BP, 2002, CAN J FISH AQUAT SCI, V59, P925, DOI [10.1139/f02-070, 10.1139/F02-070]; Kennedy BP, 1997, NATURE, V387, P766, DOI 10.1038/42835; Kennedy BP, 2000, CAN J FISH AQUAT SCI, V57, P2280, DOI 10.1139/cjfas-57-11-2280; Killick R, 2014, J STAT SOFTW, V58, P1; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; Muhlfeld CC, 2012, CAN J FISH AQUAT SCI, V69, P906, DOI 10.1139/F2012-033; Petrere M, 2004, REV FISH BIOL FISHER, V14, P403, DOI 10.1007/s11160-004-8362-7; Pikitch EK, 2005, FISH FISH, V6, P233, DOI 10.1111/j.1467-2979.2005.00190.x; Pirker LEM, 2008, MORFOMETRIA DESCRICA; PIRKER LEM, 2001, DETERMINACAO IDADE C; Poiani KA, 2000, BIOSCIENCE, V50, P133, DOI 10.1641/0006-3568(2000)050[0133:BCAMSF]2.3.CO;2; Pompeu PS, 2012, RIVER RES APPL, V28, P504, DOI 10.1002/rra.1557; Rosenberg DM, 2000, BIOSCIENCE, V50, P746, DOI 10.1641/0006-3568(2000)050[0746:GSEEOH]2.0.CO;2; Santos RV, 2013, HYDROL PROCESS; Secor DH, 1991, MANUAL OTOLITH REMOV, V1, P85; SIOLI HARALD, 1956, BOL TECN INST AGRON NORTE [BELEM], V32, P117; Stone R, 2007, SCIENCE, V316, P1684, DOI 10.1126/science.316.5832.1684; Tang KS, 1996, IEEE SIGNAL PROC MAG, V13, P22, DOI 10.1109/79.543973; Tavener B, 2012, RIO TIMES; Thorrold SR, 2001, SCIENCE, V291, P297, DOI 10.1126/science.291.5502.297; Tockner K., 2011, Ecohydrology and Hydrobiology, V11, P167; USGS, 1996, GTOPO30 30 ARC 2 EL; USGS, 1999, GEOL MAP AM REG; Walther BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018351; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Winemiller KO, 2005, CAN J FISH AQUAT SCI, V62, P872, DOI 10.1139/F05-040	78	38	40	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0129697	10.1371/journal.pone.0129697	http://dx.doi.org/10.1371/journal.pone.0129697			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26153984	Green Published, Green Submitted, gold			2022-12-27	WOS:000358159700016
J	Kalo, D; Hadas, R; Furman, O; Ben-Ari, J; Maor, Y; Patterson, DG; Tomey, C; Roth, Z				Kalo, Dorit; Hadas, Ron; Furman, Ori; Ben-Ari, Julius; Maor, Yehoshua; Patterson, Donald G.; Tomey, Cynthia; Roth, Zvi			Carryover Effects of Acute DEHP Exposure on Ovarian Function and Oocyte Developmental Competence in Lactating Cows	PLOS ONE			English	Article							DI(2-ETHYLHEXYL) PHTHALATE DEHP; IN-VITRO MATURATION; DI-(2-ETHYLHEXYL) PHTHALATE; MONO-(2-ETHYLHEXYL) PHTHALATE; MONO(2-ETHYLHEXYL) PHTHALATE; DIETHYLHEXYL PHTHALATE; REPRODUCTIVE HORMONES; LIQUID-CHROMATOGRAPHY; DISRUPTING COMPOUNDS; INDUCED MASTITIS	We examined acute exposure of Holstein cows to di(2-ethylhexyl)phthalate (DEHP) and its carryover effects on ovarian function and oocyte developmental competence. Synchronized cows were tube-fed with water or 100 mg/kg DEHP per day for 3 days. Blood, urine and milk samples were collected before, during and after DEHP exposure to examine its clearance pattern. Ovarian follicular dynamics was monitored through an entire estrous cycle by ultrasonographic scanning. Follicular fluids were aspirated from the preovulatory follicles on days 0 and 29 of the experiment and analyzed for phthalate metabolites and estradiol concentration. The aspirated follicular fluid was used as maturation medium for in-vitro embryo production. Findings revealed that DEHP impairs the pattern of follicular development, with a prominent effect on dominant follicles. The diameter and growth rate of the first- and second-wave dominant follicles were lower (P < 0.05) in the DEHP-treated group. Estradiol concentration in the follicular fluid was lower in the DEHP-treated group than in controls, and associated with a higher number of follicular pathologies (follicle diameter >25 mm). The pattern of growth and regression of the corpus luteum differed between groups, with a lower volume in the DEHP-treated group (P < 0.05). The follicular fluid aspirated from the DEHP-treated group, but not the controls, contained 23 nM mono(2-ethylhexyl) phthalate. Culturing of cumulus oocyte complexes in the follicular fluid aspirated from DEHP-treated cows reduced the proportion of oocytes progressing to the MII stage, and the proportions of 2- to 4-cell-stage embryos (P < 0.04) and 7-day blastocysts (P < 0.06). The results describe the risk associated with acute exposure to DEHP and its deleterious carryover effects on ovarian function, nuclear maturation and oocyte developmental competence.	[Kalo, Dorit; Hadas, Ron; Furman, Ori; Roth, Zvi] Hebrew Univ Jerusalem, Dept Anim Sci, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Kalo, Dorit; Maor, Yehoshua; Roth, Zvi] Hebrew Univ Jerusalem, Ctr Excellence Agr & Environm Hlth, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Ben-Ari, Julius] Hebrew Univ Jerusalem, Interdept Equipment Facil, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Patterson, Donald G.; Tomey, Cynthia] AXYS Analyt Serv Inc, Sidney, BC V8L 5X2, Canada	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Roth, Z (corresponding author), Hebrew Univ Jerusalem, Dept Anim Sci, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel.	roth@agri.huji.ac.il	Roth, Zvi/AAA-1581-2020; Roth, Zvi/R-8025-2019		Environment and Health Fund, Jerusalem, Israel; Israeli Dairy Board [821-130-10]; AXYS Analytical Services Inc.	Environment and Health Fund, Jerusalem, Israel; Israeli Dairy Board; AXYS Analytical Services Inc.	The study was conducted in the framework of The Hebrew University Center of Excellence in Agriculture and Environmental Health funded by the Environment and Health Fund, Jerusalem, Israel, and by the Israeli Dairy Board (project #821-130-10). The author who received the funding is ZR. AXYS Analytical Services Inc., provided support in the form of salaries for authors DP and CT, but did not have any additional role in the study design, data collection and data analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ambruosi B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027452; Anas MKI, 2003, REPROD TOXICOL, V17, P305, DOI 10.1016/S0890-6238(03)00014-5; Asaf S, 2014, REPRODUCTION, V147, P33, DOI 10.1530/REP-13-0383; ATSDR, 2002, TOXICOLOGICAL PROFIL; Beker ARCL, 2002, THERIOGENOLOGY, V58, P1663, DOI 10.1016/S0093-691X(02)01082-8; Bosnir J, 2003, COLLEGIUM ANTROPOL, V27, P23; Carnevali O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010201; Clarke HG, 2006, REPRODUCTION, V132, P119, DOI 10.1530/rep.1.00960; Cobellis L, 2003, HUM REPROD, V18, P1512, DOI 10.1093/humrep/deg254; DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200; Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656; ECHA, 2008, EUROPEAN UNION SUMMA; EDWARDS RG, 1974, J REPROD FERTIL, V37, P189, DOI 10.1530/jrf.0.0370189; Frederiksen H, 2010, J ANAL TOXICOL, V34, P400, DOI 10.1093/jat/34.7.400; Gendelman M, 2010, REPRODUCTION, V140, P73, DOI 10.1530/REP-10-0055; Grande SW, 2007, TOXICOLOGY, V229, P114, DOI 10.1016/j.tox.2006.10.005; Grossman D, 2012, CELL BIOL TOXICOL, V28, P383, DOI 10.1007/s10565-012-9230-1; Gupta RK, 2010, TOXICOL APPL PHARM, V242, P224, DOI 10.1016/j.taap.2009.10.011; Hannon PR, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00008; Hannon PR, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.119032; HEINDEL JJ, 1989, FUND APPL TOXICOL, V12, P508, DOI 10.1016/0272-0590(89)90024-9; Herreros MA, 2013, REPROD BIOL, V13, P66, DOI 10.1016/j.repbio.2013.01.177; Hirosawa N, 2006, PROTEOMICS, V6, P958, DOI 10.1002/pmic.200401344; Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515, DOI 10.1289/ehp.02110515; Inada H, 2012, J TOXICOL SCI, V37, P483; Ito Y, 2005, ARCH TOXICOL, V79, P147, DOI 10.1007/s00204-004-0615-7; Izadyar F, 1998, MOL REPROD DEV, V49, P444, DOI 10.1002/(SICI)1098-2795(199804)49:4&lt;444::AID-MRD12&gt;3.0.CO;2-U; Jarosova A, 2006, CZECH J FOOD SCI, V24, P223, DOI 10.17221/3318-CJFS; Kalo D, 2015, REPROD TOXICOL, V53, P141, DOI 10.1016/j.reprotox.2015.04.007; Kalo D, 2011, REPROD FERT DEVELOP, V23, P876, DOI 10.1071/RD10330; Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248; Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1; Kessler W, 2012, TOXICOL APPL PHARM, V264, P284, DOI 10.1016/j.taap.2012.08.009; Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x; Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4; Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208; Krejcikova M, 2013, MENDELNET 2013, P592; Krotz SP, 2012, J ASSIST REPROD GEN, V29, P773, DOI 10.1007/s10815-012-9775-1; Kurata Y, 2012, J TOXICOL SCI, V37, P33, DOI 10.2131/jts.37.33; LASKEY JW, 1993, REPROD TOXICOL, V7, P25, DOI 10.1016/0890-6238(93)90006-S; Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202; Lavon Y, 2011, THERIOGENOLOGY, V76, P942, DOI 10.1016/j.theriogenology.2011.05.001; Lenie S, 2009, TOXICOL LETT, V185, P143, DOI 10.1016/j.toxlet.2008.12.015; Li N, 2012, ENVIRON TOXICOL PHAR, V34, P869, DOI 10.1016/j.etap.2012.08.013; Liang P, 2008, ANAL CHIM ACTA, V609, P53, DOI 10.1016/j.aca.2007.12.025; LINDGREN A, 1982, TOXICOLOGY, V23, P149, DOI 10.1016/0300-483X(82)90094-4; Liu T, 2014, REPROD TOXICOL, V46, P141, DOI 10.1016/j.reprotox.2014.03.006; Ljungvall K, 2004, ARCH TOXICOL, V78, P384, DOI 10.1007/s00204-004-0558-z; Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156; Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139, DOI 10.1289/ehp.5658; LUSSIER JG, 1987, J REPROD FERTIL, V81, P301, DOI 10.1530/jrf.0.0810301; Lyche JL, 2009, J TOXICOL ENV HEAL B, V12, P225, DOI 10.1080/10937400903094091; Ma MY, 2006, TOXICOL SCI, V93, P164, DOI 10.1093/toxsci/kfl036; Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075; Martino-Andrade AJ, 2010, MOL NUTR FOOD RES, V54, P148, DOI 10.1002/mnfr.200800312; Mlynarcikova A, 2009, TOXICOL IN VITRO, V23, P371, DOI 10.1016/j.tiv.2008.12.017; Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690; Peters JM, 1997, TERATOLOGY, V56, P311, DOI 10.1002/(SICI)1096-9926(199711)56:5<311::AID-TERA4>3.0.CO;2-#; Reinsberg J, 2009, TOXICOL APPL PHARM, V239, P116, DOI 10.1016/j.taap.2009.05.022; Rhind SM, 2010, ANIMAL, V4, P1227, DOI 10.1017/S1751731110000595; Rhind SM, 2005, REPROD DOMEST ANIM, V40, P282, DOI 10.1111/j.1439-0531.2005.00594.x; Rhind SM, 2005, ENVIRON HEALTH PERSP, V113, P447, DOI 10.1289/ehp.7469; RHODES C, 1986, ENVIRON HEALTH PERSP, V65, P299, DOI 10.2307/3430197; Roth Z, 2012, J DAIRY SCI, V95, P1729, DOI 10.3168/jds.2011-4513; Roth Z, 2001, REPRODUCTION, V122, P737, DOI 10.1530/rep.0.1220737; Rudel RA, 2009, ATMOS ENVIRON, V43, P170, DOI 10.1016/j.atmosenv.2008.09.025; Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4; SIROIS J, 1988, BIOL REPROD, V39, P308, DOI 10.1095/biolreprod39.2.308; Svechnikova I, 2007, J ENDOCRINOL, V194, P603, DOI 10.1677/JOE-07-0238; TOMITA I, 1986, ENVIRON HEALTH PERSP, V65, P249, DOI 10.2307/3430190; van Woudenberg AB, 2012, REPROD TOXICOL, V34, P251, DOI 10.1016/j.reprotox.2012.05.098; Wang W, 2012, TOXICOL APPL PHARM, V258, P288, DOI 10.1016/j.taap.2011.11.008; World Health Organization, 2003, DI 2 ETHYLHEXYL PHTH; Xu CA, 2010, TOXICOL LETT, V199, P323, DOI 10.1016/j.toxlet.2010.09.015; Zeng F, 2009, J HAZARD MATER, V164, P1171, DOI 10.1016/j.jhazmat.2008.09.029; Zhang T, 2014, ENVIRON MOL MUTAGEN, V55, P343, DOI 10.1002/em.21847; Zhang XF, 2013, ENVIRON MOL MUTAGEN, V54, P354, DOI 10.1002/em.21776	77	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130896	10.1371/journal.pone.0130896	http://dx.doi.org/10.1371/journal.pone.0130896			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154164	Green Published, Green Submitted, gold			2022-12-27	WOS:000358159700043
J	Kondo, MC; Keene, D; Hohl, BC; MacDonald, JM; Branas, CC				Kondo, Michelle C.; Keene, Danya; Hohl, Bernadette C.; MacDonald, John M.; Branas, Charles C.			A Difference-In-Differences Study of the Effects of a New Abandoned Building Remediation Strategy on Safety	PLOS ONE			English	Article							CRIME; HEALTH; DISORDER; VACANT; NEIGHBORHOODS; MULTILEVEL; IMPACTS; POLICY; LAND; CITY	Vacant and abandoned buildings pose significant challenges to the health and safety of communities. In 2011 the City of Philadelphia began enforcing a Doors and Windows Ordinance that required property owners of abandoned buildings to install working doors and windows in all structural openings or face significant fines. We tested the effects of the new ordinance on the occurrence of crime surrounding abandoned buildings from January 2011 to April 2013 using a difference-in-differences approach. We used Poisson regression models to compare differences in pre- and post-treatment measures of crime for buildings that were remediated as a result of the ordinance (n = 676) or permitted for renovation (n = 241), and randomly-matched control buildings that were not remediated (n = 676) or permitted for renovation (n = 964), while also controlling for sociodemographic and other confounders measured around each building. Building remediations were significantly associated with citywide reductions in overall crimes, total assaults, gun assaults and nuisance crimes (p < 0.001). Building remediations were also significantly associated with reductions in violent gun crimes in one city section (p < 0.01). At the same time, some significant increases were seen in narcotics sales and possession and property crimes around remediated buildings (p < 0.001). Building renovation permits were significantly associated with reductions in all crime classifications across multiple city sections (p < 0.001). We found no significant spatial displacement effects. Doors and windows remediation offers a relatively low-cost method of reducing certain crimes in and around abandoned buildings. Cities with an abundance of decaying and abandoned housing stock might consider some form of this structural change to their built environments as one strategy to enhance public safety.	[Kondo, Michelle C.] US Forest Serv, USDA, No Res Stn, Philadelphia, MS 39350 USA; [Kondo, Michelle C.; Hohl, Bernadette C.; Branas, Charles C.] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Keene, Danya] Yale Univ, Sch Publ Hlth, Social & Behav Sci, New Haven, CT USA; [MacDonald, John M.] Univ Penn, Sch Arts & Sci, Dept Criminol, Philadelphia, PA USA	United States Department of Agriculture (USDA); United States Forest Service; University of Pennsylvania; Pennsylvania Medicine; Yale University; University of Pennsylvania	Kondo, MC (corresponding author), US Forest Serv, USDA, No Res Stn, Philadelphia, MS 39350 USA.	michelleckondo@fs.fed.us		Kondo, Michelle/0000-0001-9152-1589	Robert Wood Johnson Health and Societies Program; National Institutes of Health [R01AA020331]; Centers for Disease Control [R49CE002474]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL [R49CE002474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020331] Funding Source: NIH RePORTER	Robert Wood Johnson Health and Societies Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was funded in part by the Robert Wood Johnson Health and Societies Program, the National Institutes of Health (grant no. R01AA020331), and the Centers for Disease Control (grant no. R49CE002474).	Accordino J, 2000, J URBAN AFF, V22, P301, DOI 10.1111/0735-2166.00058; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Berk R, 2008, J QUANT CRIMINOL, V24, P269, DOI 10.1007/s10940-008-9048-4; Branas CC, 2012, ISRN PUBLIC HLTH, DOI [10.5402/ 2012/ 246142, DOI 10.5402/2012/246142]; Branas CC, 2014, J PUBLIC HEALTH MAN, V20, P157, DOI 10.1097/PHH.0000000000000051; Branas CC, 2011, AM J EPIDEMIOL, V174, P1296, DOI 10.1093/aje/kwr273; Cameron A.C., 2009, MICROECONOMETRICS US; Cohen D, 2000, AM J PUBLIC HEALTH, V90, P230, DOI 10.2105/AJPH.90.2.230; Cohen DA, 2003, AM J PUBLIC HEALTH, V93, P467, DOI 10.2105/AJPH.93.3.467; Cohen JR, 2001, HOUS POLICY DEBATE, V12, P415; Federal Bureau of Investigation, 2004, CRIME IN THE UNITED; Frazier AE, 2013, APPL GEOGR, V41, P55, DOI 10.1016/j.apgeog.2013.02.014; Furr-Holden CDM, 2011, J STUD ALCOHOL DRUGS, V72, P371, DOI 10.15288/jsad.2011.72.371; Garvin E, 2012, INJURY PREV, V19, P198, DOI [10.1136/injuryprev-2012-040439, DOI 10.1136/INJURYPREV-2012-040439]; Garvin E, 2013, J URBAN HEALTH, V90, P412, DOI 10.1007/s11524-012-9782-7; Han HS, 2014, HOUS POLICY DEBATE, V24, P311, DOI 10.1080/10511482.2013.832350; Hannon L, 2006, AM J DRUG ALCOHOL AB, V32, P453, DOI 10.1080/00952990600753966; Keizer K, 2008, SCIENCE, V322, P1681, DOI 10.1126/science.1161405; Mallach A, 2010, FACING THE URBAN CHA; MEYER BD, 1995, J BUS ECON STAT, V13, P151, DOI 10.2307/1392369; Redevelopment Authority of the City of Philadelphia Philadelphia Association of Community Development Corporations, 2010, VACANT LAND MANAGEME; Robinson JB, 2003, J QUANT CRIMINOL, V19, P237, DOI 10.1023/A:1024956925170; Sampson RJ, 1999, AM J SOCIOL, V105, P603, DOI 10.1086/210356; SAMPSON RJ, 1989, AM J SOCIOL, V94, P774, DOI 10.1086/229068; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Sampson RJ, 2013, CRIMINOLOGY, V51, P1, DOI 10.1111/1745-9125.12002; Skogan Wesley G., 1992, DISORDER AND DECLINE; SPELMAN W, 1993, J CRIM JUST, V21, P481, DOI 10.1016/0047-2352(93)90033-J; Taylor Ralph B., 2001, BREAKING AWAY FROM B; Teixeira S, 2013, J COMMUNITY PRACT, V21, P248, DOI 10.1080/10705422.2013.811621; United States Government Accountability Office, 2011, VACANT PROPERTIES GR; Wilson JQ, 1982, BROKEN WINDOWS POLIC, P249	32	41	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0129582	10.1371/journal.pone.0129582	http://dx.doi.org/10.1371/journal.pone.0129582			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26153687	gold, Green Published			2022-12-27	WOS:000358159700014
J	Cremaschi, P; Oliverio, M; Leva, V; Bione, S; Carriero, R; Mazzucco, G; Palamidessi, A; Scita, G; Biamonti, G; Montecucco, A				Cremaschi, Paolo; Oliverio, Matteo; Leva, Valentina; Bione, Silvia; Carriero, Roberta; Mazzucco, Giulia; Palamidessi, Andrea; Scita, Giorgio; Biamonti, Giuseppe; Montecucco, Alessandra			Chronic Replication Problems Impact Cell Morphology and Adhesion of DNA Ligase I Defective Cells	PLOS ONE			English	Article							DAMAGE RESPONSE; GENOMIC INSTABILITY; EXPRESSION ANALYSIS; RNA-SEQ; GENE; PHOSPHORYLATION; CANCER; CYCLE; ATM; PROLIFERATION	Moderate DNA damage resulting from metabolic activities or sub-lethal doses of exogenous insults may eventually lead to cancer onset. Human 46BR.1G1 cells bear a mutation in replicative DNA ligase I (LigI) which results in low levels of replication-dependent DNA damage. This replication stress elicits a constitutive phosphorylation of the ataxia telangiectasia mutated (ATM) checkpoint kinase that fails to arrest cell cycle progression or to activate apoptosis or cell senescence. Stable transfection of wild type Ligl, as in 7A3 cells, prevents DNA damage and ATM activation. Here we show that parental 46BR.1G1 and 7A3 cells differ in important features such as cell morphology, adhesion and migration. Comparison of gene expression profiles in the two cell lines detects Bio-Functional categories consistent with the morphological and migration properties of LigI deficient cells. Interestingly, ATM inhibition makes 46BR.1G1 more similar to 7A3 cells for what concerns morphology, adhesion and expression of cell-cell adhesion receptors. These observations extend the influence of the DNA damage response checkpoint pathways and unveil a role for ATM kinase activity in modulating cell biology parameters relevant to cancer progression.	[Cremaschi, Paolo; Oliverio, Matteo; Leva, Valentina; Bione, Silvia; Carriero, Roberta; Mazzucco, Giulia; Biamonti, Giuseppe; Montecucco, Alessandra] CNR, Ist Genet Mol, I-27100 Pavia, Italy; [Cremaschi, Paolo; Mazzucco, Giulia] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, I-27100 Pavia, Italy; [Carriero, Roberta] IUSS, Pavia, Italy; [Palamidessi, Andrea; Scita, Giorgio] IFOM, Fdn Ist FIRC Oncol Mol, Milan, Italy; [Scita, Giorgio] Univ Milan, Dipartimento Sci Salute, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Pavia; IUSS PAVIA; IFOM - FIRC Institute of Molecular Oncology; University of Milan	Montecucco, A (corresponding author), CNR, Ist Genet Mol, I-27100 Pavia, Italy.	montecucco@igm.cnr.it	Carriero, Roberta/AAA-4709-2019; Palamidessi, Andrea/F-1203-2018	palamidessi, andrea/0000-0002-7134-7023; Oliverio, Matteo/0000-0002-7969-2796; Cremaschi, Paolo/0000-0001-5349-4188; BIAMONTI, GIUSEPPE/0000-0001-6804-4315; Montecucco, Alessandra/0000-0002-9388-9149; Carriero, Roberta/0000-0001-8619-6152; Bione, Silvia/0000-0002-3924-4606	Associazione Italiana per la Ricerca sul Cancro; Italian Ministry of Education-University-Research (MIUR); PNR-CNR Aging Program CNR-MIUR; Flagship project Epigen CNR-MIUR; Association for International Cancer Research; CARIPLO Foundation; Fondazione Adriano Buzzati Traverso	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Education-University-Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); PNR-CNR Aging Program CNR-MIUR; Flagship project Epigen CNR-MIUR; Association for International Cancer Research; CARIPLO Foundation(Fondazione Cariplo); Fondazione Adriano Buzzati Traverso	This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (to GB, GS, AP), the Italian Ministry of Education-University-Research (MIUR) (to GS), PNR-CNR Aging Program CNR-MIUR and Flagship project Epigen CNR-MIUR (to GB), the Association for International Cancer Research (to GS), and the CARIPLO Foundation (to GB, GS, AP). VL was supported by a postdoctoral fellowship from Fondazione Adriano Buzzati Traverso; MO was supported by a fellowship from PNR-CNR Aging Program CNR-MIUR; PC is a student of the PhD program in Genetics, Molecular and Cellular Biology of the University of Pavia; RC is a student of the PhD program in Scienze Biomolecolari e Biotecnologia, IUSS, Pavia.	Alzu A, 2012, CELL, V151, P835, DOI 10.1016/j.cell.2012.09.041; BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; Bennetzen MV, 2010, MOL CELL PROTEOMICS, V9, P1314, DOI 10.1074/mcp.M900616-MCP200; Bensimon A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001034; Biamonti G, 2014, SEMIN CELL DEV BIOL, V32, P30, DOI 10.1016/j.semcdb.2014.03.016; Bonacci TM, 2012, CELL SIGNAL, V24, P2102, DOI 10.1016/j.cellsig.2012.07.015; Camarda G, 2004, J CELL BIOL, V167, P417, DOI 10.1083/jcb.200408164; Chikh A, 2011, EMBO J, V30, P4261, DOI 10.1038/emboj.2011.302; GARIBOLDI M, 1995, MOL CARCINOGEN, V14, P71, DOI 10.1002/mc.2940140202; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Harrison C, 2002, CANCER RES, V62, P4065; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; House NCM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00296; Imanirad P, 2013, BLOOD CELL MOL DIS, V51, P256, DOI 10.1016/j.bcmd.2013.08.005; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Leva V, 2012, NUCLEIC ACIDS RES, V40, P1106, DOI 10.1093/nar/gkr837; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Lidonnici MR, 2004, J CELL SCI, V117, P5221, DOI 10.1242/jcs.01405; Lin YL, 2013, UROL INT, V90, P225, DOI 10.1159/000345054; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MONTECUCCO A, 1992, NUCLEIC ACIDS RES, V20, P6209, DOI 10.1093/nar/20.23.6209; Montecucco Alessandra, 2013, Frontiers in Genetics, V4, P102, DOI 10.3389/fgene.2013.00102; Moore MJ, 2010, CELL, V142, P625, DOI 10.1016/j.cell.2010.07.019; Peng XA, 2011, INT REV CEL MOL BIO, V287, P191, DOI 10.1016/B978-0-12-386043-9.00005-0; Reinhardt HC, 2010, MOL CELL, V40, P34, DOI 10.1016/j.molcel.2010.09.018; Rossi R, 2006, CANCER RES, V66, P1675, DOI 10.1158/0008-5472.CAN-05-2741; Saito M, 2012, J CELL SCI, V125, P2547, DOI 10.1242/jcs.066654; Santos MA, 2014, NATURE, V514, P107, DOI 10.1038/nature13483; Semenza GL, 2012, TRENDS MOL MED, V18, P534, DOI 10.1016/j.molmed.2012.08.001; Sherman MH, 2011, TRENDS CELL BIOL, V21, P312, DOI 10.1016/j.tcb.2011.01.004; Shultz JC, 2010, CANCER RES, V70, P9185, DOI 10.1158/0008-5472.CAN-10-1545; Soza S, 2009, MOL CELL BIOL, V29, P2032, DOI 10.1128/MCB.01730-08; Sulli G, 2012, NAT REV CANCER, V12, DOI 10.1038/nrc3344; Sun DY, 2001, CLIN CANCER RES, V7, P4143; Thedieck C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000657; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vijayakumar S, 2009, MOL CELL BIOL, V29, P2042, DOI 10.1128/MCB.01732-08; Vitolo B, 2005, EUR J HISTOCHEM, V49, P349; Wang JF, 2011, ONCOL REP, V26, P101, DOI 10.3892/or.2011.1286; WEBSTER ADB, 1992, LANCET, V339, P1508, DOI 10.1016/0140-6736(92)91266-B; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	46	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0130561	10.1371/journal.pone.0130561	http://dx.doi.org/10.1371/journal.pone.0130561			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151554	Green Published, gold, Green Submitted			2022-12-27	WOS:000358158900011
J	Stutz, C; Reinz, E; Honegger, A; Bulkescher, J; Schweizer, J; Zanier, K; Trave, G; Lohrey, C; Hoppe-Seyler, K; Hoppe-Seyler, F				Stutz, Christina; Reinz, Eileen; Honegger, Anja; Bulkescher, Julia; Schweizer, Johannes; Zanier, Katia; Trave, Gilles; Lohrey, Claudia; Hoppe-Seyler, Karin; Hoppe-Seyler, Felix			Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides	PLOS ONE			English	Article							POSITIVE CANCER-CELLS; CERVICAL-CANCER; E6-MEDIATED DEGRADATION; NUCLEAR-LOCALIZATION; P53; PROTEIN; AGGRESOMES; ASSOCIATION; INDUCTION; APOPTOSIS	Oncogenic types of human papillomaviruses (HPVs) cause cervical cancer and other malignancies in humans. The HPV E6 oncoprotein is considered to be an attractive therapeutic target since its inhibition can lead to the apoptotic cell death of HPV-positive cancer cells. The HPV type 16 (HPV16) E6-binding peptide pep11, and variants thereof, induce cell death specifically in HPV16-positive cancer cells. Although they do not encompass the LxxLL binding motif found in cellular HPV16 E6 interaction partners, such as E6AP, the pep11 variants strongly bind to HPV16 E6 by contacting the recently identified E6AP binding pocket. Thus, these peptides can serve as prototype E6-inhibitory molecules which target the E6AP pocket. We here analyzed their intracellular interaction with HPV16 E6. By comprehensive intracellular binding studies and GST pull-down assays, we show that E6-binding competent pep11 variants induce the formation of a trimeric complex, consisting of pep11, HPV16 E6 and p53. These findings indicate that peptides, which do not contain the LxxLL motif, can reshape E6 to enable its interaction with p53. The formation of the trimeric HPV16 E6 / peptide / p53 complex was associated with an increase of endogenous HPV16 E6 protein amounts. Yet, total cellular p53 amounts were also increased, indicating that the E6 / E6AP-mediated degradation of p53 is blocked. These findings suggest that inhibition of oncogenic activities by targeting the E6AP pocket on HPV16 E6 could be a strategy for therapeutic intervention.	[Stutz, Christina; Reinz, Eileen; Honegger, Anja; Bulkescher, Julia; Lohrey, Claudia; Hoppe-Seyler, Karin; Hoppe-Seyler, Felix] German Canc Res Ctr, Program Infect & Canc, Mol Therapy Virus Associated Canc F065, D-69120 Heidelberg, Germany; [Schweizer, Johannes] Arbor Vita Corp, Fremont, CA 94085 USA; [Zanier, Katia; Trave, Gilles] IREBS, F-67412 Illkirch Graffenstaden, France	Helmholtz Association; German Cancer Research Center (DKFZ)	Hoppe-Seyler, F (corresponding author), German Canc Res Ctr, Program Infect & Canc, Mol Therapy Virus Associated Canc F065, D-69120 Heidelberg, Germany.	hoppe-seyler@dkfz.de	TRAVE, Gilles/P-8577-2016	Hoppe-Seyler, Felix/0000-0002-1864-300X	Deutsche Krebshilfe [109392]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by a grant of the Deutsche Krebshilfe (http://www.krebshilfe.de/metanavigation/english.html) to F.H.S (# 109392). One author (Dr. J. Schweizer) is employed by a commercial company (Arbor Vita Corporation). He provided antibodies for E6 detection. The funder provided support in the form of salary for JS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ansari T, 2012, J VIROL, V86, P11386, DOI 10.1128/JVI.01236-12; Butz K, 2000, P NATL ACAD SCI USA, V97, P6693, DOI 10.1073/pnas.110538897; Butz K, 2003, ONCOGENE, V22, P5938, DOI 10.1038/sj.onc.1206894; Camus S, 2007, ONCOGENE, V26, P4059, DOI 10.1038/sj.onc.1210188; Dymalla S, 2009, J MOL MED, V87, P321, DOI 10.1007/s00109-008-0432-1; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Griffin H, 2006, J MOL BIOL, V355, P360, DOI 10.1016/j.jmb.2005.10.077; Hellner K, 2011, J CLIN ONCOL, V29, P1785, DOI 10.1200/JCO.2010.28.2186; Hoppe-Seyler F, 2011, INT J CANCER, V129, P1289, DOI 10.1002/ijc.26087; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kuballa P, 2007, J BIOL CHEM, V282, P65, DOI 10.1074/jbc.M605117200; Lagrange M, 2007, BIOCHEM BIOPH RES CO, V361, P487, DOI 10.1016/j.bbrc.2007.07.040; Li XQ, 1996, J VIROL, V70, P4509, DOI 10.1128/JVI.70.7.4509-4516.1996; Massimi P, 2008, ONCOGENE, V27, P1800, DOI 10.1038/sj.onc.1210810; Masson M, 2003, J GEN VIROL, V84, P2099, DOI 10.1099/vir.0.18961-0; McLaughlin-Drubin ME, 2009, VIRUS RES, V143, P195, DOI 10.1016/j.virusres.2009.06.008; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Shal A, 2007, ONCOGENE, V26, P3321, DOI 10.1038/sj.onc.1210130; Spangle JM, 2012, J VIROL, V86, P7466, DOI 10.1128/JVI.00487-12; Stanley MA, 2012, J GEN VIROL, V93, P681, DOI 10.1099/vir.0.039677-0; Tao MF, 2003, J VIROL, V77, P13232, DOI 10.1128/JVI.77.24.13232-13247.2003; Tomai E, 2006, J BIOL CHEM, V281, P21345, DOI 10.1074/jbc.M604258200; Tomaic V, 2009, VIROLOGY, V393, P7, DOI 10.1016/j.virol.2009.07.029; Yamato K, 2006, CANCER GENE THER, V13, P234, DOI 10.1038/sj.cgt.7700891; Zanier K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112514; Zanier K, 2013, SCIENCE, V339, P694, DOI 10.1126/science.1229934; Zanier K, 2012, STRUCTURE, V20, P604, DOI 10.1016/j.str.2012.02.001; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	32	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132339	10.1371/journal.pone.0132339	http://dx.doi.org/10.1371/journal.pone.0132339			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151636	Green Published, Green Submitted, gold			2022-12-27	WOS:000358158900042
J	Suvorova, IA; Korostelev, YD; Gelfand, MS				Suvorova, Inna A.; Korostelev, Yuri D.; Gelfand, Mikhail S.			GntR Family of Bacterial Transcription Factors and Their DNA Binding Motifs: Structure, Positioning and Co-Evolution	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACILLUS-SUBTILIS; COMPARATIVE GENOMICS; ARABINOSE REGULON; REGULATORY SITES; GENE-REGULATION; PROTEIN; RECOGNITION; METABOLISM; SPECIFICITY	The GNTR family of transcription factors (TFs) is a large group of proteins present in diverse bacteria and regulating various biological processes. Here we use the comparative genomics approach to reconstruct regulons and identify binding motifs of regulators from three subfamilies of the GNTR family, FADR, HUTC, and YTRA. Using these data, we attempt to predict DNA-protein contacts by analyzing correlations between binding motifs in DNA and amino acid sequences of TFs. We identify pairs of positions with high correlation between amino acids and nucleotides for FADR, HUTC, and YTRA subfamilies and show that the most predicted DNA-protein interactions are quite similar in all subfamilies and conform well to the experimentally identified contacts formed by FadR from E. coli and AraR from B. subtilis. The most frequent predicted contacts in the analyzed subfamilies are Arg-G, Asn-A, Asp-C. We also analyze the divergon structure and preferred site positions relative to regulated genes in the FADR and HUTC subfamilies. A single site in a divergon usually regulates both operons and is approximately in the middle of the intergenic area. Double sites are either involved in the co-operative regulation of both operons and then are in the center of the intergenic area, or each site in the pair independently regulates its own operon and tends to be near it. We also identify additional candidate TF-binding boxes near palindromic binding sites of TFs from the FADR, HUTC, and YTRA subfamilies, which may play role in the binding of additional TF-subunits.	[Suvorova, Inna A.; Korostelev, Yuri D.; Gelfand, Mikhail S.] RAS, Res & Training Ctr Bioinformat, Kharkevich Inst, Inst Informat Transmiss Problems, Moscow 117901, Russia; [Gelfand, Mikhail S.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia	Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Lomonosov Moscow State University	Suvorova, IA (corresponding author), RAS, Res & Training Ctr Bioinformat, Kharkevich Inst, Inst Informat Transmiss Problems, Moscow 117901, Russia.	inn1313@yandex.ru	Gelfand, Mikhail S/F-3425-2012	Gelfand, Mikhail/0000-0003-4181-0846	Russian Science Foundation [14-24-00155]	Russian Science Foundation(Russian Science Foundation (RSF))	This research was supported by the Russian Science Foundation via grant 14-24-00155 (http://PHdp.pdp/, to MSG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 2003, FEMS MICROBIOL LETT, V222, P17, DOI 10.1016/S0378-1097(03)00242-8; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Belitsky BR, 2004, J MOL BIOL, V340, P655, DOI 10.1016/j.jmb.2004.05.020; Benson DA, 1999, NUCLEIC ACIDS RES, V27, P12, DOI 10.1093/nar/27.1.12; Bramucci E, 2011, BIOCHEM BIOPH RES CO, V415, P88, DOI 10.1016/j.bbrc.2011.10.017; Brinkman AB, 2003, MOL MICROBIOL, V48, P287, DOI 10.1046/j.1365-2958.2003.03442.x; Camas FM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000989; Condemine G, 2005, J BACTERIOL, V187, P1959, DOI 10.1128/JB.187.6.1959-1965.2005; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Desai TA, 2009, NUCLEIC ACIDS RES, V37, P2493, DOI 10.1093/nar/gkp079; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Feng YJ, 2013, MOL MICROBIOL, V88, P77, DOI 10.1111/mmi.12170; Franco IS, 2007, NUCLEIC ACIDS RES, V35, P4755, DOI 10.1093/nar/gkm509; Franco IS, 2006, J BACTERIOL, V188, P3024, DOI 10.1128/JB.188.8.3024-3036.2006; Gelfand MS, 2000, NUCLEIC ACIDS RES, V28, P695, DOI 10.1093/nar/28.3.695; Gromiha MM, 2011, J CHEM INF MODEL, V51, P721, DOI 10.1021/ci1003703; Hill T., 2007, STAT METHODS APPL; Huang N, 2009, STRUCTURE, V17, P939, DOI 10.1016/j.str.2009.05.012; Jain D, 2013, NUCLEIC ACIDS RES, V41, P639, DOI 10.1093/nar/gks962; Jochmann N, 2011, MICROBIOL-SGM, V157, P77, DOI 10.1099/mic.0.044818-0; Konig B, 2009, NUCLEIC ACIDS RES, V37, P1915, DOI 10.1093/nar/gkp044; Lee MH, 2003, J BACTERIOL, V185, P4315, DOI 10.1128/JB.185.15.4315-4325.2003; Luscombe NM, 2002, J MOL BIOL, V320, P991, DOI 10.1016/S0022-2836(02)00571-5; LUSTIG B, 1995, NUCLEIC ACIDS RES, V23, P4707, DOI 10.1093/nar/23.22.4707; Madar D, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-111; Magarvey N, 2001, MICROBIOL-SGM, V147, P2103, DOI 10.1099/00221287-147-8-2103; Mahony S, 2007, BIOINFORMATICS, V23, pI297, DOI 10.1093/bioinformatics/btm215; Marabotti A, 2008, J COMPUT CHEM, V29, P1955, DOI 10.1002/jcc.20954; Martinez-Antonio A, 2008, J MOL BIOL, V381, P238, DOI 10.1016/j.jmb.2008.05.054; Mirny LA, 2002, NUCLEIC ACIDS RES, V30, P1704, DOI 10.1093/nar/30.7.1704; Mironov A. A., 2000, Molekulyarnaya Biologiya (Moscow), V34, P253; Morozov AV, 2007, P NATL ACAD SCI USA, V104, P7068, DOI 10.1073/pnas.0701356104; Morozov AV, 2005, NUCLEIC ACIDS RES, V33, P5781, DOI 10.1093/nar/gki875; Mota LJ, 2001, J BACTERIOL, V183, P4190, DOI 10.1128/JB.183.14.4190-4201.2001; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pW299, DOI 10.1093/nar/gkq531; Ofran Y, 2007, BIOINFORMATICS, V23, pI347, DOI 10.1093/bioinformatics/btm174; Perez-Rueda E, 2000, NUCLEIC ACIDS RES, V28, P1838, DOI 10.1093/nar/28.8.1838; QUAIL MA, 1994, FEBS LETT, V356, P183, DOI 10.1016/0014-5793(94)01264-4; Ravcheev DA, 2012, J BACTERIOL, V194, P1145, DOI 10.1128/JB.06412-11; Rigali S, 2004, NUCLEIC ACIDS RES, V32, P3418, DOI 10.1093/nar/gkh673; Rigali S, 2002, J BIOL CHEM, V277, P12507, DOI 10.1074/jbc.M110968200; Rodionov DA, 2006, FEMS MICROBIOL LETT, V255, P102, DOI 10.1111/j.1574-6968.2005.00070.x; Rodionov DA, 2007, CHEM REV, V107, P3467, DOI 10.1021/cr068309+; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Sharadamma N, 2011, FEBS J, V278, P3447, DOI 10.1111/j.1742-4658.2011.08267.x; Suvorova IA, 2012, J BACTERIOL, V194, P3234, DOI 10.1128/JB.00163-12; Tan K, 2005, GENOME RES, V15, P312, DOI 10.1101/gr.3069205; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; van Aalten DMF, 2001, EMBO J, V20, P2041, DOI 10.1093/emboj/20.8.2041; Wiethaus J, 2008, J BACTERIOL, V190, P487, DOI 10.1128/JB.01510-07; Xu YB, 2001, J BIOL CHEM, V276, P17373, DOI 10.1074/jbc.M100195200; Yang C, 2006, J BIOL CHEM, V281, P29872, DOI 10.1074/jbc.M605052200; Zhang L, 2012, J BACTERIOL, V194, P1055, DOI 10.1128/JB.06241-11; Zheng MY, 2009, ACTA CRYSTALLOGR D, V65, P356, DOI 10.1107/S0907444909004727	57	50	56	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132618	10.1371/journal.pone.0132618	http://dx.doi.org/10.1371/journal.pone.0132618			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151451	Green Published, gold, Green Submitted			2022-12-27	WOS:000358158900050
J	Becerra-Fajardo, L; Ivorra, A				Becerra-Fajardo, Laura; Ivorra, Antoni			In Vivo Demonstration of Addressable Microstimulators Powered by Rectification of Epidermically Applied Currents for Miniaturized Neuroprostheses	PLOS ONE			English	Article							FUNCTIONAL ELECTRICAL-STIMULATION; FREQUENCY; NERVES; SYSTEM	Electrical stimulation is used in order to restore nerve mediated functions in patients with neurological disorders, but its applicability is constrained by the invasiveness of the systems required to perform it. As an alternative to implantable systems consisting of central stimulation units wired to the stimulation electrodes, networks of wireless microstimulators have been devised for fine movement restoration. Miniaturization of these microstimulators is currently hampered by the available methods for powering them. Previously, we have proposed and demonstrated a heterodox electrical stimulation method based on electronic rectification of high frequency current bursts. These bursts can be delivered through textile electrodes on the skin. This approach has the potential to result in an unprecedented level of miniaturization as no bulky parts such as coils or batteries are included in the implant. We envision microstimulators designs based on application-specific integrated circuits (ASICs) that will be flexible, thread-like (diameters <0.5 mm) and not only with controlled stimulation capabilities but also with sensing capabilities for artificial proprioception. We in vivo demonstrate that neuroprostheses composed of addressable microstimulators based on this electrical stimulation method are feasible and can perform controlled charge-balanced electrical stimulation of muscles. We developed miniature external circuit prototypes connected to two bipolar probes that were percutaneously implanted in agonist and antagonist muscles of the hindlimb of an anesthetized rabbit. The electronic implant architecture was able to decode commands that were amplitude modulated on the high frequency (1 MHz) auxiliary current bursts. The devices were capable of independently stimulating the target tissues, accomplishing controlled dorsiflexion and plantarflexion joint movements. In addition, we numerically show that the high frequency current bursts comply with safety standards both in terms of tissue heating and unwanted electro-stimulation. We demonstrate that addressable microstimulators powered by rectification of epidermically applied currents are feasible.	[Becerra-Fajardo, Laura; Ivorra, Antoni] Univ Pompeu Fabra, Dept Informat & Commun Technol, Barcelona, Spain	Pompeu Fabra University	Becerra-Fajardo, L (corresponding author), Univ Pompeu Fabra, Dept Informat & Commun Technol, Barcelona, Spain.	laura.becerra.fajardo@gmail.com	Ivorra, Antoni/A-3155-2008	Ivorra, Antoni/0000-0001-7718-8767; Becerra-Fajardo, Laura/0000-0002-5414-8380	Ramon y Cajal fellowship from the Spanish government [RYC-2009-04271]; Marie Curie grant from the European Commission [IRG 256376]	Ramon y Cajal fellowship from the Spanish government; Marie Curie grant from the European Commission	This work was supported in part by the Ramon y Cajal fellowship (RYC-2009-04271) from the Spanish government and by a Marie Curie grant (IRG 256376) from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo A, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056012; [Anonymous], 2010, HLTH PHYS, V99; Becerra-Fajardo L, 2014, IEEE ENG MED BIO, P3973, DOI 10.1109/EMBC.2014.6944494; BRINDLEY GS, 1994, PARAPLEGIA, V32, P795, DOI 10.1038/sc.1994.126; BRINDLEY GS, 1995, BAILLIERE CLIN NEUR, V4, P1; Cho N, 2007, IEEE T MICROW THEORY, V55, P1080, DOI 10.1109/TMTT.2007.895640; Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518; Constandinou TG, 2008, IEEE T BIOMED CIRC S, V2, P106, DOI 10.1109/TBCAS.2008.927238; Davis R, 1999, ARTIF ORGANS, V23, P418, DOI 10.1046/j.1525-1594.1999.06368.x; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; Ho CH, 2014, PHYS MED REH CLIN N, V25, P631, DOI 10.1016/j.pmr.2014.05.001; Ibrahiem A, 2005, PROG ELECTROMAGN RES, V52, P23, DOI 10.2528/PIER04062501; IEEE, 2006, IEEE STANDARD SAFETY, V1, P238; Ivorra A, 2013, WORLD C MED PHYS BIO, P1581; Ivorra A., 2013, 18 IFESS ANN C, P213; Ivorra A, 2014, BIOSYST BIOROBOT, V7, P447, DOI 10.1007/978-3-319-08072-7_67; Ivorra A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023456; Kane MJ, 2011, MED ENG PHYS, V33, P7, DOI 10.1016/j.medengphy.2010.08.010; Kesar T, 2008, J ELECTROMYOGR KINES, V18, P662, DOI 10.1016/j.jelekin.2007.01.001; Loeb GE, 2001, MED ENG PHYS, V23, P9, DOI 10.1016/S1350-4533(01)00011-X; Loeb GE., 2006, NEUROSURG FOCUS, V20, P1, DOI [10.3171/foc.2006.20.5.3, DOI 10.3171/FOC.2006.20.5.3]; Mortimer JT, 2009, NEUROMODULATION, VOLS 1 AND 2, P109; NIH; American Heart Association; The Centers for Disease Control and Prevention, 2015, HEART DIS STROKE STA; PALTI Y, 1962, B RES COUNC ISRAEL, VE 10, P54; Peckham PH, 2013, IEEE T BIO-MED ENG, V60, P602, DOI 10.1109/TBME.2013.2245128; Peckham PH, 2005, ANNU REV BIOMED ENG, V7, P327, DOI 10.1146/annurev.bioeng.6.040803.140103; Reardon S, 2014, NATURE, V511, P18, DOI 10.1038/511018a; Riso RR, 2000, IEEE T REHABIL ENG, V8, P244, DOI 10.1109/86.847826; Schuder JC, 1964, ASAIO J, V10; Schulman JH, 2008, P IEEE, V96, P1226, DOI 10.1109/JPROC.2008.922588; Smith B, 2005, I IEEE EMBS C NEUR E, P454; van Swigchem R, 2012, PHYS THER, V92, P398, DOI 10.2522/ptj.20100405; Ziaie B, 1997, IEEE T BIO-MED ENG, V44, P909, DOI 10.1109/10.634643; Zimmerman TG, 1996, IBM SYST J, V35, P609, DOI 10.1147/sj.353.0609	34	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131666	10.1371/journal.pone.0131666	http://dx.doi.org/10.1371/journal.pone.0131666			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147771	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600123
J	Connelly, SJ; Walling, K; Wilbert, SA; Catlin, DM; Monaghan, CE; Hlynchuk, S; Meehl, PG; Resch, LN; Carrera, JV; Bowles, SM; Clark, MD; Tan, LT; Cody, JA				Connelly, Sandra J.; Walling, Kelly; Wilbert, Steven A.; Catlin, Diane M.; Monaghan, Cailin E.; Hlynchuk, Sofiya; Meehl, Pamela G.; Resch, Lauren N.; Carrera, J. Valerie; Bowles, Stephanie M.; Clark, Michael D.; Tan, Loraine T.; Cody, Jeremy A.			UV-Stressed Daphnia pulex Increase Fitness through Uptake of Vitamin D-3	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; B RADIATION; DNA; ZOOPLANKTON; REPRODUCTION; EXPOSURE; SURVIVAL; CC	Ultraviolet radiation is known to be highly variable in aquatic ecosystems. It has been suggested that UV-exposed organisms may demonstrate enough phenotypic plasticity to maintain the relative fitness of natural populations. Our long-term objective is to determine the potential photoprotective effect of vitamin D-3 on Daphnia pulex exposed to acute or chronic UV radiation. Herein we report our initial findings in this endeavor. D. pulex survival and reproduction (fitness) was monitored for 5 d as a proof of concept study. Significantly higher fitness was observed in the D. pulex with D-3 than those without (most extreme effects observed were 0% survival in the absence of D-3 and 100% with 10 ppm D-3). Vitamin D-3 was isolated from the culture media, the algal food (Pseudokirchneriella), and the D. pulex and quantified using high performance liquid chromatography (HPLC). Vitamin D-3 was fluorescently labeled using a phenothiazinium dye and added to cultures of D. pulex. Images demonstrating the uptake of D-3 into the tissues and carapace of the D. pulex were acquired. Our initial findings suggest a positive role for D-3 in ecosystems as both UV-stressed algae and Daphnia sequester D-3, and D. pulex demonstrate increased fitness in the presence of D-3.	[Connelly, Sandra J.] Rochester Inst Technol, Thomas H Gosnell Sch Life Sci, Rochester, NY 14623 USA; [Walling, Kelly] Rochester Inst Technol, Sch Hlth Sci & Technol, Rochester, NY 14623 USA; [Wilbert, Steven A.] Rochester Inst Technol, Coll Imaging Arts & Sci, Rochester, NY 14623 USA; [Catlin, Diane M.; Monaghan, Cailin E.; Hlynchuk, Sofiya; Meehl, Pamela G.; Resch, Lauren N.; Carrera, J. Valerie; Bowles, Stephanie M.; Clark, Michael D.; Tan, Loraine T.; Cody, Jeremy A.] Rochester Inst Technol, Sch Chem & Mat Sci, Rochester, NY 14623 USA	Rochester Institute of Technology; Rochester Institute of Technology; Rochester Institute of Technology; Rochester Institute of Technology	Connelly, SJ (corresponding author), Rochester Inst Technol, Thomas H Gosnell Sch Life Sci, Rochester, NY 14623 USA.	Sandra.Connelly@rit.edu			Rochester Institute of Technology: College of Science (RIT) Faculty Development Awards; College of Science (RIT) Undergraduate Summer Scholars Fellowship Awards; RIT Honors Program Undergraduate Student Summer Scholarship Award; RIT Ronald E. McNair Post-Baccalaureate Achievement Program; RIT School of Chemistry and Materials Science Dr. Terry Morrill Endowed Student Research Fund; RIT School of Chemistry and Materials Science Daniel Pasto Award; RIT Office of Sponsored Research Sponsored Research Grants; RIT School of Chemistry and Materials Science; Thomas H. Gosnell School of Life Sciences; National Science Foundation Major Research Instrumentation Program [1126629]	Rochester Institute of Technology: College of Science (RIT) Faculty Development Awards; College of Science (RIT) Undergraduate Summer Scholars Fellowship Awards; RIT Honors Program Undergraduate Student Summer Scholarship Award; RIT Ronald E. McNair Post-Baccalaureate Achievement Program; RIT School of Chemistry and Materials Science Dr. Terry Morrill Endowed Student Research Fund; RIT School of Chemistry and Materials Science Daniel Pasto Award; RIT Office of Sponsored Research Sponsored Research Grants; RIT School of Chemistry and Materials Science; Thomas H. Gosnell School of Life Sciences; National Science Foundation Major Research Instrumentation Program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors received funding to support from the following entities within Rochester Institute of Technology: College of Science (RIT) Faculty Development Awards; the College of Science (RIT) Undergraduate Summer Scholars Fellowship Awards; the RIT Honors Program Undergraduate Student Summer Scholarship Award; the RIT Ronald E. McNair Post-Baccalaureate Achievement Program; the RIT School of Chemistry and Materials Science Dr. Terry Morrill Endowed Student Research Fund; the RIT School of Chemistry and Materials Science Daniel Pasto Award; the RIT Office of Sponsored Research Sponsored Research Grants; the RIT School of Chemistry and Materials Science; the Thomas H. Gosnell School of Life Sciences; and the National Science Foundation Major Research Instrumentation Program (#1126629). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar NS, 2004, P NATL ACAD SCI USA, V101, P4954, DOI 10.1073/pnas.0401141101; Brunetto MR, 2004, TALANTA, V64, P1364, DOI 10.1016/j.talanta.2004.04.035; Cody JA, 2012, TETRAHEDRON LETT, V53, P4896, DOI 10.1016/j.tetlet.2012.07.012; CONKLIN DE, 1977, BIOL BULL, V152, P337, DOI 10.2307/1540422; Connelly SJ, 2009, PHOTOCHEM PHOTOBIOL, V85, P144, DOI 10.1111/j.1751-1097.2008.00408.x; Curino A, 2001, PHYTOCHEMISTRY, V58, P81, DOI 10.1016/S0031-9422(01)00090-5; De Lange HJ, 2003, FRESHWATER BIOL, V48, P678, DOI 10.1046/j.1365-2427.2003.01036.x; Douki T, 2001, BIOCHEMISTRY-US, V40, P2495, DOI 10.1021/bi0022543; Gouveia GR, 2005, PHOTOCHEM PHOTOBIOL, V81, P398, DOI 10.1562/2004-05-26-RA-179.1; Grad G, 2001, LIMNOL OCEANOGR, V46, P584, DOI 10.4319/lo.2001.46.3.0584; Holick MF, 2003, J CELL BIOCHEM, V88, P296, DOI 10.1002/jcb.10338; Holick MF, 2003, RECENT RESULTS CANC, V164, P3; Hurtubise RD, 1998, LIMNOL OCEANOGR, V43, P1082, DOI 10.4319/lo.1998.43.6.1082; KEATING KI, 1985, J CRUSTACEAN BIOL, V5, P130, DOI 10.2307/1548225; KERFOOT WC, 1982, ECOLOGY, V63, P538, DOI 10.2307/1938969; Leech DM, 2001, LIMNOL OCEANOGR, V46, P416, DOI 10.4319/lo.2001.46.2.0416; McKenzie RL, 2007, PHOTOCH PHOTOBIO SCI, V6, P218, DOI 10.1039/b700017k; Meyer-Rochow V B, 2000, Int J Circumpolar Health, V59, P38; Miguel NCD, 2002, MICRON, V33, P627, DOI 10.1016/S0968-4328(02)00030-6; Mitchell D, 1991, ENV UV PHOTOBIOLOGY, P345; Noval M, 2015, PHOTOBIOLOGY SCI LIG, P365; Overholt EP, 2012, ECOL LETT, V15, P47, DOI 10.1111/j.1461-0248.2011.01707.x; Peraza MA, 1998, ENVIRON HEALTH PERSP, V106, P203, DOI 10.2307/3433921; Persaud AD, 2007, FRESHWATER BIOL, V52, P2121, DOI 10.1111/j.1365-2427.2007.01833.x; Rautio M, 2002, LIMNOL OCEANOGR, V47, P295, DOI 10.4319/lo.2002.47.1.0295; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; Rhode SC, 2001, NATURE, V412, P69, DOI 10.1038/35083567; Storz UC, 1998, J COMP PHYSIOL A, V183, P709, DOI 10.1007/s003590050293; Wallin H, 2000, MUTAT RES-FUND MOL M, V447, P317, DOI 10.1016/S0027-5107(99)00214-6; Wang T, 2001, J PHOTOCH PHOTOBIO B, V62, P118, DOI 10.1016/S1011-1344(01)00160-9; Williamson CE, 2001, ECOL APPL, V11, P1843, DOI 10.1890/1051-0761(2001)011[1843:BADEOU]2.0.CO;2; Williamson CE, 2014, NAT CLIM CHANGE, V4, P434, DOI [10.1038/nclimate2225, 10.1038/NCLIMATE2225]; WITKIN EM, 1969, ANNU REV GENET, V3, P525, DOI 10.1146/annurev.ge.03.120169.002521; ZELLMER ID, 1995, HYDROBIOLOGIA, V307, P153, DOI 10.1007/BF00032007	34	10	10	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131847	10.1371/journal.pone.0131847	http://dx.doi.org/10.1371/journal.pone.0131847			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147286	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600153
J	Jung, M; Hwang, J; Tani, J				Jung, Minju; Hwang, Jungsik; Tani, Jun			Self-Organization of Spatio-Temporal Hierarchy via Learning of Dynamic Visual Image Patterns on Action Sequences	PLOS ONE			English	Article							CORTEX; MECHANISMS; GRADIENT	It is well known that the visual cortex efficiently processes high-dimensional spatial information by using a hierarchical structure. Recently, computational models that were inspired by the spatial hierarchy of the visual cortex have shown remarkable performance in image recognition. Up to now, however, most biological and computational modeling studies have mainly focused on the spatial domain and do not discuss temporal domain processing of the visual cortex. Several studies on the visual cortex and other brain areas associated with motor control support that the brain also uses its hierarchical structure as a processing mechanism for temporal information. Based on the success of previous computational models using spatial hierarchy and temporal hierarchy observed in the brain, the current report introduces a novel neural network model for the recognition of dynamic visual image patterns based solely on the learning of exemplars. This model is characterized by the application of both spatial and temporal constraints on local neural activities, resulting in the self-organization of a spatio-temporal hierarchy necessary for the recognition of complex dynamic visual image patterns. The evaluation with the Weizmann dataset in recognition of a set of prototypical human movement patterns showed that the proposed model is significantly robust in recognizing dynamically occluded visual patterns compared to other baseline models. Furthermore, an evaluation test for the recognition of concatenated sequences of those prototypical movement patterns indicated that the model is endowed with a remarkable capability for the contextual recognition of long-range dynamic visual image patterns.	[Jung, Minju; Hwang, Jungsik; Tani, Jun] Korea Adv Inst Sci & Technol, Dept Elect Engn, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Tani, J (corresponding author), Korea Adv Inst Sci & Technol, Dept Elect Engn, Taejon 305701, South Korea.	tani1216jp@gmail.com	Tani, Jun/AAI-8287-2020; Tani, Jun/H-3681-2012		National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2014R1A2A2A01005491]	National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2014R1A2A2A01005491). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccouche Moez, 2011, Human Behavior Unterstanding. Proceedings Second International Workshop, HBU 2011, P29, DOI 10.1007/978-3-642-25446-8_4; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Barnsley M, 1993, FRACTALS EVERYWHERE; Blank M, 2005, IEEE I CONF COMP VIS, P1395; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Friston KJ, 2000, PHILOS T ROY SOC B, V355, P253, DOI 10.1098/rstb.2000.0562; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Hasson U, 2008, J NEUROSCI, V28, P2539, DOI 10.1523/JNEUROSCI.5487-07.2008; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hubel David H, 1995, EYE BRAIN VISION, P6; Ji SW, 2013, IEEE T PATTERN ANAL, V35, P221, DOI 10.1109/TPAMI.2012.59; Karpathy A, 2014, PROC CVPR IEEE, P1725, DOI 10.1109/CVPR.2014.223; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Kruger N, 2013, IEEE T PATTERN ANAL, V35, P1847, DOI 10.1109/TPAMI.2012.272; LeCun Y, 1998, LECT NOTES COMPUT SC, V1524, P9, DOI 10.1007/3-540-49430-8_2; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lee H., 2009, P ANN INT C MACH LEA, P609; MISHKIN M, 1982, BEHAV BRAIN RES, V6, P57, DOI 10.1016/0166-4328(82)90081-X; POLLACK JB, 1991, MACH LEARN, V7, P227, DOI 10.1007/BF00114845; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rumelhart D., 1986, PARALLEL DISTRIBUTED; Scherer D, 2010, LECT NOTES COMPUT SC, V6354, P92, DOI 10.1007/978-3-642-15825-4_10; Schindler K., 2008, IEEE C COMP VIS PATT, P1, DOI DOI 10.1109/CVPR.2008.4587730; Simonyan Karen, 2014, ADV NEURAL INFORM PR, P568, DOI DOI 10.1002/14651858.CD001941.PUB3; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TANAKA K, 1993, SCIENCE, V262, P685, DOI 10.1126/science.8235589; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; Udden J, 2012, PHILOS T R SOC B, V367, P2023, DOI 10.1098/rstb.2012.0009; Yamashita Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000220	33	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131214	10.1371/journal.pone.0131214	http://dx.doi.org/10.1371/journal.pone.0131214			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147887	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600070
J	Li, DM; Fan, QH; Waite, DW; Gunawardana, D; George, S; Kumarasinghe, L				Li, Dongmei; Fan, Qing-Hai; Waite, David W.; Gunawardana, Disna; George, Sherly; Kumarasinghe, Lalith			Development and Validation of a Real-Time PCR Assay for Rapid Detection of Two-Spotted Spider Mite, Tetranychus urticae (Acari: Tetranychidae)	PLOS ONE			English	Article							RIBOSOMAL ITS2 SEQUENCES; DNA-SEQUENCES; MOLECULAR SYSTEMATICS; MITOCHONDRIAL-DNA; SPECIES ACARI; RFLP ANALYSIS; LIFE-HISTORY; IDENTIFICATION; NUCLEAR; POLYMORPHISM	Spider mites of the genus Tetranychus are difficult to identify due to their limited diagnostic characters. Many of them are morphologically similar and males are needed for species-level identification. Tetranychus urticae is a common interception and non-regulated pest at New Zealand's borders, however, most of the intercepted specimens are females and the identification was left at Tetranychus sp. Consequently, the shipments need to be fumigated. DNA sequencing and PCR-restriction fragment length polymorphism (PCR-RFLP) protocols could be used to facilitate the accurate identification. However, in the context of border security practiced in New Zealand, insect identifications are required to be provided within four hours of receiving the samples; thus, those molecular methods are not sufficient to meet this requirement. Therefore, a real-time PCR TaqMan assay was developed for identification of T. urticae by amplification of a 142 bp Internal Transcribed Spacer (ITS) 1 sequence. The developed assay is rapid, detects all life stages of T. urticae within three hours, and does not react with closely related species. Plasmid DNA containing ITS1 sequence of T. uritcae was serially diluted and used as standards in the real-time PCR assay. The quantification cycle (Cq) value of the assay depicted a strong linear relationship with T. urticae DNA content, with a regression coefficient of 0.99 and efficiency of 98%. The detection limit was estimated to be ten copies of the T. urticae target region. The assay was validated against a range of T. urticae specimens from various countries and hosts in a blind panel test. Therefore the application of the assay at New Zealand will reduce the unnecessary fumigation and be beneficial to both the importers and exporters. It is expected that the implementation of this real-time PCR assay would have wide applications in diagnostic and research agencies worldwide.	[Li, Dongmei; Fan, Qing-Hai; Waite, David W.; Gunawardana, Disna; George, Sherly; Kumarasinghe, Lalith] Minist Primary Ind, Plant Hlth & Environm Lab, Auckland, New Zealand		Li, DM (corresponding author), Minist Primary Ind, Plant Hlth & Environm Lab, Auckland, New Zealand.	dongmei.li@mpi.govt.nz	FAN, QING-HAI/ABB-2925-2021; Fan, Qing-Hai/AAW-4256-2021	Waite, David/0000-0002-0184-2942				Ali ZB, 2000, J MED ENTOMOL, V37, P787, DOI 10.1603/0022-2585-37.6.787; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arimoto M, 2013, J ECON ENTOMOL, V106, P661, DOI 10.1603/EC12440; Auger P, 2013, ACAROLOGIA, V53, P383; Ben-David T, 2007, EXP APPL ACAROL, V41, P169, DOI 10.1007/s10493-007-9058-1; Boubou A, 2011, BIOL INVASIONS, V13, P81, DOI 10.1007/s10530-010-9791-y; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caterino MS, 2000, ANNU REV ENTOMOL, V45, P1, DOI 10.1146/annurev.ento.45.1.1; Chen DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110625; de Mendonca RS, 2011, EXP APPL ACAROL, V55, P1, DOI 10.1007/s10493-011-9453-5; Ehara Shozo, 1999, Species Diversity, V4, P63; Fenton B, 1997, INSECT MOL BIOL, V6, P23, DOI 10.1046/j.1365-2583.1997.00152.x; Foley DH, 1998, MOL PHYLOGENET EVOL, V9, P262, DOI 10.1006/mpev.1997.0457; FOURNIER D, 1994, GENETICA, V94, P73, DOI 10.1007/BF01429222; Gotoh T, 2009, INT J ACAROL, V35, P485, DOI 10.1080/01647950903431156; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Hinomoto N, 2007, INT J ACAROL, V33, P53, DOI 10.1080/01647950708684501; Hurtado MA, 2008, ANN APPL BIOL, V153, P167, DOI 10.1111/j.1744-7348.2008.00250.x; Macke E, 2012, AM NAT, V179, pE147, DOI 10.1086/665002; Matsuda T, 2013, J ECON ENTOMOL, V106, P463, DOI 10.1603/EC12328; Matsuda T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108672; Migeon A, 2010, TRENDS IN ACAROLOGY, P557, DOI 10.1007/978-90-481-9837-5_96; Navajas M, 2000, EXP APPL ACAROL, V24, P365, DOI 10.1023/A:1006432604611; Navajas M, 1998, HEREDITY, V80, P742, DOI 10.1046/j.1365-2540.1998.00349.x; Navajas M, 2003, P ROY SOC B-BIOL SCI, V270, pS124, DOI 10.1098/rsbl.2003.0034; Navajas M, 1996, INSECT MOL BIOL, V5, P281, DOI 10.1111/j.1365-2583.1996.tb00102.x; Navajas M, 2001, B ENTOMOL RES, V91, P117; Navajas M, 2000, EXP APPL ACAROL, V24, P751, DOI 10.1023/A:1006497906793; NAVAJAS M, 1992, EXP APPL ACAROL, V15, P211, DOI 10.1007/BF01246563; Navia D, 2005, B ENTOMOL RES, V95, P505, DOI 10.1079/BER2005382; Nunn CL, 1992, THESIS U NOTTINGHAM; Omoto K, 2009, GENE, V441, P80, DOI 10.1016/j.gene.2008.10.030; Osakabe M, 2002, APPL ENTOMOL ZOOL, V37, P399, DOI 10.1303/aez.2002.399; Osakabe M., 1994, Insect Molecular Biology, V3, P63, DOI 10.1111/j.1365-2583.1994.tb00152.x; Osakabe M, 2008, J ECON ENTOMOL, V101, P1167, DOI 10.1603/0022-0493(2008)101[1167:RFLPCF]2.0.CO;2; Owczarzy R, 2008, NUCLEIC ACIDS RES, V36, pW163, DOI 10.1093/nar/gkn198; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ros VID, 2007, EXP APPL ACAROL, V42, P239, DOI 10.1007/s10493-007-9092-z; Roy M, 2003, OECOLOGIA, V135, P322, DOI 10.1007/s00442-002-1160-9; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SPERLING FAH, 1994, J FORENSIC SCI, V39, P418; Vilgalys R, 2003, NEW PHYTOL, V160, P4, DOI 10.1046/j.1469-8137.2003.00894.x; WALTER D.E., 2009, MANUAL ACAROLOGY; Yang B, 2011, PARASITOL RES, V108, P497, DOI 10.1007/s00436-010-2153-y; Yuan ML, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-597	46	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131887	10.1371/journal.pone.0131887	http://dx.doi.org/10.1371/journal.pone.0131887			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147599	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600157
J	Li, R; Tang, CL; Zhang, Y; Ma, KS; Zhang, XH; Guo, DY; Yan, XC				Li, Rui; Tang, Chun-Lin; Zhang, Yi; Ma, Kuan-sheng; Zhang, Xiao-Hang; Guo, De-Yu; Yan, Xiao-Chu			Diagnosis of Hepatic Angiomyolipoma by Combination of Baseline and Contrast-Enhanced Ultrasound-A Prospective Study in Non-Cirrhotic Patients	PLOS ONE			English	Article							FOCAL LIVER-LESIONS; MALIGNANT ANGIOMYOLIPOMA; HEPATOCELLULAR ADENOMA; NODULAR HYPERPLASIA; MULTICENTER TRIAL; FEATURES; DELINEATION; SONOGRAPHY; PATTERNS; SONOVUE	Objectives Hepatic angiomyolipoma (HAML) is a rare, benign mesenchymal tumor of the liver and its diagnosis has been considered challenging. The aim of this study was to investigate prospectively the diagnostic efficacy of the incorporation of both baseline ultrasound (US) and contrast-enhanced ultrasound (CEUS) features of HAML in patients without cirrhosis. Materials and Methods Consecutive 1748 non-cirrhotic patients with focal liver lesions (FLLs) were prospectively enrolled. Baseline US and CEUS were performed before resection or biopsy. Ultrasound imaging diagnosis of FLLs was compared with the pathological results. Results Final diagnoses were established in 41 patients with HAML (2.3%) with normal alpha fetal protein (AFP) level and in 1707 patients with FLL other than HAML. Diagnostic criteria for HAML was based on the combination of baseline US and CEUS appearance of the nodule: (1) Well-defined, marked hyper-echoic nodule without surrounding hypo-echoic halo on baseline US; (2) hyper-enhancement in the arterial phase (exclude initial peripheral nodular enhancement and spoke-wheel arteries) and remains hyper-enhancement or iso-enhancement in the late phase. The diagnostic criteria were fulfilled in 31 HAMLs, 1 hepatocellular adenoma and 1 hemangioma. Ten HAMLs were misdiagnosed as other liver tumors because they did not meet the diagnostic criteria mentioned above and consequently yielded a sensitivity, specificity, positive predictive values, negative predictive values and Youden index of 75.61%, 99.88%, 93.94%, 99.42%, and 0.75 respectively. Conclusion The combination of baseline US and CEUS may lead to the correct diagnosis noninvasively in the majority of HAMLs in non-cirrhotic patients with normal AFP level.	[Li, Rui; Ma, Kuan-sheng] Third Mil Med Univ, Southwest Hosp, Dept Hepatobiliary Pancreat Surg, Chongqing, Peoples R China; [Tang, Chun-Lin; Zhang, Yi; Zhang, Xiao-Hang] Third Mil Med Univ, Southwest Hosp, Dept Ultrasound, Chongqing, Peoples R China; [Guo, De-Yu; Yan, Xiao-Chu] Third Mil Med Univ, Southwest Hosp, Dept Pathol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Li, R (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Hepatobiliary Pancreat Surg, Chongqing, Peoples R China.	raylee7991@163.com						Chang ZG, 2011, J GASTROINTEST LIVER, V20, P65; Claudon M, 2013, ULTRASCHALL MED, V34, P11, DOI 10.1055/s-0032-1325499; Croquet V, 2000, EUR J GASTROEN HEPAT, V12, P579, DOI 10.1097/00042737-200012050-00018; Dalle I, 2000, HISTOPATHOLOGY, V36, P443; Deng YF, 2008, PATHOL RES PRACT, V204, P911, DOI 10.1016/j.prp.2008.06.007; Dhingra S, 2014, ARCH PATHOL LAB MED, V138, P1090, DOI 10.5858/arpa.2013-0183-RA; Dietrich CF, 2005, BRIT J RADIOL, V78, P704, DOI 10.1259/bjr/88181612; Dietrich CF, 2007, HEPATOLOGY, V45, P1139, DOI 10.1002/hep.21615; Hirche TO, 2007, LIVER INT, V27, P748, DOI 10.1111/j.1478-3231.2007.01491.x; Hogemann D, 2001, EUR RADIOL, V11, P1389, DOI 10.1007/s003300000750; Leen E, 2006, AM J ROENTGENOL, V186, P1551, DOI 10.2214/AJR.05.0138; Li R, 2014, PLOS ONE, V9, P1; Li R, 2010, ABDOM IMAGING, V35, P676, DOI 10.1007/s00261-009-9592-x; Lin HM, 2011, J GASTROEN HEPATOL, V26, P28, DOI 10.1111/j.1440-1746.2010.06502.x; NONOMURA A, 1994, J GASTROENTEROL, V29, P95, DOI 10.1007/BF01229084; Nonomura A, 2012, HISTOPATHOLOGY, V61, P863, DOI 10.1111/j.1365-2559.2012.04306.x; Petrolla AA, 2008, ARCH PATHOL LAB MED, V132, P1679, DOI 10.1043/1543-2165(2008)132[1679:HA]2.0.CO;2; Ricci P, 2005, AM J ROENTGENOL, V184, P821, DOI 10.2214/ajr.184.3.01840821; Salvatore V, 2012, CURR PHARM DESIGN, V18, P2236, DOI 10.2174/138161212800099892; Strobel D, 2008, ULTRASCHALL MED, V29, P499, DOI 10.1055/s-2008-1027806; Tranquart F, 2009, J RADIOL, V90, P109, DOI 10.1016/S0221-0363(09)70089-7; Tsui WMS, 1999, AM J SURG PATHOL, V23, P34, DOI 10.1097/00000478-199901000-00004; Wang W, 2013, EUR RADIOL, V23, P2546, DOI 10.1007/s00330-013-2849-3; Wang Z, 2010, BRIT J RADIOL, V83, P411, DOI 10.1259/bjr/81174247; Wei RX, 2012, ASIAN PAC J CANCER P, V13, P493, DOI 10.7314/APJCP.2012.13.2.493; Zhou YM, 2008, HEPATOB PANCREAT DIS, V7, P284	26	3	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132290	10.1371/journal.pone.0132290	http://dx.doi.org/10.1371/journal.pone.0132290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147859	gold, Green Submitted, Green Published			2022-12-27	WOS:000358157600232
J	Nakajima, Y; Shinzato, C; Satoh, N; Mitarai, S				Nakajima, Yuichi; Shinzato, Chuya; Satoh, Noriyuki; Mitarai, Satoshi			Novel Polymorphic Microsatellite Markers Reveal Genetic Differentiation between Two Sympatric Types of Galaxea fascicularis	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; SCLERACTINIAN CORAL; MORPHOLOGICAL CONVERGENCE; EVOLUTIONARY HISTORY; ACROPORA-HYACINTHUS; NUCLEOTIDE-SEQUENCE; SELF-FERTILIZATION; SPAWNING CORALS; CARIBBEAN CORAL	The reef-building, scleractinian coral, Galaxea fascicularis, is classified into soft and hard types, based on nematocyst morphology. This character is correlated with the length of the mitochondrial non-coding region (mt-Long: soft colony type, and nematocysts with wide capsules and long shafts; mt-Short: hard colony type, and nematocysts with thin capsules and short shafts). We isolated and characterized novel polymorphic microsatellite markers for G. fascicularis using next-generation sequencing. Based upon the mitochondrial non-coding region, 53 of the 97 colonies collected were mt-Long (mt-L) and 44 were mt-Short (mt-S). Among the 53 mt-L colonies, 27 loci were identified as amplifiable, polymorphic microsatellite loci, devoid of somatic mutations and free of scoring errors. Eleven of those 27 loci were also amplifiable and polymorphic in the 44 mt-S colonies; these 11 are cross-type microsatellite loci. The other 16 loci were considered useful only for mt-L colonies. These 27 loci identified 10 multilocus lineages (MLLs) among the 53 mt-L colonies (N-MLL/N = 0.189), and the 11 cross-type loci identified 7 MLLs in 44 mt-S colonies (N-MLL/N = 0.159). Significant genetic differentiation between the two types was detected based on the genetic differentiation index (F-ST = 0.080, P = 0.001). Bayesian clustering also indicated that these two types are genetically isolated. While nuclear microsatellite genotypes also showed genetic differentiation between mitochondrial types, the mechanism of divergence is not yet clear. These markers will be useful to estimate genetic diversity, differentiation, and connectivity among populations, and to understand evolutionary processes, including divergence of types in G. fascicularis.	[Nakajima, Yuichi; Mitarai, Satoshi] Grad Univ, Okinawa Inst Sci & Technol, Marine Biophys Unit, Okinawa, Japan; [Shinzato, Chuya; Satoh, Noriyuki] Grad Univ, Okinawa Inst Sci & Technol, Marine Genom Unit, Okinawa, Japan	Okinawa Institute of Science & Technology Graduate University; Okinawa Institute of Science & Technology Graduate University	Nakajima, Y (corresponding author), Grad Univ, Okinawa Inst Sci & Technol, Marine Biophys Unit, Okinawa, Japan.	yuichi.nakajima@oist.jp	Nakajima, Yuichi/A-4330-2013; Satoh, Nori/C-4123-2009; Mitarai, Satoshi/G-8560-2015	Nakajima, Yuichi/0000-0001-6558-5378; Satoh, Nori/0000-0002-4480-3572; Mitarai, Satoshi/0000-0003-3033-2332; Shinzato, Chuya/0000-0001-7843-3381	Japan Society for the Promotion of Science (JSPS) KAKENHI grant [25840152, 25660172, 26290065]; Pro Natura Foundation grant for natural conservation of the Nansei Islands; Okinawa Institute of Science and Technology Graduate University; Grants-in-Aid for Scientific Research [25840152] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Pro Natura Foundation grant for natural conservation of the Nansei Islands; Okinawa Institute of Science and Technology Graduate University(Okinawa Institute of Science & Technology Graduate University); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Japan Society for the Promotion of Science (JSPS) KAKENHI grant (25840152 to YN, 25660172 and 26290065 to CS), a Pro Natura Foundation grant for natural conservation of the Nansei Islands to YN (http://www.pronaturajapan.com/), and by the Okinawa Institute of Science and Technology Graduate University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2008, FISHERIES SCI, V74, P1342, DOI 10.1111/j.1444-2906.2008.01663.x; Abe Mariko, 2008, Plankton & Benthos Research, V3, P174, DOI 10.3800/pbr.3.174; Aranceta-Garza F, 2012, CORAL REEFS, V31, P1157, DOI 10.1007/s00338-012-0941-9; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Aronesty E., 2011, EA UTILS COMMAND LIN; Ayre DJ, 2000, EVOLUTION, V54, P1590; Baums IB, 2006, ECOL MONOGR, V76, P503, DOI 10.1890/0012-9615(2006)076[0503:GVICSI]2.0.CO;2; Ben-Haim Y, 2003, APPL ENVIRON MICROB, V69, P4236, DOI 10.1128/AEM.69.7.4236-4242.2003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bird CE, 2011, MOL ECOL, V20, P2128, DOI 10.1111/j.1365-294X.2011.05081.x; Castoe TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030953; Chen DD, 2013, CONSERV GENET RESOUR, V5, P741, DOI 10.1007/s12686-013-9895-7; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Cristescu R, 2010, CONSERV GENET, V11, P1043, DOI 10.1007/s10592-009-9949-2; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Flot JF, 2008, CORAL REEFS, V27, P789, DOI 10.1007/s00338-008-0407-2; Flot Jean-Francois, 2011, BMC Ecology, V11, P22, DOI 10.1186/1472-6785-11-22; Harrison PL, 1988, P 6 INT CORAL REEF S, V2, P699; Hatta M, 1999, MOL BIOL EVOL, V16, P1607, DOI 10.1093/oxfordjournals.molbev.a026073; Hayakawa H, 2007, ZOOL SCI, V24, P249, DOI 10.2108/zsj.24.249; Hayashibara T, 2002, CORAL REEFS, V21, P224; HEYWARD AJ, 1986, MAR BIOL, V90, P191, DOI 10.1007/BF00569127; HIDAKA M, 1984, CORAL REEFS, V3, P77, DOI 10.1007/BF00263757; Hidaka Michio, 1992, Galaxea, V11, P21; Isomura N, 2013, MAR BIOL RES, V9, P181, DOI 10.1080/17451000.2012.707321; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Keshavmurthy S, 2012, ZOOL STUD, V51, P143; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Marquez LM, 2002, P ROY SOC B-BIOL SCI, V269, P1289, DOI 10.1098/rspb.2002.2014; Marquez LM, 2002, MOL ECOL, V11, P1339, DOI 10.1046/j.1365-294X.2002.01526.x; Nakajima Y, 2012, MOL PHYLOGENET EVOL, V63, P527, DOI 10.1016/j.ympev.2012.01.006; Nishihira M., 1995, HERMATYPIC CORALS JA; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pinzon JH, 2011, MOL ECOL, V20, P311, DOI 10.1111/j.1365-294X.2010.04939.x; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schmidt-Roach S, 2013, CORAL REEFS, V32, P161, DOI 10.1007/s00338-012-0959-z; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; STODDART JA, 1988, MAR BIOL, V99, P489, DOI 10.1007/BF00392556; van Oppen MJH, 2001, MOL BIOL EVOL, V18, P1315, DOI 10.1093/oxfordjournals.molbev.a003916; Veron J.E.N., 2000, CORALS WORLD, V1-3; Vollmer SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003718; Watanabe T, 2005, MAR BIOTECHNOL, V7, P33, DOI 10.1007/s10126-004-3200-4; Wewengkang DS, 2007, GALAXEA, V9, P49; Williams DE, 2008, CORAL REEFS, V27, P697, DOI 10.1007/s00338-008-0386-3; Yasuda N, 2014, B MAR SCI, V90, P233, DOI 10.5343/bms.2012.1105	53	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130176	10.1371/journal.pone.0130176	http://dx.doi.org/10.1371/journal.pone.0130176			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147677	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600032
J	Nakamura, M; Akiyoshi, M				Nakamura, Mayumi; Akiyoshi, Mito			What Determines the Perception of Fairness Regarding Household Division of Labor between Spouses?	PLOS ONE			English	Article							SEX-ROLE ATTITUDES; RELATIVE DEPRIVATION; MARITAL QUALITY; FAMILY WORK; HOUSEWORK; SATISFACTION; WIVES; HAPPINESS; IDEOLOGY; HUSBANDS	Married women often undertake a larger share of housework inmany countries and yet they do not always perceive the inequitable division of household labor to be "unfair." Several theories have been proposed to explain the pervasive perception of fairness that is incongruent with the observed inequity in household tasks. These theories include 1) economic resource theory, 2) time constraint theory, 3) gender value theory, and 4) relative deprivation theory. This paper re-examines these theories with newly available data collected on Japanese married women in 2014 in order to achieve a new understanding of the gendered nature of housework. It finds that social comparison with others is a key mechanism that explains women's perception of fairness. The finding is compatible with relative deprivation theory. In addition to confirming the validity of the theory of relative deprivation, it further uncovers that a woman's reference groups tend to be people with similar life circumstances rather than non-specific others. The perceived fairness is also found to contribute to the sense of overall happiness. The significant contribution of this paper is to explicate how this seeming contradiction of inequity in the division of housework and the perception of fairness endures.	[Nakamura, Mayumi] Toyama Univ, Dept Econ, Toyama, Toyama 930, Japan; [Akiyoshi, Mito] Senshu Univ, Dept Sociol, Kawasaki, Kanagawa, Japan	University of Toyama	Akiyoshi, M (corresponding author), Senshu Univ, Dept Sociol, Kawasaki, Kanagawa, Japan.	mito.akiyoshi@gmail.com			Japan Society for the Promotion of Science [24530656]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study is made possible by a three-year grant from the Japan Society for the Promotion of Science ("Work-life Balance and Happiness" Grant number: 24530656). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, CATEGORICAL DATA ANA; Batalova JA, 2002, J MARRIAGE FAM, V64, P743, DOI 10.1111/j.1741-3737.2002.00743.x; BENIN MH, 1988, J MARRIAGE FAM, V50, P349, DOI 10.2307/352002; BLAIR SL, 1992, J MARRIAGE FAM, V54, P570, DOI 10.2307/353243; Blood R.O., 1960, HUSBAND WIVES DYNAMI; Braun M, 2008, J MARRIAGE FAM, V70, P1145, DOI 10.1111/j.1741-3737.2008.00556.x; Coltrane S, 2000, J MARRIAGE FAM, V62, P1208, DOI 10.1111/j.1741-3737.2000.01208.x; Easterlin RA, 2003, P NATL ACAD SCI USA, V100, P11176, DOI 10.1073/pnas.1633144100; Ex CTGM, 1998, SEX ROLES, V38, P171; Frisco ML, 2003, J FAM ISSUES, V24, P51, DOI 10.1177/0192513X02238520; Fuwa M., 2010, KAZOKU SHAKAIGAKU KE, V22, P52, DOI [10.4234/jjoffamilysociology.22.52, DOI 10.4234/JJOFFAMILYSOCIOLOGY.22.52]; Fuwa M, 2007, SOC SCI RES, V36, P512, DOI 10.1016/j.ssresearch.2006.04.005; Gager CT, 1998, J FAM ISSUES, V19, P622, DOI 10.1177/019251398019005007; Gambetta D., 2009, WERE THEY PUSHED DID; Geist C, 2005, EUR SOCIOL REV, V21, P23, DOI 10.1093/esr/jci002; Greenstein TN, 2009, J MARRIAGE FAM, V71, P1039, DOI 10.1111/j.1741-3737.2009.00651.x; Greenstein TN, 1996, J MARRIAGE FAM, V58, P585, DOI 10.2307/353719; Greenstein TN, 1996, SOC FORCES, V74, P1029, DOI 10.2307/2580391; Guimond S, 2002, PERS SOC PSYCHOL B, V28, P900, DOI 10.1177/01467202028007004; Harth NS, 2008, PERS SOC PSYCHOL B, V34, P115, DOI 10.1177/0146167207309193; Hochschild AR, 2003, 2 SHIFT; LENNON MC, 1994, AM J SOCIOL, V100, P506, DOI 10.1086/230545; Major B., 1987, SEX GENDER, P124; OECD, 2012, BETTER POLICIES; Osborne D, 2013, PERS SOC PSYCHOL B, V39, P991, DOI 10.1177/0146167213487997; Sanchez L, 1996, J FAM ISSUES, V17, P358, DOI 10.1177/019251396017003004; Smith HL, 1998, SOC SCI RES, V27, P305, DOI 10.1006/ssre.1998.0624; Smith TW, 2013, NATL DATA PRORAM SOC, V21; Statistics Bureau, 2011, SURVEY TIME USE LEIS; SUITOR JJ, 1991, J MARRIAGE FAM, V53, P221, DOI 10.2307/353146; THOMPSON L, 1991, J FAM ISSUES, V12, P181, DOI 10.1177/019251391012002003; TOMEH AK, 1984, SOCIOL INQ, V54, P72, DOI 10.1111/j.1475-682X.1984.tb00046.x; Treiman Donald J., 2008, QUANTITATIVE DATA AN; Twaronite L, 2013, REUTERS 1213; VANYPEREN NW, 1991, SOC PSYCHOL QUART, V54, P169, DOI 10.2307/2786934; Veenhoven R., 2008, SCI SUBJECTIVE WELL, P44; Waite LJ., 2001, CASE MARRIAGE WHY MA; Wunderink S, 1997, ECONOMIST, V145, P399, DOI 10.1023/A:1003024732314; Yu W-H., 2009, GENDERED TRAJECTORIE; Zuo JP, 2001, J MARRIAGE FAM, V63, P1122, DOI 10.1111/j.1741-3737.2001.01122.x	40	10	10	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132608	10.1371/journal.pone.0132608	http://dx.doi.org/10.1371/journal.pone.0132608			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26147921	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600305
J	Negri, I; Mavris, C; Di Prisco, G; Caprio, E; Pellecchia, M				Negri, Ilaria; Mavris, Christian; Di Prisco, Gennaro; Caprio, Emilio; Pellecchia, Marco			Honey Bees (Apis mellifera, L.) as Active Samplers of Airborne Particulate Matter	PLOS ONE			English	Article							HEAVY-METALS; PARTICLES; SARDINIA; MIDGUT	Honey bees (Apis mellifera L.) are bioindicators of environmental pollution levels. During their wide-ranging foraging activity, these hymenopterans are exposed to pollutants, thus becoming a useful tool to trace the environmental contaminants as heavy metals, pesticides, radionuclides and volatile organic compounds. In the present work we demonstrate that bees can also be used as active samplers of airborne particulate matter. Worker bees were collected from hives located in a polluted postmining area in South West Sardinia (Italy) that is also exposed to dust emissions from industrial plants. The area is included in an official list of sites of national interest for environmental remediation, and has been characterized for the effects of pollutants on the health of the resident population. The head, wings, hind legs and alimentary canal of the bees were investigated with Scanning Electron Microscopy coupled with Xray spectroscopy (SEM-EDX). The analyses pointed to specific morphological and chemical features of the particulate, and resulted into the identification of three categories of particles: industry -, postmining -, and soil -derived. With the exception of the gut, all the analyzed body districts displayed inorganic particles, mostly concentrated in specific areas of the body (i.e. along the costal margin of the fore wings, the medial plane of the head, and the inner surface of the hind legs). The role of both past mining activities and the industrial activity close to the study area as sources of the particulate matter is also discussed. We conclude that honey bees are able to collect samples of the main airborne particles emitted from different sources, therefore could be an ideal tool for monitoring such a kind of pollutants.	[Negri, Ilaria; Pellecchia, Marco] Koine Environm Consulting Snc, Parma, Italy; [Mavris, Christian] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Di Prisco, Gennaro; Caprio, Emilio] Univ Naples Federico II, Dipartimento Agr, Lab Entomol E Tremblay, Naples, Italy	Natural History Museum London; University of Naples Federico II	Negri, I (corresponding author), Koine Environm Consulting Snc, Parma, Italy.	ilarianegri@koineambiente.com	Di Prisco, Gennaro/AGY-3511-2022; Negri, Ilaria/E-5099-2012	Negri, Ilaria/0000-0001-5188-1408; Mavris, Christian/0000-0002-0254-8673	Koine-Environmental Consulting S.n.c., Parma, Italy; Koine-Environmental Consulting S.n.c.	Koine-Environmental Consulting S.n.c., Parma, Italy; Koine-Environmental Consulting S.n.c.	The study was funded by Koine-Environmental Consulting S.n.c., Parma, Italy www.koineambiente.com. The authors declare that the funder of this study, Koine-Environmental Consulting S.n.c., provided support in the form of salaries for authors Ilaria Negri and Marco Pellecchia, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DL, 2005, P NATL ACAD SCI USA, V102, P18213, DOI 10.1073/pnas.0506590102; Ardau C, 2001, RENDICONTI SEMIN S71; Ballan-Dufrancais CN, 2002, MICROSC RES TECHNIQ, V56, P403, DOI 10.1002/jemt.10041; BARBATTINI R, 1991, APICOLTURA, V7, P113; Bomphrey RJ, 2009, EXP FLUIDS, V46, P811, DOI 10.1007/s00348-009-0631-8; Boni M, 2011, HIST RES MONERAL RES, V13, P25; BROMENSHENK JJ, 1985, SCIENCE, V227, P632, DOI 10.1126/science.227.4687.632; Cadelis G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091136; Casteel DB, 1912, BAHV HONEY POLLEN CO; Casteel DB, 1912, BUREAU ENTOMOLOGY B, V161; Cherchi A, 2009, MAR POLLUT BULL, V59, P281, DOI 10.1016/j.marpolbul.2009.09.016; Choel M, 2007, ATMOS ENVIRON, V41, P2820, DOI 10.1016/j.atmosenv.2006.11.038; Chou M-S, 2012, SUSTAIN ENV RES, V22, P225; Cidu R., 2005, MINE WATER ENVIRON, V24, P77, DOI DOI 10.1007/S10230-005-0075-1; Costa E, 1981, INTRODUZIONE LETTURA; Costa LG, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/736385; Couvillon MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093495; DaCruzLandim C, 1997, NETH J ZOOL, V47, P21, DOI 10.1163/156854297X00210; Dickinson M, 2006, CURR BIOL, V16, pR309, DOI 10.1016/j.cub.2006.03.087; Fernandez-Caliani JC, 2013, MINERAL MAG, V77, P2793, DOI 10.1180/minmag.2013.077.6.07; Grandi G, 1978, I ENTOMOLOGIA GEN; Heal MR, 2012, CHEM SOC REV, V41, P6606, DOI 10.1039/c2cs35076a; Kloog I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088578; Kutchko B, FUEL, V85, P2537; Lambert O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067007; Leita L, 1996, ENVIRON MONIT ASSESS, V43, P1, DOI 10.1007/BF00399566; Lipovsek S, 2012, MICROSC RES TECHNIQ, V75, P397, DOI 10.1002/jemt.21069; Miousse IR, 2014, ENVIRON MOL MUTAGEN, V55, P428, DOI 10.1002/em.21855; Negri I, 2009, Italian patent, Patent No. 0001356726; Okuyama Y, 2007, ATMOS ENVIRON, V41, P253, DOI 10.1016/j.atmosenv.2006.08.009; Pirastu R, 2011, Epidemiol Prev, V35, P29; Porrini C, 2002, HONEY BEES: ESTIMATING THE ENVIRONMENTAL IMPACT OF CHEMICALS, P186; Porrini C, 2014, B INSECTOL, V67, P137; Satta A, 2012, ENVIRON SCI POLLUT R, V19, P3977, DOI 10.1007/s11356-012-0921-1; Schintu M, 1999, SCI TOTAL ENVIRON, V241, P129, DOI 10.1016/S0048-9697(99)00336-8; SCHONITZER K, 1984, APIDOLOGIE, V15, P23, DOI 10.1051/apido:19840103; Societa Geologica Italiana, 1994, APP LIG EM, V6; Stara P., 1996, IGLESIENTE ARBURESE; Valavanidis A, 2008, J ENVIRON SCI HEAL C, V26, P339, DOI 10.1080/10590500802494538; Varrica D, 2014, ENVIRON RES, V134, P366, DOI 10.1016/j.envres.2014.08.013; Jacobson LDV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104177; Wang TH, 2013, J AGR FOOD CHEM, V61, P5009, DOI 10.1021/jf400695w; Wang Y, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000983; Yu XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095682	44	49	49	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132491	10.1371/journal.pone.0132491	http://dx.doi.org/10.1371/journal.pone.0132491			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147982	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600288
J	Stuqui, B; de Paula-Silva, M; Carlos, CP; Ullah, A; Arni, RK; Gil, CD; Oliani, SM				Stuqui, Bruna; de Paula-Silva, Marina; Carlos, Carla Patricia; Ullah, Anwar; Arni, Raghuvir Krishnaswamy; Gil, Cristiane Damas; Oliani, Sonia Maria			Ac2-26 Mimetic Peptide of Annexin A1 Inhibits Local and Systemic Inflammatory Processes Induced by Bothrops moojeni Venom and the Lys-49 Phospholipase A(2) in a Rat Model	PLOS ONE			English	Article							ASPER SNAKE-VENOM; MAST-CELLS; MYOTOXIN-II; ADHESION MOLECULES; HEPARIN-BINDING; EXPRESSION; RELEASE; EDEMA; PROTEIN; INJURY	Annexin A1 (AnxA1) is an endogenous glucocorticoid regulated protein that modulates antiinflammatory process and its therapeutic potential has recently been recognized in a range of systemic inflammatory disorders. The effect of the N-terminal peptide Ac2-26 of AnxA1 on the toxic activities of Bothrops moojeni crude venom (CV) and its myotoxin II (MjTX-II) were evaluated using a peritonitis rat model. Peritonitis was induced by the intraperitoneal injection of either CV or MjTX-II, a Lys-49 phospholipase A2. Fifteen minutes after the injection, the rats were treated with either Ac2-26 or PBS. Four hours later, the CV and MjTX-II-induced peritonitis were characterized by neutrophilia (in the peritoneal exudate, blood and mesentery) and increased number of mesenteric degranulated mast cells and macrophages. At 24 hours post-injection, the local inflammatory response was attenuated in the CV-induced peritonitis while the MjTX-II group exhibited neutrophilia (peritoneal exudates and blood). Ac2-26 treatment prevented the influx of neutrophils in MjTX-II-induced peritonitis and diminished the proportion of mesenteric degranulated mast cells and macrophages in CV-induced peritonitis. Additionally, CV and MjTX-II promoted increased levels of IL-1 beta and IL-6 in the peritoneal exudates which were significantly reduced after Ac2-26 treatment. At 4 and 24 hours, the endogenous expression of AnxA1 was upregulated in the mesenteric neutrophils (CV and MjTX-II groups) and mast cells (CV group). In the kidneys, CV and MjTX-II administrations were associated with an increased number of macrophages and morphological alterations in the juxtamedullary nephrons in proximal and distal tubules. Ac2-26 promoted significant recovery of the juxtamedullary structures, decreased the number of macrophages and diminished the AnxA1 in epithelial cells from distal tubules and renal capsules. Our results show that Ac2-26 treatment significantly attenuates local and systemic inflammatory processes and indicate this peptide as a potential target for the development of new therapeutic strategies for the snakebite envenomation treatment.	[Stuqui, Bruna; de Paula-Silva, Marina; Carlos, Carla Patricia; Oliani, Sonia Maria] Sao Paulo State Univ UNESP, Dept Biol, Lab Immunomorphol, Sao Paulo, Brazil; [Ullah, Anwar; Arni, Raghuvir Krishnaswamy] Sao Paulo State Univ UNESP, Dept Phys, Multiuser Ctr Biomol Innovat, Sao Paulo, Brazil; [Gil, Cristiane Damas] Sao Paulo Fed Univ UNIFESP, Dept Morphol & Genet, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP)	Oliani, SM (corresponding author), Sao Paulo State Univ UNESP, Dept Biol, Lab Immunomorphol, Sao Paulo, Brazil.	smoliani@ibilce.unesp.br	Ullah, Anwar/B-1720-2013; Arni, Raghuvir K/N-9338-2018; DAMAS GIL, CRISTIANE/GQA-9650-2022; Silva, Marina/P-7857-2017; Oliani, Sonia Maria/E-3476-2012; Carlos, Carla P/K-1403-2014; Damas Gil, Cristiane/E-1187-2012; Arni, Raghuvir K/B-2222-2013	Ullah, Anwar/0000-0003-3793-7393; Arni, Raghuvir K/0000-0003-2460-1145; Oliani, Sonia Maria/0000-0003-0918-2130; Carlos, Carla P/0000-0003-0516-4533; Damas Gil, Cristiane/0000-0001-6979-4126; Arni, Raghuvir K/0000-0003-2460-1145	State of Sao Paulo Research Foundation (FAPESP); National Council for Scientific and Technological Development (CNPq), Brazil	State of Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the State of Sao Paulo Research Foundation (FAPESP) and by the National Council for Scientific and Technological Development (CNPq), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuebor MN, 1999, J IMMUNOL, V162, P1685; ANTUNES E, 1990, BRIT J PHARMACOL, V101, P986, DOI 10.1111/j.1476-5381.1990.tb14193.x; Araujo LP, 2010, AM J NEPHROL, V31, P527, DOI 10.1159/000309756; Araujo LP, 2012, INFLAMM RES, V61, P189, DOI 10.1007/s00011-011-0400-z; Araujo SD, 2007, INFLAMM RES, V56, P409, DOI 10.1007/s00011-007-7054-x; ASSAKURA MT, 1985, TOXICON, V23, P691, DOI 10.1016/0041-0101(85)90374-5; Bandeira-Melo C, 2005, J PHARMACOL EXP THER, V313, P1416, DOI 10.1124/jpet.104.080473; Boer-Lima PA, 1999, AM J TROP MED HYG, V61, P698, DOI 10.4269/ajtmh.1999.61.698; Carlos CP, 2010, TRANSPLANTATION, V89, P1362, DOI 10.1097/TP.0b013e3181da0587; Carneiro AS, 2008, TOXICON, V52, P619, DOI 10.1016/j.toxicon.2008.07.012; Chutipongtanate S, 2012, J PROTEOME RES, V11, P3650, DOI 10.1021/pr3000738; COLEMAN JW, 1981, BIOCHEM J, V198, P615, DOI 10.1042/bj1980615; Collares-Buzato CB, 2002, TOXICOL APPL PHARM, V181, P124, DOI 10.1006/taap.2002.9404; da Silva PS, 2011, MOL VIS, V17, P1310; Damazo AS, 2006, J IMMUNOL, V176, P4410, DOI 10.4049/jimmunol.176.7.4410; de Castroa I, 2004, TOXICON, V43, P833, DOI 10.1016/j.toxicon.2004.03.015; dos Santos JI, 2011, PROTEINS, V79, P61, DOI 10.1002/prot.22858; ENNIS M, 1980, BRIT J PHARMACOL, V70, P329, DOI 10.1111/j.1476-5381.1980.tb07940.x; Facio FN, 2011, J MOL MED, V89, P51, DOI 10.1007/s00109-010-0684-4; Fernandes CM, 2006, TOXICON, V47, P549, DOI 10.1016/j.toxicon.2006.01.009; Fundacao Nacional de Saude, 1999, MAN DIAGN TRAT AC AN; Gastardelo TS, 2009, AM J PATHOL, V174, P177, DOI 10.2353/ajpath.2009.080342; Gil CD, 2006, CELL BIOL INT, V30, P338, DOI 10.1016/j.cellbi.2005.12.010; Girol AP, 2013, J IMMUNOL, V190, P5689, DOI 10.4049/jimmunol.1202030; Guido BC, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-10; GUTIERREZ J M, 1989, Memorias do Instituto Butantan (Sao Paulo), V51, P211; GUTIERREZ JM, 1986, REV BIOL TROP, V34, P209; GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z; ITO NMK, 1989, RES VET SCI, V46, P192, DOI 10.1016/S0034-5288(18)31144-5; Kamiguti AS, 1996, TOXICON, V34, P627, DOI 10.1016/0041-0101(96)00017-7; Kanaoka Y, 2003, PROSTAG LEUKOTR ESS, V69, P163, DOI 10.1016/S0952-3278(03)00077-2; Kanashiro MM, 2002, BIOCHEM PHARMACOL, V64, P1179, DOI 10.1016/S0006-2952(02)01288-1; KINI RM, 1989, TOXICON, V27, P613, DOI 10.1016/0041-0101(89)90013-5; Kumar V, 2010, ROBBINS COTRAN PATOL, V8th; Landucci ECT, 1998, EUR J PHARMACOL, V343, P257, DOI 10.1016/S0014-2999(97)01546-X; Landucci ECT, 2000, BIOCHEM PHARMACOL, V59, P1289, DOI 10.1016/S0006-2952(00)00248-3; Leoni G, 2015, J CLIN INVEST, V125, P1215, DOI 10.1172/JCI76693; Lomonte B, 2003, TOXICON, V42, P885, DOI 10.1016/j.toxicon.2003.11.008; LOMONTE B, 1994, J BIOL CHEM, V269, P29867; Lomonte B, 2012, TOXICON, V60, P520, DOI 10.1016/j.toxicon.2012.02.007; Maria DA, 2003, TOXICON, V42, P579, DOI 10.1016/S0041-0101(03)00237-X; Markoff A, 2005, AM J PHYSIOL-RENAL, V289, pF949, DOI 10.1152/ajprenal.00089.2005; MEBS D, 1990, PHARMACOL THERAPEUT, V48, P223, DOI 10.1016/0163-7258(90)90081-C; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; MOLITORIS BA, 1991, AM J PHYSIOL, V260, pF769; Moreira V, 2008, TOXICON, V52, P428, DOI 10.1016/j.toxicon.2008.06.012; MORENO JJ, 1992, AGENTS ACTIONS, V36, P258; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; Murakami M, 1996, J BIOL CHEM, V271, P30041, DOI 10.1074/jbc.271.47.30041; Nascimento NG, 2010, TOXICON, V55, P343, DOI 10.1016/j.toxicon.2009.08.009; Nourshargh S, 2005, TRENDS IMMUNOL, V26, P157, DOI 10.1016/j.it.2005.01.006; Oliani SM, 2008, INFLAMM RES, V57, P450, DOI 10.1007/s00011-008-7222-7; Oliani SM, 2001, AM J PATHOL, V158, P603, DOI 10.1016/S0002-9440(10)64002-3; PALLER MS, 1994, J MEMBRANE BIOL, V142, P127; Perretti M, 2004, J LEUKOCYTE BIOL, V76, P25, DOI 10.1189/jlb.1103552; Polli-Lopes AC, 2013, INT J CLIN EXP PATHO, V6, P13; Santos NA, 2008, TOXICON, V52, P908, DOI 10.1016/j.toxicon.2008.08.020; Saude Md, 2011, AC AN PEC SERPENTES2; SCHWARTZ LB, 1994, CURR OPIN IMMUNOL, V6, P91, DOI 10.1016/0952-7915(94)90039-6; Sena AAS, 2006, CLIN EXP ALLERGY, V36, P1260, DOI 10.1111/j.1365-2222.2006.02570.x; Sgrignolli LR, 2011, NEPHRON CLIN PRACT, V119, pC131, DOI 10.1159/000324228; Silistino-Souza R, 2007, INT J CANCER, V120, P2582, DOI 10.1002/ijc.22639; Soares AM, 1998, TOXICON, V36, P503, DOI 10.1016/S0041-0101(97)00133-5; Soerensen B., 1990, ANIMAIS PECONHENTOS, P138; Solito E, 2003, FASEB J, V17, P1544, DOI 10.1096/fj.02-0941fje; Voronov E., 1999, J VENOM ANIM TOXINS, V5, P5, DOI [10.1590/S0104-79301999000100002, DOI 10.1590/S0104-79301999000100002]; Watanabe L, 2005, BIOCHIMIE, V87, P161, DOI 10.1016/j.biochi.2004.11.005; Yang YH, 2009, J IMMUNOL, V183, P1435, DOI 10.4049/jimmunol.0804000; Zamuner SR, 2005, TOXICON, V46, P806, DOI 10.1016/j.toxicon.2005.08.011	69	19	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130803	10.1371/journal.pone.0130803	http://dx.doi.org/10.1371/journal.pone.0130803			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147724	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600050
J	Baldeck, CA; Asner, GP; Martin, RE; Anderson, CB; Knapp, DE; Kellner, JR; Wright, SJ				Baldeck, Claire A.; Asner, Gregory P.; Martin, Robin E.; Anderson, Christopher B.; Knapp, David E.; Kellner, James R.; Wright, S. Joseph			Operational Tree Species Mapping in a Diverse Tropical Forest with Airborne Imaging Spectroscopy	PLOS ONE			English	Article							VECTOR DOMAIN DESCRIPTION; REMOTE-SENSING IMAGES; HYPERSPECTRAL DATA; LIDAR DATA; AERIAL-PHOTOGRAPHY; CLASSIFICATION; DISCRIMINATION; IDENTIFICATION; LEAF; BIODIVERSITY	Remote identification and mapping of canopy tree species can contribute valuable information towards our understanding of ecosystem biodiversity and function over large spatial scales. However, the extreme challenges posed by highly diverse, closed-canopy tropical forests have prevented automated remote species mapping of non-flowering tree crowns in these ecosystems. We set out to identify individuals of three focal canopy tree species amongst a diverse background of tree and liana species on Barro Colorado Island, Panama, using airborne imaging spectroscopy data. First, we compared two leading singleclass classification methods-binary support vector machine (SVM) and biased SVM-for their performance in identifying pixels of a single focal species. From this comparison we determined that biased SVM was more precise and created a multi-species classification model by combining the three biased SVM models. This model was applied to the imagery to identify pixels belonging to the three focal species and the prediction results were then processed to create a map of focal species crown objects. Crown-level cross-validation of the training data indicated that the multi-species classification model had pixel-level producer's accuracies of 94-97% for the three focal species, and field validation of the predicted crown objects indicated that these had user's accuracies of 94-100%. Our results demonstrate the ability of high spatial and spectral resolution remote sensing to accurately detect non-flowering crowns of focal species within a diverse tropical forest. We attribute the success of our model to recent classification and mapping techniques adapted to species detection in diverse closed-canopy forests, which can pave the way for remote species mapping in a wider variety of ecosystems.	[Baldeck, Claire A.; Asner, Gregory P.; Martin, Robin E.; Anderson, Christopher B.; Knapp, David E.] Carnegie Inst Sci, Dept Plant Biol, Dept Global Ecol, Stanford, CA 94305 USA; [Kellner, James R.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Wright, S. Joseph] Smithsonian Trop Res Inst, Washington, DC USA	Carnegie Institution for Science; Brown University; Smithsonian Institution; Smithsonian Tropical Research Institute	Baldeck, CA (corresponding author), Carnegie Inst Sci, Dept Plant Biol, Dept Global Ecol, 290 Panama St, Stanford, CA 94305 USA.	cbaldeck@carnegiescience.edu	Asner, Gregory/G-9268-2013; Wright, Stuart Joseph/M-3311-2013; Martin, Roberta/A-5073-2015	Asner, Gregory/0000-0001-7893-6421; Wright, Stuart Joseph/0000-0003-4260-5676; Martin, Roberta/0000-0003-3509-8530	Avatar Alliance Foundation; Gordon and Betty Moore Foundation; John D. and Catherine R. MacArthur Foundation; Grantham Foundation for the Protection of the Environment; W. M. Keck Foundation; Margaret A. Cargill Foundation; Direct For Biological Sciences [1358915] Funding Source: National Science Foundation	Avatar Alliance Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); John D. and Catherine R. MacArthur Foundation; Grantham Foundation for the Protection of the Environment; W. M. Keck Foundation(W.M. Keck Foundation); Margaret A. Cargill Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study has been supported by the Avatar Alliance Foundation, Gordon and Betty Moore Foundation, John D. and Catherine R. MacArthur Foundation, Grantham Foundation for the Protection of the Environment, W. M. Keck Foundation, Margaret A. Cargill Foundation, Mary Anne Nyburg Baker and G. Leonard Baker Jr., and William R. Hearst III. There are no grant numbers or URLs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizerman A., 1964, AUTOMAT REM CONTR, V25, P821; Alonzo M, 2014, REMOTE SENS ENVIRON, V148, P70, DOI 10.1016/j.rse.2014.03.018; Asner GP, 2014, NEW PHYTOL, V204, P127, DOI 10.1111/nph.12895; Asner GP, 2012, REMOTE SENS ENVIRON, V124, P454, DOI 10.1016/j.rse.2012.06.012; Asner GP, 2011, NEW PHYTOL, V189, P999, DOI 10.1111/j.1469-8137.2010.03549.x; Baldeck CA, 2014, ECOL APPL, V24, P84, DOI 10.1890/13-0307.1; Baldeck CA, 2015, IEEE J-STARS, V8, P2501, DOI 10.1109/JSTARS.2014.2346475; Baldeck CA, 2014, REMOTE SENS-BASEL, V6, P2682, DOI 10.3390/rs6042682; Bing L, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P179, DOI 10.1109/icdm.2003.1250918; BOSER B, 1992, P 5 ANN WORKSH COMP, V5, P144; Bunting P, 2006, REMOTE SENS ENVIRON, V101, P230, DOI 10.1016/j.rse.2005.12.015; Caillaud D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015002; Camps-Valls G, 2004, IEEE T GEOSCI REMOTE, V42, P1530, DOI 10.1109/TGRS.2004.827262; Castro-Esau KL, 2006, AM J BOT, V93, P517, DOI 10.3732/ajb.93.4.517; Castro-Esau KL, 2004, REMOTE SENS ENVIRON, V90, P353, DOI 10.1016/j.rse.2004.01.013; Clark ML, 2005, REMOTE SENS ENVIRON, V96, P375, DOI 10.1016/j.rse.2005.03.009; Cochrane MA, 2000, INT J REMOTE SENS, V21, P2075, DOI 10.1080/01431160050021303; Colgan MS, 2012, REMOTE SENS-BASEL, V4, P3462, DOI 10.3390/rs4113462; Condit R, 2000, J VEG SCI, V11, P649, DOI 10.2307/3236572; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Croat T.B., 1978, FLORA BARRO COLORADO; Dalponte M, 2013, IEEE T GEOSCI REMOTE, V51, P2632, DOI 10.1109/TGRS.2012.2216272; Dalponte M, 2012, REMOTE SENS ENVIRON, V123, P258, DOI 10.1016/j.rse.2012.03.013; Duin RPW, 2000, LECT NOTES COMPUT SC, V1857, P16; Feret JB, 2013, IEEE T GEOSCI REMOTE, V51, P73, DOI 10.1109/TGRS.2012.2199323; Feret JB, 2012, REMOTE SENS-BASEL, V4, P2457, DOI 10.3390/rs4082457; Ferreira MP, 2014, INT GEOSCI REMOTE SE, P784, DOI 10.1109/IGARSS.2014.6946541; Foody GM, 2005, ECOL APPL, V15, P1233, DOI 10.1890/04-1061; Fung T, 1998, INT GEOSCI REMOTE SE, P1298, DOI 10.1109/IGARSS.1998.691383; Garwood N.C., 2009, SEEDLINGS BARRO COLO; Garzon-Lopez CX, 2014, J VEG SCI, V25, P349, DOI 10.1111/jvs.12090; Garzon-Lopez CX, 2013, BIOTROPICA, V45, P308, DOI 10.1111/btp.12009; Gillespie TW, 2008, PROG PHYS GEOG, V32, P203, DOI 10.1177/0309133308093606; Gougeon F.A., 1995, CANADIAN J REMOTE SE, V21, P274, DOI [DOI 10.1080/07038992.1995.10874622, 10.1080/07038992.1995.10874622]; Ingwell LL, 2010, J ECOL, V98, P879, DOI 10.1111/j.1365-2745.2010.01676.x; Kalacska M, 2007, REMOTE SENS ENVIRON, V109, P406, DOI 10.1016/j.rse.2007.01.012; Kellner JR, 2008, POPULATION COMMUNITY; Leckie DG, 2003, REMOTE SENS ENVIRON, V85, P355, DOI 10.1016/S0034-4257(03)00013-0; Lee WS, 2003, 20 INT C MACH LEARN, V3, P448; Lucas R, 2008, REMOTE SENS ENVIRON, V112, P2088, DOI 10.1016/j.rse.2007.10.011; McGraw JB, 1998, TRENDS ECOL EVOL, V13, P300, DOI 10.1016/S0169-5347(98)01414-1; Melgani F, 2004, IEEE T GEOSCI REMOTE, V42, P1778, DOI 10.1109/TGRS.2004.831865; Meyer P, 1996, ISPRS J PHOTOGRAMM, V51, P5, DOI 10.1016/0924-2716(96)00003-2; Mountrakis G, 2011, ISPRS J PHOTOGRAMM, V66, P247, DOI 10.1016/j.isprsjprs.2010.11.001; Munoz-Mari J, 2007, IEEE T GEOSCI REMOTE, V45, P2683, DOI 10.1109/TGRS.2007.897425; Munoz-Mari J, 2010, IEEE T GEOSCI REMOTE, V48, P3188, DOI 10.1109/TGRS.2010.2045764; Nagendra H, 2008, BIODIVERS CONSERV, V17, P3431, DOI 10.1007/s10531-008-9479-0; Papes M, 2013, IEEE J-STARS, V6, P339, DOI 10.1109/JSTARS.2012.2228468; Sanchez-Azofeifa A, 2011, SENSORS-BASEL, V11, P3831, DOI 10.3390/s110403831; Schimel DS, 2013, FRONT ECOL ENVIRON, V11, P129, DOI 10.1890/120111; Schnitzer SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052114; Tax DMJ, 1999, PATTERN RECOGN LETT, V20, P1191, DOI 10.1016/S0167-8655(99)00087-2; Thorington Jr RW, 1982, ECOLOGY TROPICAL FOR; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; VALENCIA R, 1994, BIODIVERS CONSERV, V3, P21, DOI 10.1007/BF00115330; Vapnik V., 1998, STAT LEARNING THEORY; Wang L, 2004, PHOTOGRAMM ENG REM S, V70, P351, DOI 10.14358/PERS.70.3.351; Zhang JK, 2006, REMOTE SENS ENVIRON, V105, P129, DOI 10.1016/j.rse.2006.06.010	58	81	81	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0118403	10.1371/journal.pone.0118403	http://dx.doi.org/10.1371/journal.pone.0118403			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26153693	Green Published, gold, Green Submitted			2022-12-27	WOS:000358159700001
J	Cubo, J; Woodward, H; Wolff, E; Horner, JR				Cubo, Jorge; Woodward, Holly; Wolff, Ewan; Horner, John R.			First Reported Cases of Biomechanically Adaptive Bone Modeling in Non-Avian Dinosaurs	PLOS ONE			English	Article							CROSS-SECTIONAL GEOMETRY; GROWTH-RATE; ADAPTATION; DISEASES; ABSCESS; LOAD; AGE	Predator confrontation or predator evasion frequently produces bone fractures in potential prey in the wild. Although there are reports of healed bone injuries and pathologies in nonavian dinosaurs, no previously published instances of biomechanically adaptive bone modeling exist. Two tibiae from an ontogenetic sample of fifty specimens of the herbivorous dinosaur Maiasaura peeblesorum (Ornithopoda: Hadrosaurinae) exhibit exostoses. We show that these outgrowths are cases of biomechanically adaptive periosteal bone modeling resulting from overstrain on the tibia after a fibula fracture. Histological and biomechanical results are congruent with predictions derived from this hypothesis. Histologically, the outgrowths are constituted by radial fibrolamellar periosteal bone tissue formed at very high growth rates, as expected in a process of rapid strain equilibration response. These outgrowths show greater compactness at the periphery, where tensile and compressive biomechanical constraints are higher. Moreover, these outgrowths increase the maximum bending strength in the direction of the stresses derived from locomotion. They are located on the antero-lateral side of the tibia, as expected in a presumably bipedal one year old individual, and in the posterior position of the tibia, as expected in a presumably quadrupedal individual at least four years of age. These results reinforce myological evidence suggesting that Maiasaura underwent an ontogenetic shift from the primitive ornithischian bipedal condition when young to a derived quadrupedal posture when older.	[Cubo, Jorge] Univ Paris 06, Sorbonne Univ, ISTeP, UMR 7193, 4 Pl Jussieu,BC19, F-75005 Paris, France; [Cubo, Jorge] CNRS, ISTeP, UMR 7193, F-75005 Paris, France; [Woodward, Holly; Horner, John R.] Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; [Woodward, Holly] Oklahoma State Univ, Ctr Hlth Sci, Dept Anat & Cell Biol, Tulsa, OK 74107 USA; [Wolff, Ewan] Purdue Univ, Coll Vet Med, Small Anim Internal Med, W Lafayette, IN 47907 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Montana State University System; Montana State University Bozeman; Oklahoma State University System; Oklahoma State University Center for Health Sciences; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Cubo, J (corresponding author), Univ Paris 06, Sorbonne Univ, ISTeP, UMR 7193, 4 Pl Jussieu,BC19, F-75005 Paris, France.	jorge.cubo_garcia@upmc.fr	Ballard, HollyNoelle/AED-7676-2022; CUBO, Jorge/I-8498-2016	Ballard, HollyNoelle/0000-0003-0413-0681; CUBO, Jorge/0000-0002-8160-779X; Wolff, Ewan/0000-0002-5726-4766	Gerry Ohrstrom; Museum of the Rockies; Jurassic Foundation; Geological Society of America; NSF [EAR 8705986]; CNRS (France); UPMC-Sorbonne Universites (France); Spanish Ministry of Economy and Competitiveness [CGL-2011-23919, CGL-2012-34459]	Gerry Ohrstrom; Museum of the Rockies; Jurassic Foundation; Geological Society of America; NSF(National Science Foundation (NSF)); CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); UPMC-Sorbonne Universites (France); Spanish Ministry of Economy and Competitiveness(Spanish Government)	Funding and support for HW was provided by Gerry Ohrstrom, the Museum of the Rockies, the Jurassic Foundation, the Geological Society of America, and NSF grant #EAR 8705986. Funding and support for JC was provided by the CNRS (France), the UPMC-Sorbonne Universites (France) and by the grants CGL-2011-23919 and CGL-2012-34459 of the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTRAM JEA, 1988, J THEOR BIOL, V131, P75, DOI 10.1016/S0022-5193(88)80122-X; Bourdon E, 2009, BIOL LETTERS, V5, P639, DOI 10.1098/rsbl.2009.0310; BOYDE A, 1978, METAB BONE DIS RELAT, V1, P235, DOI 10.1016/0221-8747(78)90008-5; Brothwell Don, 2002, Acta Zoologica Cracoviensia, V45, P315; Bybee PJ, 2006, J MORPHOL, V267, P347, DOI 10.1002/jmor.10406; Campbell JG, 1965, J ROYAL MICROSCOPICA, V85, P163; Casinos A, 2001, COMP BIOCHEM PHYS A, V131, P159, DOI 10.1016/S1095-6433(01)00463-9; Castanet J, 2006, CR PALEVOL, V5, P629, DOI 10.1016/j.crpv.2005.10.006; Chinsamy A, 2009, ANAT REC, V292, P1478, DOI 10.1002/ar.20991; Cubo J, 1997, NETH J ZOOL, V47, P209, DOI 10.1163/156854297X00175; Cubo J, 1998, EUR J MORPHOL, V36, P19, DOI 10.1076/ejom.36.1.19.9029; de Margerie E, 2004, J EXP BIOL, V207, P869, DOI 10.1242/jeb.00841; de Margerie E, 2002, CR BIOL, V325, P221, DOI 10.1016/S1631-0691(02)01429-4; Dilkes DW, 2001, CAN J EARTH SCI, V38, P1205, DOI 10.1139/e01-016; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; EDEIKEN J, 1966, AMER J ROENTGENOL RA, V97, P708, DOI 10.2214/ajr.97.3.708; GOODSHIP AE, 1979, J BONE JOINT SURG AM, V61, P539, DOI 10.2106/00004623-197961040-00008; Horner JR, 2004, P ROY SOC B-BIOL SCI, V271, P1875, DOI 10.1098/rspb.2004.2829; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; Huchzermeyer FW, 2000, VET REC, V147, P515, DOI 10.1136/vr.147.18.515; Judex S, 1997, J BONE MINER RES, V12, P1737, DOI 10.1359/jbmr.1997.12.10.1737; LANYON LE, 1982, J BIOMECH, V15, P141, DOI 10.1016/0021-9290(82)90246-9; Lee TC, 2002, J ANAT, V201, P437, DOI 10.1046/j.1469-7580.2002.00123.x; Lieberman DE, 2004, AM J PHYS ANTHROPOL, V123, P156, DOI 10.1002/ajpa.10316; Lieberman DE, 2003, J EXP BIOL, V206, P3125, DOI 10.1242/jeb.00514; Main RP, 2007, J ANAT, V210, P272, DOI 10.1111/j.1469-7580.2007.00696.x; McWhinney Lorrie, 2001, P364; Mead AJ, 2009, J WILDLIFE DIS, V45, P325, DOI 10.7589/0090-3558-45.2.325; MILLER WB, 1979, RADIOLOGY, V132, P15, DOI 10.1148/132.1.15; Montes L, 2007, BIOL J LINN SOC, V92, P63, DOI 10.1111/j.1095-8312.2007.00881.x; Redelstorff R, 2015, LETHAIA, V48, P47, DOI 10.1111/let.12086; REECE RL, 1992, J ZOO WILDLIFE MED, V23, P301; Rothschild BM, 1998, J RHEUMATOL, V25, P2221; RUFF CB, 1983, AM J PHYS ANTHROPOL, V60, P359, DOI 10.1002/ajpa.1330600308; SCHMIDT EV, 1982, AM J PATHOL, V106, P297; Schmitt James G., 2014, P486; Schultz AH., 1939, B HIST MED, V7, P571; TAYLOR ME, 1971, CAN J ZOOLOG, V49, P1035, DOI 10.1139/z71-159; Wallace IJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099108; Wolff EDS, 2008, HIST BIOL, V20, P185, DOI 10.1080/08912960802556642; Wolff EDS, 2009, HIST BIOL, V21, P235, DOI 10.1080/08912960903471196; Yang PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094525	43	18	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131131	10.1371/journal.pone.0131131	http://dx.doi.org/10.1371/journal.pone.0131131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26153689	Green Published, Green Submitted, gold			2022-12-27	WOS:000358159700053
J	Wilke, A; Minich, S; Panis, M; Langen, TA; Skufca, JD; Todd, PM				Wilke, Andreas; Minich, Steven; Panis, Megane; Langen, Tom A.; Skufca, Joseph D.; Todd, Peter M.			A Game of Hide and Seek: Expectations of Clumpy Resources Influence Hiding and Searching Patterns	PLOS ONE			English	Article							DISTRIBUTIONS REDUCE PILFERAGE; SEX-DIFFERENCES; SPATIAL MEMORY; HOT-HAND; CACHE RECOVERY; DECISION RULES; FOOD CACHES; BEHAVIOR; EVOLUTION; RANDOMNESS	Resources are often distributed in clumps or patches in space, unless an agent is trying to protect them from discovery and theft using a dispersed distribution. We uncover human expectations of such spatial resource patterns in collaborative and competitive settings via a sequential multi-person game in which participants hid resources for the next participant to seek. When collaborating, resources were mostly hidden in clumpy distributions, but when competing, resources were hidden in more dispersed (random or hyperdispersed) patterns to increase the searching difficulty for the other player. More dispersed resource distributions came at the cost of higher overall hiding (as well as searching) times, decreased payoffs, and an increased difficulty when the hider had to recall earlier hiding locations at the end of the experiment. Participants' search strategies were also affected by their underlying expectations, using a win-stay lose-shift strategy appropriate for clumpy resources when searching for collaboratively-hidden items, but moving equally far after finding or not finding an item in competitive settings, as appropriate for dispersed resources. Thus participants showed expectations for clumpy versus dispersed spatial resources that matched the distributions commonly found in collaborative versus competitive foraging settings.	[Wilke, Andreas; Langen, Tom A.] Clarkson Univ, Dept Psychol, Potsdam, NY 13676 USA; [Minich, Steven; Skufca, Joseph D.] Clarkson Univ, Dept Math & Comp Sci, Potsdam, NY USA; [Panis, Megane] Univ Lyon, Dept Psychol, Lyon, France; [Langen, Tom A.] Clarkson Univ, Dept Biol, Potsdam, NY USA; [Todd, Peter M.] Indiana Univ, Cognit Sci Program, Bloomington, IN USA	Clarkson University; Clarkson University; Clarkson University; Indiana University System; Indiana University Bloomington	Wilke, A (corresponding author), Clarkson Univ, Dept Psychol, Potsdam, NY 13676 USA.	awilke@clarkson.edu			National Science Foundation [DBI-0926568]	National Science Foundation(National Science Foundation (NSF))	SM received funding from the National Science Foundation (DBI-0926568).	Bell WJ, 1991, SEARCHING BEHAV BEHA, DOI DOI 10.1371/journal.pone.0086271; Blanchard TC, 2014, J EXP PSYCHOL-ANIM L, V40, P280, DOI 10.1037/xan0000033; Brodin A, 1997, BEHAVIOUR, V134, P881, DOI 10.1163/156853997X00205; Bugnyar T, 2002, ANIM BEHAV, V64, P185, DOI 10.1006/anbe.2002.3056; Cashdan E, 2012, EVOL HUM BEHAV, V33, P274, DOI 10.1016/j.evolhumbehav.2011.10.005; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; CLARK DA, 1984, AM NAT, V124, P769, DOI 10.1086/284316; CLARKE MF, 1994, BEHAV ECOL, V5, P353, DOI 10.1093/beheco/5.4.353; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; CORNELL EH, 1986, CHILD DEV, V57, P603; Dally JM, 2006, ANIM BEHAV, V72, P13, DOI 10.1016/j.anbehav.2005.08.020; DALY M, 1992, BEHAV ECOL, V3, P102, DOI 10.1093/beheco/3.2.102; Dufour CMS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046706; EALS M, 1994, ETHOL SOCIOBIOL, V15, P95, DOI 10.1016/0162-3095(94)90020-5; Emlen J., 1973, ECOLOGY EVOLUTIONARY; Falk R, 1997, PSYCHOL REV, V104, P301, DOI 10.1037/0033-295X.104.2.301; Falk R, 1975, THESIS HEBREW U; Falk R, 2009, J EXP PSYCHOL HUMAN, V35, P203, DOI 10.1037/0096-1523.35.1.203; Fawcett TW, 2014, TRENDS COGN SCI, V18, P153, DOI 10.1016/j.tics.2013.12.012; Galvez D, 2009, ANIM BEHAV, V78, P1327, DOI 10.1016/j.anbehav.2009.08.015; GILOVICH T, 1985, COGNITIVE PSYCHOL, V17, P295, DOI 10.1016/0010-0285(85)90010-6; Gordon DM, 1997, TRENDS ECOL EVOL, V12, P63, DOI 10.1016/S0169-5347(96)10069-0; Haselton MG, 2009, SOC COGNITION, V27, P733, DOI 10.1521/soco.2009.27.5.733; Hills TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060488; Hills TT, 2006, COGNITIVE SCI, V30, P3, DOI 10.1207/s15516709cog0000_50; Hopewell LJ, 2008, BEHAV ECOL, V19, P1143, DOI 10.1093/beheco/arn095; Hutchinson JMC, 2005, BIOL REV, V80, P73, DOI 10.1017/S1464793104006554; Hutchinson JMC, 2008, ANIM BEHAV, V75, P1331, DOI 10.1016/j.anbehav.2007.09.006; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; IWASA Y, 1981, AM NAT, V117, P710, DOI 10.1086/283754; KAMIL AC, 1994, J COMP PSYCHOL, V108, P385, DOI 10.1037/0735-7036.108.4.385; Krause J., 2002, LIVING GROUPS OXFORD; Laca EA, 1998, J RANGE MANAGE, V51, P370, DOI 10.2307/4003320; Lahti K, 1996, ANIM BEHAV, V52, P631, DOI 10.1006/anbe.1996.0204; Langen TA, 2004, ENCY ANIMAL BEHAV, V1, P290; Legge ELG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036993; Louapre P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014251; Male LH, 2008, J AVIAN BIOL, V39, P170, DOI 10.1111/j.2008.0908-8857.04019.x; Male LH, 2007, ANIM BEHAV, V73, P717, DOI 10.1016/j.anbehav.2006.06.017; Male LH, 2007, BEHAV ECOL, V18, P456, DOI 10.1093/beheco/arl107; MENZEL EW, 1973, SCIENCE, V182, P943, DOI 10.1126/science.182.4115.943; Mussweiler T, 2012, STRUNGMANN FORUM REP, P275; New J, 2007, P ROY SOC B-BIOL SCI, V274, P2679, DOI 10.1098/rspb.2007.0826; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; Pacheco-Cobos L, 2010, EVOL HUM BEHAV, V31, P289, DOI 10.1016/j.evolhumbehav.2009.12.008; REICHMAN OJ, 1979, ECOLOGY, V60, P1085, DOI 10.2307/1936954; Rubinstein A, 1997, UNDERSTANDING STRATEGIC INTERACTION, P394; Scheibehenne B, 2011, EVOL HUM BEHAV, V32, P326, DOI 10.1016/j.evolhumbehav.2010.11.003; SHERRY D, 1982, Z TIERPSYCHOL, V58, P153; Smulders TV, 2010, PHILOS T R SOC B, V365, P883, DOI 10.1098/rstb.2009.0211; STAPANIAN MA, 1978, ECOLOGY, V59, P884, DOI 10.2307/1938541; STAPANIAN MA, 1984, ECOLOGY, V65, P1387, DOI 10.2307/1939119; Stoet G, 2011, EVOL HUM BEHAV, V32, P416, DOI 10.1016/j.evolhumbehav.2011.03.001; Talbot KJ, 2009, LEARN MOTIV, V40, P221, DOI 10.1016/j.lmot.2009.01.003; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; TAYLOR LR, 1978, J ANIM ECOL, V47, P383, DOI 10.2307/3790; WAITE TA, 1992, BEHAVIOUR, V120, P51, DOI 10.1163/156853992X00200; Wilke A, 2014, EVOL HUM BEHAV, V35, P291, DOI 10.1016/j.evolhumbehav.2014.02.010; Wilke A, 2010, PSICOTHEMA, V22, P4; Wilke A, 2009, COGNITIVE SCI, V33, P497, DOI 10.1111/j.1551-6709.2009.01020.x; Wilke A, 2009, EVOL HUM BEHAV, V30, P161, DOI 10.1016/j.evolhumbehav.2008.11.004	62	8	8	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130976	10.1371/journal.pone.0130976	http://dx.doi.org/10.1371/journal.pone.0130976			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154661	gold, Green Published, Green Submitted			2022-12-27	WOS:000358159700050
J	Zhang, XP; Yang, J; Zhao, JM; Zhang, PH; Huang, XY				Zhang, Xipeng; Yang, Jie; Zhao, Jiming; Zhang, Pihong; Huang, Xiaoyuan			MicroRNA-23b Inhibits the Proliferation and Migration of Heat-Denatured Fibroblasts by Targeting Smad3	PLOS ONE			English	Article							CELLS IN-VITRO; EXPRESSED MICRORNAS; CANCER; SKIN; BIOGENESIS; PROTEIN; MIR-23B; GROWTH	Background Skin grafting with the preservation of denatured dermis is a novel strategy for the treatment of burn-injured skin. Denatured dermis has the ability to restore to the morphology and function of normal skin, but the underlying molecular mechanism is elusive. MicroRNAs (miRNA) are small noncoding RNAs and regulate normal physiology as well as disease development. In this study, we assessed the potential role of miRNA-23b (miR-23b) in the regulation of cell proliferation and migration of heat-denatured fibroblasts and identified the underlying mechanism. Methods The expression of miR-23b in denatured dermis and heat-denatured fibroblasts was detected by quantitative real-time polymerase chain reaction (RT-PCR). The effects of miR-23b on cell proliferation and migration of heat-denatured fibroblasts were assessed by transient transfection of miR-23b mimics and inhibitor. The target gene of miR-23b and the downstream pathway were further investigated. Results miR-23b was downregulated in denatured dermis and heat-denatured fibroblasts. Downregulation of miR-23b dramatically promoted the proliferation and migration of heat-denatured fibroblasts. Subsequent analyses demonstrated that Smad3 was a direct and functional target of miR-23b in heat-denatured fibroblasts, which was validated by the dual luciferase reporter assay. Moreover, immunohistochemistry analysis showed that denatured dermis from rats displayed enhanced staining of Smad3. In addition, miR-23b modulated denatured dermis by activating the Notch1 and TGF-beta signaling pathways. Conclusions Our findings suggest that downregulation of miR-23b contributes to the recovery of denatured dermis, which may be valuable for treatment of skin burns.	[Zhang, Xipeng; Zhang, Pihong; Huang, Xiaoyuan] Cent S Univ, Xiangya Hosp, Dept Burns & Plast Surg, Changsha 410008, Hunan, Peoples R China; [Yang, Jie] Southern Med Univ, Zhujiang Hosp, Dept Pathol, Guangzhou 510282, Guangdong, Peoples R China; [Zhao, Jiming] Jinzhou Tradit Chinese Med Hosp, Dept Tradit Chinese Med, Zhangjiajie 427000, Hunan, Peoples R China	Central South University; Southern Medical University - China	Huang, XY (corresponding author), Cent S Univ, Xiangya Hosp, Dept Burns & Plast Surg, Changsha 410008, Hunan, Peoples R China.	huxzhongxy@163.com			National Nature Science Foundation of China [30973121]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (No: 30973121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bai XZ, 2015, EXP DERMATOL, V24, P355, DOI 10.1111/exd.12665; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Chen LY, 2014, ONCOL REP, V31, P1573, DOI 10.3892/or.2014.3012; Cubison TCS, 2006, BURNS, V32, P714, DOI 10.1016/j.burns.2006.01.023; Fan Peng-Ju, 2008, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V33, P596; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Huang XY, 2001, ZHONGHUA SHAO SHANG, V17, P60; Kimura Hitomi, 2004, Nucleic Acids Symp Ser (Oxf), P213; Lai WF, 2014, J BIOSCIENCES, V39, P519, DOI 10.1007/s12038-014-9421-4; Leone V, 2012, J CLIN ENDOCR METAB, V97, P3292, DOI 10.1210/jc.2012-1349; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Li C, 2013, ACTA BIOCH BIOPH SIN, V45, P692, DOI 10.1093/abbs/gmt057; [李德全 Li Dequan], 2008, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V12, P2056; Li WP, 2014, FEBS LETT, V588, P1608, DOI 10.1016/j.febslet.2014.02.055; Liang PF, 2012, BURNS, V38, P534, DOI 10.1016/j.burns.2011.10.014; Liu W, 2010, ONCOGENE, V29, P4914, DOI 10.1038/onc.2010.237; Liu Ying, 2005, Zhonghua Shao Shang Za Zhi, V21, P14; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Moura J, 2014, GENES-BASEL, V5, P926, DOI 10.3390/genes5040926; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Rogler CE, 2009, HEPATOLOGY, V50, P575, DOI 10.1002/hep.22982; RUDOLPH R, 1979, PLAST RECONSTR SURG, V63, P473, DOI 10.1097/00006534-197904000-00005; Salvi A, 2009, FEBS J, V276, P2966, DOI 10.1111/j.1742-4658.2009.07014.x; Sand M, 2009, J DERMATOL SCI, V53, P169, DOI 10.1016/j.jdermsci.2008.10.004; Wang JF, 2008, LAB INVEST, V88, P1278, DOI 10.1038/labinvest.2008.101; Wang KC, 2010, P NATL ACAD SCI USA, V107, P3234, DOI 10.1073/pnas.0914825107; Yang Xing-Hua, 2005, Zhonghua Shao Shang Za Zhi, V21, P27; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yuan B, 2011, FEBS LETT, V585, P927, DOI 10.1016/j.febslet.2011.02.031; Zhao Yao-hua, 2013, Zhonghua Shao Shang Za Zhi, V29, P365; Zheng J, 2012, ALLERGY, V67, P362, DOI 10.1111/j.1398-9995.2011.02776.x	33	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131867	10.1371/journal.pone.0131867	http://dx.doi.org/10.1371/journal.pone.0131867			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26153982	Green Submitted, Green Published, gold			2022-12-27	WOS:000358159700081
J	Xu, XJ; Zhao, XY; Qian, D; Dong, Q; Gu, ZF				Xu, Xujuan; Zhao, Xiaoyan; Qian, Duo; Dong, Qing; Gu, Zhifeng			Investigating Factors Associated with Depression of Type 2 Diabetic Retinopathy Patients in China	PLOS ONE			English	Article							QUALITY-OF-LIFE; RISK-FACTORS; PREVALENCE; PEOPLE; SEVERITY; SYMPTOMS; MELLITUS; ANXIETY	Aims and objectives To assess the depression status of type 2 diabetic retinopathy patients in Nantong China and to identify factors associated with depression. Methods Two hundred and ninety-four patients with type 2 diabetic retinopathy were recruited from the Affiliated Hospital of Nantong University. The severity of DR was measured in the worse eye. Depressive symptoms were assessed with the Center for Epidemiologic Studies Depression Scale (CES-D); the quality of life was measured with the Medical Outcomes Study Short Form 36 (SF-36). The logistic regression analyses were used to identify the independent factors of depression. Results The mean age of the study subjects was 57.77 years (SD: 9.64). Approximately 35.7% of subjects reported depressive symptoms (n = 105). Multiple logistic regression analyses showed that female gender (p = 0.014), low monthly income (p = 0.01), poor vision in the better eye (P = 0.002), laser treatment history (p = 0.01) were significant risk factors for depression. The quality of life of individuals with CES-D score<16 was significantly better compared with individuals with CES-D score >= 16. Conclusion The reported depressive symptoms among type 2 diabetic retinopathy population is higher in Nantong China. Gender, salary, vision acuity and treatment history were important risk factors linked to this disorder in the Chinese type 2 diabetic retinopathy population from Nantong. More attention by medical care personnel needs to be paid to the psychological health of this population.	[Xu, Xujuan; Dong, Qing] Nantong Univ, Affiliated Hosp, Dept Nursing, Nantong, Peoples R China; [Zhao, Xiaoyan; Qian, Duo] Nantong Univ, Sch Nursing, Nantong, Peoples R China; [Gu, Zhifeng] Nantong Univ, Affiliated Hosp, Dept Rheumatol, Nantong, Peoples R China	Nantong University; Nantong University; Nantong University	Gu, ZF (corresponding author), Nantong Univ, Affiliated Hosp, Dept Rheumatol, Nantong, Peoples R China.	guzhifeng@126.com	Gu, Zhifeng/AAP-9566-2021		College graduate research and innovation of Jiangsu Province [CXLX13_877]; Nantong University Graduate Innovation Program [YKC13047]	College graduate research and innovation of Jiangsu Province; Nantong University Graduate Innovation Program	This work was supported by the College graduate research and innovation of Jiangsu Province(CXLX13_877) and the Nantong University Graduate Innovation Program (YKC13047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Bailey CC, 2001, DIABETIC MED, V18, P883, DOI 10.1046/j.1464-5491.2001.00589.x; BOYD JH, 1982, ARCH GEN PSYCHIAT, V39, P1195; Camara A, 2015, DIABETES METAB, V41, P62, DOI 10.1016/j.diabet.2014.04.007; Chen CK, 2010, PSYCHOSOMATICS, V51, P528, DOI 10.1176/appi.psy.51.6.528; Consultation W, 1999, DEF DIAGN CLASS DIAB, P1; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; Devenney R, 2011, BRIT J HEALTH PSYCH, V16, P707, DOI 10.1111/j.2044-8287.2010.02008.x; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Fenwick EK, 2012, QUAL LIFE RES, V21, P1771, DOI 10.1007/s11136-012-0110-1; Ganasegeran K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004794; Hirai FE, 2011, OPHTHALMOLOGY, V118, P353, DOI 10.1016/j.ophtha.2010.06.022; Klein BEK, 2007, OPHTHAL EPIDEMIOL, V14, P179, DOI 10.1080/09286580701396720; Lamoureux EL, 2004, ARCH OPHTHALMOL-CHIC, V122, P84, DOI 10.1001/archopht.122.1.84; Li L, 2003, J EPIDEMIOL COMMUN H, V57, P259, DOI 10.1136/jech.57.4.259; Mathew RS, 2011, OPHTHAL PHYSL OPT, V31, P375, DOI 10.1111/j.1475-1313.2011.00848.x; Mazhar K, 2011, OPHTHALMOLOGY, V118, P649, DOI 10.1016/j.ophtha.2010.08.003; McGrath E., 1990, WOMEN DEPRESSION RIS; McHale M, 2008, PSYCHOSOM MED, V70, P869, DOI 10.1097/PSY.0b013e318186dea9; Niraula K, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-309; Palizgir M, 2013, IRAN RED CRESCENT ME, V15, P644, DOI 10.5812/ircmj.12107; Pang C, 2012, DIABETES-METAB RES, V28, P276, DOI 10.1002/dmrr.1307; Peden AR, 2000, NURS RES, V49, P201, DOI 10.1097/00006199-200007000-00003; Porta M, 2002, DIABETOLOGIA, V45, P1617, DOI 10.1007/s00125-002-0990-7; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rein DB, 2006, ARCH OPHTHALMOL-CHIC, V124, P1754, DOI 10.1001/archopht.124.12.1754; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Trento M, 2013, ACTA DIABETOL, V50, P873, DOI 10.1007/s00592-013-0470-1; Wang J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-633; Ware J.E., 2000, SF 36 HLTH SURVEY MA; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Xu Y, 2008, RES NURS HEALTH, V31, P613, DOI 10.1002/nur.20293; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yau JWY, 2012, DIABETES CARE; Yu Y, 2013, INT J OPHTHALMOL-CHI, V6, P71, DOI 10.3980/j.issn.2222-3959.2013.01.15; [章婕 ZHANG Jie], 2010, [中国心理卫生杂志, Chinese Mental Health Journal], V24, P139; Zhou XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099692	37	15	16	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132616	10.1371/journal.pone.0132616	http://dx.doi.org/10.1371/journal.pone.0132616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EC	26151365	gold, Green Published, Green Submitted			2022-12-27	WOS:000358158900049
J	Fujigaki, JLZ; Valerio, AGA; Alvarenga, JCL; Reyes, EGG; Kershenobich, D; Ruiz, JH				Zaldivar Fujigaki, Jose Luis; Arroyo Valerio, America Guadalupe; Lopez Alvarenga, Juan Carlos; Gutierrez Reyes, Esperanza Gabriela; Kershenobich, David; Hernandez Ruiz, Joselin			Alterations in Activation, Cytotoxic Capacity and Trafficking Profile of Peripheral CD8 T Cells in Young Adult Binge Drinkers	PLOS ONE			English	Article							ALCOHOLIC LIVER-DISEASE; HEPATIC-FIBROSIS; ETHANOL EXPOSURE; IMMUNE CELLS; MICE; EXPRESSION; CONSUMPTION; INNATE; MEMORY; CD69	Background Excess of alcohol consumption is a public health problem and has documented effects on the immune system of humans and animals. Animal and in vitro studies suggest that alcohol abuse changes CD8 T cell (CD8) characteristics, however it remains unknown if the CD8 profile of binge drinkers is different in terms of activation, trafficking and cytotoxic capacity. Aim To analyze the peripheral CD8 cytotoxic capacity, activation and trafficking phenotypic profile of Mexican young adults with regard to alcohol consumption pattern. Methods 55 Mexican young adults were stratified as Light (20), Intermediate (18) or Binge drinkers (17) according to their reported alcohol consumption pattern. Blood samples were obtained and hematic biometry and liver enzyme analysis were performed. Peripheral CD8 profile was established by expression of Granzyme B (GB), CD137, CD127, CD69, TLR4, PD1, CCR2, CCR4, CCR5 and CXCR4 by FACS. Data was analyzed by ANOVA, posthoc DMS and Tamhane, and principal component analysis (PCA) with varimax rotation, p<0.05. Results The Binge drinking group showed increased. GT together with increased expression of CD69 and reduced expression of TLR4, PD1, CCR2 and CXCR4 in peripheral CD8 cells. Other parameters were also specific to Binge drinkers. PCA established 3 factors associated with alcohol consumption: "Early Activation" represented by CD69 and TLR4 expression in the CD8 population; "Effector Activation" by CD69 expression in CD8 CD127(+)CD137(+) and CD8 CD25(+)CD137(+); and Trafficking by CXCR4 expression on total CD8 and CD8 GB(+-)CXCR4(+), and CCR2 expression on total CD8. Binge drinking pattern showed low expression of Early Activation and Trafficking factors while Light drinking pattern exhibited high expression of Effector Activation factor. Conclusions Alcohol consumption affects the immune phenotype of CD8 cells since binge drinking pattern was found to be associated with high CD69 and low TLR4, CXCR4 and CCR2 expression, which suggest recent activation, decreased sensitivity to LPS and lower migration capacity in response to chemokines SDF-1 and MCP-1. These results indicate that a binge-drinking pattern of alcohol consumption may induce an altered immune profile that could be related with liver damage and the increased susceptibility to infection reported to this behavior.	[Zaldivar Fujigaki, Jose Luis; Gutierrez Reyes, Esperanza Gabriela; Hernandez Ruiz, Joselin] Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Lab Liver Pancreas & Motil, Mexico City 04510, DF, Mexico; [Arroyo Valerio, America Guadalupe; Lopez Alvarenga, Juan Carlos; Hernandez Ruiz, Joselin] Hosp Gen Mexico Dr Eduardo Liceaga, Direcc Invest, Mexico City, DF, Mexico; [Kershenobich, David] Inst Nacl Ciencias Med & Nutr Salvador Zubrian, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Ruiz, JH (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Lab Liver Pancreas & Motil, Mexico City 04510, DF, Mexico.	joselin.hernandezr@hgm.mx		Lopez-Alvarenga, Juan/0000-0002-0966-8766; Hernandez Ruiz, Joselin/0000-0002-0571-2563; Zaldivar Fujigaki, Jose Luis/0000-0001-7210-5475	Instituto de Ciencia y Tecnologia del Distrito Federal [PICSA 10-164, 231]	Instituto de Ciencia y Tecnologia del Distrito Federal	This research was funded by the Instituto de Ciencia y Tecnologia del Distrito Federal, number: PICSA 10-164, agreement 231. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albano E, 2010, GENES NUTR, V5, P141, DOI 10.1007/s12263-009-0151-4; Amsen D, 2013, ADV EXP MED BIOL, V785, P107, DOI 10.1007/978-1-4614-6217-0_12; Babor T., 2001, BRIEF INTERVENTION H; Babor TF, 2001, AUDIT ALC USE DISORD; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Chen CP, 2006, ALCOHOL CLIN EXP RES, V30, P1925, DOI 10.1111/j.1530-0277.2006.00237.x; Craston R, 1997, J IMMUNOL METHODS, V209, P37, DOI 10.1016/S0022-1759(97)00143-9; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Gonzalez-Amaro R, 2013, TRENDS MOL MED, V19, P625, DOI 10.1016/j.molmed.2013.07.006; Gonzalez-Reimers E, 2012, ALCOHOL ALCOHOLISM, V47, P390, DOI 10.1093/alcalc/ags041; Haringer B, 2009, J EXP MED, V206, P1009, DOI 10.1084/jem.20082238; Hemann EA, 2014, ALCOHOL CLIN EXP RES, V38, P2403, DOI 10.1111/acer.12522; Hritz I, 2008, HEPATOLOGY, V48, P1224, DOI 10.1002/hep.22470; Inokuchi S, 2011, ALCOHOL CLIN EXP RES, V35, P1509, DOI 10.1111/j.1530-0277.2011.01487.x; Laso FJ, 2010, ALCOHOL CLIN EXP RES, V34, P876, DOI 10.1111/j.1530-0277.2010.01160.x; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; Jerrells TR, 2002, ALCOHOL, V27, P47, DOI 10.1016/S0741-8329(02)00210-0; Jiang Q, 2004, MOL CELL BIOL, V24, P6501, DOI 10.1128/MCB.24.14.6501-6513.2004; Jimenez-Ortega V, 2011, ALCOHOL, V45, P183, DOI 10.1016/j.alcohol.2010.08.008; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Karim S, 2013, TOXICOL SCI, V132, P131, DOI 10.1093/toxsci/kfs337; Kobayashi N, 2004, EUR J IMMUNOL, V34, P3370, DOI 10.1002/eji.200425587; Komai-Koma M, 2009, EUR J IMMUNOL, V39, P1564, DOI 10.1002/eji.200838866; Li TK, 2008, J GASTROEN HEPATOL, V23, pS2, DOI 10.1111/j.1440-1746.2007.05298.x; Markwick LJL, 2015, GASTROENTEROLOGY, V148, P590, DOI 10.1053/j.gastro.2014.11.041; Moreno C, 2005, HEPATOLOGY, V42, P854, DOI 10.1002/hep.20865; National Institute on Alcohol Abuse and Alcoholism, 2004, NIAAA COUNC APPR DEF; Nelson S, 2002, NAT REV IMMUNOL, V2, P205, DOI 10.1038/nri744; Parlet CP, 2014, ALCOHOL CLIN EXP RES, V38, P1356, DOI 10.1111/acer.12358; Petrasek J, 2013, ADV CLIN CHEM, V59, P155, DOI 10.1016/B978-0-12-405211-6.00006-1; Pruett SB, 2010, TOXICOL SCI, V117, P314, DOI 10.1093/toxsci/kfq215; Rabin RL, 1999, J IMMUNOL, V162, P3840; Rehm J, 2011, ALCOHOL RES HEALTH, V34, P135; RUIZ JH, 2012, REV GASTROENTEROL S3, V77, P43; Sacanella E, 1998, ALCOHOL CLIN EXP RES, V22, P897, DOI 10.1097/00000374-199806000-00020; Safadi R, 2004, GASTROENTEROLOGY, V127, P870, DOI 10.1053/j.gastro.2004.04.062; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Secretaria de Salud, 2012, ENC NAC AD 2011 REP; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Setshedi M, 2010, OXID MED CELL LONGEV, V3, P178, DOI 10.4161/oxim.3.3.12288; Singh M, 2013, J CLIN DIAGN RES, V7, P1568, DOI 10.7860/JCDR/2013/5596.3210; Taylor AL, 2012, IMMUNOLOGY, V135, P158, DOI 10.1111/j.1365-2567.2011.03529.x; Thiele GM, 2010, ALCOHOL CLIN EXP RES, V34, P2126, DOI 10.1111/j.1530-0277.2010.01309.x; Topic A, 2013, CLIN LAB, V59, P233, DOI 10.7754/Clin.Lab.2012.120318; United States Department of Agriculture and United States Department of Health and Human Services, 2005, DIET GUID AM 2005; van Beek JHDA, 2014, DRUG ALCOHOL DEPEN, V134, P99, DOI 10.1016/j.drugalcdep.2013.09.016; Vidali M, 2008, TRENDS MOL MED, V14, P63, DOI 10.1016/j.molmed.2007.12.005; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Ward RJ, 2014, ALCOHOL ALCOHOLISM, V49, P193, DOI 10.1093/alcalc/agu002; Watanabe K, 2008, INT J HEMATOL, V88, P311, DOI 10.1007/s12185-008-0134-z; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wolfl M, 2008, CYTOM PART A, V73A, P1043, DOI 10.1002/cyto.a.20594; Zhang H, 2005, J LEUKOCYTE BIOL, V78, P1070, DOI 10.1189/jlb0605-317; Zhang H, 2015, TOXICOL APPL PHARM, V282, P139, DOI 10.1016/j.taap.2014.11.013	55	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132521	10.1371/journal.pone.0132521	http://dx.doi.org/10.1371/journal.pone.0132521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151816	gold, Green Published, Green Submitted			2022-12-27	WOS:000358158900044
J	Chen, K; Li, EC; Li, TY; Xu, C; Wang, XD; Lin, HZ; Qin, JG; Chen, LQ				Chen, Ke; Li, Erchao; Li, Tongyu; Xu, Chang; Wang, Xiaodan; Lin, Heizhao; Qin, Jian G.; Chen, Liqiao			Transcriptome and Molecular Pathway Analysis of the Hepatopancreas in the Pacific White Shrimp Litopenaeus vannamei under Chronic Low-Salinity Stress	PLOS ONE			English	Article							TISSUE-SPECIFIC EXPRESSION; CHINESE MITTEN CRAB; RNA-SEQ DATA; GLUTAMATE-DEHYDROGENASE; ERIOCHEIR-SINENSIS; PENAEUS-VANNAMEI; LIPID-METABOLISM; ACID-METABOLISM; NA+/K+-ATPASE; ION-TRANSPORT	The Pacific white shrimp Litopenaeus vannamei is a euryhaline penaeid species that shows ontogenetic adaptations to salinity, with its larvae inhabiting oceanic environments and postlarvae and juveniles inhabiting estuaries and lagoons. Ontogenetic adaptations to salinity manifest in L. vannamei through strong hyper-osmoregulatory and hypo-osmoregulatory patterns and an ability to tolerate extremely low salinity levels. To understand this adaptive mechanism to salinity stress, RNA-seq was used to compare the transcriptomic response of L. vannamei to changes in salinity from 30 (control) to 3 practical salinity units (psu) for 8 weeks. In total, 26,034 genes were obtained from the hepatopancreas tissue of L. vannamei using the Illumina HiSeq 2000 system, and 855 genes showed significant changes in expression under salinity stress. Eighteen top Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were significantly involved in physiological responses, particularly in lipid metabolism, including fatty-acid biosynthesis, arachidonic acid metabolism and glycosphingolipid and glycosaminoglycan metabolism. Lipids or fatty acids can reduce osmotic stress in L. vannamei by providing additional energy or changing the membrane structure to allow osmoregulation in relevant organs, such as the gills. Steroid hormone biosynthesis and the phosphonate and phosphinate metabolism pathways were also involved in the adaptation of L. vannamei to low salinity, and the differential expression patterns of 20 randomly selected genes were validated by quantitative real-time PCR (qPCR). This study is the first report on the long-term adaptive transcriptomic response of L. vannamei to low salinity, and the results will further our understanding of the mechanisms underlying osmoregulation in euryhaline crustaceans.	[Chen, Ke; Li, Erchao; Li, Tongyu; Xu, Chang; Wang, Xiaodan; Chen, Liqiao] E China Normal Univ, Lab Aquaculture Nutr & Environm Hlth, Sch Life Sci, Shanghai 200062, Peoples R China; [Lin, Heizhao] Shenzhen Base South China Sea Fisheries Res Inst, Shenzhen, Peoples R China; [Qin, Jian G.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia	East China Normal University; Flinders University South Australia	Li, EC (corresponding author), E China Normal Univ, Lab Aquaculture Nutr & Environm Hlth, Sch Life Sci, Shanghai 200062, Peoples R China.	ecli@bio.ecnu.edu.cn; lqchen@bio.ecnu.edu.cn	Wang, Xiaodan/AAH-1305-2021; Li, Tongyu/GQA-7514-2022	Chen, Liqiao/0000-0003-0138-7828; LI, Erchao/0000-0001-8495-2241; Qin, Jianguang/0000-0003-2448-8058	National Natural Science Foundation of China [31472291, 31172422]; Special Fund for Agro-scientific Research in the Public Interest [201003020, 201203065]; National 'Twelfth Five-Year' Plan for Science AMP; Technology Support [2012BAD25B03]; National Basic Research Program (973Program) [2014CB138803]; Shanghai University Knowledge Service Platform Shanghai Ocean University aquatic animal breeding center [ZF1206]; E-Institute of Shanghai Municipal Education Commission [E03009]; ECNU innovation fund	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; National 'Twelfth Five-Year' Plan for Science AMP; Technology Support; National Basic Research Program (973Program)(National Basic Research Program of China); Shanghai University Knowledge Service Platform Shanghai Ocean University aquatic animal breeding center; E-Institute of Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); ECNU innovation fund	This research was supported by grants from the National Natural Science Foundation of China (No. 31472291, 31172422), the Special Fund for Agro-scientific Research in the Public Interest (No. 201003020, 201203065), National 'Twelfth Five-Year' Plan for Science & Technology Support (2012BAD25B03), the National Basic Research Program (973Program, No. 2014CB138803), Shanghai University Knowledge Service Platform Shanghai Ocean University aquatic animal breeding center (ZF1206), and partly by the E-Institute of Shanghai Municipal Education Commission (No. E03009) and ECNU innovation fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; BECKMAN B, 1992, FISH PHYSIOL BIOCHEM, V10, P213, DOI 10.1007/BF00004515; Bhoite S, 2013, MAR FRESHW BEHAV PHY, V46, P287, DOI 10.1080/10236244.2013.832525; Birukawa N, 2005, ZOOL SCI, V22, P1245, DOI 10.2108/zsj.22.1245; BLUM K, 2012, GOOGLE PATENTS; Buckle LF, 2006, REV BIOL TROP, V54, P745; Capdevila JH, 2000, J LIPID RES, V41, P163; CASTILLE FL, 1981, PHYSIOLOGY, V68, P75; Charmantier G, 2001, AM ZOOL, V41, P1078, DOI 10.1668/0003-1569(2001)041[1078:OOOICT]2.0.CO;2; Charmantier Guy, 2009, P165; Chen K, 2014, J SHELLFISH RES, V33, P825, DOI 10.2983/035.033.0317; Chu YJ, 2012, NUCLEIC ACID THER, V22, P271, DOI 10.1089/nat.2012.0367; Clavero-Salas A, 2007, FISH SHELLFISH IMMUN, V23, P459, DOI 10.1016/j.fsi.2007.01.010; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davis D.A., 2002, AVANCES NUTR ACUICOL, P3; Deering MJ, 1997, AQUACULTURE, V151, P131, DOI 10.1016/S0044-8486(96)01480-9; DEMOPOULOS CA, 1979, J BIOL CHEM, V254, P9355; Diaz F, 2001, MAR FRESHW BEHAV PHY, V34, P93, DOI 10.1080/10236240109379062; FAO, 2004, AMERICA; Freire CA, 2008, COMP BIOCHEM PHYS A, V151, P272, DOI 10.1016/j.cbpa.2007.05.008; Frye C A, 2009, Minerva Ginecol, V61, P541; Gao WH, 2012, AQUACULTURE, V364, P186, DOI 10.1016/j.aquaculture.2012.08.024; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gupta BBP, 2002, CURR SCI INDIA, V83, P1103; Hardwick JP, 2008, BIOCHEM PHARMACOL, V75, P2263, DOI 10.1016/j.bcp.2008.03.004; Hurtado MA, 2007, COMP BIOCHEM PHYS A, V147, P703, DOI 10.1016/j.cbpa.2006.07.002; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kroetz DL, 2002, CURR OPIN LIPIDOL, V13, P273, DOI 10.1097/00041433-200206000-00007; Lago-Leston A, 2007, AQUACULTURE, V270, P343, DOI 10.1016/j.aquaculture.2007.04.014; Lemos D, 2001, J EXP MAR BIOL ECOL, V261, P55, DOI 10.1016/S0022-0981(01)00260-X; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047442; Li EC, 2008, AQUACULTURE, V274, P80, DOI 10.1016/j.aquaculture.2007.11.001; Li EC, 2007, AQUACULTURE, V265, P385, DOI 10.1016/j.aquaculture.2007.02.018; Li EC, 2014, PHYSIOL GENOMICS, V46, P177, DOI 10.1152/physiolgenomics.00191.2013; Li EC, 2011, CHIN J OCEANOL LIMN, V29, P343, DOI 10.1007/s00343-011-0093-8; Li EC, 2009, J CRUSTACEAN BIOL, V29, P379, DOI 10.1651/08-3104.1; Martins TG, 2006, AQUACULTURE, V252, P525, DOI 10.1016/j.aquaculture.2005.07.022; Palacios E, 2004, AQUACULTURE, V234, P497, DOI 10.1016/j.aquaculture.2003.12.001; Palacios E, 2004, J EXP MAR BIOL ECOL, V299, P201, DOI 10.1016/j.jembe.2003.09.007; Palstra AP, 2013, FISH SHELLFISH IMMUN, V8, DOI 10.1371/journal.pone.0053171; Pan LQ, 2007, AQUACULTURE, V273, P711, DOI 10.1016/j.aquaculture.2007.07.218; Pan LQ, 2014, J OCEAN U CHINA, V13, P453, DOI 10.1007/s11802-014-2013-y; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; PEQUEUX A, 1995, J CRUSTACEAN BIOL, V15, P1, DOI 10.2307/1549010; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ponce-Palafox J, 1997, AQUACULTURE, V157, P107, DOI 10.1016/S0044-8486(97)00148-8; Qian X, 2014, OMICS, V18, P98, DOI 10.1089/omi.2013.0110; Rainbow PS, 2001, J EXP MAR BIOL ECOL, V264, P1, DOI 10.1016/S0022-0981(01)00289-1; Ranallo RF, 1998, SPORTS MED, V26, P29, DOI 10.2165/00007256-199826010-00003; Robalino J, 2007, PHYSIOL GENOMICS, V29, P44, DOI 10.1152/physiolgenomics.00165.2006; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romano N, 2012, AQUACULTURE, V334, P12, DOI 10.1016/j.aquaculture.2011.12.035; Sang HM, 2004, AQUACULTURE, V234, P601, DOI 10.1016/j.aquaculture.2004.01.008; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shinji J, 2012, FISHERIES SCI, V78, P833, DOI 10.1007/s12562-012-0514-4; Smith S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-375; SODERQUIST CA, 1994, GOOGLE PATENTS; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Sui L, 2007, AQUACULTURE, V273, P139, DOI 10.1016/j.aquaculture.2007.09.016; Tocher Douglas R., 1995, Biochemistry and Molecular Biology of Fishes, V4, P119; Trowbridge JM, 2002, J BIOL CHEM, V12, p117R; Tseng YC, 2008, COMP BIOCHEM PHYS C, V148, P419, DOI 10.1016/j.cbpc.2008.04.009; Van Anholt RD, 2004, J EXP BIOL, V207, P3419, DOI 10.1242/jeb.01166; Wang YH, 2013, MOL BIOL REP, V40, P6213, DOI 10.1007/s11033-013-2733-x; Xia JH, 2013, DNA RES, V20, P449, DOI 10.1093/dnares/dst022; Xue SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076718	69	87	90	7	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131503	10.1371/journal.pone.0131503	http://dx.doi.org/10.1371/journal.pone.0131503			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147449	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600101
J	Mualif, SA; Teow, SY; Omar, TC; Chew, YW; Yusoff, NM; Ali, SA				Mualif, Siti Aisyah; Teow, Sin-Yeang; Omar, Tasyriq Che; Chew, Yik Wei; Yusoff, Narazah Mohd; Ali, Syed A.			Engineering and Validation of a Vector for Concomitant Expression of Rare Transfer RNA (tRNA) and HIV-1 nef Genes in Escherichia coli	PLOS ONE			English	Article							HETEROLOGOUS PROTEIN EXPRESSION; CODON USAGE; CLUSTERS; YEAST	Relative ease in handling and manipulation of Escherichia coli strains make them primary candidate to express proteins heterologously. Overexpression of heterologous genes that contain codons infrequently used by E. coli is related with difficulties such as mRNA instability, early termination of transcription and/or translation, deletions and/or misincorporation, and cell growth inhibition. These codon bias-associated problems are addressed by co-expressing ColE1-compatible, rare tRNA expressing helper plasmids. However, this approach has inadequacies, which we have addressed by engineering an expression vector that concomitantly expresses the heterologous protein of interest, and rare tRNA genes in E. coli. The expression vector contains three (argU, ileY, leuW) rare tRNA genes and a useful multiple cloning site for easy in-frame cloning. To maintain the overall size of the parental plasmid vector, the rare tRNA genes replaced the non-essential DNA segments in the vector. The cloned gene is expressed under the control of T7 promoter and resulting recombinant protein has a C-terminal 6His tag for IMAC-mediated purification. We have evaluated the usefulness of this expression vector by expressing three HIV-1 genes namely HIV-1 p27 (nef), HIV-1 p24 (ca), and HIV-1 vif in NiCo21(DE3) E. coli and demonstrated the advantages of using expression vector that concomitantly expresses rare tRNA and heterologous genes.	[Mualif, Siti Aisyah; Teow, Sin-Yeang; Omar, Tasyriq Che; Chew, Yik Wei; Ali, Syed A.] Univ Sains Malaysia, Adv Med & Dent Inst, Oncol & Radiol Sci, George Town, Malaysia; [Yusoff, Narazah Mohd] Univ Sains Malaysia, Adv Med & Dent Inst, Regenerat Med, George Town, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia	Ali, SA (corresponding author), Univ Sains Malaysia, Adv Med & Dent Inst, Oncol & Radiol Sci, George Town, Malaysia.	ali2@amdi.usm.edu.my	Omar, Mohammad Tasyriq Che/L-3839-2017; Teow, Sin-Yeang/L-3736-2016; Mualif, Siti Aisyah/AAB-7313-2021; Chew, Yik Wei/M-9669-2017; Teow, Sin-Yeang/J-2253-2019; Omar, Mohammad Tasyriq Che/AFP-0240-2022; Mohd Yusoff, Narazah/I-3203-2017	Omar, Mohammad Tasyriq Che/0000-0002-1294-7520; Teow, Sin-Yeang/0000-0002-3824-0224; Chew, Yik Wei/0000-0003-4772-0702; Teow, Sin-Yeang/0000-0002-3824-0224; Omar, Mohammad Tasyriq Che/0000-0002-1294-7520; Mohd Yusoff, Narazah/0000-0001-6801-2508	FRGS grant from Ministry of Higher Education (MOHE), Government of Malaysia [203/CIPPT/6711206]; MyPhD scholarship (KPT) under MyBrain15 program of MOHE [890416075223]; USM [USM/IPPT/2000/G-2/xiv, 1001/CIPPT/846048]; MOHE scholarship (KPT (BS)) [841003015520]; ASTS (Academic Staff Training Scheme) of Universiti Sains Malaysia; SLAB from Ministry of Education, Malaysia; AMDI	FRGS grant from Ministry of Higher Education (MOHE), Government of Malaysia; MyPhD scholarship (KPT) under MyBrain15 program of MOHE; USM; MOHE scholarship (KPT (BS)); ASTS (Academic Staff Training Scheme) of Universiti Sains Malaysia(Universiti Sains Malaysia); SLAB from Ministry of Education, Malaysia; AMDI	This work was supported by the FRGS grant (203/CIPPT/6711206) from Ministry of Higher Education (MOHE), Government of Malaysia to Syed A Ali and Narazah Mohd Yusoff. Sin-Yeang Teow is a recipient of MyPhD scholarship (KPT (B) 890416075223) under MyBrain15 program of MOHE and part of his research is supported by AMDI, USM under a Research Student Fund (USM/IPPT/2000/G-2/xiv) and RU-PRGS grant (1001/CIPPT/846048) from USM. Siti Aisyah Mualif is a recipient of MOHE scholarship (KPT (BS) 841003015520) and part of her research is funded by AMDI, USM (USM/IPPT/2000/G-2/xiv). Tasyriq Che Omar is a recipient of ASTS (Academic Staff Training Scheme) of Universiti Sains Malaysia together with SLAB from Ministry of Education, Malaysia.	Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; BENTLEY WE, 1990, BIOTECHNOL BIOENG, V35, P668, DOI 10.1002/bit.260350704; Bouchet J, 2011, BLOOD, V117, P3559, DOI 10.1182/blood-2010-07-296749; Chen JQ, 2002, J MOL MICROB BIOTECH, V4, P519; DELTITO BJD, 1995, J BACTERIOL, V177, P7086, DOI 10.1128/jb.177.24.7086-7091.1995; Emert-Sedlak LA, 2013, CHEM BIOL, V20, P82, DOI 10.1016/j.chembiol.2012.11.005; Eschenfeldt William H., 2013, Journal of Structural and Functional Genomics, V14, P135, DOI 10.1007/s10969-013-9163-9; Gorry PR, 2007, JAIDS-J ACQ IMM DEF, V46, P390, DOI 10.1097/QAI.0b013e31815aba08; Huang YP, 2012, PROTEIN SCI, V21, P625, DOI 10.1002/pro.2046; Iyer PC, 2014, BIOORG MED CHEM LETT, V24, P1702, DOI 10.1016/j.bmcl.2014.02.045; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; Kim S, 2006, PROTEIN EXPRES PURIF, V50, P49, DOI 10.1016/j.pep.2006.07.014; Kolmsee T, 2011, RNA BIOL, V8, P913, DOI 10.4161/rna.8.5.16265; Lawrence Ann-Marie, 2009, J Vis Exp, DOI 10.3791/1350; Lulf S, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-24; Macreadie I, 1998, BIOCHEM MOL BIOL INT, V46, P277; Macreadie IG, 1997, BIOCHEM BIOPH RES CO, V232, P707, DOI 10.1006/bbrc.1997.6349; McNulty DE, 2003, PROTEIN EXPRES PURIF, V27, P365, DOI 10.1016/S1046-5928(02)00610-1; Perrakis Anastassis, 2008, V426, P247, DOI 10.1007/978-1-60327-058-8_15; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Sambrook J, 2013, MOL CLONING LAB MANU; Samuelson JC, 2011, METHODS MOL BIOL, V705, P195, DOI 10.1007/978-1-61737-967-3_11; Smithgall Thomas E, 2013, Drug Discov Today Technol, V10, pe523, DOI 10.1016/j.ddtec.2013.07.002; Sorensen HP, 2005, J BIOTECHNOL, V115, P113, DOI 10.1016/j.jbiotec.2004.08.004; SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X; Teow SY, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-107; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Thangadurai C, 2008, BIOCHEM BIOPH RES CO, V376, P647, DOI 10.1016/j.bbrc.2008.09.024; Thomas JG, 1997, PROTEIN EXPRES PURIF, V11, P289, DOI 10.1006/prep.1997.0796; Trinh T, 1994, FOCUS, V16, P78; Winter J, 2000, J BIOTECHNOL, V84, P175, DOI 10.1016/S0168-1656(00)00356-4; Witkowski W, 2013, EXPERT OPIN THER TAR, V17, P1345, DOI 10.1517/14728222.2013.830712; Zaunders J, 2011, CURR OPIN HIV AIDS, V6, P151, DOI 10.1097/COH.0b013e3283454d5b	33	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130446	10.1371/journal.pone.0130446	http://dx.doi.org/10.1371/journal.pone.0130446			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147991	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600037
J	Neergaard-Petersen, S; Hvas, AM; Grove, EL; Larsen, SB; Gregersen, S; Kristensen, SD				Neergaard-Petersen, Sos; Hvas, Anne-Mette; Grove, Erik Lerkevang; Larsen, Sanne Bojet; Gregersen, Soren; Kristensen, Steen Dalby			The Influence of Haemoglobin A1c Levels on Platelet Aggregation and Platelet Turnover in Patients with Coronary Artery Disease Treated with Aspirin	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; IMPAIRED GLUCOSE-TOLERANCE; TYPE-2 DIABETIC-PATIENTS; REDUCED SENSITIVITY; GLYCEMIC CONTROL; FASTING GLUCOSE; MELLITUS; REACTIVITY; RESISTANCE; VOLUME	Background Hyperglycaemia may attenuate the antiplatelet effect of aspirin and thereby increase the risk of cardiovascular events. We investigated the influence of increased haemoglobin A1c (HbA1c) levels on platelet aggregation and turnover in a large cohort of patients with coronary artery disease (CAD) with type 2 diabetes, prediabetes or no diabetes. Methods In this observational study, we included 865 stable CAD patients on 75 mg aspirin as monotherapy of whom 242 patients had type 2 diabetes and were receiving antidiabetic drugs. Among 623 patients without diabetes, we classified 303 patients with prediabetes (HbA1c >= 5.7-6.4% [39-47 mmol/mol]) naive to antidiabetic drugs. Platelet aggregation was evaluated by the Multiplate Analyzer using arachidonic acid and collagen and by the VerifyNow Aspirin. Platelet turnover was evaluated by immature platelets using flow cytometry and platelet activation by soluble P-selectin. Results CAD patients with type 2 diabetes had higher platelet aggregation (all p-values <0.01), platelet turnover (immature platelet count, p<0.01) and platelet activation (p<0.001) than patients without diabetes. CAD patients with prediabetes had increased platelet aggregation (p = 0.02) and platelet count (p = 0.02) compared with patients without diabetes. Increased levels of HbA1c correlated positively with increased platelet aggregation using arachidonic acid (r = 0.19, p<0.0001), collagen (r = 0.10, p<0.01) and VerifyNow (r = 0.15, p<0.0001), and with platelet count (r = 0.08, p = 0.01), immature platelet count (r = 0.11, p<0.001) and soluble P-selectin (r = 0.15, p<0.0001). These associations were mainly evident in non-diabetic and prediabetic CAD patients. Conclusions CAD patients with prediabetes and diabetes may have attenuated antiplatelet effect of aspirin compared with CAD patients without diabetes. This may be related to increased platelet count in patients with prediabetes. Increased levels of HbA1c correlated positively, though weakly, with increased platelet aggregation, platelet turnover and platelet activation.	[Neergaard-Petersen, Sos; Grove, Erik Lerkevang; Larsen, Sanne Bojet; Kristensen, Steen Dalby] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark; [Hvas, Anne-Mette] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; [Gregersen, Soren] Aarhus Univ Hosp, Dept Endocrinol & Internal Med MEA, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Kristensen, SD (corresponding author), Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark.	steendk@dadlnet.dk			Danish Agency for Science Technology and Innovation [2101-05-0052]; Faculty of Health Sciences, Aarhus University; Eva and Henry Fraenkels foundation; A.P. Moeller Foundation; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF14OC0008817] Funding Source: researchfish	Danish Agency for Science Technology and Innovation; Faculty of Health Sciences, Aarhus University; Eva and Henry Fraenkels foundation; A.P. Moeller Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was financially supported by the Danish Agency for Science Technology and Innovation (grant no. 2101-05-0052), The Faculty of Health Sciences, Aarhus University, Eva and Henry Fraenkels foundation, A.P. Moeller Foundation and Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjan R, 2008, DIABETOLOGIA, V51, P385, DOI 10.1007/s00125-007-0898-3; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Angiolillo DJ, 2006, J AM COLL CARDIOL, V48, P298, DOI 10.1016/j.jacc.2006.03.038; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; Bonten TN, 2014, THROMB HAEMOSTASIS, V112, P1209, DOI 10.1160/TH14-05-0453; Capodanno D, 2011, CIRC-CARDIOVASC INTE, V4, P180, DOI 10.1161/CIRCINTERVENTIONS.110.960187; Christensen KH, 2014, PLATELETS; DeFronzo RA, 2011, AM J CARDIOL, V108, p3B, DOI 10.1016/j.amjcard.2011.03.013; Demirtunc R, 2009, J DIABETES COMPLICAT, V23, P89, DOI 10.1016/j.jdiacomp.2008.01.006; DiChiara J, 2007, DIABETES, V56, P3014, DOI 10.2337/db07-0707; Doerr R, 2011, DIABETOLOGIA, V54, P2923, DOI 10.1007/s00125-011-2253-y; Fox CS, 2007, CIRCULATION, V115, P1544, DOI 10.1161/CIRCULATIONAHA.106.658948; Funck-Jensen KL, 2013, PLATELETS, V24, P528, DOI 10.3109/09537104.2012.738838; Gaborit B, 2009, J THROMB HAEMOST, V7, P1939, DOI 10.1111/j.1538-7836.2009.03599.x; Gresele P, 2010, DIABETES CARE, V33, P1262, DOI 10.2337/dc09-2013; Grove EL, 2011, J THROMB HAEMOST, V9, P185, DOI 10.1111/j.1538-7836.2010.04115.x; Grove EL, 2014, THROMB HAEMOSTASIS, V112, P1077, DOI 10.1160/TH14-08-0702; Grove EL, 2009, THROMB HAEMOSTASIS, V101, P151, DOI 10.1160/TH08-03-0186; Henry P, 2011, THROMB HAEMOSTASIS, V105, P336, DOI 10.1160/TH10-02-0082; Hess K, 2011, THROMB HAEMOSTASIS, V105, pS43, DOI 10.1160/THS10-11-0739; Keating FK, 2003, AM J CARDIOL, V92, P1362, DOI 10.1016/j.amjcard.2003.08.033; Krasopoulos G, 2008, BMJ-BRIT MED J, V336, P195, DOI 10.1136/bmj.39430.529549.BE; Larsen SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085566; Lee EY, 2013, THROMB RES, V132, P692, DOI 10.1016/j.thromres.2013.09.035; Lemkes BA, 2012, J THROMB HAEMOST, V10, P639, DOI 10.1111/j.1538-7836.2012.04632.x; Lordkipanidze M, 2012, CURR PHARM DESIGN, V18, P5328, DOI 10.2174/138161212803251952; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Malmberg K, 1997, BRIT MED J, V314, P1512, DOI 10.1136/bmj.314.7093.1512; Mangiacapra F, 2011, J THROMB THROMBOLYS, V32, P54, DOI 10.1007/s11239-010-0547-4; Martin JF, 2012, NAT REV CARDIOL, V9, P658, DOI 10.1038/nrcardio.2012.131; Mayer K, 2014, J AM COLL CARDIOL, V64, P863, DOI 10.1016/j.jacc.2014.05.049; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Mortensen SB, 2010, THROMB RES, V126, pE318, DOI 10.1016/j.thromres.2010.03.013; Neergaard-Petersen S, 2014, THROMB HAEMOSTASIS, V112, P1142, DOI 10.1160/TH14-05-0468; Neergaard-Petersen S, 2014, THROMB RES, V133, P1161, DOI 10.1016/j.thromres.2014.03.039; Neergaard-Petersen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071150; Nielsen HL, 2008, THROMB RES, V123, P267, DOI 10.1016/j.thromres.2008.03.023; Norhammar A, 2002, LANCET, V359, P2140, DOI 10.1016/S0140-6736(02)09089-X; Patrono C, 2007, NAT CLIN PRACT CARD, V4, P42, DOI 10.1038/ncpcardio0728; Pedersen SB, 2009, PLATELETS, V20, P415, DOI 10.1080/09537100903100643; Perneby C, 2006, THROMB HAEMOSTASIS, V95, P652, DOI 10.1160/TH05-10-0653; Pulcinelli FM, 2009, EUR HEART J, V30, P1279, DOI 10.1093/eurheartj/ehp097; Serebruany V, 2008, THROMB HAEMOSTASIS, V100, P76, DOI 10.1160/TH08-03-0136; Shimodaira M, 2014, J DIABETES INVEST, V5, P66, DOI 10.1111/jdi.12117; Singla A, 2009, AM HEART J, V158, DOI 10.1016/j.ahj.2009.08.013; Van Der Stelt CAK, 2007, PLATELETS, V18, P550, DOI 10.1080/09537100701326721; Vivas D, 2011, HEART, V97, P803, DOI 10.1136/hrt.2010.219949; Watala C, 2005, CURR PHARM DESIGN, V11, P2331, DOI 10.2174/1381612054367337; Watala C, 2005, J MOL MED-JMM, V83, P148, DOI 10.1007/s00109-004-0600-x; Watala C, 2004, THROMB RES, V113, P101, DOI 10.1016/j.thromres.2003.12.016; Watala C, 1999, PLATELETS, V10, P52, DOI 10.1080/09537109976356; Wiviott SD, 2008, CIRCULATION, V118, P1626, DOI 10.1161/CIRCULATIONAHA.108.791061; Wurtz M, 2012, CURR PHARM DESIGN, V18, P5344, DOI 10.2174/138161212803251925; Wurtz M, 2012, THROMB RES, V129, P56, DOI 10.1016/j.thromres.2011.08.019; Wurtz M, 2010, JACC-CARDIOVASC INTE, V3, P828, DOI 10.1016/j.jcin.2010.05.014; Zuberi BF, 2008, SINGAP MED J, V49, P114	57	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132629	10.1371/journal.pone.0132629	http://dx.doi.org/10.1371/journal.pone.0132629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148094	gold, Green Submitted, Green Published			2022-12-27	WOS:000358157600307
J	Parker, LM; O'Connor, WA; Raftos, DA; Portner, HO; Ross, PM				Parker, Laura M.; O'Connor, Wayne A.; Raftos, David A.; Poertner, Hans-Otto; Ross, Pauline M.			Persistence of Positive Carryover Effects in the Oyster, Saccostrea glomerata, following Transgenerational Exposure to Ocean Acidification	PLOS ONE			English	Article							ACID-BASE-BALANCE; LIFE-HISTORY; CARBON-DIOXIDE; CO2; IMPACT; GROWTH; EPIGENETICS; HYPERCAPNIA; SEAWATER; FERTILIZATION	Ocean acidification (OA) is predicted to have widespread implications for marine organisms, yet the capacity for species to acclimate or adapt over this century remains unknown. Recent transgenerational studies have shown that for some marine species, exposure of adults to OA can facilitate positive carryover effects to their larval and juvenile offspring that help them to survive in acidifying oceanic conditions. But whether these positive carryover effects can persist into adulthood or the next generation is unknown. Here we tested whether positive carryover effects found in larvae of the oyster, Saccostrea glomerata following transgenerational exposure to elevated CO2, could persist into adulthood and whether subsequent transgenerational exposure of adults to elevated CO2 would facilitate similar adaptive responses in the next generation of larvae and juveniles. Following our previous transgenerational exposure of parental adults and first generation (F1) larvae to ambient (385 mu atm) and elevated (856 mu atm) CO2, newly settled F1 juveniles were transferred to the field at ambient CO2 for 14 months, until they reached reproductive maturity. At this time, the F1 adults were returned to the laboratory and the previous transgenerational CO2 exposure was repeated to produce F2 offspring. We found that the capacity of adults to regulate extracellular pH at elevated CO2 was improved if they had a prior history of transgenerational exposure to elevated CO2. In addition, subsequent transgenerational exposure of these adults led to an increase in the resilience of their larval and juvenile offspring. Offspring with a history of transgenerational exposure to elevated CO2 had a lower percentage abnormality, faster development rate, faster shell growth and increased heart rate at elevated CO2 compared with F2 offspring with no prior history of exposure to elevated CO2. Our results suggest that positive carryover effects originating	[Parker, Laura M.; Ross, Pauline M.] Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW 2751, Australia; [O'Connor, Wayne A.] Port Stephens Fisheries Ctr, NSW Dept Primary Ind, Taylors Beach, NSW, Australia; [Raftos, David A.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia; [Poertner, Hans-Otto] Hermann von Helmholtz Assoc Natl Res Ctr e V HGF, Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany	Western Sydney University; NSW Department of Primary Industries; Macquarie University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Ross, PM (corresponding author), Univ Western Sydney, Sch Sci & Hlth, Hawkesbury K12,Locked Bag 1797, Sydney, NSW 2751, Australia.	pm.ross@uws.edu.au	Pörtner, Hans-O./K-9429-2016; /AAL-3738-2021; O'Connor, Wayne/AAL-8097-2020	Pörtner, Hans-O./0000-0001-6535-6575; Parker, Laura/0000-0003-3139-1844; Ross, Pauline/0000-0002-8714-5194; O'Connor, Wayne/0000-0002-0972-4668	Australian Research Council [DI100100158]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council (http://www.arc.gov.au) Grant number: DI100100158 to LMP, PMR, WAO, DAR, HOP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RM, 2008, AM NAT, V171, P225, DOI 10.1086/524952; Beniash E, 2010, MAR ECOL PROG SER, V419, P95, DOI 10.3354/meps08841; Berge JA, 2006, CHEMOSPHERE, V62, P681, DOI 10.1016/j.chemosphere.2005.04.111; Burton T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0311; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Calosi P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0444; Crews D, 2010, HORM-INT J ENDOCRINO, V9, P41, DOI 10.14310/horm.2002.1251; Cummings V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016069; Dupont S, 2013, MAR BIOL, V160, P1835, DOI 10.1007/s00227-012-1921-x; Ellis RP, 2009, AQUAT BIOL, V5, P41, DOI 10.3354/ab00118; Foo SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042497; Form AU, 2012, GLOBAL CHANGE BIOL, V18, P843, DOI 10.1111/j.1365-2486.2011.02583.x; Gazeau F, 2013, MAR BIOL, V160, P2207, DOI 10.1007/s00227-013-2219-3; Green MA, 2009, LIMNOL OCEANOGR, V54, P1037, DOI 10.4319/lo.2009.54.4.1037; Gutowska MA, 2008, MAR ECOL PROG SER, V373, P303, DOI 10.3354/meps07782; Hammer KM, 2011, MAR ENVIRON RES, V72, P135, DOI 10.1016/j.marenvres.2011.07.002; Hettinger A, 2013, BIOGEOSCI DISCUSS, V10, P5781, DOI [10.5194/bgd-10-5781-2013, DOI 10.5194/BGD-10-5781-2013]; Hettinger A, 2012, ECOLOGY, V93, P2758, DOI 10.1890/12-0567.1; IPCC (Intergovernmental Panel on Climate Change), 2007, CONTRIBUTION WORKING, P793; Ivanina AV, 2013, AQUAT TOXICOL, V140, P123, DOI 10.1016/j.aquatox.2013.05.019; Kelly MW, 2013, FUNCT ECOL, V27, P980, DOI 10.1111/j.1365-2435.2012.02061.x; Lannig G, 2010, MAR DRUGS, V8, P2318, DOI 10.3390/md8082318; Lewis E., 1998, PROGRAM DEV CO2 SYST; Lischka S, 2010, BIOGEOSCIENCES, V7, P8177, DOI DOI 10.5194/BGD-7-8177-2010; Marchant HK, 2010, J MAR BIOL ASSOC UK, V90, P1379, DOI 10.1017/S0025315410000457; Matozzo V, 2013, MAR POLLUT BULL, V72, P34, DOI 10.1016/j.marpolbul.2013.05.004; McCarthy MM, 2008, FRONT NEUROENDOCRIN, V29, P341, DOI 10.1016/j.yfrne.2008.01.002; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223; Michaelidis B, 2005, MAR ECOL PROG SER, V293, P109, DOI 10.3354/meps293109; Miller GM, 2012, NAT CLIM CHANGE, V2, P858, DOI 10.1038/NCLIMATE1599; Moran AL, 2009, BIOL BULL-US, V216, P226, DOI 10.1086/BBLv216n3p226; Munday PL, 2013, ECOL LETT, V16, P1488, DOI 10.1111/ele.12185; Munday PL, 2014, F1000 PRIME REPORTS, V6, DOI 10.12703/P6-99; Navarro-Martin L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002447; O'Connor WA, 2008, NEW SOUTH WALES DEPA, V20; Parker LM, 2011, MAR BIOL, V158, P689, DOI 10.1007/s00227-010-1592-4; Parker Laura M., 2013, Biology - Basel, V2, P651, DOI 10.3390/biology2020651; Parker LM, 2012, GLOBAL CHANGE BIOL, V18, P82, DOI 10.1111/j.1365-2486.2011.02520.x; Parker LM, 2010, MAR BIOL, V157, P2435, DOI 10.1007/s00227-010-1508-3; Parker LM, 2009, GLOBAL CHANGE BIOL, V15, P2123, DOI 10.1111/j.1365-2486.2009.01895.x; Pespeni MH, 2013, EVOLUTION, V67, P1901, DOI 10.1111/evo.12036; Pespeni MH, 2013, P NATL ACAD SCI USA, V110, P6937, DOI 10.1073/pnas.1220673110; Pistevos JCA, 2011, OIKOS, V120, P675, DOI 10.1111/j.1600-0706.2010.19470.x; Podolsky RD, 2006, INTEGR COMP BIOL, V46, P577, DOI 10.1093/icb/icl026; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2000, J EXP BIOL, V203, P2417; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; Range P, 2011, J EXP MAR BIOL ECOL, V396, P177, DOI 10.1016/j.jembe.2010.10.020; Riviere G, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00129; Schade FM, 2014, MAR BIOL, V161, P1667, DOI 10.1007/s00227-014-2450-6; Schlegel P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053118; Shirayama Y, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002618; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Sunday JM, 2014, TRENDS ECOL EVOL, V29, P117, DOI 10.1016/j.tree.2013.11.001; Sunday JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022881; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; Thomsen J, 2010, BIOGEOSCIENCES, V7, P3879, DOI 10.5194/bg-7-3879-2010; Thomsen J, 2013, GLOBAL CHANGE BIOL, V19, P1017, DOI 10.1111/gcb.12109; Thor P, 2015, GLOBAL CHANGE BIOL, V21, P2261, DOI 10.1111/gcb.12815; Trenaman R, 2014, AQUACULTURE PRODUCTI; Underwood AJ, 1997, EXPERIMENTS IN ECOLO; Vandegehuchte MB, 2014, MUTAT RES-GEN TOX EN, V764, P36, DOI 10.1016/j.mrgentox.2013.08.008; Vehmaa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048538; Videla JA, 1998, MAR BIOL, V132, P635, DOI 10.1007/s002270050428; Walther K, 2009, BIOGEOSCIENCES, V6, P2207, DOI 10.5194/bg-6-2207-2009; Watson SA, 2009, J SHELLFISH RES, V28, P431, DOI 10.2983/035.028.0302; Welch MJ, 2014, NAT CLIM CHANGE, V4, P1086, DOI 10.1038/NCLIMATE2400; Wilson ME, 2013, INT J DEV NEUROSCI	70	116	116	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132276	10.1371/journal.pone.0132276	http://dx.doi.org/10.1371/journal.pone.0132276			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147612	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600229
J	Queiroz, MA; Delso, G; Wollenweber, S; Deller, T; Zeimpekis, K; Huellner, M; Barbosa, FD; von Schulthess, G; Veit-Haibach, P				Queiroz, Marcelo A.; Delso, Gaspar; Wollenweber, Scott; Deller, Timothy; Zeimpekis, Konstantinos; Huellner, Martin; Barbosa, Felipe de Galiza; von Schulthess, Gustav; Veit-Haibach, Patrick			Dose Optimization in TOF-PET/MR Compared to TOF-PET/CT	PLOS ONE			English	Article								Purpose To evaluate the possible activity reduction in FDG-imaging in a Time-of-Flight (TOF) PET/MR, based on cross-evaluation of patient-based NECR (noise equivalent count rate) measurements in PET/CT, cross referencing with phantom-based NECR curves as well as initial evaluation of TOF-PET/MR with reduced activity. Materials and Methods A total of 75 consecutive patients were evaluated in this study. PET/CT imaging was performed on a PET/CT (time-of-flight (TOF) Discovery D 690 PET/CT). Initial PET/MR imaging was performed on a newly available simultaneous TOF-PET/MR (Signa PET/MR). An optimal NECR for diagnostic purposes was defined in clinical patients (NECRP) in PET/CT. Subsequent optimal activity concentration at the acquisition time ([A](0)) and target NECR (NECRT) were obtained. These data were used to predict the theoretical FDG activity requirement of the new TOF-PET/MR system. Twenty-five initial patients were acquired with (retrospectively reconstructed) different imaging times equivalent for different activities on the simultaneous PET/MR for the evaluation of clinically realistic FDG-activities. Results The obtained values for NECRP, [A](0) and NECRT were 114.6 (+/- 14.2) kcps (Kilocounts per second), 4.0 (+/- 0.7) kBq/mL and 45 kcps, respectively. Evaluating the NECRT together with the phantom curve of the TOF-PET/MR device, the theoretical optimal activity concentration was found to be approximately 1.3 kBq/mL, which represents 35% of the activity concentration required by the TOF-PET/CT. Initial evaluation on patients in the simultaneous TOF-PET/MR shows clinically realistic activities of 1.8 kBq/mL, which represent 44% of the required activity. Conclusion The new TOF-PET/MR device requires significantly less activity to generate PET-images with good-to-excellent image quality, due to improvements in detector geometry and detector technologies. The theoretically achievable dose reduction accounts for up to 65% but cannot be fully translated into clinical routine based on the coils within the FOV and MR-sequences applied at the same time. The clinically realistic reduction in activity is slightly more than 50%. Further studies in a larger number of patients are needed to confirm our findings.	[Queiroz, Marcelo A.; Zeimpekis, Konstantinos; Huellner, Martin; Barbosa, Felipe de Galiza; von Schulthess, Gustav; Veit-Haibach, Patrick] Univ Zurich Hosp, Dept Med Imaging, Nucl Med, CH-8091 Zurich, Switzerland; [Delso, Gaspar; Wollenweber, Scott; Deller, Timothy] GE Healthcare, Waukesha, WI USA; [Huellner, Martin; Veit-Haibach, Patrick] Univ Zurich Hosp, Dept Med Imaging Diagnost & Intervent Radiol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; General Electric; University of Zurich; University Zurich Hospital	Queiroz, MA (corresponding author), Univ Zurich Hosp, Dept Med Imaging, Nucl Med, CH-8091 Zurich, Switzerland.	marcelo.araujoqueiroz@gmail.com	Delso, Gaspar/I-1814-2013	Delso, Gaspar/0000-0003-0438-8244; Queiroz, Marcelo/0000-0003-0052-0682; Zeimpekis, Konstantinos/0000-0003-2769-7533	GE Healthcare	GE Healthcare(General ElectricGE Healthcare)	This research project was supported by an institutional research grant from GE Healthcare. Coauthors Gaspar Delso, Scott D. Wollenweber and Timothy Deller are employed by GE Healthcare. GE Healthcare provided support in the form of salaries for authors GD, SDW and TD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akamatsu G, CLIN NUCL MED, V38, P407, DOI [10.1097/RLU.0b013e31828da3bd, DOI 10.1097/RLU.OB013E31828DA3BD]; Badawi RD, 2005, J NUCL MED, V46, P1767; Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Chang TT, 2012, MED PHYS, V39, P5891, DOI 10.1118/1.4750053; Chang TT, 2011, PHYS MED BIOL, V56, P5275, DOI 10.1088/0031-9155/56/16/013; Danna M, 2006, IEEE T NUCL SCI, V53, P86, DOI 10.1109/TNS.2005.862966; Daube-Witherspoon ME, J NUCL MED, V43, P1398; de Groot E, EJNMMI RES, V3, P1, DOI [10.1186/2191-219X-3-1, DOI 10.1186/2191-219X-3-1]; Delso G, 2010, PHYS MED BIOL, V55, P4361, DOI 10.1088/0031-9155/55/15/011; Delso G, 2011, J NUCL MED, V52, P1914, DOI 10.2967/jnumed.111.092726; Delso G, 2009, MED PHYS, V36, P4126, DOI 10.1118/1.3193676; Everaert H, 2003, EUR J NUCL MED MOL I, V30, P1615, DOI 10.1007/s00259-003-1317-8; Kalemis A, 2013, MAGN RESON MATER PHY, V26, P5, DOI 10.1007/s10334-012-0330-y; Kuhn FP, 2014, J NUCL MED, V55, P551, DOI 10.2967/jnumed.113.125443; Lartizien C, 2002, J NUCL MED, V43, P1268; Li X, IEEE T NUCL SCI, V58, P590; MacDonald LR, 2011, MED PHYS, V38, P2948, DOI 10.1118/1.3583697; McDermott GM, 2013, ANN NUCL MED, V27, P855, DOI 10.1007/s12149-013-0760-2; Mizuta T, 2009, MOL IMAGING BIOL, V11, P480, DOI 10.1007/s11307-009-0214-3; Paulus DH, 2012, MED PHYS, V39, P4306, DOI 10.1118/1.4729716; Queiroz M, EJNMMI PHYS, V1, P1; Queiroz M, 2014, EUR J NUCL MED MOL I, V41, P1066, DOI 10.1007/s00259-014-2707-9; Reiner CS, 2014, EUR J NUCL MED MOL I, V41, P649, DOI 10.1007/s00259-013-2654-x; Schaart DR, 2009, PHYS MED BIOL, V54, P3501, DOI 10.1088/0031-9155/54/11/015; STROTHER SC, 1990, IEEE T NUCL SCI, V37, P783, DOI 10.1109/23.106715; Tellmann L, THE EFFECT OF MR SUR; Wagadarikar AA, 2014, IEEE T NUCL SCI, V61, P121, DOI 10.1109/TNS.2013.2282119; Walker MD, 2009, J NUCL MED, V50, P1409, DOI 10.2967/jnumed.109.062679; Watson CC, 2005, J NUCL MED, V46, P1825; Weirich C, 2012, IEEE T MED IMAGING, V31, P1372, DOI 10.1109/TMI.2012.2188903; Wollenweber SD, 2014, MAGN RESON MATER PHY, V27, P149, DOI 10.1007/s10334-013-0388-1	31	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0128842	10.1371/journal.pone.0128842	http://dx.doi.org/10.1371/journal.pone.0128842			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147919	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000358157600017
J	Rice, WL; Li, W; Mamuya, F; McKee, M; Paunescu, TG; Lu, HAJ				Rice, William L.; Li, Wei; Mamuya, Fahmy; McKee, Mary; Paunescu, Teodor G.; Lu, Hua A. Jenny			Polarized Trafficking of AQP2 Revealed in Three Dimensional Epithelial Culture	PLOS ONE			English	Article							AQUAPORIN-2 WATER CHANNEL; CANINE KIDNEY-CELLS; COLLECTING DUCT; PLASMA-MEMBRANE; RAT-KIDNEY; BRATTLEBORO RATS; APICAL MEMBRANE; MDCK CYSTS; PHOSPHORYLATION; VASOPRESSIN	In renal collecting duct (CD) principal cells (PCs), vasopressin (VP) acts through its receptor, V2R, to increase intracellular cAMP leading to phosphorylation and apical membrane accumulation of the water channel aquaporin 2 (AQP2). The trafficking and function of basolaterally located AQP2 is, however, poorly understood. Here we report the successful application of a 3-dimensional Madin-Darby canine kidney (MDCK) epithelial model to study polarized AQP2 trafficking. This model recapitulates the luminal architecture of the CD and bi-polarized distribution of AQP2 as seen in kidney. Without stimulation, AQP2 is located in the subapical and basolateral regions. Treatment with VP, forskolin (FK), or 8-(4-Chlorophenylthio)-20-O-methyladenosine 30,50-cyclic monophosphate monosodium hydrate (CPT-cAMP) leads to translocation of cytosolic AQP2 to the apical membrane, but not to the basolateral membrane. Treating cells with methyl-beta-cyclodextrin (m beta CD) to acutely block endocytosis causes accumulation of AQP2 on the basolateral membrane, but not on the apical membrane. Our data suggest that AQP2 may traffic differently at the apical and basolateral domains in this 3D epithelial model. In addition, application of a panel of phosphorylation specific AQP2 antibodies reveals the polarized, subcellular localization of differentially phosphorylated AQP2 at S256, S261, S264 and S269 in the 3D culture model, which is consistent with observations made in the CDs of VP treated animals, suggesting the preservation of phosphorylation dependent regulatory mechanism of AQP2 trafficking in this model. Therefore we have established a 3D culture model for the study of trafficking and regulation of both the apical and basolaterally targeted AQP2. The new model will enable further characterization of the complex mechanism regulating bi-polarized trafficking of AQP2 in vitro.	[Lu, Hua A. Jenny] Massachusetts Gen Hosp, Dept Med, Ctr Syst Biol, Program Membrane Biol,Div Nephrol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lu, HAJ (corresponding author), Massachusetts Gen Hosp, Dept Med, Ctr Syst Biol, Program Membrane Biol,Div Nephrol, Boston, MA 02114 USA.	Halu@partners.org	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018; Paunescu, Teodor/AAX-7533-2020	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Paunescu, Teodor/0000-0003-0227-9028	National Institutes of Health [NIH 5T32 DK007540-24]; NIH [R01 DK096015, R01 DK38452, R01 DK096586]; Gottschalk research grant from the American Society of Nephrology (ASN); Nephcure Foundation grant; Boston Area Diabetes and Endocrinology Research Center [NIH DK-57521]; Center for the Study of Inflammatory Bowel Disease [NIH DK-43351]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038452, P30DK043351, R01DK096586, T32DK007540, P30DK057521, R01DK096015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gottschalk research grant from the American Society of Nephrology (ASN); Nephcure Foundation grant; Boston Area Diabetes and Endocrinology Research Center; Center for the Study of Inflammatory Bowel Disease; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	WL Rice is supported by an National Institutes of Health training grant (NIH 5T32 DK007540-24). HAJ Lu is supported by an NIH R01 DK096015 and a Gottschalk research grant from the American Society of Nephrology (ASN) and the Nephcure Foundation grant. Additional material support was from NIH grant R01 DK38452 (D. Brown) and R01 DK096586 (D. Brown). The Microscopy Core Facility of the Program in Membrane Biology receives additional support from the Boston Area Diabetes and Endocrinology Research Center (NIH DK-57521) and from the Center for the Study of Inflammatory Bowel Disease (NIH DK-43351). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assadi F, 2012, J NEPHROL, V25, P473, DOI 10.5301/jn.5000060; Bagnis C, 2001, AM J PHYSIOL-RENAL, V280, pF437, DOI 10.1152/ajprenal.2001.280.3.F437; Barile M, 2005, MOL CELL PROTEOMICS, V4, P1095, DOI 10.1074/mcp.M500049-MCP200; Bouley R, 2011, J AM SOC NEPHROL, V22, P59, DOI 10.1681/ASN.2009121267; Brown D, 2012, AM J PHYSIOL-CELL PH, V302, pC1421, DOI 10.1152/ajpcell.00085.2012; Chen Y, 2012, J AM SOC NEPHROL, V23, P1506, DOI 10.1681/ASN.2012010079; Christensen BM, 2003, AM J PHYSIOL-RENAL, V284, pF701, DOI 10.1152/ajprenal.00234.2002; Coleman RA, 2000, AM J PHYSIOL-RENAL, V279, pF874, DOI 10.1152/ajprenal.2000.279.5.F874; de Seigneux S, 2007, AM J PHYSIOL-RENAL, V293, pF87, DOI 10.1152/ajprenal.00431.2006; Deen PMT, 1997, J AM SOC NEPHROL, V8, P1493; Deen PMT, 2002, AM J PHYSIOL-RENAL, V282, pF330, DOI 10.1152/ajprenal.0168.2001; DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421; Gade Wayne, 2006, Clin Lab Sci, V19, P80; Hoffert JD, 2007, AM J PHYSIOL-RENAL, V292, pF691, DOI 10.1152/ajprenal.00284.2006; Hoffert JD, 2008, J BIOL CHEM, V283, P24617, DOI 10.1074/jbc.M803074200; Hoffert JD, 2006, P NATL ACAD SCI USA, V103, P7159, DOI 10.1073/pnas.0600895103; Jeon US, 2003, NEPHRON EXP NEPHROL, V93, pE36, DOI 10.1159/000066651; KATSURA T, 1995, P NATL ACAD SCI USA, V92, P7212, DOI 10.1073/pnas.92.16.7212; KUWAHARA M, 1995, J BIOL CHEM, V270, P10384, DOI 10.1074/jbc.270.18.10384; Li W, 2011, AM J PHYSIOL-RENAL, V301, pF309, DOI 10.1152/ajprenal.00001.2011; Lu H, 2004, AM J PHYSIOL-RENAL, V286, pF233, DOI 10.1152/ajprenal.00179.2003; Lu HAJ, 2007, J BIOL CHEM, V282, P28721, DOI 10.1074/jbc.M611101200; Lu HJ, 2008, AM J PHYSIOL-RENAL, V295, pF290, DOI 10.1152/ajprenal.00072.2008; Cano-Penalver JL, 2014, FASEB J, V28, P3645, DOI 10.1096/fj.13-249250; MANGOOKARIM R, 1989, P NATL ACAD SCI USA, V86, P6007, DOI 10.1073/pnas.86.15.6007; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Moeller HB, 2010, P NATL ACAD SCI USA, V107, P424, DOI 10.1073/pnas.0910683107; Nejsum LN, 2005, AM J PHYSIOL-RENAL, V288, pF930, DOI 10.1152/ajprenal.00291.2004; Nielsen S, 1997, P NATL ACAD SCI USA, V94, P5450, DOI 10.1073/pnas.94.10.5450; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; OJAKIAN GK, 1988, J CELL BIOL, V107, P2377, DOI 10.1083/jcb.107.6.2377; Paunescu TG, 2013, AM J PHYSIOL-RENAL, V305, pF1783, DOI 10.1152/ajprenal.00622.2012; Rice WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032843; SCHOENENBERGER CA, 1994, J CELL SCI, V107, P527; Tajika Y, 2004, ENDOCRINOLOGY, V145, P4375, DOI 10.1210/en.2004-0073; Tamma G, 2011, CELL PHYSIOL BIOCHEM, V27, P739, DOI 10.1159/000330082; Tamma G, 2011, AM J PHYSIOL-CELL PH, V300, pC636, DOI 10.1152/ajpcell.00433.2009; van Balkom BWM, 2003, J BIOL CHEM, V278, P1101, DOI 10.1074/jbc.M207339200; van Balkom BWM, 2002, J BIOL CHEM, V277, P41473, DOI 10.1074/jbc.M207525200; van Beest M, 2006, BBA-BIOMEMBRANES, V1758, P1126, DOI 10.1016/j.bbamem.2006.03.007; WANG AZ, 1990, J CELL SCI, V95, P137; WANG AZ, 1990, J CELL SCI, V95, P153; Xie LK, 2010, AM J PHYSIOL-RENAL, V298, pF1018, DOI 10.1152/ajprenal.00580.2009; YAMAMOTO T, 1995, AM J PHYSIOL-CELL PH, V268, pC1546, DOI 10.1152/ajpcell.1995.268.6.C1546; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Yui N, 2013, AM J PHYSIOL-CELL PH, V304, pC38, DOI 10.1152/ajpcell.00109.2012; Yui N, 2009, AM J PHYSIOL-CELL PH, V297, pC1389, DOI 10.1152/ajpcell.00098.2009	48	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131719	10.1371/journal.pone.0131719	http://dx.doi.org/10.1371/journal.pone.0131719			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147297	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000358157600135
J	Sugimoto, M; Gotoh, Y; Kawahara, T; Sugimoto, Y				Sugimoto, Mayumi; Gotoh, Yusaku; Kawahara, Takayoshi; Sugimoto, Yoshikazu			Molecular Effects of Polymorphism in the 3'UTR of Unc-5 homolog C Associated with Conception Rate in Holsteins	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCI; FERTILITY TRAITS; CANDIDATE GENES; MILK-PRODUCTION; DAIRY-CATTLE; COMPLEX; RHOX5; METHYLATION; EXPRESSION	Conception rates among dairy cows in Japan have declined in recent decades. To enhance our understanding of the genes involved in conception rates, we conducted a genome-wide association study (GWAS) using 822 Holsteins and identified a single-nucleotide polymorphism (SNP) associated with conception rate: A+169G in the 3' untranslated region (UTR) of unc-5 homolog C (UNC5C). Cows with higher conception rates carried the A polymorphism in the UNC5C 3'UTR. Luciferase assays and quantitative analysis of allele ratios revealed that UNC5C transcripts with the A polymorphism were expressed at higher levels than those carrying the G polymorphism. UNC5C transmits either pro- or anti-apoptotic signals depending on the availability of its ligand, Netrin-1. UNC5C expression is negatively regulated by reproductive homeobox X-linked 5 (Rhox5), and the Rhox5 locus is methylated by G9a methyltransferase. G9a-knockout mice have previously been demonstrated to be subfertile, and we found that UNC5C, G9a, and Netrin-1 expression levels increased from the 4-cell stage to the blastocyst stage in fertilized murine embryos, whereas Rhox5 expression decreased. Repression of UNC5C, G9a, or Netrin-1 or forced expression of Rhox5 in the anterior nucleus stage inhibited development to the blastocyst stage, suggesting that cows carrying the G polymorphism in UNC5C might have lower conception rates because of the poor development of preimplantation embryos. This study provides novel insights into the role of UNC5C during embryonic development.	[Sugimoto, Mayumi] Natl Livestock Breeding Ctr, Nishigo, Fukushima, Japan; [Gotoh, Yusaku; Kawahara, Takayoshi] Holstein Cattle Assoc Japan, Hokkaido Branch, Sapporo, Hokkaido, Japan; [Sugimoto, Yoshikazu] Shirakawa Inst Anim Genet, Nishigo, Fukushima, Japan		Sugimoto, M (corresponding author), Natl Livestock Breeding Ctr, Nishigo, Fukushima, Japan.	m0komats@nlbc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan (Research Program on Innovative Technologies for Animal Breeding, Reproduction, and Vaccine Development) [AGB-2004]	Ministry of Agriculture, Forestry and Fisheries of Japan (Research Program on Innovative Technologies for Animal Breeding, Reproduction, and Vaccine Development)	This work was supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Research Program on Innovative Technologies for Animal Breeding, Reproduction, and Vaccine Development, AGB-2004).	Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Averill TA, 2004, J DAIRY SCI, V87, P3947, DOI 10.3168/jds.S0022-0302(04)73534-1; Berruti G, 2010, BIOL REPROD, V82, P930, DOI 10.1095/biolreprod.109.081679; Berry DP, 2012, ANIMAL, V6, P1206, DOI 10.1017/S1751731112000067; Blaschek M, 2011, J DAIRY SCI, V94, P4695, DOI 10.3168/jds.2010-3728; Brown RM, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103267; Burns BM, 2010, ANIM REPROD SCI, V122, P1, DOI 10.1016/j.anireprosci.2010.04.010; Charlier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043085; Chen KX, 2008, CARCINOGENESIS, V29, P1306, DOI 10.1093/carcin/bgn116; Daetwyler HD, 2008, J DAIRY SCI, V91, P3225, DOI 10.3168/jds.2007-0333; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; Fortes MRS, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101089; Hu Z, 2008, J BIOL CHEM, V283, P3866, DOI 10.1074/jbc.M706717200; Kawahara T., 2010, NIHON CHIKUSAN GAKKA, V81, P121, DOI [10.2508/chikusan.81.121, DOI 10.2508/CHIKUSAN.81.121]; Khan MA, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-84; Kosova G, 2012, AM J HUM GENET, V90, P950, DOI 10.1016/j.ajhg.2012.04.016; MacLean JA, 2010, REPRODUCTION, V140, P195, DOI 10.1530/REP-10-0100; Minozzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080219; Myant K, 2011, GENOME RES, V21, P83, DOI 10.1101/gr.108498.110; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohnishi Y, 2010, NUCLEIC ACIDS RES, V38, P5141, DOI 10.1093/nar/gkq229; Olsen HG, 2011, ANIM GENET, V42, P466, DOI 10.1111/j.1365-2052.2011.02179.x; Pausch H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004044; Penagaricano F, 2012, ANIM GENET, V43, P65, DOI 10.1111/j.1365-2052.2012.02350.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pryce JE, 2010, J DAIRY SCI, V93, P3331, DOI 10.3168/jds.2009-2893; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Round J, 2007, CURR OPIN NEUROBIOL, V17, P15, DOI 10.1016/j.conb.2007.01.003; Sahana G, 2010, ANIM GENET, V41, P579, DOI 10.1111/j.1365-2052.2010.02064.x; Schulman NF, 2011, ANIM GENET, V42, P263, DOI 10.1111/j.1365-2052.2010.02149.x; Shanker S, 2008, INT J ANDROL, V31, P462, DOI 10.1111/j.1365-2605.2008.00904.x; Sugimoto M, 2013, P NATL ACAD SCI USA, V110, P19495, DOI 10.1073/pnas.1309307110; Tachibana M, 2009, ANNOUNCING WEBSITES; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Thiebault K, 2003, P NATL ACAD SCI USA, V100, P4173, DOI 10.1073/pnas.0738063100; Wang LQ, 2004, BIOINFORMATICS, V20, P1818, DOI 10.1093/bioinformatics/bth164; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	38	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131283	10.1371/journal.pone.0131283	http://dx.doi.org/10.1371/journal.pone.0131283			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147436	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600083
J	Xu, M; Jiao, Y; Li, XM; Cao, QF; Wang, XY				Xu, Ming; Jiao, Yan; Li, Xiaoming; Cao, Qingfeng; Wang, Xiaoyang			A Multi-Period Optimization Model for Service Providers Using Online Reservation Systems: An Application to Hotels	PLOS ONE			English	Article							LENGTH-OF-STAY; AIRLINE OVERBOOKING; MARKET-SEGMENTATION; TOURISTS; MANAGEMENT; ALGORITHM; STRATEGY; POLICY; ROOMS	This paper presents a multi-period optimization model for high margin and zero salvage products in online distribution channels with classifying customers based on number of products required. Taking hotel customers as an example, one is regular customers who reserve rooms for one day, and the other is long term stay (LTS) customers who reserve rooms for a number of days. LTS may guarantee a specific amount of demand and generate opportunity income for a certain number of periods, meanwhile with risk of punishment incurred by overselling. By developing an operational optimization model and exploring the effects of parameters on optimal decisions, we suggest that service providers should make decisions based on the types of customers, number of products required, and duration of multi-period to reduce the loss of reputation and obtain more profit; at the same time, multi-period buying customers should buy products early. Finally, the paper conducts a numerical experiment, and the results are consistent with prevailing situations.	[Xu, Ming; Jiao, Yan; Li, Xiaoming] Nankai Univ, Coll Tourism & Serv Management, Tianjin 300074, Peoples R China; [Cao, Qingfeng] Nankai Univ, Inst Urban & Reg Econ, Tianjin 300071, Peoples R China; [Wang, Xiaoyang] Beijing Inst Technol, Sch Math & Stat, Beijing 100081, Peoples R China	Nankai University; Nankai University; Beijing Institute of Technology	Xu, M (corresponding author), Nankai Univ, Coll Tourism & Serv Management, Tianjin 300074, Peoples R China.	mirandajy@163.com						Alen E, 2014, ANN TOURISM RES, V49, P19, DOI 10.1016/j.annals.2014.08.002; ALSTRUP J, 1986, EUR J OPER RES, V27, P274, DOI 10.1016/0377-2217(86)90325-5; Aydin N, 2013, TRANSPORT SCI, V47, P560, DOI 10.1287/trsc.1120.0444; Bailey J, 2007, NY TIMES, V30; Barros C.P., 2010, ANN TOURISM RES, V37, P692, DOI DOI 10.1016/j.annals.2009.12.005; BECKMANN MJ, 1958, ECONOMETRICA, V26, P134, DOI 10.2307/1907387; Bertsimas D, 2005, J REVENUE PRICING MA, V3, P303, DOI 10.1057/palgrave.rpm.5170117; Bhattacharjee S, 2000, EUR J OPER RES, V122, P584, DOI 10.1016/S0377-2217(99)00097-1; Bitran GR, 1996, OPER RES, V44, P35, DOI 10.1287/opre.44.1.35; Chatwin RE, 1999, TRANSPORT SCI, V33, P182, DOI 10.1287/trsc.33.2.182; Chatwin RE, 1992, OPTIMAL AIRLINE OVER; Coughlan J, 1999, J OPER RES SOC, V50, P1098, DOI 10.1057/palgrave.jors.2600712; Cui XY, 2014, EUR J OPER RES, V234, P459, DOI 10.1016/j.ejor.2013.02.040; Dayarian I, 2015, COMPUT OPER RES, V55, P167, DOI 10.1016/j.cor.2014.06.004; Dong YF, 2014, ASIA PAC J TOUR RES, V19, P1417, DOI 10.1080/10941665.2013.866581; Erdelyi A, 2010, INFORMS J COMPUT, V22, P443, DOI 10.1287/ijoc.1090.0359; Gallego G, 1997, OPER RES, V45, P24, DOI 10.1287/opre.45.1.24; Guo XL, 2013, INT J HOSP MANAG, V35, P274, DOI 10.1016/j.ijhm.2013.07.001; Hwang J, 2009, INT J CONTEMP HOSP M, V21, P659, DOI 10.1108/09596110910975945; Karaesmen I, 2004, OPER RES, V52, P83, DOI 10.1287/opre.1030.0079; Kunnumkal S, 2012, TRANSPORT SCI, V46, P90, DOI 10.1287/trsc.1110.0386; Kunnumkal S, 2011, NAV RES LOG, V58, P323, DOI 10.1002/nav.20448; Ladany SP, 1996, OMEGA-INT J MANAGE S, V24, P29, DOI 10.1016/0305-0483(95)00045-3; LIBERMAN V, 1978, MANAGE SCI, V24, P1117, DOI 10.1287/mnsc.24.11.1117; Ling LY, 2012, INT J SERV TECHNOL M, V17, P72, DOI 10.1504/IJSTM.2012.048024; Littlewood K, 2005, J REVENUE PRICING MA, V4, P111, DOI 10.1057/palgrave.rpm.5170134; Liu YJ, 2015, EUR J OPER RES, V242, P933, DOI 10.1016/j.ejor.2014.10.061; Noone BM, 2011, J HOSP TOUR RES, V35, P334, DOI 10.1177/1096348010382238; Peypoch N, 2012, TOURISM MANAGE, V33, P1230, DOI 10.1016/j.tourman.2011.11.003; Phumchusri N, 2014, J HOSP TOUR TECHNOL, V5, P261, DOI 10.1108/JHTT-03-2014-0006; ROBINSON B, 1975, MANAGE SCI B-APPL, V21, P1113, DOI 10.1287/mnsc.21.10.1113; Rothstein M., 1971, Transportation Science, V5, P180, DOI 10.1287/trsc.5.2.180; Saracoglu I, 2014, EXPERT SYST APPL, V41, P8189, DOI 10.1016/j.eswa.2014.07.003; Shlifer E., 1975, Transportation Science, V9, P101, DOI 10.1287/trsc.9.2.101; SMITH BC, 1992, INTERFACES, V22, P8, DOI 10.1287/inte.22.1.8; Subramanian J, 1999, TRANSPORT SCI, V33, P147, DOI 10.1287/trsc.33.2.147; THOMPSON HR, 1961, OPER RES QUART, V12, P167, DOI 10.2307/3006774; Thrane C, 2012, TOURISM MANAGE, V33, P126, DOI 10.1016/j.tourman.2011.02.011; Toh R. S., 2002, Cornell Hotel and Restaurant Administration Quarterly, V43, P79, DOI 10.1016/S0010-8804(02)80044-1; Toh R. S., 1985, Journal of Travel Research, V23, P24; Toh RS, 2011, CORNELL HOSP Q; Topaloglu H, 2012, TRANSPORT SCI, V46, P460, DOI 10.1287/trsc.1110.0403; Wang ED, 2012, TOUR MANAG PERSPECT, V4, P67, DOI 10.1016/j.tmp.2012.03.005; WERNERFELT B, 1986, MANAGE SCI, V32, P1562, DOI 10.1287/mnsc.32.12.1562	44	0	0	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0128574	10.1371/journal.pone.0128574	http://dx.doi.org/10.1371/journal.pone.0128574			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147663	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600014
J	Allender, S; Owen, B; Kuhlberg, J; Lowe, J; Nagorcka-Smith, P; Whelan, J; Bell, C				Allender, Steven; Owen, Brynle; Kuhlberg, Jill; Lowe, Janette; Nagorcka-Smith, Phoebe; Whelan, Jill; Bell, Colin			A Community Based Systems Diagram of Obesity Causes	PLOS ONE			English	Article							HEALTH; SCRIPTS; SCIENCE	Introduction Application of system thinking to the development, implementation and evaluation of childhood obesity prevention efforts represents the cutting edge of community-based prevention. We report on an approach to developing a system oriented community perspective on the causes of obesity. Methods Group model building sessions were conducted in a rural Australian community to address increasing childhood obesity. Stakeholders (n = 12) built a community model that progressed from connection circles to causal loop diagrams using scripts from the system dynamics literature. Participants began this work in identifying change over time in causes and effects of childhood obesity within their community. The initial causal loop diagram was then reviewed and elaborated by 50 community leaders over a full day session. Results The process created a causal loop diagram representing community perceptions of determinants and causes of obesity. The causal loop diagram can be broken down into four separate domains; social influences; fast food and junk food; participation in sport; and general physical activity. Discussion This causal loop diagram can provide the basis for community led planning of a prevention response that engages with multiple levels of existing settings and systems.	[Allender, Steven; Owen, Brynle; Whelan, Jill] Deakin Univ, WHO, Collaborating Ctr Obes Prevent, Geelong, Vic 3217, Australia; [Kuhlberg, Jill] Washington Univ, George Warren Brown Sch Social Work, St Louis, MO USA; [Lowe, Janette] Southern Grampians Glenelg Primary Care Partnersh, Hamilton, Vic, Australia; [Nagorcka-Smith, Phoebe] Portland Dist Hlth, Portland, Vic, Australia; [Bell, Colin] Deakin Univ, Sch Med, Geelong, Vic 3217, Australia	Deakin University; World Health Organization; Washington University (WUSTL); Deakin University	Allender, S (corresponding author), Deakin Univ, WHO, Collaborating Ctr Obes Prevent, Geelong, Vic 3217, Australia.	steven.allender@deakin.edu.au	Allender, Steven/G-9881-2011; Whelan, Jill/O-7030-2019; Bell, Colin/X-9902-2019	Whelan, Jill/0000-0001-9434-109X; Bell, Colin/0000-0003-2731-9858; Nagorcka-Smith, Phoebe/0000-0003-1696-4624; Allender, Steven/0000-0002-4842-3294	Australian National Health and Medical Research Council/Australian National Heart Foundation [APP1045836]; US National Institutes of Health [1R01HL115485-01A1]; NHMRC Centre for Research Excellence in Obesity Policy and Food Systems [APP1041020]; Southern Grampians Glenelg Primary Care; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115485] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council/Australian National Heart Foundation(National Health and Medical Research Council (NHMRC) of Australia); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC Centre for Research Excellence in Obesity Policy and Food Systems(National Health and Medical Research Council (NHMRC) of Australia); Southern Grampians Glenelg Primary Care; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SA is supported by funding from an Australian National Health and Medical Research Council/Australian National Heart Foundation Career Development Fellowship (APP1045836). He is also a researcher on the US National Institutes of Health grant titled, "Systems Science to Guide Whole-of-Community Childhood Obesity Interventions" (1R01HL115485-01A1) and within a NHMRC Centre for Research Excellence in Obesity Policy and Food Systems (APP1041020). The Southern Grampians Glenelg Primary Care Partnership provided support in the form of salaries for author JL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the'author contributions' section.	Andersen DF, 1997, SYST DYNAM REV, V13, P107, DOI 10.1002/(SICI)1099-1727(199722)13:2<107::AID-SDR120>3.3.CO;2-Z; Carr Wilfred., 2003, BECOMING CRITICAL ED; Finegood DT, 2010, OBESITY, V18, pS13, DOI 10.1038/oby.2009.426; Green LW, 2006, AM J PUBLIC HEALTH, V96, P406, DOI 10.2105/AJPH.2005.066035; Hammond RA, 2009, PREV CHRONIC DIS, V6; Hawe P, 2009, AM J COMMUN PSYCHOL, V43, P267, DOI 10.1007/s10464-009-9229-9; Hovmand P., 2013, SCRIPTAPEDIA 4 0 6; Hovmand PS, 2012, SYST RES BEHAV SCI, V29, P179, DOI 10.1002/sres.2105; HOVMAND PETER S., 2014, COMMUNITY BASED SYST; Institute of Medicine, 2012, INT FRAM ASS VAL COM; Ison R, 2010, SYSTEMS PRACTICE: HOW TO ACT IN A CLIMATE-CHANGE WORLD, P1, DOI 10.1007/978-1-84996-125-7; Kemmis S., 2004, ACTION RES PLANNER; King L, 2011, OBES REV, V12, P329, DOI 10.1111/j.1467-789X.2010.00798.x; Mabry PL, 2008, AM J PREV MED, V35, pS211, DOI 10.1016/j.amepre.2008.05.018; Merzel C, 2003, AM J PUBLIC HEALTH, V93, P557, DOI 10.2105/AJPH.93.4.557; National Institute for Health and Clinical Excellence United Kingdom, 2012, OB WORK LOC COMM; Public Health England, 2014, PRET WHOL SYST APPR; RICHARDSON GP, 1995, SYST DYNAM REV, V11, P113, DOI 10.1002/sdr.4260110203; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vennix J.A., 1996, ENCY LIFE SUPPORT SY, V2, P97; Ventana Systems Inc, 2014, VENS SOFTW; Victorian Department of Health, 2014, HLTH TOG VICT; Waters E, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001871.pub3; World Health Organization, 2014, 1 M AD HOC WORK GROU	24	127	127	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0129683	10.1371/journal.pone.0129683	http://dx.doi.org/10.1371/journal.pone.0129683			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26153893	Green Published, Green Submitted, gold			2022-12-27	WOS:000358159700015
J	Aze, J; Sola, C; Zhang, J; Lafosse-Marin, F; Yasmin, M; Siddiqui, R; Kremer, K; van Soolingen, D; Refregier, G				Aze, Jerome; Sola, Christophe; Zhang, Jian; Lafosse-Marin, Florian; Yasmin, Memona; Siddiqui, Rubina; Kremer, Kristin; van Soolingen, Dick; Refregier, Guislaine			Genomics and Machine Learning for Taxonomy Consensus: The Mycobacterium tuberculosis Complex Paradigm	PLOS ONE			English	Article							VARIABLE-NUMBER; GENETIC DIVERSITY; MOLECULAR EPIDEMIOLOGY; STRAIN DIFFERENTIATION; DISCRIMINATORY POWER; GLOBAL DISTRIBUTION; DNA POLYMORPHISM; CLASSIFICATION; HYBRIDIZATION; TOOL	Infra-species taxonomy is a prerequisite to compare features such as virulence in different pathogen lineages. Mycobacterium tuberculosis complex taxonomy has rapidly evolved in the last 20 years through intensive clinical isolation, advances in sequencing and in the description of fast-evolving loci (CRISPR and MIRU-VNTR). On-line tools to describe new isolates have been set up based on known diversity either on CRISPRs (also known as spoligotypes) or on MIRU-VNTR profiles. The underlying taxonomies are largely concordant but use different names and offer different depths. The objectives of this study were 1) to explicit the consensus that exists between the alternative taxonomies, and 2) to provide an on-line tool to ease classification of new isolates. Genotyping (24-VNTR, 43-spacers spoligotypes, IS6110-RFLP) was undertaken for 3,454 clinical isolates from the Netherlands (2004-2008). The resulting database was enlarged with African isolates to include most human tuberculosis diversity. Assignations were obtained using TB-Lineage, MIRU-VNTRPlus, SITVITWEB and an algorithm from Borile et al. By identifying the recurrent concordances between the alternative taxonomies, we proposed a consensus including 22 sublineages. Original and consensus assignations of the all isolates from the database were subsequently implemented into an ensemble learning approach based on Machine Learning tool Weka to derive a classification scheme. All assignations were reproduced with very good sensibilities and specificities. When applied to independent datasets, it was able to suggest new sublineages such as pseudo-Beijing. This Lineage Prediction tool, efficient on 15-MIRU, 24-VNTR and spoligotype data is available on the web interface "TBminer." Another section of this website helps summarizing key molecular epidemiological data, easing tuberculosis surveillance. Altogether, we successfully used Machine Learning on a large dataset to set up and make available the first consensual taxonomy for human Mycobacterium tuberculosis complex. Additional developments using SNPs will help stabilizing it.	[Aze, Jerome] LIRMM UM CNRS, UMR 5506, F-34095 Montpellier 2, France; [Sola, Christophe; Zhang, Jian; Lafosse-Marin, Florian; Refregier, Guislaine] Univ Paris 11, CNRS, CEA, Inst Integrat Biol Cell I2BC, F-91405 Orsay, France; [Yasmin, Memona] PIEAS, Islamabad, Pakistan; [Yasmin, Memona; Siddiqui, Rubina] NIBGE, Hlth Biotechnol Div, Faisalabad, Pakistan; [Kremer, Kristin; van Soolingen, Dick] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [van Soolingen, Dick] Radbout Univ Nijmegen, Univ Lung Ctr Dekkerswald, Med Ctr, Dept Pulm Dis, NL-6500 HB Nijmegen, Netherlands; [van Soolingen, Dick] Radbout Univ Nijmegen, Univ Lung Ctr Dekkerswald, Med Ctr, Dept Microbiol, NL-6500 HB Nijmegen, Netherlands	Centre National de la Recherche Scientifique (CNRS); Universite Paul-Valery; Universite Perpignan Via Domitia; Universite de Montpellier; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Pakistan Institute of Engineering & Applied Science; Pakistan Institute of Engineering & Applied Science; Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; Radboud University Nijmegen	Refregier, G (corresponding author), Univ Paris 11, CNRS, CEA, Inst Integrat Biol Cell I2BC, Rue Gregor Mendal,Bat 400, F-91405 Orsay, France.	guislaine.refregier@u-psud.fr	Refregier, Guislaine/AAU-8777-2021; Sola, Christophe/A-7992-2016	Refregier, Guislaine/0000-0003-3749-7981; Sola, Christophe/0000-0003-4672-2140	National Institute for Public Health and the Environment, The Netherlands	National Institute for Public Health and the Environment, The Netherlands(Netherlands Government)	This work was supported by National Institute for Public Health and the Environment, The Netherlands, www.rivm.nl/ (CS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia E, 2010, INFECT GENET EVOL, V10, P1066, DOI 10.1016/j.meegid.2010.07.006; Alexander KA, 2010, EMERG INFECT DIS, V16, P1296, DOI 10.3201/eid1608.100314; Allix-Beguec C, 2008, J CLIN MICROBIOL; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Amancio DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094137; Amarreh I, 2014, NEUROIMAGE-CLIN, V4, P757, DOI 10.1016/j.nicl.2014.02.006; [Anonymous], [No title captured]; Aranaz A, 1999, INT J SYST BACTERIOL, V49, P1263, DOI 10.1099/00207713-49-3-1263; Blouin Y, 2014, EMERG INFECT DIS, V20, P21, DOI 10.3201/eid2001.130652; Blouin Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052841; Borgdorff MW, 2005, EMERG INFECT DIS, V11, P597, DOI 10.3201/eid1104.041103; Borile C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-224; Bouckaert RR, 2010, BIOINFORMATICS, V26, P1372, DOI 10.1093/bioinformatics/btq110; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Castets M, 1968, Rev Tuberc Pneumol (Paris), V32, P179; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Coll F, 2014, TUBERCULOSIS, V94, P346, DOI 10.1016/j.tube.2014.02.005; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cousins DV, 2003, INT J SYST EVOL MICR, V53, P1305, DOI 10.1099/ijs.0.02401-0; Cowan LS, 2004, J CLIN MICROBIOL, V42, P474, DOI 10.1128/JCM.42.1.474-477.2004; de Beer JL, 2013, J CLIN MICROBIOL, V51, P1193, DOI 10.1128/JCM.03061-12; Demay C, 2012, INFECT GENE IN PRESS; DOWNEY JC, 1962, SYST ZOOL, V11, P150, DOI 10.2307/2411462; Evans JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017930; Fenner L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024737; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Filliol I, 2000, J CLIN MICROBIOL, V38, P2520, DOI 10.1128/JCM.38.7.2520-2524.2000; Filliol I, 2002, EMERG INFECT DIS, V8, P1347, DOI 10.3201/eid0811.020125; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Ghorbani M, 2013, J NUCLEIC ACIDS, V2013, DOI 10.1155/2013/689798; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; GROENEN PMA, 1993, MOL MICROBIOL, V10, P1057, DOI 10.1111/j.1365-2958.1993.tb00976.x; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Homolka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039855; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; KARLSON A G, 1970, International Journal of Systematic Bacteriology, V20, P273; Kato-Maeda M, 2011, INT J TUBERC LUNG D, V15, P131; Kremer K, 2005, J CLIN MICROBIOL, V43, P5628, DOI 10.1128/JCM.43.11.5628-5638.2005; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; Lan NTN, 2003, EMERG INFECT DIS, V9, P1633, DOI 10.3201/eid0912.030169; LASZLO A, 1983, J CLIN MICROBIOL, V18, P1335, DOI 10.1128/JCM.18.6.1335-1339.1983; Lawson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038409; Lehmann K. B., 1907, LEHMANNS MED HANDATL; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Mokrousov I, 2014, J BACTERIOL, V196, P1833, DOI 10.1128/JB.01485-13; Murray M, 2002, EMERG INFECT DIS, V8, P363, DOI 10.3201/eid0804.000444; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; Niobe-Eyangoh SN, 2004, J CLIN MICROBIOL, V42, P5029, DOI 10.1128/JCM.42.11.5029-5035.2004; Niobe-Eyangoh SN, 2003, J CLIN MICROBIOL, V41, P2547, DOI 10.1128/JCM.41.6.2547-2553.2003; Oelemann MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018256; Parsons SDC, 2013, EMERG INFECT DIS, V19, P2004, DOI 10.3201/eid1912.130268; Reed GB., 1957, BERGEYS MANUAL DETER, P703; Reyes JF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-496; Schurch AC, 2011, J CLIN MICROBIOL, V49, P1318, DOI 10.1128/JCM.01848-10; Schurch AC, 2010, J CLIN MICROBIOL, V48, P3403, DOI 10.1128/JCM.00370-10; Sebban M, 2002, BIOINFORMATICS, V18, P235, DOI 10.1093/bioinformatics/18.2.235; Shabbeer A, 2012, INFECT GENET EVOL, V12, P789, DOI 10.1016/j.meegid.2012.02.010; Sloot R, 2013, J CLIN MICROBIOL, V51, P2427, DOI 10.1128/JCM.00489-13; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Sola C, 1999, EMERG INFECT DIS, V5, P404, DOI 10.3201/eid0503.990311; Sola C, 2003, INFECT GENET EVOL, V3, P125, DOI 10.1016/S1567-1348(03)00011-X; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Streicher EM, 2007, J CLIN MICROBIOL, V45, P237, DOI 10.1128/JCM.01429-06; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Supply P, 2013, NAT GENET, V45, P172, DOI 10.1038/ng.2517; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; van der Zanden AGM, 2002, J CLIN MICROBIOL, V40, P4628, DOI 10.1128/JCM.40.12.4628-4639.2002; van Embden JDA, 2000, J BACTERIOL, V182, P2393, DOI 10.1128/JB.182.9.2393-2401.2000; van Ingen J, 2012, EMERG INFECT DIS, V18, P653, DOI 10.3201/eid1804.110888; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; vanSoolingen D, 1997, INT J SYST BACTERIOL, V47, P1236, DOI 10.1099/00207713-47-4-1236; Vitol I, 2006, INFECT GENET EVOL, V6, P491, DOI 10.1016/j.meegid.2006.03.003; Walker TM, 2013, CLIN MICROBIOL INFEC, V19, P796, DOI 10.1111/1469-0691.12183; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Warren RM, 2002, J CLIN MICROBIOL, V40, P4457, DOI 10.1128/JCM.40.12.4457-4465.2002; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; WHO, 2006, WHOCDSTB2002295; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Yasmin M, 2014, INFECT GENET EVOL, V27, P6, DOI 10.1016/j.meegid.2014.06.017; Zhang J, 2010, J MED MICROBIOL, V59, P285, DOI 10.1099/jmm.0.016949-0	85	23	23	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130912	10.1371/journal.pone.0130912	http://dx.doi.org/10.1371/journal.pone.0130912			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154264	Green Published, Green Submitted, gold			2022-12-27	WOS:000358159700045
J	Estupinan, M; Alvarez-Garcia, D; Barril, X; Diaz, P; Manresa, A				Estupinan, Monica; Alvarez-Garcia, Daniel; Barril, Xavier; Diaz, Pilar; Manresa, Angeles			In Silico/In Vivo Insights into the Functional and Evolutionary Pathway of Pseudomonas aeruginosa Oleate-Diol Synthase. Discovery of a New Bacterial Di-Heme Cytochrome C Peroxidase Subfamily	PLOS ONE			English	Article							RUBBER OXYGENASE ROXA; UNSATURATED FATTY-ACIDS; PALINDROMIC REPEATS; IDENTIFICATION; OXIDATION; ISOMERASE; EXPRESSION; GENERATION; PREDICTION; OXYLIPINS	As previously reported, P. aeruginosa genes PA2077 and PA2078 code for 10S-DOX (10S-Dioxygenase) and 7,10-DS (7,10-Diol Synthase) enzymes involved in long-chain fatty acid oxygenation through the recently described oleate-diol synthase pathway. Analysis of the amino acid sequence of both enzymes revealed the presence of two heme-binding motifs (CXXCH) on each protein. Phylogenetic analysis showed the relation of both proteins to bacterial di-heme cytochrome c peroxidases (Ccps), similar to Xanthomonas sp. 35Y rubber oxidase RoxA. Structural homology modelling of PA2077 and PA2078 was achieved using RoxA (pdb 4b2n) as a template. From the 3D model obtained, presence of significant amino acid variations in the predicted heme-environment was found. Moreover, the presence of palindromic repeats located in enzyme-coding regions, acting as protein evolution elements, is reported here for the first time in P. aeruginosa genome. These observations and the constructed phylogenetic tree of the two proteins, allow the proposal of an evolutionary pathway for P. aeruginosa oleate-diol synthase operon. Taking together the in silico and in vivo results obtained we conclude that enzymes PA2077 and PA2078 are the first described members of a new subfamily of bacterial peroxidases, designated as Fatty acid-di-heme Cytochrome c peroxidases (FadCcp).	[Estupinan, Monica; Manresa, Angeles] Univ Barcelona, Fac Farm, Unitat Microbiol & Parasitol Sanitaries, E-08028 Barcelona, Spain; [Estupinan, Monica; Diaz, Pilar] Univ Barcelona, Fac Biol, Dept Microbiol, Barcelona, Spain; [Alvarez-Garcia, Daniel; Barril, Xavier] Univ Barcelona, Fac Pharm, Dept Fisicoquim, Barcelona, Spain; [Alvarez-Garcia, Daniel; Barril, Xavier] Univ Barcelona IBUB, Inst Biomed, PCB, Barcelona, Spain; [Barril, Xavier] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona; University of Barcelona; ICREA	Diaz, P (corresponding author), Univ Barcelona, Fac Biol, Dept Microbiol, Barcelona, Spain.	pdiaz@ub.edu	Estupiñán Romero, Mónica/L-1438-2017; Barril, Xavier/K-9607-2014; Diaz, Pilar/I-2465-2014	Estupiñán Romero, Mónica/0000-0001-7347-3341; Barril, Xavier/0000-0002-0281-1347; Manresa, Angeles/0000-0003-2337-9060; Alvarez-Garcia, Daniel/0000-0002-2867-5005; Diaz, Pilar/0000-0003-4008-0669	Ministerio de Economia y Competitividad (MINECO) [CTQ2010-21183-CO2-01/02, CTQ2014-59632]; IV Pla de Recerca de Catalunya (Generalitat de Catalunya) [2009SGR-819]; "Comissionat per a Universitats i Recerca" (CUR) of "Departament d'Innovacio, Universitats i Empresa" (DIUE); Generalitat de Catalunya; European Social Source (FI-DGR); ICREA Funding Source: Custom	Ministerio de Economia y Competitividad (MINECO)(Spanish Government); IV Pla de Recerca de Catalunya (Generalitat de Catalunya)(Generalitat de Catalunya); "Comissionat per a Universitats i Recerca" (CUR) of "Departament d'Innovacio, Universitats i Empresa" (DIUE); Generalitat de Catalunya(Generalitat de Catalunya); European Social Source (FI-DGR); ICREA(ICREA)	This work was partially funded by the Ministerio de Economia y Competitividad (MINECO, projects CTQ2010-21183-CO2-01/02 and CTQ2014-59632), by the IV Pla de Recerca de Catalunya (Generalitat de Catalunya), grant 2009SGR-819, to the "Xarxa de Referencia en Biotecnologia" (XRB). ME acknowledges a fellowship from the "Comissionat per a Universitats i Recerca" (CUR) of "Departament d'Innovacio, Universitats i Empresa" (DIUE) from Generalitat de Catalunya and European Social Source (FI-DGR2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alves T, 1999, BBA-PROTEIN STRUCT M, V1434, P248, DOI 10.1016/S0167-4838(99)00188-0; Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; Atack JM, 2007, ADV MICROB PHYSIOL, V52, P73, DOI 10.1016/S0065-2911(06)52002-8; BERNSTEIN FC, 1978, ARCH BIOCHEM BIOPHYS, V185, P584, DOI 10.1016/0003-9861(78)90204-7; Birke J, 2012, APPL ENVIRON MICROB, V78, P7876, DOI 10.1128/AEM.02385-12; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodhun F, 2011, FEBS J, V278, P1047, DOI 10.1111/j.1742-4658.2011.08027.x; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cao YJ, 2013, APPL MICROBIOL BIOT, V97, P3323, DOI 10.1007/s00253-013-4815-z; Claverie JM, 2003, TRENDS BIOCHEM SCI, V28, P75, DOI 10.1016/S0968-0004(02)00036-1; De Smet L, 2006, J BIOL CHEM, V281, P4371, DOI 10.1074/jbc.M509582200; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Estupinan M, 2014, BBA-MOL CELL BIOL L, V1841, P1360, DOI 10.1016/j.bbalip.2014.06.010; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Frimmersdorf E, 2010, ENVIRON MICROBIOL, V12, P1734, DOI 10.1111/j.1462-2920.2010.02253.x; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Garreta A, 2013, FASEB J, P1; Garscha U, 2007, J BIOL CHEM, V282, P34707, DOI 10.1074/jbc.M705366200; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GILMOUR R, 1994, BIOCHEM J, V300, P907, DOI 10.1042/bj3000907; Hambsch N, 2010, J APPL MICROBIOL, V109, P1067, DOI 10.1111/j.1365-2672.2010.04732.x; Hiseni A, 2014, BIOTECHNOL J, V9, P814, DOI 10.1002/biot.201300412; Hoffmann I, 2012, BBA-MOL CELL BIOL L, V1821, P1508, DOI 10.1016/j.bbalip.2012.09.001; Hoffmann I, 2011, ARCH BIOCHEM BIOPHYS, V506, P216, DOI 10.1016/j.abb.2010.11.022; Hofmann, 1993, BIOL CHEM HOPPE SEYL, V374; Hou CT, 2009, NEW BIOTECHNOL, V26, P2, DOI 10.1016/j.nbt.2009.05.001; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jendrossek D, 2003, FEMS MICROBIOL LETT, V224, P61, DOI 10.1016/S0378-1097(03)00424-5; Jerneren F, 2012, LIPIDS, V47, P707, DOI 10.1007/s11745-012-3673-2; Jerneren F, 2010, BBA-MOL CELL BIOL L, V1801, P503, DOI 10.1016/j.bbalip.2009.12.012; Jerneren F, 2010, J BIOL CHEM, V285, P5308, DOI 10.1074/jbc.M109.062810; Lewenza S, 2005, GENOME RES, V15, P321, DOI 10.1101/gr.3257305; Lucchetti-Miganeh C, 2014, PATHOGENS, V3, P309, DOI 10.3390/pathogens3020309; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Martin-Arjol I, 2010, CHEM PHYS LIPIDS, V163, P341, DOI 10.1016/j.chemphyslip.2010.02.003; Martin-Arjol I, 2014, APPL MICROBIOL BIOTE; Martinez E, 2013, BIOCHIMIE, V95, P290, DOI 10.1016/j.biochi.2012.09.032; Martinez E, 2010, J BIOL CHEM, V285, P9339, DOI 10.1074/jbc.M109.078147; Massey KA, 2011, BIOCHEM SOC T, V39, P1240, DOI 10.1042/BST0391240; Mosblech A, 2009, PLANT PHYSIOL BIOCH, V47, P511, DOI 10.1016/j.plaphy.2008.12.011; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Noverr MC, 2003, CLIN MICROBIOL REV, V16, P517, DOI 10.1128/CMR.16.3.517-533.2003; Ogata H, 2005, TRENDS MICROBIOL, V13, P253, DOI 10.1016/j.tim.2005.03.013; Oliw EH, 2011, J LIPID RES, V52, P1995, DOI 10.1194/jlr.M018259; Pearson CE, 1996, J CELL BIOCHEM, V63, P1; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; Sambrook J., 2001, MOL CLONING LAB MANU; Seidel J, 2013, P NATL ACAD SCI USA, V110, P13833, DOI 10.1073/pnas.1305560110; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang YT, 2003, BIOCHEMISTRY-US, V42, P7318, DOI 10.1021/bi034243q; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869	58	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131462	10.1371/journal.pone.0131462	http://dx.doi.org/10.1371/journal.pone.0131462			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154497	Green Published, gold			2022-12-27	WOS:000358159700063
J	Lee, HF; Pei, Q; Zhang, DD; Choi, KPK				Lee, Harry F.; Pei, Qing; Zhang, David D.; Choi, Kan P. K.			Quantifying the Intra-Regional Precipitation Variability in Northwestern China over the Past 1,400 Years	PLOS ONE			English	Article							EAST-ASIAN WINTER; NORTH CENTRAL CHINA; ICE-AGE; HIGH-RESOLUTION; MONSOON PRECIPITATION; SURFACE TEMPERATURES; DROUGHT VARIABILITY; TROPICAL PACIFIC; TIBETAN PLATEAU; INDIAN MONSOON	There has been a surge of paleo-climatic/environmental studies of Northwestern China (NW China), a region characterized by a diverse assortment of hydro-climatic systems. Their common approach, however, focuses on "deducing regional resemblance" rather than "exploring regional variance." To date, efforts to produce a quantitative assessment of long-term intra-regional precipitation variability (IRPV) in NW China has been inadequate. In the present study, we base on historical flood/drought records to compile a decadal IRPV index for NW China spanned AD580-1979 and to find its major determinants via wavelet analysis. Results show that our IRPV index captures the footprints of internal hydro-climatic disparity in NW China. In addition, we find distinct similar to 120-200 year periodicities in the IRPV index over the Little Ice Age, which are attributable to the change of hydro-climatic influence of ocean-atmospheric modes during the period. Also, we offer statistical evidence of El Nino Southern Oscillation (Indo-Pacific warm pool sea surface temperature and China-wide land surface temperature) as the prominent multi-decadal to centennial (centennial to multi-centennial) determinant of the IRPV in NW China. The present study contributes to the quantitative validation of the long-term IRPV in NW China and its driving forces, covering the periods with and without instrumental records. It may help to comprehend the complex hydro-climatic regimes in the region.	[Lee, Harry F.; Pei, Qing; Zhang, David D.; Choi, Kan P. K.] Univ Hong Kong, Dept Geog, Hong Kong, Hong Kong, Peoples R China; [Lee, Harry F.; Pei, Qing; Zhang, David D.] Univ Hong Kong, Int Ctr China Dev Studies, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Lee, HF (corresponding author), Univ Hong Kong, Dept Geog, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	harrylee@hku.hk	Lee, Harry F./M-9979-2019	Lee, Harry F./0000-0001-5415-7845; Pei, Qing/0000-0002-9699-2950	Hui Oi-Chow Trust Fund [201205172003, 201302172003]; HKU Seed Funding Programme for Basic Research [201109159014]; Research Grants Council of The Government of the Hong Kong Special Administrative Region of the People's Republic of China [HKU758712H, HKU745113H]; CAS/SAFEA International Partnership Program for Creative Research Teams	Hui Oi-Chow Trust Fund; HKU Seed Funding Programme for Basic Research; Research Grants Council of The Government of the Hong Kong Special Administrative Region of the People's Republic of China(Hong Kong Research Grants Council); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences)	This research was supported by the Hui Oi-Chow Trust Fund (201205172003 and 201302172003), HKU Seed Funding Programme for Basic Research (201109159014), Research Grants Council of The Government of the Hong Kong Special Administrative Region of the People's Republic of China (HKU758712H and HKU745113H), and the CAS/SAFEA International Partnership Program for Creative Research Teams. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri R, 2002, EARTH PLANET SC LETT, V198, P521, DOI 10.1016/S0012-821X(02)00530-7; Agung I.G.N., 2009, TIME SERIES DATA ANA; [Anonymous], 2013, CONTRIBUTION WORKING, P1535; Bai H.Z., 2010, YEARLY CHARTS DRYNES; Boos WR, 2010, NATURE, V463, P218, DOI 10.1038/nature08707; Cai YJ, 2010, EARTH PLANET SC LETT, V291, P21, DOI 10.1016/j.epsl.2009.12.039; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; Cazelles B, 2007, J R SOC INTERFACE, V4, P625, DOI 10.1098/rsif.2007.0212; Chen FH, 2010, QUATERNARY SCI REV, V29, P1055, DOI 10.1016/j.quascirev.2010.01.005; Chen FH, 2008, QUATERNARY SCI REV, V27, P351, DOI 10.1016/j.quascirev.2007.10.017; Chen FH, 2006, SCI CHINA SER D, V49, P1280, DOI 10.1007/s11430-006-2027-4; Chen F, 2013, HOLOCENE, V23, P1095, DOI 10.1177/0959683613483614; Chen JH, 2015, QUATERNARY SCI REV, V107, P98, DOI 10.1016/j.quascirev.2014.10.012; Chen JH, 2009, CHINESE SCI BULL, V54, P3749, DOI [10.1007/s11434-009-0201-8, 10.1007/S11434-009-0201-8]; [陈建徽 CHEN Jianhui], 2008, [地理学报, Acta Geographica Sinica], V63, P23; Chen JM, 2009, ADV ATMOS SCI, V26, P803, DOI 10.1007/s00376-009-9018-2; Chinese National Meteorological Administration, 1981, YEARLY CHARTS DRYNES; Chu GQ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034475; Conroy JL, 2009, NAT GEOSCI, V2, P46, DOI 10.1038/NGEO390; Cook ER, 2010, SCIENCE, V328, P486, DOI 10.1126/science.1185188; Cosford J, 2008, EARTH PLANET SC LETT, V275, P296, DOI 10.1016/j.epsl.2008.08.018; Deng XN, 2005, AGR SYST, V84, P155, DOI 10.1016/j.agsy.2004.05.004; Dykoski CA, 2005, EARTH PLANET SC LETT, V233, P71, DOI 10.1016/j.epsl.2005.01.036; EDDY JA, 1976, SCIENCE, V192, P1189, DOI 10.1126/science.192.4245.1189; Fang KY, 2012, GLOBAL PLANET CHANGE, V80-81, P190, DOI 10.1016/j.gloplacha.2011.10.009; Fang KY, 2010, CLIM DYNAM, V35, P577, DOI 10.1007/s00382-009-0636-2; Fang KY, 2009, CLIM RES, V38, P129, DOI 10.3354/cr00781; Fox J., 2019, R COMPANION APPL REG, V.; Ge Q, 2013, CLIM PAST, V9, P1153, DOI 10.5194/cp-9-1153-2013; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Huang RH, 2004, ADV ATMOS SCI, V21, P407, DOI 10.1007/BF02915568; Jiang T, 2005, THEOR APPL CLIMATOL, V82, P131, DOI 10.1007/s00704-005-0125-4; Kang SY, 2014, J ARID ENVIRON, V110, P53, DOI 10.1016/j.jaridenv.2014.06.003; Kang SY, 2013, QUATERN INT, V283, P85, DOI 10.1016/j.quaint.2012.03.011; Kang SY, 2012, CLIMATIC CHANGE, V115, P519, DOI 10.1007/s10584-012-0440-6; Lee HF, 2011, J ARID ENVIRON, V75, P1114, DOI 10.1016/j.jaridenv.2011.06.008; Lee HF, 2012, ASIAN GEOGR, V29, P89, DOI 10.1080/10225706.2012.742615; Lee HF, 2015, HOLOCENE, V25, P1271, DOI 10.1177/0959683615581203; Lee HF, 2010, CLIM RES, V41, P245, DOI 10.3354/cr00858; Li CY, 2000, CHINESE SCI BULL, V45, P1448, DOI 10.1007/BF02898885; Li JB, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025803; Li JB, 2007, INT J CLIMATOL, V27, P903, DOI 10.1002/joc.1450; Li JB, 2013, NAT CLIM CHANGE, V3, P822, DOI [10.1038/nclimate1936, 10.1038/NCLIMATE1936]; Li Y, 2000, CLIMATIC ENV RES, V5, P205; MacDonald GM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022478; Mann ME, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017814; Mann ME, 2009, SCIENCE, V326, P1256, DOI 10.1126/science.1177303; McPhaden MJ, 2006, SCIENCE, V314, P1740, DOI 10.1126/science.1132588; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Nie JS, 2014, SCI REP-UK, V4, DOI 10.1038/srep05474; Oppo DW, 2009, NATURE, V460, P1113, DOI 10.1038/nature08233; Osborn TJ, 2006, SCIENCE, V311, P841, DOI 10.1126/science.1120514; Rigozo NR, 2008, J ATMOS SOL-TERR PHY, V70, P1012, DOI 10.1016/j.jastp.2008.01.002; Sachs JP, 2009, NAT GEOSCI, V2, P519, DOI 10.1038/ngeo554; Sheppard PR, 2004, CLIM DYNAM, V23, P869, DOI 10.1007/s00382-004-0473-2; Shi YF, 2007, CLIMATIC CHANGE, V80, P379, DOI 10.1007/s10584-006-9121-7; Su MF, 2007, SCI CHINA SER D, V50, P145, DOI 10.1007/s11430-007-2006-4; Tan L, 2011, CLIM PAST, V7, P685, DOI 10.5194/cp-7-685-2011; Tan LC, 2008, CLIM PAST, V4, P19; Tan LC, 2011, HOLOCENE, V21, P287, DOI 10.1177/0959683610378880; Thompson LG, 2006, P NATL ACAD SCI USA, V103, P10536, DOI 10.1073/pnas.0603900103; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Torrence C, 1999, J CLIMATE, V12, P2679, DOI 10.1175/1520-0442(1999)012<2679:ICITEM>2.0.CO;2; Trouet V, 2009, SCIENCE, V324, P78, DOI 10.1126/science.1166349; Wang B, 2003, J CLIMATE, V16, P1195, DOI 10.1175/1520-0442(2003)16&lt;1195:AOIAII&gt;2.0.CO;2; Wang B., 2006, ASIAN MONSOON, P1; Wang L, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035287; WANG WC, 1990, J CLIMATE, V3, P769, DOI 10.1175/1520-0442(1990)003<0769:PFOSRI>2.0.CO;2; Xu ZX, 2007, HYDROL PROCESS, V21, P61, DOI 10.1002/hyp.6180; Yadava MG, 2007, NEW ASTRON, V12, P544, DOI 10.1016/j.newast.2007.04.001; Yan Z, 1993, SCI ATMOSPHERICA SIN, V17, P663; Yang B, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014485; Yang B, 2014, CLIM DYNAM, V43, P845, DOI 10.1007/s00382-013-1962-y; Yang B, 2014, P NATL ACAD SCI USA, V111, P2903, DOI 10.1073/pnas.1319238111; Yang B, 2011, INT J CLIMATOL, V31, P1166, DOI 10.1002/joc.2143; Yang MX, 2000, CLIMATIC CHANGE, V47, P401, DOI 10.1023/A:1005696702385; Yao TD, 1996, SCI CHINA SER D, V39, P587; Yi L, 2012, CLIMATIC CHANGE, V110, P469, DOI 10.1007/s10584-011-0052-6; Yu YT, 2006, PALAEOGEOGR PALAEOCL, V233, P149, DOI 10.1016/j.palaeo.2005.09.008; Yuan L, 1994, HIST DROUGHT FAMINE; Zhang DE, 2010, CHINESE SCI BULL, V55, P77, DOI 10.1007/s11434-009-0584-6; Zhang JW, 2009, QUATERN INT, V194, P119, DOI 10.1016/j.quaint.2008.05.003; Zhang PZ, 2008, SCIENCE, V322, P940, DOI 10.1126/science.1163965; Zhang ZB, 2009, P ROY SOC B-BIOL SCI, V276, P823, DOI 10.1098/rspb.2008.1284; Zhao S, 1986, PHYS GEOGRAPHYS CHIN; Zhou W, 2007, METEOROL ATMOS PHYS, V98, P283, DOI 10.1007/s00703-007-0263-6	86	10	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131693	10.1371/journal.pone.0131693	http://dx.doi.org/10.1371/journal.pone.0131693			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154711	Green Submitted, Green Published, gold			2022-12-27	WOS:000358159700077
J	Novak, J; Bailoo, JD; Melotti, L; Rommen, J; Wurbel, H				Novak, Janja; Bailoo, Jeremy D.; Melotti, Luca; Rommen, Jonas; Wuerbel, Hanno			An Exploration Based Cognitive Bias Test for Mice: Effects of Handling Method and Stereotypic Behaviour	PLOS ONE			English	Article							AMBIGUOUS-CUE INTERPRETATION; CAGE-INDUCED STEREOTYPIES; ENVIRONMENTAL ENRICHMENT; JUDGMENT BIAS; ANIMAL-MODEL; LABORATORY RATS; RISK-ASSESSMENT; BASAL GANGLIA; PLUS-MAZE; STRESS	Behavioural tests to assess affective states are widely used in human research and have recently been extended to animals. These tests assume that affective state influences cognitive processing, and that animals in a negative affective state interpret ambiguous information as expecting a negative outcome (displaying a negative cognitive bias). Most of these tests however, require long discrimination training. The aim of the study was to validate an exploration based cognitive bias test, using two different handling methods, as previous studies have shown that standard tail handling of mice increases physiological and behavioural measures of anxiety compared to cupped handling. Therefore, we hypothesised that tail handled mice would display a negative cognitive bias. We handled 28 female CD-1 mice for 16 weeks using either tail handling or cupped handling. The mice were then trained in an eight arm radial maze, where two adjacent arms predicted a positive outcome (darkness and food), while the two opposite arms predicted a negative outcome (no food, white noise and light). After six days of training, the mice were also given access to the four previously unavailable intermediate ambiguous arms of the radial maze and tested for cognitive bias. We were unable to validate this test, as mice from both handling groups displayed a similar pattern of exploration. Furthermore, we examined whether maze exploration is affected by the expression of stereotypic behaviour in the home cage. Mice with higher levels of stereotypic behaviour spent more time in positive arms and avoided ambiguous arms, displaying a negative cognitive bias. While this test needs further validation, our results indicate that it may allow the assessment of affective state in mice with minimal training-a major confound in current cognitive bias paradigms.	[Novak, Janja; Bailoo, Jeremy D.; Melotti, Luca; Wuerbel, Hanno] Univ Bern, VPH Inst, Div Anim Welf, CH-3012 Bern, Switzerland; [Rommen, Jonas] Univ Marburg, Fac Biol, Dept Zool Systemat & Evolut, D-35037 Marburg, Germany	University of Bern; Philipps University Marburg	Novak, J (corresponding author), Univ Bern, VPH Inst, Div Anim Welf, Langgassstr 120, CH-3012 Bern, Switzerland.	j.novak2@gmail.com	Bailoo, Jeremy D./H-5011-2019; Wuerbel, Hanno/D-6281-2012	Bailoo, Jeremy D./0000-0002-3767-2922; Wuerbel, Hanno/0000-0002-2934-3010	German Research Foundation DFG project [WU494/4-1]; ERC	German Research Foundation DFG project(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission)	The authors were funded by the German Research Foundation DFG project WU494/4-1 (JN) and an ERC Advanced Grant "REFINE" (JDB).	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ARCHER J, 1973, ANIM BEHAV, V21, P205, DOI 10.1016/S0003-3472(73)80065-X; Augustsson H, 2004, PHYSIOL BEHAV, V81, P685, DOI 10.1016/j.physbeh.2004.03.014; Bailoo JD, 2010, J NEUROSCI METH, V188, P45, DOI 10.1016/j.jneumeth.2010.01.035; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Bateson M, 2007, ANIM WELFARE, V16, P33; Bayne K, 2014, REV SCI TECH OIE, V33, P273, DOI 10.20506/rst.33.1.2282; Belzung C, 1997, BEHAV PHARMACOL, V8, P541, DOI 10.1097/00008877-199711000-00012; Birrell JM, 2000, J NEUROSCI, V20, P4320; Boleij H, 2012, BEHAV BRAIN RES, V233, P45, DOI 10.1016/j.bbr.2012.04.039; Burman OHP, 2008, ANIM BEHAV, V76, P801, DOI 10.1016/j.anbehav.2008.02.014; Burman OHP, 2009, PHYSIOL BEHAV, V98, P345, DOI 10.1016/j.physbeh.2009.06.012; Cabib S, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P227, DOI 10.1079/9780851990040.0227; Calvo-Torrent A, 1999, PHYSIOL BEHAV, V67, P189, DOI 10.1016/S0031-9384(99)00051-7; Coles ME, 2002, CLIN PSYCHOL REV, V22, P587, DOI 10.1016/S0272-7358(01)00113-1; Dallaire JA, 2011, BEHAV BRAIN RES, V224, P213, DOI 10.1016/j.bbr.2011.03.061; Deacon RMJ, 2006, NAT PROTOC, V1, P936, DOI 10.1038/nprot.2006.120; Dunn BD, 2009, BEHAV RES THER, V47, P374, DOI 10.1016/j.brat.2009.01.016; Enkel T, 2010, NEUROPSYCHOPHARMACOL, V35, P1008, DOI 10.1038/npp.2009.204; EYSENCK MW, 1991, J ABNORM PSYCHOL, V100, P144, DOI 10.1037/0021-843X.100.2.144; Franks B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083578; Fridgeirsdottir GA, 2014, UPSALA J MED SCI, V119, P1, DOI 10.3109/03009734.2013.847511; Garner JP, 2011, BEHAV BRAIN RES, V219, P189, DOI 10.1016/j.bbr.2011.01.002; Garner JP, 2002, BEHAV BRAIN RES, V136, P83, DOI 10.1016/S0166-4328(02)00111-0; Gouveia K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066401; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; GRIEBEL G, 1993, BEHAV PHARMACOL, V4, P637; Gross AN, 2012, BEHAV BRAIN RES, V234, P61, DOI 10.1016/j.bbr.2012.06.007; Gross AN, 2011, BEHAV BRAIN RES, V216, P613, DOI 10.1016/j.bbr.2010.09.003; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Horvath J, 2013, BEHAV BRAIN RES, V250, P32, DOI 10.1016/j.bbr.2013.04.014; Hurst JL, 2010, NAT METHODS, V7, P825, DOI [10.1038/nmeth.1500, 10.1038/NMETH.1500]; Kloke V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105431; Latham N, 2010, BEHAV BRAIN RES, V211, P96, DOI 10.1016/j.bbr.2010.03.018; Lewis M, 2009, J NEURODEV DISORD, V1, P114, DOI 10.1007/s11689-009-9019-6; LISTER RG, 1990, PHARMACOL THERAPEUT, V46, P321, DOI 10.1016/0163-7258(90)90021-S; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; Mason GJ, 2004, ANIM WELFARE, V13, pS57; Matheson SM, 2008, APPL ANIM BEHAV SCI, V109, P374, DOI 10.1016/j.applanim.2007.03.007; Maurer BM, 2008, APPL ANIM BEHAV SCI, V114, P554, DOI 10.1016/j.applanim.2008.04.013; Meijer MK, 2007, LAB ANIM-UK, V41, P161, DOI 10.1258/002367707780378168; Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Moberg Gary P MJA, 2000, BIOL ANIMAL STRESS B; Nevison CM, 1999, BEHAV PROCESS, V47, P95, DOI 10.1016/S0376-6357(99)00053-4; ODBERG FO, 1986, BIOL BEHAV, V11, P130; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; Parker RMA, 2014, BEHAV BRAIN RES, V274, P73, DOI 10.1016/j.bbr.2014.07.048; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Pomerantz O, 2012, ANIM COGN, V15, P689, DOI 10.1007/s10071-012-0497-7; Powell SB, 2004, BEHAV BRAIN RES, V152, P341, DOI 10.1016/j.bbr.2003.10.020; Presti MF, 2005, BEHAV BRAIN RES, V157, P363, DOI 10.1016/j.bbr.2004.08.003; Redbo I, 1998, PHYSIOL BEHAV, V64, P273, DOI 10.1016/S0031-9384(98)00059-6; Richter SH, 2012, COGN AFFECT BEHAV NE, V12, P527, DOI 10.3758/s13415-012-0101-2; Rodgers RJ, 1997, BEHAV PHARMACOL, V8, P477, DOI 10.1097/00008877-199711000-00003; Rommen J, 2014, EFFECTS 2 DIFFERENT; ROWAN AN, 1990, FUND APPL TOXICOL, V15, P25, DOI 10.1016/0272-0590(90)90159-H; Roy V, 2004, BEHAV BRAIN RES, V154, P439, DOI 10.1016/j.bbr.2004.03.010; Rygula R, 2014, EUR NEUROPSYCHOPHARM, V24, P1103, DOI 10.1016/j.euroneuro.2014.01.012; Rygula R, 2013, NEUROPSYCHOPHARMACOL, V38, P2188, DOI 10.1038/npp.2013.116; Schmidt MV, 2010, HORM BEHAV, V57, P415, DOI 10.1016/j.yhbeh.2010.01.010; Steiner H, 1998, EXP BRAIN RES, V123, P60, DOI 10.1007/s002210050545; Stuart SA, 2013, NEUROPSYCHOPHARMACOL, V38, P1625, DOI 10.1038/npp.2013.69; Taylor K, 2008, ATLA-ALTERN LAB ANIM, V36, P327, DOI 10.1177/026119290803600310; Tilly SLC, 2010, ANIM BEHAV, V80, P363, DOI 10.1016/j.anbehav.2010.06.008; Vestergaard KS, 1997, PHYSIOL BEHAV, V62, P413, DOI 10.1016/S0031-9384(97)00041-3; Vickery SS, 2005, APPL ANIM BEHAV SCI, V91, P247, DOI 10.1016/j.applanim.2005.01.005; Voikar V, 2004, GENES BRAIN BEHAV, V3, P27, DOI 10.1046/j.1601-183X.2003.0044.x; Wiedenmayer C, 1997, BEHAV PROCESS, V39, P215, DOI 10.1016/S0376-6357(96)00751-6; Wurbel H, 1996, ETHOLOGY, V102, P371; Wurbel H, 1997, ANIM BEHAV, V53, P891, DOI 10.1006/anbe.1996.0424; Wurbel H, 1998, BEHAV PROCESS, V43, P61, DOI 10.1016/S0376-6357(97)00086-7	73	27	27	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130718	10.1371/journal.pone.0130718	http://dx.doi.org/10.1371/journal.pone.0130718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154309	Green Published, gold			2022-12-27	WOS:000358159700036
J	Paparazzo, F; Tellier, A; Stephan, W; Hutter, S				Paparazzo, Francesco; Tellier, Aurelien; Stephan, Wolfgang; Hutter, Stephan			Survival Rate and Transcriptional Response upon Infection with the Generalist Parasite Beauveria bassiana in a World-Wide Sample of Drosophila melanogaster	PLOS ONE			English	Article							GENETIC-VARIATION; GEOGRAPHICAL VARIATION; NATURAL-SELECTION; IMMUNE-RESPONSE; LIFE-HISTORY; HOST; RESISTANCE; EVOLUTION; POPULATIONS; EXPRESSION	The ability to cope with infection by a parasite is one of the major challenges for any host species and is a major driver of evolution. Parasite pressure differs between habitats. It is thought to be higher in tropical regions compared to temporal ones. We infected Drosophila melanogaster from two tropical (Malaysia and Zimbabwe) and two temperate populations (the Netherlands and North Carolina) with the generalist entomopathogenic fungus Beauveria bassiana to examine if adaptation to local parasite pressures led to differences in resistance. Contrary to previous findings we observed increased survival in temperate populations. This, however, is not due to increased resistance to infection per se, but rather the consequence of a higher general vigor of the temperate populations. We also assessed transcriptional response to infection within these flies eight and 24 hours after infection. Only few genes were induced at the earlier time point, most of which are involved in detoxification. In contrast, we identified more than 4,000 genes that changed their expression state after 24 hours. This response was generally conserved over all populations with only few genes being uniquely regulated in the temperate populations. We furthermore found that the American population was transcriptionally highly diverged from all other populations concerning basal levels of gene expression. This was particularly true for stress and immune response genes, which might be the genetic basis for their elevated vigor.	[Paparazzo, Francesco; Stephan, Wolfgang; Hutter, Stephan] Univ Munich, Dept Biol 2, D-82152 Planegg Martinsried, Germany; [Tellier, Aurelien] Tech Univ Munich, Sect Populat Genet, D-85354 Freising Weihenstephan, Germany	University of Munich; Technical University of Munich	Hutter, S (corresponding author), Univ Munich, Dept Biol 2, D-82152 Planegg Martinsried, Germany.	hutter@bio.lmu.de	Tellier, Aurelien/C-3852-2017; Stephan, Wolfgang/GOV-6503-2022	Tellier, Aurelien/0000-0002-8895-0785; Hutter, Stephan/0000-0003-2432-8898	Deutsche Forschungsgemeinschaft from Priority Program 1399 [HU 1776/1-1]	Deutsche Forschungsgemeinschaft from Priority Program 1399	This research was supported by the Deutsche Forschungsgemeinschaft (www.dfg.de) grant HU 1776/1-1 from the Priority Program 1399 to SH and WS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apidianakis Y, 2005, P NATL ACAD SCI USA, V102, P2573, DOI 10.1073/pnas.0409588102; Valencia JWA, 2011, CURR MICROBIOL, V63, P306, DOI 10.1007/s00284-011-9977-2; Beaver LM, 2010, TOXICOL SCI, V115, P513, DOI 10.1093/toxsci/kfq083; BEGUN DJ, 1993, NATURE, V365, P548, DOI 10.1038/365548a0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bubliy OA, 2000, GENETICA, V110, P79, DOI 10.1023/A:1017990814142; Buteler M, 2011, PESTICIDES IN THE MODERN WORLD - PESTICIDES USE AND MANAGEMENT, P119; Clancy David J., 2001, Drosophila Information Service, V84, P168; COHET Y, 1980, J THERM BIOL, V5, P69, DOI 10.1016/0306-4565(80)90002-9; Corby-Harris V, 2008, J ANIM ECOL, V77, P768, DOI 10.1111/j.1365-2656.2008.01399.x; Cornet S, 2009, OECOLOGIA, V159, P257, DOI 10.1007/s00442-008-1211-y; COX DR, 1972, J R STAT SOC B, V34, P187; DAVID JR, 1988, TRENDS GENET, V4, P106, DOI 10.1016/0168-9525(88)90098-4; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Duchen P, 2013, GENETICS, V193, P291, DOI 10.1534/genetics.112.145912; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gibert P, 2004, GENETICA, V120, P165, DOI 10.1023/B:GENE.0000017639.62427.8b; Gillespie JP, 2000, ARCH INSECT BIOCHEM, V44, P49, DOI 10.1002/1520-6327(200006)44:2&lt;49::AID-ARCH1&gt;3.0.CO;2-F; Glinka S, 2005, J GENET, V84, P173, DOI 10.1007/BF02715842; Glinka S, 2003, GENETICS, V165, P1269; Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794; Haddrill PR, 2005, GENOME RES, V15, P790, DOI 10.1101/gr.3541005; Hoffmann AA, 1999, HEREDITY, V83, P637, DOI 10.1038/sj.hdy.6886490; Horrocks NPC, 2012, PHYSIOL BIOCHEM ZOOL, V85, P504, DOI 10.1086/666988; Hutter S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r12; Jordan KW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r172; Kawecki TJ, 1998, AM NAT, V152, P635, DOI 10.1086/286195; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Klein JP, 2003, SURVIVAL ANAL TECHNI, Vxv; Kraaijeveld AR, 1999, AM NAT, V153, pS61, DOI 10.1086/303212; LANGE BW, 1990, GENETICS, V126, P921; Laurent SJY, 2011, MOL BIOL EVOL, V28, P2041, DOI 10.1093/molbev/msr031; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lockyer AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051102; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lovegrove FE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-295; Luong LT, 2007, J EVOLUTION BIOL, V20, P79, DOI 10.1111/j.1420-9101.2006.01226.x; McDade TW, 2003, YEARB PHYS ANTHROPOL, V46, P100, DOI 10.1002/ajpa.10398; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Moller AP, 2006, OIKOS, V115, P463, DOI 10.1111/j.2006.0030-1299.15312.x; Moller AP, 1998, OIKOS, V82, P265, DOI 10.2307/3546966; Moscou MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002208; Muller L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-81; Obbard DJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000698; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Okado K, 2009, BIOCHEM BIOPH RES CO, V379, P6, DOI 10.1016/j.bbrc.2008.11.097; Parkash R, 2008, J INSECT PHYSIOL, V54, P1050, DOI 10.1016/j.jinsphys.2008.04.008; Parvez H., 2001, MOLECULAR RESPONSES; Polesani M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-117; R Core Team, 2013, R LANG ENV STAT COMP; Roxstrom-Lindquist K, 2004, EMBO REP, V5, P207, DOI 10.1038/sj.embor.7400073; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Schlotterer C, 1997, GENETICS, V146, P309; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Schulenburg H, 2009, PHILOS T R SOC B, V364, P3, DOI 10.1098/rstb.2008.0249; Sedlazeck FJ, 2013, BIOINFORMATICS, V29, P2790, DOI 10.1093/bioinformatics/btt468; Shirasu-Hiza MM, 2007, CURR BIOL, V17, pR353, DOI 10.1016/j.cub.2007.03.049; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Stephan W, 2007, HEREDITY, V98, P65, DOI 10.1038/sj.hdy.6800901; Stone EF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002445; Thompson J. N., 2005, INTERSPEC INTERACT; Tinsley MC, 2006, PARASITOLOGY, V132, P767, DOI 10.1017/S0031182006009929; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Ulvila J, 2011, APMIS, V119, P651, DOI 10.1111/j.1600-0463.2011.02792.x; Wilfert L, 2013, EVOLUTION, V67, P761, DOI 10.1111/j.1558-5646.2012.01832.x; Williams KD, 2009, CURR BIOL, V19, pR63, DOI 10.1016/j.cub.2008.11.035; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131	70	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0132129	10.1371/journal.pone.0132129	http://dx.doi.org/10.1371/journal.pone.0132129			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154519	Green Published, gold			2022-12-27	WOS:000358159700089
J	Pavlova, MA; Scheffler, K; Sokolov, AN				Pavlova, Marina A.; Scheffler, Klaus; Sokolov, Alexander N.			Face-n-Food: Gender Differences in Tuning to Faces	PLOS ONE			English	Article							FACIAL EMOTION RECOGNITION; SEX-DIFFERENCES; PERCEPTION; CHILDREN; EXPRESSIONS; INTENSITY; ADHD; FEAR; EPIDEMIOLOGY; PERFORMANCE	Faces represent valuable signals for social cognition and non-verbal communication. A wealth of research indicates that women tend to excel in recognition of facial expressions. However, it remains unclear whether females are better tuned to faces. We presented healthy adult females and males with a set of newly created food-plate images resembling faces (slightly bordering on the Giuseppe Arcimboldo style). In a spontaneous recognition task, participants were shown a set of images in a predetermined order from the least to most resembling a face. Females not only more readily recognized the images as a face (they reported resembling a face on images, on which males still did not), but gave on overall more face responses. The findings are discussed in the light of gender differences in deficient face perception. As most neuropsychiatric, neurodevelopmental and psychosomatic disorders characterized by social brain abnormalities are sex specific, the task may serve as a valuable tool for uncovering impairments in visual face processing.	[Pavlova, Marina A.; Scheffler, Klaus] Univ Tubingen, Sch Med, Dept Biomed Magnet, Tubingen, Germany; [Scheffler, Klaus] Max Planck Inst Biol Cybernet, High Field Magnet Resonance Ctr, D-72076 Tubingen, Germany; [Sokolov, Alexander N.] Univ Tubingen, Univ Hosp, Womens Hlth Res Inst, Dept Womens Hlth, Tubingen, Germany	Eberhard Karls University of Tubingen; Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Pavlova, MA (corresponding author), Univ Tubingen, Sch Med, Dept Biomed Magnet, Tubingen, Germany.	marina.pavlova@uni-tuebingen.de		Scheffler, Klaus/0000-0001-6316-8773; Pavlova, Marina/0000-0001-8239-3589	Else Kroner-Fresenius Foundation [P2013_127]; Reinhold Beitlich Foundation; Heidehof Foundation [59073.01.1/3.13]	Else Kroner-Fresenius Foundation; Reinhold Beitlich Foundation; Heidehof Foundation	This work was made possible by financial support from the Else Kroner-Fresenius Foundation (Grant P2013_127 to MAP), the Reinhold Beitlich Foundation, and the Heidehof Foundation (grant 59073.01.1/3.13). The authors greatly appreciate donation made by Dr. Michael Klett. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors acknowledge support toward open access publishing by the Deutsche Forschungsgemeinschaft (DFG) and the Open Access Publishing Fund of Eberhard Karls University of Tubingen.	Alaerts K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020989; Anderson LC, 2013, NEUROIMAGE, V83, P751, DOI 10.1016/j.neuroimage.2013.07.040; Arrais KC, 2010, J PSYCHIATR RES, V44, P535, DOI 10.1016/j.jpsychires.2009.11.003; Beesdo-Baum K, 2012, CHILD ADOL PSYCH CL, V21, P457, DOI 10.1016/j.chc.2012.05.001; Biele C, 2006, EXP BRAIN RES, V171, P1, DOI 10.1007/s00221-005-0254-0; Bloom B, 2012, VITAL HLTH STAT, V10, P10; Bourne VJ, 2005, NEUROPSYCHOLOGIA, V43, P953, DOI 10.1016/j.neuropsychologia.2004.08.007; BOYATZIS CJ, 1993, J GENET PSYCHOL, V154, P375; Briceno EM, 2015, AM J GERIAT PSYCHIAT, V23, P304, DOI 10.1016/j.jagp.2014.05.007; Bruce V, 1988, RECOGNISING FACES; Buchala S, 2005, PROC IEEE ICMI, V7; Campbell R, 2002, NEUROPSYCHOLOGIA, V40, P575, DOI 10.1016/S0028-3932(01)00164-6; Coffman MC, 2015, J AUTISM DEV DISORD, V45, P589, DOI 10.1007/s10803-013-2006-5; Collignon O, 2010, NEUROPSYCHOLOGIA, V48, P220, DOI 10.1016/j.neuropsychologia.2009.09.007; Craske M. G., 2003, ORIGINS OF PHOBIAS A; Derntl B, 2009, PSYCHONEUROENDOCRINO, V34, P687, DOI 10.1016/j.psyneuen.2008.11.007; Diflorio A, 2010, INT REV PSYCHIATR, V22, P437, DOI 10.3109/09540261.2010.514601; Farzin F, 2009, J VISION, V9, DOI 10.1167/9.6.18; Fazzi E, 2009, DEV MED CHILD NEUROL, V51, P974, DOI 10.1111/j.1469-8749.2009.03272.x; Feuerriegel D, 2015, CLIN NEUROPHYSIOL, V126, P1141, DOI 10.1016/j.clinph.2014.09.015; FOREMAN N, 1991, J GEN PSYCHOL, V118, P13, DOI 10.1080/00221309.1991.9711129; Gilboa-Schechtman E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00904; Golan O, 2006, J AUTISM DEV DISORD, V36, P169, DOI 10.1007/s10803-005-0057-y; Goos LM, 2002, J NONVERBAL BEHAV, V26, P27, DOI 10.1023/A:1014418503754; Hadjikhani N, 2009, NEUROREPORT, V20, P403, DOI 10.1097/WNR.0b013e328325a8e1; Hall JA, 2004, EMOTION, V4, P201, DOI 10.1037/1528-3542.4.2.201; HALL JA, 1978, PSYCHOL BULL, V85, P845, DOI 10.1037/0033-2909.85.4.845; Halliday DWR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094013; Hampson E, 2006, EVOL HUM BEHAV, V27, P401, DOI 10.1016/j.evolhumbehav.2006.05.002; Han DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091214; Hoffmann H, 2010, ACTA PSYCHOL, V135, P278, DOI 10.1016/j.actpsy.2010.07.012; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Ino T, 2010, BRAIN IMAGING BEHAV, V4, P55, DOI 10.1007/s11682-009-9085-0; Jones Lynne, 2008, Eat Behav, V9, P389, DOI 10.1016/j.eatbeh.2008.03.001; Kana RK, 2012, SOC COGN AFFECT NEUR, V7, P446, DOI 10.1093/scan/nsr022; Killgore WDS, 2001, NEUROREPORT, V12, P427, DOI 10.1097/00001756-200102120-00047; Kochel A, 2014, J CHILD NEUROL, V29, P459, DOI 10.1177/0883073813476139; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Kret ME, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00003; Kruger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081716; Kucharska-Pietura K, 2004, INT J EAT DISORDER, V35, P42, DOI 10.1002/eat.10219; Kuhnpast N, 2012, PSYCHOSOM MED, V74, P736, DOI 10.1097/PSY.0b013e31825ca15a; Lai MC, 2013, BRAIN, V136, P2799, DOI 10.1093/brain/awt216; Lazar SM, 2014, BEHAV BRAIN RES, V263, P1, DOI 10.1016/j.bbr.2014.01.010; Legenbauer T, 2008, J CLIN PSYCHOL, V64, P687, DOI 10.1002/jclp.20483; Lewin C, 2002, BRAIN COGNITION, V50, P121, DOI 10.1016/S0278-2626(02)00016-7; Liu JG, 2014, CORTEX, V53, P60, DOI 10.1016/j.cortex.2014.01.013; LoBue V, 2009, DEVELOPMENTAL SCI, V12, P305, DOI 10.1111/j.1467-7687.2008.00767.x; MANDAL MK, 1985, PERCEPT MOTOR SKILL, V60, P96, DOI 10.2466/pms.1985.60.1.96; Marsh PJ, 2006, NEUROSCI BIOBEHAV R, V30, P651, DOI 10.1016/j.neubiorev.2005.11.004; McBain R, 2009, ACTA PSYCHOL, V130, P168, DOI 10.1016/j.actpsy.2008.12.005; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; Montagne Barbara, 2005, Cogn Process, V6, P136, DOI 10.1007/s10339-005-0050-6; Nelson NL, 2011, J EXP CHILD PSYCHOL, V110, P52, DOI 10.1016/j.jecp.2011.03.014; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; NOWICKI S, 1988, J SOC PSYCHOL, V128, P363, DOI 10.1080/00224545.1988.9713753; Okazaki Y, 2010, BRAIN TOPOGR, V23, P14, DOI 10.1007/s10548-009-0112-7; Pavlova M, 2010, NEUROIMAGE, V50, P1327, DOI 10.1016/j.neuroimage.2009.12.096; Pavlova MA, 2015, CEREB CORTEX, V25, P3468, DOI 10.1093/cercor/bhu175; Pavlova MA, 2013, BRAIN, V136, P998, DOI 10.1093/brain/aws334; Pavlova MA, 2012, CEREB CORTEX, V22, P981, DOI 10.1093/cercor/bhr156; Picchioni MM, 2007, BMJ-BRIT MED J, V335, P91, DOI 10.1136/bmj.39227.616447.BE; Pollatos O, 2008, PSYCHOSOM MED, V70, P701, DOI 10.1097/PSY.0b013e31817e41e6; Proverbio AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011242; Rahko J, 2010, BRAIN IMAGING BEHAV, V4, P164, DOI 10.1007/s11682-010-9096-x; Rehnman J, 2006, MEMORY, V14, P289, DOI 10.1080/09658210500233581; Rehnman J, 2007, ACTA PSYCHOL, V124, P344, DOI 10.1016/j.actpsy.2006.04.004; Rhodes G, 2013, NEUROPSYCHOLOGIA, V51, P2702, DOI 10.1016/j.neuropsychologia.2013.08.016; Ridout N, 2012, APPETITE, V59, P181, DOI 10.1016/j.appet.2012.04.013; Rose SA, 2002, DEV PSYCHOL, V38, P895, DOI 10.1037//0012-1649.38.6.895; ROTTER NG, 1988, J NONVERBAL BEHAV, V12, P139, DOI 10.1007/BF00986931; Sokolov AA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00016; Thayer JF, 2000, SCAND J PSYCHOL, V41, P243, DOI 10.1111/1467-9450.00193; Tiedt HO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069107; Uekermann J, 2010, NEUROSCI BIOBEHAV R, V34, P734, DOI 10.1016/j.neubiorev.2009.10.009; Verhallen RJ, 2014, NEUROPSYCHOLOGIA, V63, P19, DOI 10.1016/j.neuropsychologia.2014.08.011; WAGNER HL, 1986, J PERS SOC PSYCHOL, V50, P737, DOI 10.1037/0022-3514.50.4.737; Weigelt S, 2012, NEUROSCI BIOBEHAV R, V36, P1060, DOI 10.1016/j.neubiorev.2011.12.008; Wild B, 2001, PSYCHIAT RES, V102, P109, DOI 10.1016/S0165-1781(01)00225-6; Yuill N, 2007, EUR CHILD ADOLES PSY, V16, P398, DOI 10.1007/s00787-007-0612-5	80	24	25	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130363	10.1371/journal.pone.0130363	http://dx.doi.org/10.1371/journal.pone.0130363			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26154177	gold, Green Published, Green Submitted			2022-12-27	WOS:000358159700032
J	van der Veer, SN; Haller, MC; Pittens, CACM; Broerse, J; Castledine, C; Gallieni, M; Inston, N; Monros, AM; Peek, N; van Biesen, W				van der Veer, Sabine N.; Haller, Maria C.; Pittens, Carina A. C. M.; Broerse, Jacqueline; Castledine, Clare; Gallieni, Maurizio; Inston, Nicholas; Monros, Anna Marti; Peek, Niels; van Biesen, Wim			Setting Priorities for Optimizing Vascular Access Decision Making - An International Survey of Patients and Clinicians	PLOS ONE			English	Article							PRACTICE GUIDELINES; ARTERIOVENOUS-FISTULA; VIEWS; CARE	Background Many decisions around vascular access for haemodialysis warrant a collaborative treatment decision-making process, involving both clinician and patient. Yet, patients' experiences in this regard have been suboptimal. Although clinical practice guidelines could facilitate collaborative decision making, they often focus on the clinicians' side of the process, while failing to address the patients' perspective. The objective of this study was to explore and compare kidney patients' and clinicians' views on what vascular access-related decisions deserved priority for developing guidelines that will contribute to optimizing collaborative decision making. Methods In the context of updating their vascular access guideline, European Renal Best Practice surveyed an international panel of 85 kidney patients, 687 nephrologists, 194 nurses, and 140 surgeons/radiologists. In an electronic questionnaire, respondents rated 42 vascular access-related topics on a 5-point Likert scale. Based on mean standardized ratings, we compared priority ratings between patients and each clinician group. Results Selection of access type and site, as well as prevention of access infections received top priority across all respondent groups. Patients generally assigned higher priority to decisions regarding managing adverse effects of arteriovenous access and patient involvement in care, while clinicians more often prioritized decisions around sustaining patients' access options, technical aspects of access creation, and optimizing fistula maturation and patency. Conclusion Apart from identifying the most pressing knowledge gaps, our study provides pointers for developing guidelines that may improve healthcare professionals' understanding of when to involve patients along the vascular access pathway.	[van der Veer, Sabine N.; Haller, Maria C.; van Biesen, Wim] Univ Hosp Ghent, ERBP Methods Support Team, Ghent, Belgium; [van der Veer, Sabine N.; Peek, Niels] Univ Manchester, Inst Populat Hlth, Hlth E Res Ctr, Manchester, Lancs, England; [Haller, Maria C.] Med Univ Vienna, Sect Clin Biometr, Ctr Med Stat Informat & Intelligent Syst CeMSIIS, Vienna, Austria; [Haller, Maria C.] Krankenhaus Elisabethinen, Dept Internal Med Nephrol & Hypertens Dis Traspla, Linz, Austria; [Pittens, Carina A. C. M.; Broerse, Jacqueline] Vrije Univ Amsterdam, Athena Inst Res Innovat & Commun Hlth & Life Sci, Amsterdam, Netherlands; [Castledine, Clare] Brighton & Sussex Univ Hosp, Sussex Kidney Unit, Brighton, E Sussex, England; [Gallieni, Maurizio] VAS, Maastricht, Netherlands; [Gallieni, Maurizio] Osped San Carlo Borromeo Milano, Nephrol & Dialysis Unit, Milan, Italy; [Inston, Nicholas] VASBI, Glasgow, Lanark, Scotland; [Inston, Nicholas] Queen Elizabeth Hosp, Dept Renal Transplantat & Renal Surg, Birmingham B15 2TH, W Midlands, England; [Monros, Anna Marti] CHGU Valencia, Dept Nephrol, Valencia, Spain; [van Biesen, Wim] Univ Hosp, Div Renal, Ghent, Belgium	Ghent University; Ghent University Hospital; University of Manchester; Medical University of Vienna; Ordensklinikum Linz Elisabethinen; Vrije Universiteit Amsterdam; Brighton and Sussex University Hospitals NHS Trust; San Carlo Borromeo Hospital; University of Birmingham; Ghent University; Ghent University Hospital	van der Veer, SN (corresponding author), Univ Hosp Ghent, ERBP Methods Support Team, Ghent, Belgium.	sabine.vanderveer@manchester.ac.uk	Haller, Maria C./S-8390-2019; Gallieni, Maurizio/H-2895-2019; Peek, Niels/AAD-9334-2019	Haller, Maria C./0000-0003-4635-6291; Gallieni, Maurizio/0000-0002-2011-2160; Peek, Niels/0000-0002-6393-9969; van der Veer, Sabine/0000-0003-0929-436X; castledine, clare/0000-0003-0699-1653	European Renal Association-European Dialysis Transplantation Association (ERA-EDTA); Medical Research Council [MR/K006665/1, MC_PC_13042] Funding Source: researchfish; MRC [MR/K006665/1] Funding Source: UKRI	European Renal Association-European Dialysis Transplantation Association (ERA-EDTA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	SV and MH are fellows of the Methods Support Team of European Renal Best Practice (ERBP), supported by a grant of the European Renal Association-European Dialysis Transplantation Association (ERA-EDTA; www.era-edta.org). The funder enabled dissemination of the survey among ERA-EDTA members.	Ahmad N, 2014, BRINGING EVIDENCE SH; Altman DG, 1991, PRACTICAL STAT MED R, P54; Brouwers MC, 2010, J CLIN EPIDEMIOL, V63, P1308, DOI 10.1016/j.jclinepi.2010.07.001; Casey JR, 2014, AM J KIDNEY DIS, V64, P937, DOI 10.1053/j.ajkd.2014.06.024; Charles C, 1999, SOC SCI MED, V49, P651, DOI 10.1016/S0277-9536(99)00145-8; Chin GK, 2012, KHA CARI GUIDELINE P; Dember LM, 2014, AM J KIDNEY DIS, V63, P104, DOI 10.1053/j.ajkd.2013.06.024; Eccles MP, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-60; Fissell RB, 2013, J VASC ACCESS, V14, P264, DOI 10.5301/jva.5000140; Fluck R, 2011, UK REN ASS CLIN PRAC; Flynn KE, 2006, SOC SCI MED, V63, P1158, DOI 10.1016/j.socscimed.2006.03.030; Graham R, 2011, CLIN PRACT GUIDELINE; Guidelines International Network (GIN) Public Working Group, 2012, GIN PUBLIC TOOLK PAT; Haller MC, 2015, NEPHROL DIAL TRANSPL, V30, P1066, DOI 10.1093/ndt/gfu288; Institute of Medicine, 2001, CROSS QUAL CHASM; Legare F, 2008, PATIENT EDUC COUNS, V73, P526, DOI 10.1016/j.pec.2008.07.018; Lopez-Vargas P, 2012, KHA CARI GUIDELINE S; Lopez-Vargas P, 2012, KHA CARI GUIDELINE N; Manns B, 2014, CLIN J AM SOC NEPHRO, V9, P1813, DOI 10.2215/CJN.01610214; Morton RL, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c112; Moura A, 2014, J VASC ACCESS, V15, P175, DOI 10.5301/jva.5000182; National Kidney Foundation Kidney Disease Outcomes Quality Initiative, 2006, 2006 UPD CLIN PRACT, P227; Polkinghorne KR, 2013, NEPHROLOGY, V18, P701, DOI 10.1111/nep.12132; Quinn RR, 2008, J VASC ACCESS, V9, P122, DOI 10.1177/112972980800900208; Raats CJI, 2008, PATIENT EDUC COUNS, V73, P413, DOI 10.1016/j.pec.2008.07.038; Ravani P, 2013, J AM SOC NEPHROL, V24, P465, DOI 10.1681/ASN.2012070643; ReDVA research collaboration, 2013, DEV HEM SOL REN DIAL; Sousa CN, 2014, J CLIN NURS, V23, P1796, DOI 10.1111/jocn.12207; Streiner DL, 2003, HLTH MEASUREMENT SCA, P93; Tong A, 2012, HEALTH EXPECT, V15, P410, DOI 10.1111/j.1369-7625.2011.00676.x; Tordoir J, 2007, NEPHROL DIAL TRANSPL, V22, P88, DOI 10.1093/ndt/gfm021; Van Biesen W, 2013, NEPHROL DIAL TRANSPL, V28, P1980, DOI 10.1093/ndt/gft291; van der Weijden T, 2013, BMJ QUAL SAF, V22, P855, DOI 10.1136/bmjqs-2012-001502; Wong CS, 2013, J VASC SURG, V57, P1129, DOI 10.1016/j.jvs.2012.11.094; Wyatt KD, 2014, MED CARE, V52, pS92, DOI 10.1097/MLR.0b013e3182a51b3d; Xi W, 2011, NEPHROL DIAL TRANSPL, V26, P3302, DOI 10.1093/ndt/gfr055	37	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0128228	10.1371/journal.pone.0128228	http://dx.doi.org/10.1371/journal.pone.0128228			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EC	26151822	Green Published, Green Submitted, gold			2022-12-27	WOS:000358158900004
J	Allaire, SE; Sylvain, C; Lange, SF; Theriault, G; Lafrance, P				Allaire, Suzanne Edith; Sylvain, Claudia; Lange, Sebastien F.; Theriault, George; Lafrance, Pierre			Potential Efficiency of Riparian Vegetated Buffer Strips in Intercepting Soluble Compounds in the Presence of Subsurface Preferential Flows	PLOS ONE			English	Article							MACROPORE CHARACTERISTICS; AGRICULTURAL LANDSCAPES; SORPTION COEFFICIENTS; SOLUTE MOVEMENT; SOIL; CATCHMENT; WATER; ADSORPTION; MANAGEMENT; LIKELIHOOD	Buffer strips have been widely recognized as to promote infiltration, deposition and sorption of contaminants for protecting surface water against agricultural contamination. However, such strips do not intercept all contaminants, particularly soluble ones. Although preferential flow (PF) has been suggested as one factor among several decreasing the efficiency of buffer strips, the mechanisms involved are not well understood. This project examines buffer strip efficiency at intercepting solutes when subsurface PF occurs. Two soluble sorbed tracers, FD&C Blue #1 and rhodamine WT, were applied on an agricultural sandy loam soil to evaluate the ability of a naturally vegetated buffer strip to intercept soluble contaminants. Rhodamine was applied about 15 m from the creek, while the Blue was applied 15 m to 165 m from the creek. Tracer concentration was measured over a two-year period in both the creek and the buffer strip through soil and water samples. Although the tracers traveled via different pathways, they both quickly moved toward the creek, passing beneath the buffer strip through the soil matrix. Our results demonstrate that the risk of water contamination by soluble contaminants is high in such systems, even when a well-vegetated buffer strip is used. The design of buffer strips should be modified to account for underground bypass, either by using plants that have deep, fine roots that do not favour PF or by adding a filter extending deep underground that can be regularly changed.	[Allaire, Suzanne Edith; Sylvain, Claudia; Lange, Sebastien F.] Univ Laval, Dept Sols & Genie Agroalimentaire, Quebec City, PQ, Canada; [Theriault, George] Agr & Agri Food Canada, Soils & Crops Res & Dev Ctr, Quebec City, PQ, Canada; [Lafrance, Pierre] Ctr Eau Terre Environm, Inst Natl Rech Sci, Quebec City, PQ, Canada	Laval University; Agriculture & Agri Food Canada; University of Quebec; Institut national de la recherche scientifique (INRS)	Allaire, SE (corresponding author), Univ Laval, Dept Sols & Genie Agroalimentaire, Quebec City, PQ, Canada.	suzanne.allaire@fsaa.ulaval.ca			Agriculture and AgriFood Canada; NSERC Discovry grant	Agriculture and AgriFood Canada(Agriculture & Agri Food Canada); NSERC Discovry grant	This work was supported by the Agriculture and AgriFood Canada to GT and the NSERC Discovry grant to SEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Zreig M, 2003, J ENVIRON QUAL, V32, P613, DOI 10.2134/jeq2003.0613; Allaire SE, 2011, J HYDROL, V403, P261, DOI 10.1016/j.jhydrol.2011.04.005; Allaire SE, 2009, J HYDROL, V378, P179, DOI 10.1016/j.jhydrol.2009.08.013; Allaire-Leung SE, 2000, J CONTAM HYDROL, V41, P283, DOI 10.1016/S0169-7722(99)00079-0; Allaire-Leung SE, 2000, J CONTAM HYDROL, V41, P303, DOI 10.1016/S0169-7722(99)00074-1; Allaire-Leung SE, 1999, J ENVIRON QUAL, V28, P1831, DOI 10.2134/jeq1999.00472425002800060020x; Anderson AE, 2005, EOS T AM GEOPHYS U S, V86; ANDERSON MG, 1990, PROCESS STUDIES HILL; BACHE BW, 1971, J SOIL SCI, V22, P289, DOI 10.1111/j.1365-2389.1971.tb01617.x; BARLING RD, 1994, ENVIRON MANAGE, V18, P543, DOI 10.1007/BF02400858; Blake GR, 1986, ASA MONOGR, V9, P362; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Burt TP, 2005, PROG PHYS GEOG, V29, P297, DOI 10.1191/0309133305pp450ra; Correll D, 2002, VEGETATIVE STREAM RI; CPVQ (Conseil des productions vegetales du Quebec), 1997, METH AN SOLS FUM TIS, V533; Dadfar H, 2010, J HYDROL, V386, P142, DOI 10.1016/j.jhydrol.2010.03.016; Dadfar H, 2010, CAN J SOIL SCI, V90, P129, DOI 10.4141/CJSS09066; DILLAHA TA, 1989, T ASAE, V32, P513, DOI 10.13031/2013.31033; Dorioz JM, 2006, AGR ECOSYST ENVIRON, V117, P4, DOI 10.1016/j.agee.2006.03.029; FIHOQ (Federation Interdisciplinaire de l'Horticulture Ornementale du Quebec), 2013, GUID BONN PRAT AM TE; Flury M, 2003, REV GEOPHYS, V41, DOI 10.1029/2001RG000109; FLURY M, 1995, SOIL SCI SOC AM J, V59, P22, DOI 10.2136/sssaj1995.03615995005900010003x; Hickey MBC, 2004, WATER QUAL RES J CAN, V39, P311, DOI 10.2166/wqrj.2004.042; Jin C-X, 2000, T AM SOC AGR ENG, V42, P1679; Ketelsen H, 1999, GEODERMA, V90, P131, DOI 10.1016/S0016-7061(98)00119-0; Klute A., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P687; Kookana RS, 2008, J AGR FOOD CHEM, V56, P3208, DOI 10.1021/jf073152n; Lacas JG, 2005, AGRON SUSTAIN DEV, V25, P253, DOI 10.1051/agro:2005001; Lamontagne L., 2010, ETUDE PEDOLOGIQUE BA; Liu XM, 2008, J ENVIRON QUAL, V37, P1667, DOI 10.2134/jeq2007.0437; McKergow LA, 2003, J HYDROL, V270, P253, DOI 10.1016/S0022-1694(02)00286-X; McLean E., 1983, METHODS SOIL ANAL PA, V9, P199, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C12; MDDELCC (Ministere du Developpement Durable de l'Environnement et de la Lutte aux changements Climatiques), 2009, PORTR QUAL EAUX SURF; Michaud AR, 2009, RESEAU ACTIONS CONCE; Polyakov Viktor, 2005, Environmental Reviews, V13, P129, DOI 10.1139/a05-010; Qi HH, 2011, WATER RESOUR MANAG, V25, P565, DOI 10.1007/s11269-010-9714-9; Roberts WM, 2012, J ENVIRON QUAL, V41, P389, DOI 10.2134/jeq2010.0543; SABATINI DA, 1991, GROUND WATER, V29, P341, DOI 10.1111/j.1745-6584.1991.tb00524.x; Sidle RC, 2001, HYDROL PROCESS, V15, P1675, DOI 10.1002/hyp.233; Simunek J, 2003, J HYDROL, V272, P14, DOI 10.1016/S0022-1694(02)00252-4; TRUDGILL ST, 1987, HYDROL PROCESS, V1, P149, DOI 10.1002/hyp.3360010204; Uchida T, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000261; Uhlenbrook S, 2006, HYDROL PROCESS, V20, P3581, DOI 10.1002/hyp.6564; Viaud V, 2004, ENVIRON MANAGE, V34, P559, DOI 10.1007/s00267-004-0271-y; Weber JB, 2004, CHEMOSPHERE, V55, P157, DOI 10.1016/j.chemosphere.2003.10.049; Wenger S., 1999, REV SCI LIT RIPARIAN; Wierenga PJ, 1986, AGRONOMY MON, V9; Zhang XY, 2010, J ENVIRON QUAL, V39, P76, DOI 10.2134/jeq2008.0496	48	12	13	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131840	10.1371/journal.pone.0131840	http://dx.doi.org/10.1371/journal.pone.0131840			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147093	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600151
J	Booij, SH; Bos, EH; Bouwmans, MEJ; van Faassen, M; Kema, IP; Oldehinkel, AJ; de Jonge, P				Booij, Sanne H.; Bos, Elisabeth H.; Bouwmans, Mara E. J.; van Faassen, Martijn; Kema, Ido P.; Oldehinkel, Albertine J.; de Jonge, Peter			Cortisol and alpha-Amylase Secretion Patterns between and within Depressed and Non-Depressed Individuals	PLOS ONE			English	Article							SALIVARY CORTISOL; HPA AXIS; STRESS; DISORDERS; HUMANS; SYSTEM; DYSREGULATIONS; DETERMINANTS; PSYCHOLOGY; SERTRALINE	Objectives Associations between biological stress markers and depression are inconsistent across studies. We assessed whether inter-and intra-individual variability explain these inconsistencies. Methods Pair-matched depressed and non-depressed participants (N = 30) collected saliva thrice a day for 30 days, resulting in 90 measurements per individual. The relationships between measures of stress-system function and depression were examined at the group level by means of mixed model analyses, and at the individual level by means of pair-matched comparisons. The analyses were repeated after adjusting for time-varying lifestyle factors by means of time-series regression analyses. Results Cortisol and a-amylase levels were higher, the a-amylase/cortisol ratio larger, and the daily cortisol slope steeper in the depressed compared to the non-depressed group. Adjusting for lifestyle factors and antidepressant use reduced the associations under study. In 40%-60% of the matched comparisons, depressed individuals had higher cortisol and a-amylase levels, a larger a-amylase/cortisol ratio, and a steeper daily slope than their non-depressed match, regardless of adjustment. Conclusions Our group-level findings were mostly in line with the literature but generalization to individuals appeared troublesome. Findings of studies on this topic should be interpreted with care, because in clinical practice the focus is on individuals instead of groups.	[Booij, Sanne H.; Bos, Elisabeth H.; Bouwmans, Mara E. J.; Oldehinkel, Albertine J.; de Jonge, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Bos, Elisabeth H.] Lentis, Ctr Integrat Psychiat, Groningen, Netherlands; [van Faassen, Martijn; Kema, Ido P.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen	Booij, SH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.	s.h.booij@umcg.nl	Bouwmans, Mara/A-1252-2017; de Jonge, Peter/L-6395-2013	Bouwmans, Mara/0000-0003-4930-5051; Van Faassen, Martijn/0000-0002-9142-6263; Booij, Sanne/0000-0002-0611-4784; de Jonge, Peter/0000-0002-0866-6929	NWO/ZonMW VICI-Grant [91812607]; Research School of Behavioural and Cognitive Neurosciences (BCN), University Medical Center Groningen, The Netherlands	NWO/ZonMW VICI-Grant; Research School of Behavioural and Cognitive Neurosciences (BCN), University Medical Center Groningen, The Netherlands	PdJ, EHB and MEJB are supported by a NWO/ZonMW VICI-Grant (no: 91812607; website: http://www.zonmw.nl/en/). SHB is financially supported by the Research School of Behavioural and Cognitive Neurosciences (BCN), University Medical Center Groningen, The Netherlands (website: http://www.rug.nl/research/behaviouralc-ognitive-neurosciences/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali N, 2012, PHYSIOL BEHAV, V106, P65, DOI 10.1016/j.physbeh.2011.10.003; Bauer AM, 2002, J DEV BEHAV PEDIATR, V23, P102, DOI 10.1097/00004703-200204000-00007; Beck A, 1996, MANUAL FOR THE BDI 2; Bhake R. C., 2013, Journal of Medical Engineering & Technology, V37, P180, DOI 10.3109/03091902.2013.773096; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Csikszentmihalyi M., 2006, EXPERIENCE PSYCHOPAT; Engert V, 2011, PSYCHONEUROENDOCRINO, V36, P1294, DOI 10.1016/j.psyneuen.2011.02.018; Gibson EL, 1999, PSYCHOSOM MED, V61, P214, DOI 10.1097/00006842-199903000-00014; HARTMANN DP, 1980, J APPL BEHAV ANAL, V13, P543, DOI 10.1901/jaba.1980.13-543; Heil DP, 2006, RES Q EXERCISE SPORT, V77, P64, DOI 10.5641/027013606X13080769703920; Hernandez ME, 2008, EUR NEUROPSYCHOPHARM, V18, P917, DOI 10.1016/j.euroneuro.2008.08.001; HILLIARD RB, 1993, J CONSULT CLIN PSYCH, V61, P373, DOI 10.1037/0022-006X.61.3.373; Holsboer F, 2010, ANNU REV PSYCHOL, V61, P81, DOI 10.1146/annurev.psych.093008.100321; HONAKER J, 2011, J STAT SOFTWARE, V45; Hruschka DJ, 2005, PSYCHONEUROENDOCRINO, V30, P698, DOI 10.1016/j.psyneuen.2005.03.002; Jarcho MR, 2013, BIOL PSYCHOL, V93, P150, DOI 10.1016/j.biopsycho.2013.01.018; Kalsbeek A, 2012, MOL CELL ENDOCRINOL, V349, P20, DOI 10.1016/j.mce.2011.06.042; Kudielka BM, 2009, PSYCHONEUROENDOCRINO, V34, P2, DOI 10.1016/j.psyneuen.2008.10.004; Lamiell JT, 1998, THEOR PSYCHOL, V8, P23, DOI 10.1177/0959354398081002; LAMIELL JT, 1981, AM PSYCHOL, V36, P276, DOI 10.1037/0003-066X.36.3.276; Laurent HK, 2013, PHYSIOL BEHAV, V119, P52, DOI 10.1016/j.physbeh.2013.05.019; Lightman SL, 2010, NAT REV NEUROSCI, V11, P710, DOI 10.1038/nrn2914; Lutkepohl H., 2005, NEW INTRO MULTIPLE T, DOI DOI 10.1007/078-3-540-27752-1; Manthey L, 2011, EUR NEUROPSYCHOPHARM, V21, P691, DOI 10.1016/j.euroneuro.2011.03.002; Molenaar PCM, 2009, CURR DIR PSYCHOL SCI, V18, P112, DOI 10.1111/j.1467-8721.2009.01619.x; Myin-Germeys I, 2011, SCHIZOPHRENIA BULL, V37, P244, DOI 10.1093/schbul/sbq164; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; Out D, 2013, PSYCHONEUROENDOCRINO, V38, P367, DOI 10.1016/j.psyneuen.2012.06.013; Peeters F, 2004, PSYCHIAT RES, V126, P1, DOI 10.1016/j.psychres.2003.12.010; Robinson O.C., 2011, HIST PHILOS PSYCHOL, V13, P32; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; Rohleder N, 2009, PSYCHONEUROENDOCRINO, V34, P469, DOI 10.1016/j.psyneuen.2008.12.004; SACHAR EJ, 1970, ARCH GEN PSYCHIAT, V23, P289; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Schumacher S, 2013, PSYCHONEUROENDOCRINO, V38, P729, DOI 10.1016/j.psyneuen.2013.02.003; Shores MM, 2001, PSYCHONEUROENDOCRINO, V26, P433, DOI 10.1016/S0306-4530(01)00002-6; Siepmann M, 2003, PSYCHOPHARMACOLOGY, V168, P293, DOI 10.1007/s00213-003-1448-4; Stetler C, 2011, PSYCHOSOM MED, V73, P114, DOI 10.1097/PSY.0b013e31820ad12b; THASE ME, 2009, HDB DEPRESSION, V2, P187; vanEck M, 1996, PSYCHOSOM MED, V58, P447, DOI 10.1097/00006842-199609000-00007; Vigil JM, 2010, CHILD DEV, V81, P1228, DOI 10.1111/j.1467-8624.2010.01464.x; Vythilingam M, 2004, BIOL PSYCHIAT, V56, P101, DOI 10.1016/j.biopsych.2004.04.002; Weibel L, 2002, NEUROSCI LETT, V318, P89, DOI 10.1016/S0304-3940(01)02496-X; World Health Organization, 1990, COMP INT DIAGN INT C	44	58	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131002	10.1371/journal.pone.0131002	http://dx.doi.org/10.1371/journal.pone.0131002			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148294	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600058
J	Ganjurjav, H; Gao, QZ; Zhang, WN; Liang, Y; Li, YW; Cao, XJ; Wan, YF; Li, Y; Danjiu, LB				Ganjurjav, Hasbagan; Gao, Qingzhu; Zhang, Weina; Liang, Yan; Li, Yawei; Cao, Xujuan; Wan, Yunfan; Li, Yue; Danjiu, Luobu			Effects of Warming on CO2 Fluxes in an Alpine Meadow Ecosystem on the Central Qinghai-Tibetan Plateau	PLOS ONE			English	Article							SOIL RESPIRATION; CARBON EXCHANGE; TERRESTRIAL ECOSYSTEMS; GRASSLAND ECOSYSTEMS; RESPONSES; DIOXIDE; GROWTH; FOREST; WATER; TERM	To analyze CO2 fluxes under conditions of climate change in an alpine meadow on the central Qinghai-Tibetan Plateau, we simulated the effect of warming using open top chambers (OTCs) from 2012 to 2014. The OTCs increased soil temperature by 1.62 degrees C (P < 0.05), but decreased soil moisture (1.38%, P < 0.05) during the experiments. The response of ecosystem CO2 fluxes to warming was variable, and dependent on the year. Under conditions of warming, mean gross ecosystem productivity (GEP) during the growing season increased significantly in 2012 and 2014 (P < 0.05); however, ecosystem respiration (ER) increased substantially only in 2012 (P < 0.05). The net ecosystem CO2 exchange (NEE) increased marginally in 2012 (P = 0.056), did not change in 2013(P > 0.05), and increased significantly in 2014 (P = 0.034) under conditions of warming. The GEP was more sensitive to climate variations than was the ER, resulting in a large increase in net carbon uptake under warming in the alpine meadow. Under warming, the 3-year averages of GEP, ER, and NEE increased by 19.6%, 15.1%, and 21.1%, respectively. The seasonal dynamic patterns of GEP and NEE, but not ER, were significantly impacted by warming. Aboveground biomass, particularly the graminoid biomass increased significantly under conditions of warming. Soil moisture, soil temperature, and aboveground biomass were the main factors that affected the variation of the ecosystem CO2 fluxes. The effect of warming on inter-and intra-annual patterns of ecosystem CO2 fluxes and the mechanism of different sensitivities in GEP and ER to warming, require further researched.	[Ganjurjav, Hasbagan; Gao, Qingzhu; Zhang, Weina; Liang, Yan; Cao, Xujuan; Wan, Yunfan; Li, Yue] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China; [Ganjurjav, Hasbagan; Gao, Qingzhu; Zhang, Weina; Liang, Yan; Cao, Xujuan; Wan, Yunfan; Li, Yue] Minist Agr, Key Lab Agroenvironm & Climate Change, Beijing, Peoples R China; [Li, Yawei] Clin Pharm Qinghai Hosp Tradit Chinese Med, Xining, Qinghai Provinc, Peoples R China; [Danjiu, Luobu] Nagqu Agr & Anim Husb Bur, Nagqu, Tibet Autonomou, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Ministry of Agriculture & Rural Affairs	Gao, QZ (corresponding author), Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China.	gaoqingzhu@caas.cn	Ganjurjav, Hasbagan/AAA-9698-2019		National Key Project of Scientific and Technical Supporting Program of China [2012BAC01B02]; National Natural Science Foundation of China [31170460]; Nagqu Grassland Station; Institute of Agricultural Environment and Sustainable Development in agriculture	National Key Project of Scientific and Technical Supporting Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nagqu Grassland Station; Institute of Agricultural Environment and Sustainable Development in agriculture	Support was provided by the National Key Project of Scientific and Technical Supporting Program of China (2012BAC01B02), the National Natural Science Foundation of China (31170460) and the cooperation project with Nagqu Grassland Station and Institute of Agricultural Environment and Sustainable Development in agriculture.	ADAMS JM, 1990, NATURE, V348, P711, DOI 10.1038/348711a0; Biasi C, 2008, PLANT SOIL, V307, P191, DOI 10.1007/s11104-008-9596-2; Cao GM, 2004, SOIL BIOL BIOCHEM, V36, P237, DOI 10.1016/j.soilbio.2003.09.010; De Boeck HJ, 2007, NEW PHYTOL, V175, P512, DOI 10.1111/j.1469-8137.2007.02122.x; Dias ATC, 2010, OECOLOGIA, V163, P805, DOI 10.1007/s00442-010-1569-5; Dong G, 2011, ECOHYDROLOGY, V4, P211, DOI 10.1002/eco.200; Gao QZ, 2014, MITIG ADAPT STRAT GL, V19, P199, DOI 10.1007/s11027-012-9434-y; Gao QZ, 2013, QUATERN INT, V304, P126, DOI 10.1016/j.quaint.2013.04.022; Gao QZ, 2006, REMOTE SENSING MONIT, V9, P1; Grogan P, 2000, OECOLOGIA, V125, P512, DOI 10.1007/s004420000490; Gunderson CA, 2000, TREE PHYSIOL, V20, P87; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045205; Kato T, 2004, AGR FOREST METEOROL, V124, P121, DOI 10.1016/j.agrformet.2003.12.008; Klanderud K, 2005, ECOLOGY, V86, P2047, DOI 10.1890/04-1563; Klein JA, 2008, ECOSYSTEMS, V11, P775, DOI 10.1007/s10021-008-9160-1; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Law BE, 2002, AGR FOREST METEOROL, V113, P97, DOI 10.1016/S0168-1923(02)00104-1; Liu YS, 2013, PLANT SOIL, V366, P491, DOI 10.1007/s11104-012-1442-x; Lu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059054; Mertens S, 2001, ECOSYSTEMS, V4, P226, DOI 10.1007/s10021-001-0006-3; Moyano FE, 2008, AGR FOREST METEOROL, V148, P135, DOI 10.1016/j.agrformet.2007.09.006; Nakano T, 2010, SOIL SCI PLANT NUTR, V56, P773, DOI 10.1111/j.1747-0765.2010.00502.x; Niu SL, 2010, ECOLOGY, V91, P3261, DOI 10.1890/09-1634.1; Niu SL, 2009, ECOSYSTEMS, V12, P915, DOI 10.1007/s10021-009-9265-1; Oberbauer SF, 2007, ECOL MONOGR, V77, P221, DOI 10.1890/06-0649; Peng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109319; Risch AC, 2006, OECOLOGIA, V147, P291, DOI 10.1007/s00442-005-0261-7; Saleska SR, 1999, GLOB CHANGE BIOL, V5, P125, DOI 10.1046/j.1365-2486.1999.00216.x; Scott-Denton LE, 2003, SOIL BIOL BIOCHEM, V35, P525, DOI 10.1016/S0038-0717(03)00007-5; Shi FS, 2010, PHOTOSYNTHETICA, V48, P437, DOI 10.1007/s11099-010-0058-8; Tang JW, 2008, AGR FOREST METEOROL, V148, P171, DOI 10.1016/j.agrformet.2007.08.008; Trumbore S, 2006, GLOBAL CHANGE BIOL, V12, P141, DOI 10.1111/j.1365-2486.2006.01067.x; Wan S, 2007, GLOBAL CHANGE BIOL, V13, P2411, DOI 10.1111/j.1365-2486.2007.01433.x; Wang XX, 2014, SOIL BIOL BIOCHEM, V76, P140, DOI 10.1016/j.soilbio.2014.05.014; Welker JM, 2004, GLOBAL CHANGE BIOL, V10, P1981, DOI 10.1111/j.1365-2486.2004.00857.x; Welp LR, 2007, AGR FOREST METEOROL, V147, P172, DOI 10.1016/j.agrformet.2007.07.010; Wu ZT, 2011, GLOBAL CHANGE BIOL, V17, P927, DOI 10.1111/j.1365-2486.2010.02302.x; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; Zhao L, 2006, GLOBAL CHANGE BIOL, V12, P1940, DOI 10.1111/j.1365-2486.2006.01197.x	39	37	49	15	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132044	10.1371/journal.pone.0132044	http://dx.doi.org/10.1371/journal.pone.0132044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147223	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600188
J	Hu, JD; Ma, LZ; Wang, S; Yang, JM; Chang, KK; Hu, XR; Sun, XH; Chen, RP; Jiang, M; Zhu, JH; Zhao, YY				Hu, Jiandong; Ma, Liuzheng; Wang, Shun; Yang, Jianming; Chang, Keke; Hu, Xinran; Sun, Xiaohui; Chen, Ruipeng; Jiang, Min; Zhu, Juanhua; Zhao, Yuanyuan			Biomolecular Interaction Analysis Using an Optical Surface Plasmon Resonance Biosensor: The Marquardt Algorithm vs Newton Iteration Algorithm	PLOS ONE			English	Article							QUANTITATIVE-ANALYSIS; KINETIC-ANALYSIS; DNA; ELLIPSOMETRY; ANTIGEN; KINASE	Kinetic analysis of biomolecular interactions are powerfully used to quantify the binding kinetic constants for the determination of a complex formed or dissociated within a given time span. Surface plasmon resonance biosensors provide an essential approach in the analysis of the biomolecular interactions including the interaction process of antigen-antibody and receptors-ligand. The binding affinity of the antibody to the antigen (or the receptor to the ligand) reflects the biological activities of the control antibodies (or receptors) and the corresponding immune signal responses in the pathologic process. Moreover, both the association rate and dissociation rate of the receptor to ligand are the substantial parameters for the study of signal transmission between cells. A number of experimental data may lead to complicated real-time curves that do not fit well to the kinetic model. This paper presented an analysis approach of biomolecular interactions established by utilizing the Marquardt algorithm. This algorithm was intensively considered to implement in the homemade bioanalyzer to perform the nonlinear curve-fitting of the association and disassociation process of the receptor to ligand. Compared with the results from the Newton iteration algorithm, it shows that the Marquardt algorithm does not only reduce the dependence of the initial value to avoid the divergence but also can greatly reduce the iterative regression times. The association and dissociation rate constants, k(a), k(d) and the affinity parameters for the biomolecular interaction, K-A, K-D, were experimentally obtained 6.969x10(5) mL.g(-1).s(-1), 0.00073 s(-1), 9.5466x10(8) mL.g(-1) and 1.0475x10(-9) g.mL(-1), respectively from the injection of the HBsAg solution with the concentration of 16ng.mL(-1). The kinetic constants were evaluated distinctly by using the obtained data from the curve-fitting results.	[Hu, Jiandong; Ma, Liuzheng; Wang, Shun; Chang, Keke; Sun, Xiaohui; Chen, Ruipeng; Zhu, Juanhua] Henan Agr Univ, Dept Elect Engn, Zhengzhou, Peoples R China; [Hu, Jiandong] State Key Lab Wheat & Maize Crop Sci, Zhengzhou, Peoples R China; [Yang, Jianming] Shanghai Univ, Sch Mat Sci & Engn, Shanghai, Peoples R China; [Hu, Xinran] McGill Univ, Sch Human Nutr & Dietet, Ste Anne De Bellevue, PQ, Canada; [Jiang, Min] Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China; [Zhao, Yuanyuan] Hanan Mech & Elect Vocat Coll, Zhengzhou, Peoples R China	Henan Agricultural University; Shanghai University; McGill University; Henan Agricultural University	Hu, JD (corresponding author), Henan Agr Univ, Dept Elect Engn, Zhengzhou, Peoples R China.	jiandonghu@163.com	ZHAO, YUAN/HCI-5831-2022		State Key Laboratory of Wheat and Maize Crop Science [SKL2014ZH-06]; Henan Province Joint Funding Program (National Natural Science Foundation of China) [U1304305]	State Key Laboratory of Wheat and Maize Crop Science; Henan Province Joint Funding Program (National Natural Science Foundation of China)	This study was funded by the State Key Laboratory of Wheat and Maize Crop Science (Grant No. SKL2014ZH-06) and the Henan Province Joint Funding Program (Grant No. U1304305 of the National Natural Science Foundation of China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi H, 2014, SPECTROCHIM ACTA A, V127, P137, DOI 10.1016/j.saa.2014.02.020; Adeyemi OS, 2013, INT J BIOL MACROMOL, V62, P450, DOI 10.1016/j.ijbiomac.2013.09.008; Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019; Balevicius Z, 2014, THIN SOLID FILMS, V571, P744, DOI 10.1016/j.tsf.2013.10.090; Bhattarai JK, 2015, CARBOHYD RES, V405, P55, DOI 10.1016/j.carres.2014.08.019; Blancas-Mejia LM, 2014, J MOL BIOL, V426, P347, DOI 10.1016/j.jmb.2013.10.016; Boozer C, 2006, CURR OPIN BIOTECH, V17, P400, DOI 10.1016/j.copbio.2006.06.012; Campagnolo C, 2004, J BIOCHEM BIOPH METH, V61, P283, DOI 10.1016/j.jbbm.2004.05.006; Ensafi AA, 2014, SENSOR ACTUAT B-CHEM, V202, P224, DOI 10.1016/j.snb.2014.05.001; Esadze A, 2014, J MOL BIOL, V426, P230, DOI 10.1016/j.jmb.2013.09.019; Gill A, 1996, J BIOTECHNOL, V48, P117, DOI 10.1016/0168-1656(96)01410-1; Glass TR, 2014, ANAL BIOCHEM, V456, P38, DOI 10.1016/j.ab.2014.04.011; Hu JD, 2009, BIOSENS BIOELECTRON, V24, P1974, DOI 10.1016/j.bios.2008.10.033; Hudson CS, 2013, BBA-PROTEINS PROTEOM, V1834, P1107, DOI 10.1016/j.bbapap.2013.02.008; Kalyani D, 2014, SPECTROCHIM ACTA A, V124, P148, DOI 10.1016/j.saa.2014.01.013; Katsamba PS, 2006, ANAL BIOCHEM, V352, P208, DOI 10.1016/j.ab.2006.01.034; Moirangthem RS, 2010, BIOSENS BIOELECTRON, V25, P2633, DOI 10.1016/j.bios.2010.04.037; Oluwole OO, 2007, COMBUST THEOR MODEL, V11, P127, DOI 10.1080/13647830600924601; Reverte C, 2007, J ANAL APPL PYROL, V79, P297, DOI 10.1016/j.jaap.2006.12.021; Ritz P, 2007, DIABETES RES CLIN PR, V77, P405, DOI 10.1016/j.diabres.2007.01.007; Scarano S, 2010, BIOSENS BIOELECTRON, V25, P957, DOI 10.1016/j.bios.2009.08.039; Tanious FA, 2008, METHOD CELL BIOL, V84, P53, DOI 10.1016/S009911-679X(07)84003-9; Villiers MB, 2010, BIOSENS BIOELECTRON, V26, P1554, DOI 10.1016/j.bios.2010.07.110; Xue TY, 2014, BIOSENS BIOELECTRON, V58, P374, DOI 10.1016/j.bios.2014.03.002; Zanier K, 2005, J MOL BIOL, V349, P401, DOI 10.1016/j.jmb.2005.03.071; Zhao YY, 2010, SPIE, V7656; Zheng XW, 2014, J CHROMATOGR B, V968, P49, DOI 10.1016/j.jchromb.2014.01.026; Zordok WA, 2014, SPECTROCHIM ACTA A, V129, P519, DOI 10.1016/j.saa.2014.02.087	28	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132098	10.1371/journal.pone.0132098	http://dx.doi.org/10.1371/journal.pone.0132098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147997	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600199
J	Karbin, S; Guillet, C; Kammann, CI; Niklaus, PA				Karbin, Saeed; Guillet, Cecile; Kammann, Claudia I.; Niklaus, Pascal A.			Effects of Long-Term CO2 Enrichment on Soil-Atmosphere CH4 Fluxes and the Spatial Micro-Distribution of Methanotrophic Bacteria	PLOS ONE			English	Article							CARBON-DIOXIDE ENRICHMENT; METHANE OXIDATION; ELEVATED CO2; GRASSLAND; N2O; AIR; CONSUMPTION; ECOSYSTEMS; EMISSIONS; DYNAMICS	Background Effects of elevated atmospheric CO2 concentrations on plant growth and associated C cycling have intensively been studied, but less is known about effects on the fluxes of radiatively active trace gases other than CO2. Net soil-atmosphere CH4 fluxes are determined by the balance of soil microbially-driven methane (CH4) oxidation and methanogenesis, and both might change under elevated CO2. Methods and Results Here, we studied CH4 dynamics in a permanent grassland exposed to elevated CO2 for 14 years. Soil-atmosphere fluxes of CH4 were measured using large static chambers, over a period of four years. The ecosystem was a net sink for atmospheric CH4 for most of the time except summer to fall when net CH4 emissions occurred. We did not detect any elevated CO2 effects on CH4 fluxes, but emissions were difficult to quantify due to their discontinuous nature, most likely because of ebullition from the saturated zone. Potential methanotrophic activity, determined by incubation of fresh sieved soil under standardized conditions, also did not reveal any effect of the CO2 treatment. Finally, we determined the spatial micro-distribution of methanotrophic activity at less than 5x atmospheric (10 ppm) and elevated (10000 ppm) CH4 concentrations, using a novel auto-radiographic technique. These analyses indicated that domains of net CH4 assimilation were distributed throughout the analyzed top 15 cm of soils, with no dependence on CH4 concentration or CO2 treatment. Conclusions Our investigations suggest that elevated CO2 exerts no or only minor effects on CH4 fluxes in the type of ecosystem we studied, at least as long as soil moisture differences are small or absent as was the case here. The autoradiographic analyses further indicate that the spatial niche of CH4 oxidation does not shift in response to CO2 enrichment or CH4 concentration, and that the same type of methanotrophs may oxidize CH4 from atmospheric and soil- internal sources.	[Karbin, Saeed; Niklaus, Pascal A.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Guillet, Cecile; Kammann, Claudia I.] Univ Giessen, Inst Plant Ecol, D-35390 Giessen, Germany; [Kammann, Claudia I.] Hsch Geisenheim Univ, Climate Change Res Special Crops, Geisenheim, Germany	University of Zurich; Justus Liebig University Giessen	Kammann, CI (corresponding author), Univ Giessen, Inst Plant Ecol, D-35390 Giessen, Germany.	Claudia.Kamman@hs-gm.de; Pascal.Niklaus@ieu.uzh.ch	Kammann, Claudia/GSD-6286-2022; Niklaus, Pascal A/G-5786-2010	Niklaus, Pascal A/0000-0002-2360-1357	Aga Khan Foundation; University of Zurich	Aga Khan Foundation; University of Zurich	SK has been funded by a stipend of Aga Khan Foundation. PAN supported the study from regular funds from the University of Zurich. The Hessian Agency for the Environment and Geology (HLUG) contributed to the running costs of the Giessen Free Air CO2 Enrichment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral JA, 1998, APPL ENVIRON MICROB, V64, P520; Ambus P, 1999, PLANT SOIL, V209, P1, DOI 10.1023/A:1004518730970; Baani M, 2008, P NATL ACAD SCI USA, V105, P10203, DOI 10.1073/pnas.0702643105; Barnard R, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002282; BENDER M, 1992, FEMS MICROBIOL ECOL, V101, P261, DOI 10.1111/j.1574-6968.1992.tb05783.x; Billings SA, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002137; Bodelier PLE, 2004, FEMS MICROBIOL ECOL, V47, P265, DOI 10.1016/S0168-6496(03)00304-0; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; Czepiel PM, 2003, WASTE MANAGE, V23, P593, DOI 10.1016/S0956-053X(03)00103-X; Davidson EA, 2002, AGR FOREST METEOROL, V113, P21, DOI 10.1016/S0168-1923(02)00100-4; DIAZ S, 1993, NATURE, V364, P616, DOI 10.1038/364616a0; Dijkstra FA, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001288; DORR H, 1993, CHEMOSPHERE, V26, P697, DOI 10.1016/0045-6535(93)90454-D; Dubbs LL, 2010, BIOL FERT SOILS, V46, P597, DOI 10.1007/s00374-010-0467-7; Dunfield PF, 2007, GREENHOUSE GAS SINKS, P152, DOI 10.1079/9781845931896.0152; Dunfield PF, 1999, APPL ENVIRON MICROB, V65, P1009; Dutaur L, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002734; EAMUS D, 1991, PLANT CELL ENVIRON, V14, P843, DOI 10.1111/j.1365-3040.1991.tb01447.x; Horz HP, 2002, FEMS MICROBIOL ECOL, V41, P247, DOI 10.1111/j.1574-6941.2002.tb00986.x; HUTCHINSON GL, 1981, SOIL SCI SOC AM J, V45, P311, DOI 10.2136/sssaj1981.03615995004500020017x; Ineson P, 1998, PLANT SOIL, V198, P89, DOI 10.1023/A:1004298309606; Jackel U, 2004, SOIL BIOL BIOCHEM, V36, P835, DOI 10.1016/j.soilbio.2004.01.013; Jager HJ, 2003, J APPL BOT-ANGEW BOT, V77, P117; Kammann C, 2001, ENVIRON POLLUT, V115, P261, DOI 10.1016/S0269-7491(01)00103-8; Kammann C, 2009, SOIL BIOL BIOCHEM, V41, P622, DOI 10.1016/j.soilbio.2008.12.025; Keppler F, 2006, NATURE, V439, P187, DOI 10.1038/nature04420; Lam SK, 2011, SOIL BIOL BIOCHEM, V43, P458, DOI 10.1016/j.soilbio.2010.10.012; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; Lenhart K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2049; McLain JET, 2008, BIOL FERT SOILS, V44, P623, DOI 10.1007/s00374-007-0246-2; Morgan JA, 2004, OECOLOGIA, V140, P11, DOI 10.1007/s00442-004-1550-2; Mosier AR, 2002, PLANT SOIL, V240, P201, DOI 10.1023/A:1015783801324; Niklaus PA, 1998, OECOLOGIA, V117, P201, DOI 10.1007/s004420050649; Niklaus PA, 2001, OECOLOGIA, V127, P540, DOI 10.1007/s004420000612; ROGERS HH, 1994, ENVIRON POLLUT, V83, P155, DOI 10.1016/0269-7491(94)90034-5; Shrestha PM, 2012, ISME J, V6, P1115, DOI 10.1038/ismej.2011.179; Smith KA, 2000, GLOBAL CHANGE BIOL, V6, P791, DOI 10.1046/j.1365-2486.2000.00356.x; Smith KE, 2010, SOIL SCI, V175, P349, DOI 10.1097/SS.0b013e3181e93d3c; Stiehl-Braun PA, 2011, SOIL BIOL BIOCHEM, V43, P1034, DOI 10.1016/j.soilbio.2011.01.020; Stiehl-Braun PA, 2011, GLOBAL CHANGE BIOL, V17, P2629, DOI 10.1111/j.1365-2486.2011.02410.x; Wang B, 2013, ATMOS ENVIRON, V80, P290, DOI 10.1016/j.atmosenv.2013.08.010; Weber HE, 2000, J VEG SCI, V11, P739, DOI 10.2307/3236580; West AE, 2002, MICROB ECOL, V43, P408, DOI 10.1007/s00248-001-1049-x; Wieczorek AS, 2011, FEMS MICROBIOL ECOL, V77, P28, DOI 10.1111/j.1574-6941.2011.01080.x	44	5	5	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131665	10.1371/journal.pone.0131665	http://dx.doi.org/10.1371/journal.pone.0131665			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147694	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000358157600122
J	Kljashtorny, V; Nikonov, S; Ovchinnikov, L; Lyabin, D; Vodovar, N; Curmi, P; Manivet, P				Kljashtorny, Vladislav; Nikonov, Stanislav; Ovchinnikov, Lev; Lyabin, Dmitry; Vodovar, Nicolas; Curmi, Patrick; Manivet, Philippe			The Cold Shock Domain of YB-1 Segregates RNA from DNA by Non-Bonded Interactions	PLOS ONE			English	Article							MESSENGER-RIBONUCLEOPROTEIN PARTICLES; SINGLE STRANDS BIND; MAJOR CORE PROTEIN; Y-BOX PROTEIN; Y-BOX-BINDING-PROTEIN-1 YB-1; MOLECULAR-DYNAMICS; P50; RECOGNITION; CELLS; SITE	The human YB-1 protein plays multiple cellular roles, of which many are dictated by its binding to RNA and DNA through its Cold Shock Domain (CSD). Using molecular dynamics simulation approaches validated by experimental assays, the YB1 CSD was found to interact with nucleic acids in a sequence-dependent manner and with a higher affinity for RNA than DNA. The binding properties of the YB1 CSD were close to those observed for the related bacterial Cold Shock Proteins (CSP), albeit some differences in sequence specificity. The results provide insights in the molecular mechanisms whereby YB-1 interacts with nucleic acids.	[Kljashtorny, Vladislav; Nikonov, Stanislav; Ovchinnikov, Lev; Lyabin, Dmitry] Russian Acad Sci, Inst Prot Res, Pushchino 142290, Moscow Region, Russia; [Kljashtorny, Vladislav; Curmi, Patrick] INSERM, UMR 829, Lab Struct Activite Biomol Normales & Patholog, F-91025 Evry, France; [Kljashtorny, Vladislav; Vodovar, Nicolas; Manivet, Philippe] Hop Lariboisiere, INSERM, UMRS 942, F-75475 Paris 10, France; [Kljashtorny, Vladislav; Manivet, Philippe] Hop Lariboisiere, AP HP, Serv Biochim & Biol Mol, F-75475 Paris, France; [Manivet, Philippe] Ctr Ressources Biol BB 0033 00064, Unite Biol Clin Struct, F-75475 Paris 10, France	Russian Academy of Sciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Manivet, P (corresponding author), Hop Lariboisiere, INSERM, UMRS 942, 41 Blvd Chapelle, F-75475 Paris 10, France.	philippe.manivet@lrb.aphp.fr	Ovchinnikov, Lev/L-2397-2015; Manivet, Philippe/AAA-1884-2021; Lyabin, Dmitry/K-3178-2013; Vodovar, Nicolas/S-2947-2019	CURMI, Patrick A./0000-0001-5045-8501; Vodovar, Nicolas/0000-0001-8087-387X	GDRI "Early Events in Human Diseases (EEHD)"; Presidium of Russian Academy of Sciences	GDRI "Early Events in Human Diseases (EEHD)"; Presidium of Russian Academy of Sciences(Russian Academy of Sciences)	VK receive a PhD grant from the GDRI "Early Events in Human Diseases (EEHD)" and the Programs on "Molecular and Cellular Biology" and on "Basic Sciences to Medicine" from the Presidium of Russian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BOUVET P, 1995, J BIOL CHEM, V270, P28297; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chansky HA, 2001, CANCER RES, V61, P3586; Cohen J.E., 1988, STAT POWER ANAL BEHA; Das S, 2007, J BIOL CHEM, V282, P28474, DOI 10.1074/jbc.M704672200; Davydova EK, 1997, NUCLEIC ACIDS RES, V25, P2911, DOI 10.1093/nar/25.14.2911; Doreleijers JF, 2009, J BIOMOL NMR, V45, P389, DOI 10.1007/s10858-009-9378-z; DUNN OJ, 1959, ANN MATH STAT, V30, P192, DOI 10.1214/aoms/1177706374; Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Evdokimova VM, 1998, J BIOL CHEM, V273, P3574, DOI 10.1074/jbc.273.6.3574; EVDOKIMOVA VM, 1995, J BIOL CHEM, V270, P3186, DOI 10.1074/jbc.270.7.3186; Gaudreault I, 2004, NUCLEIC ACIDS RES, V32, P316, DOI 10.1093/nar/gkh170; Guryanov SG, 2013, BBA-PROTEINS PROTEOM, V1834, P559, DOI 10.1016/j.bbapap.2012.11.007; HASEGAWA SL, 1991, NUCLEIC ACIDS RES, V19, P4915, DOI 10.1093/nar/19.18.4915; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kloks CPAM, 2002, J MOL BIOL, V316, P317, DOI 10.1006/jmbi.2001.5334; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lim VI, 2006, MOL BIOL+, V40, P572; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Matsumoto Ken, 2005, J Mol Genet Med, V1, P11; Max KEA, 2007, FEBS J, V274, P1265, DOI 10.1111/j.1742-4658.2007.05672.x; Max KEA, 2006, J MOL BIOL, V360, P702, DOI 10.1016/j.jmb.2006.05.044; MINICH WB, 1993, EUR J BIOCHEM, V212, P633, DOI 10.1111/j.1432-1033.1993.tb17701.x; Nekrasov MP, 2003, J BIOL CHEM, V278, P13936, DOI 10.1074/jbc.M209145200; Raffetseder U, 2003, J BIOL CHEM, V278, P18241, DOI 10.1074/jbc.M212518200; Sachs R, 2012, RNA, V18, P65, DOI 10.1261/rna.02809212; Shen Y, 2007, J BIOMOL NMR, V38, P289, DOI 10.1007/s10858-007-9166-6; Shibahara K, 2004, CANCER SCI, V95, P348, DOI 10.1111/j.1349-7006.2004.tb03214.x; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Skabkin MA, 2006, MOL BIOL+, V40, P620; Skabkin MA, 2001, J BIOL CHEM, V276, P44841, DOI 10.1074/jbc.M107581200; SOMMERVILLE J, 1993, J CELL BIOL, V120, P277, DOI 10.1083/jcb.120.2.277; Soop T, 2003, J CELL SCI, V116, P1493, DOI 10.1242/jcs.00353; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Svitkin YV, 2009, EMBO J, V28, P58, DOI 10.1038/emboj.2008.259; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Yamanaka K, 1998, MOL MICROBIOL, V27, P247, DOI 10.1046/j.1365-2958.1998.00683.x; Zasedateleva OA, 2002, J MOL BIOL, V324, P73, DOI 10.1016/S0022-2836(02)00937-3	46	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130318	10.1371/journal.pone.0130318	http://dx.doi.org/10.1371/journal.pone.0130318			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147853	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600034
J	Mancini, M; Leo, E; Takemaru, KI; Campi, V; Castagnetti, F; Soverini, S; De Benedittis, C; Rosti, G; Cavo, M; Santucci, MA; Martinelli, G				Mancini, Manuela; Leo, Elisa; Takemaru, Ken-Ichi; Campi, Virginia; Castagnetti, Fausto; Soverini, Simona; De Benedittis, Caterina; Rosti, Gianantonio; Cavo, Michele; Santucci, Maria Alessandra; Martinelli, Giovanni			14-3-3 Binding and Sumoylation Concur to the Down-Modulation of beta-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia	PLOS ONE			English	Article							STEM-CELLS; PROGENITOR CELLS; TYROSINE KINASE; CML STEM; C-ABL; BCR; PROTEIN; ACTIVATION; IMATINIB; PREVENTS	The down-modulation of the beta-catenin antagonist Chibby 1 (CBY1) associated with the BCR-ABL1 fusion gene of chronic myeloid leukemia (CML) contributes to the aberrant activation of beta-catenin, particularly in leukemic stem cells (LSC) resistant to tyrosine kinase (TK) inhibitors. It is, at least partly, driven by transcriptional events and gene promoter hyper-methylation. Here we demonstrate that it also arises from reduced protein stability upon binding to 14-3-3 sigma adapter protein. CBY1/14-3-3 sigma interaction in BCR-ABL1+ cells is mediated by the fusion protein TK and AKT phosphorylation of CBY1 at critical serine 20, and encompasses the 14-3-3 sigma binding modes I and II involved in the binding with client proteins. Moreover, it is impaired by c-Jun N-terminal kinase (JNK) phosphorylation of 14-3-3 sigma at serine 186, which promotes dissociation of client proteins. The ubiquitin proteasome system UPS participates in reducing stability of CBY1 bound with 14-3-3 sigma through enhanced SUMOylation. Our results open new routes towards the research on molecular pathways promoting the proliferative advantage of leukemic hematopoiesis over the normal counterpart.	[Mancini, Manuela; Leo, Elisa; Campi, Virginia; Castagnetti, Fausto; Soverini, Simona; De Benedittis, Caterina; Rosti, Gianantonio; Cavo, Michele; Santucci, Maria Alessandra; Martinelli, Giovanni] Univ Bologna, Sch Med, Dept Expt Diagnost & Specialty Med DIMES, Inst Hematol L&A Seragnoli, Bologna, Italy; [Takemaru, Ken-Ichi] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	University of Bologna; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Mancini, M (corresponding author), Univ Bologna, Sch Med, Dept Expt Diagnost & Specialty Med DIMES, Inst Hematol L&A Seragnoli, Bologna, Italy.	mancini_manu@yahoo.com	CAVO, MICHELE/AAK-8274-2020; Simona, Soverini/A-3608-2016; DE BENEDITTIS, CATERINA/AGA-9478-2022; Martinelli, Giovanni/AAK-9211-2020	CAVO, MICHELE/0000-0003-4514-3227; Simona, Soverini/0000-0002-4508-0353; DE BENEDITTIS, CATERINA/0000-0003-4315-5996; Martinelli, Giovanni/0000-0002-1025-4210	University of Bologna (RFO funds); Ministero della Pubblica Istruzione e della Ricerca (PRIN funds); Umberto Veronesi Foundation; AIRC; FP7 NGS-PTL project; Progetto Regione-Universita; Fondazione del Monte di Bologna e Ravenna; BolognaAIL; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107493] Funding Source: NIH RePORTER	University of Bologna (RFO funds); Ministero della Pubblica Istruzione e della Ricerca (PRIN funds)(Ministry of Education, Universities and Research (MIUR)); Umberto Veronesi Foundation(Fondazione Umberto Veronesi); AIRC(Fondazione AIRC per la ricerca sul cancro); FP7 NGS-PTL project; Progetto Regione-Universita; Fondazione del Monte di Bologna e Ravenna(Fondazione del Monte di Bologna e Ravenna); BolognaAIL; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	University of Bologna (RFO funds), Ministero della Pubblica Istruzione e della Ricerca (PRIN funds), Umberto Veronesi Foundation, AIRC, FP7 NGS-PTL project, Progetto Regione-Universita 2010-12 (L. Bolondi), Fondazione del Monte di Bologna e Ravenna and BolognaAIL finantially supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson AE, 2009, P NATL ACAD SCI USA, V106, P3925, DOI 10.1073/pnas.0900189106; Aguirre RS, 2013, MOL PHARMACOL, V84, P218, DOI 10.1124/mol.113.085555; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Bhattacharyya S, 2014, NAT REV MOL CELL BIO, V15, P122, DOI 10.1038/nrm3741; Burchert A, 2005, LEUKEMIA, V19, P1774, DOI 10.1038/sj.leu.2403898; Chang TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040193; Coluccia AML, 2007, EMBO J, V26, P1456, DOI 10.1038/sj.emboj.7601485; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Einsele H, 2014, RECENT RESULTS CANC, V201, P325, DOI 10.1007/978-3-642-54490-3_20; Feligioni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028185; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Hamilton A, 2012, BLOOD, V119, P1501, DOI 10.1182/blood-2010-12-326843; Hu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006640; Hu D, 2008, CARCINOGENESIS, V29, P2317, DOI 10.1093/carcin/bgn239; Hu Y, 2009, LEUKEMIA, V23, P109, DOI 10.1038/leu.2008.262; Huang WQ, 2013, J BIOL CHEM, V288, P12766, DOI 10.1074/jbc.M112.429696; Huang WQ, 2010, MOL CELL BIOL, V30, P4575, DOI 10.1128/MCB.01595-09; Keeshan K, 2002, LEUKEMIA, V16, P1725, DOI 10.1038/sj.leu.2402576; Kharas NG, 2005, CANCER RES, V65, P2047, DOI 10.1158/0008-5472.CAN-04-3888; Kim W, 2013, BIOCHEM J, V450, P9, DOI 10.1042/BJ20121284; Lee MH, 2009, FASEB J, V23, P3874, DOI 10.1096/fj.08-117804; Leo E, 2014, J CELL BIOCH; Leo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081425; Li FQ, 2008, J CELL BIOL, V181, P1141, DOI 10.1083/jcb.200709091; Li XH, 2005, J BIOL CHEM, V280, P15061, DOI 10.1074/jbc.M414262200; Mancini M, 2004, LEUKEMIA, V18, P370, DOI 10.1038/sj.leu.2403207; Mancini M, 2014, CELL SIGNAL, V26, P1690, DOI 10.1016/j.cellsig.2014.04.010; Mancini M, 2013, CELL SIGNAL, V25, P1820, DOI 10.1016/j.cellsig.2013.05.019; Mancini M, 2011, J PHARMACOL EXP THER, V336, P596, DOI 10.1124/jpet.110.172536; Mancini M, 2010, J CELL BIOCHEM, V109, P320, DOI 10.1002/jcb.22380; Mancini M, 2009, TRAFFIC, V10, P637, DOI 10.1111/j.1600-0854.2009.00897.x; MCWHIRTER JR, 1993, MOL CELL BIOL, V13, P7587, DOI 10.1128/MCB.13.12.7587; Mhawech P, 2005, CELL RES, V15, P228, DOI 10.1038/sj.cr.7290291; Minami Y, 2008, P NATL ACAD SCI USA, V105, P17967, DOI 10.1073/pnas.0808303105; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Rui HL, 2002, J BIOL CHEM, V277, P42981, DOI 10.1074/jbc.M208099200; Ryu J, 2010, BIOCHEM BIOPH RES CO, V393, P280, DOI 10.1016/j.bbrc.2010.01.122; Saadeddin A, 2009, MOL CANCER RES, V7, P1189, DOI 10.1158/1541-7786.MCR-09-0027; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Zhang B, 2013, BLOOD, V121, P1824, DOI 10.1182/blood-2012-02-412890; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zhou HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086195	46	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131074	10.1371/journal.pone.0131074	http://dx.doi.org/10.1371/journal.pone.0131074			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147002	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600060
J	Marquez, EA; Kane, KP				Marquez, Elsa A.; Kane, Kevin P.			Identities of P2 and P3 Residues of H-2K(b)-Bound Peptides Determine Mouse Ly49C Recognition	PLOS ONE			English	Article							MHC CLASS-I; H-2-DEFICIENT LYMPHOMA VARIANTS; CYTOTOXIC T-LYMPHOCYTES; KILLER-CELL RECEPTORS; CRYSTAL-STRUCTURE; BINDING; IDENTIFICATION; SPECIFICITY; MOLECULES; SELF	Ly49 receptors can be peptide selective in their recognition of MHC-I-peptide complexes, affording them a level of discrimination beyond detecting the presence or absence of specific MHC-I allele products. Despite this ability, little is understood regarding the properties that enable some peptides, when bound to MHC-I molecules, to support Ly49 recognition, but not others. Using RMA-S target cells expressing MHC-I molecules loaded with individual peptides and effector cells expressing the ectodomain of the inhibitory Ly49C receptor, we found that two adjacent amino acid residues, P2 and P3, both buried in the peptide binding groove of H-2K(b), determine mouse Ly49C specificity. If both are aliphatic residues, this is supportive. Whereas, small amino acids at P2 and aromatic amino acids at the P3 auxiliary anchor residue are detrimental to Ly49C recognition. These results resemble those with a rat Ly49 where the identity of a peptide anchor residue determines recognition, suggesting that dependence on specific peptide residues buried in the MHC-I peptide-binding groove may be fundamental to Ly49 peptide selectivity and recognition.	[Marquez, Elsa A.; Kane, Kevin P.] Univ Alberta, Med Microbiol & Immunol, Edmonton, AB, Canada	University of Alberta	Kane, KP (corresponding author), Univ Alberta, Med Microbiol & Immunol, Edmonton, AB, Canada.	kevin.kane@ualberta.ca			Canadian Institutes of Health Research grant [43864]	Canadian Institutes of Health Research grant(Canadian Institutes of Health Research (CIHR))	This work was funded by Canadian Institutes of Health Research grant 43864 to KPK (http://cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biron CA, 1997, CURR OPIN IMMUNOL, V9, P24, DOI 10.1016/S0952-7915(97)80155-0; Caron E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.68; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Dam J, 2003, NAT IMMUNOL, V4, P1213, DOI 10.1038/ni1006; de Verteuil D, 2012, AUTOIMMUN REV, V11, P627, DOI 10.1016/j.autrev.2011.11.003; Deng L, 2008, J BIOL CHEM, V283, P16840, DOI 10.1074/jbc.M801526200; Franksson L, 1999, EUR J IMMUNOL, V29, P2748, DOI 10.1002/(SICI)1521-4141(199909)29:09<2748::AID-IMMU2748>3.0.CO;2-C; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; Granados DP, 2012, BLOOD, V119, pE181, DOI 10.1182/blood-2012-02-412593; Guimezanes A, 2001, EUR J IMMUNOL, V31, P421, DOI 10.1002/1521-4141(200102)31:2<421::AID-IMMU421>3.0.CO;2-4; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; JAMESON SC, 1992, EUR J IMMUNOL, V22, P2663, DOI 10.1002/eji.1830221028; Johansson S, 2005, J EXP MED, V201, P1145, DOI 10.1084/jem.20050167; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Liu LZ, 1999, J IMMUNOL, V163, P868; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; Ma BJ, 2011, J IMMUNOL, V187, P3267, DOI 10.4049/jimmunol.1002809; Madhurantakam C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032805; Malarkannan S, 1996, P NATL ACAD SCI USA, V93, P13991, DOI 10.1073/pnas.93.24.13991; MALNATI MS, 1995, SCIENCE, V267, P1016, DOI 10.1126/science.7863326; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; Meiring HD, 2006, MOL CELL PROTEOMICS, V5, P902, DOI 10.1074/mcp.T500014-MCP200; Michaelsson J, 2000, EUR J IMMUNOL, V30, P300; Natarajan K, 2002, ANNU REV IMMUNOL, V20, P853, DOI 10.1146/annurev.immunol.20.100301.064812; NUCHTERN JG, 1989, NATURE, V339, P223, DOI 10.1038/339223a0; Obst R, 2000, J EXP MED, V191, P805, DOI 10.1084/jem.191.5.805; Pyzik M, 2011, J EXP MED, V208, P1105, DOI 10.1084/jem.20101831; REYNOLDS CW, 1984, J IMMUNOL, V132, P534; ROTZSCHKE O, 1991, EUR J IMMUNOL, V21, P2891, DOI 10.1002/eji.1830211136; Sadovnikova E, 1996, P NATL ACAD SCI USA, V93, P13114, DOI 10.1073/pnas.93.23.13114; SIJTS AJAM, 1994, J IMMUNOL, V152, P106; Silver ET, 2000, J IMMUNOL, V165, P1771, DOI 10.4049/jimmunol.165.4.1771; Silver ET, 2001, J IMMUNOL, V166, P2333, DOI 10.4049/jimmunol.166.4.2333; Tallquist MD, 1996, J EXP MED, V184, P1017, DOI 10.1084/jem.184.3.1017; Thananchai H, 2007, J IMMUNOL, V178, P33, DOI 10.4049/jimmunol.178.1.33; VANBLEEK GM, 1990, NATURE, V348, P213; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; YEWDELL JW, 1989, SCIENCE, V244, P1072, DOI 10.1126/science.2471266; Zarling AL, 2000, J EXP MED, V192, P1755, DOI 10.1084/jem.192.12.1755	43	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131308	10.1371/journal.pone.0131308	http://dx.doi.org/10.1371/journal.pone.0131308			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147851	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600088
J	Niu, JY; Sahni, S; Liao, SS; Tucker, KL; Dawson-Hughes, B; Gao, X				Niu, Jinya; Sahni, Shivani; Liao, Susu; Tucker, Katherine L.; Dawson-Hughes, Bess; Gao, Xiang			Association between Sleep Duration, Insomnia Symptoms and Bone Mineral Density in Older Boston Puerto Rican Adults	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR RISK; PHYSICAL-ACTIVITY; OSTEOPOROSIS; INFLAMMATION; BIOMARKERS; FRACTURES; WOMEN; METAANALYSIS; QUALITY	Objective To examine the association between sleep patterns (sleep duration and insomnia symptoms) and total and regional bone mineral density (BMD) among older Boston Puerto Rican adults. Materials/Methods We conducted a cross-sectional study including 750 Puerto Rican adults, aged 47-79 y living in Massachusetts. BMD at 3 hip sites and the lumbar spine were measured using dual-energy X-ray absorptiometry. Sleep duration (<= 5 h, 6 h, 7 h, 8 h, or <= 9 h/d) and insomnia symptoms (difficulty initiating sleep, difficulty maintaining sleep, early-morning awaking, and non-restorative sleep) were assessed by a questionnaire. Multivariable regression was used to examine sex-specific associations between sleep duration, insomnia symptoms and BMD adjusting for standard confounders and covariates. Results Men who slept >= 9h/d had significantly lower femoral neck BMD, relative to those reporting 8 h/d sleep, after adjusting for age, education level, smoking, physical activity, depressive symptomatology, comorbidity and serum vitamin D concentration. This association was attenuated and lost significance after further adjustment for urinary cortisol and serum inflammation biomarkers. In contrast, the association between sleep duration and BMD was not significant in women. Further, we did not find any significant associations between insomnia symptoms and BMD in men or women. Conclusions Our study does not support the hypothesis that shorter sleep duration and insomnia symptoms are associated with lower BMD levels in older adults. However, our results should be interpreted with caution. Future studies with larger sample size, objective assessment of sleep pattern, and prospective design are needed before a conclusion regarding sleep and BMD can be reached.	[Niu, Jinya; Liao, Susu] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol & Biostat, Peking Union Med Coll, Beijing 100730, Peoples R China; [Sahni, Shivani] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Inst Aging Res,Hebrew SeniorLife, Boston, MA 02215 USA; [Tucker, Katherine L.] Univ Massachusetts Lowell, Dept Clin Lab & Nutr Sci, Boston, MA USA; [Dawson-Hughes, Bess] Tufts Univ, Bone Metab Lab, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Gao, Xiang] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Hebrew SeniorLife; University of Massachusetts System; University of Massachusetts Boston; Tufts University; United States Department of Agriculture (USDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gao, X (corresponding author), Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA.	xxg14@psu.edu	Sahni, Shivani/AFQ-8601-2022	Sahni, Shivani/0000-0002-9827-0986; , Xiang/0000-0003-2617-6509; Tucker, Katherine/0000-0001-7640-662X	National Institutes of Health [P01 AG023394, P50 HL105185, R01 AG027087, R01 NS062879-01A2]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL105185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027087, P01AG023394] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by grants (P01 AG023394, P50 HL105185, R01 AG027087, and R01 NS062879-01A2) from the National Institutes of Health. None of the sponsors participated in the design of study or in the collection, analysis, or interpretation of the data.	Braun T, 2012, CURR OSTEOPOROS REP, V10, P101, DOI 10.1007/s11914-012-0104-5; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Chapotot F, 1996, J CLIN ENDOCR METAB, V81, P3759, DOI 10.1210/jc.81.10.3759; Chaput JP, 2009, SLEEP MED, V10, P919, DOI 10.1016/j.sleep.2008.09.016; Chen G, 2014, J CLIN ENDOCR METAB, V99, P2869, DOI 10.1210/jc.2013-3629; Chien KL, 2010, SLEEP, V33, P177, DOI 10.1093/sleep/33.2.177; Colten HR, 2006, SLEEP DISORDERS SLEE; Dowd JB, 2011, ANN EPIDEMIOL, V21, P799, DOI 10.1016/j.annepidem.2011.07.004; Ferrie JE, 2013, AM J EPIDEMIOL, V178, P956, DOI 10.1093/aje/kwt072; Fu XH, 2011, BONE, V49, P1062, DOI 10.1016/j.bone.2011.08.008; Kobayashi D, 2012, SLEEP BREATH, V16, P579, DOI 10.1007/s11325-011-0545-6; McLean Robert R, 2009, Curr Osteoporos Rep, V7, P134; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; Miller MA, 2013, J HUM HYPERTENS, V27, P583, DOI 10.1038/jhh.2013.27; National Institute of Health, INSOMNIA; Nicole CW, 2014, J BONE MINER RES, DOI [10.1002/jbmr.2269, DOI 10.1002/JBMR.2269]; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; PAFFENBARGER RS, 1978, AM J EPIDEMIOL, V108, P161, DOI 10.1093/oxfordjournals.aje.a112608; Patel SR, 2009, SLEEP, V32, P200, DOI 10.1093/sleep/32.2.200; Radloff L, 1986, USE CTR EPIDEMIOLOGI; Schiza SE, 2013, SLEEP BREATH, V17, P17, DOI 10.1007/s11325-012-0699-x; Sogaard AJ, 2005, OSTEOPOROSIS INT, V16, P887, DOI 10.1007/s00198-004-1784-1; Specker BL, 2007, OSTEOPOROSIS INT, V18, P93, DOI 10.1007/s00198-006-0207-x; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Stone KL, 2008, SLEEP MED, V9, pS18, DOI 10.1016/S1389-9457(08)70012-1; Stone KL, 2006, J AM GERIATR SOC, V54, P1177, DOI 10.1111/j.1532-5415.2006.00818.x; Tucker KL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-107; Tucker KL, 2000, J GERONTOL A-BIOL, V55, pM90; Wang K, 2014, ENDOCRINE, V2, pM90; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; White J, J CLIN DENSITOM, V6, P159; Wu YL, 2014, SLEEP MED, V15, P1456, DOI 10.1016/j.sleep.2014.07.018	35	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132342	10.1371/journal.pone.0132342	http://dx.doi.org/10.1371/journal.pone.0132342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147647	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600247
J	Rafiq, RA; Quadri, A; Nazir, LA; Peerzada, K; Ganai, BA; Tasduq, SA				Rafiq, Rather A.; Quadri, Afnan; Nazir, Lone A.; Peerzada, Kaiser; Ganai, Bashir A.; Tasduq, Sheikh A.			A Potent Inhibitor of Phosphoinositide 3-Kinase (PI3K) and Mitogen Activated Protein (MAP) Kinase Signalling, Quercetin (3, 3 ', 4 ', 5, 7-Pentahydroxyflavone) Promotes Cell Death in Ultraviolet (UV)-B-Irradiated B16F10 Melanoma Cells	PLOS ONE			English	Article							NF-KAPPA-B; INDUCED APOPTOSIS; MOLECULAR-MECHANISMS; ANTIOXIDANT DEFENSE; UVB IRRADIATION; RADIATION; TRANSLOCATION; KERATINOCYTES; PREVENTION; RESISTANCE	Ultraviolet (UV) radiation-induced skin damage contributes strongly to the formation of melanoma, a highly lethal form of skin cancer. Quercetin (Qu), the most widely consumed dietary bioflavonoid and well known inhibitor of phosphoinositide 3-kinase (PI3K) and mitogen activated protein (MAP) kinase signalling, has been reported to be chemopreventive in several forms of non-melanoma skin cancers. Here, we report that the treatment of ultraviolet (UV)-B-irradiated B16F10 melanoma cells with quercetin resulted in a dose dependent reduction in cell viability and increased apoptosis. The present study has brought out that the pro-apoptotic effects of quercetin in UVB-irradiated B16F10 cells are mediated through the elevation of intracellular reactive oxygen species (ROS) formation, calcium homeostasis imbalance, modulation of anti-oxidant defence response and depolarization of mitochondrial membrane potential (Delta psi(M)). Promotion of UVB-induced cell death by quercetin was further revealed by cleavage of chromosomal DNA, caspase activation, poly (ADP) ribose polymerase (PARP) cleavage, and an increase in sub-G1 cells. Quercetin markedly attenuated MEK-ERK signalling, influenced PI3K/Akt pathway, and potentially enhanced the UVB-induced NF-kappa B nuclear translocation. Furthermore, combined UVB and quercetin treatment decreased the ratio of Bcl-2 to that of Bax, and upregulated the expression of Bim and apoptosis inducing factor (AIF). Overall, these results suggest the possibility of using quercetin in combination with UVB as a possible treatment option for melanoma in future.	[Rafiq, Rather A.; Quadri, Afnan; Nazir, Lone A.; Peerzada, Kaiser; Tasduq, Sheikh A.] CSIR, Indian Inst Integrat Med, PK PD & Toxicol Div, Jammu, Jammu & Kashmir, India; [Nazir, Lone A.; Tasduq, Sheikh A.] Acad Sci & Innovat Res AcSIR, New Delhi, India; [Ganai, Bashir A.] Univ Kashmir, Ctr Res Dev CORD, Srinagar 190006, Jammu & Kashmir, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Academy of Scientific & Innovative Research (AcSIR); University of Kashmir	Tasduq, SA (corresponding author), CSIR, Indian Inst Integrat Med, PK PD & Toxicol Div, Jammu, Jammu & Kashmir, India.	stabdullah@iiim.ac.in	LONE, NAZIR A./ABD-6296-2020	LONE, NAZIR A./0000-0003-3341-8879; Abdullah, Tasduq/0000-0001-6474-1009	Council of Scientific and Industrial Research (CSIR), New Delhi, India [BSC 0302]; Council of Scientific and Industrial Research (CSIR); Human Resource Development Group (HRDG), Pusa, New Delhi, India	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Human Resource Development Group (HRDG), Pusa, New Delhi, India	This study was funded by Council of Scientific and Industrial Research (CSIR), New Delhi, India, under its 12th Five Year Plan Project titled, "Towards Understanding Skin Cell Homeostasis (TOUCH)," Project No. BSC 0302. Financial assistance to RAR by Council of Scientific and Industrial Research (CSIR), Human Resource Development Group (HRDG), Pusa, New Delhi, India is highly acknowledged.	Adil MD, 2010, J ETHNOPHARMACOL, V132, P109, DOI 10.1016/j.jep.2010.07.047; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Beani JC, 2001, B ACAD NAT MED PARIS, V185, P1507, DOI 10.1016/S0001-4079(19)34432-2; Beani JC, 2001, B ACAD NATL MED, V185, P26; Bivik CA, 2006, J INVEST DERMATOL, V126, P1119, DOI 10.1038/sj.jid.5700124; Cao HH, 2014, BIOCHEM PHARMACOL, V87, P424, DOI 10.1016/j.bcp.2013.11.008; Clydesdale GJ, 2001, IMMUNOL CELL BIOL, V79, P547, DOI 10.1046/j.1440-1711.2001.01047.x; Collins JA, 1997, J HISTOCHEM CYTOCHEM, V45, P923, DOI 10.1177/002215549704500702; Cosentino K, 2014, CHEM PHYS LIPIDS, V181, P62, DOI 10.1016/j.chemphyslip.2014.04.001; D'Anneo A, 2013, J CELL PHYSIOL, V228, P952, DOI 10.1002/jcp.24131; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Ferraresi R, 2005, FREE RADICAL RES, V39, P1249, DOI 10.1080/10715760500306935; Fishman D, 2001, P NATL ACAD SCI USA, V98, P1740, DOI 10.1073/pnas.041591298; Gibellini L, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq053; Grossman D, 2001, CANCER METAST REV, V20, P3, DOI 10.1023/A:1013123532723; Heck DE, 2004, TOXICOL APPL PHARM, V195, P288, DOI 10.1016/j.taap.2003.09.028; Hirota A, 2005, J INVEST DERMATOL, V124, P825, DOI 10.1111/j.0022-202X.2005.23670.x; Kitagawa D, 2002, J BIOL CHEM, V277, P366, DOI 10.1074/jbc.M107110200; Kulms D, 2000, PHOTODERMATOL PHOTO, V16, P195, DOI 10.1034/j.1600-0781.2000.160501.x; Lee CH, 2013, INT J MOL SCI, V14, P6414, DOI 10.3390/ijms14036414; Lee DH, 2005, J CATARACT REFR SURG, V31, P614, DOI 10.1016/j.jcrs.2004.05.053; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Li NX, 1999, FASEB J, V13, P1137, DOI 10.1096/fasebj.13.10.1137; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Masaki H, 2009, J INVEST DERM SYMP P, V14, P50, DOI 10.1038/jidsymp.2009.12; MENON LG, 1995, CANCER LETT, V95, P221, DOI 10.1016/0304-3835(95)03887-3; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Murakami A, 2008, CANCER LETT, V269, P315, DOI 10.1016/j.canlet.2008.03.046; Olson ER, 2008, CANCER PREV RES, V1, P362, DOI 10.1158/1940-6207.CAPR-08-0101; Panka DJ, 2006, CLIN CANCER RES, V12, p2371S, DOI 10.1158/1078-0432.CCR-05-2539; Placzek M, 2007, BRIT J DERMATOL, V156, P843, DOI 10.1111/j.1365-2133.2007.07795.x; Plotz M, 2013, CANCER LETT, V335, P100, DOI 10.1016/j.canlet.2013.02.005; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; Rieber M, 2000, INT J CANCER, V86, P462, DOI 10.1002/(SICI)1097-0215(20000515)86:4<462::AID-IJC3>3.0.CO;2-B; Russo GL, 2014, CANCER TREAT RES, V159, P185, DOI 10.1007/978-3-642-38007-5_11; Russo M, 2003, ONCOGENE, V22, P3330, DOI 10.1038/sj.onc.1206493; Ryu HC, 2010, J INVEST DERMATOL, V130, P1095, DOI 10.1038/jid.2009.436; Salucci S, 2013, INT J MOL SCI, V14, P532, DOI 10.3390/ijms14010532; Sarkar M, 2006, CYTOM PART B-CLIN CY, V70B, P20, DOI 10.1002/cyto.b.20082; SHINDO Y, 1993, J INVEST DERMATOL, V100, P260, DOI 10.1111/1523-1747.ep12469048; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Smalley KSM, 2010, J INVEST DERMATOL, V130, P28, DOI 10.1038/jid.2009.177; Uchide N, 2009, INTERVIROLOGY, V52, P164, DOI 10.1159/000224644; Ueda Y, 2006, PIGM CELL RES, V19, P112, DOI 10.1111/j.1600-0749.2006.00304.x; van den Berg R, 2001, BRIT J NUTR, V86, pS121, DOI 10.1079/BJN2001340; Vermeulen K, 2003, CELL PROLIFERAT, V36, P165, DOI 10.1046/j.1365-2184.2003.00267.x; Yu WP, 2003, CANCER RES, V63, P2483; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang W, 2009, EUR J GYNAECOL ONCOL, V30, P60	50	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131253	10.1371/journal.pone.0131253	http://dx.doi.org/10.1371/journal.pone.0131253			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148186	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600076
J	Uchiyama, M; Terunuma, J; Hanaoka, F				Uchiyama, Masashi; Terunuma, Junko; Hanaoka, Fumio			The Protein Level of Rev1, a TLS Polymerase in Fission Yeast, Is Strictly Regulated during the Cell Cycle and after DNA Damage	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE REV1; C-TERMINAL DOMAIN; SCHIZOSACCHAROMYCES-POMBE; TRANSLESION SYNTHESIS; LESION BYPASS; S-PHASE; CHROMATIN BINDING; COMPLEX-FORMATION; STRUCTURAL BASIS; 26S PROTEASOME	Translesion DNA synthesis provides an alternative DNA replication mechanism when template DNA is damaged. In fission yeast, Eso1 (pol eta), Kpa1/DinB (pol kappa), Rev1, and Pol zeta (a complex of Rev3 and Rev7) have been identified as translesion synthesis polymerases. The enzymatic characteristics and protein-protein interactions of these polymerases have been intensively characterized; however, how these proteins are regulated during the cell cycle remains unclear. Therefore, we examined the cell cycle oscillation of translesion polymerases. Interestingly, the protein levels of Rev1 peaked during G(1) phase and then decreased dramatically at the entry of S phase; this regulation was dependent on the proteasome. Temperature-sensitive proteasome mutants, such as mts2-U31 and mts3-U32, stabilized Rev1 protein when the temperature was shifted to the restrictive condition. In addition, deletion of pop1 or pop2, subunits of SCF ubiquitin ligase complexes, upregulated Rev1 protein levels. Besides these effects during the cell cycle, we also observed upregulation of Rev1 protein upon DNA damage. This upregulation was abolished when rad3, a checkpoint protein, was deleted or when the Rev1 promoter was replaced with a constitutive promoter. From these results, we hypothesize that translesion DNA synthesis is strictly controlled through Rev1 protein levels in order to avoid unwanted mutagenesis.	[Uchiyama, Masashi; Terunuma, Junko; Hanaoka, Fumio] Gakushuin Univ, Fac Sci, Inst Biomol Sci, Toshima Ku, Tokyo 171, Japan	Gakushuin University	Hanaoka, F (corresponding author), Gakushuin Univ, Fac Sci, Inst Biomol Sci, Toshima Ku, Tokyo 171, Japan.	fumio.hanaoka@gakushuin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22131008]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas (22131008 to FH) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya N, 2005, MOL CELL BIOL, V25, P9734, DOI 10.1128/MCB.25.21.9734-9740.2005; Acharya N, 2009, P NATL ACAD SCI USA, V106, P9631, DOI 10.1073/pnas.0902175106; Akagi JI, 2009, DNA REPAIR, V8, P585, DOI 10.1016/j.dnarep.2008.12.006; AVES SJ, 1985, EMBO J, V4, P457, DOI 10.1002/j.1460-2075.1985.tb03651.x; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Callegari AJ, 2010, P NATL ACAD SCI USA, V107, P8219, DOI 10.1073/pnas.1003449107; Carr AM, 1998, MICROBIOL-UK, V144, P5, DOI 10.1099/00221287-144-1-5; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; D'Souza S, 2006, MOL CELL BIOL, V26, P8173, DOI 10.1128/MCB.00202-06; Feng WY, 2001, MOL CELL BIOL, V21, P4495, DOI 10.1128/MCB.21.14.4495-4504.2001; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Forsburg SL, 1997, GENE, V191, P191, DOI 10.1016/S0378-1119(97)00058-9; Gao J, 2014, CURR GENET, V60, P109, DOI 10.1007/s00294-013-0406-x; Goodman MF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010363; GORDON C, 1993, NATURE, V366, P355, DOI 10.1038/366355a0; Gordon C, 1996, J BIOL CHEM, V271, P5704, DOI 10.1074/jbc.271.10.5704; Guo CX, 2006, MOL CELL, V23, P265, DOI 10.1016/j.molcel.2006.05.038; Guo DY, 2001, NUCLEIC ACIDS RES, V29, P2875, DOI 10.1093/nar/29.13.2875; Haracska L, 2002, J BIOL CHEM, V277, P15546, DOI 10.1074/jbc.M112146200; Harkins V, 2009, GENETICS, V183, P1269, DOI 10.1534/genetics.109.110155; Harris P, 1996, MOL GEN GENET, V252, P284; Hicks JK, 2010, MOL CELL BIOL, V30, P1217, DOI 10.1128/MCB.00993-09; Hirano Y, 2006, CURR BIOL, V16, P586, DOI 10.1016/j.cub.2006.01.063; Jallepalli PV, 1998, P NATL ACAD SCI USA, V95, P8159, DOI 10.1073/pnas.95.14.8159; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; Kai M, 2003, MUTAT RES-FUND MOL M, V532, P59, DOI 10.1016/j.mrfmmm.2003.08.010; Kearsey SE, 2000, EMBO J, V19, P1681, DOI 10.1093/emboj/19.7.1681; Kikuchi S, 2012, J BIOL CHEM, V287, P33847, DOI 10.1074/jbc.M112.396838; Kim H, 2012, NAT STRUCT MOL BIOL, V19, P164, DOI 10.1038/nsmb.2222; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kominami K, 1998, GENES CELLS, V3, P721, DOI 10.1046/j.1365-2443.1998.00225.x; Kominami K, 1997, GENE DEV, V11, P1548, DOI 10.1101/gad.11.12.1548; Kosarek JN, 2008, DNA REPAIR, V7, P439, DOI 10.1016/j.dnarep.2007.11.016; LARIMER FW, 1989, J BACTERIOL, V171, P230, DOI 10.1128/jb.171.1.230-237.1989; Lawrence CW, 2002, DNA REPAIR, V1, P425, DOI 10.1016/S1568-7864(02)00038-1; Lawrence CW, 2001, PHILOS T R SOC B, V356, P41, DOI 10.1098/rstb.2000.0001; Leatherwood J, 1996, NATURE, V379, P360, DOI 10.1038/379360a0; Livneh Z, 2010, CELL CYCLE, V9, P729, DOI 10.4161/cc.9.4.10727; Lopez-Girona A, 1998, MOL BIOL CELL, V9, P63, DOI 10.1091/mbc.9.1.63; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Masutani C, 2008, ADV EXP MED BIOL, V637, P93; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; Matsuyama A, 2008, YEAST, V25, P371, DOI 10.1002/yea.1593; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morita T, 2004, YEAST, V21, P613, DOI 10.1002/yea.1104; MuziFalconi M, 1996, P NATL ACAD SCI USA, V93, P1566, DOI 10.1073/pnas.93.4.1566; NASMYTH K, 1981, MOL GEN GENET, V182, P119, DOI 10.1007/BF00422777; NASMYTH KA, 1979, J MOL BIOL, V130, P273, DOI 10.1016/0022-2836(79)90541-2; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; NISHITANI H, 1995, CELL, V83, P397, DOI 10.1016/0092-8674(95)90117-5; Northam MR, 2010, GENETICS, V184, P27, DOI 10.1534/genetics.109.107482; Ohmori H, 2009, ADV PROTEIN CHEM STR, V78, P99, DOI 10.1016/S1876-1623(09)78004-0; Pages V, 2009, GENE DEV, V23, P1438, DOI 10.1101/gad.1793409; Pozhidaeva A, 2012, BIOCHEMISTRY-US, V51, P5506, DOI 10.1021/bi300566z; Prakash S, 2002, GENE DEV, V16, P1872, DOI 10.1101/gad.1009802; Pustovalova Y, 2013, J MOL BIOL, V425, P3091, DOI 10.1016/j.jmb.2013.05.029; Pustovalova Y, 2012, FEBS LETT, V586, P3051, DOI 10.1016/j.febslet.2012.07.021; Ricke RM, 2005, BIOL PROCED ONLINE, V7, P60, DOI 10.1251/bpo106; Sabbioneda S, 2007, DNA REPAIR, V6, P121, DOI 10.1016/j.dnarep.2006.09.002; Tanaka K, 2000, MOL CELL BIOL, V20, P3459, DOI 10.1128/MCB.20.10.3459-3469.2000; Uchiyama M, 2004, MOL CELL BIOL, V24, P7419, DOI 10.1128/MCB.24.17.7419-7434.2004; Vaisman A, 2002, MUTAT RES-FUND MOL M, V510, P9, DOI 10.1016/S0027-5107(02)00248-8; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Waters LS, 2006, P NATL ACAD SCI USA, V103, P8971, DOI 10.1073/pnas.0510167103; Wilkinson CRM, 1999, PHILOS T R SOC B, V354, P1523, DOI 10.1098/rstb.1999.0496; Wiltrout ME, 2011, DNA REPAIR, V10, P169, DOI 10.1016/j.dnarep.2010.10.008; Wiltrout ME, 2011, GENETICS, V187, P21, DOI 10.1534/genetics.110.124172; Wojtaszek J, 2012, J BIOL CHEM, V287, P33836, DOI 10.1074/jbc.M112.394841; Wojtaszek J, 2012, J BIOL CHEM, V287, P26400, DOI 10.1074/jbc.M112.380998; Xie W, 2012, PROTEIN CELL, V3, P864, DOI 10.1007/s13238-012-2102-x; Yanagida M, 1999, PHILOS T R SOC B, V354, P1559, DOI 10.1098/rstb.1999.0499	73	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130000	10.1371/journal.pone.0130000	http://dx.doi.org/10.1371/journal.pone.0130000			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147350	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600028
J	Chappell, J; Phillips, AC; van Noordwijk, MA; Setia, TM; Thorpe, SKS				Chappell, Jackie; Phillips, Abigail C.; van Noordwijk, Maria A.; Setia, Tatang Mitra; Thorpe, Susannah K. S.			The Ontogeny of Gap Crossing Behaviour in Bornean Orangutans (Pongo pygmaeus wurmbii)	PLOS ONE			English	Article							POSITIONAL BEHAVIOR; WILD ORANGUTANS; SUMATRAN ORANGUTANS; POSTURAL BEHAVIOR; LOCOMOTOR ECOLOGY; BODY SIZE; PRIMATES; INDONESIA; ABELII; COMPETENCE	For orangutans, the largest predominantly arboreal primates, discontinuous canopy presents a particular challenge. The shortest gaps between trees lie between thin peripheral branches, which offer the least stability to large animals. The affordances of the forest canopy experienced by orangutans of different ages however, must vary substantially as adult males are an order of magnitude larger in size than infants during the early stages of locomotor independence. Orangutans have developed a diverse range of locomotor behaviour to cross gaps between trees, which vary in their physical and cognitive demands. The aims of this study were to examine the ontogeny of orangutan gap crossing behaviours and to determine which factors influence the distance orangutans crossed. A non-invasive photographic technique was used to quantify forearm length as a measure of body size. We also recorded locomotor behaviour, support use and the distance crossed between trees. Our results suggest that gap crossing varies with both physical and cognitive development. More complex locomotor behaviours, which utilized compliant trunks and lianas, were used to cross the largest gaps, but these peaked in frequency much earlier than expected, between the ages of 4 and 5 years old, which probably reflects play behaviour to perfect locomotor techniques. Smaller individuals also crossed disproportionately large gaps relative to their size, by using support deformation. Our results suggest that orangutans acquire the full repertoire of gap crossing techniques, including the more cognitively demanding ones, before weaning, but adjust the frequency of the use of these techniques to their increasing body size.	[Chappell, Jackie; Phillips, Abigail C.; Thorpe, Susannah K. S.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [van Noordwijk, Maria A.] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland; [Setia, Tatang Mitra] Univ Nas, Fac Biol, Jakarta, Indonesia	University of Birmingham; University of Zurich; Universitas Nasional Pionir Perubahan	Thorpe, SKS (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	S.K.Thorpe@bham.ac.uk	Chappell, Jackie/W-6772-2019	Chappell, Jackie/0000-0001-7338-9449; Thorpe, Susannah/0000-0002-6160-4452; Mitra Setia, Tatang/0000-0003-2667-5199	NERC [NE/H526427/1]; A.H. Schultz foundation; NERC [NE/F003307/1] Funding Source: UKRI; Natural Environment Research Council [NE/F003307/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); A.H. Schultz foundation; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by NERC (NE/H526427/1; www.nerc.ac.uk) and the A.H. Schultz foundation, who provide major financial support for the Tuanan orangutan research project.	ADOLPH KE, 1993, CHILD DEV, V64, P1158, DOI 10.2307/1131332; ALEXANDER R M, 1991, Zeitschrift fuer Morphologie und Anthropologie, V78, P315; BARD KA, 1995, PRIMATES, V36, P297, DOI 10.1007/BF02382855; CANNON CH, 1994, AM J PHYS ANTHROPOL, V93, P505, DOI 10.1002/ajpa.1330930409; CANT JGH, 1992, AM J PHYS ANTHROPOL, V88, P273, DOI 10.1002/ajpa.1330880302; CANT JGH, 1987, AM J PHYS ANTHROPOL, V74, P143, DOI 10.1002/ajpa.1330740202; CANT JGH, 1987, AM J PRIMATOL, V12, P71, DOI 10.1002/ajp.1350120104; CANT JGH, 1994, CURRENT PRIMATOLOGY, V1, P187; CHEVALIERSKOLNIKOFF S, 1982, J HUM EVOL, V11, P639, DOI 10.1016/S0047-2484(82)80010-9; CHEVALIERSKOLNIKOFF S, 1983, J HUM EVOL, V12, P545, DOI 10.1016/S0047-2484(83)80034-7; DEMES B, 1995, AM J PHYS ANTHROPOL, V96, P419, DOI 10.1002/ajpa.1330960407; GEBO DL, 1992, AM J PRIMATOL, V26, P277, DOI 10.1002/ajp.1350260405; GIBSON EJ, 1988, ANNU REV PSYCHOL, V39, P1, DOI 10.1146/annurev.ps.39.020188.000245; GRAND TI, 1972, J MAMMAL, V53, P198, DOI 10.2307/1378849; Hunt KD, 1996, PRIMATES, V37, P363, DOI 10.1007/BF02381373; Jaeggi AV, 2010, AM J PRIMATOL, V72, P62, DOI 10.1002/ajp.20752; MACKINNON J, 1974, ANIM BEHAV, V22, P3, DOI 10.1016/S0003-3472(74)80054-0; Manduell KL, 2012, AM J PRIMATOL, V74, P1128, DOI 10.1002/ajp.22072; Manduell KL, 2011, AM J PHYS ANTHROPOL, V145, P348, DOI 10.1002/ajpa.21495; Manduell KL, 2012, THESIS U BIRMINGHAM; Myatt JP, 2011, AM J PHYS ANTHROPOL, V146, P73, DOI 10.1002/ajpa.21548; PALMER CF, 1989, DEV PSYCHOL, V25, P885, DOI 10.1037/0012-1649.25.6.885; Phillips AC, 2011, THESIS U BIRMINGHAM; Rothman JM, 2008, AM J PRIMATOL, V70, P1191, DOI 10.1002/ajp.20611; Schuppli C, 2012, J HUM EVOL, V63, P843, DOI 10.1016/j.jhevol.2012.08.009; SUGARDJITO J, 1986, FOLIA PRIMATOL, V47, P14, DOI 10.1159/000156260; TEMERIN LA, 1983, AM NAT, V122, P335, DOI 10.1086/284139; Thorpe SKS, 2007, BIOLOGY LETT, V3, P253, DOI 10.1098/rsbl.2007.0049; Thorpe SKS, 2005, AM J PHYS ANTHROPOL, V127, P58, DOI 10.1002/ajpa.20151; Thorpe SKS, 2006, AM J PHYS ANTHROPOL, V131, P384, DOI 10.1002/ajpa.20422; Thorpe SKS, 2009, P NATL ACAD SCI USA, V106, P12646, DOI 10.1073/pnas.0811537106; van Noordwijk MA, 2005, AM J PHYS ANTHROPOL, V127, P79, DOI 10.1002/ajpa.10426; van Noordwijk MA, 2013, BEHAV ECOL SOCIOBIOL, V67, P805, DOI 10.1007/s00265-013-1504-y; van Noordwijk Maria A., 2009, P189; van Schaik CP, 2005, PRIMATES, V46, P249, DOI 10.1007/s10329-005-0134-z; Wich SA, 2004, J HUM EVOL, V47, P385, DOI 10.1016/j.jhevol.2004.08.006	36	14	14	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130291	10.1371/journal.pone.0130291	http://dx.doi.org/10.1371/journal.pone.0130291			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154061	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000358159700029
J	van der Zee, R; Gray, A; Pisa, L; de Rijk, T				van der Zee, Romee; Gray, Alison; Pisa, Lennard; de Rijk, Theo			An Observational Study of Honey Bee Colony Winter Losses and Their Association with Varroa destructor, Neonicotinoids and Other Risk Factors	PLOS ONE			English	Article							APIS-MELLIFERA; INSECTICIDES; POLLEN; TOXICITY; RESIDUES	This article presents results of an analysis of honey bee losses over the winter of 2011-2012 in the Netherlands, from a sample of 86 colonies, located at 43 apiaries. The apiaries were selected using spatially stratified random sampling. Colony winter loss data were collected and related to various measures of colony strength recorded in summer, as well as data from laboratory analysis of sample material taken from two selected colonies in each of the 43 apiaries. The logistic regression model which best explained the risk of winter loss included, in order of statistical importance, the variables (1) Varroa destructor mite infestation rate in October 2011, (2) presence of the cyano-substituted neonicotinoids acetamiprid or thiacloprid in the first 2 weeks of August 2011 in at least one of the honey bee matrices honey, bees or bee bread (pollen), (3) presence of Brassica napus (oilseed rape) or Sinapis arvensis (wild mustard) pollen in bee bread in early August 2011, and (4) a measure of the unexplained winter losses for the postal code area where the colonies were located, obtained from a different dataset. We consider in the discussion that reduced opportunities for foraging in July and August because of bad weather may have added substantially to the adverse effects of acetamiprid and thiacloprid. A novel feature of this work is its use of postal code random effects from two other independent datasets collected in the annual national monitoring by questionnaires of winter losses of honey bees in the Netherlands. These were used to plan the sample selection and also in the model fitting of the data in this study. It should however be noted that the results of the present pilot study are based on limited data, which may consequently reveal strong factors but fail to demonstrate possible interaction effects.	[van der Zee, Romee; Pisa, Lennard] Netherlands Ctr Bee Res, Tersoal, Netherlands; [Gray, Alison] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland; [de Rijk, Theo] RIKILT Wageningen UR, Inst Food Safety, Wageningen, Netherlands	University of Strathclyde; Wageningen University & Research	van der Zee, R (corresponding author), Netherlands Ctr Bee Res, Tersoal, Netherlands.	romee.van.der.zee@beemonitoring.org	Gray, Alison/GWQ-4596-2022; Gray, Alison/L-1063-2017	Gray, Alison/0000-0002-6273-0637	Dutch Ministry of Economic Affairs	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This research was funded by an award from the Dutch Ministry of Economic Affairs (http://www.government.nl/ministries/ez). The funders had no role in study design, data collection or analysis, decision to publish or manuscript preparation.	Becher MA, 2013, J APPL ECOL, V50, P868, DOI 10.1111/1365-2664.12112; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bleker H, 2011, BEANTWOORDING VRAGEN; Botias C, 2012, ENVIRON MICROBIOL, V14, P845, DOI 10.1111/j.1462-2920.2011.02647.x; CBS PBL Wageningen UR, 2011, GERBRUIK GEWASBESCHE; Chantawannakul P, 2006, J INVERTEBR PATHOL, V91, P69, DOI 10.1016/j.jip.2005.11.001; Chauzat MP, 2009, ENVIRON ENTOMOL, V38, P514, DOI 10.1603/022.038.0302; Drager K, 2012, LANG VAR CHANGE, V24, P59, DOI 10.1017/S0954394512000014; FLURI P, 1982, J INSECT PHYSIOL, V28, P61, DOI 10.1016/0022-1910(82)90023-3; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Kleijn D, 2008, ECOLOGY, V89, P1811, DOI 10.1890/07-1275.1; Laurino D, 2011, B INSECTOL, V64, P107; Liebig G., 2001, APIDOLOGIE, V32, P484, DOI [10.1051/apido:2001156, DOI 10.1051/APIDO:2001156]; Maccagnani B., 2008, Informatore Agrario, V64, P53; Nguyen BK, 2009, J ECON ENTOMOL, V102, P616, DOI 10.1603/029.102.0220; OIE Terrestrial Manual, 2008, OIE TERRESTRIAL MANU, P428; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramirez-Romero R, 2005, APIDOLOGIE, V36, P601, DOI 10.1051/apido:2005039; Ravoet J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072443; Retschnig G, 2015, ENVIRON MICROBIOL, V17, P4322, DOI 10.1111/1462-2920.12825; Rijksinstituut voor Volksgezondheid en Milieu ( RIVM), 2013, MIN HLTH WELF SPORT; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; SANCO, SANCO125712013; Simon-Delso N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103073; Van Der Zee R, 2011, NCB REPORTS MONITOR; Van Der Zee R, 2013, NCB REPORTS MONITOR; Van Der Zee R, 2012, NCB REPORTS MONITOR; van der Zee R, 2014, J APICULT RES, V53, P19, DOI 10.3896/IBRA.1.53.1.02; van der Zee R, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.18; van der Zee R, 2012, J APICULT RES, V51, P91, DOI 10.3896/IBRA.1.51.1.12; van der Zee R, 2010, J APICULT RES, V49, P121, DOI 10.3896/IBRA.1.49.1.25; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374; van Dooremalen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036285; Wallner K, 1999, APIDOLOGIE, V30, P235, DOI 10.1051/apido:19990212; WILLE H, 1985, REV SUISSE ZOOL, V92, P897, DOI 10.5962/bhl.part.81921; Wille M, 1983, BIENENZTG, V5, P253; Zuur Alain F., 2009, P1	40	47	50	3	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131611	10.1371/journal.pone.0131611	http://dx.doi.org/10.1371/journal.pone.0131611			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154346	gold, Green Published			2022-12-27	WOS:000358159700074
J	Rodenburg-Vandenbussche, S; Pieterse, AH; Kroonenberg, PM; Scholl, I; van der Weijden, T; Luyten, GPM; Kruitwagen, RFPM; den Ouden, H; Carlier, IVE; van Vliet, IM; Zitman, FG; Stiggelbout, AM				Rodenburg-Vandenbussche, Sumayah; Pieterse, Arwen H.; Kroonenberg, Pieter M.; Scholl, Isabelle; van der Weijden, Trudy; Luyten, Gre P. M.; Kruitwagen, Roy F. P. M.; den Ouden, Henk; Carlier, Ingrid V. E.; van Vliet, Irene M.; Zitman, Frans G.; Stiggelbout, Anne M.			Dutch Translation and Psychometric Testing of the 9-Item Shared Decision Making Questionnaire (SDM-Q-9) and Shared Decision Making Questionnaire-Physician Version (SDM-Q-Doc) in Primary and Secondary Care	PLOS ONE			English	Article								Purpose The SDM-Q-9 and SDM-Q-Doc measure patient and physician perception of the extent of shared decision making (SDM) during a physician-patient consultation. So far, no self-report instrument for SDM was available in Dutch, and validation of the scales in other languages has been limited. The aim of this study was to translate both scales into Dutch and assess their psychometric characteristics. Methods Participants were patients and their treating physicians (general practitioners and medical specialists). Patients (N = 182) rated their consultation using the SDM-Q-9, 43 physicians rated their consultations using the SDM-Q-Doc (N = 201). Acceptability, reliability (internal consistency), and the factorial structure of the instruments were determined. For convergent validity the CPSpost was used. Results Reliabilities of both scales were high (alpha SDM-Q-9 0.88; SDM-Q-Doc 0.87). The SDM-Q-9 and SDM-Q-Doc total scores correlated as expected with the CPSpost (SDM-Q-9: r = 0.29; SDM-Q-Doc: r = 0.48) and were significantly different between the CPSpost categories, with lowest mean scores when the physician made the decision alone. Principal Component Analyses showed a two-component model for each scale. A confirmatory factor analysis yielded a mediocre, but acceptable, one-factor model, if Item 1 was excluded; for both scales the best indices of fit were obtained for a one-factor solution, if both Items 1 and 9 were excluded. Conclusion The Dutch SDM-Q-9 and SDM-Q-Doc demonstrate good acceptance and reliability; they correlated as expected with the CPSpost and are suitable for use in Dutch primary and specialised care. Although the best model fit was found when excluding Items 1 and 9, we believe these items address important aspects of SDM. Therefore, also based on the coherence with theory and comparability with other studies, we suggest keeping all nine items of the scale. Further research on the SDM-concept in patients and physicians, in different clinical settings and different countries, is necessary to gain a better understanding of the SDM-onstruct and its measurement.	[Rodenburg-Vandenbussche, Sumayah; Carlier, Ingrid V. E.; van Vliet, Irene M.; Zitman, Frans G.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Pieterse, Arwen H.; Stiggelbout, Anne M.] Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands; [Kroonenberg, Pieter M.] Leiden Univ, Med Ctr, Dept Child & Family Studies, Leiden, Netherlands; [Scholl, Isabelle] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [van der Weijden, Trudy] Maastricht Univ, Dept Family Med, Sch CAPHRI, Maastricht, Netherlands; [Luyten, Gre P. M.] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands; [Kruitwagen, Roy F. P. M.] Maastricht Univ, Dept Gynaecol, Maastricht, Netherlands; [den Ouden, Henk] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Hamburg; University Medical Center Hamburg-Eppendorf; Maastricht University; Maastricht University Medical Centre (MUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Maastricht University; Utrecht University; Utrecht University Medical Center	Rodenburg-Vandenbussche, S (corresponding author), Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands.	S.Rodenburg-Vandenbussche@lumc.nl	Stiggelbout, Anne M/D-2293-2018; Pieterse, Arwen/C-2367-2018; Scholl, Isabelle/AAN-9450-2020	Stiggelbout, Anne M/0000-0002-6293-4509; Scholl, Isabelle/0000-0002-7639-0880; Kroonenberg, Pieter M./0000-0002-0018-0975; van der weijden, trudy/0000-0002-7469-3781; Pieterse, Arwen/0000-0001-6395-0052				Byrne B. M., 2006, STRUCTURAL EQUATION, V2nd; Coulter A, 2010, MAKING SHARED DECISI; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; De las Cuevas C, 2015, HEALTH EXPECT, V18, P2143, DOI 10.1111/hex.12183; De las Cuevas C, 2013, NEUROPSYCH DIS TREAT, V9, P1045, DOI 10.2147/NDT.S49021; Degner L F, 1997, Can J Nurs Res, V29, P21; Elwyn G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5146; Field A., 2009, DISCOVERING SPSS USI; General Medical Council UK, 1998, ETH GUID PROT PAT GU; Glass KE, 2012, PATIENT EDUC COUNS, V88, P100, DOI 10.1016/j.pec.2012.02.010; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.1037/1082[HYPHEN]989X.12.1.58, 10.21427/D79B73]; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kasper J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026255; Kriston L, 2010, PATIENT EDUC COUNS, V80, P94, DOI 10.1016/j.pec.2009.09.034; Scholl I, 2015, HEALTH EXPECT, V18, P137, DOI 10.1111/hex.12022; Scholl I, 2012, PATIENT EDUC COUNS, V88, P284, DOI 10.1016/j.pec.2012.03.005; Shay LA, 2015, MED DECIS MAKING, V35, P114, DOI 10.1177/0272989X14551638; Shay LA, 2014, PATIENT EDUC COUNS, V96, P295, DOI 10.1016/j.pec.2014.07.017; Simon D, 2006, PATIENT EDUC COUNS, V63, P319, DOI 10.1016/j.pec.2006.04.012; Stiggelbout AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e256; STRULL WM, 1984, JAMA-J AM MED ASSOC, V252, P2990, DOI 10.1001/jama.252.21.2990; SUTHERLAND HJ, 1989, J ROY SOC MED, V82, P260, DOI 10.1177/014107688908200506; van Prooijen JW, 2001, EDUC PSYCHOL MEAS, V61, P777, DOI 10.1177/00131640121971518; Wollschlager D, 2012, Z EVIDENZ FORTBILD Q, V106, P272, DOI 10.1016/j.zefq.2012.04.004; Yuan K, 1989, SOCIOL METHOD, P363	26	75	75	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132158	10.1371/journal.pone.0132158	http://dx.doi.org/10.1371/journal.pone.0132158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EC	26151946	Green Published, Green Submitted, gold			2022-12-27	WOS:000358158900037
J	Acosta-Herrera, M; Lorenzo-Diaz, F; Pino-Yanes, M; Corrales, A; Valladares, F; Klassert, TE; Valladares, B; Slevogt, H; Ma, SF; Villar, J; Flores, C				Acosta-Herrera, Marialbert; Lorenzo-Diaz, Fabian; Pino-Yanes, Maria; Corrales, Almudena; Valladares, Francisco; Klassert, Tilman E.; Valladares, Basilio; Slevogt, Hortense; Ma, Shwu-Fan; Villar, Jesus; Flores, Carlos			Lung Transcriptomics during Protective Ventilatory Support in Sepsis-Induced Acute Lung Injury	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENE-EXPRESSION; MECHANICAL VENTILATION; NEUROEPITHELIAL BODIES; ANGIOGENESIS; RESPONSES; MODELS; MICROARRAYS; VALIDATION; RECEPTORS	Acute lung injury (ALI) is a severe inflammatory process of the lung. The only proven life-saving support is mechanical ventilation (MV) using low tidal volumes (LVT) plus moderate to high levels of positive end-expiratory pressure (PEEP). However, it is currently unknown how they exert the protective effects. To identify the molecular mechanisms modulated by protective MV, this study reports transcriptomic analyses based on microarray and microRNA sequencing in lung tissues from a clinically relevant animal model of sepsis-induced ALI. Sepsis was induced by cecal ligation and puncture (CLP) in male Sprague-Dawley rats. At 24 hours post-CLP, septic animals were randomized to three ventilatory strategies: spontaneous breathing, LVT (6 ml/kg) plus 10 cmH(2)O PEEP and high tidal volume (HVT, 20 ml/kg) plus 2 cmH2O PEEP. Healthy, non-septic, non-ventilated animals served as controls. After 4 hours of ventilation, lung samples were obtained for histological examination and gene expression analysis using microarray and microRNA sequencing. Validations were assessed using parallel analyses on existing publicly available genome-wide association study findings and transcriptomic human data. The catalogue of deregulated processes differed among experimental groups. The 'response to microorganisms' was the most prominent biological process in septic, non-ventilated and in HVT animals. Unexpectedly, the 'neuron projection morphogenesis' process was one of the most significantly deregulated in LVT. Further support for the key role of the latter process was obtained by microRNA studies, as four species targeting many of its genes (Mir-27a, Mir-103, Mir-17-5p and Mir-130a) were found deregulated. Additional analyses revealed 'VEGF signaling' as a central underlying response mechanism to all the septic groups (spontaneously breathing or mechanically ventilated). Based on this data, we conclude that a co-deregulation of 'VEGF signaling' along with 'neuron projection morphogenesis', which have been never anticipated in ALI pathogenesis, promotes lung-protective effects of LVT with high levels of PEEP.	[Acosta-Herrera, Marialbert; Lorenzo-Diaz, Fabian; Pino-Yanes, Maria; Corrales, Almudena; Valladares, Francisco; Villar, Jesus; Flores, Carlos] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain; [Acosta-Herrera, Marialbert; Lorenzo-Diaz, Fabian; Pino-Yanes, Maria; Corrales, Almudena; Flores, Carlos] Hosp Univ NS Candelaria, Res Unit, Santa Cruz De Tenerife, Spain; [Acosta-Herrera, Marialbert; Villar, Jesus] Hosp Univ Dr Negrin, Res Unit, Las Palmas Gran Canaria, Spain; [Lorenzo-Diaz, Fabian; Valladares, Basilio; Flores, Carlos] Univ La Laguna, Inst Univ Enfermedades Trop & Salud Publ Canarias, Santa Cruz De Tenerife, Spain; [Pino-Yanes, Maria] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Valladares, Francisco] Univ La Laguna, Dept Anat Pathol & Histol, Santa Cruz De Tenerife, Spain; [Klassert, Tilman E.; Slevogt, Hortense] Jena Univ Hosp, Sept Res Ctr, Jena, Germany; [Ma, Shwu-Fan] Univ Chicago, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA; [Villar, Jesus] St Michaels Hosp, Li KaShing Knowledge Inst, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1W8, Canada	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Universidad de la Laguna; University of California System; University of California San Francisco; Universidad de la Laguna; Friedrich Schiller University of Jena; University of Chicago; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Flores, C (corresponding author), Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain.	cflores@ull.edu.es	Diaz, Fabian Lorenzo/M-2259-2016; Flores, Carlos/R-1159-2019; Villar, Jesús/R-4526-2019; Pino-Yanes, Maria/C-8498-2017; Corrales, Almudena/G-5391-2017	Diaz, Fabian Lorenzo/0000-0002-3398-198X; Villar, Jesús/0000-0001-5687-3562; Pino-Yanes, Maria/0000-0003-0332-437X; Corrales, Almudena/0000-0002-2207-5463; Flores, Carlos/0000-0001-5352-069X	Instituto de Salud Carlos III, Spain [CB06/06/1088, PI10/0393, PI14/00844]; European Regional Development Funds; European Union; Instituto de Salud Carlos III [FI11/00074, CD13/00304]; Fundacion Ramon Areces; German Research Foundation (Collaborative Research Center) [Transregio 124, A5]; German Federal Ministry of Education and Research (BMBF) [03Z2JN22]	Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); European Regional Development Funds(European Commission); European Union(European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Ramon Areces; German Research Foundation (Collaborative Research Center)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by CB06/06/1088, PI10/0393 and PI14/00844 from Instituto de Salud Carlos III, Spain, and co-financed by the European Regional Development Funds, "A way of making Europe" from the European Union to JV and CF. MAH and FLD were supported with fellowships from Instituto de Salud Carlos III (FI11/00074 and Sara Borrell CD13/00304, respectively). MPY was funded by Fundacion Ramon Areces. TEK and HS were supported by the German Research Foundation (Collaborative Research Center/Transregio 124, A5) and the German Federal Ministry of Education and Research (BMBF 03Z2JN22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Herrera M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00020; Adriaensen D, 2006, J APPL PHYSIOL, V101, P960, DOI 10.1152/japplphysiol.00267.2006; Altemeier WA, 2004, AM J PHYSIOL-LUNG C, V287, pL533, DOI 10.1152/ajplung.00004.2004; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barratt S, 2014, RESPIRATION, V87, P329, DOI 10.1159/000356034; Becker PM, 2001, AM J PHYSIOL-LUNG C, V281, pL1500, DOI 10.1152/ajplung.2001.281.6.L1500; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Bregeon F, 2005, ANESTHESIOLOGY, V102, P331; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Christie JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028268; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Copland IB, 2003, AM J RESP CRIT CARE, V168, P1051, DOI 10.1164/rccm.200208-964OC; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; de Paulis A, 2006, J IMMUNOL, V177, P7322, DOI 10.4049/jimmunol.177.10.7322; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; dos Santos CC, 2004, PHYSIOL GENOMICS, V19, P331, DOI 10.1152/physiolgenomics.00153.2004; Eichstaedt CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093314; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gharib SA, 2006, AM J RESP CRIT CARE, V173, P653, DOI 10.1164/rccm.200509-1473OC; Glaab E, 2012, BIOINFORMATICS, V28, pI451, DOI 10.1093/bioinformatics/bts389; Grigoryev DN, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r34; Herrera MT, 2003, INTENS CARE MED, V29, P1345, DOI 10.1007/s00134-003-1756-5; Hoshino M, 2001, J ALLERGY CLIN IMMUN, V107, P1034, DOI 10.1067/mai.2001.115626; Howrylak JA, 2009, PHYSIOL GENOMICS, V37, P133, DOI 10.1152/physiolgenomics.90275.2008; Huang CQ, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-46; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; Isella C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-382; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; Liu J, 2014, RESP PHYSIOL NEUROBI, V193, P52, DOI 10.1016/j.resp.2014.01.002; Madala SK, 2012, AM J RESP CELL MOL, V46, P380, DOI 10.1165/rcmb.2011-0237OC; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Nagy JA, 2003, TRENDS CARDIOVAS MED, V13, P169, DOI 10.1016/S1050-1738(03)00056-2; PARKER JC, 1993, CRIT CARE MED, V21, P131, DOI 10.1097/00003246-199301000-00024; Pogach MS, 2007, J CELL BIOCHEM, V100, P1415, DOI 10.1002/jcb.21142; Poli-De-Figueiredo LF, 2008, SHOCK, V30, P53, DOI 10.1097/SHK.0b013e318181a343; R Core Team, 2019, R LANG ENV STAT COMP; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Reynolds SD, 2000, AM J PATHOL, V156, P269, DOI 10.1016/S0002-9440(10)64727-X; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Segura I, 2009, TRENDS MOL MED, V15, P439, DOI 10.1016/j.molmed.2009.08.005; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thickett DR, 2002, AM J RESP CRIT CARE, V166, P1332, DOI 10.1164/rccm.2105057; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; Villar J, 2011, INTENS CARE MED, V37, P1932, DOI 10.1007/s00134-011-2380-4; Villar J, 2011, INTENS CARE MED, V37, P1201, DOI 10.1007/s00134-011-2234-0; Villar J, 2010, INTENS CARE MED, V36, P1049, DOI 10.1007/s00134-010-1799-3; Villar J, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-27; Villar J, 2009, ANESTHESIOLOGY, V110, P1341, DOI 10.1097/ALN.0b013e31819fcba9; Wang HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038885; Wurfel Mark M, 2007, Proc Am Thorac Soc, V4, P77, DOI 10.1513/pats.200608-149JG; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xing GQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002342; Yang GH, 2015, GENE, V562, P138, DOI 10.1016/j.gene.2015.02.065; Zacchigna S, 2008, NAT REV NEUROSCI, V9, P169, DOI 10.1038/nrn2336; Zhang R, 2015, AM J RESP CRIT CARE	59	20	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132296	10.1371/journal.pone.0132296	http://dx.doi.org/10.1371/journal.pone.0132296			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147972	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600234
J	Amaya, R; Pierides, A; Tarbell, JM				Amaya, Ronny; Pierides, Alexis; Tarbell, John M.			The Interaction between Fluid Wall Shear Stress and Solid Circumferential Strain Affects Endothelial Gene Expression	PLOS ONE			English	Article							FACTOR-KAPPA-B; CAROTID BIFURCATION; PHASE-ANGLE; IN-VITRO; HYPERCHOLESTEROLEMIC RABBITS; THERAPEUTIC IMPLICATIONS; SCAVENGER RECEPTOR; VE-CADHERIN; FAS LIGAND; ATHEROSCLEROSIS	Endothelial cells lining the walls of blood vessels are exposed simultaneously to wall shear stress (WSS) and circumferential stress (CS) that can be characterized by the temporal phase angle between WSS and CS (stress phase angle-SPA). Regions of the circulation with highly asynchronous hemodynamics (SPA close to -180 degrees) such as coronary arteries are associated with the development of pathological conditions such as atherosclerosis and intimal hyperplasia whereas more synchronous regions (SPA closer to 0 degrees) are spared of disease. The present study evaluates endothelial cell gene expression of 42 atherosclerosis-related genes under asynchronous hemodynamics (SPA=-180 degrees) and synchronous hemodynamics (SPA= 0 degrees). This study used a novel bioreactor to investigate the cellular response of bovine aortic endothelial cells (BAECS) exposed to a combination of pulsatile WSS and CS at SPA= 0 or SPA=-180. Using a PCR array of 42 genes, we determined that BAECS exposed to non-reversing sinusoidal WSS (10 +/- 10 dyne/cm(2)) and CS (4 +/- 4 %) over a 7 hour testing period displayed 17 genes that were up regulated by SPA = -180 degrees, most of them proatherogenic, including NF kappa B and other NF kappa B target genes. The up regulation of NF kappa B p50/p105 and p65 by SPA =-180 degrees was confirmed by Western blots and immunofluorescence staining demonstrating the nuclear translocation of NF kappa B p50/p105 and p65. These data suggest that asynchronous hemodynamics (SPA=-180 degrees) can elicit proatherogenic responses in endothelial cells compared to synchronous hemodynamics without shear stress reversal, indicating that SPA may be an important parameter characterizing arterial susceptibility to disease.	[Amaya, Ronny; Pierides, Alexis; Tarbell, John M.] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Tarbell, JM (corresponding author), CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA.	tarbell@ccny.cuny.edu			National Institutes of Health [HL 086543]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL 086543. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolakis S, 2010, ACTA PHARMACOL SIN, V31, P1103, DOI 10.1038/aps.2010.131; Barseghian A, 2011, J AM COLL CARDIOL, V57, P761, DOI 10.1016/j.jacc.2010.11.011; Berardi DE, 2009, CELL MOL BIOENG, V2, P320, DOI 10.1007/s12195-009-0073-7; Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Cancel LM, 2010, ATHEROSCLEROSIS, V208, P335, DOI 10.1016/j.atherosclerosis.2009.07.051; Celletti FL, 2001, NAT MED, V7, P425, DOI 10.1038/86490; Chang K, 2007, CIRCULATION, V116, P1258, DOI 10.1161/CIRCULATIONAHA.106.683227; Collins T, 2001, J CLIN INVEST, V107, P255, DOI 10.1172/JCI10373; Dancu MB, 2004, ARTERIOSCL THROM VAS, V24, P2088, DOI 10.1161/01.ATV.0000143855.85343.0e; Dancu MB, 2007, ATHEROSCLEROSIS, V192, P9, DOI 10.1016/j.atherosclerosis.2006.05.042; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; Denk A, 2001, J BIOL CHEM, V276, P28451, DOI 10.1074/jbc.M102698200; Faraci FM, 2004, ARTERIOSCL THROM VAS, V24, P1367, DOI 10.1161/01.ATV.0000133604.20182.cf; Fico A, 2011, CELL MOL LIFE SCI, V68, P923, DOI 10.1007/s00018-007-7471-6; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; IADEMARCO MF, 1992, J BIOL CHEM, V267, P16323; Ishino S, 2007, ATHEROSCLEROSIS, V195, P48, DOI 10.1016/j.atherosclerosis.2006.11.031; Joshi AK, 2004, ARTERIOSCL THROM VAS, V24, P2408, DOI 10.1161/01.ATV.0000147118.97474.4b; Kempe S, 2005, NUCLEIC ACIDS RES, V33, P5308, DOI 10.1093/nar/gki836; KOSLOW AR, 1986, J BIOMECH ENG-T ASME, V108, P338, DOI 10.1115/1.3138625; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; Leychenko A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029055; Li JJ, 2005, MED HYPOTHESES, V64, P694, DOI 10.1016/j.mehy.2004.11.043; Lucerna M, 2007, BLOOD, V109, P122, DOI 10.1182/blood-2006-07-031773; Marx N, 1998, AM J PATHOL, V153, P17, DOI 10.1016/S0002-9440(10)65540-X; Miao H, 2005, J VASC RES, V42, P77, DOI 10.1159/000083094; Miyazaki T, 2011, CIRCULATION, V124, P2522, DOI 10.1161/CIRCULATIONAHA.111.021675; Mofrad MRK, 2010, CELLULAR MECHANOTRAN, V465, pxii; Murphy JE, 2008, J CELL SCI, V121, P2136, DOI 10.1242/jcs.020917; Nagase M, 1998, J BIOL CHEM, V273, P33702, DOI 10.1074/jbc.273.50.33702; Naj AC, 2010, CIRC-CARDIOVASC GENE, V3, P47, DOI 10.1161/CIRCGENETICS.109.903195; NEUHAUS KL, 1980, Z KARDIOL, V69, P235; Nuotio K, 2007, STROKE, V38, P1791, DOI 10.1161/STROKEAHA.106.478867; Oscuii HN, 2007, J MECH MED BIOL, V7, P433; Peiffer V, 2013, CARDIOVASC RES, V99, P242, DOI 10.1093/cvr/cvt044; Qiao DH, 2012, J BIOL CHEM, V287, P5898, DOI 10.1074/jbc.M111.325282; Qiu YC, 1996, ASAIO J, V42, pM702, DOI 10.1097/00002480-199609000-00078; Qiu YC, 2000, J VASC RES, V37, P147, DOI 10.1159/000025726; Sadeghi MR, 2011, J BIOMECH, V44, P2614, DOI 10.1016/j.jbiomech.2011.08.017; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Schneider DB, 2000, ARTERIOSCL THROM VAS, V20, P298, DOI 10.1161/01.ATV.20.2.298; Schulick AH, 1998, P NATL ACAD SCI USA, V95, P6983, DOI 10.1073/pnas.95.12.6983; Singh NP, 2007, MOL PHARMACOL, V71, P145, DOI 10.1124/mol.106.028365; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Steinman DA, 2002, MAGN RESON MED, V47, P149, DOI 10.1002/mrm.10025; Stoneman VEA, 2004, CLIN SCI, V107, P343, DOI 10.1042/CS20040086; Tada S, 2005, ANN BIOMED ENG, V33, P1202, DOI 10.1007/s10439-005-5630-1; Tada S, 2007, BIOPHYS J, V93, P3026, DOI 10.1529/biophysj.106.100685; Taylor FB, 2001, BLOOD, V97, P1685, DOI 10.1182/blood.V97.6.1685; Toda M, 2008, J BIOTECHNOL, V133, P239, DOI 10.1016/j.jbiotec.2007.08.009; van Popele NM, 2001, STROKE, V32, P454, DOI 10.1161/01.STR.32.2.454; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WANG DL, 1993, BIOCHEM BIOPH RES CO, V195, P1050, DOI 10.1006/bbrc.1993.2150; Wang WL, 2008, J CELL PHYSIOL, V214, P750, DOI 10.1002/jcp.21271; Wilson SH, 2000, ATHEROSCLEROSIS, V148, P23, DOI 10.1016/S0021-9150(99)00211-7; Yang ZH, 2006, CLIN MED RES, V4, P53, DOI 10.3121/cmr.4.1.53; Zhu NL, 2007, GENE, V393, P70, DOI 10.1016/j.gene.2007.01.016	58	31	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0129952	10.1371/journal.pone.0129952	http://dx.doi.org/10.1371/journal.pone.0129952			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147292	Green Published, gold			2022-12-27	WOS:000358157600027
J	Chen, Q; Sun, XD; Cao, H; Zhang, GC; Chen, LW; Hu, YN				Chen, Qiang; Sun, Xu-Dong; Cao, Hua; Zhang, Gui-Can; Chen, Liang-Wan; Hu, Yun-Nan			Echocardiographic Evaluation of Changes in Cardiac Hemodynamics and Loading Conditions after Transthoracic Minimally Invasive Device Closure of Atrial Septal Defect	PLOS ONE			English	Article							RIGHT-VENTRICULAR FUNCTION; TRANSCATHETER CLOSURE; 3-DIMENSIONAL ECHOCARDIOGRAPHY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; CHILDREN; VOLUME; SYNCHRONICITY; OCCLUSION; OCCLUDER; IMPACTS	Purpose To evaluate transthoracic minimally invasive device closure of atrial septal defects by performing transthoracic echocardiography to measure changes in cardiac hemodynamics and loading conditions. Methods Between January 2012 and December 2012, we performed transthoracic minimally invasive device closure of atrial septal defects in 95 patients with secundum atrial septal defects (ASD), and performed transthoracic echocardiography to measure blood flow velocities at the tricuspid valve orifice and at the pulmonary valve orifice, sizes of the left and right atria and ventricles, right ventricular fractional area change, right ventricular Tei index, three-dimensional right ventricular ejection fraction, tricuspid annular plane systolic excursion and left ventricular ejection fractions before the procedure and 1 week, 3 months, and 1 year post-procedure. Results Varying degrees of improvement were observed post-procedure at later time points. The maximum blood flow velocity at the pulmonary valve orifice, mean flow velocity, velocity-time integral, and A peak and E peak blood flow velocity at the tricuspid valve orifice decreased significantly post-procedure (P < 0.05). In 3 months and 1 year's follow-up, the inner diameter of the middle portion of the pulmonary artery, and diameters of the right atrium and right ventricle decreased significantly post-procedure (P < 0.05). The diameters of the left atrium and left ventricle increased after the procedure (P < 0.05). One week after the procedure, the right ventricular fractional area change, three-dimensional right ventricular ejection fraction, right ventricular Tei index and tricuspid annular plane systolic excursion had significantly reduced compared with the preoperative data (P < 0.05). While these four parameters were still decreased at the 3 months and at 1 year's follow-up, but the differences were not statistically significant compared with the 1 week's postoperative data (P > 0.05). One week post-procedure, left ventricular ejection fraction had not changed significantly, but at 3 months and at 1 year post-procedure, left ejection fraction had increased significantly compared with the preoperative data (P < 0.05). Conclusion Echocardiographic evaluation has demonstrated that cardiac hemodynamics and loading conditions improved significantly after transthoracic minimally invasive device closure of atrial septal defects.	[Chen, Qiang; Cao, Hua; Zhang, Gui-Can; Chen, Liang-Wan; Hu, Yun-Nan] Fujian Med Univ, Union Hosp, Dept Cardiovasc Surg, Fuzhou, Peoples R China; [Sun, Xu-Dong] Fujian Med Univ, Union Hosp, Dept Cardiol, Fuzhou, Peoples R China	Fujian Medical University; Fujian Medical University	Chen, Q (corresponding author), Fujian Med Univ, Union Hosp, Dept Cardiovasc Surg, Fuzhou, Peoples R China.	chenqiang2228@163.com			Chinese national program; Fujian provincial key clinical specialty construction program	Chinese national program; Fujian provincial key clinical specialty construction program	This research was sponsored by Chinese national and Fujian provincial key clinical specialty construction programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agac MT, 2012, ECHOCARDIOGR-J CARD, V29, P358, DOI 10.1111/j.1540-8175.2011.01558.x; Anavekar NS, 2008, AM J CARDIOL, V101, P607, DOI 10.1016/j.amjcard.2007.09.115; Aytemir K, 2013, CONGENIT HEART DIS, V8, P418, DOI 10.1111/chd.12057; Bartakian S, 2013, JACC-CARDIOVASC INTE, V6, P974, DOI 10.1016/j.jcin.2013.05.007; Chen Q, 2012, EUR J CARDIO-THORAC, V41, P121, DOI 10.1016/j.ejcts.2011.04.001; Chen QA, 2011, J THORAC CARDIOV SUR, V141, P631, DOI 10.1016/j.jtcvs.2010.07.077; Chen Q, 2010, ANN THORAC SURG, V89, P1250, DOI 10.1016/j.athoracsur.2010.01.004; Ding JD, 2009, ECHOCARDIOGR-J CARD, V26, P1146, DOI 10.1111/j.1540-8175.2009.00941.x; Ding JD, 2009, ACTA CARDIOL, V64, P303, DOI 10.2143/AC.64.3.2038014; Erdem A, 2013, INT J CARDIOVAS IMAG, V29, P53, DOI 10.1007/s10554-011-9933-z; Eroglu E, 2013, ECHOCARDIOGR-J CARD, V30, P324, DOI 10.1111/echo.12053; Gao CH, 2010, ECHOCARDIOGR-J CARD, V27, P324, DOI 10.1111/j.1540-8175.2009.01054.x; Grison A, 2007, J AM SOC ECHOCARDIOG, V20, P921, DOI 10.1016/j.echo.2007.01.018; Hongxin L, 2005, CHINESE J SURG, V43, P653; Jiang L, 1997, ECHOCARDIOGR-J CARD, V14, P189, DOI 10.1111/j.1540-8175.1997.tb00711.x; Kaya MG, 2010, PEDIATR CARDIOL, V31, P474, DOI 10.1007/s00246-009-9623-y; KIRKLIN JW, 1993, CARDIAC SURG, P609; Kucinska B, 2010, ARCH MED SCI, V6, P567, DOI 10.5114/aoms.2010.14469; Lee MS, 2013, CARDIOL CLIN, V31, P441, DOI 10.1016/j.ccl.2013.04.004; Ma XJ, 2008, ECHOCARDIOGR-J CARD, V25, P1101, DOI 10.1111/j.1540-8175.2008.00730.x; Manole S, 2012, MED ULTRASON, V14, P331; Mesihovic-Dinarevic Senka, 2012, Acta Med Acad, V41, P145, DOI 10.5644/ama2006-124.47; Nunez-Gil IJ, 2011, REV ESP CARDIOL, V64, P674, DOI [10.1016/j.recesp.2011.04.006, 10.1016/j.rec.2011.04.005]; Rigatelli G, 2012, AM J CARDIOVASC DIS, V2, P68; Takaya Y, 2013, J INTERV CARDIOL, V26, P195, DOI 10.1111/joic.12002; Tamborini G, 2010, J AM SOC ECHOCARDIOG, V23, P109, DOI 10.1016/j.echo.2009.11.026; Taniguchi M, 2013, INT J CARDIOVAS IMAG, V29, P1273, DOI 10.1007/s10554-013-0212-z; Tao L, 2006, ANN THORAC SURG, V81, P1417, DOI 10.1016/j.athoracsur.2005.09.081; Tei C, 1996, J Am Soc Echocardiogr, V9, P838, DOI 10.1016/S0894-7317(96)90476-9; Tei C, 1997, J AM SOC ECHOCARDIOG, V10, P169, DOI 10.1016/S0894-7317(97)70090-7; Tomar M, 2011, ANN PEDIAT CARDIOL, V4, P22, DOI 10.4103/0974-2069.79618; Vitarelli A, 2012, INT J CARDIOVAS IMAG, V28, P1905, DOI 10.1007/s10554-012-0022-8; Watanabe N, 2012, J AM SOC ECHOCARDIOG, V25, P376, DOI 10.1016/j.echo.2012.01.002; Zanjani KS, 2011, IRAN J PEDIATR, V21, P473	34	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0128475	10.1371/journal.pone.0128475	http://dx.doi.org/10.1371/journal.pone.0128475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147594	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600013
J	Cheng, QH; Zhang, JL; Wang, HW; Zhang, RJ; Yue, Y; Li, L				Cheng, Qinghao; Zhang, Jieli; Wang, Hongwu; Zhang, Rujin; Yue, Yun; Li, Lei			Effect of Acute Hypercapnia on Outcomes and Predictive Risk Factors for Complications among Patients Receiving Bronchoscopic Interventions under General Anesthesia	PLOS ONE			English	Article							FREQUENCY JET VENTILATION; SHORTENS EMERGENCE TIME; PERMISSIVE HYPERCAPNIA; RIGID BRONCHOSCOPY; HYPERVENTILATION; SURGERY	Background The aim of this study is to investigate the effect of acute hypercapnia on surgery outcomes among patients receiving bronchoscopic interventions under general anesthesia. Furthermore, independent predictive factors for surgery complications were analyzed. Method A total of 323 patients with airway stenosis were enrolled in this retrospective study. Each patient underwent interventional rigid bronchoscopy under general anesthesia. Arterial blood gas (ABG) was measured intraoperatively. In light of PaCO2 levels in ABG, patients were divided into three groups: Group C (control) (PaCO2:<= 60 mmHg), Group M (moderate) (PaCO2: 61-100 mmHg), and Group S (severe) (PaCO2: > 100 mmHg). Parameters, including PaO2 levels and recovery delays, were compared across three groups. Complications among patients receiving bronchoscopic interventions were evaluated as well. Independent predictive factors for surgery related complications were analyzed by multivariable regression method. Results Significant differences in weight (p=0.04), ASA IV (p=0.008), dyspnea index (p=0.003), COPD (p=0.02), dynamic airway collapse (p=0.002), severe stenosis severity (p=0.02), and stenosis locations among three groups were observed. Mild (PaCO2:similar to 60 mmHg) to moderate (PaCO2:60-100 mmHg) hypercapnia was not associated with delayed recovery, whereas severe hypercapnia (PaCO2:>100 mmHg) was associated with delayed recovery, as well as declined PaO2 (p=0.00) and elevated blood glucose levels (p=0.00). The complications of bronchoscopic interventions included postoperative congestive heart failure (14 cases, 4.3%), tracheorrhagia (8 cases, 2.5%), delayed recovery (19 cases, 5.9%), and transfers to ICU after surgery (10 cases, 3.1%). The multivariable regression analysis showed that procedure duration (p=0.003), lobectomy (p=0.007), dynamic airway collapse (p=0.01), severe bronchial stenosis (p=0.01) and hypercapnia (p=0.02) were independent predictive factors for surgery related complications. Conclusions Acute hypercapnia lower than 100 mmHg was not associated with detrimental consequences, whereas severe hypercapnia (PaCO2: >100 mmHg) was associated with lower levels of PaO2. Hypercapnia was an independent predictive factor for bronchoscopic intervention complication, which may help physicians to optimize the therapeutic choices.	[Cheng, Qinghao; Li, Lei] China Meitan Gen Hosp, Dept Anesthesiol, Beijing 100028, Peoples R China; [Zhang, Jieli; Wang, Hongwu] China Meitan Gen Hosp, Minimal Invas Tumor Therapy Ctr, Beijing 100028, Peoples R China; [Zhang, Rujin] Beijing United Family Hosp, Dept Anesthesiol, Beijing 100015, Peoples R China; [Yue, Yun] Capital Med Univ, Beijing Chaoyang Hosp, Dept Anesthesiol, Beijing 100020, Peoples R China	Capital Medical University	Li, L (corresponding author), China Meitan Gen Hosp, Dept Anesthesiol, Beijing 100028, Peoples R China.	lilei927@126.com						Bourgain JL, 2001, BRIT J ANAESTH, V87, P870, DOI 10.1093/bja/87.6.870; Buczkowski PW, 2007, BRIT J ANAESTH, V99, P891, DOI 10.1093/bja/aem312; Conacher ID, 2004, ANAESTHESIA, V59, P290, DOI 10.1111/j.1365-2044.2004.03610.x; Ernst A, 2003, CHEST, V123, P1693, DOI 10.1378/chest.123.5.1693; Fernandez-Bustamante A, 2006, J CLIN ANESTH, V18, P349, DOI 10.1016/j.jclinane.2005.12.011; Ginsberg Robert J., 1997, P858; Gopalakrishnan NA, 2007, ANESTH ANALG, V104, P815, DOI 10.1213/01.ane.0000255199.43961.87; Gorden JA, 2009, SEMIN THORAC CARDIOV, V21, P263, DOI 10.1053/j.semtcvs.2009.08.002; Hautmann H, 2000, ANESTH ANALG, V90, P1436, DOI 10.1097/00000539-200006000-00034; Jin FG, 2008, RESPIRATION, V76, P429, DOI 10.1159/000151656; Mas A, 2000, CRIT CARE MED, V28, P360, DOI 10.1097/00003246-200002000-00012; Morisaki H, 1999, ACTA ANAESTH SCAND, V43, P845, DOI 10.1034/j.1399-6576.1999.430811.x; Mukhtar AM, 2008, ANESTH ANALG, V106, P84, DOI 10.1213/01.ane.0000297419.02643.d7; Natalini G, 1999, EUR J ANAESTH, V16, P605, DOI 10.1046/j.1365-2346.1999.00548.x; ORCHARD CH, 1990, AM J PHYSIOL, V258, pC967, DOI 10.1152/ajpcell.1990.258.6.C967; Sakata DJ, 2007, ANESTH ANALG, V105, P79, DOI 10.1213/01.ane.0000265849.33203.60; Sakata DJ, 2007, ANESTH ANALG, V104, P587, DOI 10.1213/01.ane.0000255074.96657.39; SHIBATA K, 1994, ANESTHESIOLOGY, V81, P1454, DOI 10.1097/00000542-199412000-00021; Unzueta MC, 2003, ANESTH ANALG, V96, P298, DOI 10.1097/00000539-200301000-00059; Zhou Q, 2010, ANESTHESIOLOGY, V112, P288, DOI 10.1097/ALN.0b013e3181ca8257	20	16	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130771	10.1371/journal.pone.0130771	http://dx.doi.org/10.1371/journal.pone.0130771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147645	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600049
J	Cremona, A; Orsini, F; Corsetto, PA; Hoogenboom, BW; Rizzo, AM				Cremona, Andrea; Orsini, Francesco; Corsetto, Paola A.; Hoogenboom, Bart W.; Rizzo, Angela M.			Reversible Dissolution of Microdomains in Detergent-Resistant Membranes at Physiological Temperature	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; BREAST-CANCER CELLS; LIPID RAFTS; PLASMA-MEMBRANE; CRITICAL FLUCTUATIONS; DOMAIN FORMATION; PHASE-BEHAVIOR; VESICLES; MODEL; ORGANIZATION	The formation of lipid microdomains ("rafts") is presumed to play an important role in various cellular functions, but their nature remains controversial. Here we report on microdomain formation in isolated, detergent-resistant membranes from MDA-MB-231 human breast cancer cells, studied by atomic force microscopy (AFM). Whereas microdomains were readily observed at room temperature, they shrunk in size and mostly disappeared at higher temperatures. This shrinking in microdomain size was accompanied by a gradual reduction of the height difference between the microdomains and the surrounding membrane, consistent with the behaviour expected for lipids that are laterally segregated in liquid ordered and liquid disordered domains. Immunolabeling experiments demonstrated that the microdomains contained flotillin-1, a protein associated with lipid rafts. The microdomains reversibly dissolved and reappeared, respectively, on heating to and cooling below temperatures around 37 degrees C, which is indicative of radical changes in local membrane order close to physiological temperature.	[Cremona, Andrea; Corsetto, Paola A.; Rizzo, Angela M.] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Orsini, Francesco] Univ Milan, Dipartimento Fis, Milan, Italy; [Hoogenboom, Bart W.] UCL, London Ctr Nanotechnol, London, England; [Hoogenboom, Bart W.] UCL, Dept Phys & Astron, London, England	University of Milan; University of Milan; University of London; University College London; University of London; University College London	Hoogenboom, BW (corresponding author), UCL, London Ctr Nanotechnol, London, England.	b.hoogenboom@ucl.ac.uk	CORSETTO, PAOLA ANTONIA/O-2244-2015; RIzzo, Angela Maria/E-4786-2012; Orsini, Francesco/S-1283-2017	CORSETTO, PAOLA ANTONIA/0000-0003-3849-8548; RIzzo, Angela Maria/0000-0002-8582-0432; Orsini, Francesco/0000-0001-5601-9825; Hoogenboom, Bart/0000-0002-8882-4324	Royal Society [JP09001]; BBSRC [BB/G011729/1, BB/J006254/1]; Biotechnology and Biological Sciences Research Council [BB/J006254/1] Funding Source: researchfish	Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Royal Society, JP09001, (https://royalsociety.org) and BBSRC, BB/G011729/1 and BB/J006254/1, (http://bbsrc.ac.uk/home/home.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderton CR, 2011, BBA-BIOMEMBRANES, V1808, P307, DOI 10.1016/j.bbamem.2010.09.016; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Cai MJ, 2012, SMALL, V8, P1243, DOI 10.1002/smll.201102183; Charrier A, 2005, BIOPHYS J, V89, P1094, DOI 10.1529/biophysj.105.062463; Connell SD, 2013, FARADAY DISCUSS, V161, P91, DOI 10.1039/c2fd20119d; Corsetto PA, 2012, CELL BIOCHEM BIOPHYS, V64, P45, DOI 10.1007/s12013-012-9365-y; Coskun U, 2010, FEBS LETT, V584, P1685, DOI 10.1016/j.febslet.2009.12.043; de la Serna JB, 2004, J BIOL CHEM, V279, P40715, DOI 10.1074/jbc.M404648200; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Frisz JF, 2013, P NATL ACAD SCI USA, V110, pE613, DOI 10.1073/pnas.1216585110; Fujiwara M, 2009, PLANT CELL PHYSIOL, V50, P1191, DOI 10.1093/pcp/pcp077; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Gousset K, 2002, J CELL PHYSIOL, V190, P117, DOI 10.1002/jcp.10039; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Heberle FA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004630; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Honerkamp-Smith AR, 2008, BIOPHYS J, V95, P236, DOI 10.1529/biophysj.107.128421; Keller D, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.025701; Kraft ML, 2013, MOL BIOL CELL, V24, P2765, DOI 10.1091/mbc.E13-03-0165; Levental I, 2009, BIOCHEM J, V424, P163, DOI 10.1042/BJ20091283; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Orsini F, 2012, BBA-BIOMEMBRANES, V1818, P2943, DOI 10.1016/j.bbamem.2012.07.024; Owen DM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2273; Pathak P, 2011, BIOPHYS J, V101, P2417, DOI 10.1016/j.bpj.2011.08.059; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; Podyma-Inoue KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032351; Prinetti A, 2001, J BIOL CHEM, V276, P21136, DOI 10.1074/jbc.M010666200; Prinetti A, 2000, J BIOL CHEM, V275, P11658, DOI 10.1074/jbc.275.16.11658; SCOTT RE, 1976, SCIENCE, V194, P743, DOI 10.1126/science.982043; Seantier B, 2008, CURR OPIN COLLOID IN, V13, P326, DOI 10.1016/j.cocis.2008.01.003; Sezgin E, 2012, BBA-BIOMEMBRANES, V1818, P1777, DOI 10.1016/j.bbamem.2012.03.007; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Sonnino S, 2013, CURR MED CHEM, V20, P4; Sot J, 2006, BIOPHYS J, V90, P903, DOI 10.1529/biophysj.105.067710; Tanigawa M, 2012, MOL CELL BIOL, V32, P2861, DOI 10.1128/MCB.06111-11; Tokumasu F, 2002, J ELECTRON MICROSC, V51, P1, DOI 10.1093/jmicro/51.1.1; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Veatch SL, 2008, ACS CHEM BIOL, V3, P287, DOI 10.1021/cb800012x; Veatch SL, 2007, P NATL ACAD SCI USA, V104, P17650, DOI 10.1073/pnas.0703513104; Yarrow F, 2005, J CRYST GROWTH, V275, pE1417, DOI 10.1016/j.jcrysgro.2004.11.237	43	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132696	10.1371/journal.pone.0132696	http://dx.doi.org/10.1371/journal.pone.0132696			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147107	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600313
J	Hinton, JW; van Manen, FT; Chamberlain, MJ				Hinton, Joseph W.; van Manen, Frank T.; Chamberlain, Michael J.			Space Use and Habitat Selection by Resident and Transient Coyotes (Canis latrans)	PLOS ONE			English	Article							HOME-RANGE; RED WOLF; BODY-SIZE; BEHAVIORAL-RESPONSES; NATIONAL-PARK; SPATIAL-USE; DISPERSAL; SURVIVAL; MOVEMENTS; PATTERNS	Little information exists on coyote (Canis latrans) space use and habitat selection in the southeastern United States and most studies conducted in the Southeast have been carried out within small study areas (e.g., <= 1,000 km(2)). Therefore, studying the placement, size, and habitat composition of coyote home ranges over broad geographic areas could provide relevant insights regarding how coyote populations adjust to regionally varying ecological conditions. Despite an increasing number of studies of coyote ecology, few studies have assessed the role of transiency as a life-history strategy among coyotes. During 2009-2011, we used GPS radio-telemetry to study coyote space use and habitat selection on the Albemarle Peninsula of northeastern North Carolina. We quantified space use and 2nd- and 3rd-order habitat selection for resident and transient coyotes to describe space use patterns in a predominantly agricultural landscape. The upper limit of coyote home-range size was approximately 47 km(2) and coyotes exhibiting shifting patterns of space use of areas >65 km(2) were transients. Transients exhibited localized space use patterns for short durations prior to establishing home ranges, which we defined as "biding" areas. Resident and transient coyotes demonstrated similar habitat selection, notably selection of agricultural over forested habitats. However, transients exhibited stronger selection for roads than resident coyotes. Although transient coyotes are less likely to contribute reproductively to their population, transiency may be an important life history trait that facilitates metapopulation dynamics through dispersal and the eventual replacement of breeding residents lost to mortality.	[Hinton, Joseph W.; Chamberlain, Michael J.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [van Manen, Frank T.] US Geol Survey, Northern Rocky Mt Sci Ctr, Interagency Grizzly Bear Study Team, Bozeman, MT USA	University System of Georgia; University of Georgia; United States Department of the Interior; United States Geological Survey	Hinton, JW (corresponding author), Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	jhinton@uga.edu		T. van Manen, Frank/0000-0001-5340-8489	U.S. Fish and Wildlife Service Red Wolf Recovery Program	U.S. Fish and Wildlife Service Red Wolf Recovery Program	We particularly appreciate the support of the U.S. Fish and Wildlife Service Red Wolf Recovery Program, specifically R. Bartel, A. Beyer, C. Lucash, F. Mauney, M. Morse, R. Nordsven, and D. Rabon. We thank Weyerhaeuser Company for providing access to their properties. The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the U.S. Fish and Wildlife Service or Weyerhaeuser Company. Any use of trade, product, or firm names is for descriptive purposes only and does not imply endorsement by the U.S. Government. We thank E. Beever for review of this manuscript for the U.S. Geological Survey's Fundamental Science Practices.	Abbott KC, 2011, ECOL LETT, V14, P1158, DOI 10.1111/j.1461-0248.2011.01670.x; ANDELT WF, 1985, WILDLIFE MONOGR, P1; Arjo WM, 1999, CAN J ZOOL, V77, P1919, DOI 10.1139/z99-177; BAKER M, 1995, CONDOR, V97, P663, DOI 10.2307/1369175; BASSET A, 1995, ECOLOGY, V76, P1027, DOI 10.2307/1940913; BEKOFF M, 1980, SCI AM, V242, P130, DOI 10.1038/scientificamerican0480-130; BEKOFF M, 1981, OECOLOGIA, V50, P386, DOI 10.1007/BF00344981; Bekoff M, 2003, WILD MAMMALS N AM BI, P467; Benson JF, 2015, OIKOS, V124, P1664, DOI 10.1111/oik.01883; Benson JF, 2013, METHODS ECOL EVOL, V4, P244, DOI 10.1111/2041-210x.12006; BOWEN WD, 1982, J WILDLIFE MANAGE, V46, P201, DOI 10.2307/3808423; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Bromley C, 2001, J WILDLIFE MANAGE, V65, P510, DOI 10.2307/3803104; Burnham KP, 2007, MODEL SELECTION MULT; Byrne ME, 2014, J ANIM ECOL, V83, P1234, DOI 10.1111/1365-2656.12205; Camenzind F.J., 1978, P267; Chamberlain MJ, 2000, CAN J ZOOL, V78, P2087, DOI 10.1139/cjz-78-12-2087; Collier B, 2013, MOVEUD CREATES DYNAM; Crete M, 2001, ECOSCIENCE, V8, P311, DOI 10.1080/11956860.2001.11682658; Dellinger JA, 2013, BIOL CONSERV, V157, P324, DOI 10.1016/j.biocon.2012.09.004; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; GASTON AJ, 1978, AM NAT, V112, P1091, DOI 10.1086/283348; Geffen E, 1996, AM NAT, V147, P140, DOI 10.1086/285844; Gehrt SD, 2009, J MAMMAL, V90, P1045, DOI 10.1644/08-MAMM-A-277.1; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; GESE EM, 1988, J WILDLIFE MANAGE, V52, P640, DOI 10.2307/3800923; Gese EM, 2001, CAN J ZOOL, V79, P980, DOI 10.1139/cjz-79-6-980; Gese EM, 2015, CURR ZOOL, V61, P191, DOI 10.1093/czoolo/61.1.191; Gier H. T., 1968, AGR EXPT STATION B, V393, P1; Gittleman J.L., 1989, P183; GOMPPER ME, 1991, OECOLOGIA, V87, P343, DOI 10.1007/BF00634589; Gosselink TE, 2003, J WILDLIFE MANAGE, V67, P90, DOI 10.2307/3803065; Hackshaw A, 2008, EUR RESPIR J, V32, P1141, DOI 10.1183/09031936.00136408; HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x; Hinton J. W., 2014, THESIS; Hinton JW, 2014, J MAMMAL, V95, P855, DOI 10.1644/13-MAMM-A-202; Hinton Joseph W., 2013, Animals, V3, P722, DOI 10.3390/ani3030722; Hinton JW, 2012, AM MIDL NAT, V168, P281; Hirzel AH, 2006, ECOL MODEL, V199, P142, DOI 10.1016/j.ecolmodel.2006.05.017; HOLZMAN S, 1992, J WILDLIFE MANAGE, V56, P139, DOI 10.2307/3808801; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; James ARC, 2000, J WILDLIFE MANAGE, V64, P154, DOI 10.2307/3802985; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kamler JF, 2000, CAN J ZOOL, V78, P2106, DOI 10.1139/cjz-78-12-2106; Kamler JF, 2005, AM MIDL NAT, V153, P396, DOI 10.1674/0003-0031(2005)153[0396:HRAHUO]2.0.CO;2; Karlin M, 2012, J ZOOL, V286, P266, DOI 10.1111/j.1469-7998.2011.00876.x; Kleiman DG, 2011, BEHAV GENET, V41, P803, DOI 10.1007/s10519-011-9459-0; Kranstauber B., 2013, MOVE VISUALIZING ANA; Leopold B.D., 2001, WILDLIFE SO FORESTS, P248; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Manly B.F.J., 2002, RESOURCE SELECTION A; McKerrow AJ, 2006, N CAROLINA GAP ANAL; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; PERSON DK, 1991, J WILDLIFE MANAGE, V55, P433, DOI 10.2307/3808971; R Core Team, 2021, R LANGUAGE ENV STAT; Sacks BN, 1999, J WILDLIFE MANAGE, V63, P593, DOI 10.2307/3802648; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schrecengost JD, 2009, AM MIDL NAT, V162, P346, DOI 10.1674/0003-0031-162.2.346; Seidler RG, 2012, J ETHOL, V30, P345, DOI 10.1007/s10164-012-0330-4; SWIHART RK, 1988, ECOLOGY, V69, P393, DOI 10.2307/1940437; TAYLOR AD, 1990, ECOLOGY, V71, P429, DOI 10.2307/1940297; Tigas LA, 2002, BIOL CONSERV, V108, P299, DOI 10.1016/S0006-3207(02)00120-9; Van Deelen TR, 2006, CAN J ZOOL, V84, P1630, DOI 10.1139/Z06-170; Way JG, 2009, CAN FIELD NAT, V123, P206, DOI 10.22621/cfn.v123i3.965; Whittington J, 2005, ECOL APPL, V15, P543, DOI 10.1890/03-5317; WINDBERG LA, 1988, J WILDLIFE MANAGE, V52, P632, DOI 10.2307/3800922; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	70	55	57	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132203	10.1371/journal.pone.0132203	http://dx.doi.org/10.1371/journal.pone.0132203			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148130	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600218
J	Keller, M; Naue, J; Zengerle, R; von Stetten, F; Schmidt, U				Keller, Mark; Naue, Jana; Zengerle, Roland; von Stetten, Felix; Schmidt, Ulrike			Automated Forensic Animal Family Identification by Nested PCR and Melt Curve Analysis on an Off-the-Shelf Thermocycler Augmented with a Centrifugal Microfluidic Disk Segment	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; DNA COPY NUMBER; SPECIES IDENTIFICATION; QUANTIFICATION; ASSAY; PLATFORM; DYE	Nested PCR remains a labor-intensive and error-prone biomolecular analysis. Laboratory workflow automation by precise control of minute liquid volumes in centrifugal microfluidic Lab-on-a-Chip systems holds great potential for such applications. However, the majority of these systems require costly custom-made processing devices. Our idea is to augment a standard laboratory device, here a centrifugal real-time PCR thermocycler, with inbuilt liquid handling capabilities for automation. We have developed a microfluidic disk segment enabling an automated nested real-time PCR assay for identification of common European animal groups adapted to forensic standards. For the first time we utilize a novel combination of fluidic elements, including pre-storage of reagents, to automate the assay at constant rotational frequency of an off-the-shelf thermocycler. It provides a universal duplex pre-amplification of short fragments of the mitochondrial 12S rRNA and cytochrome b genes, animal-group-specific main-amplifications, and melting curve analysis for differentiation. The system was characterized with respect to assay sensitivity, specificity, risk of cross-contamination, and detection of minor components in mixtures. 92.2% of the performed tests were recognized as fluidically failure-free sample handling and used for evaluation. Altogether, augmentation of the standard real-time thermocycler with a self-contained centrifugal microfluidic disk segment resulted in an accelerated and automated analysis reducing hands-on time, and circumventing the risk of contamination associated with regular nested PCR protocols.	[Keller, Mark; Zengerle, Roland; von Stetten, Felix] Univ Freiburg, IMTEK Dept Microsyst Engn, Lab MEMS Applicat, D-79106 Freiburg, Germany; [Keller, Mark; Zengerle, Roland; von Stetten, Felix] Hahn Schickard, Freiburg, Germany; [Naue, Jana; Schmidt, Ulrike] Univ Freiburg, Med Ctr, Inst Legal Med, Freiburg, Germany; [Naue, Jana] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Zengerle, Roland] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Schmidt, U (corresponding author), Univ Freiburg, Med Ctr, Inst Legal Med, Freiburg, Germany.	ulrike.schmidt@uniklinik-freiburg.de	von Stetten, Felix/A-6360-2014; Zengerle, Roland/B-2451-2012; von Stetten, Felix/V-5488-2019	von Stetten, Felix/0000-0002-8547-0495; 	Deutsche Forschungsgemeinschaft [SCHM2471/1-1]; German Research Foundation (DFG); Albert Ludwigs University Freiburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	This work was granted by Deutsche Forschungsgemeinschaft (SCHM2471/1-1). The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Samra K, 2011, LAB CHIP, V11, P723, DOI 10.1039/c0lc00160k; Alacs EA, 2010, FORENSIC SCI MED PAT, V6, P180, DOI 10.1007/s12024-009-9131-7; Amasia M, 2012, SENSOR ACTUAT B-CHEM, V161, P1191, DOI 10.1016/j.snb.2011.11.080; Andersson P, 2007, ANAL CHEM, V79, P4022, DOI 10.1021/ac061692y; DECORTE R, 1993, J MED GENET, V30, P625, DOI 10.1136/jmg.30.8.625; Ducree J, 2007, J MICROMECH MICROENG, V17, pS103, DOI 10.1088/0960-1317/17/7/S07; Duffy DC, 1999, ANAL CHEM, V71, P4669, DOI 10.1021/ac990682c; Focke M, 2011, 15 INT C MIN SYST CH, P659; Focke M, 2010, LAB CHIP, V10, P3210, DOI 10.1039/c0lc00161a; Focke M, 2010, LAB CHIP, V10, P2519, DOI 10.1039/c004954a; Garcia-Cordero JL, 2010, LAB CHIP, V10, P2680, DOI 10.1039/c004980h; Gorkin R, 2010, LAB CHIP, V10, P1758, DOI 10.1039/b924109d; Gorkin R, 2010, MICROFLUID NANOFLUID, V9, P541, DOI 10.1007/s10404-010-0571-x; Jobling MA, 2004, NAT REV GENET, V5, P739, DOI 10.1038/nrg1455; Kinahan DJ, 2015, RSC ADV, V5, P1818, DOI 10.1039/c4ra14887h; Kitano T, 2007, INT J LEGAL MED, V121, P423, DOI 10.1007/s00414-006-0113-y; Koppel R, 2009, EUR FOOD RES TECHNOL, V230, P125, DOI 10.1007/s00217-009-1154-5; Laube I, 2007, INT J FOOD SCI TECH, V42, P336, DOI 10.1111/j.1365-2621.2006.01249.x; Mark D, 2012, LAB CHIP, V12, P2464, DOI 10.1039/c2lc00043a; Mark D, 2011, MICROFLUID NANOFLUID, V10, P1279, DOI 10.1007/s10404-010-0759-0; Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060; Naue J, 2014, INT J LEGAL MED, V128, P11, DOI 10.1007/s00414-013-0857-0; Naue J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115575; Naue J, 2015, MITOCHONDRION, V20, P82, DOI 10.1016/j.mito.2014.12.002; Naue J, 2012, INT J LEGAL MED, V126, P483, DOI 10.1007/s00414-012-0674-x; Park JM, 2007, LAB CHIP, V7, P557, DOI 10.1039/b616112j; Qiagen, ROT GEN Q US MAN; Ramon-Laca A, 2013, ELECTROPHORESIS, V34, P3370, DOI 10.1002/elps.201300324; REMICK DG, 1990, AM J CLIN PATHOL, V93, pS49; Rombach M, 2014, BIOTECHNIQUES, V57, P151, DOI 10.2144/000114207; Safdar M, 2014, MOL BIOTECHNOL, V56, P770, DOI 10.1007/s12033-014-9756-y; Schaff UY, 2011, CLIN CHEM, V57, P753, DOI 10.1373/clinchem.2011.162206; SCHEMBRI CT, 1995, J AUTOM CHEM, V17, P99, DOI 10.1155/S1463924695000174; Siegrist J, 2010, MICROFLUID NANOFLUID, V9, P55, DOI 10.1007/s10404-009-0523-5; Strohmeier O, 2014, MICROCHIM ACTA, V181, P1681, DOI 10.1007/s00604-013-1099-z; Strohmeier O, 2014, ANAL METHODS-UK, V6, P2038, DOI 10.1039/c3ay41822g; Tobe SS, 2010, FORENSIC SCI MED PAT, V6, P195, DOI 10.1007/s12024-010-9168-7; Tobe SS, 2008, FORENSIC SCI INT-GEN, V2, P249, DOI 10.1016/j.fsigen.2008.03.002; Ukita Y, 2012, 16 INT C MIN SYST CH, P1465; Varga A, 2006, J VIROL METHODS, V132, P146, DOI 10.1016/j.jviromet.2005.10.004	40	11	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131845	10.1371/journal.pone.0131845	http://dx.doi.org/10.1371/journal.pone.0131845			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147196	gold, Green Submitted, Green Published			2022-12-27	WOS:000358157600152
J	Krueger, MC; Hofmann, U; Moeder, M; Schlosser, D				Krueger, Martin C.; Hofmann, Ulrike; Moeder, Monika; Schlosser, Dietmar			Potential of Wood-Rotting Fungi to Attack Polystyrene Sulfonate and Its Depolymerisation by Gloeophyllum trabeum via Hydroquinone-Driven Fenton Chemistry	PLOS ONE			English	Article							BROWN-ROT FUNGUS; POLYVINYL-ALCOHOL; FLUOROQUINOLONE ENROFLOXACIN; DEGRADATION; LIGNIN; HYDROXYL; LACCASE; BIODEGRADATION; OXIDATION; 2,5-DIMETHOXYHYDROQUINONE	Synthetic polymers often pose environmental hazards due to low biodegradation rates and resulting accumulation. In this study, a selection of wood-rotting fungi representing different lignocellulose decay types was screened for oxidative biodegradation of the polymer polystyrene sulfonate (PSS). Brown-rot basidiomycetes showed PSS depolymerisation of up to 50% reduction in number-average molecular mass (M-n) within 20 days. In-depth investigations with the most efficient depolymeriser, a Gloeophyllum trabeum strain, pointed at extracellular hydroquinone-driven Fenton chemistry responsible for depolymerisation. Detection of hydroxyl radicals present in the culture supernatants showed good compliance with depolymerisation over the time course of PSS degradation. 2,5-Dimethoxy-1,4-hydroquinone (2,5-DMHQ), which was detected in supernatants of active cultures via liquid chromatography and mass spectrometry, was demonstrated to drive the Fenton processes in G. trabeum cultures. Up to 80% reduction in Mn of PSS where observed when fungal cultures were additionally supplemented with 2,5-dimethoxy benzoquinone, the oxidized from of 2,5-DMHQ. Furthermore, 2,5-DMHQ could initiate the Fenton's reagent-mediated PSS depolymerisation in cell-free systems. In contrast, white-rot fungi were unable to cause substantial depolymerising effects despite the expression of lignin-modifying exo-enzymes. Detailed investigations with laccase from Trametes versicolor revealed that only in presence of certain redox mediators limited PSS depolymerisation occurred. Our results indicate that brown-rot fungi might be suitable organisms for the biodegradation of recalcitrant synthetic polymeric pollutants.	[Krueger, Martin C.; Hofmann, Ulrike; Schlosser, Dietmar] UFZ Helmholtz Ctr Environm Res, Dept Environm Microbiol, Leipzig, Germany; [Moeder, Monika] UFZ Helmholtz Ctr Environm Res, Dept Analyt Chem, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Schlosser, D (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Environm Microbiol, Leipzig, Germany.	dietmar.schlosser@ufz.de		Schlosser, Dietmar/0000-0003-1353-8136; Krueger, Martin/0000-0001-8613-5800; Moeder, Monika/0000-0002-1154-9168	European Commission [312100]; Helmholtz Association	European Commission(European CommissionEuropean Commission Joint Research Centre); Helmholtz Association(Helmholtz Association)	The European Commission provided resources for this research as part of the BIOCLEAN project under the 7th Framework Programme (EC grant agreement 312100). This work was further supported by the Helmholtz Association and contributes to the integrated project `Controlling Chemicals' Fate' in the CITE (Chemicals In The Environment) research program conducted at the Helmholtz Centre for Environmental Research - UFZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cole M, 2011, MAR POLLUT BULL, V62, P2588, DOI 10.1016/j.marpolbul.2011.09.025; Deguchi T, 1998, APPL ENVIRON MICROB, V64, P1366; Deguchi T, 1997, APPL ENVIRON MICROB, V63, P329, DOI 10.1128/AEM.63.1.329-331.1997; Dockheer SM, 2013, PHYS CHEM CHEM PHYS, V15, P4975, DOI 10.1039/c3cp44341h; Dockheer SM, 2010, PHYS CHEM CHEM PHYS, V12, P11609, DOI 10.1039/c0cp00082e; Fahr K, 1999, FEMS MICROBIOL LETT, V175, P127, DOI 10.1111/j.1574-6968.1999.tb13611.x; Feng HM, 2011, ENVIRON SCI TECHNOL, V45, P744, DOI 10.1021/es102182g; Fichou D., 1999, HDB OLIGO POLYTHIOPH; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Friedrich J, 2007, CHEMOSPHERE, V67, P2089, DOI 10.1016/j.chemosphere.2006.09.038; Fujisawa M, 2001, J POLYM ENVIRON, V9, P103, DOI 10.1023/A:1020472426516; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Gomez-Toribio V, 2009, APPL ENVIRON MICROB, V75, P3944, DOI 10.1128/AEM.02137-08; Gusse AC, 2006, ENVIRON SCI TECHNOL, V40, P4196, DOI 10.1021/es060408h; Gutierrez A, 2012, BIORESOURCE TECHNOL, V119, P114, DOI 10.1016/j.biortech.2012.05.112; GUTTERIDGE JMC, 1984, BIOCHEM J, V224, P761, DOI 10.1042/bj2240761; HALLIWELL B, 1981, FEBS LETT, V128, P347, DOI 10.1016/0014-5793(81)80114-7; Harms H, 2011, NAT REV MICROBIOL, V9, P177, DOI 10.1038/nrmicro2519; Hofer C, 1999, FEBS LETT, V451, P186, DOI 10.1016/S0014-5793(99)00566-9; Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0; Huang MH, 2002, J ENVIRON SCI HEAL A, V37, P29, DOI 10.1081/ESE-100108480; Inagaki Y, 1999, LANGMUIR, V15, P4171, DOI 10.1021/la981185e; Jahangiri E, 2014, MOLECULES, V19, P11860, DOI 10.3390/molecules190811860; Jensen KA, 2001, APPL ENVIRON MICROB, V67, P2705, DOI 10.1128/AEM.67.6.2705-2711.2001; Junghanns C, 2005, MICROBIOL-SGM, V151, P45, DOI 10.1099/mic.0.27431-0; Kawai F, 2009, APPL MICROBIOL BIOT, V84, P227, DOI 10.1007/s00253-009-2113-6; Kerem Z, 1998, P NATL ACAD SCI USA, V95, P10373, DOI 10.1073/pnas.95.18.10373; Kerem Z, 1999, FEBS LETT, V446, P49, DOI 10.1016/S0014-5793(99)00180-5; KLANING UK, 1985, J PHYS CHEM-US, V89, P760, DOI 10.1021/j100251a008; Korripally P, 2013, APPL ENVIRON MICROB, V79, P2377, DOI 10.1128/AEM.03880-12; Kramer C, 2004, APPL MICROBIOL BIOT, V64, P387, DOI 10.1007/s00253-003-1445-x; Larking DM, 1999, APPL ENVIRON MICROB, V65, P1798; Martens R, 1996, APPL ENVIRON MICROB, V62, P4206, DOI 10.1128/AEM.62.11.4206-4209.1996; Paszczynski A, 1999, APPL ENVIRON MICROB, V65, P674; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Salvachua D, 2013, APPL ENVIRON MICROB, V79, P4316, DOI 10.1128/AEM.00699-13; Schlosser D, 2002, APPL ENVIRON MICROB, V68, P3514, DOI 10.1128/AEM.68.7.3514-3521.2002; Shah AA, 2008, BIOTECHNOL ADV, V26, P246, DOI 10.1016/j.biotechadv.2007.12.005; Sterns RH, 2010, J AM SOC NEPHROL, V21, P733, DOI 10.1681/ASN.2010010079; Strittmatter E, 2013, J BIOL CHEM, V288, P4095, DOI 10.1074/jbc.M112.400176; Sundarapandiyan S, 2010, J POLYM ENVIRON, V18, P674, DOI 10.1007/s10924-010-0241-9; Suzuki MR, 2006, ENVIRON MICROBIOL, V8, P2214, DOI 10.1111/j.1462-2920.2006.01160.x; Tokiwa Y, 2009, INT J MOL SCI, V10, P3722, DOI 10.3390/ijms10093722; Tsujiyama S, 2013, BIOTECHNOL LETT, V35, P1907, DOI 10.1007/s10529-013-1281-8; Wei DS, 2010, APPL ENVIRON MICROB, V76, P2091, DOI 10.1128/AEM.02929-09; Wetzstein HG, 1997, APPL ENVIRON MICROB, V63, P4272, DOI 10.1128/AEM.63.11.4272-4281.1997; Yelle DJ, 2008, ENVIRON MICROBIOL, V10, P1844, DOI 10.1111/j.1462-2920.2008.01605.x; Yelle DJ, 2011, ENVIRON MICROBIOL, V13, P1091, DOI 10.1111/j.1462-2920.2010.02417.x	48	41	41	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131773	10.1371/journal.pone.0131773	http://dx.doi.org/10.1371/journal.pone.0131773			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147966	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600143
J	Leray, E; Vukusic, S; Debouverie, M; Clanet, M; Brochet, B; de Seze, J; Zephir, H; Defer, G; Lebrun-Frenay, C; Moreau, T; Clavelou, P; Pelletier, J; Berger, E; Cabre, P; Camdessanche, JP; Kalson-Ray, S; Confavreux, C; Edan, G				Leray, Emmanuelle; Vukusic, Sandra; Debouverie, Marc; Clanet, Michel; Brochet, Bruno; de Seze, Jerome; Zephir, Helene; Defer, Gilles; Lebrun-Frenay, Christine; Moreau, Thibault; Clavelou, Pierre; Pelletier, Jean; Berger, Eric; Cabre, Philippe; Camdessanche, Jean-Philippe; Kalson-Ray, Shoshannah; Confavreux, Christian; Edan, Gilles			Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study	PLOS ONE			English	Article							DIAGNOSTIC-CRITERIA; PROGNOSTIC-FACTORS; LIFE EXPECTANCY; SURVIVAL; DEATH; DISABILITY; PROGRESSION; PREVALENCE; COHORT; MS	Background Recent studies in multiple sclerosis (MS) showed longer survival times from clinical onset than older hospital-based series. However estimated median time ranges widely, from 24 to 45 years, which makes huge difference for patients as this neurological disease mainly starts around age 20 to 40. Precise and up-to-date reference data about mortality in MS are crucial for patients and neurologists, but unavailable yet in France. Objectives Estimate survival in MS patients and compare mortality with that of the French general population. Methods We conducted a multicenter observational study involving clinical longitudinal data from 30,413 eligible patients, linked to the national deaths register. Inclusion criteria were definite MS diagnosis and clinical onset prior to January, 1st 2009 in order to get a minimum of 1-year disease duration. Results After removing between-center duplicates and applying inclusion criteria, the final population comprised 27,603 MS patients (F/M sex ratio 2.5, mean age at onset 33.0 years, 85.5% relapsing onset). During the follow-up period (mean 15.2 +/-10.3 years), 1569 deaths (5.7%) were identified; half related to MS. Death rates were significantly higher in men, patients with later clinical onset, and in progressive MS. Overall excess mortality compared with the general population was moderate (Standardized Mortality Ratio 1.48, 95% confidence interval [1.41-1.55]), but increased considerably after 20 years of disease (2.20 [2.10-2.31]). Conclusions This study revealed a moderate decrease in life expectancy in MS patients, and showed that the risk of dying is strongly correlated to disease duration and disability, highlighting the need for early actions that can slow disability progression.	[Leray, Emmanuelle] CHU Rennes, Sorbonne Paris Cite, EHESP Rennes, Dept Epidemiol,CIC P 1414,WENNE, Rennes, France; [Vukusic, Sandra] CHU Lyon, Dept Neurol, OFSEP, Lyon, France; [Debouverie, Marc] CHU Nancy, Dept Neurol, ReLSEP, Lorraine Register MS,EA 4360, Nancy, France; [Clanet, Michel] CHU Toulouse, Dept Neurol, Toulouse, France; [Brochet, Bruno] CHU Bordeaux, Dept Neurol, Bordeaux, France; [de Seze, Jerome] Hop Univ Strasbourg, Dept Neurol, Clin Invest Ctr CIC,INSERM 1434, Strasbourg, France; [de Seze, Jerome] Federat Med Translat FMTS, UMR INSERM 1119, Strasbourg, France; [Zephir, Helene] Univ Lille, Dept Neurol, Hop Roger Salengro, CHRU Lille, Lille, France; [Defer, Gilles] CHU Caen, Dept Neurol, F-14000 Caen, France; [Lebrun-Frenay, Christine] CHU Nice, Dept Neurol, F-06202 Nice, France; [Moreau, Thibault] CHU Dijon, Dept Neurol, Dijon, France; [Clavelou, Pierre] CHU Clermont Ferrand, Dept Neurol, Clermont Ferrand, France; [Pelletier, Jean] Hop Enfants La Timone, APHM, Pole Neurosci Clin, Dept Neurol, Marseille, France; [Berger, Eric] CHU Besancon, Dept Neurol, F-25030 Besancon, France; [Cabre, Philippe] CHU Martinique, Dept Neurol, Martinique, France; [Camdessanche, Jean-Philippe] CHU St Etienne, Dept Neurol, St Etienne, France; [Kalson-Ray, Shoshannah] Sorbonne Paris Cite, EHESP Rennes, Dept Epidemiol, Paris, France; [Confavreux, Christian] CHU Lyon, Dept Neurol, Lyon, France; [Edan, Gilles] CHU Rennes, WEst Neurosci Network Excellence WENNE, Dept Neurol, Rennes, France	CHU Rennes; CHU Lyon; CHU de Nancy; CHU de Toulouse; CHU Bordeaux; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU Nice; CHU Dijon Bourgogne; CHU Clermont Ferrand; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Franche-Comte; CHU Besancon; CHU Martinique; CHU de St Etienne; CHU Lyon; CHU Rennes	Leray, E (corresponding author), CHU Rennes, Sorbonne Paris Cite, EHESP Rennes, Dept Epidemiol,CIC P 1414,WENNE, Rennes, France.	emmanuelle.leray@ehesp.fr	Edan, Gilles/AAI-5944-2020; DEFER, Gilles/AAM-4393-2020; De Seze, Jerome/M-8316-2016; Leray, Emmanuelle/ABH-4374-2020; Camdessanché, Jean-Philippe/N-9652-2017; Zéphir, Helene/AAV-9407-2020; lebrun-frenay, christine/AAP-9539-2021	De Seze, Jerome/0000-0002-7197-7578; Leray, Emmanuelle/0000-0001-8424-4499; Camdessanché, Jean-Philippe/0000-0002-5282-6707; lebrun-frenay, christine/0000-0002-3713-2416; Zephir, Helene/0000-0003-4029-2012; Clavelou, Pierre/0000-0003-2363-9352	Fondation ARSEP (Aide a la Recherche sur la Sclerose En Plaques)	Fondation ARSEP (Aide a la Recherche sur la Sclerose En Plaques)	The study was funded by Fondation ARSEP (Aide a la Recherche sur la Sclerose En Plaques), a French association promoting research in multiple sclerosis. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bronnum-Hansen H, 2004, BRAIN, V127, P844, DOI 10.1093/brain/awh104; CONFAVREUX C, 1992, J NEUROL NEUROSUR PS, V55, P671, DOI 10.1136/jnnp.55.8.671; Confavreux C, 2000, NEW ENGL J MED, V343, P1430, DOI 10.1056/NEJM200011163432001; El Adssi H, 2012, MULT SCLER J, V18, P1244, DOI 10.1177/1352458512437811; Fromont A, 2010, BRAIN, V133, P1889, DOI 10.1093/brain/awq134; Goodin DS, 2012, NEUROLOGY, V78, P1315, DOI 10.1212/WNL.0b013e3182535cf6; Hader WJ, 2010, CAN J NEUROL SCI, V37, P28, DOI 10.1017/S0317167100009616; Hirst C, 2008, J NEUROL NEUROSUR PS, V79, P1016, DOI 10.1136/jnnp.2007.127332; Kantarci O, 1998, NEUROLOGY, V51, P765, DOI 10.1212/WNL.51.3.765; Kingwell E, 2012, J NEUROL NEUROSUR PS, V83, P61, DOI 10.1136/jnnp-2011-300616; Leray E, 2010, BRAIN, V133, P1900, DOI 10.1093/brain/awq076; Leroy E, 2007, MULT SCLER J, V13, P865, DOI 10.1177/1352458507077410; Levic ZM, 1999, MULT SCLER J, V5, P171, DOI 10.1191/135245899678846005; Lublin RS, 1996, NEUROLOGY, V46, P5; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Noyes K, 2013, AM J MANAG CARE, V19, pS321; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; Pekmezovic T, 2002, NEUROEPIDEMIOLOGY, V21, P235, DOI 10.1159/000065641; PHADKE JG, 1987, J NEUROL NEUROSUR PS, V50, P523, DOI 10.1136/jnnp.50.5.523; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; POSER S, 1989, J CLIN EPIDEMIOL, V42, P159, DOI 10.1016/0895-4356(89)90089-9; Ragonese P, 2008, EUR J NEUROL, V15, P123, DOI 10.1111/j.1468-1331.2007.02019.x; RIISE T, 1988, J CLIN EPIDEMIOL, V41, P1031, DOI 10.1016/0895-4356(88)90041-8; SADOVNICK AD, 1992, NEUROLOGY, V42, P991, DOI 10.1212/WNL.42.5.991; SADOVNICK AD, 1991, NEUROLOGY, V41, P1193, DOI 10.1212/WNL.41.8.1193; Scalfari A, 2013, NEUROLOGY, V81, P184, DOI 10.1212/WNL.0b013e31829a3388; Sellner J, 2011, AUTOIMMUN REV, V10, P495, DOI 10.1016/j.autrev.2011.02.006; Smestad C, 2009, MULT SCLER J, V15, P1263, DOI 10.1177/1352458509107010; Sumelahti ML, 2010, MULT SCLER J, V16, P1437, DOI 10.1177/1352458510379244; Torkildsen NG, 2008, MULT SCLER J, V14, P1191, DOI 10.1177/1352458508093890; Trojano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048078; Wallin MT, 2000, BRAIN, V123, P1677, DOI 10.1093/brain/123.8.1677	33	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132033	10.1371/journal.pone.0132033	http://dx.doi.org/10.1371/journal.pone.0132033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148099	Green Published, gold			2022-12-27	WOS:000358157600184
J	Marcelletti, S; Scortichini, M				Marcelletti, Simone; Scortichini, Marco			Comparative Genomic Analyses of Multiple Pseudomonas Strains Infecting Corylus avellana Trees Reveal the Occurrence of Two Genetic Clusters with Both Common and Distinctive Virulence and Fitness Traits	PLOS ONE			English	Article							SYRINGAE PV AVELLANAE; BACTERIUM CAUSING CANKER; MOLECULAR-CLONING; SEQUENCE-ANALYSIS; CAUSAL AGENT; IV PILI; EVOLUTION; HAZELNUT; MANGOTOXIN; TOMATO	The European hazelnut (Corylus avellana) is threatened in Europe by several pseudomonads which cause symptoms ranging from twig dieback to tree death. A comparison of the draft genomes of nine Pseudomonas strains isolated from symptomatic C. avellana trees was performed to identify common and distinctive genomic traits. The thorough assessment of genetic relationships among the strains revealed two clearly distinct clusters: P. avellanae and P. syringae. The latter including the pathovars avellanae, coryli and syringae. Between these two clusters, no recombination event was found. A genomic island of approximately 20 kb, containing the hrp/hrc type III secretion system gene cluster, was found to be present without any genomic difference in all nine pseudomonads. The type III secretion system effector repertoires were remarkably different in the two groups, with P. avellanae showing a higher number of effectors. Homologue genes of the antimetabolite mangotoxin and ice nucleation activity clusters were found solely in all P. syringae pathovar strains, whereas the siderophore yersiniabactin was only present in P. avellanae. All nine strains have genes coding for pectic enzymes and sucrose metabolism. By contrast, they do not have genes coding for indolacetic acid and anti-insect toxin. Collectively, this study reveals that genomically different Pseudomonas can converge on the same host plant by suppressing the host defence mechanisms with the use of different virulence weapons. The integration into their genomes of a horizontally acquired genomic island could play a fundamental role in their evolution, perhaps giving them the ability to exploit new ecological niches.	[Marcelletti, Simone; Scortichini, Marco] Consiglio Ric Agr & Anal Econ Agr CRA, Ctr Ric Frutticoltura, I-00134 Rome, Italy; [Scortichini, Marco] Consiglio Ric Agr & Anal Econ Agr CRA, Unita Ric Frutticoltura, I-81100 Caserta, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Scortichini, M (corresponding author), Consiglio Ric Agr & Anal Econ Agr CRA, Ctr Ric Frutticoltura, Via Fioranello 52, I-00134 Rome, Italy.	marco.scortichini@entecra.it		Scortichini, Marco/0000-0003-1565-9097				Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856; Almeida NF, 2009, MOL PLANT MICROBE IN, V22, P52, DOI 10.1094/MPMI-22-1-0052; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arrebola E, 2009, INT MICROBIOL, V12, P87, DOI 10.2436/20.1501.01.85; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Bauer DW, 1997, MOL PLANT MICROBE IN, V10, P369, DOI 10.1094/MPMI.1997.10.3.369; BENDER CL, 1987, J BACTERIOL, V169, P470, DOI 10.1128/jb.169.2.470-474.1987; BENDER CL, 1986, J BACTERIOL, V165, P534, DOI 10.1128/jb.165.2.534-541.1986; Berge O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105547; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Bultreys A, 2006, APPL ENVIRON MICROB, V72, P3814, DOI 10.1128/AEM.00119-06; Carrion VJ, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-46; Carrion VJ, 2013, APPL ENVIRON MICROB, V79, P756, DOI 10.1128/AEM.03007-12; Carrion VJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036709; Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]; Cirvilleri G, 2007, J PHYTOPATHOL, V155, P397, DOI 10.1111/j.1439-0434.2007.01249.x; COOKSEY DA, 1990, APPL ENVIRON MICROB, V56, P431, DOI 10.1128/AEM.56.2.431-435.1990; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; DENNY TP, 1995, ANNU REV PHYTOPATHOL, V33, P173, DOI 10.1146/annurev.py.33.090195.001133; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Forest F, 2005, SYST BOT, V30, P118, DOI 10.1600/0363644053661850; Freeling M, 2008, GENOME RES, V18, P1924, DOI 10.1101/gr.081026.108; Galeva A, 2014, J BACTERIOL, V196, P1215, DOI 10.1128/JB.01278-13; Gardan L, 1999, INT J SYST BACTERIOL, V49, P469, DOI 10.1099/00207713-49-2-469; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guttman DS, 2014, NAT REV GENET, V15, P797, DOI 10.1038/nrg3748; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jackson RW, 2011, MOBILE GENETIC ELEME, V1, P1; Janse JD, 1996, SYST APPL MICROBIOL, V19, P589, DOI 10.1016/S0723-2020(96)80030-0; Jin F, 2011, P NATL ACAD SCI USA, V108, P12617, DOI 10.1073/pnas.1105073108; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; Kaluzna M, 2010, J PLANT PATHOL, V92, P781; Khandekar S, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-79; Liao CH, 2006, CAN J MICROBIOL, V52, P1051, DOI 10.1139/W06-063; Loreti S, 2008, J PLANT PATHOL, V90, P57; Loreti Stefania, 1999, Journal of Plant Pathology, V81, P234; Marcelletti S, 2014, PHYTOPATHOLOGY, V104, P1274, DOI 10.1094/PHYTO-12-13-0344-R; Marcelletti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027297; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; McCann HC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003503; Nakajima Masami, 2002, Journal of General Plant Pathology, V68, P68, DOI 10.1007/PL00013056; Natalini E, 2007, FEMS MICROBIOL LETT, V271, P274, DOI 10.1111/j.1574-6968.2007.00725.x; Newman MA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00139; Nowell RW, 2014, GENOME BIOL EVOL, V6, P1514, DOI 10.1093/gbe/evu123; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; O'Brien HE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-141; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; Ortega MA, 2015, NATURE, V517, P509, DOI 10.1038/nature13888; Ou HY, 2007, NUCLEIC ACIDS RES, V35, pW97, DOI 10.1093/nar/gkm380; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pechy-Tarr M, 2008, ENVIRON MICROBIOL, V10, P2368, DOI 10.1111/j.1462-2920.2008.01662.x; Polz MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/j.tig.2012.12.006; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Poptsova MS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-120; Poschenrieder G, 2006, JAHRESBERICHT, V2005, P32; PSALLIDAS P G, 1987, Bulletin OEPP, V17, P257, DOI 10.1111/j.1365-2338.1987.tb00036.x; PSALLIDAS PG, 1993, PLANT PATHOL, V42, P358, DOI 10.1111/j.1365-3059.1993.tb01512.x; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sahl HG, 1998, ANNU REV MICROBIOL, V52, P41, DOI 10.1146/annurev.micro.52.1.41; SANO Y, 1993, MOL GEN GENET, V237, P161, DOI 10.1007/BF00282797; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; Sarris PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059366; Scortichini M, 2000, J PHYTOPATHOL, V148, P523, DOI 10.1046/j.1439-0434.2000.00495.x; Scortichini M, 2007, J PLANT PATHOL, V89, P431; Scortichini M, 2006, PLANT PATHOL, V55, P451, DOI 10.1111/j.1365-3059.2006.01352.x; Scortichini M, 2005, PHYTOPATHOLOGY, V95, P1316, DOI 10.1094/PHYTO-95-1316; Scortichini M, 1996, J PHYTOPATHOL, V144, P215, DOI 10.1111/j.1439-0434.1996.tb01517.x; Scortichini M, 1998, J PHYTOPATHOL, V146, P417, DOI 10.1111/j.1439-0434.1998.tb04774.x; SCORTICHINI M, 1994, J PHYTOPATHOL, V140, P65, DOI 10.1111/j.1439-0434.1994.tb00177.x; Scortichini M, 2002, APPL ENVIRON MICROB, V68, P476, DOI 10.1128/AEM.68.2.476-484.2002; Scortichini M, 2002, PLANT DIS, V86, P704, DOI 10.1094/PDIS.2002.86.7.704; Scortichini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075794; Shrivastava S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002955; Sohn KH, 2012, J BACTERIOL, V194, P3733, DOI 10.1128/JB.00567-12; Tibayrenc M, 2012, P NATL ACAD SCI USA, V109, pE3305, DOI 10.1073/pnas.1212452109; Wall DP, 2003, METHOD MOL BIOL, V396, P95; Wang PW, 2007, MICROBIOL-SGM, V153, P2067, DOI 10.1099/mic.0.2006/001545-0; Yeaman S, 2013, P NATL ACAD SCI USA, V110, pE1743, DOI 10.1073/pnas.1219381110	85	12	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131112	10.1371/journal.pone.0131112	http://dx.doi.org/10.1371/journal.pone.0131112			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147218	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600062
J	Oluyinka, OO; Tong, HV; Tien, SB; Fagbami, AH; Adekanle, O; Ojurongbe, O; Bock, CT; Kremsner, PG; Velavan, TP				Oluyinka, Opaleye O.; Hoang Van Tong; Tien, Sy Bui; Fagbami, Ademola H.; Adekanle, Olusegun; Ojurongbe, Olusola; Bock, C. -Thomas; Kremsner, Peter G.; Velavan, Thirumalaisamy P.			Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks	PLOS ONE			English	Article							GENOTYPE-E; ANTI-HBC; WEST-AFRICA; TRANSFUSION; POPULATION; PREVALENCE; MECHANISMS; STRAINS; ADULTS; KOREA	Background Occult hepatitis B virus infection (OBI) characterized by the absence of detectable HBsAg remains a potential threat in blood safety. We investigated the actual prevalence, viral factors and genotype of OBI infections in Nigerian blood donors. Methods Serum collected from two blood banks were reconfirmed as HBsAg seronegative by ELISA. Forty HBsAg positive samples were employed as controls. HBV-DNA was amplified from all donors and viral loads were determined using quantitative real-time PCR. Antibodies to the HBV core, surface and HBe antigen (anti-HBc, anti-HBs, HBeAg) were measured. The PreS/S and PreC/C regions of the HBV genome were sequenced. Results Of the 429 blood donors, 72(17%) were confirmed as OBI by DNA detection in different reference labs and excluded the concern of possible contamination. Of the 72 OBI samples, 48(67%) were positive for anti-HBc, 25(35%) positive for anti-HBs, and 2(3%) positive for HBeAg. Of the 72 OBI samples, 31(43%) were seropositive for either anti-HBc, anti-HBs or HBeAg, 21 (30%) positive for both anti-HBc and anti-HBs, one positive for both anti-HBc and HBeAg. None of the OBI samples were positive for all three serological markers. The viral load was <50copies/ml in the OBI samples and genotype E was predominant. The L217R polymorphism in the reverse transcriptase domain of the HBV polymerase gene was observed significantly higher in OBI compared with HBsAg positive individuals (P<0.0001). Conclusion High incidence of OBI is relevant in high endemic areas worldwide and is a general burden in blood safety. This study signifies the high prevalence of OBI and proposes blood donor samples in Nigeria should be pre-tested for OBI by nucleic acid testing (NAT) and/or anti-HBc prior to transfusion to minimize the HBV infection risk.	[Oluyinka, Opaleye O.; Hoang Van Tong; Ojurongbe, Olusola; Kremsner, Peter G.; Velavan, Thirumalaisamy P.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Oluyinka, Opaleye O.; Fagbami, Ademola H.; Ojurongbe, Olusola] Ladoke Akintola Univ Technol, Deparment Med Microbiol & Parasitol, Ogbomosho, Nigeria; [Tien, Sy Bui; Bock, C. -Thomas] Robert Koch Inst, Dept Infect Dis, Berlin, Germany; [Adekanle, Olusegun] Obafemi Awolowo Univ, Ife, Nigeria; [Bock, C. -Thomas] Univ Tubingen, Dept Mol Pathol, Tubingen, Germany; [Velavan, Thirumalaisamy P.] Fdn Congolaise Rech Med, Brazzaville, Rep Congo; [Tien, Sy Bui] 108 Mil Cent Hosp, Dept Mol Biol, Hanoi, Vietnam	Eberhard Karls University of Tubingen; Robert Koch Institute; Obafemi Awolowo University; Eberhard Karls University of Tubingen	Velavan, TP (corresponding author), Univ Tubingen, Inst Trop Med, Tubingen, Germany.	velavan@medizin.uni-tuebingen.de	Velavan, Thirumalaisamy P/C-1223-2010; van Tong, Hoang/E-9448-2011	Velavan, Thirumalaisamy P/0000-0002-9809-9883; van Tong, Hoang/0000-0002-7170-8810	Deutscher Akademischer Austausch Dienst (DAAD); Vietnam Ministry of Education and Training, Vietnam [322]; Deutsche Forschungsgemeinschaft (DFG); Tuebingen University	Deutscher Akademischer Austausch Dienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Vietnam Ministry of Education and Training, Vietnam; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Tuebingen University	Opaleye Oluyinka received support from Deutscher Akademischer Austausch Dienst (DAAD) (https://www.daad.de/en/) for this work period. Sy Bui Tien was supported by a scholarship from project 322 of Vietnam Ministry of Education and Training, Vietnam (www.moet.gov.vn). The authors acknowledge the support by the Deutsche Forschungsgemeinschaft (DFG) and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain JP, 2009, BLOOD TRANSFUS-ITALY, V7, P174, DOI 10.2450/2008.0062-08; Antar W, 2010, TRANSFUSION MED, V20, P409, DOI 10.1111/j.1365-3148.2010.01021.x; Besharat S, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.15275; Brechot C, 2001, HEPATOLOGY, V34, P194, DOI 10.1053/jhep.2001.25172; Brojer E, 2006, HEPATOLOGY, V44, P1666, DOI 10.1002/hep.21413; Candotti D, 2008, J HEPATOL, V49, P537, DOI 10.1016/j.jhep.2008.04.017; Candotti D, 2012, GUT, V61, P1744, DOI 10.1136/gutjnl-2011-301281; Delfino CM, 2012, J CLIN VIROL, V54, P174, DOI 10.1016/j.jcv.2012.02.023; Emechebe GO, 2009, NIGERIAN MED J, V50, P18; Fang Y, 2009, J INFECTION, V58, P383, DOI 10.1016/j.jinf.2009.02.013; Huang CH, 2012, J HEPATOL, V57, P720, DOI 10.1016/j.jhep.2012.05.009; Jutavijittum P, 2014, VOX SANG, V106, P31, DOI 10.1111/vox.12073; Kang SY, 2010, J MED VIROL, V82, P1508, DOI 10.1002/jmv.21862; Kim DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047372; Kimbi GC, 2004, J GEN VIROL, V85, P1211, DOI 10.1099/vir.0.19749-0; Kurbanov F, 2005, J GEN VIROL, V86, P2047, DOI 10.1099/vir.0.80922-0; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Levicnik-Stezinar S, 2008, J HEPATOL, V48, P1022, DOI 10.1016/j.jhep.2008.02.016; Li L, 2008, TRANSFUSION, V48, P1198, DOI 10.1111/j.1537-2995.2008.01672.x; Lok ASF, 2000, J HEPATOL, V32, P89, DOI 10.1016/S0168-8278(00)80418-3; Makuwa M, 2006, J MED VIROL, V78, P1175, DOI 10.1002/jmv.20678; Marusawa H, 2000, HEPATOLOGY, V31, P488, DOI 10.1002/hep.510310232; Minuk GY, 2005, J HEPATOL, V42, P480, DOI 10.1016/j.jhep.2004.11.037; Mudawi H, 2014, INT J INFECT DIS, V29, P65, DOI 10.1016/j.ijid.2014.07.004; Mulders MN, 2004, J INFECT DIS, V190, P400, DOI 10.1086/421502; N'Dri-Yoman T, 2010, ANTIVIR THER, V15, P1029, DOI 10.3851/IMP1641; Nna E, 2014, PATHOG GLOB HEALTH, V108, P223, DOI 10.1179/2047773214Y.0000000144; Odemuyiwa SO, 2001, J MED VIROL, V65, P463, DOI 10.1002/jmv.2058; Ola SO, 2009, J INFECT DEV COUNTR, V3, P442, DOI 10.3855/jidc.415; Panhotra BR, 2005, J INFECTION, V51, P263, DOI 10.1016/j.jinf.2005.07.023; Pollicino T, 2007, HEPATOLOGY, V45, P277, DOI 10.1002/hep.21529; Ponde RAA, 2010, ARCH VIROL, V155, P149, DOI 10.1007/s00705-009-0559-6; Prati D, 2006, J HEPATOL, V44, P818, DOI 10.1016/j.jhep.2005.12.009; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Raimondo G, 2007, J HEPATOL, V46, P160, DOI 10.1016/j.jhep.2006.10.007; Samal J, 2012, CLIN MICROBIOL REV, V25, P142, DOI 10.1128/CMR.00018-11; Song EY, 2009, INTERVIROLOGY, V52, P57, DOI 10.1159/000214633; Torbenson M, 2002, LANCET INFECT DIS, V2, P479, DOI 10.1016/S1473-3099(02)00345-6; Tramuto F, 2013, J IMMIGR MINOR HEALT, V15, P725, DOI 10.1007/s10903-012-9699-y; Yuen MF, 2010, GUT, V59, P1389, DOI 10.1136/gut.2010.209148; Zahn A, 2008, J GEN VIROL, V89, P409, DOI 10.1099/vir.0.83347-0	41	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131912	10.1371/journal.pone.0131912	http://dx.doi.org/10.1371/journal.pone.0131912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148052	Green Published, gold			2022-12-27	WOS:000358157600164
J	Ozawa, M; Himaki, T; Ookutsu, S; Mizobe, Y; Ogawa, J; Miyoshi, K; Yabuki, A; Fan, JL; Yoshida, M				Ozawa, Masayuki; Himaki, Takehiro; Ookutsu, Shoji; Mizobe, Yamato; Ogawa, Junki; Miyoshi, Kazuchika; Yabuki, Akira; Fan, Jianglin; Yoshida, Mitsutoshi			Production of Cloned Miniature Pigs Expressing High Levels of Human Apolipoprotein(a) in Plasma	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; TRANSGENIC MICE; ANIMAL-MODELS; ATHEROSCLEROSIS; LIPOPROTEIN(A); CLONING; DISEASE; DIET	High lipoprotein(a) [Lp(a)] levels are a major risk factor for the development of atherosclerosis. However, because apolipoprotein(a) [apo(a)], the unique component of Lp(a), is found only in primates and humans, the study of human Lp(a) has been hampered due to the lack of appropriate animal models. Using somatic cell nuclear transfer (SCNT) techniques, we produced transgenic miniature pigs expressing human apo(a) in the plasma. First, we placed the hemagglutinin (HA)-tagged cDNA of human apo(a) under the control of the beta actin promoter and cytomegalovirus enhancer, and then introduced this construct into kidney epithelial cells. Immunostaining of cells with anti-HA antibody allowed identification of cells stably expressing apo(a); one of the positive clones was used to provide donor cells for SCNT, yielding blastocysts that expressed apo(a). Immunohistochemical analysis of tissue sections and RT-PCR analysis of total RNA from organs of cloned piglet revealed that apo(a) is expressed in various tissues/organs including heart, liver, kidney, and intestine. More importantly, a transgenic line exhibited a high level (>400 mg/dL) of Lp(a) in plasma, and the transgenic apo(a) gene was transmitted to the offspring. Thus, we generated a human apo(a)-transgenic miniature pig that can be used as a model system to study advanced atherosclerosis related to human disease. The anatomical and physiological similarities between the swine and human cardiovascular systems will make this pig model a valuable source of information on the role of apo(a) in the formation of atherosclerosis, as well as the mechanisms underlying vascular health and disease.	[Ozawa, Masayuki] Kagoshima Univ, Dept Biochem & Mol Biol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Himaki, Takehiro; Ookutsu, Shoji; Mizobe, Yamato; Ogawa, Junki; Miyoshi, Kazuchika; Yoshida, Mitsutoshi] Kagoshima Univ, Fac Agr, Lab Anim Reprod, Kagoshima 890, Japan; [Yabuki, Akira] Kagoshima Univ, Lab Vet Clin Pathol, Joint Fac Vet Med, Kagoshima 890, Japan; [Fan, Jianglin] Univ Yamanashi, Dept Mol Pathol, Interdisciplinary Grad Sch Med & Engn, Yamanashi, Japan	Kagoshima University; Kagoshima University; Kagoshima University; University of Yamanashi	Ozawa, M (corresponding author), Kagoshima Univ, Dept Biochem & Mol Biol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan.	mozawa@m.kufm.kagoshima-u.ac.jp	Mizobe, Yamato/AAT-4580-2021	Fan, Jianglin/0000-0002-1737-6130	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science [20580311]; Grants-in-Aid for Scientific Research [25450475] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Management Expenses Grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 20580311 to MY). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mashhadi RH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004853; Albers JJ, 1996, J LIPID RES, V37, P192; Ando A, 2005, XENOTRANSPLANTATION, V12, P121, DOI 10.1111/j.1399-3089.2005.00204.x; Berg K, 2002, ATHEROSCLEROSIS, V163, P99, DOI 10.1016/S0021-9150(01)00772-9; Boffa MB, 2004, CLIN BIOCHEM, V37, P333, DOI 10.1016/j.clinbiochem.2003.12.007; CHIESA G, 1992, J BIOL CHEM, V267, P24369; Cho SK, 2007, DEV DYNAM, V236, P3369, DOI 10.1002/dvdy.21308; Ding YY, 2011, TRANSGENIC RES, V20, P867, DOI 10.1007/s11248-010-9467-5; Dukes JD, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-43; Fan JL, 1999, BIOCHEM BIOPH RES CO, V255, P639, DOI 10.1006/bbrc.1999.0242; Fan JL, 2001, ARTERIOSCL THROM VAS, V21, P88, DOI 10.1161/01.ATV.21.1.88; Himaki T, 2010, CELL REPROGRAM, V12, P127, DOI 10.1089/cell.2009.0066; JOKINEN MP, 1985, EXP MOL PATHOL, V42, P1, DOI 10.1016/0014-4800(85)90015-2; KOSCHINSKY ML, 1993, J BIOL CHEM, V268, P19819; LAWN RM, 1992, NATURE, V360, P670, DOI 10.1038/360670a0; Longhurst JC, 1993, COLLATERAL CIRCULATI, P195; MAHER VMG, 1995, CURR OPIN LIPIDOL, V6, P229, DOI 10.1097/00041433-199508000-00007; Mahley RW, 1975, BIOCHEMISTRY-US, V14, P2871; Marcovina Santica M, 2002, Semin Vasc Med, V2, P335, DOI 10.1055/s-2002-35404; Mastromonaco GF, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-41; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Meadus W. J., 2003, Biological Procedures Online, V5, P20, DOI 10.1251/bpo43; Miyoshi K, 2007, MOL REPROD DEV, V74, P1568, DOI 10.1002/mrd.20730; NAKANISHI Y, 1991, Japanese Journal of Swine Science, V28, P211; Nakayama A, 2007, CLONING STEM CELLS, V9, P523, DOI 10.1089/clo.2007.0021; Nishimura T, 2010, XENOTRANSPLANTATION, V17, P313, DOI 10.1111/j.1399-3089.2010.00599.x; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Pariyarath R, 2001, J BIOL CHEM, V276, P541, DOI 10.1074/jbc.M007944200; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Prather RS, 2008, BIOTECHNOL GENET ENG, V25, P245; Rohrer GA, 1996, GENOME RES, V6, P371, DOI 10.1101/gr.6.5.371; SCANU AM, 1991, ANN INTERN MED, V115, P209, DOI 10.7326/0003-4819-115-3-209; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Turk JR, 2005, INT J EXP PATHOL, V86, P335, DOI 10.1111/j.0959-9673.2005.00446.x; UTERMANN G, 1989, SCIENCE, V246, P904, DOI 10.1126/science.2530631; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/annals.1334.015; Wang J, 2001, J LIPID RES, V42, P60; Wei JY, 2012, FEBS J, V279, P91, DOI 10.1111/j.1742-4658.2011.08401.x; Yabuki A, 2002, KIDNEY INT, V62, P2294, DOI 10.1046/j.1523-1755.2002.00688.x; YOSHIDA M, 1990, J REPROD FERTIL, V88, P1, DOI 10.1530/jrf.0.0880001; Zhao JG, 2009, BIOL REPROD, V81, P525, DOI 10.1095/biolreprod.109.077016	43	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132155	10.1371/journal.pone.0132155	http://dx.doi.org/10.1371/journal.pone.0132155			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147378	Green Submitted, gold, Green Published			2022-12-27	WOS:000358157600208
J	Peiker, I; Schneider, TR; Milne, E; Schottle, D; Vogeley, K; Munchau, A; Schunke, O; Siegel, M; Engel, AK; David, N				Peiker, Ina; Schneider, Till R.; Milne, Elizabeth; Schoettle, Daniel; Vogeley, Kai; Muenchau, Alexander; Schunke, Odette; Siegel, Markus; Engel, Andreas K.; David, Nicole			Stronger Neural Modulation by Visual Motion Intensity in Autism Spectrum Disorders	PLOS ONE			English	Article							GAMMA-BAND ACTIVITY; ASPERGER-SYNDROME; ILLUSORY FIGURES; RECEPTIVE-FIELD; TOP-DOWN; AREA MT; SYNCHRONIZATION; OSCILLATIONS; PERCEPTION; FREQUENCY	Theories of autism spectrum disorders (ASD) have focused on altered perceptual integration of sensory features as a possible core deficit. Yet, there is little understanding of the neuronal processing of elementary sensory features in ASD. For typically developed individuals, we previously established a direct link between frequency-specific neural activity and the intensity of a specific sensory feature: Gamma-band activity in the visual cortex increased approximately linearly with the strength of visual motion. Using magnetoencephalography (MEG), we investigated whether in individuals with ASD neural activity reflect the coherence, and thus intensity, of visual motion in a similar fashion. Thirteen adult participants with ASD and 14 control participants performed a motion direction discrimination task with increasing levels of motion coherence. A polynomial regression analysis revealed that gamma-band power increased significantly stronger with motion coherence in ASD compared to controls, suggesting excessive visual activation with increasing stimulus intensity originating from motion-responsive visual areas V3, V6 and hMT/V5. Enhanced neural responses with increasing stimulus intensity suggest an enhanced response gain in ASD. Response gain is controlled by excitatory-inhibitory interactions, which also drive high-frequency oscillations in the gamma-band. Thus, our data suggest that a disturbed excitatory-inhibitory balance underlies enhanced neural responses to coherent motion in ASD.	[Peiker, Ina; Schneider, Till R.; Engel, Andreas K.; David, Nicole] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany; [Milne, Elizabeth] Univ Sheffield, Clin Psychol Unit, Sheffield, S Yorkshire, England; [Schoettle, Daniel] Univ Med Ctr Hamburg Eppendorf, Dept Psychiat & Psychotherapy, Hamburg, Germany; [Vogeley, Kai] Univ Cologne, Dept Psychiat, D-50931 Cologne, Germany; [Vogeley, Kai] Res Ctr Juelich, Inst Neurosci & Med, Cognit Neurol Sect INM3, Julich, Germany; [Muenchau, Alexander; Schunke, Odette] Univ Lubeck, Inst Neurogenet, Dept Pediat & Adult Movement Disorders & Neuropsy, Lubeck, Germany; [Schunke, Odette] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Schunke, Odette] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Siegel, Markus] Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany; [Siegel, Markus] Univ Tubingen, MEG Ctr, Tubingen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Sheffield; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Cologne; Helmholtz Association; Research Center Julich; University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Peiker, I (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany.		Engel, Andreas K./AAH-6384-2019; Siegel, Markus/H-5225-2012; David, Nicole/H-1682-2012; Engel, Andreas K/C-7781-2012; Schneider, Till/B-3751-2010; Vogeley, Kai/E-4860-2012	Engel, Andreas K./0000-0003-4899-8466; Siegel, Markus/0000-0001-5115-936X; David, Nicole/0000-0001-5233-1977; Engel, Andreas K/0000-0003-4899-8466; Schneider, Till/0000-0002-8889-6248; Vogeley, Kai/0000-0002-5891-5831	European Union [FP7-ICT-270212, H2020-641321]; Else-Kroner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft [EXC 307]	European Union(European Commission); Else-Kroner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by European Union (FP7-ICT-270212, H2020-641321, A.K.E.), Else-Kroner-Fresenius-Stiftung (A.M.), and Deutsche Forschungsgemeinschaft (EXC 307, M.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Bastos AM, 2015, NEURON, V85, P390, DOI 10.1016/j.neuron.2014.12.018; Born RT, 2000, NEURON, V26, P725, DOI 10.1016/S0896-6273(00)81208-8; BORN RT, 1992, NATURE, V357, P497, DOI 10.1038/357497a0; Braddick OJ, 2001, PERCEPTION, V30, P61, DOI 10.1068/p3048; Brieber S, 2010, NEUROPSYCHOLOGIA, V48, P1644, DOI 10.1016/j.neuropsychologia.2010.02.007; Brown C, 2005, CORTEX, V41, P364, DOI 10.1016/S0010-9452(08)70273-9; Buchel C, 1998, NEUROIMAGE, V8, P140, DOI 10.1006/nimg.1998.0351; Buxbaum JD, 2002, MOL PSYCHIATR, V7, P311, DOI 10.1038/sj.mp.4001011; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carl C, 2012, NEUROIMAGE, V59, P1657, DOI 10.1016/j.neuroimage.2011.09.020; Caron MJ, 2006, BRAIN, V129, P1789, DOI 10.1093/brain/awl072; Dakin S, 2005, NEURON, V48, P497, DOI 10.1016/j.neuron.2005.10.018; Davis RAO, 2006, J AUTISM DEV DISORD, V36, P199, DOI 10.1007/s10803-005-0055-0; de Jonge MV, 2007, NEUROPSYCHOLOGY, V21, P65, DOI 10.1037/0894-4105.21.1.65; Donner TH, 2007, J NEUROPHYSIOL, V98, P345, DOI 10.1152/jn.01141.2006; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fatemi SH, 2009, J AUTISM DEV DISORD, V39, P223, DOI 10.1007/s10803-008-0646-7; Foss-Feig JH, 2013, J NEUROSCI, V33, P8243, DOI 10.1523/JNEUROSCI.1608-12.2013; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; FRITH U, 1994, COGNITION, V50, P115, DOI 10.1016/0010-0277(94)90024-8; Frith U., 1989, AUTISM EXPLAINING EN, V6th; Gieselmann MA, 2008, EUR J NEUROSCI, V28, P447, DOI 10.1111/j.1460-9568.2008.06358.x; Gillberg C, 2000, ACTA PSYCHIAT SCAND, V102, P321, DOI 10.1034/j.1600-0447.2000.102005321.x; GRAY CM, 1990, EUR J NEUROSCI, V2, P607, DOI 10.1111/j.1460-9568.1990.tb00450.x; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Greimel E, 2013, BEHAV BRAIN RES, V251, P168, DOI 10.1016/j.bbr.2013.05.055; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Hall SD, 2005, NEUROIMAGE, V26, P13, DOI 10.1016/j.neuroimage.2005.01.009; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hayasaka S, 2004, NEUROIMAGE, V23, P54, DOI 10.1016/j.neuroimage.2004.04.035; Helfrich RF, 2013, BRAIN TOPOGR, V26, P247, DOI 10.1007/s10548-012-0226-1; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Hipp JF, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00338; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Jones CRG, 2011, AUTISM RES, V4, P347, DOI 10.1002/aur.209; KANNER L, 1968, ACTA PAEDOPSYCHIATR, V35, P100; Katzner S, 2011, J NEUROSCI, V31, P5931, DOI 10.1523/JNEUROSCI.5753-10.2011; Khan S, 2015, BRAIN J NEUROL; Kitzbichler MG, 2015, BIOL PSYCHIAT, V77, P794, DOI 10.1016/j.biopsych.2014.05.012; Koldewyn K, 2011, DEVELOPMENTAL SCI, V14, P1075, DOI 10.1111/j.1467-7687.2011.01058.x; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; LEHRL S, 1995, ACTA NEUROL SCAND, V91, P335, DOI 10.1111/j.1600-0404.1995.tb07018.x; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Mann EO, 2010, NAT NEUROSCI, V13, P205, DOI 10.1038/nn.2464; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Milne E, 2002, J CHILD PSYCHOL PSYC, V43, P255, DOI 10.1111/1469-7610.00018; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Nolte G, 2003, PHYS MED BIOL, V48, P3637, DOI 10.1088/0031-9155/48/22/002; Oblak AL, 2010, J NEUROCHEM, V114, P1414, DOI 10.1111/j.1471-4159.2010.06858.x; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pei F, 2012, INT J PSYCHOPHYSIOL, V85, P298, DOI 10.1016/j.ijpsycho.2012.06.027; Pellicano E, 2005, NEUROPSYCHOLOGIA, V43, P1044, DOI 10.1016/j.neuropsychologia.2004.10.003; Pitzalis S, 2013, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00091; RAIGUEL S, 1995, EUR J NEUROSCI, V7, P2064, DOI 10.1111/j.1460-9568.1995.tb00629.x; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Robertson CE, 2014, BRAIN, V137, P2588, DOI 10.1093/brain/awu189; Robertson CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048173; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Samson F, 2012, HUM BRAIN MAPP, V33, P1553, DOI 10.1002/hbm.21307; Siegel M, 2000, J COMPUT NEUROSCI, V8, P161, DOI 10.1023/A:1008973215925; Siegel M, 2003, J NEUROSCI, V23, P4251; Siegel M, 2007, CEREB CORTEX, V17, P732, DOI 10.1093/cercor/bhk025; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Sokhadze EM, 2009, J AUTISM DEV DISORD, V39, P619, DOI 10.1007/s10803-008-0662-7; Spencer J, 2000, NEUROREPORT, V11, P2765, DOI 10.1097/00001756-200008210-00031; Stewart ME, 2006, AUTISM, V10, P103, DOI 10.1177/1362361306062013; Stroganova TA, 2012, CORTEX, V48, P701, DOI 10.1016/j.cortex.2011.02.016; Sun LM, 2012, J NEUROSCI, V32, P9563, DOI 10.1523/JNEUROSCI.1073-12.2012; Sutherland A, 2010, BRAIN, V133, P2089, DOI 10.1093/brain/awq122; Tootell RBH, 1997, J NEUROSCI, V17, P7060; van Kerkoerle T, 2014, P NATL ACAD SCI USA, V111, P14332, DOI 10.1073/pnas.1402773111; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027	82	13	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132531	10.1371/journal.pone.0132531	http://dx.doi.org/10.1371/journal.pone.0132531			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147342	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600298
J	Rodstrom, KEJ; Regenthal, P; Lindkvist-Petersson, K				Rodstrom, Karin E. J.; Regenthal, Paulina; Lindkvist-Petersson, Karin			Structure of Staphylococcal Enterotoxin E in Complex with TCR Defines the Role of TCR Loop Positioning in Superantigen Recognition	PLOS ONE			English	Article							T-CELL-RECEPTOR; MHC CLASS-II; PROTEIN-PROTEIN DOCKING; CRYSTAL-STRUCTURE; BETA-CHAIN; BACTERIAL SUPERANTIGEN; 3-DIMENSIONAL STRUCTURE; NAPTUMOMAB ESTAFENATOX; BINDING-SITES; PEPTIDE	T cells are crucial players in cell-mediated immunity. The specificity of their receptor, the T cell receptor (TCR), is central for the immune system to distinguish foreign from host antigens. Superantigens are bacterial toxins capable of inducing a toxic immune response by cross-linking the TCR and the major histocompatibility complex (MHC) class II and circumventing the antigen specificity. Here, we present the structure of staphylococcal enterotoxin E (SEE) in complex with a human T cell receptor, as well as the unligated T cell receptor structure. There are clear structural changes in the TCR loops upon superantigen binding. In particular, the HV4 loop moves to circumvent steric clashes upon complex formation. In addition, a predicted ternary model of SEE in complex with both TCR and MHC class II displays intermolecular contacts between the TCR alpha-chain and the MHC, suggesting that the TCR a-chain is of importance for complex formation.	[Rodstrom, Karin E. J.; Regenthal, Paulina; Lindkvist-Petersson, Karin] Lund Univ, Dept Expt Med Sci, BMC C13, S-22184 Lund, Sweden	Lund University	Lindkvist-Petersson, K (corresponding author), Lund Univ, Dept Expt Med Sci, BMC C13, S-22184 Lund, Sweden.	karin.lindkvist@med.lu.se		Lindkvist, Karin/0000-0002-5209-3160; Rodstrom, Karin/0000-0002-2952-0400	Swedish Research Council [VR-2011-2891]; Cancer Foundation; Olle Engkvist Byggmastare foundation; Ake Wiberg foundation; AFA forsakring; Kungliga Fysiografiska Sallskapet; Wilhelm and Martina Lundgren Foundation; Helge Ax:son Johnson Foundation; Foundation in Memory of Lars Hierta; Novo Nordisk Fonden [NNF14OC0009807] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancer Foundation; Olle Engkvist Byggmastare foundation; Ake Wiberg foundation; AFA forsakring; Kungliga Fysiografiska Sallskapet; Wilhelm and Martina Lundgren Foundation; Helge Ax:son Johnson Foundation; Foundation in Memory of Lars Hierta; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by Swedish Research Council (VR-2011-2891), the Cancer Foundation, the Olle Engkvist Byggmastare foundation, Ake Wiberg foundation, AFA forsakring, Kungliga Fysiografiska Sallskapet, the Wilhelm and Martina Lundgren Foundation, the Helge Ax:son Johnson Foundation and the Foundation in Memory of Lars Hierta. The funders had no role in study	ABRAHMSEN L, 1995, EMBO J, V14, P2978, DOI 10.1002/j.1460-2075.1995.tb07300.x; Al-Daccak R, 1998, J IMMUNOL, V160, P225; Andersen PS, 1999, IMMUNITY, V10, P473, DOI 10.1016/S1074-7613(00)80047-3; Archbold JK, 2009, J EXP MED, V206, P209, DOI 10.1084/jem.20082136; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; BENTLEY GA, 1995, SCIENCE, V267, P1984, DOI 10.1126/science.7701320; Bhati M, 2014, PROTEIN SCI, V23, P260, DOI 10.1002/pro.2412; Borbulevych OY, 2011, J IMMUNOL, V187, P2453, DOI 10.4049/jimmunol.1101268; Borghaei H, 2009, J CLIN ONCOL, V27, P4116, DOI 10.1200/JCO.2008.20.2515; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Bricogne G., 2011, BUSTER VERSION X Y Z; Brouillard JNP, 2007, J MOL BIOL, V367, P925, DOI 10.1016/j.jmb.2007.01.024; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bulek AM, 2012, NAT IMMUNOL, V13, P283, DOI 10.1038/ni.2206; Cavallin A, 2000, J BIOL CHEM, V275, P1665, DOI 10.1074/jbc.275.3.1665; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Cho SW, 2005, STRUCTURE, V13, P1775, DOI 10.1016/j.str.2005.08.015; CHOI YW, 1990, NATURE, V346, P471, DOI 10.1038/346471a0; Cole DK, 2009, J BIOL CHEM, V284, P27281, DOI 10.1074/jbc.M109.022509; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; deAlba YB, 1997, EUR J IMMUNOL, V27, P92, DOI 10.1002/eji.1830270114; Deng L, 2007, NAT IMMUNOL, V8, P398, DOI 10.1038/ni1447; Deng L, 2012, P NATL ACAD SCI USA, V109, P14960, DOI 10.1073/pnas.1207186109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fernandez MM, 2006, J BIOL CHEM, V281, P25356, DOI 10.1074/jbc.M603969200; Fernandez MM, 2011, J BIOL CHEM, V286, P1189, DOI 10.1074/jbc.M110.142471; Fields BA, 1996, NATURE, V384, P188, DOI 10.1038/384188a0; FLEISCHER B, 1988, J EXP MED, V167, P1697, DOI 10.1084/jem.167.5.1697; Forsberg G, 2010, J IMMUNOTHER, V33, P492, DOI 10.1097/CJI.0b013e3181d75820; FRASER JD, 1992, P NATL ACAD SCI USA, V89, P5507, DOI 10.1073/pnas.89.12.5507; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; Gadola SD, 2006, J EXP MED, V203, P699, DOI 10.1084/jem.20052369; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Gras S, 2010, J EXP MED, V207, P1555, DOI 10.1084/jem.20100603; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Gunther S, 2007, J MOL BIOL, V371, P210, DOI 10.1016/j.jmb.2007.05.038; Hakansson M, 2000, J MOL BIOL, V302, P527, DOI 10.1006/jmbi.2000.4093; Hargreaves REG, 1995, EUR J IMMUNOL, V25, P3437, DOI 10.1002/eji.1830251235; Hedlund G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079082; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; Hoare HL, 2006, NAT IMMUNOL, V7, P256, DOI 10.1038/ni1312; HUDSON KR, 1993, J EXP MED, V177, P175, DOI 10.1084/jem.177.1.175; HUDSON KR, 1995, J EXP MED, V182, P711, DOI 10.1084/jem.182.3.711; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KARP DR, 1992, J EXP MED, V175, P415, DOI 10.1084/jem.175.2.415; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leder L, 1998, J EXP MED, V187, P823, DOI 10.1084/jem.187.6.823; Li HM, 1998, IMMUNITY, V9, P807, DOI 10.1016/S1074-7613(00)80646-9; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Liao L, 1996, J EXP MED, V184, P1471, DOI 10.1084/jem.184.4.1471; Liu YC, 2013, J BIOL CHEM, V288, P15442, DOI 10.1074/jbc.M112.447185; Lopez-Sagaseta J, 2013, J IMMUNOL, V191, P5268, DOI 10.4049/jimmunol.1301958; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moza B, 2007, EMBO J, V26, P1187, DOI 10.1038/sj.emboj.7601531; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neill RJ, 1996, INFECT IMMUN, V64, P3007, DOI 10.1128/IAI.64.8.3007-3015.1996; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Petersen J, 2014, NAT STRUCT MOL BIOL, V21, P480, DOI 10.1038/nsmb.2817; Petersson K, 2002, STRUCTURE, V10, P1619, DOI 10.1016/S0969-2126(02)00895-X; Petersson K, 2001, EMBO J, V20, P3306, DOI 10.1093/emboj/20.13.3306; Petersson K, 2004, SCAND J IMMUNOL, V59, P345, DOI 10.1111/j.0300-9475.2004.01404.x; Rodstrom KEJ, 2014, J IMMUNOL, V193, P1998, DOI 10.4049/jimmunol.1401268; Roggiani M, 1997, INFECT IMMUN, V65, P2868, DOI 10.1128/IAI.65.7.2868-2875.1997; Saline M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1117; SCHAD EM, 1995, EMBO J, V14, P3292, DOI 10.1002/j.1460-2075.1995.tb07336.x; Sethi DK, 2011, J EXP MED, V208, P91, DOI 10.1084/jem.20100725; Shimizu A, 2013, SCI REP-UK, V3, DOI 10.1038/srep03097; Sundberg EJ, 2002, STRUCTURE, V10, P687, DOI 10.1016/S0969-2126(02)00759-1; Sundstrom M, 1996, J BIOL CHEM, V271, P32212, DOI 10.1074/jbc.271.50.32212; SWAMINATHAN S, 1992, NATURE, V359, P801, DOI 10.1038/359801a0; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang C, 2005, PROTEIN SCI, V14, P1328, DOI 10.1110/ps.041222905; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; ZINKERNA.RM, 1974, NATURE, V251, P547, DOI 10.1038/251547a0	85	10	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131988	10.1371/journal.pone.0131988	http://dx.doi.org/10.1371/journal.pone.0131988			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147596	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600175
J	Saha, SC; Henderson, AJ; Powl, AM; Wallace, BA; de Planque, MRR; Morgan, H				Saha, Shimul Chandra; Henderson, Alexander J.; Powl, Andrew M.; Wallace, B. A.; de Planque, Maurits R. R.; Morgan, Hywel			Characterization of the Prokaryotic Sodium Channel Na(v)Sp Pore with a Microfluidic Bilayer Platform	PLOS ONE			English	Article								This paper describes the use of a newly-developed micro-chip bilayer platform to examine the electrophysiological properties of the prokaryotic voltage-gated sodium channel pore (Na(v)Sp) from Silicibacter pomeroyi. The platform allows up to 6 bilayers to be analysed simultaneously. Proteoliposomes were incorporated into suspended lipid bilayers formed within the microfluidic bilayer chips. The chips provide access to bilayers from either side, enabling the fast and controlled titration of compounds. Dose-dependent modulation of the opening probability by the channel blocking drug nifedipine was measured and its IC50 determined.	[Saha, Shimul Chandra; de Planque, Maurits R. R.; Morgan, Hywel] Univ Southampton, Elect & Comp Sci, Southampton SO17 1BJ, Hants, England; [de Planque, Maurits R. R.; Morgan, Hywel] Univ Southampton, Inst Life Sci, Southampton SO17 1BJ, Hants, England; [Henderson, Alexander J.; Powl, Andrew M.; Wallace, B. A.] Univ London Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England	University of Southampton; University of Southampton; University of London; Birkbeck University London	Wallace, BA (corresponding author), Univ London Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England.	b.wallace@mail.cryst.bbk.ac.uk; hm@ecs.soton.ac.uk	Powl, Andrew/C-4443-2008; Wallace, B A/C-3753-2008	Powl, Andrew/0000-0003-3397-2837; Wallace, B A/0000-0001-9649-5092; de Planque, Maurits/0000-0002-8787-0513; Morgan, Hywel/0000-0003-4850-5676	UK Engineering and Physical Sciences Research Council [EP/H044795/1, EP/H043888/1]; Biotechnology and Biological Sciences Research Council [BB/L006790]; Biotechnology and Biological Sciences Research Council [BB/L006790/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H043888/1, EP/H044795/1] Funding Source: researchfish; BBSRC [BB/L006790/1] Funding Source: UKRI; EPSRC [EP/H043888/1] Funding Source: UKRI	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by a linked grant from the UK Engineering and Physical Sciences Research Council (EP/H044795/1 to HM and MRRDP and EP/H043888/1 to BAW), http://www.epsrc.ac.uk/. It was also supported by a grant from the Biotechnology and Biological Sciences Research Council (BB/L006790 to BAW).	Altamirano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081222; [Anonymous], PCLAMP 10 SOFTW; [Anonymous], SIGM; Bagneris C, 2014, P NATL ACAD SCI USA, V111, P8428, DOI 10.1073/pnas.1406855111; Bagneris C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3465; Clare JJ, 2000, DRUG DISCOV TODAY, V5, P506, DOI 10.1016/S1359-6446(00)01570-1; Crescentini M, 2015, IEEE T BIOM IN PRESS; D'Avanzo N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061216; Kass RS, 2005, J CLIN INVEST, V115, P1986, DOI 10.1172/JCI26011; Marban E, 2002, NATURE, V415, P213, DOI 10.1038/415213a; McCusker EC, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.C111.228122; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Saha SC, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4905313; Saha SC, 2014, SENSOR ACTUAT B-CHEM, V199, P76, DOI 10.1016/j.snb.2014.03.111; Scriabine A, 1985, DRUGS, V3, P197; Shaya D, 2011, P NATL ACAD SCI USA, V108, P12313, DOI 10.1073/pnas.1106811108; Studer A, 2011, BIOSENS BIOELECTRON, V26, P1924, DOI 10.1016/j.bios.2010.06.008; Walker GM, 2002, LAB CHIP, V2, P131, DOI 10.1039/b204381e	19	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131286	10.1371/journal.pone.0131286	http://dx.doi.org/10.1371/journal.pone.0131286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147601	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000358157600085
J	Shiboski, CH; Chen, HC; Secours, R; Lee, A; Webster-Cyriaque, J; Ghannoum, M; Evans, S; Bernard, D; Reznik, D; Dittmer, DP; Hosey, L; Severe, P; Aberg, JA				Shiboski, Caroline H.; Chen, Huichao; Secours, Rode; Lee, Anthony; Webster-Cyriaque, Jennifer; Ghannoum, Mahmoud; Evans, Scott; Bernard, Daphne; Reznik, David; Dittmer, Dirk P.; Hosey, Lara; Severe, Patrice; Aberg, Judith A.		AIDS Clinical Trial Grp	High Accuracy of Common HIV-Related Oral Disease Diagnoses by Non-Oral Health Specialists in the AIDS Clinical Trial Group	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; PROTEASE INHIBITOR THERAPY; WOMENS INTERAGENCY HIV; HAIRY LEUKOPLAKIA; SAN-FRANCISCO; BISEXUAL MEN; VIRAL LOAD; LESIONS; MANIFESTATIONS	Objective Many studies include oral HIV-related endpoints that may be diagnosed by non-oral-health specialists (non-OHS) like nurses or physicians. Our objective was to assess the accuracy of clinical diagnoses of HIV-related oral lesions made by non-OHS compared to diagnoses made by OHS. Methods A5254, a cross-sectional study conducted by the Oral HIV/AIDS Research Alliance within the AIDS Clinical Trial Group, enrolled HIV-1-infected adults participants from six clinical trial units (CTU) in the US (San Francisco, New York, Chapel Hill, Cleveland, Atlanta) and Haiti. CTU examiners (non-OHS) received standardized training on how to perform an oral examination and make clinical diagnoses of specific oral disease endpoints. Diagnoses by calibrated non-OHS were compared to those made by calibrated OHS, and sensitivity and specificity computed. Results Among 324 participants, the majority were black (73%), men (66%), and the median CD4+ cell count 138 cells/mm3. The overall frequency of oral mucosal disease diagnosed by OHS was 43% in US sites, and 90% in Haiti. Oral candidiasis (OC) was detected in 153 (47%) by OHS, with erythematous candidiasis (EC) the most common type (39%) followed by pseudomembranous candidiasis (PC; 26%). The highest prevalence of OC (79%) was among participants in Haiti, and among those with CD4+ cell count <= 200 cells/mm(3) and HIV-1 RNA > 1000 copies/mL (71%). The sensitivity and specificity of OC diagnoses by non-OHS were 90% and 92% (for EC: 81% and 94%; PC: 82% and 95%). Sensitivity and specificity were also high for KS (87% and 94%, respectively), but sensitivity was < 60% for HL and oral warts in all sites combined. The Candida culture confirmation of OC clinical diagnoses (as defined by >= 1 colony forming unit per mL of oral/throat rinse) was >= 93% for both PC and EC. Conclusion Trained non-OHS showed high accuracy of clinical diagnoses of OC in comparison with OHS, suggesting their usefulness in studies in resource-poor settings, but detection of less common lesions may require OHS.	[Shiboski, Caroline H.] Univ Calif San Francisco, Sch Dent, Dept Orofacial Sci, San Francisco, CA 94143 USA; [Chen, Huichao; Lee, Anthony; Evans, Scott] Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Cambridge, MA 02138 USA; [Secours, Rode; Bernard, Daphne; Severe, Patrice] Ctr GHESKIO, Port Au Prince, Haiti; [Webster-Cyriaque, Jennifer] Univ N Carolina, Sch Dent, Dept Dent Ecol, Chapel Hill, NC 27599 USA; [Webster-Cyriaque, Jennifer; Dittmer, Dirk P.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Webster-Cyriaque, Jennifer; Dittmer, Dirk P.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Ghannoum, Mahmoud] Case Med Ctr, Dept Dermatol, Ctr Med Mycol, Cleveland, OH USA; [Ghannoum, Mahmoud] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Reznik, David] Grady Hlth Syst, Atlanta, GA USA; [Reznik, David] Emory Univ, Sch Med, Atlanta, GA USA; [Hosey, Lara] Social & Sci Syst Inc, Silver Spring, MD USA; [Aberg, Judith A.] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA; [Aberg, Judith A.] NYU, Sch Med, Dept Med, New York, NY USA	University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Case Western Reserve University; Case Western Reserve University; Emory University; Social & Scientific Systems; Icahn School of Medicine at Mount Sinai; New York University	Shiboski, CH (corresponding author), Univ Calif San Francisco, Sch Dent, Dept Orofacial Sci, San Francisco, CA 94143 USA.	caroline.shiboski@ucsf.edu	Dittmer, Dirk/AAH-3535-2021; Dittmer, Dirk/GPW-7423-2022	Dittmer, Dirk/0000-0003-4968-5656; 	National Institutes of Health from the National Institute of Allergy and Infectious Diseases [U01AI068636]; National Institute of Dental and Craniofacial Research [U01 AI068634]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001111] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069501, U01AI068634, UM1AI069496, UM1AI069501, UM1AI069470, UM1AI069532, P30AI050410, U01AI068636, UM1AI068636, U01AI069421, UM1AI068634, UM1AI069423, U01AI069418, P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018304] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute of Allergy and Infectious Diseases; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Cooperative Agreement U01AI068636 from the National Institute of Allergy and Infectious Diseases and the National Institute of Dental and Craniofacial Research, and U01 AI068634 for the Statistical and Data Management Center for the AIDS Clinical Trials Group. Social and Scientific Systems, Inc is contracted to provide administrative support to the AIDS Clinical Trial Group and the Oral HIV/AIDS Research Alliance. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	ACTG AIDS Clinical Trials Group Network, HIST ACTG; Arribas JR, 2000, AIDS, V14, P979, DOI 10.1097/00002030-200005260-00009; Cameron JE, 2005, SEX TRANSM DIS, V32, P703, DOI 10.1097/01.olq.0000175398.34610.2e; Ceballos-Salobrena A, 2000, AIDS PATIENT CARE ST, V14, P627, DOI 10.1089/10872910050206540; Chidzonga MM, 2008, JAIDS-J ACQ IMM DEF, V47, P579, DOI 10.1097/QAI.0b013e318160a554; FEIGAL DW, 1991, AIDS, V5, P519, DOI 10.1097/00002030-199105000-00007; GLICK M, 1994, ORAL SURG ORAL MED O, V77, P344, DOI 10.1016/0030-4220(94)90195-3; Greenspan D, 2004, J DENT RES, V83, P145, DOI 10.1177/154405910408300212; Greenspan D, 2001, LANCET, V357, P1411, DOI 10.1016/S0140-6736(00)04578-5; Greenspan D, 2000, J ACQ IMMUN DEF SYND, V25, P44, DOI 10.1097/00126334-200009010-00006; Hilton JF, 2001, COMMUNITY DENT ORAL, V29, P362, DOI 10.1034/j.1600-0528.2001.290506.x; Hodgson T A, 2006, Adv Dent Res, V19, P57; KATZ MH, 1992, AIDS, V6, P95, DOI 10.1097/00002030-199201000-00013; King MD, 2002, CLIN INFECT DIS, V34, P641, DOI 10.1086/338637; NAVAZESH M, 1992, J DENT RES, V71, P1363, DOI 10.1177/00220345920710070301; Nicolatou-Galitis O, 2004, ORAL DIS, V10, P145, DOI 10.1046/j.1601-0825.2003.00994.x; Patton LL, 2000, ORAL SURG ORAL MED O, V89, P299, DOI 10.1016/S1079-2104(00)70092-8; Patton LL, 1999, AIDS, V13, P2174, DOI 10.1097/00002030-199910220-00026; Ramirez-Amador V, 2003, MEDICINE, V82, P39, DOI 10.1097/00005792-200301000-00004; Schmidt-Westhausen AM, 2000, J ORAL PATHOL MED, V29, P336, DOI 10.1034/j.1600-0714.2000.290708.x; Shiboski CH, 2014, INT J TUBERC LUNG D, V18, P682, DOI 10.5588/ijtld.13.0729; Shiboski C H, 2011, Adv Dent Res, V23, P28, DOI 10.1177/0022034511399084; Shiboski CH, 2009, J ORAL PATHOL MED, V38, P481, DOI 10.1111/j.1600-0714.2009.00749.x; Shiboski CH, 1996, ARCH INTERN MED, V156, P2249, DOI 10.1001/archinte.156.19.2249; SHIBOSKI CH, 1994, J ACQ IMMUN DEF SYND, V7, P964; Shiboski CH, 2001, J ADOLESCENT HEALTH, V29, P109, DOI 10.1016/S1054-139X(01)00280-4; Tappuni AR, 2001, ORAL SURG ORAL MED O, V92, P623, DOI 10.1067/moe.2001.118902; Umadevi KMR, 2007, J ORAL PATHOL MED, V36, P136, DOI 10.1111/j.1600-0714.2006.00505.x	28	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131001	10.1371/journal.pone.0131001	http://dx.doi.org/10.1371/journal.pone.0131001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148192	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600057
J	Panneton, WM; Gan, Q; Ariel, M				Panneton, W. Michael; Gan, Qi; Ariel, Michael			Injections of Algesic Solutions into Muscle Activate the Lateral Reticular Formation: A Nociceptive Relay of the Spinoreticulothalamic Tract	PLOS ONE			English	Article							C-FOS EXPRESSION; DISTINCT CENTRAL REPRESENTATIONS; PUNCTATE MIDLINE MYELOTOMY; BRAIN-STEM PROJECTIONS; CERVICAL-SPINAL CORD; PARABRACHIAL NUCLEUS; PERIAQUEDUCTAL GRAY; SKELETAL-MUSCLE; REFERRED PAIN; DORSAL-HORN	Although musculoskeletal pain disorders are common clinically, the central processing of muscle pain is little understood. The present study reports on central neurons activated by injections of algesic solutions into the gastrocnemius muscle of the rat, and their subsequent localization by c-Fos immunohistochemistry in the spinal cord and brainstem. An injection (300 mu l) of an algesic solution (6% hypertonic saline, pH 4.0 acetate buffer, or 0.05% capsaicin) was made into the gastrocnemius muscle and the distribution of immunolabeled neurons compared to that obtained after control injections of phosphate buffered saline [pH 7.0]. Most labeled neurons in the spinal cord were found in laminae IV-V, VI, VII and X, comparing favorably with other studies, with fewer labeled neurons in laminae I and II. This finding is consistent with the diffuse pain perception due to noxious stimuli to muscles mediated by sensory fibers to deep spinal neurons as compared to more restricted pain localization during noxious stimuli to skin mediated by sensory fibers to superficial laminae. Numerous neurons were immunolabeled in the brainstem, predominantly in the lateral reticular formation (LRF). Labeled neurons were found bilaterally in the caudalmost ventrolateral medulla, where neurons responsive to noxious stimulation of cutaneous and visceral structures lie. Immunolabeled neurons in the LRF continued rostrally and dorsally along the intermediate reticular nucleus in the medulla, including the subnucleus reticularis dorsalis caudally and the parvicellular reticular nucleus more rostrally, and through the pons medial and lateral to the motor trigeminal nucleus, including the subcoerulear network. Immunolabeled neurons, many of them catecholaminergic, were found bilaterally in the nucleus tractus solitarii, the gracile nucleus, the A1 area, the CVLM and RVLM, the superior salivatory nucleus, the nucleus locus coeruleus, the A5 area, and the nucleus raphe magnus in the pons. The external lateral and superior lateral subnuclei of the parabrachial nuclear complex were consistently labeled in experimental data, but they also were labeled in many control cases. The internal lateral subnucleus of the parabrachial complex was labeled moderately. Few immunolabeled neurons were found in the medial reticular formation, however, but the rostroventromedial medulla was labeled consistently. These data are discussed in terms of an interoceptive, multisynaptic spinoreticulothalamic path, with its large receptive fields and role in the motivational-affective components of pain perceptions.	[Panneton, W. Michael; Gan, Qi; Ariel, Michael] St Louis Univ, Dept Pharmacol & Physiol Sci, St Louis, MO 63103 USA	Saint Louis University	Panneton, WM (corresponding author), St Louis Univ, Dept Pharmacol & Physiol Sci, St Louis, MO 63103 USA.	pannetwm@slu.edu		Ariel, Michael/0000-0001-8155-3261	National Institutes of Health [HL64772]; Presidential Research Fund of Saint Louis University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Presidential Research Fund of Saint Louis University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health grant HL64772 TO WMP. Presidential Research Fund of Saint Louis University to WMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida TF, 2004, BRAIN RES, V1000, P40, DOI 10.1016/j.brainres.2003.10.073; Arendt-Nielsen L, 2001, CLIN J PAIN, V17, P11, DOI 10.1097/00002508-200103000-00003; Ariel M, 2014, NEUROSCI ABSTR, V39; BELCZYNSKI CR, 1990, BRAIN RES, V527, P204, DOI 10.1016/0006-8993(90)91139-8; Bellavance LL, 1996, J COMP NEUROL, V366, P431, DOI 10.1002/(SICI)1096-9861(19960311)366:3<431::AID-CNE5>3.0.CO;2-5; BERNARD JF, 1995, J COMP NEUROL, V353, P480, DOI 10.1002/cne.903530403; Bester H, 1999, J COMP NEUROL, V405, P421; BESTER H, 1995, J NEUROPHYSIOL, V73, P568, DOI 10.1152/jn.1995.73.2.568; BLOMQVIST A, 1992, BRAIN RES, V579, P17, DOI 10.1016/0006-8993(92)90737-T; Braz J, 2014, NEURON, V82, P522, DOI 10.1016/j.neuron.2014.01.018; BULLITT E, 1992, BRAIN RES, V580, P172, DOI 10.1016/0006-8993(92)90941-2; CASEY KL, 1969, EXP NEUROL, V25, P35, DOI 10.1016/0014-4886(69)90070-3; CECHETTO DF, 1985, J COMP NEUROL, V240, P153, DOI 10.1002/cne.902400205; CERVERO F, 1984, BRAIN RES, V294, P370, DOI 10.1016/0006-8993(84)91053-9; Cervero F, 2009, DIGEST DIS, V27, P3, DOI 10.1159/000268115; Chaitow L, 2014, J BODYW MOV THER, V18, P149, DOI 10.1016/j.jbmt.2014.02.001; Chen YK, 2013, EUR J PAIN, V17, P336, DOI 10.1002/j.1532-2149.2012.00207.x; Clement CI, 1996, J COMP NEUROL, V366, P495, DOI 10.1002/(SICI)1096-9861(19960311)366:3<495::AID-CNE9>3.0.CO;2-#; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; FIELDS HL, 1975, EXP NEUROL, V47, P118, DOI 10.1016/0014-4886(75)90241-1; Furuta S, 2009, NEUROSCIENCE, V164, P1252, DOI 10.1016/j.neuroscience.2009.09.021; Gao ZH, 2006, J APPL PHYSIOL, V100, P421, DOI 10.1152/japplphysiol.00659.2005; Gauriau C, 2002, EXP PHYSIOL, V87, P251, DOI 10.1113/eph8702357; Gerdle B, 2014, J PAIN RES, V7, P313, DOI 10.2147/JPR.S59144; GIESLER GJ, 1981, J NEUROPHYSIOL, V46, P1285, DOI 10.1152/jn.1981.46.6.1285; Graven-Nielsen T, 2006, SCAND J RHEUMATOL, V35, P1, DOI 10.1080/03009740600865980; GravenNielsen T, 1997, PAIN, V69, P137, DOI 10.1016/S0304-3959(96)03270-8; Grob GN, 2011, PERSPECT BIOL MED, V54, P417, DOI 10.1353/pbm.2011.0044; Han F, 2003, WORLD J GASTROENTERO, V9, P1045; Henderson LA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00569; Hermanson O, 1997, J COMP NEUROL, V387, P114; Hermanson O, 1996, J COMP NEUROL, V368, P45, DOI 10.1002/(SICI)1096-9861(19960422)368:1<45::AID-CNE4>3.0.CO;2-K; Hirshberg RM, 1996, PAIN, V67, P291, DOI 10.1016/0304-3959(96)03127-2; Hoheisel U, 2004, PAIN, V110, P149, DOI 10.1016/j.pain.2004.03.043; HOLSTEGE G, 1977, BRAIN, V100, P265, DOI 10.1093/brain/100.2.265; Hoskin KL, 1999, BRAIN RES, V824, P133, DOI 10.1016/S0006-8993(99)01135-X; Hwang SL, 2004, J PAIN SYMPTOM MANAG, V27, P79, DOI 10.1016/j.jpainsymman.2003.05.005; KAUFMAN MP, 1982, CIRC RES, V50, P133, DOI 10.1161/01.RES.50.1.133; Keay KA, 2000, NEUROSCI LETT, V290, P157, DOI 10.1016/S0304-3940(00)01329-X; Keay KA, 2002, EXP PHYSIOL, V87, P275, DOI 10.1113/eph8702355; Kellgren JH, 1938, CLIN SCI, V3, P175; KEVETTER GA, 1982, J COMP NEUROL, V207, P61, DOI 10.1002/cne.902070106; KITAMURA T, 1993, J COMP NEUROL, V328, P449, DOI 10.1002/cne.903280310; Knight YE, 2005, BRAIN RES, V1045, P1, DOI 10.1016/j.brainres.2005.01.091; Krout KE, 2002, J COMP NEUROL, V448, P53, DOI 10.1002/cne.10236; Lewis T, 1939, CLIN SCI, V4, P47; Light AR, 2008, J NEUROPHYSIOL, V100, P1184, DOI 10.1152/jn.01344.2007; Lu GW, 1999, BRAIN RES REV, V29, P50, DOI 10.1016/S0165-0173(98)00048-4; Maisky VA, 2002, AUTON NEUROSCI-BASIC, V101, P1, DOI 10.1016/S1566-0702(02)00146-7; Marchettini P, 1996, BRAIN RES, V740, P109, DOI 10.1016/S0006-8993(96)00851-7; MARTIN GF, 1979, J COMP NEUROL, V187, P373, DOI 10.1002/cne.901870208; MARTIN GF, 1981, J COMP NEUROL, V196, P663, DOI 10.1002/cne.901960411; McCulloch PF, 1997, NEUROSCIENCE, V78, P913, DOI 10.1016/S0306-4522(96)00633-1; MEHLER WR, 1960, BRAIN, V83, P718, DOI 10.1093/brain/83.4.718; MENSE S, 1993, PAIN, V54, P241, DOI 10.1016/0304-3959(93)90027-M; Mense S, 2009, EXP BRAIN RES, V196, P89, DOI 10.1007/s00221-008-1674-4; Mense S, 1986, PROGR SENSORY PHYSL, V6, P139; Millan MJ, 1999, PROG NEUROBIOL, V57, P1, DOI 10.1016/S0301-0082(98)00048-3; MORGAN C, 1981, J COMP NEUROL, V201, P415, DOI 10.1002/cne.902010308; Multon S, 2005, ACTA NEUROL BELG, V105, P62; Nauta HJW, 2000, J NEUROSURG, V92, P125, DOI 10.3171/spi.2000.92.2.0125; Panfil C, 2006, CEPHALALGIA, V26, P128, DOI 10.1111/j.1468-2982.2005.01005.x; Panneton WM, 2006, NEUROSCIENCE, V141, P889, DOI 10.1016/j.neuroscience.2006.04.055; Panneton WM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00111; Panneton WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024499; Panneton WM, 2010, EXP EYE RES, V90, P388, DOI 10.1016/j.exer.2009.11.018; PANNETON WM, 1991, J COMP NEUROL, V308, P51, DOI 10.1002/cne.903080106; Panneton WM, 2005, NEUROSCIENCE, V134, P175, DOI 10.1016/j.neuroscience.2005.02.032; PANNETON WM, 1981, J COMP NEUROL, V199, P199, DOI 10.1002/cne.901990303; Panneton WM, 2012, NEUROSCI ABSTR, V37; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perl ER, 2007, NAT REV NEUROSCI, V8, P71, DOI 10.1038/nrn2042; Pinto M, 2003, EUR J NEUROSCI, V17, P1393, DOI 10.1046/j.1460-9568.2003.02586.x; Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7; Ren Y, 2009, J NEUROPHYSIOL, V102, P244, DOI 10.1152/jn.90985.2008; Rinaman L, 2011, AM J PHYSIOL-REG I, V300, pR222, DOI 10.1152/ajpregu.00556.2010; ROTTOPERCELAY DM, 1992, BRAIN RES, V574, P291, DOI 10.1016/0006-8993(92)90829-X; Sabbatini M, 2004, EXP BRAIN RES, V157, P315, DOI 10.1007/s00221-004-1845-x; SANDOZ PA, 1986, ANAT EMBRYOL, V174, P207, DOI 10.1007/BF00824336; SCHAIBLE HG, 1993, PAIN, V55, P5, DOI 10.1016/0304-3959(93)90183-P; Shin DS, 2008, J KOREAN NEUROSURG S, V43, P97, DOI 10.3340/jkns.2008.43.2.97; SLUGG RM, 1994, J COMP NEUROL, V339, P49, DOI 10.1002/cne.903390106; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Sluka KA, 2001, MUSCLE NERVE, V24, P37, DOI 10.1002/1097-4598(200101)24:1<37::AID-MUS4>3.0.CO;2-8; STACEY MJ, 1969, J ANAT, V105, P231; Sun W, 2005, J COMP NEUROL, V482, P273, DOI 10.1002/cne.20434; Svendsen O, 2005, BASIC CLIN PHARMACOL, V97, P52, DOI 10.1111/j.1742-7843.2005.pto_97108.x; TABER E, 1961, J COMP NEUROL, V116, P27, DOI 10.1002/cne.901160104; TAKAYAMA K, 1994, NEUROSCI LETT, V176, P59, DOI 10.1016/0304-3940(94)90871-0; Tesarz J, 2013, EXP BRAIN RES, V224, P571, DOI 10.1007/s00221-012-3337-8; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Walder RY, 2010, J PAIN, V11, P210, DOI 10.1016/j.jpain.2009.07.004; Wang CC, 1999, J COMP NEUROL, V415, P341, DOI 10.1002/(SICI)1096-9861(19991220)415:3<341::AID-CNE3>3.0.CO;2-7; Wang LX, 2009, BRAIN RES, V1247, P79, DOI 10.1016/j.brainres.2008.09.094; Willis WD, 1999, P NATL ACAD SCI USA, V96, P7675, DOI 10.1073/pnas.96.14.7675; Willis WD, 1997, J CLIN NEUROPHYSIOL, V14, P2, DOI 10.1097/00004691-199701000-00002; WILLIS WD, 1979, J COMP NEUROL, V188, P543, DOI 10.1002/cne.901880404; Yeo SS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00416; Zhang MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059234	100	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130939	10.1371/journal.pone.0130939	http://dx.doi.org/10.1371/journal.pone.0130939			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154308	Green Submitted, Green Published, gold			2022-12-27	WOS:000358159700047
J	Cordier, R; Speyer, R; Chen, YW; Wilkes-Gillan, S; Brown, T; Bourke-Taylor, H; Doma, K; Leicht, A				Cordier, Reinie; Speyer, Renee; Chen, Yu-Wei; Wilkes-Gillan, Sarah; Brown, Ted; Bourke-Taylor, Helen; Doma, Kenji; Leicht, Anthony			Evaluating the Psychometric Quality of Social Skills Measures: A Systematic Review	PLOS ONE			English	Article							BEHAVIOR RATING-SCALE; AUTISM SPECTRUM DISORDERS; HIGH-FUNCTIONING AUTISM; MATSON EVALUATION; CONSTRUCT-VALIDITY; METHODOLOGICAL QUALITY; ANTISOCIAL-BEHAVIOR; QUESTIONNAIRE CSBQ; ADJUSTMENT SCALES; EARLY-CHILDHOOD	Introduction Impairments in social functioning are associated with an array of adverse outcomes. Social skills measures are commonly used by health professionals to assess and plan the treatment of social skills difficulties. There is a need to comprehensively evaluate the quality of psychometric properties reported across these measures to guide assessment and treatment planning. Objective To conduct a systematic review of the literature on the psychometric properties of social skills and behaviours measures for both children and adults. Methods A systematic search was performed using four electronic databases: CINAHL, PsycINFO, Embase and Pubmed; the Health and Psychosocial Instruments database; and grey literature using PsycExtra and Google Scholar. The psychometric properties of the social skills measures were evaluated against the COSMIN taxonomy of measurement properties using pre-set psychometric criteria. Results Thirty-Six studies and nine manuals were included to assess the psychometric properties of thirteen social skills measures that met the inclusion criteria. Most measures obtained excellent overall methodological quality scores for internal consistency and reliability. However, eight measures did not report measurement error, nine measures did not report cross-ultural validity and eleven measures did not report criterion validity. Conclusions The overall quality of the psychometric properties of most measures was satisfactory. The SSBS-2, HCSBS and PKBS-2 were the three measures with the most robust evidence of sound psychometric quality in at least seven of the eight psychometric properties that were appraised. A universal working definition of social functioning as an overarching construct is recommended. There is a need for ongoing research in the area of the psychometric properties of social skills and behaviours instruments.	[Cordier, Reinie] Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA 6845, Australia; [Speyer, Renee; Doma, Kenji; Leicht, Anthony] James Cook Univ, Coll Healthcare Sci, Townsville, Qld 4811, Australia; [Chen, Yu-Wei] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [Wilkes-Gillan, Sarah] Australian Catholic Univ, Sch Allied Hlth, Sydney, NSW 2059, Australia; [Brown, Ted] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Occupat Therapy, Frankston, Vic, Australia; [Bourke-Taylor, Helen] Australian Catholic Univ, Sch Allied Hlth, Fitzroy, Vic, Australia	Curtin University; James Cook University; University of Sydney; Australian Catholic University; Monash University; Australian Catholic University	Cordier, R (corresponding author), Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA 6845, Australia.	reinie.cordier@curtin.edu.au	Chen, Yu-Wei Ryan/AFN-1975-2022; Bourke-Taylor, Helen/AAY-6882-2020; Leicht, Anthony/C-7187-2009; Cordier, Reinie/AAH-6290-2019	Chen, Yu-Wei Ryan/0000-0001-5965-1279; Bourke-Taylor, Helen/0000-0002-9064-3274; Leicht, Anthony/0000-0002-0537-5392; Cordier, Reinie/0000-0002-9906-5300; Speyer, Renee/0000-0003-2828-8897; Wilkes-Gillan, Sarah/0000-0001-5670-2974	James Cook University, Internal Faculty Grant	James Cook University, Internal Faculty Grant	Support was provided by James Cook University, Internal Faculty Grant.	Adams C, 2002, J CHILD PSYCHOL PSYC, V43, P973, DOI 10.1111/1469-7610.00226; Ajzen I., 1985, ACTION CONTROL, P11, DOI DOI 10.1007/978-3-642-69746-3_2; Al Awmleh A., 2013, J SOCIAL SCI, V9, P54, DOI [DOI 10.3844/JSSP.2013.54.58, 10.3844/jssp.2013.54.58]; AMAN MG, 1985, AM J MENT DEF, V89, P485; Anme T, 2011, ISRN Pediatr, V2011, P272913, DOI 10.5402/2011/272913; Anme T., 2013, INT J APPL PSYCHOL, V3, P169; Anme T, 2012, PUBLIC HLTH RES, V2, P208, DOI DOI 10.5923/J.PHR.20120206.06; Anme T, 2014, PUBLIC HLTH, V4, P25, DOI DOI 10.5923/J.PHR.20140401.05; Anme T, 2010, J EPIDEMIOL, V20, pS419, DOI 10.2188/jea.JE20090171; ASHER SR, 1990, PEER REJECTION CHILD, P3; Bagwell CL, 2001, J AM ACAD CHILD PSY, V40, P1285, DOI 10.1097/00004583-200111000-00008; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bedell JR, 1997, HDB COMMUNICATION PR; Bellack AS, 1982, INT HDB BEHAVIOR MOD, P717; Bellini S, 2007, FOCUS AUTISM DEV DIS, V22, P80, DOI [10.1177/10883576070220020801, DOI 10.1177/10883576070220020801]; Bettencourt BA, 2001, J PERS SOC PSYCHOL, V81, P1131, DOI 10.1037/0022-3514.81.6.1131; Bogels SM, 1999, J PSYCHOPATHOL BEHAV, V21, P51, DOI 10.1023/A:1022812227606; Bolsoni-Silva AT, 2009, SPAN J PSYCHOL, V12, P349, DOI 10.1017/S1138741600001748; Bronson MB., 1990, CHILD BEHAV RATING S; Brown LJ, 1984, SCH SOCIAL SKILLS RA; BULLIS M, 1994, J EMOT BEHAV DISORD, V2, P173, DOI 10.1177/106342669400200305; Burt SA, 2009, AGGRESSIVE BEHAV, V35, P376, DOI 10.1002/ab.20314; Cacioppo JT, 2002, AM PSYCHOL, V57, P819, DOI 10.1037/0003-066X.57.11.819; Canivez GL, 2002, J PSYCHOEDUC ASSESS, V20, P30, DOI 10.1177/073428290202000103; Canivez GL, 2002, PSYCHOL SCHOOLS, V39, P621, DOI 10.1002/pits.10063; Carlson SM, 2013, WIRES COGN SCI, V4, P391, DOI 10.1002/wcs.1232; Carney AG, 2002, PSYCHOL SCHOOLS, V39, P367, DOI 10.1002/pits.10033; Carney AG, 2005, ASSES EFF INTERV, V30, P65, DOI 10.1177/073724770503000305; Centre for Reviews and Disssemination, 2008, SYSTEMATIC REV CRDS; Chou KL, 1997, PERS INDIV DIFFER, V22, P123; Conner TS, 2009, SOC PERSONAL PSYCHOL, V3, P292, DOI 10.1111/j.1751-9004.2009.00170.x; Cordier R, 2016, DEV NEUROREHABIL, V19, P103, DOI 10.3109/17518423.2014.915244; Cordier R, 2014, RES DEV DISABIL, V35, P1588, DOI 10.1016/j.ridd.2014.03.050; Cordier R, 2010, OTJR-OCCUP PART HEAL, V30, P122, DOI 10.3928/15394492-20090518-02; CORNEY RH, 1985, PSYCHOL MED, V15, P637, DOI 10.1017/S0033291700031494; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Crothers LM, 2009, J PSYCHOEDUC ASSESS, V27, P17, DOI 10.1177/0734282908319664; Crowe LM, 2011, CLIN PSYCHOL REV, V31, P767, DOI 10.1016/j.cpr.2011.03.008; de Bildt A, 2009, J AUTISM DEV DISORD, V39, P1350, DOI 10.1007/s10803-009-0749-9; DELUTY RH, 1979, J CONSULT CLIN PSYCH, V47, P1061, DOI 10.1037/0022-006X.47.6.1061; Demaray MK, 1995, SCHOOL PSYCHOL REV, V24, P648; Donohue Mary V, 2005, Can J Occup Ther, V72, P164; Donohue MV, 2007, AUST OCCUP THER J, V54, P49, DOI 10.1111/j.1440-1630.2006.00622.x; Donohue MV, 2013, SOCIAL PROFILE MANUA; Edwards MC, 2003, J PSYCHOEDUC ASSESS, V21, P16, DOI 10.1177/073428290302100102; ELLIOTT SN, 1987, J COUNS DEV, V66, P96, DOI 10.1002/j.1556-6676.1987.tb00808.x; FARINA A, 1957, J CONSULT PSYCHOL, V21, P265, DOI 10.1037/h0044648; Fernandez M., 2010, ELECTRON J RES EDUC, V8, P1229, DOI DOI 10.25115/EJREP.V8I22.1415; Feshbach ND, 1997, EMPATHY RECONSIDERED, P33, DOI DOI 10.1037/10226-001; Fink E, 2013, INFANT CHILD DEV, V22, P539, DOI 10.1002/icd.1809; Fisher AG, 2014, EVALUATION SOCIAL IN; Frankel F, 2002, CHILD PSYCHIAT HUM D, V33, P125, DOI 10.1023/A:1020730224907; Fujiki M, 2008, INT J LANG COMM DIS, V43, P330, DOI 10.1080/13682820701507377; Galeazzi A, 2002, PSYCHOL REP, V90, P1115, DOI 10.2466/PR0.90.3.1115-1121; Gifford-Smith ME, 2003, J SCHOOL PSYCHOL, V41, P235, DOI 10.1016/S0022-4405(03)00048-7; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Greenberg MT, 2006, SCI AOTNYAO; Gresham F.M., 1986, CHILDRENS SOCIAL BEH, P143; Gresham F. M., 2008, SOCIAL SKILLS IMPROV, DOI [10.1007/s00586-009-0944-6, DOI 10.1007/S00586-009-0944-6]; GRESHAM FM, 1986, J CLIN CHILD PSYCHOL, V15, P3, DOI 10.1207/s15374424jccp1501_1; Gresham FM, 2010, PSYCHOL ASSESSMENT, V22, P157, DOI 10.1037/a0018124; Griswold LA, 2012, AM J OCCUP THER, V66, P709, DOI 10.5014/ajot.2012.004051; GROOT M, 1989, J PSYCHOPATHOL BEHAV, V11, P195, DOI 10.1007/BF00960492; Guedeney A, 2001, INFANT MENT HEALTH J, V22, P559, DOI 10.1002/imhj.1018; Gully K J, 2001, Child Maltreat, V6, P260, DOI 10.1177/1077559501006003007; Guralnick MJ, 1999, MENT RETARD DEV D R, V5, P21; GUYATT G, 1987, J CHRON DIS, V40, P171, DOI 10.1016/0021-9681(87)90069-5; Hartman CA, 2006, J AUTISM DEV DISORD, V36, P325, DOI 10.1007/s10803-005-0072-z; HAYS RD, 1989, EDUC PSYCHOL MEAS, V49, P629, DOI 10.1177/001316448904900315; Healy KL, 2014, J CHILD FAM STUD, P1; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hill J, 2002, J CHILD PSYCHOL PSYC, V43, P133, DOI 10.1111/1469-7610.00007; Hilton C, 2007, RES AUTISM SPECT DIS, V1, P164, DOI 10.1016/j.rasd.2006.10.002; Hyler S. O., 1987, PERSONALITY DISORDER; Inderbitzen H. M., 1992, PSYCHOL ASSESSMENT, V4, P451, DOI DOI 10.1037/1040-3590.4.4.451; Ingles CJ, 2003, J ADOLESCENCE, V26, P505, DOI 10.1016/S0140-1971(03)00032-0; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kirmayer LJ, 2007, J AM ACAD PSYCHIATRY, V35, P98; KRUG DA, 1980, J CHILD PSYCHOL PSYC, V21, P221, DOI 10.1111/j.1469-7610.1980.tb01797.x; Lang FR, 2001, J PERS SOC PSYCHOL, V81, P509, DOI 10.1037//0022-3514.81.3.509; Lee LC, 2007, RES AUTISM SPECT DIS, V1, P126, DOI 10.1016/j.rasd.2006.08.004; LENTZ RJ, 1971, J ABNORM PSYCHOL, V78, P69, DOI 10.1037/h0031486; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lim SM, 2011, HONG KONG J OCCUP TH, V21, P2, DOI 10.1016/j.hkjot.2011.06.001; Lim SM, 2010, HONG KONG J OCCUP TH, V20, P52, DOI 10.1016/S1569-1861(11)70004-3; Locke J, 2014, J PSYCHOEDUC ASSESS, V32, P62, DOI 10.1177/0734282913485543; LOEBER R, 1989, NATO ADV SCI I D-BEH, V50, P203; Lund J, 2001, J PSYCHOEDUC ASSESS, V19, P112, DOI 10.1177/073428290101900201; Luteijn E, 2000, J AUTISM DEV DISORD, V30, P317, DOI 10.1023/A:1005527300247; Luteijn EEF, 1998, J AUTISM DEV DISORD, V28, P559, DOI 10.1023/A:1026060330122; MACPHILLAMY DJ, 1982, J CONSULT CLIN PSYCH, V50, P363, DOI 10.1037/0022-006X.50.3.363; Martin RP, 1986, ASSESSMENT CHILD ADO, P309; Martins T., 2005, INTERAMERICAN J PSYC, V39, P239; Marton I, 2009, J ABNORM CHILD PSYCH, V37, P107, DOI 10.1007/s10802-008-9262-4; Masten AS, 1999, DEV PSYCHOPATHOL, V11, P143, DOI 10.1017/S0954579499001996; Matson J. L., 1988, ENHANCING CHILDRENS; MATSON JL, 1994, BEHAV MODIF, V18, P186, DOI 10.1177/01454455940182003; Matson JL, 2007, RES AUTISM SPECT DIS, V1, P75, DOI 10.1016/j.rasd.2006.09.001; Matson JL, 2007, BEHAV MODIF, V31, P682, DOI 10.1177/0145445507301650; Matson JL, 2013, RES AUTISM SPECT DIS, V7, P405, DOI 10.1016/j.rasd.2012.10.005; Matson JL, 2012, RES DEV DISABIL, V33, P2067, DOI 10.1016/j.ridd.2010.09.026; Matson JL, 2010, BEHAV MODIF, V34, P539, DOI 10.1177/0145445510384844; Matson JL, 2009, RES DEV DISABIL, V30, P249, DOI 10.1016/j.ridd.2008.04.002; Matthey S, 2005, INF MENTAL HLTH J, V26, P442, DOI 10.1002/imhj.20061; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; McLoyd VC, 1998, AM PSYCHOL, V53, P185, DOI 10.1037/0003-066X.53.2.185; Mendez FX, 2002, EUR J PSYCHOL ASSESS, V18, P30, DOI 10.1027//1015-5759.18.1.30; Merrell K, 2011, SEARS SOCIAL EMOTION; Merrell K.W., 2003, PRESCHOOL KINDERGART; Merrell K. W., 1995, EARLY EDUC DEV, V6, P253; Merrell K. W, 2002, SCH SOCIAL BEHAV SCA, VSecond; Merrell K.W., 2001, EXCEPTIONALITY, V9, P3, DOI [10.1207/S15327035EX0912_2, DOI 10.1207/S15327035EX0912_2, 10.1080/09362835.2001.9666988, DOI 10.1080/09362835.2001.9666988]; Merrell KW, 2011, J CHILD FAM STUD, V20, P529, DOI 10.1007/s10826-010-9425-0; Merrell KW, 2011, SCHOOL PSYCHOL REV, V40, P226; Merrell KW, 1996, J EARLY INTERVENTION, V20, P132, DOI 10.1177/105381519602000205; Merrell KW, 2001, PSYCHOL SCHOOLS, V38, P313, DOI 10.1002/pits.1021; Merrell KW, 1999, J PSYCHOEDUC ASSESS, V17, P36, DOI 10.1177/073428299901700104; MERRELL KW, 1995, J PSYCHOEDUC ASSESS, V13, P230, DOI 10.1177/073428299501300302; Merrell KW, 2000, HOME COMMUNITY SOCIA; MICHELSON L, 1982, J BEHAV ASSESS, V4, P3, DOI 10.1007/BF01321378; Mills AC, 2013, J PSYCHOPATHOL BEHAV, V35, P346, DOI 10.1007/s10862-013-9339-4; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Morosini PL, 2000, ACTA PSYCHIAT SCAND, V101, P323, DOI 10.1111/j.1600-0447.2000.tb10933.x; Mostow AJ, 2002, CHILD DEV, V73, P1775, DOI 10.1111/1467-8624.00505; Mrug S, 2001, New Dir Child Adolesc Dev, P51; MUHLENKAMP AF, 1975, NURS RES, V24, P109; Parker James D. A, 1990, COPING INVENTORY STR; Pascoe J M, 1988, Fam Med, V20, P271; Priebe S, 2007, BRIT J PSYCHIAT, V191, pS15, DOI 10.1192/bjp.191.50.s15; PRINZ RJ, 1979, J APPL BEHAV ANAL, V12, P691, DOI 10.1901/jaba.1979.12-691; Raimundo R, 2012, SPAN J PSYCHOL, V15, P1473, DOI 10.5209/rev_SJOP.2012.v15.n3.39431; Rao PA, 2008, J AUTISM DEV DISORD, V38, P353, DOI 10.1007/s10803-007-0402-4; Reynolds C. R., 1992, BEHAV ASSESSMENT SYS; Riggio R. E, 2003, SOCIAL SKILLS INVENT; Roff MF, 1972, SOCIAL ADJUSTMENT PE; Romer N, 2012, ASSESSMENT EFFECTIVE, V38, P185, DOI DOI 10.1177/1534508412444955; RoseKrasnor L, 1997, SOC DEV, V6, P111, DOI 10.1111/j.1467-9507.1997.tb00097.x; Rydell AM, 1997, DEV PSYCHOL, V33, P824, DOI 10.1037/0012-1649.33.5.824; Scourfield J, 2004, J CHILD PSYCHOL PSYC, V45, P927, DOI 10.1111/j.1469-7610.2004.t01-1-00286.x; Scourfield J, 1999, BRIT J PSYCHIAT, V175, P559, DOI 10.1192/bjp.175.6.559; Simmons CD, 2010, AM J OCCUP THER, V64, P10, DOI 10.5014/ajot.64.1.10; Sondergaard M, 2012, AM J OCCUP THER, V66, P356, DOI 10.5014/ajot.2012.003582; Sparrow SS, 1998, VINELAND SEEC SOCIAL; Speyer R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/458678; Stephens TM, 1992, SOCIAL BEHAV ASSESSM; Streiner DL, 2008, HLTH MEASUREMENT SCA, V4th; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; Tougas F, 1999, PERS SOC PSYCHOL B, V25, P1487, DOI 10.1177/01461672992510005; Turner S. M., 1989, PSYCHOL ASSESSMENT J, V1, P35, DOI [10.1037/1040-3590.1.1.35, DOI 10.1037/1040-3590.1.1.35]; vanderMeulen S, 1997, J COMMUN DISORD, V30, P155, DOI 10.1016/S0021-9924(96)00059-7; Wade DT, 2004, CLIN REHABIL, V18, P233, DOI 10.1191/0269215504cr183ed; Waksman SA, 1985, WAKSMAN SOCIAL SKILL; Walker HM., 1988, WALKER MCCONNELL SCA; Wang HT, 2011, J AUTISM DEV DISORD, V41, P1487, DOI 10.1007/s10803-010-1175-8; WATERS E, 1983, DEV REV, V3, P79, DOI 10.1016/0273-2297(83)90010-2; WEISSMAN MM, 1976, ARCH GEN PSYCHIAT, V33, P1111; World Health Organization, 2001, ICF INT CLASFUNCT; Yager JA, 2006, PSYCHIATRY, V69, P47, DOI 10.1521/psyc.2006.69.1.47; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535	161	39	39	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132299	10.1371/journal.pone.0132299	http://dx.doi.org/10.1371/journal.pone.0132299			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EC	26151362	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000358158900039
J	Pells, S; Koutsouraki, E; Morfopoulou, S; Valencia-Cadavid, S; Tomlinson, SR; Kalathur, R; Futschik, ME; De Sousa, PA				Pells, Steve; Koutsouraki, Eirini; Morfopoulou, Sofia; Valencia-Cadavid, Sara; Tomlinson, Simon R.; Kalathur, Ravi; Futschik, Matthias E.; De Sousa, Paul A.			Novel Human Embryonic Stem Cell Regulators Identified by Conserved and Distinct CpG Island Methylation State	PLOS ONE			English	Article							DNA METHYLATION; TRANSCRIPTION FACTOR; EPIGENETIC SIGNATURE; GENE-EXPRESSION; SOMATIC-CELLS; HUMAN ES; CULTURE; DIFFERENTIATION; LINES; PLURIPOTENCY	Human embryonic stem cells (hESCs) undergo epigenetic changes in vitro which may compromise function, so an epigenetic pluripotency "signature" would be invaluable for line validation. We assessed Cytosine-phosphate-Guanine Island (CGI) methylation in hESCs by genomic DNA hybridisation to a CGI array, and saw substantial variation in CGI methylation between lines. Comparison of hESC CGI methylation profiles to corresponding somatic tissue data and hESC mRNA expression profiles identified a conserved hESC-specific methylation pattern associated with expressed genes. Transcriptional repressors and activators were over-represented amongst genes whose associated CGIs were methylated or unmethylated specifically in hESCs, respectively. Knockdown of candidate transcriptional regulators (HMGA1, GLIS2, PFDN5) induced differentiation in hESCs, whereas ectopic expression in fibroblasts modulated iPSC colony formation. Chromatin immunoprecipitation confirmed interaction between the candidates and the core pluripotency transcription factor network. We thus identify novel pluripotency genes on the basis of a conserved and distinct epigenetic configuration in human stem cells.	[Pells, Steve; Koutsouraki, Eirini; Morfopoulou, Sofia; Valencia-Cadavid, Sara; Tomlinson, Simon R.; De Sousa, Paul A.] Univ Edinburgh, Sch Clin Studies, MRC Ctr Regenerat Med, Edinburgh EH16 4SB, Midlothian, Scotland; [Pells, Steve; De Sousa, Paul A.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh EH16 4SB, Midlothian, Scotland; [Kalathur, Ravi; Futschik, Matthias E.] Univ Algarve, Ctr Mol & Struct Biomed, P-8005139 Faro, Portugal	University of Edinburgh; University of Edinburgh; Universidade do Algarve	Pells, S (corresponding author), Univ Edinburgh, Sch Clin Studies, MRC Ctr Regenerat Med, Edinburgh EH16 4SB, Midlothian, Scotland.	steve.pells@ed.ac.uk; paul.desousa@ed.ac.uk	Futschik, Matthias/AAK-8837-2020; De Sousa, Paul A/H-7416-2013	Futschik, Matthias/0000-0002-6245-8071; De Sousa, Paul A/0000-0003-0745-2504; Pells, Stephen/0000-0001-5866-5759; Morfopoulou, Sofia/0000-0001-8181-4548	EUFP7; Portuguese FCT [PTDC/BIA-GEN/116519/2010]; ESNATS (Embryonic Stem Cell Novel Alternative Testing Strategies) [FP7-201619]; MRC [G0300484] Funding Source: UKRI; Medical Research Council [G0300484] Funding Source: researchfish; Fundação para a Ciência e a Tecnologia [PTDC/BIA-GEN/116519/2010] Funding Source: FCT	EUFP7(European Commission); Portuguese FCT(Portuguese Foundation for Science and Technology); ESNATS (Embryonic Stem Cell Novel Alternative Testing Strategies); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Fundação para a Ciência e a Tecnologia	This work was supported by EUFP7 funding to PDS and ST as part of the ESNATS (Embryonic Stem Cell Novel Alternative Testing Strategies) consortium (FP7-201619) and by the Portuguese FCT to MF (PTDC/BIA-GEN/116519/ 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrucci C, 2007, HUM MOL GENET, V16, P1253, DOI 10.1093/hmg/ddm074; Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Au KF, 2013, P NATL ACAD SCI USA, V110, pE4821, DOI 10.1073/pnas.1320101110; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Cleynen I, 2008, INT J ONCOL, V32, P289; De Sousa PA, 2009, STEM CELL RES, V2, P188, DOI 10.1016/j.scr.2009.01.002; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Ermakov A, 2012, STEM CELL RES, V9, P171, DOI 10.1016/j.scr.2012.06.007; Ezkurdia I, 2014, HUM MOL GENET, V23, P5866, DOI 10.1093/hmg/ddu309; Fletcher JM, 2006, CLONING STEM CELLS, V8, P319, DOI 10.1089/clo.2006.8.319; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Hanson C, 2005, APMIS, V113, P751, DOI 10.1111/j.1600-0463.2005.apm_305.x; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Imreh MP, 2006, J CELL BIOCHEM, V99, P508, DOI 10.1002/jcb.20897; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim KP, 2007, GENOME RES, V17, P1731, DOI 10.1101/gr.6609207; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lee SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011353; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Minoguchi S, 2008, STEM CELLS, V26, P1166, DOI 10.1634/stemcells.2007-1106; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; NORRIS DP, 1991, MAMM GENOME, V1, P78, DOI 10.1007/BF02443782; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Redmer T, 2011, EMBO REP, V12, P720, DOI 10.1038/embor.2011.88; Rugg-Gunn PJ, 2007, HUM MOL GENET, V16, pR243, DOI 10.1093/hmg/ddm245; Ruiz S, 2012, P NATL ACAD SCI USA, V109, P16196, DOI 10.1073/pnas.1202352109; Ruzov A, 2011, CELL RES, V21, P1332, DOI 10.1038/cr.2011.113; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Shah SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048533; Shen Y, 2006, HUM MOL GENET, V15, P2623, DOI 10.1093/hmg/ddl188; Tang X, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S5-S3; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Yeo S, 2007, BIOCHEM BIOPH RES CO, V359, P536, DOI 10.1016/j.bbrc.2007.05.120; Yoshida T, 2008, EXP CELL RES, V314, P1217, DOI 10.1016/j.yexcr.2008.01.002; Zhang F, 2002, J BIOL CHEM, V277, P10139, DOI 10.1074/jbc.M108062200; Zhang R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2341	53	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131102	10.1371/journal.pone.0131102	http://dx.doi.org/10.1371/journal.pone.0131102			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151932	gold, Green Published, Green Submitted			2022-12-27	WOS:000358158900017
J	Wu, LJ; Yin, XM; Zheng, L; Zou, JH; Jin, P; Hu, YW; Kudinha, T; Kong, FR; Chen, X; Wang, Q				Wu, Lijuan; Yin, Xiaomao; Zheng, Lei; Zou, Jianhua; Jin, Ping; Hu, Yanwei; Kudinha, Timothy; Kong, Fanrong; Chen, Xu; Wang, Qian			Practical Prediction of Ten Common Streptococcus pneumoniae Serotypes/Serogroups in One PCR Reaction by Multiplex Ligation-Dependent Probe Amplification and Melting Curve (MLPA-MC) Assay in Shenzhen, China	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; SEROTYPE DISTRIBUTION; CAPSULAR SEROTYPES; INVASIVE DISEASE; CHILDREN; EPIDEMIOLOGY; VACCINE; YOUNGER; 19A; 6C	Background Streptococcus pneumoniae has more than 95 distinct serotypes described to date. However, only certain serotypes are more likely to cause pneumococcal diseases. Thus serotype surveillance is important for vaccine formula design as well as in post-vaccine serotype shift monitor. The goal of this study was to develop a practical screening assay for ten Shenzhen China common pneumococcal serotypes/serogroups in one molecular reaction. Methods A molecular assay, based on multiplex ligation-dependent probe amplification (MLPA) and melting curve (MC) analysis, was developed in an integrated approach (MLPA-MC) for the detection of ten capsular serotypes/serogroups 4, 6 (6A/6B/6C/6D), 9V/9A, 14, 15F/15A, 15B/15C, 18 (18F/18A/18B/18C), 19F, 19A and 23F. We designed serotype/serogroupspecific MLPA probes and fluorescent detection probes to discriminate the different serotypes/serogroups in one molecular reaction. The three steps of MLPA-MC assay are continuous reactions in one well detected by LightCycler 480. A total of 210 S. pneumoniae isolates from our local Maternity and Child Health Hospital were randomly chosen to evaluate the assay against published multiplex PCR assays. Results Our results showed that 198 (94.3%) of S. pneumoniae isolates were type-able by our assays and the results were in complete concordance with the published multiplex PCRs. Using the MLPA-MC assay, 96 S. pneumoniae isolates could be typed within 3 hours with limited hands-on time. This serotype/serogroup-screening assay can be easily modified or extended by modification of the serotype/serogroup-specific MLPA probes combinations according to the needs of different laboratories. Conclusions We recommend use of this assay as a starting point for screening serotype/serogroup frequencies. There is a need for this assay to be combined with other molecular typing assays, like published serotype specific PCRs, or even the Quellung reaction for serotype confirmation.	[Wu, Lijuan; Zheng, Lei; Hu, Yanwei; Wang, Qian] Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou, Guangdong, Peoples R China; [Wu, Lijuan; Zou, Jianhua; Jin, Ping; Chen, Xu] Baoan Matern & Child Hlth Hosp, Clin Lab, Shenzhen, Guangdong, Peoples R China; [Yin, Xiaomao] Southern Med Univ, Affiliated Hosp 1, Clin Lab, Guangzhou, Guangdong, Peoples R China; [Kudinha, Timothy] Charles Sturt Univ, Orange, NSW, Australia; [Kong, Fanrong] Westmead Hosp, Inst Clin Pathol & Med Res Pathol West, Ctr Infect Dis & Microbiol, Westmead, NSW, Australia	Southern Medical University - China; Southern Medical University - China; Charles Sturt University; University of Sydney	Wang, Q (corresponding author), Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou, Guangdong, Peoples R China.	nfyyWangQian@163.com			Science and Technology plan of Bureau of Health of Shenzhen Municipality; China [201302168]	Science and Technology plan of Bureau of Health of Shenzhen Municipality; China	This work was supported by the grant of Science and Technology plan of Bureau of Health of Shenzhen Municipality; China (201302168) to LW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzari C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009282; Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09; Croucher NJ, 2013, NAT GENET, V45, P656, DOI 10.1038/ng.2625; Dortet L, 2009, DIAGN MICR INFEC DIS, V65, P49, DOI 10.1016/j.diagmicrobio.2009.05.009; Elberse K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025018; Jin P, 2009, J INFECT DIS, V200, P1375, DOI 10.1086/606118; Jin P, 2009, J CLIN MICROBIOL, V47, P2470, DOI 10.1128/JCM.00484-09; Kim SH, 2012, ANTIMICROB AGENTS CH, V56, P1418, DOI 10.1128/AAC.05658-11; Kong FR, 2006, J CLIN MICROBIOL, V44, P1887, DOI 10.1128/JCM.44.5.1887-1891.2006; Kong FR, 2005, J MED MICROBIOL, V54, P351, DOI 10.1099/jmm.0.45924-0; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Liu YD, 2008, DIAGN MICR INFEC DIS, V61, P256, DOI 10.1016/j.diagmicrobio.2008.02.004; Ma X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067507; McEllistrem MC, 2009, FUTURE MICROBIOL, V4, P857, DOI 10.2217/FMB.09.58; Miernyk K, 2011, J CLIN MICROBIOL, V49, P3209, DOI 10.1128/JCM.00610-11; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Reijans M, 2008, J CLIN MICROBIOL, V46, P1232, DOI 10.1128/JCM.02294-07; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Selva L, 2012, J CLIN MICROBIOL, V50, P3451, DOI 10.1128/JCM.01368-12; Siira L, 2012, J CLIN MICROBIOL, V50, P2727, DOI 10.1128/JCM.00689-12; Tan TQ, 2012, CLIN MICROBIOL REV, V25, P409, DOI 10.1128/CMR.00018-12; Thomas JC, 2011, J BACTERIOL, V193, P3409, DOI 10.1128/JB.05079-11; Tyrrell GJ, 2011, J INFECT DIS, V203, P1345, DOI 10.1093/infdis/jir056; van Selm S, 2003, INFECT IMMUN, V71, P6192, DOI 10.1128/IAI.71.11.6192-6198.2003; Xue L, 2010, CLIN INFECT DIS, V50, P741, DOI 10.1086/650534; Yao KH, 2011, VACCINE, V29, P2296, DOI 10.1016/j.vaccine.2011.01.027	27	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0130664	10.1371/journal.pone.0130664	http://dx.doi.org/10.1371/journal.pone.0130664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151828	gold, Green Published, Green Submitted			2022-12-27	WOS:000358158900014
J	Barchiesi, D; Moat, HS; Alis, C; Bishop, S; Preis, T				Barchiesi, Daniele; Moat, Helen Susannah; Alis, Christian; Bishop, Steven; Preis, Tobias			Quantifying International Travel Flows Using Flickr	PLOS ONE			English	Article							BEHAVIOR; NETWORK	Online social media platforms are opening up new opportunities to analyse human behaviour on an unprecedented scale. In some cases, the fast, cheap measurements of human behaviour gained from these platforms may offer an alternative to gathering such measurements using traditional, time consuming and expensive surveys. Here, we use geotagged photographs uploaded to the photo-sharing website Flickr to quantify international travel flows, by extracting the location of users and inferring trajectories to track their movement across time. We find that Flickr based estimates of the number of visitors to the United Kingdom significantly correlate with the official estimates released by the UK Office for National Statistics, for 28 countries for which official estimates are calculated. Our findings underline the potential for indicators of key aspects of human behaviour, such as mobility, to be generated from data attached to the vast volumes of photographs posted online.	[Barchiesi, Daniele; Alis, Christian; Bishop, Steven] UCL, Dept Math, London, England; [Moat, Helen Susannah; Preis, Tobias] Univ Warwick, Warwick Business Sch, Coventry CV4 7AL, W Midlands, England	University of London; University College London; University of Warwick	Barchiesi, D (corresponding author), UCL, Dept Math, London, England.	d.barchiesi@ucl.ac.uk	Preis, Tobias/A-2874-2009; Alis, Christian/GRJ-3506-2022	Preis, Tobias/0000-0001-9185-0892; Alis, Christian/0000-0001-7397-6803; Moat, Helen Susannah/0000-0001-8974-9277	Engineering and Physical Sciences Research Council [EP/K039830/1]; EPSRC [EP/K039830/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Engineering and Physical Sciences Research Council, grant number EP/K039830/1 (http://gow.epsrc.ac.uk/NGBOViewGrant.aspx?GrantRef=EP/K039830/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alis CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077793; [Anonymous], 2009, NATURE, DOI DOI 10.1038/nature07634; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Asur S., 2010, Proceedings 2010 IEEE/ACM International Conference on Web Intelligence-Intelligent Agent Technology (WI-IAT), P492, DOI 10.1109/WI-IAT.2010.63; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; King G, 2011, SCIENCE, V331, P719, DOI 10.1126/science.1197872; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lieberman Michael D., 2009, P 3 INT ICWSM C, P106; Mestyan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071226; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Moat HS, 2014, BEHAV BRAIN SCI, V37, P92, DOI 10.1017/S0140525X13001817; Moat HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01801; Mocanu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061981; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Petersen AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00943; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00752; Schich M, 2014, SCIENCE, V345, P558, DOI 10.1126/science.1240064; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Sui D., 2013, CROWDSOURCING GEOGRA, DOI [10.1007/978-94-007-4587-2, DOI 10.1007/978-94-007-4587-2]; Tumasjan A., 2010, P 4 INT AAAI C WEBLO, V4, P178, DOI DOI 10.1074/JBC.M501708200; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Wang D., 2011, P 17 ACM SIGKDD INT, P1100, DOI DOI 10.1145/2020408.2020581	27	34	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0128470	10.1371/journal.pone.0128470	http://dx.doi.org/10.1371/journal.pone.0128470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147500	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600012
J	Beaulieu, LM; Clancy, L; Tanriverdi, K; Benjamin, EJ; Kramer, CD; Weinberg, EO; He, XB; Mekasha, S; Mick, E; Ingalls, RR; Genco, CA; Freedman, JE				Beaulieu, Lea M.; Clancy, Lauren; Tanriverdi, Kahraman; Benjamin, Emelia J.; Kramer, Carolyn D.; Weinberg, Ellen O.; He, Xianbao; Mekasha, Samrawit; Mick, Eric; Ingalls, Robin R.; Genco, Caroline A.; Freedman, Jane E.			Specific Inflammatory Stimuli Lead to Distinct Platelet Responses in Mice and Humans	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; APOLIPOPROTEIN-E; PORPHYROMONAS-GINGIVALIS; CHLAMYDIA-PNEUMONIAE; CHLAMYDOPHILA-PNEUMONIAE; ACCELERATES ATHEROSCLEROSIS; GENECHIP DATA; INFECTION; EXPRESSION; PROGRESSION	Introduction Diverse and multi-factorial processes contribute to the progression of cardiovascular disease. These processes affect cells involved in the development of this disease in varying ways, ultimately leading to atherothrombosis. The goal of our study was to compare the differential effects of specific stimuli - two bacterial infections and a Western diet - on platelet responses in ApoE(-/-) mice, specifically examining inflammatory function and gene expression. Results from murine studies were verified using platelets from participants of the Framingham Heart Study (FHS; n = 1819 participants). Methods Blood and spleen samples were collected at weeks 1 and 9 from ApoE(-/-) mice infected with Porphyromonas gingivalis or Chlamydia pneumoniae and from mice fed a Western diet for 9 weeks. Transcripts based on data from a Western diet in ApoE(-/-) mice were measured in platelet samples from FHS using high throughput qRT-PCR. Results At week 1, both bacterial infections increased circulating platelet-neutrophil aggregates. At week 9, these cells individually localized to the spleen, while Western diet resulted in increased platelet-neutrophil aggregates in the spleen only. Microarray analysis of platelet RNA from infected or Western diet-fed mice at week 1 and 9 showed differential profiles. Genes, such as Serpina1a, Ttr, Fgg, Rpl21, and Alb, were uniquely affected by infection and diet. Results were reinforced in platelets obtained from participants of the FHS. Conclusion Using both human studies and animal models, results demonstrate that variable sources of inflammatory stimuli have the ability to influence the platelet phenotype in distinct ways, indicative of the diverse function of platelets in thrombosis, hemostasis, and immunity.	[Beaulieu, Lea M.; Clancy, Lauren; Tanriverdi, Kahraman; Freedman, Jane E.] Univ Massachusetts, Sch Med, Dept Med, Div Cardiovasc Med, Worcester, MA 01655 USA; [Benjamin, Emelia J.] NHLBI, Framingham, MA USA; [Benjamin, Emelia J.] Boston Univ, Framingham Heart Inst, Framingham, MA USA; [Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Med, Cardiol & Prevent Med Sect, Boston, MA 02118 USA; [Kramer, Carolyn D.; Weinberg, Ellen O.; Ingalls, Robin R.; Genco, Caroline A.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [He, Xianbao; Genco, Caroline A.] Boston Univ, Sch Med, Dept Med, Infect Dis Sect, Boston, MA 02118 USA; [Mekasha, Samrawit; Ingalls, Robin R.] Boston Med Ctr, Boston, MA USA; [Mick, Eric] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA; [Genco, Caroline A.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA	University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Framingham Heart Study; Boston University; Boston University; Boston University; Boston Medical Center; University of Massachusetts System; University of Massachusetts Worcester; Boston University	Beaulieu, LM (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Cardiovasc Med, Worcester, MA 01655 USA.	lea.beaulieu@umassmed.edu	He, Xianbao/AAE-4838-2019; Benjamin, Emelia/E-7103-2011	Benjamin, Emelia/0000-0003-4076-2336; Weinberg, Ellen/0000-0002-6937-0371	National Institutes of Health [N01-HC 25195, RFA-HL-12-008, RFA-RM-12-013, P-01-HL085381, P01 AI078894, 1RO1 HL64753, R01 HL076784, 1 R01 AG028321]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076784, R01HL064753, U54HL112311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI078894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work presented was supported by N01-HC 25195, RFA-HL-12-008 (JEF, EM), RFA-RM-12-013 (JEF), P-01-HL085381 (JEF), P01 AI078894 (LMB, CDK, EOW, XH, SM, RI, CAG, and JEF), 1RO1 HL64753, R01 HL076784, and 1 R01 AG028321 (EJB), from the National Institutes of Health (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Beaulieu LM, 2014, ARTERIOSCL THROM VAS, V34, P552, DOI 10.1161/ATVBAHA.113.302700; Beaulieu LM, 2011, BLOOD, V117, P5963, DOI 10.1182/blood-2010-09-304949; Bertola A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013577; Blair P, 2009, CIRC RES, V104, P346, DOI 10.1161/CIRCRESAHA.108.185785; Brettschneider J, 2008, TECHNOMETRICS, V50, P241, DOI 10.1198/004017008000000334; Browning LM, 2008, OBESITY FACTS, V1, P259, DOI 10.1159/000169832; Cheng C, 2011, CIRC RES, V109, P385, DOI 10.1161/CIRCRESAHA.111.243444; Ciervo A, 2008, INT J IMMUNOPATH PH, V21, P421, DOI 10.1177/039463200802100222; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dhingra R, 2007, AM J MED, V120, P1054, DOI 10.1016/j.amjmed.2007.08.037; Eitzman DT, 2000, ARTERIOSCL THROM VAS, V20, P1831, DOI 10.1161/01.ATV.20.7.1831; Freedman JE, 2010, CIRCULATION, V122, P119, DOI 10.1161/CIRCULATIONAHA.109.928192; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gibson FC, 2004, CIRCULATION, V109, P2801, DOI 10.1161/01.CIR.0000129769.17895.F0; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; Hayashi C, 2010, MOL ORAL MICROBIOL, V25, P305, DOI 10.1111/j.2041-1014.2010.00582.x; Hayashi C, 2012, J IMMUNOL, V189, P3681, DOI 10.4049/jimmunol.1201541; Hayashi C, 2011, ATHEROSCLEROSIS, V215, P52, DOI 10.1016/j.atherosclerosis.2010.12.009; He XB, 2010, J IMMUNOL, V184, P5743, DOI 10.4049/jimmunol.0903937; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jha HC, 2009, APMIS, V117, P905, DOI 10.1111/j.1600-0463.2009.02553.x; Kalvegren H, 2003, ARTERIOSCL THROM VAS, V23, P1677, DOI 10.1161/01.ATV.0000084810.52464.D5; Karshovska E, 2015, CIRC RES, V116, P587, DOI 10.1161/CIRCRESAHA.116.304035; Kramer CD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1176; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; Lindemann S, 2001, J CELL BIOL, V154, P485, DOI 10.1083/jcb.200105058; McManus DD, 2013, ARTERIOSCL THROM VAS, V33, P2666, DOI 10.1161/ATVBAHA.112.301112; Moazed TC, 1997, J INFECT DIS, V175, P883, DOI 10.1086/513986; Moustardas P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108240; Naiki Y, 2008, J IMMUNOL, V181, P7176, DOI 10.4049/jimmunol.181.10.7176; Nakano K, 2008, ORAL MICROBIOL IMMUN, V23, P170, DOI 10.1111/j.1399-302X.2007.00406.x; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nassar H, 2002, INFECT IMMUN, V70, P268, DOI 10.1128/IAI.70.1.268-276.2002; Nie P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097009; Ohki T, 2012, AM HEART J, V163, P164, DOI 10.1016/j.ahj.2011.10.012; Player MS, 2014, EUR J PREV CARDIOL, V21, P559, DOI 10.1177/2047487312472078; Risitano A, 2012, BLOOD, V119, P6288, DOI 10.1182/blood-2011-12-396440; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakurai-Komada N, 2014, ATHEROSCLEROSIS, V233, P338, DOI 10.1016/j.atherosclerosis.2014.01.023; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Scott NJA, 2012, AM J PHYSIOL-ENDOC M, V302, pE576, DOI 10.1152/ajpendo.00222.2011; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Velsko IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097811; Yakob M, 2011, J PERIODONTAL RES, V46, P749, DOI 10.1111/j.1600-0765.2011.01398.x	50	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131688	10.1371/journal.pone.0131688	http://dx.doi.org/10.1371/journal.pone.0131688			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148065	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600129
J	Gijsberts, CM; Seneviratna, A; Hoefer, IE; Agostoni, P; Rittersma, SZH; Pasterkamp, G; Hartman, M; de Carvalho, LP; Richards, AM; Asselbergs, FW; de Kleijn, DPV; Chan, MY				Gijsberts, Crystel M.; Seneviratna, Aruni; Hoefer, Imo E.; Agostoni, Pierfrancesco; Rittersma, Saskia Z. H.; Pasterkamp, Gerard; Hartman, Mikael; de Carvalho, Leonardo Pinto; Richards, A. Mark; Asselbergs, Folkert W.; de Kleijn, Dominique P. V.; Chan, Mark Y.			Inter-Ethnic Differences in Quantified Coronary Artery Disease Severity and All-Cause Mortality among Dutch and Singaporean Percutaneous Coronary Intervention Patients	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ETHNIC-DIFFERENCES; SYNTAX SCORE; RISK-FACTORS; CARDIOVASCULAR RISK; CAUCASIAN PATIENTS; HEART-DISEASE; ASIAN INDIANS; SOUTH ASIANS; OUTCOMES	Background Coronary artery disease (CAD) is a global problem with increasing incidence in Asia. Prior studies reported inter-ethnic differences in the prevalence of CAD rather than the severity of CAD. The angiographic "synergy between percutaneous coronary intervention (PCI) with taxus and cardiac surgery" (SYNTAX) score quantifies CAD severity and predicts outcomes. We studied CAD severity and all-cause mortality in four globally populous ethnic groups: Caucasians, Chinese, Indians and Malays. Methods We quantified SYNTAX scores of 1,000 multi-ethnic patients undergoing PCI in two tertiary hospitals in the Netherlands (Caucasians) and Singapore (Chinese, Indians and Malays). Within each ethnicity we studied 150 patients with stable CAD and 100 with ST-elevated myocardial infarction (STEMI). We made inter-ethnic comparisons of SYNTAX scores and all-cause mortality. Results Despite having a younger age (mean age Indians: 56.8 and Malays: 57.7 vs. Caucasians: 63.7 years), multivariable adjusted SYNTAX scores were significantly higher in Indians and Malays than Caucasians with stable CAD: 13.4 [11.9-14.9] and 13.4 [12.0-14.8] vs. 9.4 [8.1-10.8], p<0.001. Among STEMI patients, SYNTAX scores were highest in Chinese and Malays: 17.7 [15.9-19.5] and 18.8 [17.1-20.6] vs. 15.5 [13.5-17.4] and 12.7 [10.9-14.6] in Indians and Caucasians, p<0.001. Over a median follow-up of 709 days, 67 deaths (stable CAD: 37, STEMI: 30) occurred. Among STEMI patients, the SYNTAX score independently predicted all-cause mortality: HR 2.5 [1.7-3.8], p<0.001 for every 10-point increase. All-cause mortality was higher in Indian and Malay STEMI patients than Caucasians, independent of SYNTAX score (adjusted HR 7.2 [1.5-34.7], p= 0.01 and 5.8 [1.2-27.2], p=0.02). Conclusion Among stable CAD and STEMI patients requiring PCI, CAD is more severe in Indians and Malays than in Caucasians, despite having a younger age. Moreover, Indian and Malay STEMI patients had a greater adjusted risk of all-cause mortality than Caucasians, independent of SYNTAX score.	[Gijsberts, Crystel M.; Hoefer, Imo E.; Pasterkamp, Gerard; de Kleijn, Dominique P. V.] Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands; [Gijsberts, Crystel M.; de Kleijn, Dominique P. V.] Netherlands Heart Inst ICIN, Utrecht, Netherlands; [Seneviratna, Aruni; de Carvalho, Leonardo Pinto; Richards, A. Mark; Chan, Mark Y.] Natl Univ Singapore Hosp, Dept Cardiac, Singapore, Singapore; [Agostoni, Pierfrancesco; Rittersma, Saskia Z. H.; Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Hartman, Mikael; de Kleijn, Dominique P. V.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore; [Hartman, Mikael] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [de Carvalho, Leonardo Pinto] Albert Einstein Hosp, Dept Cardiol, Sao Paulo, Brazil; [Richards, A. Mark; de Kleijn, Dominique P. V.; Chan, Mark Y.] Natl Univ Hlth Syst, Natl Univ Heart Ctr NUHCS, Cardiovasc Res Inst CVRI, Singapore, Singapore; [Asselbergs, Folkert W.] ICIN Netherlands Heart Inst, Durrer Ctr Cardiogenet Res, Utrecht, Netherlands; [Asselbergs, Folkert W.] UCL, Fac Populat Hlth Sci, Inst Cardiovasc Sci, London, England	Utrecht University; Utrecht University Medical Center; National University of Singapore; Utrecht University; Utrecht University Medical Center; National University of Singapore; National University of Singapore; Hospital Israelita Albert Einstein; National University of Singapore; University of London; University College London	de Kleijn, DPV (corresponding author), Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands.	surdvp@nus.edu.sg	Agostoni, Pierfrancesco/A-3681-2008; Asselbergs, Folkert W./ABD-6752-2021; Chan, Yan Yee Mark/ABE-1929-2021; Hartman, Mikael/B-4324-2011	Agostoni, Pierfrancesco/0000-0002-1505-9369; Asselbergs, Folkert W./0000-0002-1692-8669; Chan, Yan Yee Mark/0000-0003-0389-7450; Seneviratna, Aruni/0000-0001-5010-1422; Hartman, Mikael/0000-0001-5726-9965	Royal Netherlands Academy of Arts and Sciences; National University Singapore Startup grant; Singapore National Medical Research Council Centre Grant; ATTRaCT grant BMRC [SPF 2014/003]	Royal Netherlands Academy of Arts and Sciences; National University Singapore Startup grant; Singapore National Medical Research Council Centre Grant(National Medical Research Council, Singapore); ATTRaCT grant BMRC	This work is supported by a strategic grant from the Royal Netherlands Academy of Arts and Sciences to the Interuniversity Cardiology Institute of the Netherlands, ICIN (DdK); National University Singapore Startup grant to DdK, Singapore National Medical Research Council Centre Grant to AMR, MYC and DdK and the ATTRaCT, SPF 2014/003 grant BMRC to DdK and AMR. These funding sources in no way influenced the analyses or the content of this manuscript.	Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; Anand S S, 2000, Indian Heart J, V52, pS35; Austen W G, 1975, Circulation, V51, P5; Bild DE, 2005, CIRCULATION, V111, P1313, DOI 10.1161/01.CIR.0000157730.94423.4B; Capodanno D, 2009, CIRC-CARDIOVASC INTE, V2, P302, DOI 10.1161/CIRCINTERVENTIONS.108.847137; Chiu M, 2010, CAN MED ASSOC J, V182, P1334, DOI 10.1503/cmaj.110-2098; Chow CK, 2008, ATHEROSCLEROSIS, V199, P116, DOI 10.1016/j.atherosclerosis.2007.10.008; ENAS EA, 1995, CLIN CARDIOL, V18, P131, DOI 10.1002/clc.4960180305; Enas EA, INDIAN HEART J, V48, P343; Gasevic D, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-121; Genereux P, 2011, CIRC-CARDIOVASC INTE, V4, P553, DOI 10.1161/CIRCINTERVENTIONS.111.961862; Gijsberts CM, 2015, GLOB HEART, V10, P301, DOI 10.1016/j.gheart.2014.11.004; Goff Jr DC, 2013, J AM COLL CARDIOL, V63, P2935, DOI DOI 10.1016/J.JACC.2013.11.005; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Jiang SS, 2008, ANGIOLOGY, V59, P442, DOI 10.1177/0003319707306302; Kanaya AM, 2014, ATHEROSCLEROSIS, V234, P102, DOI 10.1016/j.atherosclerosis.2014.02.017; Khan NA, 2010, CIRCULATION, V122, P1570, DOI 10.1161/CIRCULATIONAHA.109.850297; Klomp M, 2012, CORONARY ARTERY DIS, V23, P271, DOI 10.1097/MCA.0b013e328351aaed; Koulaouzidis G, 2013, INT J CARDIOL, V167, P2472, DOI 10.1016/j.ijcard.2012.05.102; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Maitra A, 2008, THROMB HAEMOSTASIS, V99, P944, DOI 10.1160/TH07-11-0686; Mak KH, 2003, EUR HEART J, V24, P151, DOI 10.1016/S0195-668X(02)00423-2; McManus RJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e181; Meadows TA, 2011, MAYO CLIN PROC, V86, P960, DOI 10.4065/mcp.2011.0010; Ministry of Health, 2007, NATIONAL HEALTH SURV; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Paisano E., 1993, THE AMERICAN ASIANS; Palaniappan L, 2004, ANN EPIDEMIOL, V14, P499, DOI 10.1016/j.annepidem.2003.12.001; Qian F, 2012, CIRC-CARDIOVASC QUAL, V5, P126, DOI 10.1161/CIRCOUTCOMES.111.961987; R Core Team, 2021, R LANGUAGE ENV STAT; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Serruys PW, 2009, EUROINTERVENTION, V5, P50, DOI 10.4244/EIJV5I1A9; Shaw LJ, 2008, CIRCULATION, V117, P1787, DOI 10.1161/CIRCULATIONAHA.107.726562; Sianos Georgios, 2005, EuroIntervention, V1, P219; SYNTAX Steering Committee, 2012, SYNTAX SCORE CALCULA; Tan JHH, 2003, HUM GENET, V113, P106, DOI 10.1007/s00439-003-0943-3; Thompson JH, 2014, POPULATION CLOCK INT; Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001; Vallapuri S, 2002, AM J CARDIOL, V90, P1147, DOI 10.1016/S0002-9149(02)02786-8; Wang JW, 2013, NETH HEART J, V21, P467, DOI 10.1007/s12471-013-0462-3; WHO, 2006, DEFINITION AND DIAGN; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890; Zaman MJS, 2013, HEART, V99, P729, DOI 10.1136/heartjnl-2012-302925; Zheng YL, 2010, CLIN RES CARDIOL, V99, P45, DOI 10.1007/s00392-009-0076-3	45	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131977	10.1371/journal.pone.0131977	http://dx.doi.org/10.1371/journal.pone.0131977			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147437	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600173
J	Li, N; Cheng, WL; Huang, TQ; Yuan, J; Wang, X; Song, MY				Li, Na; Cheng, Wenli; Huang, Tiequn; Yuan, Jie; Wang, Xi; Song, Meiyue			Vascular Adventitia Calcification and Its Underlying Mechanism	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; TRANSFORMING GROWTH-FACTOR-BETA-1; AORTIC DISTENSIBILITY; MOLECULAR-MECHANISMS; DISEASE; AGE; FIBROBLASTS; TGF-BETA-1	Previous research on vascular calcification has mainly focused on the vascular intima and media. However, we show here that vascular calcification may also occur in the adventitia. The purpose of this work is to help elucidate the pathogenic mechanisms underlying vascular calcification. The calcified lesions were examined by Von Kossa staining in ApoE-/-mice which were fed high fat diets (HFD) for 48 weeks and human subjects aged 60 years and older that had died of coronary heart disease, heart failure or acute renal failure. Explant cultured fibroblasts and smooth muscle cells (SMCs) were obtained from rat adventitia and media, respectively. After calcification induction, cells were collected for Alizarin Red S staining. Calcified lesions were observed in the aorta adventitia and coronary artery adventitia of ApoE-/-mice, as well as in the aorta adventitia of human subjects examined. Explant culture of fibroblasts, the primary cell type comprising the adventitia, was successfully induced for calcification after incubation with TGF-beta 1 (20 ng/ml) + mineralization media for 4 days, and the phenotype conversion vascular adventitia fibroblasts into myofibroblasts was identified. Culture of SMCs, which comprise only a small percentage of all cells in the adventitia, in calcifying medium for 14 days resulted in significant calcification. Vascular calcification can occur in the adventitia. Adventitia calcification may arise from the fibroblasts which were transformed into myofibroblasts or smooth muscle cells.	[Li, Na; Huang, Tiequn] Minist Hlth, China Japan Friendship Hosp, Dept Hlth Care, Beijing, Peoples R China; [Cheng, Wenli] Minist Hlth, China Japan Friendship Hosp, Ctr Cardiovasc Dis, Beijing, Peoples R China; [Yuan, Jie; Wang, Xi; Song, Meiyue] Beijing Univ Tradit Chinese Med, Grad Sch, Beijing, Peoples R China	China-Japan Friendship Hospital; China-Japan Friendship Hospital; Beijing University of Chinese Medicine	Cheng, WL (corresponding author), Minist Hlth, China Japan Friendship Hosp, Ctr Cardiovasc Dis, Beijing, Peoples R China.	chengwenli2013@163.com			general program of the national natural science foundation of China [81173420]	general program of the national natural science foundation of China(National Natural Science Foundation of China (NSFC))	Supported by the general program of the national natural science foundation of China, No: 81173420. The funder has an role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bulick AS, 2009, TISSUE ENG PT A, V15, P815, DOI 10.1089/ten.tea.2008.0179; Cai Y, 2010, CARDIOVASC RES, V85, P864, DOI 10.1093/cvr/cvp366; Cianciolo G, 2010, MINERVA UROL NEFROL, V62, P51; DART AM, 1991, LANCET, V338, P270, DOI 10.1016/0140-6736(91)90415-L; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Dourron HM, 2005, AM J PHYSIOL-HEART C, V288, pH946, DOI 10.1152/ajpheart.00413.2004; Dunkern TR, 2007, EUR J PHARMACOL, V572, P12, DOI 10.1016/j.ejphar.2007.06.036; El-Hamamsy I, 2009, NAT REV CARDIOL, V6, P771, DOI 10.1038/nrcardio.2009.191; Ellam T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088767; Harvey A, 2015, J MOL CELL CARDIOL, V83, P112, DOI 10.1016/j.yjmcc.2015.04.011; Hruska KA, 2009, CIRC RES, V104, P710, DOI 10.1161/CIRCRESAHA.109.195487; Iribarren C, 2000, JAMA-J AM MED ASSOC, V283, P2810, DOI 10.1001/jama.283.21.2810; Jiang LQ, 2012, HYPERTENSION, V60, P1192, DOI 10.1161/HYPERTENSIONAHA.112.196840; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Lai CF, 2012, ENDOCRINOLOGY, V153, P3897, DOI 10.1210/en.2012-1216; Lanzer P, 2014, EUR HEART J, V35, P1515, DOI 10.1093/eurheartj/ehu163; Maiellaro K, 2007, CARDIOVASC RES, V75, P640, DOI 10.1016/j.cardiores.2007.06.023; MITCHELL JRA, 1977, ATHEROSCLEROSIS, V27, P437, DOI 10.1016/0021-9150(77)90162-9; Moe SM, 2004, NEPHROL DIAL TRANSPL, V19, P2387, DOI 10.1093/ndt/gfh303; Moreno PR, 2002, CIRCULATION, V105, P2504, DOI 10.1161/01.CIR.0000017265.52501.37; Nesti LJ, 2007, J CELL BIOCHEM, V101, P348, DOI 10.1002/jcb.21180; Newman AB, 2001, CIRCULATION, V104, P2679, DOI 10.1161/hc4601.099464; OHTSUKA S, 1994, J AM COLL CARDIOL, V24, P1406, DOI 10.1016/0735-1097(94)90127-9; Persy V, 2009, TRENDS MOL MED, V15, P405, DOI 10.1016/j.molmed.2009.07.001; Rayner K, 2000, J VASC RES, V37, P93, DOI 10.1159/000025720; Sakamoto S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105739; Sata M, 2003, TRENDS CARDIOVAS MED, V13, P249, DOI 10.1016/S1050-1738(03)00106-3; Shao JS, 2006, ARTERIOSCL THROM VAS, V26, P1423, DOI 10.1161/01.ATV.0000220441.42041.20; Simionescu A, 2007, AM J PATHOL, V171, P116, DOI 10.2353/ajpath.2007.060930; SIMONSON E, 1960, CIRCULATION, V22, P126, DOI 10.1161/01.CIR.22.1.126; Sui YB, 2013, PEPTIDES, V42, P25, DOI 10.1016/j.peptides.2012.12.023; Wang HD, 1999, HYPERTENSION, V33, P1225, DOI 10.1161/01.HYP.33.5.1225; Wang MY, 2006, ARTERIOSCL THROM VAS, V26, P1503, DOI 10.1161/01.ATV.0000225777.58488.f2; Wang MY, 2010, CURR HYPERTENS REV, V6, P266, DOI 10.2174/157340210793611668; Weaver M, 2006, AM J PHYSIOL-HEART C, V290, pH1933, DOI 10.1152/ajpheart.00690.2005; Wilcox JN, 1996, INT J CARDIOL, V54, pS21, DOI 10.1016/S0167-5273(96)02811-2; Yan JY, 2011, ARTERIOSCL THROM VAS, V31, P608, DOI 10.1161/ATVBAHA.110.220749; Zhang YG, 2010, CHINESE MED J-PEKING, V123, P3634, DOI 10.3760/cma.j.issn.0366-6999.2010.24.023	39	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132506	10.1371/journal.pone.0132506	http://dx.doi.org/10.1371/journal.pone.0132506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148272	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600292
J	Parrish, HL; Glassman, CR; Keenen, MM; Deshpande, NR; Bronnimann, MP; Kuhns, MS				Parrish, Heather L.; Glassman, Caleb R.; Keenen, Madeline M.; Deshpande, Neha R.; Bronnimann, Matthew P.; Kuhns, Michael S.			A Transmembrane Domain GGxxG Motif in CD4 Contributes to Its Lck-Independent Function but Does Not Mediate CD4 Dimerization	PLOS ONE			English	Article							T-CELL-RECEPTOR; BINDING-SITE; KINASE P56LCK; PEPTIDE-MHC; LIPID RAFTS; COMPLEX; ACTIVATION; ANTIGEN; IDENTIFICATION; REQUIREMENTS	CD4 interactions with class II major histocompatibility complex (MHC) molecules are essential for CD4(+) T cell development, activation, and effector functions. While its association with p56(lck) (Lck), a Src kinase, is important for these functions CD4 also has an Lck-independent role in TCR signaling that is incompletely understood. Here, we identify a conserved GGxxG motif in the CD4 transmembrane domain that is related to the previously described GxxxG motifs of other proteins and predicted to form a flat glycine patch in a transmembrane helix. In other proteins, these patches have been reported to mediate dimerization of transmembrane domains. Here we show that introducing bulky side-chains into this patch (GGxxG to GVxxL) impairs the Lck-independent role of CD4 in T cell activation upon TCR engagement of agonist and weak agonist stimulation. However, using Forster's Resonance Energy Transfer (FRET), we saw no evidence that these mutations decreased CD4 dimerization either in the unliganded state or upon engagement of pMHC concomitantly with the TCR. This suggests that the CD4 transmembrane domain is either mediating interactions with an unidentified partner, or mediating some other function such as membrane domain localization that is important for its role in T cell activation.	[Parrish, Heather L.; Glassman, Caleb R.; Keenen, Madeline M.; Deshpande, Neha R.; Bronnimann, Matthew P.; Kuhns, Michael S.] Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85721 USA; [Deshpande, Neha R.; Kuhns, Michael S.] Univ Arizona, Coll Med, Arizona Ctr Aging, Tucson, AZ USA; [Kuhns, Michael S.] Univ Arizona, Coll Med, Inst BIO5, Tucson, AZ USA	University of Arizona; University of Arizona; University of Arizona	Kuhns, MS (corresponding author), Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85721 USA.	mkuhns@u.arizona.edu			NIH/NIAID, The Pew Charitable Trusts [1R01AI101053]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101053] Funding Source: NIH RePORTER	NIH/NIAID, The Pew Charitable Trusts; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by NIH/NIAID 1R01AI101053, The Pew Charitable Trusts (http://www.pewtrusts.org/en/projects/pew-biomedical-scholars/program-details).	Beemiller P, 2012, NAT IMMUNOL, V13, P787, DOI 10.1038/ni.2364; Birnbaum ME, 2012, IMMUNOL REV, V250, P82, DOI 10.1111/imr.12006; Bock J, 2003, FEBS LETT, V534, P169, DOI 10.1016/S0014-5793(02)03784-5; Bronnimann MP, 2013, J VIROL, V87, P464, DOI 10.1128/JVI.01539-12; CAMMAROTA G, 1992, NATURE, V356, P799, DOI 10.1038/356799a0; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; CRISE B, 1992, J BIOL CHEM, V267, P13593; Dixon AM, 2014, J BIOL CHEM, V289, P11695, DOI 10.1074/jbc.M113.516997; Faingold O, 2012, J BIOL CHEM, V287, P33503, DOI 10.1074/jbc.M112.370817; Fournier M, 2010, MOL IMMUNOL, V47, P2594, DOI 10.1016/j.molimm.2010.06.010; Gaidukov L, 2011, J BIOL CHEM, V286, P18452, DOI 10.1074/jbc.M111.229872; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Holst J, 2008, NAT IMMUNOL, V9, P658, DOI 10.1038/ni.1611; James JR, 2011, J BIOL CHEM, V286, P31993, DOI 10.1074/jbc.M111.219212; Jia-huai Wang RM, 2001, PNAS, V98, P10799; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; KILLEEN N, 1993, NATURE, V364, P729, DOI 10.1038/364729a0; KIM KJ, 1979, J IMMUNOL, V122, P549; KONIG R, 1995, J EXP MED, V182, P779, DOI 10.1084/jem.182.3.779; KONIG R, 1992, NATURE, V356, P796, DOI 10.1038/356796a0; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Kuhns MS, 2007, IMMUNITY, V26, P357, DOI 10.1016/j.immuni.2007.01.015; Kuhns MS, 2010, P NATL ACAD SCI USA, V107, P5094, DOI 10.1073/pnas.1000925107; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; Kuhns MS, 2012, IMMUNOLOGICAL REV, V250; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LETOURNEUR F, 1989, EUR J IMMUNOL, V19, P2269, DOI 10.1002/eji.1830191214; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; Moldovan MC, 2006, J IMMUNOL, V176, P5438, DOI 10.4049/jimmunol.176.9.5438; Moldovan MC, 2002, J IMMUNOL, V169, P6261, DOI 10.4049/jimmunol.169.11.6261; Nadiri A, 2011, EUR J IMMUNOL, V41, P2358, DOI 10.1002/eji.201041143; PERSCHL A, 1995, J CELL SCI, V108, P1033; Popik W, 2004, J BIOL CHEM, V279, P704, DOI 10.1074/jbc.M306380200; Rabinowitz JD, 1996, IMMUNITY, V5, P125, DOI 10.1016/S1074-7613(00)80489-6; REAY PA, 1994, J IMMUNOL, V152, P3946; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Scott CA, 1996, J EXP MED, V183, P2087, DOI 10.1084/jem.183.5.2087; SHAW AS, 1989, CELL, V59, P627, DOI 10.1016/0092-8674(89)90008-1; TREUTLEIN HR, 1992, BIOCHEMISTRY-US, V31, P12726, DOI 10.1021/bi00166a003; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Vidal K, 1999, J IMMUNOL, V163, P4811; Vignali DAA, 1996, J EXP MED, V183, P2097, DOI 10.1084/jem.183.5.2097; Weinglass AB, 1999, P NATL ACAD SCI USA, V96, P11178, DOI 10.1073/pnas.96.20.11178; Wu H, 1997, NATURE, V387, P527, DOI 10.1038/387527a0; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Xiong Y, 2001, J BIOL CHEM, V276, P5659, DOI 10.1074/jbc.M009580200; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yin YY, 2012, P NATL ACAD SCI USA, V109, P5405, DOI 10.1073/pnas.1118801109; Zhang H, 2011, P NATL ACAD SCI USA, V108, P19323, DOI 10.1073/pnas.1108052108	50	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132333	10.1371/journal.pone.0132333	http://dx.doi.org/10.1371/journal.pone.0132333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147390	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600244
J	Ran, C; He, SX; Yang, YL; Huang, L; Zhou, ZG				Ran, Chao; He, Suxu; Yang, Yalin; Huang, Lu; Zhou, Zhigang			A Novel Lipase as Aquafeed Additive for Warm-Water Aquaculture	PLOS ONE			English	Article							SALMON SALMO-SALAR; FATTY-ACID COMPOSITION; CRUDE PALM OIL; RAINBOW-TROUT; EXTRACELLULAR LIPASE; LIPID DIGESTIBILITY; MOLECULAR-BIOLOGY; SEQUENCE-ANALYSIS; FISH-OIL; PURIFICATION	A novel Acinetobacter lipase gene lipG1 was cloned from DNA extracted from intestinal sample of common carp (Cyprinus carpio), and expressed in E. coli BL21. The encoded protein was 406 amino acids in length. Phylogenetic analysis indicated that LipG1 and its relatives comprised a novel group of true lipases produced by Gram-negative bacteria. LipG1 showed maximal activity at 40 degrees C and pH 8.0 when pNP decanoate (C10) was used as the substrate, and remained high activity between 20 degrees C and 35 degrees C Activity of the lipase was promoted by Ca2+ and Mg2+, and inhibited by Zn2+ and Cu2+. Moreover, LipG1 is stable with proteases, most commercial detergents and organic solvents. Substrate specificity test indicated that LipG1can hydrolyse pNP esters with acyl chain length from C2 to C16, with preference for medium-chain pNP esters (C8, C10). Lastly, LipG1 was evaluated as an aquafeed additive for juvenile common carp (Cyprinus carpio). Results showed that supplementation of LipG1 significantly improved the gut and heptaopancreas lipase activity of fish fed with palm oil diet. Consistently, improved feed conversion ratio and growth performance were recorded in the LipG1 feeding group, to levels comparable to the group of fish fed with soybean oil diet. Collectively, LipG1 exhibited good potential as an aquafeed additive enzyme, and deserves further characterization as the representative of a novel group of lipases.	[Ran, Chao; He, Suxu; Yang, Yalin; Huang, Lu; Zhou, Zhigang] Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Zhou, ZG (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China.	zhou_zg@msn.com			National Science and Technology Support Program Project of China [2012BAD25B02, 2013BAD10B01]; Beijing earmarked fund for Modern Agro-industry Technology Research System (SCGWZJ) [20121104-4]	National Science and Technology Support Program Project of China; Beijing earmarked fund for Modern Agro-industry Technology Research System (SCGWZJ)	This work was supported by the National Science and Technology Support Program Project of China (2012BAD25B02 and 2013BAD10B01) and Beijing earmarked fund for Modern Agro-industry Technology Research System (SCGWZJ 20121104-4). Z.Z. was the author who received the funding. The URL of funder's websites is not available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed EH, 2010, BIORESOURCE TECHNOL, V101, P3628, DOI 10.1016/j.biortech.2009.12.107; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Bell JG, 2002, J NUTR, V132, P222, DOI 10.1093/jn/132.2.222; Caballero MJ, 2002, AQUACULTURE, V214, P253, DOI 10.1016/S0044-8486(01)00852-3; FAO, 2014, FISH STAT COLL; Han SJ, 2003, BIOCHIMIE, V85, P501, DOI 10.1016/S0300-9084(03)00057-9; He SX, 2010, ARCH MICROBIOL, V192, P985, DOI 10.1007/s00203-010-0627-z; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Johnsen RI, 2000, AQUACULT NUTR, V6, P255, DOI 10.1046/j.1365-2095.2000.00146.x; Kademi A, 2000, APPL MICROBIOL BIOT, V54, P173, DOI 10.1007/s002530000353; KOK RG, 1995, MOL MICROBIOL, V15, P803, DOI 10.1111/j.1365-2958.1995.tb02351.x; KOVEN WM, 1993, FISH PHYSIOL BIOCHEM, V10, P357, DOI 10.1007/BF00004502; Ng WK, 2004, AQUAC RES, V35, P1228, DOI 10.1111/j.1365-2109.2004.01131.x; Ng WK, 2000, AQUAC RES, V31, P337, DOI 10.1046/j.1365-2109.2000.00437.x; Ng WK, 2003, LIPIDS, V38, P1031, DOI 10.1007/s11745-006-1157-y; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Park IH, 2009, J MICROBIOL BIOTECHN, V19, P128, DOI 10.4014/jmb.0802.130; Samuelsen T, 2001, AQUACULTURE, V194, P161, DOI 10.1016/S0044-8486(00)00519-6; Snellman EA, 2004, J IND MICROBIOL BIOT, V31, P391, DOI 10.1007/s10295-004-0167-0; Snellman EA, 2002, EUR J BIOCHEM, V269, P5771, DOI 10.1046/j.1432-1033.2002.03235.x; Sullivan ER, 1999, GENE, V230, P277, DOI 10.1016/S0378-1119(99)00026-8; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Timothy M, 2005, VIROL J, V2, P1; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; Torstensen BE, 2000, LIPIDS, V35, P653, DOI 10.1007/s11745-000-0570-6; Varghese S, 2000, LIPIDS, V35, P757, DOI 10.1007/s11745-000-0582-2; Wang HK, 2011, FOOD TECHNOL BIOTECH, V49, P96; Zheng XM, 2011, APPL MICROBIOL BIOT, V90, P971, DOI 10.1007/s00253-011-3154-1; Zhou ZG, 2009, J WORLD AQUACULT SOC, V40, P450, DOI 10.1111/j.1749-7345.2009.00272.x	29	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132049	10.1371/journal.pone.0132049	http://dx.doi.org/10.1371/journal.pone.0132049			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147311	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600189
J	Seino, S; Shinkai, S; Iijima, K; Obuchi, S; Fujiwara, Y; Yoshida, H; Kawai, H; Nishi, M; Murayama, H; Taniguchi, Y; Amano, H; Takahashi, R				Seino, Satoshi; Shinkai, Shoji; Iijima, Katsuya; Obuchi, Shuichi; Fujiwara, Yoshinori; Yoshida, Hideyo; Kawai, Hisashi; Nishi, Mariko; Murayama, Hiroshi; Taniguchi, Yu; Amano, Hidenori; Takahashi, Ryutaro			Reference Values and Age Differences in Body Composition of Community-Dwelling Older Japanese Men and Women: A Pooled Analysis of Four Cohort Studies	PLOS ONE			English	Article							FAT-FREE MASS; X-RAY ABSORPTIOMETRY; BIOELECTRICAL-IMPEDANCE ANALYSIS; MULTIFREQUENCY BIOIMPEDANCE; SKELETAL-MUSCLE; SARCOPENIA; POPULATION; DEXA; ACCURACY; INDEX	Objectives To determine age- and sex-specific body composition reference values and investigate age differences in these parameters for community-dwelling older Japanese men and women, using direct segmental multi-frequency bioelectrical impedance analysis. Methods We conducted a pooled analysis of data collected in four cohort studies between 2008 and 2012: Kusatsu Longitudinal Study, Hatoyama Cohort Study, Itabashi Cohort Study, and Kashiwa Cohort Study. The pooled analysis included cross-sectional data from 4478 non-disabled, community-dwelling adults aged 65-94 years (2145 men, 2333 women; mean age: 72.9 years in men and 72.6 years in women). Body weight, fat mass (FM), percentage FM, fat-free mass (FFM), and appendicular lean soft tissue mass were measured using the InBody 720 and 430 (Biospace Co. Ltd, Seoul, Korea). The values were then normalized by height in meters squared to determine body mass index (BMI), FM index (FMI), FFM index (FFMI), and skeletal muscle mass index (SMI). Results Simple means (standard deviation) of BMI, percentage FM, FMI, FFMI, and SMI were 23.4 (2.9) kg/m(2), 24.9 (6.3)%, 5.96 (2.09) kg/m(2), 17.4 (1.5) kg/m(2), and 7.29 (0.76) kg/m(2), respectively, in men and 22.7 (3.3) kg/m(2), 31.7 (7.1)%, 7.40 (2.61) kg/m(2), 15.3 (1.2) kg/m(2), and 5.86 (0.67) kg/m(2), respectively, in women. We then calculated quartiles and quintiles for these indices after stratifying for sex and 5-year age group. FFMI and SMI decreased significantly with age in both sexes (P < 0.001 for trends), but FFMI remained constant among the women with only a 1% decrease up to age 84 years. Percentage FM increased significantly, with age (P < 0.001 in men and P = 0.045 in women for trends), but FMI was unchanged in both sexes (P = 0.147 in men and P = 0.176 in women for trends). Conclusion The present data should be useful in the clinical evaluation of body composition of older Japanese and for international comparisons. The small age-related decrease in FFMI may be a noteworthy characteristic of body composition change in older Japanese women.	[Seino, Satoshi; Shinkai, Shoji; Obuchi, Shuichi; Fujiwara, Yoshinori; Yoshida, Hideyo; Kawai, Hisashi; Nishi, Mariko; Murayama, Hiroshi; Taniguchi, Yu; Amano, Hidenori; Takahashi, Ryutaro] Tokyo Metropolitan Inst Gerontol, Itabashi Ku, Tokyo, Japan; [Iijima, Katsuya] Univ Tokyo, Inst Gerontol, Bunkyo Ku, Tokyo, Japan	Tokyo Metropolitan Institute of Gerontology; University of Tokyo	Shinkai, S (corresponding author), Tokyo Metropolitan Inst Gerontol, Itabashi Ku, 35-2 Sakae, Tokyo, Japan.	sshinkai@tmig.or.jp		Seino, Satoshi/0000-0002-3620-8730	Tokyo Metropolitan Government; Japan Arteriosclerosis Prevention Fund; Research Institute of Science and Technology for Society; Japan Science and Technology Agency; Japan Society for the Promotion of Science [17390194, 21390212]; Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan [H23-Chouju-Ippan-001, H23-Chouju-Ippan-002, H24-Choju-Ippan-002]; Grants-in-Aid for Scientific Research [26310111] Funding Source: KAKEN	Tokyo Metropolitan Government(Tokyo Metropolitan Government); Japan Arteriosclerosis Prevention Fund; Research Institute of Science and Technology for Society; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Tokyo Metropolitan Government, the Japan Arteriosclerosis Prevention Fund (http://jals.gr.jp/en/index.html), the Research Institute of Science and Technology for Society, the Japan Science and Technology Agency, Grants-in-Aid for Scientific Research (B) (2) 17390194 and 21390212 from the Japan Society for the Promotion of Science, and Health Labour Sciences Research Grants H23-Chouju-Ippan-001, H23-Chouju-Ippan-002, and H24-Choju-Ippan-002 from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LJ, 2012, NUTR RES, V32, P479, DOI 10.1016/j.nutres.2012.05.009; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Cawthon PM, 2013, GERONTOLOGIST, V53, P594, DOI 10.1093/gerona/glu023; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Chumlea WC, 2002, INT J OBESITY, V26, P1596, DOI 10.1038/sj.ijo.0802167; Coin A, 2008, CLIN NUTR, V27, P87, DOI 10.1016/j.clnu.2007.10.008; Coin A, 2013, J AM MED DIR ASSOC, V14, P507, DOI 10.1016/j.jamda.2013.02.010; Coin A, 2012, CLIN NUTR, V31, P506, DOI 10.1016/j.clnu.2012.01.012; Demura Shinichi, 2004, Journal of Physiological Anthropology and Applied Human Science, V23, P93, DOI 10.2114/jpa.23.93; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Dey DK, 2009, NUTRITION, V25, P613, DOI 10.1016/j.nut.2008.11.023; Franssen FME, 2014, J AM MED DIR ASSOC, V15, DOI 10.1016/j.jamda.2014.03.012; Fujiwara Y, 2013, J GERIATR PSYCH NEUR, V26, P209, DOI 10.1177/0891988713497096; Genton L, 2011, CLIN NUTR, V30, P436, DOI 10.1016/j.clnu.2011.01.009; Han SS, 2010, J AM GERIATR SOC, V58, P312, DOI 10.1111/j.1532-5415.2009.02672.x; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hughes VA, 2002, AM J CLIN NUTR, V76, P473, DOI 10.1093/ajcn/76.2.473; Ishii S, 2014, GERIATR GERONTOL INT, V14, P93, DOI 10.1111/ggi.12197; Ito H, 2001, EUR J CLIN NUTR, V55, P462, DOI 10.1038/sj.ejcn.1601206; Kim CH, 2011, OBES RES CLIN PRACT, V5, pE210, DOI 10.1016/j.orcp.2011.01.004; Kim M, 2013, EUR J CLIN NUTR, V67, P395, DOI 10.1038/ejcn.2013.9; Kim M, 2014, GERIATR GER IN PRESS; Kitamura I, 2014, GERIATR GERONTOL INT, V14, P354, DOI 10.1111/ggi.12109; Kyle UG, 2001, EUR J CLIN NUTR, V55, P663, DOI 10.1038/sj.ejcn.1601198; Kyle UG, 2001, NUTRITION, V17, P534, DOI 10.1016/S0899-9007(01)00555-X; Ling CHY, 2011, CLIN NUTR, V30, P610, DOI 10.1016/j.clnu.2011.04.001; Lu Y, 2012, EUR J CLIN NUTR, V66, P1004, DOI 10.1038/ejcn.2012.86; MAZESS RB, 1990, AM J CLIN NUTR, V51, P1106, DOI 10.1093/ajcn/51.6.1106; Murayama H, 2012, J EPIDEMIOL, V22, P551, DOI 10.2188/jea.JE20120015; Rossi A, 2008, INT J OBESITY, V32, P1423, DOI 10.1038/ijo.2008.103; Seino S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099487; Shafer KJ, 2009, NUTRITION, V25, P25, DOI 10.1016/j.nut.2008.07.004; Sillanpaa E, 2014, OBESITY, V22, P101, DOI 10.1002/oby.20583; Tagliabue A, 2001, ACTA DIABETOL, V38, P93, DOI 10.1007/s005920170020; Taniguchi Y, 2012, J GERONTOL A-BIOL, V67, P796, DOI 10.1093/gerona/glr243; VANITALLIE TB, 1990, AM J CLIN NUTR, V52, P953, DOI 10.1093/ajcn/52.6.953; Visser M, 2003, J APPL PHYSIOL, V94, P2368, DOI 10.1152/japplphysiol.00124.2002; Yamada M, 2014, GERIATR GERONTOL INT, V14, P8, DOI 10.1111/ggi.12209	39	47	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131975	10.1371/journal.pone.0131975	http://dx.doi.org/10.1371/journal.pone.0131975			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147341	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600172
J	Tseng, CY; Chang, JF; Wang, JS; Chang, YJ; Gordon, MK; Chao, MW				Tseng, Chia-Yi; Chang, Jing-Fen; Wang, Jhih-Syuan; Chang, Yu-Jung; Gordon, Marion K.; Chao, Ming-Wei			Protective Effects of N-Acetyl Cysteine against Diesel Exhaust Particles-Induced Intracellular ROS Generates Pro-Inflammatory Cytokines to Mediate the Vascular Permeability of Capillary-Like Endothelial Tubes	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HEME OXYGENASE-1; OXIDATIVE STRESS; VE-CADHERIN; AIR-POLLUTION; IN-VITRO; MICROVASCULAR PERMEABILITY; PULMONARY INFLAMMATION; PARTICULATE MATTER; LUNG INFLAMMATION	Exposure to diesel exhaust particles (DEP) is associated with pulmonary and cardiovascular diseases. Previous studies using in vitro endothelial tubes as a simplified model of capillaries have found that DEP-induced ROS increase vascular permeability with rearrangement or internalization of adherens junctional VE-cadherin away from the plasma membrane. This allows DEPs to penetrate into the cell and capillary lumen. In addition, pro-inflammatory cytokines are up-regulated and mediate vascular permeability in response to DEP. However, the mechanisms through which these DEP-induced pro-inflammatory cytokines increase vascular permeability remain unknown. Hence, we examined the ability of DEP to induce permeability of human umbilical vein endothelial cell tube cells to investigate these mechanisms. Furthermore, supplementation with NAC reduces ROS production following exposure to DEP. HUVEC tube cells contributed to a pro-inflammatory response to DEP-induced intracellular ROS generation. Endothelial oxidative stress induced the release of TNF-alpha and IL-6 from tube cells, subsequently stimulating the secretion of VEGF-A independent of HO-1. Our data suggests that DEP-induced intracellular ROS and release of the pro-inflammatory cytokines TNF- alpha and IL-6, which would contribute to VEGF-A secretion and disrupt cell-cell borders and increase vasculature permeability. Addition of NAC suppresses DEP-induced ROS efficiently and reduces subsequent damages by increasing endogenous glutathione.	[Tseng, Chia-Yi] Chung Yuan Christian Univ, Coll Engn, Dept Biomed Engn, Taoyuan, Taiwan; [Tseng, Chia-Yi; Chao, Ming-Wei] Chung Yuan Christian Univ, Ctr Nanotechnol, Taoyuan, Taiwan; [Chang, Jing-Fen; Wang, Jhih-Syuan; Chang, Yu-Jung; Chao, Ming-Wei] Chung Yuan Christian Univ, Coll Sci, Dept Biosci Technol, Taoyuan, Taiwan; [Gordon, Marion K.] Rutgers State Univ, Joint Program Toxicol, Piscataway, NJ USA	Chung Yuan Christian University; Chung Yuan Christian University; Chung Yuan Christian University; Rutgers State University New Brunswick	Chao, MW (corresponding author), Chung Yuan Christian Univ, Ctr Nanotechnol, Taoyuan, Taiwan.	chao@cycu.edu.tw			Ministry of Science and Technology in Taiwan [NSC-102-2320-B-033-001-MY3]	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by a grant from Ministry of Science and Technology (NSC-102-2320-B-033-001-MY3) in Taiwan.	Alagappan VKT, 2005, CELL BIOCHEM BIOPHYS, V43, P119, DOI 10.1385/CBB:43:1:119; Alfaro-Moreno E, 2002, ENVIRON HEALTH PERSP, V110, P715, DOI 10.1289/ehp.02110715; Bai YS, 2001, FREE RADICAL BIO MED, V30, P555, DOI 10.1016/S0891-5849(00)00499-8; Beck-Speier I, 2005, FREE RADICAL BIO MED, V38, P1080, DOI 10.1016/j.freeradbiomed.2005.01.004; Becker S, 2005, ENVIRON HEALTH PERSP, V113, P1032, DOI 10.1289/ehp.7996; Becker Susanne, 2005, Toxicol Appl Pharmacol, V207, P269, DOI 10.1016/j.taap.2005.01.023; Brook RD, 2002, CIRCULATION, V105, P1534, DOI 10.1161/01.CIR.0000013838.94747.64; Brouard S, 2002, J BIOL CHEM, V277, P17950, DOI 10.1074/jbc.M108317200; Bussolati B, 2004, BLOOD, V103, P761, DOI 10.1182/blood-2003-06-1974; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Chao MW, 2012, TOXICOLOGY, V297, P34, DOI 10.1016/j.tox.2012.03.009; Chao MW, 2015, J APPL TOXICOL, V35, P466, DOI 10.1002/jat.3046; Chao MW, 2011, TOXICOLOGY, V279, P73, DOI 10.1016/j.tox.2010.09.011; Cisowski J, 2005, BIOCHEM BIOPH RES CO, V326, P670, DOI 10.1016/j.bbrc.2004.11.083; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Cromer WE, 2014, ANGIOGENESIS, V17, P395, DOI 10.1007/s10456-013-9393-2; Davin JC, 2016, PEDIATR NEPHROL, V31, P207, DOI 10.1007/s00467-015-3082-x; Dean O, 2011, J PSYCHIATR NEUROSCI, V36, P78, DOI 10.1503/jpn.100057; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dodd S, 2008, EXPERT OPIN BIOL TH, V8, P1955, DOI 10.1517/14728220802517901 ; Du YP, 2015, FASEB J, V29, P2194, DOI 10.1096/fj.14-269431; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Dulak J, 2008, CURR OPIN LIPIDOL, V19, P505, DOI 10.1097/MOL.0b013e32830d81e9; FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8; FLECK A, 1985, LANCET, V1, P781; Forchhammer L, 2012, TOXICOL LETT, V209, P121, DOI 10.1016/j.toxlet.2011.12.003; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gavard J, 2013, CELL ADHES MIGR, V7, P455, DOI 10.4161/cam.27330; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Hartz AMS, 2008, FASEB J, V22, P2723, DOI 10.1096/fj.08-106997; Inoue KI, 2006, EXP BIOL MED, V231, P1626; Jozkowicz A, 2003, ANTIOXID REDOX SIGN, V5, P155, DOI 10.1089/152308603764816514; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; Kelly FJ, 2011, CLIN EXP ALLERGY, V41, P1059, DOI 10.1111/j.1365-2222.2011.03776.x; Kerkar S, 2006, J SURG RES, V132, P40, DOI 10.1016/j.jss.2005.06.033; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Krishnan RM, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-7; Kuhnert F, 2008, P NATL ACAD SCI USA, V105, P10185, DOI 10.1073/pnas.0803194105; Lampugnani MG, 2007, NOVART FDN SYMP, V283, P238; Lee GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060632; Li YJ, 2013, OXID MED CELL LONGEV, V2013, DOI [DOI 10.1155/2013/323607, 10.1155/2013/323607]; Lin HH, 2008, J MOL CELL CARDIOL, V45, P44, DOI 10.1016/j.yjmcc.2008.04.011; Ma JYC, 2002, J ENVIRON SCI HEAL C, V20, P117, DOI 10.1081/GNC-120016202; MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710; Masha A, 2014, CURR MED CHEM, V21, P3616, DOI 10.2174/0929867321666140706132900; Matsunaga T, 2009, CHEM-BIOL INTERACT, V181, P52, DOI 10.1016/j.cbi.2009.05.005; McWhinney RD, 2013, ENVIRON SCI TECHNOL, V47, P3362, DOI 10.1021/es304676x; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Nagy JA, 2002, COLD SPRING HARB SYM, V67, P227, DOI 10.1101/sqb.2002.67.227; Nemmar A, 2003, AM J RESP CRIT CARE, V168, P1366, DOI 10.1164/rccm.200306-801OC; NEMMAR A, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/279371; Nemmar A, 2008, TOXICOL LETT, V176, P20, DOI 10.1016/j.toxlet.2007.09.006; Nemmar A, 2012, TOXICOLOGY, V292, P162, DOI 10.1016/j.tox.2011.12.009; Nwariaku FE, 2002, SURGERY, V132, P180, DOI 10.1067/msy.2002.125305; Paolicchi A, 2002, BIOCHEM PHARMACOL, V64, P1027, DOI 10.1016/S0006-2952(02)01173-5; Ristovski ZD, 2006, ENVIRON SCI TECHNOL, V40, P1314, DOI 10.1021/es050094i; Rusznak C, 2000, AM J RESP CELL MOL, V23, P530, DOI 10.1165/ajrcmb.23.4.3959; Salvi S, 1999, AM J RESP CRIT CARE, V159, P702, DOI 10.1164/ajrccm.159.3.9709083; Scallan J., 2010, FLUID EXCHANGE REGUL; Schwarze PE, 2013, BIOMED RES INT, V2013, DOI [DOI 10.1155/2013/685142, 10.1155/2013/685142]; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Sheikpranbabu Sardarpasha, 2009, Journal of Nanobiotechnology, V7, P8, DOI 10.1186/1477-3155-7-8; Silva G, 2006, J IMMUNOL, V177, P1894, DOI 10.4049/jimmunol.177.3.1894; Singh P, 2004, ENVIRON HEALTH PERSP, V112, P820, DOI 10.1289/ehp.6579; Suarez S, 2001, J CELL SCI, V114, P1229; Terry CM, 1999, AM J PHYSIOL-HEART C, V276, pH1493, DOI 10.1152/ajpheart.1999.276.5.H1493; Terry CM, 1998, AM J PHYSIOL-HEART C, V274, pH883, DOI 10.1152/ajpheart.1998.274.3.H883; Tornqvist H, 2007, AM J RESP CRIT CARE, V176, P395, DOI 10.1164/rccm.200606-872OC; Toyooka T, 2012, TOXICOL APPL PHARM, V264, P404, DOI 10.1016/j.taap.2012.08.017; Tseng CY, 2015, CARDIOVASC TOXICOL, V15, P345, DOI 10.1007/s12012-014-9302-y; Ulrich MMW, 2002, J TOXICOL ENV HEAL A, V65, P1571, DOI 10.1080/00984100290071676; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Wang Z, 2007, AM J PHYSIOL-HEART C, V292, pH2083, DOI 10.1152/ajpheart.00944.2006; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Wichmann HE, 2007, INHAL TOXICOL, V19, P241, DOI 10.1080/08958370701498075; Wilson SJ, 2003, VASC PHARMACOL, V40, P109, DOI 10.1016/S1537-1891(02)00340-3; Wong SS, 2004, LUNG, V182, P319, DOI 10.1007/s00408-004-2512-5; Xu M, 2012, TOXICOL SCI, V127, P42, DOI 10.1093/toxsci/kfs087; Yokota S, 2008, J TOXICOL SCI, V33, P1, DOI 10.2131/jts.33.1	80	46	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131911	10.1371/journal.pone.0131911	http://dx.doi.org/10.1371/journal.pone.0131911			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148005	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600163
J	Wang, Y; Xi, CY; Zhang, S; Zhang, WY; Yu, DJ				Wang, Yan; Xi, Chengyu; Zhang, Shuai; Zhang, Wenyu; Yu, Dejian			Combined Approach for Government E-Tendering Using GA and TOPSIS with Intuitionistic Fuzzy Information	PLOS ONE			English	Article							GENETIC ALGORITHM APPROACH; DECISION-MAKING; SYSTEM; OPTIMIZATION; MANAGEMENT; AHP	As E-government continues to develop with ever-increasing speed, the requirement to enhance traditional government systems and affairs with electronic methods that are more effective and efficient is becoming critical. As a new product of information technology, Etendering is becoming an inevitable reality owing to its efficiency, fairness, transparency, and accountability. Thus, developing and promoting government E-tendering (GeT) is imperative. This paper presents a hybrid approach combining genetic algorithm (GA) and Technique for Order Preference by Similarity to an Ideal Solution (TOPSIS) to enable GeT to search for the optimal tenderer efficiently and fairly under circumstances where the attributes of the tenderers are expressed as fuzzy number intuitionistic fuzzy sets (FNIFSs). GA is applied to obtain the optimal weights of evaluation criteria of tenderers automatically. TOPSIS is employed to search for the optimal tenderer. A prototype system is built and validated with an illustrative example from GeT to verify the feasibility and availability of the proposed approach.	[Wang, Yan; Xi, Chengyu; Zhang, Shuai; Zhang, Wenyu; Yu, Dejian] Zhejiang Univ Finance & Econ, Sch Informat, Hangzhou, Zhejiang, Peoples R China	Zhejiang University of Finance & Economics	Zhang, S (corresponding author), Zhejiang Univ Finance & Econ, Sch Informat, Hangzhou, Zhejiang, Peoples R China.	zs760914@sina.com		Yu, Dejian/0000-0003-2796-9148	China National Natural Science Foundation [51475410, 51375429]; Zhejiang Natural Science Foundation of China [LY13E050010]; Zhejiang Science & Technology Plan of China [2014C33084]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Zhejiang Natural Science Foundation of China; Zhejiang Science & Technology Plan of China	The work has been supported by China National Natural Science Foundation (No. 51475410, No. 51375429), Zhejiang Natural Science Foundation of China (No. LY13E050010), and Zhejiang Science & Technology Plan of China (No. 2014C33084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajam M, 2010, AUTOMAT CONSTR, V19, P762, DOI 10.1016/j.autcon.2010.04.001; Altiparmak F, 2006, COMPUT IND ENG, V51, P196, DOI 10.1016/j.cie.2006.07.011; ATANASSOV KT, 1986, FUZZY SET SYST, V20, P87, DOI 10.1016/S0165-0114(86)80034-3; Awasthi A, 2011, COMPUT IND ENG, V61, P637, DOI 10.1016/j.cie.2011.04.019; Baker J.E., P INT C GEN ALG THEI, P101; Betts M, 2006, J INF TECHNOL CONSTR, V11, P89; Buyukozkan G, 2012, EXPERT SYST APPL, V39, P2341, DOI 10.1016/j.eswa.2011.08.061; Byun HS, 2005, INT J ADV MANUF TECH, V26, P1338, DOI 10.1007/s00170-004-2099-2; Cai M, 2011, IEEE T SYST MAN CY A, V41, P574, DOI 10.1109/TSMCA.2010.2076395; Chan LS, 2007, P IEEE I C SERV COMP, P582; CHEN SM, 1994, FUZZY SET SYST, V67, P163, DOI 10.1016/0165-0114(94)90084-1; Chen TY, 2008, FUZZY SET SYST, V159, P1410, DOI 10.1016/j.fss.2007.11.004; Chen YC, 2008, PUBLIC ADMIN REV, V68, P537, DOI 10.1111/j.1540-6210.2008.00889.x; Christenses S, 2006, MURDOCH U ELECT J LA, V13; Chu PY, 2004, GOV INFORM Q, V21, P219, DOI 10.1016/j.giq.2004.01.005; Dagdeviren M, 2009, EXPERT SYST APPL, V36, P8143, DOI 10.1016/j.eswa.2008.10.016; Du TC, 2009, DECIS SUPPORT SYST, V47, P13, DOI 10.1016/j.dss.2008.12.009; Fan C, 2011, J XIHUA U NATURAL SC, V3, P019; Gai YG, 2014, J COMPUT, V9, P475, DOI 10.4304/jcp.9.2.475-482; Gumus AT, 2009, EXPERT SYST APPL, V36, P4067, DOI 10.1016/j.eswa.2008.03.013; Herrera F, 2000, IEEE T FUZZY SYST, V8, P746, DOI 10.1109/91.890332; Holland J.H., 1975, ADAPTATION NATURAL A; Hong DH, 2000, FUZZY SET SYST, V114, P103, DOI 10.1016/S0165-0114(98)00271-1; Hu YC, 2011, APPL SOFT COMPUT, V11, P3764, DOI 10.1016/j.asoc.2011.02.008; Hwang C. L., 1981, MULTIPLE ATTRIBUTE D; Janikow C.Z., 1991, ICGA, P31; Jian-Hua Z, 2013, J COMPUT, V8, P1456, DOI 10.4304/jcp.8.6.1456-1463; Kahraman C, 2007, COMPUT IND ENG, V52, P414, DOI 10.1016/j.cie.2007.01.005; Krohling RA, 2011, EXPERT SYST APPL, V38, P4190, DOI 10.1016/j.eswa.2010.09.081; Li GS, 2014, J COMPUT, V9, P1309, DOI 10.4304/jcp.9.6.1309-1315; Liao TS, 2002, AUTOMAT CONSTR, V11, P731, DOI 10.1016/S0926-5805(02)00013-4; [刘锋 LIU Feng], 2007, [模糊系统与数学, Fuzzy Systems and Mathematics], V21, P88; Lou ECW, 2009, J INF TECHNOL CONSTR, V14, P98; Man KF, 1996, IEEE T IND ELECTRON, V43, P519, DOI 10.1109/41.538609; Mondorf A., 2008, ICE GOV 2008 P 2 INT, P110; Opricovic S, 2004, EUR J OPER RES, V156, P445, DOI 10.1016/s0377-2217(03)00020-1; Pasupathinathan V, 2008, SECRYPT 2008: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON SECURITY AND CRYPTOGRAPHY, P294; Reddick CG, 2004, SOC SCI COMPUT REV, V22, P293, DOI 10.1177/0894439304263636; Wang Xin-fan, 2008, Control and Decision, V23, P607; Wang ZJ, 2009, INFORM SCIENCES, V179, P3026, DOI 10.1016/j.ins.2009.05.001; WHITLEY D, 1989, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P116; Xu ZS, 2006, INT J GEN SYST, V35, P417, DOI 10.1080/03081070600574353; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zhang S, 2014, SCI WORLD J, DOI 10.1155/2014/234241; Zhang WY, 2011, INT J ADV MANUF TECH, V53, P1247, DOI 10.1007/s00170-010-2900-3; Zhang WY, 2009, INT J PROD RES, V47, P3079, DOI 10.1080/00207540701769966; Zhou GG, 1999, EUR J OPER RES, V114, P141, DOI 10.1016/S0377-2217(98)00016-2	47	7	7	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130767	10.1371/journal.pone.0130767	http://dx.doi.org/10.1371/journal.pone.0130767			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147468	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600047
J	Chan, RPY; Majid, SR				Chan, Rusi P. Y.; Majid, S. R.			Layer by Layer Ex-Situ Deposited Cobalt-Manganese Oxide as Composite Electrode Material for Electrochemical Capacitor	PLOS ONE			English	Article							PERFORMANCE; BEHAVIOR; NANOPARTICLES; FABRICATION; FILMS; RUO2	The composite metal oxide electrode films were fabricated using ex situ electrodeposition method with further heating treatment at 300 degrees C. The obtained composite metal oxide film had a spherical structure with mass loading from 0.13 to 0.21 mg cm(-2). The structure and elements of the composite was investigated using X-ray diffraction (XRD) and energy dispersive X-ray (EDX). The electrochemical performance of different composite metal oxides was studied by cyclic voltammetry (CV) and galvanostatic charge-discharge (CD). As an active electrode material for a supercapacitor, the Co-Mn composite electrode exhibits a specific capacitance of 285 Fg(-1) at current density of 1.85 Ag-1 in 0.5M Na2SO4 electrolyte. The best composite electrode, Co-Mn electrode was then further studied in various electrolytes (i.e., 0.5M KOH and 0.5M KOH/0.04M K3Fe(CN)(6) electrolytes). The pseudocapacitive nature of the material of Co-Mn lead to a high specific capacitance of 2.2 x 10(3) Fg(-1) and an energy density of 309 Whkg(-1) in a 0.5MKOH/0.04MK(3)Fe(CN)(6) electrolyte at a current density of 10 Ag-1. The specific capacitance retention obtained 67% of its initial value after 750 cycles. The results indicate that the ex situ deposited composite metal oxide nanoparticles have promising potential in future practical applications.	[Chan, Rusi P. Y.; Majid, S. R.] Univ Malaya, Fac Sci, Dept Phys, Ctr Ion, Kuala Lumpur, Malaysia	Universiti Malaya	Majid, SR (corresponding author), Univ Malaya, Fac Sci, Dept Phys, Ctr Ion, Kuala Lumpur, Malaysia.	shana@um.edu.my	MAJID, SITI ROHANA/B-9806-2010	MAJID, SITI ROHANA/0000-0003-0616-4260; , Rusi/0000-0001-8882-0393	University of Malaya [C/625/1/HIR/157, RP025B-14AFR, PG010-2013A]; Skim Bright Sparks University Malaya (SBSUM)	University of Malaya(Universiti Malaya); Skim Bright Sparks University Malaya (SBSUM)	The authors thank the University of Malaya for financial assistance through grants UM. C/625/1/HIR/157, RP025B-14AFR, and PG010-2013A. Rusi acknowledges the Skim Bright Sparks University Malaya (SBSUM) for the scholarship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babakhani B, 2011, J POWER SOURCES, V196, P10762, DOI 10.1016/j.jpowsour.2011.08.102; Babakhani B, 2010, J POWER SOURCES, V195, P2110, DOI 10.1016/j.jpowsour.2009.10.045; Cai Y, 2014, CERAM INT, V40, P4109, DOI 10.1016/j.ceramint.2013.08.065; Chen KF, 2014, RSC ADV, V4, P23338, DOI 10.1039/c4ra03037k; Chen Y, 2013, ELECTROCHIM ACTA, V109, P678, DOI 10.1016/j.electacta.2013.07.174; Conway B. E., 1999, ELECTROCHEMICAL SUPE; Ding R, 2013, ELECTROCHIM ACTA, V107, P494, DOI 10.1016/j.electacta.2013.05.114; Dubal DP, 2013, ELECTROCHIM ACTA, V103, P103, DOI 10.1016/j.electacta.2013.04.055; Enachi M, 2015, PHYS STATUS SOLIDI-R, V9, P171, DOI 10.1002/pssr.201409562; Engstrom AM, 2013, J POWER SOURCES, V228, P120, DOI 10.1016/j.jpowsour.2012.11.075; Farsi H, 2010, J SOLID STATE ELECTR, V14, P681, DOI 10.1007/s10008-009-0828-z; Girija TC, 2006, J POWER SOURCES, V156, P705, DOI 10.1016/j.jpowsour.2005.05.051; Gobal F, 2012, J SOLID STATE ELECTR, V16, P1561, DOI 10.1007/s10008-011-1561-y; Gujar TP, 2007, ELECTROCHEM COMMUN, V9, P504, DOI 10.1016/j.elecom.2006.10.017; Hu CC, 2011, J POWER SOURCES, V196, P847, DOI 10.1016/j.jpowsour.2010.08.001; Hung CJ, 2013, J POWER SOURCES, V243, P594, DOI 10.1016/j.jpowsour.2013.06.055; Hwang BJ, J ELECTROCHEMICAL SO, V147, P2252; Hyun TS, 2010, J MATER CHEM, V20, P9172, DOI 10.1039/c0jm00494d; Jagadale AD, 2013, J COLLOID INTERF SCI, V406, P225, DOI 10.1016/j.jcis.2013.05.037; Kumar M, 2014, PLASMONICS, V9, P129, DOI 10.1007/s11468-013-9605-z; Lee HM, 2014, MATERIALS, V7, P265, DOI 10.3390/ma7010265; Li SH, 2012, CHINESE J ANAL CHEM, V40, P339, DOI 10.1016/S1872-2040(11)60534-3; Li Y, 2011, MATER LETT, V65, P403, DOI 10.1016/j.matlet.2010.10.048; Li ZP, 2014, J POWER SOURCES, V245, P224, DOI 10.1016/j.jpowsour.2013.06.121; LING HS, 2009, PHYS CHEM CHEM PHYS, V11, P2195, DOI DOI 10.1039/B814844A; Lokhande CD, 2014, CURRENT APPL PHYS, V11, P255; Lu XH, 2014, ENERG ENVIRON SCI, V7, P2160, DOI 10.1039/c4ee00960f; Lupan O, 2014, J NANOELECTRON OPTOE, V9, P257, DOI 10.1166/jno.2014.1579; Nithya VD, 2013, ELECTROCHIM ACTA, V109, P720, DOI 10.1016/j.electacta.2013.07.138; Prasad KR, 2004, ELECTROCHEM COMMUN, V6, P1004, DOI 10.1016/j.elecom.2004.07.017; Rusi, 2014, SOLID STATE IONICS, V262, P220, DOI 10.1016/j.ssi.2013.10.003; Rusi, 2013, MATER LETT, V108, P69, DOI 10.1016/j.matlet.2013.06.069; Saranya S, 2012, APPL SURF SCI, V258, P4881, DOI 10.1016/j.apsusc.2012.01.104; Sharma AS, 2012, ADV MAT LETT, V3, P82; Sugimoto W, 2005, J PHYS CHEM B, V109, P7330, DOI 10.1021/jp044252o; Trigilio J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048147; Wang Y, 2011, MATER LETT, V65, P222, DOI 10.1016/j.matlet.2010.09.090; Wei WF, 2011, CHEM SOC REV, V40, P1697, DOI 10.1039/c0cs00127a; Wu CH, 2012, CURR APPL PHYS, V12, P1190, DOI 10.1016/j.cap.2012.02.056; Wu ZY, 2014, NANO ENERGY, V8, P118, DOI 10.1016/j.nanoen.2014.05.019; Yun TG, 2013, J POWER SOURCES, V244, P783, DOI 10.1016/j.jpowsour.2013.02.087; Zhang YX, 2014, J POWER SOURCES, V246, P449, DOI 10.1016/j.jpowsour.2013.07.115; Zhao CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02986	43	3	3	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0129780	10.1371/journal.pone.0129780	http://dx.doi.org/10.1371/journal.pone.0129780			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158447	Green Published, gold, Green Submitted			2022-12-27	WOS:000358161200008
J	da Silva, CP; de Oliveira, LA; Nuvunga, JJ; Pamplona, AKA; Balestre, M				da Silva, Carlos Pereira; de Oliveira, Luciano Antonio; Nuvunga, Joel Jorge; Alves Pamplona, Andrezza Kellen; Balestre, Marcio			A Bayesian Shrinkage Approach for AMMI Models	PLOS ONE			English	Article							ENVIRONMENT INTERACTION PROCEED; LINEAR-BILINEAR MODELS; MULTIPLICATIVE INTERACTION; BIPLOT ANALYSIS; TRIALS	Linear-bilinear models, especially the additive main effects and multiplicative interaction (AMMI) model, are widely applicable to genotype-by-environment interaction (GEI) studies in plant breeding programs. These models allow a parsimonious modeling of GE interactions, retaining a small number of principal components in the analysis. However, one aspect of the AMMI model that is still debated is the selection criteria for determining the number of multiplicative terms required to describe the GE interaction pattern. Shrinkage estimators have been proposed as selection criteria for the GE interaction components. In this study, a Bayesian approach was combined with the AMMI model with shrinkage estimators for the principal components. A total of 55 maize genotypes were evaluated in nine different environments using a complete blocks design with three replicates. The results show that the traditional Bayesian AMMI model produces low shrinkage of singular values but avoids the usual pitfalls in determining the credible intervals in the biplot. On the other hand, Bayesian shrinkage AMMI models have difficulty with the credible interval for model parameters, but produce stronger shrinkage of the principal components, converging to GE matrices that have more shrinkage than those obtained using mixed models. This characteristic allowed more parsimonious models to be chosen, and resulted in models being selected that were similar to those obtained by the Cornelius F-test (alpha = 0.05) in traditional AMMI models and cross validation based on leave-one-out. This characteristic allowed more parsimonious models to be chosen and more GEI pattern retained on the first two components. The resulting model chosen by posterior distribution of singular value was also similar to those produced by the cross-validation approach in traditional AMMI models. Our method enables the estimation of credible interval for AMMI biplot plus the choice of AMMI model based on direct posterior distribution retaining more GEI pattern in the first components and discarding noise without Gaussian assumption as requested in F-based tests or deal with parametric problems as observed in traditional AMMI shrinkage method.	[da Silva, Carlos Pereira; Nuvunga, Joel Jorge; Alves Pamplona, Andrezza Kellen; Balestre, Marcio] Univ Fed Lavras, DEX, Lavras, MG, Brazil; [de Oliveira, Luciano Antonio] Fed Univ Grande Dourados, Fac Exact Sci & Technol FACET, Grande Dourados, MS, Brazil	Universidade Federal de Lavras; Universidade Federal da Grande Dourados	Balestre, M (corresponding author), Univ Fed Lavras, DEX, Lavras, MG, Brazil.	marciobalestre@dex.ufla.br						Balestre M, 2009, CROP BREED APPL BIOT, V9, P219, DOI 10.12702/1984-7033.v09n03a03; Burgueno J, 2008, CROP SCI, V48, P1291, DOI 10.2135/cropsci2007.11.0632; Chen MH, 1999, J COMPUT GRAPH STAT, V8, P69, DOI 10.2307/1390921; Cornelius P. L., 1996, P199; CORNELIUS PL, 1992, THEOR APPL GENET, V84, P161, DOI 10.1007/BF00223996; Cornelius PL, 1999, CROP SCI, V39, P998, DOI 10.2135/cropsci1999.0011183X003900040007x; Cornelius PL, 1997, J STAT COMPUT SIM, V58, P287, DOI 10.1080/00949659708811837; Crossa J, 2011, CROP SCI, V51, P1458, DOI 10.2135/cropsci2010.06.0343; de Oliveira LA, 2015, CROP SCI, V55, P465, DOI 10.2135/cropsci2014.05.0369; Dias CTD, 2003, CROP SCI, V43, P865, DOI 10.2135/cropsci2003.0865; Forkman J, 2014, BIOMETRICS; GABRIEL K.R., 2002, J SOC FRANCAISE STAT, V143, P5; GABRIEL KR, 1971, BIOMETRIKA, V58, P453, DOI 10.1093/biomet/58.3.453; Gauch HG, 2006, CROP SCI, V46, P1488, DOI 10.2135/cropsci2005.07-0193; Gauch HG, 2013, CROP SCI, V53, P1860, DOI 10.2135/cropsci2013.04.0241; GOLLOB HF, 1968, PSYCHOMETRIKA, V33, P73, DOI 10.1007/BF02289676; HEIDELBERGER P, 1983, OPER RES, V31, P1109, DOI 10.1287/opre.31.6.1109; James W., 1961, P 4 BERK S MATH STAT, V1, P361, DOI DOI 10.1007/978-1-4612-0919-5; Jaynes E. T., 2003, PROBABILITY THEORY T; Liu G., 2001, THESIS U KENTUCKY; MANDEL J, 1971, TECHNOMETRICS, V13, P1, DOI 10.2307/1267072; MANDEL J, 1969, J RES NBS B MATH SCI, VB 73, P309, DOI 10.6028/jres.073B.031; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Ooms JCL, 2009, THESIS UTRECHT U; Perez-Elizalde S, 2012, J AGR BIOL ENVIR ST, V17, P15, DOI 10.1007/s13253-011-0063-9; Piepho HP, 1997, BIOMETRICS, V53, P761, DOI 10.2307/2533976; R Core Team, 2021, R LANGUAGE ENV STAT; Rodrigues PC, 2014, CROP SCI, V54, P1555, DOI 10.2135/cropsci2013.07.0462; Silverberg T. R., 1952, MACH DES, V24, P131; Smith A, 2001, AUST NZ J STAT, V43, P129, DOI 10.1111/1467-842X.00163; Stein C., 1956, INADMISSIBILITY USUA, DOI DOI 10.1525/9780520313880-018; ter Braak CJF, 2006, COMPUT STAT DATA AN, V51, P1232, DOI 10.1016/j.csda.2006.06.011; ter Braak CJF, 2005, GENETICS, V170, P1435, DOI 10.1534/genetics.105.040469; Viele K, 2000, J STAT PLAN INFER, V84, P201, DOI 10.1016/S0378-3758(99)00151-2; WILLIAMS EJ, 1952, BIOMETRIKA, V39, P65, DOI 10.1093/biomet/39.1-2.65; Yan WK, 2010, CROP SCI, V50, P1121, DOI 10.2135/cropsci2010.01.0001le; Yang RC, 2009, CROP SCI, V49, P1564, DOI 10.2135/cropsci2008.11.0665	38	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131414	10.1371/journal.pone.0131414	http://dx.doi.org/10.1371/journal.pone.0131414			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158452	Green Published, gold, Green Submitted			2022-12-27	WOS:000358161200029
J	Lyu, ML; Yu, YJ; Jiang, JJ; Song, LM; Liang, Y; Ma, ZM; Xiong, XP; Cao, JS				Lyu, Meiling; Yu, Youjian; Jiang, Jingjing; Song, Limin; Liang, Ying; Ma, Zhiming; Xiong, Xingpeng; Cao, Jiashu			BcMF26a and BcMF26b Are Duplicated Polygalacturonase Genes with Divergent Expression Patterns and Functions in Pollen Development and Pollen Tube Formation in Brassica campestris	PLOS ONE			English	Article							CELL-SEPARATION; ARABIDOPSIS-THALIANA; PECTIC POLYSACCHARIDES; FAMILY; PROTEIN; GERMINATION; EVOLUTION; DYNAMICS; GENOME; POLYPLOIDY	Polygalacturonase (PG) is one of the cell wall hydrolytic enzymes involving in pectin degradation. A comparison of two highly conserved duplicated PG genes, namely, Brassica campestris Male Fertility 26a (BcMF26a) and BcMF26b, revealed the different features of their expression patterns and functions. We found that these two genes were orthologous genes of At4g33440, and they originated from a chromosomal segmental duplication. Although structurally similar, their regulatory and intron sequences largely diverged. QRT-PCR analysis showed that the expression level of BcMF26b was higher than that of BcMF26a in almost all the tested organs and tissues in Brassica campestris. Promoter activity analysis showed that, at reproductive development stages, BcMF26b promoter was active in tapetum, pollen grains, and pistils, whereas BcMF26a promoter was only active in pistils. In the subcellular localization experiment, BcMF26a and BcMF26b proteins could be localized to the cell wall. When the two genes were co-inhibited, pollen intine was formed abnormally and pollen tubes could not grow or stretch. Moreover, the knockout mutants of At4g33440 delayed the growth of pollen tubes. Therefore, BcMF26a/b can participate in the construction of pollen wall by modulating intine information and BcMF26b may play a major role in co-inhibiting transformed plants.	[Lyu, Meiling; Yu, Youjian; Song, Limin; Liang, Ying; Ma, Zhiming; Xiong, Xingpeng; Cao, Jiashu] Zhejiang Univ, Inst Vegetable Sci, Lab Cell & Mol Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Lyu, Meiling; Song, Limin; Liang, Ying; Ma, Zhiming; Xiong, Xingpeng; Cao, Jiashu] Zhejiang Univ, Zhejiang Prov Key Lab Hort Plant Integrat Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Yu, Youjian] Zhejiang A&F Univ, Coll Agr & Food Sci, Dept Hort, Linan, Peoples R China; [Jiang, Jingjing] Chinese Univ Hong Kong, Shenzhen Res Inst, State Key Lab Agrobiotechnol Shenzhen Base, Shenzhen, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang A&F University; Chinese University of Hong Kong, Shenzhen	Cao, JS (corresponding author), Zhejiang Univ, Inst Vegetable Sci, Lab Cell & Mol Biol, Hangzhou 310003, Zhejiang, Peoples R China.	jshcao@zju.edu.cn		ma, zhiming/0000-0002-8610-4876	National Program on Key Basic Research Projects [2012CB113900]; National Natural Science Foundation of China [31272176]; Ministry of Education of China [20120101110078]; Natural Science Foundation of China [31301790]; Guangdong Natural Science Foundation [S2013040016220]	National Program on Key Basic Research Projects(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was funded by the National Program on Key Basic Research Projects (2012CB113900) to JSC; National Natural Science Foundation of China (31272176) to JSC; Specialized Research Fund for the Doctoral Program of Higher Education from the Ministry of Education of China (20120101110078) to JSC; Natural Science Foundation of China (31301790) to JJJ; Guangdong Natural Science Foundation (S2013040016220) to JJJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Allen GC, 2006, NAT PROTOC, V1, P2320, DOI 10.1038/nprot.2006.384; Ariizumi T, 2011, ANNU REV PLANT BIOL, V62, P437, DOI 10.1146/annurev-arplant-042809-112312; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046944; Carvajal F, 2014, PLANT BIOLOGY, V16, P457, DOI 10.1111/plb.12070; Castro AJ, 2013, ANN BOT-LONDON, V112, P503, DOI 10.1093/aob/mct118; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Danilevskaya ON, 2003, PLANT CELL, V15, P425, DOI 10.1105/tpc.006759; Demura T, 2002, P NATL ACAD SCI USA, V99, P15794, DOI 10.1073/pnas.232590499; Dick-Perez M, 2012, MAGN RESON CHEM, V50, P539, DOI 10.1002/mrc.3836; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Geitmann A, 2010, SEX PLANT REPROD, V23, P63, DOI 10.1007/s00497-009-0121-4; Gonzalez-Carranza ZH, 2007, J EXP BOT, V58, P3719, DOI 10.1093/jxb/erm222; Gu X, 2003, TRENDS GENET, V19, P354, DOI 10.1016/S0168-9525(03)00139-2; Hadfield KA, 1998, PLANT PHYSIOL, V117, P337, DOI 10.1104/pp.117.2.337; HESLOPHARRISON J, 1987, INT REV CYTOL, V107, P1, DOI 10.1016/S0074-7696(08)61072-4; Honys D, 2003, PLANT PHYSIOL, V132, P640, DOI 10.1104/pp.103.020925; Huang L, 2008, PLANT BIOLOGY, V10, P342, DOI 10.1111/j.1438-8677.2008.00039.x; Huang L, 2009, J EXP BOT, V60, P301, DOI 10.1093/jxb/ern295; Huang L, 2010, PLANT SYST EVOL, V286, P103, DOI 10.1007/s00606-010-0283-4; Huang L, 2009, ANN BOT-LONDON, V104, P1339, DOI 10.1093/aob/mcp244; Jiang JJ, 2014, J INTEGR PLANT BIOL, V56, P1095, DOI 10.1111/jipb.12209; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kim J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9r87; Kim J, 2006, PLANT SIGNAL BEHAV, V1, P281, DOI 10.4161/psb.1.6.3541; Kirik V, 2004, PLANT MOL BIOL, V55, P389, DOI 10.1007/s11103-004-0893-8; Li S, 2013, PLANT J, V74, P486, DOI 10.1111/tpj.12139; LI YQ, 1994, SEX PLANT REPROD, V7, P145; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Markovic O, 2001, PROTEIN ENG, V14, P615, DOI 10.1093/protein/14.9.615; Moon S, 2013, PLANT PHYSIOL, V161, P663, DOI 10.1104/pp.112.210948; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Ogawa M, 2009, PLANT CELL, V21, P216, DOI 10.1105/tpc.108.063768; OWEN HA, 1995, PROTOPLASMA, V185, P7, DOI 10.1007/BF01272749; Park KC, 2008, GENOME, V51, P30, DOI [10.1139/G07-093, 10.1139/g07-093]; Park KC, 2010, GENES GENOM, V32, P570, DOI 10.1007/s13258-010-0076-8; Qi Ming-Fang, 2014, ScientificWorldJournal, V2014, P389896, DOI 10.1155/2014/389896; Rhee SY, 2003, PLANT PHYSIOL, V133, P1170, DOI 10.1104/pp.103.028266; Rhee SY, 1998, PLANT J, V15, P79, DOI 10.1046/j.1365-313X.1998.00183.x; Saleh A, 2008, PLANT CELL, V20, P568, DOI 10.1105/tpc.107.056614; Sander L, 2001, PLANT MOL BIOL, V46, P469, DOI 10.1023/A:1010619002833; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Simillion C, 2002, P NATL ACAD SCI USA, V99, P13627, DOI 10.1073/pnas.212522399; Sun LX, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-152; Taylor LP, 1997, ANNU REV PLANT PHYS, V48, P461, DOI 10.1146/annurev.arplant.48.1.461; Torki M, 2000, GENE, V242, P427, DOI 10.1016/S0378-1119(99)00497-7; Ueda K, 2013, PLANT PHYSIOL, V162, P858, DOI 10.1104/pp.113.216523; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Xu GX, 2012, P NATL ACAD SCI USA, V109, P1187, DOI 10.1073/pnas.1109047109; Yang ZL, 2013, NEW PHYTOL, V197, P1353, DOI 10.1111/nph.12107; Yeung EC, 2011, SEX PLANT REPROD, V24, P307, DOI 10.1007/s00497-011-0168-x; Yu XL, 2004, J HORTIC SCI BIOTECH, V79, P833, DOI 10.1080/14620316.2004.11511851; Yu YJ, 2014, PLANT MOL BIOL REP, V32, P476, DOI 10.1007/s11105-013-0666-0; Zhang AH, 2012, PLANT MOL BIOL REP, V30, P330, DOI 10.1007/s11105-011-0341-2; Zhang AH, 2011, PLANT MOL BIOL REP, V29, P943, DOI 10.1007/s11105-011-0298-1; Zhang Q, 2008, PLANT CELL REP, V27, P1207, DOI 10.1007/s00299-008-0541-x	65	18	24	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131173	10.1371/journal.pone.0131173	http://dx.doi.org/10.1371/journal.pone.0131173			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26153985	gold, Green Submitted, Green Published			2022-12-27	WOS:000358159700055
J	Minnerup, J; Wersching, H; Unrath, M; Berger, K				Minnerup, Jens; Wersching, Heike; Unrath, Michael; Berger, Klaus			Explaining the Decrease of In-Hospital Mortality from Ischemic Stroke	PLOS ONE			English	Article							TRENDS; MANAGEMENT; DECLINE	Background Mortality from ischemic stroke has declined over time. However, little is known about the reasons for the decreased mortality. We therefore aimed to evaluate trends in in-hospital mortality and to identify factors associated with these trends. Methods This study was based on a prospective database of 26 hospitals of the Stroke Register of Northwestern Germany, which included 73,614 patients admitted between 2000 and 2011. Time trends in observed (crude) and risk-adjusted in-hospital mortality were assessed. Independent factors associated with death after stroke were evaluated using multivariable logistic regression analysis. Results The observed in-hospital mortality decreased from 6.6% in 2000 to 4.6% in 2008 (P < 0.001 for trend) and then remained fairly stable. The risk-adjusted mortality decreased from 2.85% in 2000 to 1.86% in 2008 (P < 0.01 for trend) and then increased to 2.32% in 2011. Use of in-hospital treatments including antiplatelets within 48 hours, antihypertensive therapy, statins, antidiabetics, physiotherapy and anticoagulants increased over time and was significantly associated with a decrease in mortality. The association of the year of admission with mortality became insignificant after adjustment for antiplatelet therapy within 48 hours (from OR 0.96; 95% CI, 0.94-0.98, to OR 0.99; 95% CI, 0.97-1.01) and physiotherapy (from OR 0.96; 95% CI, 0.94-0.97, to OR 0.99; 95% CI, 0.97-1.00). Conclusions In-hospital mortality decreased by approximately one third between 2000 and 2008. This decline was paralleled by improvements in different in-hospital managements, and we demonstrated that it was partly mediated by early antiplatelet therapy and physiotherapy use.	[Minnerup, Jens] Univ Munster, Dept Neurol, D-48149 Munster, Germany; [Wersching, Heike; Unrath, Michael; Berger, Klaus] Univ Munster, Inst Epidemiol & Social Med, D-48149 Munster, Germany	University of Munster; University of Munster	Minnerup, J (corresponding author), Univ Munster, Dept Neurol, Albert Schweitzer Campus 1, D-48149 Munster, Germany.	minnerup@uni-muenster.de	Wersching, Heike/B-7775-2017	Wersching, Heike/0000-0002-9706-7599	Deutsche Forschungsgemeinschaft; Open Access Publication Fund of Universtiy of Muenster	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of Universtiy of Muenster	We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of Universtiy of Muenster.	Carandang R, 2006, JAMA-J AM MED ASSOC, V296, P2939, DOI 10.1001/jama.296.24.2939; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Lackland DT, 2014, STROKE, V45, P315, DOI 10.1161/01.str.0000437068.30550.cf; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Minnerup J, 2011, STROKE, V42, P2838, DOI 10.1161/STROKEAHA.111.616565; Ovbiagele B, 2010, STROKE, V41, P1748, DOI 10.1161/STROKEAHA.110.585455; Sandercock PAG, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000029.pub2; Saunders DH, 2013, COCHRANE DATABASE SY, P10; Schmidt M, 2014, NEUROLOGY, V82, P340, DOI 10.1212/WNL.0000000000000062; Tanne D, 2012, STROKE, V43, P2136, DOI 10.1161/STROKEAHA.111.647610; Teuschl Y, 2013, STROKE, V44, P1070, DOI 10.1161/STROKEAHA.111.676114; Towfighi A, 2011, STROKE, V42, P2740, DOI 10.1161/STROKEAHA.110.612648; Vaartjes I, 2013, STROKE, V44, P591, DOI 10.1161/STROKEAHA.112.677724	15	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131473	10.1371/journal.pone.0131473	http://dx.doi.org/10.1371/journal.pone.0131473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154704	Green Published, Green Submitted, gold			2022-12-27	WOS:000358159700065
J	Ortiz, A; Pilbrow, V; Villamil, CI; Korsgaard, JG; Bailey, SE; Harrison, T				Ortiz, Alejandra; Pilbrow, Varsha; Villamil, Catalina I.; Korsgaard, Jessica G.; Bailey, Shara E.; Harrison, Terry			The Taxonomic and Phylogenetic Affinities of Bunopithecus sericus, a Fossil Hylobatid from the Pleistocene of China	PLOS ONE			English	Article							DENTAL MORPHOLOGY; PLIOPLEISTOCENE HOMINIDS; MOLECULAR PHYLOGENY; MANDIBULAR MOLARS; DIVERGENCE DATES; EVOLUTION; GIBBONS; GIGANTOPITHECUS; BIOGEOGRAPHY; SEQUENCES	Fossil hylobatids are rare, but are known from late Miocene and Pleistocene sites throughout East Asia. The best-known fossil hylobatid from the Pleistocene of China is a left mandibular fragment with M2-3 (AMNH 18534), recovered from a pit deposit near the village of Yanjinggou in Wanzhou District, Chongqing Province. Matthew and Granger described this specimen in 1923 as a new genus and species, Bunopithecus sericus. Establishing the age of Bunopithecus has proved difficult because the Yanjinggou collection represents a mixed fauna of different ages, but it likely comes from early or middle Pleistocene deposits. Although the Bunopithecus specimen has featured prominently in discussions of hylobatid evolution and nomenclature, its systematic status has never been satisfactorily resolved. The present study reexamines the taxonomic and phylogenetic relationships of Bunopithecus by carrying out a detailed comparative morphometric study of its lower molars in relation to a large sample of modern hylobatids. Our results show that differences in M-2 and M-3 discriminate extant hylobatids fairly well, at least at the generic level, and that AMNH 18534 is not attributable to Hylobates, Nomascus or Symphalangus. Support for a close relationship between Bunopithecus and Hoolock is more equivocal. In most multivariate analyses, Bunopithecus presents a unique morphological pattern that falls outside the range of variation of any hylobatid taxon, although its distance from the cluster represented by extant hoolocks is relatively small. Our results support the generic distinction of Bunopithecus, which most likely represents an extinct crown hylobatid, and one that may possibly represent the sister taxon to Hoolock.	[Ortiz, Alejandra; Villamil, Catalina I.; Korsgaard, Jessica G.; Bailey, Shara E.; Harrison, Terry] NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA; [Ortiz, Alejandra; Villamil, Catalina I.; Bailey, Shara E.; Harrison, Terry] NYCEP, New York, NY USA; [Pilbrow, Varsha] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia	New York University; University of Melbourne	Ortiz, A (corresponding author), NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA.	ao706@nyu.edu	Pilbrow, Varsha/AAI-9897-2020; Villamil, Catalina/K-8880-2019	Pilbrow, Varsha/0000-0002-6677-9390; Bailey, Shara/0000-0002-4626-9262	National Science Foundation [SBR-9815546]; Wenner-Gren Foundation; Leakey Foundation; Center for the Study of Human Origins at New York University	National Science Foundation(National Science Foundation (NSF)); Wenner-Gren Foundation; Leakey Foundation; Center for the Study of Human Origins at New York University	This research was supported by the National Science Foundation (SBR-9815546), the Wenner-Gren Foundation, the Leakey Foundation, and the Center for the Study of Human Origins at New York University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon AM, 2008, CR PALEVOL, V7, P277, DOI 10.1016/j.crpv.2008.03.009; Badoux DM, 1959, FOSSIL MAMMALS 2 FIS; Bailey S, 2002, THESIS ARIZONA STATE; Bailey SE, 2004, J HUM EVOL, V47, P183, DOI 10.1016/j.jhevol.2004.07.001; Bailey SE, 2004, J ANAT, V205, P323, DOI 10.1111/j.0021-8782.2004.00334.x; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Carbone L, 2014, NATURE, V513, P195, DOI 10.1038/nature13679; Chan YC, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-150; Chan YC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014419; Chatterjee HJ, 2006, INT J PRIMATOL, V27, P699, DOI 10.1007/s10764-006-9044-1; Chatterjee Helen J., 2009, P13, DOI 10.1007/978-0-387-88604-6_2; Chen SK, 2013, CHINESE SCI BULL, V58, P3780, DOI 10.1007/s11434-013-5839-6; Ciochon R, 1996, P NATL ACAD SCI USA, V93, P3016, DOI 10.1073/pnas.93.7.3016; CIOCHON RL, 1986, J HUM EVOL, V15, P623, DOI 10.1016/S0047-2484(86)80075-6; Colbert E. H., 1940, American Museum Novitates, Vno. 1099; COLBERT EH, 1953, B AM MUS NAT HIST, V102, P1; DAHLBERG AA, 1945, J AM DENT ASSOC, V32, P676, DOI 10.14219/jada.archive.1945.0112; Fabre PH, 2009, MOL PHYLOGENET EVOL, V53, P808, DOI 10.1016/j.ympev.2009.08.004; Fan Peng-Fei, 2009, Gibbon Journal, V5, P44; Finstermeier K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069504; Frisch, 1973, GIBBON SIAMANG, V2, P55; FRISCH JE, 1965, BIBL PRIMATOL, P1; GAO Y-T, 1981, Zoological Research, V2, P1; Geissmann Thomas, 1995, IZN (International Zoo News), V42, P467; Geissmann Thomas, 2007, Gibbon Journal, V3, P5; Groves C.P., 1972, P1; Groves C.P., 2001, PRIMATE TAXONOMY; Gu Yumin, 1996, Vertebrata Palasiatica, V34, P235; Gu Yumin, 1986, Acta Anthropologica Sinica, V5, P208; Gu Yumin, 1989, Human Evolution, V4, P509; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harrison T, 2008, AM J PHYS ANTHROPOL, P113; Harrison T., 2000, B INDOPACIFIC PREHIS, V20, P133; Harrison T., EVOLUTION GIBBIONS S; HARRISON T, 1996, B INDOPACIFIC PREHIS, V14, P90, DOI DOI 10.7152/BIPPA.V14I0.11592; HARRISON T, 1998, B INDOPACIFIC PREHIS, V17, P85, DOI DOI 10.7152/BIPPA.V17I0.11670; Harrison T, 2014, QUATERN INT, V354, P59, DOI 10.1016/j.quaint.2014.01.013; Harrison T, 2006, DEV PRIMATOL, P331; HAYASHI S, 1995, J MOL EVOL, V41, P359, DOI 10.1007/BF01215183; Hooijer D. A., 1960, Zoologische Verhandelingen, VNo. 46, P1; Hooijer D. A., 1962, Sarawak Museum Journal, V10, P428; Hooijer D. A., 1961, Sarawak Museum Journal, V9, P408; Ingicco T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099531; Israfil H, 2011, MOL PHYLOGENET EVOL, V58, P447, DOI 10.1016/j.ympev.2010.11.005; Jablonski NG, 2000, J HUM EVOL, V39, P131, DOI 10.1006/jhev.2000.0405; Jablonski Nina G., 2009, P111, DOI 10.1007/978-0-387-88604-6_7; Ji WZ, 2004, INT J PRIMATOL, V25, P1077, DOI 10.1023/B:IJOP.0000043352.64428.8c; Kahlke HD, 1961, VERTEBRAT PALASIATIC, V6, P83; Marshall J., 1986, P137; Matsudaira K, 2010, MOL PHYLOGENET EVOL, V55, P454, DOI 10.1016/j.ympev.2010.01.032; Matthew WD, 1923, B AM MUS NAT HIST, V48, P563; Meyer TJ, 2012, MOL BIOL EVOL, V29, P3441, DOI 10.1093/molbev/mss149; Mittermeier R., 2013, HDB MAMMALS WORLD, V3; Mootnick A, 2005, INT J PRIMATOL, V26, P971, DOI 10.1007/s10764-005-5332-4; NISBETT RA, 1993, INT J PRIMATOL, V14, P765, DOI 10.1007/BF02192190; Pan Y., 2006, LUFENGPITHECUS HUDIE, p[131, 320]; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Pilbrow V, 2006, J HUM EVOL, V51, P646, DOI 10.1016/j.jhevol.2006.07.008; Pilbrow V, 2010, J HUM EVOL, V59, P16, DOI 10.1016/j.jhevol.2010.01.009; PILBROW VC, 2003, THESIS NEW YORK U; Porter CA, 1997, INT J PRIMATOL, V18, P261, DOI 10.1023/A:1026328804319; PROUTY LA, 1983, CYTOGENET CELL GENET, V35, P141, DOI 10.1159/000131856; PROUTY LA, 1983, AM J PRIMATOL, V5, P83, DOI 10.1002/ajp.1350050110; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; Quam R, 2009, J ANAT, V214, P655, DOI 10.1111/j.1469-7580.2009.01064.x; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; Roos C, 2001, MOL PHYLOGENET EVOL, V19, P486, DOI 10.1006/mpev.2001.0939; Schwartz Jeffrey H., 1994, Anthropological Papers of the American Museum of Natural History, V73, P1; Springer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049521; Storm Paul, 2006, Senckenbergiana Lethaea, V86, P271; Swindler D.R., 2002, PRIMATE DENTITION; Takai M, 2014, QUATERN INT, V354, P75, DOI 10.1016/j.quaint.2014.02.021; Teilhard de Chardin P., 1935, B GEOL SOC CHINA, V2, P179; Thinh VN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-74; Tougard C, 2001, PALAEOGEOGR PALAEOCL, V168, P337, DOI 10.1016/S0031-0182(00)00243-1; Uchida A., 1996, CAMBRIDGE PEABODY MU, V4; van Gulik R. H., 2015, GIBBON CHINA ESSAY C; WOOD BA, 1988, J ANAT, V161, P1; WOOD BA, 1983, J ANAT, V137, P287; WOOD BA, 1983, J ANAT, V136, P197; Wu X, 1995, HUMAN EVOLUTION CHIN, P241; Zeitoun V, 2010, QUATERN INT, V220, P160, DOI 10.1016/j.quaint.2009.11.022; Zhang YQ, 2014, QUATERN INT, V354, P35, DOI 10.1016/j.quaint.2013.12.008	83	8	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131206	10.1371/journal.pone.0131206	http://dx.doi.org/10.1371/journal.pone.0131206			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154175	Green Published, gold, Green Submitted			2022-12-27	WOS:000358159700058
J	Xiang, LB; Li, JJ; Yang, WT; Xu, XL; Wu, XH; Wang, HY; Li, ZT; Yang, HJ				Xiang, Libing; Li, Jiajia; Yang, Wentao; Xu, Xiaoli; Wu, Xiaohua; Wang, Huaying; Li, Ziting; Yang, Huijuan			Conization Using an Electrosurgical Knife for Cervical Intraepithelial Neoplasia and Microinvasive Carcinoma	PLOS ONE			English	Article							LARGE-LOOP EXCISION; TERM-FOLLOW-UP; COLD-KNIFE; TRANSFORMATION ZONE; RESIDUAL DISEASE; RISK-FACTORS; RECURRENCE; MANAGEMENT; SPECIMENS; BIOPSY	Objective The aim of the present study was to evaluate the incidences of margin involvement, disease relapse, and complications in patients who had undergone conization using an electrosurgical knife (EKC) for cervical intraepithelial neoplasia (CIN) or microinvasive carcinomas (micro-CAs). Materials and Methods A retrospective case series analysis was performed with a total of 1359 patients who underwent EKC in Fudan University Shanghai Cancer Center between June 2004 and July 2010. Results The median age of the patients was 39 years old (range: 19-72). Conization revealed the presence of CIN in 1113 (81.9%) patients, micro-CA in 72 (5.3%) patients and invasive carcinomas in 44 (3.2%) patients. The remaining 130 (9.6%) patients were free of diseases in the cone specimens. Positive surgical margins, or endocervical curettages (ECCs) were found in 90 (7.6%) patients with CINs or micro-CAs. Three factors were associated with positive margins and ECCs and included age (>50 years; odds ratio (OR), 3.0, P<0.01), postmenopausal status (OR, 3.1, P<0.01) and microinvasive disease (OR, 2.7, P<0.01). One thousand and eighty-nine (92.0%) patients were followed-up regularly for a median follow-up duration of 46 months (range: 24-106 months). Disease relapse was documented in 50 (4.6%) patients. Eighty-two (6.0%) cases experienced surgical complications that needed to be addressed, including early or late hemorrhages, infections, cervical stenosis, etc. Conclusions Our patients demonstrated that EKC was an alternative technique for diagnosis and treatment of CIN or micro-CAs with relatively low rate of recurrence and acceptable rate of complications. A randomized clinical trial is warranted to compare EKC, CKC and LEEP in the management of CIN or micro-CA.	[Xiang, Libing; Li, Jiajia; Wu, Xiaohua; Wang, Huaying; Li, Ziting; Yang, Huijuan] Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Oncol,Dept Gynecol Oncol, Shanghai 200032, Peoples R China; [Yang, Wentao; Xu, Xiaoli] Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Oncol,Dept Pathol, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Yang, HJ (corresponding author), Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Oncol,Dept Gynecol Oncol, Shanghai 200032, Peoples R China.	huijuanyang@hotmail.com			Shanghai Municipal Health Bureau [2007140]	Shanghai Municipal Health Bureau	This study was supported by a grant from Shanghai Municipal Health Bureau (2007140, YHJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae HS, 2013, ACTA OBSTET GYN SCAN, V92, P185, DOI 10.1111/aogs.12025; Chen YX, 2009, INT J GYNECOL OBSTET, V107, P107, DOI 10.1016/j.ijgo.2009.05.027; Dane C, 2008, AUST NZ J OBSTET GYN, V48, P343, DOI 10.1111/j.1479-828X.2008.00853.x; Ghaem-Maghami S, 2011, BJOG-INT J OBSTET GY, V118, P679, DOI 10.1111/j.1471-0528.2010.02770.x; Ghaem-Maghami S, 2007, LANCET ONCOL, V8, P985, DOI 10.1016/S1470-2045(07)70283-8; Grimm C, 2013, ARCH GYNECOL OBSTET, V288, P1081, DOI 10.1007/s00404-013-2873-1; Katki HA, 2013, J LOW GENIT TRACT DI, V17, pS78, DOI 10.1097/LGT.0b013e31828543c5; Leguevaque P, 2010, EJSO-EUR J SURG ONC, V36, P1073, DOI 10.1016/j.ejso.2010.08.135; Malapati R, 2011, J LOW GENIT TRACT DI, V15, P177, DOI 10.1097/LGT.0b013e3181fee61d; Manchanda R, 2008, BJOG-INT J OBSTET GY, V115, P1238, DOI 10.1111/j.1471-0528.2008.01853.x; Mathevet P, 2003, EUR J OBSTET GYN R B, V106, P214, DOI 10.1016/S0301-2115(02)00245-2; Melnikow J, 2009, JNCI-J NATL CANCER I, V101, P721, DOI 10.1093/jnci/djp089; Miroshnichenko GG, 2009, J LOW GENIT TRACT DI, V13, P10, DOI 10.1097/LGT.0b013e31817ff940; Nasu K, 2010, ARCH GYNECOL OBSTET, V281, P887, DOI 10.1007/s00404-009-1205-y; Panna S, 2009, ASIAN PAC J CANCER P, V10, P637; PAPAKONSTANTINO.K, 2014, AM J OBSTET GYNECOL, V211, P621; Papoutsis D, 2013, GYNECOL OBSTET INVES, V75, P163, DOI 10.1159/000345864; Papoutsis D, 2011, IN VIVO, V25, P691; Park JY, 2009, OBSTET GYNECOL, V114, P87, DOI 10.1097/AOG.0b013e3181ab6dca; Serati M, 2012, EUR J OBSTET GYN R B, V165, P86, DOI 10.1016/j.ejogrb.2012.06.026; Shi JF, 2012, INT J CANCER, V130, P641, DOI 10.1002/ijc.26042; Shin JW, 2009, J OBSTET GYNAECOL RE, V35, P126, DOI 10.1111/j.1447-0756.2008.00834.x; Socolov D, 2009, CHIRURGIA-BUCHAREST, V104, P295; Monteiro ACS, 2008, SAO PAULO MED J, V126, P209, DOI 10.1590/S1516-31802008000400002; van Hamont D, 2006, INT J GYNECOL CANCER, V16, P615, DOI 10.1111/j.1525-1438.2006.00404.x; [向礼兵 Xiang Libing], 2013, [中国癌症杂志, China Oncology], V23, P370; Yang H, 2006, CHINA ONCOLOGY, V16, P922; Zeng SY, 2012, EUR J GYNAECOL ONCOL, V33, P257	28	15	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131790	10.1371/journal.pone.0131790	http://dx.doi.org/10.1371/journal.pone.0131790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26153692	Green Published, Green Submitted, gold			2022-12-27	WOS:000358159700079
J	Audet, CM; Gutin, SA; Blevins, M; Chiau, E; Alvim, F; Jose, E; Vaz, LME; Shepherd, BE; Rose, CD				Audet, Carolyn M.; Gutin, Sarah A.; Blevins, Meridith; Chiau, Elvino; Alvim, Fernanda; Jose, Eurico; Vaz, Lara M. E.; Shepherd, Bryan E.; Rose, Carol Dawson			The Impact of Visual Aids and Enhanced Training on the Delivery of Positive Health, Dignity, and Prevention Messages to Adult Patients Living with HIV in Rural North Central Mozambique	PLOS ONE			English	Article							RISK-REDUCTION INTERVENTION; UNPROTECTED SEXUAL-BEHAVIOR; ANTIRETROVIRAL THERAPY; CLINICAL CARE; DEVELOPING-COUNTRIES; INFECTED PATIENTS; YOUNG-PEOPLE; SOUTH-AFRICA; CONDOM USE; PROVIDERS	Introduction Positive health, dignity, and prevention (PHDP) interventions target people living with HIV and AIDS (PLHIV) to promote well-being and prevent onward transmission. Concern that increased life expectancy and improved well-being would lead to increased risky sexual behaviour and subsequent HIV transmission motivated researchers to test novel strategies to support treatment adherence, encourage safer sex, STI treatment and partner testing, prevention of mother to child transmission, and support uptake of family planning. Methods We assessed the number and type of PHDP messages delivered to PLHIV before and after the implementation of an educational intervention for health providers combined with the distribution of visual job aids and monthly technical assistance. Results From April 21, 2013 to March 20, 2014, we documented 54,731 clinical encounters at three rural health centres in Zambezia province, Mozambique from 9,248 unique patients. The percentage of patients who received all seven PHDP messages during their last three visits was 1.9% pre-intervention vs. 13.6% post-intervention (p=<0.001). Younger patients (25 years vs. 35) and those with a recent HIV diagnosis (two weeks vs. two years) had higher odds of receiving any PHDP message (Odds Ratio [OR]: 1.22 and 2.79, respectively). Patients >59 days late collecting medications were not more likely to receive adherence messages than adherent patients (p=0.17). Discussion Targeting HIV prevention efforts to PLHIV is an effective HIV prevention approach to eliminate HIV transmission. Despite intensive training and support, PHDP message delivery remained unacceptably low in rural Mozambique. Patients at high risk for treatment abandonment were not more likely to be counselled about adherence and support measures, something that needs to be addressed. Conclusions We need to develop novel strategies to motivate health care providers to deliver these messages more consistently to all patients and develop a system that assists counsellors and clinicians to quickly and effectively determine which messages should be delivered.	[Audet, Carolyn M.; Blevins, Meridith; Vaz, Lara M. E.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Audet, Carolyn M.] Vanderbilt Univ, Sch Med, Dept Hlth Policy, Nashville, TN 37212 USA; [Blevins, Meridith; Shepherd, Bryan E.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Gutin, Sarah A.] Univ Calif San Francisco, Sch Nursing, Community Hlth Syst, San Francisco, CA 94143 USA; [Chiau, Elvino; Alvim, Fernanda; Jose, Eurico; Rose, Carol Dawson] Friends Global Hlth, Maputo, Mozambique; [Chiau, Elvino; Alvim, Fernanda; Jose, Eurico; Rose, Carol Dawson] Friends Global Hlth, Quelimane, Mozambique; [Audet, Carolyn M.; Blevins, Meridith; Vaz, Lara M. E.] Vanderbilt Univ, Vanderbilt Inst Global Hlth, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of California System; University of California San Francisco; Vanderbilt University	Audet, CM (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.	carolyn.m.audet@vanderbilt.edu		Gutin, Sarah/0000-0002-7634-1296	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Department of Health and Human Services; Centers for Disease Control and Prevention (CDC) [1U2GPS002770-01, 5U2GPS002770-02, 5U2GPS002770-03, 5U2GPS002770-04]; Vanderbilt career development award [UL1TR000445]; NIMH [1K01MH107255-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH107255] Funding Source: NIH RePORTER	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Department of Health and Human Services; Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Vanderbilt career development award; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Department of Health and Human Services and the Centers for Disease Control and Prevention (CDC) under the terms of Cooperative Agreement Numbers 1U2GPS002770-01, 5U2GPS002770-02, 5U2GPS002770-03 and 5U2GPS002770-04. The findings and conclusions presented in this manuscript are those of the authors and do not necessarily represent the official position of the CDC. CMA was supported, in part, by a Vanderbilt career development award, UL1TR000445 (PI Bernard) and NIMH No. 1K01MH107255-01.	Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; ALLEN S, 1993, AM J PUBLIC HEALTH, V83, P705, DOI 10.2105/AJPH.83.5.705; [Anonymous], 2012, DAT SIZ HIV AIDS EP; Auerbach JD, 2004, JAIDS-J ACQ IMM DEF, V37, pS122, DOI 10.1097/01.qai.0000140611.82134.aa; Bachanas P, 2012, HIV PREVENTION PEOPL; Bachanas P, 2013, AIDS PATIENT CARE ST, V27, P425, DOI 10.1089/apc.2012.0388; Bateganya M, 2005, AIDS PATIENT CARE ST, V19, P760, DOI 10.1089/apc.2005.19.760; Bunnell R, 2006, JAMA-J AM MED ASSOC, V296, P855, DOI 10.1001/jama.296.7.855; Cocohoba J, 2013, J MANAGE CARE PHARM, V19, P454, DOI 10.18553/jmcp.2013.19.6.454; Conselho Nacional de Combate ao HIV e SIDA, 2010, NAT STRAT HIV AIDS R; Cornman DH, 2008, JAIDS-J ACQ IMM DEF, V48, P553, DOI 10.1097/QAI.0b013e31817bebd7; Cornman DH, 2011, PSYCHOL HEALTH, V26, P1623, DOI 10.1080/08870446.2011.552180; da Silveira MF, 2006, J EVAL CLIN PRACT, V12, P102, DOI 10.1111/j.1365-2753.2005.00626.x; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Fisher JD, 2006, JAIDS-J ACQ IMM DEF, V41, P44, DOI 10.1097/01.qai.0000192000.15777.5c; Fisher JD, 2004, JAIDS-J ACQ IMM DEF, V37, pS78, DOI 10.1097/01.qai.0000140605.51640.5c; Fisher JD, 2014, JAIDS-J ACQ IMM DEF, V67, P499, DOI 10.1097/QAI.0000000000000348; Fisher JD, 2009, CURR OPIN HIV AIDS, V4, P279, DOI 10.1097/COH.0b013e32832c7ce5; Flickinger TE, 2013, AIDS PATIENT CARE ST, V27, P416, DOI 10.1089/apc.2012.0426; Flickinger TE, 2013, JAIDS-J ACQ IMM DEF, V63, P362, DOI 10.1097/QAI.0b013e318295b86a; Global Network of People Living with HIV UNAIDS, 2011, POS HLTH DIGN PREV P; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grimley DM, 2007, AIDS BEHAV, V11, pS39, DOI 10.1007/s10461-006-9196-1; Gutin SA, 2014, EVAL PROGRAM PLANN, V43, P38, DOI 10.1016/j.evalprogplan.2013.10.006; Hagopian A, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-3; Harrell FEJr, 2001, REGRESSION MODELING, DOI DOI 10.1007/978-1-4757-3462-1; Hilliard S, 2014, INT J WOMENS HEALTH, V6, P1057, DOI 10.2147/IJWH.S67038; Hirschhorn Lisa R, 2006, Hum Resour Health, V4, P1, DOI 10.1186/1478-4491-4-1; Janssen RS, 2001, AM J PUBLIC HEALTH, V91, P1019, DOI 10.2105/AJPH.91.7.1019; Kalichman SC, 2001, AM J PREV MED, V21, P84, DOI 10.1016/S0749-3797(01)00324-5; Kalichman SC, 2005, POSITIVE PREVENTION, pxxii; Kembabazi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069634; Kennedy C, 2007, AIDS CARE, V19, P707, DOI 10.1080/09540120701203261; Kennedy CE, 2010, B WORLD HEALTH ORGAN, V88, P615, DOI 10.2471/BLT.09.068213; KING R, 1995, AIDS, V9, pS45; Mhalu A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17342; Miranda J, 2013, JMIR RES PROTOC, V2, DOI 10.2196/resprot.2723; Mmbaga EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041700; Morin SF, 2004, JAIDS-J ACQ IMM DEF, V36, P960, DOI 10.1097/00126334-200408010-00010; Myers JJ, 2010, AIDS BEHAV, V14, P483, DOI 10.1007/s10461-010-9679-y; National Institute of Statistics Mozambique, 2010, AD LIT RAT; Parker L, 2013, AIDS EDUC PREV, V25, P135, DOI 10.1521/aeap.2013.25.2.135; Parker L, 2013, EVAL PROGRAM PLANN, V36, P124, DOI 10.1016/j.evalprogplan.2012.09.002; Penn C, 2011, PATIENT EDUC COUNS, V83, P310, DOI 10.1016/j.pec.2011.02.018; Pettifor A, 2011, AIDS BEHAV, V15, P1243, DOI 10.1007/s10461-010-9839-0; PICKERING H, 1993, AIDS, V7, P271, DOI 10.1097/00002030-199302000-00017; Richardson JL, 2004, AIDS, V18, P1179, DOI 10.1097/00002030-200405210-00011; Rose CD, 2011, J ASSOC NURSE AIDS C, V22, P38, DOI 10.1016/j.jana.2010.04.001; Rose CD, 2010, JAIDS-J ACQ IMM DEF, V55, P572, DOI 10.1097/QAI.0b013e3181ee4c62; Roth DL, 2001, INT J STD AIDS, V12, P181, DOI 10.1258/0956462011916992; Rotheram-Borus MJ, 2004, JAIDS-J ACQ IMM DEF, V37, pS68, DOI 10.1097/01.qai.0000140604.57478.67; ROTHERAMBORUS MJ, 1997, AIDS BEHAV, V1, P43, DOI DOI 10.1023/A:1026213905034; Saberi P, 2012, PATIENT PREFER ADHER, V6, P297, DOI 10.2147/PPA.S30244; Safren SA, 2011, AIDS BEHAV, V15, P949, DOI 10.1007/s10461-010-9807-8; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Sikkema KJ, 2011, J COMMUNITY PSYCHOL, V39, P717, DOI 10.1002/jcop.20463; Sikkema KJ, 2010, AIDS BEHAV, V14, P252, DOI 10.1007/s10461-009-9650-y; University of California San Francisco, 2012, POS PREV TOOLK SAN F; Venkatesh KK, 2011, AIDS, V25, P1939, DOI 10.1097/QAD.0b013e32834b4ced; Vergara AE, 2011, BASELINE SURVEY REPO; Walensky RP, 2008, J INFECT DIS, V197, P1324, DOI 10.1086/587184; Wamoyi J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-633; World Health Organization, 2013, WHO CONS GUID USE AR; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019	65	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130676	10.1371/journal.pone.0130676	http://dx.doi.org/10.1371/journal.pone.0130676			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26147115	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600043
J	Dong, Z; Zhao, DB; Yang, CD; Zhou, JR; Qian, QX; Ma, YY; He, HJ; Ji, HD; Yang, YJ; Wang, XF; Xu, X; Pang, YF; Zou, HJ; Jin, L; Wang, JC				Dong, Zheng; Zhao, Dongbao; Yang, Chengde; Zhou, Jingru; Qian, Qiaoxia; Ma, Yanyun; He, Hongjun; Ji, Hengdong; Yang, Yajun; Wang, Xiaofeng; Xu, Xia; Pang, Yafei; Zou, Hejian; Jin, Li; Wang, Jiucun			Common Variants in LRP2 and COMT Genes Affect the Susceptibility of Gout in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; EXCRETION	Gout is a common inflammation disease resulting from an increase in serum uric acid. Nearly 70% of uric acid is excreted via the kidneys. To date, evidence for an association between genetic loci and gout is absent, equivocal or not replicated. Our study aims to test variants in two genes abundantly expressed in the kidney, LRP2 and COMT, for their association with uric acid and gout. In total, 1318 Chinese individuals were genotyped for rs2544390 in LRP2 and rs4680 in COMT. These LRP2 and COMT gene polymorphisms showed no significant effect on uric acid (P = 0.204 and 0.188, separately); however, rs2544390 in LRP2 did influence uric acid levels in individuals with BMI >= 25 (P = 0.009). In addition, the allele frequency distributions of the two loci showed a significant difference between gout patients and healthy controls. A missense variation in rs4680 (G > A) decreased the risk of gout (OR = 0.77, P = 0.015), whereas the T allele of rs2544390 was associated with gout pathogenesis risk (OR = 1.26, P = 0.020). The present study provides the first evidence for an association between COMT and gout. Rs2544390 in LRP2 only influenced uric acid levels in individuals with BMI >= 25, which might explain the discrepant results among previous studies. In addition, we are the first to identify the association between LRP2 and gout in a Chinese population and to confirm this association in Asians.	[Dong, Zheng; Zhou, Jingru; Qian, Qiaoxia; Ma, Yanyun; Yang, Yajun; Wang, Xiaofeng; Jin, Li; Wang, Jiucun] Fudan Univ, Sch Life Sci, Minist Educ, Collaborat Innovat Ctr Genet & Dev,Key Lab Contem, Shanghai 200433, Peoples R China; [Zhao, Dongbao; Xu, Xia; Pang, Yafei] Changhai Hosp, Div Rheumatol & Immunol, Shanghai, Peoples R China; [Yang, Chengde] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Div Rheumatol, Shanghai 200030, Peoples R China; [He, Hongjun; Wang, Jiucun] Taixing Peoples Hosp, Div Rheumatol, Taizhou, Jiangsu, Peoples R China; [Ji, Hengdong] Taizhou Peoples Hosp, Div Rheumatol, Taizhou, Jiangsu, Peoples R China; [Yang, Yajun; Wang, Xiaofeng; Jin, Li] Fudan Taizhou Inst Hlth Sci, Taizhou, Jiangsu, Peoples R China; [Zou, Hejian] Fudan Univ, Huashan Hosp, Div Rheumatol, Shanghai 200433, Peoples R China; [Zou, Hejian; Wang, Jiucun] Fudan Univ, Inst Rheumatol Immunol & Allergy, Shanghai 200433, Peoples R China	Fudan University; Naval Medical University; Shanghai Jiao Tong University; Fudan University; Fudan University	Wang, JC (corresponding author), Fudan Univ, Sch Life Sci, Minist Educ, Collaborat Innovat Ctr Genet & Dev,Key Lab Contem, Shanghai 200433, Peoples R China.	jcwang@fudan.edu.cn	Jin, Li/M-5063-2019; Jin, Li/C-1468-2009; Wang, Jiucun/J-8744-2012; MA, YAN/HHN-2912-2022	Jin, Li/0000-0002-4546-2415; Wang, Jiucun/0000-0003-2765-0620; 	Science and Technology Committee of Shanghai Municipality [11DJ1400100]; International S&T Cooperation Program of China [2013DFA30870]; Ministry of Science and Technology [2011BAI09B00]; Program for 2012 Outstanding Medical Academic Leader for Hejian Zou; Fudan University High-End Computing Center	Science and Technology Committee of Shanghai Municipality(Shanghai Science & Technology Committee); International S&T Cooperation Program of China; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Program for 2012 Outstanding Medical Academic Leader for Hejian Zou; Fudan University High-End Computing Center	This research was supported by grants from the Science and Technology Committee of Shanghai Municipality (11DJ1400100), International S&T Cooperation Program of China (2013DFA30870), Ministry of Science and Technology (2011BAI09B00), and Program for 2012 Outstanding Medical Academic Leader for Hejian Zou. The computations involved in this study were supported by Fudan University High-End Computing Center.	[Anonymous], 2006, PUBLIC HEALTH NUTR, V9, P658, DOI 10.1079/PHN2006967; Eklof AC, 1997, KIDNEY INT, V52, P742, DOI 10.1038/ki.1997.390; Hamajima N, 2012, GENE, V503, P131, DOI 10.1016/j.gene.2012.04.064; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Kornek M, 2013, DIS MARKERS, V2013, P129, DOI 10.1155/2013/279046; Mandell Brian F, 2008, Cleve Clin J Med, V75 Suppl 5, pS5; Marzolo MP, 2011, BIOL RES, V44, P89, DOI 10.4067/S0716-97602011000100012; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; Nakayama A, 2014, RHEUMATOL INT, V34, P473, DOI 10.1007/s00296-013-2924-8; Pascual E, 2006, ANN RHEUM DIS, V65, P981, DOI 10.1136/ard.2005.049023; Pestana M, 2001, NEPHROL DIAL TRANSPL, V16, P53, DOI 10.1093/ndt/16.suppl_1.53; Phipps-Green AJ, 2016, ANN RHEUM DIS, V75, P124, DOI 10.1136/annrheumdis-2014-205877; Rasheed H, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4366; SCANLON PD, 1979, SCIENCE, V203, P63, DOI 10.1126/science.758679; Sulikowska B, 2008, AM J NEPHROL, V28, P391, DOI 10.1159/000112271; Tu HP, 2010, HUM GENET, V127, P223, DOI 10.1007/s00439-009-0765-z; Urano W, 2013, J RHEUMATOL, V40, P1374, DOI 10.3899/jrheum.121244; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; Wang XF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-223; Yang BY, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-10; Zeng CY, 2007, CLIN SCI, V112, P583, DOI 10.1042/CS20070018	23	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131302	10.1371/journal.pone.0131302	http://dx.doi.org/10.1371/journal.pone.0131302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147675	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600086
J	Dubovskaya, OP; Tang, KW; Gladyshev, MI; Kirillin, G; Buseva, Z; Kasprzak, P; Tolomeev, AP; Grossart, HP				Dubovskaya, Olga P.; Tang, Kam W.; Gladyshev, Michail I.; Kirillin, Georgiy; Buseva, Zhanna; Kasprzak, Peter; Tolomeev, Aleksandr P.; Grossart, Hans-Peter			Estimating In Situ Zooplankton Non-Predation Mortality in an Oligo-Mesotrophic Lake from Sediment Trap Data: Caveats and Reality Check	PLOS ONE			English	Article							FRESH-WATER; NONCONSUMPTIVE MORTALITY; NONPREDATORY MORTALITY; CRUSTACEAN ZOOPLANKTON; SEASONAL DYNAMICS; COPEPOD CARCASSES; SINKING SPEED; ANILINE BLUE; DEAD; DAPHNIA	Background Mortality is a main driver in zooplankton population biology but it is poorly constrained in models that describe zooplankton population dynamics, food web interactions and nutrient dynamics. Mortality due to non-predation factors is often ignored even though anecdotal evidence of non-predation mass mortality of zooplankton has been reported repeatedly. One way to estimate non-predation mortality rate is to measure the removal rate of carcasses, for which sinking is the primary removal mechanism especially in quiescent shallow water bodies. Objectives and Results We used sediment traps to quantify in situ carcass sinking velocity and non-predation mortality rate on eight consecutive days in 2013 for the cladoceran Bosmina longirostris in the oligo-mesotrophic Lake Stechlin; the outcomes were compared against estimates derived from in vitro carcass sinking velocity measurements and an empirical model correcting in vitro sinking velocity for turbulence resuspension and microbial decomposition of carcasses. Our results show that the latter two approaches produced unrealistically high mortality rates of 0.58-1.04 d(-1), whereas the sediment trap approach, when used properly, yielded a mortality rate estimate of 0.015 d(-1), which is more consistent with concurrent population abundance data and comparable to physiological death rate from the literature. Ecological implications Zooplankton carcasses may be exposed to water column microbes for days before entering the benthos; therefore, non-predation mortality affects not only zooplankton population dynamics but also microbial and benthic food webs. This would be particularly important for carbon and nitrogen cycles in systems where recurring mid-summer decline of zooplankton population due to non-predation mortality is observed.	[Dubovskaya, Olga P.; Gladyshev, Michail I.; Tolomeev, Aleksandr P.] Russian Acad Sci, Siberian Branch, Inst Biophys, Krasnoyarsk 660036, Russia; [Dubovskaya, Olga P.; Gladyshev, Michail I.] Siberian Fed Univ, Krasnoyarsk 660041, Russia; [Tang, Kam W.] Swansea Univ, Dept Biosci, Swansea SA2 8PP, W Glam, Wales; [Tang, Kam W.] Swansea Univ, Ctr Sustainable Aquat Res, Swansea SA2 8PP, W Glam, Wales; [Kirillin, Georgiy] MU, Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecohydrol, D-12587 Berlin, Germany; [Buseva, Zhanna] Natl Acad Sci Belarus Bioresources, Sci & Pract Ctr, Minsk 220072, BELARUS; [Kasprzak, Peter; Grossart, Hans-Peter] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Expt Limnol, D-16775 Neuglobsow, Germany; [Grossart, Hans-Peter] Univ Potsdam, Inst Biochem & Biol, D-14469 Potsdam, Germany	Russian Academy of Sciences; Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences; Biophysics Institute, Siberian Branch, Russian Academy of Sciences; Siberian Federal University; Swansea University; Swansea University; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); National Academy of Sciences of Belarus (NASB); Scientific & Practical Center for Bioresources of the National Academy of Sciences of Belarus; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Potsdam	Tang, KW (corresponding author), Swansea Univ, Dept Biosci, Swansea SA2 8PP, W Glam, Wales.	k.w.tang@swansea.ac.uk	Dubovskaya, Olga/S-2163-2016; Kirillin, Georgiy/B-5410-2010; Tolomeev, Aleksandr/I-9601-2018	Kirillin, Georgiy/0000-0001-7337-3586; Buseva, Zhanna/0000-0001-8663-6808; Tolomeev, Aleksandr/0000-0002-9124-4566	Russian Foundation for Basic Research; Belarusian Republican Foundation for Fundamental Research [14-05-90005-Bel-a, B14R-066]; Humboldt Fellowship for Experienced Researchers (Germany); Russian Federal Tasks of Fundamental Research [51.1.1]; German Science Foundation [GR 1540/20-1, KI-853/8-1]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Belarusian Republican Foundation for Fundamental Research; Humboldt Fellowship for Experienced Researchers (Germany); Russian Federal Tasks of Fundamental Research; German Science Foundation(German Research Foundation (DFG))	This work was supported by joint projects of Russian Foundation for Basic Research and Belarusian Republican Foundation for Fundamental Research (No 14-05-90005-Bel-a to O.P.D and A.P.T., and No B14R-066 to Zh.B.). K.W.T. was supported by a Humboldt Fellowship for Experienced Researchers (Germany), M.I.G. was supported by Russian Federal Tasks of Fundamental Research (project No. 51.1.1), H.P.G. and G.K. were supported by grants from the German Science Foundation (GR 1540/20-1 and KI-853/8-1).	Aksnes DL, 1997, SARSIA, V82, P279, DOI 10.1080/00364827.1997.10413657; ALLDREDGE AL, 1988, LIMNOL OCEANOGR, V33, P339, DOI 10.4319/lo.1988.33.3.0339; ASPER VL, 1987, DEEP-SEA RES, V34, P1, DOI 10.1016/0198-0149(87)90117-8; Balushkina E.V., 1979, GEN BACKGROUNDS STUD, P169; Baumann HI, 2008, LIMNOLOGICA, V38, P350, DOI 10.1016/j.limno.2008.05.010; Bickel SL, 2009, FRESHWATER BIOL, V54, P971, DOI 10.1111/j.1365-2427.2008.02141.x; BLOESCH J, 1980, SCHWEIZ Z HYDROL, V42, P15, DOI 10.1007/BF02502505; Buesseler KO, 2007, J MAR RES, V65, P345, DOI 10.1357/002224007781567621; CADEE GC, 1992, POLAR BIOL, V12, P75; Casper S. J., 1985, LAKE STECHLIN TEMPER; Cerbin S, 2003, HYDROBIOLOGIA, V491, P111, DOI 10.1023/A:1024491011742; DEARDORFF JW, 1970, J ATMOS SCI, V27, P1211, DOI 10.1175/1520-0469(1970)027<1211:CVATSF>2.0.CO;2; Dubovskaya OP, 2009, ZH OBSHCH BIOL, V70, P168; Dubovskaya Olga P., 2008, Journal of Siberian Federal University Biology, V1, P145; Dubovskaya OP, 2003, HYDROBIOLOGIA, V504, P223, DOI 10.1023/B:HYDR.0000008522.88010.45; Dubovskaya OP, 1999, ZH OBSHCH BIOL, V60, P543; Dubovskaya OP, 2006, THESIS ZOOL I RUSSIA; Elliott DT, 2011, MAR ECOL PROG SER, V427, P1, DOI 10.3354/meps09063; Elliott DT, 2010, LIMNOL OCEANOGR, V55, P1821, DOI 10.4319/lo.2010.55.5.1821; Ferguson RI, 2004, J SEDIMENT RES, V74, P933, DOI 10.1306/051204740933; Frangoulis C, 2011, ESTUAR COAST SHELF S, V92, P456, DOI 10.1016/j.ecss.2011.02.005; GARDNER WD, 1985, DEEP-SEA RES, V32, P349, DOI 10.1016/0198-0149(85)90083-4; GLADYSHEV M I, 1985, Gidrobiologicheskii Zhurnal, V21, P65; Gladyshev MI, 1996, DOKL AKAD NAUK+, V348, P127; Gladyshev MI, 2003, J PLANKTON RES, V25, P999, DOI 10.1093/plankt/25.8.999; Gries T, 1999, LIMNOL OCEANOGR, V44, P459, DOI 10.4319/lo.1999.44.2.0459; GROSSART HP, 1993, LIMNOL OCEANOGR, V38, P532, DOI 10.4319/lo.1993.38.3.0532; Guenet B, 2010, ECOLOGY, V91, P2850, DOI 10.1890/09-1968.1; HAKANSON L, 1984, SCHWEIZ Z HYDROL, V46, P171; HAKANSON L, 1989, HYDROBIOLOGIA, V176, P481, DOI 10.1007/BF00026583; Hansen PJ, 1997, LIMNOL OCEANOGR, V42, P687, DOI 10.4319/lo.1997.42.4.0687; Hirst AG, 2002, MAR ECOL PROG SER, V230, P195, DOI 10.3354/meps230195; Hulsmann S, 2002, FRESHWATER BIOL, V47, P2313, DOI 10.1046/j.1365-2427.2002.00991.x; HUNTER JR, 1993, J COMPUT PHYS, V106, P366; Ivanova M.B., 1985, NAUKA, V220; Ivory JA, 2014, MAR ECOL PROG SER, V505, P107, DOI 10.3354/meps10775; Kiorboe T, 1998, HYDROBIOLOGIA, V363, P13, DOI 10.1023/A:1003173721751; Kirillin G, 2012, LIMNOL OCEANOGR, V57, P881, DOI 10.4319/lo.2012.57.3.0881; Koschel R, 2003, ADV LIMNOL, V58, P1; KRYLOV PI, 1988, ARCH HYDROBIOL, V113, P231; LAU YL, 1979, J FISH RES BOARD CAN, V36, P1288, DOI 10.1139/f79-184; Lebrato M, 2013, LIMNOL OCEANOGR, V58, P1113, DOI 10.4319/lo.2013.58.3.1113; McDonnell AMP, 2010, LIMNOL OCEANOGR, V55, P2085, DOI 10.4319/lo.2010.55.5.2085; MCQUEEN DJ, 1986, CAN J FISH AQUAT SCI, V43, P1571, DOI 10.1139/f86-195; Parsons T.R., 1988, BIOL OCEANOGRAPHIC P; PINELALLOUL B, 1995, HYDROBIOLOGIA, V300, P17; Prandke H, 1998, AQUAT SCI, V60, P191, DOI 10.1007/s000270050036; Sampei M, 2009, LIMNOL OCEANOGR, V54, P1894, DOI 10.4319/lo.2009.54.6.1894; Schulz M, 2003, ADV LIMNOL, V58, P215; SEEPERSAD B, 1978, J FISH RES BOARD CAN, V35, P1363, DOI 10.1139/f78-213; Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175; STAKER R D, 1974, Journal of the Arizona Academy of Science, V9, P85, DOI 10.2307/40023604; Stepanov VN, 1981, RES HYDROMECHANICAL; Tang K.W., 2013, COPEPODS DIVERSITY H, P255; Tang KW, 2006, ESTUAR COAST SHELF S, V68, P499, DOI 10.1016/j.ecss.2006.02.021; Tang KW, 2014, J PLANKTON RES, V36, P597, DOI 10.1093/plankt/fbu014; Tang KW, 2009, AQUAT MICROB ECOL, V57, P89, DOI 10.3354/ame01331; WETZEL RG, 1992, HYDROBIOLOGIA, V229, P181, DOI 10.1007/BF00007000; Zadereev ES, 2010, AQUAT ECOL, V44, P531, DOI 10.1007/s10452-010-9329-5; Zelezinskaya LM, 1966, THESIS IBSS UAS ODES	60	12	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131431	10.1371/journal.pone.0131431	http://dx.doi.org/10.1371/journal.pone.0131431			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146995	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600096
J	Gou, XL; Tan, B; Wu, FZ; Yang, WQ; Xu, ZF; Li, ZP; Zhang, XT				Gou, Xiaolin; Tan, Bo; Wu, Fuzhong; Yang, Wanqin; Xu, Zhengfeng; Li, Zhiping; Zhang, Xitao			Seasonal Dynamics of Soil Microbial Biomass C and N along an Elevational Gradient on the Eastern Tibetan Plateau, China	PLOS ONE			English	Article							LATE WINTER; SNOW COVER; TEMPERATURE; COMMUNITY; NITROGEN; DECLINE; MEADOW; WET	Little information is available on the seasonal response of soil microbial biomass to climate warming even though it is very sensitive to climate change. A two-year field experiment was conducted in the subalpine and alpine forests of the eastern Tibetan Plateau, China. The intact soil cores from 3,600 m site were incubated in three elevations (3,000 m, 3,300 m and 3,600 m) to simulate climate warming. Soil microbial biomass carbon (MBC) and nitrogen (MBN) were measured at different periods (early growing season [EG], late growing season [LG], onset of soil freezing period [OF], deep soil frozen period [DF] and soil thawing period [ET]) from May 2010 to August 2012. Average air temperature and soil temperature increased with the decrease of elevation during the experimental period. MBC and MBN showed a sharp decrease during the OF and ET in both organic layer and mineral layer at the three sites. Additionally, a relatively high MBC was observed during the DF. MBC and MBN in the soil organic layer decreased with the decrease of elevation but the opposite was true in the mineral soil layer. Warming had stronger effects on soil microbial biomass in the organic layer than in the mineral soil layer. The results indicated that future warming would alter soil microbial biomass and biogeochemical cycling in the forest ecosystems on the eastern Tibetan Plateau.	[Gou, Xiaolin; Tan, Bo; Wu, Fuzhong; Yang, Wanqin; Xu, Zhengfeng; Li, Zhiping; Zhang, Xitao] Sichuan Agr Univ, Key Lab Ecol Forestry Engn, Inst Ecol & Forestry, Chengdu 611130, Peoples R China	Sichuan Agricultural University	Yang, WQ (corresponding author), Sichuan Agr Univ, Key Lab Ecol Forestry Engn, Inst Ecol & Forestry, 211 Huimin Rd, Chengdu 611130, Peoples R China.	scyangwq@163.com			National Natural Science Foundation of China [31170423, 31270498, 31200474]; National Key Technologies RD Program [2011BAC09B05]; Program of Sichuan Youth Sci-tech Foundation [2012JQ0008, 2012JQ0059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies RD Program(National Key Technology R&D Program); Program of Sichuan Youth Sci-tech Foundation	The project was financially supported by the National Natural Science Foundation of China (No. 31170423; No. 31270498; No. 31200474), http://www.nsfc.gov.cn/Portal0/default166.htm; National Key Technologies R&D Program (No. 2011BAC09B05), http://www.most.gov.cn; and Program of Sichuan Youth Sci-tech Foundation (No. 2012JQ0008; No.2012JQ0059), http://xmgl.scst.gov.cn/.	Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P2898, DOI 10.1111/j.1365-2486.2008.01716.x; Beniston M., 2003, CLIMATIC CHANGE MOUN; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; CABRERA ML, 1993, SOIL SCI SOC AM J, V57, P1007, DOI 10.2136/sssaj1993.03615995005700040021x; Edwards KA, 2006, SOIL BIOL BIOCHEM, V38, P2843, DOI 10.1016/j.soilbio.2006.04.042; Edwards KA, 2013, SOIL BIOL BIOCHEM, V57, P83, DOI 10.1016/j.soilbio.2012.07.018; GOODRICH LE, 1982, CAN GEOTECH J, V19, P421, DOI 10.1139/t82-047; Groffman PM, 2001, BIOGEOCHEMISTRY, V56, P135, DOI 10.1023/A:1013039830323; Hentschel K, 2008, J PLANT NUTR SOIL SC, V171, P699, DOI 10.1002/jpln.200700154; IPCC, 2007, CLIM CHANG 2007 PHYS; IUSS Working Group WRB, 2006, WORLD SOIL RES REP; Jefferies RL, 2010, SOIL BIOL BIOCHEM, V42, P129, DOI 10.1016/j.soilbio.2009.10.008; Kaarlejarvi E, 2012, ECOSYSTEMS, V15, P1219, DOI 10.1007/s10021-012-9580-9; KOCH O, 2007, GLOBAL BIOGEOCHEMICA, V21, P497; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Lipson DA, 2002, MICROB ECOL, V43, P307, DOI 10.1007/s00248-001-1057-x; Lipson DA, 2000, SOIL BIOL BIOCHEM, V32, P441, DOI 10.1016/S0038-0717(99)00068-1; Schindlbacher A, 2011, SOIL BIOL BIOCHEM, V43, P1417, DOI 10.1016/j.soilbio.2011.03.005; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Tan B, 2011, ACTA AGR SCAND B-S P, V61, P670, DOI 10.1080/09064710.2010.541489; Templer PH, 2012, PLANT SOIL, V353, P15, DOI 10.1007/s11104-011-1064-8; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wu FZ, 2011, AFR J MICROBIOL RES, V5, P5575, DOI 10.5897/AJMR11.288; Wu FZ, 2010, ACTA OECOL, V36, P135, DOI 10.1016/j.actao.2009.11.002; Xu ZF, 2010, PLANT SOIL, V336, P183, DOI 10.1007/s11104-010-0461-8; Yergeau E, 2012, ISME J, V6, P692, DOI 10.1038/ismej.2011.124; Yu XF, 2011, PEDOSPHERE, V21, P251, DOI 10.1016/S1002-0160(11)60125-2; Zhang W, 2005, GLOBAL CHANGE BIOL, V11, P266, DOI 10.1111/j.1365-2486.2005.00902.x; Zhang Y, 2008, COLD REG SCI TECHNOL, V52, P355, DOI 10.1016/j.coldregions.2007.07.001; Zhu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062073; Zogg GP, 1997, SOIL SCI SOC AM J, V61, P475, DOI 10.2136/sssaj1997.03615995006100020015x	31	8	11	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132443	10.1371/journal.pone.0132443	http://dx.doi.org/10.1371/journal.pone.0132443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147974	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600270
J	Pomelova, VG; Korenberg, EI; Kuznetsova, TI; Bychenkova, TA; Bekman, NI; Osin, NS				Pomelova, Vera G.; Korenberg, Edward I.; Kuznetsova, Tatiana I.; Bychenkova, Tatiana A.; Bekman, Natalya I.; Osin, Nikolay S.			C6 Peptide-Based Multiplex Phosphorescence Analysis (PHOSPHAN) for Serologic Confirmation of Lyme Borreliosis	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; IMMUNODOMINANT CONSERVED REGION; IMMUNE-RESPONSES; VLSE LIPOPROTEIN; UNITED-STATES; BURGDORFERI; DIAGNOSIS; SERODIAGNOSIS; ANTIBODY; DISEASE	Background A single-tier immunoassay using the C6 peptide of VlsE (C6) from Borrelia burgdorferi sensu stricto (Bb) has been proposed as a potential alternative to conventional two-tier testing for the serologic diagnosis of Lyme disease in the United States and Europe. Objective To evaluate the performance of C6 peptide based multiplex Phosphorescence Analysis (PHOSPHAN) for the serologic confirmation of Lyme borreliosis (LB) in Russian patients. Methods Serum samples (n = 351) were collected from 146 patients with erythema migrans (EM); samples from 131 of these patients were taken several times prior to treatment and at different stages of recovery. The control group consisted of 197 healthy blood donors and 31 patients with other diseases, all from the same highly endemic region of Russia. All samples were analyzed by PHOSPHAN for IgM and IgG to Bb C6, recombinant OspC and VlsE proteins, and C6 peptides from B. garinii and B. afzelii. Results IgM and IgG to Bb C6 were identified in 43 and 95 out of 131 patients (32.8 and 72.5%, respectively); seroconversion of IgM antibodies was observed in about half of the patients (51.2%), and of IgG antibodies, in almost all of them (88.4%). Additional detection of OspC-IgM and VlsE-IgM or IgG to C6 from B. garinii or B. afzelii did not contribute significantly to the overall sensitivity of the multiplex immunoassay. Conclusions The multiplex phosphorescence immunoassay is a promising method for simultaneously revealing the spectrum of antibodies to several Borrelia antigens. Detection of IgM and IgG to Bb C6 in the sera of EM patients provides effective serologic confirmation of LB and, with high probability, indicates an active infection process.	[Pomelova, Vera G.; Bychenkova, Tatiana A.; Bekman, Natalya I.] State Res Inst Biol Engn, Dept Biol Microassay, Lab Mol Diagnost, Moscow, Russia; [Korenberg, Edward I.] NF Gamalei Inst Epidemiol & Microbiol, Dept Infect Nat Focal, Moscow, Russia; [Kuznetsova, Tatiana I.] Clin Infect Dis Hosp, Clin Immunol Lab, Perm, Russia; [Osin, Nikolay S.] Immunoscreen Closed Joint Stock Co, Moscow, Russia	Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS	Pomelova, VG (corresponding author), State Res Inst Biol Engn, Dept Biol Microassay, Lab Mol Diagnost, Moscow, Russia.	v.pomelova@immunoscreen.ru	Korenberg, Eduard/O-9575-2015	Korenberg, Eduard/0000-0002-4452-4231; Kuznetsova, Tatiana/0000-0002-6694-3656; Pomelova, Vera/0000-0003-3377-3731	US Department of Health and Human Services/International Science and Technology Center, Moscow (BTEP) [104/ISTC, 3135]; Immunoscreen Closed Joint Stock Company	US Department of Health and Human Services/International Science and Technology Center, Moscow (BTEP); Immunoscreen Closed Joint Stock Company	This study was supported by (BTEP #104/ISTC #3135) (www.hhs.gov) (www.istc.ru) the US Department of Health and Human Services/International Science and Technology Center, Moscow (VP EK TB NB NO). Immunoscreen Closed Joint Stock Company provided support in the form of salary for author NO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the Author Contributions section.	Aguero-Rosenfeld ME, 2005, CLIN MICROBIOL REV, V18, P484, DOI 10.1128/CMR.18.3.484-509.2005; AgueroRosenfeld ME, 1996, J CLIN MICROBIOL, V34, P1; Bacon RM, 2003, J INFECT DIS, V187, P1187, DOI 10.1086/374395; Bieniarz C, 1996, BIOCONJUGATE CHEM, V7, P88, DOI 10.1021/bc950080+; Branda JA, 2013, CLIN INFECT DIS, V57, P333, DOI 10.1093/cid/cit235; Brouqui P, 2004, CLIN MICROBIOL INFEC, V10, P1108, DOI 10.1111/j.1469-0691.2004.01019.x; Burbelo PD, 2010, CLIN VACCINE IMMUNOL, V17, P904, DOI 10.1128/CVI.00476-09; Embers ME, 2007, CLIN VACCINE IMMUNOL, V14, P931, DOI 10.1128/CVI.00075-07; Goettner G, 2005, J CLIN MICROBIOL, V43, P3602, DOI 10.1128/JCM.43.8.3602-3609.2005; Gomes-Solecki MJC, 2007, CLIN VACCINE IMMUNOL, V14, P875, DOI 10.1128/CVI.00122-07; Korenberg E., 1995, WHO WORKSH LYM BORR, P128; Korenberg E., 2013, INFECT NATURAL FOCAL; Korenberg Edward I., 2002, P175, DOI 10.1079/9780851996325.0175; Krupka I, 2009, CLIN VACCINE IMMUNOL, V16, P1546, DOI 10.1128/CVI.00201-09; Liang FT, 2000, J INFECT DIS, V182, P1455, DOI 10.1086/315862; Liang FT, 1999, J IMMUNOL, V163, P5566; Liang FT, 1999, J CLIN MICROBIOL, V37, P3990, DOI 10.1128/JCM.37.12.3990-3996.1999; Osin NS, 2008, FRONTIERS RES, V1, P233; Philipp MT, 2001, J INFECT DIS, V184, P870, DOI 10.1086/323392; Pomelova VG, 2010, EPIDEMIOLOGY VACCINE, V1, P22; Porwancher RB, 2011, CLIN VACCINE IMMUNOL, V18, P851, DOI 10.1128/CVI.00409-10; Schwantzer, 2012, ISRN IMMUNOL, P1, DOI [10.5402/2012/719821, DOI 10.5402/2012/719821]; Sillanpaa H, 2007, INT J MED MICROBIOL, V297, P45, DOI 10.1016/j.ijmm.2006.09.001; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P69, DOI 10.1111/j.1469-0691.2010.03175.x; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Strle Franc, 2009, V37, P51, DOI 10.1159/000213070; Templin MF, 2002, TRENDS BIOTECHNOL, V20, P160, DOI 10.1016/S0167-7799(01)01910-2; Tjernberg I, 2009, INT J MED MICROBIOL, V299, P439, DOI 10.1016/j.ijmm.2008.10.006; Vaz A, 2001, INFECT IMMUN, V69, P7437, DOI 10.1128/IAI.69.12.7437-7444.2001; Vorob'eva N. N., 1998, CLIN MANIFESTATIONS; Wilske B, 2007, FEMS IMMUNOL MED MIC, V49, P13, DOI 10.1111/j.1574-695X.2006.00139.x; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Wormser GP, 2014, MED MICROBIOL IMMUN, V203, P65, DOI 10.1007/s00430-013-0315-0; Wormser GP, 2013, DIAGN MICR INFEC DIS, V75, P9, DOI 10.1016/j.diagmicrobio.2012.09.003	34	9	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130048	10.1371/journal.pone.0130048	http://dx.doi.org/10.1371/journal.pone.0130048			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147441	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600029
J	Wierzba, M; Riegel, M; Wypych, M; Jednorog, K; Turnau, P; Grabowska, A; Marchewka, A				Wierzba, Malgorzata; Riegel, Monika; Wypych, Marek; Jednorog, Katarzyna; Turnau, Pawel; Grabowska, Anna; Marchewka, Artur			Basic Emotions in the Nencki Affective Word List (NAWL BE): New Method of Classifying Emotional Stimuli	PLOS ONE			English	Article							AFFECTIVE NORMS; ENGLISH WORDS; ADAPTATION; ANEW; NOUNS; BAWL	The Nencki Affective Word List (NAWL) has recently been introduced as a standardized database of Polish words suitable for studying various aspects of language and emotions. Though the NAWL was originally based on the most commonly used dimensional approach, it is not the only way of studying emotions. Another framework is based on discrete emotional categories. Since the two perspectives are recognized as complementary, the aim of the present study was to supplement the NAWL database by the addition of categories corresponding to basic emotions. Thus, 2902 Polish words from the NAWL were presented to 265 subjects, who were instructed to rate them according to the intensity of each of the five basic emotions: happiness, anger, sadness, fear and disgust. The general characteristics of the present word database, as well as the relationships between the studied variables are shown to be consistent with typical patterns found in previous studies using similar databases for different languages. Here we present the Basic Emotions in the Nencki Affective Word List (NAWL BE) as a database of verbal material suitable for highly controlled experimental research. To make the NAWL more convenient to use, we introduce a comprehensive method of classifying stimuli to basic emotion categories. We discuss the advantages of our method in comparison to other methods of classification. Additionally, we provide an interactive online tool (http://exp.lobi.nencki.gov.pl/nawl-analysis) to help researchers browse and interactively generate classes of stimuli to meet their specific requirements.	[Wierzba, Malgorzata; Riegel, Monika; Wypych, Marek; Turnau, Pawel; Marchewka, Artur] M Nencki Inst Expt Biol, Lab Brain Imaging, Neurobiol Ctr, PL-02093 Warsaw, Poland; [Jednorog, Katarzyna; Grabowska, Anna] M Nencki Inst Expt Biol, Dept Neurophysiol, Psychophysiol Lab, PL-02093 Warsaw, Poland; [Grabowska, Anna] Univ Social Sci & Humanities, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; SWPS University of Social Sciences & Humanities	Wierzba, M (corresponding author), M Nencki Inst Expt Biol, Lab Brain Imaging, Neurobiol Ctr, PL-02093 Warsaw, Poland.	m.wierzba@nencki.gov.pl; a.marchewka@nencki.gov.pl	Wierzba, Małgorzata/GVS-1264-2022; Wypych, Marek/C-1371-2019; Wierzba, Małgorzata/C-3077-2019; Jednoróg, Katarzyna/AFO-8052-2022; Marchewka, Artur/ABF-5174-2021; Wierzba, Małgorzata/ABE-2665-2021; Riegel, Monika/AAP-9544-2020	Wierzba, Małgorzata/0000-0003-0820-2662; Wypych, Marek/0000-0002-8710-0244; Wierzba, Małgorzata/0000-0003-0820-2662; Jednoróg, Katarzyna/0000-0003-3072-6956; Wierzba, Małgorzata/0000-0003-0820-2662; Riegel, Monika/0000-0001-6359-1184; Marchewka, Artur/0000-0002-1982-3299; Grabowska, Anna/0000-0003-2156-350X	National Science Centre [2013/11/N/HS6/01786, 2012/07/B/HS6/02112]; Polish Ministry of Science and Higher Education, Iuventus Plus Grants [IP2011 033471, IP2012 042072]	National Science Centre(National Science Centre, Poland); Polish Ministry of Science and Higher Education, Iuventus Plus Grants	This study was supported by the National Science Centre, PRELUDIUM grant, No. 2013/11/N/HS6/01786 (MW), OPUS grant, number 2012/07/B/HS6/02112 (AG), and by the Polish Ministry of Science and Higher Education, Iuventus Plus Grants No. IP2011 033471 (AM) and IP2012 042072 (AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett LF, 2006, CURR DIR PSYCHOL SCI, V15, P79, DOI 10.1111/j.0963-7214.2006.00411.x; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Briesemeister BB, 2015, COGN AFFECT BEHAV NE, V15, P287, DOI 10.3758/s13415-014-0327-2; Briesemeister BB, 2014, BRAIN RES, V1564, P62, DOI 10.1016/j.brainres.2014.03.045; Briesemeister BB, 2011, BEHAV RES METHODS, V43, P441, DOI 10.3758/s13428-011-0059-y; Eilola TM, 2010, BEHAV RES METHODS, V42, P134, DOI 10.3758/BRM.42.1.134; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Imbir KK, 2015, BEHAV RES METHODS, V47, P860, DOI 10.3758/s13428-014-0509-4; Jacobs AM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00714; Janschewitz K, 2008, BEHAV RES METHODS, V40, P1065, DOI 10.3758/BRM.40.4.1065; Kloumann IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029484; Lang P. J., 2008, TECHNICAL REPORT A 8; Lang PJ, 1999, TECHNICAL REPORT C 1; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Mandera P, 2015, BEHAV RES METHODS, V47, P471, DOI 10.3758/s13428-014-0489-4; Marchewka A, 2014, BEHAV RES METHODS, V46, P596, DOI 10.3758/s13428-013-0379-1; Mauss I, 2009, COGNITION EMOTION, V23, P209, DOI 10.1080/02699930802204677; Mikels JA, 2005, BEHAV RES METHODS, V37, P626, DOI 10.3758/BF03192732; Monnier C, 2014, BEHAV RES METHODS, V46, P1128, DOI 10.3758/s13428-013-0431-1; Montefinese M, 2014, BEHAV RES METHODS, V46, P887, DOI 10.3758/s13428-013-0405-3; Moors A, 2013, BEHAV RES METHODS, V45, P169, DOI 10.3758/s13428-012-0243-8; Moors A, 2009, COGNITION EMOTION, V23, P625, DOI 10.1080/02699930802645739; ORTONY A, 1990, PSYCHOL REV, V97, P315, DOI 10.1037/0033-295X.97.3.315; Osgood CE, 1967, THE MEASUREMENT OF M; PANKSEPP J, 1992, PSYCHOL REV, V99, P554, DOI 10.1037/0033-295X.99.3.554; Pezik Piotr, 2012, NARODOWY KORPUS JEZY; Redondo J, 2007, BEHAV RES METHODS, V39, P600, DOI 10.3758/BF03193031; Riegel M, 2015, BEHAV RES METHODS, V47, P1222, DOI 10.3758/s13428-014-0552-1; RUSSELL JA, 1977, J RES PERS, V11, P273, DOI 10.1016/0092-6566(77)90037-X; Scherer KR, 2005, SOC SCI INFORM, V44, P695, DOI 10.1177/0539018405058216; Schlochtermeier LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055619; Schmidtke DS, 2014, BEHAV RES METHODS, V46, P1108, DOI 10.3758/s13428-013-0426-y; Soares AP, 2012, BEHAV RES METHODS, V44, P256, DOI 10.3758/s13428-011-0131-7; Stevenson RA, 2007, BEHAV RES METHODS, V39, P1020, DOI 10.3758/BF03192999; Vo MLH, 2009, BEHAV RES METHODS, V41, P534, DOI 10.3758/BRM.41.2.534; Zachar P., 2012, CATEGORICAL VERSUS D	36	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132305	10.1371/journal.pone.0132305	http://dx.doi.org/10.1371/journal.pone.0132305			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26148193	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600238
J	Field, BA; Buck, CL; McClure, SM; Nystrom, LE; Kahneman, D; Cohen, JD				Field, Brent A.; Buck, Cara L.; McClure, Samuel M.; Nystrom, Leigh E.; Kahneman, Daniel; Cohen, Jonathan D.			Attentional Modulation of Brain Responses to Primary Appetitive and Aversive Stimuli	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS SHELL; HUMAN WORKING-MEMORY; ORBITOFRONTAL CORTEX; FACIAL ATTRACTIVENESS; SELECTIVE ATTENTION; PREFRONTAL CORTEX; CIRCULAR ANALYSIS; REWARD; VALENCE; HUMANS	Studies of subjective well-being have conventionally relied upon self-report, which directs subjects' attention to their emotional experiences. This method presumes that attention itself does not influence emotional processes, which could bias sampling. We tested whether attention influences experienced utility (the moment-by-moment experience of pleasure) by using functional magnetic resonance imaging (fMRI) to measure the activity of brain systems thought to represent hedonic value while manipulating attentional load. Subjects received appetitive or aversive solutions orally while alternatively executing a low or high attentional load task. Brain regions associated with hedonic processing, including the ventral striatum, showed a response to both juice and quinine. This response decreased during the high-load task relative to the low-load task. Thus, attentional allocation may influence experienced utility by modulating (either directly or indirectly) the activity of brain mechanisms thought to represent hedonic value.	[Field, Brent A.; Nystrom, Leigh E.; Cohen, Jonathan D.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08540 USA; [Buck, Cara L.] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; [McClure, Samuel M.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Kahneman, Daniel] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08540 USA; [Cohen, Jonathan D.] Princeton Univ, Dept Psychol, Princeton, NJ 08540 USA; [Cohen, Jonathan D.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15213 USA	Princeton University; University of California System; University of California San Diego; Stanford University; Princeton University; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Field, BA (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08540 USA.	bfield@princeton.edu			NIH [P30 AG024361]; John Templeton Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024361] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Templeton Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support came from NIH P30 AG024361 (http://www.nih.gov/). This publication was made possible in part through the support of a grant from the John Templeton Foundation (http://www.templeton.org/). The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043101; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Awh E, 1996, PSYCHOL SCI, V7, P25, DOI 10.1111/j.1467-9280.1996.tb00662.x; Baddeley AD, 1986, WORKING MEMORY; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Carelli RM, 2003, J NEUROSCI, V23, P11214; Chen ZJ, 2009, MEM COGNITION, V37, P829, DOI 10.3758/MC.37.6.829; Cloutier J, 2008, J COGNITIVE NEUROSCI, V20, P941, DOI 10.1162/jocn.2008.20062; Cohen J D, 1994, Hum Brain Mapp, V1, P293, DOI 10.1002/hbm.460010407; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; Cooper JC, 2008, NEUROIMAGE, V39, P538, DOI 10.1016/j.neuroimage.2007.08.009; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; Faure A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011223; GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; Jensen J, 2007, HUM BRAIN MAPP, V28, P294, DOI 10.1002/hbm.20274; Kim SH, 2007, J COGNITIVE NEUROSCI, V19, P776, DOI 10.1162/jocn.2007.19.5.776; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Krebs RM, 2012, CEREB CORTEX, V22, P607, DOI 10.1093/cercor/bhr134; Krebs RM, 2011, J NEUROSCI, V31, P9752, DOI 10.1523/JNEUROSCI.0732-11.2011; Kriegeskorte N, 2010, J CEREBR BLOOD F MET, V30, P1551, DOI 10.1038/jcbfm.2010.86; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kringelbach ML, 2003, CEREB CORTEX, V13, P1064, DOI 10.1093/cercor/13.10.1064; Kringelbach ML, 2009, TRENDS COGN SCI, V13, P479, DOI 10.1016/j.tics.2009.08.006; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Lewis PA, 2007, CEREB CORTEX, V17, P742, DOI 10.1093/cercor/bhk024; Litt A, 2011, CEREB CORTEX, V21, P95, DOI 10.1093/cercor/bhq065; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; Mcclure SM, 2004, NEUROSCIENTIST, V10, P260, DOI 10.1177/1073858404263526; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Nitschke JB, 2006, NAT NEUROSCI, V9, P435, DOI 10.1038/nn1645; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; O'Doherty J, 2003, J NEUROSCI, V23, P7931; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Pecina S, 2005, J NEUROSCI, V25, P11777, DOI 10.1523/JNEUROSCI.2329-05.2005; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Peyron R, 1999, BRAIN, V122, P1765, DOI 10.1093/brain/122.9.1765; Posner M., 1975, INFORM PROCESSING CO; Reynolds SM, 2002, J NEUROSCI, V22, P7308; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Smith DV, 2010, J NEUROSCI, V30, P2490, DOI 10.1523/JNEUROSCI.3319-09.2010; Smith EE, 1996, CEREB CORTEX, V6, P11, DOI 10.1093/cercor/6.1.11; Volkow ND, 1999, J PHARMACOL EXP THER, V291, P409; Zaehle T, 2013, J NEUROSCI, V33, P8764, DOI 10.1523/JNEUROSCI.5276-12.2013; Zald DH, 2002, J NEUROPHYSIOL, V87, P1068, DOI 10.1152/jn.00358.2001; Zink CF, 2006, NEUROIMAGE, V29, P977, DOI 10.1016/j.neuroimage.2005.08.006; Zink CF, 2004, NEURON, V42, P509, DOI 10.1016/S0896-6273(04)00183-7; Zink CF, 2003, J NEUROSCI, V23, P8092	53	4	4	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0130880	10.1371/journal.pone.0130880	http://dx.doi.org/10.1371/journal.pone.0130880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EW	26158468	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000358161200022
J	Arndt, DL; Peterson, CJ; Cain, ME				Arndt, David L.; Peterson, Christy J.; Cain, Mary E.			Differential Rearing Alters Forced Swim Test Behavior, Fluoxetine Efficacy, and Post-Test Weight Gain in Male Rats	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; DEPRESSIVE-LIKE BEHAVIOR; ENVIRONMENTAL-ENRICHMENT; SOCIAL-ISOLATION; ANIMAL-MODEL; ANTIDEPRESSANTS; SEROTONIN; ANXIETY; STRESS; PATHOPHYSIOLOGY	Environmental factors play a key role in the etiology of depression. The rodent forced swim test (FST) is commonly used as a preclinical model of depression, with increases in escape-directed behavior reflecting antidepressant effects, and increases in immobility reflecting behavioral despair. Environmental enrichment leads to serotonergic alterations in rats, but it is unknown whether these alterations may influence the efficacy of common antidepressants. Male Sprague-Dawley rats were reared in enriched (EC), standard (SC), or isolated (IC) conditions. Following the rearing period, fluoxetine (10 or 20 mg/kg, i.p.) was administered 23.5 hrs, 5 hrs, and 1 hr before locomotor and FST measures. Following locomotor testing and FST exposure, rats were weighed to assess fluoxetine-, FST-, and environmental condition-induced moderations in weight gain. Results revealed an antidepressant effect of environmental enrichment and a depressant effect of isolation. Regardless of significant fluoxetine effects on locomotor activity, fluoxetine generally decreased swimming and increased immobility in all three environmental conditions, with IC-fluoxetine (10 mg/kg) rats and EC-fluoxetine (20 mg/kg) rats swimming less than vehicle counterparts. Subchronic 20 mg/kg fluoxetine also induced significant weight loss, and differential rearing appeared to moderate weight gain following FST stress. These results suggest that differential rearing has the ability to alter FST behaviors, fluoxetine efficacy, and post-stressor well-being. Moreover, 20 mg/kg fluoxetine, administered subchronically, may lead to atypical effects of those commonly observed in the FST, highlighting the importance and impact of both environmental condition and dosing regimen in common animal models of depression.	[Arndt, David L.; Peterson, Christy J.; Cain, Mary E.] Kansas State Univ, Dept Psychol Sci, Manhattan, KS 66506 USA	Kansas State University	Arndt, DL (corresponding author), Kansas State Univ, Dept Psychol Sci, Manhattan, KS 66506 USA.	david23@ksu.edu		Cain, Mary/0000-0002-2165-990X	Kansas State University; Mark Chapman Scholars Program through Kansas State University; Kansas State University Open Access Publishing Fund	Kansas State University; Mark Chapman Scholars Program through Kansas State University; Kansas State University Open Access Publishing Fund	Research reported in this article was supported by Kansas State University. CJP was supported by the Mark Chapman Scholars Program through Kansas State University. Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund.	Arndt DL, 2014, EXP CLIN PSYCHOPHARM, V22, P257, DOI 10.1037/a0035273; Artola A, 2006, EUR J NEUROSCI, V23, P261, DOI 10.1111/j.1460-9568.2005.04552.x; Bach-Mizrachi H, 2006, NEUROPSYCHOPHARMACOL, V31, P814, DOI 10.1038/sj.npp.1300897; Bogdanova OV, 2013, PHYSIOL BEHAV, V118, P227, DOI 10.1016/j.physbeh.2013.05.012; Brenes JC, 2008, PHARMACOL BIOCHEM BE, V89, P85, DOI 10.1016/j.pbb.2007.11.004; Brenes JC, 2009, BEHAV BRAIN RES, V197, P125, DOI 10.1016/j.bbr.2008.08.014; Campbell S, 2004, J PSYCHIATR NEUROSCI, V29, P417; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; Crofton EJ, 2015, NEUROSCI BIOBEHAV R, V49, P19, DOI 10.1016/j.neubiorev.2014.11.017; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Cui MH, 2006, NEUROSCI LETT, V404, P208, DOI 10.1016/j.neulet.2006.05.048; D'Souza DN, 2002, PSYCHOPHARMACOLOGY, V164, P392, DOI 10.1007/s00213-002-1232-x; D'Souza DN, 2004, AM J PHYSIOL-REG I, V286, pR390, DOI 10.1152/ajpregu.00335.2003; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Detke MJ, 1996, BEHAV BRAIN RES, V73, P43; Detke MJ, 1997, EXP CLIN PSYCHOPHARM, V5, P107, DOI 10.1037/1064-1297.5.2.107; DETKE MJ, 1995, PSYCHOPHARMACOLOGY, V121, P66, DOI 10.1007/BF02245592; DREVETS WC, 1992, J NEUROSCI, V12, P3628; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; FULLER RW, 1974, LIFE SCI, V15, P1161, DOI 10.1016/S0024-3205(74)80012-3; Furay AR, 2011, BEHAV BRAIN RES, V224, P350, DOI 10.1016/j.bbr.2011.06.016; Gill MJ, 2012, PSYCHOPHARMACOLOGY, V221, P227, DOI 10.1007/s00213-011-2565-0; GREEN EJ, 1986, J NEUROPHYSIOL, V55, P739, DOI 10.1152/jn.1986.55.4.739; Green TA, 2010, BIOL PSYCHIAT, V67, P28, DOI 10.1016/j.biopsych.2009.06.022; Homberg JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016646; Homberg JR, 2010, TRENDS PHARMACOL SCI, V31, P60, DOI 10.1016/j.tips.2009.11.003; Huang GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035901; Institute of Laboratory Animal Resources. Commission on Life Sciences National Research Council, 1996, GUIDE CARE USE LAB A; Jang DP, 2009, NEUROSCI LETT, V451, P60, DOI 10.1016/j.neulet.2008.12.024; Klomp A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097603; Knapska E, 2010, LEARN MEMORY, V17, P824, DOI 10.1101/lm.1670910; Kokare DM, 2010, NEUROPHARMACOLOGY, V58, P1009, DOI 10.1016/j.neuropharm.2010.01.006; Konkle ATM, 2010, J AM ASSOC LAB ANIM, V49, P427; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Kulkarni SK, 2007, PROG NEURO-PSYCHOPH, V31, P1248, DOI 10.1016/j.pnpbp.2007.05.002; Licinio J, 2005, NAT REV DRUG DISCOV, V4, P165, DOI 10.1038/nrd1634; Lin X, 1999, CARCINOGENESIS, V20, P1793, DOI 10.1093/carcin/20.9.1793; Llorens-Martin MV, 2007, NEUROSCIENCE, V147, P631, DOI 10.1016/j.neuroscience.2007.04.054; Lucki I, 1997, BEHAV PHARMACOL, V8, P523, DOI 10.1097/00008877-199711000-00010; Macgillivray L, 2012, SYNAPSE, V66, P465, DOI 10.1002/syn.21511; Mason SS, 2009, EUR J PHARMACOL, V602, P306, DOI 10.1016/j.ejphar.2008.11.010; Mosaferi B, 2015, PHYSL BEHAV IN PRESS; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Olivier JDA, 2011, PROG NEURO-PSYCHOPH, V35, P1400, DOI 10.1016/j.pnpbp.2010.09.013; Page ME, 1999, PSYCHOPHARMACOLOGY, V147, P162, DOI 10.1007/s002130051156; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; PRENDERGAST MA, 2002, MED SCI MONITOR, V8, P385; Rasmuson S, 1998, MOL BRAIN RES, V53, P285, DOI 10.1016/S0169-328X(97)00317-3; Raz S, 2010, PHARMACOL BIOCHEM BE, V96, P59, DOI 10.1016/j.pbb.2010.04.007; Refaey HE, 2011, BAHRAIN MED B, V33, P1; Reneric JP, 1998, PSYCHOPHARMACOLOGY, V136, P190, DOI 10.1007/s002130050555; Renner M.J., 1987, ENRICHED IMPOVERISHE; Ressler KJ, 2000, DEPRESS ANXIETY, V12, P2, DOI 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.3.CO;2-W; Riad N, 2000, J COMP NEUROL, V417, P181, DOI 10.1002/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A; ROSENZWEIG MR, 1972, J COMP PHYSIOL PSYCH, V79, P56, DOI 10.1037/h0032527; Schiller L, 2006, BRAIN RES, V1103, P76, DOI 10.1016/j.brainres.2006.05.051; SHARP PE, 1985, BRAIN RES, V339, P361, DOI 10.1016/0006-8993(85)90105-2; Slattery DA, 2012, NAT PROTOC, V7, P1009, DOI 10.1038/nprot.2012.044; Stahl SM, 1997, J CLIN PSYCHIAT, V58, P20; Tanti A, 2013, HIPPOCAMPUS, V23, P797, DOI 10.1002/hipo.22134; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; TROUVIN JH, 1993, LIFE SCI, V52, pPL187, DOI 10.1016/0024-3205(93)90116-K; Van de Kar LD, 2002, NEUROPHARMACOLOGY, V43, P45, DOI 10.1016/S0028-3908(02)00075-8; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; VORHEES CV, 1994, FUND APPL TOXICOL, V23, P194, DOI 10.1006/faat.1994.1098; WONG DT, 1974, LIFE SCI, V15, P471, DOI 10.1016/0024-3205(74)90345-2; YEN TT, 1992, AM J CLIN NUTR, V55, P177, DOI 10.1093/ajcn/55.1.177s; Yildirim E, 2012, PHARMACOL BIOCHEM BE, V101, P278, DOI 10.1016/j.pbb.2011.12.017	69	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131709	10.1371/journal.pone.0131709	http://dx.doi.org/10.1371/journal.pone.0131709			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154768	gold, Green Submitted, Green Published			2022-12-27	WOS:000358159700078
J	Martin, NL; Bass, P; Liss, SN				Martin, Nancy L.; Bass, Paul; Liss, Steven N.			Antibacterial Properties and Mechanism of Activity of a Novel Silver-Stabilized Hydrogen Peroxide	PLOS ONE			English	Article							DISINFECTION BY-PRODUCTS; WATER DISTRIBUTION-SYSTEMS; OXIDATIVE STRESS-RESPONSE; DRINKING-WATER; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; PHYSICAL-CHARACTERIZATION; RESPIRATORY-CHAIN; RESISTANCE; CATALASE	Huwa-San peroxide (hydrogen peroxide; HSP) is a NSF Standard 60 (maximum 8mg/L-1) new generation peroxide stabilized with ionic silver suitable for continuous disinfection of potable water. Experiments were undertaken to examine the mechanism of HSP against planktonic and biofilm cultures of indicator bacterial strains. Contact/kill time (CT) relationships that achieve effective control were explored to determine the potential utility in primary disinfection. Inhibitory assays were conducted using both nutrient rich media and a medium based on synthetic wastewater. Assays were compared for exposures to three disinfectants (HSP, laboratory grade hydrogen peroxide (HP) and sodium hypochlorite) at concentrations of 20 ppm (therefore at 2.5 and 5 times the NSF limit for HP and sodium hypochlorite, respectively) and at pH 7.0 and 8.5 in dechlorinated tap water. HSP was found to be more or equally effective as hypochlorite or HP. Results from CT assays comparing HSP and HP at different bacterial concentrations with neutralization of residual peroxide with catalase suggested that at a high bacterial concentration HSP, but not HP, was protected from catalase degradation possibly through sequestration by bacterial cells. Consistent with this hypothesis, at a low bacterial cell density residual HSP was more effectively neutralized as less HSP was associated with bacteria and therefore accessible to catalase. Silver in HSP may facilitate this association through electrostatic interactions at the cell surface. This was supported by experiments where the addition of mono (K+) and divalent (Ca+2) cations (0.005-0.05M) reduced the killing efficacy of HSP but not HP. Experiments designed to distinguish any inhibitory effect of silver from that of peroxide in HSP were carried out by monitoring the metabolic activity of established P. aeruginosa PAO1 biofilms. Concentrations of 70-500 ppm HSP had a pronounced effect on metabolic activity while the equivalent concentrations of ionic silver (50-375 ppb) had a negligible effect, demonstrating that the microbiocidal activity of HSP was due to peroxide rather than silver. Overall, it was found that the antimicrobial activity of HSP is enhanced over that of hydrogen peroxide; the presence of the ionic silver enhances interactions of HSP with the bacterial cell surface rather than acting directly as a biocide at the tested concentrations.	[Martin, Nancy L.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Bass, Paul; Liss, Steven N.] Queens Univ, Sch Environm Studies, Kingston, ON, Canada; [Liss, Steven N.] Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada	Martin, NL (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	nancy.martin@queensu.ca; steven.liss@queensu.ca			Natural Sciences and Engineering Research Council (Canada); Engage Program FedDev Ontario ARC (Canada)	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Engage Program FedDev Ontario ARC (Canada)	Funding was provided by two federal programs: Natural Sciences and Engineering Research Council (Canada) and Engage Program FedDev Ontario ARC (Canada). Supplies of the new generation peroxide were provided by: SanEcoTec. The funding agency did not play any role in the design, data collection and analysis, decision to publish or preparation of the manuscript. The authors regularly discussed the progress of the work with SanEcoTec and they provided a copy of the draft manuscript for review of statements of fact. They did not design, collect data, analyze or contribute to the preparation of the manuscript.	Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Armon R, 2000, WATER SCI TECHNOL, V42, P187, DOI 10.2166/wst.2000.0312; BALDRY MGC, 1983, J APPL BACTERIOL, V54, P417, DOI 10.1111/j.1365-2672.1983.tb02637.x; Batarseh KI, 2012, CURR MED CHEM, V19, P3635; Berry D, 2006, CURR OPIN BIOTECH, V17, P297, DOI 10.1016/j.copbio.2006.05.007; Bester E, 2010, APPL ENVIRON MICROB, V76, P1189, DOI 10.1128/AEM.01719-09; Bonvillain RW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-112; BRAGG PD, 1974, CAN J MICROBIOL, V20, P883, DOI 10.1139/m74-135; BROWN SM, 1995, J BACTERIOL, V177, P6536, DOI 10.1128/jb.177.22.6536-6544.1995; Committee NRCUSDW, 1987, DRINKING WATER AND H; Cosgrove K, 2007, J BACTERIOL, V189, P1025, DOI 10.1128/JB.01524-06; Davoudi M, 2012, ANTIBACTERIAL EFFECT; Ehdaie B, 2014, ENVIRON SCI TECHNOL, V48, P13901, DOI 10.1021/es503534c; Emtiazi F, 2004, WATER RES, V38, P1197, DOI 10.1016/j.watres.2003.10.056; Fernandes PN, 2007, REDOX REP, V12, P236, DOI 10.1179/135100007X200344; Flemming HC, 2002, APPL MICROBIOL BIOT, V59, P629, DOI 10.1007/s00253-002-1066-9; Florentin A, 2011, INT J HYG ENVIR HEAL, V214, P461, DOI 10.1016/j.ijheh.2011.07.012; Fu FL, 2014, J HAZARD MATER, V267, P194, DOI 10.1016/j.jhazmat.2013.12.062; Gadd G M, 1989, Biol Met, V2, P168, DOI 10.1007/BF01142556; GHANDOUR W, 1988, APPL MICROBIOL BIOT, V28, P559, DOI 10.1007/BF00250412; Hare NJ, 2011, PROTEOMICS, V11, P3056, DOI 10.1002/pmic.201000807; Holt KB, 2005, BIOCHEMISTRY-US, V44, P13214, DOI 10.1021/bi0508542; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jin X, 2010, ENVIRON SCI TECHNOL, V44, P7321, DOI 10.1021/es100854g; Juven BJ, 1996, J FOOD PROTECT, V59, P1233, DOI 10.4315/0362-028X-59.11.1233; Kim M-J, 2001, THESIS U TORONTO; Kroukamp O, 2010, APPL ENVIRON MICROB, V76, P6025, DOI 10.1128/AEM.00070-10; Kroukamp O, 2009, APPL ENVIRON MICROB, V75, P4391, DOI 10.1128/AEM.01567-08; Kumari P, 2015, J BIOCHEM, V157, P113, DOI 10.1093/jb/mvu072; Linley E, 2012, J ANTIMICROB CHEMOTH, V67, P1589, DOI 10.1093/jac/dks129; Liu G, 2013, APPL MICROBIOL BIOT, V97, P9265, DOI 10.1007/s00253-013-5217-y; LOEWEN PC, 1987, J BACTERIOL, V169, P3601, DOI 10.1128/jb.169.8.3601-3607.1987; Loo SL, 2013, ENVIRON SCI TECHNOL, V47, P9363, DOI 10.1021/es401219s; Maillard JY, 2013, CRIT REV MICROBIOL, V39, P373, DOI 10.3109/1040841X.2012.713323; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; MULVEY MR, 1988, GENE, V73, P337, DOI 10.1016/0378-1119(88)90498-2; Munoz M, 2011, J HAZARD MATER, V190, P993, DOI 10.1016/j.jhazmat.2011.04.038; Nabizadeh R, 2008, IRAN J ENVIRON HEALT, V5, P235; Ochsner UA, 2000, J BACTERIOL, V182, P4533, DOI 10.1128/JB.182.16.4533-4544.2000; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; Pedahzur R, 1997, WATER SCI TECHNOL, V35, P87, DOI 10.2166/wst.1997.0715; PEDAHZUR R, 1995, WATER SCI TECHNOL, V31, P123, DOI 10.1016/0273-1223(95)00252-I; Pomposiello PJ, 2001, TRENDS BIOTECHNOL, V19, P109, DOI 10.1016/S0167-7799(00)01542-0; Richardson SD, 2003, TRAC-TREND ANAL CHEM, V22, P666, DOI 10.1016/S0165-9936(03)01003-3; Richardson SD, 2007, MUTAT RES-REV MUTAT, V636, P178, DOI 10.1016/j.mrrev.2007.09.001; Roeder RS, 2010, INT J HYG ENVIR HEAL, V213, P183, DOI 10.1016/j.ijheh.2010.04.007; Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276; Sadiq R, 2004, SCI TOTAL ENVIRON, V321, P21, DOI 10.1016/j.scitotenv.2003.05.001; Schel AJ, 2006, APPL ENVIRON MICROB, V72, P1380, DOI 10.1128/AEM.72.2.1380-1387.2006; Schoenen D, 2002, WATER RES, V36, P3874, DOI 10.1016/S0043-1354(02)00076-3; Schwartz T, 1998, WATER RES, V32, P2787, DOI 10.1016/S0043-1354(98)00026-8; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Shuval H, 2009, INT J INFECTION CONT, V5; Silver S, 2006, J IND MICROBIOL BIOT, V33, P627, DOI 10.1007/s10295-006-0139-7; Silvestry-Rodriguez N, 2007, J ENVIRON SCI HEAL A, V42, P1579, DOI 10.1080/10934520701517689; SLAWSON RM, 1992, PLASMID, V27, P72, DOI 10.1016/0147-619X(92)90008-X; Smaill F, 2000, CAN J GASTROENTEROL, V14, P871, DOI 10.1155/2000/382415; Smith EM, 2010, ENVIRON SCI TECHNOL, V44, P8446, DOI 10.1021/es102746u; STEINER AA, 1970, PLANT PHYSIOL, V46, P862, DOI 10.1104/pp.46.6.862; Szabo J, 2014, ENVIRON INT, V72, P124, DOI 10.1016/j.envint.2014.01.031; Szewzyk U, 2000, ANNU REV MICROBIOL, V54, P81, DOI 10.1146/annurev.micro.54.1.81; Tao K, 1999, FEBS LETT, V457, P90, DOI 10.1016/S0014-5793(99)01013-3; Tote K, 2010, APPL ENVIRON MICROB, V76, P3135, DOI 10.1128/AEM.02095-09; TRIGGSRAINE BL, 1987, GENE, V52, P121, DOI 10.1016/0378-1119(87)90038-2; Tugulea AM, 2014, ENVIRON SCI POLLUT R, V21, P11823, DOI 10.1007/s11356-014-2508-5; Vatansever F, 2013, FEMS MICROBIOL REV, V37, P955, DOI 10.1111/1574-6976.12026; Vianna ME, 2004, ORAL SURG ORAL MED O, V97, P79, DOI 10.1016/S1079-2104(03)00360-3; WALLING C, 1975, ACCOUNTS CHEM RES, V8, P125, DOI 10.1021/ar50088a003; White G.C., 1999, HDB CHLORINATION ALT; Wingender J, 2011, INT J HYG ENVIR HEAL, V214, P417, DOI 10.1016/j.ijheh.2011.05.009; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; World Health Organization, 2004, GUID DRINK WAT QUAL, P237; Yudkin J., 1937, ENZYMOLOGIA, V2, P161	73	22	22	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131345	10.1371/journal.pone.0131345	http://dx.doi.org/10.1371/journal.pone.0131345			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154263	Green Submitted, gold, Green Published			2022-12-27	WOS:000358159700059
J	Murayama, S; Ishikawa, S; Chumsakul, O; Ogasawara, N; Oshima, T				Murayama, Satohiko; Ishikawa, Shu; Chumsakul, Onuma; Ogasawara, Naotake; Oshima, Taku			The Role of alpha-CTD in the Genome-Wide Transcriptional Regulation of the Bacillus subtilis Cells	PLOS ONE			English	Article							COLI RNA-POLYMERASE; C-TERMINAL DOMAIN; DNA-BINDING PROTEIN; ESCHERICHIA-COLI; BACTERIAL PROMOTERS; CATABOLITE REPRESSION; DEPENDENT REGULATION; RIBOSOME SYNTHESIS; SUBUNIT; EXPRESSION	The amino acid sequence of the RNA polymerase (RNAP) alpha-subunit is well conserved throughout the Eubacteria. Its C-terminal domain (alpha-CTD) is important for the transcriptional regulation of specific promoters in both Escherichia coli and Bacillus subtilis, through interactions with transcription factors and/or a DNA element called the "UP element". However, there is only limited information regarding the alpha-CTD regulated genes in B. subtilis and the importance of this subunit in the transcriptional regulation of B. subtilis. Here, we established strains and the growth conditions in which the alpha-subunit of RNAP was replaced with a C-terminally truncated version. Transcriptomic and ChAP-chip analyses revealed that alpha-CTD deficiency reduced the transcription and RNAP binding of genes related to the utilization of secondary carbon sources, transition state responses, and ribosome synthesis. In E. coli, it is known that alpha-CTD also contributes to the expression of genes related to the utilization of secondary carbon sources and ribosome synthesis. Our results suggest that the biological importance of alpha-CTD is conserved in B. subtilis and E. coli, but that its specific roles have diversified between these two bacteria.	[Murayama, Satohiko; Ishikawa, Shu; Chumsakul, Onuma; Ogasawara, Naotake; Oshima, Taku] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara 6300192, Japan	Nara Institute of Science & Technology	Oshima, T (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Ikoma, Nara 6300192, Japan.	taku@bs.naist.jp	Ishikawa, Shu/K-5383-2017	Ishikawa, Shu/0000-0002-2239-1116	JSPS KAKENHI [23241062]; JST Advanced Low Carbon Technology Research and Development Program, ALCA	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST Advanced Low Carbon Technology Research and Development Program, ALCA	This work was supported by JSPS KAKENHI, Grant Numbers 23241062 (to TO, SI and NO) and JST Advanced Low Carbon Technology Research and Development Program, ALCA, (to NO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allenby NEE, 2006, J BACTERIOL, V188, P5299, DOI 10.1128/JB.00084-06; Ball MS, 2007, J PROTEOME RES, V6, P4313, DOI 10.1021/pr070398z; BANNER CDB, 1983, J MOL BIOL, V168, P351, DOI 10.1016/S0022-2836(83)80023-0; BLATTER EE, 1994, CELL, V78, P889, DOI 10.1016/S0092-8674(94)90682-3; BOYLAN SA, 1989, J BACTERIOL, V171, P2553, DOI 10.1128/jb.171.5.2553-2562.1989; Brill J, 2011, J BACTERIOL, V193, P5335, DOI 10.1128/JB.05490-11; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Butcher BG, 2007, J BACTERIOL, V189, P8616, DOI 10.1128/JB.01181-07; Caramori T, 1998, MOL GEN GENET, V258, P385, DOI 10.1007/s004380050745; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; Comella N, 2005, MOL MICROBIOL, V57, P1159, DOI 10.1111/j.1365-2958.2005.04749.x; Darbon E, 2002, MOL MICROBIOL, V43, P1039, DOI 10.1046/j.1365-2958.2002.02800.x; DOMBROSKI AJ, 1992, CELL, V70, P501, DOI 10.1016/0092-8674(92)90174-B; EBRIGHT RH, 1995, CURR OPIN GENET DEV, V5, P197, DOI 10.1016/0959-437X(95)80008-5; Estrem ST, 1999, GENE DEV, V13, P2134, DOI 10.1101/gad.13.16.2134; Estrem ST, 1998, P NATL ACAD SCI USA, V95, P9761, DOI 10.1073/pnas.95.17.9761; FREDRICK K, 1995, P NATL ACAD SCI USA, V92, P2582, DOI 10.1073/pnas.92.7.2582; FRISBY D, 1991, J BACTERIOL, V173, P7557, DOI 10.1128/jb.173.23.7557-7564.1991; Gaal T, 1996, GENE DEV, V10, P16, DOI 10.1101/gad.10.1.16; Gaugue I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063025; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gourse RL, 2000, MOL MICROBIOL, V37, P687, DOI 10.1046/j.1365-2958.2000.01972.x; Gourse RL, 1996, ANNU REV MICROBIOL, V50, P645, DOI 10.1146/annurev.micro.50.1.645; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; HAYWARD RS, 1991, J MOL BIOL, V221, P23, DOI 10.1016/0022-2836(91)80197-3; IGARASHI K, 1991, J MOL BIOL, V218, P1, DOI 10.1016/0022-2836(91)90865-4; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; ISHIHAMA A, 1993, J BACTERIOL, V175, P2483, DOI 10.1128/JB.175.9.2483-2489.1993; ISHIHAMA A, 1992, MOL MICROBIOL, V6, P3283, DOI 10.1111/j.1365-2958.1992.tb02196.x; Ishikawa S, 2010, J BACTERIOL, V192, P5778, DOI 10.1128/JB.00489-10; Jeon YH, 1997, J MOL BIOL, V267, P953, DOI 10.1006/jmbi.1997.0902; Joyet P, 2010, MOL MICROBIOL, V76, P1279, DOI 10.1111/j.1365-2958.2010.07175.x; Krasny L, 2004, EMBO J, V23, P4473, DOI 10.1038/sj.emboj.7600423; Kusuya Y, 2011, J BACTERIOL, V193, P3090, DOI 10.1128/JB.00086-11; Lei Y, 2013, THESIS NARA I SCI TE; Lemke JJ, 2011, P NATL ACAD SCI USA, V108, P5712, DOI 10.1073/pnas.1019383108; Ludwig H, 2002, MOL MICROBIOL, V45, P543, DOI 10.1046/j.1365-2958.2002.03034.x; Meijer WJJ, 2004, NUCLEIC ACIDS RES, V32, P1166, DOI 10.1093/nar/gkh290; Mencia M, 1998, J MOL BIOL, V275, P177, DOI 10.1006/jmbi.1997.1463; Mencia M, 1996, P NATL ACAD SCI USA, V93, P6616, DOI 10.1073/pnas.93.13.6616; MORAN CP, 1982, MOL GEN GENET, V186, P339, DOI 10.1007/BF00729452; Msadek T, 1999, TRENDS MICROBIOL, V7, P201, DOI 10.1016/S0966-842X(99)01479-1; NEGISHI T, 1995, J MOL BIOL, V248, P723, DOI 10.1006/jmbi.1995.0254; Newberry KJ, 2005, P NATL ACAD SCI USA, V102, P15839, DOI 10.1073/pnas.0506592102; Niu W, 1996, CELL, V87, P1123, DOI 10.1016/S0092-8674(00)81806-1; Ohtsubo Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-376; Osmundson J, 2012, CELL, V151, P1005, DOI 10.1016/j.cell.2012.10.034; Reizer J, 1999, MICROBIOL-UK, V145, P3419, DOI 10.1099/00221287-145-12-3419; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; Ross W, 1998, J BACTERIOL, V180, P5375, DOI 10.1128/JB.180.20.5375-5383.1998; Sadaie Y, 2008, FEMS MICROBIOL LETT, V279, P103, DOI 10.1111/j.1574-6968.2007.01018.x; Schmiedel D, 1996, MOL GEN GENET, V250, P259; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; STRAUCH MA, 1995, J BACTERIOL, V177, P6727, DOI 10.1128/jb.177.23.6727-6731.1995; Tagami H, 1998, EMBO J, V17, P1759, DOI 10.1093/emboj/17.6.1759; Ujiie H, 2009, J BIOCHEM, V145, P59, DOI 10.1093/jb/mvn143; Wenzel M, 2013, MOL MICROBIOL, V88, P562, DOI 10.1111/mmi.12209; Winkelman JT, 2013, MOL MICROBIOL, V88, P984, DOI 10.1111/mmi.12235; Zhang GY, 1998, SCIENCE, V281, P262, DOI 10.1126/science.281.5374.262; Zhang Y, 2006, J BACTERIOL, V188, P4300, DOI 10.1128/JB.00220-06	62	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131588	10.1371/journal.pone.0131588	http://dx.doi.org/10.1371/journal.pone.0131588			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154296	Green Published, Green Submitted, gold			2022-12-27	WOS:000358159700073
J	Tamura, M; Isojima, T; Kawashima, M; Yoshida, H; Yamamoto, K; Kitaoka, T; Namba, N; Oka, A; Ozono, K; Tokunaga, K; Kitanaka, S				Tamura, Mayuko; Isojima, Tsuyoshi; Kawashima, Minae; Yoshida, Hideki; Yamamoto, Keiko; Kitaoka, Taichi; Namba, Noriyuki; Oka, Akira; Ozono, Keiichi; Tokunaga, Katsushi; Kitanaka, Sachiko			Detection of Hereditary 1,25-Hydroxyvitamin D-Resistant Rickets Caused by Uniparental Disomy of Chromosome 12 Using Genome-Wide Single Nucleotide Polymorphism Array	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; INTESTINAL CALCIUM-ABSORPTION; MINERAL ION HOMEOSTASIS; ABLATED MICE; D-DEFICIENCY; 3 KINDREDS; GENE; ASSOCIATION; MECHANISMS; MUTATIONS	Context Hereditary 1,25-dihydroxyvitamin D-resistant rickets (HVDRR) is an autosomal recessive disease caused by biallelic mutations in the vitamin D receptor (VDR) gene. No patients have been reported with uniparental disomy (UPD). Objective Using genome-wide single nucleotide polymorphism (SNP) array to confirm whether HVDRR was caused by UPD of chromosome 12. Materials and Methods A 2-year-old girl with alopecia and short stature and without any family history of consanguinity was diagnosed with HVDRR by typical laboratory data findings and clinical features of rickets. Sequence analysis of VDR was performed, and the origin of the homozygous mutation was investigated by target SNP sequencing, short tandem repeat analysis, and genome-wide SNP array. Results The patient had a homozygous p.Arg73Ter nonsense mutation. Her mother was heterozygous for the mutation, but her father was negative. We excluded gross deletion of the father's allele or paternal discordance. Genome-wide SNP array of the family (the patient and her parents) showed complete maternal isodisomy of chromosome 12. She was successfully treated with high-dose oral calcium. Conclusions This is the first report of HVDRR caused by UPD, and the third case of complete UPD of chromosome 12, in the published literature. Genome-wide SNP array was useful for detecting isodisomy and the parental origin of the allele. Comprehensive examination of the homozygous state is essential for accurate genetic counseling of recurrence risk and appropriate monitoring for other chromosome 12 related disorders. Furthermore, oral calcium therapy was effective as an initial treatment for rickets in this instance.	[Tamura, Mayuko; Isojima, Tsuyoshi; Oka, Akira; Kitanaka, Sachiko] Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo, Japan; [Kawashima, Minae; Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo, Japan; [Yoshida, Hideki] Kyoto Prefectural Univ Med, Med Ctr N, Dept Pediat, Kyoto, Japan; [Yamamoto, Keiko; Kitaoka, Taichi; Namba, Noriyuki; Ozono, Keiichi] Osaka Univ, Grad Sch Med, Dept Pediat, Osaka, Japan	University of Tokyo; University of Tokyo; Kyoto Prefectural University of Medicine; Osaka University	Kitanaka, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo, Japan.	sachi-tky@umin.ac.jp		Isojima, Tsuyoshi/0000-0003-0011-0325	Japan Society for the Promotion of Science [23591489]; Ministry of Health, Labor and welfare	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and welfare(Ministry of Health, Labour and Welfare, Japan)	This study was supported by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (to T.I. and S.K., grant number 23591489), and for Research on Intractable Diseases from the Ministry of Health, Labor and welfare (to K.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amling M, 1999, ENDOCRINOLOGY, V140, P4982, DOI 10.1210/en.140.11.4982; Boisseau P, 2011, HAEMATOL-HEMATOL J, V96, P1567, DOI 10.3324/haematol.2010.036897; Bronner F, 2009, NUTR REV, V67, P109, DOI 10.1111/j.1753-4887.2008.00147.x; BROOKS MH, 1978, NEW ENGL J MED, V298, P996, DOI 10.1056/NEJM197805042981804; Chaturvedi D, 2012, HORM RES PAEDIAT, V78, P326, DOI 10.1159/000341405; Cho SY, 2013, CLIN CHIM ACTA, V426, P13, DOI 10.1016/j.cca.2013.08.013; Christakos Sylvia, 2014, Bonekey Rep, V3, P496, DOI 10.1038/bonekey.2013.230; Cockerill FJ, 1997, J CLIN ENDOCR METAB, V82, P3156, DOI 10.1210/jc.82.9.3156; de Macedo LC, 2008, ARQ BRAS ENDOCRINOL, V52, P1244, DOI 10.1590/S0004-27302008000800007; Engel E, 2006, EUR J HUM GENET, V14, P1158, DOI 10.1038/sj.ejhg.5201619; Goldstein BA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-49; Han L, 2011, GENET EPIDEMIOL, V35, P557, DOI 10.1002/gepi.20606; Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0; HUGHES MR, 1988, SCIENCE, V242, P1702, DOI 10.1126/science.2849209; Kagami M, 2005, AM J MED GENET A, V138A, P127, DOI 10.1002/ajmg.a.30941; Kitanaka S, 2004, J CLIN ENDOCR METAB, V89, P1369, DOI 10.1210/jc.2003-031308; Kitanaka S, 1998, NEW ENGL J MED, V338, P653, DOI 10.1056/NEJM199803053381004; Kitanaka S, 2012, ENDOCR J, V59, P1007, DOI 10.1507/endocrj.EJ12-0143; Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391; Liehr T, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-8; Malloy P, 2011, VITAMIN D; Malloy PJ, 2010, MOL GENET METAB, V99, P72, DOI 10.1016/j.ymgme.2009.09.004; Malloy PJ, 1999, ENDOCR REV, V20, P156, DOI 10.1210/er.20.2.156; Matsubara K, 2011, J HUM GENET, V56, P566, DOI 10.1038/jhg.2011.59; Papenhausen P, 2011, AM J MED GENET A, V155A, P757, DOI 10.1002/ajmg.a.33939; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roberts JL, 2012, P NATL ACAD SCI USA, V109, P10456, DOI 10.1073/pnas.1202249109; Robinson WP, 2000, BIOESSAYS, V22, P452; Sakai Y, 2001, J CLIN INVEST, V107, P961, DOI 10.1172/JCI11676; SAKATI N, 1986, HORM RES, V24, P280, DOI 10.1159/000180568; Schroeder C, 2013, BIOINFORMATICS, V29, P1562, DOI 10.1093/bioinformatics/btt174; SPENCE JE, 1988, AM J HUM GENET, V42, P217; WIESE RJ, 1993, MOL CELL ENDOCRINOL, V90, P197, DOI 10.1016/0303-7207(93)90152-A; Yamazawa K, 2010, AM J MED GENET C, V154C, P329, DOI 10.1002/ajmg.c.30270	35	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131157	10.1371/journal.pone.0131157	http://dx.doi.org/10.1371/journal.pone.0131157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26153892	gold, Green Submitted, Green Published			2022-12-27	WOS:000358159700054
J	Hammerton, G; Mahedy, L; Mars, B; Harold, GT; Thapar, A; Zammit, S; Collishaw, S				Hammerton, Gemma; Mahedy, Liam; Mars, Becky; Harold, Gordon T.; Thapar, Anita; Zammit, Stanley; Collishaw, Stephan			Association between Maternal Depression Symptoms across the First Eleven Years of Their Child's Life and Subsequent Offspring Suicidal Ideation	PLOS ONE			English	Article							POSTNATAL DEPRESSION; RISK-FACTORS; ADOLESCENT SUICIDE; SELF-HARM; PSYCHOPATHOLOGY; PREVALENCE; VALIDATION; BEHAVIOR; TRAJECTORIES; POPULATION	Depression is common, especially in women of child-bearing age; prevalence estimates for this group range from 8% to 12%, and there is robust evidence that maternal depression is associated with mental health problems in offspring. Suicidal behaviour is a growing concern amongst young people and those exposed to maternal depression are likely to be especially at high risk. The aim of this study was to utilise a large, prospective population cohort to examine the relationship between depression symptom trajectories in mothers over the first eleven years of their child's life and subsequent adolescent suicidal ideation. An additional aim was to test if associations were explained by maternal suicide attempt and offspring depressive disorder. Data were utilised from a population-based birth cohort: the Avon Longitudinal Study of Parents and Children. Maternal depression symptoms were assessed repeatedly from pregnancy to child age 11 years. Offspring suicidal ideation was assessed at age 16 years. Using multiple imputation, data for 10,559 families were analysed. Using latent class growth analysis, five distinct classes of maternal depression symptoms were identified (minimal, mild, increasing, sub-threshold, chronic-severe). The prevalence of past-year suicidal ideation at age 16 years was 15% (95% CI: 14-17%). Compared to offspring of mothers with minimal symptoms, the greatest risk of suicidal ideation was found for offspring of mothers with chronic-severe symptoms [OR 3.04 (95% CI 2.19, 4.21)], with evidence for smaller increases in risk of suicidal ideation in offspring of mothers with sub-threshold, increasing and mild symptoms. These associations were not fully accounted for by maternal suicide attempt or offspring depression diagnosis. Twenty-six percent of non-depressed offspring of mothers with chronic-severe depression symptoms reported suicidal ideation. Risk for suicidal ideation should be considered in young people whose mothers have a history of sustained high levels of depression symptoms, even when the offspring themselves do not have a depression diagnosis.	[Hammerton, Gemma; Mahedy, Liam; Thapar, Anita; Zammit, Stanley; Collishaw, Stephan] Cardiff Univ, Inst Psychol Med & Clin Neurosci, Cardiff CF10 3AX, S Glam, Wales; [Mars, Becky; Zammit, Stanley] Univ Bristol, Ctr Acad Mental Hlth, Bristol, Avon, England; [Harold, Gordon T.] Univ Sussex, Sch Psychol, Andrew & Virginia Rudd Ctr Adopt Res & Practice, Sussex, England; [Harold, Gordon T.] Tomsk State Univ, Int Ctr Res Human Dev, Tomsk 634050, Tomsk Oblast, Russia	Cardiff University; University of Bristol; University of Sussex; Tomsk State University	Hammerton, G (corresponding author), Cardiff Univ, Inst Psychol Med & Clin Neurosci, Cardiff CF10 3AX, S Glam, Wales.	hammertongl@cardiff.ac.uk	Harold, Gordon Thomas/O-1363-2014; Thapar, Anita/AAH-5555-2020	Thapar, Anita/0000-0002-3689-737X; Hammerton, Gemma/0000-0002-7781-3857; Collishaw, Stephan/0000-0002-4296-820X; Mars, Becky/0000-0002-8132-6920; Zammit, Stanley/0000-0002-2647-9211; Mahedy, Liam/0000-0001-5417-6595	Neuroscience and Mental Health Interdisciplinary Research Group (NNH-IRG) at Cardiff University; Waterloo Foundation; Elizabeth Blackwell Institute for Health Research Institutional Wellcome Trust Strategic Award [097822/Z/11/ZR]; Medical Research Council [MR/L010305/1, MC_PC_15018] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [06JTA] Funding Source: researchfish	Neuroscience and Mental Health Interdisciplinary Research Group (NNH-IRG) at Cardiff University; Waterloo Foundation; Elizabeth Blackwell Institute for Health Research Institutional Wellcome Trust Strategic Award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust	This research was specifically funded by a PhD stipend from the Neuroscience and Mental Health Interdisciplinary Research Group (NNH-IRG) at Cardiff University. SC is supported by the Waterloo Foundation. BM is supported by an Elizabeth Blackwell Institute for Health Research Institutional Wellcome Trust Strategic Award (grant reference: 097822/Z/11/ZR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker ED, 2013, PSYCHOL MED, V43, P1587, DOI 10.1017/S0033291712002450; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; BRENT DA, 1994, ACTA PSYCHIAT SCAND, V89, P52, DOI 10.1111/j.1600-0447.1994.tb01485.x; Bridge JA, 2006, J CHILD PSYCHOL PSYC, V47, P372, DOI 10.1111/j.1469-7610.2006.01615.x; Brown G., 1978, SOCIAL ORIGINS DEPRE; Brown GK, 2000, J CONSULT CLIN PSYCH, V68, P371, DOI 10.1037/0022-006X.68.3.371; Campbell SB, 2007, DEV PSYCHOL, V43, P1202, DOI 10.1037/0012-1649.43.5.1202; Campbell SB, 2009, J ABNORM PSYCHOL, V118, P479, DOI 10.1037/a0015923; Cents RAM, 2013, PSYCHOL MED, V43, P13, DOI 10.1017/S0033291712000657; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Eberhard-Gran M, 2001, ACTA PSYCHIAT SCAND, V104, P243, DOI 10.1034/j.1600-0447.2001.00187.x; Enders C. K., 2010, APPL MISSING DATA AN; Evans E, 2004, CLIN PSYCHOL REV, V24, P957, DOI 10.1016/j.cpr.2004.04.005; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Garber J, 1998, J ADOLESCENCE, V21, P445, DOI 10.1006/jado.1998.0161; Geulayov G, 2012, PSYCHOL MED, V42, P1567, DOI 10.1017/S0033291711002753; Geulayov G, 2014, J AM ACAD CHILD PSY, V53, P509, DOI 10.1016/j.jaac.2013.12.022; Goodman A, 2011, SOC PSYCH PSYCH EPID, V46, P521, DOI 10.1007/s00127-010-0219-x; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Goodman SH, 1999, PSYCHOL REV, V106, P458, DOI 10.1037/0033-295X.106.3.458; Gureje O, 2011, MOL PSYCHIATR, V16, P1221, DOI 10.1038/mp.2010.111; Johnson JG, 2002, ARCH GEN PSYCHIAT, V59, P741, DOI 10.1001/archpsyc.59.8.741; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Kidger J, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-69; Lewinsohn PM, 1996, CLIN PSYCHOL-SCI PR, V3, P25, DOI 10.1111/j.1468-2850.1996.tb00056.x; Lewis G, 2011, J AM ACAD CHILD PSY, V50, P451, DOI 10.1016/j.jaac.2011.01.015; Mars B, 2015, J AFFECT DISORDERS, V182, P32, DOI 10.1016/j.jad.2015.04.018; Matijasevich A, 2015, J AFFECT DISORDERS, V174, P424, DOI 10.1016/j.jad.2014.12.012; Mittendorfer-Rutz E, 2008, SOC PSYCH PSYCH EPID, V43, P28, DOI 10.1007/s00127-007-0266-0; Moodie EEM, 2008, INT J BIOSTAT, V4; MURRAY L, 1990, BRIT J PSYCHIAT, V157, P288, DOI 10.1192/bjp.157.2.288; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; Nagin D. S, 2005, GROUP BASED MODELLIN; Nandi A, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-31; Nivard MG, 2015, PSYCHOL MED, V45, P1039, DOI 10.1017/S003329171400213X; Nock MK, 2013, JAMA PSYCHIAT, V70, P300, DOI 10.1001/2013.jamapsychiatry.55; Pearson RM, 2013, JAMA PSYCHIAT, V70, P1312, DOI 10.1001/jamapsychiatry.2013.2163; Pel A. J., 2015, PSYCHOL MED, P1, DOI [DOI 10.1080/14719037.2015.1045020, 10.3997/2214-4609.201412939]; Potter R, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X652355; Skipstein Anni, 2010, BMC Public Health, V10, P589, DOI 10.1186/1471-2458-10-589; StataCorp, 2013, STAT STAT SOFTW REL; Van Buuren S., 2000, MICE MULTIVARIATE IM; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wilcox HC, 2010, J AFFECT DISORDERS, V127, P287, DOI 10.1016/j.jad.2010.04.017; Zanarini M, 2004, UK VERSION CHI UNPUB	45	28	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131885	10.1371/journal.pone.0131885	http://dx.doi.org/10.1371/journal.pone.0131885			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EC	26151929	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000358158900027
J	Moustafa, AM; Seemann, T; Gladman, S; Adler, B; Harper, M; Boyce, JD; Bennett, MD				Moustafa, Ahmed M.; Seemann, Torsten; Gladman, Simon; Adler, Ben; Harper, Marina; Boyce, John D.; Bennett, Mark D.			Comparative Genomic Analysis of Asian Haemorrhagic Septicaemia-Associated Strains of Pasteurella multocida Identifies More than 90 Haemorrhagic Septicaemia-Specific Genes	PLOS ONE			English	Article							CONJUGATIVE ELEMENT ICE; SEQUENCE; PHAGE; ORGANIZATION; VIRULENCE; ICEPMU1	Pasteurella multocida is the primary causative agent of a range of economically important diseases in animals, including haemorrhagic septicaemia (HS), a rapidly fatal disease of ungulates. There is limited information available on the diversity of P. multocida strains that cause HS. Therefore, we determined draft genome sequences of ten disease-causing isolates and two vaccine strains and compared these genomes using a range of bioinformatic analyses. The draft genomes of the 12 HS strains were between 2,298,035 and 2,410,300 bp in length. Comparison of these genomes with the North American HS strain, M1404, and other available P. multocida genomes (Pm70, 3480, 36950 and HN06) identified a core set of 1,824 genes. A set of 96 genes was present in all HS isolates and vaccine strains examined in this study, but absent from Pm70, 3480, 36950 and HN06. Moreover, 59 genes were shared only by the Asian B: 2 strains. In two Pakistani isolates, genes with high similarity to genes in the integrative and conjugative element, ICEPmu1 from strain 36950 were identified along with a range of other antimicrobial resistance genes. Phylogenetic analysis indicated that the HS strains formed clades based on their country of isolation. Future analysis of the 96 genes unique to the HS isolates will aid the identification of HS-specific virulence attributes and facilitate the development of disease-specific diagnostic tests.	[Moustafa, Ahmed M.; Bennett, Mark D.] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Seemann, Torsten; Gladman, Simon] Monash Univ, Victorian Bioinformat Consortium, Melbourne, Vic 3004, Australia; [Adler, Ben; Harper, Marina; Boyce, John D.] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Melbourne, Vic 3004, Australia; [Adler, Ben; Harper, Marina; Boyce, John D.] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia; [Seemann, Torsten; Gladman, Simon] Victorian Life Sci Computat Initiat, Melbourne, Vic, Australia	Murdoch University; Monash University; Monash University; Monash University	Boyce, JD (corresponding author), Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Wellington Rd, Melbourne, Vic 3004, Australia.	john.boyce@monash.edu	Seemann, Torsten/B-2318-2010; Moustafa, Ahmed/S-2185-2018; Boyce, John D/F-5058-2012	Seemann, Torsten/0000-0001-6046-610X; Moustafa, Ahmed/0000-0002-9949-6936; Boyce, John D/0000-0002-8614-3074; Harper, Marina/0000-0001-8396-0311	Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics [CE0562063]; Australian Research Council	Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council); Australian Research Council(Australian Research Council)	Funding was provided by the Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics, Grant number CE0562063; Australian Research Council, http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahante Juan E, 2013, Genome Announc, V1, DOI 10.1128/genomeA.00058-12; Ahir VB, 2011, J BACTERIOL, V193, P5604, DOI 10.1128/JB.05706-11; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANBA J, 1995, J BACTERIOL, V177, P3818, DOI 10.1128/jb.177.13.3818-3823.1995; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Benkirane A, 2002, VET MED-CZECH, V47, P234, DOI 10.17221/5830-VETMED; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Boyce JD, 2012, CURR TOP MICROBIOL, V361, P23, DOI 10.1007/82_2012_203; Boyce JD, 2000, VET MICROBIOL, V72, P121, DOI 10.1016/S0378-1135(99)00193-5; Boyd EF, 2002, TRENDS MICROBIOL, V10, P521, DOI 10.1016/S0966-842X(02)02459-9; Campoy S, 2006, APPL ENVIRON MICROB, V72, P3154, DOI 10.1128/AEM.72.5.3154-3160.2006; CARTER GR, 1955, AM J VET RES, V16, P481; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; De Alwis MCL, 1999, HAEMORRHAGIC SEPTICA, P11; Dziva F, 2008, VET MICROBIOL, V128, P1, DOI 10.1016/j.vetmic.2007.10.018; GARVEY P, 1995, APPL ENVIRON MICROB, V61, P4321, DOI 10.1128/AEM.61.12.4321-4328.1995; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Harper M, 2007, INFECT IMMUN, V75, P3885, DOI 10.1128/IAI.00212-07; Harper M, 2010, INFECT IMMUN, V78, P3669, DOI 10.1128/IAI.00457-10; HEDDLESTON KL, 1972, AVIAN DIS, V16, P925, DOI 10.2307/1588773; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Liu WJ, 2012, J BACTERIOL, V194, P3292, DOI 10.1128/JB.00215-12; May BJ, 2001, P NATL ACAD SCI USA, V98, P3460, DOI 10.1073/pnas.051634598; Michael FS, 2009, J BACTERIOL, V191, P6950, DOI 10.1128/JB.00787-09; Michael GB, 2012, J ANTIMICROB CHEMOTH, V67, P84, DOI 10.1093/jac/dkr406; Michael GB, 2012, J ANTIMICROB CHEMOTH, V67, P91, DOI 10.1093/jac/dkr411; Mohd-Zain Z, 2004, J BACTERIOL, V186, P8114, DOI 10.1128/JB.186.23.8114-8122.2004; Moustafa AM, 2013, RES VET SCI, V95, P986, DOI 10.1016/j.rvsc.2013.07.003; Neramitmansook P, 1993, ACIAR P, V43, P234; Pullinger GD, 2004, MOL MICROBIOL, V51, P255, DOI 10.1046/j.1365-2958.2003.03829.x; Rimler R. B., 1989, PASTEURELLA PASTEURE, P37; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; Townsend KM, 1998, J CLIN MICROBIOL, V36, P1096, DOI 10.1128/JCM.36.4.1096-1100.1998; Townsend KM, 2001, J CLIN MICROBIOL, V39, P924, DOI 10.1128/JCM.39.3.924-929.2001; Vaid R K, 2014, Genome Announc, V2, DOI 10.1128/genomeA.00755-14; Wilson BA, 2013, CLIN MICROBIOL REV, V26, P631, DOI 10.1128/CMR.00024-13; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	41	28	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0130296	10.1371/journal.pone.0130296	http://dx.doi.org/10.1371/journal.pone.0130296			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151935	Green Published, gold			2022-12-27	WOS:000358158900007
J	Cho, SH; Ko, JJ; Kim, JO; Jeon, YJ; Yoo, JK; Oh, J; Oh, D; Kim, JW; Kim, NK				Cho, Sung Hwan; Ko, Jung Jae; Kim, Jung Oh; Jeon, Young Joo; Yoo, Jung Ki; Oh, Jisu; Oh, Doyeun; Kim, Jong Woo; Kim, Nam Keun			3 '-UTR Polymorphisms in the MiRNA Machinery Genes DROSHA, DICER1, RAN, and XPO5 Are Associated with Colorectal Cancer Risk in a Korean Population	PLOS ONE			English	Article							INSULIN-RESISTANCE SYNDROME; MICRORNA-RELATED GENES; LOW FOLATE LEVELS; METABOLIC SYNDROME; COLON-CANCER; IMMUNOHISTOCHEMICAL ANALYSIS; ADENOMA RECURRENCE; REDUCED EXPRESSION; PROGNOSTIC-FACTORS; POOR-PROGNOSIS	MicroRNAs play an important role in cancer initiation and development. The aim of this study was to investigate whether polymorphisms in miRNA machinery genes are associated with the development of colorectal cancer (CRC). RAN rs14035 CT heterozygotes and T allele carriers (CT + TT) genotypes had lower risk of CRC, while the DICER1 rs3742330, DROSHA rs10719, and XPO5 rs11077 polymorphisms were not associated with CRC in the full study sample. Specifically, male RAN rs14035 CT heterozygotes and XPO5 rs11077 AA genotype (CT/AA) carriers experienced reduced CRC susceptibility (both colon and rectal). Subgroup analysis demonstrated that the combined RAN rs14035 CT + TT genotype was associated with rectal cancer, but not colon cancer. In addition, the DICER1 rs3742330 AG genotype was associated with a significantly increased risk of colon cancer. Stratified analysis revealed the RAN rs14035 combined CT+TT genotype was associated with decreased CRC risk in male patients without diabetes mellitus (DM) and in patients with rectal cancer. In addition, we found the RAN rs14035 CC genotype was related to a decreased risk of CRC with respect to tumor size and metabolism of homocysteine and folate. Furthermore, patients diagnosed with hypertension or DM who carried the DROSHA rs10719 CC genotype showed increased CRC risk, while the XPO5 rs11077 AC+CC genotype led to increased CRC risk in patients with hypertension only. Our results indicate variations in RANrs14035, DICER1 rs3742330, XPO5 rs11077, and DROSHA rs10719 of Korean patients are significantly associated with their risk of CRC.	[Cho, Sung Hwan; Ko, Jung Jae; Kim, Jung Oh; Jeon, Young Joo; Yoo, Jung Ki; Kim, Nam Keun] CHA Univ, Dept Biomed Sci, Coll Life Sci, Seongnam, South Korea; [Cho, Sung Hwan; Kim, Jung Oh; Jeon, Young Joo; Oh, Doyeun; Kim, Nam Keun] CHA Univ, Inst Clin Res, CHA Bundang Med Ctr, Seongnam, South Korea; [Oh, Jisu; Oh, Doyeun] CHA Univ, Dept Internal Med, CHA Bundang Med Ctr, Seongnam, South Korea; [Kim, Jong Woo] CHA Univ, Dept Surg, CHA Bundang Med Ctr, Seongnam, South Korea	Pochon Cha University; Pochon Cha University; Pochon Cha University; Pochon Cha University	Kim, JW (corresponding author), CHA Univ, Dept Surg, CHA Bundang Med Ctr, Seongnam, South Korea.	kjw@cha.ac.kr; namkkim@naver.com		Kim, Jung Oh/0000-0002-4171-2034	Korean Government, Republic of Korea [NRF-2012R1A1A2007033, 2009-0093821]	Korean Government, Republic of Korea(Korean Government)	National Research Foundation of Korea Grants funded by the Korean Government (NRF-2012R1A1A2007033 & 2009-0093821), Republic of Korea (http://www.nrf.re.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abotchie PN, 2012, J WOMENS HEALTH, V21, P393, DOI 10.1089/jwh.2011.2992; Abrahams Y, 2013, ANN HUM GENET, V77, P204, DOI 10.1111/ahg.12013; Ahmed RL, 2006, CANCER-AM CANCER SOC, V107, P28, DOI 10.1002/cncr.21950; Akdeli N, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-87; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bahubeshi A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002493; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boni V, 2010, MOL CANCER THER, V9, P2265, DOI 10.1158/1535-7163.MCT-10-0061; Bowers K, 2006, AM J EPIDEMIOL, V164, P652, DOI 10.1093/aje/kwj253; Boyle P, 2008, WORLD CANC REPORT 20, P374; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Campayo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022509; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chiosea SI, 2008, VIRCHOWS ARCH, V452, P629, DOI 10.1007/s00428-007-0574-5; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; Clague J, 2010, MOL CARCINOGEN, V49, P183, DOI 10.1002/mc.20588; Colangelo LA, 2002, CANCER EPIDEM BIOMAR, V11, P385; Compton C, 2000, CANCER-AM CANCER SOC, V88, P1739, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1739::AID-CNCR30>3.0.CO;2-T; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; Dewi DL, 2012, INT J MOL MED, V29, P1060, DOI 10.3892/ijmm.2012.945; Eamens AL, 2009, RNA, V15, P2219, DOI 10.1261/rna.1646909; Faggad A, 2012, HISTOPATHOLOGY, V61, P552, DOI 10.1111/j.1365-2559.2011.04110.x; Fan HW, 2013, INT J CLIN ONCOL, V18, P856, DOI 10.1007/s10147-012-0465-x; Ferlay J., 2013, IARC CANCERBASE, V11; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; GIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327, DOI 10.7326/0003-4819-122-5-199503010-00002; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435; Grelier G, 2009, BRIT J CANCER, V101, P673, DOI 10.1038/sj.bjc.6605193; Gylling B, 2014, CANCER EPIDEM BIOMAR, V23, P2136, DOI 10.1158/1055-9965.EPI-13-1352; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hamaya Y, 2012, CLIN TRANSL GASTROEN, V3, DOI 10.1038/ctg.2012.12; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Horikawa Y, 2008, CLIN CANCER RES, V14, P7956, DOI 10.1158/1078-0432.CCR-08-1199; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Izaurralde E, 1997, J CELL BIOL, V137, P27, DOI 10.1083/jcb.137.1.27; Jaggers JR, 2009, EUR J CANCER, V45, P1831, DOI 10.1016/j.ejca.2009.01.031; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jeon YJ, 2012, GENE, V494, P168, DOI 10.1016/j.gene.2011.12.026; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kurisetty VV, 2008, ONCOGENE, V27, P7139, DOI 10.1038/onc.2008.325; Leaderer D, 2011, INT J MOL EPIDEMIOL, V2, P9; Lee HC, 2010, J CANCER RES CLIN, V136, P1073, DOI 10.1007/s00432-009-0754-6; Lee JE, 2012, CANCER CAUSE CONTROL, V23, P537, DOI 10.1007/s10552-012-9911-3; Levine AJ, 2010, CANCER EPIDEM BIOMAR, V19, P2541, DOI 10.1158/1055-9965.EPI-10-0536; Li X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051640; Li X, 2010, RNA, V16, P1096, DOI 10.1261/rna.2017210; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lin MB, 2012, CLIN CANCER RES, V18, P3982, DOI 10.1158/1078-0432.CCR-11-2951; Martinez ME, 2006, INT J CANCER, V119, P1440, DOI 10.1002/ijc.21978; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Pais R, 2009, WORLD J GASTROENTERO, V15, P5141, DOI 10.3748/wjg.15.5141; Papachristou DJ, 2012, HISTOPATHOLOGY, V60, pE28, DOI 10.1111/j.1365-2559.2012.04192.x; Papachristou DJ, 2012, CANCER INVEST, V30, P172, DOI 10.3109/07357907.2011.633293; Papachristou DJ, 2011, VIRCHOWS ARCH, V459, P431, DOI 10.1007/s00428-011-1119-5; Persson H, 2011, CANCER RES, V71, P78, DOI 10.1158/0008-5472.CAN-10-1869; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Sand M, 2010, CANCER INVEST, V28, P649, DOI 10.3109/07357901003630918; Sazer S, 2000, J CELL SCI, V113, P1111; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schoen RE, 1999, JNCI-J NATL CANCER I, V91, P1147, DOI 10.1093/jnci/91.13.1147; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Stocks T, 2008, INT J OBESITY, V32, P304, DOI 10.1038/sj.ijo.0803713; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Tsoi KKF, 2009, CLIN GASTROENTEROL H, V7, P682, DOI 10.1016/j.cgh.2009.02.016; Van Guelpen B, 2006, GUT, V55, DOI 10.1136/gut.2005.085480; Wang J, 2011, J BIOSCIENCES, V36, P481, DOI 10.1007/s12038-011-9083-4; Ye YQ, 2008, CANCER PREV RES, V1, P460, DOI 10.1158/1940-6207.CAPR-08-0135; Yuhara H, 2011, AM J GASTROENTEROL, V106, P1911, DOI 10.1038/ajg.2011.301; Zhao YF, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S78647	75	32	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131125	10.1371/journal.pone.0131125	http://dx.doi.org/10.1371/journal.pone.0131125			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147304	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600063
J	Cox, RJ; Major, D; Pedersen, G; Pathirana, RD; Hoschler, K; Guilfoyle, K; Roseby, S; Bredholt, G; Assmus, J; Breakwell, L; Campitelli, L; Sjursen, H				Cox, Rebecca J.; Major, Diane; Pedersen, Gabriel; Pathirana, Rishi D.; Hoschler, Katja; Guilfoyle, Kate; Roseby, Sarah; Bredholt, Geir; Assmus, Jorg; Breakwell, Lucy; Campitelli, Laura; Sjursen, Haakon			Matrix M H5N1 Vaccine Induces Cross-H5 Clade Humoral Immune Responses in a Randomized Clinical Trial and Provides Protection from Highly Pathogenic Influenza Challenge in Ferrets	PLOS ONE			English	Article							MEMORY B-CELLS; PHASE-I; MF59-ADJUVANTED INFLUENZA; ANTIBODY-RESPONSES; REACTIVE IMMUNITY; M(TM) ADJUVANT; PLASMA-CELLS; SAFETY; IMMUNOGENICITY	Background and Methods Highly pathogenic avian influenza (HPAI) viruses constitute a pandemic threat and the development of effective vaccines is a global priority. Sixty adults were recruited into a randomized clinical trial and were intramuscularly immunized with two virosomal vaccine H5N1 (NIBRG-14) doses (21 days apart) of 30 mu g HA alone or 1.5, 7.5 or 30 mu g HA adjuvanted with Matrix M. The kinetics and longevity of the serological responses against NIBRG-14 were determined by haemagglutination inhibition (HI), single radial haemolysis (SRH), microneutralization (MN) and ELISA assays. The cross-H5 clade responses in sera were determined by HI and the antibody-secreting (ASC) cell ELISPOT assays. The protective efficacy of the vaccine against homologous HPAI challenge was evaluated in ferrets. Results The serological responses against the homologous and cross-reactive strains generally peaked one week after the second dose, and formulation with Matrix M augmented the responses. The NIBRG-14-specific seroprotection rates fell significantly by six months and were low against cross-reactive strains although the adjuvant appeared to prolong the longevity of the protective responses in some subjects. By 12 months post-vaccination, nearly all vaccinees had NIBRG-14-specific antibody titres below the protective thresholds. The Matrix M adjuvant was shown to greatly improve ASC and serum IgG responses following vaccination. In a HPAI ferret challenge model, the vaccine protected the animals from febrile responses, severe weight loss and local and systemic spread of the virus. Conclusion Our findings show that the Matrix M-adjuvanted virosomal H5N1 vaccine is a promising prepandemic vaccine candidate.	[Cox, Rebecca J.; Pedersen, Gabriel; Pathirana, Rishi D.; Bredholt, Geir; Sjursen, Haakon] Univ Bergen, Dept Clin Sci, Influenza Ctr, Bergen, Norway; [Cox, Rebecca J.; Pathirana, Rishi D.; Bredholt, Geir; Assmus, Jorg] Haukeland Hosp, Dept Res & Dev, N-5021 Bergen, Norway; [Cox, Rebecca J.; Pathirana, Rishi D.; Bredholt, Geir] Univ Bergen, Jebsen Ctr Influenza Vaccine Res, Bergen, Norway; [Major, Diane; Guilfoyle, Kate; Roseby, Sarah] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England; [Hoschler, Katja; Breakwell, Lucy] Publ Hlth England PHE Colindale, Resp Unit, London, England; [Campitelli, Laura] Ist Super Sanita, I-00161 Rome, Italy; [Sjursen, Haakon] Haukeland Hosp, Infect Dis Sect, Dept Med, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; National Institute for Biological Standards & Control; Public Health England; Istituto Superiore di Sanita (ISS); University of Bergen; Haukeland University Hospital	Cox, RJ (corresponding author), Univ Bergen, Dept Clin Sci, Influenza Ctr, Bergen, Norway.	rebecca.cox@k2.uib.no		Bredholt, Geir/0000-0002-8953-8821; Pedersen, Gabriel/0000-0001-6872-3975	Ministry of Health and Care Services, Norway; EU FP7 UniVax [601738]; Helse Vest, Norway; RCN Globvac, Norway [220670]; K.G. Jebsen Centre for Influenza Vaccine Research	Ministry of Health and Care Services, Norway; EU FP7 UniVax; Helse Vest, Norway; RCN Globvac, Norway; K.G. Jebsen Centre for Influenza Vaccine Research	The work was financed by the Ministry of Health and Care Services, Norway; EU FP7 UniVax (601738); Helse Vest, Norway; RCN Globvac, Norway (220670) and the K.G. Jebsen Centre for Influenza Vaccine Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banner D, 2012, J INFECT DEV COUNTR, V6, P465; Banzhoff A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004384; Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; Baz M, 2013, VIRUS RES, V178, P78, DOI 10.1016/j.virusres.2013.05.006; Bengtsson KL, 2011, EXPERT REV VACCINES, V10, P401, DOI [10.1586/erv.11.25, 10.1586/ERV.11.25]; Bihari I, 2012, CLIN VACCINE IMMUNOL, V19, P1943, DOI 10.1128/CVI.00373-12; BROKSTAD KA, 1995, J INFECT DIS, V171, P198, DOI 10.1093/infdis/171.1.198; Brown IH, 2009, INFLUENZA OTHER RESP, V3, P59, DOI 10.1111/j.1750-2659.2009.00078.x; Cox RJ, 2011, VACCINE, V29, P8049, DOI 10.1016/j.vaccine.2011.08.042; Cox RJ, 2009, VACCINE, V27, P1889, DOI 10.1016/j.vaccine.2009.01.116; COX RJ, 1994, VACCINE, V12, P993, DOI 10.1016/0264-410X(94)90334-4; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Donis R. O., 2008, Emerging Infectious Diseases, V14, pe1; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Forrest HL, 2009, VACCINE, V27, P4187, DOI 10.1016/j.vaccine.2009.04.050; Frolich D, 2010, J IMMUNOL, V185, P3103, DOI 10.4049/jimmunol.1000911; Hovden AO, 2005, SCAND J IMMUNOL, V62, P36, DOI 10.1111/j.1365-3083.2005.01633.x; Leroux-Roels I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001665; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Madhun AS, 2009, VACCINE, V27, P7367, DOI 10.1016/j.vaccine.2009.09.044; Mahy BWJ, 1996, VIROLOGY METHODS MAN; Montomoli E, 2011, EXPERT REV VACCINES, V10, P1053, DOI [10.1586/erv.11.48, 10.1586/ERV.11.48]; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Nolan TM, 2008, VACCINE, V26, P4160, DOI 10.1016/j.vaccine.2008.05.077; Pathirana RD, 2012, J INFECT DIS, V206, P1660, DOI 10.1093/infdis/jis589; Pedersen G, 2011, INFLUENZA OTHER RESP, V5, P426, DOI 10.1111/j.1750-2659.2011.00256.x; Pedersen GK, 2012, J INFECT DIS, V206, P158, DOI 10.1093/infdis/jis330; Pedersen GK, 2014, VACCINE, V32, P4550, DOI 10.1016/j.vaccine.2014.06.009; Pedersen GK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026973; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; Stephenson I, 2005, J INFECT DIS, V191, P1210, DOI 10.1086/428948; Stephenson I, 2008, NEW ENGL J MED, V359, P1631, DOI 10.1056/NEJMc0805274; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Treanor JJ, 2013, VACCINE, V31, P5760, DOI 10.1016/j.vaccine.2013.08.064; Van Kerkhove MD, 2013, INFLUENZA OTHER RESP, V7, P26, DOI 10.1111/irv.12077; *WHO, REC LAB PROC DET AV; WHO Expert Committee on Biological Standardization, 2005, WHO BIOS RISK ASS GU; World Health Organization, 2014, INFL HUM AN INT SUMM	38	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131652	10.1371/journal.pone.0131652	http://dx.doi.org/10.1371/journal.pone.0131652			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147369	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600118
J	Li, K; Cui, YC; Zhang, H; Liu, XP; Zhang, D; Wu, AL; Li, JJ; Tang, Y				Li, Kai; Cui, Yong-Chun; Zhang, Hong; Liu, Xiao-Peng; Zhang, Dong; Wu, Ai-Li; Li, Jian-Jun; Tang, Yue			Glutamine Reduces the Apoptosis of H9C2 Cells Treated with High-Glucose and Reperfusion through an Oxidation-Related Mechanism	PLOS ONE			English	Article							COMPLEX-I; MITOCHONDRIAL GLUTATHIONE; CARDIAC MITOCHONDRIA; SUPEROXIDE FORMATION; REDOX REGULATION; STRESS; INJURY; ANTIOXIDANT; METABOLISM; PROTEIN	Mitochondrial overproduction of reactive oxygen species (ROS) in diabetic hearts during ischemia/reperfusion injury and the anti-oxidative role of glutamine have been demonstrated. However, in diabetes mellitus the role of glutamine in cardiomyocytes during ischemia/reperfusion injury has not been explored. To examine the effects of glutamine and potential mechanisms, in the present study, rat cardiomyoblast H9C2 cells were exposed to high glucose (33 mM) and hypoxia-reoxygenation. Cell viability, apoptosis, intracellular glutamine, and mitochondrial and intracellular glutathione were determined. Moreover, ROS formation, complex I activity, membrane potential and adenosine triphosphate (ATP) content were also investigated. The levels of S-glutathionylated complex I and mitochondrial apoptosis-related proteins, including cytochrome c and caspase-3, were analyzed by western blot. Data indicated that high glucose and hypoxia-reoxygenation were associated with a dramatic decline of intercellular glutamine and increase in apoptosis. Glutamine supplementation correlated with a reduction in apoptosis and increase of glutathione and glutathione reduced/oxidized ratio in both cytoplasm and mitochondria, but a reduction of intracellular ROS. Glutamine supplementation was also associated with less S-glutathionylation and increased the activity of complex I, leading to less mitochondrial ROS formation. Furthermore, glutamine supplementation prevented from mitochondrial dysfunction presented as mitochondrial membrane potential and ATP levels and attenuated cytochrome c release into the cytosol and caspase-3 activation. We conclude that apoptosis induced by high glucose and hypoxia-reoxygenation was reduced by glutamine supplementation, via decreased oxidative stress and inactivation of the intrinsic apoptotic pathway.	[Li, Kai; Cui, Yong-Chun; Zhang, Hong; Liu, Xiao-Peng; Zhang, Dong; Wu, Ai-Li; Tang, Yue] Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Beijing Key Lab Preclin Res & Evaluat Cardiovasc, Anim Expt Ctr,Fu Wai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Li, Kai; Cui, Yong-Chun; Zhang, Hong; Liu, Xiao-Peng; Zhang, Dong; Wu, Ai-Li; Tang, Yue] Peking Union Med Coll, Beijing 100021, Peoples R China; [Li, Jian-Jun] Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Div Dyslipidemia, Fu Wai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Li, JJ (corresponding author), Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Div Dyslipidemia, Fu Wai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China.	lijianjun938@126.com; Tangyue1226@vip.sina.com	Cui, Yong/AAF-9300-2020		Beijing Science and Technology Committee Fund [Z101107052210004]; Peking Union Medical College Youth Fund [2012-XHQN04]; Peking Union Medical College Student Innovation Fund [2013-1002-45]	Beijing Science and Technology Committee Fund; Peking Union Medical College Youth Fund; Peking Union Medical College Student Innovation Fund	Beijing Science and Technology Committee Fund (Project No: Z101107052210004), YT. Peking Union Medical College Youth Fund (Project No: 2012-XHQN04), YCC. Peking Union Medical College Student Innovation Fund (Project No: 2013-1002-45), KL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow J, 2015, REDOX BIOL, V4, P14, DOI 10.1016/j.redox.2014.11.009; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; Bi J, 2008, NEUROSCI LETT, V442, P224, DOI 10.1016/j.neulet.2008.07.029; Cao HQ, 2012, APMIS, V120, P441, DOI 10.1111/j.1600-0463.2011.02825.x; Chen YR, 2014, CIRC RES, V114, P524, DOI 10.1161/CIRCRESAHA.114.300559; Circu ML, 2008, FREE RADICAL RES, V42, P689, DOI 10.1080/10715760802317663; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Dimauro Ivan, 2012, BMC Res Notes, V5, P513, DOI 10.1186/1756-0500-5-513; Eaton S, 2003, P NUTR SOC, V62, P745, DOI 10.1079/PNS2003284; Filippi C, 2015, NANOTOXICOLOGY, V9, P126, DOI 10.3109/17435390.2014.895437; Galli S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007541; Ghosh S, 2005, AM J PHYSIOL-HEART C, V289, pH768, DOI 10.1152/ajpheart.00038.2005; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Johansen JS, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-5; Lee Min Goo, 2009, Korean Circ J, V39, P243, DOI 10.4070/kcj.2009.39.6.243; Liu J, 2007, J MOL CELL CARDIOL, V42, P177, DOI 10.1016/j.yjmcc.2006.09.015; Lluis JM, 2005, J BIOL CHEM, V280, P3224, DOI 10.1074/jbc.M408244200; Mailloux RJ, 2013, TRENDS BIOCHEM SCI, V38, P592, DOI 10.1016/j.tibs.2013.09.001; Mapanga RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047322; Mari M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]; Mari M, 2013, BBA-GEN SUBJECTS, V1830, P3317, DOI 10.1016/j.bbagen.2012.10.018; Mates JM, 2009, INT J BIOCHEM CELL B, V41, P2051, DOI 10.1016/j.biocel.2009.03.003; Munzel T, 2010, EUR HEART J, V31, P2741, DOI 10.1093/eurheartj/ehq396; Natalicchio A, 2015, DIABETOLOGIA, V58, P1260, DOI 10.1007/s00125-015-3563-2; Naudi A, 2012, EXP DIABETES RES, DOI 10.1155/2012/696215; Ogunlesi F, 2004, BBA-MOL BASIS DIS, V1688, P112, DOI 10.1016/j.bbadis.2003.10.008; Paillard M, 2013, CIRCULATION, V128, P1555, DOI 10.1161/CIRCULATIONAHA.113.001225; Passarelli C, 2010, INT J MOL MED, V26, P95, DOI 10.3892/ijmm_00000439; Raza JA, 2003, INT J CARDIOL, V89, P123, DOI 10.1016/S0167-5273(02)00510-7; Ribas V, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00151; Santos DL, 2003, MOL CELL BIOCHEM, V246, P163, DOI 10.1023/A:1023475022025; Shen Garry X., 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P106; Sugioka R, 2003, ONCOGENE, V22, P8432, DOI 10.1038/sj.onc.1207180; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; Tsai CY, 2013, INT J CARDIOL, V168, P1286, DOI 10.1016/j.ijcard.2012.12.004; Tsutsui H, 2009, CARDIOVASC RES, V81, P449, DOI 10.1093/cvr/cvn280; Wischmeyer PE, 2003, JPEN-PARENTER ENTER, V27, P396, DOI 10.1177/0148607103027006396; Wu HL, 2011, FREE RADICAL BIO MED, V51, P2108, DOI 10.1016/j.freeradbiomed.2011.09.011; Wu HL, 2010, BBA-BIOENERGETICS, V1797, P1705, DOI 10.1016/j.bbabio.2010.06.003; Xu F, 2014, PHARMACOLOGY, V93, P155, DOI 10.1159/000360181; Zabot GP, 2014, WORLD J GASTROENTERO, V20, P11406, DOI 10.3748/wjg.v20.i32.11406; Zhu SS, 2011, DIABETOLOGIA, V54, P2440, DOI 10.1007/s00125-011-2226-1; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028	43	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132402	10.1371/journal.pone.0132402	http://dx.doi.org/10.1371/journal.pone.0132402			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146991	Green Submitted, gold, Green Published			2022-12-27	WOS:000358157600258
J	Li, Q; Wu, L; Hao, JJ; Luo, LX; Cao, YS; Li, JQ				Li, Qian; Wu, Lei; Hao, Jianjun; Luo, Laixin; Cao, Yongsong; Li, Jianqiang			Biofumigation on Post-Harvest Diseases of Fruits Using a New Volatile-Producing Fungus of Ceratocystis fimbriata	PLOS ONE			English	Article							MUSCODOR-ALBUS; RHIZOCTONIA-SOLANI; BIOLOGICAL-CONTROL; IN-VITRO; GROWTH; BIOCONTROL; TRICHODERMA; METABOLITES; ANTIFUNGAL; AGENT	A variety of volatile organic compounds (VOCs) produced by Ceratocystis fimbriata have strong bioactivity against a wide range of fungi, bacteria and oomycetes. Mycelial growth, conidial production, and spore germination of fungi and oomycetes were significantly inhibited after exposure to cultures of C. fimbriata, and colony formation of bacteria was also inhibited. Two post-harvest diseases, peach brown rot caused by Monilinia fructicola and citrus green mold caused by Penicillium digitatum, were controlled during a 4-day storage by enclosing wound-inoculated fruits with 10 standard diameter Petri plate cultures of C. fimbriata in a 15 L box. The fruits were freshly inoculated at onset of storage and the cultures of C. fimbriata were 6 days old. Percentage of control was 92 and 97%, respectively. After exposure to C. fimbriata VOCs, severely misshapen hyphae and conidia of these two post-harvest pathogens were observed by scanning electron microscopy, and their pathogenicity was lost or greatly reduced.	[Li, Qian; Luo, Laixin; Cao, Yongsong; Li, Jianqiang] Beijing Engn Res Ctr Seed & Plant Hlth BERC SPH, Beijing Key Lab Seed Dis Testing & Control BKL SD, Beijing, Peoples R China; [Wu, Lei] Zhejiang Univ, Lab Fruit Qual Biol, State Agr Minist, Lab Hort Plant Growth Dev & Qual Improvement, Hangzhou 310003, Zhejiang, Peoples R China; [Hao, Jianjun] Univ Maine, Sch Food & Agr, Orono, ME USA	Zhejiang University; University of Maine System; University of Maine Orono	Li, JQ (corresponding author), Beijing Engn Res Ctr Seed & Plant Hlth BERC SPH, Beijing Key Lab Seed Dis Testing & Control BKL SD, Beijing, Peoples R China.	lijq231@cau.edu.cn	LI, JIAN/GRY-2197-2022; li, jian/GSE-0245-2022; cao, yongsong/P-8718-2019		Natural Science Foundation of China [31071726]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1042]; Chinese Ministry of Education	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Chinese Ministry of Education(Ministry of Education, China)	This work was supported by the Natural Science Foundation of China (Grant No. 31071726): http://www.nsfc.gov.cn/; Program for Changjiang Scholars and Innovative Research Team in University (Grant No. IRT1042); and Project for Ph.D. graduate academic new artist (supported by Chinese Ministry of Education). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare C, 1999, APPL ENVIRON MICROB, V65, P2926; Boukaew S, 2013, BIOCONTROL, V58, P471, DOI 10.1007/s10526-013-9510-6; Bruce A, 2003, INT BIODETER BIODEGR, V51, P101, DOI 10.1016/S0964-8305(02)00088-4; Chaurasia B, 2005, MICROBIOL RES, V160, P75, DOI 10.1016/j.micres.2004.09.013; Deng J, 2007, PLANT PROTECTION, V32, P97; Dicke M, 1988, FUNCT ECOL, V2, P131, DOI 10.2307/2389687; Grimme E, 2007, PLANT DIS, V91, P220, DOI 10.1094/PDIS-91-2-0220; Hashem M, 2011, MYCOPATHOLOGIA, V172, P37, DOI 10.1007/s11046-010-9390-6; Howell CR, 2003, PLANT DIS, V87, P4, DOI 10.1094/PDIS.2003.87.1.4; Janisiewicz WJ, 2002, ANNU REV PHYTOPATHOL, V40, P411, DOI 10.1146/annurev.phyto.40.120401.130158; Khan MSA, 2011, PHYTOMEDICINE, V19, P48, DOI 10.1016/j.phymed.2011.07.005; Korpi A, 2009, CRIT REV TOXICOL, V39, P139, DOI [10.1080/10408440802291497, 10.1080/10408440802291497 ]; Kumar S, 2012, PHYTOCHEM REV, V11, P507, DOI 10.1007/s11101-013-9271-y; Lacey LA, 2006, J INVERTEBR PATHOL, V91, P195, DOI 10.1016/j.jip.2006.01.002; Mercier J, 2005, CROP PROT, V24, P355, DOI 10.1016/j.cropro.2004.09.004; Mercier J, 2004, POSTHARVEST BIOL TEC, V31, P1, DOI 10.1016/j.postharvbio.2003.08.004; Mercier J, 2007, CAN J MICROBIOL, V53, P404, DOI 10.1139/W06-124; Minerdi D, 2011, FEMS MICROBIOL ECOL, V76, P342, DOI 10.1111/j.1574-6941.2011.01051.x; Minerdi D, 2009, ENVIRON MICROBIOL, V11, P844, DOI 10.1111/j.1462-2920.2008.01805.x; Mitchell AM, 2010, MICROBIOL-SGM, V156, P270, DOI 10.1099/mic.0.032540-0; Morath Shannon U., 2012, Fungal Biology Reviews, V26, P73, DOI 10.1016/j.fbr.2012.07.001; Nalini S, 2014, BIORESOURCE TECHNOL, V173, P231, DOI 10.1016/j.biortech.2014.09.051; Naznin HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086882; Plodpai P, 2013, CROP PROT, V43, P65, DOI 10.1016/j.cropro.2012.09.004; Riga E, 2008, BIOL CONTROL, V45, P380, DOI 10.1016/j.biocontrol.2008.01.002; Ryu CM, 2004, PLANT PHYSIOL, V134, P1017, DOI 10.1104/pp.103.026583; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; Samtani JB, 2011, CROP PROT, V30, P45, DOI 10.1016/j.cropro.2010.08.023; SPRECHER E, 1983, A VAN LEEUW J MICROB, V49, P493; Strobel GA, 2001, MICROBIOL-SGM, V147, P2943, DOI 10.1099/00221287-147-11-2943; Strobel G, 2014, CURR OPIN MICROBIOL, V19, P52, DOI 10.1016/j.mib.2014.06.003; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Verma M, 2007, BIOCHEM ENG J, V37, P1, DOI 10.1016/j.bej.2007.05.012; Zhao ZZ, 2010, BIORESOURCE TECHNOL, V101, P292, DOI 10.1016/j.biortech.2009.07.071	34	25	27	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132009	10.1371/journal.pone.0132009	http://dx.doi.org/10.1371/journal.pone.0132009			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147922	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600179
J	Su, J; Liu, HY; Tan, XL; Ji, Y; Jiang, YX; Prabhakar, M; Rong, ZH; Zhou, HW; Zhang, GX				Su, Jin; Liu, Hai-yue; Tan, Xi-lan; Ji, Yong; Jiang, Yun-xia; Prabhakar, M.; Rong, Zu-hua; Zhou, Hong-wei; Zhang, Guo-xia			Sputum Bacterial and Fungal Dynamics during Exacerbations of Severe COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIRWAY MICROBIOTA; DIVERSITY; INFECTION; END	The changes in the microbial community structure during acute exacerbations of severe chronic obstructive pulmonary disease (COPD) in hospitalized patients remain largely uncharacterized. Therefore, further studies focused on the temporal dynamics and structure of sputum microbial communities during acute exacerbation of COPD (AECOPD) would still be necessary. In our study, the use of molecular microbiological techniques provided insight into both fungal and bacterial diversities in AECOPD patients during hospitalization. In particular, we examined the structure and varieties of lung microbial community in 6 patients with severe AECOPD by amplifying 16S rRNA V4 hyper-variable and internal transcribed spacer (ITS) DNA regions using barcoded primers and the Illumina sequencing platform. Sequence analysis showed 261 bacterial genera representing 20 distinct phyla, with an average number of genera per patient of >157, indicating high diversity. Acinetobacter, Prevotella, Neisseria, Rothia, Lactobacillus, Leptotrichia, Streptococcus, Veillonella, and Actinomyces were the most commonly identified genera, and the average total sequencing number per sputum sample was >10000 18S ITS sequences. The fungal population was typically dominated by Candia, Phialosimplex, Aspergillus, Penicillium, Cladosporium and Eutypella. Our findings highlight that COPD patients have personalized structures and varieties in sputum microbial community during hospitalization periods.	[Su, Jin; Liu, Hai-yue; Tan, Xi-lan; Ji, Yong; Jiang, Yun-xia; Prabhakar, M.; Rong, Zu-hua; Zhou, Hong-wei; Zhang, Guo-xia] Southern Med Univ, Sch Publ Hlth & Trop Med, Guangdong Prov Key Lab Trop Dis Res, State Key Lab Organ Failure Res,Dept Environm Hlt, Guangzhou, Guangdong, Peoples R China; [Su, Jin] Southern Med Univ, Nanfang Hosp, Dept Resp Phys, Guangzhou, Guangdong, Peoples R China; [Tan, Xi-lan] Southern Med Univ, Zhujiang Hosp, Dept Hosp Infect Management, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Zhang, GX (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Guangdong Prov Key Lab Trop Dis Res, State Key Lab Organ Failure Res,Dept Environm Hlt, Guangzhou, Guangdong, Peoples R China.	guoxiazhang@126.com	Zhou, Hongwei/B-4193-2008		National Science Foundation of China (NSFC) [31270152, 31322003]; Educational Commission of Guangdong Province of China [2012KJCX0031]; School of Public Health and Tropical Medicine of Southern Medical University, China [GW201435, GW201431]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Educational Commission of Guangdong Province of China; School of Public Health and Tropical Medicine of Southern Medical University, China	This work was supported by the National Science Foundation of China (NSFC 31270152, 31322003) (http://www.nsfc.gov.cn/), who provided support for the lab materials; the Educational Commission of Guangdong Province of China (2012KJCX0031), (http://www.gdhed.edu.cn/), who provided support for the Illumina sequencing; and a grant from School of Public Health and Tropical Medicine of Southern Medical University, China (grant no. GW201435, GW201431) (http://portal.smu.edu.cn/gwxy/), who provided support for the AJE costs.	Adamantia L, 2014, EXPERT OPIN PHARMACO, V15, P2307, DOI 10.1517/14656566.2014.959927; Barberan J, 2014, REV IBEROAM MICOL, V31, P237, DOI 10.1016/j.riam.2014.07.004; Bhatt SP, 2013, AM J RESP CRIT CARE, V188, P1046, DOI 10.1164/rccm.201309-1651ED; Cabrera-Rubio R, 2012, J CLIN MICROBIOL, V50, P3562, DOI 10.1128/JCM.00767-12; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Chhabra Sunil K, 2014, Indian J Chest Dis Allied Sci, V56, P93; Clark TW, 2015, EUR RESPIR J, V45, P76, DOI 10.1183/09031936.00092214; Daniels JMA, 2010, CHEST, V138, P1108, DOI 10.1378/chest.09-2927; Dickson RP, 2013, EXPERT REV RESP MED, V7, P245, DOI [10.1586/ers.13.24, 10.1586/ERS.13.24]; Du QX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113048; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gao JM, 2013, J THORAC DIS, V5, P549, DOI 10.3978/j.issn.2072-1439.2013.08.04; He Y, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-208; Huang YJ, 2014, J CLIN MICROBIOL, V52, P2813, DOI 10.1128/JCM.00035-14; Huang YJ, 2011, EXPERT REV RESP MED, V5, P809, DOI [10.1586/ERS.11.76, 10.1586/ers.11.76]; Huang YJ, 2010, OMICS, V14, P9, DOI 10.1089/omi.2009.0100; King Paul T, 2013, Transl Respir Med, V1, P13, DOI 10.1186/2213-0802-1-13; Kiser TH, 2014, AM J RESP CRIT CARE, V189, P1052, DOI 10.1164/rccm.201401-0058OC; Matsuda F, 2013, ANAL CHEM, V85, P8291, DOI 10.1021/ac401564v; Moller LVM, 1998, AM J RESP CRIT CARE, V157, P950; Morris A, 2008, COPD, V5, P43, DOI 10.1080/15412550701817656; Murphy TF, 2005, AM J RESP CRIT CARE, V172, P195, DOI 10.1164/rccm.200412-1747OC; Murphy TF, 2008, AM J RESP CRIT CARE, V177, P853, DOI 10.1164/rccm.200709-1413OC; Pashley CH, 2014, MYCOPATHOLOGIA, V178, P457, DOI 10.1007/s11046-014-9804-y; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sethi S, 2000, CHEST, V118, P1557, DOI 10.1378/chest.118.6.1557; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Sze MA, 2014, INT J CHRONIC OBSTR, V9, P229, DOI 10.2147/COPD.S38932; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Tang C, 2014, RESPIROLOGY, V19, P50; Werner JJ, 2012, ISME J, V6, P1273, DOI 10.1038/ismej.2011.186; Wu XD, 2014, MOL BIOL REP, V41, P4743, DOI 10.1007/s11033-014-3345-9	34	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130736	10.1371/journal.pone.0130736	http://dx.doi.org/10.1371/journal.pone.0130736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147303	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600045
J	Arrieta, J; Cartwright, JHE; Gouillart, E; Piro, N; Piro, O; Tuval, I				Arrieta, Jorge; Cartwright, Julyan H. E.; Gouillart, Emmanuelle; Piro, Nicolas; Piro, Oreste; Tuval, Idan			Geometric Mixing, Peristalsis, and the Geometric Phase of the Stomach	PLOS ONE			English	Article							STOKES-FLOW; FLUID; TRANSPORT; MIXER	Mixing fluid in a container at low Reynolds number-in an inertialess environment-is not a trivial task. Reciprocating motions merely lead to cycles of mixing and unmixing, so continuous rotation, as used in many technological applications, would appear to be necessary. However, there is another solution: movement of the walls in a cyclical fashion to introduce a geometric phase. We show using journal-bearing flow as a model that such geometric mixing is a general tool for using deformable boundaries that return to the same position to mix fluid at low Reynolds number. We then simulate a biological example: we show that mixing in the stomach functions because of the "belly phase," peristaltic movement of the walls in a cyclical fashion introduces a geometric phase that avoids unmixing.	[Arrieta, Jorge; Tuval, Idan] UIB, CSIC, Mediterranean Inst Adv Studies, E-07190 Esporles, Spain; [Arrieta, Jorge] Univ Carlos III Madrid, Area Mecan Fluidos, E-28911 Leganes, Spain; [Cartwright, Julyan H. E.] Univ Granada, CSIC, Inst Andaluz Ciencias Tierra, E-18071 Granada, Spain; [Gouillart, Emmanuelle] CNRS St Gobain, Surface Verre Interfaces, UMR 125, F-93303 Aubervilliers, France; [Piro, Nicolas] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Piro, Oreste] Univ Illes Balears, Dept Fis, E-07071 Palma De Mallorca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; Universidad Carlos III de Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); University of Granada; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Universitat de les Illes Balears	Piro, N (corresponding author), Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland.	nicolas.piro@gmail.com	Arrieta, Jorge/E-4113-2013; Cartwright, Julyan/C-1387-2016; Sanagustin, Jorge Arrieta/AAA-9490-2020; P, N/AAQ-5967-2021; Piro, Oreste/B-4899-2014; Tuval, Idan/G-9732-2011	Arrieta, Jorge/0000-0003-1260-6168; Cartwright, Julyan/0000-0001-7392-0957; Sanagustin, Jorge Arrieta/0000-0003-1260-6168; Piro, Oreste/0000-0002-6966-2796; Tuval, Idan/0000-0002-6629-0851	Ministry of Science and Innovation (MICINN) [FIS2010-22322-C02-01/02]; subprograma Ramon y Cajal	Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); subprograma Ramon y Cajal(Spanish Government)	The authors acknowledge the financial support of the grant FIS2010-22322-C02-01/02 from The Ministry of Science and Innovation (MICINN) and from the "subprograma Ramon y Cajal" (IT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alim K, 2013, P NATL ACAD SCI USA, V110, P13306, DOI 10.1073/pnas.1305049110; ANDERSON D., 1984, COMPUTATIONAL FLUID; AREF H, 1986, PHYS FLUIDS, V29, P3515, DOI 10.1063/1.865828; BALLAL BY, 1976, ARCH RATION MECH AN, V62, P237, DOI 10.1007/BF00280016; Barrett KE., 2013, GASTROINTESTINAL PHY; Cartwright JHE, 1992, INT J BIFURCAT CHAOS, V2, P427; CHAIKEN J, 1986, P ROY SOC LOND A MAT, V408, P165, DOI 10.1098/rspa.1986.0115; Dillard S, 2007, WORLD J GASTROENTERO, V13, P1365, DOI 10.3748/wjg.v13.i9.1365; Finn MD, 2001, J ENG MATH, V41, P75, DOI 10.1023/A:1011840630170; GHIA U, 1982, J COMPUT PHYS, V48, P387, DOI 10.1016/0021-9991(82)90058-4; Heller JP, 1960, AM J PHYS, V28, P348, DOI [10.1119/1.1935802, DOI 10.1119/1.1935802]; Imai Y, 2013, AM J PHYSIOL-GASTR L, V304, pG536, DOI 10.1152/ajpgi.00350.2012; Indireshkumar K, 2000, AM J PHYSIOL-GASTR L, V278, pG604, DOI 10.1152/ajpgi.2000.278.4.G604; Ishikawa T, 2011, J THEOR BIOL, V279, P63, DOI 10.1016/j.jtbi.2011.03.026; JAFFRIN MY, 1971, ANNU REV FLUID MECH, V3, P13, DOI 10.1146/annurev.fl.03.010171.000305; Jeffery GB, 1922, P R SOC LOND A-CONTA, V102, P161, DOI 10.1098/rspa.1922.0078; Jose J., 1998, CLASSICAL DYNAMICS C; Koiller K, 1996, J NONLINEAR SCI, V6, P507, DOI [10.1007/BF02434055, DOI 10.1007/BF02434055]; Kumar S, 2007, J FLUID ENG-T ASME, V129, P1361, DOI 10.1115/1.2786480; Kwiatek MA, 2006, J MAGN RESON IMAGING, V24, P1101, DOI 10.1002/jmri.20738; Leal L, 2007, ADV TRANSPORT PHENOM, V1st; Lichtenberg A. J., 2010, REGULAR CHAOTIC DYNA; Lin ZY, 2003, DIGEST DIS SCI, V48, P837, DOI 10.1023/A:1023099206939; OTTINO JM, 1988, NATURE, V333, P419, DOI 10.1038/333419a0; Ottino JM, 1989, KINEMATICS MIXING ST; Pal A, 2004, P ROY SOC B-BIOL SCI, V271, P2587, DOI 10.1098/rspb.2004.2886; Pal A, 2007, J BIOMECH, V40, P1202, DOI 10.1016/j.jbiomech.2006.06.006; Rinaldi M, 2009, NUTR THERAPY METABOL, V27, P134; Schulze K, 2006, NEUROGASTROENT MOTIL, V18, P172, DOI 10.1111/j.1365-2982.2006.00759.x; Shapere A, 1989, GEOMETRIC PHASES PHY; Shapiro H, 1969, J FLUID MECH, V37, P799, DOI 10.1017/S0022112069000899; Stroock AD, 2002, SCIENCE, V295, P647, DOI 10.1126/science.1066238; Tabor M, 1989, CHAOS INTEGRABILITY; Tams TR, 2003, HDB SMALL ANIMAL GAS; Taylor GI, 1960, LOW REYNOLDS NUMBER; Yamada T, 2011, TXB GASTROENTEROLOGY	37	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130735	10.1371/journal.pone.0130735	http://dx.doi.org/10.1371/journal.pone.0130735			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154384	Green Submitted, Green Published, gold			2022-12-27	WOS:000358159700037
J	Kim, ES; Sonstegard, TS; Van Tassell, CP; Wiggans, G; Rothschild, MF				Kim, Eui-Soo; Sonstegard, Tad S.; Van Tassell, Curtis P.; Wiggans, George; Rothschild, Max F.			The Relationship between Runs of Homozygosity and Inbreeding in Jersey Cattle under Selection	PLOS ONE			English	Article							COMPLEX VERTEBRAL MALFORMATION; DEPRESSION; FERTILITY; HOLSTEIN; MUTATION; HETEROZYGOSITY; GENETICS; SURVIVAL; FITNESS; TRAITS	Inbreeding is often an inevitable outcome of strong directional artificial selection but on average it reduces population fitness with increased frequency of recessive deleterious alleles. Runs of homozygosity (ROH) representing genomic autozygosity that occur from mating between selected and genomically related individuals may be able to reveal the regions affecting fitness. To examine the influence of genomic autozygosity on fitness, we used a genome-wide association test to evaluate potential negative correlations between ROH and daughter pregnancy rate (DPR) or somatic cell score (SCS) in US Jersey cattle. In addition, relationships between changes of local ROH and inbreeding coefficients (F) were assessed to locate genomic regions with increased inbreeding. Despite finding some decreases in fertility associated with incremental increases in F, most emerging local ROH were not significantly associated with DPR or SCS. Furthermore, the analyses of ROH could be approximated with the most frequent haplotype(s), including the associations of ROH and F or traits. The analysis of the most frequent haplotype revealed that associations of ROH and fertility could be accounted for by the additive genetic effect on the trait. Thus, we suggest that a change of autozygosity is more likely to demonstrate footprints of selected haplotypes for production rather than highlight the possible increased local autozygosity of a recessive detrimental allele resulting from the mating between closely related animals in Jersey cattle.	[Kim, Eui-Soo; Sonstegard, Tad S.; Van Tassell, Curtis P.; Wiggans, George] ARS, Anim Genom & Improvement Lab, Beltsville Agr Res Ctr, USDA, Beltsville, MD USA; [Kim, Eui-Soo; Rothschild, Max F.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA	United States Department of Agriculture (USDA); Iowa State University	Rothschild, MF (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	mfrothsc@iastate.edu	Van Tassell, Curtis P./O-4247-2019	Van Tassell, Curtis P./0000-0002-8416-2087	USDA-ARS-BFGL [1265-31000-104]; College of Agriculture and Life Sciences; State of Iowa and Hatch funds; Next-Generation BioGreen 21 Program [PJ011044]; Rural Development Administration, Republic of Korea	USDA-ARS-BFGL; College of Agriculture and Life Sciences; State of Iowa and Hatch funds; Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by the USDA-ARS-BFGL applied genomics project 1265-31000-104, the College of Agriculture and Life Sciences, the State of Iowa and Hatch funds. E.-S. Kim was partially supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ011044), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm JS, 2001, J VET DIAGN INVEST, V13, P283, DOI 10.1177/104063870101300401; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chun S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002240; CHURCHILL GA, 1994, GENETICS, V138, P963; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Curik I, 2014, LIVEST SCI, V166, P26, DOI 10.1016/j.livsci.2014.05.034; David P, 1998, HEREDITY, V80, P531, DOI 10.1046/j.1365-2540.1998.00393.x; Druet T, 2008, GENETICS, V178, P2227, DOI 10.1534/genetics.107.085035; Gillespie JH, 1998, POPULATION GENETICS; GURTNER GC, 1995, GENE DEV, V9, P1, DOI 10.1101/gad.9.1.1; Hedrick P, 2001, EVOLUTION, V55, P1256; Hedrick P.W., 2011, GENETICS POPULATIONS; Holmberg M, 2006, J DAIRY SCI, V89, P3664, DOI 10.3168/jds.S0022-0302(06)72406-7; HOULE D, 1992, NATURE, V359, P58, DOI 10.1038/359058a0; Howard JT, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1352-4; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Karkkainen K, 1996, EVOLUTION, V50, P111, DOI 10.1111/j.1558-5646.1996.tb04477.x; Keller MC, 2012, PLOS GENET, V8, P425, DOI 10.1371/journal.pgen.1002656; Keller MC, 2011, GENETICS, V189, P237, DOI 10.1534/genetics.111.130922; Khatib H, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-13; Kim ES, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1500-x; Kim ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080813; Kinghorn B.P., 1994, P 5 WORLD C GEN APPL, VVolume 22, P85; Kristensen TN, 2010, TRENDS ECOL EVOL, V25, P44, DOI 10.1016/j.tree.2009.06.014; Kuhn C, 2004, GENETICS, V167, P1873, DOI 10.1534/genetics.103.022749; Leroy G, 2014, ANIM GENET, V45, P618, DOI 10.1111/age.12178; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Markert JA, 2004, HEREDITY, V92, P306, DOI 10.1038/sj.hdy.6800409; Mc Parland S, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-16; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Morris JA, 2001, MED HYPOTHESES, V56, P646, DOI 10.1054/mehy.2000.1200; Nielsen US, 2003, LIVEST PROD SCI, V79, P233, DOI 10.1016/S0301-6226(02)00170-7; Nothnagel M, 2010, HUM MOL GENET, V19, P2927, DOI 10.1093/hmg/ddq198; Palucci V, 2007, GENET SEL EVOL, V39, P181, DOI 10.1051/gse:2006041; Pemberton J, 2004, TRENDS ECOL EVOL, V19, P613, DOI 10.1016/j.tree.2004.09.010; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pryce JE, 2014, GENET SEL EVOL, V46, DOI 10.1186/s12711-014-0071-7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purfield DC, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-70; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Slate J, 2002, J EVOLUTION BIOL, V15, P20, DOI 10.1046/j.1420-9101.2002.00373.x; Sonstegard TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054872; Thomsen B, 2006, GENOME RES, V16, P97, DOI 10.1101/gr.3690506; VanRaden PM, 2011, J DAIRY SCI, V94, P6153, DOI 10.3168/jds.2011-4624; VanRaden PM, 2011, J DAIRY SCI, V94, P5673, DOI 10.3168/jds.2011-4500; VanRaden PM, 2004, J DAIRY SCI, V87, P2285, DOI 10.3168/jds.S0022-0302(04)70049-1; VanRaden PM, 2003, INTERBULL B, V30, P43; Vermeulen CJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-297; Weigel KA, 2006, ANIM REPROD SCI, V96, P323, DOI 10.1016/j.anireprosci.2006.08.010; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015	53	49	52	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0129967	10.1371/journal.pone.0129967	http://dx.doi.org/10.1371/journal.pone.0129967			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154171	Green Published, Green Submitted, gold			2022-12-27	WOS:000358159700018
J	Liu, TX; Babaniyi, OA; Hall, TJ; Barbone, PE; Oberai, AA				Liu, Tengxiao; Babaniyi, Olalekan A.; Hall, Timothy J.; Barbone, Paul E.; Oberai, Assad A.			Noninvasive In-Vivo Quantification of Mechanical Heterogeneity of Invasive Breast Carcinomas	PLOS ONE			English	Article							ELASTOGRAPHY; US; ELASTICITY; TISSUE	Heterogeneity is a hallmark of cancer whether one considers the genotype of cancerous cells, the composition of their microenvironment, the distribution of blood and lymphatic microvasculature, or the spatial distribution of the desmoplastic reaction. It is logical to expect that this heterogeneity in tumor microenvironment will lead to spatial heterogeneity in its mechanical properties. In this study we seek to quantify the mechanical heterogeneity within malignant and benign tumors using ultrasound based elasticity imaging. By creating in-vivo elastic modulus images for ten human subjects with breast tumors, we show that Young's modulus distribution in cancerous breast tumors is more heterogeneous when compared with tumors that are not malignant, and that this signature may be used to distinguish malignant breast tumors. Our results complement the view of cancer as a heterogeneous disease on multiple length scales by demonstrating that mechanical properties within cancerous tumors are also spatially heterogeneous.	[Liu, Tengxiao; Oberai, Assad A.] Rensselaer Polytech Inst, Sci Computat Res Ctr, Troy, NY 12180 USA; [Babaniyi, Olalekan A.; Barbone, Paul E.] Boston Univ, Mech Engn, Boston, MA 02215 USA; [Hall, Timothy J.] Univ Wisconsin, Med Phys, Madison, WI USA	Rensselaer Polytechnic Institute; Boston University; University of Wisconsin System; University of Wisconsin Madison	Oberai, AA (corresponding author), Rensselaer Polytech Inst, Sci Computat Res Ctr, Troy, NY 12180 USA.	oberaa@rpi.edu		Babaniyi, Olalekan/0000-0003-1991-4403; Oberai, Assad/0000-0002-7668-7713	National Institutes of Health [NCI-R01CA100373, NCI-R01CA140271]; National Science Foundation [1148124, 1148111]; NATIONAL CANCER INSTITUTE [R01CA100373, R01CA140271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NCI-R01CA100373 & NCI-R01CA140271) and National Science Foundation (grant nos. 1148124 and 1148111).	Barbone PE, 2010, COMPUTATIONAL MODELING IN BIOMECHANICS, P375, DOI 10.1007/978-90-481-3575-2_13; Berg WA, 2004, RADIOLOGY, V233, P830, DOI 10.1148/radiol.2333031484; Berg WA, 2012, RADIOLOGY, V262, P435, DOI 10.1148/radiol.11110640; Burnside ES, 2007, RADIOLOGY, V245, P401, DOI 10.1148/radiol.2452061805; Gokhale NH, 2008, INVERSE PROBL, V24, DOI 10.1088/0266-5611/24/4/045010; Jiang JF, 2009, ULTRASOUND MED BIOL, V35, P1863, DOI 10.1016/j.ultrasmedbio.2009.05.016; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Lopez JI, 2011, INTEGR BIOL-UK, V3, P910, DOI 10.1039/c1ib00043h; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Oberai AA, 2003, INVERSE PROBL, V19, P297, DOI 10.1088/0266-5611/19/2/304; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Parker KJ, 2011, PHYS MED BIOL, V56, pR1, DOI 10.1088/0031-9155/56/1/R01; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Rudnick JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024605; Schedin P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003228; Schnitt SJ, 2009, BIOPSY INTERPRETATIO; Shore SW, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004231; Sinkus R, 2005, MAGNET RESON MED, V53, P372, DOI 10.1002/mrm.20355; Weaver J, 2002, MED PHYS, V29, P1291; Zhu CY, 1997, ACM T MATH SOFTWARE, V23, P550, DOI 10.1145/279232.279236; Zhu YN, 2002, ULTRASONIC IMAGING, V24, P161, DOI 10.1177/016173460202400303	22	24	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130258	10.1371/journal.pone.0130258	http://dx.doi.org/10.1371/journal.pone.0130258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154737	Green Published, gold, Green Submitted			2022-12-27	WOS:000358159700026
J	Wang, HY; Wang, C; Yang, K; Liu, J; Zhang, Y; Wang, YN; Xu, XW; Michal, JJ; Jiang, ZH; Liu, B				Wang, Hongyang; Wang, Chao; Yang, Kui; Liu, Jing; Zhang, Yu; Wang, Yanan; Xu, Xuewen; Michal, Jennifer J.; Jiang, Zhihua; Liu, Bang			Genome Wide Distributions and Functional Characterization of Copy Number Variations between Chinese and Western Pigs	PLOS ONE			English	Article							GENE-EXPRESSION; IDENTIFICATION; VARIANTS; POLYMORPHISMS; DUPLICATION; ASSOCIATION; EXPANSION; SELECTION; PATTERNS; PROTEIN	Copy number variations (CNVs) refer to large insertions, deletions and duplications in the genomic structure ranging from one thousand to several million bases in size. Since the development of next generation sequencing technology, several methods have been well built for detection of copy number variations with high credibility and accuracy. Evidence has shown that CNV occurring in gene region could lead to phenotypic changes due to the alteration in gene structure and dosage. However, it still remains unexplored whether CNVs underlie the phenotypic differences between Chinese and Western domestic pigs. Based on the read-depth methods, we investigated copy number variations using 49 individuals derived from both Chinese and Western pig breeds. A total of 3,131 copy number variation regions (CNVRs) were identified with an average size of 13.4 Kb in all individuals during domestication, harboring 1,363 genes. Among them, 129 and 147 CNVRs were Chinese and Western pig specific, respectively. Gene functional enrichments revealed that these CNVRs contribute to strong disease resistance and high prolificacy in Chinese domestic pigs, but strong muscle tissue development in Western domestic pigs. This finding is strongly consistent with the morphologic characteristics of Chinese and Western pigs, indicating that these group-specific CNVRs might have been preserved by artificial selection for the favored phenotypes during independent domestication of Chinese and Western pigs. In this study, we built high-resolution CNV maps in several domestic pig breeds and discovered the group specific CNVs by comparing Chinese and Western pigs, which could provide new insight into genomic variations during pigs' independent domestication, and facilitate further functional studies of CNV-associated genes.	[Wang, Hongyang; Wang, Chao; Liu, Jing; Zhang, Yu; Wang, Yanan; Xu, Xuewen; Jiang, Zhihua; Liu, Bang] Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Peoples R China; [Wang, Hongyang; Wang, Chao; Liu, Jing; Zhang, Yu; Wang, Yanan; Xu, Xuewen; Liu, Bang] Huazhong Agr Univ, Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan, Peoples R China; [Yang, Kui] Huazhong Agr Univ, Modern Educ & Technol Ctr, Wuhan, Peoples R China; [Michal, Jennifer J.; Jiang, Zhihua] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Washington State University	Liu, B (corresponding author), Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Peoples R China.	liubang@mail.hzau.edu.cn	Jiang, Zhihua/A-3378-2008	Jiang, Zhihua/0000-0003-1986-088X	Major International Cooperation NSFC [31210103917]; National High Technology Research and Development Program of China [2011AA100304, 2013AA102502]	Major International Cooperation NSFC; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the Major International Cooperation NSFC (31210103917) (http://www.nsfc.gov.cn/) and the National High Technology Research and Development Program of China (2011AA100304, 2013AA102502) (http://program.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Bae JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-232; Bickhart DM, 2012, GENOME RES, V22, P778, DOI 10.1101/gr.133967.111; Cahan P, 2009, NAT GENET, V41, P430, DOI 10.1038/ng.350; Chen CY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-733; Chen WK, 2009, GENOME RES, V19, P500, DOI 10.1101/gr.083741.108; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Nguyen DT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-584; Dong K, 2015, ANIM GENET, V46, P101, DOI 10.1111/age.12247; Durkin K, 2012, NATURE, V482, P81, DOI 10.1038/nature10757; Giuffra E, 2002, MAMM GENOME, V13, P569, DOI 10.1007/s00335-002-2184-5; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Guberman JM, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar041; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Imsland F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002775; Jarick I, 2011, HUM MOL GENET, V20, P840, DOI 10.1093/hmg/ddq518; Jia X, 2013, ANIM GENET, V44, P276, DOI 10.1111/age.12009; Kim PM, 2008, GENOME RES, V18, P1865, DOI 10.1101/gr.081422.108; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lachke SA, 2012, HUM GENET, V131, P235, DOI 10.1007/s00439-011-1064-z; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Larson G, 2010, P NATL ACAD SCI USA, V107, P7686, DOI 10.1073/pnas.0912264107; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JZ, 2004, NAT GENET, V36, P952, DOI 10.1038/ng1417; Li MZ, 2013, NAT GENET, V45, P1431, DOI 10.1038/ng.2811; Li Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-725; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Liu WN, 2009, CANCER RES, V69, P2176, DOI 10.1158/0008-5472.CAN-08-3151; Martin TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082696; Misra A, 2012, INT J BIOCHEM CELL B, V44, P928, DOI 10.1016/j.biocel.2012.02.020; Nicholas TJ, 2009, GENOME RES, V19, P491, DOI 10.1101/gr.084715.108; Orozco LD, 2009, HUM MOL GENET, V18, P4118, DOI 10.1093/hmg/ddp360; Paudel Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-449; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Ramayo-Caldas Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-593; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sha BY, 2009, J HUM GENET, V54, P199, DOI 10.1038/jhg.2009.10; Smit A, 1996, REPEATMASKER OPEN 30; Snijders AM, 2005, GENOME RES, V15, P302, DOI 10.1101/gr.2902505; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Sundstrom E, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-365; Tang ZL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r115; Tardif S, 2011, MOL HUM REPROD, V17, P661, DOI 10.1093/molehr/gar039; Wang C, 2014, MOL ECOL RESOUR; Wang YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106780; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Wright D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000512; Wu ATH, 2007, J BIOL CHEM, V282, P12164, DOI 10.1074/jbc.M609132200; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Xu LY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-683; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; Zhao M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S11-S1; Zhao X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019774, 10.1371/journal.pone.0021739]	61	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131522	10.1371/journal.pone.0131522	http://dx.doi.org/10.1371/journal.pone.0131522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154170	Green Submitted, gold, Green Published			2022-12-27	WOS:000358159700070
J	Coll, A; Wilson, ML; Gruden, K; Peccoud, J				Coll, Anna; Wilson, Mandy L.; Gruden, Kristina; Peccoud, Jean			Rule-Based Design of Plant Expression Vectors Using GenoCAD	PLOS ONE			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; PROTEIN-PROTEIN INTERACTIONS; PHYTOPHTHORA-INFESTANS; LIVING CELLS; INTERACTOME; STANDARD; BIFC; DNA; VISUALIZATION; CONSTRUCTS	Plant synthetic biology requires software tools to assist on the design of complex multigenic expression plasmids. Here a vector design strategy to express genes in plants is formalized and implemented as a grammar in GenoCAD, a Computer-Aided Design software for synthetic biology. It includes a library of plant biological parts organized in structural categories and a set of rules describing how to assemble these parts into large constructs. Rules developed here are organized and divided into three main subsections according to the aim of the final construct: protein localization studies, promoter analysis and protein-protein interaction experiments. The GenoCAD plant grammar guides the user through the design while allowing users to customize vectors according to their needs. Therefore the plant grammar implemented in GenoCAD will help plant biologists take advantage of methods from synthetic biology to design expression vectors supporting their research projects.	[Coll, Anna; Gruden, Kristina] Natl Inst Biol, Dept Biotechnol & Syst Biol, Ljubljana, Slovenia; [Wilson, Mandy L.; Peccoud, Jean] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA USA	National Institute of Biology - Slovenia; Virginia Polytechnic Institute & State University	Coll, A (corresponding author), Natl Inst Biol, Dept Biotechnol & Syst Biol, Ljubljana, Slovenia.	anna.coll@nib.si	Gruden, kristina/AAI-6439-2020; Peccoud, Jean/A-2374-2008; Coll, Anna/ABD-4199-2021	Peccoud, Jean/0000-0001-7649-6127; Coll, Anna/0000-0003-0672-1530; gruden, kristina/0000-0001-5906-8569	National Science Foundation [1241328]; Slovenian Research Agency [P4-0165, N4-0026]; Direct For Biological Sciences [1241328] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Slovenian Research Agency(Slovenian Research Agency - Slovenia); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is supported by National Science Foundation Awards 1241328, JP and The Slovenian Research Agency Program P4-0165 and Project N4-0026, KG.	Adames NR, 2015, NUCLEIC ACIDS RES, V43, P4823, DOI 10.1093/nar/gkv272; Ball DA, 2010, BIOCOMPUT-PAC SYM, P385; Baltes NJ, 2015, TRENDS BIOTECHNOL, V33, P120, DOI 10.1016/j.tibtech.2014.11.008; Braun P, 2013, ANNU REV PLANT BIOL, V64, P161, DOI 10.1146/annurev-arplant-050312-120140; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Cai Y, 2007, BIOINFORMATICS, V23, P2760, DOI 10.1093/bioinformatics/btm446; Cai YZ, 2010, NUCLEIC ACIDS RES, V38, P2637, DOI 10.1093/nar/gkq086; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; Czar MJ, 2009, NUCLEIC ACIDS RES, V37, pW40, DOI 10.1093/nar/gkp361; Czar MJ, 2009, TRENDS BIOTECHNOL, V27, P63, DOI 10.1016/j.tibtech.2008.10.007; Dreze M, 2010, METHOD ENZYMOL, V470, P281, DOI 10.1016/S0076-6879(10)70012-4; Fukao Y, 2012, PLANT CELL PHYSIOL, V53, P617, DOI 10.1093/pcp/pcs026; Galdzicki M, 2014, NAT BIOTECHNOL, V32, P545, DOI 10.1038/nbt.2891; Horstman A, 2014, INT J MOL SCI, V15, P9628, DOI 10.3390/ijms15069628; Hu Y, 2013, INT SYMP QUAL, P8, DOI 10.1109/ISQED.2013.6523583; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; King SRF, 2014, PLANT CELL, V26, P1345, DOI 10.1105/tpc.113.120055; Kodama Y, 2012, BIOTECHNIQUES, V53, P285, DOI [10.2144/0000113943, 10.2144/000113943]; Lazar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104553; Lee LY, 2008, PLANT PHYSIOL, V146, P325, DOI 10.1104/pp.107.113001; Overend C, 2012, TRENDS BIOTECHNOL, V30, P497, DOI 10.1016/j.tibtech.2012.06.002; Pan YL, 2015, PLANTA, V241, P57, DOI 10.1007/s00425-014-2164-5; Patron NJ, 2014, CURR OPIN PLANT BIOL, V19, P14, DOI 10.1016/j.pbi.2014.02.004; Peccoud J, 2012, METHOD MOL BIOL, P297, DOI [10.1007/978-1-62703-239-1_1, DOI 10.1007/978-1-62703-239-1_]; Purcell O, 2014, ACS SYNTH BIOL, V3, P737, DOI 10.1021/sb400134k; RANSONE LJ, 1995, ELSEVIER, P491, DOI DOI 10.1016/0076-6879(95)54034-2; Runions John, 2007, V390, P239; Silver PA, 2014, NATURE, V509, P166, DOI 10.1038/509166a; Speth C, 2014, METHODS MOL BIOL, V1158, P175, DOI 10.1007/978-1-4939-0700-7_11; Tian ZD, 2015, PLANT CELL PHYSIOL, V56, P992, DOI 10.1093/pcp/pcv025; Voss U, 2013, INT J DEV BIOL, V57, P525, DOI 10.1387/ijdb.130208dw; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wilson ML, 2014, BIOINFORMATICS, V30, P251, DOI 10.1093/bioinformatics/btt646; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Zhang YX, 2010, CURR GENOMICS, V11, P40, DOI 10.2174/138920210790218016	38	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132502	10.1371/journal.pone.0132502	http://dx.doi.org/10.1371/journal.pone.0132502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148190	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600291
J	Couch, Y; Xie, Q; Lundberg, L; Sharp, T; Anthony, DC				Couch, Yvonne; Xie, Qin; Lundberg, Louise; Sharp, Trevor; Anthony, Daniel C.			A Model of Post-Infection Fatigue Is Associated with Increased TNF and 5-HT2A Receptor Expression in Mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; BACILLE CALMETTE-GUERIN; TRYPTOPHAN DEPLETION; CEREBROSPINAL-FLUID; SICKNESS BEHAVIOR; MAJOR DEPRESSION; OPEN-FIELD; ACTIVATION; ANXIETY; INFLAMMATION	It is well documented that serotonin (5-HT) plays an important role in psychiatric illness. For example, myalgic encephalomyelitis (ME/CFS), which is often provoked by infection, is a disabling illness with an unknown aetiology and diagnosis is based on symptom-specific criteria. However, 5-HT2A receptor expression and peripheral cytokines are known to be upregulated in ME. We sought to examine the relationship between the 5-HT system and cytokine expression following systemic bacterial endotoxin challenge (LPS, 0.5mg/kg i.p.), at a time when the acute sickness behaviours have largely resolved. At 24 hours post-injection mice exhibit no overt changes in locomotor behaviour, but do show increased immobility in a forced swim test, as well as decreased sucrose preference and reduced marble burying activity, indicating a depressive-like state. While peripheral IDO activity was increased after LPS challenge, central activity levels remained stable and there was no change in total brain 5-HT levels or 5-HIAA/5-HT. However, within the brain, levels of TNF and 5-HT2A receptor mRNA within various regions increased significantly. This increase in receptor expression is reflected by an increase in the functional response of the 5-HT2A receptor to agonist, DOI. These data suggest that regulation of fatigue and depressive-like moods after episodes of systemic inflammation may be regulated by changes in 5-HT receptor expression, rather than by levels of enzyme activity or cytokine expression in the CNS.	[Couch, Yvonne; Xie, Qin; Lundberg, Louise; Sharp, Trevor; Anthony, Daniel C.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Lundberg, Louise] Publ Hlth England, Ctr Radiat Chem & Environm Hazards, Didcot OX11 0RQ, Oxon, England	University of Oxford; Public Health England	Couch, Y (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	yvonne.couch@rdm.ox.ac.uk	Anthony, Daniel/F-7765-2010	Anthony, Daniel/0000-0003-1380-6655; Sharp, Trevor/0000-0001-7434-9713	Biology and Biotechnology Research Society (UK)	Biology and Biotechnology Research Society (UK)	This work was supported by the Biology and Biotechnology Research Society (UK) in vivo additional studentship to YC/DA/TS.	Alesci S, 2005, J CLIN ENDOCR METAB, V90, P2522, DOI 10.1210/jc.2004-1667; Barton DA, 2008, ARCH GEN PSYCHIAT, V65, P38, DOI 10.1001/archgenpsychiatry.2007.11; Benedetti F, 2008, PROG NEURO-PSYCHOPH, V32, P1863, DOI 10.1016/j.pnpbp.2008.08.017; Bhagwagar Z, 2006, AM J PSYCHIAT, V163, P1580, DOI 10.1176/appi.ajp.163.9.1580; BLUTHE RM, 1991, EUR J PHARMACOL, V209, P281, DOI 10.1016/0014-2999(91)90184-R; Bluthe RM, 2000, EUR J NEUROSCI, V12, P4447, DOI 10.1046/j.1460-9568.2000.01348.x; Cadusseau J, 2014, CURR MED CHEM, V21, P511; Capuron L, 2002, NEUROPSYCHOPHARMACOL, V26, P643, DOI 10.1016/S0893-133X(01)00407-9; Couch Y, 2013, NEUROIMAGE, V75, P177, DOI 10.1016/j.neuroimage.2013.02.046; Couch Y, 2013, BRAIN BEHAV IMMUN, V29, P136, DOI 10.1016/j.bbi.2012.12.017; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; Deacon RMJ, 2006, NAT PROTOC, V1, P122, DOI 10.1038/nprot.2006.20; GJERRIS A, 1987, J AFFECT DISORDERS, V12, P13, DOI 10.1016/0165-0327(87)90056-5; Gonzalez-Maeso J, 2007, NEURON, V53, P439, DOI 10.1016/j.neuron.2007.01.008; Hale MW, 2008, NEUROSCIENCE, V157, P733, DOI 10.1016/j.neuroscience.2008.09.050; Hughes MM, 2012, BRAIN BEHAV IMMUN, V26, P979, DOI 10.1016/j.bbi.2012.05.010; Jennings KA, 2006, J NEUROSCI, V26, P8955, DOI 10.1523/JNEUROSCI.5356-05.2006; Jiang Y, 2008, NEUROBIOL DIS, V32, P125, DOI 10.1016/j.nbd.2008.06.017; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Levine J, 1999, NEUROPSYCHOBIOLOGY, V40, P171, DOI 10.1159/000026615; Maes M, 1997, CYTOKINE, V9, P853, DOI 10.1006/cyto.1997.0238; Maes M, 1995, J AFFECT DISORDERS, V36, P29, DOI 10.1016/0165-0327(95)00049-6; Maes M, 2007, NEUROENDOCRINOL LETT, V28, P826; Maes M, 2012, PSYCHOTHER PSYCHOSOM, V81, P286, DOI 10.1159/000336803; Maes M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-66; MANN JJ, 1986, ARCH GEN PSYCHIAT, V43, P954; Miller KJ, 1998, ANN NY ACAD SCI, V861, P169, DOI 10.1111/j.1749-6632.1998.tb10188.x; Miyaoka T, 2012, PROG NEURO-PSYCHOPH, V37, P222, DOI 10.1016/j.pnpbp.2012.02.002; Moreau M, 2005, J INFECT DIS, V192, P537, DOI 10.1086/431603; Murphy CF, 2004, AM J GERIAT PSYCHIAT, V12, P50, DOI 10.1176/appi.ajgp.12.1.50; Nau F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075426; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; O'Connor JC, 2009, J IMMUNOL, V182, P3202, DOI 10.4049/jimmunol.0802722; Pang TYC, 2009, HUM MOL GENET, V18, P753, DOI 10.1093/hmg/ddn385; Pitychoutis PM, 2009, NEUROSCIENCE, V159, P1216, DOI 10.1016/j.neuroscience.2009.01.072; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Serres F, 1999, EUR PSYCHIAT, V14, P451, DOI 10.1016/S0924-9338(99)00222-9; Simen BB, 2006, BIOL PSYCHIAT, V59, P775, DOI 10.1016/j.biopsych.2005.10.013; Slattery DA, 2012, NAT PROTOC, V7, P1009, DOI 10.1038/nprot.2012.044; Smith AK, 2008, PSYCHONEUROENDOCRINO, V33, P188, DOI 10.1016/j.psyneuen.2007.11.001; STANLEY M, 1983, LANCET, V1, P214; Stanley M, 1986, Ann N Y Acad Sci, V487, P122, DOI 10.1111/j.1749-6632.1986.tb27892.x; Strekalova T, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-9; Sullivan GM, 2006, INT J NEUROPSYCHOPH, V9, P547, DOI 10.1017/S1461145705006231; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Tyring S, 2006, LANCET, V367, P29, DOI 10.1016/S0140-6736(05)67763-X; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Wu C, 1999, EXP NEUROL, V158, P529, DOI 10.1006/exnr.1999.7105; Yu BN, 2008, J PHARMACOL EXP THER, V327, P316, DOI 10.1124/jpet.108.143461; Zhang XQ, 2009, J CHROMATOGR B, V877, P1678, DOI 10.1016/j.jchromb.2009.04.013; Zhang YQ, 2001, ACTA PHARMACOL SIN, V22, P923	54	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130643	10.1371/journal.pone.0130643	http://dx.doi.org/10.1371/journal.pone.0130643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147001	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600042
J	Crossey, E; Frietze, K; Narum, DL; Peabody, DS; Chackerian, B				Crossey, Erin; Frietze, Kathryn; Narum, David L.; Peabody, David S.; Chackerian, Bryce			Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; INHIBITORY MONOCLONAL-ANTIBODY; MALARIA VACCINE; ERYTHROCYTE INVASION; DIVERSE PEPTIDES; FULL-LENGTH; PROTEIN; AFFINITY; LOCALIZATION; EXPRESSION	We have developed a peptide display platform based on VLPs of the RNA bacteriophage MS2 that combines the high immunogenicity of VLP display with affinity selection capabilities. Random peptides can be displayed on the VLP surface by genetically inserting sequences into a surface-exposed loop of the viral coat protein. VLP-displayed peptides can then be isolated by selection using antibodies, and the VLP selectants can then be used directly as immunogens. Here, we investigated the ability of this platform to identify mimotopes of a highly conserved conformational epitope present on the Plasmodium falciparum blood-stage protein AMA1. Using 4G2, a monoclonal antibody that binds to this epitope and is a potent inhibitor of erythrocyte invasion, we screened three different VLP-peptide libraries and identified specific VLPs that bound strongly to the selecting mAb. We then tested the ability of a handful of selected VLPs to elicit anti-AMA1 antibody responses in mice. Most of the selected VLPs failed to reliably elicit AMA1 specific antibodies. However, one VLP consistently induced antibodies that cross-reacted with AMA1. Surprisingly, this VLP bound to 4G2 more weakly than the other selectants we identified. Taken together, these data demonstrate that VLP-peptide display can identify immunogenic mimics of a complex conformational epitope and illustrate the promise and challenges of this approach.	[Crossey, Erin; Frietze, Kathryn; Peabody, David S.; Chackerian, Bryce] Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Narum, David L.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD 20852 USA	University of New Mexico; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chackerian, B (corresponding author), Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA.	bchackerian@salud.unm.edu		Narum, David/0000-0003-3041-5402	NIH [R01 AI083305]; NIAID, NIH; University of New Mexico Biology of Infectious Diseases and Inflammation Training Grant [T31-AI007538]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083305, T32AI007538] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of New Mexico Biology of Infectious Diseases and Inflammation Training Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIH grant R01 AI083305 (to BC) and by the Intramural Research Program of NIAID, NIH. EC was supported by the University of New Mexico Biology of Infectious Diseases and Inflammation Training Grant (T31-AI007538). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Beenhouwer DO, 2002, J IMMUNOL, V169, P6992, DOI 10.4049/jimmunol.169.12.6992; Caldeira JD, 2010, VACCINE, V28, P4384, DOI 10.1016/j.vaccine.2010.04.049; Casey JL, 2004, INFECT IMMUN, V72, P1126, DOI 10.1128/IAI.72.2.1126-1134.2004; Chackerian B, 2011, J MOL BIOL, V409, P225, DOI 10.1016/j.jmb.2011.03.072; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; Collins CR, 2007, J BIOL CHEM, V282, P7431, DOI 10.1074/jbc.M610562200; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dutta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003840; Dutta S, 2010, INFECT IMMUN, V78, P661, DOI 10.1128/IAI.00866-09; Hill AVS, 2006, NAT REV IMMUNOL, V6, P21, DOI 10.1038/nri1746; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Irving MB, 2001, CURR OPIN CHEM BIOL, V5, P314, DOI 10.1016/S1367-5931(00)00208-8; Jennings GT, 2008, BIOL CHEM; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Kocken CHM, 1998, J BIOL CHEM, V273, P15119, DOI 10.1074/jbc.273.24.15119; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Laurens MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079323; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Mueller MS, 2003, INFECT IMMUN, V71, P4749, DOI 10.1128/IAI.71.8.4749-4758.2003; NARUM DL, 1994, MOL BIOCHEM PARASIT, V67, P59, DOI 10.1016/0166-6851(94)90096-5; Olszewska W, 2000, VIROLOGY, V272, P98, DOI 10.1006/viro.2000.0285; Ord RL, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-326; Peabody DS, 2008, J MOL BIOL, V380, P252, DOI 10.1016/j.jmb.2008.04.049; Peabody DS, 1997, ARCH BIOCHEM BIOPHYS, V347, P85, DOI 10.1006/abbi.1997.0312; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Richards JS, 2013, J IMMUNOL, V191, P795, DOI 10.4049/jimmunol.1300778; Sabo JK, 2007, INFECT IMMUN, V75, P61, DOI 10.1128/IAI.01041-06; Sok D, 2013, CELL, V155, P728, DOI 10.1016/j.cell.2013.10.009; Thera MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001465; THOMAS AW, 1994, AM J TROP MED HYG, V51, P730, DOI 10.4269/ajtmh.1994.51.730; Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912	38	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132560	10.1371/journal.pone.0132560	http://dx.doi.org/10.1371/journal.pone.0132560			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147502	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600300
J	Hinna, KH; Rich, K; Fex-Svenningsen, A; Benedikz, E				Hinna, Katja Hvid; Rich, Karen; Fex-Svenningsen, Asa; Benedikz, Eirikur			The Rat Homolog of the Schizophrenia Susceptibility Gene ZNF804A Is Highly Expressed during Brain Development, Particularly in Growth Cones	PLOS ONE			English	Article							STEM-CELLS; ASSOCIATION; RISK; ARC; CONSOLIDATION; NEUROBIOLOGY; DYNAMICS; TISSUES; MEMORY; PCR	A single nucleotide polymorphism in the ZNF804A gene, rs1344706, is associated with schizophrenia. The polymorphism has been suggested to alter fetal expression of ZNF804A. It has also been reported to be associated with altered cortical functioning and neural connectivity in the brain. Since developmental mechanisms are suggested in the pathophysiology for schizophrenia, expression of Zfp804A, the rat homolog of ZNF804A, was investigated in the developing rat brain. We found that expression of Zfp804A in most brain regions is developmentally regulated and peaks around birth, where after it decreases towards adult levels. This time point is developmentally the equivalent to the second trimester of fetal development in humans. An exception to this expression pattern is the hippocampus where the expression of Zfp804A appears to increase again in the adult brain. Using laser capture and quantitative PCR we found that Zfp804A mRNA expression in the adult rat hippocampus is highest in the CA1 sub region, where the overall firing rates of neurons is higher than in the CA3 region. In cultured cortical neurons Zfp804A mRNA expression peaked at day 4 and then decreased. The ZFP804A protein expression was therefore investigated with immunochemistry in such cultures. Interestingly, before day 4, the protein is mostly found in the perinuclear region of the cell but at day 4, ZFP804A was instead found throughout the cell and particularly in the growth cones. In conclusion we demonstrate that Zfp804A increases in the rat brain at the time of birth, coinciding with neuronal differentiation. We also show that ZFP804A is localized to growth cones of growing neurites. These data implicate ZFP804A in growth cone function and neurite elongation. The polymorphism rs1344706 lowers expression of ZNF804A during prenatal brain development. This may affect ZNF804A's role in cone function and neurite elongation leading to synaptic deficits and altered neural connectivity.	[Hinna, Katja Hvid; Rich, Karen; Fex-Svenningsen, Asa; Benedikz, Eirikur] Univ Southern Denmark, Inst Mol Med, Neurobiol Res, Odense, Denmark	University of Southern Denmark	Benedikz, E (corresponding author), Univ Southern Denmark, Inst Mol Med, Neurobiol Res, Odense, Denmark.	ebenedikz@health.sdu.dk	Svenningsen, Åsa Fex/H-5443-2015	Svenningsen, Åsa Fex/0000-0002-5651-265X; Benedikz, Eirikur/0000-0001-6789-8837	Lundbeckfonden [R67-A6538]; Fonden til laegevidenskabens fremme	Lundbeckfonden(Lundbeckfonden); Fonden til laegevidenskabens fremme	This work was supported by Lundbeckfonden (R67-A6538) and Fonden til laegevidenskabens fremme to EB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; del Re EC, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.117; Donohoe G, 2010, SCHIZOPHRENIA BULL, V36, P904, DOI 10.1093/schbul/sbq080; Esslinger C, 2009, SCIENCE, V324, P605, DOI 10.1126/science.1167768; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Girgenti MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032404; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hill MJ, 2012, AM J PSYCHIAT, V169, P1301, DOI 10.1176/appi.ajp.2012.11121845; Hill MJ, 2012, HUM MOL GENET, V21, P1018, DOI 10.1093/hmg/ddr532; Kindlundh-Hogberg AMS, 2010, CELL MOL NEUROBIOL, V30, P13, DOI 10.1007/s10571-009-9426-y; Kraemer N, 2012, NEUROL RES, V34, P664, DOI 10.1179/1743132812Y.0000000060; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lewis DA, 2000, NEURON, V28, P325, DOI 10.1016/S0896-6273(00)00111-2; Mizuseki K, 2012, HIPPOCAMPUS, V22, P1659, DOI 10.1002/hipo.22002; MURRAY RM, 1987, BRIT MED J, V295, P681, DOI 10.1136/bmj.295.6600.681; Nieratschker Vanessa, 2010, Front Behav Neurosci, V4, P23, DOI 10.3389/fnbeh.2010.00023; O'Donoghue T, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.115; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Pantelis C, 2005, SCHIZOPHRENIA BULL, V31, P672, DOI 10.1093/schbul/sbi034; Pevzner A, 2012, NEUROBIOL LEARN MEM, V97, P313, DOI 10.1016/j.nlm.2012.02.004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Rasetti R, 2011, ARCH GEN PSYCHIAT, V68, P1207, DOI 10.1001/archgenpsychiatry.2011.103; Riley B, 2010, MOL PSYCHIATR, V15, P29, DOI 10.1038/mp.2009.109; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steinberg S, 2011, MOL PSYCHIATR, V16, P59, DOI 10.1038/mp.2009.149; Svenningsen AF, 2003, J NEUROSCI RES, V72, P565, DOI 10.1002/jnr.10610; Tao R, 2014, JAMA PSYCHIAT, V71, P1112, DOI 10.1001/jamapsychiatry.2014.1079; Umeda-Yano S, 2014, NEUROSCI LETT, V568, P12, DOI 10.1016/j.neulet.2014.03.031; Umeda-Yano S, 2013, SCHIZOPHR RES, V146, P273, DOI 10.1016/j.schres.2013.01.026; Walters JTR, 2010, ARCH GEN PSYCHIAT, V67, P692, DOI 10.1001/archgenpsychiatry.2010.81; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Williams HJ, 2011, MOL PSYCHIATR, V16, P429, DOI 10.1038/mp.2010.36; Zhang R, 2011, MOL PSYCHIATR, V16, P360, DOI 10.1038/mp.2010.55	38	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132456	10.1371/journal.pone.0132456	http://dx.doi.org/10.1371/journal.pone.0132456			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148198	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600274
J	Iguchi, T; Wang, CY; Delongchamps, NB; Kato, M; Tamada, S; Yamasaki, T; de la Roza, G; Nakatani, T; Haas, GP				Iguchi, Taro; Wang, Ching Y.; Delongchamps, Nicolas B.; Kato, Minoru; Tamada, Satoshi; Yamasaki, Takeshi; de la Roza, Gustavo; Nakatani, Tatsuya; Haas, Gabriel P.			Association of MnSOD AA Genotype with the Progression of Prostate Cancer	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; GENE POLYMORPHISM; RISK; DIMORPHISM; LUNG; MPO	Purpose To investigate whether manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with the clinical significance of prostate cancer. Materials and Methods Prostates were obtained from 194 deceased men 45 years or older who did not have a history of prostate cancer. Serial sections and histological examinations of the prostate were performed. The MnSOD genotypes of the specimens were determined by polymerase chain reaction restriction fragment length polymorphism analysis. Results Of the 194 men, 31 and 26 had clinically insignificant and significant prostate cancer. Clinically significant cancer comprised 29% and 58% of the cancers in men <70 and >70 years old, respectively. The age-specific proportion of significant cancer significantly increased with the advance of age (p<0.001). MnSOD AA, as compared with the other genotypes (VA and VV together), was associated with significant prostate cancer across all ages, odds ratio (OR) 2.34, 95% confidence interval (CI) 0.99-5.49, and in men older than 69 years (OR 4.89, 95% CI 1.51-15.8), but not in men younger than 70 years. The genotype was not associated with clinically insignificant cancer regardless of age. The comparison between significant and insignificant cancer, the OR (95% CI) for MnSOD AA was 5.04 (1.05-24.2) (sensitivity 0.57, specificity 0.78, positive predictive value 0.78) in men older than 69 years. Conclusions MnSOD polymorphism is strongly associated with the clinical significance of prostate cancer in men older than 69 years, but not in men younger than 70 years suggesting that oxidative stress may be involved in the progression of the disease. MnSOD may be a clinically useful marker to predict the potential of progression of prostate cancer.	[Iguchi, Taro; Wang, Ching Y.; Delongchamps, Nicolas B.; Haas, Gabriel P.] SUNY Upstate Med Univ, Dept Urol, Syracuse, NY 13210 USA; [Iguchi, Taro; Kato, Minoru; Tamada, Satoshi; Yamasaki, Takeshi; Nakatani, Tatsuya] Osaka City Univ, Grad Sch Med, Dept Urol, Osaka 558, Japan; [Delongchamps, Nicolas B.] Cochin Hosp, Dept Urol, Paris, France; [de la Roza, Gustavo] SUNY Upstate Med Univ, Dept Pathol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Osaka Metropolitan University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Iguchi, T (corresponding author), SUNY Upstate Med Univ, Dept Urol, Syracuse, NY 13210 USA.	taro@msic.med.osaka-cu.ac.jp	Delongchamps, Nicolas Barry/AAE-8651-2020; Iguchi, Taro/AAS-5209-2021		National Cancer Institute [CA097751]; National Institute on Aging [AG021389]; Ministry of Education, Science, Sports and Culture [21791524]; Osaka Medical Research Foundation for Incurable Disease; NATIONAL CANCER INSTITUTE [R03CA097751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021389] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Osaka Medical Research Foundation for Incurable Disease; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by research grants from the National Cancer Institute (CA097751; GPH) and the National Institute on Aging (AG021389; GPH), the Ministry of Education, Science, Sports and Culture (Grant-in-Aid for Young Scientists (B) 21791524; TI) and the Osaka Medical Research Foundation for Incurable Disease (TI).	Choi JY, 2008, CARCINOGENESIS, V29, P964, DOI 10.1093/carcin/bgn056; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Costello LC, 2000, ONCOLOGY-BASEL, V59, P269, DOI 10.1159/000012183; EPSTEIN JI, 1994, JAMA-J AM MED ASSOC, V271, P368, DOI 10.1001/jama.271.5.368; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Haas GP, 2008, CAN J UROL, V15, P3866; Haas GP, 2007, JNCI-J NATL CANCER I, V99, P1484, DOI 10.1093/jnci/djm153; Hung RJ, 2004, CARCINOGENESIS, V25, P973, DOI 10.1093/carcin/bgh080; Iguchi T, 2008, ANTICANCER RES, V28, P3007; Iguchi T, 2008, UROLOGY, V72, P238, DOI 10.1016/j.urology.2008.03.064; Iguchi T, 2009, IN VIVO, V23, P7; Kang D, 2007, CANCER EPIDEM BIOMAR, V16, P1581, DOI 10.1158/1055-9965.EPI-07-0160; Kaplan SA, 2009, UROLOGY, V73, P935, DOI 10.1016/j.urology.2008.09.079; KUROSAWA K, 1990, J BIOCHEM-TOKYO, V108, P9, DOI 10.1093/oxfordjournals.jbchem.a123169; Li HJ, 2005, CANCER RES, V65, P2498, DOI 10.1158/0008-5472.CAN-04-3535; Lin K, 2008, ANN INTERN MED, V149, P192, DOI 10.7326/0003-4819-149-3-200808050-00009; Liu LW, 2009, UROLOGY, V74, P884, DOI 10.1016/j.urology.2008.11.016; Mao C, 2010, J CANCER RES CLIN, V136, P975, DOI 10.1007/s00432-009-0742-x; Miar A, 2015, FREE RADICAL BIO MED, V85, P45, DOI 10.1016/j.freeradbiomed.2015.04.001; Mikhak B, 2008, CARCINOGENESIS, V29, P2335, DOI 10.1093/carcin/bgn212; Mitrunen K, 2001, CARCINOGENESIS, V22, P827, DOI 10.1093/carcin/22.5.827; Murphy SJ, 2007, CARCINOGENESIS, V28, P1323, DOI 10.1093/carcin/bgm007; ShimodaMatsubayashi S, 1996, BIOCHEM BIOPH RES CO, V226, P561, DOI 10.1006/bbrc.1996.1394; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; STAMEY TA, 1993, CANCER, V71, P933, DOI 10.1002/1097-0142(19930201)71:3+<933::AID-CNCR2820711408>3.0.CO;2-L; Sutton A, 2003, PHARMACOGENETICS, V13, P145, DOI 10.1097/00008571-200303000-00004; Tong SY, 2009, GYNECOL ONCOL, V115, P272, DOI 10.1016/j.ygyno.2009.07.032; Wang LI, 2001, J NATL CANCER I, V93, P1818, DOI 10.1093/jnci/93.23.1818; Wang SM, 2009, EUR J CANCER, V45, P2874, DOI 10.1016/j.ejca.2009.04.024; Woodson K, 2003, CANCER CAUSE CONTROL, V14, P513, DOI 10.1023/A:1024840823328	30	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131325	10.1371/journal.pone.0131325	http://dx.doi.org/10.1371/journal.pone.0131325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147925	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600089
J	Junier, T; Herve, V; Wunderlin, T; Junier, P				Junier, Thomas; Herve, Vincent; Wunderlin, Tina; Junier, Pilar			MLgsc: A Maximum-Likelihood General Sequence Classifier	PLOS ONE			English	Article							TAXONOMIC CLASSIFICATION; SPORULATION; ALIGNMENT; SEARCH; PERFORMANCE; PLACEMENT; ACCURACY	We present software package for classifying protein or nucleotide sequences to user-specified sets of reference sequences. The software trains a model using a multiple sequence alignment and a phylogenetic tree, both supplied by the user. The latter is used to guide model construction and as a decision tree to speed up the classification process. The software was evaluated on all the 16S rRNA gene sequences of the reference dataset found in the GreenGenes database. On this dataset, the software was shown to achieve an error rate of around 1% at genus level. Examples of applications based on the nitrogenase subunit NifH gene and a protein-coding gene found in endospore-forming Firmicutes is also presented. The programs in the package have a simple, straightforward command-line interface for the Unix shell, and are free and open-source. The package has minimal dependencies and thus can be easily integrated in command-line based classification pipelines.	[Junier, Thomas; Herve, Vincent; Wunderlin, Tina; Junier, Pilar] Univ Neuchatel, Microbiol Lab, CH-2000 Neuchatel, Switzerland; [Junier, Thomas] Swiss Inst Bioinformat, Vital IT Grp, Lausanne, Vaud, Switzerland; [Herve, Vincent] Univ Lausanne, Inst Earth Sci, Lab Biogeosci, Lausanne, Vaud, Switzerland	University of Neuchatel; Swiss Institute of Bioinformatics; University of Lausanne	Junier, T (corresponding author), Univ Neuchatel, Microbiol Lab, CH-2000 Neuchatel, Switzerland.	thomas.junier@unine.ch		Herve, Vincent/0000-0002-3495-561X	Swiss National Science Foundation [31003A-132358/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors acknowledge the elemo project (elemo.ch) for the sampling campaigns using the MIR submersibles. The authors are grateful for the help of the MIR team and colleagues from the elemo project. This work was supported by Swiss National Science Foundation grant No. 31003A-132358/1.	Abecasis AB, 2013, J BACTERIOL, V195, P2101, DOI 10.1128/JB.02110-12; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bazinet AL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-92; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; Diaz NN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-56; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fish JA, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00291; Galperin MY, 2012, ENVIRON MICROBIOL, V14, P2870, DOI 10.1111/j.1462-2920.2012.02841.x; Gerlach W, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr225; Glass E.M., 2010, COLD SPRING HARB PRO, V2010, DOI DOI 10.1101/PDB.PROT5368; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HENIKOFF S, 1994, J MOL BIOL, V243, P574, DOI 10.1016/0022-2836(94)90032-9; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kelley DR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-544; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Munoz R, 2011, SYST APPL MICROBIOL, V34, P169, DOI 10.1016/j.syapm.2011.03.001; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wunderlin T, 2013, ENV MICROBIOL REP, V5, P911, DOI 10.1111/1758-2229.12094	27	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0129384	10.1371/journal.pone.0129384	http://dx.doi.org/10.1371/journal.pone.0129384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148002	Green Submitted, gold, Green Published			2022-12-27	WOS:000358157600020
J	Murre, JMJ; Dros, J				Murre, Jaap M. J.; Dros, Joeri			Replication and Analysis of Ebbinghaus' Forgetting Curve	PLOS ONE			English	Article							POWER-LAW; MEMORY; SAVINGS; SLEEP; RETENTION; TIME; CONSOLIDATION; MODEL	We present a successful replication of Ebbinghaus' classic forgetting curve from 1880 based on the method of savings. One subject spent 70 hours learning lists and relearning them after 20 min, 1 hour, 9 hours, 1 day, 2 days, or 31 days. The results are similar to Ebbinghaus' original data. We analyze the effects of serial position on forgetting and investigate what mathematical equations present a good fit to the Ebbinghaus forgetting curve and its replications. We conclude that the Ebbinghaus forgetting curve has indeed been replicated and that it is not completely smooth but most probably shows a jump upwards starting at the 24 hour data point.	[Murre, Jaap M. J.; Dros, Joeri] Univ Amsterdam, Amsterdam, Netherlands	University of Amsterdam	Murre, JMJ (corresponding author), Univ Amsterdam, Amsterdam, Netherlands.	jaap@murre.com	Murre, Jaap MJ/A-3813-2010					Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; AMMONS RB, 1958, J EXP PSYCHOL, V55, P318, DOI 10.1037/h0041893; ANDERSON JR, 1991, PSYCHOL SCI, V2, P396, DOI 10.1111/j.1467-9280.1991.tb00174.x; Anderson RB, 1997, MEM COGNITION, V25, P724, DOI 10.3758/BF03211315; Anderson RB, 2001, MEM COGNITION, V29, P1061, DOI 10.3758/BF03195767; [Anonymous], 2004, INT J BILINGUAL, DOI DOI 10.1177/13670069040080031101; BAHRICK HP, 1967, J VERB LEARN VERB BE, V6, P89, DOI 10.1016/S0022-5371(67)80055-0; Bartlett FC, 1932, REMBERING; Bergman ET, 1999, MEM COGNITION, V27, P937, DOI 10.3758/BF03201224; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Burtt HE, 1925, J APPL PSYCHOL, V9, P5, DOI 10.1037/h0073966; Chessa AG, 2007, MARKET SCI, V26, P130, DOI 10.1287/mksc.1060.0212; De Bot K, 2000, APPL LINGUIST, V21, P333, DOI 10.1093/applin/21.3.333; de Groot A., 2011, LANGUAGE COGNITION B; Ebbinghaus H., 1913, MEMORY CONTRIBUTION; Ebbinghaus H., 1880, URMANUSKRIPT UEBER G; Ebbinghaus H.A., 1885, MEMORY; Finkenbinder EO, 1913, AM J PSYCHOL, V24, P8, DOI 10.2307/1413271; Gais S, 2006, LEARN MEMORY, V13, P259, DOI 10.1101/lm.132106; GRONINGER LK, 1980, B PSYCHONOMIC SOC, V15, P263; Hansen L, 2002, LANG LEARN, V52, P653, DOI 10.1111/1467-9922.00200; HELLER O, 1991, Z PSYCHOL, V199, P3; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; Krueger WCF, 1929, J EXP PSYCHOL, V12, P71, DOI 10.1037/h0072036; Linton M., 1975, EXPLORATIONS COGNITI, P376; Luh CW, 1922, PSYCHOL MONOGR, V31, pi; Luria A., 1968, MIND MNEMONIST; Mednick S, 2003, NAT NEUROSCI, V6, P697, DOI 10.1038/nn1078; Meeter M, 2004, PSYCHOL BULL, V130, P843, DOI 10.1037/0033-2909.130.6.843; Muller G. E., 1900, Z PSYCHOLOGIE, V1, P1; Muller GE, 1894, Z PSYCHOL PHYSL SINN, V5, P81; MULLER GE, 1894, Z PSYCHOL PHYSL SINN, V6, P257; Murre JMJ, 2011, PSYCHON B REV, V18, P592, DOI 10.3758/s13423-011-0076-y; Murre JMJ, 2013, FRONTIERS PSYCHOL, V4; Murre JMJ, 2007, STAT PROCESS MODELS, P119; Myung IJ, 2000, MEM COGNITION, V28, P832, DOI 10.3758/BF03198418; Nadel L, 2000, HIPPOCAMPUS, V10, P352, DOI 10.1002/1098-1063(2000)10:4<352::AID-HIPO2>3.3.CO;2-4; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; NELSON TO, 1978, J EXP PSYCHOL-HUM L, V4, P453, DOI 10.1037/0278-7393.4.5.453; NELSON TO, 1985, J EXP PSYCHOL LEARN, V11, P472, DOI 10.1037/0278-7393.11.3.472; NELSON TO, 1971, J VERB LEARN VERB BE, V10, P568, DOI 10.1016/S0022-5371(71)80030-0; Newell A., 1981, COGNITIVE SKILLS THE; Parker ES, 2006, NEUROCASE, V12, P35, DOI 10.1080/13554790500473680; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Radossawljewitsch PR, 1907, BEHALTEN VERGESSEN B; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rubin DC, 1999, J EXP PSYCHOL LEARN, V25, P1161, DOI 10.1037/0278-7393.25.5.1161; Rubin DC, 1996, PSYCHOL REV, V103, P734, DOI 10.1037/0033-295X.103.4.734; SEHULSTER JR, 1989, MEM COGNITION, V17, P590, DOI 10.3758/BF03197082; Squire L. R., 1984, MEMORY CONSOLIDATION, P185; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; WAGENAAR WA, 1986, COGNITIVE PSYCHOL, V18, P225, DOI 10.1016/0010-0285(86)90013-7; Wickelgren WA, 1977, LEARNING MEMORY; Wixted JT, 2007, PSYCHOL SCI, V18, P133, DOI 10.1111/j.1467-9280.2007.01862.x; WIXTED JT, 1991, PSYCHOL SCI, V2, P409, DOI 10.1111/j.1467-9280.1991.tb00175.x; Wynn VE, 1998, APPL COGNITIVE PSYCH, V12, P1, DOI 10.1002/(SICI)1099-0720(199802)12:1<1::AID-ACP493>3.0.CO;2-M; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	58	213	219	26	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0120644	10.1371/journal.pone.0120644	http://dx.doi.org/10.1371/journal.pone.0120644			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148023	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600002
J	Puncher, GN; Arrizabalaga, H; Alemany, F; Cariani, A; Oray, IK; Karakulak, FS; Basilone, G; Cuttitta, A; Mazzola, S; Tinti, F				Puncher, Gregory Neils; Arrizabalaga, Haritz; Alemany, Francisco; Cariani, Alessia; Oray, Isik K.; Karakulak, F. Saadet; Basilone, Gualtiero; Cuttitta, Angela; Mazzola, Salvatore; Tinti, Fausto			Molecular Identification of Atlantic Bluefin Tuna (Thunnus thynnus, Scombridae) Larvae and Development of a DNA Character-Based Identification Key for Mediterranean Scombrids	PLOS ONE			English	Article							GULF-OF-MEXICO; EGG-PRODUCTION METHOD; GADUS-MORHUA L.; PHYLOGENETIC-RELATIONSHIPS; SPECIES IDENTIFICATION; GENETIC IDENTIFICATION; POPULATION-STRUCTURE; SEQUENCE-ANALYSIS; FISH ASSEMBLAGES; WESTERN	The Atlantic bluefin tuna, Thunnus thynnus, is a commercially important species that has been severely over-exploited in the recent past. Although the eastern Atlantic and Mediterranean stock is now showing signs of recovery, its current status remains very uncertain and as a consequence their recovery is dependent upon severe management informed by rigorous scientific research. Monitoring of early life history stages can inform decision makers about the health of the species based upon recruitment and survival rates. Misidentification of fish larvae and eggs can lead to inaccurate estimates of stock biomass and productivity which can trigger demands for increased quotas and unsound management conclusions. Herein we used a molecular approach employing mitochondrial and nuclear genes (CO1 and ITS1, respectively) to identify larvae (n = 188) collected from three spawning areas in the Mediterranean Sea by different institutions working with a regional fisheries management organization. Several techniques were used to analyze the genetic sequences (sequence alignments using search algorithms, neighbour joining trees, and a genetic character-based identification key) and an extensive comparison of the results is presented. During this process various inaccuracies in related publications and online databases were uncovered. Our results reveal important differences in the accuracy of the taxonomic identifications carried out by different ichthyoplanktologists following morphology-based methods. While less than half of larvae provided were bluefin tuna, other dominant taxa were bullet tuna (Auxis rochei), albacore (Thunnus alalunga) and little tunny (Euthynnus alletteratus). We advocate an expansion of expertise for a new generation of morphology-based taxonomists, increased dialogue between morphology-based and molecular taxonomists and increased scrutiny of public sequence databases.	[Puncher, Gregory Neils; Cariani, Alessia; Tinti, Fausto] Univ Bologna, Dept Biol Geol & Environm Sci, Lab Genet & Genom Marine Resources & Environm Gen, Ravenna, Italy; [Arrizabalaga, Haritz] AZTI Tecnalia, Div Marine Res, Pasaia, Gipuzkoa, Spain; [Alemany, Francisco] Ctr Oceanog Baleares, Inst Espanol Oceanog, Palma De Mallorca, Spain; [Oray, Isik K.; Karakulak, F. Saadet] Istanbul Univ, Fac Fisheries, Istanbul, Turkey; [Basilone, Gualtiero; Cuttitta, Angela; Mazzola, Salvatore] CNR, Inst Marine & Coastal Environm IAMC CNR, Lab Mol Ecol & Biotechnol, Detached Unit Capo Granitola, Trapani, Italy	University of Bologna; AZTI; Spanish Institute of Oceanography; Istanbul University; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR)	Puncher, GN (corresponding author), Univ Bologna, Dept Biol Geol & Environm Sci, Lab Genet & Genom Marine Resources & Environm Gen, Ravenna, Italy.	gregoryneil.puncher2@unibo.it	Arrizabalaga, Haritz/B-8238-2009; Karakulak, F. Saadet/B-7602-2018; Cariani, Alessia/L-3459-2016; Cuttitta, Angela/AAK-2097-2020; Tinti, Fausto/D-4847-2012; Basilone, Gualtiero/D-2896-2017	Arrizabalaga, Haritz/0000-0002-3861-6316; Karakulak, F. Saadet/0000-0002-6053-5256; Cariani, Alessia/0000-0002-5513-0086; Cuttitta, Angela/0000-0002-4896-5114; Tinti, Fausto/0000-0002-8649-5387; Basilone, Gualtiero/0000-0002-5732-5055; Alemany, F. (Francisco)/0000-0001-6265-5545; PUNCHER, GREGORY NEILS/0000-0002-4372-8435; Mazzola, Salvatore/0000-0002-4622-8129	European Community [SI2/542789, NMFS NA11NMF4720107]; ICCAT Secretariat; Marine Ecosystem Health and Conservation (MARES) Joint Doctorate programme [FPA 2011-0016]	European Community(European Commission); ICCAT Secretariat; Marine Ecosystem Health and Conservation (MARES) Joint Doctorate programme	This work was carried out under the provision of the ICCAT Atlantic Wide Research Program for Bluefin Tuna (GBYP), funded by the European Community (Grant SI2/542789), Canada, Croatia, Japan, Norway, Turkey, United States (NMFS NA11NMF4720107), Chinese Taipei, and the ICCAT Secretariat (see: http://www.iccat.int/GBYP/en/Budget.htm). The contents of this paper do not necessarily reflect the point of view of ICCAT or of the other funders. This work was co-funded by the Marine Ecosystem Health and Conservation (MARES) Joint Doctorate programme selected under Erasmus Mundus and coordinated by Ghent University (FPA 2011-0016). The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2009, BLUEFIN TUNA LARVAL; Alemany F, 2006, J PLANKTON RES, V28, P473, DOI 10.1093/plankt/fbi123; Alemany F, 2010, PROG OCEANOGR, V86, P21, DOI 10.1016/j.pocean.2010.04.014; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aranda G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076445; Armstrong MJ, 2001, ICES J MAR SCI, V58, P183, DOI 10.1006/jmsc.2000.1001; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; BOEHLERT GW, 1994, MAR ECOL PROG SER, V107, P1, DOI 10.3354/meps107001; Boero F, 2001, TRENDS ECOL EVOL, V16, P266, DOI 10.1016/S0169-5347(01)02133-4; Bremer JRA, 1997, J FISH BIOL, V50, P540, DOI 10.1006/jfbi.1996.0321; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Cermeno P, 2012, INT COMM CONS ATL CO, V68, P151; Chow S, 2006, J FISH BIOL, V68, P24, DOI 10.1111/j.0022-1112.2006.00945.x; Chow S, 1995, J MOL EVOL, V41, P741, DOI 10.1007/BF00173154; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Costa FO., 2007, GENOMICS SOC POLICY, V3, P29; Cuttitta A, 2004, HYDROBIOLOGIA, V527, P177, DOI 10.1023/B:HYDR.0000043299.65829.2f; D'Alessandro EK, 2010, MAR ECOL PROG SER, V410, P159, DOI 10.3354/meps08632; DANIEL LB, 1994, FISH B-NOAA, V92, P254; Elliott NG, 1995, MAR FRESHWATER RES, V46, P1021, DOI 10.1071/MF9951021; Fahay M.P., 1983, Journal of Northwest Atlantic Fishery Science, V4, P1; Fahay MP, 2007, EARLY STAGES FISHES, V1; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fox CJ, 2005, MOL ECOL, V14, P879, DOI 10.1111/j.1365-294X.2005.02439.x; Fromentin JM, 2014, MAR POLICY, V47, P8, DOI 10.1016/j.marpol.2014.01.018; Fromentin JM, 2014, FISH OCEANOGR, V23, P147, DOI 10.1111/fog.12050; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Garcia A, 2013, FISH OCEANOGR, V22, P273, DOI 10.1111/fog.12021; Garcia A., 2005, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V58, P535; Garcia A, 2005, COL VOL SCI PAP ICCA, V58, P1261; Giovanardi Otello, 2010, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V65, P740; Hopkins GW, 2002, ANIM CONSERV, V5, P245, DOI 10.1017/S1367943002002299; Hyde JR, 2005, MAR ECOL PROG SER, V286, P269, DOI 10.3354/meps286269; ICCAT, 2013, ICCAT 2013 BLUEF M B, P1; ICCAT, 2014, ICCAT REP STAND COMM; Ingram GW, 2010, AQUAT LIVING RESOUR, V23, P35, DOI 10.1051/alr/2009053; Ingram Jr GW, 2013, INT COMM CONS ATL CO, V69, P1057; Isari S, 2008, ESTUAR COAST SHELF S, V79, P607, DOI 10.1016/j.ecss.2008.06.001; Karakulak S, 2004, J APPL ICHTHYOL, V20, P318, DOI 10.1111/j.1439-0426.2004.00561.x; Kawamura G, 2003, BIG FISH BANG, P123; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Ko HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053451; Koched W, 2013, MEDITERR MAR SCI, V14, P5, DOI 10.12681/mms.314; Kohno H, 1982, JPN J ICHTHYOL, P1; Lindo-Atichati D, 2012, MAR ECOL PROG SER, V463, P245, DOI 10.3354/meps09860; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Lowenstein JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007866; Mariani P, 2010, PROG OCEANOGR, V86, P45, DOI 10.1016/j.pocean.2010.04.027; Matarese AC, 2011, ICHTHYOL RES, V58, P170, DOI 10.1007/s10228-010-0198-7; Mather F.J., 1995, NOAA TECHNICAL MEMOR, V370, P1; MATSUMOTO WM, 1972, FISH BULL NATL OC AT, V70, P1; Muhling BA, 2013, MAR ECOL PROG SER, V486, P257, DOI 10.3354/meps10397; Nei M., 2000, MOL EVOLUTION PHYLOG; Oray IK, 2005, J APPL ICHTHYOL, V21, P236, DOI 10.1111/j.1439-0426.2005.00658.x; Paine MA, 2008, ICHTHYOL RES, V55, P7, DOI 10.1007/s10228-007-0003-4; Paine MA, 2007, B MAR SCI, V80, P353; Piccinetti C., 1997, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V46, P207; POTTHOFF T, 1970, B MAR SCI, V20, P389; POTTHOFF T, 1974, FISH B-NOAA, V72, P563; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reglero P, 2012, MAR ECOL PROG SER, V463, P273, DOI 10.3354/meps09800; Riccioni G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080105; Riccioni G, 2010, P NATL ACAD SCI USA, V107, P2102, DOI 10.1073/pnas.0908281107; Richards W.J., 1974, P623; RICHARDS WJ, 1990, FISH B-NOAA, V88, P607; RICHARDS WJ, 2006, EARLY STAGES ATLANTI, P2187; Richardson DE, 2007, MOL ECOL NOTES, V7, P199, DOI 10.1111/j.1471-8286.2006.01620.x; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Rooker JR, 2014, MAR ECOL PROG SER, V504, P265, DOI 10.3354/meps10781; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanzo L, 1932, UOVA PRIMI STADI LAR, P189; Scott Gerald P., 2003, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V55, P1123; SCOTT GP, 1993, B MAR SCI, V53, P912; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Stratoudakis Y, 2006, FISH FISH, V7, P35, DOI 10.1111/j.1467-2979.2006.00206.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsuji S., 1997, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V46, P161; Vecchione M, 2000, ICES J MAR SCI, V57, P677, DOI 10.1006/jmsc.2000.0707; Vinas J, 2011, REV FISH BIOL FISHER, V21, P527, DOI 10.1007/s11160-010-9174-6; Vinas J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007606; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Wilson EO, 2003, TRENDS ECOL EVOL, V18, P77, DOI 10.1016/S0169-5347(02)00040-X; Zhang AB, 2012, MOL ECOL, V21, P1848, DOI 10.1111/j.1365-294X.2011.05235.x	86	23	24	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130407	10.1371/journal.pone.0130407	http://dx.doi.org/10.1371/journal.pone.0130407			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147931	Green Published, gold			2022-12-27	WOS:000358157600035
J	Smith, AC; Hudson, MAR; Downes, CM; Francis, CM				Smith, Adam C.; Hudson, Marie-Anne R.; Downes, Constance M.; Francis, Charles M.			Change Points in the Population Trends of Aerial-Insectivorous Birds in North America: Synchronized in Time across Species and Regions	PLOS ONE			English	Article							DECLINES	North American populations of aerial insectivorous birds are in steep decline. Aerial insectivores (AI) are a group of bird species that feed almost exclusively on insects in flight, and include swallows, swifts, nightjars, and flycatchers. The causes of the declines are not well understood. Indeed, it is not clear when the declines began, or whether the declines are shared across all species in the group (e.g., caused by changes in flying insect populations) or specific to each species (e.g., caused by changes in species' breeding habitat). A recent study suggested that population trends of aerial insectivores changed for the worse in the 1980s. If there was such a change point in trends of the group, understanding its timing and geographic pattern could help identify potential causes of the decline. We used a hierarchical Bayesian, penalized regression spline, change point model to estimate group-level change points in the trends of 22 species of AI, across 153 geographic strata of North America. We found evidence for group-level change points in 85% of the strata. Change points for flycatchers (FC) were distinct from those for swallows, swifts and nightjars (SSN) across North America, except in the Northeast, where all AI shared the same group-level change points. During the 1980s, there was a negative change point acrossmost of North America, in the trends of SSN. For FC, the group-level change points were more geographically variable, and in many regions there were two: a positive change point followed by a negative change point. This group-level synchrony in AI population trends is likely evidence of a response to a common environmental factor(s) with similar effects on many species across broad spatial extents. The timing and geographic patterns of the change points that we identify here should provide a spring-board for research into the causes behind aerial insectivore declines.	[Smith, Adam C.; Hudson, Marie-Anne R.; Downes, Constance M.; Francis, Charles M.] Environm Canada, Canadian Wildlife Serv, Ottawa, ON K1A 0H3, Canada	Environment & Climate Change Canada; Canadian Wildlife Service	Smith, AC (corresponding author), Environm Canada, Canadian Wildlife Serv, Ottawa, ON K1A 0H3, Canada.	Adam.Smith@ec.gc.ca		Smith, Adam Clark/0000-0002-2829-4843				[Anonymous], 2004, DATA BIRD; Barry R, 2001, SYNOPTIC DYNAMIC CLI, P358; Beckage B, 2007, NEW PHYTOL, V174, P456, DOI 10.1111/j.1469-8137.2007.01991.x; Bled F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081867; Fraser KC, 2012, P ROY SOC B-BIOL SCI, V279, P4901, DOI 10.1098/rspb.2012.2207; Garcia-Perez B, 2014, AUK, V131, P351, DOI 10.1642/AUK-13-145.1; Garcia-Perez B, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00116.1; GEISSLER P H, 1990, U S Fish and Wildlife Service Biological Report, V90, P54; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; Jahn AE, 2013, AUK, V130, P247, DOI 10.1525/auk.2013.13010; Link WA, 2002, ECOLOGY, V83, P2832, DOI 10.1890/0012-9658(2002)083[2832:AHAOPC]2.0.CO;2; Lunn DJ, 2009, STAT COMPUT, V19, P395, DOI 10.1007/s11222-008-9100-0; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; NABCI, 2012, STAT CAN BIRDS; Nebel S, 2010, AVIAN CONSERV ECOL, V5; Paquette SR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0649; Saracco JF, 2008, J WILDLIFE MANAGE, V72, P1665, DOI 10.2193/2008-129; Sauer JR, 2011, AUK, V128, P87, DOI 10.1525/auk.2010.09220; Smith Adam C., 2014, Canadian Field-Naturalist, V128, P119; SMITH GW, 1995, 5 US DEP INT NAT BIO; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Thomas A., 2004, GEOBUGS USER MANUAL; Thomas L, 1996, ECOLOGY, V77, P49, DOI 10.2307/2265653; Thomson JR, 2010, ECOL APPL, V20, P1431, DOI 10.1890/09-0998.1; Zimmerman GS, 2012, J WILDLIFE MANAGE, V76, P1165, DOI 10.1002/jwmg.351	25	42	41	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130768	10.1371/journal.pone.0130768	http://dx.doi.org/10.1371/journal.pone.0130768			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147572	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600048
J	Takeuchi, F; Sekizuka, T; Ogasawara, Y; Yokoyama, H; Kamikawa, R; Inagaki, Y; Nozaki, T; Sugita-Konishi, Y; Ohnishi, T; Kuroda, M				Takeuchi, Fumihiko; Sekizuka, Tsuyoshi; Ogasawara, Yumiko; Yokoyama, Hiroshi; Kamikawa, Ryoma; Inagaki, Yuji; Nozaki, Tomoyoshi; Sugita-Konishi, Yoshiko; Ohnishi, Takahiro; Kuroda, Makoto			The Mitochondrial Genomes of a Myxozoan Genus Kudoa Are Extremely Divergent in Metazoa	PLOS ONE			English	Article							BASIC LOCAL ALIGNMENT; PHYLOGENETIC-RELATIONSHIPS; PARALICHTHYS-OLIVACEUS; CTENOPHORE MNEMIOPSIS; EVOLUTION; ANNOTATION; SEPTEMPUNCTATA; IDENTIFICATION; VISUALIZATION; CHAETOGNATHS	The Myxozoa are oligo-cellular parasites with alternate hosts-fish and annelid worms- and some myxozoan species harm farmed fish. The phylum Myxozoa, comprising 2,100 species, was difficult to position in the tree of life, due to its fast evolutionary rate. Recent phylogenomic studies utilizing an extensive number of nuclear-encoded genes have confirmed that Myxozoans belong to Cnidaria. Nevertheless, the evolution of parasitism and extreme body simplification in Myxozoa is not well understood, and no myxozoan mitochondrial DNA sequence has been reported to date. To further elucidate the evolution of Myxozoa, we sequenced the mitochondrial genomes of the myxozoan species Kudoa septempunctata, K. hexapunctata and K. iwatai and compared them with those of other metazoans. The Kudoa mitochondrial genomes code for ribosomal RNAs, transfer RNAs, eight proteins for oxidative phosphorylation and three proteins of unknown function, and they are among the metazoan mitochondrial genomes coding the fewest proteins. The mitochondrial- encoded proteins were extremely divergent, exhibiting the fastest evolutionary rate in Metazoa. Nevertheless, the dN/dS ratios of the protein genes in genus Kudoa were approximately 0.1 and similar to other cnidarians, indicating that the genes are under negative selection. Despite the divergent genetic content, active oxidative phosphorylation was indicated by the transcriptome, metabolism and structure of mitochondria in K. septempunctata. As possible causes, we attributed the divergence to the population genetic characteristics shared between the two most divergent clades, Ctenophora and Myxozoa, and to the parasitic lifestyle of Myxozoa. The fast-evolving, functional mitochondria of the genus Kudoa expanded our understanding of metazoan mitochondrial evolution.	[Takeuchi, Fumihiko; Sekizuka, Tsuyoshi; Ogasawara, Yumiko; Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Shinjuku Ku, Tokyo, Japan; [Yokoyama, Hiroshi] Univ Tokyo, Dept Aquat Biosci, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Kamikawa, Ryoma] Kyoto Univ, Grad Sch Human & Environm Studies, Grad Sch Global Environm Studies, Sakyou Ku, Kyoto, Japan; [Inagaki, Yuji; Nozaki, Tomoyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Nozaki, Tomoyoshi] Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo 1628640, Japan; [Sugita-Konishi, Yoshiko] Azabu Univ, Dept Food & Life Sci, Sagamihara, Kanagawa, Japan; [Ohnishi, Takahiro] Natl Inst Hlth Sci, Div Microbiol, Setagaya Ku, Tokyo 1588501, Japan	National Institute of Infectious Diseases (NIID); University of Tokyo; Kyoto University; University of Tsukuba; National Institute of Infectious Diseases (NIID); Azabu University; National Institute of Health Sciences - Japan	Takeuchi, F (corresponding author), Natl Inst Infect Dis, Pathogen Genom Ctr, Shinjuku Ku, Tokyo, Japan.	fumihiko@takeuchi.name		Sekizuka, Tsuyoshi/0000-0002-1302-5472; Inagaki, Yuji/0000-0003-0101-8483	Ministry of Health, Labor, and Welfare [H23-Shokuhin-Ippan-007]; Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI) [23117005, 15H05606, 15H14591]	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Health, Labor, and Welfare (H23-Shokuhin-Ippan-007) and the Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI 23117005, 15H05606, 15H14591). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bawono P, 2014, METHODS MOL BIOL, V1079, P245, DOI 10.1007/978-1-62703-646-7_16; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Canning EU, 2004, ADV PARASIT, V56, P43, DOI 10.1016/S0065-308X(03)56002-X; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; Chazotte Brad, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot4948; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eitel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057131; El-Matbouli M, 1998, INT J PARASITOL, V28, P195, DOI 10.1016/S0020-7519(97)00176-8; Evans NM, 2010, MOL BIOL EVOL, V27, P2733, DOI 10.1093/molbev/msq159; Feng JM, 2014, MOL PHYLOGENET EVOL, V81, P10, DOI 10.1016/j.ympev.2014.08.016; Gardner Paul P, 2011, Nucleic Acids Res, V39, pD141, DOI 10.1093/nar/gkq1129; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Helfenbein KG, 2004, P NATL ACAD SCI USA, V101, P10639, DOI 10.1073/pnas.0400941101; Hwang Ui-Wook, 1999, Korean Journal of Parasitology, V37, P215, DOI 10.3347/kjp.1999.37.4.215; Jimenez-Guri E, 2007, SCIENCE, V317, P116, DOI 10.1126/science.1142024; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kawai T, 2012, CLIN INFECT DIS, V54, P1046, DOI 10.1093/cid/cir1040; Kayal E, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-5; Kent ML, 2001, J EUKARYOT MICROBIOL, V48, P395, DOI 10.1111/j.1550-7408.2001.tb00173.x; Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925; Kohn AB, 2012, MOL PHYLOGENET EVOL, V63, P203, DOI 10.1016/j.ympev.2011.12.009; Lavrov DV, 2011, KEY TRANSITIONS IN ANIMAL EVOLUTION, P34; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lom J, 2006, FOLIA PARASIT, V53, P1, DOI 10.14411/fp.2006.001; Makiuchi T, 2014, BIOCHIMIE, V100, P3, DOI 10.1016/j.biochi.2013.11.018; Miyamoto H, 2010, COMP BIOCHEM PHYS D, V5, P65, DOI 10.1016/j.cbd.2009.11.002; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Nesnidal MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054576; Ohnishi T, 2013, JPN J INFECT DIS, V66, P348, DOI 10.7883/yoken.66.348; OHTA T, 1972, J MOL EVOL, V1, P305, DOI 10.1007/BF01653959; Papillon D, 2004, MOL BIOL EVOL, V21, P2122, DOI 10.1093/molbev/msh229; Petkau A, 2010, BIOINFORMATICS, V26, P3125, DOI 10.1093/bioinformatics/btq588; Pett W, 2011, MITOCHONDR DNA, V22, P130, DOI 10.3109/19401736.2011.624611; Poyton RO, 2003, OXYGEN SENSING RESPO, P23; Purcell JE, 2001, HYDROBIOLOGIA, V451, P145, DOI 10.1023/A:1011826618539; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rota-Stabelli O, 2009, MOL PHYLOGENET EVOL, V52, P268, DOI 10.1016/j.ympev.2009.01.011; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Siddall ME, 1995, J PARASITOL, V81, P961, DOI 10.2307/3284049; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; SMOTHERS JF, 1994, SCIENCE, V265, P1719, DOI 10.1126/science.8085160; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sugahara Junichi, 2006, In Silico Biology, V6, P411; Sugahara J, 2007, RNA, V13, P671, DOI 10.1261/rna.309507; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Torruella G, 2012, MOL BIOL EVOL, V29, P531, DOI 10.1093/molbev/msr185; Vaidya AB, 2009, ANNU REV MICROBIOL, V63, P249, DOI 10.1146/annurev.micro.091208.073424; Whelan NV, 2015, P NATL ACAD SCI USA, V112, P5773, DOI 10.1073/pnas.1503453112; Woolfit M, 2003, MOL BIOL EVOL, V20, P1545, DOI 10.1093/molbev/msg167; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yokoyama H, 2012, HEALTH AND ENVIRONMENT IN AQUACULTURE, P3; Zhang P, 2005, GENE, V346, P133, DOI 10.1016/j.gene.2004.10.012; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595	68	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132030	10.1371/journal.pone.0132030	http://dx.doi.org/10.1371/journal.pone.0132030			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148004	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600182
J	Houston, K; Burton, RA; Sznajder, B; Rafalski, AJ; Dhugga, KS; Mather, DE; Taylor, J; Steffenson, BJ; Waugh, R; Fincher, GB				Houston, Kelly; Burton, Rachel A.; Sznajder, Beata; Rafalski, Antoni J.; Dhugga, Kanwarpal S.; Mather, Diane E.; Taylor, Jillian; Steffenson, Brian J.; Waugh, Robbie; Fincher, Geoffrey B.			A Genome-Wide Association Study for Culm Cellulose Content in Barley Reveals Candidate Genes Co-Expressed with Members of the CELLULOSE SYNTHASE A Gene Family	PLOS ONE			English	Article							CELL-WALL BIOSYNTHESIS; WOOD PROPERTY TRAITS; PINUS-TAEDA L.; POPULATION-STRUCTURE; ANCHORED PROTEIN; LINKAGE DISEQUILIBRIUM; PLASMA-MEMBRANE; QTL; EXPRESSION; KORRIGAN	Cellulose is a fundamentally important component of cell walls of higher plants. It provides a scaffold that allows the development and growth of the plant to occur in an ordered fashion. Cellulose also provides mechanical strength, which is crucial for both normal development and to enable the plant to withstand both abiotic and biotic stresses. We quantified the cellulose concentration in the culm of 288 two - rowed and 288 six - rowed spring type barley accessions that were part of the USDA funded barley Coordinated Agricultural Project (CAP) program in the USA. When the population structure of these accessions was analysed we identified six distinct populations, four of which we considered to be comprised of a sufficient number of accessions to be suitable for genome-wide association studies (GWAS). These lines had been genotyped with 3072 SNPs so we combined the trait and genetic data to carry out GWAS. The analysis allowed us to identify regions of the genome containing significant associations between molecular markers and cellulose concentration data, including one region cross-validated in multiple populations. To identify candidate genes we assembled the gene content of these regions and used these to query a comprehensive RNA-seq based gene expression atlas. This provided us with gene annotations and associated expression data across multiple tissues, which allowed us to formulate a supported list of candidate genes that regulate cellulose biosynthesis. Several regions identified by our analysis contain genes that are co-expressed with CELLULOSE SYNTHASE A (HvCesA) across a range of tissues and developmental stages. These genes are involved in both primary and secondary cell wall development. In addition, genes that have been previously linked with cellulose synthesis by biochemical methods, such as HvCOBRA, a gene of unknown function, were also associated with cellulose levels in the association panel. Our analyses provide new insights into the genes that contribute to cellulose content in cereal culms and to a greater understanding of the interactions between them.	[Houston, Kelly; Waugh, Robbie] Invergowrie, James Hutton Inst, Dundee DD2 5DA, Scotland; [Burton, Rachel A.; Taylor, Jillian; Fincher, Geoffrey B.] Univ Adelaide, Sch Agr Food & Wine, ARC Ctr Excellence Plant Cell Walls, Glen Osmond, SA 5064, Australia; [Sznajder, Beata; Mather, Diane E.] Univ Adelaide, Australian Ctr Plant Funct Genom, Glen Osmond, SA 5064, Australia; [Rafalski, Antoni J.] DuPont Pioneer, Genet Discovery Grp, DuPont Agr Biotechnol, DuPont Expt Stn, Wilmington, DE 19803 USA; [Dhugga, Kanwarpal S.] DuPont Pioneer, Genet Discovery Grp, DuPont Agr Biotechnol, Johnston, IA 50131 USA; [Steffenson, Brian J.] Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA; [Waugh, Robbie] Univ Dundee, James Hutton Inst, Div Plant Sci, Dundee DD2 5DA, Scotland	James Hutton Institute; University of Adelaide; University of Adelaide; DuPont; DuPont; Pioneer Hi-Bred International, Inc.; University of Minnesota System; University of Minnesota Twin Cities; James Hutton Institute; University of Dundee	Houston, K (corresponding author), Invergowrie, James Hutton Inst, Dundee DD2 5DA, Scotland.	Kelly.Houston@hutton.ac.uk	Burton, Rachel A/C-4441-2011; Mather, Diane/AAB-6606-2019	Burton, Rachel A/0000-0002-0638-4709; Mather, Diane/0000-0001-7506-2589; Dhugga, Kanwarpal/0000-0003-2477-3422; , Kelly/0000-0003-2136-245X; Steffenson, Brian/0000-0001-7961-5363	USDA National Institute of Food and Agriculture Barley Coordinated Agricultural Project DuPont Agricultural Biotechnology [2006-55606-16722]; Australian Research Council; BBSRC [BB/J014869/1]; Scottish Government Research Program; DuPont Pioneer; BBSRC [BB/L026317/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L026317/1, BB/J014869/1] Funding Source: researchfish	USDA National Institute of Food and Agriculture Barley Coordinated Agricultural Project DuPont Agricultural Biotechnology; Australian Research Council(Australian Research Council); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Government Research Program; DuPont Pioneer; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the USDA National Institute of Food and Agriculture Barley Coordinated Agricultural Project (#2006-55606-16722) DuPont Agricultural Biotechnology, the Australian Research Council and the BBSRC responsive mode scheme Grant number BB/J014869/1 and the Scottish Government Research Program Work Package 5.2. During the period in which the research was undertaken, JAR and KSD were affiliated with the DuPont Agricultural Biotechnology division at the commercial company DuPont Pioneer. DuPont Pioneer provided support in the form of salaries for authors JAR and KSD, and reviewed and approved the manuscript for publication. The specific roles of these authors are articulated in the 'author contributions' section.	Appenzeller L, 2004, CELLULOSE, V11, P287, DOI 10.1023/B:CELL.0000046417.84715.27; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brady SM, 2007, PLANT PHYSIOL, V143, P172, DOI 10.1104/pp.106.087262; Buchanan M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-235; Burton RA, 2006, SCIENCE, V311, P1940, DOI 10.1126/science.1122975; Burton RA, 2004, PLANT PHYSIOL, V134, P224, DOI 10.1104/pp.103.032904; Burton RA, 2010, PLANT PHYSIOL, V153, P1716, DOI 10.1104/pp.110.158329; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carpita NC, 2011, PLANT PHYSIOL, V155, P171, DOI 10.1104/pp.110.163360; Chagne D, 2003, MOL BREEDING, V12, P185, DOI 10.1023/A:1026318327911; Ching A, 2006, PLANTA, V224, P1174, DOI 10.1007/s00425-006-0299-8; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Dabney A, 2010, QVALUE Q VALUE ESTIM; Doblin MS, 2002, PLANT CELL PHYSIOL, V43, P1407, DOI 10.1093/pcp/pcf164; Druka A, 2011, PLANT PHYSIOL, V155, P617, DOI 10.1104/pp.110.166249; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fagard M, 2000, PLANT CELL, V12, P2409, DOI 10.1105/tpc.12.12.2409; GIDDINGS TH, 1980, J CELL BIOL, V84, P327, DOI 10.1083/jcb.84.2.327; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Hamblin MT, 2010, CROP SCI, V50, P556, DOI 10.2135/cropsci2009.04.0198; Hazen SP, 2002, PLANT PHYSIOL, V128, P336, DOI 10.1104/pp.010875; Held MA, 2008, P NATL ACAD SCI USA, V105, P20534, DOI 10.1073/pnas.0809408105; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hirano K, 2013, PLANT CELL PHYSIOL, V54, P1803, DOI 10.1093/pcp/pct121; His I, 2001, PLANTA, V212, P348, DOI 10.1007/s004250000437; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Koppolu R, 2013, P NATL ACAD SCI USA, V110, P13198, DOI 10.1073/pnas.1221950110; Lane DR, 2001, PLANT PHYSIOL, V126, P278, DOI 10.1104/pp.126.1.278; Liu LF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003704; Markussen T, 2003, SILVAE GENET, V52, P8; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; McWilliams DA, 1999, CORN GROWTH MANAGEME, VA-1173; Mohammadi M, 2015, THEOR APPL GENET, P1, DOI [10.1007/s00122-014-2399-3, DOI 10.1007/S00122-014-2399-3]; Mohammadi M, 2014, MOL BREEDING, V34, P1229, DOI 10.1007/s11032-014-0112-5; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; MUELLER SC, 1980, J CELL BIOL, V84, P315, DOI 10.1083/jcb.84.2.315; Murray SC, 2008, CROP SCI, V48, P2180, DOI 10.2135/cropsci2008.01.0068; Nicol F, 1998, EMBO J, V17, P5563, DOI 10.1093/emboj/17.19.5563; Park YW, 2003, PLANT J, V33, P1099, DOI 10.1046/j.1365-313X.2003.01696.x; Pauli D, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.11.0037; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pear JR, 1996, P NATL ACAD SCI USA, V93, P12637, DOI 10.1073/pnas.93.22.12637; Pettolino FA, 2012, NAT PROTOC, V7, P1590, DOI 10.1038/nprot.2012.081; Porth I, 2013, NEW PHYTOL, V200, P710, DOI 10.1111/nph.12422; Pritchard JK, 2000, GENETICS, V155, P945; Ramsay L, 2011, NAT GENET, V43, P169, DOI 10.1038/ng.745; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Roudier F, 2005, PLANT CELL, V17, P1749, DOI 10.1105/tpc.105.031732; Sanchez-Rodriguez C, 2012, PLANT CELL, V24, P589, DOI 10.1105/tpc.111.094672; Sato S, 2001, PLANT CELL PHYSIOL, V42, P251, DOI 10.1093/pcp/pce045; Schindelman G, 2001, GENE DEV, V15, P1115, DOI 10.1101/gad.879101; Sewell MM, 2002, THEOR APPL GENET, V104, P214, DOI 10.1007/s001220100697; Shiringani AL, 2011, THEOR APPL GENET, V123, P999, DOI 10.1007/s00122-011-1642-4; Slavov GT, 2014, NEW PHYTOL, V201, P1227, DOI 10.1111/nph.12621; Szucs P, 2009, PLANT GENOME-US, V2, P134, DOI [10.3835/plantgenome2008.01.005, 10.3835/plantgenome2008.01.0005]; Szyjanowicz PMJ, 2004, PLANT J, V37, P730, DOI 10.1111/j.1365-313X.2003.02000.x; The International Barley Genome Sequencing Consortium, 2012, Nature (London), V491, P711; Thomas LH, 2013, PLANT PHYSIOL, V161, P465, DOI 10.1104/pp.112.206359; Thumma BR, 2010, TREE GENET GENOMES, V6, P305, DOI 10.1007/s11295-009-0250-9; Thumma BR, 2009, GENETICS, V183, P1153, DOI 10.1534/genetics.109.106591; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Wang HY, 2012, THEOR APPL GENET, V124, P111, DOI 10.1007/s00122-011-1691-8; Waugh R, 2014, GENOMICS PLANT GENET, V237; Wu B, 2012, PLANT PHYSIOL, V159, P1440, DOI 10.1104/pp.112.195529; Zhang QS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-27; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhou H, 2012, J ZHEJIANG UNIV-SC B, V13, P438, DOI 10.1631/jzus.B1200003; Zhou HL, 2006, PLANT MOL BIOL, V60, P137, DOI 10.1007/s11103-005-2972-x	74	12	12	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130890	10.1371/journal.pone.0130890	http://dx.doi.org/10.1371/journal.pone.0130890			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154104	Green Published, Green Submitted, gold			2022-12-27	WOS:000358159700042
J	Masi, S; Mundry, R; Ortmann, S; Cipolletta, C; Boitani, L; Robbins, MM				Masi, Shelly; Mundry, Roger; Ortmann, Sylvia; Cipolletta, Chloe; Boitani, Luigi; Robbins, Martha M.			The Influence of Seasonal Frugivory on Nutrient and Energy Intake in Wild Western Gorillas	PLOS ONE			English	Article							BAI-HOKOU; NATIONAL-PARK; ECOLOGICAL CONSTRAINTS; BEHAVIORAL ECOLOGY; FRUIT AVAILABILITY; GROUPING PATTERNS; TROPICAL FORESTS; SAMPLING METHODS; LEAF CHEMISTRY; FOOD SELECTION	The daily energy requirements of animals are determined by a combination of physical and physiological factors, but food availability may challenge the capacity to meet nutritional needs. Western gorillas (Gorilla gorilla) are an interesting model for investigating this topic because they are folivore-frugivores that adjust their diet and activities to seasonal variation in fruit availability. Observations of one habituated group of western gorillas in Bai-Hokou, Central African Republic (December 2004-December 2005) were used to examine seasonal variation in diet quality and nutritional intake. We tested if during the high fruit season the food consumed by western gorillas was higher in quality (higher in energy, sugar, fat but lower in fibre and antifeedants) than during the low fruit season. Food consumed during the high fruit season was higher in digestible energy, but not any other macronutrients. Second, we investigated whether the gorillas increased their daily intake of carbohydrates, metabolizable energy (KCal/g OM), or other nutrients during the high fruit season. Intake of dry matter, fibers, fat, protein and the majority of minerals and phenols decreased with increased frugivory and there was some indication of seasonal variation in intake of energy (KCal/g OM), tannins, protein/fiber ratio, and iron. Intake of non-structural carbohydrates and sugars was not influenced by fruit availability. Gorillas are probably able to extract large quantities of energy via fermentation since they rely on proteinaceous leaves during the low fruit season. Macronutrients and micronutrients, but not digestible energy, may be limited for them during times of low fruit availability because they are hind-gut fermenters. We discuss the advantages of seasonal frugivores having large dietary breath and flexibility, significant characteristics to consider in the conservation strategies of endangered species.	[Masi, Shelly; Mundry, Roger; Robbins, Martha M.] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Ortmann, Sylvia] Leibniz Inst Zoo & Wildlife Res, RG Evolutionary Ecol, D-10315 Berlin, Germany; [Cipolletta, Chloe] WSC Rwanda Program, WCS Nyungwe Project, Kigali, Rwanda; [Masi, Shelly; Boitani, Luigi] Univ Roma La Sapienza, Dept Anim & Human Biol, I-00185 Rome, Italy	Max Planck Society; Leibniz Institut fur Zoo und Wildtierforschung; Sapienza University Rome	Masi, S (corresponding author), Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany.	masi@mnhn.fr	Ortmann, Sylvia/B-7088-2015	Ortmann, Sylvia/0000-0003-2520-6251	University of Rome; Max Planck Society	University of Rome; Max Planck Society(Max Planck Society)	This study was funded both by the University of Rome "La Sapienza" and the Max Planck Society.	ALTMANN J, 1993, AM J PRIMATOL, V30, P149, DOI 10.1002/ajp.1350300207; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2014, R LANG ENV STAT COMP; Arnold W, 2004, AM J PHYSIOL-REG I, V286, pR174, DOI 10.1152/ajpregu.00593.2002; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Breuer T, 2009, AM J PRIMATOL, V71, P106, DOI 10.1002/ajp.20628; Brockman DK, 2005, CAM S BIO EVOL ANTHR, V44, P1, DOI 10.1017/CBO9780511542343; Bronikowski AM, 1996, BEHAV ECOL SOCIOBIOL, V39, P11, DOI 10.1007/s002650050262; CALVERT JJ, 1985, OECOLOGIA, V65, P236, DOI 10.1007/BF00379223; Carpenter K, 1994, PROTEIN ENERGY STUDY; CHAPMAN CA, 1995, BEHAV ECOL SOCIOBIOL, V36, P59, DOI 10.1007/BF00175729; Chapman CA, 2002, INT J PRIMATOL, V23, P283, DOI 10.1023/A:1013831511405; Chapman CA, 2004, AM J PRIMATOL, V62, P55, DOI 10.1002/ajp.20006; CHAPMAN CA, 1994, BIOTROPICA, V26, P160, DOI 10.2307/2388805; Chapman CA, 2003, INT J PRIMATOL, V24, P317, DOI 10.1023/A:1023049200150; CHAPMAN CA, 1990, PRIMATES, V31, P121, DOI 10.1007/BF02381035; CHIVERS DJ, 1980, J MORPHOL, V166, P337, DOI 10.1002/jmor.1051660306; Cipolletta C, 2004, AM J PRIMATOL, V64, P193, DOI 10.1002/ajp.20072; Cipolletta C, 2007, INT J PRIMATOL, V28, P457, DOI 10.1007/s10764-007-9129-5; Conklin-Brittain Nancy Lou, 2006, P445; Conklin-Brittain NL, 1999, J CHEM ECOL, V25, P2601, DOI 10.1023/A:1020835120701; Conklin-Brittain NL, 1998, INT J PRIMATOL, V19, P917; Doran D, 1997, INT J PRIMATOL, V18, P183, DOI 10.1023/A:1026368518431; Doran DM, 2002, AM J PRIMATOL, V58, P91, DOI 10.1002/ajp.10053; Doran-Sheehy D, 2009, AM J PHYS ANTHROPOL, V140, P727, DOI 10.1002/ajpa.21118; Doran-Sheehy DM, 2004, AM J PRIMATOL, V64, P207, DOI 10.1002/ajp.20075; DUNBAR RIM, 1992, BEHAV ECOL SOCIOBIOL, V31, P35, DOI 10.1007/BF00167814; Felton AM, 2010, FOREST ECOL MANAG, V259, P1642, DOI 10.1016/j.foreco.2010.01.042; Felton AM, 2009, BEHAV ECOL, V20, P685, DOI 10.1093/beheco/arp021; Freeland WJ, 1974, AM NATUR, V108; Ganzhorn JU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008253; GANZHORN JU, 1992, OECOLOGIA, V91, P540, DOI 10.1007/BF00650329; Goldsmith ML, 1999, INT J PRIMATOL, V20, P1, DOI 10.1023/A:1020528115829; Grueter CC, 2014, PHYSIOL BEHAV, V127, P13, DOI 10.1016/j.physbeh.2014.01.009; Haccou P, 1994, STAT ANAL BEHAV DATA; Harrison ME, 2010, INT J PRIMATOL, V31, P585, DOI 10.1007/s10764-010-9415-5; Head JS, 2011, INT J PRIMATOL, V32, P755, DOI 10.1007/s10764-011-9499-6; JANSON C, 1985, BEHAV ECOL SOCIOBIOL, V18, P125, DOI 10.1007/BF00299041; Janson C. H., 1999, PRIMATE COMMUNITIES; Kay RF, 1997, P NATL ACAD SCI USA, V94, P13023, DOI 10.1073/pnas.94.24.13023; Knott CD, 1998, INT J PRIMATOL, V19, P1061, DOI 10.1023/A:1020330404983; Knott CD, 2005, CAM S BIO EVOL ANTHR, V44, P351, DOI 10.1017/CBO9780511542343.013; Krief S, 2006, AM J PRIMATOL, V68, P51, DOI 10.1002/ajp.20206; Krief S, 2005, J NAT PROD, V68, P897, DOI 10.1021/np049576i; Krief S, 2004, ANTIMICROB AGENTS CH, V48, P3196, DOI 10.1128/AAC.48.8.3196-3199.2004; Lambert J. E., 2007, PRIMATES PERSPECTIVE; Lambert JE, 1998, EVOL ANTHROPOL, V7, P8, DOI 10.1002/(SICI)1520-6505(1998)7:1<8::AID-EVAN3>3.0.CO;2-C; Lechtig A, 1976, J Trop Pediatr Environ Child Health, V22, P121; Leonard WR, 1997, AM J PHYS ANTHROPOL, V102, P265, DOI 10.1002/(SICI)1096-8644(199702)102:2<265::AID-AJPA8>3.0.CO;2-X; MAKKAR HPS, 1993, J SCI FOOD AGR, V61, P161, DOI 10.1002/jsfa.2740610205; Masi S, 2008, THESIS U ROME SAPIEN; Masi S, 2013, PHYSIOL BEHAV, V105, P337; Masi S, 2013, COGN AFFECT BEHAV NE, V13, P916, DOI 10.3758/s13415-013-0171-9; Masi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049805; Masi S, 2011, ANIM COGN, V14, P921, DOI 10.1007/s10071-011-0457-7; Masi S, 2009, AM J PRIMATOL, V71, P91, DOI 10.1002/ajp.20629; McGregor PK., 1992, PLAYBACK STUDIES ANI; Miller KE, 2006, AM J PRIMATOL, V68, P1037, DOI 10.1002/ajp.20306; Milton K, 1999, NUTRITION, V15, P488, DOI 10.1016/S0899-9007(99)00078-7; MILTON K, 1979, AM NAT, V114, P362, DOI 10.1086/283485; MILTON K, 1981, BIOTROPICA, V13, P177, DOI 10.2307/2388122; MILTON K, 1993, SCI AM, V269, P86, DOI 10.1038/scientificamerican0893-86; MILTON K, 1990, J TROP ECOL, V6, P493, DOI 10.1017/S0266467400004909; Milton K, 2000, NUTRITION, V16, P480, DOI 10.1016/S0899-9007(00)00293-8; N. R. C. (National Research Council), 1980, REC DIET ALL RDA; N'guessan AK, 2009, INT J PRIMATOL, V30, P481, DOI 10.1007/s10764-009-9354-1; Parker KL, 2005, J MAMMAL, V86, P610, DOI 10.1644/1545-1542(2005)86[610:PCIFCR]2.0.CO;2; Popovich DG, 1997, MANAGEMENT GORILLAS; PORTER LJ, 1985, PHYTOCHEMISTRY, V25, P223, DOI 10.1016/S0031-9422(00)94533-3; Remis MJ, 1997, AM J PRIMATOL, V43, P111; Remis MJ, 2004, INT J PRIMATOL, V25, P825, DOI 10.1023/B:IJOP.0000029124.04610.c7; Remis MJ, 2002, INT J PRIMATOL, V23, P251, DOI 10.1023/A:1013827310497; Remis MJ, 2001, INT J PRIMATOL, V22, P807, DOI 10.1023/A:1012021617737; Rogers ME, 2004, AM J PRIMATOL, V64, P173, DOI 10.1002/ajp.20071; ROGERS ME, 1990, OECOLOGIA, V84, P326, DOI 10.1007/BF00329756; ROGERS ME, 1987, BIOTROPICA, V19, P278, DOI 10.2307/2388348; Rothman JM, 2008, OECOLOGIA, V155, P111, DOI 10.1007/s00442-007-0901-1; Rothman JM, 2006, AM J PRIMATOL, V68, P675, DOI 10.1002/ajp.20243; Rothman JM, 2011, BIOL LETTERS, V7, P847, DOI 10.1098/rsbl.2011.0321; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; Schlulke O, 2006, AM J PRIMATOL, V68, P951, DOI 10.1002/ajp.20300; Simmen B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009860; Simpson SJ, 2003, APPETITE, V41, P123, DOI 10.1016/S0195-6663(03)00049-7; Steiner JE, 2001, NEUROSCI BIOBEHAV R, V25, P53, DOI 10.1016/S0149-7634(00)00051-8; Sterck EHM, 1997, BEHAVIOUR, V134, P749, DOI 10.1163/156853997X00052; Stevenson PR, 2004, INT J PRIMATOL, V25, P367, DOI 10.1023/B:IJOP.0000019157.35464.a0; Stoinski TS, 2013, AM J PHYS ANTHR, P00; Sun C, 1996, BIOTROPICA, V28, P668, DOI 10.2307/2389053; Tutin Caroline E. G., 1996, P58, DOI 10.1017/CBO9780511752414.007; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; Van Soest PJ, 1982, NUTR ECOLOGY RUMINAN; Vogel ER, 2012, BIOL LETTERS, V8, P333, DOI 10.1098/rsbl.2011.1040; Waterman P.G., 1984, P177; WATERMAN PG, 1988, BIOL J LINN SOC, V34, P1, DOI 10.1111/j.1095-8312.1988.tb01946.x; Wrangham RW, 1998, INT J PRIMATOL, V19, P949, DOI 10.1023/A:1020318102257; Wright E, 2014, BEHAV ECOL SOCIOBIOL, DOI [10.1007/s00265014-1708-9, DOI 10.1007/S00265014-1708-9]; Wright E, 2014, BEHAV ECOL IN PRESS; Yamagiwa J, 2003, CAM S BIO EVOL ANTHR, V35, P328	100	26	27	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0129254	10.1371/journal.pone.0129254	http://dx.doi.org/10.1371/journal.pone.0129254			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154509	Green Submitted, Green Published, gold			2022-12-27	WOS:000358159700012
J	Mhurchu, CN; Eyles, H; Genc, M; Scarborough, P; Rayner, M; Mizdrak, A; Nnoaham, K; Blakely, T				Mhurchu, Cliona Ni; Eyles, Helen; Genc, Murat; Scarborough, Peter; Rayner, Mike; Mizdrak, Anja; Nnoaham, Kelechi; Blakely, Tony			Effects of Health-Related Food Taxes and Subsidies on Mortality from Diet-Related Disease in New Zealand: An Econometric-Epidemiologic Modelling Study	PLOS ONE			English	Article							COMPARATIVE RISK-ASSESSMENT; SUGAR-SWEETENED BEVERAGES; CARDIOVASCULAR-DISEASE; VEGETABLE CONSUMPTION; METAANALYSIS; OBESITY; IMPACT; REDUCTION; PATTERNS; FRUIT	Background Health-related food taxes and subsidies may promote healthier diets and reduce mortality. Our aim was to estimate the effects of health-related food taxes and subsidies on deaths prevented or postponed (DPP) in New Zealand. Methods A macrosimulation model based on household expenditure data, demand elasticities and population impact fractions for 18 diet-related diseases was used to estimate effects of five tax and subsidy regimens. We used price elasticity values for 24 major commonly consumed food groups in New Zealand, and food expenditure data from national Household Economic Surveys. Changes in mortality from cardiovascular disease, cancer, diabetes and other diet-related diseases were estimated. Findings A 20% subsidy on fruit and vegetables would result in 560 (95% uncertainty interval, 400 to 700) DPP each year (1.9% annual all-cause mortality). A 20% tax on major dietary sources of saturated fat would result in 1,500 (950 to 2,100) DPP (5.0%), and a 20% tax on major dietary sources of sodium would result in 2,000 (1300 to 2,700) DPP (6.8%). Combining taxes on saturated fat and sodium with a fruit and vegetable subsidy would result in 2,400 (1,800 to 3,000) DPP (8.1% mortality annually). A tax on major dietary sources of greenhouse gas emissions would generate 1,200 (750 to 1,700) DPP annually (4.0%). Effects were similar or greater for Maori and low-income households in relative terms. Conclusions Health-related food taxes and subsidies could improve diets and reduce mortality from dietrelated disease in New Zealand. Our study adds to the growing evidence base suggesting food pricing policies should improve population health and reduce inequalities, but there is still much work to be done to improve estimation of health impacts.	[Mhurchu, Cliona Ni; Eyles, Helen] Univ Auckland, Natl Inst Hlth Innovat, Auckland 1, New Zealand; [Genc, Murat] Univ Otago, Dept Econ, Dunedin, New Zealand; [Scarborough, Peter; Rayner, Mike; Mizdrak, Anja; Nnoaham, Kelechi] Univ Oxford, British Heart Fdn Ctr Populat Approaches Noncommu, Oxford, England; [Blakely, Tony] Univ Otago, Dept Publ Hlth, Wellington, New Zealand	University of Auckland; University of Otago; University of Oxford; University of Otago	Mhurchu, CN (corresponding author), Univ Auckland, Natl Inst Hlth Innovat, Auckland 1, New Zealand.	c.nimhurchu@auckland.ac.nz	Genc, Murat/AAE-1568-2019; Scarborough, Peter/ABD-6111-2021	Scarborough, Peter/0000-0002-2378-2944; Genc, Murat/0000-0002-5443-2146; Mizdrak, Anja/0000-0002-2897-3002; nnoaham, kelechi/0000-0002-5362-4605; Blakely, Tony/0000-0002-6995-4369; Ni Mhurchu, Cliona/0000-0002-1144-9167	Health Research Council of New Zealand [10/077]; New Zealand Heart Foundation [1463]; University of Otago; British Heart Foundation [FS/13/37/30295]	Health Research Council of New Zealand(Health Research Council of New Zealand); New Zealand Heart Foundation; University of Otago; British Heart Foundation(British Heart Foundation)	This research was funded by a Health Research Council of New Zealand (http://www.hrc.govt.nz/) programme grant (10/077). Helen Eyles was supported by a New Zealand Heart Foundation (http://www.heartfoundation.org.nz/) Postgraduate Scholarship (Grant 1463). Murat Genc was supported by a University of Otago (http://www.otago.ac.nz/) Research Grant. Anja Mizdrak is funded by a British Heart Foundation Non-Clinical PhD Studentship (FS/13/37/30295) and Peter Scarborough and Mike Rayner are also supported by the British Heart Foundation (http://www.bhf.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajwani S., 2003, DECADES DISPARITY ET; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Basu S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001582; Basu S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6048; Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Belanger M, PUBLIC HLTH; Berners-Lee M, 2012, ENERG POLICY, V43, P184, DOI 10.1016/j.enpol.2011.12.054; Blakely T, 2007, TRACKING DISPARITY T; Blakely T, 2008, BRIT MED J, V336, P371, DOI 10.1136/bmj.39455.596181.25; Briggs ADM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-860; Briggs ADM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6189; Briggs ADM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003543; Cornelsen L, 2015, HEALTH ECON, V24, P1548, DOI 10.1002/hec.3107; Dauchet L, 2005, NEUROLOGY, V65, P1193, DOI 10.1212/01.wnl.0000180600.09719.53; Dauchet L, 2006, J NUTR, V136, P2588, DOI 10.1093/jn/136.10.2588; Epstein LH, 2012, AM J CLIN NUTR, V95, P789, DOI 10.3945/ajcn.111.024380; Eyles H, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001353; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; Instituto Nacional de Salud Publica, 2014, RES PREL EF IMP PES; Irz X, 2014, TSE473; James W.P.T., 2004, COMP QUANTIFICATION, P497; Jensen JD, 2013, FOOD POLICY, V42, P18, DOI 10.1016/j.foodpol.2013.06.004; Kristensen A, 2014, AM J PREVENTIVE MED; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; McLeod M, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-15; Mhurchu CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075934; Ministry of Health, 2013, HLTH LOSS NZ REP NZ; Ministry of Health, 2013, NZ HLTH SURV ANN UPD; Ministry of Health, 2012, MORT DEM DAT 2009; Moskowitz P., 2014, GUARDIAN; Mozaffarian D, 2014, JAMA-J AM MED ASSOC, V312, P889, DOI 10.1001/jama.2014.8232; Mytton O, 2007, J EPIDEMIOL COMMUN H, V61, P689, DOI 10.1136/jech.2006.047746; Mytton OT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-886; Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931; National Health and Medical Research Council, 2006, NUTR REF VAL AUSTR N, DOI [10.1017/S1368980008003212, DOI 10.1017/S1368980008003212]; New Zealand Institute of Plant & Food Research Limited and the Ministry of Health, 2012, CONC NZ FOOD COMP TA; Nghiem N., 2011, PRICE ELASTICITIES H; Nnoaham KE, 2009, INT J EPIDEMIOL, V38, P1324, DOI 10.1093/ije/dyp214; OECD, 2012, OBESITY; OECD, 2014, OBESITY; Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228; Scarborough P, 2012, EUR J CLIN NUTR, V66, P710, DOI 10.1038/ejcn.2012.34; Scarborough P, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/748750; Scarborough P, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000263; Scarborough P, 2012, J EPIDEMIOL COMMUN H, V66, P420, DOI 10.1136/jech.2010.114520; Sharma A, 2014, HEALTH ECON, V23, P1159, DOI 10.1002/hec.3070; Shonkwiler JS, 1999, AM J AGR ECON, V81, P972, DOI 10.2307/1244339; Statistics New Zealand, 2007, 2006 NZ CENS POP DWE; Statistics New Zealand, 2008, FOOD PRIC IND; Statistics New Zealand, 2010, 2009 10 HOUS EC SURV; Statistics New Zealand, 2007, 2006 07 HOUS EC SURV; Thow AM, 2014, NUTR REV, V72, P551, DOI 10.1111/nure.12123; Thow AM, 2010, B WORLD HEALTH ORGAN, V88, P609, DOI 10.2471/BLT.09.070987; United Nations General Assembly, 2011, REPORT OF THE SECRET; University of Otago and Ministry of Health, 2011, FOC NUTR KEY FIND 20; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	59	35	37	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0128477	10.1371/journal.pone.0128477	http://dx.doi.org/10.1371/journal.pone.0128477			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26154289	Green Published, gold			2022-12-27	WOS:000358159700008
J	Qin, JY; Huang, ZP; Liu, CW; Su, SJ; Zhou, J				Qin, Jiangyi; Huang, Zhiping; Liu, Chunwu; Su, Shaojing; Zhou, Jing			Novel Blind Recognition Algorithm of Frame Synchronization Words Based on Soft-Decision in Digital Communication Systems	PLOS ONE			English	Article							THEORETICAL-ANALYSIS; CHANNELS	A novel blind recognition algorithm of frame synchronization words is proposed to recognize the frame synchronization words parameters in digital communication systems. In this paper, a blind recognition method of frame synchronization words based on the hard-decision is deduced in detail. And the standards of parameter recognition are given. Comparing with the blind recognition based on the hard-decision, utilizing the soft-decision can improve the accuracy of blind recognition. Therefore, combining with the characteristics of Quadrature Phase Shift Keying (QPSK) signal, an improved blind recognition algorithm based on the soft-decision is proposed. Meanwhile, the improved algorithm can be extended to other signal modulation forms. Then, the complete blind recognition steps of the hard-decision algorithm and the soft-decision algorithm are given in detail. Finally, the simulation results show that both the hard-decision algorithm and the soft-decision algorithm can recognize the parameters of frame synchronization words blindly. What's more, the improved algorithm can enhance the accuracy of blind recognition obviously.	[Qin, Jiangyi; Huang, Zhiping; Liu, Chunwu; Su, Shaojing; Zhou, Jing] Natl Univ Def Technol, Coll Mech Engn & Automat, Changsha 410073, Hunan, Peoples R China	National University of Defense Technology - China	Qin, JY (corresponding author), Natl Univ Def Technol, Coll Mech Engn & Automat, Changsha 410073, Hunan, Peoples R China.	qjyacmilan@163.com						Cassaro TM, 2004, IEEE T COMMUN, V52, P484, DOI 10.1109/TCOMM.2004.823636; Cluzeau M., 2009, P ISIT2009 SEOUL KOR; Houcke S., 2006, P EUSIPCO2006 FLOR I; Imad R., 2009, P ICC2009 DRESD GERM; Imad R., 2010, P SPAWC2010 MARR US; Imad R, 2009, IEEE T WIREL COMMUN, V8, P5472, DOI 10.1109/TWC.2009.090410; Imad R, 2009, IEEE T COMMUN, V57, P1574, DOI 10.1109/TCOMM.2009.06.070445; Jing Z., 2013, OPTIK, V124, P998; LUI GL, 1987, IEEE T COMMUN, V35, P818; MASSEY JL, 1972, IEEE T COMMUN, VCO20, P115, DOI 10.1109/TCOM.1972.1091127; Mostofa M., 2001, IEEE COMMUN LETT, V5, P307; Qi YH, 2011, IEEE T WIREL COMMUN, V10, P3127, DOI 10.1109/TWC.2011.081611.101809	12	11	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0132114	10.1371/journal.pone.0132114	http://dx.doi.org/10.1371/journal.pone.0132114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154439	Green Published, Green Submitted, gold			2022-12-27	WOS:000358159700088
J	Faille, A; Pluot-Sigwalt, D				Faille, Arnaud; Pluot-Sigwalt, Dominique			Convergent Reduction of Ovariole Number Associated with Subterranean Life in Beetles	PLOS ONE			English	Article							COLEOPTERA CARABIDAE; REGRESSIVE EVOLUTION; SCARABAEIDAE; PHYLOGENY; TRECHINAE; LARVE	Background Some species of obligate cavernicolous beetles are known to possess a unique feature-a contraction of the larval cycle. In contrast to many other subterranean beetles, life-cycle contraction in Trechini ground beetles (Carabidae) is correlated with a reduction in the number of eggs and a drastic reduction in the number of ovarioles. This remarkable peculiarity has only been reported for a small number of closely related species. Results We give a description of the female internal reproductive system for six species of Trechini, including five subterranean species, with a particular focus on the western Pyrenean radiation of Aphaenops, a group for which nothing is known regarding the early life stages. We redescribe the internal female genitalia of A. crypticola Linder. Study of the ovarioles allowed us to infer the postembryonic development of the larvae for each species examined. We then used a phylogenetic framework to recognize two independent reductions in the number of ovarioles in the Pyrenean lineage. We discuss the multiple convergent evolutions in ovariole number and the potential link between a reduction of ovariole number and troglobiomorphism in a phylogenetic context. Conclusions There is an extreme reduction in ovariole number and size within the species studied; the eggs produced by small ovarioles have a remarkably large size. A reduction to one ovariole has occurred independently at least twice in this subterranean group. A reduction in the number of ovarioles in ground beetles is one of the striking consequences of subterranean specialization and it is correlated with another remarkable adaptation of subterranean beetles, a reduction in the number of larval instars.	[Faille, Arnaud] Zool Staatssammlung, Dept Entomol, Munich, Germany; [Pluot-Sigwalt, Dominique] CNRS, MNHN, Dept Syst & Evolut, Inst Syst Evolut Biodivers,UMR 7205, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Faille, A (corresponding author), Zool Staatssammlung, Dept Entomol, Munich, Germany.	arnaud1140@yahoo.fr			German Research Foundation project [FA 1042/1-1]	German Research Foundation project	This work has been funded by a German Research Foundation project to AF (FA 1042/1-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buning J., 1994, INSECT OVARY ULTRAST, Vfirst; Cabidoche M, 1966, THESIS; Casale A, 1998, ENCY BIOSPEOLOGICA, VII, P1047; Cieslak A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2978; CULVER D C, 1990, Memoires de Biospeologie, V17, P13; DELEURANCE S, 1960, CR HEBD ACAD SCI, V251, P974; DELEURANCE S, 1958, CR HEBD ACAD SCI, V247, P752; DELEURANCE S, 1959, CR HEBD ACAD SCI, V249, P2620; DELEURANCE-GLACON SYLVIE, 1963, ANN SPELEOL, V18, P227; DELEURANCEGLACO.S, 1964, CR HEBD ACAD SCI, V258, P4369; Deuve Thierry, 1993, Memoires du Museum National d'Histoire Naturelle Serie A Zoologie, V155, P1; Faille A, 2010, MOL PHYLOGENET EVOL, V54, P97, DOI 10.1016/j.ympev.2009.10.008; Faille A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-248; Faille A, 2011, ZOOL SCR, V40, P282, DOI 10.1111/j.1463-6409.2010.00467.x; FORSYTH D J, 1972, Transactions of the Zoological Society of London, V32, P249; Glacon S, 1953, RECHERCHES BIOL COLE, V3, P39; Green DA, 2012, DEV BIOL, V372, P120, DOI 10.1016/j.ydbio.2012.09.014; Green II DA, 2014, DEV GEN MECH OV NUMB; GRENIER AM, 1994, GENET SEL EVOL, V26, P413, DOI 10.1051/gse:19940503; Halffter G., 1982, PUBLICATION I ECOLOG, V10; HALFFTER GONZALO, 1966, FOLIA ENTOMOL MEX, V12/14, P1; Halffter G, 2013, COLEOPTS BULL, V67, P94, DOI 10.1649/0010-065X-67.2.94; Havill NP, 2007, ANNU REV ENTOMOL, V52, P325, DOI 10.1146/annurev.ento.52.110405.091303; Heymons R., 1930, Zeitschrift fuer Morphologie und Oekologie der Tiere Berlin, V18, P536, DOI 10.1007/BF00403096; HEYMONS R., 1929, ZOOL AM, V85, P35; Hinton H. E., 1981, BIOL INSECTS EGGS; Hodin J., 2009, PHENOTYPIC PLASTICIT, P423, DOI DOI 10.1201/B10201-12; Ikeda H, 2008, EVOLUTION, V62, P2065, DOI 10.1111/j.1558-5646.2008.00432.x; Iwata K., 1955, Mushi Fukuoka, V29, P17; IWATA KUNIO, 1966, JAP J ECOL, V16, P4; IZQUIERDO I, 1990, Memoires de Biospeologie, V17, P107; JAY SC, 1968, CAN J ZOOLOG, V46, P345, DOI 10.1139/z68-052; Jeannel R., 1920, Archives de Zoologie Experimentale Paris, V59; Jeannel R., 1927, Abeille Paris, V33, P1; Jeannel R., 1928, ABEILLE, V35, P1; Jeannel R., 1926, FAUNE CAVERNICOLE FR; Jeannel R., 1941, COLEOPTERES CARABIQU, V39; Jeannel R., 1943, FOSSILES VIVANTS CAV; JONES R, 1992, EVOLUTION, V46, P353, DOI 10.1111/j.1558-5646.1992.tb02043.x; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Larsen EB, 1952, T 9 INT C ENTOMOLOGY, V1, P502; LEATHER SR, 1988, J NAT HIST, V22, P381, DOI 10.1080/00222938800770271; LEITNER ELISABETH, 1943, ZOOL JAHRB ABT ANAT U ONTOG TIERE, V68, P227; Leys R, 2005, BIOL LETTERS, V1, P496, DOI 10.1098/rsbl.2005.0358; MAC ARTHUR ROBERT H., 1967; MARCHAL P., 1913, Ann. Sci. nat., Zool., V18, P153; Martinez I, 1998, P ENTOMOL SOC WASH, V100, P269; Moravec P., 2003, CATALOGUE PALAEARCTI, V1, P288; MURDOCH WW, 1966, J ANIM ECOL, V35, P127, DOI 10.2307/2694; NOIROT C, 1974, ANNU REV ENTOMOL, V19, P61, DOI 10.1146/annurev.en.19.010174.000425; Pesson P., 1951, TRAITE ZOOL, V10, P1390; PLUOT D, 1979, ANN SOC ENTOMOL FR, V15, P575; POULSON TL, 1969, SCIENCE, V165, P971; Queinnec E, 2011, COLEOPTERES CARABIQU, V1, P119; Racovitza E.G., 1907, ARCH ZOOLOGIE EXPT G, V6, P371; RITCHER PO, 1974, P ENTOMOL SOC WASH, V76, P480; ROBERTSON J, 1961, CAN J ZOOLOG, V39, P245, DOI 10.1139/z61-028; Serrano J., 2013, NEW CATALOGUE FAMILY; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; STEIN F, 1847, VERGLEICHENDE ANATOM, V1; STYS P, 1990, BIOL REV, V65, P401, DOI 10.1111/j.1469-185X.1990.tb01232.x; Tanaka ED, 2009, APIDOLOGIE, V40, P163, DOI 10.1051/apido/2008071; Vandel A., 1964, BIOSPEOLOGIE BIOLOGI; WARD SA, 1983, J ANIM ECOL, V52, P451, DOI 10.2307/4565; Weber H, 1930, BIOL HEMIPTEREN, V9; WELCH RC, 1993, INVERTEBR REPROD DEV, V23, P225, DOI 10.1080/07924259.1993.9672319; Williams Joseph L., 1945, PROC ENT SOC WASHINGTON, V47, P73; WYATT TD, 1989, BEHAVIOUR, V110, P76, DOI 10.1163/156853989X00394	69	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131986	10.1371/journal.pone.0131986	http://dx.doi.org/10.1371/journal.pone.0131986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151557	gold, Green Submitted, Green Published			2022-12-27	WOS:000358158900031
J	Calvo, C; Garcia-Garcia, ML; Sanchez-Dehesa, R; Roman, C; Tabares, A; Pozo, F; Casas, I				Calvo, Cristina; Luz Garcia-Garcia, Maria; Sanchez-Dehesa, Rosa; Roman, Cristina; Tabares, Ana; Pozo, Francisco; Casas, Inmaculada			Eight Year Prospective Study of Adenoviruses Infections in Hospitalized Children. Comparison with Other Respiratory Viruses	PLOS ONE			English	Article							CLINICAL PRESENTATION; SYNCYTIAL-VIRUS; TRACT INFECTION; INFANTS; SAMPLES	Human adenovirus (HAdV) cause upper and lower respiratory tract infections. However, there are few large prospective studies focused on HAdVs acute infections requiring hospitalization. From 2005 to 2013 a prospective study was conducted on children admitted with acute respiratory infections. Specimens of nasopharyngeal aspirate were taken for virological study by PCR and clinical data was recorded. HAdV specimens were genotyped. Frequency and clinical course of HAdV infections were compared with RSV, rhinovirus (RV), human bocavirus (HBoV) and influenza in the same population. HAdV was detected in 403 cases of 2371 confirmed viral infections (17.2%), of which 154 were single virus infections (38%). We genotyped 154 HAdVs. The most frequent genotypes were HAdV-3 (24%), HAdV-6 (21%), and HAdV-5 (20%). A total of 262 children had fever (64.9%); 194 suffered hypoxia (48%), and 147 presented infiltrate in chest x-rays (36.4%). The most frequent diagnoses were recurrent wheezing or asthma (51.7%), bronchiolitis (18.3 %), and pneumonia (11.9%), and 46 (11.4%) episodes required prolonged hospitalization (>7 days) due to the severity. Adenovirus single infections were compared with single infections of 598 RSV, 494 RV, 83 influenza and 78 HBoV. Significant clinical differences were found between HAdV, RSV and RV infections.	[Calvo, Cristina; Luz Garcia-Garcia, Maria; Sanchez-Dehesa, Rosa; Roman, Cristina; Tabares, Ana] Severo Ochoa Hosp, Dept Pediat, Madrid, Spain; [Pozo, Francisco; Casas, Inmaculada] Natl Microbiol Ctr ISCIII, Resp Virus & Influenza Unit, Madrid, Spain	Severo Ochoa University Hospital	Calvo, C (corresponding author), Severo Ochoa Hosp, Dept Pediat, Madrid, Spain.	ccalvorey@ono.com	Casas, Inmaculada/H-9442-2015; Pozo, Francisco/F-4426-2012; Calvo, Cristina/T-5028-2018; Casas, Inmaculada/X-7579-2019	Casas, Inmaculada/0000-0003-1840-1198; Pozo, Francisco/0000-0003-1828-733X; Calvo, Cristina/0000-0002-6503-3423; Casas, Inmaculada/0000-0003-1840-1198; GARCIA-GARCIA, MARIA LUZ/0000-0003-4906-4227	FIS (Fondo de Investigaciones Sanitarias - Spanish Health Research Fund) [PI06/0532, PS09/0246, PI12/0129]	FIS (Fondo de Investigaciones Sanitarias - Spanish Health Research Fund)	This study has been supported by FIS (Fondo de Investigaciones Sanitarias - Spanish Health Research Fund) Grants No: PI06/0532, PS09/0246, and PI12/0129. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, VIRUS TAXONOMY; Calvo C, 2010, ACTA PAEDIATR, V99, P883, DOI 10.1111/j.1651-2227.2010.01714.x; Calvo C, 2008, PEDIATR INFECT DIS J, V27, P677, DOI 10.1097/INF.0b013e31816be052; CARBALLAL G, 2002, BMC PEDIATR, V16, P2; Casas I, 2005, J CLIN MICROBIOL, V43, P6176, DOI 10.1128/JCM.43.12.6176-6182.2005; Chan PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024734; Chen SP, 2013, J CLIN VIROL, V56, P7, DOI 10.1016/j.jcv.2012.08.021; Coiras MT, 2004, J MED VIROL, V72, P484, DOI 10.1002/jmv.20008; Coiras MT, 2003, J MED VIROL, V69, P132, DOI 10.1002/jmv.10255; Dominguez O, 2005, PEDIATR INFECT DIS J, V24, P733, DOI 10.1097/01.inf.0000172942.96436.2d; Echavarria M, 2008, CLIN MICROBIOL REV, V21, P704, DOI 10.1128/CMR.00052-07; Ferone EA, 2014, J PEDIAT-BRAZIL, V90, P42, DOI 10.1016/j.jped.2013.05.005; Jin Y, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-271; Kunz Anjali N, 2010, Curr Infect Dis Rep, V12, P81, DOI 10.1007/s11908-010-0084-5; Lai CY, 2013, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0053614; Selvaraju SB, 2011, J CLIN VIROL, V51, P126, DOI 10.1016/j.jcv.2011.02.014; Siminovich M, 2011, PEDIATR DEVEL PATHOL, V14, P214, DOI 10.2350/10-05-0838-OA.1; 2002, J ALLERGY CLIN IMMUN, V110, pS141	18	11	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132162	10.1371/journal.pone.0132162	http://dx.doi.org/10.1371/journal.pone.0132162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147465	Green Submitted, gold, Green Published			2022-12-27	WOS:000358157600209
J	Deng, MJ; Lin, XD; Lin, QT; Wen, DF; Zhang, ML; Wang, XQ; Gao, HC; Xu, JP				Deng, Ming-Jie; Lin, Xiao-Dong; Lin, Qiu-Ting; Wen, De-Fu; Zhang, Mei-Ling; Wang, Xian-Qin; Gao, Hong-Chang; Xu, Jia-Ping			A H-1-NMR Based Study on Hemolymph Metabolomics in Eri Silkworm after Oral Administration of 1-Deoxynojirimycin	PLOS ONE			English	Article							SUGAR-MIMIC ALKALOIDS; TREHALOSE CONCENTRATION; ADIPOKINETIC HORMONE; POSSIBLE INVOLVEMENT; NMR-SPECTROSCOPY; MULBERRY LATEX; BOMBYX-MORI; SERUM; METABOLISM; URINE	We aimed to investigate whether 1-deoxynojirimycin (DNJ) modulates glycometabolism and has toxicity in Eri silkworm (Samia cynthia ricini, Saturniidae). In this paper, hemolymph metabolites were used to explore metabolic changes after oral administration of DNJ or mulberry latex and to characterize the biological function of DNJ at the metabolic and systemic levels. Hemolymph samples were collected from fourth-instar larvae of Eri silkworm and exvivo high-resolution H-1 nuclear magnetic resonance (NMR) spectra were acquired from the collected hemolymph samples. Then the obtained spectra were analyzed by principal component analysis (PCA) and independent-samples t-test. Metabolic pattern recognition analysis of hemolymph samples indicated that the groups of 0.25% DNJ, latex, and the mixture of 0.5% DNJ and latex (1:1) were significantly different from the control group. Moreover, compared to the control group, the groups of 0.25% DNJ, latex, and the mixture of 0.5% DNJ and latex (1:1) showed the decreased levels of citrate, succinate, fumarate, malate, and glutamine in hemolymph, the groups of 0.25% DNJ and the mixture of 0.5% DNJ and latex (1:1) showed the increased levels of trehalose and lactate. In addition, mulberry leaves exude latex was highly toxic to Eri silkworm because rich unidentified high-molecular-weight factor (s) acted as toxic substances. In our results, latex caused 20 deaths among 50 fourth-instar larvae of Eri silkmoth, but DNJ or the mixture did not caused death. All these results suggest that DNJ has a positive impact on the reverse glycometabolism by modulating glycometabolism and inhibiting glucogenesis and energy metabolism. DNJ is a secure substance as a single-ingredient antidiabetic medicine due to its nontoxicity and bioactivity.	[Deng, Ming-Jie; Wen, De-Fu; Wang, Xian-Qin; Xu, Jia-Ping] Anhui Agr Univ, Sch Life Sci, Hefei, Peoples R China; [Deng, Ming-Jie; Lin, Xiao-Dong; Lin, Qiu-Ting; Zhang, Mei-Ling; Wang, Xian-Qin; Gao, Hong-Chang] Wenzhou Med Univ, Analyt & Testing Ctr, Wenzhou, Peoples R China	Anhui Agricultural University; Wenzhou Medical University	Gao, HC (corresponding author), Wenzhou Med Univ, Analyt & Testing Ctr, Wenzhou, Peoples R China.	gaohc27@gmail.com; jiapingxu@163.com	Xu, Jiaping/T-4327-2019	Xu, Jiaping/0000-0001-9020-7248	National 863 plans projects of China [2011AA100306]; Natural Science Foundation of China [31472148]; International cooperation project of Anhui province [1403062018]	National 863 plans projects of China(National High Technology Research and Development Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International cooperation project of Anhui province	This work was supported by the National 863 plans projects of China (2011AA100306), the Natural Science Foundation of China (31472148) and International cooperation project of Anhui province (1403062018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai A, 2011, J DIABETES INVEST, V2, P318, DOI 10.1111/j.2040-1124.2011.00101.x; Asano N, 2001, J AGR FOOD CHEM, V49, P4208, DOI 10.1021/jf010567e; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Brock EA, 2013, ORG BIOMOL CHEM, V11, P3187, DOI 10.1039/c3ob40205c; Carroll JD, 2007, FEBS J, V274, P1701, DOI 10.1111/j.1742-4658.2007.05715.x; Chih CP, 2003, J CEREBR BLOOD F MET, V23, P1263, DOI 10.1097/01.WCB.0000081369.51727.6F; Diao CF, 2014, MOL BIOSYST, V10, P686, DOI 10.1039/c3mb70609e; Gao HC, 2008, ANAL CHIM ACTA, V624, P269, DOI 10.1016/j.aca.2008.06.051; Griffin JL, 2008, PHYSIOL GENOMICS, V34, P1, DOI 10.1152/physiolgenomics.00009.2008; Guan MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060409; Hirayama C, 2007, INSECT BIOCHEM MOLEC, V37, P1348, DOI 10.1016/j.ibmb.2007.09.001; Hori M, 2014, APPL ENTOMOL ZOOL, V49, P571, DOI 10.1007/s13355-014-0288-5; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; Kong WH, 2008, J AGR FOOD CHEM, V56, P2613, DOI 10.1021/jf073223i; Konno K, 2006, P NATL ACAD SCI USA, V103, P1337, DOI 10.1073/pnas.0506944103; Kwon HJ, 2011, J AGR FOOD CHEM, V59, P3014, DOI 10.1021/jf103463f; LEVINE RJ, 1967, J CLIN INVEST, V46, P2012, DOI 10.1172/JCI105690; Li Y. -B., 2013, ELECTRON J DIFFER EQ, V2013, P1, DOI DOI 10.1038/SREP01377; Li YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065892; Liebl M, 2010, J INSECT PHYSIOL, V56, P567, DOI 10.1016/j.jinsphys.2009.11.021; Ma YL, 2012, MOL BIOL REP, V39, P7505, DOI 10.1007/s11033-012-1584-1; MILLER SG, 1990, ARCH INSECT BIOCHEM, V14, P151, DOI 10.1002/arch.940140304; Nakagawa K, 2013, BIOSCI BIOTECH BIOCH, V77, P900, DOI 10.1271/bbb.120908; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Oda Y, 2000, ARCH INSECT BIOCHEM, V45, P156, DOI 10.1002/1520-6327(200012)45:4&lt;156::AID-ARCH3&gt;3.0.CO;2-E; PORTER RK, 1995, BIOCHEM J, V310, P379, DOI 10.1042/bj3100379; Qian K, 2008, DIABETES, V57, pA400; SAMARANAYAKA M, 1976, J EXP BIOL, V65, P415; Schilman PE, 2008, J COMP PHYSIOL B, V178, P157, DOI 10.1007/s00360-007-0207-y; Shang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070841; Shuang E, 2014, EXP GERONTOL, V55, P63, DOI 10.1016/j.exger.2014.03.025; Silva MCP, 2004, INSECT BIOCHEM MOLEC, V34, P1089, DOI 10.1016/j.ibmb.2004.07.001; Spiga L, 2013, J MATERN-FETAL NEO M, V26, P20, DOI 10.3109/14767058.2013.832062; Tang B, 2014, APPL ENTOMOL ZOOL, V49, P255, DOI 10.1007/s13355-014-0244-4; Tatun N, 2008, J INSECT PHYSIOL, V54, P351, DOI 10.1016/j.jinsphys.2007.10.006; Tatun N, 2009, APPL ENTOMOL ZOOL, V44, P85, DOI 10.1303/aez.2009.85; Tsuduki T, 2013, FOOD CHEM, V139, P16, DOI 10.1016/j.foodchem.2013.02.025; Tsuduki T, 2009, J AGR FOOD CHEM, V57, P11024, DOI 10.1021/jf903132r; Tyagi R, 2014, CHEM-BIOL INTERACT, V211, P20, DOI 10.1016/j.cbi.2013.12.016; Tyagi R, 2011, J APPL TOXICOL, V31, P663, DOI 10.1002/jat.1617; Tyagi R, 2012, METABOLOMICS, V8, P940, DOI 10.1007/s11306-011-0390-4; van Doorn M, 2007, BRIT J CLIN PHARMACO, V63, P562, DOI 10.1111/j.1365-2125.2006.02816.x; Zhang AH, 2012, ANAL BIOANAL CHEM, V404, P1239, DOI 10.1007/s00216-012-6117-1; Zhao LC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/431894; Zhao LC, 2011, ANAL LETT, V44, P1579, DOI 10.1080/00032719.2010.520390	45	9	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131696	10.1371/journal.pone.0131696	http://dx.doi.org/10.1371/journal.pone.0131696			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148185	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600130
J	Frank, DN; Bales, ES; Monks, J; Jackman, MJ; MacLean, PS; Ir, D; Robertson, CE; Orlicky, DJ; McManaman, JL				Frank, Daniel N.; Bales, Elise S.; Monks, Jenifer; Jackman, Matthew J.; MacLean, Paul S.; Ir, Diana; Robertson, Charles E.; Orlicky, David J.; McManaman, James L.			Perilipin-2 Modulates Lipid Absorption and Microbiome Responses in the Mouse Intestine	PLOS ONE			English	Article							FATTY LIVER-DISEASE; DIET-INDUCED OBESITY; GUT MICROBIOME; BILE-ACIDS; DROPLETS; DATABASE; TOOLS; GENE; METABOLISM; EXPRESSION	Obesity and its co-morbidities, such as fatty liver disease, are increasingly prevalent worldwide health problems. Intestinal microorganisms have emerged as critical factors linking diet to host physiology and metabolic function, particularly in the context of lipid homeostasis. We previously demonstrated that deletion of the cytoplasmic lipid drop (CLD) protein Perilipin-2 (Plin2) in mice largely abrogates long-term deleterious effects of a high fat (HF) diet. Here we test the hypotheses that Plin2 function impacts the earliest steps of HF diet-mediated pathogenesis as well as the dynamics of diet-associated changes in gut microbiome diversity and function. WT and perilipin-2 null mice raised on a standard chow diet were randomized to either low fat (LF) or HF diets. After four days, animals were assessed for changes in physiological (body weight, energy balance, and fecal triglyceride levels), histochemical (enterocyte CLD content), and fecal microbiome parameters. Plin2-null mice had significantly lower respiratory exchange ratios, diminished frequencies of enterocyte CLDs, and increased fecal triglyceride levels compared with WT mice. Microbiome analyses, employing both 16S rRNA profiling and metagenomic deep sequencing, indicated that dietary fat content and Plin2 genotype were significantly and independently associated with gut microbiome composition, diversity, and functional differences. These data demonstrate that Plin2 modulates rapid effects of diet on fecal lipid levels, enterocyte CLD contents, and fuel utilization properties of mice that correlate with structural and functional differences in their gut microbial communities. Collectively, the data provide evidence of Plin2 regulated intestinal lipid uptake, which contributes to rapid changes in the gut microbial communities implicated in diet-induced obesity.	[Frank, Daniel N.; Ir, Diana; Robertson, Charles E.] Univ Colorado, Sch Med, Div Infect Dis, Aurora, CO USA; [Frank, Daniel N.; Robertson, Charles E.] Univ Colorado, Sch Med, Microbiome Res Consortium, Aurora, CO USA; [Bales, Elise S.; Monks, Jenifer; McManaman, James L.] Univ Colorado, Sch Med, Div Basic Reprod Sci, Aurora, CO 80045 USA; [Jackman, Matthew J.; MacLean, Paul S.] Univ Colorado, Sch Med, Div Endocrinol & Metab, Aurora, CO USA; [Orlicky, David J.] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO USA; [Jackman, Matthew J.; MacLean, Paul S.; McManaman, James L.] Univ Colorado, Sch Med, Ctr Human Nutr, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	McManaman, JL (corresponding author), Univ Colorado, Sch Med, Div Basic Reprod Sci, Aurora, CO 80045 USA.	jim.mcmanaman@ucdenver.edu	MacLean, Paul/A-7887-2008; Monks, Jenifer/GLS-6662-2022	MacLean, Paul/0000-0002-1123-6612; Monks, Jenifer/0000-0002-7990-3389; ROBERTSON, CHARLES/0000-0002-4136-4121	National Institutes of Health [2RO1HD045962]; National Institutes of Health University of Colorado Cancer Center [P30CA046934]; National Institutes of Health Colorado Nutrition and Obesity Research Center [DK48520]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD075285] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health University of Colorado Cancer Center; National Institutes of Health Colorado Nutrition and Obesity Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support was provided by the National Institutes of Health 2RO1HD045962 (JLM), National Institutes of Health University of Colorado Cancer Center Support Grant P30CA046934, and National Institutes of Health Colorado Nutrition and Obesity Research Center DK48520. The funders had no role in study design, data collection and analysis, decision to publish, or in preparation of the manuscript.	Aitchison J., 1986, THE STATISTICAL ANAL; Alkanani AK, 2014, DIABETES, V63, P619, DOI 10.2337/db13-1007; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Aron-Wisnewsky J, 2013, CLIN MICROBIOL INFEC, V19, P338, DOI 10.1111/1469-0691.12140; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouchoux J, 2011, BIOL CELL, V103, P499, DOI 10.1042/BC20110024; Bougneres L, 2009, IMMUNITY, V31, P232, DOI 10.1016/j.immuni.2009.06.022; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Catenacci VA, 2009, CLIN CHEST MED, V30, P415, DOI 10.1016/j.ccm.2009.05.001; Crunk AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067631; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; Demignot S, 2014, BIOCHIMIE, V96, P48, DOI 10.1016/j.biochi.2013.07.009; Dillon SM, 2014, MUCOSAL IMMUNOL, V7, P983, DOI 10.1038/mi.2013.116; Drozdowski L, 2006, WORLD J GASTROENTERO, V12, P4614, DOI 10.3748/wjg.v12.i29.4614; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Finucane MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084689; Frank DN, 2011, TRENDS MICROBIOL, V19, P427, DOI 10.1016/j.tim.2011.06.005; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Frank DN, 2011, HANDBOOK OF MOLECULA; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Hara N, 2012, J IMMUNOL, V189, P3805, DOI 10.4049/jimmunol.1201257; Hullar MAJ, 2014, CANCER J, V20, P170, DOI 10.1097/PPO.0000000000000053; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Imai Y, 2012, PHYSIOL GENOMICS, V44, P1125, DOI 10.1152/physiolgenomics.00045.2012; Jiang CT, 2015, J CLIN INVEST, V125, P386, DOI 10.1172/JCI76738; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kelder T, 2014, DIABETES, V4, pe122, DOI [10.1038/nutd.2014.18, DOI 10.1038/NUTD.2014.18]; Kelly CJ, 2012, NUTR CLIN PRACT, V27, P215, DOI 10.1177/0884533611434934; Kotera M, 2012, METHODS MOL BIOL, V802, P19, DOI 10.1007/978-1-61779-400-1_2; Kumar SPDS, 2014, ENDOCR J, V61, P457, DOI 10.1507/endocrj.EJ13-0455; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lee B, 2009, BBA-MOL CELL BIOL L, V1791, P1173, DOI 10.1016/j.bbalip.2009.08.002; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Ling AL, 2014, ENVIRON SCI TECHNOL, V48, P7357, DOI 10.1021/es500763e; Little TJ, 2007, AM J CLIN NUTR, V86, P531, DOI 10.1093/ajcn/86.3.531; Liu XJ, 2014, BIOCHEM BIOPH RES CO, V450, P117, DOI 10.1016/j.bbrc.2014.05.072; Lynes MD, 2011, LIFE SCI, V88, P384, DOI 10.1016/j.lfs.2010.12.015; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Magurran A.E., 2004, MEASURING BIOL DIVER; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063; Mehal WZ, 2012, HEPATOLOGY, V55, P1647, DOI 10.1002/hep.25704; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Monks J, 2007, BIOL REPROD; Mouzaki M, 2013, HEPATOLOGY, V58, P120, DOI 10.1002/hep.26319; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270; Pruesse E, 2012, BIOINFORMATICS; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Raman M, 2013, CLIN GASTROENTEROL H, V11, P868, DOI 10.1016/j.cgh.2013.02.015; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Schloss PD, 2007, ANNU REV MICROBIOL, V61, P23, DOI 10.1146/annurev.micro.61.011507.151712; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Semova I, 2012, CELL HOST MICROBE, V12, P277, DOI 10.1016/j.chom.2012.08.003; Seyer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058224; Speakman JR, 2013, MOL METAB, V2, P5, DOI 10.1016/j.molmet.2012.10.002; Straub BK, 2008, HEPATOLOGY, V47, P1936, DOI 10.1002/hep.22268; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Team RDC, 2006, R LANG ENV STAT COMP; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Wahlig JL, 2012, OBESITY, V20, P65, DOI 10.1038/oby.2011.196; Wilke A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-141; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Wong VWS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062885; Zupancic ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043052	74	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131944	10.1371/journal.pone.0131944	http://dx.doi.org/10.1371/journal.pone.0131944			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147095	gold, Green Submitted, Green Published			2022-12-27	WOS:000358157600169
J	Gijsberts, CM; Seneviratna, A; de Carvalho, LP; den Ruijter, HM; Vidanapthirana, P; Sorokin, V; Stella, P; Agostoni, P; Asselbergs, FW; Richards, AM; Low, AF; Lee, CH; Tan, HC; Hoefer, IE; Pasterkamp, G; de Kleijn, DPV; Chan, MY				Gijsberts, Crystel M.; Seneviratna, Aruni; de Carvalho, Leonardo P.; den Ruijter, Hester M.; Vidanapthirana, Puwalani; Sorokin, Vitaly; Stella, Pieter; Agostoni, Pierfrancesco; Asselbergs, Folkert W.; Richards, A. Mark; Low, Adrian F.; Lee, Chi-Hang; Tan, Huay Cheem; Hoefer, Imo E.; Pasterkamp, Gerard; de Kleijn, Dominique P. V.; Chan, Mark Y.			Ethnicity Modifies Associations between Cardiovascular Risk Factors and Disease Severity in Parallel Dutch and Singapore Coronary Cohorts	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; SOUTH ASIANS; CAUCASIAN PATIENTS; HEART-DISEASE; MORTALITY; CHINESE; ATHEROSCLEROSIS; CHOLESTEROL; OUTCOMES; STROKE	Background In 2020 the largest number of patients with coronary artery disease (CAD) will be found in Asia. Published epidemiological and clinical reports are overwhelmingly derived from western (White) cohorts and data from Asia are scant. We compared CAD severity and all-cause mortality among 4 of the world's most populous ethnicities: Whites, Chinese, Indians and Malays. Methods The UNIted CORoNary cohort (UNICORN) simultaneously enrolled parallel populations of consecutive patients undergoing coronary angiography or intervention for suspected CAD in the Netherlands and Singapore. Using multivariable ordinal regression, we investigated the independent association of ethnicity with CAD severity and interactions between risk factors and ethnicity on CAD severity. Also, we compared all-cause mortality among the ethnic groups using multivariable Cox regression analysis. Results We included 1,759 White, 685 Chinese, 201 Indian and 224 Malay patients undergoing coronary angiography. We found distinct inter-ethnic differences in cardiovascular risk factors. Furthermore, the associations of gender and diabetes with severity of CAD were significantly stronger in Chinese than Whites. Chinese (OR 1.3 [1.1-1.7], p = 0.008) and Malay (OR 1.9 [1.4-2.6], p<0.001) ethnicity were independently associated with more severe CAD as compared to White ethnicity. Strikingly, when stratified for diabetes status, we found a significant association of all three Asian ethnic groups as compared to White ethnicity with more severe CAD among diabetics, but not in non-diabetics. Crude all-cause mortality did not differ, but when adjusted for covariates mortality was higher in Malays than the other ethnic groups. Conclusion In this population of individuals undergoing coronary angiography, ethnicity is independently associated with the severity of CAD and modifies the strength of association between certain risk factors and CAD severity. Furthermore, mortality differs among ethnic groups. Our data provide insight in inter-ethnic differences in CAD risk factors, CAD severity and mortality.	[Gijsberts, Crystel M.; den Ruijter, Hester M.; Hoefer, Imo E.; Pasterkamp, Gerard; de Kleijn, Dominique P. V.] Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands; [Gijsberts, Crystel M.; de Kleijn, Dominique P. V.] Netherlands Heart Inst ICIN, Utrecht, Netherlands; [Seneviratna, Aruni; de Carvalho, Leonardo P.; Richards, A. Mark; Low, Adrian F.; Lee, Chi-Hang; Tan, Huay Cheem; Chan, Mark Y.] Natl Univ Singapore Hosp, Dept Cardiac, Natl Univ Heart Ctr, Singapore 117548, Singapore; [Vidanapthirana, Puwalani; Sorokin, Vitaly; de Kleijn, Dominique P. V.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore; [Stella, Pieter; Agostoni, Pierfrancesco; Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Asselbergs, Folkert W.] ICIN Netherlands Heart Inst, Durrer Ctr Cardiogenet Res, Utrecht, Netherlands; [Asselbergs, Folkert W.] UCL, Fac Populat Hlth Sci, Inst Cardiovasc Sci, London, England; [Richards, A. Mark; de Kleijn, Dominique P. V.; Chan, Mark Y.] Natl Univ Hlth Syst, Cardiovasc Res Inst CVRI, Natl Univ Heart Ctr NUHCS, Singapore, Singapore	Utrecht University; Utrecht University Medical Center; National University of Singapore; National University of Singapore; Utrecht University; Utrecht University Medical Center; University of London; University College London; National University of Singapore	de Kleijn, DPV (corresponding author), Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands.	surdvp@nus.edu.sg	Sorokin, Vitaly/A-2773-2014; Chan, Yan Yee Mark/ABE-1929-2021; Agostoni, Pierfrancesco/A-3681-2008; Asselbergs, Folkert W./ABD-6752-2021; Sorokin, Vitaly/ABI-3359-2020	Chan, Yan Yee Mark/0000-0003-0389-7450; Agostoni, Pierfrancesco/0000-0002-1505-9369; Asselbergs, Folkert W./0000-0002-1692-8669; Seneviratna, Aruni/0000-0001-5010-1422; Lee, Chi-Hang/0000-0001-8777-2705; den Ruijter, Hester/0000-0001-9762-014X	Royal Netherlands Academy of Arts and Sciences; National University Singapore Startup grant; Singapore National Medical Research Council Centre Grant	Royal Netherlands Academy of Arts and Sciences; National University Singapore Startup grant; Singapore National Medical Research Council Centre Grant(National Medical Research Council, Singapore)	This work is supported by a Strategic grant from the Royal Netherlands Academy of Arts and Sciences to the Interuniversity Cardiology Institute of the Netherlands, ICIN (DPVK); National University Singapore Startup grant to DPVK and Singapore National Medical Research Council Centre Grant to AMR, MYC and DPVK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; Anand S S, 2000, Indian Heart J, V52, pS35; [Anonymous], 2013, HUMAN DEV REPORT 201; Bansal N, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003415; Bellary S, 2010, CURR MED RES OPIN, V26, P1873, DOI 10.1185/03007995.2010.490468; Bild DE, 2005, CIRCULATION, V111, P1313, DOI 10.1161/01.CIR.0000157730.94423.4B; CBS, 2014, INKOMEN PARTICULIERE; Chiu M, 2010, CAN MED ASSOC J, V182, P1334, DOI 10.1503/cmaj.110-2098; Chow CK, 2008, ATHEROSCLEROSIS, V199, P116, DOI 10.1016/j.atherosclerosis.2007.10.008; Clark AM, 2009, NAT REV CARDIOL, V6, P712, DOI 10.1038/nrcardio.2009.163; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Gijsberts CM, 2015, GLOB HEART, V10, P301, DOI 10.1016/j.gheart.2014.11.004; Goff David C Jr, 2014, J Am Coll Cardiol, V63, P2935, DOI 10.1016/j.jacc.2013.11.005; HARRIS PJ, 1980, CIRCULATION, V62, P240, DOI 10.1161/01.CIR.62.2.240; Jones DA, 2012, HEART, V98, P414, DOI 10.1136/heartjnl-2011-300130; Jones DA, 2014, JACC-CARDIOVASC INTE, V7, P362, DOI 10.1016/j.jcin.2013.11.013; Joshi P, 2007, JAMA-J AM MED ASSOC, V297, P286, DOI 10.1001/jama.297.3.286; Khan NA, 2010, CIRCULATION, V122, P1570, DOI 10.1161/CIRCULATIONAHA.109.850297; Kim W, 2010, CENSUS POPULATION 20; Klomp M, 2012, CORONARY ARTERY DIS, V23, P271, DOI 10.1097/MCA.0b013e328351aaed; Kressin NR, 2001, ANN INTERN MED, V135, P352, DOI 10.7326/0003-4819-135-5-200109040-00012; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Mak KH, 2003, EUR HEART J, V24, P151, DOI 10.1016/S0195-668X(02)00423-2; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McManus RJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e181; Meadows TA, 2011, MAYO CLIN PROC, V86, P960, DOI 10.4065/mcp.2011.0010; Nakamura Y, 1999, AM HEART J, V138, P500, DOI 10.1016/S0002-8703(99)70153-5; Quan HD, 2010, CAN J CARDIOL, V26, pE236, DOI 10.1016/S0828-282X(10)70414-1; R Core Team, 2021, R LANGUAGE ENV STAT; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Silbiger JJ, 2013, ETHNIC DIS, V23, P292; Toor IS, 2011, INT J CLIN PRACT, V65, P1259, DOI 10.1111/j.1742-1241.2011.02776.x; Wang JW, 2013, NETH HEART J, V21, P467, DOI 10.1007/s12471-013-0462-3; Woodward M, 2005, EUR J CARDIOV PREV R, V12, P484; World Health Organization, 2011, World health statistics 2011; World Health Organization, 2000, HLTH SYST IMPR PERF; World Health Organization, 2012, WORLD HLTH STAT 2012; World Health Organization, 2006, DEF DIAGN DIAB MELL; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zaman MJS, 2013, HEART, V99, P729, DOI 10.1136/heartjnl-2012-302925; Zhang X, 2003, INT J EPIDEMIOL, V32, P563, DOI 10.1093/ije/dyg106; Zheng YL, 2010, CLIN RES CARDIOL, V99, P45, DOI 10.1007/s00392-009-0076-3	42	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132278	10.1371/journal.pone.0132278	http://dx.doi.org/10.1371/journal.pone.0132278			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147693	gold, Green Submitted, Green Published			2022-12-27	WOS:000358157600230
J	Hossain, MA; Xu, YF; Peshek, TJ; Ji, L; Abramson, AR; French, RH				Hossain, Mohammad Akram; Xu, Yifan; Peshek, Timothy J.; Ji, Liang; Abramson, Alexis R.; French, Roger H.			Microinverter Thermal Performance in the Real-World: Measurements and Modeling	PLOS ONE			English	Article							PV MODULE TEMPERATURE; OPERATING TEMPERATURE; BATTERIES	Real-world performance, durability and reliability of microinverters are critical concerns for microinverter-equipped photovoltaic systems. We conducted a data-driven study of the thermal performance of 24 new microinverters (Enphase M215) connected to 8 different brands of PV modules on dual-axis trackers at the Solar Durability and Lifetime Extension (SDLE) SunFarm at Case Western Reserve University, based on minute by minute power and thermal data from the microinverters and PV modules along with insolation and environmental data from July through October 2013. The analysis shows the strengths of the associations of microinverter temperature with ambient temperature, PV module temperature, irradiance and AC power of the PV systems. The importance of the covariates are rank ordered. A multiple regression model was developed and tested based on stable solar noon-time data, which gives both an overall function that predicts the temperature of microinverters under typical local conditions, and coefficients adjustments reecting refined prediction of the microinverter temperature connected to the 8 brands of PV modules in the study. The model allows for prediction of internal temperature for the Enphase M215 given similar climatic condition and can be expanded to predict microinverter temperature in fixed-rack and roof-top PV systems. This study is foundational in that similar models built on later stage data in the life of a device could reveal potential influencing factors in performance degradation.	[Hossain, Mohammad Akram; Abramson, Alexis R.] Case Western Reserve Univ, Dept Mech & Aerosp Engn, Cleveland, OH 44106 USA; [Hossain, Mohammad Akram; Xu, Yifan; Peshek, Timothy J.; French, Roger H.] Case Western Reserve Univ, Solar Durabil & Lifetime Extens SDLE Ctr, Cleveland, OH 44106 USA; [Xu, Yifan] Case Western Reserve Univ, Ctr Stat Res Comp & Collaborat, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Ji, Liang] Underwriters Labs, Northbrook, IL USA; [French, Roger H.] Case Western Reserve Univ, Dept Mat Sci & Engn, Cleveland, OH 44106 USA; [French, Roger H.] Case Western Reserve Univ, Dept Macromol Sci & Engn, Cleveland, OH 44106 USA; [Peshek, Timothy J.; French, Roger H.] Case Western Reserve Univ, Dept Phys, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	French, RH (corresponding author), Case Western Reserve Univ, Solar Durabil & Lifetime Extens SDLE Ctr, Cleveland, OH 44106 USA.	roger.french@case.edu	French, Roger H/E-1986-2011	French, Roger H/0000-0002-6162-0532; Hossain, Mohammad/0000-0002-8059-0789	Underwriters Laboratories; Ohio Third Frontier [Tech 11-060, Tech 12-004]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER	Underwriters Laboratories; Ohio Third Frontier; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Underwriters Laboratories provided the funding for the study. Mohammad A. Hossain and Dr. Timothy J. Peshek received the funding from them. This research was performed in the SDLE Center at Case Western Reserve University, established with Ohio Third Frontier funding under award Tech 11-060, Tech 12-004. Underwriters Laboratories helped to develop the study design.	Adler J, 2010, R NUTSHELL DESKTOP Q; [Anonymous], 1995, 61215 IEC; Armstrong S, 2010, APPL THERM ENG, V30, P1488, DOI 10.1016/j.applthermaleng.2010.03.012; Bird L, 2012, WORLD REN EN FOR P D; Bruckman LS, 2013, IEEE ACCESS, V1, P384, DOI 10.1109/ACCESS.2013.2267611; Bruckman LS, 2013, SPIE SOLAR ENERGY TE; California Energy Commission, 2014, LIST EL INV SB1 GUID; Campbell Scientific Inc., 2013, AM1632B 16 32 CHANN; Campbell Scientific Inc., 2014, CR1000 MEAS CONTR DA; Chan F. T., 2006, 2006 IEEE C CYBERNET, P1; Chan F, 2006, 2006 IEEE INTERNATIONAL SYMPOSIUM ON INDUSTRIAL ELECTRONICS, VOLS 1-7, P1583, DOI 10.1109/ISIE.2006.295708; Clement-Nyns K, 2011, ELECTR POW SYST RES, V81, P185, DOI 10.1016/j.epsr.2010.08.007; Deline C, 2011, CONTRACT, DOI DOI 10.2172/1004490; Deline C, 2012, CONTRACT; Denholm P, 2006, VERY LARGE SCALE DEP; Enphase Energy, 2009, REL ENPH MICR; Faiman D, 2008, PROG PHOTOVOLTAICS, V16, P307, DOI 10.1002/pip.813; Faraway J., 2004, LINEAR MODELS R; Feldman David, 2014, PHOTOVOLTAIC PV PRIC; FLIR Systems Inc., 2013, TECHN DAT FLIR T300; French RH, 2015, CURRENT OPINION SOLI; Harada K., 1993, IEEE Transactions on Power Electronics, V8, P355, DOI 10.1109/63.261004; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hossain MA, 2014, SPIE SOLAR ENERGY TE; Hossain MA, 2014, PHOT SPEC C PVSC 201; Hossain MA., 2014, THERMAL CHARACTERIST; Hu XS, 2014, IEEE T IND INFORM, V10, P1948, DOI 10.1109/TII.2013.2284713; Hu XS, 2014, IEEE T INTELL TRANSP, V15, P1193, DOI 10.1109/TITS.2013.2294675; Hu XS, 2013, J POWER SOURCES, V239, P449, DOI 10.1016/j.jpowsour.2013.03.157; Hu Y., 2013, 2013 IEEE ENERGYTECH, P1, DOI DOI 10.1109/ENERGYTECH.2013.6645317; Hu Y., 2014, PV MODULE PERFORMANC; IEA Technology, 2010, ROADM SOL PHOT EN 20; Kaplani E, 2014, SOL ENERGY, V107, P443, DOI 10.1016/j.solener.2014.05.037; King DL., 2004, PHOTOVOLTAIC ARRAY P; Koehl M, 2011, SOL ENERG MAT SOL C, V95, P1638, DOI 10.1016/j.solmat.2011.01.020; Kulkarni CS, 2013, INT J PROGNOSTICS HL; Kurnik J, 2011, SOL ENERG MAT SOL C, V95, P373, DOI 10.1016/j.solmat.2010.04.022; Kurtz S, 2011, PROG PHOTOVOLTAICS, V19, P954, DOI 10.1002/pip.1103; Lemire HM, 2013, MRS ONLINE P LIB, V1537; Mattei M, 2006, RENEW ENERG, V31, P553, DOI 10.1016/j.renene.2005.03.010; Notton G, 2005, APPL THERM ENG, V25, P2854, DOI 10.1016/j.applthermaleng.2005.02.008; O'Neil C, 2013, DOING DATA SCI STRAT; Patil N, 2010, P 2 INT C REL SAF HA, P68, DOI DOI 10.1109/ICRESH.2010.5779635; Patil N, 2012, MICROELECTRON RELIAB, V52, P482, DOI 10.1016/j.microrel.2011.10.017; Petrone G, 2008, IEEE T IND ELECTRON, V55, P2569, DOI 10.1109/TIE.2008.924016; Photovoltaic Education Network, 2010, SOLAR TIME; R Core Team, 2021, R LANGUAGE ENV STAT; Seltman H.J., 2012, EXPT DESIGN ANAL; Skoplaki E, 2008, SOL ENERG MAT SOL C, V92, P1393, DOI 10.1016/j.solmat.2008.05.016; Smith R, 2011, SOLARPRO, V4, P90; Sorensen NR, 2013, IEEE J PHOTOVOLT, V3, P807, DOI 10.1109/JPHOTOV.2013.2244162; Weisberg S, 2014, APPL LINEAR REGRESSI, V4th; Wohlgemuth J, 2014, SPIE SOLAR ENERGY TE; Wohlgemuth J, 2014, 2014 IEEE 40TH PHOTOVOLTAIC SPECIALIST CONFERENCE (PVSC), P2191, DOI 10.1109/PVSC.2014.6925359	54	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131279	10.1371/journal.pone.0131279	http://dx.doi.org/10.1371/journal.pone.0131279			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147339	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600082
J	Lasram, FB; Hattab, T; Halouani, G; Romdhane, MS; Le Loc'h, F				Lasram, Frida Ben Rais; Hattab, Tarek; Halouani, Ghassen; Romdhane, Mohamed Salah; Le Loc'h, Francois			Modeling of Beta Diversity in Tunisian Waters: Predictions Using Generalized Dissimilarity Modeling and Bioregionalisation Using Fuzzy Clustering	PLOS ONE			English	Article							SPECIES DISTRIBUTION; CLIMATE-CHANGE; COASTAL; BIODIVERSITY; ASSEMBLAGES; INDICATOR; PATTERNS; REGIONS; GABES; SCALE	Spatial patterns of beta diversity are a major focus of ecology. They can be especially valuable in conservation planning. In this study, we used a generalized dissimilarity modeling approach to analyze and predict the spatial patterns of beta diversity for commercially exploited, demersal marine species assemblages along the Tunisian coasts. For this study, we used a presence/absence dataset which included information on 174 species (invertebrates and fishes) and 9 environmental variables. We first performed the modeling analyses and assessed beta diversity using the turnover component of the Jaccard's dissimilarity index. We then performed nonmetric multidimensional scaling to map predicted beta diversity. To delineate the biogeographical regions, we used fuzzy cluster analysis. Finally, we also identified a set of indicator species which characterized the species assemblages in each identified biogeographical region. The predicted beta diversity map revealed two patterns: an inshore-offshore gradient and a south-north latitudinal gradient. Three biogeographical regions were identified and 14 indicator species. These results constitute a first contribution of the bioregionalisation of the Tunisian waters and highlight the issues associated with current fisheries management zones and conservation strategies. Results could be useful to follow an Ecosystem Based Management approach by proposing an objective spatial partitioning of the Tunisian waters. This partitioning could be used to prioritize the adjustment of the actual fisheries management entities, identify current data gaps, inform future scientific surveys and improve current MPA network.	[Lasram, Frida Ben Rais; Hattab, Tarek; Halouani, Ghassen; Romdhane, Mohamed Salah] Inst Natl Agron Tunisie, Unite Rech Ecosyst & Ressources Aquat UR03AGRO1, Tunis, Tunisia; [Hattab, Tarek] Univ Picardie Jules Verne, Unite Rech Ecol & Dynam Syst Anthropises EDYSAN, CNRS, FRE 3498, Amiens, France; [Hattab, Tarek; Halouani, Ghassen; Le Loc'h, Francois] Inst Univ Europeen Mer, Lab Sci Environm Marin, UMR 6539, LEMAR,CNRS,UBO,IRD,Ifremer, Plouzane, France	Universite de Carthage; Centre National de la Recherche Scientifique (CNRS); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale	Lasram, FB (corresponding author), Inst Natl Agron Tunisie, Unite Rech Ecosyst & Ressources Aquat UR03AGRO1, Tunis, Tunisia.	frida.lasram@gmail.com	Le Loc'h, François/A-5038-2008; Halouani, Ghassen/I-7487-2019; Romdhane, Mohamed Salah/GTB-5864-2022; Hattab, Tarek/K-2992-2014	Le Loc'h, François/0000-0002-3372-6997; Halouani, Ghassen/0000-0001-6610-293X; Romdhane, Mohamed Salah/0000-0002-3343-7554; Hattab, Tarek/0000-0002-1420-5758	IRD (GAMBAS project); Fondation Total (CHARMMED project)	IRD (GAMBAS project); Fondation Total (CHARMMED project)	The authors received funding from IRD (GAMBAS project) and Fondation Total (CHARMMED project).	Afli A., 2005, BIODIVERSITE MARINE; Albouy C, 2013, J BIOGEOGR, V40, P534, DOI 10.1111/jbi.12013; Barton PS, 2013, GLOBAL ECOL BIOGEOGR, V22, P639, DOI 10.1111/geb.12031; Baselga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P1223, DOI 10.1111/j.1466-8238.2011.00756.x; Ben Ismail S, 2014, J MARINE SYST, V135, P14, DOI 10.1016/j.jmarsys.2013.06.010; Ben Mustapha K., 2007, MEDSUDMED TECHNICAL, P32; BEZDEK JC, 1984, COMPUT GEOSCI, V10, P191, DOI 10.1016/0098-3004(84)90020-7; Carstensen DW, 2013, ECOGRAPHY, V36, P1310, DOI 10.1111/j.1600-0587.2013.00329.x; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; De Caceres M, 2010, J VEG SCI, V21, P1138, DOI 10.1111/j.1654-1103.2010.01211.x; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; DGPA, 2012, DIR GEN PECH TUN; Diniz JAF, 2004, OECOLOGIA, V140, P633, DOI 10.1007/s00442-004-1577-4; DOUVERE F, 2001, MANAGEMENT, V44, P563, DOI DOI 10.1163/22116001-90000188; Duff TJ, 2014, J VEG SCI, V25, P323, DOI 10.1111/jvs.12092; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Ellison AM, 2010, ECOLOGY, V91, P1962, DOI 10.1890/09-1692.1; FAO, 2003, TECHN GUID RESP FISH, P173; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Froese R., 2014, WORLD WIDE WEB ELECT; Fuller RA, 2007, BIOLOGY LETT, V3, P390, DOI 10.1098/rsbl.2007.0149; Gaertner JC, 2005, VIE MILIEU, V55, P81; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Harborne AR, 2006, ECOLOGY, V87, P2871, DOI 10.1890/0012-9658(2006)87[2871:MTBDOC]2.0.CO;2; Hattab T, 2015, J BIOGEOGR, V42, P1336, DOI 10.1111/jbi.12505; Hattab T, 2014, GLOBAL ECOL BIOGEOGR, V23, P1417, DOI 10.1111/geb.12217; Hattab T, 2013, J MARINE SYST, V128, P159, DOI 10.1016/j.jmarsys.2013.04.017; Hattab T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076430; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Jabeur C, 2000, AQUAT LIVING RESOUR, V13, P421; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Lasram FB, 2009, MAR ECOL PROG SER, V376, P253, DOI 10.3354/meps07786; Leaper R, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00089.1; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre P., 2012, NUMERICAL ECOLOGY; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Micheli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079889; Monk J, 2011, CONT SHELF RES, V31, pS17, DOI 10.1016/j.csr.2010.02.012; NAJAR B, 2010, COMM INT EXPLOR SCI, V39, P601; Nieblas AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111251; Norse EA, 2012, MAR POLICY, V36, P307, DOI 10.1016/j.marpol.2011.06.008; Palumbi SR, 2009, FRONT ECOL ENVIRON, V7, P204, DOI 10.1890/070135; Papaconstantinou C., 2000, Mediterranean Marine Science, V1, P5; Reygondeau G, 2013, GLOBAL BIOGEOCHEM CY, V27, P1046, DOI 10.1002/gbc.20089; Rice J, 2011, OCEAN COAST MANAGE, V54, P110, DOI 10.1016/j.ocecoaman.2010.10.010; Roberts CM, 2003, ECOL APPL, V13, pS215; Rodriguez P, 2004, ECOGRAPHY, V27, P547, DOI 10.1111/j.0906-7590.2004.03788.x; SAMMARI C, 1995, B I NATL SC TECHNOL, V22, P10; Sbrocco E.J., 2013, ECOLOGY, V94, P979, DOI DOI 10.1890/12-1358.1; Shackell NL, 2012, ECOL APPL, V22, P336, DOI 10.1890/10-2093.1; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Svenning JC, 2011, J ANIM ECOL, V80, P393, DOI 10.1111/j.1365-2656.2010.01771.x; Ulrich W, 2007, ECOLOGY, V88, P1824, DOI 10.1890/06-1208.1; Valavanis VD, 2008, HYDROBIOLOGIA, V612, P5, DOI 10.1007/s10750-008-9493-y; Webb TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010223; Whitehead Peter J. P, 1986, FISHES N E ATLANTIC; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WHITTAKER RH, 1960, ECOL MONOGR, V30, P280, DOI 10.2307/1943563; Woodcock CE, 2000, INT J GEOGR INF SCI, V14, P153, DOI 10.1080/136588100240895; WoRMS Editorial Board, WORLD REG MAR SPEC	64	15	15	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131728	10.1371/journal.pone.0131728	http://dx.doi.org/10.1371/journal.pone.0131728			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147371	gold, Green Published			2022-12-27	WOS:000358157600136
J	Morais-Santos, M; Nunes, AEB; Oliveira, AG; Moura-Cordeiro, JD; Mahecha, GAB; Avellar, MCW; Oliveira, CA				Morais-Santos, Monica; Nunes, Aryane E. B.; Oliveira, Andre G.; Moura-Cordeiro, Junia Dayrell; Mahecha, Germn A. B.; Avellar, Maria Christina W.; Oliveira, Cleida A.			Changes in Estrogen Receptor ER beta (ESR2) Expression without Changes in the Estradiol Levels in the Prostate of Aging Rats	PLOS ONE			English	Article							MALE REPRODUCTIVE-SYSTEM; DIFFERENTIAL EXPRESSION; INTRAEPITHELIAL NEOPLASIA; SPONTANEOUS HYPERPLASIA; ANDROGEN RECEPTOR; VENTRAL PROSTATE; CANINE PROSTATE; GROWTH-FACTOR; ALPHA; CANCER	Although the prostate is androgen-dependent, it is also influenced by estrogens, which act via the estrogen receptors ER alpha and ER beta. In the prostate, ER beta is highly expressed in the epithelium and appears to participate in the regulation of cell proliferation, apoptosis and differentiation. Evidence shows that ER beta is decreased in malignant prostate, suggesting that it plays an important role in protecting this tissue. Despite the relationship between reductions in ER beta and abnormal growth of the gland, little is known about the age-dependent variation of this receptor. Therefore, we aimed to investigate ER beta expression in the prostatic lobes of aging Wistar rats (3 to 24 months). Histopathological alterations, including hyperplasia, intraluminal concretions, nuclear atypia and prostate intraepithelial neoplasias (PIN), were observed in the prostates of aging rats. Epithelial proliferation led to cribriform architecture in some acini, especially in the ventral prostate (VP). In the VP, areas of epithelial atrophy were also observed. Furthermore, in the lateral prostate, there was frequent prostatitis. Immunohistochemistry revealed that the expression of ER beta is reduced in specific areas related to PIN, atrophic abnormalities and cellular atypia in the prostate epithelium of senile rats. Corroborating the involvement of the receptor with proliferative activity, the punctual reduction in ER beta paralleled the increase in cell proliferation especially in areas of PIN and nuclear atypies. The decrease in ER beta reactivity occurred in a hormonal milieu characterized by a constant concentration of estradiol and decreased plasmatic and tissue DHT. This paper is a pioneering study that reveals focal ER beta reduction in the prostate of aging rats and indicates a potential disorder in the ER beta pathway. These data corroborate previous data from humans and dogs that silencing of this receptor may be associated with premalignant or malignant conditions in the prostate.	[Morais-Santos, Monica; Nunes, Aryane E. B.; Oliveira, Andre G.; Moura-Cordeiro, Junia Dayrell; Mahecha, Germn A. B.; Oliveira, Cleida A.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, Belo Horizonte, MG, Brazil; [Avellar, Maria Christina W.] Univ Fed Sao Paulo, Dept Pharmacol, Sect Expt Endocrinol, Escola Paulista Med, Sao Paulo, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Sao Paulo (UNIFESP)	Oliveira, CA (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, Belo Horizonte, MG, Brazil.	cleida@icb.ufmg.br	Mahecha, German/A-7350-2016; Avellar, Maria Christina W./E-2865-2013; Oliveira, Cleida A./AAA-3221-2020; Oliveira, Cleida A./C-4966-2013	Mahecha, German/0000-0003-2907-0945; Avellar, Maria Christina W./0000-0003-4392-7554; Oliveira, Cleida A./0000-0001-9610-7846; Oliveira, Cleida A./0000-0001-9610-7846	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq/Brazil; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG/Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG/Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq/Brazil (Grant and research fellowship to C.A.O.; doctoral fellowship to A.G.O. and M.M.S.) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG/Brazil (Grant to C.A.O.; PROBIC scholarship to A.E.B.N.).	Asgari M, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-61; Banerjee PP, 2001, ENDOCRINOLOGY, V142, P4066, DOI 10.1210/en.142.9.4066; Banerjee PP, 1998, BIOL REPROD, V59, P1163, DOI 10.1095/biolreprod59.5.1163; Bianchi-Frias D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012501; Campos SGP, 2008, INT J EXP PATHOL, V89, P13, DOI 10.1111/j.1365-2613.2007.00550.x; Cheng J, 2004, FEBS LETT, V566, P169, DOI 10.1016/j.febslet.2004.04.025; Colciago A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/801473; Daniels G, 2014, AM J TRANSL RES, V6, P140; Dey P, 2013, J MOL ENDOCRINOL, V51, pT61, DOI 10.1530/JME-13-0150; Ellem SJ, 2010, J STEROID BIOCHEM, V118, P246, DOI 10.1016/j.jsbmb.2009.10.015; Ellem SJ, 2009, ANN NY ACAD SCI, V1155, P174, DOI 10.1111/j.1749-6632.2009.04360.x; Gallardo F, 2007, J COMP PATHOL, V136, P1, DOI 10.1016/j.jcpa.2006.08.007; Gaskell TL, 2003, J CLIN ENDOCR METAB, V88, P424, DOI 10.1210/jc.2002-020811; Gist DH, 2007, GEN COMP ENDOCR, V151, P27, DOI 10.1016/j.ygcen.2006.06.012; Grieco V, 2006, J COMP PATHOL, V135, P11, DOI 10.1016/j.jcpa.2006.02.005; Grover SK, 2014, PATHOL ONCOL RES; Hany J, 1999, TOXICOL APPL PHARM, V158, P231, DOI 10.1006/taap.1999.8710; Hetzl AC, 2012, MICROSC RES TECHNIQ, V75, P1197, DOI 10.1002/jemt.22049; Hetzl AC, 2013, MICROSC RES TECHNIQ, V76, P321, DOI 10.1002/jemt.22170; Horvath LG, 2001, CANCER RES, V61, P5331; Hussain S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040732; Imamov O, 2004, NEW ENGL J MED, V351, P2773, DOI 10.1056/NEJM200412233512622; ISAACS JT, 1984, CANCER RES, V44, P5785; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; KRIEG M, 1993, J CLIN ENDOCR METAB, V77, P375, DOI 10.1210/jc.77.2.375; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Kuiper GGJM, 1998, FRONT NEUROENDOCRIN, V19, P253, DOI 10.1006/frne.1998.0170; Lau KM, 2003, LAB INVEST, V83, P743, DOI 10.1097/01.LAB.0000069519.06988.24; Leav I, 2001, AM J PATHOL, V159, P79, DOI 10.1016/S0002-9440(10)61676-8; Mak P, 2013, P NATL ACAD SCI USA, V110, P4708, DOI 10.1073/pnas.1221654110; Makela S, 2000, MOL CELL ENDOCRINOL, V164, P109, DOI 10.1016/S0303-7207(00)00233-1; Maruyama K, 1998, BIOCHEM BIOPH RES CO, V246, P142, DOI 10.1006/bbrc.1998.8590; McPherson SJ, 2008, DIFFERENTIATION, V76, P660, DOI 10.1111/j.1432-0436.2008.00291.x; McPherson SJ, 2007, ENDOCRINOLOGY, V148, P566, DOI 10.1210/en.2006-0906; McPherson SJ, 2010, P NATL ACAD SCI USA, V107, P3123, DOI 10.1073/pnas.0905524107; MITSUMORI K, 1988, ENVIRON HEALTH PERSP, V77, P11, DOI 10.2307/3430623; Muthusamy S, 2011, P NATL ACAD SCI USA, V108, P20090, DOI 10.1073/pnas.1117772108; Oliveira AG, 2007, STEROIDS, V72, P914, DOI 10.1016/j.steroids.2007.08.001; Pasquali D, 2001, J CLIN ENDOCR METAB, V86, P2051, DOI 10.1210/jc.86.5.2051; Pasquali D, 2001, MOL CELL ENDOCRINOL, V178, P47, DOI 10.1016/S0303-7207(01)00418-X; Petersen DN, 1998, ENDOCRINOLOGY, V139, P1082, DOI 10.1210/en.139.3.1082; Picciarelli-Lima P, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-51; POLLARD M, 1973, J NATL CANCER I, V51, P1235, DOI 10.1093/jnci/51.4.1235; Pravettoni A, 2007, MOL CELL ENDOCRINOL, V263, P46, DOI 10.1016/j.mce.2006.08.008; Prezioso D, 2007, INT J UROL, V14, P1, DOI 10.1111/j.1442-2042.2006.01476.x; Prins GS, 1998, ENDOCRINOLOGY, V139, P874, DOI 10.1210/en.139.3.874; Rago V, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-23; Rittmaster RS, 2009, EUR UROL, V55, P1064, DOI 10.1016/j.eururo.2009.01.037; SAKR WA, 1993, J UROLOGY, V150, P379, DOI 10.1016/S0022-5347(17)35487-3; Sar M, 2000, ANDROLOGIA, V32, P295, DOI 10.1046/j.1439-0272.2000.00396.x; Saunders PTK, 2001, MOL HUM REPROD, V7, P227, DOI 10.1093/molehr/7.3.227; Saunders PTK, 2002, J CLIN ENDOCR METAB, V87, P2706, DOI 10.1210/jc.87.6.2706; Scobie GA, 2002, STEROIDS, V67, P985, DOI 10.1016/S0039-128X(02)00047-8; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Shibata Y, 2000, PROSTATE, V42, P45; Tsurusaki T, 2003, J CLIN ENDOCR METAB, V88, P1333, DOI 10.1210/jc.2002-021015; VERMEULE.A, 1972, J CLIN ENDOCR METAB, V34, P730, DOI 10.1210/jcem-34-4-730; Vermeulen A, 2002, Aging Male, V5, P98, DOI 10.1080/713604678; WARD JM, 1980, LAB INVEST, V43, P517; Weihua Z, 2002, P NATL ACAD SCI USA, V99, P13589, DOI 10.1073/pnas.162477299; Xie W, 2000, PROSTATE, V44, P31; Yang GS, 2007, CHINESE MED J-PEKING, V120, P1611, DOI 10.1097/00029330-200709020-00012; Yun H, 2015, ONCOTARGET; Zhang WH, 2001, P NATL ACAD SCI USA, V98, P6330; Zhou Q, 2002, J ANDROL, V23, P870	65	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131901	10.1371/journal.pone.0131901	http://dx.doi.org/10.1371/journal.pone.0131901			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147849	gold, Green Submitted, Green Published			2022-12-27	WOS:000358157600160
J	Saha, A; Jeon, M; Tan, AC; Kang, J				Saha, Ashis; Jeon, Minji; Tan, Aik Choon; Kang, Jaewoo			iCOSSY: An Online Tool for Context-Specific Subnetwork Discovery from Gene Expression Data	PLOS ONE			English	Article							KNOWLEDGE	Pathway analyses help reveal underlying molecular mechanisms of complex biological phenotypes. Biologists tend to perform multiple pathway analyses on the same dataset, as there is no single answer. It is often inefficient for them to implement and/or install all the algorithms by themselves. Online tools can help the community in this regard. Here we present an online gene expression analytical tool called iCOSSY which implements a novel pathway-based COntext-specific Subnetwork discoverY (COSSY) algorithm. iCOSSY also includes a few modifications of COSSY to increase its reliability and interpretability. Users can upload their gene expression datasets, and discover important subnetworks of closely interacting molecules to differentiate between two phenotypes (context). They can also interactively visualize the resulting subnetworks. iCOSSY is a web server that finds subnetworks that are differentially expressed in two phenotypes. Users can visualize the subnetworks to understand the biology of the difference.	[Saha, Ashis; Jeon, Minji; Kang, Jaewoo] Korea Univ, Dept Comp Sci & Engn, Seoul, South Korea; [Tan, Aik Choon] Univ Colorado, Dept Med Med Oncol, Aurora, CO USA; [Kang, Jaewoo] Korea Univ, Interdisciplinary Grad Program Bioinformat, Seoul, South Korea	Korea University; University of Colorado System; University of Colorado Anschutz Medical Campus; Korea University	Kang, J (corresponding author), Korea Univ, Dept Comp Sci & Engn, Seoul, South Korea.	kangj@korea.ac.kr	Tan, Aik Choon/A-3135-2011	Tan, Aik Choon/0000-0003-2955-8369	National Research Foundation of Korea [NRF-2014R1A2A1A10051238, 2014M3C9A3063543, 2012R1A2A2A01014729, 2012M3C4A7033341]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF-2014R1A2A1A10051238, 2014M3C9A3063543, 2012R1A2A2A01014729, and 2012M3C4A7033341).	Chopra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014305; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Eddy JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000792; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Geman Donald, 2004, Stat Appl Genet Mol Biol, V3, pArticle19; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Khatri P, 2007, NUCLEIC ACIDS RES, V35, pW206, DOI 10.1093/nar/gkm327; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Lim K, 2014, BIOINFORMATICS, V30, P189, DOI 10.1093/bioinformatics/btt625; Marc C, KEGG DB SET ANNOTATI; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Martini P, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks866; Ooms J, 2014, JSONLITE SMARTER JSO; Saha A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084227; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Sales G, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-20; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Soh D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-449; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan AC, 2005, BIOINFORMATICS, V21, P3896, DOI 10.1093/bioinformatics/bti631; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Urbanek S, RSERVE FAST WAY PROV; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Zhang JD, 2013, KEGGGRAPH APPL EXAMP	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131656	10.1371/journal.pone.0131656	http://dx.doi.org/10.1371/journal.pone.0131656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147457	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600119
J	Sieswerda, E; Font-Gonzalez, A; Dijkgraaf, MGW; Geskus, RB; Heinen, RC; van der Pal, HJ; van Leeuwen, FE; Caron, HN; Kremer, LC; Reitsma, JB				Sieswerda, Elske; Font-Gonzalez, Anna; Dijkgraaf, Marcel G. W.; Geskus, Ronald B.; Heinen, Richard C.; van der Pal, Helena J.; van Leeuwen, Flora E.; Caron, Huib N.; Kremer, Leontien C.; Reitsma, Johannes B.			Studying Hospitalizations and Mortality in the Netherlands: Feasible and Valid Using Two-Step Medical Record Linkage with Nationwide Registers	PLOS ONE			English	Article							CHILDHOOD-CANCER; SURVIVORS	In the Netherlands, the postal code is needed to study hospitalizations of individuals in the nationwide hospitalization register. Studying hospitalizations longitudinally becomes troublesome if individuals change address. We aimed to report on the feasibility and validity of a two-step medical record linkage approach to examine longitudinal trends in hospitalizations and mortality in a study cohort. First, we linked a study cohort of 1564 survivors of childhood cancer with the Municipal Personal Records Database (GBA) which has postal code history and mortality data available. Within GBA, we sampled a reference population matched on year of birth, gender and calendar year. Second, we extracted hospitalizations from the Hospital Discharge Register (LMR) with a date of discharge during unique follow-up (based on date of birth, gender and postal code in GBA). We calculated the agreement of death and being hospitalized in survivors according to the registers and to available cohort data. We retrieved 1477 (94%) survivors from GBA. Median percentages of unique/potential follow-up were 87% (survivors) and 83% (reference persons). Characteristics of survivors and reference persons contributing to unique follow-up were comparable. Agreement of hospitalization during unique follow-up was 94% and agreement of death was 98%. In absence of unique identifiers in the Dutch hospitalization register, it is feasible and valid to study hospitalizations and mortality of individuals longitudinally using a two-step medical record linkage approach. Cohort studies in the Netherlands have the opportunity to study mortality and hospitalization rates over time. These outcomes provide insight into the burden of clinical events and healthcare use in studies on patients at risk of long-term morbidities.	[Sieswerda, Elske; Font-Gonzalez, Anna; Heinen, Richard C.; van der Pal, Helena J.; Caron, Huib N.; Kremer, Leontien C.] Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Oncol, Amsterdam, Netherlands; [Dijkgraaf, Marcel G. W.] Univ Amsterdam, Acad Med Ctr, Clin Res Unit, NL-1105 AZ Amsterdam, Netherlands; [Geskus, Ronald B.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [van der Pal, Helena J.] Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, NL-1105 AZ Amsterdam, Netherlands; [van Leeuwen, Flora E.] Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands; [Reitsma, Johannes B.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Cancer Institute; Utrecht University; Utrecht University Medical Center	Font-Gonzalez, A (corresponding author), Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Oncol, Amsterdam, Netherlands.	a.fontgonzalez@amc.uva.nl	Geskus, Ronald B/H-3684-2019	Geskus, Ronald B/0000-0002-2740-3155; Reitsma, Johannes/0000-0003-4026-4345; kremer, leontien/0000-0002-7619-7845; Kremer, Leontien/0000-0001-7422-3248	Stichting Kinderen Kankervrij (KiKa)	Stichting Kinderen Kankervrij (KiKa)	This study was supported by the Stichting Kinderen Kankervrij (KiKa), Project 84, https://www. kika.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, REC HOSP DEATH COH S; Council of the Federation of Medical Scientific Societies, 2004, COD COND MED RES; de Bruin A, 2003, KOPPELING LMR GBA GE; desBruin A., 2004, STAT J UN EC COMM EU, V21, P23; Dijkgraaf MGW, 1996, HEALTH POLICY, V35, P13, DOI 10.1016/0168-8510(95)00772-5; Dutch Hospital Data, 2013, DOC REP HOSP DISCH R; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Howards PP, 2007, AM J EPIDEMIOL, V165, P444, DOI 10.1093/aje/kwk027; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; Metcalfe C, 2003, EUR HEART J, V24, P105, DOI 10.1016/S0195-668X(02)00384-6; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Paas G, 2002, RES VALIDITY LMR; Prins CJ, 2000, DUTCH POPULATION STA; Reitsma J B, 2003, Ned Tijdschr Geneeskd, V147, P2286; Reulen RC, 2011, JAMA-J AM MED ASSOC, V305, P2311, DOI 10.1001/jama.2011.747; Reulen RC, 2010, JAMA-J AM MED ASSOC, V304, P172, DOI 10.1001/jama.2010.923; Sieswerda E, 2013, J CANCER SURVIV, V7, P439, DOI 10.1007/s11764-013-0283-9; Van Veen EB., 2011, PATIENT DATA HLTH RE	18	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132444	10.1371/journal.pone.0132444	http://dx.doi.org/10.1371/journal.pone.0132444			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147988	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600271
J	Thamattoor, U; Thomas, T; Banandur, P; Rajaram, S; Duchesne, T; Abdous, B; Washington, R; Ramesh, BM; Moses, S; Alary, M				Thamattoor, Usha; Thomas, Tinku; Banandur, Pradeep; Rajaram, S.; Duchesne, Thierry; Abdous, Belkacem; Washington, Reynold; Ramesh, B. M.; Moses, Stephen; Alary, Michel			Multilevel Analysis of the Predictors of HIV Prevalence among Pregnant Women Enrolled in Annual HIV Sentinel Surveillance in Four States in Southern India	PLOS ONE			English	Article							FEMALE SEX WORKERS; HIGH-RISK; INFECTION; ASSOCIATION; POPULATION; EPIDEMIC; OUTCOMES; PROGRAM	Background Heterogeneity of the HIV epidemic across districts of south India is reflected in HIV positivity among antenatal clinic (ANC) attendees. Along with individual factors, contextual factors also need consideration for effective HIV interventions. Thus, identifying district and individual level factors that influence ANC HIV positivity assumes importance to intervene effectively. Methods Data on HIV sentinel surveillance among the ANC population were obtained from the National AIDS Control Organization (NACO) between years 2004 and 2007. Data from serial cross-sectional studies among female sex workers (FSWs) conducted during this time period in 24 districts were used to generate district level variables corresponding to parameters concerning this high risk population. Other district level data were obtained from various official/governmental agencies. Multilevel logistic regression was used to identify individual and district level factors associated with ANC-HIV positivity. Results The average ANC-HIV prevalence from 2004 to 2007 in the 24 integrated biological and behavioural assessments (IBBA) districts ranged from 0.25 to 3.25%. HIV positivity was significantly higher among ANC women with age >= 25 years [adjusted odds ratio (AOR): 1.49; 95% confidence interval (95% CI): 1.27 to 1.76] compared to those with age<25 years; illiterate (AOR: 1.62; 95% CI: 1.03 to 2.54) compared to literate; employed in agriculture (AOR: 1.34; 95% CI: 1.11 to 1.62) or with occupations like driver/helper/industry/factory workers/hotel staff (AOR: 1.59; 95% CI: 1.26 to 2.01) compared to unemployed. District level HIV prevalence among FSWs (AOR: 1.03; 95% CI: 1.0 to 1.05) and percentage women marrying under 18 years were significantly associated with ANC-HIV positivity (AOR: 1.02; 95% CI: 1.00 to 1.04). Conclusion Illiteracy of the woman, higher HIV prevalence among FSWs and early marriage were associated with HIV positivity among pregnant women in southern India. In addition to targeted HIV preventive interventions among FSWs, studying and changing the behavior of FSW clients and addressing structural drivers of the epidemic might indirectly help reduce HIV infection among women in southern India.	[Thamattoor, Usha; Thomas, Tinku; Washington, Reynold] St Johns Res Inst, Bangalore 560034, Karnataka, India; [Thamattoor, Usha; Thomas, Tinku; Banandur, Pradeep; Rajaram, S.; Ramesh, B. M.; Alary, Michel] CHARME II Project, Bangalore 560044, Karnataka, India; [Banandur, Pradeep] Natl Inst Med Sci NIMHANS, Dept Epidemiol, Bangalore 560029, Karnataka, India; [Rajaram, S.; Washington, Reynold; Ramesh, B. M.] Karnataka Hlth Promot Trust, Bangalore 560044, Karnataka, India; [Duchesne, Thierry; Abdous, Belkacem; Alary, Michel] CHU Quebec, Ctr Rech, Quebec City, PQ, Canada; [Duchesne, Thierry] Univ Laval, Dept Math & Stat, Quebec City, PQ G1K 7P4, Canada; [Abdous, Belkacem; Alary, Michel] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada; [Moses, Stephen] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada	St. John's National Academy of Health Sciences; St. John's Research Institute; National Institute of Mental Health & Neurosciences - India; Laval University; Laval University; Laval University; University of Manitoba	Thamattoor, U (corresponding author), St Johns Res Inst, Bangalore 560034, Karnataka, India.	ushakm@rediffmail.com	Washington, Reynold/AAD-7447-2020		Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was funded by the Bill & Melinda Gates Foundation. The views expressed herein are those of the authors and do not necessarily reflect the official policy or position of the Bill & Melinda Gates Foundation.	Alary M, 2010, SEX TRANSM INFECT, V86, pI10, DOI 10.1136/sti.2009.038323; [Anonymous], DET REG IBBA ROUND 1; [Anonymous], 2005, EARLY MARRIAGE HARMF; [Anonymous], 2008, AVAHAN THE INDIA AID; Banandur P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S13; BARONGO LR, 1992, AIDS, V6, P1521, DOI 10.1097/00002030-199212000-00016; Bhattacharya G, 2004, HEALTH EDUC BEHAV, V31, P101, DOI 10.1177/1090198103259204; Bill & Melinda Gates Foundation, 2008, US IT LOS IT AV US D; Clark S, 2004, STUD FAMILY PLANN, V35, P149, DOI 10.1111/j.1728-4465.2004.00019.x; Dandona R, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-87; Jenson R, 2003, JSTOR, V11, P9; Kumar GA, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-65; Mainkar MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S2; Mehta SH, 2006, JAIDS-J ACQ IMM DEF, V41, P75, DOI 10.1097/01.qai.0000174653.17911.4a; Morgenstern H, 2008, MODERN EPIDEMIOLOGY, P511; Mukhopadhyay Chiranjoy, 2001, Journal of Communicable Diseases, V33, P136; NACO Online, 2007, HIV SENT SURV HIV ES; Ng M, 2011, LANCET, V378, P1643, DOI 10.1016/S0140-6736(11)61390-1; Pettifor AE, 2004, AIDS, V18, P1435, DOI 10.1097/01.aids.0000131338.61042.b8; Ramesh B, 2008, AIDS, V22, P10; Solomon E, 2011, AIDS CARE; Thilakavathi S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S3; UNAIDS, AS AIDS EP SUMM REG; UNAIDS. UNGASS country progress report United Kingdom, 2010, UNGASS COUNTR PROGR; *UNFPA, STAT WORLD POP 2005; Vickerman P, 2010, AIDS, V24, P2554, DOI 10.1097/QAD.0b013e32833e8663	26	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131629	10.1371/journal.pone.0131629	http://dx.doi.org/10.1371/journal.pone.0131629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147208	Green Submitted, gold, Green Published			2022-12-27	WOS:000358157600116
J	Walter, C; Dimova, V; Bu, J; Parnham, MJ; Oertel, BG; Lotsch, J				Walter, Carmen; Dimova, Violeta; Bu, Julia; Parnham, Michael J.; Oertel, Bruno G.; Loetsch, Joern			Inverted Perceptual Judgment of Nociceptive Stimuli at Threshold Level following Inconsistent Cues	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; HUMAN NASAL-MUCOSA; PHARMACOKINETIC PARAMETERS; CHEMICAL-STIMULATION; PERIAQUEDUCTAL GRAY; PLACEBO ANALGESIA; EVOKED-POTENTIALS; PAIN MODULATION; PERCEIVED PAIN; HUMANS	Objective The perception of pain is susceptible to modulation by psychological and contextual factors. It has been shown that subjects judge noxious stimuli as more painful in a respective suggestive context, which disappears when the modifying context is resolved. However, a context in which subjects judge the painfulness of a nociceptive stimulus in exactly the opposite direction to that of the cues has never been shown so far. Methods Nociceptive stimuli (300 ms intranasal gaseous CO2) at the individual pain threshold level were applied after a visual cue announcing the stimulus as either "no pain", merely a "stimulus", or "pain". Among the stimuli at threshold level, other CO2 stimuli that were clearly below or above pain threshold were randomly interspersed. These were announced beforehand in 12 subjects randomly with correct or incorrect cues, i.e., clearly painful or clearly non-painful stimuli were announced equally often as not painful or painful. By contrast, in a subsequent group of another 12 subjects, the stimuli were always announced correctly with respect to the evoked pain. Results The random and often incorrect announcement of stimuli clearly below or above pain threshold caused the subjects to rate the stimuli at pain-threshold level in the opposite direction of the cue, i.e., when the stimuli were announced as "pain" significantly more often than as non-painful and vice versa (p < 10(-4)). By contrast, in the absence of incongruence between announcement and perception of the far-from-threshold stimuli, stimuli at pain threshold were rated in the cued direction. Conclusions The present study revealed the induction of associations incongruent with a given message in the perception of pain. We created a context of unreliable cues whereby subjects perceived the stimulus opposite to that suggested by a prior cue, i.e., potentially nociceptive stimuli at pain threshold level that were announced as painful were judged as non-painful and vice versa. These findings are consistent with reported data on the effects of distrust on non-painful cognitive responses.	[Walter, Carmen; Dimova, Violeta; Bu, Julia; Loetsch, Joern] Goethe Univ Frankfurt, Inst Clin Pharmacol, D-60590 Frankfurt, Germany; [Dimova, Violeta] Univ Hosp Frankfurt, Intens Care Med & Pain Therapy, Dept Anesthesiol, D-60590 Frankfurt, Germany; [Parnham, Michael J.; Oertel, Bruno G.] Project Grp Translat Med & Pharmacol TMP, Fraunhofer Inst Mol Biol & Appl Ecol IME, D-60596 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Fraunhofer Gesellschaft	Lotsch, J (corresponding author), Goethe Univ Frankfurt, Inst Clin Pharmacol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	j.loetsch@em.uni-frankfurt.de	Parnham, Michael J/D-8733-2014	Parnham, Michael J/0000-0002-7098-8451; Lotsch, Jorn/0000-0002-5818-6958	August-Scheidel Foundation, Frankfurt am Main, Germany; Else Kroner - Fresenius Foundation (EKFS); Research Training Group Translational Research Innovation Pharma (TRIP); Landesoffensive zur Entwicklung wissenschaftlich-okonomischer Exzellenz (LOEWE); Schwerpunkt: Anwendungsorientierte Arzneimittelforschung	August-Scheidel Foundation, Frankfurt am Main, Germany; Else Kroner - Fresenius Foundation (EKFS); Research Training Group Translational Research Innovation Pharma (TRIP); Landesoffensive zur Entwicklung wissenschaftlich-okonomischer Exzellenz (LOEWE); Schwerpunkt: Anwendungsorientierte Arzneimittelforschung	This work was supported by the August-Scheidel Foundation, Frankfurt am Main, Germany (CW). The research also received funding, in particular for additional personnel costs, from the Else Kroner - Fresenius Foundation (EKFS), Research Training Group Translational Research Innovation Pharma (TRIP, JL) and from the Landesoffensive zur Entwicklung wissenschaftlich-okonomischer Exzellenz (LOEWE), Schwerpunkt: Anwendungsorientierte Arzneimittelforschung (JL, MP). The funders had no role in method design, data selection and analysis, decision to publish, or preparation of the manuscript.	Arntz A, 2004, PAIN, V109, P20, DOI 10.1016/j.pain.2003.12.030; Atlas LY, 2012, NEUROSCI LETT, V520, P140, DOI 10.1016/j.neulet.2012.03.039; Atlas LY, 2010, J NEUROSCI, V30, P12964, DOI 10.1523/JNEUROSCI.0057-10.2010; Bartels DJP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091727; Benedetti F, 2013, PHYSIOL REV, V93, P1207, DOI 10.1152/physrev.00043.2012; Bjorkedal E, 2011, PSYCHOPHARMACOLOGY, V215, P537, DOI 10.1007/s00213-011-2233-4; Boeckmann AJ, 1994, NONMEM USERS GUIDE; Bostick NA, 2008, J CLIN ETHIC, V19, P58; Brown CA, 2008, PAIN, V139, P324, DOI 10.1016/j.pain.2008.04.028; Chua P, 1999, NEUROIMAGE, V9, P563, DOI 10.1006/nimg.1999.0407; Colloca L, 2006, PAIN, V124, P126, DOI 10.1016/j.pain.2006.04.005; Desmond JE, 2002, J NEUROSCI METH, V118, P115, DOI 10.1016/S0165-0270(02)00121-8; Dillmann J, 2000, NEUROSCI LETT, V284, P53, DOI 10.1016/S0304-3940(00)00957-5; Donohue SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062802; Efron B., 1995, INTRO BOOTSTRAP; FEIN S, 1994, MOTIV EMOTION, V18, P167, DOI 10.1007/BF02249398; Galinsky AD, 2000, J EXP SOC PSYCHOL, V36, P384, DOI 10.1006/jesp.1999.1409; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; HUMMEL T, 1994, ELECTROEN CLIN NEURO, V92, P426, DOI 10.1016/0168-5597(94)90020-5; Hummel T, 2003, INT J PSYCHOPHYSIOL, V47, P147, DOI 10.1016/S0167-8760(02)00150-2; Hummel T, 1998, ANN NY ACAD IN PRESS; HUTTUNEN J, 1986, ELECTROEN CLIN NEURO, V64, P347, DOI 10.1016/0013-4694(86)90159-8; Keltner JR, 2006, J NEUROSCI, V26, P4437, DOI 10.1523/JNEUROSCI.4463-05.2006; Kenntner-Mabiala R, 2005, PSYCHOPHYSIOLOGY, V42, P559, DOI 10.1111/j.1469-8986.2005.00310.x; KOBAL G, 1985, PAIN, V22, P151, DOI 10.1016/0304-3959(85)90175-7; KOBAL G, 1990, AGENTS ACTIONS, V29, P342, DOI 10.1007/BF01966467; Kobal G, 1981, ELEKTROPHYSIOLOGISCH; Kong J, 2006, J NEUROSCI, V26, P381, DOI 10.1523/JNEUROSCI.3556-05.2006; Kong J, 2013, PAIN, V154, P459, DOI 10.1016/j.pain.2012.12.004; Koyama T, 2005, P NATL ACAD SCI USA, V102, P12950, DOI 10.1073/pnas.0408576102; Leknes S, 2013, PAIN, V154, P402, DOI 10.1016/j.pain.2012.11.018; Lin CS, 2014, NEUROPSYCHOLOGIA, V64, P85, DOI 10.1016/j.neuropsychologia.2014.09.021; Lotsch J, 2006, BEHAV NEUROSCI, V120, P1218, DOI 10.1037/0735-7044.120.6.1218; Lotsch J, 2003, PAIN, V102, P151, DOI 10.1016/S0304-3959(02)00349-4; Lotsch J, 1998, INFLAMM RES, V47, P446, DOI 10.1007/s000110050359; Magerl W, 2010, PAIN, V151, P598, DOI 10.1016/j.pain.2010.07.026; Oertel BG, 2008, CLIN PHARMACOL THER, V83, P577, DOI 10.1038/sj.clpt.6100441; Oertel BG, 2012, HUM BRAIN MAPP, V33, P883, DOI 10.1002/hbm.21256; Pariente J, 2005, NEUROIMAGE, V25, P1161, DOI 10.1016/j.neuroimage.2005.01.016; Pearson SD, 2000, J GEN INTERN MED, V15, P509, DOI 10.1046/j.1525-1497.2000.11002.x; Pierce CA, 2004, EDUC PSYCHOL MEAS, V64, P916, DOI 10.1177/0013164404264848; Ploghaus A, 2001, J NEUROSCI, V21, P9896, DOI 10.1523/JNEUROSCI.21-24-09896.2001; Ploghaus A, 2000, P NATL ACAD SCI USA, V97, P9281, DOI 10.1073/pnas.160266497; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Reeh P W, 2001, Curr Opin Pharmacol, V1, P45, DOI 10.1016/S1471-4892(01)00014-5; Richter M, 2014, PAIN RES MANAG, V19, P69, DOI 10.1155/2014/425321; Ring C, 2013, BIOL PSYCHOL, V93, P373, DOI 10.1016/j.biopsycho.2013.04.006; Sawamoto N, 2000, J NEUROSCI, V20, P7438; Schienle A, 2002, NEUROREPORT, V13, P2023, DOI 10.1097/00001756-200211150-00006; Schul Y, 2004, J PERS SOC PSYCHOL, V86, P668, DOI 10.1037/0022-3514.86.5.668; Sher N, 2011, INCIDENTAL DISTRUST; Small DM, 2005, NEURON, V47, P593, DOI 10.1016/j.neuron.2005.07.022; STEEN KH, 1992, J NEUROSCI, V12, P86; Strigo IA, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.15; Student, 1908, BIOMETRIKA, V6; Tarun AS, 2003, CHEM SENSES, V28, P621, DOI 10.1093/chemse/bjg054; Thirion B, 2007, NEUROIMAGE, V35, P105, DOI 10.1016/j.neuroimage.2006.11.054; Thom DH, 1997, J FAM PRACTICE, V44, P169; Tracey I, 2002, J NEUROSCI, V22, P2748, DOI 10.1523/JNEUROSCI.22-07-02748.2002; VOUDOURIS NJ, 1990, PAIN, V43, P121, DOI 10.1016/0304-3959(90)90057-K; Wang YYY, 2010, J NEUROSCI, V30, P12958, DOI 10.1523/JNEUROSCI.2715-10.2010; Wiech K, 2010, J NEUROSCI, V30, P16324, DOI 10.1523/JNEUROSCI.2087-10.2010; Yafune A, 1999, STAT MED, V18, P581, DOI 10.1002/(SICI)1097-0258(19990315)18:5<581::AID-SIM47>3.0.CO;2-1; Yoshida W, 2013, J NEUROSCI, V33, P5638, DOI 10.1523/JNEUROSCI.4984-12.2013; Ziv M, 2010, HUM BRAIN MAPP, V31, P326, DOI 10.1002/hbm.20867; Zubieta JK, 2006, BRAIN BEHAV IMMUN, V20, P15, DOI 10.1016/j.bbi.2005.08.006	67	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132069	10.1371/journal.pone.0132069	http://dx.doi.org/10.1371/journal.pone.0132069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26147732	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600194
J	Earley, ZM; Akhtar, S; Green, SJ; Naqib, A; Khan, O; Cannon, AR; Hammer, AM; Morris, NL; Li, XL; Eberhardt, JM; Gamelli, RL; Kennedy, RH; Choudhry, MA				Earley, Zachary M.; Akhtar, Suhail; Green, Stefan J.; Naqib, Ankur; Khan, Omair; Cannon, Abigail R.; Hammer, Adam M.; Morris, Niya L.; Li, Xiaoling; Eberhardt, Joshua M.; Gamelli, Richard L.; Kennedy, Richard H.; Choudhry, Mashkoor A.			Burn Injury Alters the Intestinal Microbiome and Increases Gut Permeability and Bacterial Translocation	PLOS ONE			English	Article							BARRIER FUNCTION; CROHNS-DISEASE; EPITHELIAL-CELLS; SEPSIS; INFLAMMATION; HOST; ENTEROBACTERIACEAE; MICROFLORA; EXPRESSION; MUTATIONS	Sepsis remains one of the leading causes of death in burn patients who survive the initial insult of injury. Disruption of the intestinal epithelial barrier has been shown after burn injury; this can lead to the translocation of bacteria or their products (e.g., endotoxin) from the intestinal lumen to the circulation, thereby increasing the risk for sepsis in immunocompromised individuals. Since the maintenance of the epithelial barrier is largely dependent on the intestinal microbiota, we examined the diversity of the intestinal microbiome of severely burned patients and a controlled mouse model of burn injury. We show that burn injury induces a dramatic dysbiosis of the intestinal microbiome of both humans and mice and allows for similar overgrowths of Gram-negative aerobic bacteria. Furthermore, we show that the bacteria increasing in abundance have the potential to translocate to extra-intestinal sites. This study provides an insight into how the diversity of the intestinal microbiome changes after burn injury and some of the consequences these gut bacteria can have in the host.	[Earley, Zachary M.; Akhtar, Suhail; Khan, Omair; Cannon, Abigail R.; Hammer, Adam M.; Morris, Niya L.; Li, Xiaoling; Gamelli, Richard L.; Kennedy, Richard H.; Choudhry, Mashkoor A.] Loyola Univ Chicago, Div Hlth Sci, Burn & Shock Trauma Res Inst, Maywood, IL 60153 USA; [Earley, Zachary M.; Hammer, Adam M.; Morris, Niya L.; Choudhry, Mashkoor A.] Loyola Univ Chicago, Div Hlth Sci, Integrat Cell Biol Program, Maywood, IL 60153 USA; [Akhtar, Suhail; Li, Xiaoling; Eberhardt, Joshua M.; Gamelli, Richard L.; Choudhry, Mashkoor A.] Loyola Univ Chicago, Div Hlth Sci, Dept Surg, Maywood, IL 60153 USA; [Cannon, Abigail R.; Choudhry, Mashkoor A.] Loyola Univ Chicago, Div Hlth Sci, Dept Microbiol, Maywood, IL 60153 USA; [Cannon, Abigail R.; Choudhry, Mashkoor A.] Loyola Univ Chicago, Div Hlth Sci, Dept Immunol, Maywood, IL 60153 USA; [Green, Stefan J.; Naqib, Ankur] Univ Illinois, DNA Serv Facil, Chicago, IL 60612 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Choudhry, MA (corresponding author), Loyola Univ Chicago, Div Hlth Sci, Burn & Shock Trauma Res Inst, Maywood, IL 60153 USA.	mchoudhry@luc.edu		Green, Stefan/0000-0003-2781-359X; Khan, Omair/0000-0002-7597-3662	National Institutes of Health [R01AA015731, T32AA013527]; Department of Defense [W81XWH-09-1-0619]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015731, T32AA013527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Support for this study comes from National Institutes of Health under award numbers R01AA015731 (MAC), R01AA015731 (MAC) and T32AA013527. Support was also provided by the Department of Defense W81XWH-09-1-0619 (RHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Bybee SM, 2011, GENOME BIOL EVOL, V3, P1312, DOI 10.1093/gbe/evr106; Canny G, 2006, METH MOL B, V341, P17; Choudhry MA, 2004, ALCOHOL, V33, P199, DOI 10.1016/j.alcohol.2004.05.004; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; de Carcer DA, 2011, APPL ENVIRON MICROB, V77, P6310, DOI 10.1128/AEM.05146-11; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faunce DE, 1999, BURNS, V25, P403, DOI 10.1016/S0305-4179(99)00014-5; Fedwick JP, 2005, INFECT IMMUN, V73, P7844, DOI 10.1128/IAI.73.12.7844-7852.2005; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gilpin DA, 1996, BURNS, V22, P607, DOI 10.1016/S0305-4179(96)00064-2; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Lamb-Rosteski JM, 2008, INFECT IMMUN, V76, P3390, DOI 10.1128/IAI.01698-07; LEVIN J, 1970, NEW ENGL J MED, V283, P1313, DOI 10.1056/NEJM197012102832404; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; MacFie J, 1999, GUT, V45, P223, DOI 10.1136/gut.45.2.223; Magnotti LJ, 2005, J BURN CARE REHABIL, V26, P383, DOI 10.1097/01.bcr.0000176878.79267.e8; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Moonsamy PV, 2013, TISSUE ANTIGENS, V81, P141, DOI 10.1111/tan.12071; Murphy TJ, 2004, J LEUKOCYTE BIOL, V75, P400, DOI 10.1189/jlb.0503233; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Raetz M, 2013, NAT IMMUNOL, V14, P136, DOI 10.1038/ni.2508; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Shankar R, 2007, J BURN CARE RES, V28, P566, DOI 10.1097/BCR.0B013E318093DF16; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Song JQ, 2008, SHOCK, V30, P184, DOI 10.1097/SHK.0b013e318162a3f6; Song JQ, 2014, J SURG RES, V187, P128, DOI 10.1016/j.jss.2013.09.042; Stoecklein VM, 2012, J LEUKOCYTE BIOL, V92, P539, DOI 10.1189/jlb.0212072; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Voigt RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097500; Wade CE, 2013, CRIT CARE, V17, DOI 10.1186/cc13048; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	53	154	163	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0129996	10.1371/journal.pone.0129996	http://dx.doi.org/10.1371/journal.pone.0129996			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154283	Green Published, gold, Green Submitted			2022-12-27	WOS:000358159700020
J	Eddy, MD; Hasselquist, L; Giles, G; Hayes, JF; Howe, J; Rourke, J; Coyne, M; O'Donovan, M; Batty, J; Brunye, TT; Mahoney, CR				Eddy, Marianna D.; Hasselquist, Leif; Giles, Grace; Hayes, Jacqueline F.; Howe, Jessica; Rourke, Jennifer; Coyne, Megan; O'Donovan, Meghan; Batty, Jessica; Brunye, Tad T.; Mahoney, Caroline R.			The Effects of Load Carriage and Physical Fatigue on Cognitive Performance	PLOS ONE			English	Article							CHOICE-REACTION TIME; ACUTE EXERCISE; ACUTE BOUTS; INTENSITY; DURATION	In the current study, ten participants walked for two hours while carrying no load or a 40 kg load. During the second hour, treadmill grade was manipulated between a constant downhill or changing between flat, uphill, and downhill grades. Throughout the prolonged walk, participants performed two cognitive tasks, an auditory go no/go task and a visual target detection task. The main findings were that the number of false alarms increased over time in the loaded condition relative to the unloaded condition on the go no/go auditory task. There were also shifts in response criterion towards responding yes and decreased sensitivity in responding in the loaded condition compared to the unloaded condition. In the visual target detection there were no reliable effects of load carriage in the overall analysis however, there were slower reaction times in the loaded compared to unloaded condition during the second hour.	[Eddy, Marianna D.; Hasselquist, Leif; Giles, Grace; Hayes, Jacqueline F.; Howe, Jessica; Rourke, Jennifer; Coyne, Megan; O'Donovan, Meghan; Batty, Jessica; Brunye, Tad T.; Mahoney, Caroline R.] US Army Natick Soldier Res Dev & Engn Ctr, Natick, MA USA; [Eddy, Marianna D.; Giles, Grace; Brunye, Tad T.; Mahoney, Caroline R.] Tufts Univ, Dept Psychol, Medford, MA 02155 USA	United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); Tufts University	Eddy, MD (corresponding author), US Army Natick Soldier Res Dev & Engn Ctr, Natick, MA USA.	marianna.d.eddy.civ@mail.mil		Hayes, Jacqueline/0000-0002-6241-1839	United States Army	United States Army(United States Department of DefenseUnited States Army)	This work was funded by the United States Army. The opinions expressed herein are those of the authors and not necessarily of the United States Army. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audiffren M, 2008, ACTA PSYCHOL, V129, P410, DOI 10.1016/j.actpsy.2008.09.006; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Coles K, 2008, J SPORT SCI, V26, P333, DOI 10.1080/02640410701591417; Collardeau M, 2001, PERCEPT MOTOR SKILL, V93, P679, DOI 10.2466/PMS.93.7.679-689; Delignieres D., 1994, J HUM MOV STUD, V27, P173; Dietrich A, 2004, BRAIN COGNITION, V55, P516, DOI 10.1016/j.bandc.2004.03.002; Dietrich A, 2003, CONSCIOUS COGN, V12, P231, DOI 10.1016/S1053-8100(02)00046-6; Dietrich A, 2011, NEUROSCI BIOBEHAV R, V35, P1305, DOI 10.1016/j.neubiorev.2011.02.001; Ehrlich R., 2000, SOLD LOAD C FORT BEN; Ferris LT, 2007, MED SCI SPORT EXER, V39, P728, DOI 10.1249/mss.0b013e31802f04c7; Grego F, 2004, NEUROSCI LETT, V364, P76, DOI 10.1016/j.neulet.2004.03.085; Grego F, 2005, INT J SPORTS MED, V26, P27, DOI 10.1055/s-2004-817915; Joyce J, 2009, BRAIN COGNITION, V71, P14, DOI 10.1016/j.bandc.2009.03.004; Knapik JJ, 1997, MIL MED, V162, P62, DOI 10.1093/milmed/162.1.62; Labelle V, 2013, BRAIN COGNITION, V81, P10, DOI 10.1016/j.bandc.2012.10.001; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Lieberman HR, 2006, AVIAT SPACE ENVIR MD, V77, P929; Mahoney CR, 2007, AVIAT SPACE ENVIR MD, V78, pB51; May B, 2009, MIL MED, V174, P1308, DOI 10.7205/MILMED-D-00-0809; McMorris T, 2011, PHYSIOL BEHAV, V102, P421, DOI 10.1016/j.physbeh.2010.12.007; Pontifex MB, 2011, J COGNITIVE NEUROSCI, V23, P1332, DOI 10.1162/jocn.2010.21528; Tomporowski PD, 2003, ACTA PSYCHOL, V112, P297, DOI 10.1016/S0001-6918(02)00134-8; Yanagisawa H, 2010, NEUROIMAGE, V50, P1702, DOI 10.1016/j.neuroimage.2009.12.023	23	23	23	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130817	10.1371/journal.pone.0130817	http://dx.doi.org/10.1371/journal.pone.0130817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26154515	Green Published, Green Submitted, gold			2022-12-27	WOS:000358159700039
J	Pi, EX; Qu, LQ; Tang, X; Peng, TT; Jiang, B; Guo, JF; Lu, HF; Du, LQ				Pi, Erxu; Qu, Liqun; Tang, Xi; Peng, Tingting; Jiang, Bo; Guo, Jiangfeng; Lu, Hongfei; Du, Liqun			Application of Genetic Algorithm to Predict Optimal Sowing Region and Timing for Kentucky Bluegrass in China	PLOS ONE			English	Article							POA-PRATENSIS L.; THERMAL-TIME MODEL; SEED-GERMINATION; HEAT TOLERANCE; DIFFERENTIAL RESPONSES; CONSTANT-TEMPERATURE; ANTIOXIDANT ENZYMES; HYDROTHERMAL TIME; DORMANCY RELEASE; DROUGHT STRESS	Temperature is a predominant environmental factor affecting grass germination and distribution. Various thermal-germination models for prediction of grass seed germination have been reported, in which the relationship between temperature and germination were defined with kernel functions, such as quadratic or quintic function. However, their prediction accuracies warrant further improvements. The purpose of this study is to evaluate the relative prediction accuracies of genetic algorithm (GA) models, which are automatically parameterized with observed germination data. The seeds of five P. pratensis (Kentucky bluegrass, KB) cultivars were germinated under 36 day/night temperature regimes ranging from 5/5 to 40/40 degrees C with 5 degrees C increments. Results showed that optimal germination percentages of all five tested KB cultivars were observed under a fluctuating temperature regime of 20/25 degrees C. Meanwhile, the constant temperature regimes (e.g., 5/5, 10/10, 15/15 degrees C, etc.) suppressed the germination of all five cultivars. Furthermore, the back propagation artificial neural network (BP-ANN) algorithm was integrated to optimize temperature-germination response models from these observed germination data. It was found that integrations of GA-BPANN (back propagation aided genetic algorithm artificial neural network) significantly reduced the Root Mean Square Error (RMSE) values from 0.21 similar to 0.23 to 0.02 similar to 0.09. In an effort to provide a more reliable prediction of optimum sowing time for the tested KB cultivars in various regions in the country, the optimized GA-BP-ANN models were applied to map spatial and temporal germination percentages of blue grass cultivars in China. Our results demonstrate that the GA-BP-ANN model is a convenient and reliable option for constructing thermal-germination response models since it automates model parameterization and has excellent prediction accuracy.	[Pi, Erxu; Qu, Liqun; Peng, Tingting; Du, Liqun] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Tang, Xi; Lu, Hongfei] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Jiang, Bo] Coll Biol & Food Engn, Changshu Inst Technol, Changshu, Peoples R China; [Guo, Jiangfeng] Meteorol Bur Shaanxi Prov, Xian, Shaanxi, Peoples R China	Hangzhou Normal University; Zhejiang Sci-Tech University; Changshu Institute of Technology	Lu, HF (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	luhongfei63@yahoo.com.cn; liqundu@msn.com	Qu, Liqun/HHN-2317-2022		National Science Foundation of China [31301053, U1130304]; Science and Technology Project of Changshu City [CN201302]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Changshu City	This work was partially supported by grants 31301053 and U1130304 from the National Science Foundation of China, and grant CN201302 from the Science and Technology Project of Changshu City. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliabadi M, 2014, ENVIRON MONIT ASSESS, V186, P1855, DOI 10.1007/s10661-013-3499-2; Barnhart BL, 2012, AGR FOREST METEOROL, V162, P58, DOI 10.1016/j.agrformet.2012.04.003; Batlla D, 2003, SEED SCI RES, V13, P55, DOI 10.1079/SSR2002124; Blanco AM, 2014, ECOL MODEL, V272, P293, DOI 10.1016/j.ecolmodel.2013.10.013; Bonos SA, 2012, J PLANT REGIST, V6, P6, DOI 10.3198/jpr2011.04.0237crc; Bradford KJ, 2002, WEED SCI, V50, P248, DOI 10.1614/0043-1745(2002)050[0248:AOHTTQ]2.0.CO;2; Catalogna M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044587; Chai Q, 2010, J AM SOC HORTIC SCI, V135, P125, DOI 10.21273/JASHS.135.2.125; CHANG W, 1993, IEEE T NEURAL NETWOR, V4, P993, DOI 10.1109/72.286895; Chantre GR, 2009, ANN BOT-LONDON, V103, P1291, DOI 10.1093/aob/mcp070; Coppede F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074012; DEB K, 2000, P PAR PROBL SOLV NAT, V6, P849, DOI DOI 10.1007/3-540-45356-3_; ELLIS RH, 1987, J EXP BOT, V38, P1033, DOI 10.1093/jxb/38.6.1033; Gao N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062156; Garcia-Mozo H, 2009, AGR FOREST METEOROL, V149, P256, DOI 10.1016/j.agrformet.2008.08.013; GARCIAHUIDOBRO J, 1982, J EXP BOT, V33, P288, DOI 10.1093/jxb/33.2.288; Gazola S, 2011, CIENC RURAL, V41, P551, DOI 10.1590/S0103-84782011005000022; Grundy AC, 2000, NEW PHYTOL, V148, P433, DOI 10.1046/j.1469-8137.2000.00778.x; Guo B, 1987, POA ANNUA L; Hardegree SP, 1999, ENVIRON EXP BOT, V41, P209, DOI 10.1016/S0098-8472(99)00004-0; Hardegree SP, 1999, J RANGE MANAGE, V52, P83, DOI 10.2307/4003496; Hardegree SP, 2006, ANN BOT-LONDON, V97, P1115, DOI 10.1093/aob/mcl071; Hardegree SP, 2006, ANN BOT-LONDON, V98, P403, DOI 10.1093/aob/mcl112; Hardegree SP, 2006, ANN BOT-LONDON, V98, P827, DOI 10.1093/aob/mcl163; He YL, 2010, J AM SOC HORTIC SCI, V135, P116, DOI 10.21273/JASHS.135.2.116; Honig JA, 2012, HORTSCIENCE, V47, P1356, DOI 10.21273/HORTSCI.47.9.1356; HORN J, 1994, P 1 IEEE C EV COMP, P82, DOI [10.1109/ICEC.1994.350037, DOI 10.1109/ICEC.1994.350037]; Hu LX, 2012, CROP SCI, V52, P2332, DOI 10.2135/cropsci2012.02.0106; Jiang YW, 2001, J EXP BOT, V52, P341, DOI 10.1093/jexbot/52.355.341; Judson RA, 1999, ECON LETT, V65, P9, DOI 10.1016/S0165-1765(99)00130-5; Kang Y, 2011, MYCOLOGIA, V103, P1341, DOI 10.3852/10-352; Karnin E D, 1990, IEEE Trans Neural Netw, V1, P239, DOI 10.1109/72.80236; Li ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083739; Liu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069364; Lu HF, 2008, AGR FOREST METEOROL, V148, P931, DOI 10.1016/j.agrformet.2008.01.004; Merewitz E, 2010, AGRON J, V102, P258, DOI 10.2134/agronj2009.0328; Modi YK, 2012, S AFR J IND ENG, V23, P230; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Ni XX, 2012, PLANT DIS, V96, P1821, DOI 10.1094/PDIS-04-12-0406-PDN; Onofri A, 2010, WEED RES, V50, P5, DOI 10.1111/j.1365-3180.2009.00758.x; Peng Y, 2012, CROP SCI, V52, P807, DOI 10.2135/cropsci2011.06.0327; Pi EX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082413; Porceddu A, 2002, THEOR APPL GENET, V104, P273, DOI 10.1007/s001220100659; Poss JA, 2010, HORTSCIENCE, V45, P952, DOI 10.21273/HORTSCI.45.6.952; Rasul G, 2012, PLANT BREEDING, V131, P244, DOI 10.1111/j.1439-0523.2011.01931.x; Recio M, 2010, AGR FOREST METEOROL, V150, P931, DOI 10.1016/j.agrformet.2010.02.012; Rivera-Reyes JG, 2009, PHYTON-INT J EXP BOT, V78, P37; ROBERTS EH, 1988, SYM SOC EXP BIOL, V42, P109; Shen H, 2009, HORTSCIENCE, V44, P2009, DOI 10.21273/HORTSCI.44.7.2009; Shen JB, 2008, GRASS FORAGE SCI, V63, P249, DOI 10.1111/j.1365-2494.2008.00630.x; Shetty N, 2012, J CHEMOMETR, V26, P462, DOI 10.1002/cem.1415; Shi HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035781; Shi H, 2012, DIABETES TECHNOL THE, V14, P293, DOI 10.1089/dia.2011.0071; Shortell RR, 2009, HORTSCIENCE, V44, P274, DOI 10.21273/HORTSCI.44.2.274; THOMPSON K, 1977, NATURE, V267, P147, DOI 10.1038/267147a0; van Oort PAJ, 2011, AGR FOREST METEOROL, V151, P1545, DOI 10.1016/j.agrformet.2011.06.012; Vandelook F, 2008, ANN BOT-LONDON, V102, P865, DOI 10.1093/aob/mcn165; Wang YQ, 2014, METEOROL APPL, V21, P360, DOI 10.1002/met.1345; Wang YQ, 2012, COMPUT GEOSCI-UK, V48, P330, DOI 10.1016/j.cageo.2011.12.003; Xu R, 2013, SOIL SCI PLANT NUTR, V59, P168, DOI 10.1080/00380768.2012.763215; Yang ZM, 2012, J AM SOC HORTIC SCI, V137, P96, DOI 10.21273/JASHS.137.2.96; Zhang PP, 2012, ECOTOXICOLOGY, V21, P1911, DOI 10.1007/s10646-012-0924-1	62	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131489	10.1371/journal.pone.0131489	http://dx.doi.org/10.1371/journal.pone.0131489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154163	Green Published, gold, Green Submitted			2022-12-27	WOS:000358159700069
J	van Schaik, J; Janssen, R; Bosch, T; Haarsma, AJ; Dekker, JJA; Kranstauber, B				van Schaik, Jaap; Janssen, Rene; Bosch, Thijs; Haarsma, Anne-Jifke; Dekker, Jasja J. A.; Kranstauber, Bart			Bats Swarm Where They Hibernate: Compositional Similarity between Autumn Swarming and Winter Hibernation Assemblages at Five Underground Sites	PLOS ONE			English	Article							EARED BAT; PLECOTUS-AURITUS; PIPISTRELLE BAT; MYOTIS-DAUBENTONII; POPULATION-SIZE; NATTERERS BATS; TEMPERATE ZONE; CATCHMENT-AREA; GENE FLOW; BEHAVIOR	During autumn in the temperate zone of both the new and old world, bats of many species assemble at underground sites in a behaviour known as swarming. Autumn swarming behaviour is thought to primarily serve as a promiscuous mating system, but may also be related to the localization and assessment of hibernacula. Bats subsequently make use of the same underground sites during winter hibernation, however it is currently unknown if the assemblages that make use of a site are comparable across swarming and hibernation seasons. Our purpose was to characterize the bat assemblages found at five underground sites during both the swarming and the hibernation season and compare the assemblages found during the two seasons both across sites and within species. We found that the relative abundance of individual species per site, as well as the relative proportion of a species that makes use of each site, were both significantly correlated between the swarming and hibernation seasons. These results suggest that swarming may indeed play a role in the localization of suitable hibernation sites. Additionally, these findings have important conservation implications, as this correlation can be used to improve monitoring of underground sites and predict the importance of certain sites for rare and cryptic bat species.	[van Schaik, Jaap] Max Planck Inst Ornithol, Dept Behav Ecol & Evolutionary Genet, D-82319 Seewiesen, Germany; [Janssen, Rene] Bionet Natuuronderzoek, NL-6171 EL Stein, Netherlands; [Bosch, Thijs] Ad Hoc Zoogdieronderzoek, NL-6824 HE Arnhem, Netherlands; [Haarsma, Anne-Jifke] Radboud Univ Nijmegen, Inst Water & Wetland Res, Anim Ecol & Ecophysiol Grp, NL-6500 GL Nijmegen, Netherlands; [Dekker, Jasja J. A.] Dutch Mammal Soc, NL-6503 GA Nijmegen, Netherlands; [Kranstauber, Bart] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, D-78315 Radolfzell am Bodensee, Germany; [Kranstauber, Bart] Univ Konstanz, Dept Biol, Constance, Germany	Max Planck Society; Radboud University Nijmegen; Max Planck Society; University of Konstanz	van Schaik, J (corresponding author), Max Planck Inst Ornithol, Dept Behav Ecol & Evolutionary Genet, Eberhard Gwinner Str, D-82319 Seewiesen, Germany.	JaapvanSchaik@gmail.com	van Schaik, Jaap/H-5180-2019	van Schaik, Jaap/0000-0003-4825-7676; Bosch, Thijs/0000-0001-7905-7402; Kranstauber, Bart/0000-0001-8303-780X; Dekker, Jasja/0000-0001-6453-4480	province of Limburg (Landschap in Uitvoering); Bionet Natuuronderzoek; Ad Hoc Zoogdieronderzoek	province of Limburg (Landschap in Uitvoering); Bionet Natuuronderzoek; Ad Hoc Zoogdieronderzoek	This project was funded by a grant from the province of Limburg (Landschap in Uitvoering). Bionet Natuuronderzoek and Ad Hoc Zoogdieronderzoek provided support in the form of salaries for authors RJ and TB respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agosta SJ, 2005, J MAMMAL, V86, P1210, DOI 10.1644/05-MAMM-A-012R1.1; Angell RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054194; Auguie B, 2017, GRIDEXTRA MISCELLANE; Boratynski JS, 2012, ACTA CHIROPTEROL, V14, P417, DOI 10.3161/150811012X661738; Boyles JG, 2007, J EXP BIOL, V210, P4345, DOI 10.1242/jeb.007294; Brunet-Rossinni Anja K., 2009, P315; Buechner H. K., 1965, Zeitschrift fuer Tierpsychologie, V22, P209; Clutton-Brock J, 1989, P ROYAL SOC B, V236, P339; CLUTTONBROCK TH, 1988, BEHAV ECOL SOCIOBIOL, V23, P281, DOI 10.1007/BF00300575; DAAN S, 1968, Zeitschrift fuer Saeugetierkunde, V33, P262; FENTON MB, 1969, CAN J ZOOLOG, V47, P597, DOI 10.1139/z69-103; Furmankiewicz J, 2008, CAN J ZOOL, V86, P207, DOI 10.1139/Z07-134; Furmankiewicz J, 2007, CONSERV GENET, V8, P913, DOI 10.1007/s10592-006-9246-2; Glover AM, 2008, BIOL CONSERV, V141, P1493, DOI 10.1016/j.biocon.2008.03.012; Haarsma Anne-Jifke, 2009, Lutra, V52, P47; HALL JS, 1968, J MAMMAL, V49, P779, DOI 10.2307/1378754; HORACEK I, 1978, FOLIA ZOOL, V27, P135; Humphrey SR, 1976, SPECIAL PUBLICATION, V4, P1; Hutterer R., 2005, BAT MIGRATIONS EUROP; Ingersoll TE, 2010, J MAMMAL, V91, P1242, DOI 10.1644/09-MAMM-A-288.1; Johnson JB, 2006, WILDLIFE SOC B, V34, P1368, DOI 10.2193/0091-7648(2006)34[1368:AEMECR]2.0.CO;2; Kerth G, 2003, CONSERV GENET, V4, P491, DOI 10.1023/A:1024771713152; Kokurewicz T, 2004, ACTA CHIROPTEROL, V6, P121, DOI 10.3161/001.006.0110; Kugelschafter K, 2009, BIERKELLER SULZTHAL; KUIPERS B, 1970, Bijdragen tot de Dierkunde, V40, P51; LESINSKI G, 1986, ACTA THERIOL, V31, P507, DOI 10.4098/AT.arch.86-45; Masing Matti, 2007, Acta Zoologica Lituanica, V17, P47; NAGEL A, 1991, COMP BIOCHEM PHYS A, V99, P323, DOI 10.1016/0300-9629(91)90008-Z; Oksanen J., **DATA OBJECT**; Orbons J, 2005, INVENTARISATIE INGAN; Parsons KN, 2003, ANIM CONSERV, V6, P283, DOI 10.1017/S1367943003003342; Parsons KN, 2003, J ZOOL, V261, P257, DOI 10.1017/S0952836903004199; Parsons KN, 2003, BIOL CONSERV, V111, P63, DOI 10.1016/S0006-3207(02)00250-1; Piksa K, 2008, ACTA CHIROPTEROL, V10, P69, DOI 10.3161/150811008X331108; Piksa K, 2011, ACTA CHIROPTEROL, V13, P113, DOI 10.3161/150811011X578660; Punt A, 1957, CELLULAR MOL LIFE SC, V13, P51; Randall J, 2014, ACTA CHIROPTEROL, V16, P109, DOI 10.3161/150811014X683327; Rivers NM, 2006, BIOL CONSERV, V127, P215, DOI 10.1016/j.biocon.2005.08.010; Rivers NM, 2005, MOL ECOL, V14, P4299, DOI 10.1111/j.1365-294X.2005.02748.x; Sachteleben J, 2006, ACTA CHIROPTEROL, V8, P391, DOI 10.3161/1733-5329(2006)8[391:SBAMSO]2.0.CO;2; Safi K, 2007, AM NAT, V170, P465, DOI 10.1086/520116; Sendor T, 2003, J ANIM ECOL, V72, P308, DOI 10.1046/j.1365-2656.2003.00702.x; Senior P, 2005, P ROY SOC B-BIOL SCI, V272, P2467, DOI 10.1098/rspb.2005.3237; Siivonen Y, 2008, MAMMALIA, V72, P50, DOI 10.1515/MAMM.2008.003; SPEAKMAN JR, 1989, J ANIM ECOL, V58, P797, DOI 10.2307/5125; THOMAS DW, 1992, PHYSIOL ZOOL, V65, P443, DOI 10.1086/physzool.65.2.30158262; Toth CA, 2013, J ZOOL, V291, P3, DOI 10.1111/jzo.12069; Veith M, 2004, HEREDITY, V93, P342, DOI 10.1038/sj.hdy.6800509; Webb PI, 1996, CAN J ZOOL, V74, P761, DOI 10.1139/z96-087; Zahn A, 1997, J ZOOL, V243, P659, DOI 10.1111/j.1469-7998.1997.tb01968.x	50	34	37	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130850	10.1371/journal.pone.0130850	http://dx.doi.org/10.1371/journal.pone.0130850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26153691	gold, Green Submitted, Green Published			2022-12-27	WOS:000358159700040
J	Aitken, SC; Wallis, CL; Stevens, W; de Wit, TR; Schuurman, R				Aitken, Susan C.; Wallis, Carole L.; Stevens, Wendy; de Wit, Tobias Rinke; Schuurman, Rob			Stability of HIV-1 Nucleic Acids in Dried Blood Spot Samples for HIV-1 Drug Resistance Genotyping	PLOS ONE			English	Article							VIRUS TYPE-1 RNA; DYNAMICS IN-VIVO; REVERSE-TRANSCRIPTASE; WHOLE-BLOOD; FILTER-PAPER; ANTIRETROVIRAL THERAPY; PERIPHERAL-BLOOD; VIRAL LOAD; STORAGE-CONDITIONS; MONONUCLEAR-CELLS	Dried blood spots (DBS) are an easy to collect sample-type that can stabilize biological material at ambient temperature for transport and storage, making them ideal for use in resource-limited settings (RLS). We investigated the effect of storage temperature and duration on ability to detect mixed HIV-1 viral RNA populations, and subsequently viral RNA populations in a background of proviral DNA. Part one of the study used DBS samples of whole blood spiked with specific quantities of HIV-1 subtype-B and -C RNA to study mixed virus population detection. Part two used DBS comprising of HIV-1 subtype-B proviral DNA containing U1 cells combined with HIV-1 subtype-C RNA to mimic HIV-1 infected clinical samples as a model system to study the relative stability of HIV-1 RNA and DNA in DBS. Prepared DBS were stored at -20 degrees C and +30 degrees C for periods of one day, one, two, and four weeks. Samples were genotyped to determine changes in the detection of mixtures in the sample over time. From two weeks onwards, storage at +30 degrees C resulted in gradual, time-related reduction in the detection of mixed virus population at log(10) VL 4.0 but not at log(10) 5.0. Proviral DNA and viral RNA were both stable for at least 52 weeks when stored at -20 degrees C, compared to progressive RNA decay over time at +30 degrees C. DBS storage conditions and duration had a significant effect on HIV-1 RNA amplification. Our results demonstrate that DBS storage at ambient temperature (+30 degrees C) should not exceed two weeks, with long-term storage at -20 degrees C or lower.	[Aitken, Susan C.; Schuurman, Rob] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Wallis, Carole L.] Lancet Labs, Johannesburg, South Africa; [Stevens, Wendy] Univ Witwatersrand, Dept Mol Med & Hematol, Johannesburg, South Africa; [Stevens, Wendy] Natl Hlth Lab Serv, Johannesburg, South Africa; [de Wit, Tobias Rinke] PharmAccess Int, Amsterdam, Netherlands; [de Wit, Tobias Rinke] Univ Amsterdam, Acad Med Ctr, Global Hlth Dept, AIGHD, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; University of Witwatersrand; National Health Laboratory Service; University of Amsterdam; Academic Medical Center Amsterdam	Schuurman, R (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	R.Schuurman-1@umcutrecht.nl	Schuurman, Rob/M-4687-2019	Schuurman, Rob/0000-0002-0060-9831; Wallis, Carole/0000-0001-8408-8772	NWO/WOTRO under the Netherlands African Partnership for Capacity Development and Clinical Interventions against Poverty related Diseases (NACCAP) [W.07.05.204.00]; Hague; Netherlands	NWO/WOTRO under the Netherlands African Partnership for Capacity Development and Clinical Interventions against Poverty related Diseases (NACCAP); Hague; Netherlands(Netherlands Government)	ART-A: Consortium to develop an Affordable Resistance Test for Africa, supported by NWO/WOTRO under the Netherlands African Partnership for Capacity Development and Clinical Interventions against Poverty related Diseases (NACCAP; grant: W.07.05.204.00), The Hague, The Netherlands. Lancet Laboratories provided support in the form of a salary for author CW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Aitken SC, 2013, J CLIN MICROBIOL, V51, P1757, DOI 10.1128/JCM.00118-13; Aitken SC, 2012, J CLIN VIROL, V54, P21, DOI 10.1016/j.jcv.2012.01.010; Alvarez-Munoz MT, 2005, ARCH MED RES, V36, P382, DOI 10.1016/j.arcmed.2005.03.010; Ayele W, 2007, J CLIN MICROBIOL, V45, P891, DOI 10.1128/JCM.01919-06; Barth RE, 2012, ANTIVIR THER, V17, P377, DOI 10.3851/IMP2010; Bertagnolio S, 2007, ANTIVIR THER, V12, P107; Brambilla D, 2003, J CLIN MICROBIOL, V41, P1888, DOI 10.1128/JCM.41.5.1888-1893.2003; Buckton AJ, 2008, J ANTIMICROB CHEMOTH, V62, P1191, DOI 10.1093/jac/dkn412; Cassol S, 1997, J CLIN MICROBIOL, V35, P2795, DOI 10.1128/JCM.35.11.2795-2801.1997; Chew CB, 2005, J CLIN VIROL, V33, P206, DOI 10.1016/j.jcv.2004.11.006; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Drosten C, 2006, CLIN CHEM, V52, P1258, DOI 10.1373/clinchem.2006.066498; Fiscus SA, 1998, J CLIN MICROBIOL, V36, P258, DOI 10.1128/JCM.36.1.258-260.1998; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Grant RM, 2003, J CLIN MICROBIOL, V41, P1586, DOI 10.1128/JCM.41.4.1586-1593.2003; Hallack R, 2008, J CLIN VIROL, V41, P283, DOI 10.1016/j.jcv.2007.12.011; HARPER ME, 1986, P NATL ACAD SCI USA, V83, P772, DOI 10.1073/pnas.83.3.772; Hearps AC, 2010, CURR HIV RES, V8, P134, DOI 10.2174/157016210790442740; Kearney M, 2008, AIDS, V22, P497, DOI 10.1097/QAD.0b013e3282f29478; Korn K, 2003, J CLIN MICROBIOL, V41, P3559, DOI 10.1128/JCM.41.8.3559-3565.2003; Leelawiwat W, 2009, J VIROL METHODS, V155, P109, DOI 10.1016/j.jviromet.2008.09.022; Masciotra S, 2007, AIDS, V21, P2503, DOI 10.1097/QAD.0b013e3281c618db; McNulty A, 2007, J CLIN MICROBIOL, V45, P517, DOI 10.1128/JCM.02016-06; Monleau M, 2010, J ANTIMICROB CHEMOTH, V65, P1562, DOI 10.1093/jac/dkq205; Parisi SG, 2007, J CLIN MICROBIOL, V45, P1783, DOI 10.1128/JCM.00056-07; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Ribeiro RM, 1998, AIDS, V12, P461, DOI 10.1097/00002030-199805000-00006; Riva E, 2001, AIDS RES HUM RETROV, V17, P1599, DOI 10.1089/088922201753342004; Rottinghaus EK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109060; Sanchez G, 1997, J VIROL, V71, P2233, DOI 10.1128/JVI.71.3.2233-2240.1997; Saracino A, 2008, J MED VIROL, V80, P1695, DOI 10.1002/jmv.21261; Schuurman R, 1999, J CLIN MICROBIOL, V37, P2291, DOI 10.1128/JCM.37.7.2291-2296.1999; Schuurman R, 2002, AIDS RES HUM RETROV, V18, P243, DOI 10.1089/088922202753472801; Steegen K, 2006, J VIROL METHODS, V133, P137, DOI 10.1016/j.jviromet.2005.11.004; Steegen K, 2007, J CLIN MICROBIOL, V45, P3342, DOI 10.1128/JCM.00814-07; Venturi G, 2002, ANTIVIR THER, V7, P245; Viljoen J, 2010, JAIDS-J ACQ IMM DEF, V55, P290, DOI 10.1097/QAI.0b013e3181edaaf5; Wallis CL, 2010, J VIROL METHODS, V163, P505, DOI 10.1016/j.jviromet.2009.11.011; Waters L, 2007, JAIDS-J ACQ IMM DEF, V46, P590, DOI 10.1097/QAI.0b013e318159d7f4; Youngpairoj AS, 2008, J ANTIMICROB CHEMOTH, V61, P1217, DOI 10.1093/jac/dkn100; Ziemniak C, 2006, J VIROL METHODS, V136, P238, DOI 10.1016/j.jviromet.2006.05.030	44	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131541	10.1371/journal.pone.0131541	http://dx.doi.org/10.1371/journal.pone.0131541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147689	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600104
J	Boes, A; Spiegel, H; Voepel, N; Edgue, G; Beiss, V; Kapelski, S; Fendel, R; Scheuermayer, M; Pradel, G; Bolscher, JM; Behet, MC; Dechering, KJ; Hermsen, CC; Sauerwein, RW; Schillberg, S; Reimann, A; Fischer, R				Boes, Alexander; Spiegel, Holger; Voepel, Nadja; Edgue, Gueven; Beiss, Veronique; Kapelski, Stephanie; Fendel, Rolf; Scheuermayer, Matthias; Pradel, Gabriele; Bolscher, Judith M.; Behet, Marije C.; Dechering, Koen J.; Hermsen, Cornelus C.; Sauerwein, Robert W.; Schillberg, Stefan; Reimann, Andreas; Fischer, Rainer			Analysis of a Multi-component Multi-stage Malaria Vaccine Candidate-Tackling the Cocktail Challenge	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; MEROZOITE SURFACE PROTEIN-3; PLASMODIUM-FALCIPARUM; IMMUNOGENICITY; TRANSMISSION; ANTIBODIES; STAGE; GROWTH; PROTECTION; PARASITE	Combining key antigens from the different stages of the P. falciparum life cycle in the context of a multi-stage-specific cocktail offers a promising approach towards the development of a malaria vaccine ideally capable of preventing initial infection, the clinical manifestation as well as the transmission of the disease. To investigate the potential of such an approach we combined proteins and domains (11 in total) from the pre-erythrocytic, blood and sexual stages of P. falciparum into a cocktail of four different components recombinantly produced in plants. After immunization of rabbits we determined the domain-specific antibody titers as well as component-specific antibody concentrations and correlated them with stage specific in vitro efficacy. Using purified rabbit immune IgG we observed strong inhibition in functional in vitro assays addressing the pre-erythrocytic (up to 80%), blood (up to 90%) and sexual parasite stages (100%). Based on the component-specific antibody concentrations we calculated the IC50 values for the pre-erythrocytic stage (17-25 mu g/ml), the blood stage (4060 mu g/ml) and the sexual stage (1.75 mu g/ml). While the results underline the feasibility of a multi-stage vaccine cocktail, the analysis of component-specific efficacy indicates significant differences in IC50 requirements for stage-specific antibody concentrations providing valuable insights into this complex scenario and will thereby improve future approaches towards malaria vaccine cocktail development regarding the selection of suitable antigens and the ratios of components, to fine tune overall and stage-specific efficacy.	[Boes, Alexander; Spiegel, Holger; Voepel, Nadja; Edgue, Gueven; Beiss, Veronique; Kapelski, Stephanie; Fendel, Rolf; Schillberg, Stefan; Reimann, Andreas; Fischer, Rainer] Fraunhofer Inst Mol Biol & Appl Ecol IME, Aachen, Germany; [Fendel, Rolf; Pradel, Gabriele; Fischer, Rainer] Rhein Westfal TH Aachen, Inst Mol Biotechnol, Aachen, Germany; [Scheuermayer, Matthias] Zentrum Infekt Forsch, Wurzburg, Germany; [Bolscher, Judith M.; Dechering, Koen J.; Sauerwein, Robert W.] TropIQ Hlth Sci, Nijmegen, Netherlands; [Behet, Marije C.; Hermsen, Cornelus C.; Sauerwein, Robert W.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Fraunhofer Gesellschaft; RWTH Aachen University; Radboud University Nijmegen	Spiegel, H (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol IME, Aachen, Germany.	holger.spiegel@ime.fraunhofer.de	Fendel, Rolf/K-3985-2013; Schillberg, Stefan/K-4211-2019; Hermsen, C.C./L-4368-2015; Sauerwein, Robert/C-8519-2013; Kapelski, Stephanie/AAG-7251-2021; Behet, Marije/D-7785-2016; Schillberg, Stefan/I-5449-2013	Fendel, Rolf/0000-0003-4716-0311; Behet, Marije/0000-0002-8683-4449; Beiss, Veronique/0000-0002-0953-053X; Boes, Alexander/0000-0001-7722-692X; Schillberg, Stefan/0000-0002-1896-4575	Fraunhofer Zukunftsstiftung; "Richtlinien zur Forderung des wissenschaftlichen Nachwuchses (RFwN) Ph.D. grant" from Rheinisch-Westfalische Technische Hochschule (RWTH) Aachen University; TropIQ Health Sciences	Fraunhofer Zukunftsstiftung; "Richtlinien zur Forderung des wissenschaftlichen Nachwuchses (RFwN) Ph.D. grant" from Rheinisch-Westfalische Technische Hochschule (RWTH) Aachen University; TropIQ Health Sciences	This work was supported by the Fraunhofer Zukunftsstiftung (http://www.fraunhofer.de/). SK was supported by a "Richtlinien zur Forderung des wissenschaftlichen Nachwuchses (RFwN) Ph.D. grant" from Rheinisch-Westfalische Technische Hochschule (RWTH) Aachen University (http://www.rwth-aachen.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TropIQ Health Sciences provided support in the form of salaries for authors JMB, KLD and RWS but did	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Alaro JR, 2012, INFECT IMMUN, V80, P2473, DOI 10.1128/IAI.00211-12; AMADOR R, 1992, J INFECT DIS, V166, P139, DOI 10.1093/infdis/166.1.139; BATHURST IC, 1993, VACCINE, V11, P449, DOI 10.1016/0264-410X(93)90287-8; Behet MC, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-136; Beiss V, 2015, BIOTECHNOL BIOENG, V112, P1297, DOI 10.1002/bit.25548; Bergmann-Leitner E. S., 2014, Trials in Vaccinology, V3, P6, DOI 10.1016/j.trivac.2013.11.002; Bergmann-Leitner ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012294; BISHOP A, 1946, PARASITOLOGY, V37, P85, DOI 10.1017/S0031182000013202; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; Boes A, 2015, PLANT BIOTECHNOL J, V13, P222, DOI 10.1111/pbi.12255; Boyle MJ, 2010, BLOOD, V115, P4559, DOI 10.1182/blood-2009-09-243725; Burgess BR, 2005, J BIOL CHEM, V280, P37236, DOI 10.1074/jbc.M506753200; CHAPPEL JA, 1994, INFECT IMMUN, V62, P4488, DOI 10.1128/IAI.62.10.4488-4494.1994; Cheru L, 2010, VACCINE, V28, P4423, DOI 10.1016/j.vaccine.2010.04.036; Coppi A, 2011, J EXP MED, V208, P341, DOI 10.1084/jem.20101488; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Doolan DL, 2001, INT J PARASITOL, V31, P753, DOI 10.1016/S0020-7519(01)00184-9; Drew DR, 2005, INFECT IMMUN, V73, P3912, DOI 10.1128/IAI.73.7.3912-3922.2005; Dutta S, 2002, INFECT IMMUN, V70, P3101, DOI 10.1128/IAI.70.6.3101-3110.2002; Faber BW, 2013, INFECT IMMUN, V81, P1479, DOI 10.1128/IAI.01267-12; Farrance CE, 2011, CLIN VACCINE IMMUNOL, V18, P1351, DOI 10.1128/CVI.05105-11; Farrance CE, 2011, HUM VACCINES, V7, P191, DOI 10.4161/hv.7.0.14588; Feller T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079920; Fischer R, 2013, CURR PHARM DESIGN, V19, P5471, DOI 10.2174/1381612811319310002; Gantt S, 2000, INFECT IMMUN, V68, P3667, DOI 10.1128/IAI.68.6.3667-3673.2000; Gregory JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037179; Hill AVS, 2011, PHILOS T R SOC B, V366, P2806, DOI 10.1098/rstb.2011.0091; Hill AVS, 2010, HUM VACCINES, V6, P78, DOI 10.4161/hv.6.1.10116; Jones RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079538; Kapelski S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0577-7; Kapelski S, 2014, J LEUKOCYTE BIOL, V96, P1131, DOI 10.1189/jlb.4A0614-283RR; Kariu T, 2006, MOL MICROBIOL, V59, P1369, DOI 10.1111/j.1365-2958.2005.05024.x; KASLOW DC, 1991, SCIENCE, V252, P1310, DOI 10.1126/science.1925544; Kumar S, 2000, INFECT IMMUN, V68, P2215, DOI 10.1128/IAI.68.4.2215-2223.2000; Mahajan B, 2010, INFECT IMMUN, V78, P4613, DOI 10.1128/IAI.00533-10; Miura K, 2009, CLIN VACCINE IMMUNOL, V16, P963, DOI 10.1128/CVI.00042-09; Moorthy VS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-312; Morahan BJ, 2009, TRENDS PARASITOL, V25, P77, DOI 10.1016/j.pt.2008.11.004; NARUM DL, 1994, MOL BIOCHEM PARASIT, V67, P59, DOI 10.1016/0166-6851(94)90096-5; OEUVRAY C, 1994, BLOOD, V84, P1594; Organization WH, 2013, LD MALARIA REPORT 20; Pan WQ, 2004, J IMMUNOL, V172, P6167, DOI 10.4049/jimmunol.172.10.6167; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; Pol E, 2007, J MOL RECOGNIT, V20, P22, DOI 10.1002/jmr.804; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Rybicki EP, 2010, PLANT BIOTECHNOL J, V8, P620, DOI 10.1111/j.1467-7652.2010.00507.x; Saul A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000850; Schofield L, 2002, NATURE, V418, P785, DOI 10.1038/nature00937; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; Tachibana M, 2011, CLIN VACCINE IMMUNOL, V18, P1343, DOI 10.1128/CVI.05104-11; van Schaijk BCL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003549; Voepel N, 2014, BIOTECHNOL J, V9, P1435, DOI 10.1002/biot.201400350; Wang L, 2001, INFECT IMMUN, V69, P4390, DOI 10.1128/IAI.69.7.4390-4397.2001; Williamson KC, 1995, MOL BIOCHEM PARASIT, V75, P33, DOI 10.1016/0166-6851(95)02507-3; Zhou ZY, 2006, HUM VACCINES, V2, P14, DOI 10.4161/hv.2.1.2437	58	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131456	10.1371/journal.pone.0131456	http://dx.doi.org/10.1371/journal.pone.0131456			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147206	Green Published, gold			2022-12-27	WOS:000358157600098
J	Meuwese, CL; Olauson, H; Qureshi, AR; Ripsweden, J; Barany, P; Vermeer, C; Drummen, N; Stenvinkel, P				Meuwese, Christiaan Lucas; Olauson, Hannes; Qureshi, Abdul Rashid; Ripsweden, Jonaz; Barany, Peter; Vermeer, Cees; Drummen, Nadja; Stenvinkel, Peter			Associations between Thyroid Hormones, Calcification Inhibitor Levels and Vascular Calcification in End-Stage Renal Disease	PLOS ONE			English	Article							MATRIX GLA PROTEIN; CORONARY-ARTERY CALCIFICATION; CHRONIC KIDNEY-DISEASE; VITAMIN-K STATUS; HEMODIALYSIS-PATIENTS; NONTHYROIDAL ILLNESS; PERITONEAL-DIALYSIS; CARDIOVASCULAR-DISEASE; RISK-FACTOR; KLOTHO	Introduction Vascular calcification is a common, serious and elusive complication of end-stage renal disease (ESRD). As a pro-calcifying risk factor, non-thyroidal illness may promote vascular calcification through a systemic lowering of vascular calcification inhibitors such as matrix-gla protein (MGP) and Klotho. Methods and Material In 97 ESRD patients eligible for living donor kidney transplantation, blood levels of thyroid hormones (fT3, fT4 and TSH), total uncarboxylated MGP (t-ucMGP), desphospho-uncar-boxylated MGP (dp-ucMGP), descarboxyprothrombin (PIVKA-II), and soluble Klotho (sKlotho) were measured. The degree of coronary calcification and arterial stiffness were assessed by means of cardiac CT-scans and applanation tonometry, respectively. Results fT3 levels were inversely associated with coronary artery calcification (CAC) scores and measures of arterial stiffness, and positively with dp-ucMGP and sKlotho concentrations. Subfractions of MGP, PIVKA-II and sKlotho did not associate with CAC scores and arterial stiffness. fT4 and TSH levels were both inversely associated with CAC scores, but not with arterial stiffness. Discussion The positive associations between fT3 and dp-ucMGP and sKlotho suggest that synthesis of MGP and Klotho is influenced by thyroid hormones, and supports a link between non-thyroidal illness and alterations in calcification inhibitor levels. However, the absence of an association between serum calcification inhibitor levels and coronary calcification/arterial stiffness and the fact that MGP and Klotho undergo post-translational modifications underscore the complexity of this association. Further studies, measuring total levels of MGP and membrane bound Klotho, should examine this proposed pathway in further detail.	[Meuwese, Christiaan Lucas; Olauson, Hannes; Qureshi, Abdul Rashid; Barany, Peter; Stenvinkel, Peter] Karolinska Inst, Dept Renal Med, CLINTEC, Stockholm, Sweden; [Ripsweden, Jonaz] Karolinska Inst, Med Imaging & Technol, CLINTEC, Stockholm, Sweden; [Vermeer, Cees; Drummen, Nadja] Maastricht Univ, VitaK, Maastricht, Netherlands	Karolinska Institutet; Karolinska Institutet; Maastricht University	Stenvinkel, P (corresponding author), Karolinska Inst, Dept Renal Med, CLINTEC, Stockholm, Sweden.	peter.stenvinkel@ki.se	Qureshi, Abdul Rashid Tony/G-1358-2010	Qureshi, Abdul Rashid Tony/0000-0003-0536-5327; Stenvinkel, Peter/0000-0002-8785-4820; Ripsweden, Jonaz/0000-0003-2118-5414; Barany, Peter/0000-0001-6501-8293				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Ammirati AL, 2006, NEPHRON CLIN PRACT, V104, pC33, DOI 10.1159/000093257; Barreto DV, 2005, KIDNEY INT, V67, P1576, DOI 10.1111/j.1523-1755.2005.00239.x; Budoff MJ, 2008, VASC HEALTH RISK MAN, V4, P315, DOI 10.2147/VHRM.S1160; Buiten MS, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-197; Chen CH, 1997, CIRCULATION, V95, P1827; Cranenburg ECM, 2012, KIDNEY INT, V82, P605, DOI 10.1038/ki.2012.191; Cranenburg ECM, 2010, THROMB HAEMOSTASIS, V104, P811, DOI 10.1160/TH09-11-0786; Cranenburg ECM, 2009, THROMB HAEMOSTASIS, V101, P359, DOI 10.1160/TH08-04-0241; Delanaye P, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-145; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Kaptein EM, 1996, ENDOCR REV, V17, P45, DOI 10.1210/er.17.1.45; Krueger T, 2009, KIDNEY INT, V76, P18, DOI 10.1038/ki.2009.126; Lanzer P, 2014, EUR HEART J, V35, P1515, DOI 10.1093/eurheartj/ehu163; Liu YP, 2015, HYPERTENSION, V65, P463, DOI 10.1161/HYPERTENSIONAHA.114.04494; Meuwese CL, 2013, J INTERN MED, V274, P584, DOI 10.1111/joim.12107; Meuwese CL, 2013, NAT REV NEPHROL, V9, P599, DOI 10.1038/nrneph.2013.170; Meuwese CL, 2012, CLIN J AM SOC NEPHRO, V7, P131, DOI 10.2215/CJN.05250511; MITCHELL JR, 1962, BRIT MED J, P1293; Mizuno I, 2001, LIFE SCI, V68, P2917, DOI 10.1016/S0024-3205(01)01092-X; Olauson H, 2013, CURR OPIN NEPHROL HY, V22, P397, DOI 10.1097/MNH.0b013e32836213ee; Rumberger JA, 1999, MAYO CLIN PROC, V74, P243, DOI 10.4065/74.3.243; Sato Y, 2005, CIRC RES, V97, P550, DOI 10.1161/01.RES.0000181431.04290.bd; Schlieper G, 2011, J AM SOC NEPHROL, V22, P387, DOI 10.1681/ASN.2010040339; Seiler S, 2013, KIDNEY INT, V83, P121, DOI 10.1038/ki.2012.288; Shanahan CM, 2013, NAT REV NEPHROL, V9, P661, DOI 10.1038/nrneph.2013.176; SOLBERG LA, 1968, ANN NY ACAD SCI, V149, P956, DOI 10.1111/j.1749-6632.1968.tb53849.x; Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Stompor T, 2006, INT J ARTIF ORGANS, V29, P736, DOI 10.1177/039139880602900802; Tatar E, 2012, INT UROL NEPHROL, V44, P601, DOI 10.1007/s11255-011-0034-7; Tatar E, 2011, CLIN J AM SOC NEPHRO, V6, P2240, DOI 10.2215/CJN.02540311; Theuwissen E, 2014, FOOD FUNCT, V5, P229, DOI 10.1039/c3fo60464k; Ueland T, 2010, J INTERN MED, V268, P483, DOI 10.1111/j.1365-2796.2010.02264.x; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wallin R, 2010, OSTEOARTHR CARTILAGE, V18, P1096, DOI 10.1016/j.joca.2010.05.013; Warner MH, 2010, J ENDOCRINOL, V205, P1, DOI 10.1677/JOE-09-0412; Zhang J, 2015, CALCIFIED TISSUE INT, V96, P80, DOI 10.1007/s00223-014-9934-8; Zhang YY, 2014, ARTERIOSCL THROM VAS, V34, P2128, DOI 10.1161/ATVBAHA.114.303889; Zoccali C, 2006, KIDNEY INT, V70, P523, DOI 10.1038/sj.ki.5001566	40	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132353	10.1371/journal.pone.0132353	http://dx.doi.org/10.1371/journal.pone.0132353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147960	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600251
J	Turjeman, K; Bavli, Y; Kizelsztein, P; Schilt, Y; Allon, N; Katzir, TB; Sasson, E; Raviv, U; Ovadia, H; Barenholz, Y				Turjeman, Keren; Bavli, Yaelle; Kizelsztein, Pablo; Schilt, Yaelle; Allon, Nahum; Katzir, Tamar Blumenfeld; Sasson, Efrat; Raviv, Uri; Ovadia, Haim; Barenholz, Yechezkel			Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; DOSE INTRAVENOUS METHYLPREDNISOLONE; MYELIN BASIC-PROTEIN; MULTIPLE-SCLEROSIS; BLOOD-BRAIN; SPINAL-CORD; VASCULAR-PERMEABILITY; BARRIER PERMEABILITY; ALZHEIMERS-DISEASE	The present study shows the advantages of liposome-based nano-drugs as a novel strategy of delivering active pharmaceutical ingredients for treatment of neurodegenerative diseases that involve neuroinflammation. We used the most common animal model for multiple sclerosis (MS), mice experimental autoimmune encephalomyelitis (EAE). The main challenges to overcome are the drugs' unfavorable pharmacokinetics and biodistribution, which result in inadequate therapeutic efficacy and in drug toxicity (due to high and repeated dosage). We designed two different liposomal nano-drugs, i.e., nano sterically stabilized liposomes (NSSL), remote loaded with: (a) a "water-soluble" amphipathic weak acid glucocorticosteroid prodrug, methylprednisolone hemisuccinate (MPS) or (b) the amphipathic weak base nitroxide, Tempamine (TMN). For the NSSL-MPS we also compared the effect of passive targeting alone and of active targeting based on short peptide fragments of ApoE or of beta-amyloid. Our results clearly show that for NSSL-MPS, active targeting is not superior to passive targeting. For the NSSL-MPS and the NSSL-TMN it was demonstrated that these nano-drugs ameliorate the clinical signs and the pathology of EAE. We have further investigated the MPS nano-drug's therapeutic efficacy and its mechanism of action in both the acute and the adoptive transfer EAE models, as well as optimizing the perfomance of the TMN nano-drug. The highly efficacious anti-inflammatory therapeutic feature of these two nano-drugs meets the criteria of disease-modifying drugs and supports further development and evaluation of these nano-drugs as potential therapeutic agents for diseases with an inflammatory component.	[Turjeman, Keren; Bavli, Yaelle; Kizelsztein, Pablo; Allon, Nahum; Barenholz, Yechezkel] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Lab Membrane & Liposome Res,Dept Biochem & Mol Bi, IL-91010 Jerusalem, Israel; [Schilt, Yaelle; Raviv, Uri] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel; [Katzir, Tamar Blumenfeld; Sasson, Efrat] BioImage MRI Res & Consulting, Tel Aviv, Israel; [Ovadia, Haim] Hadassah Univ Hosp, Dept Neurol, Agnes Ginges Ctr Human Neurogenet, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Turjeman, K (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Lab Membrane & Liposome Res,Dept Biochem & Mol Bi, IL-91010 Jerusalem, Israel.	kerenbarhum@gmail.com	Raviv, Uri/C-3600-2019	Bavli, Yaelle/0000-0002-2408-542X	Barenholz Fund; Hebrew University regular support system	Barenholz Fund; Hebrew University regular support system	This study was supported in part by the Barenholz Fund. The Barenholz Fund is a fund established by Professor Barenholz from royalties that the Hebrew University and Professor Barenholz get from various patents which are dedicated to support research in his lab. There are no connections between the patents for which he gets the royalties and this research, so it is basically a research fund. The other support was the Hebrew University regular support system. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors TBK and ES are employed by BioImage MRI Research & Consulting. The company was hired to perform the MRI and to process the data obtained but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AFZAL V, 1984, INVEST RADIOL, V19, P549, DOI 10.1097/00004424-198411000-00014; Allon N, 2012, J CONTROL RELEASE, V160, P217, DOI 10.1016/j.jconrel.2011.10.033; ANDERSON BD, 1981, J PHARM SCI, V70, P181, DOI 10.1002/jps.2600700217; Avnir Y, 2008, ARTHRITIS RHEUM-US, V58, P119, DOI 10.1002/art.23230; Avnir Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025721; Barenholz Y, 2000, PHYSICAL CHEMISTRY OF BIOLOGICAL INTERFACES, P171; Barenholz Y, 2001, CURR OPIN COLLOID IN, V6, P66, DOI 10.1016/S1359-0294(00)00090-X; Barenholz Y, 2002, TEMPAMINE COMPOSITIO; Barenholz Y, 2000, PHYS CHEM BIOL INTER; Barenholz Y, 2011, J COLLOID INTERF SCI, V356, P46, DOI 10.1016/j.jcis.2010.11.062; BARLOW CF, 1956, J NEUROPATH EXP NEUR, V15, P196, DOI 10.1097/00005072-195604000-00005; BARNES MP, 1985, J NEUROL NEUROSUR PS, V48, P157, DOI 10.1136/jnnp.48.2.157; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Ben-Nun T, 2010, J APPL CRYSTALLOGR, V43, P1522, DOI 10.1107/S0021889810032772; Borlongan C V, 1996, J Fla Med Assoc, V83, P335; BRANN DW, 1995, J STEROID BIOCHEM, V52, P113, DOI 10.1016/0960-0760(94)00160-N; Brusaferri F, 2000, J NEUROL, V247, P435, DOI 10.1007/s004150070172; Buttgereit F, 1998, ARTHRITIS RHEUM, V41, P761, DOI 10.1002/1529-0131(199805)41:5<761::AID-ART2>3.0.CO;2-M; Cern A, 2011, J CONTROLLED RELEASE; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; CUTLER RWP, 1967, J NEUROPATH EXP NEUR, V26, P558, DOI 10.1097/00005072-196710000-00004; DEGRAFF WG, 1992, FREE RADICAL BIO MED, V13, P479, DOI 10.1016/0891-5849(92)90142-4; DURELLI L, 1986, NEUROLOGY, V36, P238, DOI 10.1212/WNL.36.2.238; Ebadi M, 1996, PROG NEUROBIOL, V48, P1, DOI 10.1016/0301-0082(95)00029-1; Emanuel N, 1996, PHARMACEUT RES, V13, P861, DOI 10.1023/A:1016096910822; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Floris S, 2004, BRAIN, V127, P616, DOI 10.1093/brain/awh068; Gaillard PJ, 2012, J CONTROLLED RELEASE; Garbuzenko O, 2005, CHEM PHYS LIPIDS, V135, P117, DOI 10.1016/j.chemphyslip.2005.02.003; GASS A, 1994, ANN NEUROL, V36, P62, DOI 10.1002/ana.410360113; Gold R, 2001, J NEUROIMMUNOL, V117, P1, DOI 10.1016/S0165-5728(01)00330-7; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Hahn SM, 1997, FREE RADICAL BIO MED, V23, P879, DOI 10.1016/S0891-5849(97)00079-8; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; Hammersley AP, 1996, HIGH PRESSURE RES, V14, P235, DOI 10.1080/08957959608201408; HAWKINS CP, 1991, BRAIN, V114, P801, DOI 10.1093/brain/114.2.801; Hoven J.M., 2011, INT J PHARMACEUT, V416, P471, DOI DOI 10.1016/J.IJPHARM.2011.03.025; JUHLER M, 1984, BRAIN RES, V302, P347, DOI 10.1016/0006-8993(84)90249-X; Kappos L, 1990, MULTIPLE SCLEROSIS D, P127; Karlik SJ, 1999, MAGN RESON IMAGING, V17, P731, DOI 10.1016/S0730-725X(98)00216-1; KERMODE AG, 1990, BRAIN, V113, P1477, DOI 10.1093/brain/113.5.1477; KESSELRING J, 1989, J NEUROL NEUROSUR PS, V52, P14, DOI 10.1136/jnnp.52.1.14; Kizelsztein P, 2009, J NEUROIMMUNOL, V213, P20, DOI 10.1016/j.jneuroim.2009.05.019; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; KRISHNA MC, 1992, P NATL ACAD SCI USA, V89, P5537, DOI 10.1073/pnas.89.12.5537; LEIBOWITZ S, 1972, IMMUNOLOGY, V22, P859; Linker RA, 2008, EXP NEUROL, V211, P397, DOI 10.1016/j.expneurol.2008.02.005; Lu FM, 2000, J NEUROL SCI, V177, P95, DOI 10.1016/S0022-510X(00)00343-9; Mabrey S, 1978, METHODS MEMBR BIOL, P237, DOI [10.1007/978-1-4613-4036-2_3, DOI 10.1007/978-1-4613-4036-2_3]; Maier C, 2005, J CELL SCI, V118, P3353, DOI 10.1242/jcs.02462; Markesbery WR, 1999, BRAIN PATHOL, V9, P133; McCombe PA, 1996, J NEUROIMMUNOL, V70, P93, DOI 10.1016/S0165-5728(96)00043-4; MILLER DH, 1992, J NEUROL NEUROSUR PS, V55, P450, DOI 10.1136/jnnp.55.6.450; MILLER H, 1961, LANCET, V2, P1120; MILLIGAN NM, 1987, J NEUROL NEUROSUR PS, V50, P511, DOI 10.1136/jnnp.50.5.511; MITCHELL JB, 1991, ARCH BIOCHEM BIOPHYS, V289, P62, DOI 10.1016/0003-9861(91)90442-L; Morrissey SP, 1996, BRAIN, V119, P239, DOI 10.1093/brain/119.1.239; Nessler S, 2007, BRAIN, V130, P2186, DOI 10.1093/brain/awm105; NINOMIYA H, 1993, J CELL BIOL, V121, P879, DOI 10.1083/jcb.121.4.879; Pozzilli C, 2004, J NEUROL SCI, V223, P47, DOI 10.1016/j.jns.2004.04.019; Re F, 2011, J BIOTECHNOL, V156, P341, DOI 10.1016/j.jbiotec.2011.06.037; Reichardt Holger M, 2006, Expert Rev Neurother, V6, P1657, DOI 10.1586/14737175.6.11.1657; Saper G, 2013, NUCLEIC ACIDS RES, V41, P1569, DOI 10.1093/nar/gks1270; Sarsero JP, 2003, J GENE MED, V5, P72, DOI 10.1002/jgm.320; Schellenberg AE, 2007, MAGN RESON MED, V58, P298, DOI 10.1002/mrm.21289; Schmidt J, 2003, BRAIN, V126, P1895, DOI 10.1093/brain/awg176; Stein W., 2012, TRANSPORT DIFFUSION; Szekely P, 2010, LANGMUIR, V26, P13110, DOI 10.1021/la101433t; THOMPSON AJ, 1989, NEUROLOGY, V39, P969, DOI 10.1212/WNL.39.7.969; Tischner D, 2007, MOL CELL ENDOCRINOL, V275, P62, DOI 10.1016/j.mce.2007.03.007; TRIARHOU LC, 1986, ARCH NEUROL-CHICAGO, V43, P121, DOI 10.1001/archneur.1986.00520020015008; TROIANO R, 1984, ANN NEUROL, V15, P257, DOI 10.1002/ana.410150309; Ulmansky R, 2011, J CONTROLLED RELEASE; Vosoughi R, 2010, CLIN NEUROL NEUROSUR, V112, P365, DOI 10.1016/j.clineuro.2010.03.010; Wasserman V, 2007, LANGMUIR, V23, P1937, DOI 10.1021/la060218k; Yong VW, 2010, NEUROSCIENTIST, V16, P408, DOI 10.1177/1073858410371379; YOUL BD, 1991, BRAIN, V114, P2437, DOI 10.1093/brain/114.6.2437; Zamir E, 1999, FREE RADICAL BIO MED, V27, P7, DOI 10.1016/S0891-5849(99)00026-X; Zlokovic BV, 2008, NEUROTHERAPEUTICS, V5, P409, DOI 10.1016/j.nurt.2008.05.011; Zucker D, 2009, J CONTROL RELEASE, V139, P73, DOI 10.1016/j.jconrel.2009.05.036	80	49	49	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130442	10.1371/journal.pone.0130442	http://dx.doi.org/10.1371/journal.pone.0130442			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147975	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600036
J	Zhu, CC; Tang, B; Su, J; Zhao, H; Bu, X; Li, Z; Zhao, J; Gong, WD; Wu, ZQ; Yao, LB; Li, W; Zhang, YQ				Zhu, Chu-chao; Tang, Bin; Su, Jin; Zhao, Hu; Bu, Xin; Li, Zhen; Zhao, Jie; Gong, Wei-dong; Wu, Zhi-qun; Yao, Li-bo; Li, Wei; Zhang, Yuan-qiang			Abnormal Accumulation of Collagen Type I Due to the Loss of Discoidin Domain Receptor 2 (Ddr2) Promotes Testicular Interstitial Dysfunction	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX PROTEINS; RAT LEYDIG-CELLS; HUMAN TESTIS; VASECTOMY; SPERMATOGENESIS; MOUSE; IMPAIRMENT; EXPRESSION; FIBROSIS; GENE	Background Loss of functional allele for discoidin domain receptor 2 (Ddr2) results in impaired Leydig cell response to luteinizing hormone (LH), low testosterone production and arrested spermatogenesis in older male Ddr2(slie/slie) mice. However, the underlying mechanism responsible for this phenotype remains unknown. Herein, we reported for the first time that the deregulated expression of Ddr2 cognate ligand, namely collagen type I (COL1), may account for the disruption of the testicular steroidogenesis in Ddr2(slie/slie) mutant testes. Methodology/Principal Findings Expression of Ddr2 increased gradually along postnatal development, whereas COL1 expression became negligible from adulthood onwards. In Ddr2(slie/slie) mutant testis, however, in contrast to the undetectable staining of Ddr2, COL1 expression was constantly detected, with the highest values detected during adulthood. In the experimental vasectomy model, Ddr2(slie/slie) mutant mice exhibited an early androgen deficiency than wild-type mice, along with the accumulation of fibrotic tissue in the interstitium. Functionally, ablation of endogenous Ddr2 resulted in a significant decrease of testosterone (T) level in TM3 cells in the presence of higher concentration of COL1 treatment. Conversely, overexpression of Ddr2 could help TM3 cells to maintain a normal testicular steroidogenesis even in the presence of high concentration of COL1. Additionally, attenuated expression of Ddr2 correlates to the deregulated level of serum T levels in human pathological testes. Conclusions Abnormal accumulation of interstitial COL1 may be responsible for the steroidogenic dysfunction in Ddr2(slie/slie) mutant testes.	[Zhu, Chu-chao; Li, Zhen; Zhao, Jie; Li, Wei; Zhang, Yuan-qiang] Fourth Mil Med Univ, Dept Human Anat Histol & Embryol, Xian 710032, Peoples R China; [Tang, Bin] China Japan Friendship Hosp, Dept Int Med, Beijing 100029, Peoples R China; [Su, Jin; Zhao, Hu; Bu, Xin; Yao, Li-bo] Fourth Mil Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Gong, Wei-dong; Wu, Zhi-qun] Fourth Mil Med Univ, Dept Intervent Radiol, Tangdu Hosp, Xian 710038, Peoples R China	Air Force Military Medical University; China-Japan Friendship Hospital; Air Force Military Medical University; Air Force Military Medical University	Yao, LB (corresponding author), Fourth Mil Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China.	bioyao@fmmu.edu.cn; liweipepeyato@163.com; zhangyq@fmmu.edu.cn	Su, Jin/H-9027-2016	Su, Jin/0000-0002-2134-4895	Natural Science Foundation of China [31371216, 31171154, 31271248]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Natural Science Foundation of China (No. 31371216, 31171154 and 31271248). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbalagan M, 2004, REPROD BIOMED ONLINE, V9, P391, DOI 10.1016/S1472-6483(10)61274-6; Belleannee C, 2013, HUM REPROD, V28, P1455, DOI 10.1093/humrep/det088; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Cheng JH, 2008, AM J PHYSIOL-GASTR L, V294, pG39, DOI 10.1152/ajpgi.00263.2007; Cook LA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004112.pub4; Diaz ES, 2005, MOL REPROD DEV, V72, P208, DOI 10.1002/mrd.20259; Diaz ES, 2002, MOL REPROD DEV, V61, P493, DOI 10.1002/mrd.10111; Erdogru T, 2002, ANDROLOGIA, V34, P98, DOI 10.1046/j.0303-4569.2001.00482.x; Evaul K, 2008, J BIOL CHEM, V283, P27525, DOI 10.1074/jbc.M803867200; Fagundes AKF, 2014, THERIOGENOLOGY, V81, P230, DOI 10.1016/j.theriogenology.2013.09.013; Flynn LA, 2010, J MOL BIOL, V395, P533, DOI 10.1016/j.jmb.2009.10.073; Guittot SM, 2008, REPRODUCTION, V135, P479, DOI 10.1530/REP-07-0561; Gulkesen KH, 2002, ASIAN J ANDROL, V4, P55; Guo SJ, 2012, MED HYPOTHESES, V78, P536, DOI 10.1016/j.mehy.2012.01.029; JAROW JP, 1994, UROLOGY, V43, P521, DOI 10.1016/0090-4295(94)90246-1; Kano K, 2008, MOL ENDOCRINOL, V22, P1866, DOI 10.1210/me.2007-0310; Kano K, 2010, MOL REPROD DEV, V77, P29, DOI 10.1002/mrd.21093; Khosravi R, 2014, BONE, V58, P33, DOI 10.1016/j.bone.2013.10.001; Kumar PA, 2006, HUM REPROD, V21, P1033, DOI 10.1093/humrep/dei444; Lee NPY, 2004, HUM REPROD UPDATE, V10, P349, DOI 10.1093/humupd/dmh026; Li W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.223; Lui WY, 2003, INT J ANDROL, V26, P147, DOI 10.1046/j.1365-2605.2003.00410.x; Margarucci L, 2011, MOL BIOSYST, V7, P2311, DOI 10.1039/c1mb05145h; Mountain DJH, 2013, J SURG RES, V184, P619, DOI 10.1016/j.jss.2013.05.070; Odet F, 2006, ENDOCRINOLOGY, V147, P4374, DOI 10.1210/en.2006-0484; Olaso E, 2001, J CLIN INVEST, V108, P1369, DOI 10.1172/JCI12373; Qu N, 2008, REPRODUCTION, V135, P859, DOI 10.1530/REP-08-0018; Raleigh D, 2004, FERTIL STERIL, V81, P1595, DOI 10.1016/j.fertnstert.2003.10.046; Ruiz PA, 2011, J BIOL CHEM, V286, P12912, DOI 10.1074/jbc.M110.143693; Shiraishi K, 2003, AKTUEL UROL, V34, P262; Shiraishi K, 2002, CONTRACEPTION, V65, P245, DOI 10.1016/S0010-7824(01)00311-0; Suarez-Quian CA, 1999, J CLIN ENDOCR METAB, V84, P350, DOI 10.1210/jc.84.1.350; Svechnikov K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/684504; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Xiang Y, 2013, ASIAN J ANDROL, V15, P434, DOI 10.1038/aja.2012.154; Yan R, 2009, ARCH BIOCHEM BIOPHYS, V485, P41, DOI 10.1016/j.abb.2009.02.014; Yu XZ, 2009, TOXICOL APPL PHARM, V239, P325, DOI 10.1016/j.taap.2009.06.014; Zhang S, 2013, REPRODUCTION, V145, P177, DOI 10.1530/REP-12-0336; Zhang S, 2012, J BIOL CHEM, V287, P40471, DOI 10.1074/jbc.M112.383802; Zhang Y, 2014, BBA-MOL BASIS DIS, V1842, P1350, DOI 10.1016/j.bbadis.2014.04.018; Zhang Y, 2011, J BONE MINER RES, V26, P604, DOI 10.1002/jbmr.225; Zhou LL, 2013, J AM SOC NEPHROL, V24, P771, DOI 10.1681/ASN.2012080865; Zhu CC, 2013, FERTIL STERIL, V99, P918, DOI 10.1016/j.fertnstert.2012.11.022	43	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131947	10.1371/journal.pone.0131947	http://dx.doi.org/10.1371/journal.pone.0131947			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158267	gold, Green Published, Green Submitted			2022-12-27	WOS:000358161200042
J	Negro, E; D'Agata, F; Caroppo, P; Coriasco, M; Ferrio, F; Celeghin, A; Diano, M; Rubino, E; de Gelder, B; Rainero, I; Pinessi, L; Tamietto, M				Negro, Elisa; D'Agata, Federico; Caroppo, Paola; Coriasco, Mario; Ferrio, Federica; Celeghin, Alessia; Diano, Matteo; Rubino, Elisa; de Gelder, Beatrice; Rainero, Innocenzo; Pinessi, Lorenzo; Tamietto, Marco			Neurofunctional Signature of Hyperfamiliarity for Unknown Faces	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; HUMAN NEURAL SYSTEM; DELUSIONAL MISIDENTIFICATIONS; STATISTICAL-ANALYSES; PERSONALLY FAMILIAR; RECOGNITION; RECOLLECTION; PERCEPTION; REPRESENTATIONS; PROSOPAGNOSIA	Hyperfamiliarity for unknown faces is a rare selective disorder that consists of the disturbing and abnormal feeling of familiarity for unknown faces, while recognition of known faces is normal. In one such patient we investigated with a multimodal neuroimaging design the hitherto undescribed neural signature associated with hyperfamiliarity feelings. Behaviorally, signal detection methods revealed that the patient's discrimination sensitivity between familiar and unfamiliar faces was significantly lower than that of matched controls, and her response criterion for familiarity decisions was significantly more liberal. At the neural level, while morphometric analysis and single-photon emission CT (SPECT) showed the atrophy and hypofunctioning of the left temporal regions, functional magnetic resonance imaging (fMRI) revealed that hyperfamiliarity feelings were selectively associated to enhanced activity in the right medial and inferior temporal cortices. We therefore characterize the neurofunctional signature of hyperfamiliarity for unknown faces as related to the loss of coordinated activity between the complementary face processing functions of the left and right temporal lobes.	[Negro, Elisa; Rubino, Elisa; Rainero, Innocenzo; Pinessi, Lorenzo] Univ Turin, Dept Neurosci, Turin, Italy; [D'Agata, Federico; Caroppo, Paola; Coriasco, Mario; Ferrio, Federica] Univ Turin, Dept Neurosci, Neuroradiol, Turin, Italy; [Celeghin, Alessia; Diano, Matteo; Tamietto, Marco] Univ Turin, Dept Psychol, Turin, Italy; [Celeghin, Alessia; Tamietto, Marco] Tilburg Univ, Dept Med & Clin Psychol, NL-5000 LE Tilburg, Netherlands; [Celeghin, Alessia; Tamietto, Marco] Tilburg Univ, CoRPS Ctr Res Psychol Somat Dis, NL-5000 LE Tilburg, Netherlands; [de Gelder, Beatrice] Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands; [Tamietto, Marco] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Turin; University of Turin; University of Turin; Tilburg University; Tilburg University; Maastricht University; University of Oxford	Tamietto, M (corresponding author), Univ Turin, Dept Psychol, Turin, Italy.	marco.tamietto@unito.it	Caroppo, Paola/J-5044-2018; D'Agata, Federico/ABG-8839-2021; Diano, Matteo/U-4333-2017; Rubino, Elisa/K-3282-2016	Caroppo, Paola/0000-0003-4274-9004; D'Agata, Federico/0000-0001-9432-0248; Diano, Matteo/0000-0001-7024-5183; Rubino, Elisa/0000-0002-7553-7553; Celeghin, Alessia/0000-0002-4624-3564; Tamietto, Marco/0000-0002-8815-8499; Coriasco, Mario/0000-0001-9000-7473	Netherlands Organization for Scientific Research (NWO) [452-11-015]; Italian Ministry of Education University and Research (MIUR) [RBFR12F0BD]; Advanced ERC grant from the EU	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Italian Ministry of Education University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Advanced ERC grant from the EU	MT is supported by a Vidi grant from the Netherlands Organization for Scientific Research (NWO) (grant 452-11-015) and by a FIRB-Futuro in Ricerca 2012-grant from the Italian Ministry of Education University and Research (MIUR) (grant RBFR12F0BD). BdG is supported by an Advanced ERC grant from the EU-FP7.	Amlerova J, 2012, EPILEPSY BEHAV, V24, P332, DOI 10.1016/j.yebeh.2012.04.116; [Anonymous], 1994, ASSESSMENT CLIN MANU; Bowles B, 2007, P NATL ACAD SCI USA, V104, P16382, DOI 10.1073/pnas.0705273104; Bujarski K, 2008, EPILEPSY BEHAV, V13, P567, DOI 10.1016/j.yebeh.2008.06.003; Burra N, 2013, J NEUROSCI, V33, P10483, DOI 10.1523/JNEUROSCI.3994-12.2013; Corsi AT, 1972, HUMAN MEMORY MEDIAL; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; DERENZI E, 1991, CORTEX, V27, P213, DOI 10.1016/S0010-9452(13)80125-6; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Devinsky O, 2010, NEUROLOGY, V74, P970, DOI 10.1212/WNL.0b013e3181d5dc22; Devinsky O, 2009, NEUROLOGY, V72, P80, DOI 10.1212/01.wnl.0000338625.47892.74; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Dubois S, 1999, NEUROIMAGE, V9, P278, DOI 10.1006/nimg.1998.0409; ELLIS HD, 1990, BRIT J PSYCHIAT, V157, P239, DOI 10.1192/bjp.157.2.239; Evans S, 2007, SPATIAL VISION, V20, P61, DOI 10.1163/156856807779369742; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gainotti G, 2008, CORTEX, V44, P238, DOI 10.1016/j.cortex.2006.09.001; Gainotti G, 2007, BRAIN RES REV, V56, P214, DOI 10.1016/j.brainresrev.2007.07.009; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Gobbini MI, 2004, NEUROIMAGE, V22, P1628, DOI 10.1016/j.neuroimage.2004.03.049; Green DM, 1966, SIGNAL DETECTION THE; Grill-Spector K, 2014, NAT REV NEUROSCI, V15, P536, DOI 10.1038/nrn3747; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Harvey LO, 2010, RSCOREPLUS; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Julian JB, 2012, NEUROIMAGE, V60, P2357, DOI 10.1016/j.neuroimage.2012.02.055; Kosaka H, 2003, NEUROIMAGE, V20, P1734, DOI 10.1016/S1053-8119(03)00447-6; Kovalev VA, 2006, LECT NOTES COMPUT SC, V4191, P421; KRAEPELIN E, 1887, ARCH PSYCHIAT NERVEN, V18, P199; Lee TMC, 2002, EPILEPSIA, V43, P283, DOI 10.1046/j.1528-1157.2002.09901.x; Leveroni CL, 2000, J NEUROSCI, V20, P878, DOI 10.1523/JNEUROSCI.20-02-00878.2000; Michelucci R, 2010, EPILEPSY BEHAV, V19, P518, DOI 10.1016/j.yebeh.2010.08.008; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; Ohta Y, 2008, ANN NUCL MED, V22, P495, DOI 10.1007/s12149-008-0140-5; Rey A., 1958, LEXAMEN CLINIQUE PSY; Roberts DJ, 2015, CORTEX J DEVOTED STU, DOI [10.1016/j.cortex.2015.02.003, DOI 10.1016/J.CORTEX.2015.02.003]; Rossion B, 2001, J COGNITIVE NEUROSCI, V13, P1019, DOI 10.1162/089892901753165917; Shah NJ, 2001, BRAIN, V124, P804, DOI 10.1093/brain/124.4.804; Spinnler H, 1987, ITALIAN J NEUROLOGIC, V8, P539; Street R. F., 1931, GESTALT COMPLETION T; Sugiura M, 2011, J COGNITIVE NEUROSCI, V23, P699, DOI 10.1162/jocn.2010.21469; Sugiura M, 2009, J COGNITIVE NEUROSCI, V21, P1855, DOI 10.1162/jocn.2008.21150; Tamietto M, 2005, NEUROCASE, V11, P399, DOI 10.1080/13554790500259717; Tamietto M, 2007, J COGNITIVE NEUROSCI, V19, P445, DOI 10.1162/jocn.2007.19.3.445; Taylor MJ, 2009, HUM BRAIN MAPP, V30, P2008, DOI 10.1002/hbm.20646; Todorov A, 2013, CURR OPIN NEUROBIOL, V23, P373, DOI 10.1016/j.conb.2012.12.010; TUOKKO H, 1992, J AM GERIATR SOC, V40, P579, DOI 10.1111/j.1532-5415.1992.tb02106.x; Van den Stock J, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00030; Van den Stock J, 2013, J NEUROPSYCH CLIN N, V25, pE52, DOI 10.1176/appi.neuropsych.12120390; Vuilleumier P, 2003, BRAIN, V126, P889, DOI 10.1093/brain/awg086; Wechsler D, 1987, WMS R WECHSLER MEMOR; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961	54	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0129970	10.1371/journal.pone.0129970	http://dx.doi.org/10.1371/journal.pone.0129970			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154253	Green Published, gold, Green Submitted			2022-12-27	WOS:000358159700019
J	Todaro, MA; Dal Zotto, M; Leasi, F				Todaro, M. Antonio; Dal Zotto, Matteo; Leasi, Francesca			An Integrated Morphological and Molecular Approach to the Description and Systematisation of a Novel Genus and Species of Macrodasyida (Gastrotricha)	PLOS ONE			English	Article							ITALIAN MARINE GASTROTRICHA; NERVOUS-SYSTEM; DACTYLOPODOLA-BALTICA; MEDITERRANEAN SEA; MUSCULAR SYSTEM; CHAETONOTIDA; PHYLOGENY; FRESH; THAUMASTODERMATIDAE; KEY	Background Gastrotricha systematics is in a state of flux mainly due to the conflicts between cladistic studies base on molecular markers and the classical systematisation based on morphological traits. In sandy samples from Thailand, we found numerous macrodasyidan gastrotrichs belonging to an undescribed species of difficult taxonomic affiliation. The abundance and original nature of the specimens prompted us to undertake a deep survey of both morphological and molecular traits aiming at a reliable systematisation of the new taxon. Methodology/Principal Findings Using several microscopical techniques we investigated the external and internal anatomy, including the muscular and nervous systems of the new species. Additional specimens were used to obtain the 18S rRNA gene sequence; molecular data was analysed cladistically in conjunction with data from additional species belonging to the near complete Macrodasyida taxonomic spectrum. Specimens are vermiform, up to 806 mu m in total length, and show a well-defined head equipped with peculiar leaf-like sensorial organs and a single-lobed posterior end. The adhesive apparatus includes anterior, ventrolateral, dorsal and posterior tubes. Pharynx is about 1/4 of the total length and shows pores at its posterior 3/4. Adult specimens exhibit maturing eggs and a bulky, muscular caudal organ, but do not show sperm nor the frontal organ. Musculature and nervous system organisation resemble the usual macrodasyidan plan; however, the somatic circular muscles of the intestinal region surround all other muscular components and a third FMRFamide-IR commissure ventral to the pharyngo-intestinal junction appear to be an autoapomorphic traits of the new species. Conclusions/Significance While the anatomical characteristics of the Asian specimens appear so unique to grant the establishment of a new taxon, for which the name Thaidasys tongiorgii gen. et sp. nov. is proposed, the result of phylogenetic analyses based on the 18S rRNA gene unites the new genus with the family Macrodasyidae.	[Todaro, M. Antonio; Dal Zotto, Matteo] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Dal Zotto, Matteo] Consorzio Interuniv Ctr Biol Marina & Ecol Applic, Livorno, Italy; [Leasi, Francesca] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA	Universita di Modena e Reggio Emilia; Smithsonian Institution; Smithsonian National Museum of Natural History	Todaro, MA (corresponding author), Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy.	antonio.todaro@unimore.it	Leasi, Francesca/E-4361-2017; Todaro, M. Antonio/H-1311-2013	Leasi, Francesca/0000-0001-6995-0934; Todaro, M. Antonio/0000-0002-6353-7281; Dal Zotto, Matteo/0000-0003-1386-7626	TIOME project (MAT, PI)	TIOME project (MAT, PI)	Funding for this research was provided by the TIOME project (MAT, PI); the study falls within the framework of the strategic research line Environment, food and health (WP2) - of UNIMORE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Todaro MA, 2013, ZOOKEYS, P77, DOI 10.3897/zookeys.315.5593; Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Araujo TQ, 2014, MAR BIODIVERS, V44, P243, DOI 10.1007/s12526-013-0196-x; Atherton S, 2014, MAR BIOL RES, V10, P530, DOI 10.1080/17451000.2013.831179; Gilsa AVUZ, 2014, CAH BIOL MAR, V55, P333; Giribet G, 2004, CLADISTICS, V20, P1, DOI 10.1111/j.1096-0031.2004.00004.x; Guidi L., 2014, CONTRIBUTION ZOOLOGY, V83, P121; Hochberg R, 2005, MAR BIOL, V146, P315, DOI 10.1007/s00227-004-1437-0; Hochberg R, 2000, BIOL BULL, V198, P299, DOI 10.2307/1542532; Hochberg R, 2003, ACTA ZOOL-STOCKHOLM, V84, P171, DOI 10.1046/j.1463-6395.2003.00144.x; Hochberg R, 2001, ZOOL SCR, V30, P325, DOI 10.1046/j.1463-6409.2001.00066.x; Hochberg R, 2007, ZOOMORPHOLOGY, V126, P245, DOI 10.1007/s00435-007-0044-2; Hochberg R, 2014, MAR BIODIVERS, V44, P237, DOI 10.1007/s12526-013-0165-4; Hochberg R, 2014, MAR BIODIVERS, V44, P89, DOI 10.1007/s12526-013-0186-z; Hochberg R, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.289.4764; Hochberg R, 2011, ZOOL ANZ, V250, P111, DOI 10.1016/j.jcz.2010.12.002; HUMMON WD, 1992, B ZOOL, V59, P499, DOI 10.1080/11250009209386711; HUMMON WD, 1993, B ZOOL, V60, P109, DOI 10.1080/11250009309355798; Hummon WD, 2010, ZOOTAXA, P1; Kanneby T, 2014, MAR BIOL RES, V10, P983, DOI 10.1080/17451000.2013.872797; Kanneby T, 2013, ZOOTAXA, V3701, P551, DOI 10.11646/zootaxa.3701.5.3; Kanneby T, 2013, ZOOL SCR, V42, P88, DOI 10.1111/j.1463-6409.2012.00558.x; Kieneke A, 2014, HDB ZOOLOGY, V3, P1; Kieneke A, 2008, ZOOL SCR, V37, P429, DOI 10.1111/j.1463-6409.2008.00334.x; Kieneke Alexander, 2013, Meiofauna Marina, V20, P49; Kolicka M, 2013, ZOOTAXA, V3717, P231; Leasi F, 2008, BIOL J LINN SOC, V94, P379, DOI 10.1111/j.1095-8312.2008.00974.x; Leasi F, 2009, ZOOL ANZ, V248, P47, DOI 10.1016/j.jcz.2008.10.002; Leasi F, 2009, MAR BIOL, V156, P1335, DOI 10.1007/s00227-009-1175-4; Lee Jimin, 2014, Animal Systematics Evolution and Diversity, V30, DOI 10.5635/ASED.2014.30.2.103; Lee J, 2014, P BIOL SOC WASH, V127, P209, DOI 10.2988/0006-324X-127.1.209; Lee JM, 2013, ZOOTAXA, V3709, P483; Liesenjohann T, 2006, J MORPHOL, V267, P897, DOI 10.1002/jmor.10419; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Petrov NB, 2007, MOL BIOL+, V41, P445, DOI 10.1134/S0026893307030107; Remane A., 1936, Bolk Handbuch der Vergleichenden Anatomie der Wirbeltiere Wien, V4, P1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rothe BH, 2011, ZOOMORPHOLOGY, V130, P51, DOI 10.1007/s00435-011-0123-2; Rothe Birgen H., 2010, Meiofauna Marina, V18, P49; Rothe BH, 2009, ZOOMORPHOLOGY, V128, P227, DOI 10.1007/s00435-008-0077-1; Rothe Birgen H., 2008, Meiofauna Marina, V16, P175; Ruppert E.E., 1991, P41; RUPPERT EE, 1978, ZOOMORPHOLOGIE, V89, P207, DOI 10.1007/BF00993948; Schmidt-Rhaesa A, 2014, DEEP METAZOAN PHYLOGENY: THE BACKBONE OF THE TREE OF LIFE, P93; Schwank P, 2014, ZOOTAXA, V3811, P463, DOI 10.11646/zootaxa.3811.4.3; SEWARDTHOMPSON BL, 1973, SEDIMENTOLOGY, V20, P161, DOI 10.1111/j.1365-3091.1973.tb01612.x; Sorensen MV, 2006, CLADISTICS, V22, P32, DOI 10.1111/j.1096-0031.2006.00085.x; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Suzuki TG, 2013, ZOOTAXA, V3691, P229, DOI 10.11646/zootaxa.3691.2.3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Todaro MA, 2006, J MAR BIOL ASSOC UK, V86, P1005, DOI 10.1017/S0025315406013981; Todaro M. A., 2015, WORLD REGISTER MARIN; Todaro MA, 2006, ZOOL SCR, V35, P251, DOI 10.1111/j.1463-6409.2006.00228.x; Todaro MA, 2006, MAR BIOL, V149, P1079, DOI 10.1007/s00227-006-0299-z; Todaro MA, 2015, ZOOTAXA, V3905, P193, DOI 10.11646/zootaxa.3905.2.2; Todaro MA, 2014, SYST BIODIVERS, V12, P473, DOI 10.1080/14772000.2014.942718; Todaro M. Antonio, 2013, Meiofauna Marina, V20, P33; Todaro MA, 2013, ZOOKEYS, P13, DOI 10.3897/zookeys.289.4683; Todaro MA, 2012, ZOOMORPHOLOGY, V131, P115, DOI 10.1007/s00435-012-0147-2; Todaro MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031740; Todaro MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017892; Todaro M. Antonio, 2008, Meiofauna Marina, V16, P3; Todaro MA, 2002, J MAR BIOL ASSOC UK, V82, P555, DOI 10.1017/S0025315402005878; Todaro MA, 2015, GASTROTRICHA WORLD P	65	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130278	10.1371/journal.pone.0130278	http://dx.doi.org/10.1371/journal.pone.0130278			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26153694	Green Published, gold			2022-12-27	WOS:000358159700027
J	Wittig, C; Scheuer, C; Parakenings, J; Menger, MD; Laschke, MW				Wittig, Christine; Scheuer, Claudia; Parakenings, Julia; Menger, Michael D.; Laschke, Matthias W.			Geraniol Suppresses Angiogenesis by Downregulating Vascular Endothelial Growth Factor (VEGF)/VEGFR-2 Signaling	PLOS ONE			English	Article							IN-VITRO; CHEMOPREVENTIVE EFFICACY; 4-HYDROXYBENZYL ALCOHOL; TUMOR ANGIOGENESIS; CELL-MIGRATION; ESSENTIAL OILS; CANCER CELLS; HOST TISSUE; LINE; CARCINOGENESIS	Geraniol exerts several direct pharmacological effects on tumor cells and, thus, has been suggested as a promising anti-cancer compound. Because vascularization is a major precondition for tumor growth, we analyzed in this study the anti-angiogenic action of geraniol. In vitro, geraniol reduced the migratory activity of endothelial-like eEND2 cells. Western blot analyses further revealed that geraniol downregulates proliferating cell nuclear antigen (PCNA) and upregulates cleaved caspase-3 (Casp-3) expression in eEND2 cells. Moreover, geraniol blocked vascular endothelial growth factor (VEGF)/VEGFR-2 signal transduction, resulting in a suppression of downstream AKT and ERK signaling pathways. In addition, geraniol significantly reduced vascular sprout formation in a rat aortic ring assay. In vivo, geraniol inhibited the vascularization of CT26 tumors in dorsal skinfold chambers of BALB/c mice, which was associated with a smaller tumor size when compared to vehicle-treated controls. Immunohistochemical analyses confirmed a decreased number of Ki67-positive cells and CD31-positive microvessels with reduced VEGFR-2 expression within geraniol-treated tumors. Taken together, these findings indicate that geraniol targets multiple angiogenic mechanisms and, therefore, is an attractive candidate for the anti-angiogenic treatment of tumors.	[Wittig, Christine; Scheuer, Claudia; Parakenings, Julia; Menger, Michael D.; Laschke, Matthias W.] Univ Saarland, Inst Clin & Expt Surg, Homburg, Germany	Saarland University	Laschke, MW (corresponding author), Univ Saarland, Inst Clin & Expt Surg, Homburg, Germany.	matthias.laschke@uks.eu						Ahmad ST, 2011, TOXICOLOGY, V290, P69, DOI 10.1016/j.tox.2011.08.020; Araujo FA, 2010, BIOMED PHARMACOTHER, V64, P29, DOI 10.1016/j.biopha.2009.03.003; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; BAKER M, 1974, MICROVASC RES, V7, P131, DOI 10.1016/0026-2862(74)90043-0; Besser D, 1995, ONCOGENE, V11, P2383; Carnesecchi S, 2004, CANCER LETT, V215, P53, DOI 10.1016/j.canlet.2004.06.019; Chaudhary SC, 2013, J APPL TOXICOL, V33, P828, DOI 10.1002/jat.2739; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; De Vriese AS, 2000, J VASC RES, V37, P26, DOI 10.1159/000025710; Ehrmantraut S, 2010, EUR CELLS MATER, V19, P107, DOI 10.22203/eCM.v019a11; Feng Chong, 2006, Semin Ophthalmol, V21, P29, DOI 10.1080/08820530500509382; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Galle M, 2014, NUTR CANC, V29, P1; GRISWOLD DP, 1975, CANCER, V36, P2441, DOI 10.1002/1097-0142(197512)36:6<2441::AID-CNCR2820360627>3.0.CO;2-P; Gu Y, 2013, ANTI-CANCER DRUG, V24, P781, DOI 10.1097/CAD.0b013e328362fb84; Jin XX, 2013, J INT MED RES, V41, P993, DOI 10.1177/0300060513480919; Katsukawa M, 2011, BIOSCI BIOTECH BIOCH, V75, P1010, DOI 10.1271/bbb.110039; Khan AQ, 2013, EXP MOL PATHOL, V94, P419, DOI 10.1016/j.yexmp.2013.01.006; Kim SH, 2012, INT J ONCOL, V40, P1683, DOI 10.3892/ijo.2011.1318; Kim SH, 2011, BIOCHEM BIOPH RES CO, V407, P129, DOI 10.1016/j.bbrc.2011.02.124; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Kollmar O, 2007, NEOPLASIA, V9, P862, DOI 10.1593/neo.07559; Laschke MW, 2013, ACTA BIOMATER, V9, P6876, DOI 10.1016/j.actbio.2013.02.013; Laschke MW, 2011, EUR CELLS MATER, V22, P147, DOI 10.22203/eCM.v022a12; Laschke MW, 2011, BRIT J PHARMACOL, V163, P835, DOI 10.1111/j.1476-5381.2011.01292.x; Laschke MW, 2013, LIFE SCI, V93, P44, DOI 10.1016/j.lfs.2013.05.022; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lauro S, 2014, ANTICANCER RES, V34, P1537; Madankumar A, 2013, EUR J PHARMACOL, V705, P148, DOI 10.1016/j.ejphar.2013.02.048; Manoharan S, 2012, J ENVIRON BIOL, V33, P255; Marcuzzi A, 2011, IN VIVO, V25, P87; Marques I, 2013, WORLD J GASTROENTERO, V19, P7955, DOI 10.3748/wjg.v19.i44.7955; de Carvalho KIM, 2014, N-S ARCH PHARMACOL, V387, P355, DOI 10.1007/s00210-013-0947-z; Nenicu A, 2014, HUM REPROD, V29, P1011, DOI 10.1093/humrep/deu035; NICOSIA RF, 1995, LAB INVEST, V73, P658; Ong TP, 2012, CURR CANCER DRUG TAR, V12, P1173; Polo MP, 2011, CELL BIOCHEM FUNCT, V29, P452, DOI 10.1002/cbf.1772; RAK JW, 1995, ANTI-CANCER DRUG, V6, P3, DOI 10.1097/00001813-199502000-00001; Sagar S M, 2006, Curr Oncol, V13, P14; Saif Muhammad Wasif, 2013, Cancer Manag Res, V5, P103, DOI 10.2147/CMAR.S45193; Schmidt E, 2012, NAT PROD COMMUN, V7, P1095; Tsai ML, 2011, BIOSCI BIOTECH BIOCH, V75, P1977, DOI 10.1271/bbb.110377; Unger RE, 2002, MICROVASC RES, V64, P384, DOI 10.1006/mvre.2002.2434; Vinothkumar V, 2012, MOL CELL BIOCHEM, V369, P17, DOI 10.1007/s11010-012-1364-1; Vinothkumar V, 2011, REDOX REP, V16, P91, DOI 10.1179/174329211X13020951739839; Walser R, 2013, EUR CELLS MATER, V26, P222, DOI 10.22203/eCM.v026a16; Wiseman DA, 2007, J PHARMACOL EXP THER, V320, P1163, DOI 10.1124/jpet.106.111666; YU SG, 1995, J NUTR, V125, P2763; Zhang F, 2014, J CELL MOL MED, V18, P1392, DOI 10.1111/jcmm.12286	49	32	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131946	10.1371/journal.pone.0131946	http://dx.doi.org/10.1371/journal.pone.0131946			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154255	Green Published, gold, Green Submitted			2022-12-27	WOS:000358159700084
J	Menoret, M; Bourguignon, M; Hari, R				Menoret, Mathilde; Bourguignon, Mathieu; Hari, Riitta			Modulation of Rolandic Beta-Band Oscillations during Motor Simulation of Joint Actions	PLOS ONE			English	Article							FUNCTIONAL-ORGANIZATION; NEURAL SIMULATION; INFERIOR AREA-6; MACAQUE MONKEY; MIRROR-IMAGE; REPRESENTATION; CORTEX; IMITATION; PREMOTOR; TASK	Successful joint actions require precise temporal and spatial coordination between individuals who aim to achieve a common goal. A growing number of behavioral data suggest that to efficiently couple and coordinate a joint task, the actors have to represent both own and the partner's actions. However it is unclear how the motor system is specifically recruited for joint actions. To find out how the goal and the presence of the partner's hand can impact the motor activity during joint action, we assessed the functional state of 16 participants' motor cortex during observation and associated motor imagery of joint actions, individual actions, and non-goal-directed actions performed with either 1 or 2 hands. As an indicator of the functional state of the motor cortex, we used the reactivity of the rolandic magnetoencephalographic (MEG) beta rhythm following median-nerve stimulation. Motor imagery combined with action observation was associated with activation of the observer's motor cortex, mainly in the hemisphere contralateral to the viewed (and at the same time imagined) hand actions. The motor-cortex involvement was enhanced when the goal of the actions was visible but also, in the ipsilateral hemisphere, when the partner's hand was visible in the display. During joint action, the partner's action, in addition to the participant's own action, thus seems to be represented in the motor cortex so that it can be triggered by the mere presence of an acting hand in the peripersonal space.	[Menoret, Mathilde; Bourguignon, Mathieu; Hari, Riitta] Aalto Univ, Dept Neurosci & Biomed Engn, Brain Res Unit, Aalto, Finland; [Menoret, Mathilde] CNRS UCBL, UMR5304, Lab Langage Cerveau & Cognit L2C2, Lyon, France; [Menoret, Mathilde; Bourguignon, Mathieu; Hari, Riitta] Aalto Univ, Aalto NeuroImaging, MEG Core, Aalto, Finland	Aalto University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Aalto University	Menoret, M (corresponding author), Aalto Univ, Dept Neurosci & Biomed Engn, Brain Res Unit, Aalto, Finland.	menoret@neuro.hut.fi	Bourguignon, Mathieu/I-6967-2012; Hari, Riitta K/J-1880-2012	Bourguignon, Mathieu/0000-0003-1694-5087; Hari, Riitta K/0000-0002-3142-2703; Menoret, Mathilde/0000-0002-9431-4339	Direction Generale de l'Armement (DGA); Academy of Finland [131483, 263800]; European Research Council [232946]	Direction Generale de l'Armement (DGA)(General Electric); Academy of Finland(Academy of Finland); European Research Council(European Research Council (ERC)European Commission)	This study was supported by a postdoctoral grant from the Direction Generale de l'Armement (DGA) and funding from Academy of Finland (Grants #131483, #263800), and European Research Council (Advanced Grant #232946). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avikainen S, 2003, CURR BIOL, V13, P339, DOI 10.1016/S0960-9822(03)00087-3; Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Bekkering H, 2009, TOP COGN SCI, V1, P340, DOI 10.1111/j.1756-8765.2009.01023.x; Blomberg O, 2011, REV PHILOS PSYCHOL, V2, P335, DOI 10.1007/s13164-011-0054-3; Brozzoli C, 2014, NEUROSCIENTIST, V20, P122, DOI 10.1177/1073858413511153; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Butterfill SA, 2011, REV PHILOS PSYCHOL, V2, P137, DOI 10.1007/s13164-011-0062-3; Caetano G, 2007, P NATL ACAD SCI USA, V104, P9058, DOI 10.1073/pnas.0702453104; Cattaneo L, 2009, J NEUROSCI, V29, P11134, DOI 10.1523/JNEUROSCI.2605-09.2009; Chiavarino C, 2007, NEUROPSYCHOLOGIA, V45, P784, DOI 10.1016/j.neuropsychologia.2006.08.007; de Bruijn ERA, 2008, CORTEX, V44, P580, DOI 10.1016/j.cortex.2007.09.003; de Vignemont F, 2014, NEUROPSYCHOLOGIA, V55, P128, DOI 10.1016/j.neuropsychologia.2013.08.013; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; GENTILUCCI M, 1988, EXP BRAIN RES, V71, P475, DOI 10.1007/BF00248741; Gerloff C, 1998, BRAIN, V121, P1695, DOI 10.1093/brain/121.9.1695; Gilbert M, 2009, PHILOS STUD, V144, P167, DOI 10.1007/s11098-009-9372-z; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Hari R, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0171; ISHIKURA T, 1995, PERCEPT MOTOR SKILL, V80, P651, DOI 10.2466/pms.1995.80.2.651; Jarvelainen J, 2004, NEUROIMAGE, V23, P187, DOI 10.1016/j.neuroimage.2004.06.010; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Keller PE, 2007, CONSCIOUS COGN, V16, P102, DOI 10.1016/j.concog.2005.12.004; Kilner JM, 2006, SOC COGN AFFECT NEUR, V1, P143, DOI 10.1093/scan/nsl017; Knoblich G, 2011, PSYCHOL LEARN MOTIV, V54, P59, DOI 10.1016/B978-0-12-385527-5.00003-6; Koski L, 2003, J NEUROPHYSIOL, V89, P460, DOI 10.1152/jn.00248.2002; Koski L, 2002, CEREB CORTEX, V12, P847, DOI 10.1093/cercor/12.8.847; Kourtis D, 2014, J COGNITIVE NEUROSCI, V26, P2275, DOI 10.1162/jocn_a_00634; Kourtis D, 2013, NEUROPSYCHOLOGIA, V51, P1240, DOI 10.1016/j.neuropsychologia.2013.04.001; Lorey B, 2014, HUM BRAIN MAPP, V35, P1212, DOI 10.1002/hbm.22246; Menoret M, 2014, NEUROPSYCHOLOGIA, V55, P85, DOI 10.1016/j.neuropsychologia.2013.10.001; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Muthukumaraswamy SD, 2004, COGNITIVE BRAIN RES, V19, P195, DOI 10.1016/j.cogbrainres.2003.12.001; Newman-Norlund RD, 2008, NEUROIMAGE, V41, P169, DOI 10.1016/j.neuroimage.2008.02.026; Newman-Norlund RD, 2007, NAT NEUROSCI, V10, P817, DOI 10.1038/nn1911; Nishitani N, 2000, P NATL ACAD SCI USA, V97, P913, DOI 10.1073/pnas.97.2.913; Novembre G, 2014, SOC COGN AFFECT NEUR, V9, P1062, DOI 10.1093/scan/nst086; Ocampo B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026945; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pacherie E, 2011, REV PHILOS PSYCHOL, V2, P173, DOI 10.1007/s13164-011-0052-5; Pezzulo G, 2011, REV PHILOS PSYCHOL, V2, P303, DOI 10.1007/s13164-011-0060-5; Pogosyan A, 2009, CURR BIOL, V19, P1637, DOI 10.1016/j.cub.2009.07.074; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Sartori L, 2012, SOC NEUROSCI-UK, V7, P146, DOI 10.1080/17470919.2011.586579; Schnitzler A, 1997, NEUROIMAGE, V6, P201, DOI 10.1006/nimg.1997.0286; Schuch S, 2010, EXP BRAIN RES, V205, P235, DOI 10.1007/s00221-010-2358-4; Sebanz N, 2006, J COGNITIVE NEUROSCI, V18, P859, DOI 10.1162/jocn.2006.18.5.859; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Streltsova A, 2010, EXP BRAIN RES, V205, P363, DOI 10.1007/s00221-010-2371-7; Taulu S, 2006, PHYS MED BIOL, V51, P1759, DOI 10.1088/0031-9155/51/7/008; Tsai CC, 2008, J COGNITIVE NEUROSCI, V20, P2015, DOI 10.1162/jocn.2008.20144; Uutela K, 2001, NEUROIMAGE, V14, P1424, DOI 10.1006/nimg.2001.0915; Valchev N, 2014, NEUROPSYCHOLOGIA C, V66C, P237, DOI [10.1016/j.neuropsychologia.2014.11.030, DOI 10.1016/J.NEUR0PSYCHOLOGIA.2014.11.030]; van Elk M, 2012, EXP BRAIN RES, V218, P189, DOI 10.1007/s00221-012-3016-9; Vesper C, 2014, NEUROPSYCHOLOGIA, V55, P115, DOI 10.1016/j.neuropsychologia.2013.05.024; Vesper C, 2013, J EXP PSYCHOL HUMAN, V39, P48, DOI 10.1037/a0028066; Vogt S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00807; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238	62	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131655	10.1371/journal.pone.0131655	http://dx.doi.org/10.1371/journal.pone.0131655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151634	Green Published, gold, Green Submitted			2022-12-27	WOS:000358158900022
J	Mori, M; Adland, E; Paioni, P; Swordy, A; Mori, L; Laker, L; Muenchhoff, M; Matthews, PC; Tudor-Williams, G; Lavandier, N; van Zyl, A; Hurst, J; Walker, BD; Ndung'u, T; Prendergast, A; Goulder, P; Jooste, P				Mori, Masahiko; Adland, Emily; Paioni, Paolo; Swordy, Alice; Mori, Luisa; Laker, Leana; Muenchhoff, Maximilian; Matthews, Philippa C.; Tudor-Williams, Gareth; Lavandier, Nora; van Zyl, Anriette; Hurst, Jacob; Walker, Bruce D.; Ndung'u, Thumbi; Prendergast, Andrew; Goulder, Philip; Jooste, Pieter			Sex Differences in Antiretroviral Therapy Initiation in Pediatric HIV Infection	PLOS ONE			English	Article							GENDER-DIFFERENCES; RNA LEVELS; IMMUNOLOGICAL OUTCOMES; CHILDREN; PROGRESSION; WOMEN; MORTALITY; RISK; TRANSMISSION; SUPPRESSION	The incidence and severity of infections in childhood is typically greater in males. The basis for these observed sex differences is not well understood, and potentially may facilitate novel approaches to reducing disease from a range of conditions. We here investigated sex differences in HIV-infected children in relation to antiretroviral therapy (ART) initiation and post-treatment outcome. In a South African cohort of 2,101 HIV-infected children, we observed that absolute CD4+ count and CD4% were significantly higher in ART-naive female, compared to age-matched male, HIV-infected children. Absolute CD4 count and CD4% were also significantly higher in HIV-uninfected female versus male neonates. We next showed that significantly more male than female children were initiated on ART (47% female); and children not meeting criteria to start ART by >5yrs were more frequently female (59%; p<0.001). Among ART-treated children, immune reconstitution of CD4 T-cells was more rapid and more complete in female children, even after adjustment for pre-ART absolute CD4 count or CD4% (p=0.011, p=0.030, respectively). However, while ART was initiated as a result of meeting CD4 criteria less often in females (45%), ART initiation as a result of clinical disease in children whose CD4 counts were above treatment thresholds occurred more often in females (57%, p<0.001). The main sex difference in morbidity observed in children initiating ART above CD4 thresholds, above that of TB disease, was as a result of wasting and stunting observed in females with above-threshold CD4 counts (p=0.002). These findings suggest the possibility that optimal treatment of HIV-infected children might incorporate differential CD4 treatment thresholds for ART initiation according to sex.	[Mori, Masahiko; Adland, Emily; Paioni, Paolo; Swordy, Alice; Mori, Luisa; Muenchhoff, Maximilian; Matthews, Philippa C.; Lavandier, Nora; Goulder, Philip] Univ Oxford, Dept Paediat, Oxford, England; [Mori, Luisa; van Zyl, Anriette; Jooste, Pieter] Kimberley Hosp, Durban, South Africa; [Tudor-Williams, Gareth] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London, England; [Hurst, Jacob] Univ Oxford, Nuffield Dept Med, Oxford, England; [Walker, Bruce D.] MIT & Harvard, Ragon Inst MGH, Boston, MA USA; [Walker, Bruce D.; Ndung'u, Thumbi; Goulder, Philip] Univ KwaZulu Natal, Doris Duke Med Res Inst, Durban, South Africa; [Ndung'u, Thumbi] Univ KwaZulu Natal, KwaZulu Natal Res Inst TB & HIV K RITH, Durban, South Africa; [Ndung'u, Thumbi] Max Planck Inst Infect Biol, Berlin, Germany; [Prendergast, Andrew] Queen Mary Univ London, Ctr Paediat, Blizard Inst, London, England	University of Oxford; Imperial College London; University of Oxford; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Kwazulu Natal; University of Kwazulu Natal; Max Planck Society; University of London; Queen Mary University London	Goulder, P (corresponding author), Univ Oxford, Dept Paediat, Oxford, England.	philip.goulder@paediatrics.ox.ac.uk	Laker, Leana/AAW-1247-2020; Matthews, Philippa/P-7810-2019	Matthews, Philippa/0000-0002-4036-4269; Muenchhoff, Maximilian/0000-0001-7016-0470; Ndung'u, Thumbi/0000-0003-2962-3992; Paioni, Paolo/0000-0002-3904-1606; Prendergast, Andrew/0000-0001-7904-7992	Medical Research Council [G0501777, G0500384] Funding Source: Medline; Wellcome Trust [104748] Funding Source: Medline; National Institute for Health Research [CL-2011-13-005, CL-2009-13-005] Funding Source: researchfish; MRC [G0500384, G0501777] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aaby P, 2011, J INFECT DIS, V204, P245, DOI 10.1093/infdis/jir240; Aaby P, 2011, HUM VACCINES, V7, P120, DOI 10.4161/hv.7.1.13848; Alonso LC, 2002, BEST PRACT RES CL EN, V16, P13, DOI 10.1053/beem.2002.0177; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Biggar RJ, 2006, JAIDS-J ACQ IMM DEF, V41, P509, DOI 10.1097/01.qai.0000191283.85578.46; Bong CN, 2007, AIDS, V21, P1805, DOI 10.1097/QAD.0b013e3282c3a9e4; Delmas MC, 1997, AIDS, V11, P1071; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; Foca M, 2006, PEDIATRICS, V118, P146, DOI 10.1542/peds.2005-0294; Furman D, 2014, P NATL ACAD SCI USA, V111, P869, DOI 10.1073/pnas.1321060111; Gabrielli L, 2012, CLIN MICROBIOL INFEC, V18, pE419, DOI 10.1111/j.1469-0691.2012.03983.x; Galli L, 2005, JAIDS-J ACQ IMM DEF, V40, P479, DOI 10.1097/01.qai.0000164247.49098.0e; Gandhi M, 2002, CLIN INFECT DIS, V35, P313, DOI 10.1086/341249; Gandhi RT, 2006, JAIDS-J ACQ IMM DEF, V42, P426, DOI 10.1097/01.qai.0000226789.51992.3f; Giaquinto C, 2004, AIDS, V18, P2009, DOI 10.1097/00002030-200410210-00005; Hunt PW, 2003, AIDS, V17, P1907, DOI 10.1097/00002030-200309050-00009; Khosla S, 1998, J CLIN ENDOCR METAB, V83, P2266, DOI 10.1210/jc.83.7.2266; Kiboneka A, 2008, AIDS, V22, P2493, DOI 10.1097/QAD.0b013e328318f148; Klein SL, 2013, VACCINE, V31, P2599, DOI 10.1016/j.vaccine.2013.02.070; Klein SL, 2000, BEHAV PROCESS, V51, P149, DOI 10.1016/S0376-6357(00)00125-X; Leyenaar JK, 2010, PEDIATR INFECT DIS J, V29, P340, DOI 10.1097/INF.0b013e3181bf8ecb; Lowenthal ED, 2014, LANCET INFECT DIS, V14, P627, DOI 10.1016/S1473-3099(13)70363-3; Maini MK, 1996, GENITOURIN MED, V72, P27; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Mphatswe W, 2007, AIDS, V21, P1253, DOI 10.1097/QAD.0b013e3281a3bec2; Muenchhoff M, 2014, J INFECT DIS, V209, pS120, DOI 10.1093/infdis/jiu232; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Pernis AB, 2007, CURR OPIN RHEUMATOL, V19, P414, DOI 10.1097/BOR.0b013e328277ef2a; Picone O, 2005, PRENATAL DIAG, V25, P34, DOI 10.1002/pd.944; Piwoz EG, 2006, AIDS, V20, P1981, DOI 10.1097/01.aids.0000247123.04703.6e; Prendergast A, 2008, AIDS, V22, P1333, DOI 10.1097/QAD.0b013e32830437df; Prendergast AJ, 2012, NAT REV IMMUNOL, V12, P636, DOI 10.1038/nri3277; Puthanakit T, 2009, PEDIATR INFECT DIS J, V28, P488, DOI 10.1097/INF.0b013e318194eea6; Ruel TD, 2011, CLIN INFECT DIS, V53, P592, DOI 10.1093/cid/cir484; Shann F, 2010, ARCH DIS CHILD, V95, P662, DOI 10.1136/adc.2009.157537; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Siberry GK, 2011, JAIDS-J ACQ IMM DEF, V57, P223, DOI 10.1097/QAI.0b013e318218e068; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; Sterling TR, 1999, J INFECT DIS, V180, P666, DOI 10.1086/314967; Taha TE, 2005, PEDIATRICS, V115, pE167, DOI 10.1542/peds.2004-1590; van de Berg PJEJ, 2012, CLIN VACCINE IMMUNOL, V19, P772, DOI 10.1128/CVI.00011-12; Yin DE, 2014, PEDIATRICS, V134, pE1104, DOI 10.1542/peds.2014-0527; Zanoni BC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022706	45	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131591	10.1371/journal.pone.0131591	http://dx.doi.org/10.1371/journal.pone.0131591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151555	Green Published, Green Submitted, gold			2022-12-27	WOS:000358158900021
J	Castro-Vale, I; Severo, M; Carvalho, D; Mota-Cardoso, R				Castro-Vale, Ivone; Severo, Milton; Carvalho, Davide; Mota-Cardoso, Rui			Emotion Recognition Ability Test Using JACFEE Photos: A Validity/Reliability Study of a War Veterans' Sample and Their Offspring	PLOS ONE			English	Article							FACIAL EXPRESSIONS; BIPOLAR DISORDER; FACES; PERCEPTION; CHILDREN; VALIDATION; AUTISM; DEPRESSION; MODELS; RISK	Emotion recognition is very important for social interaction. Several mental disorders influence facial emotion recognition. War veterans and their offspring are subject to an increased risk of developing psychopathology. Emotion recognition is an important aspect that needs to be addressed in this population. To our knowledge, no test exists that is validated for use with war veterans and their offspring. The current study aimed to validate the JACFEE photo set to study facial emotion recognition in war veterans and their offspring. The JACFEE photo set was presented to 135 participants, comprised of 62 male war veterans and 73 war veterans' offspring. The participants identified the facial emotion presented from amongst the possible seven emotions that were tested for: anger, contempt, disgust, fear, happiness, sadness, and surprise. A loglinear model was used to evaluate whether the agreement between the intended and the chosen emotions was higher than the expected. Overall agreement between chosen and intended emotions was 76.3%(Cohen kappa = 0.72). The agreement ranged from 63% (sadness expressions) to 91% (happiness expressions). The reliability by emotion ranged from 0.617 to 0.843 and the overall JACFEE photo set Cronbach alpha was 0.911. The offspring showed higher agreement when compared with the veterans (RR: 41.52 vs 12.12, p < 0.001), which confirms the construct validity of the test. The JACFEE set of photos showed good validity and reliability indices, which makes it an adequate instrument for researching emotion recognition ability in the study sample of war veterans and their respective offspring.	[Castro-Vale, Ivone; Mota-Cardoso, Rui] Univ Porto, Med Psychol Unit, Dept Clin Neurosci & Mental Hlth, Fac Med, P-4100 Porto, Portugal; [Severo, Milton] Univ Porto, Dept Clin Epidemiol Predict Med & Publ Hlth, Fac Med, P-4100 Porto, Portugal; [Severo, Milton] Univ Porto, Dept Med Educ & Simulat, Fac Med, P-4100 Porto, Portugal; [Carvalho, Davide] Univ Porto, Dept Endocrinol Diabet & Metab, Fac Med, Ctr Hosp Sao Joao, P-4100 Porto, Portugal; [Carvalho, Davide] Univ Porto, Inst Invest & Inovacao Saude, P-4100 Porto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Sao Joao Hospital; Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto	Castro-Vale, I (corresponding author), Univ Porto, Med Psychol Unit, Dept Clin Neurosci & Mental Hlth, Fac Med, Rua Campo Alegre 823, P-4100 Porto, Portugal.	ivonecastrovale@med.up.pt	Severo, Milton/I-3497-2012; Carvalho, Davide/AAR-2081-2020; Castro-Vale, Ivone/V-6018-2019	Severo, Milton/0000-0002-5787-4871; Carvalho, Davide/0000-0002-3156-3741; Castro-Vale, Ivone/0000-0002-5343-0229				ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Adolphs R, 2010, CURR BIOL, V20, pR549, DOI 10.1016/j.cub.2010.05.046; Atkinson MJ, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-65; Biehl M, 1997, J NONVERBAL BEHAV, V21, P3, DOI 10.1023/A:1024902500935; Burkhouse KL, 2016, COGNITION EMOTION, V30, P275, DOI 10.1080/02699931.2014.996531; Cai LQ, 2012, PSYCHOPATHOLOGY, V45, P294, DOI 10.1159/000334252; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Davidson AC, 2001, AUST NZ J PSYCHIAT, V35, P345, DOI 10.1046/j.1440-1614.2001.00897.x; Dawel A, 2012, NEUROSCI BIOBEHAV R, V36, P2288, DOI 10.1016/j.neubiorev.2012.08.006; De Albuquerque Afonso, 2003, Acta Med Port, V16, P309; Demenescu LR, 2014, EXP AGING RES, V40, P187, DOI 10.1080/0361073X.2014.882210; Demirbuga S, 2013, SCHIZOPHR RES, V144, P142, DOI 10.1016/j.schres.2012.12.015; Dickey CC, 2011, SCHIZOPHR RES, V131, P242, DOI 10.1016/j.schres.2011.04.020; Dodich A, 2014, NEUROL SCI, V35, P1015, DOI 10.1007/s10072-014-1631-x; Ekman P, 2011, EMOT REV, V3, P364, DOI 10.1177/1754073911410740; Elfenbein HA, 2004, COGNITION EMOTION, V18, P613, DOI 10.1080/02699930341000257; Enticott PG, 2014, COGNITION EMOTION, V28, P1110, DOI 10.1080/02699931.2013.867832; Farb NAS, 2013, CURR OPIN NEUROBIOL, V23, P393, DOI 10.1016/j.conb.2013.01.015; Friesen E., 1978, FACIAL ACTION CODING, V3, P5; Goeleven E, 2008, COGNITION EMOTION, V22, P1094, DOI 10.1080/02699930701626582; Greimel E, 2014, J NEURAL TRANSM, V121, P1171, DOI 10.1007/s00702-014-1206-2; Hipp G, 2014, J NEUROL SCI, V338, P178, DOI 10.1016/j.jns.2013.12.047; Kessler H, 2008, PSYCHOSOC MED, V5; Kohler CG, 2011, PSYCHIAT RES, V188, P303, DOI 10.1016/j.psychres.2011.04.019; Kohler Christian G, 2010, Schizophr Bull, V36, P1009, DOI 10.1093/schbul/sbn192; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Le Masurier M, 2007, PSYCHOL MED, V37, P403, DOI 10.1017/S003391706009184; LeDoux J, 2012, NEURON, V73, P653, DOI 10.1016/j.neuron.2012.02.004; LEVENSON RW, 1990, PSYCHOPHYSIOLOGY, V27, P363, DOI 10.1111/j.1469-8986.1990.tb02330.x; LEVENSON RW, 1992, J PERS SOC PSYCHOL, V62, P972, DOI 10.1037/0022-3514.62.6.972; Lin IM, 2013, PSYCHIAT INVEST, V10, P393, DOI 10.4306/pi.2013.10.4.393; Lopez-Duran NL, 2013, J CHILD PSYCHOL PSYC, V54, P565, DOI 10.1111/jcpp.12005; MacPherson SE, 2006, AGING CLIN EXP RES, V18, P418; Matsumoto D, 2004, J PERS SOC PSYCHOL, V87, P529, DOI 10.1037/0022-3514.87.4.529; MATSUMOTO D, 1994, AUST J PSYCHOL, V46, P58, DOI 10.1080/00049539408259471; Matsumoto D, 1988, JAPANESE AND CAUCASI; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; Meyer D, 2006, J STAT SOFTW, V17; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; Montagne Barbara, 2005, Cogn Process, V6, P136, DOI 10.1007/s10339-005-0050-6; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Pedras S, 2014, MIL BEHAV HEALTH, V2, P52; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Poljac E, 2011, CORTEX, V47, P974, DOI 10.1016/j.cortex.2010.10.002; Ruffman T, 2008, NEUROSCI BIOBEHAV R, V32, P863, DOI 10.1016/j.neubiorev.2008.01.001; Sareen J, 2007, ARCH GEN PSYCHIAT, V64, P843, DOI 10.1001/archpsyc.64.7.843; Sauter DA, 2010, P NATL ACAD SCI USA, V107, P2408, DOI 10.1073/pnas.0908239106; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; Scrimin S, 2009, DEV PSYCHOL, V45, P1341, DOI 10.1037/a0016689; Sprengelmeyer R, 1996, BRAIN, V119, P1647, DOI 10.1093/brain/119.5.1647; Surguladze SA, 2010, NEUROIMAGE, V53, P58, DOI 10.1016/j.neuroimage.2010.05.069; Susskind JM, 2007, NEUROPSYCHOLOGIA, V45, P152, DOI 10.1016/j.neuropsychologia.2006.05.001; Vandekerckhove M, 2014, NEUROPSYCHOLOGY, V28, P605, DOI 10.1037/neu0000057; Yehuda R, 2008, J PSYCHIATR RES, V42, P1104, DOI 10.1016/j.jpsychires.2008.01.002; Yu SH, 2012, BIOMED ENVIRON SCI, V25, P697, DOI 10.3967/0895-3988.2012.06.012; Zheng LL, 2011, PSYCHIAT CLIN NEUROS, V65, P648, DOI 10.1111/j.1440-1819.2011.02285.x	60	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132293	10.1371/journal.pone.0132293	http://dx.doi.org/10.1371/journal.pone.0132293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26147938	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600233
J	Di Rosa, V; Frigato, E; Lopez-Olmeda, JF; Sanchez-Vazquez, FJ; Bertolucci, C				Di Rosa, Viviana; Frigato, Elena; Lopez-Olmeda, Jose F.; Sanchez-Vazquez, Francisco J.; Bertolucci, Cristiano			The Light Wavelength Affects the Ontogeny of Clock Gene Expression and Activity Rhythms in Zebrafish Larvae	PLOS ONE			English	Article							SOLE SOLEA-SENEGALENSIS; CIRCADIAN CLOCK; DANIO-RERIO; TRANSCRIPTION FACTORS; LOCOMOTOR-ACTIVITY; PINEAL-GLAND; IDENTIFICATION; EVOLUTION; SURVIVAL; SPECTRUM	Light plays a key role in synchronizing rhythms and setting the phase of early development. However, to date, little is known about the impact of light wavelengths during the ontogeny of the molecular clock and the behavioural rhythmicity. The aim of this research was to determine the effect of light of different wavelengths (white, blue and red) on the onset of locomotor activity and clock gene (per1b, per2, clock1, bmal1 and dbp) expression rhythms. For this purpose, 4 groups of zebrafish embryo/larvae were raised from 0 to 7 days post-fertilization (dpf) under the following lighting conditions: three groups maintained under light: dark (LD) cycles with white (full visible spectrum, LDW), blue (LDB), or red light (LDR), and one group raised under constant darkness (DD). The results showed that lighting conditions influenced activity rhythms. Larvae were arrhythmic under DD, while under LD cycles they developed wavelength-dependent daily activity rhythms which appeared earlier under LDB (4 dpf) than under LDW or LDR (5 dpf). The results also revealed that development and lighting conditions influenced clock gene expression. While clock1 rhythmic expression appeared in all lighting conditions at 7 dpf, per1b, per2 and dbp showed daily variations already at 3 dpf. Curiously, bmal1 showed consistent rhythmic expression from embryonic stage (0 dpf). Summarizing, the data revealed that daily rhythms appeared earlier in the larvae reared under LDB than in those reared under LDW and LDR. These results emphasize the importance of lighting conditions and wavelengths during early development for the ontogeny of daily rhythms of gene expression and how these rhythms are reflected on the behavioural rhythmicity of zebrafish larvae.	[Di Rosa, Viviana; Lopez-Olmeda, Jose F.; Sanchez-Vazquez, Francisco J.] Univ Murcia, Dept Physiol, Fac Biol, Murcia, Spain; [Frigato, Elena; Bertolucci, Cristiano] Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy	University of Murcia; University of Ferrara	Sanchez-Vazquez, FJ (corresponding author), Univ Murcia, Dept Physiol, Fac Biol, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain.	javisan@um.es	Lopez-Olmeda, Jose Fernando/K-3848-2014; Bertolucci, Cristiano/H-1916-2015	Lopez-Olmeda, Jose Fernando/0000-0003-4920-5704; Bertolucci, Cristiano/0000-0003-0252-3107	Spanish MINECO [AGL2010-22139-C03-01, AGL2013-49027-C3-1-R]; FEDER fund; MINECO (Juan de la Cierva Program); University of Ferrara (Italy)	Spanish MINECO(Spanish Government); FEDER fund; MINECO (Juan de la Cierva Program)(Spanish Government); University of Ferrara (Italy)	This research was partially financed by the Spanish MINECO through the following projects (AGL2010-22139-C03-01 - "Cronosolea", and AGL2013-49027-C3-1-R - "Solembryo") cofunded with FEDER fund. JFLO was funded through a research fellowship granted by MINECO (Juan de la Cierva Program). EF and CB were supported by funding from the University of Ferrara (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Moshe Z, 2014, NUCLEIC ACIDS RES, V42, P3750, DOI 10.1093/nar/gkt1359; Ben-Moshe Z, 2010, CHRONOBIOL INT, V27, P1509, DOI 10.3109/07420528.2010.510229; Bjorn L. O, 2002, PHOTOBIOLOGY THE SCI; Blanco-Vives B, 2012, J BIOL RHYTHM, V27, P135, DOI 10.1177/0748730411435303; Blanco-Vives B, 2010, AQUACULTURE, V306, P137, DOI 10.1016/j.aquaculture.2010.05.034; Brustein E, 2003, J PHYSIOL-PARIS, V97, P77, DOI 10.1016/j.jphysparis.2003.10.009; Cahill GM, 1998, NEUROREPORT, V9, P3445, DOI 10.1097/00001756-199810260-00020; Carr AJF, 2005, NAT CELL BIOL, V7, P319, DOI 10.1038/ncb1232; Cavallari N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001142; Colwill RM, 2011, BEHAV PROCESS, V86, P222, DOI 10.1016/j.beproc.2010.12.003; Cuesta IH, 2014, CHRONOBIOL INT, V31, P468, DOI 10.3109/07420528.2013.856316; Davie A, 2011, CHRONOBIOL INT, V28, P177, DOI 10.3109/07420528.2010.550407; Dekens MPS, 2008, EMBO J, V27, P2757, DOI 10.1038/emboj.2008.183; Dekens MPS, 2003, CURR BIOL, V13, P2051, DOI 10.1016/j.cub.2003.10.022; Devlin PF, 2001, ANNU REV PHYSIOL, V63, P677, DOI 10.1146/annurev.physiol.63.1.677; Fadool JM, 2008, PROG RETIN EYE RES, V27, P89, DOI 10.1016/j.preteyeres.2007.08.002; Fernandes AM, 2012, CURR BIOL, V22, P2042, DOI 10.1016/j.cub.2012.08.016; Fisher N. I., 1993, STAT ANAL; Gachon F, 2007, ANN MED, V39, P562, DOI 10.1080/07853890701491034; Haffter P, 1996, DEVELOPMENT, V123, P1; Harvey SA, 2013, DEVELOPMENT, V140, P2703, DOI 10.1242/dev.095091; Hurd MW, 2002, J BIOL RHYTHM, V17, P307, DOI 10.1177/074873002129002618; Hurd MW, 1998, PHYSIOL BEHAV, V65, P465, DOI 10.1016/S0031-9384(98)00183-8; Hut RA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0433; Idda ML, 2012, PROG BRAIN RES, V199, P41, DOI 10.1016/B978-0-444-59427-3.00003-4; Idda ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034203; Jerlov N.G., 1968, OPTICAL OCEANOGRAPHY; Kaneko M, 2005, PLOS BIOL, V3, P313, DOI 10.1371/journal.pbio.0030034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loew E.R., 1990, P1; Lopez-Olmeda JF, 2006, CHRONOBIOL INT, V23, P537, DOI 10.1080/07420520600651065; Lythgoe J.N., 1988, P57; Martin-Robles AJ, 2012, CHRONOBIOL INT, V29, P1195, DOI 10.3109/07420528.2012.719963; Matos-Cruz V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025111; Mracek P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067858; Mracek P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051278; MUELLER CR, 1990, CELL, V61, P279, DOI 10.1016/0092-8674(90)90808-R; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Nusslein-Volhard C., 2002, ZEBRAFISH A PRACTICA; Peirson SN, 2009, PHILOS T R SOC B, V364, P2849, DOI 10.1098/rstb.2009.0050; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Ramos BCR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106252; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JA, 2000, GENE DEV, V14, P679; Sanchez-Vazquez FJ, 2011, CHRONOBIOL INT, V28, P109, DOI 10.3109/07420528.2010.538105; Tamai TK, 2004, CURR BIOL, V14, pR104, DOI 10.1016/j.cub.2004.01.014; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Vallone D, 2005, ZEBRAFISH, V2, P171, DOI 10.1089/zeb.2005.2.171; Vanhauwaert S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109091; Vatine G, 2011, FEBS LETT, V585, P1485, DOI 10.1016/j.febslet.2011.04.007; Vatine G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000223; Vera LM, 2010, AQUACULTURE, V307, P29, DOI 10.1016/j.aquaculture.2010.06.028; Vignet C, 2013, ZEBRAFISH, V10, P365, DOI 10.1089/zeb.2013.0871; Villamizar N, 2009, AQUACULTURE, V292, P80, DOI 10.1016/j.aquaculture.2009.03.045; Villamizar N, 2014, ZEBRAFISH, V11, P173, DOI 10.1089/zeb.2013.0926; Vuilleumier R, 2006, ENDOCRINOLOGY, V147, P2273, DOI 10.1210/en.2005-1565; Weger BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017080; Ziv L, 2006, P NATL ACAD SCI USA, V103, P4146, DOI 10.1073/pnas.0600571103; Ziv L, 2005, J NEUROENDOCRINOL, V17, P314, DOI 10.1111/j.1365-2826.2005.01315.x	60	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132235	10.1371/journal.pone.0132235	http://dx.doi.org/10.1371/journal.pone.0132235			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147202	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600224
J	Froschauer, A; Kube, L; Kegler, A; Rieger, C; Gutzeit, HO				Froschauer, Alexander; Kube, Lisa; Kegler, Alexandra; Rieger, Christiane; Gutzeit, Herwig O.			Tunable Protein Stabilization In Vivo Mediated by Shield-1 in Transgenic Medaka	PLOS ONE			English	Article							GENE-EXPRESSION; ORYZIAS-LATIPES; STEM-CELLS; STABILITY; FISH; IDENTIFICATION; REPORTER; GONADS; SYSTEM	Techniques for conditional gene or protein expression are important tools in developmental biology and in the analysis of physiology and disease. On the protein level, the tunable and reversible expression of proteins can be achieved by the fusion of the protein of interest to a destabilizing domain (DD). In the absence of its specific ligand (Shield-1), the protein is degraded by the proteasome. The DD-Shield system has proven to be an excellent tool to regulate the expression of proteins of interests in mammalian systems but has not been applied in teleosts like the medaka. We present the application of the DD-Shield technique in transgenic medaka and show the ubiquitous conditional expression throughout life. Shield-1 administration to the water leads to concentration-dependent induction of a YFP reporter gene in various organs and in spermatogonia at the cellular level.	[Froschauer, Alexander; Kube, Lisa; Kegler, Alexandra; Rieger, Christiane; Gutzeit, Herwig O.] Tech Univ Dresden, Inst Zool, D-01062 Dresden, Germany	Technische Universitat Dresden	Froschauer, A (corresponding author), Tech Univ Dresden, Inst Zool, D-01062 Dresden, Germany.	alexander.froschauer@tu-dresden.de	Froschauer, Alexander/D-4856-2013	Froschauer, Alexander/0000-0001-9326-7967	Technische Universitat Dresden; German Research Foundation (DFG); Open Access Publication Funds of the TU Dresden	Technische Universitat Dresden; German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Funds of the TU Dresden	This work was funded by Technische Universitat Dresden (to HG, http://tu-dresden.de/) and its research pool (to AF, http://tudresden.de/ forschung/forschungsfoerderung/forschungspool/). We acknowledge support by the German Research Foundation (DFG) and the Open Access Publication Funds of the TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansai S, 2014, BIOL OPEN, V3, P362, DOI 10.1242/bio.20148177; Banaszynski LA, 2008, NAT MED, V14, P1123, DOI 10.1038/nm.1754; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Chen CC, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt805; Cho U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072393; Emelyanov A, 2006, GENETICS, V174, P1095, DOI 10.1534/genetics.106.061184; Field CM, 2011, CURR BIOL, V21, pR825, DOI 10.1016/j.cub.2011.07.043; Froschauer A, 2013, MOL REPROD DEV, V80, P48, DOI 10.1002/mrd.22135; Froschauer A, 2012, TRANSGENIC RES, V21, P149, DOI 10.1007/s11248-011-9514-x; Gong Z, 2001, GENETICA, V111, P213, DOI 10.1023/A:1013796810782; Hardy ME, 2007, DEV DYNAM, V236, P3071, DOI 10.1002/dvdy.21318; Herpin A, 2013, MOL BIOL EVOL, V30, P2328, DOI 10.1093/molbev/mst130; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Kinoshita M., 2009, MEDAKA BIOL MANAGEME; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Liu YC, 2014, INT J PARASITOL, V44, P729, DOI 10.1016/j.ijpara.2014.05.002; Maynard-Smith LA, 2007, J BIOL CHEM, V282, P24866, DOI 10.1074/jbc.M703902200; Nakamura S, 2008, MOL REPROD DEV, V75, P472, DOI 10.1002/mrd.20764; Nakamura S, 2010, SCIENCE, V328, P1561, DOI 10.1126/science.1185473; Ng GHB, 2011, BIOCHIMIE, V93, P1858, DOI 10.1016/j.biochi.2011.07.006; Oda S, 2010, ZOOL SCI, V27, P410, DOI 10.2108/zsj.27.410; Park A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095101; Rodriguez S, 2012, CHEM BIOL, V19, P391, DOI 10.1016/j.chembiol.2011.12.022; Sanchez-Sanchez AV, 2010, DEV DYNAM, V239, P672, DOI 10.1002/dvdy.22198; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Scholz S, 2003, BIOL REPROD, V69, P673, DOI 10.1095/biolreprod.103.016873; Tai K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046269; Takeda H, 2010, ANNU REV GENET, V44, P217, DOI 10.1146/annurev-genet-051710-151001; Wada H, 1998, ZOOL SCI, V15, P123, DOI 10.2108/zsj.15.123; Wakamatsu Y, 2001, P NATL ACAD SCI USA, V98, P10046, DOI 10.1073/pnas.181204298; Wakamatsu Yuko, 2003, Environmental Sciences, V10, P291	32	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131252	10.1371/journal.pone.0131252	http://dx.doi.org/10.1371/journal.pone.0131252			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148066	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600075
J	Jung, L; Mourthe, I; Grelle, CEV; Strier, KB; Boubli, JP				Jung, Linda; Mourthe, Italo; Grelle, Carlos E. V.; Strier, Karen B.; Boubli, Jean P.			Effects of Local Habitat Variation on the Behavioral Ecology of Two Sympatric Groups of Brown Howler Monkey (Alouatta clamitans)	PLOS ONE			English	Article							WOOLLY SPIDER MONKEYS; FOREST FRAGMENT; SEASONAL-VARIATIONS; ACTIVITY PATTERN; DIET; NORTHERN; MURIQUIS; PRIMATES; PIGRA; FUSCA	Although the brown howler monkey (Alouatta clamitans) is a relatively well-studied Neotropical primate, its behavioral and dietary flexibility at the intra-population level remains poorly documented. This study presents data collected on the behavior and ecology of two closely located groups of brown howlers during the same period at the RPPN Feliciano Miguel Abdala in southeastern Brazil. One group occupied a primary valley habitat, henceforth the Valley Group (VG), and the other group occupied a regenerating hillside habitat, the Hill Group (HG). We hypothesized differences in the behavior and ecological parameters between these sympatric groups due to the predicted harsher conditions on the hillside, compared to the valley. We measured several habitat parameters within the home range of both groups and collected data on the activity budget, diet and day range lengths, from August to November 2005, between dawn and dusk. In total, behavioral data were collected for 26 (318 h) and 28 (308 h) sampling days for VG and HG, respectively. As we predicted, HG spent significantly more time feeding and consumed less fruit and more leaves than VG, consistent with our finding that the hillside habitat was of lower quality. However, HG also spent less time resting and more time travelling than VG, suggesting that the monkeys had to expend more time and energy to obtain high-energy foods, such as fruits and flowers that were more widely spaced in their hill habitat. Our results revealed that different locations in this forest vary in quality and raise the question of how different groups secure their home ranges. Fine-grained comparisons such as this are important to prioritize conservation and management areas within a reserve.	[Jung, Linda] Thuringian State Inst Agr, Jena, Germany; [Mourthe, Italo] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil; [Grelle, Carlos E. V.] Univ Fed Rio de Janeiro, Dept Ecol, Rio De Janeiro, Brazil; [Strier, Karen B.] Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA; [Boubli, Jean P.] Univ Salford, Sch Environm & Life Sci, Salford M5 4WT, Lancs, England	Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal do Rio de Janeiro; University of Wisconsin System; University of Wisconsin Madison; University of Salford	Boubli, JP (corresponding author), Univ Salford, Sch Environm & Life Sci, Salford M5 4WT, Lancs, England.	j.p.boubli@salford.ac.uk	Strier, Karen B./AAJ-3482-2020; Mourthe, Italo/I-9533-2014; Grelle, Carlos EV/A-9687-2017	Mourthe, Italo/0000-0001-6289-6517; boubli, Jean/0000-0002-5833-9264; Strier, Karen/0000-0003-2520-9110	Brazilian Ministry of Environment	Brazilian Ministry of Environment	This research was supported by a grant from the Brazilian Ministry of Environment.	Aguiar LC, 2003, NEOTROPICAL PRIMATES, V11, P78; Almeida-Silva Barbara, 2005, Neotropical Primates, V13, P25; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Amato KR, 2014, AM J PRIMATOL, V76, P774, DOI 10.1002/ajp.22268; AUGUST PV, 1983, ECOLOGY, V64, P1495, DOI 10.2307/1937504; Bicca-Marques JC, 2003, PRIMATES IN FRAGMENTS: ECOLOGY AND CONSERVATION, P283; Boubli J.P., 2008, Primate Report, V75, P3; Boubli JP, 2011, ECOTROPICA, V17, P53; Boubli JP, 2010, ECOTROPICA, V16, P63; Bronikowski AM, 1996, BEHAV ECOL SOCIOBIOL, V39, P11, DOI 10.1007/s002650050262; Chaves OM, 2013, AM J PRIMATOL, V75, P16, DOI 10.1002/ajp.22075; Chiarello Adriano Garcia, 1994, Oryx, V28, P37; CHIARELLO AG, 1993, PRIMATES, V34, P289, DOI 10.1007/BF02382623; CHIARELLO AG, 1994, PRIMATES, V35, P25, DOI 10.1007/BF02381483; CHIVERS DJ, 1980, J MORPHOL, V166, P337, DOI 10.1002/jmor.1051660306; Clutton-Brock T. H., 1977, P585; COTTAM G, 1956, ECOLOGY, V37, P451, DOI 10.2307/1930167; Dunn JC, 2010, INT J PRIMATOL, V31, P887, DOI 10.1007/s10764-010-9436-0; Dunn JC, 2009, AM J PRIMATOL, V71, P654, DOI 10.1002/ajp.20700; Estrada A, 1999, AM J PRIMATOL, V48, P167, DOI 10.1002/(SICI)1098-2345(1999)48:3&lt;167::AID-AJP1&gt;3.0.CO;2-6; Gregorin R, 2006, REV BRAS ZOOL, V23, P64, DOI 10.1590/S0101-81752006000100005; Hatton J., 1984, Oryx, V18, P24; HIXON MA, 1982, AM NAT, V119, P596, DOI 10.1086/283937; Julliot C., 1994, P67; Kinupp VF, 2005, J TROP ECOL, V21, P363, DOI 10.1017/S0266467405002440; Lambert J.E., 2007, PRIMATES PERSPECTIVE, P482, DOI DOI 10.1146/ANNUREV-ANTHRO-102313-025928; LEIGHTON M, 1982, BIOTROPICA, V14, P81, DOI 10.2307/2387735; Lopez GO, 2005, J TROP ECOL, V21, P445, DOI 10.1017/S0266467405002415; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Mendes S.L., 1989, Revista Nordestina de Biologia, V6, P71; Milton K, 2005, TROPICAL FRUITS AND FRUGIVORES: THE SEARCH FOR STRONG INTERACTORS, P5, DOI 10.1007/1-4020-3833-X_2; Milton K, 1998, INT J PRIMATOL, V19, P513, DOI 10.1023/A:1020364523213; Milton K., 1980, FORAGING STRATEGIES; Milton Katharine, 2008, Neotropical Primates, V15, P1, DOI 10.1896/044.015.0101; Miranda João M. D., 2004, Rev. Bras. Zool., V21, P821, DOI 10.1590/S0101-81752004000400016; Mourthe I, 2014, BRAZ J BIOL, V74, P720, DOI 10.1590/bjb.2014.0088; Munoz D, 2006, AM J PRIMATOL, V68, P127, DOI 10.1002/ajp.20211; NAGY KA, 1979, ECOLOGY, V60, P475, DOI 10.2307/1936066; Orihuela G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082197; Palacios E, 2001, AM J PRIMATOL, V55, P233, DOI 10.1002/ajp.1057; Pavelka MSM, 2004, PRIMATES, V45, P105, DOI 10.1007/s10329-003-0072-6; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; R Core Team, 2021, R LANGUAGE ENV STAT; Richard AF, 1985, PRIMATES NATURE; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Serio-Silva JC, 2002, J TROP ECOL, V18, P913, DOI 10.1017/S0266467402002596; Silver SC, 1998, AM J PRIMATOL, V45, P263, DOI 10.1002/(SICI)1098-2345(1998)45:3<263::AID-AJP3>3.0.CO;2-U; Strier Karen B., 2006, Primate Conservation, V20, P53, DOI 10.1896/0898-6207.20.1.53; STRIER KB, 1987, INT J PRIMATOL, V8, P575, DOI 10.1007/BF02735778; STRIER KB, 1991, AM J PRIMATOL, V23, P113, DOI 10.1002/ajp.1350230205; Strier KB, 2001, AM J PRIMATOL, V55, P87, DOI 10.1002/ajp.1042; STRIER KB, 1992, AM J PHYS ANTHROPOL, V88, P515, DOI 10.1002/ajpa.1330880407; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Terborgh J, 1983, 5 NEW WORLD PRIMATES; Valle YG, 2001, NEOTROP PRIMATES, V9, P112; Wallace RB, 2005, INT J PRIMATOL, V26, P1053, DOI 10.1007/s10764-005-6458-4	56	12	12	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0129789	10.1371/journal.pone.0129789	http://dx.doi.org/10.1371/journal.pone.0129789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147203	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000358157600026
J	Kirino, E; Imagawa, H; Goto, T; Montgomery, W				Kirino, Eiji; Imagawa, Hideyuki; Goto, Taro; Montgomery, William			Sociodemographics, Comorbidities, Healthcare Utilization and Work Productivity in Japanese Patients with Adult ADHD	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; IMPACT; DEFINITION; PREVALENCE; VALIDITY	Objectives This study compared the sociodemographic characteristics, comorbidities, healthcare resource utilization, and work productivity among Japanese adults who reported being diagnosed with attention-deficit/hyperactivity disorder (ADHD) to those of a non-ADHD control population. Methods Data for this study were captured from an online survey of adults in Japan conducted by Kantar Health using consumer panels. A total of 84 survey participants reported they had received a diagnosis of ADHD from a physician. Survey responses pertaining to functional status and resource utilization from this ADHD group were compared to those from a non-ADHD control group of 100 participants. Comparisons between the ADHD and non-ADHD groups were made using chi-square tests for categorical variables and t-tests for continuous variables. Results Participants in the ADHD group were on average slightly younger with a higher proportion of males. ADHD respondents reported significantly more comorbid depression, sleep difficulties, headaches, and anxiety than non-ADHD controls. Over the previous 6 months, the ADHD group made more visits to healthcare providers and the emergency room, and had more hospitalizations than non-ADHD controls. The ADHD group also rated their overall health status lower than the non-ADHD control group. Respondents with ADHD reported a significantly higher degree of health-related work impairment compared to non-ADHD, with greater absenteeism and decreased work productivity. The ADHD group indicated their symptoms negatively impacted relationships, self-esteem, and regular daily activities. Conclusions Japanese adults with ADHD face a substantial burden of illness, including lower overall health status, increased number of comorbidities, greater healthcare utilization, and significant health-related occupational impairment compared to those without ADHD. Additional research is needed to develop a better understanding of both the consequences and treatment approaches for Japanese adults with ADHD.	[Kirino, Eiji] Juntendo Univ, Dept Psychiat, Shizuoka Hosp, Izunokunishi City, Shizuoka, Japan; [Imagawa, Hideyuki; Goto, Taro] Eli Lilly Japan KK, Chuo Ku, Kobe, Hyogo, Japan; [Montgomery, William] Eli Lilly Australia Pty Ltd, Sydney, NSW, Australia	Juntendo University; Eli Lilly; Eli Lilly	Kirino, E (corresponding author), Juntendo Univ, Dept Psychiat, Shizuoka Hosp, Izunokunishi City, Shizuoka, Japan.	ekirino@juntendo.ac.jp	Kirino, Eiji/S-4306-2019	Kirino, Eiji/0000-0001-6806-3313	Eli Lilly Japan K.K.; Eli Lilly	Eli Lilly Japan K.K.(Eli Lilly); Eli Lilly(Eli Lilly)	Eli Lilly Japan K.K. provided funds to Kantar Health for the conduct of the web-based survey and to conduct a range of activities as follows: Kantar health was responsible for data collection, data management and data analysis. Eli Lilly and Kantar Health were jointly responsible for the design of the study and the data analysis plan. All authors were involved in the interpretation of the study results, the decision to publish, and the preparation and review of the manuscript. The specific roles of these authors are articulated in the author contributions section. Eli Lilly provided support in the form of salaries for authors HI, TG and WM. Eli Lilly Japan K.K. provided funds to Strategic Health Outcomes, Inc., for writing and editorial assistance.	Able S, 2013, ADHD ATTEN DEF HYP D, V2013, P236; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barkley RA, 2002, J ABNORM PSYCHOL, V111, P279, DOI 10.1037//0021-843X.111.2.279; Biederman J, 2000, AM J PSYCHIAT, V157, P816, DOI 10.1176/appi.ajp.157.5.816; Brod M, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-47; Chang Z, 2014, JAMA PSYCHIAT, V71, P319, DOI 10.1001/jamapsychiatry.2013.4174; Das D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031500; Doshi JA, 2012, J AM ACAD CHILD PSY, V51, P990, DOI 10.1016/j.jaac.2012.07.008; Fayyad J, 2007, BRIT J PSYCHIAT, V190, P402, DOI 10.1192/bjp.bp.106.034389; Goodman David W, 2007, J Psychiatr Pract, V13, P318, DOI 10.1097/01.pra.0000290670.87236.18; Goto T, 2017, J ATTEN DISORD, V21, P100, DOI 10.1177/1087054713510352; Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x; Kupper T, 2012, INT ARCH OCC ENV HEA, V85, P837, DOI 10.1007/s00420-012-0794-0; NAKAMURA S, 2013, JPN J PSYCHIAT TREAT, V28, P155; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; Spencer TJ, 2007, J PEDIATR PSYCHOL, V32, P631, DOI 10.1093/jpepsy/jsm005; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003	17	29	30	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132233	10.1371/journal.pone.0132233	http://dx.doi.org/10.1371/journal.pone.0132233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26147097	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600223
J	Lee, SW; Park, HJ; Jeon, SH; Lee, C; Seong, RH; Park, SH; Hong, S				Lee, Sung Won; Park, Hyun Jung; Jeon, Sung Ho; Lee, Changjin; Seong, Rho Hyun; Park, Se-Ho; Hong, Seokmann			Ubiquitous Over-Expression of Chromatin Remodeling Factor SRG3 Ameliorates the T Cell-Mediated Exacerbation of EAE by Modulating the Phenotypes of both Dendritic Cells and Macrophages	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; IMMUNE DEVIATION; TRANSGENIC MICE; M2 MACROPHAGES; TH2 CELLS; ACTIVATION; MOUSE; INFLAMMATION; MICROGLIA	Although SWI3-related gene (SRG3), a chromatin remodeling factor, is critical for various biological processes including early embryogenesis and thymocyte development, it is unclear whether SRG3 is involved in the differentiation of CD4(+) T cells, the key mediator of adaptive immune responses. Because it is known that experimental autoimmune encephalomyelitis (EAE) development is determined by the activation of CD4(+) T helper cells, here, we investigated the role of SRG3 in EAE development using SRG3 transgenic mouse models exhibiting two distinct SRG3 expression patterns: SRG3 expression driven by either the CD2 or beta-actin promoter. We found that the outcome of EAE development was completely different depending on the expression pattern of SRG3. The specific over-expression of SRG3 using the CD2 promoter facilitated EAE via the induction of Th1 and Th17 cells, whereas the ubiquitous over-expression of SRG3 using the beta-actin promoter inhibited EAE by promoting Th2 differentiation and suppressing Th1 and Th17 differentiation. In addition, the ubiquitous over-expression of SRG3 polarized CD4(+) T cell differentiation towards the Th2 phenotype by converting dendritic cells (DCs) or macrophages to Th2 types. SRG3 over-expression not only reduced pro-inflammatory cytokine production by DCs but also shifted macrophages from the inducible nitric oxide synthase (iNOS)-expressing M1 phenotype to the arginase-1-expressing M2 phenotype during EAE. In addition, Th2 differentiation in beta-actin-SRG3 Tg mice during EAE was associated with an increase in the basophil and mast cell populations and in IL4 production. Furthermore, the increased frequency of Treg cells in the spinal cord of beta-actin-SRG3 Tg mice might induce the suppression of and accelerate the recovery from EAE symptoms. Taken together, our results provide the first evidence supporting the development of a new therapeutic strategy for EAE involving the modulation of SRG3 expression to induce M2 and Th2 polarization, thereby inhibiting inflammatory immune responses.	[Lee, Sung Won; Park, Hyun Jung; Hong, Seokmann] Sejong Univ, Inst Biosci, Dept Biosci & Biotechnol, Seoul 143747, South Korea; [Jeon, Sung Ho] Hallym Univ, Dept Life Sci, Chunchon 200702, South Korea; [Lee, Changjin; Seong, Rho Hyun] Seoul Natl Univ, Dept Biol Sci, Inst Mol Biol & Genet, Res Ctr Funct Cellul, Seoul 151742, South Korea; [Lee, Sung Won; Park, Se-Ho] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea	Sejong University; Hallym University; Seoul National University (SNU); Korea University	Hong, S (corresponding author), Sejong Univ, Inst Biosci, Dept Biosci & Biotechnol, Seoul 143747, South Korea.	shong@sejong.ac.kr	Jeon, Sung Ho/B-9728-2009	Seong, Rho/0000-0001-5699-0718	Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education [2010-0023683]	Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Education (# 2010-0023683). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni R, 2000, P NATL ACAD SCI USA, V97, P11472, DOI 10.1073/pnas.97.21.11472; Akirav EM, 2009, J NEUROSCI RES, V87, P3511, DOI 10.1002/jnr.21981; Almolda B, 2011, FRONT BIOSCI-LANDMRK, V16, P1157, DOI 10.2741/3781; Bhattacharya P, 2014, CLIN IMMUNOL, V153, P187, DOI 10.1016/j.clim.2014.04.014; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Brooks WH, 2010, J AUTOIMMUN, V34, pJ207, DOI 10.1016/j.jaut.2009.12.006; Cao L, 2013, NEUROSCI BULL, V29, P189, DOI 10.1007/s12264-013-1324-0; Cao Q, 2010, J AM SOC NEPHROL, V21, P933, DOI 10.1681/ASN.2009060592; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Domingues HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015531; Eisenstein EM, 2009, PEDIATR RES, V65, p26R, DOI 10.1203/PDR.0b013e31819e76c7; El-behi M, 2010, J NEUROIMMUNE PHARM, V5, P189, DOI 10.1007/s11481-009-9188-9; Farooq SM, 2014, BRAIN BEHAV IMMUN, V42, P118, DOI 10.1016/j.bbi.2014.06.010; Farooq SM, 2014, BRAIN BEHAV IMMUN, V35, P64, DOI 10.1016/j.bbi.2013.09.016; Furtado GD, 2001, IMMUNOL REV, V182, P122; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Han D, 2008, DEV BIOL, V315, P136, DOI 10.1016/j.ydbio.2007.12.024; Han SM, 2001, J IMMUNOL, V167, P805, DOI 10.4049/jimmunol.167.2.805; Hida S, 2005, BLOOD, V106, P2011, DOI 10.1182/blood-2005-04-1344; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Jeong SM, 2010, J BIOL CHEM, V285, P2340, DOI 10.1074/jbc.M109.026997; Kim JK, 2001, MOL CELL BIOL, V21, P7787, DOI 10.1128/MCB.21.22.7787-7795.2001; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Kuroda E, 2009, J IMMUNOL, V183, P3652, DOI 10.4049/jimmunol.0900864; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Lee SW, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/460706; Lee SW, 2013, EXP DERMATOL, V22, P561, DOI 10.1111/exd.12198; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Lewis KL, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007401; Liblau R, 1997, INT IMMUNOL, V9, P799, DOI 10.1093/intimm/9.5.799; Liu CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054841; Liu GW, 2011, IMMUNOL CELL BIOL, V89, P130, DOI 10.1038/icb.2010.70; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Mikita J, 2011, MULT SCLER J, V17, P2, DOI 10.1177/1352458510379243; Murphy AC, 2010, BRAIN BEHAV IMMUN, V24, P641, DOI 10.1016/j.bbi.2010.01.014; Nagelkerken L, 1998, BRAZ J MED BIOL RES, V31, P55, DOI 10.1590/S0100-879X1998000100007; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Reddy J, 2004, P NATL ACAD SCI USA, V101, P15434, DOI 10.1073/pnas.0404444101; Sack BK, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.13; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Sohn DH, 2007, J BIOL CHEM, V282, P10614, DOI 10.1074/jbc.M610563200; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Wurster AL, 2011, MOL IMMUNOL, V48, P2178, DOI 10.1016/j.molimm.2011.07.016; Zhang H, 2010, J IMMUNOL, V184, P6629, DOI 10.4049/jimmunol.0904044; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x	48	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132329	10.1371/journal.pone.0132329	http://dx.doi.org/10.1371/journal.pone.0132329			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147219	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600242
J	Sharma, V; Jordan, JJ; Ciribilli, Y; Resnick, MA; Bisio, A; Inga, A				Sharma, Vasundhara; Jordan, Jennifer J.; Ciribilli, Yari; Resnick, Michael A.; Bisio, Alessandra; Inga, Alberto			Quantitative Analysis of NF-kappa B Transactivation Specificity Using a Yeast-Based Functional Assay	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; DNA-BINDING; P53; PROTEINS; PARTHENOLIDE; COMPLEX; MUTAGENESIS; SUBUNITS; DIVERSE; NETWORK	The NF-kappa B transcription factor family plays a central role in innate immunity and inflammation processes and is frequently dysregulated in cancer. We developed an NF-kappa B functional assay in yeast to investigate the following issues: transactivation specificity of NF-kappa B proteins acting as homodimers or heterodimers; correlation between transactivation capacity and in vitro DNA binding measurements; impact of co-expressed interacting proteins or of small molecule inhibitors on NF-kappa B-dependent transactivation. Full-length p65 and p50 cDNAs were cloned into centromeric expression vectors under inducible GAL1 promoter in order to vary their expression levels. Since p50 lacks a transactivation domain (TAD), a chimeric construct containing the TAD derived from p65 was also generated (p50TAD) to address its binding and transactivation potential. The p50TAD and p65 had distinct transactivation specificities towards seventeen different kappa B response elements (kappa B-REs) where single nucleotide changes could greatly impact transactivation. For four kappa B-REs, results in yeast were predictive of transactivation potential measured in the human MCF7 cell lines treated with the NF-kappa B activator TNF alpha. Transactivation results in yeast correlated only partially with in vitro measured DNA binding affinities, suggesting that features other than strength of interaction with naked DNA affect transactivation, although factors such as chromatin context are kept constant in our isogenic yeast assay. The small molecules BAY11-7082 and ethyl-pyruvate as well as expressed IkB alpha protein acted as NF-kappa B inhibitors in yeast, more strongly towards p65. Thus, the yeast-based system can recapitulate NF-kappa B features found in human cells, thereby providing opportunities to address various NF-kappa B functions, interactions and chemical modulators.	[Sharma, Vasundhara; Jordan, Jennifer J.; Ciribilli, Yari; Bisio, Alessandra; Inga, Alberto] Univ Trento, Lab Transcript Networks, Ctr Integrat Biol CIBIO, Trento, Italy; [Resnick, Michael A.] Natl Inst Environm Hlth Sci, Chromosome Stabil Grp, Res Triangle Pk, NC USA	University of Trento; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Bisio, A (corresponding author), Univ Trento, Lab Transcript Networks, Ctr Integrat Biol CIBIO, Trento, Italy.	bisio@science.unitn.it; inga@science.unitn.it	Inga, Alberto/AAC-3815-2022; resnick, Michael/F-1668-2019; Ciribilli, Yari/K-2751-2018	Inga, Alberto/0000-0002-8767-1637; resnick, Michael/0000-0002-8473-7506; Ciribilli, Yari/0000-0001-9231-379X; BISIO, Alessandra/0000-0002-3326-1923; Sharma, Vasundhara/0000-0003-4419-7696	intramural project "ADARE" (NIH) [RFA RM 06 004]; Italian Association for Cancer Research, AIRC [IG 12869]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES065079] Funding Source: NIH RePORTER	intramural project "ADARE" (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Association for Cancer Research, AIRC(Fondazione AIRC per la ricerca sul cancro); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by intramural project "ADARE" to MAR and Jonathan Freedman (NIH, RFA RM 06 004) and partially supported by the Italian Association for Cancer Research, AIRC (IG 12869 to AI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreotti V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020643; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Beno I, 2011, NUCLEIC ACIDS RES, V39, P1919, DOI 10.1093/nar/gkq1044; Bergqvist S, 2008, PROTEIN SCI, V17, P2051, DOI 10.1110/ps.037481.108; Bisio A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-552; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Ciribilli Y, 2013, NUCL ACIDS RES; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Epinat JC, 1997, YEAST, V13, P599, DOI 10.1002/(SICI)1097-0061(19970615)13:7<599::AID-YEA109>3.0.CO;2-H; Ethayathulla AS, 2012, P NATL ACAD SCI US; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Giorgetti L, 2010, MOL CELL, V37, P418, DOI 10.1016/j.molcel.2010.01.016; Han Y, 2004, J PHARM EXP THER; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Inga A, 2002, MOL CELL BIOL, V22, P8612, DOI 10.1128/MCB.22.24.8612-8625.2002; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Jegga AG, 2008, P NATL ACAD SCI USA, V105, P944, DOI 10.1073/pnas.0704694105; Jordan JJ, 2012, P NATL ACAD SCI USA, V109, P14387, DOI 10.1073/pnas.1205971109; Jordan JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000104; KAMENS J, 1991, NEW BIOL, V3, P1005; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kennedy BK, 2002, NAT REV MOL CELL BIO, V3, P41, DOI 10.1038/nrm704; Krishnan N, 2013, FEBS J, V280, P2830, DOI 10.1111/febs.12283; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Kwok BHB, 2001, CHEM BIOL, V8, P759, DOI 10.1016/S1074-5521(01)00049-7; Lee J, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/416036; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Menendez D, 2013, NUCLEIC ACIDS RES, V41, P7286, DOI 10.1093/nar/gkt504; Monti P, 2014, ONCOTARGET, V5, P2116, DOI 10.18632/oncotarget.1845; Monti P, 2011, MOL CANCER RES, V9, P271, DOI 10.1158/1541-7786.MCR-10-0496; O'Dea EL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100148; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Raimondi I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069152; Saadane A, 2007, AM J RESP CELL MOL, V36, P728, DOI 10.1165/rcmb.2006-0323OC; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; SIKORSKI RS, 1989, GENETICS, V122, P19; Storici F, 2003, GENET ENG P, V25, P189; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Strickson S, 2013, BIOCHEM J, V451, P427, DOI 10.1042/BJ20121651; Sullivan JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007311; Tomso DJ, 2005, P NATL ACAD SCI USA, V102, P6431, DOI 10.1073/pnas.0501721102; Udalova IA, 2002, P NATL ACAD SCI USA, V99, P8167, DOI 10.1073/pnas.102674699; Wang VYF, 2012, CELL REP, V2, P824, DOI 10.1016/j.celrep.2012.08.042; Whiteside ST, 1997, SEMIN CANCER BIOL, V8, P75, DOI 10.1006/scbi.1997.0058; Wong D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r70; Yeo AT, 2012, CANCER LETT, V318, P53, DOI 10.1016/j.canlet.2011.11.035	57	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130170	10.1371/journal.pone.0130170	http://dx.doi.org/10.1371/journal.pone.0130170			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147604	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600031
J	Sherwani, MA; Tufail, S; Khan, AA; Owais, M				Sherwani, Mohd Asif; Tufail, Saba; Khan, Aijaz Ahmed; Owais, Mohammad			Gold Nanoparticle-Photosensitizer Conjugate Based Photodynamic Inactivation of Biofilm Producing Cells: Potential for Treatment of C. albicans Infection in BALB/c Mice	PLOS ONE			English	Article							CANDIDA-ALBICANS; METHYLENE-BLUE; FUNGAL-INFECTIONS; TOLUIDINE BLUE; THERAPY; EFFICACY; LIGHT; YEAST	Background Photodynamic therapy (PDT) has been found to be effective in inhibiting biofilm producing organisms. We investigated the photodynamic effect of gold nanoparticle (GNP) conjugated photosensitizers against Candida albicans biofilm. We also examined the photodynamic efficacy of photosensitizer (PS) conjugated GNPs (GNP-PS) to treat skin and oral C. albicans infection in BALB/c mice. Methods The biomimetically synthesized GNPs were conjugated to photosensitizers viz. methylene blue (MB) or toluidine blue O (TB). The conjugation of PSs with GNPs was characterized by spectroscopic and microscopic techniques. The efficacy of gold nanoparticle conjugates against C. albicans biofilm was demonstrated by XTT assay and microscopic studies. The therapeutic efficacy of the combination of the GNP conjugates against cutaneous C. albicans infection was examined in mouse model by enumerating residual fungal burden and histopathological studies. Results The GNP-PS conjugate based PDT was found to effectively kill both C. albicans planktonic cells and biofilm populating hyphal forms. The mixture of GNPs conjugated to two different PSs significantly depleted the hyphal C. albicans burden against superficial skin and oral C. albicans infection in mice. Conclusion The GNP-PS conjugate combination exhibits synergism in photodynamic inactivation of C. albicans. The GNP conjugate based PDT can be employed effectively in treatment of cutaneous C. albicans infections in model animals. The antibiofilm potential of PDT therapy can also be exploited in depletion of C. albicans on medical appliances such as implants and catheters etc.	[Sherwani, Mohd Asif; Tufail, Saba; Owais, Mohammad] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh 202002, Uttar Pradesh, India; [Khan, Aijaz Ahmed] Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Dept Anat, Fac Med, Aligarh 202002, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University	Khan, AA (corresponding author), Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Dept Anat, Fac Med, Aligarh 202002, Uttar Pradesh, India.	aijazahmedkhan7@live.com; owais_lakhnawi@rediffmail.com	Sherwani, Mohammad Asif/AAQ-2949-2021; Sherwani, Mohammad/AAR-6089-2021	Sherwani, Mohammad Asif/0000-0001-5317-1557; Mohammad, Owais/0000-0001-7377-7388	DBT (Department of Biotechnology); ICMR (Indian Council of Medical Research); CSIR (Council of Scientific and Industrial Research)	DBT (Department of Biotechnology); ICMR (Indian Council of Medical Research)(Indian Council of Medical Research (ICMR)); CSIR (Council of Scientific and Industrial Research)(Council of Scientific & Industrial Research (CSIR) - India)	MAS is grateful to the funding agencies DBT (Department of Biotechnology) and ICMR (Indian Council of Medical Research) for financial assistance in the form of fellowships. ST also gratefully acknowledges CSIR (Council of Scientific and Industrial Research) for a Junior as well as a Senior Research Fellowship. No additional specific funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2013, NANOMED-NANOTECHNOL, V9, P247, DOI 10.1016/j.nano.2012.07.004; Allison RR, 2004, PHOTODIAGN PHOTODYN, V1, P27, DOI 10.1016/S1572-1000(04)00007-9; Bachmann SP, 2002, ANTIMICROB AGENTS CH, V46, P3591, DOI 10.1128/AAC.46.11.3591-3596.2002; Bailey DA, 1996, J BACTERIOL, V178, P5353, DOI 10.1128/jb.178.18.5353-5360.1996; Costa ACBP, 2012, OR SURG OR MED OR PA, V114, P67, DOI 10.1016/j.oooo.2012.02.002; Calzavara-Pinton PG, 2005, J PHOTOCH PHOTOBIO B, V78, P1, DOI 10.1016/j.jphotobiol.2004.06.006; Calzavara-Pinton P, 2012, PHOTOCHEM PHOTOBIOL, V88, P512, DOI 10.1111/j.1751-1097.2012.01107.x; Carvalho GG, 2009, J MICROBIOL, V47, P619, DOI 10.1007/s12275-009-0059-0; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Chandran SP, 2006, BIOTECHNOL PROGR, V22, P577, DOI 10.1021/bp0501423; Chauhan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032049; Chauhan A, 2011, INT J NANOMED, V6, P2305, DOI 10.2147/IJN.S23195; Cheng Y, 2008, J AM CHEM SOC, V130, P10643, DOI 10.1021/ja801631c; Costa ACBP, 2013, VIRULENCE, V4, P391, DOI 10.4161/viru.25199; Cowen LE, 2002, ANNU REV MICROBIOL, V56, P139, DOI 10.1146/annurev.micro.56.012302.160907; Dai TH, 2011, ANTIMICROB AGENTS CH, V55, P5710, DOI 10.1128/AAC.05404-11; de Souza SC, 2006, J PHOTOCH PHOTOBIO B, V83, P34, DOI 10.1016/j.jphotobiol.2005.12.002; Dongari-Bagtzoglou A, 2008, EXPERT REV ANTI-INFE, V6, P201, DOI 10.1586/14787210.6.2.201; Dongari-Bagtzoglou A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007967; Dougherty TJ, 2008, JNCI-J NATL CANCER I, V90, P889; Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1; Farah CS, 2010, AUST DENT J, V55, P48, DOI 10.1111/j.1834-7819.2010.01198.x; Giroldo LM, 2009, LASER MED SCI, V24, P109, DOI 10.1007/s10103-007-0530-2; Jackson Z, 1999, LASER MED SCI, V14, P150, DOI 10.1007/s101030050037; Javed F, 2014, PHOTOCH PHOTOBIO SCI, V13, P726, DOI 10.1039/c3pp50426c; Jett BD, 1997, BIOTECHNIQUES, V23, P648, DOI 10.2144/97234bm22; Jin Y, 2005, MYCOPATHOLOGIA, V159, P353, DOI 10.1007/s11046-004-6987-7; Khan S, 2012, INT J NANOMED, V7, P3245, DOI 10.2147/IJN.S31219; Kuo WS, 2012, BIOMATERIALS, V33, P3270, DOI 10.1016/j.biomaterials.2012.01.035; Kurek A, 2011, POL J MICROBIOL, V60, P3, DOI 10.33073/pjm-2011-001; Li Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030186, 10.1371/journal.pone.0029003, 10.1371/journal.pone.0042558, 10.1371/journal.pone.0030835, 10.1371/journal.pone.0044441, 10.1371/journal.pone.0035543, 10.1371/journal.pone.0035122]; Liu YP, 2011, EUKARYOT CELL, V10, P168, DOI 10.1128/EC.00279-10; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Mantareva V, 2011, EUR J MED CHEM, V46, P4430, DOI 10.1016/j.ejmech.2011.07.015; Maroof A, 2010, BIOSCIENCE REP, V30, P223, DOI 10.1042/BSR20090068; Narband N, 2009, PHYS CHEM CHEM PHYS, V11, P10513, DOI 10.1039/b909714g; Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047; Nusbaum A G, 2012, Skin Therapy Lett, V17, P1; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Pasparakis G, 2013, SMALL, V9, P4130, DOI 10.1002/smll.201301365; Pupo Yasmine M, 2011, Acta odontol. latinoam., V24, P188; Samaranayake LP, 2009, PERIODONTOL 2000, V49, P39, DOI 10.1111/j.1600-0757.2008.00291.x; Sanchez AA, 2004, INFECT IMMUN, V72, P598, DOI 10.1128/IAI.72.1.598-601.2004; Seidler M, 2006, INT J ANTIMICROB AG, V28, P568, DOI 10.1016/j.ijantimicag.2006.07.024; Sellam A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-25; Sims CR, 2005, ARCH MED RES, V36, P660, DOI 10.1016/j.arcmed.2005.05.015; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Tufail S, 2015, J BIOL CHEM, V290, P4131, DOI 10.1074/jbc.M113.540989; Wieder ME, 2006, PHOTOCH PHOTOBIO SCI, V5, P727, DOI 10.1039/b602830f; Wong TW, 2005, ANTIMICROB AGENTS CH, V49, P895, DOI 10.1128/AAC.49.3.895-902.2005	50	65	66	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131684	10.1371/journal.pone.0131684	http://dx.doi.org/10.1371/journal.pone.0131684			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148012	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600128
J	Wen, X; Zhang, DL; Liang, BS; Zhang, RB; Wang, ZJ; Wang, JJ; Liu, M; Huang, RW				Wen, Xue; Zhang, Delong; Liang, Bishan; Zhang, Ruibin; Wang, Zengjian; Wang, Junjing; Liu, Ming; Huang, Ruiwang			Reconfiguration of the Brain Functional Network Associated with Visual Task Demands	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; SMALL-WORLD NETWORKS; TOPOLOGICAL PATTERNS; MOTION ARTIFACT; WORKING-MEMORY; GLOBAL SIGNAL; CONNECTIVITY; FMRI; ORGANIZATION; ACTIVATION	Neuroimaging studies have demonstrated that the topological properties of resting-state brain functional networks are modulated through task performances. However, the reconfiguration of functional networks associated with distinct degrees of task demands is not well understood. In the present study, we acquired fMRI data from 18 healthy adult volunteers during resting-state (RS) and two visual tasks (i.e., visual stimulus watching, VSW; and visual stimulus decision, VSD). Subsequently, we constructed the functional brain networks associated with these three conditions and analyzed the changes in the topological properties (e.g., network efficiency, wiring-cost, modularity, and robustness) among them. Although the small-world attributes were preserved qualitatively across the functional networks of the three conditions, changes in the topological properties were also observed. Compared with the resting-state, the functional networks associated with the visual tasks exhibited significantly increased network efficiency and wiring-cost, but decreased modularity and network robustness. The changes in the task-related topological properties were modulated according to the task complexity (i.e., from RS to VSW and VSD). Moreover, at the regional level, we observed that the increased nodal efficiencies in the visual and working memory regions were positively associated with the increase in task complexity. Together, these results suggest that the increased efficiency of the functional brain network and higher wiring-cost were observed to afford the demands of visual tasks. These observations provide further insights into the mechanisms underlying the reconfiguration of the brain network during task performance.	[Wen, Xue; Liang, Bishan; Zhang, Ruibin; Wang, Zengjian; Wang, Junjing; Liu, Ming; Huang, Ruiwang] S China Normal Univ, Sch Psychol, Ctr Study Appl Psychol, Key Lab Mental Hlth & Cognit Sci Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Zhang, Delong] Guangdong Prov Hosp Chinese Med, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Zhang, Delong] Guangzhou Univ Chinese Med, Postdoctoral Mobile Res Stn, Guangzhou, Guangdong, Peoples R China	South China Normal University; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Liu, M (corresponding author), S China Normal Univ, Sch Psychol, Ctr Study Appl Psychol, Key Lab Mental Hlth & Cognit Sci Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	lium@scnu.edu.cn; ruiwang.huang@gmail.com			National Natural Science Foundation of China [31371049, 81371535, 81428013, 81471654]; National Social Science Foundation of China [BBA110411]; Provincial Department of Construction Project of Key Research Base of Humanities and Social Sciences of China [11JJD190003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Social Science Foundation of China; Provincial Department of Construction Project of Key Research Base of Humanities and Social Sciences of China	This study was supported by funding from the National Natural Science Foundation of China under grant numbers 31371049, 81371535, 81428013 and 81471654; the National Social Science Foundation of China under grant number BBA110411; and the Provincial Department of Construction Project of Key Research Base of Humanities and Social Sciences of China under grant number 11JJD190003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bassett DS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000748; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Bialonski S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022826; Blokland GAM, 2008, BIOL PSYCHOL, V79, P70, DOI 10.1016/j.biopsycho.2008.03.006; Bohland JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007200; Braun U, 2012, NEUROIMAGE, V59, P1404, DOI 10.1016/j.neuroimage.2011.08.044; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Calhoun VD, 2001, NEUROIMAGE, V14, P1080, DOI 10.1006/nimg.2001.0921; Cao H, 2014, NEUROIMAGE, V84, P888, DOI 10.1016/j.neuroimage.2013.09.013; Chen G, 2012, MAGN RESON MED, V68, P1828, DOI 10.1002/mrm.24201; Cohen JD, 1997, TEMPORAL DYNAMICS BR; Cole MW, 2014, NEURON, V83, P238, DOI 10.1016/j.neuron.2014.05.014; Di X, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00493; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Drobyshevsky A, 2006, NEUROIMAGE, V31, P732, DOI 10.1016/j.neuroimage.2005.12.016; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Giessing C, 2013, J NEUROSCI, V33, P5903, DOI 10.1523/JNEUROSCI.4854-12.2013; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; Hosseini SMH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067354; Jiang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082715; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kitzbichler MG, 2011, J NEUROSCI, V31, P8259, DOI 10.1523/JNEUROSCI.0440-11.2011; Langer N, 2012, HUM BRAIN MAPP, V33, P1393, DOI 10.1002/hbm.21297; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Ma S, 2012, NEUROIMAGE, V62, P1694, DOI 10.1016/j.neuroimage.2012.05.048; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Moussa MN, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00083; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Op de Beeck HP, 2008, NAT REV NEUROSCI, V9, P123, DOI 10.1038/nrn2314; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rosazza C, 2011, NEUROL SCI, V32, P773, DOI 10.1007/s10072-011-0636-y; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rzucidlo JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070275; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Toppi J, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/130985; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang L, 2010, NEUROIMAGE, V50, P862, DOI 10.1016/j.neuroimage.2010.01.044; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu J, 2013, NEUROSCIENCE, V250, P49, DOI 10.1016/j.neuroscience.2013.06.021; Yan CG, 2010, FRONTIERS SYSTEMS NE, V14, P13, DOI [10.3389/fnsys.2010.00013, DOI 10.3389/FNSYS.2010.00013]; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	64	18	18	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132518	10.1371/journal.pone.0132518	http://dx.doi.org/10.1371/journal.pone.0132518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146993	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600294
J	Yin, J; Wen, J; Hang, D; Han, J; Jiang, J; Song, C; Liu, Y; Liu, JB; Liu, L; Zhu, LG; Chen, JG; Zhai, XJ; Xie, SH; Hu, ZB; Shen, HB; Dai, M; Li, N				Yin, Jian; Wen, Juan; Hang, Dong; Han, Jing; Jiang, Jie; Song, Ci; Liu, Yao; Liu, Jibin; Liu, Li; Zhu, Liguo; Chen, Jianguo; Zhai, Xiangjun; Xie, Shuanghua; Hu, Zhibin; Shen, Hongbing; Dai, Min; Li, Ni			Expression Quantitative Trait Loci for CARD8 Contributes to Risk of Two Infection-Related Cancers-Hepatocellular Carcinoma and Cervical Cancer	PLOS ONE			English	Article							NF-KAPPA-B; NONCODING RNA HOTAIR; GENETIC-VARIANTS; ACTIVATION; PROTEIN; MEG3	Caspase recruitment domain family, member 8 (CARD8) can coordinate innate and adaptive immune responses and sensitize cells to apoptosis, which may participate in tumorigenesis of virus-induced hepatocellular carcinoma (HCC) and cervical cancer. By bioinformatics analyses, we identified several single nucleotide polymorphisms (SNPs) within a new identified long non-coding RNA (lncRNA) as expression quantitative trait loci (eQTLs) for CARD8. In this study, we therefore hypothesized that CARD8 eQTLs SNPs within lncRNA may influence the risk of HCC and cervical cancer. We performed two independent case-control studies of 1,300 cases with HBV-positive HCC and 1,344 normal controls, together with 1,486 cervical cancer patients and 1,536 control subjects to test the association between eQTLs SNP (rs7248320) for CARD8 and the risk of HCC and cervical cancer. The variant genotype of rs7248320 was significantly associated with increased risk of HCC and cervical cancer [GG vs. AA/GA: adjusted odds ratio (OR) = 1.28, 95% confidence interval (CI) = 1.03-1.61, P = 0.028 for HCC; adjusted OR = 1.34, 95% CI = 1.09-1.66, P = 0.006 for cervical cancer]. Moreover, the effect of rs7248320 on cervical cancer risk was more prominent in premenopausal women. Further interactive analysis detected a significantly multiplicative interaction between rs7248320 and menopausal status on cervical cancer risk (P = 0.018). These findings suggest that CARD8 eQTLs SNP may serve as a susceptibility marker for virus-related HCC and cervical cancer.	[Yin, Jian; Wen, Juan; Hang, Dong; Han, Jing; Jiang, Jie; Song, Ci; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Dept Epidemiol & Biostat, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Collaborat Innovat Ctr Canc Personalized Med,Sch, Nanjing, Jiangsu, Peoples R China; [Liu, Yao] Soochow Univ, Pathol Ctr, Suzhou, Peoples R China; [Liu, Yao] Soochow Univ, Dept Pathol, Suzhou, Peoples R China; [Liu, Jibin] Nantong Tumor Hosp, Dept Hepatobiliary Surg, Nantong, Peoples R China; [Liu, Li] Nanjing Med Univ, Digest Endoscopy Ctr, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Zhu, Liguo; Zhai, Xiangjun] Jiangsu Prov Ctr Dis Prevent & Control, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China; [Chen, Jianguo] Qidong Liver Canc Inst, Qidong, Peoples R China; [Xie, Shuanghua; Dai, Min; Li, Ni] Chinese Acad Med Sci, Natl Off Canc Prevent & Control, Canc Inst & Hosp, Beijing 100730, Peoples R China	Nanjing Medical University; Soochow University - China; Soochow University - China; Nanjing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Dai, M (corresponding author), Chinese Acad Med Sci, Natl Off Canc Prevent & Control, Canc Inst & Hosp, Beijing 100730, Peoples R China.	daimin2002@hotmail.com; lini1240@hotmail.com	, 雷克思/ABG-3956-2020; DAI, M/GPS-8291-2022	, 雷克思/0000-0003-4102-8934; Li, Ni/0000-0001-5530-7745; Shen, Hongbing/0000-0002-2581-5906	National Natural Science Foundation of China [81172757, 30901236]; National Science Foundation for Distinguished Young Scholars of China [81225020]; National Natural Science Fund from the National Natural Science Foundation of China [81373079]; Foundation of Jiangsu Province for Distinguished Young Scholars [BK2012042]; National Key Basic Research Program For Youth [2013CB911400]; Foundation for the Program for New Century Excellent Talents in University [NCET-10-0178]; National Program for Support of Top-notch Young Professionals; Jiangsu Province Clinical Science and Technology Projects [BL2012008]; Collaborative Innovation Center For Cancer Personalized Medicine in Jiangsu Province; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine); Beijing Natural Science Foundation [7123225]; Beijing Nova Program [xx2012067]; Scientific Research Foundation for Returned Scholars, Ministry of Education of China for the conduct of the research and preparation of the article	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Fund from the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Jiangsu Province for Distinguished Young Scholars; National Key Basic Research Program For Youth(National Basic Research Program of China); Foundation for the Program for New Century Excellent Talents in University; National Program for Support of Top-notch Young Professionals; Jiangsu Province Clinical Science and Technology Projects; Collaborative Innovation Center For Cancer Personalized Medicine in Jiangsu Province; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Nova Program(Beijing Municipal Science & Technology Commission); Scientific Research Foundation for Returned Scholars, Ministry of Education of China for the conduct of the research and preparation of the article	This work was supported by National Natural Science Fund from the National Natural Science Foundation of China (81172757); National Science Foundation for Distinguished Young Scholars of China (81225020); National Natural Science Fund from the National Natural Science Foundation of China (81373079); Foundation of Jiangsu Province for Distinguished Young Scholars (BK2012042); National Key Basic Research Program For Youth (2013CB911400); Foundation for the Program for New Century Excellent Talents in University (NCET-10-0178); National Program for Support of Top-notch Young Professionals; Jiangsu Province Clinical Science and Technology Projects (BL2012008); Collaborative Innovation Center For Cancer Personalized Medicine in Jiangsu Province and the Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine); National Natural Science Fund from the National Natural Science Foundation of China(30901236); Beijing Natural Science Foundation (7123225); Beijing Nova Program (xx2012067); Scientific Research Foundation for Returned Scholars, Ministry of Education of China for the conduct of the research and preparation of the article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atianand MK, 2014, TRENDS MOL MED; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Dang TP, 2012, ADV EXP MED BIOL, V727, P199, DOI 10.1007/978-1-4614-0899-4_15; Elsharkawy AM, 2007, HEPATOLOGY, V46, P590, DOI 10.1002/hep.21802; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gaballah HH, 2014, ASIAN PAC J CANCER P, V15, P6911, DOI 10.7314/APJCP.2014.15.16.6911; Garg AK, 2010, INT J RADIAT ONCOL, V78, P1331, DOI 10.1016/j.ijrobp.2009.09.044; Hong A, 2012, BIOCHEM BIOPH RES CO, V423, P6, DOI 10.1016/j.bbrc.2012.05.021; Hu LM, 2012, HEPATOLOGY, V55, P1426, DOI 10.1002/hep.24799; Huang L, 2014, ARCH GYNECOL OBSTET, V290, P717, DOI 10.1007/s00404-014-3236-2; Ishibashi M, 2013, ONCOL REP, V29, P946, DOI 10.3892/or.2012.2219; Jiang J, 2013, GYNECOL ONCOL, V129, P401, DOI 10.1016/j.ygyno.2013.02.017; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim SH, 2009, CARCINOGENESIS, V30, P753, DOI 10.1093/carcin/bgp066; Kuper H, 2000, INT J CANCER, V85, P498, DOI 10.1002/(SICI)1097-0215(20000215)85:4&lt;498::AID-IJC9&gt;3.0.CO;2-F; Mockelmann N, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-79; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Qin R, 2013, NEOPLASMA, V60, P486, DOI 10.4149/neo_2013_063; Ramdass B, 2007, GYNECOL ONCOL, V104, P352, DOI 10.1016/j.ygyno.2006.08.054; Razmara M, 2002, J BIOL CHEM, V277, P13952, DOI 10.1074/jbc.M107811200; Song RP, 2014, HEPATOLOGY, V60, P1659, DOI 10.1002/hep.27312; Verma D, 2008, ARTHRITIS RHEUM, V58, P888, DOI 10.1002/art.23286; Wang MR, 2012, EXP DIABETES RES, DOI 10.1155/2012/647914; Wang SM, 2012, MOL CARCINOGEN, V51, pE118, DOI 10.1002/mc.21872; Wang W, 2012, J BIOL CHEM, V287, P42856, DOI 10.1074/jbc.M112.399923; Wen J., 2014, MOL CARCINOG; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Yi MJ, 2015, INT J PSYCHIAT MED, V49, P208, DOI 10.1177/0091217415582190; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	34	16	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132352	10.1371/journal.pone.0132352	http://dx.doi.org/10.1371/journal.pone.0132352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147888	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600250
J	Mamberti, S; Prati, P; Cremaschi, P; Seppi, C; Morelli, CF; Galizzi, A; Fabbi, M; Calvio, C				Mamberti, Stefania; Prati, Paola; Cremaschi, Paolo; Seppi, Claudio; Morelli, Carlo F.; Galizzi, Alessandro; Fabbi, Massimo; Calvio, Cinzia			gamma-PGA Hydrolases of Phage Origin in Bacillus subtilis and Other Microbial Genomes	PLOS ONE			English	Article							PROTEIN FAMILIES DATABASE; GLUTAMIC ACID; BACTERIOPHAGE PHI-NIT1; CAPSULE SYNTHESIS; CRYSTAL-STRUCTURE; ANTHRACIS; DEGRADATION; SEQUENCE; GENE; TRANSPEPTIDASE	Poly-gamma-glutamate (gamma-PGA) is an industrially interesting polymer secreted mainly by members of the class Bacilli which forms a shield able to protect bacteria from phagocytosis and phages. Few enzymes are known to degrade gamma-PGA; among them is a phage-encoded gamma-PGA hydrolase, PghP. The supposed role of PghP in phages is to ensure access to the surface of bacterial cells by dismantling the gamma-PGA barrier. We identified four unannotated B. subtilis genes through similarity of their encoded products to PghP; in fact these genes reside in prophage elements of B. subtilis genome. The recombinant products of two of them demonstrate efficient polymer degradation, confirming that sequence similarity reflects functional homology. Genes encoding similar gamma-PGA hydrolases were identified in phages specific for the order Bacillales and in numerous microbial genomes, not only belonging to that order. The distribution of the gamma-PGA biosynthesis operon was also investigated with a bioinformatics approach; it was found that the list of organisms endowed with gamma-PGA biosynthetic functions is larger than expected and includes several pathogenic species. Moreover in non-Bacillales bacteria the predicted gamma-PGA hydrolase genes are preferentially found in species that do not have the genetic asset for polymer production. Our findings suggest that gamma-PGA hydrolase genes might have spread across microbial genomes via horizontal exchanges rather than via phage infection. We hypothesize that, in natural habitats rich in gamma-PGA supplied by producer organisms, the availability of hydrolases that release glutamate oligomers from gamma-PGA might be a beneficial trait under positive selection.	[Mamberti, Stefania; Seppi, Claudio; Galizzi, Alessandro; Calvio, Cinzia] Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy; [Prati, Paola; Fabbi, Massimo] Ist Zooprofilatt Sperimentale Lombardia & dellEmi, Sez Diagnost Pavia, I-27100 Pavia, Italy; [Cremaschi, Paolo] Natl Res Council Italy, Inst Mol Genet, I-27100 Pavia, Italy; [Morelli, Carlo F.] Univ Milan, Dept Chem, I-20133 Milan, Italy; [Calvio, Cinzia] Italian Interuniv Consortium Mat Sci & Technol IN, Pavia Res Unit, I-27100 Pavia, Italy	University of Pavia; IZS Lombardia e Emilia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Milan; University of Pavia	Calvio, C (corresponding author), Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy.	cinzia.calvio@unipv.it	Morelli, Carlo F./R-2869-2016; Cinzia, Calvio/E-1353-2011	Morelli, Carlo F./0000-0001-6314-6902; Cinzia, Calvio/0000-0003-1631-0452; Mamberti, Stefania/0000-0001-9099-953X; Cremaschi, Paolo/0000-0001-5349-4188	"INSTM-Regione Lombardia" grant; "Piano di Sviluppo dell'Ateneo linea B" grant; Cariplo Foundation [0253/2010]	"INSTM-Regione Lombardia" grant; "Piano di Sviluppo dell'Ateneo linea B" grant; Cariplo Foundation(Fondazione Cariplo)	The work was supported by a "2012 INSTM-Regione Lombardia" grant to CC (http://www.instm.it/consorzio/accordi/0000000384.aspx) and by a "Piano di Sviluppo dell'Ateneo 2014-linea B" grant assigned by the Dept. of Chemistry of the University of Milan to CFM. PC was supported by a Cariplo Foundation (http://www.fondazionecariplo.it/en/index.html) grant n. 0253/2010.	Agarwala R, 2015, NUCLEIC ACIDS RES, V43, pD6, DOI 10.1093/nar/gku1130; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashiuchi M, 2003, J MOL CATAL B-ENZYM, V23, P249, DOI 10.1016/S1381-1177(03)00087-0; Ashiuchi M, 2002, APPL MICROBIOL BIOT, V59, P9, DOI 10.1007/s00253-002-0984-x; Ashiuchi M, 2001, EUR J BIOCHEM, V268, P5321, DOI 10.1046/j.0014-2956.2001.02475.x; Ashiuchi M, 2006, J BIOSCI BIOENG, V102, P60, DOI 10.1263/jbb.102.60; Bateman A, 2010, ACTA CRYSTALLOGR F, V66, P1148, DOI 10.1107/S1744309110001685; Buescher JM, 2007, CRIT REV BIOTECHNOL, V27, P1, DOI 10.1080/07388550601166458; Cachat E, 2008, FEMS MICROBIOL LETT, V285, P220, DOI 10.1111/j.1574-6968.2008.01231.x; Calvio C, 2005, J BACTERIOL, V187, P5356, DOI 10.1128/JB.187.15.5356-5366.2005; Candela T, 2005, J BACTERIOL, V187, P7765, DOI 10.1128/JB.187.22.7765-7772.2005; Candela T, 2005, MOL MICROBIOL, V57, P717, DOI 10.1111/j.1365-2958.2005.04718.x; Candela T, 2006, MOL MICROBIOL, V60, P1091, DOI 10.1111/j.1365-2958.2006.05179.x; Candela T, 2014, MICROB DRUG RESIST, V20, P222, DOI 10.1089/mdr.2014.0063; Candela T, 2009, CAN J MICROBIOL, V55, P627, DOI [10.1139/W09-003, 10.1139/w09-003]; Chabot DJ, 2004, VACCINE, V23, P43, DOI 10.1016/j.vaccine.2004.05.029; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P3677, DOI 10.1128/JB.186.12.3677-3686.2004; Cumby Nichole, 2012, Bacteriophage, V2, P225; Drysdale M, 2005, EMBO J, V24, P221, DOI 10.1038/sj.emboj.7600495; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fouet A, 1996, INFECT IMMUN, V64, P4928, DOI 10.1128/IAI.64.12.4928-4932.1996; Fujimoto Z, 2012, PROTEINS, V80, P722, DOI 10.1002/prot.23229; Fujimoto Z, 2009, ACTA CRYSTALLOGR F, V65, P913, DOI 10.1107/S1744309109029881; Garofolo Giuliano, 2011, BMC Res Notes, V4, P273, DOI 10.1186/1756-0500-4-273; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Hezayen FF, 2000, APPL MICROBIOL BIOT, V54, P319, DOI 10.1007/s002530000394; International Office of Epizootics, 2012, MAN DIAGN TESTS VACC, V7th; Kimura K, 2004, MICROBIOL-SGM, V150, P4115, DOI 10.1099/mic.0.27467-0; Kimura K, 2003, APPL ENVIRON MICROB, V69, P2491, DOI 10.1128/AEM.69.5.2491-2497.2003; Kimura K, 2010, MICROBIOL MONOGR, V15, P95, DOI 10.1007/978-3-642-12453-2_6; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lazarevic V, 1999, MICROBIOL-UK, V145, P1055, DOI 10.1099/13500872-145-5-1055; MAKINO S, 1989, J BACTERIOL, V171, P722, DOI 10.1128/jb.171.2.722-730.1989; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Obst M, 2004, BIOMACROMOLECULES, V5, P1166, DOI 10.1021/bm049949u; Ogunleye A, 2015, MICROBIOL-SGM, V161, P1, DOI 10.1099/mic.0.081448-0; Oppermann-Sanio FB, 2002, NATURWISSENSCHAFTEN, V89, P11, DOI 10.1007/s00114-001-0280-0; Osera C, 2009, MICROBIOL-SGM, V155, P2282, DOI 10.1099/mic.0.026435-0; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Rehm BHA, 2010, NAT REV MICROBIOL, V8, P578, DOI 10.1038/nrmicro2354; Scoffone V, 2013, BIOTECHNOL BIOENG, V110, P2006, DOI 10.1002/bit.24846; Scorpio A, 2008, ANTIMICROB AGENTS CH, V52, P1014, DOI 10.1128/AAC.00741-07; Scorpio A, 2007, ANTIMICROB AGENTS CH, V51, P215, DOI 10.1128/AAC.00706-06; Scorpio A, 2010, MICROBIOL-SGM, V156, P1459, DOI 10.1099/mic.0.035857-0; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sung MH, 2005, CHEM REC, V5, P352, DOI 10.1002/tcr.20061; Sutherland MD, 2009, INFECT IMMUN, V77, P532, DOI 10.1128/IAI.01009-08; Suzuki T, 2003, J BACTERIOL, V185, P2379, DOI 10.1128/JB.185.7.2379-2382.2003; Tjalsma H, 2004, MICROBIOL MOL BIOL R, V68, P207, DOI 10.1128/MMBR.68.2.207-233.2004; Toshiro N., 2012, BACTERIOPHAGE, P95; UCHIDA I, 1993, MOL MICROBIOL, V9, P487, DOI 10.1111/j.1365-2958.1993.tb01710.x; Wu RY, 2009, J BIOL CHEM, V284, P24406, DOI 10.1074/jbc.M109.019034; Xu K, 1996, J BACTERIOL, V178, P4319, DOI 10.1128/jb.178.14.4319-4322.1996; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	55	13	14	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0130810	10.1371/journal.pone.0130810	http://dx.doi.org/10.1371/journal.pone.0130810			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158264	Green Published, Green Submitted, gold			2022-12-27	WOS:000358161200021
J	Lee, MTG; Wang, HM; Ho, JAA; Fan, NC; Yang, YL; Lee, CC; Chen, SC				Lee, Meng-Tse Gabriel; Wang, Hsuan-Mao; Ho, Ja-An Annie; Fan, Nien-Chu; Yang, Ya-Lin; Lee, Chien-Chang; Chen, Shyr-Chyr			Resuscitation Using Liposomal Vasopressin in an Animal Model of Uncontrolled Hemorrhagic Shock	PLOS ONE			English	Article							INJECTION IMMUNOANALYTICAL SYSTEM; MASSIVE SPLENIC INJURY; FLUID RESUSCITATION; RAT; AORTOTOMY; SURVIVAL; DELIVERY; CARRIERS; SWINE	Background Current research suggests that administration of vasopressin to patients with uncontrolled hemorrhagic shock (UHS) can avoid the detrimental effects associated with aggressive fluid resuscitation. However, vasopressin has a short half-life of 10 similar to 35 minutes in in vivo use and precludes its use in the pre-hospital setting. To increase the half-life of vasopressin, we proposed to synthesize liposome-encapsulated vasopressin and test it in a rat model of UHS. Methods The film hydration method was used to prepare liposomal vasopressin consisting of: Dipalmitoylphosphatidylcholine, cholesterol, and dipalmitoyl phosphatidylethanolamine (20: 20: 1 mole ratio). 42 rats were subjected to UHS and randomly received 5 different treatments (vasopressin, liposomal vasopressin, lactate ringer (LR), liposome only and sham). Outcome of UHS were measured using 4 common prognostic tests: mean arterial pressure (MAP), serum lactate level, inflammatory profile and pulmonary edema. Results The dynamic light scattering results confirmed that we had prepared a successful liposomal vasopressin complex. Comparing the serum vasopressin concentration of liposomal vasopressin and vasopressin treated animals by ELISA, we found that the concentration of vasopressin for the liposomal vasopressin treated group is higher at 60 minutes. However, there was no significant difference between the MAP profile of rats treated with vasopressin and liposomal vasopressin in UHS. We also observed that animals treated with liposomal vasopressin performed indifferently to vasopressin treated rats in serum lactate level, inflammatory profile and edema profile. For most of our assays, the liposome only control behaves similarly to LR resuscitation in UHS rats. Conclusion We have synthesized a liposomal vasopressin complex that can prolong the serum concentration of vasopressin in a rat model of UHS. Although UHS rats treated with either liposomal vasopressin or vasopressin showed no statistical differences, it would be worthwhile to repeat the experiments with different liposomal compositions.	[Lee, Meng-Tse Gabriel; Wang, Hsuan-Mao; Yang, Ya-Lin; Lee, Chien-Chang; Chen, Shyr-Chyr] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Ho, Ja-An Annie; Fan, Nien-Chu] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan; [Lee, Chien-Chang] Natl Taiwan Univ Hosp, Yunlin Branch, Dept Emergency Med, Touliu, Taiwan; [Lee, Chien-Chang] Natl Taiwan Univ Hosp, Yunlin Branch, Dept Gen Med, Touliu, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Lee, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan.	cclee100@gmail.com; scchen@ntu.edu.tw	Wang, Hsuan Mao/AAG-3017-2021; Hsiao, Wei-Hung/B-9931-2013; Lee, Chien-Chang/HHM-5986-2022	LEE, CHIEN-CHANG/0000-0002-1243-2463; Ho, Annie/0000-0001-6684-1118; CHEN, SHYR-CHYR/0000-0002-5858-3013	Taiwan National Science Foundation [NSC101-2314-B-002 -055-MY3]; National Taiwan University [UN102-024]; National Taiwan University Hospital Yunlin Branch Research Grant [NTUHYL104.S008]	Taiwan National Science Foundation; National Taiwan University(National Taiwan University); National Taiwan University Hospital Yunlin Branch Research Grant	This study is supported by Taiwan National Science Foundation Grant NSC101-2314-B-002 -055-MY3; National Taiwan University Grant UN102-024; and National Taiwan University Hospital Yunlin Branch Research Grant, NTUHYL104.S008. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADIN J, 2011, CRIT CARE, V15, P45384, DOI DOI 10.1186/cc10253; BICKELL WH, 1991, SURGERY, V110, P529; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; BICKELL WH, 1989, CIRC SHOCK, V28, P321; Burris D, 1999, J TRAUMA, V46, P216, DOI 10.1097/00005373-199902000-00003; CAPONE A, 1995, RESUSCITATION, V29, P143, DOI 10.1016/0300-9572(95)00829-I; COUVREUR P, 1991, PHARMACEUT RES, V8, P1079, DOI 10.1023/A:1015885814417; DEAKIN CD, 1994, J ACCID EMERG MED, V11, P154; Delmas A, 2005, CRIT CARE, V9, P212, DOI 10.1188/cc2945; Haas T, 2004, J TRAUMA, V57, P177, DOI 10.1097/01.TA.0000044357.25191.1B; Ho JA, 2005, ANAL CHEM, V77, P3431, DOI 10.1021/ac0484474; Ho JAA, 2007, ANAL CHEM, V79, P246, DOI 10.1021/ac060889n; Ho JAA, 2012, TALANTA, V99, P683, DOI 10.1016/j.talanta.2012.06.077; Holmes JF, 2002, ACAD EMERG MED, V9, P267, DOI 10.1111/j.1553-2712.2002.tb01317.x; HSU MJ, 1982, BIOCHIM BIOPHYS ACTA, V720, P411, DOI 10.1016/0167-4889(82)90120-3; JANAKY T, 1982, J ENDOCRINOL, V93, P295, DOI 10.1677/joe.0.0930295; Jesorka A, 2008, ANNU REV ANAL CHEM, V1, P801, DOI 10.1146/annurev.anchem.1.031207.112747; Kim A, 1999, INT J PHARM, V180, P75, DOI 10.1016/S0378-5173(98)00408-6; Krausz MM, 2001, SHOCK, V16, P383, DOI 10.1097/00024382-200116050-00011; Krismer AC, 2005, ANAESTHESIST, V54, P220, DOI 10.1007/s00101-004-0793-y; Lee CC, 2005, SHOCK, V24, P177, DOI 10.1097/01.shk.0000171870.42900.15; Lee CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095821; Leppaniemi A, 1996, J SURG RES, V63, P413, DOI 10.1006/jsre.1996.0285; Mock C, 2004, LANCET, V363, P2172, DOI 10.1016/S0140-6736(04)16510-0; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; PANICO AM, 1992, INT J PHARM, V80, P93, DOI 10.1016/0378-5173(92)90266-5; Poloujadoff MP, 2007, ANESTHESIOLOGY, V107, P591, DOI 10.1097/01.anes.0000281926.54940.6a; Scarpati G, 2013, TRANSL MED UNISA, V5, P32; Silva-Barcellos NM, 2001, HYPERTENSION, V38, P1266, DOI 10.1161/hy1201.096056; Solomonov E, 2000, CRIT CARE MED, V28, P749, DOI 10.1097/00003246-200003000-00024; STERN SA, 1993, ANN EMERG MED, V22, P155, DOI 10.1016/S0196-0644(05)80195-7; Tamion F, 1997, AM J PHYSIOL-GASTR L, V273, pG314, DOI 10.1152/ajpgi.1997.273.2.G314; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; WEINER A L, 1989, Advanced Drug Delivery Reviews, V3, P307, DOI 10.1016/0169-409X(89)90026-4; Were LM, 2003, J AGR FOOD CHEM, V51, P8073, DOI 10.1021/jf0348368; WOODLE MC, 1992, PHARMACEUT RES, V9, P260, DOI 10.1023/A:1018953810705; Zingarelli B, 2010, AM J PHYSIOL-GASTR L, V298, pG133, DOI 10.1152/ajpgi.00262.2009	37	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130655	10.1371/journal.pone.0130655	http://dx.doi.org/10.1371/journal.pone.0130655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154286	Green Submitted, Green Published, gold			2022-12-27	WOS:000358159700034
J	Lotz, S				Lotz, Sebastian			Spontaneous Giving under Structural Inequality: Intuition Promotes Cooperation in Asymmetric Social Dilemmas	PLOS ONE			English	Article							EVOLUTION; HETEROGENEITY; REFLECTION; PUNISHMENT; BEHAVIOR; GAMES	The present research investigates the role of intuitive mental processing on cooperation in experimental games involving structural inequality. Results from an experiment using conceptual priming to induce intuitive mental processing provide the first evidence that cooperation is promoted by intuition in an asymmetric context that distributes the gains from cooperation unequally among a group. Therefore, the results extend our understanding of the cognitive underpinnings of human cooperation by demonstrating the robustness of intuitive cooperation in games involving structural inequality regarding asymmetric gains from cooperation. Additionally, the results provide the first successful conceptual replication of the intuition-cooperation link using conceptual priming, therefore also contributing to the debate about the validity of previous research in other contexts. Taken together, the present research contributes to the literature on psychological and institutional mechanisms that promote cooperation.	[Lotz, Sebastian] Stanford Univ, Dept Sociol, Stanford, CA 94305 USA; [Lotz, Sebastian] Univ Lausanne, Dept Econ, Lausanne, Switzerland	Stanford University; University of Lausanne	Lotz, S (corresponding author), Stanford Univ, Dept Sociol, Stanford, CA 94305 USA.	sebastian.lotz@stanford.edu			Deutsche Forschungsgemeinschaft [LO1826 1/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by Deutsche Forschungsgemeinschaft (www.dfg.de) through grant LO1826 1/1 awarded to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L. R., 2008, J SOCIO-ECON, V37, P1010, DOI [10.1016/j.socec.2006.12.073, DOI 10.1016/J.SOCEC.2006.12.073, DOI 10.1016/j.socec.2006.12.073]; Bartlett MY, 2006, PSYCHOL SCI, V17, P319, DOI 10.1111/j.1467-9280.2006.01705.x; Brekke K. A., 2012, COOPERATION RE UNPUB; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; Cherry TL, 2005, J ECON BEHAV ORGAN, V57, P357, DOI 10.1016/j.jebo.2003.11.010; Cone J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115756; Cornelissen G, 2011, PERS SOC PSYCHOL B, V37, P1080, DOI 10.1177/0146167211405996; Evans A. T., 2015, REACTION TIMES REFLE; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fisher J, 1995, PUBLIC CHOICE, V85, P249, DOI 10.1007/BF01048198; Forgas JP, 1998, J PERS SOC PSYCHOL, V74, P565, DOI 10.1037/0022-3514.74.3.565; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Gervais WM, 2012, SCIENCE, V336, P493, DOI 10.1126/science.1215647; Guth W, 2007, J PUBLIC ECON, V91, P1023, DOI 10.1016/j.jpubeco.2006.10.007; Haigner SD, 2010, ECON LETT, V108, P93, DOI 10.1016/j.econlet.2010.04.025; Halali E., 2012, FRONT HUM NEUROSCI, V7, P240; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; HERTEL G, 1994, EUR J SOC PSYCHOL, V24, P131, DOI 10.1002/ejsp.2420240110; Johansson-Stenman O, 2010, ENVIRON RESOUR ECON, V46, P147, DOI 10.1007/s10640-010-9356-7; Kahneman D., 2011, THINKING FAST SLOW; Ledyard J., 1995, HDB EXPT EC; Lotz S, 2011, J EXP SOC PSYCHOL, V47, P477, DOI 10.1016/j.jesp.2010.10.004; Moxnes E, 2003, J CONFLICT RESOLUT, V47, P773, DOI 10.1177/0022002703258962; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Ostrom E., 1990, GOVERNING COMMONS EV; Oxoby RJ, 2013, ECON INQ, V51, P2071, DOI 10.1111/j.1465-7295.2012.00493.x; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P531, DOI 10.1177/1745691612463401; Peysakhovich A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5939; Rand D. G., 2014, NATURE COMMUNICATION, V5; Rand DG, 2015, J BEHAV DECIS MAKING, V28, P159, DOI 10.1002/bdm.1837; Rand DG, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00300; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Rand DG, 2013, NATURE, V498, pE2, DOI 10.1038/nature12195; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; Rivas MF, 2011, ECON LETT, V112, P176, DOI 10.1016/j.econlet.2011.04.007; Roch SG, 2000, ORGAN BEHAV HUM DEC, V83, P185, DOI 10.1006/obhd.2000.2915; Schmidt S, 2009, REV GEN PSYCHOL, V13, P90, DOI 10.1037/a0015108; Schulz JF, 2014, J ECON PSYCHOL, V41, P77, DOI 10.1016/j.joep.2012.08.007; Shenhav A, 2012, J EXP PSYCHOL GEN, V141, P423, DOI 10.1037/a0025391; Simmons J. P., 2013, M SOC PERS SOC PSYCH; Simons DJ, 2014, PERSPECT PSYCHOL SCI, V9, P76, DOI 10.1177/1745691613514755; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Stanovich KE, 1998, J EXP PSYCHOL GEN, V127, P161, DOI 10.1037/0096-3445.127.2.161; Tan FF, 2008, ECONOMIST-NETHERLAND, V156, P269, DOI 10.1007/s10645-008-9094-1; Tan HB, 2010, J EXP SOC PSYCHOL, V46, P571, DOI 10.1016/j.jesp.2010.01.007; Tinghog G, 2013, NATURE, V498, pE1, DOI 10.1038/nature12194; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Van der Heijden E., 2003, 38 TILB U; Verkoeijen PPJL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096654; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143	55	23	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131562	10.1371/journal.pone.0131562	http://dx.doi.org/10.1371/journal.pone.0131562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26154284	Green Published, gold, Green Submitted			2022-12-27	WOS:000358159700072
J	Wojan, TR; Hamrick, KS				Wojan, Timothy R.; Hamrick, Karen S.			Can Walking or Biking to Work Really Make a Difference? Compact Development, Observed Commuter Choice and Body Mass Index	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; BUILT ENVIRONMENT; URBAN SPRAWL; PUBLIC-HEALTH; SMART GROWTH; LAND-USE; OBESITY; EXERCISE; DESIGN; SCHOOL	Objectives Promoting active commuting is viewed as one strategy to increase physical activity and improve the energy balance of more sedentary individuals thereby improving health outcomes. However, the potential effectiveness of promotion policies may be seriously undermined by the endogenous choice of commute mode. Policy to promote active commuting will be most effective if it can be demonstrated that 1) those in compact cities do not necessarily have a preference for more physical activity, and 2) that current active commuting is not explained by unobserved characteristics that may be the true source of a lower body mass index (BMI). Methods Daily time-use diaries are used in combination with geographical characteristics of where respondents live and work to test 1) whether residents of more compact settlements are characterized by higher activity levels; and 2) whether residents of more compact settlements are more likely to bike or walk to work. An endogenous treatment model of active commuting allows testing whether reductions in BMI associated with walking or biking to work are in fact attributable to that activity or are more strongly associated with unobserved characteristics of these active commuters. Results The analysis of general activity levels confirms that residents of more compact cities do not expend more energy than residents of more sprawling cities, indicating that those in compact cities do not necessarily have a preference for more physical activity. The endogenous treatment model is consistent with walking or biking to work having an independent effect on BMI, as unobserved factors that contribute to a higher likelihood of active commuting are not associated with lower BMI. Conclusions Despite evidence that more compact settlement patterns enable active commuting, only a small share of workers in these areas choose to walk or bike to work. In general, the activity level of residents in more compact cities and residents in more sprawling areas is very similar. But, there is a robust association between active commuting and lower body mass index that is not explained by unobserved attributes or preferences suggests that policies to promote active commuting may be effective. In particular, active commuting has a greater effect on BMI. Consequently, compact settlement appears to be an effective infrastructure for promoting more active lifestyles. The policy challenge is finding ways to ensure that this infrastructure is more widely utilized.	[Wojan, Timothy R.; Hamrick, Karen S.] US Dept Agr Econ Res Serv, Washington, DC USA		Wojan, TR (corresponding author), US Dept Agr Econ Res Serv, Washington, DC USA.	twojan@ers.usda.gov		Wojan, Timothy/0000-0001-9863-1457				Aarts H, 1997, HEALTH EDUC RES, V12, P363, DOI 10.1093/her/12.3.363; Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; American Association of State Highway and Transportation Officials, 2013, COMMUTING AM 2013 NA; Arcaya M, 2014, PREV MED, V65, P40, DOI 10.1016/j.ypmed.2014.04.006; Brenner PS, 2013, 201302 CDE U WISC MA; Brenner PS, 2013, 201302 U WISC MAD CT; Buehler R, 2012, TRANSPORTATION, V39, P409, DOI 10.1007/s11116-011-9355-8; Burchfield M, 2006, Q J ECON, V121, P587, DOI 10.1162/qjec.2006.121.2.587; Clark A, 2014, URBAN STUD, V51, P284, DOI 10.1177/0042098013489742; Courtemanche C, 2011, J URBAN ECON, V69, P165, DOI 10.1016/j.jue.2010.09.005; Dietary Guidelines Advisory Committee, 2010, REPORT DIETARY GUIDE; Ding D, 2012, HEALTH PLACE, V18, P100, DOI 10.1016/j.healthplace.2011.08.021; Durand CP, 2011, OBES REV, V12, pe173, DOI 10.1111/j.1467-789X.2010.00826.x; Eid J, 2008, J URBAN ECON, V63, P385, DOI 10.1016/j.jue.2007.12.002; Ewing R, 2003, AM J HEALTH PROMOT, V18, P47, DOI 10.4278/0890-1171-18.1.47; Finlay KA, 2002, J APPL SOC PSYCHOL, V32, P342, DOI 10.1111/j.1559-1816.2002.tb00219.x; Forsyth A, 2008, URBAN STUD, V45, P1973, DOI 10.1177/0042098008093386; Forsyth A, 2007, URBAN STUD, V44, P679, DOI 10.1080/00420980601184729; Frank LD, 2004, AM J PREV MED, V27, P87, DOI 10.1016/j.amepre.2004.04.011; Frank LD, 2005, INT REGIONAL SCI REV, V28, P193, DOI 10.1177/0160017604273853; French SA, 2001, ANNU REV PUBL HEALTH, V22, P309, DOI 10.1146/annurev.publhealth.22.1.309; Gregory CA., 2013, ERR147 USDA EC RES S; Hamrick K, 2012, TB1934 USDA EC RES S, VTB-1934; Handy S, 2005, INT REGIONAL SCI REV, V28, P146, DOI 10.1177/0160017604273626; Heelan KA, 2005, CHILD CARE HLTH DEV, V31, P341, DOI 10.1111/j.1365-2214.2005.00513.x; Kerr J, 2006, MED SCI SPORT EXER, V38, P787, DOI 10.1249/01.mss.0000210208.63565.73; Lambe J, 2000, EUR J CLIN NUTR, V54, P166, DOI 10.1038/sj.ejcn.1600915; Lowy J, 2010, WASHINGTON POST; McKenzie B, 2014, ACS26 US BUR CENS, VACS-26; National Centers for Environmental Prediction/Environmental Modeling Center, 2012, N AM LAND DATA ASSIM; Neal DT, 2006, CURR DIR PSYCHOL SCI, V15, P198, DOI 10.1111/j.1467-8721.2006.00435.x; Owen N, 2014, BRIT J SPORT MED, V48, P174, DOI 10.1136/bjsports-2013-093107; Pinkston J, 2009, 31 INT ASS TIM US RE; Plantinga AJ, 2005, J REGIONAL SCI, V45, P473, DOI 10.1111/j.0022-4146.2005.00380.x; Plantinga AJ, 2007, J REGIONAL SCI, V47, P857, DOI 10.1111/j.1467-9787.2007.00533.x; Raux C, 2011, HALSHS00612610; Robinson J., 1999, TIME LIFE SURPRISING, V2nd; Robinson JP, 2011, MON LABOR REV, V134, P43; Saelens BE, 2008, MED SCI SPORT EXER, V40, pS550, DOI 10.1249/MSS.0b013e31817c67a4; Schmidt T., 2011, DTSCH BUNDESBANK DIS; SIVAK M, 1983, Journal of Safety Research, V14, P93, DOI 10.1016/0022-4375(83)90019-1; Sivak M, 2009, TRAFFIC INJ PREV, V10, P511, DOI 10.1080/15389580903277580; Sturm R, 2014, CA-CANCER J CLIN, V64, P337, DOI 10.3322/caac.21237; Sugiyama T, 2014, CURR OBES REP, V3, P183, DOI 10.1007/s13679-014-0096-9; Tudor-Locke C, 2009, J PHYS ACT HEALTH, V6, P347, DOI 10.1123/jpah.6.3.347; U.S. Census Bureau, 2003, CENSUS 2000 SUMMARY; U. S. Census Bureau, 2009, 2009 AM COMMUNITY SU; Wansink B, 2007, MINDLESS EATING WHY; Zhao ZX, 2010, J HEALTH ECON, V29, P779, DOI 10.1016/j.jhealeco.2010.07.006	49	17	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130903	10.1371/journal.pone.0130903	http://dx.doi.org/10.1371/journal.pone.0130903			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26154176	Green Published, Green Submitted, gold			2022-12-27	WOS:000358159700044
J	Carlsen, EM; Renault, KM; Jensen, RB; Norgaard, K; Jensen, JEB; Nilas, L; Cortes, D; Michaelsen, KF; Pryds, O				Carlsen, Emma M.; Renault, Kristina M.; Jensen, Rikke B.; Norgaard, Kirsten; Jensen, Jens-Erik B.; Nilas, Lisbeth; Cortes, Dina; Michaelsen, Kim F.; Pryds, Ole			The Association between Newborn Regional Body Composition and Cord Blood Concentrations of C-Peptide and Insulin-Like Growth Factor I	PLOS ONE			English	Article							GESTATIONAL WEIGHT-GAIN; MASS INDEX; CHILDHOOD OBESITY; BIRTH-WEIGHT; FETAL-GROWTH; ADIPOSITY; RISK; LIFE; INFANTS; UTERO	Background Third trimester fetal growth is partially regulated by C-peptide and insulin-like growth factor I (IGF-I). Prenatal exposures including maternal obesity and high gestational weight gain as well as high birth weight have been linked to subsequent metabolic disease. We evaluated the associations between newborn regional body composition and cord blood levels of C-peptide and IGF-I. Methods We prospectively included obese and normal-weight mothers and their newborns; cord blood was collected and frozen. Analyses of C-peptide and IGF-I were performed simultaneously, after recruitment was completed. Newborn regional body composition was assessed with dual-energy X-ray absorptiometry scanning (DXA) within 48 hours of birth. Results Three hundred thirty-six term infants were eligible to participate in the study; of whom 174 (52%) infants had cord blood taken. Total, abdominal and arm and leg fat mass were positively associated with C-peptide (p < 0.001). Arm and leg fat mass was associated with IGF-I concentration: 28 g [95% confidence interval: 4, 53] per doubling of IGF-I. There was no association between total or abdominal fat mass and IGF-I. Fat-free mass was positively associated with both C-peptide (p < 0.001) and IGF-I (p = 0.004). Conclusion Peripheral fat tissue accumulation was associated with cord blood C-peptide and IGF-I. Total and abdominal fat masses were related to C-peptide but not to IGF-I. Thus, newborn adiposity is partially mediated through C-peptide and early linear growth is associated with IGF-I.	[Carlsen, Emma M.; Cortes, Dina; Pryds, Ole] Univ Copenhagen, Hvidovre Univ Hosp, Dept Pediat, Hvidovre, Denmark; [Renault, Kristina M.] Univ Southern Denmark, Odense Univ Hosp, Dept Obstet & Gynecol, Odense, Denmark; [Jensen, Rikke B.] Univ Copenhagen, Rigshosp, Fac Hlth & Med Sci, Dept Growth & Reprod, DK-2100 Copenhagen, Denmark; [Norgaard, Kirsten; Jensen, Jens-Erik B.] Univ Copenhagen, Hvidovre Univ Hosp, Dept Endocrinol, Hvidovre, Denmark; [Nilas, Lisbeth; Cortes, Dina; Pryds, Ole] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Renault, Kristina M.; Nilas, Lisbeth] Univ Copenhagen, Hvidovre Univ Hosp, Dept Obstet & Gynecol, Hvidovre, Denmark; [Michaelsen, Kim F.] Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Copenhagen, Denmark	University of Copenhagen; University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Carlsen, EM (corresponding author), Univ Copenhagen, Hvidovre Univ Hosp, Dept Pediat, Hvidovre, Denmark.	emc@dadlnet.dk	Nørgaard, Kirsten/AAC-9803-2020; Jensen, Rikke Beck/AAB-3236-2020; Renault, Kristina Martha/H-7265-2019	Nørgaard, Kirsten/0000-0003-1620-8271; Jensen, Rikke Beck/0000-0002-4522-672X; Cortes, Dina/0000-0002-6852-6530; Carlsen, Emma Malchau/0000-0002-5563-1964; Jensen, Jens-Erik Beck/0000-0003-4290-0480; Renault, Kristina Martha/0000-0002-6387-9652; Michaelsen, Kim F/0000-0003-0449-0839	University of Copenhagen; Hvidovre University Hospital; Dagmar Marshalls Foundation; Dronning Louises Foundation	University of Copenhagen; Hvidovre University Hospital; Dagmar Marshalls Foundation; Dronning Louises Foundation	The study was supported by the University of Copenhagen, Hvidovre University Hospital, Dagmar Marshalls Foundation and Dronning Louises Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltrand J, 2008, J CLIN ENDOCR METAB, V93, P4027, DOI 10.1210/jc.2008-0562; Bennet L, 2001, J PHYSIOL-LONDON, V531, P835, DOI 10.1111/j.1469-7793.2001.0835h.x; Canpolat FE, 2011, TWIN RES HUM GENET, V14, P94, DOI 10.1375/twin.14.1.94; Carlsen EM, 2014, ACTA PAEDIATR, V103, P939, DOI 10.1111/apa.12713; Catalano PM, 2009, AM J CLIN NUTR, V90, P1303, DOI 10.3945/ajcn.2008.27416; Catalano PM, 2003, AM J OBSTET GYNECOL, V189, P1698, DOI 10.1016/S0002-9378(03)00828-7; Cooke RJ, 2010, PEDIATR RES, V67, P660, DOI 10.1203/PDR.0b013e3181da8d01; Crozier SR, 2010, AM J CLIN NUTR, V91, P1745, DOI 10.3945/ajcn.2009.29128; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Gaillard R, 2014, HYPERTENSION, V63, P683, DOI 10.1161/HYPERTENSIONAHA.113.02671; Gluckman PD, 2003, J NUTR, V133, p1741S, DOI 10.1093/jn/133.5.1741S; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Godang K, 2010, J CLIN DENSITOM, V13, P151, DOI 10.1016/j.jocd.2010.01.121; Grohmann M, 2005, J LIPID RES, V46, P93, DOI 10.1194/jlr.M400295-JLR200; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; Hochner H, 2012, CIRCULATION, V125, P1381, DOI 10.1161/CIRCULATIONAHA.111.070060; Ibanez L, 2008, J CLIN ENDOCR METAB, V93, P2774, DOI 10.1210/jc.2008-0526; Institute of Medicine, 2009, WEIGHT GAIN PREGN RE; Jansson N, 2008, AM J CLIN NUTR, V87, P1743, DOI 10.1093/ajcn/87.6.1743; Javaid MK, 2004, J BONE MINER RES, V19, P56, DOI 10.1359/JBMR.0301211; Juul A, 2002, CIRCULATION, V106, P939, DOI 10.1161/01.CIR.0000027563.44593.CC; Kamath CC, 2008, J CLIN ENDOCR METAB, V93, P4606, DOI 10.1210/jc.2006-2411; Kullberg J, 2009, BRIT J RADIOL, V82, P123, DOI 10.1259/bjr/80083156; Lausten-Thomsen U, 2013, EUR J PEDIATR, V172, P747, DOI 10.1007/s00431-013-1949-z; LIND T, 1991, DIABETES, V40, P8, DOI 10.2337/diab.40.2.S8; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Madsen AL, 2011, GROWTH HORM IGF RES, V21, P199, DOI 10.1016/j.ghir.2011.05.003; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Melnik BC, 2009, MED HYPOTHESES, V73, P670, DOI 10.1016/j.mehy.2009.04.047; Metzger BE, 2009, DIABETES, V58, P453, DOI 10.2337/db08-1112; Ong KK, 2009, AM J CLIN NUTR, V90, P156, DOI 10.3945/ajcn.2008.27408; ORAHILLY S, 1987, DIABETOLOGIA, V30, P394, DOI 10.1007/BF00292540; PEDERSEN J, 1952, Nord Med, V47, P1049; PEDERSEN J, 1952, ACTA ENDOCRINOL-COP, V9, P342, DOI 10.1530/acta.0.0090342; Plagemann A, 2012, BEST PRACT RES CL EN, V26, P641, DOI 10.1016/j.beem.2012.03.008; Regnault N, 2011, DIABETES, V60, P2152, DOI 10.2337/db10-1189; Renault KM, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.029; Schack-Nielsen L, 2010, INT J OBESITY, V34, P67, DOI 10.1038/ijo.2009.206; Schellong K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047776; Sorensen TIA, 2009, P NUTR SOC, V68, P43, DOI 10.1017/S0029665108008847; Tounian P, 2011, ANN NUTR METAB, V58, P30, DOI 10.1159/000328038; Vatten LJ, 2002, PEDIATRICS, V109, P1131, DOI 10.1542/peds.109.6.1131	42	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0121350	10.1371/journal.pone.0121350	http://dx.doi.org/10.1371/journal.pone.0121350			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151559	Green Published, Green Submitted, gold			2022-12-27	WOS:000358158900001
J	Solano, CM; Okoth, SA; Abdallah, JF; Pava, Z; Dorado, E; Incardona, S; Huber, CS; de Oliveira, AM; Bell, D; Udhayakumar, V; Barnwell, JW				Murillo Solano, Claribel; Okoth, Sheila Akinyi; Abdallah, Joseph F.; Pava, Zuleima; Dorado, Erika; Incardona, Sandra; Huber, Curtis S.; de Oliveira, Alexandre Macedo; Bell, David; Udhayakumar, Venkatachalam; Barnwell, John W.			Deletion of Plasmodium falciparum Histidine-Rich Protein 2 (pfhrp2) and Histidine-Rich Protein 3 (pfhrp3) Genes in Colombian Parasites	PLOS ONE			English	Article							SULFADOXINE-PYRIMETHAMINE RESISTANCE; MICROSATELLITE MARKERS; MALARIA; POPULATION; ORIGIN; BREAKPOINTS; DIVERSITY; NETWORK; SENEGAL; REGION	A number of studies have analyzed the performance of malaria rapid diagnostic tests (RDTs) in Colombia with discrepancies in performance being attributed to a combination of factors such as parasite levels, interpretation of RDT results and/ or the handling and storage of RDT kits. However, some of the inconsistencies observed with results from Plasmodium falciparum histidine-rich protein 2 (PfHRP2)-based RDTs could also be explained by the deletion of the gene that encodes the protein, pfhrp2, and its structural homolog, pfhrp3, in some parasite isolates. Given that pfhrp2- and pfhrp3-negative P. falciparum isolates have been detected in the neighboring Peruvian and Brazilian Amazon regions, we hypothesized that parasites with deletions of pfhrp2 and pfhrp3 may also be present in Colombia. In this study we tested 100 historical samples collected between 1999 and 2009 from six Departments in Colombia for the presence of pfhrp2, pfhrp3 and their flanking genes. Seven neutral microsatellites were also used to determine the genetic background of these parasites. In total 18 of 100 parasite isolates were found to have deleted pfhrp2, a majority of which (14 of 18) were collected from Amazonas Department, which borders Peru and Brazil. pfhrp3 deletions were found in 52 of the100 samples collected from all regions of the country. pfhrp2 flanking genes PF3D7_0831900 and PF3D7_0831700 were deleted in 22 of 100 and in 1 of 100 samples, respectively. pfhrp3 flanking genes PF3D7_1372100 and PF3D7_1372400 were missing in 55 of 100 and in 57 of 100 samples. Structure analysis of microsatellite data indicated that Colombian samples tested in this study belonged to four clusters and they segregated mostly based on their geographic region. Most of the pfhrp2deleted parasites were assigned to a single cluster and originated from Amazonas Department although a few pfhrp2-negative parasites originated from the other three clusters. The presence of a high proportion of pfhrp2-negative isolates in the Colombian Amazon may have implications for the use of PfHRP2-based RDTs in the region and may explain inconsistencies observed when PfHRP2-based tests and assays are performed.	[Murillo Solano, Claribel; Pava, Zuleima; Dorado, Erika] Ctr Int Entrenamiento & Invest Med CIDEIM, Cali, Colombia; [Okoth, Sheila Akinyi; Abdallah, Joseph F.; Huber, Curtis S.; de Oliveira, Alexandre Macedo; Udhayakumar, Venkatachalam; Barnwell, John W.] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Parasit Dis & Malaria, Malaria Branch, Atlanta, GA USA; [Okoth, Sheila Akinyi] Atlanta Res & Educ Fdn, Decatur, GA USA; [Incardona, Sandra; Bell, David] Fdn Innovat New Diagnost, CH-1202 Geneva, Switzerland; [Bell, David] Global Good Fund, Intellectual Ventures Lab, Bellevue, WA USA	Centers for Disease Control & Prevention - USA; Foundation For Innovative New Diagnostics; Intellectual Ventures	Solano, CM (corresponding author), Ctr Int Entrenamiento & Invest Med CIDEIM, Carrera 125 19-225 Av, Cali, Colombia.	claribel_murillo@cideim.org.co		Incardona, Sandra/0000-0003-4994-1736; Pava, Zuleima/0000-0002-4802-0647	Foundation for Innovative New Diagnostics; United States Agency for International Development; Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia Francisco Jose de Caldas, Colciencias [512-2010]; CDC based American Society for Microbiology Postdoctoral Fellowship; Atlanta Research and Educational Foundation; FOGARTY INTERNATIONAL CENTER [D43TW006589] Funding Source: NIH RePORTER	Foundation for Innovative New Diagnostics; United States Agency for International Development(United States Agency for International Development (USAID)); Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia Francisco Jose de Caldas, Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); CDC based American Society for Microbiology Postdoctoral Fellowship; Atlanta Research and Educational Foundation; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Sample collection and training were supported by Foundation for Innovative New Diagnostics. Genotyping experiments and travel were supported by the Amazon Malaria Initiative, which is funded by the United States Agency for International Development. Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia Francisco Jose de Caldas, Colciencias supported CMS (No. 512-2010). CDC based American Society for Microbiology Postdoctoral Fellowship partly supported SAO. Atlanta Research and Educational Foundation partly supported the laboratory work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah JF, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0537-7; Akinyi Okoth S, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0126805, DOI 10.1371/J0URNAL.P0NE.0126805]; Akinyi S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02797; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; [Anonymous], 2012, MAL RAP DIAGN TEST P; Aponte SL, 2011, MEM I OSWALDO CRUZ, V106, P123, DOI 10.1590/S0074-02762011000900016; Bell DR, 2005, AM J TROP MED HYG, V73, P199, DOI 10.4269/ajtmh.2005.73.199; BIGGS BA, 1989, P NATL ACAD SCI USA, V86, P2428, DOI 10.1073/pnas.86.7.2428; Bopp SER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003293; Branch OH, 2011, MOL BIOL EVOL, V28, P1973, DOI 10.1093/molbev/msq311; Chaparro P, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-330; Cheng Q, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-283; Chiodini PL, 2007, T ROY SOC TROP MED H, V101, P331, DOI 10.1016/j.trstmh.2006.09.007; Corredor V, 2010, ANTIMICROB AGENTS CH, V54, P3121, DOI 10.1128/AAC.00036-10; Martha RCD, 2007, MEM I OSWALDO CRUZ, V102, P293, DOI 10.1590/S0074-02762007005000044; Deme AB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-34; Dharia NV, 2010, GENOME RES, V20, P1534, DOI 10.1101/gr.105163.110; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Echeverry DF, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-2; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Griffing SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023486; Hoffmann EHE, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-24; Houze S, 2011, J CLIN MICROBIOL, V49, P2694, DOI 10.1128/JCM.00281-11; Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665; Kumar N, 2013, ACTA TROP, V125, P119, DOI 10.1016/j.actatropica.2012.09.015; Ospina OL, 2012, BIOMEDICA, V32, P46, DOI 10.1590/S0120-41572012000500007; Machado RLD, 2004, J INFECT DIS, V190, P1547, DOI 10.1086/424601; Maltha J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043094; McCollum AM, 2007, ANTIMICROB AGENTS CH, V51, P2085, DOI 10.1128/AAC.01228-06; Pan American Health Organization, 2011, REP SIT MAL AM 2011; Pritchard JK, 2000, GENETICS, V155, P945; Ramutton T, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-276; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; SCHERF A, 1992, NUCLEIC ACIDS RES, V20, P1491, DOI 10.1093/nar/20.7.1491; SHIRLEY MW, 1990, MOL BIOCHEM PARASIT, V40, P137, DOI 10.1016/0166-6851(90)90087-3; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; WELLEMS TE, 1987, CELL, V49, P633, DOI 10.1016/0092-8674(87)90539-3; WELLEMS TE, 1991, P NATL ACAD SCI USA, V88, P3382, DOI 10.1073/pnas.88.8.3382; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wurtz N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-34	42	45	45	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131576	10.1371/journal.pone.0131576	http://dx.doi.org/10.1371/journal.pone.0131576			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151448	Green Submitted, Green Published, gold			2022-12-27	WOS:000358158900020
J	Saarinen, PE; Kalliomaki, P; Tang, JW; Koskela, H				Saarinen, Pekka E.; Kalliomaki, Petri; Tang, Julian W.; Koskela, Hannu			Large Eddy Simulation of Air Escape through a Hospital Isolation Room Single Hinged Doorway-Validation by Using Tracer Gases and Simulated Smoke Videos	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; INFLUENZA-A; AEROSOL TRANSMISSION; AIRBORNE TRANSMISSION; SARS; VIRUS; VENTILATION; PARTICLES; OUTBREAK; EXPOSURE	The use of hospital isolation rooms has increased considerably in recent years due to the worldwide outbreaks of various emerging infectious diseases. However, the passage of staff through isolation room doors is suspected to be a cause of containment failure, especially in case of hinged doors. It is therefore important to minimize inadvertent contaminant airflow leakage across the doorway during such movements. To this end, it is essential to investigate the behavior of such airflows, especially the overall volume of air that can potentially leak across the doorway during door-opening and human passage. Experimental measurements using full-scale mock-ups are expensive and labour intensive. A useful alternative approach is the application of Computational Fluid Dynamics (CFD) modelling using a time-resolved Large Eddy Simulation (LES) method. In this study simulated air flow patterns are qualitatively compared with experimental ones, and the simulated total volume of air that escapes is compared with the experimentally measured volume. It is shown that the LES method is able to reproduce, at room scale, the complex transient airflows generated during door-opening/ closing motions and the passage of a human figure through the doorway between two rooms. This was a basic test case that was performed in an isothermal environment without ventilation. However, the advantage of the CFD approach is that the addition of ventilation airflows and a temperature difference between the rooms is, in principle, a relatively simple task. A standard method to observe flow structures is dosing smoke into the flow. In this paper we introduce graphical methods to simulate smoke experiments by LES, making it very easy to compare the CFD simulation to the experiments. The results demonstrate that the transient CFD simulation is a promising tool to compare different isolation room scenarios without the need to construct full-scale experimental models. The CFD model is able to reproduce the complex airflows and estimate the volume of air escaping as a function of time. In this test, the calculated migrated air volume in the CFD model differed by 20% from the experimental tracer gas measurements. In the case containing only a hinged door operation, without passage, the difference was only 10%.	[Saarinen, Pekka E.; Kalliomaki, Petri; Koskela, Hannu] Finnish Inst Occupat Hlth, Turku, Finland; [Tang, Julian W.] Univ Hosp Leicester, Leicester Royal Infirm, Leicester, Leics, England	Finnish Institute of Occupational Health; University Hospitals of Leicester NHS Trust; University of Leicester	Saarinen, PE (corresponding author), Finnish Inst Occupat Hlth, Turku, Finland.	pekka.saarinen@ttl.fi		Saarinen, Pekka/0000-0003-0152-7237; Tang, Julian/0000-0002-4963-1028	Finnish Funding Agency for Technology and Innovation	Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES))	This work was supported by the Finnish Funding Agency for Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NJ, 2011, AM J INFECT CONTROL, V39, P91, DOI 10.1016/j.ajic.2010.05.025; American Society of Heating Refrigerating and Air-Conditioning Engineers-ASHRAE, 2013, HVAC DES MAN HOSP CL, V2nd; Atkinson J, 2009, NATURAL VENTILATION FOR INFECTION CONTROL IN HEALTH-CARE SETTINGS, P1; Bischoff WE, 2013, J INFECT DIS, V207, P1037, DOI 10.1093/infdis/jis773; Booth TF, 2005, J INFECT DIS, V191, P1472, DOI 10.1086/429634; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Choi JI, 2008, INDOOR AIR, V18, P233, DOI 10.1111/j.1600-0668.2008.00527.x; Choi JI, 2012, INDOOR AIR, V22, P77, DOI 10.1111/j.1600-0668.2011.00741.x; Choi JI, 2007, J COMPUT PHYS, V224, P757, DOI 10.1016/j.jcp.2006.10.032; Hathway A, 2014, P IND AIR 2014 13 IN; Kalliomaki P, 2014, P IND AIR 2014 13 IN; Kalliomaki P, 2015, INT J VENT IN PRESS; Kiel DE., 1989, ASHRAE T, V95, P590; Kim SH, 2013, BUILD ENVIRON, V60, P305, DOI 10.1016/j.buildenv.2012.09.005; Lednicky John A, 2013, Influenza Res Treat, V2013, P656825, DOI 10.1155/2013/656825; Lemieux C, 2007, EMERG INFECT DIS, V13, P173, DOI 10.3201/eid1301.061202; Li Y, 2007, INDOOR AIR, V17, P2, DOI 10.1111/j.1600-0668.2006.00445.x; Li Y, 2005, INDOOR AIR, V15, P96, DOI 10.1111/j.1600-0668.2004.00318.x; Li Y, 2005, INDOOR AIR, V15, P83, DOI 10.1111/j.1600-0668.2004.00317.x; Lindsley WG, 2015, J OCCUP ENVIRON HYG, V12, P107, DOI 10.1080/15459624.2014.973113; Lindsley WG, 2012, J OCCUP ENVIRON HYG, V9, P443, DOI 10.1080/15459624.2012.684582; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Mittal R, 2005, ANNU REV FLUID MECH, V37, P239, DOI 10.1146/annurev.fluid.37.061903.175743; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; Nielsen PV, 2012, P VENT 2012 10 INT C; Nikitin N, 2014, ADV VIROL, V2014, DOI 10.1155/2014/859090; Olmedo I, 2012, INDOOR AIR, V22, P64, DOI 10.1111/j.1600-0668.2011.00736.x; Papineni RS, 1996, J AEROSOL MED, V10, P105, DOI 10.1089/jam.1997.10.105; Saarinen P, 2014, P IND AIR 2014 13 IN; Fernandez AS, 2013, INT E-J CRIM SCI; Seto WH, 2015, J HOSP INFECT, V89, P225, DOI 10.1016/j.jhin.2014.11.005; Shih YC, 2007, BUILD ENVIRON, V42, P3194, DOI 10.1016/j.buildenv.2006.08.008; Tang JW, 2006, J HOSP INFECT, V64, P100, DOI 10.1016/j.jhin.2006.05.022; Tang JW, 2007, LANCET INFECT DIS, V7, P758, DOI 10.1016/S1473-3099(07)70268-2; Tang JLW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066663; Tang JW, 2005, J HOSP INFECT, V61, P283, DOI 10.1016/j.jhin.2005.05.017; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Wong TW, 2004, EMERG INFECT DIS, V10, P269, DOI 10.3201/eid1002.030452; Yu ITS, 2014, CLIN INFECT DIS, V58, P683, DOI 10.1093/cid/cit797; Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867	41	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0130667	10.1371/journal.pone.0130667	http://dx.doi.org/10.1371/journal.pone.0130667			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151865	Green Published, Green Submitted, gold			2022-12-27	WOS:000358158900015
J	Stegeman, I; Bossuyt, PM; Yu, T; Boyd, C; Puhan, MA				Stegeman, Inge; Bossuyt, Patrick M.; Yu, Tsung; Boyd, Cynthia; Puhan, Milo A.			Aspirin for Primary Prevention of Cardiovascular Disease and Cancer. A Benefit and Harm Analysis	PLOS ONE			English	Article							COLORECTAL-CANCER; 5-YEAR SURVIVAL; RISK; STROKE; METAANALYSIS; METASTASIS; MORTALITY	Background Aspirin is widely used for prevention of cardiovascular disease. In recent years randomized trials also suggested a preventive effect for various types of cancer. We aimed to assess, in a quantitative way, benefits and harms of aspirin for primary prevention of both cardiovascular disease and cancer for a general US population between 40 and 85 years of age. Methods We used the Gail/National Cancer Institute approach for assessing benefits and harms. This approach provides a probability that a treatment is more beneficial than harmful and incorporates multiple outcomes, the importance of these outcomes, considers different outcome risks and treats mortality as a competing risk. Our main outcomes were the risks of seven types of cancer, myocardial infarction, ischemic and hemorrhagic stroke and gastrointestinal bleeding. We obtained effect estimates from recent meta-analyses of randomized trials and used baseline risks from the Centers for Disease Control. We conducted four sensitivity analyses to assess the influence of different assumptions about outcome risks and preferences and considered the sampling variation of the effect estimates for aspirin. Results The main analysis as well as the sensitivity analyses showed that aspirin has more benefits than harms. In the main analysis, the index (positive if number of prevented events > excess number of harm events over 10 years per 1,000 persons) ranged from 2 (95% CI 0.0 to 11.8; in women age 45 to 54 years) to 8 (95% CI -0.1 to 83.7; in men age 65 to 74 years). In the sensitivity analyses, the index was also positive for all age categories suggesting more benefits than harms. Conclusion This study suggests an overall benefit of aspirin for primary prevention of cardiovascular disease and cancer based on population-based data. For individual preventive counseling, additional benefit harm analyses should explore which individuals should or should not take aspirin based on their risk profile for cardiovascular, cancer and gastrointestinal outcomes and based on their outcome preferences. Thereby, risk-stratified and preference-sensitive prevention could become a reality.	[Stegeman, Inge; Bossuyt, Patrick M.] Univ Amsterdam, Acad Med Ctr, Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Stegeman, Inge] Univ Med Ctr Utrecht, Dept Otolaryngol Head & Neck Surg, Utrecht, Netherlands; [Yu, Tsung; Puhan, Milo A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Boyd, Cynthia] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Puhan, Milo A.] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland	University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of Zurich	Stegeman, I (corresponding author), Univ Amsterdam, Acad Med Ctr, Clin Epidemiol Biostat & Bioinformat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	i.stegeman@umcutrecht.nl	Puhan, Milo/ABE-6298-2020; Stegeman, Inge/AAP-3949-2021; Bossuyt, Patrick M./B-4557-2016; Bossuyt, Patrick M/AAR-1183-2021	Puhan, Milo/0000-0003-4721-1879; Bossuyt, Patrick M./0000-0003-4427-0128; Bossuyt, Patrick M/0000-0003-4427-0128; Stegeman, Inge/0000-0001-5154-7178	Paul Beeson Career Development Award Program [NIA 1K23AG032910]; AFAR; John A. Hartford Foundation; Atlantic Philanthropies; Starr Foundation; NATIONAL INSTITUTE ON AGING [K23AG032910] Funding Source: NIH RePORTER	Paul Beeson Career Development Award Program; AFAR; John A. Hartford Foundation; Atlantic Philanthropies; Starr Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr. Boyd was supported by the Paul Beeson Career Development Award Program (NIA 1K23AG032910), AFAR, The John A. Hartford Foundation, The Atlantic Philanthropies and The Starr Foundation.	Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; [Anonymous], 2012, NATL VITAL STAT SYST; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bata IR, 2006, CAN J CARDIOL, V22, P399, DOI 10.1016/S0828-282X(06)70925-4; Berger JS, 2011, AM HEART J, V162, P115, DOI 10.1016/j.ahj.2011.04.006; Boyd CM, 2012, METHODS BENEFIT HARM; Calonge N, 2009, ANN INTERN MED, V150, P396; Cappelen AW, 2006, HEALTH POLICY, V76, P312, DOI 10.1016/j.healthpol.2005.06.013; cdc, CANC INC RAT; Chen LY, 2013, JAMA INTERN MED, V173, P29, DOI 10.1001/2013.jamainternmed.744; Diehl AK, 2012, ANN INTERN MED, V157, pJC1; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Gail MH, 1999, J NATL CANCER I, V91, P1829, DOI 10.1093/jnci/91.21.1829; Hankey GJ, 2000, STROKE, V31, P2080, DOI 10.1161/01.STR.31.9.2080; He J, 1998, JAMA-J AM MED ASSOC, V280, P1930, DOI 10.1001/jama.280.22.1930; Hernandez-Diaz S, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-22; National Institutes of Health, 2006, IND PREV 2006 CHART; Puhan MA, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-173; Roberts SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049507; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Seshasai SRK, 2012, ARCH INTERN MED, V172, P209, DOI 10.1001/archinternmed.2011.628; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Thiagarajan P, 2012, BEST PRACT RES CL GA, V26, P197, DOI 10.1016/j.bpg.2012.01.007; WOLF PA, 1991, STROKE, V22, P312, DOI 10.1161/01.STR.22.3.312; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	30	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0127194	10.1371/journal.pone.0127194	http://dx.doi.org/10.1371/journal.pone.0127194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151751	gold, Green Published, Green Submitted			2022-12-27	WOS:000358158900003
J	Endres, L; Begley, U; Clark, R; Gu, C; Dziergowska, A; Malkiewicz, A; Melendez, JA; Dedon, PC; Begley, TJ				Endres, Lauren; Begley, Ulrike; Clark, Ryan; Gu, Chen; Dziergowska, Agnieszka; Malkiewicz, Andrzej; Melendez, J. Andres; Dedon, Peter C.; Begley, Thomas J.			Alkbh8 Regulates Selenocysteine-Protein Expression to Protect against Reactive Oxygen Species Damage	PLOS ONE			English	Article							TRANSFER-RNA; DNA-DAMAGE; OXIDATIVE STRESS; GLUTATHIONE-PEROXIDASE; ALKYLATION DAMAGE; CANCER; THIOREDOXIN; SELENIUM; MICE; METHYLTRANSFERASE	Environmental and metabolic sources of reactive oxygen species (ROS) can damage DNA, proteins and lipids to promote disease. Regulation of gene expression can prevent this damage and can include increased transcription, translation and post translational modification. Cellular responses to ROS play important roles in disease prevention, with deficiencies linked to cancer, neurodegeneration and ageing. Here we detail basal and damage-induced translational regulation of a group of oxidative-stress response enzymes by the tRNA methyltransferase Alkbh8. Using a new gene targeted knockout mouse cell system, we show that Alkbh8(-/-) embryonic fibroblasts (MEFs) display elevated ROS levels, increased DNA and lipid damage and hallmarks of cellular stress. We demonstrate that Alkbh8 is induced in response to ROS and is required for the efficient expression of selenocysteine-containing ROS detoxification enzymes belonging to the glutathione peroxidase (Gpx1, Gpx3, Gpx6 and likely Gpx4) and thioredoxin reductase (TrxR1) families. We also show that, in response to oxidative stress, the tRNA modification 5-methoxycarbonylmethyl-2'-Omethyluridine (mcm(5)Um) increases in normal MEFs to drive the expression of ROS detoxification enzymes, with this damage-induced reprogramming of tRNA and stop-codon recoding corrupted in Alkbh8(-/-) MEFS. These studies define Alkbh8 and tRNA modifications as central regulators of cellular oxidative stress responses in mammalian systems. In addition they highlight a new animal model for use in environmental and cancer studies and link translational regulation to the prevention of DNA and lipid damage.	[Endres, Lauren; Begley, Ulrike; Clark, Ryan; Melendez, J. Andres; Begley, Thomas J.] SUNY Albany, Polytech Inst, Coll Nanoscale Sci, Albany, NY 12203 USA; [Endres, Lauren; Begley, Ulrike; Clark, Ryan; Melendez, J. Andres; Begley, Thomas J.] SUNY Albany, Polytech Inst, Coll Engn, Albany, NY 12203 USA; [Endres, Lauren; Begley, Thomas J.] SUNY Albany, RNA Inst, Albany, NY 12222 USA; [Endres, Lauren; Begley, Thomas J.] SUNY Albany, Canc Res Ctr, Albany, NY 12222 USA; [Gu, Chen; Dedon, Peter C.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Dziergowska, Agnieszka] Lodz Univ Technol, Inst Organ Chem, Lodz, Poland; [Dedon, Peter C.] CREATE, Singapore MIT Alliance Res & Technol, Singapore, Singapore; [Dedon, Peter C.] MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Massachusetts Institute of Technology (MIT); Lodz University of Technology; Singapore-MIT Alliance for Research & Technology Centre (SMART); Massachusetts Institute of Technology (MIT)	Begley, TJ (corresponding author), SUNY Albany, Polytech Inst, Coll Nanoscale Sci, Albany, NY 12203 USA.	tbegley@albany.edu	Gu, Chen/AAO-3580-2021; Dziergowska, Agnieszka/H-5240-2017	Dziergowska, Agnieszka/0000-0002-8888-380X; Melendez, Juan/0000-0001-8021-3097	National Institute of Environmental Health Sciences [ES002109, ES015037, ES017010]; MIT Westaway Fund; NRSA Post-doctoral Fellowship from NIEHS; Howard Hughes Graduate Fellowship; Singapore-MIT Alliance for Research and Technology; David H. Koch Cancer Research Graduate Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024615, R01ES015037, R01ES017010, P30ES002109] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); MIT Westaway Fund; NRSA Post-doctoral Fellowship from NIEHS; Howard Hughes Graduate Fellowship; Singapore-MIT Alliance for Research and Technology(Singapore-MIT Alliance for Research & Technology Centre (SMART)); David H. Koch Cancer Research Graduate Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Financial support was provided by the National Institute of Environmental Health Sciences (ES002109, ES015037 and ES017010), the MIT Westaway Fund (P.C.D.), NRSA Post-doctoral Fellowship from NIEHS (L.E.), a David H. Koch Cancer Research Graduate Fellowship (C.G.), a Howard Hughes Graduate Fellowship (C.G.) and the Singapore-MIT Alliance for Research and Technology (P.C.D.) (www.nih.gov, http://ki.mit.edu, www.hhmi.org, http://web.mit.edu/sma//). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; ABRIL N, 1990, ENVIRON MOL MUTAGEN, V15, P184, DOI 10.1002/em.2850150403; Aravind L, 2001, GENOME BIOL, V2; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Avval FZ, 2009, J BIOL CHEM, V284, P8233, DOI 10.1074/jbc.M809338200; Baker A, 1997, CANCER RES, V57, P5162; Begley U, 2007, MOL CELL, V28, P860, DOI 10.1016/j.molcel.2007.09.021; Bjornstad LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049045; Carlson BA, 2005, J BIOL CHEM, V280, P5542, DOI 10.1074/jbc.M411725200; Carlson BA, 2009, MOLECULES, V14, P3509, DOI 10.3390/molecules14093509; Cavaluzzi MJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh015; Chan CTY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1938; Chan CTY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001247; Cheng WH, 1998, J NUTR, V128, P1070, DOI 10.1093/jn/128.7.1070; CHOI IS, 1994, BIOCHEMISTRY-US, V33, P601, DOI 10.1021/bi00168a027; Combs GF, 2001, BIOFACTORS, V14, P153, DOI 10.1002/biof.5520140120; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; de Haan JB, 1998, J BIOL CHEM, V273, P22528, DOI 10.1074/jbc.273.35.22528; DIAMOND AM, 1993, J BIOL CHEM, V268, P14215; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Fu D, 2013, GENE DEV, V27, P1089, DOI 10.1101/gad.215533.113; Fu D, 2010, MOL CELL BIOL, V30, P2449, DOI 10.1128/MCB.01604-09; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gladyshev VN, 1999, J BIOMED SCI, V6, P151, DOI 10.1007/BF02255899; Gupta M, 1997, CLIN CANCER RES, V3, P1653; Holmgren A, 2010, BIOCHEM BIOPH RES CO, V396, P120, DOI 10.1016/j.bbrc.2010.03.083; Kalhor HR, 2003, MOL CELL BIOL, V23, P9283, DOI 10.1128/MCB.23.24.9283-9292.2003; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Martin-Romero FJ, 2001, J BIOL CHEM, V276, P29798, DOI 10.1074/jbc.M100422200; Moustafa ME, 2003, J NUTR, V133, p2494S, DOI 10.1093/jn/133.7.2494S; Moustafa ME, 2001, MOL CELL BIOL, V21, P3840, DOI 10.1128/MCB.21.11.3840-3852.2001; Nakamura H, 2006, SEMIN CANCER BIOL, V16, P444, DOI 10.1016/j.semcancer.2006.09.001; Niedernhofer LJ, 2003, J BIOL CHEM, V278, P31426, DOI 10.1074/jbc.M212549200; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; Pan ZS, 2008, DEV DYNAM, V237, P316, DOI 10.1002/dvdy.21418; Patil A, 2012, CELL CYCLE, V11, P3656, DOI 10.4161/cc.21919; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Pouyet L, 2010, TRANSGENIC RES, V19, P155, DOI 10.1007/s11248-009-9308-6; Powis G, 2000, FREE RADICAL BIO MED, V29, P312, DOI 10.1016/S0891-5849(00)00313-0; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Shimada K, 2009, CANCER RES, V69, P3157, DOI 10.1158/0008-5472.CAN-08-3530; Songe-Moller L, 2010, MOL CELL BIOL, V30, P1814, DOI 10.1128/MCB.01602-09; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Su D, 2014, NAT PROTOC, V9, P828, DOI 10.1038/nprot.2014.047; Thalhammer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016210; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; van den Born E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1173; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	64	42	44	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131335	10.1371/journal.pone.0131335	http://dx.doi.org/10.1371/journal.pone.0131335			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147969	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600090
J	Kalisya, LM; Nyavandu, K; Machumu, B; Kwiratuwe, S; Rej, PH				Kalisya, Luc Malemo; Nyavandu, Kavira; Machumu, Bahati; Kwiratuwe, Sylvain; Rej, Peter H.			Patterns of Congenital Malformations and Barriers to Care in Eastern Democratic Republic of Congo	PLOS ONE			English	Article							CLEFT-LIP; AWARENESS; PALATE	Background An increase of congenital anomalies in the eastern Democratic Republic of the Congo (DRC) has been reported. Congenital malformations (CMs) are not uncommon among new-borns and, if left untreated, can contribute to increased neonate morbidity and mortality. Methods Medical records of all individuals admitted with a diagnosed CM to HEAL Africa Teaching Hospital (Goma, DRC) from 2002 to 2014 (n=1301) were reviewed. Data were analysed using descriptive statistics to summarize chart records, and inferential statistics to investigate significant barriers to earlier treatment. Results Since 2012, the number of patients treated each year for CMs has increased by over 200% compared to the average annual number of cases treated from 2002-2011. Though delayed presentation of patients to HEAL Hospital was very obvious, with an average age of 8.2 years. We find that patient age has been significantly decreasing (p=0.037) over time. The average distance separating patients from HEAL Hospital was 178 km, with approximately one third living 350 km or further from the treatment center. Distance is the most significant (p=3.33x10(-6)) barrier to earlier treatment. When controlling for an interaction between gender and the use of mercy funds, we also find that female patients are at a significant (p=1.04x10(-3)) disadvantage to undergo earlier corrective surgery. This disadvantage is further illustrated by our finding that 89% of women and girls, and over 81% of all patients, required mercy funds to cover the cost of surgery in 2014. Lastly, the mortality rate for surgery was low and averaged less than 1.0%. Conclusion Despite a formal end to the war in 2009, and an overall increase in individuals undergoing corrective surgery, distance, poverty, and gender are still massive barriers to CM care at HEAL Hospital, Goma, DRC. We find that patients have been successfully treated earlier by HEAL, although the average age of CM correction in 2014 (4.9 years) is still above average for Sub-Saharan Africa. Thus, we advocate for further funding from the National Government and international health agencies to enable continued treatment of CMs in rural residents of the eastern DRC. Distance, the most significant barrier to care can be mitigated by the implementation of additional mobile clinics and the construction of regional surgery centers along with the associated hiring of surgeons trained in CM repair.	[Kalisya, Luc Malemo; Nyavandu, Kavira; Machumu, Bahati; Kwiratuwe, Sylvain] HEAL Africa, Goma, Nord Kivu, DEM REP CONGO; [Rej, Peter H.] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Rej, Peter H.] Univ Florida, Genet Inst, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Rej, PH (corresponding author), Univ Florida, Dept Anthropol, Turlington Hall,Room 1112,PO 117305, Gainesville, FL 32611 USA.	peterrej@ufl.edu						Ahuka O L, 2006, East Afr Med J, V83, P95; Ambe J P, 2010, West Afr J Med, V29, P24; Donkor P, 2007, West Afr J Med, V26, P14; Enyinnah Michael, 2013, Glob J Health Sci, V5, P176, DOI 10.5539/gjhs.v5n4p176; Grover Neelam, 2000, Indian Journal of Pediatrics, V67, P249, DOI 10.1007/BF02758158; Hudgins I, 2008, PAK J MED SCI, V24, P33; Lawal TA, 2013, EUR J PEDIATR SURG, V23, P480, DOI 10.1055/s-0033-1337116; Mabula Joseph B, 2012, BMC Res Notes, V5, P585, DOI 10.1186/1756-0500-5-585; Male BD, 2007, E AFR J SURG, V9, P74; Malla BK, 2007, UNI MED J, V5, P557; Mbah N, 2007, West Afr J Med, V26, P288; Obuekwe On, 2004, Cent Afr J Med, V50, P65; Olasoji HO, 2007, BRIT J ORAL MAX SURG, V45, P302, DOI 10.1016/j.bjoms.2006.09.005; Olasoji H O, 2009, Afr J Med Med Sci, V38, P303; Onah I I, 2012, Niger J Med, V21, P296; Onyango J F, 2005, East Afr Med J, V82, P649; Owotade FJ, 2014, NIGER J CLIN PRACT, V17, P6, DOI 10.4103/1119-3077.122822; Rabiu TB, 2012, CHILD NERV SYST, V28, P2115, DOI 10.1007/s00381-012-1879-5; Turnpenny P, 2005, EMERYS ELEMENTS MED; Ugwu R O, 2007, Niger J Med, V16, P368; Westgren Magnus, 2011, Handb Exp Pharmacol, V205, P271, DOI 10.1007/978-3-642-20195-0_13	21	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132362	10.1371/journal.pone.0132362	http://dx.doi.org/10.1371/journal.pone.0132362			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147996	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600252
J	Liu, HJ; Zhou, HK; Wu, YS; Li, X; Zhao, J; Zuo, T; Zhang, X; Zhang, YZ; Liu, SS; Shen, Y; Lin, HJ; Zhang, ZM; Huang, KJ; Lubberstedt, T; Pan, GT				Liu, Hongjun; Zhou, Huangkai; Wu, Yongsheng; Li, Xiao; Zhao, Jing; Zuo, Tao; Zhang, Xuan; Zhang, Yongzhong; Liu, Sisi; Shen, Yaou; Lin, Haijian; Zhang, Zhiming; Huang, Kaijian; Luebberstedt, Thomas; Pan, Guangtang			The Impact of Genetic Relationship and Linkage Disequilibrium on Genomic Selection	PLOS ONE			English	Article							MARKER-ASSISTED SELECTION; BREEDING VALUE ESTIMATION; QUANTITATIVE TRAITS; RELATIONSHIP INFORMATION; MAIZE; PREDICTION; VALUES; POPULATION; ACCURACY; REGRESSION	Genomic selection is a promising research area due to its practical application in breeding. In this study, impact of realized genetic relationship and linkage disequilibrium (LD) on marker density and training population size required was investigated and their impact on practical application was further discussed. This study is based on experimental data of two populations derived from the same two founder lines (B73, Mo17). Two populations were genotyped with different marker sets at different density: IBM Syn4 and IBM Syn10. A high-density marker set in Syn10 was imputed into the Syn4 population with low marker density. Seven different prediction scenarios were carried out with a random regression best linear unbiased prediction (RR-BLUP) model. The result showed that the closer the real genetic relationship between training and validation population, the fewer markers were required to reach a good prediction accuracy. Taken the short-term cost for consideration, relationship information is more valuable than LD information. Meanwhile, the result indicated that accuracies based on high LD between QTL and markers were more stable over generations, thus LD information would provide more robust prediction capacity in practical applications.	[Liu, Hongjun; Zhang, Yongzhong; Liu, Sisi; Shen, Yaou; Lin, Haijian; Zhang, Zhiming; Pan, Guangtang] Sichuan Agr Univ, Maize Res Inst, Chengdu, Peoples R China; [Zhou, Huangkai; Zhang, Xuan] Guangzhou Genedenovo Biotechnol Co Ltd, Guangzhou, Guangdong, Peoples R China; [Wu, Yongsheng; Huang, Kaijian] Guangxi Acad Agr Sci, Guangxi Maize Res Inst, Nanning, Peoples R China; [Li, Xiao] Sichuan Acad Agr Sci, Inst Plant Protect, Chengdu, Peoples R China; [Zhao, Jing; Luebberstedt, Thomas] Iowa State Univ, Dept Agron, Ames, IA USA; [Zuo, Tao] Iowa State Univ, Interdept Genet Program, Ames, IA USA	Sichuan Agricultural University; Guangxi Academy of Agricultural Sciences; Sichuan Academy of Agricultural Sciences (SAAS); Iowa State University; Iowa State University	Pan, GT (corresponding author), Sichuan Agr Univ, Maize Res Inst, Chengdu, Peoples R China.	pangt@sicau.edu.cn			National Natural Science Foundation of China [31201221, 31271740, 31060191]; National Hi-Tech program of China [2012AA10307]; Maize Research & Development Center [CARS-02-07]; Key Laboratory Construction Program of Guangxi [12-071-09]; Guangzhou Genedenovo Biotechnology Co., Ltd	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech program of China; Maize Research & Development Center; Key Laboratory Construction Program of Guangxi; Guangzhou Genedenovo Biotechnology Co., Ltd	Funding for this research was provided by National Natural Science Foundation of China (31201221, 31271740, 31060191); the National Hi-Tech program of China (2012AA10307); Maize Research & Development Center, CARS-02-07; and the Key Laboratory Construction Program of Guangxi (12-071-09). Guangzhou Genedenovo Biotechnology Co., Ltd provided support in the form of salaries for authors HZ and XZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Bennewitz J, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-20; Bernardo R, 2007, CROP SCI, V47, P1082, DOI 10.2135/cropsci2006.11.0690; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Calus MPL, 2007, J ANIM BREED GENET, V124, P362, DOI 10.1111/j.1439-0388.2007.00691.x; Combs E, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2012.11.0030; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; Dekkers JCM, 2007, J ANIM BREED GENET, V124, P331, DOI 10.1111/j.1439-0388.2007.00701.x; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Habier D, 2013, GENETICS; Habier D, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-5; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Heffner EL, 2010, CROP SCI, V50, P1681, DOI 10.2135/cropsci2009.11.0662; Hill W, 2011, VARIATION ACTUAL REL; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Hussain T, 2007, J PLANT REGIST, V1, P81, DOI 10.3198/jpr2005.11.0414crs; LANDE R, 1990, GENETICS, V124, P743; Lawrence CJ, 2008, INT J PLANT, P2008; Lee M, 2002, PLANT MOL BIOL, V48, P453, DOI 10.1023/A:1014893521186; Lee SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000231; Long N, 2007, J ANIM BREED GENET, V124, P377, DOI 10.1111/j.1439-0388.2007.00694.x; Lorenzana RE, 2009, THEOR APPL GENET, V120, P151, DOI 10.1007/s00122-009-1166-3; Luan T, 2009, GENETICS, V183, P1119, DOI 10.1534/genetics.109.107391; Melchinger AE, 1998, GENETICS, V149, P383; Meuwissen THE, 2001, GENETICS, V157, P1819; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Solberg TR, 2008, J ANIM SCI, V86, P2447, DOI 10.2527/jas.2007-0010; Team RDC, 2012, R LANG ENV STAT COMP; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Wei Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000678; Whittaker JC, 2000, GENET RES, V75, P249, DOI 10.1017/S0016672399004462; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191; Zhao YuSheng, 2012, TAG Theoretical and Applied Genetics, V124, P769, DOI 10.1007/s00122-011-1745-y; Zhong SQ, 2009, GENETICS, V182, P355, DOI 10.1534/genetics.108.098277	45	16	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132379	10.1371/journal.pone.0132379	http://dx.doi.org/10.1371/journal.pone.0132379			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148055	Green Published, gold			2022-12-27	WOS:000358157600253
J	Sabunciyan, S; Maher, B; Bahn, S; Dickerson, F; Yolken, RH				Sabunciyan, Sarven; Maher, Brion; Bahn, Sabine; Dickerson, Faith; Yolken, Robert H.			Association of DNA Methylation with Acute Mania and Inflammatory Markers	PLOS ONE			English	Article							CPG ISLAND HYPERMETHYLATION; BIPOLAR DISORDER; SERUM DNA; GABA(A) RECEPTORS; MEDIATED TRANSFER; WIDE ASSOCIATION; CANCER PATIENTS; SCHIZOPHRENIA; METAANALYSIS; MECHANISM	In order to determine whether epigenetic changes specific to the manic mood state can be detected in peripheral blood samples we assayed DNA methylation levels genome-wide in serum samples obtained from 20 patients hospitalized for mania and 20 unaffected controls using the Illumina 450K methylation arrays. We identified a methylation locus in the CYP11A1 gene, which is regulated by corticotropin, that is hypo-methylated in individuals hospitalized for mania compared with unaffected controls. DNA methylation levels at this locus appear to be state related as levels in follow-up samples collected from mania patients six months after hospitalization were similar to those observed in controls. In addition, we found that methylation levels at the CYP11A1 locus were significantly correlated with three inflammatory markers in serum in acute mania cases but not in unaffected controls. We conclude that mania is associated with alterations in levels of DNA methylation and inflammatory markers. Since epigenetic markers are potentially malleable, a better understanding of the role of epigenetics may lead to new methods for the prevention and treatment of mood disorders.	[Sabunciyan, Sarven; Yolken, Robert H.] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA; [Maher, Brion] Johns Hopkins Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Bahn, Sabine] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England; [Dickerson, Faith] Sheppard Pratt Hlth Syst, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Cambridge	Sabunciyan, S (corresponding author), Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA.	ssabunc1@jhmi.edu; rhyolken@gmail.com	Dickerson, Faith/C-8311-2019; yolken, robert/AAW-2556-2021	Dickerson, Faith/0000-0003-3800-2864; Sabunciyan, Sarven/0000-0002-7231-0820	Stanley Medical Research Institute	Stanley Medical Research Institute	This study was supported by the Stanley Medical Research Institute (www.stanleyresearch.org).	Aberg KA, 2014, JAMA PSYCHIAT, V71, P255, DOI 10.1001/jamapsychiatry.2013.3730; Avraham A, 2012, INT J CANCER, V131, pE1166, DOI 10.1002/ijc.27526; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bergink V, 2014, BIOL PSYCHIAT, V75, P324, DOI 10.1016/j.biopsych.2013.09.037; Cai J, 2013, J MOL CELL BIOL, V5, P227, DOI 10.1093/jmcb/mjt011; Dargel AA, 2015, J CLIN PSYCHIAT, V76, P142, DOI 10.4088/JCP.14r09007; Davies G, 2003, SCHIZOPHRENIA BULL, V29, P587, DOI 10.1093/oxfordjournals.schbul.a007030; Dickerson F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073520; Dickerson F, 2012, SCHIZOPHR RES, V138, P198, DOI 10.1016/j.schres.2012.03.037; Eads CA, 2000, CANCER RES, V60, P5021; First M. B., 1998, STRUCTURED CLIN INTE; First MB, 1996, USERS GUIDE SCID 1 S; Fujiwara K, 2005, CLIN CANCER RES, V11, P1219; Furtado JM, 2011, J GLOB INFECT DIS, V3, P281, DOI 10.4103/0974-777X.83536; Glatt SJ, 2005, P NATL ACAD SCI USA, V102, P15533, DOI 10.1073/pnas.0507666102; Guerrero-Preston R, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12378; Harney SC, 2003, NEUROPHARMACOLOGY, V45, P873, DOI 10.1016/S0028-3908(03)00251-X; Hayashi-Takagi A, 2014, BIOL PSYCHIAT, V75, P920, DOI 10.1016/j.biopsych.2013.09.035; Hwang Y, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.94; Ikoma H, 2006, ANTICANCER RES, V26, P2313; Johansson AGM, 2011, J AFFECT DISORDERS, V133, P346, DOI 10.1016/j.jad.2011.04.009; JOHN ME, 1986, P NATL ACAD SCI USA, V83, P4715, DOI 10.1073/pnas.83.13.4715; Kang GH, 2003, AM J PATHOL, V163, P1551, DOI 10.1016/S0002-9440(10)63511-0; KENDLER KS, 1983, AM J PSYCHIAT, V140, P1413; Lazaro-Ibanez E, 2014, PROSTATE, V74, P1379, DOI 10.1002/pros.22853; Lim HK, 2013, J GASTRIC CANCER, V13, P157, DOI 10.5230/jgc.2013.13.3.157; Marx CE, 2006, PHARMACOL BIOCHEM BE, V84, P598, DOI 10.1016/j.pbb.2006.07.026; Marx CE, 2006, PHARMACOL BIOCHEM BE, V84, P609, DOI 10.1016/j.pbb.2006.07.032; Marx CE, 2008, INT J NEUROPSYCHOPH, V11, P547, DOI 10.1017/S1461145708008444; Munkholm K, 2013, J AFFECT DISORDERS, V144, P16, DOI 10.1016/j.jad.2012.06.010; O'Dushlaine C, 2015, NAT NEUROSCI, V18, P199, DOI 10.1038/nn.3922; OLSEN RW, 1995, ADV BIOCHEM PSYCHOPH, V48, P57; Patte-Mensah C, 2003, J NEUROCHEM, V86, P1233, DOI 10.1046/j.1471-4159.2003.01935.x; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Rosin A, 2009, ISR MED ASSOC J, V11, P689; Sabath BF, 2002, J INFECT DIS, V186, pS180, DOI 10.1086/344280; Schwarz E, 2012, MOL PSYCHIATR, V17, P494, DOI 10.1038/mp.2011.42; Slominski A. T., 2014, J STEROID BIOCH MOL; Smoller JW, 2003, AM J MED GENET C, V123C, P48, DOI 10.1002/ajmg.c.20013; SUSSER ES, 1992, ARCH GEN PSYCHIAT, V49, P983; Uzunov DP, 1996, P NATL ACAD SCI USA, V93, P12599, DOI 10.1073/pnas.93.22.12599; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Waldenstrom A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034653	44	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132001	10.1371/journal.pone.0132001	http://dx.doi.org/10.1371/journal.pone.0132001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147665	Green Submitted, gold, Green Published			2022-12-27	WOS:000358157600176
J	Tawani, A; Kumar, A				Tawani, Arpita; Kumar, Amit			Structural Insights Reveal the Dynamics of the Repeating r(CAG) Transcript Found in Huntington's Disease (HD) and Spinocerebellar Ataxias (SCAs)	PLOS ONE			English	Article							NEAREST-NEIGHBOR THERMODYNAMICS; CAG REPEATS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; CUG REPEATS; TRINUCLEOTIDE REPEATS; MYOTONIC-DYSTROPHY; NUCLEOLAR STRESS; BINDING PROTEIN; RNA STRUCTURE	In humans, neurodegenerative disorders such as Huntington's disease (HD) and many spinocerebellar ataxias (SCAs) have been found to be associated with CAG trinucleotide repeat expansion. An important RNA-mediated mechanism that causes these diseases involves the binding of the splicing regulator protein MBNL1 (Muscleblind-like 1 protein) to expanded r(C (A) under barG) repeats. Moreover, mutant huntingtin protein translated from expanded r (C (A) under barG) also yields toxic effects. To discern the role of mutant RNA in these diseases, it is essential to gather information about its structure. Detailed insight into the different structures and conformations adopted by these mutant transcripts is vital for developing therapeutics targeting them. Here, we report the crystal structure of an RNA model with a r(C (A) under barG) motif, which is complemented by an NMR-based solution structure obtained from restrained Molecular Dynamics (rMD) simulation studies. Crystal structure data of the RNA model resolved at 2.3 angstrom reveals non-canonical pairing of adenine in 5'-CAG/3'-GAC motif samples in different syn and anti conformations. The overall RNA structure has helical parameters intermediate to the A-and B-forms of nucleic acids due to the global widening of major grooves and base-pair preferences near internal AA loops. The comprehension of structural behaviour by studying the spectral features and the dynamics also supports the flexible nature of the r(C (A) under barG) motif.	[Tawani, Arpita; Kumar, Amit] Indian Inst Technol, Ctr Biosci & Biomed Engn, Indore, Madhya Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Indore	Kumar, A (corresponding author), Indian Inst Technol, Ctr Biosci & Biomed Engn, Indore, Madhya Pradesh, India.	amitk@iiti.ac.in	Tawani, Arpita/HGU-5783-2022	Tawani, Arpita/0000-0001-5227-321X; Kumar, Professor Amit/0000-0002-5913-4308	Department of Science & Technology (DST), India (AK) [SR/FT/LS-29/2012]	Department of Science & Technology (DST), India (AK)	This work was supported by the Fast Track Grant for Young Scientist SR/FT/LS-29/2012 awarded by the Department of Science & Technology (DST), India (AK).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Broda M, 2005, BIOCHEMISTRY-US, V44, P10873, DOI 10.1021/bi0502339; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bullock SL, 2010, NAT STRUCT MOL BIOL, V17, P703, DOI 10.1038/nsmb.1813; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; Cheng AHD, 2005, ENG ANAL BOUND ELEM, V29, P268, DOI 10.1016/j.enganabound.2004.12.001; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Danihelova Martina, 2013, Interdiscip Toxicol, V6, P209, DOI 10.2478/intox-2013-0031; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Disney MD, 2013, DRUG DISCOV TODAY, V18, P1228, DOI 10.1016/j.drudis.2013.07.024; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiszer A, 2013, J MOL MED, V91, P683, DOI 10.1007/s00109-013-1016-2; Fiszer A, 2011, NUCLEIC ACIDS RES, V39, P5578, DOI 10.1093/nar/gkr156; Furtig B, 2003, CHEMBIOCHEM, V4, P936, DOI 10.1002/cbic.200300700; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kazantsev A, 2002, NAT GENET, V30, P367, DOI 10.1038/ng864; Keel AY, 2007, STRUCTURE, V15, P761, DOI 10.1016/j.str.2007.06.003; Kiliszek A, 2010, NUCLEIC ACIDS RES, V38, P8370, DOI 10.1093/nar/gkq700; Kiliszek A, 2009, NUCLEIC ACIDS RES, V37, P4149, DOI 10.1093/nar/gkp350; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; Koplin J, 2005, STRUCTURE, V13, P1255, DOI 10.1016/j.str.2005.05.015; Kratter IH, 2010, NEURON, V67, P897, DOI 10.1016/j.neuron.2010.09.012; Krol J, 2007, MOL CELL, V25, P575, DOI 10.1016/j.molcel.2007.01.031; Kumar A, 2012, ACS CHEM BIOL, V7, P496, DOI 10.1021/cb200413a; Kumar A, 2011, CHEMBIOCHEM, V12, P2140, DOI 10.1002/cbic.201100337; Kumar A, 2011, BIOCHEMISTRY-US, V50, P9928, DOI 10.1021/bi2013068; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Mariappan SVS, 1998, J BIOMOL STRUCT DYN, V15, P723; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; McLaughlin BA, 1996, AM J HUM GENET, V59, P561; Michlewski G, 2004, J MOL BIOL, V340, P665, DOI 10.1016/j.jmb.2004.05.021; Mooers BHM, 2005, P NATL ACAD SCI USA, V102, P16626, DOI 10.1073/pnas.0505873102; Mykowska A, 2011, NUCLEIC ACIDS RES, V39, P8938, DOI 10.1093/nar/gkr608; Nielsen JE, 2001, PROTEINS, V43, P403, DOI 10.1002/prot.1053; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parkesh R, 2011, BIOCHEMISTRY-US, V50, P599, DOI 10.1021/bi101896j; Peyret N, 1999, BIOCHEMISTRY-US, V38, P3468, DOI 10.1021/bi9825091; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Sobczak K, 2005, J BIOL CHEM, V280, P3898, DOI 10.1074/jbc.M409984200; Sobczak K, 2004, J BIOL CHEM, V279, P41563, DOI 10.1074/jbc.M405130200; Sobczak K, 2003, NUCLEIC ACIDS RES, V31, P5469, DOI 10.1093/nar/gkg766; Sobczak K, 2010, J BIOL CHEM, V285, P12755, DOI 10.1074/jbc.M109.078790; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tanaka Y, 1999, NUCLEIC ACIDS RES, V27, P949, DOI 10.1093/nar/27.4.949; Thomas JR, 2008, CHEM REV, V108, P1171, DOI 10.1021/cr0681546; Todd PK, 2010, ANN NEUROL, V67, P291, DOI 10.1002/ana.21948; Tsoi H, 2013, CEREBELLUM, V12, P310, DOI 10.1007/s12311-012-0447-6; Tsoi H, 2012, P NATL ACAD SCI USA, V109, P13428, DOI 10.1073/pnas.1204089109; van Eyk CL, 2011, HUM MOL GENET, V20, P2783, DOI 10.1093/hmg/ddr177; Waragai M, 1999, HUM MOL GENET, V8, P977, DOI 10.1093/hmg/8.6.977; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yildirim I, 2013, J AM CHEM SOC, V135, P3528, DOI 10.1021/ja3108627; Zhang Q, 2006, SCIENCE, V311, P653, DOI 10.1126/science.1119488	60	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131788	10.1371/journal.pone.0131788	http://dx.doi.org/10.1371/journal.pone.0131788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148061	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600146
J	Woldesenbet, S; Jackson, D; Lombard, C; Dinh, TH; Puren, A; Sherman, G; Ramokolo, V; Doherty, T; Mogashoa, M; Bhardwaj, S; Chopra, M; Shaffer, N; Pillay, Y; Goga, A				Woldesenbet, Selamawit; Jackson, Debra; Lombard, Carl; Dinh, Thu-Ha; Puren, Adrian; Sherman, Gayle; Ramokolo, Vundli; Doherty, Tanya; Mogashoa, Mary; Bhardwaj, Sanjana; Chopra, Mickey; Shaffer, Nathan; Pillay, Yogan; Goga, Ameena		South African PMTCT Evaluation SAP	Missed Opportunities along the Prevention of Mother-to-Child Transmission Services Cascade in South Africa: Uptake, Determinants, and Attributable Risk (the SAPMTCTE)	PLOS ONE			English	Article							IMMUNIZATION CLINICS; HIV; PREGNANCY; WOMEN; CAPE	Objectives We examined uptake of prevention of mother-to-child HIV transmission (PMTCT) services, predictors of missed opportunities, and infant HIV transmission attributable to missed opportunities along the PMTCT cascade across South Africa. Methods A cross-sectional survey was conducted among 4-8 week old infants receiving first immunisations in 580 nationally representative public health facilities in 2010. This included maternal interviews and testing infants' dried blood spots for HIV. A weighted analysis was performed to assess uptake of antenatal and perinatal PMTCT services along the PMTCT cascade (namely: maternal HIV testing, CD4 count test/result, and receiving maternal and infant antiretroviral treatment) and predictors of dropout. The population attributable fraction associated with dropouts at each service point are estimated. Results Of 9,803 mothers included, 31.7% were HIV-positive as identified by reactive infant antibody tests. Of these 80.4% received some form of maternal and infant antiretroviral treatment. More than a third (34.9%) of mothers dropped out from one or more steps in the PMTCT service cascade. In a multivariable analysis, the following characteristics were associated with increased dropout from the PMTCT cascade: adolescent (<20 years) mothers, low socioeconomic score, low education level, primiparous mothers, delayed first antenatal visit, homebirth, and non-disclosure of HIV status. Adolescent mothers were twice (adjusted odds ratio: 2.2, 95% confidence interval: 1.5-3.3) as likely to be unaware of their HIV-positive status and had a significantly higher rate (85.2%) of unplanned pregnancies compared to adults aged >= 20 years (55.5%, p = 0.0001). A third (33.8%) of infant HIV infections were attributable to dropout in one or more steps in the cascade. Conclusion A third of transmissions attributable to missed opportunities of PMTCT services can be prevented by optimizing the uptake of PMTCT services. Identified risk factors for low PMTCT service uptake should be addressed through health facility and community-level interventions, including raising awareness, promoting women education, adolescent focused interventions, and strengthening linkages/referral-system between communities and health facilities.	[Woldesenbet, Selamawit; Lombard, Carl; Ramokolo, Vundli; Doherty, Tanya] MRC, Hlth Syst Res Unit, Cape Town, South Africa; [Jackson, Debra; Doherty, Tanya; Chopra, Mickey] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Jackson, Debra; Chopra, Mickey] United Nations Childrens Fund, New York, NY USA; [Dinh, Thu-Ha] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Atlanta, GA USA; [Puren, Adrian; Sherman, Gayle] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Johannesburg, South Africa; [Puren, Adrian] Univ Witwatersrand, Fac Hlth Sci, Div Virol & Communicable Dis, Johannesburg, South Africa; [Sherman, Gayle] Univ Witwatersrand, Fac Hlth Sci, Dept Paediat & Child Hlth, Johannesburg, South Africa; [Doherty, Tanya] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Mogashoa, Mary] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Pretoria, South Africa; [Bhardwaj, Sanjana] United Nations Childrens Fund, Pretoria, South Africa; [Shaffer, Nathan] World Hlth Org, Geneva, Switzerland; [Pillay, Yogan] Natl Dept Hlth, Pretoria, South Africa; [Goga, Ameena] Univ Pretoria, Dept Paediat & Child Hlth, ZA-0002 Pretoria, South Africa; [Goga, Ameena] MRC, Hlth Syst Res Unit, Pretoria, South Africa	University of the Western Cape; UNICEF; Centers for Disease Control & Prevention - USA; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; World Health Organization; University of Pretoria	Woldesenbet, S (corresponding author), MRC, Hlth Syst Res Unit, Cape Town, South Africa.	woldeselam@gmail.com	Puren, Adrian/AAC-2065-2020; Puren, Adrian/W-1679-2018	Puren, Adrian/0000-0001-7531-4010; Puren, Adrian/0000-0001-7531-4010; Jackson, Debra/0000-0003-3307-632X; ramokolo, vundli/0000-0002-9596-1909; Lombard, Carl/0000-0002-2136-6533	CDC [1U2GPS001137-02, 1U2GPS001137-03]; United Nations Children's Fund (UNICEF); National Department of Health, South Africa; South Africa National Research Foundation; South African Centre for Epidemiological Modelling and Analysis (SACEMA); African Doctoral Dissertation Research Fellowship; MRC [1U2GPS001137-02, 1U2GPS001137-03]	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United Nations Children's Fund (UNICEF); National Department of Health, South Africa; South Africa National Research Foundation(National Research Foundation - South Africa); South African Centre for Epidemiological Modelling and Analysis (SACEMA); African Doctoral Dissertation Research Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the President's Emergency Plan for AIDS Relief under the Cooperative Agreement between CDC and MRC (1U2GPS001137-02 and 1U2GPS001137-03)- A, The United Nations Children's Fund (UNICEF) - A, National Department of Health, South Africa-A, South Africa National Research Foundation-D, South African Centre for Epidemiological Modelling and Analysis (SACEMA) - S, African Doctoral Dissertation Research Fellowship-S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, S AFRICAS NEW HIGHLY; [Anonymous], 2013, GLOBAL REPORT UNAIDS; [Anonymous], 2009, NATL ANTENATL SENTIN; Basu S, 1995, AM J EPIDEMIOL, V142, P1338, DOI 10.1093/oxfordjournals.aje.a117602; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Drake AL, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001608; Fatti G., 2014, 4 INT WORKSH HIV WOM; Goga A., 2011, SAPMTCTE REPORT EARL; Goga A., 2014, J EPIDEMIOL COMMUNIT; Goga A, 2010, EVALUATION EFFECTIVE; Horwood C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074568; Horwood C, 2012, B WORLD HEALTH ORGAN, V90, P168, DOI 10.2471/BLT.11.092056; Hussain A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027907; Jones DL, 2013, AIDS CARE, V25, P702, DOI 10.1080/09540121.2013.772280; Kim HY, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-138; Marazzi M., 2009, 5 INT AIDS SOC C HIV; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; NDOH, POLICY GUIDELINES IM; Reagon G., 2003, NATL PRIMARY HLTH CA; Rollins N, 2007, AIDS, V21, P1341, DOI 10.1097/QAD.0b013e32814db7d4; Rollins N, 2009, AIDS, V23, P1851, DOI 10.1097/QAD.0b013e32832d84fd; Stinson K., 2014, LAY HLTH WORKER SUPP; Stinson K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063328; Stinson K, 2012, JAIDS-J ACQ IMM DEF, V60, P199, DOI 10.1097/QAI.0b013e31824d985e; Stinson K, 2010, TROP MED INT HEALTH, V15, P825, DOI 10.1111/j.1365-3156.2010.02538.x; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; Villar-Loubet OM, 2013, CULT HEALTH SEX, V15, P253, DOI 10.1080/13691058.2012.716166; World Health Organization, 2012, GUIDANCE COUPLES HIV	28	56	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132425	10.1371/journal.pone.0132425	http://dx.doi.org/10.1371/journal.pone.0132425			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147598	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600265
J	Elbrecht, V; Leese, F				Elbrecht, Vasco; Leese, Florian			Can DNA-Based Ecosystem Assessments Quantify Species Abundance? Testing Primer Bias and Biomass-Sequence Relationships with an Innovative Metabarcoding Protocol	PLOS ONE			English	Article							BIODIVERSITY ASSESSMENT; TRICHOPTERA; MACROINVERTEBRATES; ARTHROPODS; INSIGHTS; BARCODE; SCIENCE; SAMPLES; PCR	Metabarcoding is an emerging genetic tool to rapidly assess biodiversity in ecosystems. It involves high-throughput sequencing of a standard gene from an environmental sample and comparison to a reference database. However, no consensus has emerged regarding laboratory pipelines to screen species diversity and infer species abundances from environmental samples. In particular, the effect of primer bias and the detection limit for specimens with a low biomass has not been systematically examined, when processing samples in bulk. We developed and tested a DNA metabarcoding protocol that utilises the standard cytochrome c oxidase subunit I (COI) barcoding fragment to detect freshwater macroinverte-brate taxa. DNA was extracted in bulk, amplified in a single PCR step, and purified, and the libraries were directly sequenced in two independent MiSeq runs (300-bp paired-end reads). Specifically, we assessed the influence of specimen biomass on sequence read abundance by sequencing 31 specimens of a stonefly species with known haplotypes spanning three orders of magnitude in biomass (experiment I). Then, we tested the recovery of 52 different freshwater invertebrate taxa of similar biomass using the same standard barcoding primers (experiment II). Each experiment was replicated ten times to maximise statistical power. The results of both experiments were consistent across replicates. We found a distinct positive correlation between species biomass and resulting numbers of MiSeq reads. Furthermore, we reliably recovered 83% of the 52 taxa used to test primer bias. However, sequence abundance varied by four orders of magnitudes between taxa despite the use of similar amounts of biomass. Our metabarcoding approach yielded reliable results for high-throughput assessments. However, the results indicated that primer efficiency is highly species-specific, which would prevent straightforward assessments of species abundance and biomass in a sample. Thus, PCR-based metabarcoding assessments of biodiversity should rely on presence-absence metrics.	[Elbrecht, Vasco; Leese, Florian] Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, D-44801 Bochum, Germany	Ruhr University Bochum	Leese, F (corresponding author), Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, Univ Str 150, D-44801 Bochum, Germany.	florian.leese@rub.de	Leese, Florian/D-4277-2012	Leese, Florian/0000-0002-5465-913X; Elbrecht, Vasco/0000-0003-4672-7099	Kurt Eberhard Bode Foundation	Kurt Eberhard Bode Foundation	This work was supported by a grant of the Kurt Eberhard Bode Foundation to FL.	Agnarsson I, 2007, SYST BIOL, V56, P531, DOI 10.1080/10635150701424546; Aylagas E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090529; Blaxter M, 2003, NATURE, V421, P122, DOI 10.1038/421122a; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Carew ME, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-45; Clarke LJ, 2014, MOL ECOL RESOUR, V14, P117, DOI 10.1111/1755-0998.12162; Deagle BE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0562; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Ekrem T, 2010, ORG DIVERS EVOL, V10, P397, DOI 10.1007/s13127-010-0034-y; Elbrecht V, 2014, FRESHW SCI, V33, P181, DOI 10.1086/674536; Elbrecht V, 2015, MITOCHONDR DNA, V26, P469, DOI 10.3109/19401736.2013.830301; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gibson J, 2014, P NATL ACAD SCI USA, V111, P8007, DOI 10.1073/pnas.1406468111; Haase P, 2010, J N AM BENTHOL SOC, V29, P1279, DOI 10.1899/09-183.1; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hopkins GW, 2002, ANIM CONSERV, V5, P245, DOI 10.1017/S1367943002002299; Jackson JK, 2014, FRESHW SCI, V33, P312, DOI 10.1086/675225; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; Jones FC, 2008, ENVIRON REV, V16, P45, DOI 10.1139/A07-010; Kenney Melissa A., 2009, Terrestrial Arthropod Reviews, V2, P99, DOI 10.1163/187498209X12525675906077; Krueger F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016607; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Machler E, 2014, FRESHW SCI, V33, P1174, DOI 10.1086/678128; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Meier C, 2006, METHODISCHES HDB FLI, P1; Merritt RW, 2009, INTRO AQUATIC INSECT; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Millennium Ecosystem Assessment, 2004, EC HUM WELL BEING SY; Pauls SU, 2008, MOL PHYLOGENET EVOL, V46, P776, DOI 10.1016/j.ympev.2007.11.003; PFRENDER ME, 2010, Q REV BIOL, V85, P319, DOI DOI 10.1086/655118; Pinol J, 2015, MOL ECOL RESOUR, V15, P819, DOI 10.1111/1755-0998.12355; Poisot T, 2013, ECOL EVOL, V3, P1125, DOI 10.1002/ece3.508; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ranasinghe JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040875; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stein ED, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095525; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Sweeney BW, 2011, J N AM BENTHOL SOC, V30, P195, DOI 10.1899/10-016.1; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x; Zhou X, 2007, J N AM BENTHOL SOC, V26, P719, DOI 10.1899/06-089.1; Zhou X, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-4; Zhou X, 2010, J N AM BENTHOL SOC, V29, P814, DOI 10.1899/09-121.1; Zhou X, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-30; Zimmermann J, 2015, MOL ECOL RESOUR, V15, P526, DOI 10.1111/1755-0998.12336	56	343	375	7	183	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130324	10.1371/journal.pone.0130324	http://dx.doi.org/10.1371/journal.pone.0130324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154168	Green Published, gold, Green Submitted			2022-12-27	WOS:000358159700031
J	Ellis, W; FitzGibbon, S; Pye, G; Whipple, B; Barth, B; Johnston, S; Seddon, J; Melzer, A; Higgins, D; Bercovitch, F				Ellis, William; FitzGibbon, Sean; Pye, Geoff; Whipple, Bill; Barth, Ben; Johnston, Stephen; Seddon, Jenny; Melzer, Alistair; Higgins, Damien; Bercovitch, Fred			The Role of Bioacoustic Signals in Koala Sexual Selection: Insights from Seasonal Patterns of Associations Revealed with GPS-Proximity Units	PLOS ONE			English	Article							PHASCOLARCTOS-CINEREUS GOLDFUSS; HABITAT USE; BEHAVIOR; DYNAMICS; BELLOWS; COMPETITION; INTENSITY; EVOLUTION; CAPTIVITY; ECOLOGY	Despite being a charismatic and well-known species, the social system of the koala (Phascolarctos cinereus-the only extant member of the family Phascolarctidae) is poorly known and much of the koala's sociality and mating behaviors remain un-quantified. We evaluated these using proximity logging-GPS enabled tracking collars on wild koalas and discuss their implications for the mating system of this species. The frequency and duration of male-female encounters increased during the breeding season, with male-male encounters quite uncommon, suggesting little direct mating competition. By comparison, female-female interactions were very common across both seasons. Body mass of males was not correlated with their interactions with females during the breeding season, although male size is associated with a variety of acoustic parameters indicating individuality. We hypothesise that vocal advertising reduces the likelihood of male-male encounters in the breeding season while increasing the rate of male-female encounters. We suggest that male mating-season bellows function to reduce physical confrontations with other males allowing them to space themselves apart, while, at the same time, attracting females. We conclude that indirect male-male competition, female mate choice, and possibly female competition, mediate sexual selection in koalas.	[Ellis, William; FitzGibbon, Sean; Barth, Ben; Johnston, Stephen] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld 4072, Australia; [Pye, Geoff; Whipple, Bill] San Diego Zoo Global, San Diego, CA 92112 USA; [Seddon, Jenny] Univ Queensland, Fac Vet Sci, Brisbane, Qld 4072, Australia; [Higgins, Damien] CQUniversity, Koala Res Ctr Cent Queensland, Sch Med & Appl Sci, Rockhampton, Qld 4702, Australia; [Bercovitch, Fred] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan; [Bercovitch, Fred] Kyoto Univ, Wildlife Res Ctr, Inuyama, Aichi 4848506, Japan	University of Queensland; University of Queensland; Central Queensland University; Kyoto University; Kyoto University	Ellis, W (corresponding author), Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld 4072, Australia.	w.ellis@uq.edu.au	Seddon, Jennifer/A-1402-2010; Barth, Benjamin/AAT-3366-2021; Higgins, Damien P/A-9601-2011; Seddon, Jennifer/AAM-3827-2021; Ellis, William/AAP-8955-2021	Seddon, Jennifer/0000-0003-3789-6878; Barth, Benjamin/0000-0002-3211-5828; Seddon, Jennifer/0000-0003-3789-6878; Higgins, Damien/0000-0003-1215-6523	Queensland Smart Futures through the Queensland State Government Koala [KRG024]; San Diego Zoo; Koala Education and Conservation Program EAZA/AZA	Queensland Smart Futures through the Queensland State Government Koala; San Diego Zoo; Koala Education and Conservation Program EAZA/AZA	This project was funded by Queensland Smart Futures through the Queensland State Government Koala Funding Grant KRG024 (http://www.ehp.qld.gov.au/wildlife/koalas/strategy/koala research-grant.html) and was also funded by San Diego Zoo and the Koala Education and Conservation Program EAZA/AZA partners (http://zoo.sandiegozoo.org/). Queensland Government had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AnalystSoft, 2010, STATPLLUS MAC LE FRE; Andersson Malte, 1994; ARNOLD SJ, 1994, AM NAT, V143, P317, DOI 10.1086/285606; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Berck L., 1995, ST BEES ISLAND ITS H; Bercovitch Fred B., 2007, Biodiversity (Ottawa), V8, P33; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Charlton BD, 2011, PLOS ONE, V6; Charlton BD, 2012, ANIM BEHAV, V84, P1565, DOI 10.1016/j.anbehav.2012.09.034; Charlton BD, 2012, ANIM COGN, V15, P999, DOI 10.1007/s10071-012-0527-5; Charlton BD, 2011, J EXP BIOL, V214, P3414, DOI 10.1242/jeb.061358; Clutton-Brock T, 2013, J ZOOL, V289, P151, DOI 10.1111/jzo.12023; Darwin C., 1871, P423; Ellis W, 2011, BEHAV ECOL, V22, P372, DOI 10.1093/beheco/arq216; Ellis WA, 2002, WILDLIFE RES, V29, P19, DOI 10.1071/WR01042; ELLIS WAH, 1995, AUST J ZOOL, V43, P59, DOI 10.1071/ZO9950059; Ellis W, 2010, J MAMMAL, V91, P177, DOI 10.1644/08-MAMM-A-358R.1; Ellis WAH, 2011, BEHAV ECOL SOCIOBIOL, V65, P1229, DOI 10.1007/s00265-010-1136-4; Ellis WAH, 2009, BEHAV ECOL SOCIOBIOL, V63, P1181, DOI 10.1007/s00265-009-0761-2; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Feige S, 2007, APPL ANIM BEHAV SCI, V103, P131, DOI 10.1016/j.applanim.2006.03.014; Frey R, 2010, HBK BEHAV NEUROSCI, V19, P439, DOI 10.1016/B978-0-12-374593-4.00040-1; Gordon G., 1990, P189; Hynes EF, 2011, APPL ANIM BEHAV SCI, V134, P209, DOI 10.1016/j.applanim.2011.06.019; Johnston SD, 2000, J REPROD FERTIL, V120, P49, DOI 10.1530/reprod/120.1.49; Kemp J, 2009, VEGETATION SURVEY MA; Kollipara A, 2013, VET MICROBIOL, V167, P513, DOI 10.1016/j.vetmic.2013.08.009; LANDE R, 1980, EVOLUTION, V34, P292, DOI [10.2307/2407393, 10.1111/j.1558-5646.1980.tb04817.x]; Lee AK, 1988, KOALA NATURAL HIST; Lee AK, 1990, BIOL KOALA, P1; Lee KE, 2012, AUST J ZOOL, V60, P303, DOI 10.1071/ZO12075; McGowan MR, 1995, AUST VET J, V72, P472, DOI 10.1111/j.1751-0813.1995.tb03495.x; McLean N, 2006, AUST J ZOOL, V54, P385, DOI 10.1071/ZO06015; Melzer A., 2010, Queensland Naturalist, V48, P36; Melzer A, 2009, AUSTRALAS J ENVIRON, V16, P236; Melzer Alistair, 2003, Queensland Naturalist, V41, P38; Mitchell P., 1990, P151; Mitchell P., 1990, P171; Rosvall KA, 2011, BEHAV ECOL, V22, P1131, DOI 10.1093/beheco/arr106; Sharpe L, 1980, BEHAV KOALA PHASCOLA; SMITH M, 1980, AUST WILDLIFE RES, V7, P41; SMITH M, 1980, AUST WILDLIFE RES, V7, P35; Team RDC, 2019, R LANG ENV STAT COMP; Tobey JR, 2009, AUST J ZOOL, V57, P111, DOI 10.1071/ZO08090; TRAIL PW, 1985, AM NAT, V126, P434, DOI 10.1086/284429; Tucker G, 2007, AUST J ZOOL, V55, P285, DOI 10.1071/ZO07035; WADE MJ, 1980, ANIM BEHAV, V28, P446, DOI 10.1016/S0003-3472(80)80052-2; Weckerly FW, 2001, J MAMMAL, V82, P825, DOI 10.1644/1545-1542(2001)082<0825:SSIREC>2.0.CO;2; Wessa P, 2013, OFFICE RES DEV ED VE; Wheeler BC, 2013, BEHAV ECOL, V24, P1369, DOI 10.1093/beheco/art076	50	18	19	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130657	10.1371/journal.pone.0130657	http://dx.doi.org/10.1371/journal.pone.0130657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154295	Green Submitted, Green Published, gold			2022-12-27	WOS:000358159700035
J	Kinoshita-Kikuta, E; Kinoshita, E; Eguchi, Y; Yanagihara, S; Edahiro, K; Inoue, Y; Taniguchi, M; Yoshida, M; Yamamoto, K; Takahashi, H; Sawasaki, T; Utsumi, R; Koike, T				Kinoshita-Kikuta, Emiko; Kinoshita, Eiji; Eguchi, Yoko; Yanagihara, Shiho; Edahiro, Keisuke; Inoue, Yuki; Taniguchi, Momoka; Yoshida, Myu; Yamamoto, Kaneyoshi; Takahashi, Hirotaka; Sawasaki, Tatsuya; Utsumi, Ryutaro; Koike, Tohru			Functional Characterization of the Receiver Domain for Phosphorelay Control in Hybrid Sensor Kinases	PLOS ONE			English	Article							2-COMPONENT SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI K-12; BORDETELLA-PERTUSSIS; HISTIDINE KINASE; PHOSPHOPROTEIN ISOTYPES; GEL-ELECTROPHORESIS; IN-VITRO; PROTEIN; PHOSPHORYLATION; ARCB	Hybrid sensor kinase, which contains a histidine kinase (HK) domain, a receiver domain, and a histidine-containing phosphotransmitter (HPt) domain, conveys signals to its cognate response regulator by means of a His-Asp-His-Asp phosphorelay. We examined the multi-step phosphorelay of a recombinant EvgAS system in Escherichia coli and performed in vitro quantitative analyses of phosphorylation by using Phos-tag SDS-PAGE. Replacement of Asp in the receiver domain of EvgS by Ala markedly promoted phosphorylation at His in the HK domain compared with that in wild-type EvgS. Similar Ala-substituted mutants of other hybrid sensor kinases BarA and ArcB showed similar characteristics. In the presence of sufficient ATP, autophosphorylation of the HK domain in the mutant progressed efficiently with nearly pseudo-first-order kinetics until the phosphorylation ratio reached a plateau value of more than 95% within 60 min, and the value was maintained until 180 min. However, both wild-type EvgS and the Ala-substituted mutant of His in the HPt domain showed a phosphorylation ratio of less than 25%, which gradually decreased after 10 min. These results showed that the phosphorylation level is regulated negatively by the receiver domain. The receiver domain therefore plays a crucial role in controlling the phosphorelay to the response regulator. Furthermore, our in vitro assays confirmed the existence of a similar hyperphosphorylation reaction in the HK domain of the EvgS mutant in which the Asp residue was replaced with Ala, confirming the validity of the control mechanism proposed from profiling of phosphorylation in vitro.	[Kinoshita-Kikuta, Emiko; Kinoshita, Eiji; Yanagihara, Shiho; Edahiro, Keisuke; Inoue, Yuki; Taniguchi, Momoka; Koike, Tohru] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Funct Mol Sci, Hiroshima, Japan; [Eguchi, Yoko] Kinki Univ, Fac Biol Oriented Sci & Technol, Dept Sci & Technol Food Safety, Kinokawa, Japan; [Yoshida, Myu; Yamamoto, Kaneyoshi] Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo 184, Japan; [Takahashi, Hirotaka; Sawasaki, Tatsuya] Ehime Univ, Proteosci Ctr, Div Cell Free Sci, Matsuyama, Ehime, Japan; [Utsumi, Ryutaro] Kinki Univ, Grad Sch Agr, Dept Biosci, Nara, Japan	Hiroshima University; Kindai University (Kinki University); Hosei University; Ehime University; Kindai University (Kinki University)	Kinoshita, E (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Funct Mol Sci, Hiroshima, Japan.	kinoeiji@hiroshima-u.ac.jp	Kinoshita, Eiji/H-2284-2019	Emiko, Kinoshita/0000-0001-7355-1784; Sawasaki, Tatsuya/0000-0002-7952-0556	KAKENHI [25293005, 25560417, 15K07887, 26460036]; Takeda Science Foundation	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by KAKENHI Grants of no. 25293005 to EK, no. 25560417 to EK, no. 15K07887 to EK-K, and no. 26460036 to TK, and by research grants from the Takeda Science Foundation to EK and EK-K.	Bantscheff M, 2000, INT J MED MICROBIOL, V290, P317; BEIER D, 1995, J MOL BIOL, V248, P596, DOI 10.1006/jmbi.1995.0245; BOUCHER PE, 1994, J MOL BIOL, V241, P363, DOI 10.1006/jmbi.1994.1513; Cai SJ, 2003, J MOL BIOL, V329, P495, DOI 10.1016/S0022-2836(03)00446-7; Casino P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4258; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; Eguchi Y, 2014, J BACTERIOL, V196, P3140, DOI 10.1128/JB.01742-14; Ferris HU, 2014, J STRUCT BIOL, V186, P376, DOI 10.1016/j.jsb.2014.03.014; Georgellis D, 1998, J BIOL CHEM, V273, P32864, DOI 10.1074/jbc.273.49.32864; IUCHI S, 1993, J BIOL CHEM, V268, P23972; Johnson MD, 2014, MOL MICROBIOL, V93, P911, DOI 10.1111/mmi.12704; Jourlin C, 1997, J MOL BIOL, V267, P770, DOI 10.1006/jmbi.1997.0919; Karimova G, 1996, MOL MICROBIOL, V20, P489, DOI 10.1046/j.1365-2958.1996.5231057.x; Kato A, 2000, BIOSCI BIOTECH BIOCH, V64, P1203, DOI 10.1271/bbb.64.1203; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2008, PROTEOMICS, V8, P2994, DOI 10.1002/pmic.200800243; Kinoshita E, 2014, PROTEOMICS, V14, P668, DOI 10.1002/pmic.201300533; Kinoshita E, 2009, ELECTROPHORESIS, V30, P550, DOI 10.1002/elps.200800386; Kinoshita-Kikuta E, 2007, MOL CELL PROTEOMICS, V6, P356, DOI 10.1074/mcp.T600044-MCP200; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Mizuno T, 1998, J BIOCHEM, V123, P555; Ogino T, 1998, MOL MICROBIOL, V27, P573, DOI 10.1046/j.1365-2958.1998.00703.x; Pena-Sandoval GR, 2010, J BACTERIOL, V192, P1735, DOI 10.1128/JB.01401-09; Perraud AL, 1998, MOL MICROBIOL, V27, P875, DOI 10.1046/j.1365-2958.1998.00716.x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tomenius H, 2005, J BACTERIOL, V187, P7317, DOI 10.1128/JB.187.21.7317-7324.2005; Tsuzuki M, 1995, MOL MICROBIOL, V18, P953, DOI 10.1111/j.1365-2958.1995.18050953.x; Uhl MA, 1996, EMBO J, V15, P1028, DOI 10.1002/j.1460-2075.1996.tb00440.x; UTSUMI R, 1994, GENE, V140, P73, DOI 10.1016/0378-1119(94)90733-1; Wang C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001493; Yaginuma H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06522; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200	32	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132598	10.1371/journal.pone.0132598	http://dx.doi.org/10.1371/journal.pone.0132598			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151934	Green Published, Green Submitted, gold			2022-12-27	WOS:000358158900047
J	Kitagawa, H; Munekage, M; Ichikawa, K; Fukudome, I; Munekage, E; Takezaki, Y; Matsumoto, T; Igarashi, Y; Hanyu, H; Hanazaki, K				Kitagawa, Hiroyuki; Munekage, Masaya; Ichikawa, Kengo; Fukudome, Ian; Munekage, Eri; Takezaki, Yuka; Matsumoto, Takashi; Igarashi, Yasushi; Hanyu, Haruo; Hanazaki, Kazuhiro			Pharmacokinetics of Active Components of Yokukansan, a Traditional Japanese Herbal Medicine after a Single Oral Administration to Healthy Japanese Volunteers: A Cross-Over, Randomized Study	PLOS ONE			English	Article							GLYCYRRHETIC ACID; PSYCHOLOGICAL SYMPTOMS; RATS; DEMENTIA; LICORICE; DECOCTION; KAMPO; ROOT	Context Yokukansan (YKS) is a traditional Japanese herbal medicine called kampo medicine in Japan. Its extract comprises seven crude drugs: Atractylodis lanceae rhizoma, Poria, Cnidii rhizoma, Uncariae uncis cum ramulus, Angelicae radix, Bupleuri radix, and Glycyrrhizae radix. YKS is used to treat neurosis, insomnia, as well as behavioral and psychological symptoms of dementia. Objective To confirm the exposure and pharmacokinetics of the active components of YKS in healthy volunteers. Design, Setting, and Participants A randomized, open-label, 3-arm, 3-period, crossover trial was conducted on 21 healthy Japanese volunteers at the Kochi Medical University between May 2012 and November 2012. Interventions Single oral administration of YKS (2.5 g, 5.0 g, or 7.5 g/day) during each period. Main Outcome Measure Plasma concentrations of three active compounds in YKS, namely 18 beta-glycyrrhetinic acid (GA), geissoschizine methyl ether (GM), and hirsuteine (HTE). Results The mean maximum plasma concentrations (C-max) of GM and HTE increased dose-dependently (ranges: 0.650-1.98 ng/mL and 0.138-0.450 ng/mL, respectively). The times to maximum plasma concentration after drug administration (t(max)) were 0.500 h for GM and 0.975-1.00 h for HTE. The apparent elimination half-lives (t(1/2)) were 1.72-1.95 h for GM and 2.47-3.03 h for HTE. These data indicate the rapid absorption and elimination of GM and HTE. On the other hand, the C-max, t(max), and t(1/2) of GA were 57.7-108 ng/mL, 8.00-8.01 h, and 9.39-12.3 h, respectively. Conclusion We demonstrated that pharmacologically active components of YKS are detected in humans. Further, we determined the pharmacokinetics of GM, HTE, and GA. This information will be useful to elucidate the pharmacological effects of YKS.	[Kitagawa, Hiroyuki; Munekage, Masaya; Fukudome, Ian; Munekage, Eri; Takezaki, Yuka; Hanazaki, Kazuhiro] Kochi Univ, Kochi Med Sch, Dept Surg, Kochi 780, Japan; [Ichikawa, Kengo] Gifu Univ, Sch Med, Dept Surg Oncol, Gifu 500, Japan; [Matsumoto, Takashi] Tsumura & Co, Kampo Sci Strategies Div, Tsumura Res Labs, Ibaraki, Japan; [Igarashi, Yasushi] Tsumura & Co, Kampo Sci Strategies Div, Kampo Formulat Dev Ctr, Ibaraki, Japan; [Hanyu, Haruo] Tokyo Med Univ, Dept Elderly Gen Med, Tokyo 1608402, Japan	Kochi University; Gifu University; Tsumura & Company; Tsumura & Company; Tokyo Medical University	Matsumoto, T (corresponding author), Tsumura & Co, Kampo Sci Strategies Div, Tsumura Res Labs, Ibaraki, Japan.	matsumoto_takashi@mail.tsumura.co.jp			Tsumura Co.	Tsumura Co.(Tsumura & Company)	Tsumura & Co. provided support in the form of salaries for authors TM and YI. This study was funded by Tsumura & Co., which was responsible for the study design, and the collection, analysis and interpretation of data.	[Anonymous], 1995, DRUG INFORM J; CANTELLIFORTI G, 1994, ENVIRON HEALTH PERSP, V102, P65, DOI 10.1289/ehp.94102s965; Egashira N, 2008, PROG NEURO-PSYCHOPH, V32, P1516, DOI 10.1016/j.pnpbp.2008.05.010; GOLDSTEIN JA, 1994, PHARMACOGENETICS, V4, P285, DOI 10.1097/00008571-199412000-00001; HATTORI M, 1983, PLANTA MED, V48, P38, DOI 10.1055/s-2007-969875; Hou YC, 2005, LIFE SCI, V76, P1167, DOI 10.1016/j.lfs.2004.10.020; Imamura S, 2011, CELL MOL NEUROBIOL, V31, P787, DOI 10.1007/s10571-011-9676-3; Iwasaki K, 2012, PSYCHOGERIATRICS, V12, P235, DOI 10.1111/j.1479-8301.2012.00413.x; Kawakami Z, 2009, NEUROSCIENCE, V159, P1397, DOI 10.1016/j.neuroscience.2009.02.004; Kawakami Z, 2010, EUR J PHARMACOL, V626, P154, DOI 10.1016/j.ejphar.2009.09.046; KRAHENBUHL S, 1994, STEROIDS, V59, P121, DOI 10.1016/0039-128X(94)90088-4; Kushida H, 2013, BIOMED CHROMATOGR, V27, P1647, DOI 10.1002/bmc.2974; Matsuda Y, 2013, HUM PSYCHOPHARM CLIN, V28, P80, DOI 10.1002/hup.2286; Miyamura M, 1996, YAKUGAKU ZASSHI, V116, P209, DOI 10.1248/yakushi1947.116.3_209; Mizuhara Y, 2005, BIOL PHARM BULL, V28, P1897, DOI 10.1248/bpb.28.1897; Mizukami K, 2009, INT J NEUROPSYCHOPH, V12, P191, DOI 10.1017/S146114570800970X; Nakazawa T, 2006, BIOL PHARM BULL, V29, P1671, DOI 10.1248/bpb.29.1671; Nishi A, 2012, NEUROSCIENCE, V207, P124, DOI 10.1016/j.neuroscience.2012.01.037; Raggi M A, 1994, Boll Chim Farm, V133, P704; Smith BP, 2000, PHARMACEUT RES, V17, P1278, DOI 10.1023/A:1026451721686; Tabuchi M, 2012, CELL MOL NEUROBIOL, V32, P1139, DOI 10.1007/s10571-012-9839-x; Takeda A, 2008, NEUROCHEM INT, V53, P230, DOI 10.1016/j.neuint.2008.07.009; Takeda S, 1996, J PHARM PHARMACOL, V48, P902, DOI 10.1111/j.2042-7158.1996.tb05998.x; TERASAWA K, 1986, J PHARMACOBIO-DYNAM, V9, P95; Terawaki K, 2010, J ETHNOPHARMACOL, V127, P306, DOI 10.1016/j.jep.2009.11.003; Xu CH, 2013, J ETHNOPHARMACOL, V149, P443, DOI 10.1016/j.jep.2013.06.049	26	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131165	10.1371/journal.pone.0131165	http://dx.doi.org/10.1371/journal.pone.0131165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151135	gold, Green Published, Green Submitted			2022-12-27	WOS:000358158900018
J	Li, JB; Liu, RH; Ji, XK; Xue, H; Zhang, G; Wang, CX; Chen, QC; Xue, FZ; Cui, LQ				Li, Jiangbing; Liu, Ruihong; Ji, Xiaokang; Xue, Hao; Zhang, Guang; Wang, Chunxia; Chen, Qicai; Xue, Fuzhong; Cui, Lianqun			Insight into the Spectrum of Coronary Atherosclerosis in Asymptomatic Urban Han Chinese Population by Coronary Computed Tomography Angiography	PLOS ONE			English	Article							PROGNOSTIC VALUE; ARTERY-DISEASE; RISK STRATIFICATION; HEART-DISEASE; SEVERITY; QUANTIFICATION; PERFORMANCE; PREDICTION	Objectives Highlighted the spectrum of coronary atherosclerosis in asymptomatic population by Computed Tomography Angiography (CTA) and developed a surrogation of expensive CTA to early detect coronary atherosclerosis. Methods Three hundred and seven self-referred urban Han Chinese asymptomatic individuals underwent coronary CTA were consecutively enrolled. Total plaque score (TPS), Segment stenosis score (SSS) and Coronary Artery Disease severity (CADS) were used to measure and illustrate the spectrum of atherosclerosis burden by mapping their incidence and proportion onto coronary artery tree. Logistic regression model was further used to explore the association between lipid biomarkers and TPS (SSS) for developing a surrogation of CTA to early detect coronary atherosclerosis. Results We found that the incidence of TPS, SSS and CADS were up to 71.34%, 68.08%, and 71.34%; and high-risk individuals reached up to 11.07%, 15.31% and 16.29% respectively. All TPS, SSS and CADS were much higher in male than female, and have trend of increasing with age. The most lesion segment emerged on proximal LAD, followed by proximal RCA, mid LAD, proximal LCX, and mid RCA with mixed plaque as dominant. HDL-C was a predictor to both TPS [OR: 0.12 (0.02-0.82)] and SSS [OR: 0.15 (0.03-0.76)], and could identify the serious atherosclerosis subjects of TPS or SSS score >5 (AUC 0.73 and 0.70). Conclusions The atherosclerosis plaque burden was about one in ten as high-risk individuals in this specific urban Han Chinese population. As potential surrogation of CTA, HDL-C was recognized as a significant predictor to atherosclerosis burden and revealed a good performance for identifying high-risk individuals.	[Li, Jiangbing; Cui, Lianqun] Shandong Univ, Shandong Prov Hosp, Dept Cardiol, Jinan, Shandong, Peoples R China; [Liu, Ruihong; Ji, Xiaokang; Xue, Fuzhong] Shandong Univ, Sch Publ Hlth, Div Biostat, Jinan, Shandong, Peoples R China; [Xue, Hao] Shandong Univ, Qilu Hosp, Dept Neurosurg, Jinan, Shandong, Peoples R China; [Zhang, Guang] Shandong Prov Qianfoshan Hosp, Hlth Management Ctr, Jinan, Shandong, Peoples R China; [Wang, Chunxia] Jining Med Univ, Affiliated Hosp, Hlth Management Ctr, Jining, Shandong, Peoples R China; [Chen, Qicai] Shengli Qilfield Cent Hosp, Hlth Management Ctr, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Jining Medical University	Cui, LQ (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Cardiol, Jinan, Shandong, Peoples R China.	cuilianqun19@163.com	Xue, Hao/GXV-4717-2022; Xue, Fuzhong/AAG-4808-2020	Xue, Fuzhong/0000-0003-0378-7956	National Natural Science Foundation of China [81273177]; Science and Technology Development Planning of Jinan, Shandong Province, China [2014GSF118119]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Planning of Jinan, Shandong Province, China	The study was supported by grant 81273177 from the National Natural Science Foundation of China and by grant 2014GSF118119 from Science and Technology Development Planning of Jinan, Shandong Province, China, to FX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach S, 2006, J AM COLL CARDIOL, V48, P1919, DOI 10.1016/j.jacc.2006.08.012; Achenbach S, 2008, JACC-CARDIOVASC IMAG, V1, P472, DOI 10.1016/j.jcmg.2008.05.008; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Austen W G, 1975, Circulation, V51, P5; Burke AP, 2001, AM HEART J, V141, pS58, DOI 10.1067/mhj.2001.109946; Chang HJ, 2011, CIRC J, V75, P246, DOI 10.1253/circj.CJ-10-1206; Chow BJW, 2010, J AM COLL CARDIOL, V55, P1017, DOI 10.1016/j.jacc.2009.10.039; Coorperative Meta-analysis Group of China Obesity Task Force, 2003, CHIN J EPIDEMIOL, V23, P5; de Graaf MA, 2014, AM J CARDIOL, V113, P1947, DOI 10.1016/j.amjcard.2014.03.034; Descalzo M, 2013, REV ESP CARDIOL, V66, P504, DOI 10.1016/j.rec.2012.12.012; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Gijsen F, 2013, J BIOMECH, V46, P240, DOI 10.1016/j.jbiomech.2012.11.006; Gimbrone MA, 1997, ANN NY ACAD SCI, V811, P1, DOI 10.1111/j.1749-6632.1997.tb51983.x; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Hadamitzky M, 2013, EUR HEART J; Hadamitzky M, 2009, JACC-CARDIOVASC IMAG, V2, P404, DOI 10.1016/j.jcmg.2008.11.015; Hellerstein M, 2014, CURR OPIN LIPIDOL, V25, P40, DOI 10.1097/MOL.0000000000000050; Hoffmann U, 2004, CIRCULATION, V110, P2638, DOI 10.1161/01.CIR.0000145614.07427.9F; Huxley RR, 2011, CIRCULATION, V124, P2056, DOI 10.1161/CIRCULATIONAHA.111.028373; Kim KJ, 2013, HEART, V99, P1113, DOI 10.1136/heartjnl-2013-303631; Lansky AJ, 2012, JACC-CARDIOVASC IMAG, V5, pS62, DOI 10.1016/j.jcmg.2012.02.003; Lawlor DA, 2003, J EPIDEMIOL COMMUN H, V57, P538, DOI 10.1136/jech.57.7.538; Lee BC, 2011, INT J CARDIOVAS IMAG, V27, P669, DOI 10.1007/s10554-011-9874-6; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Manka R, 2012, EUR HEART J, V33, P2016, DOI 10.1093/eurheartj/ehs170; Maurovich-Horvat P., 2014, NAT REV CARDIOL; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058; Min JK, 2007, J AM COLL CARDIOL, V50, P1161, DOI 10.1016/j.jacc.2007.03.067; Myerburg RJ, 1997, AM J CARDIOL, V80, pF10, DOI 10.1016/S0002-9149(97)00477-3; Normann J, 2012, AM HEART J, V164, P698, DOI 10.1016/j.ahj.2012.08.003; O'Rourke RA, 2000, CIRCULATION, V102, P126, DOI 10.1161/01.CIR.102.1.126; Ostrom MP, 2008, J AM COLL CARDIOL, V52, P1335, DOI 10.1016/j.jacc.2008.07.027; Plank F, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2014-000096; Rivera JJ, 2009, ATHEROSCLEROSIS, V206, P451, DOI 10.1016/j.atherosclerosis.2009.05.027; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998	35	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132188	10.1371/journal.pone.0132188	http://dx.doi.org/10.1371/journal.pone.0132188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151132	Green Published, gold, Green Submitted			2022-12-27	WOS:000358158900038
J	Tomita, H; Yamashiro, T; Matsuoka, S; Matsushita, S; Kurihara, Y; Nakajima, Y				Tomita, Hayato; Yamashiro, Tsuneo; Matsuoka, Shin; Matsushita, Shoichiro; Kurihara, Yasuyuki; Nakajima, Yasuo			Changes in Cross-Sectional Area and Transverse Diameter of the Heart on Inspiratory and Expiratory Chest CT: Correlation with Changes in Lung Size and Influence on Cardiothoracic Ratio Measurement	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; SPONTANEOUS RESPIRATION; PRESSURE; RADIOGRAPHS; MORTALITY; MARKER	Objective The aim of this study was to investigate physiological changes in cardiac area and diameters between inspiratory and expiratory chest computed tomography (CT), and to assess their correlation with lung size change and influence on cardiothoracic ratio (CTR) measurements. Materials and Methods The institutional review board of our institution approved this study, and informed consent was waived. Forty-three subjects underwent inspiratory and expiratory chest CT as part of routine clinical care. On both inspiratory and expiratory scans, lung volumes and maximum lung diameters (transverse and vertical directions) were measured. The maximum cardiac cross-sectional area (CSA) and the maximum transverse cardiac diameter were measured on both scans, and the CT-based CTR was calculated. Changes in the lung and cardiac measurements were expressed as the expiratory/inspiratory (E/I) ratios. Comparisons between inspiratory and expiratory measurements were made by the Wilcoxon signed-rank test. Correlations between the E/I ratios of lung and heart measurements were evaluated by Spearman's rank correlation analysis. Results Cardiac CSA and transverse cardiac diameter was significantly larger on expiratory than on inspiratory CT (p< 0.0001). Significant negative correlations were found between the E/I ratios of these cardiac measurements and the E/I ratios of lung volume and vertical lung diameter (p< 0.01). CT-based CTR was significantly larger on expiration than on inspiration (p< 0.0001). Conclusions Heart size on chest CT depends on the phase of ventilation, and is correlated with changes in lung volume and craniocaudal lung diameter. The CTR is also significantly influenced by ventilation.	[Tomita, Hayato; Yamashiro, Tsuneo; Matsuoka, Shin; Matsushita, Shoichiro; Kurihara, Yasuyuki; Nakajima, Yasuo] St Marianna Univ, Sch Med, Dept Radiol, Kawasaki, Kanagawa, Japan; [Yamashiro, Tsuneo] Univ Ryukyus, Grad Sch Med Sci, Dept Radiol, Nishihara, Okinawa 90301, Japan	Saint Marianna University; University of the Ryukyus	Tomita, H (corresponding author), St Marianna Univ, Sch Med, Dept Radiol, Kawasaki, Kanagawa, Japan.	m04149@yahoo.co.jp	Yamashiro, Tsuneo/H-6409-2019; Tomita, Hayato/AAG-2617-2019	Yamashiro, Tsuneo/0000-0002-1904-2548; Tomita, Hayato/0000-0002-7024-3521				ANDERSEN K, 1984, CIRCULATION, V69, P874, DOI 10.1161/01.CIR.69.5.874; BRENNER JI, 1978, CIRCULATION, V57, P122, DOI 10.1161/01.CIR.57.1.122; Browne RFJ, 2004, J DIGIT IMAGING, V17, P120, DOI 10.1007/s10278-003-1900-3; BUDA AJ, 1979, NEW ENGL J MED, V301, P453, DOI 10.1056/NEJM197908303010901; Clark AL, 2000, POSTGRAD MED J, V76, P289, DOI 10.1136/pmj.76.895.289; Dimopoulos K, 2013, INT J CARDIOL, V166, P453, DOI 10.1016/j.ijcard.2011.10.125; Giamouzis G, 2008, AM J CARDIOL, V101, P343, DOI 10.1016/j.amjcard.2007.08.039; Gollub MJ, 2012, J COMPUT ASSIST TOMO, V36, P67, DOI 10.1097/RCT.0b013e318241e585; Hart C, 1998, BRIT MED J, V317, P1321, DOI 10.1136/bmj.317.7168.1321; Hemingway H, 1998, BRIT MED J, V316, P1353, DOI 10.1136/bmj.316.7141.1353; Iwano S, 2009, ACAD RADIOL, V16, P250, DOI 10.1016/j.acra.2008.09.019; JARDIN F, 1984, J APPL PHYSIOL, V56, P619, DOI 10.1152/jappl.1984.56.3.619; Kearney MT, 2002, J AM COLL CARDIOL, V40, P1801, DOI 10.1016/S0735-1097(02)02490-7; KIM BH, 1987, J NUCL MED, V28, P173; KONO T, 1992, JPN CIRC J, V56, P359, DOI 10.1253/jcj.56.359; ROSE CP, 1982, INVEST RADIOL, V17, P139, DOI 10.1097/00004424-198203000-00004; SANTAMORE WP, 1984, J APPL PHYSIOL, V57, P1520, DOI 10.1152/jappl.1984.57.5.1520; Silverman F.N., 1978, PEDIAT XRAY DIAGNOSI, V7th ed., P531; Tomita K., 2004, RIGAKURYOHO KAGAKU, V19, P237; Warnes CA, 2008, CIRCULATION, V118, P2395, DOI [10.1161/CIRCULATIONAHA.108.190811, 10.1016/j.jacc.2008.10.001]; Yamashiro T, 2011, ACAD RADIOL, V18, P299, DOI 10.1016/j.acra.2010.11.005; Yamashiro T, 2010, ACAD RADIOL, V17, P489, DOI 10.1016/j.acra.2009.11.004	22	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131902	10.1371/journal.pone.0131902	http://dx.doi.org/10.1371/journal.pone.0131902			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151361	Green Published, Green Submitted, gold			2022-12-27	WOS:000358158900029
J	Zhang, JH; Wei, Q; Cai, J; Zhao, X; Ma, BH				Zhang, Junhong; Wei, Qiang; Cai, Jiao; Zhao, Xiaoe; Ma, Baohua			Effect of C-Type Natriuretic Peptide on Maturation and Developmental Competence of Goat Oocytes Matured In Vitro	PLOS ONE			English	Article							NPR2 GUANYLYL CYCLASE; MOUSE OOCYTES; MEIOTIC RESUMPTION; PHOSPHODIESTERASE 3-INHIBITOR; MAMMALIAN OOCYTES; GRANULOSA-CELLS; RECEPTOR NPR2; CUMULUS CELL; ARREST; EXPRESSION	The developmental competence of oocytes during in vitro maturation (IVM) is compromised due to asynchronous nuclear and cytoplasmic maturation. To improve IVM efficiency, a prematuration culture or two-step maturation strategy has been established, involving meiosis arrest induced by pharmacological agents to provide oocytes with sufficient time to synchronize the maturation of the nucleus and cytoplasm. C-type natriuretic peptide (CNP), which has been demonstrated to function as an oocyte maturation inhibitor (OMI) in many species, provides a new alternative to improve the developmental capacity of oocytes matured in vitro. However, the effect of CNP on meiosis arrest and the maturation of goat oocytes remains unclear. In the present study, CNP was shown to function as an OMI in goat oocytes. CNP could temporarily maintain the meiotic arrest of goat oocytes cultured in vitro for 4 hours. This transient effect was partly due to the reduction of natriuretic peptide receptor 2 (Npr2). Estradiol could delay the decrease in Npr2 expression and prolong the duration of meiosis arrest up to 6 hours. Based on the above results, a two-step method was established for goat oocyte maturation, in which the oocyte maturation rate was significantly increased. After parthenogenetic activation, the cleavage rate, blastocyst rate and total cell number of blastocysts were significantly improved. Our results suggested that CNP can be used to delay meiotic resumption and enhance the developmental competence of goat oocytes matured in vitro.	[Zhang, Junhong; Wei, Qiang; Cai, Jiao; Zhao, Xiaoe; Ma, Baohua] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Zhang, Junhong; Wei, Qiang; Cai, Jiao; Zhao, Xiaoe; Ma, Baohua] Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs	Ma, BH (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	mabh@nwsuaf.edu.cn		Zhang, Junhong/0000-0003-0611-9478; Ma, Baohua/0000-0002-8332-4275	Chinese Universities Scientific Fund [QN2012016]; Natural Science Basic Research Plan in Shaanxi Province of China [2014JQ3101]	Chinese Universities Scientific Fund; Natural Science Basic Research Plan in Shaanxi Province of China	This work was supported in part by Natural Science Basic Research Plan in Shaanxi Province of China (Program No. 2014JQ3101). Chinese Universities Scientific Fund (Program No. QN2012016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuz FK, 2010, HUM REPROD, V25, P2999, DOI 10.1093/humrep/deq246; Duncan FE, 2006, DEV DYNAM, V235, P2961, DOI 10.1002/dvdy.20930; Egbert JR, 2014, DEVELOPMENT, V141, P3594, DOI 10.1242/dev.112219; EPPIG JJ, 1994, DEV BIOL, V164, P1, DOI 10.1006/dbio.1994.1175; Franciosi F, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.118869; Gharibi S, 2013, THERIOGENOLOGY, V80, P302, DOI 10.1016/j.theriogenology.2013.04.012; Gonzalez-Bulnes A, 2002, REPROD DOMEST ANIM, V37, P357, DOI 10.1046/j.1439-0531.2002.00385.x; Grondahl C, 2003, HUM REPROD, V18, P122, DOI 10.1093/humrep/deg028; Hiradate Y, 2014, ZYGOTE, V22, P372, DOI 10.1017/S0967199412000615; Jurema MW, 2006, FERTIL STERIL, V86, P1277, DOI 10.1016/j.fertnstert.2006.02.126; Kawamura K, 2011, HUM REPROD, V26, P3094, DOI 10.1093/humrep/der282; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodde V, 2007, MOL REPROD DEV, V74, P740, DOI 10.1002/mrd.20639; Lucci CM, 1999, ANIM REPROD SCI, V56, P39, DOI 10.1016/S0378-4320(99)00031-7; Luciano AM, 2004, BIOL REPROD, V70, P465, DOI 10.1095/biolreprod.103.020644; Mehlmann LM, 2005, REPRODUCTION, V130, P791, DOI 10.1530/rep.1.00793; Nogueira D, 2006, BIOL REPROD, V74, P177, DOI 10.1095/biolreprod.105.040485; Nogueira D, 2003, BIOL REPROD, V69, P2045, DOI 10.1095/biolreprod.103.021105; Peng JY, 2013, GENE, V524, P105, DOI 10.1016/j.gene.2013.04.054; Robinson JW, 2012, DEV BIOL, V366, P308, DOI 10.1016/j.ydbio.2012.04.019; Sato Y, 2012, MOL ENDOCRINOL, V26, P1158, DOI 10.1210/me.2012-1027; Thompson IR, 2012, ENDOCR-RELAT CANCER, V19, P497, DOI 10.1530/ERC-12-0129; Tripathi A, 2010, J CELL PHYSIOL, V223, P592, DOI 10.1002/jcp.22108; Trounson A, 2001, REPRODUCTION, V121, P51, DOI 10.1530/rep.0.1210051; TSAFRIRI A, 1986, CLIN ENDOCRINOL META, V15, P157, DOI 10.1016/S0300-595X(86)80047-0; Vanhoutte L, 2008, MOL REPROD DEV, V75, P1021, DOI 10.1002/mrd.20851; Zeng HT, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.118471; Zhang MJ, 2011, ENDOCRINOLOGY, V152, P4377, DOI 10.1210/en.2011-1118; Zhang MJ, 2010, SCIENCE, V330, P366, DOI 10.1126/science.1193573; Zhang MJ, 2009, MOL HUM REPROD, V15, P399, DOI 10.1093/molehr/gap031; Zhang WQ, 2014, MOL REPROD DEV, V81, P1030, DOI 10.1002/mrd.22424	31	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132318	10.1371/journal.pone.0132318	http://dx.doi.org/10.1371/journal.pone.0132318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151446	gold, Green Submitted, Green Published			2022-12-27	WOS:000358158900040
J	Bricker-Anthony, C; Rex, TS				Bricker-Anthony, Courtney; Rex, Tonia S.			Neurodegeneration and Vision Loss after Mild Blunt Trauma in the C57Bl/6 and DBA/2J Mouse	PLOS ONE			English	Article							COMBAT OCULAR TRAUMA; COMMOTIO-RETINAE; INJURY; MODEL; GLOBE; MICE; EYE; GLAUCOMA; ETHANOL	Damage to the eye from blast exposure can occur as a result of the overpressure air-wave (primary injury), flying debris (secondary injury), blunt force trauma (tertiary injury), and/or chemical/thermal burns (quaternary injury). In this study, we investigated damage in the contralateral eye after a blast directed at the ipsilateral eye in the C57Bl/6J and DBA/2J mouse. Assessments of ocular health (gross pathology, electroretinogram recordings, optokinetic tracking, optical coherence tomography and histology) were performed at 3, 7, 14 and 28 days post-trauma. Olfactory epithelium and optic nerves were also examined. Anterior pathologies were more common in the DBA/2J than in the C57Bl/6 and could be prevented with non-medicated viscous eye drops. Visual acuity decreased over time in both strains, but was more rapid and severe in the DBA/2J. Retinal cell death was present in approximately 10% of the retina at 7 and 28 days post-blast in both strains. Approximately 60% of the cell death occurred in photoreceptors. Increased oxidative stress and microglial reactivity was detected in both strains, beginning at 3 days post-injury. However, there was no sign of injury to the olfactory epithelium or optic nerve in either strain. Although our model directs an overpressure air-wave at the left eye in a restrained and otherwise protected mouse, retinal damage was detected in the contralateral eye. The lack of damage to the olfactory epithelium and optic nerve, as well as the different timing of cell death as compared to the blast-exposed eye, suggests that the injuries were due to physical contact between the contralateral eye and the housing chamber of the blast device and not propagation of the blast wave through the head. Thus we describe a model of mild blunt eye trauma.	[Bricker-Anthony, Courtney; Rex, Tonia S.] Vanderbilt Univ, Vanderbilt Eye Inst, Nashville, TN 37235 USA; [Bricker-Anthony, Courtney; Rex, Tonia S.] Vanderbilt Univ, Vanderbilt Brain Inst, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University	Rex, TS (corresponding author), Vanderbilt Univ, Vanderbilt Eye Inst, 221 Kirkland Hall, Nashville, TN 37235 USA.	tonia.rex@vanderbilt.edu	Bricker-Anthony, Courtney/AAS-9583-2021; Bricker-Anthony, Courtney/AHB-0825-2022; Bricker-Anthony, Courtney/GRR-9960-2022	Bricker-Anthony, Courtney/0000-0001-5000-3523	Department of Defense [W81XW-10-1-0528]; National Eye Institute [EY022349, P30-EY008126]; Research to Prevent Blindness Unrestricted Fund; NATIONAL EYE INSTITUTE [R01EY022349] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness Unrestricted Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Department of Defense W81XW-10-1-0528 (TSR); National Eye Institute EY022349 (TSR); Research to Prevent Blindness Unrestricted Funds (P. Sternberg); National Eye Institute P30-EY008126 (J. Schall). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airey DC, 2001, J NEUROSCI, V21, P5099, DOI 10.1523/JNEUROSCI.21-14-05099.2001; BELKNAP JK, 1993, BEHAV GENET, V23, P213, DOI 10.1007/BF01067426; Blanch RJ, 2012, INVEST OPHTH VIS SCI, V53, P7220, DOI 10.1167/iovs.12-9887; BLIGHT R, 1977, BRIT J OPHTHALMOL, V61, P573, DOI 10.1136/bjo.61.9.573; Bricker-Anthony C, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0192-5; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; BUNTMILAM AH, 1986, EXP EYE RES, V43, P397, DOI 10.1016/S0014-4835(86)80076-8; Chevallier A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053520; Cockerham GC, 2013, CLIN PRACT, V11, P225; CUNNINGHAM CL, 1995, PSYCHOPHARMACOLOGY, V120, P28, DOI 10.1007/BF02246142; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gendler S, 2015, INJURY; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; May DR, 2000, GRAEF ARCH CLIN EXP, V238, P153, DOI 10.1007/PL00007884; Mo JS, 2003, J EXP MED, V197, P1335, DOI 10.1084/jem.20022041; Paranthan RR, 2011, MOL VIS, V17, P1901; Prusky GT, 2008, J NEUROSCI, V28, P9817, DOI 10.1523/JNEUROSCI.1940-08.2008; Scott R, 2011, PHILOS T R SOC B, V366, P251, DOI 10.1098/rstb.2010.0234; SIPPERLEY JO, 1978, ARCH OPHTHALMOL-CHIC, V96, P2267, DOI 10.1001/archopht.1978.03910060563021; Ward TP, 2007, OPHTHALMOL TIMES, V32, P8; Weichel EA, 2009, J HEAD TRAUMA REHAB, V24, P41, DOI 10.1097/HTR.0b013e3181956ffd; Weichel ED, 2008, CURR OPIN OPHTHALMOL, V19, P519, DOI 10.1097/ICU.0b013e3283140e98; Xia T, 2015, IOVS	25	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131921	10.1371/journal.pone.0131921	http://dx.doi.org/10.1371/journal.pone.0131921			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148200	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600166
J	Chang, S; Linderholm, A; Harper, R				Chang, Sandra; Linderholm, Angela; Harper, Richart			DUOX-Mediated Signaling Is Not Required for LPS-Induced Neutrophilic Response in the Airways	PLOS ONE			English	Article							HYDROGEN-PEROXIDE PRODUCTION; ACUTE LUNG INJURY; EPITHELIAL-CELLS; NADPH OXIDASE; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; HOST-DEFENSE; WOUND REPAIR; IN-VIVO; EXPRESSION	Oxidant production from DUOX1 has been proposed to lead to neutrophil recruitment into the airways when lung homeostasis is compromised. The objective of this study was to determine whether DUOX-derived hydrogen peroxide is required for LPS-induced neutrophil recruitment, using a functional DUOX knock out mouse model. We found that LPS induced profound neutrophilic lung inflammation in both Duoxa+/+ and Duoxa-/-mice between 3h and 24h. Duoxa-/-mice had significantly higher neutrophil influx 24h after LPS instillation despite similar cytokine levels (KC, MIP-2, or TGF-alpha) between the two groups. These findings suggest that LPS-TLR-4-induced KC or MIP-2 cytokine induction and subsequent neutrophil recruitment in the airway does not require DUOX-derived hydrogen peroxide from airway epithelium.	[Chang, Sandra; Linderholm, Angela; Harper, Richart] Univ Calif Davis, Dept Internal Med, Sch Med, Div Pulm & Crit Care Med, Davis, CA 95616 USA	University of California System; University of California Davis	Harper, R (corresponding author), Univ Calif Davis, Dept Internal Med, Sch Med, Div Pulm & Crit Care Med, Davis, CA 95616 USA.	rwharper@ucdavis.edu			National Institutes of Health (Bethesda, MD) [NHLBI R01 HL085311, NHLBI T32 HL007013]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007013, R01HL085311] Funding Source: NIH RePORTER	National Institutes of Health (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants NHLBI R01 HL085311 and NHLBI T32 HL007013 from the National Institutes of Health (Bethesda, MD) (http://www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldieri E, 2008, CURR DRUG METAB, V9, P686, DOI 10.2174/138920008786049285; Boots AW, 2009, J BIOL CHEM, V284, P17858, DOI 10.1074/jbc.M809761200; Call DR, 2001, SHOCK, V15, P278, DOI 10.1097/00024382-200115040-00005; Chang S, 2013, FREE RADICAL BIO MED, V65, P38, DOI 10.1016/j.freeradbiomed.2013.06.012; De Deken X, 2014, ANTIOXID REDOX SIGN, V20, P2776, DOI 10.1089/ars.2013.5602; de Oliveira S, 2015, J IMMUNOL, V194, P1523, DOI 10.4049/jimmunol.1402386; de Oliveira S, 2014, J IMMUNOL, V192, P5710, DOI 10.4049/jimmunol.1302902; Enyedi B, 2013, METHOD ENZYMOL, V528, P237, DOI 10.1016/B978-0-12-405881-1.00014-8; Fan J, 2003, J CLIN INVEST, V112, P1234, DOI 10.1172/JCI200318696; Fan Jie, 2010, Open Crit Care Med J, V2, P1; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Fischer H, 2007, AM J PHYSIOL-LUNG C, V292, pL1506, DOI 10.1152/ajplung.00029.2007; Forteza R, 2005, AM J RESP CELL MOL, V32, P462, DOI 10.1165/rcmb.2004-0302OC; Gattas MV, 2009, FREE RADICAL BIO MED, V47, P1450, DOI 10.1016/j.freeradbiomed.2009.08.017; Gorissen SH, 2012, AM J RESP CELL MOL B; Grasberger H, 2012, MOL ENDOCRINOL, V26, P481, DOI 10.1210/me.2011-1320; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Hattori H, 2010, P NATL ACAD SCI USA, V107, P3546, DOI 10.1073/pnas.0914351107; Janssen-Heininger Y., 2013, J CELL BIOCHEM; Joo JH, 2011, ANTIOXID REDOX SIGNA; Kim HJ, 2008, AM J RESP CELL MOL, V39, P598, DOI 10.1165/rcmb.2007-0262OC; Klyubin IV, 1996, EUR J CELL BIOL, V70, P347; Koff JL, 2006, J IMMUNOL, V177, P8693, DOI 10.4049/jimmunol.177.12.8693; Li W., 2013, SCI REP, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0063945; Looney MR, 2006, CRIT CARE MED, V34, pS132, DOI 10.1097/01.CCM.0000214287.58444.2D; Moskwa P, 2007, AM J RESP CRIT CARE, V175, P174, DOI 10.1164/rccm.200607-1029OC; Nakanaga T, 2007, AM J PHYSL LUNG CELL; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Parinandi NL, 2003, AM J PHYSIOL-LUNG C, V284, pL26, DOI 10.1152/ajplung.00123.2002; Rada B, 2010, FEBS LETT, V584, P917, DOI 10.1016/j.febslet.2010.01.025; Razzell W, 2013, CURR BIOL, V23, P424, DOI 10.1016/j.cub.2013.01.058; Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004; Robertson NM, 2002, J IMMUNOL, V169, P5986, DOI 10.4049/jimmunol.169.10.5986; Robertson NM, 2004, VITAM HORM, V67, P149; Rovai LE, 1998, J LEUKOCYTE BIOL, V64, P494, DOI 10.1002/jlb.64.4.494; Ryu JH, 2012, J ALLERGY CLIN IMMUN; Scarcella DL, 1999, CLIN CANCER RES, V5, P335; Tazzeo T, 2009, BRIT J PHARMACOL, V158, P790, DOI 10.1111/j.1476-5381.2009.00394.x; Tisato V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115387; ULICH TR, 1991, AM J PATHOL, V138, P1485; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P2517, DOI [10.1089/ars.2009.2582, 10.1089/ARS.2009.2582]; Veal E, 2011, ANTIOXID REDOX SIGN, V15, P147, DOI 10.1089/ars.2011.3968; Wang XR, 2002, J IMMUNOL, V168, P810, DOI 10.4049/jimmunol.168.2.810; Weng TT, 2006, AM J PHYSIOL-LUNG C, V291, pL1027, DOI 10.1152/ajplung.00435.2005; Wesley UV, 2007, J BIOL CHEM, V282, P3213, DOI 10.1074/jbc.M606533200; Yi ES, 1996, INFLAMMATION, V20, P165, DOI 10.1007/BF01487403	46	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131810	10.1371/journal.pone.0131810	http://dx.doi.org/10.1371/journal.pone.0131810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148206	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600148
J	Connolly, F; Rae, MT; Spath, K; Boswell, L; McNeilly, AS; Duncan, WC				Connolly, Fiona; Rae, Michael T.; Spaeth, Katharina; Boswell, Lyndsey; McNeilly, Alan S.; Duncan, W. Colin			In an Ovine Model of Polycystic Ovary Syndrome (PCOS) Prenatal Androgens Suppress Female Fetal Renal Gluconeogenesis	PLOS ONE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE; INSULIN-RESISTANCE; GLUCOSE-PRODUCTION; GENE-EXPRESSION; LATE-GESTATION; EXCESS; SHEEP; PREVALENCE; TESTOSTERONE; SENSITIVITY	Increased maternal androgen exposure during pregnancy programmes a polycystic ovary syndrome (PCOS)-like condition, with metabolic dysfunction, in adult female offspring. Other in utero exposures associated with the development of insulin resistance, such as intrauterine growth restriction and exposure to prenatal glucocorticoids, are associated with altered fetal gluconeogenesis. We therefore aimed to assess the effect of maternal androgenisation on the expression of PEPCK and G6PC in the ovine fetus. Pregnant Scottish Greyface sheep were treated with twice weekly testosterone propionate (TP; 100mg) or vehicle control from day 62 to day102 of gestation. At day 90 and day 112 fetal plasma and liver and kidney tissue was collected for analysis. PEPCK and G6PC expression were analysed by quantitative RT-PCR, immunohistochemistry and western blotting. PEPCK and G6PC were localised to fetal hepatocytes but maternal androgens had no effect on female or male fetuses. PEPCK and G6PC were also localised to the renal tubules and renal PEPCK (P<0.01) and G6PC (P = 0.057) were lower in females after prenatal androgenisation with no change in male fetuses. These tissue and sex specific observations could not be explained by alterations in fetal insulin or cortisol. The sexual dimorphism may be related to the increase in circulating estrogen (P<0.01) and testosterone (P<0.001) in females but not males. The tissue specific effects may be related to the increased expression of ESR1 (P<0.01) and AR (P<0.05) in the kidney when compared to the fetal liver. After discontinuation of maternal androgenisation female fetal kidney PEPCK expression normalised. These data further highlight the fetal and sexual dimorphic effects of maternal androgenisation, an antecedent to adult disease and the plasticity of fetal development.	[Connolly, Fiona; Spaeth, Katharina; Boswell, Lyndsey; McNeilly, Alan S.; Duncan, W. Colin] Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Rae, Michael T.] Edinburgh Napier Univ, Sch Hlth Life & Social Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh; Edinburgh Napier University	Duncan, WC (corresponding author), Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	W.C.Duncan@ed.ac.uk			Medical Research Council [G0500717, G0901807]; Scottish Funding Council; MRC [G0500717, G0901807] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Funding Council; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by the Medical Research Council (G0500717, G0901807) and WCD was supported by a Senior Clinical Fellowship from the Scottish Funding Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2010, AM J PHYSIOL-ENDOC M, V299, pE741, DOI 10.1152/ajpendo.00058.2010; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Carmina E, 2004, FERTIL STERIL, V82, P661, DOI 10.1016/j.fertnstert.2004.01.041; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Connolly F, 2013, ENDOCRINOLOGY, V154, P1921, DOI 10.1210/en.2012-2153; De Meyts P, 2002, GROWTH HORM IGF RES, V12, P81, DOI 10.1054/ghir.2002.0264; Demissie M, 2008, AM J PHYSIOL-ENDOC M, V295, pE262, DOI 10.1152/ajpendo.90208.2008; DeUgarte CM, 2005, FERTIL STERIL, V83, P1454, DOI 10.1016/j.fertnstert.2004.11.070; Diamanti-Kandarakis E, 2006, ENDOCRINE, V30, P13, DOI 10.1385/ENDO:30:1:13; Dumesic DA, 2014, SEMIN REPROD MED, V32, P159, DOI 10.1055/s-0034-1371087; Eisner JR, 2000, J CLIN ENDOCR METAB, V85, P1206, DOI 10.1210/jc.85.3.1206; Forhead AJ, 2003, J PHYSIOL-LONDON, V548, P941, DOI 10.1113/jphysiol.2002.035816; FOWDEN AL, 1993, J ENDOCRINOL, V137, P213, DOI 10.1677/joe.0.1370213; Franko KL, 2007, J ENDOCRINOL, V192, P67, DOI 10.1677/joe.1.07063; Gerich JE, 2001, DIABETES CARE, V24, P382, DOI 10.2337/diacare.24.2.382; Goodarzi MO, 2011, NAT REV ENDOCRINOL, V7, P219, DOI 10.1038/nrendo.2010.217; Hajarnis S, 2005, J BIOL CHEM, V280, P28272, DOI 10.1074/jbc.M501204200; Hogg K, 2012, ENDOCRINOLOGY, V153, P450, DOI 10.1210/en.2011-1607; Hogg K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024877; Hogg K, 2011, ENDOCRINOLOGY, V152, P2048, DOI 10.1210/en.2010-1219; JAUSSI R, 1992, MOL CELL ENDOCRINOL, V86, P187, DOI 10.1016/0303-7207(92)90143-T; Kwong WY, 2007, MOL REPROD DEV, V74, P48, DOI 10.1002/mrd.20606; LEMONS JA, 1986, PEDIATR RES, V20, P676, DOI 10.1203/00006450-198607000-00020; McNeilly AS, 2013, MOL CELL ENDOCRINOL, V373, P2, DOI 10.1016/j.mce.2012.10.007; Mutel E, 2011, DIABETES, V60, P3121, DOI 10.2337/db11-0571; Nicol LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106527; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; Padmanabhan V, 2010, ENDOCRINOLOGY, V151, P595, DOI 10.1210/en.2009-1015; Peterside IE, 2003, AM J PHYSIOL-ENDOC M, V285, pE1258, DOI 10.1152/ajpendo.00437.2002; Rae M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056263; Rajas F, 2007, HISTOCHEM CELL BIOL, V127, P555, DOI 10.1007/s00418-006-0263-5; Recabarren SE, 2005, AM J PHYSIOL-ENDOC M, V289, pE801, DOI 10.1152/ajpendo.00107.2005; Roland AV, 2010, J ENDOCRINOL, V207, P213, DOI 10.1677/JOE-10-0217; ROSELLA G, 1993, MOL ENDOCRINOL, V7, P1456, DOI 10.1210/me.7.11.1456; Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004; Thorn SR, 2013, DIABETES, V62, P65, DOI 10.2337/db11-1727; Tomlinson JW, 2001, BEST PRACT RES CL EN, V15, P61, DOI 10.1053/beem.2000.0119; Xita N, 2006, J CLIN ENDOCR METAB, V91, P1660, DOI 10.1210/jc.2005-2757	39	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132113	10.1371/journal.pone.0132113	http://dx.doi.org/10.1371/journal.pone.0132113			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148093	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600201
J	de Groen, FLM; Timmer, LM; Menezes, RX; Diosdado, B; Hooijberg, E; Meijer, GA; Steenbergen, RDM; Carvalho, B				de Groen, Florence L. M.; Timmer, Lisette M.; Menezes, Renee X.; Diosdado, Begona; Hooijberg, Erik; Meijer, Gerrit A.; Steenbergen, Renske D. M.; Carvalho, Beatriz			Oncogenic Role of miR-15a-3p in 13q Amplicon-Driven Colorectal Adenoma-to-Carcinoma Progression	PLOS ONE			English	Article							DNA COPY NUMBER; CELL-PROLIFERATION; PROSTATE-CANCER; TUMOR-GROWTH; EXPRESSION; MICRORNA; GENE; CLUSTER; ANGIOGENESIS; CONTRIBUTES	Progression from colorectal adenoma to carcinoma is strongly associated with an accumulation of genomic alterations, including gain of chromosome 13. This gain affects the whole q arm and is present in 40%-60% of all colorectal cancers (CRCs). Several genes located at this amplicon are known to be overexpressed in carcinomas due to copy number dosage. A subset of these genes, including the mir-17 similar to 92 cluster, are functionally involved in CRC development. The present study set out to explore whether apart from mir-17 similar to 92, other miRNAs located at the 13q amplicon show a copy number dependent dosage effect that may contribute to 13q-driven colorectal adenoma-to-carcinoma progression. Integration of publically available miRNA expression, target mRNA expression and DNA copy number data from 125 CRCs yielded three miRNAs, miR-15a, -17, and -20a, of which high expression levels were significantly correlated with a 13q gain and which influenced target mRNA expression. These results could be confirmed by qRT-PCR in a series of 100 colon adenomas and carcinomas. Functional analysis of both mature miRNAs encoded by mir-15a, i.e. miR-15a-5p and miR-15a-3p, showed that silencing of miR-15a-3p significantly inhibited viability of CRC cells. Integration of miR-15a expression levels with mRNA expression data of predicted target genes identified mitochondrial uncoupling protein 2 (UCP2) and COP9 signalosome subunit 2 (COPS2) as candidates with significantly decreased expression in CRCs with 13q gain. Upon silencing of miR-15a-3p, mRNA expression of both genes increased in CRC cells, supporting miR-15a-3p mediated regulation of UPC2 and COPS2 expression. In conclusion, significant overexpression of miR-15a-3p due to gain of 13q is functionally relevant in CRC, with UCP2 and COPS2 as candidate target genes. Taken together our findings suggest that miR-15a-3p may contribute to adenoma-to-carcinoma progression.	[de Groen, Florence L. M.; Timmer, Lisette M.; Diosdado, Begona; Hooijberg, Erik; Meijer, Gerrit A.; Steenbergen, Renske D. M.; Carvalho, Beatriz] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Menezes, Renee X.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Diosdado, Begona; Meijer, Gerrit A.; Carvalho, Beatriz] Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Netherlands Cancer Institute	Carvalho, B (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands.	b.carvalho@nki.nl	Hooijberg, Erik/F-4503-2011; Carvalho, Beatriz/GXA-0720-2022	Hooijberg, Erik/0000-0002-4482-2191; Steenbergen, Renske/0000-0002-2327-9839; Meijer, Gerrit/0000-0003-0330-3130	VUmc Cancer Center Amsterdam (CCA); DeCoDe project [03O-101]	VUmc Cancer Center Amsterdam (CCA); DeCoDe project	This study was funded by the VUmc Cancer Center Amsterdam (CCA) and performed within the framework of CTMM, the Center for Translational Molecular Medicine. DeCoDe project (grant 03O-101).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Camps J, 2013, CANCER RES, V73, P2003, DOI 10.1158/0008-5472.CAN-12-3159; Carvalho B, 2009, GUT, V58, P79, DOI 10.1136/gut.2007.143065; Chai HJ, 2011, ACTA BIOCH BIOPH SIN, V43, P217, DOI 10.1093/abbs/gmq125; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; de Groen FLM, 2014, GENE CHROMOSOME CANC, V53, P339, DOI 10.1002/gcc.22144; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Diosdado B, 2009, BRIT J CANCER, V101, P707, DOI 10.1038/sj.bjc.6605037; Druz A, 2013, RNA BIOL, V10, P287, DOI 10.4161/rna.23339; Dydensborg AB, 2006, AM J PHYSIOL-GASTR L, V290, pG1067, DOI 10.1152/ajpgi.00234.2005; Esteves P, 2014, CANCER RES, V74, P3971, DOI 10.1158/0008-5472.CAN-13-3383; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Hermsen M, 2002, GASTROENTEROLOGY, V123, P1109, DOI 10.1053/gast.2002.36051; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Leal JFM, 2008, ONCOGENE, V27, P1961, DOI 10.1038/sj.onc.1210846; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo HS, 2012, BIOCHEM J, V442, P311, DOI 10.1042/BJ20111517; Ma QY, 2013, ONCOL REP, V29, P1652, DOI 10.3892/or.2013.2262; Meijer GA, 1998, J CLIN PATHOL, V51, P901, DOI 10.1136/jcp.51.12.901; Menezes RX, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-203; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakao K, 2004, CARCINOGENESIS, V25, P1345, DOI 10.1093/carcin/bgh134; Qiang XF, 2014, J CELL BIOCHEM, V115, P1269, DOI 10.1002/jcb.24778; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; SCHOUTEN JP, 2002, NUCL ACIDS RES E, V57, P30; Shi L, 2014, CANCER RES, V74, P532, DOI 10.1158/0008-5472.CAN-13-2203; Sillars-Hardebol AH, 2012, GUT, V61, P1568, DOI 10.1136/gutjnl-2011-301153; Sun CY, 2013, CARCINOGENESIS, V34, P426, DOI 10.1093/carcin/bgs333; van Iterson M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt525; Wilting SM, 2013, ONCOGENE, V32, P106, DOI 10.1038/onc.2012.20; Xu ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077890; Yang XL, 2013, NUCLEIC ACIDS RES, V41, P9688, DOI 10.1093/nar/gkt680; Young LE, 2012, MOL CANCER RES, V10, P167, DOI 10.1158/1541-7786.MCR-11-0337	47	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132495	10.1371/journal.pone.0132495	http://dx.doi.org/10.1371/journal.pone.0132495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148070	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600290
J	Gemmecker, S; Schaub, P; Koschmieder, J; Brausemann, A; Drepper, F; Rodriguez-Franco, M; Ghisla, S; Warscheid, B; Einsle, O; Beyer, P				Gemmecker, Sandra; Schaub, Patrick; Koschmieder, Julian; Brausemann, Anton; Drepper, Friedel; Rodriguez-Franco, Marta; Ghisla, Sandro; Warscheid, Bettina; Einsle, Oliver; Beyer, Peter			Phytoene Desaturase from Oryza sativa: Oligomeric Assembly, Membrane Association and Preliminary 3D-Analysis	PLOS ONE			English	Article							PLASTID TERMINAL OXIDASE; ZETA-CAROTENE DESATURASE; BETA-CAROTENE; BIOSYNTHETIC-PATHWAY; MOLECULAR-OXYGEN; LYCOPENE CYCLASE; IN-VITRO; IDENTIFICATION; EXPRESSION; ISOMERASE	Recombinant phytoene desaturase (PDS-His6) from rice was purified to near-homogeneity and shown to be enzymatically active in a biphasic, liposome-based assay system. The protein contains FAD as the sole protein-bound redox-cofactor. Benzoquinones, not replaceable by molecular oxygen, serve as a final electron acceptor defining PDS as a 15-cis-phytoene (donor): plastoquinone oxidoreductase. The herbicidal PDS-inhibitor norflurazon is capable of arresting the reaction by stabilizing the intermediary FAD(red), while an excess of the quinone acceptor relieves this blockage, indicating competition. The enzyme requires its homo-oligomeric association for activity. The sum of data collected through gel permeation chromatography, non-denaturing polyacrylamide electrophoresis, chemical cross-linking, mass spectrometry and electron microscopy techniques indicate that the high-order oligomers formed in solution are the basis for an active preparation. Of these, a tetramer consisting of dimers represents the active unit. This is corroborated by our preliminary X-ray structural analysis that also revealed similarities of the protein fold with the sequence-inhomologous bacterial phytoene desaturase CRTI and other oxidoreductases of the GR2-family of flavoproteins. This points to an evolutionary relatedness of CRTI and PDS yielding different carotene desaturation sequences based on homologous protein folds.	[Gemmecker, Sandra; Schaub, Patrick; Koschmieder, Julian; Rodriguez-Franco, Marta; Beyer, Peter] Univ Freiburg, Fac Biol, Cell Biol, D-79106 Freiburg, Germany; [Drepper, Friedel; Warscheid, Bettina] Univ Freiburg, Fac Biol Biochem & Funct Prote, D-79106 Freiburg, Germany; [Brausemann, Anton; Einsle, Oliver] Univ Freiburg, Fac Chem & Pharm, Inst Biochem, D-79106 Freiburg, Germany; [Ghisla, Sandro] Univ Konstanz, Dept Biol, Constance, Germany; [Warscheid, Bettina; Einsle, Oliver] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Konstanz; University of Freiburg	Beyer, P (corresponding author), Univ Freiburg, Fac Biol, Cell Biol, Hugstetter Str 55, D-79106 Freiburg, Germany.	peter.beyer@biologie.uni-freiburg.de	Schaub, Patrick/C-8358-2018	Rodriguez Franco, Marta/0000-0003-1183-2075; Brausemann, Anton/0000-0001-9135-301X; Warscheid, Bettina/0000-0001-5096-1975; Einsle, Oliver/0000-0001-8722-2893; Drepper, Friedel/0000-0002-2043-5795; Schaub, Patrick/0000-0002-8529-4161	European Union Seventh Framework Programme (FP7) [244348]; HarvestPlus Research Consortium; Deutsche Forschungsgemeinschaft [EI-520/3]; Excellence Initiative of the German Federal and State Governments [EXC 294]	European Union Seventh Framework Programme (FP7); HarvestPlus Research Consortium; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments	This work was supported by the European Union Seventh Framework Programme (FP7) Contract 244348, by the HarvestPlus Research Consortium (PB) and by the Deutsche Forschungsgemeinschaft (grant EI-520/3 to OE). Research in the laboratory of BW was supported by the Deutsche Forschungsgemeinschaft and the Excellence Initiative of the German Federal and State Governments Grant EXC 294 BIOSS Centre for Biological Signalling Studies (EXC 294 to BW). [URLs: Harvest Plus, www.harvestplus.org; EC Framework, http://ec.europa.eu/research/fp7/index_en.cfm; Deutsche Forschungsgemeinschaft, http://www.dfg.de/; Excellence initiative, http://www.dfg.de/en/research_funding/programmes/excellence_initiative/index.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Babili S, 2006, J EXP BOT, V57, P1007, DOI 10.1093/jxb/erj086; AlBabili S, 1996, PLANT J, V9, P601, DOI 10.1046/j.1365-313X.1996.9050601.x; Alder A, 2012, SCIENCE, V335, P1348, DOI 10.1126/science.1218094; Arnoux P, 2009, PLANT CELL, V21, P2036, DOI 10.1105/tpc.109.068007; Atmeh RF, 2007, JORDAN J CHEM, V2, P169; Avendano-Vazquez AO, 2014, PLANT CELL, V26, P2524, DOI 10.1105/tpc.114.123349; Bartley GE, 1999, EUR J BIOCHEM, V259, P396, DOI 10.1046/j.1432-1327.1999.00051.x; BEYER P, 1989, EUR J BIOCHEM, V184, P141, DOI 10.1111/j.1432-1033.1989.tb15000.x; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Carol P, 2001, TRENDS PLANT SCI, V6, P31, DOI 10.1016/S1360-1385(00)01811-2; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chen Y, 2010, PLANT PHYSIOL, V153, P66, DOI 10.1104/pp.110.153916; Chua N. H, 1980, METHOD ENZYMOL, V69, P434; CLOUGH JM, 1979, J CHEM SOC CHEM COMM, P616, DOI 10.1039/c39790000616; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cristodero M, 2013, MOL MICROBIOL, V90, P744, DOI 10.1111/mmi.12397; Dailey TA, 1998, J BIOL CHEM, V273, P13658, DOI 10.1074/jbc.273.22.13658; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Feilke K, 2014, BBA-BIOENERGETICS, V1837, P1684, DOI 10.1016/j.bbabio.2014.07.016; Forneris F, 2009, FEBS J, V276, P2833, DOI 10.1111/j.1742-4658.2009.07006.x; FRASER PD, 1993, BIOCHEM J, V291, P687, DOI 10.1042/bj2910687; Gradinaru R, 2007, BIOCHEMISTRY-US, V46, P2497, DOI 10.1021/bi0614582; Gruszecki WI, 2005, BBA-MOL BASIS DIS, V1740, P108, DOI 10.1016/j.bbadis.2004.11.015; HAMILTON RL, 1980, J LIPID RES, V21, P981; Heyno E, 2009, J BIOL CHEM, V284, P31174, DOI 10.1074/jbc.M109.021667; HUGUENEY P, 1992, EUR J BIOCHEM, V209, P399, DOI 10.1111/j.1432-1033.1992.tb17302.x; Isaacson T, 2004, PLANT PHYSIOL, V136, P4246, DOI 10.1104/pp.104.052092; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kachanovsky DE, 2012, P NATL ACAD SCI USA, V109, P19021, DOI 10.1073/pnas.1214808109; Kiser PD, 2010, PROG RETIN EYE RES, V29, P428, DOI 10.1016/j.preteyeres.2010.03.002; Kiser PD, 2009, P NATL ACAD SCI USA, V106, P17325, DOI 10.1073/pnas.0906600106; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Leitner A, 2014, NAT PROTOC, V9, P120, DOI 10.1038/nprot.2013.168; Lopez AB, 2008, PHYSIOL PLANTARUM, V133, P190, DOI 10.1111/j.1399-3054.2008.01058.x; MAYER MP, 1990, EUR J BIOCHEM, V191, P359, DOI 10.1111/j.1432-1033.1990.tb19130.x; NIEVELSTEIN V, 1995, EUR J BIOCHEM, V233, P864, DOI 10.1111/j.1432-1033.1995.864_3.x; Norris SR, 1995, PLANT CELL, V7, P2139, DOI 10.1105/tpc.7.12.2139; Park H, 2002, PLANT CELL, V14, P321, DOI 10.1105/tpc.010302; Schaub P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039550; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Shahbazi M, 2007, PLANT PHYSIOL, V145, P691, DOI 10.1104/pp.107.106336; Shumskaya M, 2013, PLANT SCI, V208, P58, DOI 10.1016/j.plantsci.2013.03.012; Suarez JV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099894; Trouillard M, 2012, BBA-BIOENERGETICS, V1817, P2140, DOI 10.1016/j.bbabio.2012.08.006; Walzthoeni T, 2012, NAT METHODS, V9, P901, DOI 10.1038/nmeth.2103; Wendt KU, 1999, J MOL BIOL, V286, P175, DOI 10.1006/jmbi.1998.2470; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Yu QJ, 2014, BBA-BIOENERGETICS, V1837, P1284, DOI 10.1016/j.bbabio.2014.04.007; Yu QJ, 2012, FEBS LETT, V586, P3415, DOI 10.1016/j.febslet.2012.07.060; Yu QJ, 2011, J BIOL CHEM, V286, P8666, DOI 10.1074/jbc.M110.208017; Yu QJ, 2010, J BIOL CHEM, V285, P12109, DOI 10.1074/jbc.M109.091843	53	24	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131717	10.1371/journal.pone.0131717	http://dx.doi.org/10.1371/journal.pone.0131717			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147209	Green Submitted, gold, Green Published			2022-12-27	WOS:000358157600134
J	Hvidberg, MF; Brinth, LS; Olesen, AV; Petersen, KD; Ehlers, L				Hvidberg, Michael Falk; Brinth, Louise Schouborg; Olesen, Anne V.; Petersen, Karin D.; Ehlers, Lars			The Health-Related Quality of Life for Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)	PLOS ONE			English	Article							FUNCTIONAL SOMATIC SYNDROMES; EQ-5D; PREVALENCE; SCORES; HOSPITALIZATION; POPULATION; CATALOG	Introduction Myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) is a common, severe condition affecting 0.2 to 0.4 per cent of the population. Even so, no recent international EQ-5D based health-related quality of life (HRQoL) estimates exist for ME/CFS patients. The main purpose of this study was to estimate HRQoL scores using the EQ-5D-3L with Danish time trade-off tariffs. Secondary, the aims were to explore whether the results are not influenced by other conditions using regression, to compare the estimates to 20 other conditions and finally to present ME/CFS patient characteristics for use in clinical practice. Material and methods All members of the Danish ME/CFS Patient Association in 2013 (n=319) were asked to fill out a questionnaire including the EQ-5D-3L. From these, 105 ME/CFS patients were identified and gave valid responses. Unadjusted EQ-5D-3L means were calculated and compared to the population mean as well as to the mean of 20 other conditions. Furthermore, adjusted estimates were calculated using ordinary least squares (OLS) regression, adjusting for gender, age, education, and co-morbidity of 18 self-reported conditions. Data from the North Denmark Health Profile 2010 was used as population reference in the regression analysis (n=23,392). Results The unadjusted EQ-5D-3L mean of ME/CFS was 0.47 [0.41-0.53] compared to a population mean of 0.85 [0.84-0.86]. The OLS regression estimated a disutility of -0.29 [-0.21;0.34] for ME/CFS patients in this study. The characteristics of ME/CFS patients are different from the population with respect to gender, relationship, employment etc. Conclusion The EQ-5D-3L-based HRQoL of ME/CFS is significantly lower than the population mean and the lowest of all the compared conditions. The adjusted analysis confirms that poor HRQoL of ME/CFS is distinctly different from and not a proxy of the other included conditions. However, further studies are needed to exclude the possible selection bias of the current study.	[Hvidberg, Michael Falk; Olesen, Anne V.; Petersen, Karin D.; Ehlers, Lars] Aalborg Univ, Danish Ctr Healthcare Improvements, Aalborg, Denmark; [Brinth, Louise Schouborg] Frederiksberg Univ Hosp, Coordinating Res Unit, Frederiksberg, Denmark	Aalborg University	Hvidberg, MF (corresponding author), Aalborg Univ, Danish Ctr Healthcare Improvements, Aalborg, Denmark.	michael@falkhvidberg.dk	Hvidberg, Michael Falk/HGE-5232-2022; Ehlers, Lars/P-7531-2019; Olesen, Anne Vingaard/C-8130-2018; Olesen, Anne Vingaard/AAL-7716-2021	Hvidberg, Michael Falk/0000-0003-0632-3866; Olesen, Anne Vingaard/0000-0002-1503-8269; Brinth, Louise/0000-0001-6546-1308; Petersen, Karin Dam/0000-0002-6491-1757; Ehlers, Lars Holger/0000-0001-6512-5566				[Anonymous], 2003, MEPS HC 0522000 MED; Fernandez AA, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-S1-S1; Baker R, 2007, BMJ-BRIT MED J, V335, P446, DOI 10.1136/bmj.39302.509005.AE; Bergmann MM, 1998, AM J EPIDEMIOL, V147, P969; Brazier J, 2011, NICE DSU TECH SUPPOR; Brurberg KG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003973; Carter K, 2010, STROKE, V41, P2678, DOI 10.1161/STROKEAHA.110.598268; Cho HJ, 2009, BRIT J PSYCHIAT, V194, P117, DOI 10.1192/bjp.bp.108.051813; Christensen AI, 2014, DANES HLTH; Christensen AI, 2010, SCAND J PUBLIC HEALT, V2012, P391, DOI DOI 10.1177/1403494812451412; Christley Y, 2012, J EVAL CLIN PRACT, V18, P25, DOI 10.1111/j.1365-2753.2010.01512.x; Chu L., 2013, PATIENT SURVEY RESUL; Fjorback LO, 2013, J PSYCHOSOM RES, V74, P31, DOI 10.1016/j.jpsychores.2012.09.006; Fluge O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026358; Hardt J, 2001, J PSYCHOSOM RES, V51, P431, DOI 10.1016/S0022-3999(01)00220-3; Hayes VS, 2013, HLTH PROFILE N DENMA; Haywood KL, 2012, QUAL LIFE RES, V21, P35, DOI 10.1007/s11136-011-9921-8; Hvidberg M, 2013, POSTER ISPOR DUBLIN, P1; Inst Med, 2015, BEYOND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME: REDEFINING AN ILLNESS, P1; Jason L, 2010, AM J BIOCH BIOTECHNO, V6, P120, DOI [DOI 10.3844/AJBBSP.2010.120, DOI 10.3844/AJBBSP.2010.120.135]; Jason LA, 2011, B IACFS ME, V17, P88; Komaroff AL, 1996, AM J MED, V101, P281, DOI 10.1016/S0002-9343(96)00174-X; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Myers C, 1999, QUAL LIFE RES, V8, P9, DOI 10.1023/A:1026459027453; Nacul LC, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-91; Nacul LC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-402; NICE, 2007, CHRONIC FATIGUE SYND; Pedersen J, 2011, SUNDHEDSPROFIL 2010; Reeves WC, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-19; Reyes M, 2003, ARCH INTERN MED, V163, P1530, DOI 10.1001/archinte.163.13.1530; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Schroder A, 2012, BRIT J PSYCHIAT, V200, P499, DOI 10.1192/bjp.bp.111.098681; Sharpe M., 2005, J MENTAL HLTH, V14, P269, DOI [DOI 10.1080/09638230500136621, 10.1080/09638230500136621]; Spratt M, 2010, AM J EPIDEMIOL, V172, P478, DOI 10.1093/aje/kwq137; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Sullivan PW, 2006, MED DECIS MAKING, V26, P410, DOI 10.1177/0272989X06290495; Sullivan PW, 2011, MED DECIS MAKING, V31, P800, DOI 10.1177/0272989X11401031; Sullivan PW, 2005, MED CARE, V43, P736, DOI 10.1097/01.mlr.0000172050.67085.4f; Wessely S, 2004, BRIT J PSYCHIAT, V185, P95, DOI 10.1192/bjp.185.2.95; Whitehead SJ, 2010, BRIT MED BULL, V96, P5, DOI 10.1093/bmb/ldq033; Wittrup-Jensen KU, 2009, SCAND J PUBLIC HEALT, V37, P459, DOI 10.1177/1403494809105287	41	79	79	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132421	10.1371/journal.pone.0132421	http://dx.doi.org/10.1371/journal.pone.0132421			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26147503	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600264
J	Nicastro, E; Lo Vecchio, A; Liguoro, I; Chmielewska, A; De Bruyn, C; Dolinsek, J; Doroshina, E; Fessatou, S; Pop, TL; Prell, C; Tabbers, MM; Tavares, M; Urenden-Elicin, P; Bruzzese, D; Zakharova, I; Sandhu, B; Guarino, A				Nicastro, Emanuele; Lo Vecchio, Andrea; Liguoro, Ilaria; Chmielewska, Anna; De Bruyn, Caroline; Dolinsek, Jernej; Doroshina, Elena; Fessatou, Smaragdi; Pop, Tudor Lucian; Prell, Christine; Tabbers, Merit Monique; Tavares, Marta; Urenden-Elicin, Pinar; Bruzzese, Dario; Zakharova, Irina; Sandhu, Bhupinder; Guarino, Alfredo			The Impact of E-Learning on Adherence to Guidelines for Acute Gastroenteritis: A Single-Arm Intervention Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; EVIDENCE-BASED MEDICINE; PEDIATRIC GASTROENTERITIS; EMERGENCY-DEPARTMENT; ACUTE DIARRHEA; PRIMARY-CARE; CHILDREN; MANAGEMENT; IMPLEMENTATION; RESUSCITATION	Objective E-learning is a candidate tool for clinical practice guidelines (CPG) implementation due to its versatility, universal access and low costs. We aimed to assess the impact of a five-module e-learning course about CPG for acute gastroenteritis (AGE) on physicians' knowledge and clinical practice. Study design This work was conceived as a pre/post single-arm intervention study. Physicians from 11 European countries registered for the online course. Personal data, pre- and post-course questionnaires and clinical data about 3 to 5 children with AGE managed by each physician before and after the course were collected. Primary outcome measures included the proportion of participants fully adherent to CPG and number of patients managed with full adherence. Results Among the 149 physicians who signed up for the e-learning course, 59 took the course and reported on their case management of 519 children <5 years of age who were referred to their practice because of AGE (281 and 264 children seen before and after the course, respectively). The course improved knowledge scores (pre-course 8.6 +/- 2.7 versus post-course 12.8 +/- 2.1, P < 0.001), average adherence (from 87.0 +/- 7.7% to 90.6 +/- 7.1%, P = 0.001) and the number of patients managed in full adherence with the guidelines (from 33.6 +/- 31.7% to 43.9 +/- 36.1%, P = 0.037). Conclusions E-learning is effective in increasing knowledge and improving clinical practice in paediatric AGE and is an effective tool for implementing clinical practice guidelines.	[Nicastro, Emanuele; Lo Vecchio, Andrea; Liguoro, Ilaria; Guarino, Alfredo] Univ Naples Federico II, Dept Translat Med Sci, Sect Pediat, Naples, Italy; [Nicastro, Emanuele] Hosp Papa Giovanni XXIII, Paediat Hepatol Gastroenterol & Transplantat Unit, Bergamo, Italy; [Chmielewska, Anna] Med Univ Warsaw, Dept Pediat, Warsaw, Poland; [De Bruyn, Caroline] Vrije Univ Brussel, Univ Ziekenhuis Brussel Kinderen, Brussels, Belgium; [Dolinsek, Jernej] Univ Med Ctr, Maribor, Slovenia; [Doroshina, Elena; Zakharova, Irina] Russian Med Postgrad Acad, Moscow, Russia; [Fessatou, Smaragdi] Univ Athens, Dept Pediat 3, GR-10679 Athens, Greece; [Pop, Tudor Lucian] Univ Med & Pharm, Iuliu Ha Hatieganu, Pediat Clin 2, Cluj Napoca, Romania; [Prell, Christine] Univ Munich, Med Ctr, Dr von Hauner Childrens Hosp, Munich, Germany; [Tabbers, Merit Monique] Univ Amsterdam, Acad Med Ctr, Emmas Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; [Tavares, Marta] Hosp Sao Joao, Dept Pediat, Oporto, Portugal; [Urenden-Elicin, Pinar] Marmara Univ, Dept Pediat, Istanbul, Turkey; [Bruzzese, Dario] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy; [Sandhu, Bhupinder] Bristol Royal Hosp Children, Dept Paediat Gastroenterol, Bristol, Avon, England	University of Naples Federico II; ASST Papa Giovanni XXIII; Medical University of Warsaw; University Hospital Brussels; Vrije Universiteit Brussel; National & Kapodistrian University of Athens; Iuliu Hatieganu University of Medicine & Pharmacy; University of Munich; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Sao Joao Hospital; Marmara University; University of Naples Federico II; Bristol Royal Hospital For Children	Guarino, A (corresponding author), Univ Naples Federico II, Dept Translat Med Sci, Sect Pediat, Naples, Italy.	alfguari@unina.it	Fessatou, Smaragdi/AAH-1592-2021; Dolinsek, Jernej/ABB-4843-2021; Nicastro, Emanuele/AAJ-2274-2020; Guarino, Alfredo/AAC-4812-2022; Nicastro, Emanuele/K-1260-2018; Vecchio, Andrea Lo/AAC-6042-2022; Pop, Tudor Lucian/I-4155-2015; Liguoro, Ilaria/AAW-1038-2021	Guarino, Alfredo/0000-0003-0199-0336; Nicastro, Emanuele/0000-0002-4518-9375; Pop, Tudor Lucian/0000-0002-4931-1219; Tabbers, Merit/0000-0001-9744-7308; Lo Vecchio, Andrea/0000-0003-4181-6842; Bruzzese, Dario/0000-0001-9911-4646; Liguoro, Ilaria/0000-0002-9177-0400	United European Gastroenterology federation; "Monothematic Initiative" educational grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041041] Funding Source: NIH RePORTER	United European Gastroenterology federation; "Monothematic Initiative" educational grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The project was supported by the United European Gastroenterology federation with a "Monothematic Initiative" educational grant (2012-2014). This grant covered the expenses for the development of the educational material, the e-learning course, and the start-up meeting with international tutors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albano F, 2010, J PEDIATR-US, V156, P226, DOI 10.1016/j.jpeds.2009.07.065; Aparicio P, 2003, JEPHC, V1, P3; Asarbakhsh M, 2013, CLIN TEACH, V10, P47, DOI 10.1111/j.1743-498X.2012.00627.x; Balas EA, 1998, PEDIATR ANN, V27, P581, DOI 10.3928/0090-4481-19980901-11; Bruzzese E, 2013, CURR OPIN GASTROEN, V29, P23, DOI 10.1097/MOG.0b013e32835a352f; Doherty S, 2007, J PAEDIATR CHILD H, V43, P611, DOI 10.1111/j.1440-1754.2007.01151.x; Drug Safety Communication-FDA, 2011, MEDWATCH THE FDA SAF; Edmonds Marcia, 2009, Evid Based Med, V14, P44, DOI 10.1136/ebm.14.2.44; Fedorowicz Z, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005506.pub5; Freedman SB, 2013, J PEDIATR GASTR NUTR, V57, P612, DOI 10.1097/MPG.0b013e3182a1dd93; Freedman SB, 2011, PEDIATRICS, V127, pE287, DOI 10.1542/peds.2010-2214; Freedman Stephen B, 2010, Paediatr Drugs, V12, P405, DOI 10.2165/11537770-000000000-00000; Goldman RD, 2008, PEDIATRICS, V122, P545, DOI 10.1542/peds.2007-3141; Gordon M, 2011, ARCH DIS CHILD, V96, P1191, DOI 10.1136/archdischild-2011-300577; Guarino A, 2008, J PEDIATR GASTR NUTR, V46, pS81, DOI 10.1097/MPG.0b013e31816f7b16; Guarino A, 2012, J PEDIATR GASTR NUTR, V55, P621, DOI 10.1097/MPG.0b013e318272b5e2; Gutmann J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122624; Hansen MM, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1051; Jones O, 2010, BEST PRACT RES CL OB, V24, P731, DOI 10.1016/j.bpobgyn.2010.04.009; Kerfoot BP, 2014, CIRC-CARDIOVASC QUAL, V7, P468, DOI 10.1161/CIRCOUTCOMES.113.000814; Kerfoot BP, 2009, ANN SURG, V249, P744, DOI 10.1097/SLA.0b013e31819f6db8; Kind T, 2009, CURR OPIN PEDIATR, V21, P805, DOI 10.1097/MOP.0b013e328331e7b4; Kulier R, 2012, JAMA-J AM MED ASSOC, V308, P2218, DOI 10.1001/jama.2012.33640; Lannon CM, 2008, PEDIATRICS, V122, pE163, DOI 10.1542/peds.2007-2700; Lau F, 2004, J MED SYST, V28, P71, DOI 10.1023/B:JOMS.0000021522.30587.ff; Legido-Quigley H, 2012, HEALTH POLICY, V107, P146, DOI 10.1016/j.healthpol.2012.08.004; Lo Vecchio A, 2014, PEDIATR INFECT DIS J, V33, P1103, DOI 10.1097/INF.0000000000000396; Lo Vecchio A, 2011, J PEDIATR GASTR NUTR, V52, P183, DOI 10.1097/MPG.0b013e3181e233ac; Mangione-Smith R, 2007, NEW ENGL J MED, V357, P1515, DOI 10.1056/NEJMsa064637; McHugh SM, 2010, J CONTIN EDUC HEALTH, V30, P257, DOI 10.1002/chp.20091; Moule P, 2008, INT J NURS PRACT, V14, P427, DOI 10.1111/j.1440-172X.2008.00716.x; O'Leary FM, 2012, J PAEDIATR CHILD H, V48, P529, DOI 10.1111/j.1440-1754.2011.02250.x; O'Leary FM, 2010, EMERG MED AUSTRALAS, V22, P324, DOI 10.1111/j.1742-6723.2010.01302.x; Ogilvie I, 2011, HUM VACCINES, V7, P523, DOI 10.4161/hv.7.5.14819; Pathak D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-32; Powell Colin V E, 2003, Paediatr Respir Rev, V4, P340, DOI 10.1016/S1526-0542(03)00092-7; Prior M, 2008, J EVAL CLIN PRACT, V14, P888, DOI 10.1111/j.1365-2753.2008.01014.x; Sanchez-Gonzalez P, 2013, J SURG RES, V182, P21, DOI 10.1016/j.jss.2012.07.047; Schroter S, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-35; Tieder JS, 2009, PEDIATRICS, V124, pE1081, DOI 10.1542/peds.2009-0473	40	23	23	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132213	10.1371/journal.pone.0132213	http://dx.doi.org/10.1371/journal.pone.0132213			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148301	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600220
J	Nossol, C; Barta-Boszormenyi, A; Kahlert, S; Zuschratter, W; Faber-Zuschratter, H; Reinhardt, N; Ponsuksili, S; Wimmers, K; Diesing, AK; Rothkotter, HJ				Nossol, Constanze; Barta-Boeszoermenyi, Anico; Kahlert, Stefan; Zuschratter, Werner; Faber-Zuschratter, Heidi; Reinhardt, Nicole; Ponsuksili, Siriluk; Wimmers, Klaus; Diesing, Anne-Kathrin; Rothkoetter, Hermann-Josef			Comparing Two Intestinal Porcine Epithelial Cell Lines (IPECs): Morphological Differentiation, Function and Metabolism	PLOS ONE			English	Article							IN-VITRO; EXPRESSION; CACO-2; P53; CULTURE; GROWTH; BCL-2	The pig shows genetical and physiological resemblance to human, which predestines it as an experimental animal model especially for mucosal physiology. Therefore, the intestinal epithelial cell lines 1 and J2 (IPEC-1, IPEC-J2) - spontaneously immortalised cell lines from the porcine intestine - are important tools for studying intestinal function. A microarray (Gene-Chip Porcine Genome Array) was performed to compare the genome wide gene expression of IPECs. Different significantly up-regulated pathways were identified, like "lysosome", "pathways in cancer", "regulation of actin cytoskeleton" and "oxidative phosphorylation" in IPEC-J2 in comparison to IPEC-1. On the other hand, "spliceosome", "ribosome", "RNA-degradation" and "tight junction" are significantly down-regulated pathways in IPEC-J2 in comparison to IPEC-1. Examined pathways were followed up by functional analyses. ATP-, oxygen, glucose and lactate-measurement provide evidence for up-regulation of oxidative phosphorylation in IPEC-J2. These cells seem to be more active in their metabolism than IPEC-1 cells due to a significant higher ATP-content as well as a higher O-2-and glucose-consumption. The down-regulated pathway "ribosome" was followed up by measurement of RNA-and protein content. In summary, IPEC-J2 is a morphologically and functionally more differentiated cell line in comparison to IPEC-1. In addition, IPEC-J2 cells are a preferential tool for in vitro studies with the focus on metabolism.	[Nossol, Constanze; Barta-Boeszoermenyi, Anico; Kahlert, Stefan; Faber-Zuschratter, Heidi; Reinhardt, Nicole; Diesing, Anne-Kathrin; Rothkoetter, Hermann-Josef] Univ Magdeburg, Inst Anat, D-39120 Magdeburg, Germany; [Zuschratter, Werner] Leibniz Inst Neurobiol, D-39120 Magdeburg, Germany; [Ponsuksili, Siriluk; Wimmers, Klaus] Leibniz Inst Farm Anim Biol FBN Dummerstorf, D-18196 Dummerstorf, Germany	Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN); Forschungsinstitut fur Nutztierbiologie (FBN)	Nossol, C (corresponding author), Univ Magdeburg, Inst Anat, D-39120 Magdeburg, Germany.	constanze.nossol@med.ovgu.de	Wimmers, Klaus/AAF-9434-2020	Wimmers, Klaus/0000-0002-9523-6790	German Research Council, DFG [Ro 743/3-3]	German Research Council, DFG(German Research Foundation (DFG))	The study was supported by the German Research Council, DFG Ro 743/3-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARGOU RC, 1995, INT J CANCER, V60, P854, DOI 10.1002/ijc.2910600622; Basora N, 1998, INT J CANCER, V75, P738, DOI 10.1002/(SICI)1097-0215(19980302)75:5<738::AID-IJC12>3.0.CO;2-2; Berschneider H., 1989, ANN M AM GASTROENTER; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brown JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009406; Cerda SR, 2001, GASTROENTEROLOGY, V120, P1700, DOI 10.1053/gast.2001.24843; CHANTRET I, 1994, J CELL SCI, V107, P213; CHANTRET I, 1988, CANCER RES, V48, P1936; COX LS, 1995, BIOESSAYS, V17, P501, DOI 10.1002/bies.950170606; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diesing AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034136; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; GonzalezVallina R, 1996, AM J PHYSIOL-GASTR L, V271, pG249, DOI 10.1152/ajpgi.1996.271.2.G249; Hidalgo IJ, 1996, ADV DRUG DELIVER REV, V22, P53, DOI 10.1016/S0169-409X(96)00414-0; Jiang P, 2006, MOL CELL BIOL, V26, P9071, DOI 10.1128/MCB.01025-06; Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103; Litten-Brown JC, 2010, ANIMAL, V4, P899, DOI 10.1017/S1751731110000200; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; MACPHERSON I, 1964, VIROLOGY, V23, P291, DOI 10.1016/0042-6822(64)90301-0; Matter K, 2003, METHODS, V30, P228, DOI 10.1016/S1046-2023(03)00029-X; MIYASHITA T, 1994, ONCOGENE, V9, P1799; MOOSEKER MS, 1983, CELL, V35, P11, DOI 10.1016/0092-8674(83)90202-7; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Nossol C, 2011, HISTOCHEM CELL BIOL, V136, P103, DOI 10.1007/s00418-011-0826-y; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Sargeant HR, 2010, LIVEST SCI, V133, P45, DOI 10.1016/j.livsci.2010.06.021; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Steube KG, 2012, CYTOTECHNOLOGY, V64, P373, DOI 10.1007/s10616-011-9420-3; Sureshkumar GK, 1991, BIOTECHNOL BIOENG, V55, P328; Zagari F, 2013, NEW BIOTECHNOL, V30, P238, DOI 10.1016/j.nbt.2012.05.021	31	37	37	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132323	10.1371/journal.pone.0132323	http://dx.doi.org/10.1371/journal.pone.0132323			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147118	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600241
J	Oka, H; Matsudaira, K; Fujii, T; Okazaki, H; Shinkai, Y; Tsuji, Y; Tanaka, S; Kato, R				Oka, Hiroyuki; Matsudaira, Ko; Fujii, Tomoko; Okazaki, Hiroshi; Shinkai, Yukari; Tsuji, Yutaka; Tanaka, Sakae; Kato, Ryuichi			Risk Factors for Prolonged Treatment of Whiplash-Associated Disorders	PLOS ONE			English	Article							FUNCTIONAL SOMATIC SYNDROMES; FOLLOW-UP; NECK PAIN; RECOVERY; INJURY; EXPECTATIONS; POPULATION; COLLISION; SYMPTOMS	Objectives Whiplash-associated disorders (WAD) are the most common injuries that are associated with car collisions in Japan and many Western countries. However, there is no clear evidence regarding the potential risk factors for poor recovery from WAD. Therefore, we used an online survey of the Japanese population to examine the association between potential risk factors and the persistence of symptoms in individuals with WAD. Materials and Methods An online survey was completed by 127,956 participants, including 4,164 participants who had been involved in a traffic collision. A random sample of the collision participants (n = 1,698) were provided with a secondary questionnaire. From among the 974 (57.4%) respondents to the secondary questionnaire, we selected 183 cases (intractable neck pain that was treated over a period of 6 months) and 333 controls (minor neck pain that was treated within 3 months). Multivariable logistic regression analysis was used to evaluate the potential risk factors for prolonged treatment of WAD. Results Female sex, the severity of the collision, poor expectations of recovery, victim mentality, dizziness, numbness or pain in the arms, and lower back pain were associated with a poor recovery from WAD. Conclusions In the present study, the baseline symptoms (dizziness, numbness or pain in the arms, and lower back pain) had the strongest associations with prolonged treatment for WAD, although the psychological and behavioral factors were also important. These risk factors should be considered when evaluating patients who may have the potential for poor outcomes.	[Oka, Hiroyuki; Matsudaira, Ko] Univ Tokyo, Dept Med Res & Management Musculoskeletal Pain, 22nd Century Med & Res Ctr, Fac Med, Tokyo 113, Japan; [Fujii, Tomoko; Okazaki, Hiroshi] Kanto Rosai Hosp, Hlth & Welf Org, Japan Labour, Dept Orthopaed Surg, Kawasaki, Kanagawa, Japan; [Shinkai, Yukari; Tsuji, Yutaka; Kato, Ryuichi] JA Kyosai Res Inst, Med Res Ctr, Tokyo, Japan; [Tanaka, Sakae] Univ Tokyo, Dept Orthopaed Surg, Tokyo 113, Japan	University of Tokyo; University of Tokyo	Oka, H (corresponding author), Univ Tokyo, Dept Med Res & Management Musculoskeletal Pain, 22nd Century Med & Res Ctr, Fac Med, Tokyo 113, Japan.	okah-tky@umin.ac.jp	Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414	JA Kyosai Research Institute	JA Kyosai Research Institute	The authors received no specific funding for this work. Co-authors YS, YT and RK are employed by JA Kyosai Research Institute. JA Kyosai Research Institute provided support in the form of salaries for authors YS, YT and RK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2007, JAPAN S POPULATION C; Barsky AJ, 1999, ANN INTERN MED, V130, P910, DOI 10.7326/0003-4819-130-11-199906010-00016; Berglund A, 2001, J CLIN EPIDEMIOL, V54, P851, DOI 10.1016/S0895-4356(00)00369-3; Black J.T, 1992, MULTIVARIATE DATA AN; Bohman T, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-264; Carroll LJ, 2011, SPINE, V36, pS250, DOI 10.1097/BRS.0b013e31823881a4; Cassidy JD, 2000, NEW ENGL J MED, V342, P1179, DOI 10.1056/NEJM200004203421606; Crutebo S, 2010, J RHEUMATOL, V37, P1527, DOI 10.3899/jrheum.091321; De Gucht V, 2003, STRESS HEALTH, V19, P195, DOI 10.1002/smi.975; Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94; Hair F., 1995, MULTIVARIATE DATA AN, V4th; Miettinen T, 2002, CLIN EXP RHEUMATOL, V20, P399; Ozegovic D, 2010, SPINE, V35, pE708, DOI 10.1097/BRS.0b013e3181d12432; Ozegovic D, 2010, J REHABIL MED, V42, P66, DOI 10.2340/16501977-0466; RADANOV BP, 1993, BRIT MED J, V307, P652, DOI 10.1136/bmj.307.6905.652; Radanov BP, 1996, PAIN, V64, P429, DOI 10.1016/0304-3959(95)00148-4; Scott D, 2005, CLIN J PAIN, V21, P175, DOI 10.1097/00002508-200503000-00009; Treleaven J, 2011, SPINE, V36, pS211, DOI 10.1097/BRS.0b013e3182387f78; Walton DM, 2013, J ORTHOP SPORT PHYS, V43, P31, DOI 10.2519/jospt.2013.4507; WHO, 2012, ICD 10 CLASS MENT BE; Wiles NJ, 2005, J RHEUMATOL, V32, P1576; Yayama T, 2012, SEIKEGEKA, V63, P797	22	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132191	10.1371/journal.pone.0132191	http://dx.doi.org/10.1371/journal.pone.0132191			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147998	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600216
J	Rojas, E; Hoyos, J; Oldfield, NJ; Lee, P; Flint, M; Jones, CH; Ala'Aldeen, DAA; Jansen, KU; Anderson, AS				Rojas, Eduardo; Hoyos, Johanna; Oldfield, Neil J.; Lee, Philip; Flint, Mike; Jones, C. Hal; Ala'Aldeen, Dlawer A. A.; Jansen, Kathrin U.; Anderson, Annaliesa S.			Optimization of Molecular Approaches to Genogroup Neisseria meningitidis Carriage Isolates and Implications for Monitoring the Impact of New Serogroup B Vaccines	PLOS ONE			English	Article							REAL-TIME PCR; H-BINDING-PROTEIN; INVASIVE MENINGOCOCCAL DISEASE; CAPSULE NULL LOCUS; HERD-IMMUNITY; BACTERIAL-MENINGITIS; BURKINA-FASO; STRAINS; IDENTIFICATION; DIVERSITY	The reservoir for Neisseria meningitidis (Nm) is the human oropharynx. Implementation of Nm serogroup C (NmC) glycoconjugate vaccines directly reduced NmC carriage. Prophylactic vaccines are now available to prevent disease caused by the five major Nm disease causing serogroups (ABCWY). Nm serogroup B (NmB) vaccines are composed of antigens that are conserved across Nm serogroups and therefore have the potential to impact all Nm carriage. To assess the effect of these vaccines on carriage, standardized approaches to identify and group Nm are required. Real-time PCR (rt-PCR) capsule grouping assays that were internally controlled to confirm Nm species were developed for eight serogroups associated with carriage (A, B, C, E, W, X, Y and Z). The grouping scheme was validated using diverse bacterial species associated with carriage and then used to evaluate a collection of diverse Nm carriage isolates (n=234). A scheme that also included porA and ctrA probes was able to speciate the isolates, while ctrA also provided insights on the integrity of the polysaccharide loci. Isolates were typed for the Nm vaccine antigen factor H binding protein (fHbp), and were found to represent the known diversity of this antigen. The porA rt-PCR yielded positive results with all 234 of the Nm carriage isolates. Genogrouping assays classified 76.5% (179/234) of these isolates to a group, categorized 53 as nongenogroupable (NGG) and two as mixed results. Thirty seven NGG isolates evidenced a disrupted capsular polysaccharide operon judged by a ctrA negative result. Only 28.6% (67/234) of the isolates were serogrouped by slide agglutination (SASG), highlighting the reduced capability of carriage strains to express capsular polysaccharide. These rt-PCR assays provide a comprehensive means to identify and genogroup N. meningitidis in carriage studies used to guide vaccination strategies and to assess the impact of novel fHbp containing vaccines on meningococcal carriage.	[Rojas, Eduardo; Hoyos, Johanna; Lee, Philip; Flint, Mike; Jones, C. Hal; Jansen, Kathrin U.; Anderson, Annaliesa S.] Pfizer Inc, Vaccine Res & Dev, Pearl River, NY 10965 USA; [Oldfield, Neil J.; Ala'Aldeen, Dlawer A. A.] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England	Pfizer; University of Nottingham	Anderson, AS (corresponding author), Pfizer Inc, Vaccine Res & Dev, Pearl River, NY 10965 USA.	annaliesa.anderson@pfizer.com	Flint, Mike/L-8355-2019; Oldfield, Neil J/C-2599-2009	Oldfield, Neil J/0000-0001-7423-8378; Flint, Michael/0000-0002-5373-787X	Pfizer Inc.	Pfizer Inc.(Pfizer)	This work was funded by Pfizer Inc. ER, JH, PL, MF, CHJ, KUJ and ASA are or were employed by Pfizer during this work and may own stock in the company. The funder provided support in the form of salaries for authors ER, JH, PL, MF, CHJ, KUJ, ASA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Ala'Aldeen DAA, 2000, J CLIN MICROBIOL, V38, P2311; Anderson AS, 2011, EXPERT REV VACCINES, V10, P617, DOI [10.1586/ERV.11.50, 10.1586/erv.11.50]; Baethgen LF, 2003, J MED MICROBIOL, V52, P793, DOI 10.1099/jmm.0.05192-0; Beddek AJ, 2009, INFECT IMMUN, V77, P2989, DOI 10.1128/IAI.00181-09; Bennett DE, 2006, J CLIN MICROBIOL, V44, P1127, DOI 10.1128/JCM.44.3.1127-1131.2006; Bennett DE, 2004, J CLIN MICROBIOL, V42, P1764, DOI 10.1128/JCM.42.4.1764-1765.2004; Cavrini F, 2010, J CLIN MICROBIOL, V48, P3016, DOI 10.1128/JCM.00103-10; Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Diggle MA, 2006, EXPERT REV MOL DIAGN, V6, P79, DOI 10.1586/14737159.6.1.79; Dolan-Livengood JM, 2003, J INFECT DIS, V187, P1616, DOI 10.1086/374740; Findlow H, 2007, J INFECT DIS, V195, P1071, DOI 10.1086/512084; FINNE J, 1983, LANCET, V2, P355; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Fraisier C, 2009, J CLIN MICROBIOL, V47, P2662, DOI 10.1128/JCM.02415-08; Frosch M., 2006, HDB MENINGOCOCCAL DI, P145, DOI DOI 10.1002/3527608508.CH8; Gasparini R, 2012, J Prev Med Hyg, V53, P50; Gasparini R, 2014, J CLIN MICROBIOL, V52, P1901, DOI 10.1128/JCM.03584-13; Guiver M, 2000, FEMS IMMUNOL MED MIC, V28, P173, DOI 10.1111/j.1574-695X.2000.tb01473.x; Hammerschmidt S, 1996, MOL MICROBIOL, V20, P1211, DOI 10.1111/j.1365-2958.1996.tb02641.x; Harris SL, 2011, HUM VACCINES, V7, P68, DOI 10.4161/hv.7.0.14564; Harrison LH, 2006, J INFECT DIS, V193, P1266, DOI 10.1086/501371; Harrison OB, 2013, EMERG INFECT DIS, V19, P566, DOI 10.3201/eid1904.111799; Hoang LMN, 2005, CLIN INFECT DIS, V40, pE38, DOI 10.1086/427875; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; Jaton K, 2010, J CLIN MICROBIOL, V48, P4590, DOI 10.1128/JCM.01766-10; Jeppesen CA, 2015, J INFECT; Jiang HQ, 2010, VACCINE, V28, P6086, DOI 10.1016/j.vaccine.2010.06.083; Jordens JZ, 2005, J MED MICROBIOL, V54, P463, DOI 10.1099/jmm.0.45847-0; Khatami A, 2010, EXPERT REV VACCINES, V9, P285, DOI 10.1586/ERV.10.3; Kristiansen PA, 2013, CLIN INFECT DIS, V56, P354, DOI 10.1093/cid/cis892; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Marri PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011835; Marsh JW, 2011, VACCINE, V29, P6049, DOI 10.1016/j.vaccine.2011.06.025; Mothershed EA, 2004, J CLIN MICROBIOL, V42, P320, DOI 10.1128/JCM.42.1.320-328.2004; Mueller JE, 2006, J INFECT DIS, V193, P812, DOI 10.1086/500511; Murphy E, 2009, J INFECT DIS, V200, P379, DOI 10.1086/600141; Read RC, 2014, CLIN MICROBIOL INFEC, V20, P391, DOI 10.1111/1469-0691.12647; Read RC, 2014, LANCET, V384, P2123, DOI 10.1016/S0140-6736(14)60842-4; Richmond PC, 2012, LANCET INFECT DIS, V12, P597, DOI 10.1016/S1473-3099(12)70087-7; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Snyder LAS, 2005, PLASMID, V54, P191, DOI 10.1016/j.plasmid.2005.04.005; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000; Thomas JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019361; TOMMASSEN J, 1990, INFECT IMMUN, V58, P1355, DOI 10.1128/IAI.58.5.1355-1359.1990; Trotter CL, 2009, EXPERT REV VACCINES, V8, P851, DOI [10.1586/erv.09.48, 10.1586/ERV.09.48]; Tzanakaki G, 2003, FEMS IMMUNOL MED MIC, V39, P31, DOI 10.1016/S0928-8244(03)00175-5; Van der Ende A, 1999, INFECT IMMUN, V67, P2928, DOI 10.1128/IAI.67.6.2928-2934.1999; Wang X, 2012, J CLIN MICROBIOL, V50, P702, DOI 10.1128/JCM.06087-11; Weinstock G, 2010, N SUBFLAVA; Whiley David M, 2003, Mol Diagn, V7, P141, DOI 10.2165/00066982-200307030-00001; Yazdankhah SP, 2004, J MED MICROBIOL, V53, P821, DOI 10.1099/jmm.0.45529-0; Zhu HF, 2012, J CLIN MICROBIOL, V50, P46, DOI 10.1128/JCM.00918-11; Zlotnick GW, 2015, HUM VACC IMMUNOTHER, V11, P5, DOI 10.4161/hv.34293	56	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132140	10.1371/journal.pone.0132140	http://dx.doi.org/10.1371/journal.pone.0132140			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147212	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600206
J	Saad, MN; Mabrouk, MS; Eldeib, AM; Shaker, OG				Saad, Mohamed N.; Mabrouk, Mai S.; Eldeib, Ayman M.; Shaker, Olfat G.			Genetic Case-Control Study for Eight Polymorphisms Associated with Rheumatoid Arthritis	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; TRANSFORMING GROWTH-FACTOR-BETA-1 T869C; MTHFR GENE; INTEGRATED WORKBENCH; A1298C POLYMORPHISM; RISK-FACTOR; DISEASE; OSTEOPOROSIS; SUSCEPTIBILITY	Rheumatoid arthritis (RA) is an autoimmune disease which has a significant socio-economic impact. The aim of the current study was to investigate eight candidate RA susceptibility loci to identify the associated variants in Egyptian population. Eight single nucleotide polymorphisms (SNPs) (MTHFR-C677T and A1298C, TGF beta 1 T869C, TNFB A252G, and VDR-ApaI, BsmI, FokI, and TaqI) were tested by genotyping patients with RA (n = 105) and unrelated controls (n = 80). Associations were tested using multiplicative, dominant, recessive, and co-dominant models. Also, the linkage disequilibrium (LD) between the VDR SNPs was measured to detect any indirect association. By comparing RA patients with controls (TNFB, BsmI, and TaqI), SNPs were associated with RA using all models. MTHFR C677T was associated with RA using all models except the recessive model. TGF beta 1 and MTHFR A1298C were associated with RA using the dominant and the co-dominant models. The recessive model represented the association for ApaI variant. There were no significant differences for FokI and the presence of RA disease by the used models examination. For LD results, There was a high D' value between BsmI and FokI (D' = 0.91), but the r(2) value between them was poor. All the studied SNPs may contribute to the susceptibility of RA disease in Egyptian population except for FokI SNP.	[Saad, Mohamed N.] Menia Univ, Dept Biomed Engn, Al Minya, Egypt; [Mabrouk, Mai S.] Misr Univ Sci & Technol, Dept Biomed Engn, 6th Of October City, Egypt; [Eldeib, Ayman M.] Cairo Univ, Fac Engn, Syst & Biomed Engn Dept, Giza, Egypt; [Shaker, Olfat G.] Cairo Univ, Fac Med, Med Biochem & Mol Biol Dept, Giza, Egypt	Egyptian Knowledge Bank (EKB); Minia University; Egyptian Knowledge Bank (EKB); Misr University for Science & Technology; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Saad, MN (corresponding author), Menia Univ, Dept Biomed Engn, Al Minya, Egypt.	m.n.saad@ieee.org	Saad, Mohamed Nagy/AAF-7628-2019; O, Shaker/Y-6125-2019; Shaker, Olfat G/S-2010-2017; Issa, Randa @M.T/E-7144-2019	Saad, Mohamed Nagy/0000-0001-8229-0280; O, Shaker/0000-0002-3031-3599; Issa, Randa @M.T/0000-0003-0619-1234				Al-Rayes H, 2011, CLIN MED INSIGHTS-AR, V4, P55, DOI 10.4137/CMAMD.S6941; Alayli G, 2009, JOINT BONE SPINE, V76, P20, DOI 10.1016/j.jbspin.2008.02.012; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Ates O, 2011, TURK J RHEUMATOL, V26, P145, DOI 10.5152/tjr.2011.021; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berkun Y, 2004, ANN RHEUM DIS, V63, P1227, DOI 10.1136/ard.2003.016337; Chang WW, 2010, RHEUMATOLOGY, V49, P652, DOI 10.1093/rheumatology/kep417; Chatzikyriakidou A, 2013, SEMIN ARTHRITIS RHEU, V43, P29, DOI 10.1016/j.semarthrit.2012.12.003; Farouk HM, 2009, BRAZ J MED BIOL RES, V42, P831, DOI 10.1590/S0100-879X2009000900010; Munoz-Valle JF, 2012, RHEUMATOL INT, V32, P367, DOI 10.1007/s00296-010-1624-x; Garcia-Lozano JR, 2001, EUR J IMMUNOGENET, V28, P89, DOI 10.1046/j.1365-2370.2001.00233.x; Goertz B, 2003, CLIN EXP RHEUMATOL, V21, P333; Hitchon CA, 2012, J RHEUMATOL, V39, P1792, DOI 10.3899/jrheum.120387; Hughes LB, 2006, ANN RHEUM DIS, V65, P1213, DOI 10.1136/ard.2005.046797; Hussein YM, 2014, GENE, V536, P393, DOI 10.1016/j.gene.2013.11.042; Hussien YM, 2013, MOL BIOL REP, V40, P3675, DOI 10.1007/s11033-012-2443-9; Inanir A, 2013, IMMUNOL LETT, V152, P104, DOI 10.1016/j.imlet.2013.05.004; KARRAY EF, 2011, J INFECT DIS IMMUN, V3, P30; Karray EF, 2012, JOINT BONE SPINE, V79, P144, DOI 10.1016/j.jbspin.2011.06.003; Kim SY, 2004, SCAND J RHEUMATOL, V33, P389, DOI 10.1080/03009740410010344; Kobayashi T, 2009, J PERIODONTOL, V80, P792, DOI 10.1902/jop.2009.080573; Laird NM, 2010, FUNDAMENTALS MODERN, P99; Lee CK, 2001, J KOREAN MED SCI, V16, P188, DOI 10.3346/jkms.2001.16.2.188; Lee YH, 2010, CLIN DRUG INVEST, V30, P101, DOI 10.2165/11531070-000000000-00000; Brambila-Tapia AJL, 2012, DIS MARKERS, V32, P109, DOI [10.1155/2012/364894, 10.3233/DMA-2011-0868]; Lewis Cathryn M, 2012, Cold Spring Harb Protoc, V2012, P297, DOI 10.1101/pdb.top068163; Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146; Li N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092272; Maalej A, 2005, GENES IMMUN, V6, P707, DOI 10.1038/sj.gene.6364260; Manni F, 2002, HUM BIOL, V74, P645, DOI 10.1353/hub.2002.0054; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Menegatti E, 2009, DIS MARKERS, V27, P217, DOI [10.1155/2009/435108, 10.3233/DMA-2009-0666]; Mosaad YM, 2014, HUM IMMUNOL, V75, P452, DOI 10.1016/j.humimm.2014.02.009; Mostowska A, 2013, MOL BIOL REP, V40, P803, DOI 10.1007/s11033-012-2118-6; Newton JL, 2004, GENES IMMUN, V5, P151, DOI 10.1038/sj.gene.6364045; Palomino-Morales R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2989; Panoulas VF, 2008, ANN RHEUM DIS, V67, P1550, DOI 10.1136/ard.2007.082594; Panoulas VF, 2009, RHEUMATOLOGY, V48, P113, DOI 10.1093/rheumatology/ken443; Pokorny V, 2003, ANN RHEUM DIS, V62, P907, DOI 10.1136/ard.62.9.907; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rass P, 2006, RHEUMATOL INT, V26, P964, DOI 10.1007/s00296-006-0106-7; Rubini M, 2008, CLIN EXP RHEUMATOL, V26, P163; Saad MN, 2016, J ADV RES, V7, P1, DOI 10.1016/j.jare.2015.01.008; Saad MN, 2015, GENE, V568, P124, DOI 10.1016/j.gene.2015.05.037; Saad MN, 2014, CAIRO INT BIOM ENG, P75, DOI 10.1109/CIBEC.2014.7020919; Santos MJ, 2011, J RHEUMATOL, V38, P1244, DOI 10.3899/jrheum.101170; Smriti Shukla, 2014, Advances in Genomics and Genetics, V4, P79; Steiner G, 1999, RHEUMATOLOGY, V38, P202, DOI 10.1093/rheumatology/38.3.202; Sugiura Y, 2002, ANN RHEUM DIS, V61, P826, DOI 10.1136/ard.61.9.826; Takeuchi F, 2005, CLIN EXP RHEUMATOL, V23, P494; Tizaoui K, 2014, CELL IMMUNOL, V290, P66, DOI 10.1016/j.cellimm.2014.05.002; Uitterlinden AG, 2004, J STEROID BIOCHEM, V89-90, P187, DOI 10.1016/j.jsbmb.2004.03.083; Valdivielso JM, 2006, CLIN CHIM ACTA, V371, P1, DOI 10.1016/j.cca.2006.02.016; VANDEVYVER C, 1994, EUR J IMMUNOGENET, V21, P377, DOI 10.1111/j.1744-313X.1994.tb00208.x; Vinasco J, 1997, TISSUE ANTIGENS, V49, P74, DOI 10.1111/j.1399-0039.1997.tb02715.x; Wang Y, 2007, CHIN J PUBLIC HLTH, V23, P1405; Yoo JH, 2005, NUCLEIC ACIDS RES, V33, pW483, DOI 10.1093/nar/gki428; Yoo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-290; Zake LN, 2002, HUM IMMUNOL, V63, P418, DOI 10.1016/S0198-8859(02)00385-3; Zhang L, 2013, MOL BIOL REP, V40, P4811, DOI 10.1007/s11033-013-2577-4; Zhou TB, 2014, J RECEPT SIG TRANSD, V34, P469, DOI 10.3109/10799893.2014.919594; Zhu Y, 2006, JIANGSU MED J, V12, P1112	62	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131960	10.1371/journal.pone.0131960	http://dx.doi.org/10.1371/journal.pone.0131960			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147289	Green Submitted, gold, Green Published			2022-12-27	WOS:000358157600171
J	Sajo, IE; Kovacs, J; Fitzsimmons, KE; Jager, V; Lengyel, G; Viola, B; Talamo, S; Hublin, JJ				Sajo, Istvan E.; Kovacs, Janos; Fitzsimmons, Kathryn E.; Jager, Viktor; Lengyel, Gyoergy; Viola, Bence; Talamo, Sahra; Hublin, Jean-Jacques			Core-Shell Processing of Natural Pigment: Upper Palaeolithic Red Ochre from Lovas, Hungary	PLOS ONE			English	Article							IRON-OXIDE COATINGS; MIDDLE STONE-AGE; GEOCHEMICAL CHARACTERIZATION; COLLAGEN EXTRACTION; UPPER PLEISTOCENE; EASTERN-EUROPE; LOESS; CAVE; BONE; ENVIRONMENTS	Ochre is the common archaeological term for prehistoric pigments. It is applied to a range of uses, from ritual burials to cave art to medications. While a substantial number of Palaeolithic paint mining pits have been identified across Europe, the link between ochre use and provenance, and their antiquity, has never yet been identified. Here we characterise the mineralogical signature of core-shell processed ochre from the Palaeolithic paint mining pits near Lovas in Hungary, using a novel integration of petrographic and mineralogical techniques. We present the first evidence for core-shell processed, natural pigment that was prepared by prehistoric people from hematitic red ochre. This involved combining the darker red outer shell with the less intensely coloured core to efficiently produce an economical, yet still strongly coloured, paint. We demonstrate the antiquity of the site as having operated between 14-13 kcal BP, during the Epigravettian period. This is based on new radiocarbon dating of bone artefacts associated with the quarry site. The dating results indicate the site to be the oldest known evidence for core-shell pigment processing. We show that the ochre mined at Lovas was exported from the site based on its characteristic signature at other archaeological sites in the region. Our discovery not only provides a methodological framework for future characterisation of ochre pigments, but also provides the earliest known evidence for "value-adding" of products for trade.	[Sajo, Istvan E.; Kovacs, Janos; Jager, Viktor] Univ Pecs, Environm Analyt & Geoanalyt Res Grp, Szentagothai Res Ctr, Pecs, Hungary; [Kovacs, Janos; Jager, Viktor] Univ Pecs, Dept Geol & Meteorol, Pecs, Hungary; [Fitzsimmons, Kathryn E.; Viola, Bence; Talamo, Sahra; Hublin, Jean-Jacques] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Lengyel, Gyoergy] Univ Miskolc, Hist Inst, Dept Prehist & Archaeol, Miskolc, Hungary; [Viola, Bence] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany	University of Pecs; University of Pecs; Max Planck Society; University of Miskolc; Max Planck Society	Kovacs, J (corresponding author), Univ Pecs, Environm Analyt & Geoanalyt Res Grp, Szentagothai Res Ctr, Pecs, Hungary.	jones@gamma.ttk.pte.hu; kathryn_fitzsimmons@eva.mpg.de	Lengyel, György/J-5604-2016; Kovács, János/A-8807-2010; Talamo, Sahra/AAD-1774-2022; Fitzsimmons, Kathryn/U-3565-2018; Sajó, István/M-8973-2018	Lengyel, György/0000-0002-7803-3043; Kovács, János/0000-0001-7742-5515; Talamo, Sahra/0000-0002-2406-3132; Fitzsimmons, Kathryn/0000-0002-9337-0793; Sajó, István/0000-0002-1228-1407; Viola, Bence/0000-0001-8052-707X	EU-funded Hungarian Social Renewal Operational Programme [SROP-4.2.2. A-11/1/KONV-2012-0065]; Max Planck Society	EU-funded Hungarian Social Renewal Operational Programme; Max Planck Society(Max Planck Society)	The mineralogical analyses were funded by the EU-funded Hungarian Social Renewal Operational Programme Grant SROP-4.2.2. A-11/1/KONV-2012-0065, "Synthesis of supramolecular systems, examination of their physicochemical properties and their utilisation for separation and sensor chemistry". The radiocarbon dating component of the research was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NM, 2012, PROG ORG COAT, V73, P76, DOI 10.1016/j.porgcoat.2011.09.003; Ahmed NM, 2010, PIGM RESIN TECHNOL, V39, P15, DOI 10.1108/03699421011009555; Allsworth-Jones P., 1986, SZELETIAN TRANSITION; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Bahn Paul G, 2012, CAVE ART GUIDE DECOR; Barnett JR, 2006, OPT LASER TECHNOL, V38, P445, DOI 10.1016/j.optlastec.2005.06.005; Bartosiewicz L, 2005, HOOVES HORNS MOLLUSC, P339; Brock F, 2007, RADIOCARBON, V49, P187, DOI 10.1017/S0033822200042107; BROWN TA, 1988, RADIOCARBON, V30, P171, DOI 10.1017/S0033822200044118; Budai T, 1999, BUDAPEST GEOLOGICAL; Buggle B, 2009, QUATERN INT, V196, P86, DOI 10.1016/j.quaint.2008.07.013; Burdukiewicz JM, 2011, QUATERN INT, V242, P302, DOI 10.1016/j.quaint.2011.02.013; Carney RP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1338; Cornell R. M., 2006, IRON OXIDES STRUCTUR; Cserny T., 2003, ACTA GEOLOGICA HUNGA, V46, P215, DOI [DOI 10.1556/AGE0L.46.2003.2.8, DOI 10.1556/AGE01.46.2003.2.8]; d'Errico F, 2010, J ARCHAEOL SCI, V37, P3099, DOI 10.1016/j.jas.2010.07.011; de Faria DLA, 2007, VIB SPECTROSC, V45, P117, DOI 10.1016/j.vibspec.2007.07.003; Dobosi V., 1979, FOLIA ARCH BUD, V30, P7; Dobosi VT, 2006, STONE AGE MINING AGE, V19, P29; Dove P.M., 1994, SILICA PHYS BEHAV GE, V29, P1; Eerkens JW, 2014, ARCHAEOL ANTHROP SCI, V6, P241, DOI 10.1007/s12520-013-0151-6; Eiselt BS, 2011, J ARCHAEOL SCI, V38, P3019, DOI 10.1016/j.jas.2011.06.030; Erlandson JM, 1999, AM ANTIQUITY, V64, P517, DOI 10.2307/2694149; Feurdean A, 2014, QUATERNARY SCI REV, V106, P206, DOI 10.1016/j.quascirev.2014.06.003; Fitzsimmons KE, 2012, QUATERNARY SCI REV, V41, P104, DOI 10.1016/j.quascirev.2012.03.002; Frechen M, 1997, QUATERNARY RES, V48, P291, DOI 10.1006/qres.1997.1929; Fuchs M, 2008, BOREAS, V37, P66, DOI 10.1111/j.1502-3885.2007.00012.x; Gaborine-Csank V., 1993, JANKOVICHIEN CIVILIS, P198; Gialanella S, 2011, ARCHAEOMETRY, V53, P950, DOI 10.1111/j.1475-4754.2011.00594.x; Gyori O, 2014, GEOFLUIDS, V14, P459, DOI 10.1111/gfl.12088; Haas J, 1999, GEOL CARPATH, V50, P459; Haas J, 2012, PALAEOGEOGR PALAEOCL, V353, P31, DOI 10.1016/j.palaeo.2012.06.031; Haase D, 2007, QUATERNARY SCI REV, V26, P1301, DOI 10.1016/j.quascirev.2007.02.003; Harzhauser M, 2007, PALAEOGEOGR PALAEOCL, V253, P8, DOI 10.1016/j.palaeo.2007.03.031; Helwig K, 1997, STUD CONSERV, V42, P181, DOI 10.2307/1506714; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Hovers E, 2003, CURR ANTHROPOL, V44, P491, DOI 10.1086/375869; Hradil D, 2003, APPL CLAY SCI, V22, P223, DOI 10.1016/S0169-1317(03)00076-0; Iriarte E, 2009, ARCHAEOMETRY, V51, P231, DOI 10.1111/j.1475-4754.2008.00397.x; Julia CG, 2004, THERMOCHIM ACTA, V413, P185, DOI 10.1016/j.tca.2003.10.016; Kaminska L, 2007, STUDIES FINAL PALAEO, P111; Kiehn AV, 2007, ACS SYM SER, V968, P460, DOI 10.1021/bk-2007-0968.ch025; Kovacs J, 2012, QUATERN INT, V276, P145, DOI 10.1016/j.quaint.2012.04.009; Kozlowski SK, 2012, QUATERN INT, V272, P288, DOI 10.1016/j.quaint.2012.02.052; Kromer B, 2013, NUCL INSTRUM METH B, V294, P11, DOI 10.1016/j.nimb.2012.01.015; Larrahondo JM, 2011, ENG GEOL, V121, P7, DOI 10.1016/j.enggeo.2011.04.009; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; MacDonald BL, 2011, J ARCHAEOL SCI, V38, P3620, DOI 10.1016/j.jas.2011.08.032; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; Markovic SB, 2012, NETH J GEOSCI, V91, P173; Mayer DEBY, 2009, J HUM EVOL, V56, P307, DOI 10.1016/j.jhevol.2008.10.005; Meszaros G., 1955, ACTA ARCHAEOL-HUNG, V5, P1; Patou-Mathis M., 2002, PRAEHISTORIA, V3, P161; Peile A., 1979, HEMISPHERE, V23, P214; Penn RL, 2001, GEOLOGY, V29, P843, DOI 10.1130/0091-7613(2001)029<0843:IOCOSG>2.0.CO;2; Pettitt P, 2011, PALAEOLITHIC ORIGINS OF HUMAN BURIAL, P1; Poltowicz-Bobak M, 2012, QUATERN INT, V272, P297, DOI 10.1016/j.quaint.2012.05.029; Pomies MP, 1998, EUR J SOL STATE INOR, V35, P9, DOI 10.1016/S0992-4361(98)80011-8; Popelka-Filcoff RS, 2007, J RADIOANAL NUCL CH, V272, P17, DOI 10.1007/s10967-006-6836-x; Popelka-Filcoff RS, 2008, J ARCHAEOL SCI, V35, P752, DOI 10.1016/j.jas.2007.05.018; Ramsey CB, 2015, ARCHAEOMETRY, V57, P177, DOI 10.1111/arcm.12134; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Rasmussen SO, 2014, QUATERNARY SCI REV, V106, P14, DOI 10.1016/j.quascirev.2014.09.007; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Roebroeks W, 2012, P NATL ACAD SCI USA, V109, P1889, DOI 10.1073/pnas.1112261109; Roper D. C., 1992, N AM ARCHAEOL, V12, P289, DOI DOI 10.2190/AH7V-FPM6-PRDX-FNQE; Scadding R, 2015, J ARCHAEOL SCI, V54, P300, DOI 10.1016/j.jas.2014.11.017; Schild R., 1981, PRZEGLAD ARCHEOLOGIC, V29, P53; SCHWARCZ HP, 1982, NATURE, V295, P590, DOI 10.1038/295590a0; STUMM W, 1992, GEOCHIM COSMOCHIM AC, V56, P3233, DOI 10.1016/0016-7037(92)90301-X; Sumegi P, 2002, QUATERN INT, V91, P53, DOI 10.1016/S1040-6182(01)00102-1; Talamo S, 2011, RADIOCARBON, V53, P443, DOI 10.1017/S0033822200034573; Ujvari G, 2010, QUATERNARY SCI REV, V29, P3157, DOI 10.1016/j.quascirev.2010.07.005; Valoch K, 2005, ARCHEOLOGICKE ROZHLE, V57; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; Varga A, 2011, QUATERN INT, V240, P71, DOI 10.1016/j.quaint.2010.10.032; VELO J, 1984, CURR ANTHROPOL, V25, P674, DOI 10.1086/203205; Verpoorte A, 2004, ANTIQUITY, V78, P257, DOI 10.1017/S0003598X0011292X; Vertes L., 1959, B SOC PREHIST, V56, P604; Vertes L, 1962, WIATOWIT, V24, P159; Vouve J, 1995, ANTHROPOLOGIE, V99, P478; Wadley L, 2004, ANTIQUITY, V78, P661, DOI 10.1017/S0003598X00113298; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Watts I, 2010, J HUM EVOL, V59, P392, DOI 10.1016/j.jhevol.2010.07.006; Willis KJ, 2004, QUATERNARY SCI REV, V23, P2369, DOI 10.1016/j.quascirev.2004.06.002; Willis KJ, 2000, QUATERNARY RES, V53, P203, DOI 10.1006/qres.1999.2119; Zipkin AM, 2015, ARCHAEOMETRY, V57, P297, DOI 10.1111/arcm.12090	87	15	15	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131762	10.1371/journal.pone.0131762	http://dx.doi.org/10.1371/journal.pone.0131762			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147808	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600141
J	Schiattarella, GG; Cerulo, G; De Pasquale, V; Cocchiaro, P; Paciello, O; Avallone, L; Belfiore, MP; Iacobellis, F; Di Napoli, D; Magliulo, F; Perrino, C; Trimarco, B; Esposito, G; Di Natale, P; Pavone, LM				Schiattarella, Gabriele Giacomo; Cerulo, Giuliana; De Pasquale, Valeria; Cocchiaro, Pasquale; Paciello, Orlando; Avallone, Luigi; Belfiore, Maria Paola; Iacobellis, Francesca; Di Napoli, Daniele; Magliulo, Fabio; Perrino, Cinzia; Trimarco, Bruno; Esposito, Giovanni; Di Natale, Paola; Pavone, Luigi Michele			The Murine Model of Mucopolysaccharidosis IIIB Develops Cardiopathies over Time Leading to Heart Failure	PLOS ONE			English	Article							ENZYME-REPLACEMENT THERAPY; MOUSE MODEL; CARDIOVASCULAR CHANGES; GENE-THERAPY; SUDDEN-DEATH; DISEASE; AUTOPHAGY; CHILDREN; ECHOCARDIOGRAPHY; MANIFESTATIONS	Mucopolysaccharidosis (MPS) IIIB is a lysosomal disease due to the deficiency of the enzyme alpha-N-acetylglucosaminidase (NAGLU) required for heparan sulfate (HS) degradation. The disease is characterized by mild somatic features and severe neurological disorders. Very little is known on the cardiac dysfunctions in MPS IIIB. In this study, we used the murine model of MPS IIIB (NAGLU knockout mice, NAGLU(-/-)) in order to investigate the cardiac involvement in the disease. Echocardiographic analysis showed a marked increase in left ventricular (LV) mass, reduced cardiac function and valvular defects in NAGLU(-/-) mice as compared to wild-type (WT) littermates. The NAGLU(-/-) mice exhibited a significant increase in aortic and mitral annulus dimension with a progressive elongation and thickening of anterior mitral valve leaflet. A severe mitral regurgitation with reduction in mitral inflow E-wave-toA- wave ratio was observed in 32-week-old NAGLU(-/-) mice. Compared to WT mice, NAGLU(-/-) mice exhibited a significantly lower survival with increased mortality observed in particular after 25 weeks of age. Histopathological analysis revealed a significant increase of myocardial fiber vacuolization, accumulation of HS in the myocardial vacuoles, recruitment of inflammatory cells and collagen deposition within the myocardium, and an increase of LV fibrosis in NAGLU(-/-) mice compared to WT mice. Biochemical analysis of heart samples from affected mice showed increased expression levels of cardiac failure hallmarks such as calcium/calmodulin-dependent protein kinase II, connexin43, alpha-smooth muscle actin, a-actinin, atrial and brain natriuretic peptides, and myosin heavy polypeptide 7. Furthermore, heart samples from NAGLU(-/-) mice showed enhanced expression of the lysosome-associated membrane protein-2 (LAMP2), and the autophagic markers Beclin1 and LC3 isoform II (LC3II). Overall, our findings demonstrate that NAGLU(-/-) mice develop heart disease, valvular abnormalities and cardiac failure associated with an impaired lysosomal autophagic flux.	[Cerulo, Giuliana; De Pasquale, Valeria; Cocchiaro, Pasquale; Di Natale, Paola; Pavone, Luigi Michele] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Schiattarella, Gabriele Giacomo; Magliulo, Fabio; Perrino, Cinzia; Trimarco, Bruno; Esposito, Giovanni] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy; [Cerulo, Giuliana; Cocchiaro, Pasquale; Paciello, Orlando; Avallone, Luigi] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy; [Belfiore, Maria Paola; Iacobellis, Francesca] Univ Naples 2, Dept Radiol, Naples, Italy; [Di Napoli, Daniele] AORN Cardarelli, Ctr Biotechnol, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; Universita della Campania Vanvitelli	Pavone, LM (corresponding author), Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy.	luigimichele.pavone@unina.it	Schiattarella, Gabriele G/M-9506-2017; Belfiore, Maria Paola/ABR-6442-2022; Pavone, Luigi Michele/H-3403-2012; Schiattarella, Gabriele/Z-2624-2019; De+Pasquale, Valeria/CAG-0544-2022; Perrino, Cinzia/K-3183-2016; Trimarco, Bruno BT/K-7851-2016; Esposito, Giovanni/F-2880-2010	Schiattarella, Gabriele G/0000-0002-7582-7171; Schiattarella, Gabriele/0000-0002-7582-7171; Perrino, Cinzia/0000-0002-2274-0048; Trimarco, Bruno BT/0000-0002-0701-6449; Esposito, Giovanni/0000-0003-0565-7127; Pavone, Luigi Michele/0000-0002-5145-7428; Iacobellis, Francesca/0000-0003-4604-7384; Magliulo, Fabio/0000-0003-3387-8517; De Pasquale, Valeria/0000-0001-5285-1980; Belfiore, Maria Paola/0000-0001-8219-1493	Italian Ministry of Health-Young Researcher Grant; Italian Ministry of Health-FIRB Grant (Futuro in Ricerca)	Italian Ministry of Health-Young Researcher Grant; Italian Ministry of Health-FIRB Grant (Futuro in Ricerca)	This study was supported in part by grants from the Italian Ministry of Health-Young Researcher Grant (2009) and from the Italian Ministry of Health-FIRB 2012 Grant (Futuro in Ricerca) to C.P.	Angrisano T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106024; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; Bandyopadhyay U, 2008, MOL CELL BIOL, V28, P5747, DOI 10.1128/MCB.02070-07; Belfiore MP, 2011, CARDIOVASC ULTRASOUN, V9, DOI 10.1186/1476-7120-9-39; Bigg PW, 2013, MOL GENET METAB, V110, P319, DOI 10.1016/j.ymgme.2013.06.013; Brands MMMG, 2013, J INHERIT METAB DIS, V36, P227, DOI 10.1007/s10545-011-9444-z; Braunlin EA, 2011, J INHERIT METAB DIS, V34, P1183, DOI 10.1007/s10545-011-9359-8; Cheitlin MD, 2003, CIRCULATION, V108, P1146, DOI 10.1161/01.CIR.0000073597.57414.A9; Dangel JH, 1998, EUR J PEDIATR, V157, P534, DOI 10.1007/s004310050872; de Oliveira PG, 2013, INT J EXP PATHOL, V94, P305, DOI 10.1111/iep.12033; Di Natale P, 2005, BIOCHEM J, V388, P639, DOI 10.1042/BJ20041702; Fox JE, 2015, MOL GENET METAB, V114, P203, DOI 10.1016/j.ymgme.2014.10.017; Golda A, 2012, INT J CARDIOL, V158, P6, DOI 10.1016/j.ijcard.2011.06.097; Hishitani T, 2000, J PEDIATR-US, V136, P268, DOI 10.1016/S0022-3476(00)70117-X; Jordan MC, 2005, MOL GENET METAB, V86, P233, DOI 10.1016/j.ymgme.2005.05.003; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kostin S, 2000, Heart Fail Rev, V5, P271; Leal GN, 2010, CARDIOL YOUNG, V20, P254, DOI 10.1017/S104795110999062X; Lee SC, 2014, MOL GENET METAB, V112, P218, DOI 10.1016/j.ymgme.2014.04.005; Li HH, 1999, P NATL ACAD SCI USA, V96, P14505, DOI 10.1073/pnas.96.25.14505; Lin HY, 2005, J INHERIT METAB DIS, V28, P1146, DOI 10.1007/s10545-005-0211-x; Martins AM, 2009, J PEDIATR-US, V155, pS32, DOI 10.1016/j.jpeds.2009.07.005; Mohan UR, 2002, ACTA PAEDIATR, V91, P799, DOI 10.1080/08035250213211; Muenzer J, 2014, MOL GENET METAB, V111, P63, DOI 10.1016/j.ymgme.2013.11.015; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Pavone LM, 2009, J MOL CELL CARDIOL, V47, P691, DOI 10.1016/j.yjmcc.2009.07.021; Perrino C, 2006, J CLIN INVEST, V116, P1547, DOI 10.1172/JCI25397; Perrino C, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000086; Ponder KP, 2007, EXPERT OPIN BIOL TH, V7, P1333, DOI 10.1517/14712598.7.9.1333; Prasad VK, 2010, SEMIN HEMATOL, V47, P59, DOI 10.1053/j.seminhematol.2009.10.008; RENTERIA VG, 1976, AM J CARDIOL, V38, P487, DOI 10.1016/0002-9149(76)90468-9; Rigante D, 2002, CARDIOLOGY, V98, P18, DOI 10.1159/000064674; Sergeeva IA, 2013, BBA-MOL BASIS DIS, V1832, P2403, DOI 10.1016/j.bbadis.2013.07.003; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Severs NJ, 2006, ADV CARDIOL, V42, P228, DOI 10.1159/000092572; Sleeper MM, 2004, CIRCULATION, V110, P815, DOI 10.1161/01.CIR.0000138747.82487.4B; Strauch OF, 2003, PEDIATR RES, V54, P701, DOI 10.1203/01.PDR.0000084085.65972.3F; Tessitore Alessandra, 2009, Pathogenetics, V2, P4, DOI 10.1186/1755-8417-2-4; Wendel B, 2000, J CELL BIOCHEM, V79, P566, DOI 10.1002/1097-4644(20001215)79:4<566::AID-JCB50>3.0.CO;2-E	40	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131662	10.1371/journal.pone.0131662	http://dx.doi.org/10.1371/journal.pone.0131662			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147524	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000358157600120
J	Wong, G; Wong, I; Chan, K; Hsieh, YC; Wong, S				Wong, Grace; Wong, Isaac; Chan, Kamfai; Hsieh, Yicheng; Wong, Season			A Rapid and Low-Cost PCR Thermal Cycler for Low Resource Settings	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; CONTINUOUS-FLOW PCR; REACTION AMPLIFICATION; MICROFLUIDIC DEVICES; INFECTIOUS-DISEASES; SAMPLE PREPARATION; DNA AMPLIFICATION; ESCHERICHIA-COLI; CHIP	Background Many modern molecular diagnostic assays targeting nucleic acids are typically confined to developed countries or to the national reference laboratories of developing-world countries. The ability to make technologies for the rapid diagnosis of infectious diseases broadly available in a portable, low-cost format would mark a revolutionary step forward in global health. Many molecular assays are also developed based on polymerase chain reactions (PCR), which require thermal cyclers that are relatively heavy (>20 pounds) and need continuous electrical power. The temperature ramping speed of most economical thermal cyclers are relatively slow (2 to 3 degrees C/s) so a polymerase chain reaction can take 1 to 2 hours. Most of all, these thermal cyclers are still too expensive ($2k to $4k) for low-resource setting uses. Methodology/Principal Findings In this article, we demonstrate the development of a low-cost and rapid water bath based thermal cycler that does not require active temperature control or continuous power supply during PCR. This unit costs $130 to build using commercial off-the-shelf items. The use of two or three vacuum-insulated stainless-steel Thermos food jars containing heated water (for denaturation and annealing/extension steps) and a layer of oil on top of the water allow for significantly stabilized temperatures for PCR to take place. Using an Arduino-based microcontroller, we automate the "archaic" method of hand-transferring PCR tubes between water baths. Conclusions/Significance We demonstrate that this innovative unit can deliver high speed PCR (17 s per PCR cycle) with the potential to go beyond the 1,522 bp long amplicons tested in this study and can amplify from templates down to at least 20 copies per reaction. The unit also accepts regular PCR tubes and glass capillary tubes. The PCR efficiency of our thermal cycler is not different from other commercial thermal cyclers. When combined with a rapid nucleic acid detection approach, the thermos thermal cycler (TTC) can enable on-site molecular diagnostics in low-resource settings.	[Wong, Grace; Wong, Isaac; Chan, Kamfai; Hsieh, Yicheng; Wong, Season] Al Biosci Inc, College Stn, TX USA		Wong, S (corresponding author), Al Biosci Inc, College Stn, TX USA.	season.wong@aibiosciences.com			Small Business Innovative Research (SBIR) grants from the US National Institutes of Health [1R43AI106239-01A1, 1R43EB018641-01]; AI Biosciences, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI106239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R43EB018641] Funding Source: NIH RePORTER	Small Business Innovative Research (SBIR) grants from the US National Institutes of Health; AI Biosciences, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work is supported by the Small Business Innovative Research (SBIR) grants from the US National Institutes of Health, Grant #s 1R43AI106239-01A1 and 1R43EB018641-01 and AI Biosciences, Inc. The funder AI Biosciences, Inc., provided support in the form of salaries for authors GW, IW, KC, YH, and SW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belgrader P, 2003, ANAL CHEM, V75, P3446, DOI 10.1021/ac034062u; BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654, DOI 10.1128/JCM.30.7.1654-1660.1992; Brooks HA, 2005, J VIROL METHODS, V127, P109, DOI 10.1016/j.jviromet.2005.03.017; Butler D, 2006, NATURE, V440, P6, DOI 10.1038/440006a; Chen ZY, 2004, ANAL CHEM, V76, P3707, DOI 10.1021/ac049914k; Cheng JY, 2005, ANALYST, V130, P931, DOI 10.1039/b501061f; Chin CD, 2007, LAB CHIP, V7, P41, DOI 10.1039/b611455e; Chiou J, 2001, ANAL CHEM, V73, P2018, DOI 10.1021/ac001227f; Elenitoba-Johnson O, 2008, BIOTECHNIQUES, V44, P487, DOI 10.2144/000112722; Farrar JS, 2015, CLIN CHEM, V61, P145, DOI 10.1373/clinchem.2014.228304; Frey O, 2007, BIOMED MICRODEVICES, V9, P711, DOI 10.1007/s10544-007-9080-4; Hennig M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2051787; Khandurina J, 2000, ANAL CHEM, V72, P2995, DOI 10.1021/ac991471a; King DA, 2006, SCIENCE, V313, P1392, DOI 10.1126/science.1129134; Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046; Lin MH, 2001, CLIN BIOCHEM, V34, P661, DOI 10.1016/S0009-9120(01)00281-8; Liu P, 2007, ANAL CHEM, V79, P1881, DOI 10.1021/ac061961k; Liu RH, 2004, ANAL CHEM, V76, P1824, DOI 10.1021/ac0353029; Logan J., 2009, REAL TIME PCR CURREN; Lounsbury JA, 2013, LAB CHIP, V13, P1384, DOI 10.1039/c3lc41326h; MANNUCCI A, 1994, INT J LEGAL MED, V106, P190, DOI 10.1007/BF01371335; Nachamkin I, 1997, CLIN INFECT DIS, V24, P894, DOI 10.1093/clinids/24.5.894; Noble RT, 2010, APPL ENVIRON MICROB, V76, P7437, DOI 10.1128/AEM.00651-10; Obeid PJ, 2003, ANAL CHEM, V75, P288, DOI 10.1021/ac0260239; Oda RP, 1998, ANAL CHEM, V70, P4361, DOI 10.1021/ac980452i; Oh MH, 2009, J FOOD PROTECT, V72, P1262, DOI 10.4315/0362-028X-72.6.1262; Pipper J, 2008, ANGEW CHEM INT EDIT, V47, P3900, DOI 10.1002/anie.200705016; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Sauer S, 2005, NAT REV GENET, V6, P465, DOI 10.1038/nrg1618; Sun K, 2002, SENSOR ACTUAT B-CHEM, V84, P283, DOI 10.1016/S0925-4005(02)00016-3; Syvanen AC, 2005, NAT GENET, V37, pS5, DOI 10.1038/ng1558; Walker FM, 2014, ANAL CHEM, V86, P9236, DOI 10.1021/ac5022419; Wang H, 2006, ANAL CHEM, V78, P6223, DOI 10.1021/ac060568b; WEISSENSTEINER T, 2004, PCR TECHNOLOGY CURRE; Wheeler EK, 2011, ANALYST, V136, P3707, DOI 10.1039/c1an15365j; Wheeler EK, 2004, ANAL CHEM, V76, P4011, DOI 10.1021/ac034941g; WITTWER CT, 1989, NUCLEIC ACIDS RES, V17, P4353, DOI 10.1093/nar/17.11.4353; Xiang Q, 2005, BIOMED MICRODEVICES, V7, P273, DOI 10.1007/s10544-005-6069-8; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064; Yang S, 2004, LANCET INFECT DIS, V4, P337, DOI 10.1016/S1473-3099(04)01044-8; Yoon DS, 2002, J MICROMECH MICROENG, V12, P813, DOI 10.1088/0960-1317/12/6/312; Yu CY, 2007, J CHIN INST CHEM ENG, V38, P333, DOI 10.1016/j.jcice.2007.05.001; Zhang CS, 2006, BIOTECHNOL ADV, V24, P243, DOI 10.1016/j.biotechadv.2005.10.002; [No title captured]	44	37	38	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131701	10.1371/journal.pone.0131701	http://dx.doi.org/10.1371/journal.pone.0131701			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146999	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600132
J	Amelot, A; De Cremoux, P; Quillien, V; Polivka, M; Adle-Biassette, H; Lehmann-Che, J; Francoise, L; Carpentier, AF; George, B; Mandonnet, E; Froelich, S				Amelot, Aymeric; De Cremoux, Patricia; Quillien, Veronique; Polivka, Marc; Adle-Biassette, Homa; Lehmann-Che, Jacqueline; Francoise, Laurence; Carpentier, Antoine F.; George, Bernard; Mandonnet, Emmanuel; Froelich, Sebastien			IDH-Mutation Is a Weak Predictor of Long-Term Survival in Glioblastoma Patients	PLOS ONE			English	Article							PROGNOSTIC VALUE; GRADE GLIOMAS; MULTIFORME; TEMOZOLOMIDE; MGMT; RESECTION; METHYLATION; IMMUNOHISTOCHEMISTRY; METAANALYSIS; SERIES	Background A very small proportion of patients diagnosed with glioblastoma (GBM) survive more than 3 years. Isocitrate dehydrogenase 1 or 2 (IDH1/2) mutations define a small subgroup of GBM patients with favourable prognosis. However, it remains controversial whether long-term survivors (LTS) are found among those IDH1/2 mutated patients. Methods We retrospectively analyzed 207 GBM patients followed at Lariboisiere Hospital (Paris) between 2005 and 2010. Clinical parameters were obtained from medical records. Mutations of IDH1/2 were analyzed in these patients, by immunohistochemistry for the R132H mutation of IDH1 and by high-resolution melting-curve analysis, followed by Sanger sequencing for IDH1 and IDH2 exon 4 mutations. Mutation rates in LTS and non-LTS groups were compared by Chi square Pearson test. Results Seventeen patients with survival >3 years were identified (8.2% of the total series). The median overall survival in long-term survivors was 4.6 years. Subgroup analysis found that the median age at diagnosis was significantly higher for non long-term survivors (non-LTS) compared to LTS (60 versus 51 years, p <0.03). The difference in the rate of IDH mutation between non-LTS and LTS was statistically not significant (1.16% versus 5.9%, p = 0.144). Among LTS, 10 out of 16 tumors presented a methylation of MGMT promoter. Conclusions This study confirms that long-term survival in GBM patients is if at all only weakly correlated to IDH-mutation.	[Amelot, Aymeric; George, Bernard; Mandonnet, Emmanuel; Froelich, Sebastien] Lariboisiere Hosp, AP HP, Dept Neurosurg, Paris, France; [De Cremoux, Patricia; Lehmann-Che, Jacqueline; Francoise, Laurence] St Louis Hosp, AP HP, Dept Biochem, Mol Oncol Unit, Paris, France; [Quillien, Veronique] Ctr Eugene Marquis, Dept Biol, F-35042 Rennes, France; [Polivka, Marc; Adle-Biassette, Homa] Lariboisiere Hosp, AP HP, Dept Pathol, Paris, France; [Carpentier, Antoine F.] Avicennes Hosp, AP HP, Dept Neurol, Bobigny, France; [George, Bernard; Mandonnet, Emmanuel; Froelich, Sebastien] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Mandonnet, Emmanuel] IMNC, UMR 8165, Orsay, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Centre Eugene Marquis; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay	Mandonnet, E (corresponding author), Lariboisiere Hosp, AP HP, Dept Neurosurg, Paris, France.	mandonnet@mac.com	Adle-Biassette, Homa/AAG-2751-2019	Quillien, Veronique/0000-0002-1465-3753; Carpentier, Antoine/0000-0003-2926-0060; Lehmann-Che, jacqueline/0000-0001-6685-3354				Barnholtz-Sloan JS, 2007, J NEURO-ONCOL, V85, P171, DOI 10.1007/s11060-007-9405-4; Burton EC, 2002, CLIN CANCER RES, V8, P180; Cheng HB, 2013, TUMOR BIOL, V34, P3555, DOI 10.1007/s13277-013-0934-5; Christensen BC, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq497; Das P, 2011, J CLIN NEUROSCI, V18, P66, DOI 10.1016/j.jocn.2010.04.050; Frenel JS, 2013, J NEURO-ONCOL, V114, P85, DOI 10.1007/s11060-013-1152-0; Gerber NK, 2014, NEURO-ONCOLOGY, V16, P1186, DOI 10.1093/neuonc/nou043; Gilbert MR, 2013, J CLIN ONCOL, V31, P4085, DOI 10.1200/JCO.2013.49.6968; Hartmann C, 2013, CLIN CANCER RES, V19, P5146, DOI 10.1158/1078-0432.CCR-13-0017; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Houillier C, 2010, NEUROLOGY, V75, P1560, DOI 10.1212/WNL.0b013e3181f96282; Johnson DR, 2012, CANCER-AM CANCER SOC, V118, P5608, DOI 10.1002/cncr.27590; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; Juratli TA, 2012, J NEURO-ONCOL, V110, P325, DOI 10.1007/s11060-012-0977-2; Kreth FW, 2013, ANN ONCOL, V24, P3117, DOI 10.1093/annonc/mdt388; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; Kuhnt D, 2011, NEURO-ONCOLOGY, V13, P1339, DOI 10.1093/neuonc/nor133; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Loussouarn D, 2012, INT J ONCOL, V40, P2058, DOI 10.3892/ijo.2012.1404; Martinez R, 2007, J NEURO-ONCOL, V83, P91, DOI 10.1007/s11060-006-9292-0; McLendon RE, 2003, CANCER-AM CANCER SOC, V98, P1745, DOI 10.1002/cncr.11666; Molenaar RJ, 2014, NEURO-ONCOLOGY, V16, P1263, DOI 10.1093/neuonc/nou005; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Qi ST, 2012, CANCER SCI, V103, P269, DOI 10.1111/j.1349-7006.2011.02134.x; Quillien V, 2014, J NEURO-ONCOL, V116, P487, DOI 10.1007/s11060-013-1332-y; Quillien V, 2012, CANCER-AM CANCER SOC, V118, P4201, DOI 10.1002/cncr.27392; Reifenberger G, 2014, INT J CANCER, V135, P1822, DOI 10.1002/ijc.28836; Ronning PA, 2012, NEURO-ONCOLOGY, V14, P1178, DOI 10.1093/neuonc/nos153; Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; Scoccianti S, 2010, NEUROSURGERY, V67, P446, DOI 10.1227/01.NEU.0000371990.86656.E8; Scott JN, 1999, ANN NEUROL, V46, P183, DOI 10.1002/1531-8249(199908)46:2<183::AID-ANA7>3.3.CO;2-Z; Shah N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016146; Shinojima N, 2004, J NEUROSURG, V101, P219, DOI 10.3171/jns.2004.101.2.0219; Siker ML, 2011, J NEURO-ONCOL, V104, P351, DOI 10.1007/s11060-010-0500-6; Solheim O, 2014, NEURO-ONCOLOGY, V16, P610, DOI 10.1093/neuonc/not312; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; The WHO, 2020, CLASSIFICATION TUMOU; Thumma SR, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-75; VERTOSICK FT, 1992, SURG NEUROL, V38, P359, DOI 10.1016/0090-3019(92)90022-F; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yan W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030339; Zhang K, 2013, FAM CANCER, V12, P449, DOI 10.1007/s10689-013-9607-1; Zou P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068782	45	36	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0130596	10.1371/journal.pone.0130596	http://dx.doi.org/10.1371/journal.pone.0130596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158269	Green Published, Green Submitted, gold			2022-12-27	WOS:000358161200014
J	Manjunath, S; Kulkarni, PG; Nagavelu, K; Samuel, RJ; Srinivasan, S; Ramasamy, N; Hegde, NR; Gudde, RS				Manjunath, Shrruthi; Kulkarni, Prachet G.; Nagavelu, Krishnaveni; Samuel, Rosa J.; Srinivasan, Sandhya; Ramasamy, Nandhini; Hegde, Nagendra R.; Gudde, Ramachandra S.			Sero-Prevalence of Rodent Pathogens in India	PLOS ONE			English	Article							LABORATORY MICE; INFECTIOUS AGENTS; CONTEMPORARY PREVALENCE; HEALTH SURVEILLANCE; SEROLOGICAL SURVEY; UNITED-KINGDOM; MURINE VIRUSES; RAT COLONIES; MOUSE; ANTIBODIES	Health monitoring is an integral part of laboratory animal quality standards. However, current or past prevalence data as well as regulatory requirements dictate the frequency, type and the expanse of health monitoring. In an effort to understand the prevalence of rodent pathogens in India, a preliminary study was carried out by sero-epidemiology. Sera samples obtained from 26 public and private animal facilities were analyzed for the presence of antibodies against minute virus of mice (MVM), ectromelia virus (ECTV), lymphocytic choriomeningitis virus (LCMV), mouse hepatitis virus (MHV), Sendai virus (SeV), and Mycoplasma pulmonis in mice, and SeV, rat parvo virus (RPV), Kilham's rat virus (KRV) and sialodacryoadenitis virus (SDAV) in rats, by sandwich ELISA. It was observed that MHV was the most prevalent agent followed by Mycoplasma pulmonis and MVM in mice, and SDAV followed by RPV were prevalent in rats. On the other hand, none of the samples were positive for ECTV in mice, or SeV or KRV in rats. Multiple infections were common in both mice and rats. The incidence of MHV and Mycoplasma pulmonis was higher in facilities maintained by public organizations than in vivaria of private organizations, although the difference was not statistically different. On the other hand the prevalence of rodent pathogens was significantly higher in the northern part of India than in the South. These studies form the groundwork for detailed sero-prevalence studies which should further lay the foundations for country-specific guidelines for health monitoring of laboratory animals.	[Manjunath, Shrruthi; Kulkarni, Prachet G.; Nagavelu, Krishnaveni; Samuel, Rosa J.; Srinivasan, Sandhya; Gudde, Ramachandra S.] Indian Inst Sci, Cent Anim Facil, Bengaluru, India; [Ramasamy, Nandhini; Hegde, Nagendra R.] Genome Valley, Ella Fdn, Hyderabad, Andhra Pradesh, India	Indian Institute of Science (IISC) - Bangalore	Gudde, RS (corresponding author), Indian Inst Sci, Cent Anim Facil, Bengaluru, India.	sgr@caf.iisc.ernet.in	Hegde, Nagendra R/H-3132-2019	Hegde, Nagendra R/0000-0001-5260-2159	Department of Biotechnology, Government of India [DBT/BT/PR13951/ADV/57/46/2010]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Department of Biotechnology, Government of India. Grant number: DBT/BT/PR13951/ADV/57/46/2010. Fund receiver: RSG NRH (Website: www.dbtindia.nic.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DG, 1998, CLIN MICROBIOL REV, V11, P231, DOI 10.1128/CMR.11.2.231; Cagliada MP, 2010, REV ARGENT MICROBIOL, V42, P27, DOI 10.1590/S0325-75412010000100006; CARTHEW P, 1978, LAB ANIM, V12, P29, DOI 10.1258/002367778780953323; CASEBOLT DB, 1988, LAB ANIM SCI, V38, P327; Clifford CB, 2008, ILAR J, V49, P291, DOI 10.1093/ilar.49.3.291; Coates ME, 1994, GUIDELINES BREEDING, P42; COLLINS MJ, 1972, J NATL CANCER I, V49, P1139; DESCOTEAUX JP, 1977, LAB ANIM SCI, V27, P621; Festing MFW, 1994, GUIDELINES BREEDING, P68; FUJIWARA K, 1976, LAB ANIM SCI, V26, P153; GANNON J, 1980, LAB ANIM, V14, P309, DOI 10.1258/002367780781071003; Gilioli R, 1996, LAB ANIM SCI, V46, P582; Hayashimoto N, 2013, EXP ANIM TOKYO, V62, P41, DOI 10.1538/expanim.62.41; Liang CT, 2009, J AM ASSOC LAB ANIM, V48, P381; Livingston RS, 2003, LAB ANIMAL, V32, P44, DOI 10.1038/laban0503-44; Loew FM, 1983, MOUSE BIOMEDICAL RES, V3, P69, DOI DOI 10.1016/B978-0-12-262503-9.50012-8; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Mahler M, 2009, LAB ANIMAL, V38, P161, DOI 10.1038/laban0509-161; McInnes EE, 2011, LAB ANIMAL, V40, P341, DOI 10.1038/laban1111-341; NAKAGAWA M, 1984, EXP ANIM TOKYO, V33, P115, DOI 10.1538/expanim1978.33.1_115; NICKLAS W, 1993, LAB ANIM SCI, V43, P296; Nicklas W., 1996, Scandinavian Journal of Laboratory Animal Science, V23, P69; Nicklas W, 1999, LAB ANIM-UK, V33, P39, DOI 10.1258/002367799780639987; POILEY SM, 1970, LAB ANIM CARE, V20, P643; Pritchett-Corning KR, 2009, LAB ANIM-UK, V43, P165, DOI 10.1258/la.2008.008009; ROWE W P, 1963, Lab Anim Care, V13, pSUPPL166; Selwyn M R, 1994, Contemp Top Lab Anim Sci, V33, P56; Seoki S, 2005, EXP ANIM TOKYO, V54, P85, DOI 10.1538/expanim.54.85; Small JD, 1984, LAB ANIMAL MED, P69; SMITH AL, 1983, LAB ANIM SCI, V33, P37; VANVUUREN M, 1990, J S AFR VET ASSOC, V61, P174; VOLLER A, 1978, J CLIN PATHOL, V31, P507, DOI 10.1136/jcp.31.6.507; Weisbroth S, 2000, LAB ANIMAL, V29, P43; Weisbroth Steven H., 1998, ILAR J, V39, P272; Won YS, 2006, EXP ANIM TOKYO, V55, P11, DOI 10.1538/expanim.55.11; YANG FC, 1995, LAB ANIM SCI, V45, P140	36	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131706	10.1371/journal.pone.0131706	http://dx.doi.org/10.1371/journal.pone.0131706			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158453	gold, Green Published, Green Submitted			2022-12-27	WOS:000358161200036
J	Krueger, PM; Tran, MK; Hummer, RA; Chang, VW				Krueger, Patrick M.; Tran, Melanie K.; Hummer, Robert A.; Chang, Virginia W.			Mortality Attributable to Low Levels of Education in the United States	PLOS ONE			English	Article							ADULT MORTALITY; HEALTH; DISPARITIES; RACE; GRADIENT	Background Educational disparities in U.S. adult mortality are large and have widened across birth cohorts. We consider three policy relevant scenarios and estimate the mortality attributable to: (1) individuals having less than a high school degree rather than a high school degree, (2) individuals having some college rather than a baccalaureate degree, and (3) individuals having anything less than a baccalaureate degree rather than a baccalaureate degree, using educational disparities specific to the 1925, 1935, and 1945 cohorts. Methods We use the National Health Interview Survey data (1986-2004) linked to prospective mortality through 2006 (N=1,008,949), and discrete-time survival models, to estimate education- and cohort-specific mortality rates. We use those mortality rates and data on the 2010 U.S. population from the American Community Survey, to calculate annual attributable mortality estimates. Results If adults aged 25-85 in the 2010 U.S. population experienced the educational disparities in mortality observed in the 1945 cohort, 145,243 deaths could be attributed to individuals having less than a high school degree rather than a high school degree, 110,068 deaths could be attributed to individuals having some college rather than a baccalaureate degree, and 554,525 deaths could be attributed to individuals having anything less than a baccalaureate degree rather than a baccalaureate degree. Widening educational disparities between the 1925 and 1945 cohorts result in a doubling of attributable mortality. Mortality attributable to having less than a high school degree is proportionally similar among women and men and among non-Hispanic blacks and whites, and is greater for cardiovascular disease than for cancer. Conclusions Mortality attributable to low education is comparable in magnitude to mortality attributable to individuals being current rather than former smokers. Existing research suggests that a substantial part of the association between education and mortality is causal. Thus, policies that increase education could significantly reduce adult mortality.	[Krueger, Patrick M.; Tran, Melanie K.] Univ Colorado, Dept Hlth & Behav Sci, Denver, CO 80202 USA; [Krueger, Patrick M.] Univ Colorado, Inst Behav Sci, Populat Program, Boulder, CO 80309 USA; [Hummer, Robert A.] Univ N Carolina, Dept Sociol, Chapel Hill, NC USA; [Hummer, Robert A.] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA; [Chang, Virginia W.] NYU, Steinhardt Sch Culture Educ & Human Dev, Global Inst Publ Hlth, New York, NY USA; [Chang, Virginia W.] NYU, Sch Med, New York, NY USA	University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Boulder; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; New York University; New York University	Krueger, PM (corresponding author), Univ Colorado, Dept Hlth & Behav Sci, Anschutz Med Campus, Denver, CO 80202 USA.	Patrick.Krueger@ucdenver.edu		Krueger, Patrick/0000-0003-3689-2488	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R24 HD066613]; NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, R24HD066613, P2CHD066613] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) funded University of Colorado Population Center (grant R24 HD066613) for administrative support. NICHD funding supported computational resources at the University of Colorado Population Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, MAKING AM HEALTHIER; Baker DP, 2011, POPUL DEV REV, V37, P307, DOI 10.1111/j.1728-4457.2011.00412.x; Bureau of the Census, 1987, STAT ABSTRACT US 198; Deaton A, 2002, HEALTH AFFAIR, V21, P13, DOI 10.1377/hlthaff.21.2.13; Galea S, 2011, AM J PUBLIC HEALTH, V101, P1456, DOI 10.2105/AJPH.2010.300086; Goldman D, 2011, SOC SCI MED, V72, P1728, DOI 10.1016/j.socscimed.2011.02.047; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Hout M, 2012, ANNU REV SOCIOL, V38, P379, DOI 10.1146/annurev.soc.012809.102503; Hummer Robert A, 2013, Popul Bull, V68, P1; Isaacs SL, 2004, NEW ENGL J MED, V351, P1137, DOI 10.1056/NEJMsb040329; Jemal A, 2008, AM J PREV MED, V34, P1, DOI 10.1016/j.amepre.2007.09.017; Kawachi I, 2010, ANN NY ACAD SCI, V1186, P56, DOI 10.1111/j.1749-6632.2009.05340.x; Kirch DG, 2013, JAMA-J AM MED ASSOC, V310, P2243, DOI 10.1001/jama.2013.282093; Korn E. L., 1999, ANAL HLTH SURVEYS; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Link BG, 2008, J HEALTH SOC BEHAV, V49, P72, DOI 10.1177/002214650804900106; Lleras-Muney A, 2005, REV ECON STUD, V72, P189, DOI 10.1111/0034-6527.00329; Lochner K, 2007, COMP ANAL PUBLIC USE; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Masters RK, 2012, AM SOCIOL REV, V77, P548, DOI 10.1177/0003122412451019; Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Montez JK, 2011, RES AGING, V33, P145, DOI 10.1177/0164027510392388; Montez JK, 2014, DEMOGRAPHY IN PRESS; National Center for Health Statistics, 2010, NAT HLTH INT SURV 19; Olshansky SJ, 2012, HEALTH AFFAIR, V31, P1803, DOI 10.1377/hlthaff.2011.0746; Pampel FC, 2005, SOC SCI RES, V34, P117, DOI 10.1016/j.ssresearch.2003.12.003; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Powers D., 1999, STAT METHODS CATEGOR; Preston S., 2000, DEMOGRAPHY MEASURING; Rogers RG, 2005, POPUL DEV REV, V31, P259, DOI 10.1111/j.1728-4457.2005.00065.x; Rogers RG, 2010, BIODEMOGR SOC BIOL, V56, P80, DOI 10.1080/19485561003727372; Rostron B.L., 2010, ED REPORTING CLASSIF; Ruggles S, 2010, INTEGRATED PUBLIC US; StataCorp, 2013, STAT REL 13 STAT SOF; US Department of Health and Human Services Office of Disease Prevention and Health Promotion, OFF DIS PREV HLTH PR; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979; Woolf SH, 2007, AM J PUBLIC HEALTH, V97, P679, DOI 10.2105/AJPH.2005.084848	39	49	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131809	10.1371/journal.pone.0131809	http://dx.doi.org/10.1371/journal.pone.0131809			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26153885	Green Published, gold, Green Submitted			2022-12-27	WOS:000358159700080
J	Vonhof, MJ; Russell, AL; Miller-Butterworth, CM				Vonhof, Maarten J.; Russell, Amy L.; Miller-Butterworth, Cassandra M.			Range-Wide Genetic Analysis of Little Brown Bat (Myotis lucifugus) Populations: Estimating the Risk of Spread of White-Nose Syndrome	PLOS ONE			English	Article							BIG-EARED BAT; SWARMING SITES; INFECTIOUS-DISEASES; MAXIMUM-LIKELIHOOD; F-STATISTICS; NUCLEAR-DNA; FLOW; MITOCHONDRIAL; SOFTWARE; PHYLOGEOGRAPHY	The little brown bat (Myotis lucifugus) is one of the most widespread bat species in North America and is experiencing severe population declines because of an emerging fungal disease, white-nose syndrome (WNS). To manage and conserve this species effectively it is important to understand patterns of gene flow and population connectivity to identify possible barriers to disease transmission. However, little is known about the population genetic structure of little brown bats, and to date, no studies have investigated population structure across their entire range. We examined mitochondrial DNA and nuclear microsatellites in 637 little brown bats (including all currently recognized subspecific lineages) from 29 locations across North America, to assess levels of genetic variation and population differentiation across the range of the species, including areas affected by WNS and those currently unaffected. We identified considerable spatial variation in patterns of female dispersal and significant genetic variation between populations in eastern versus western portions of the range. Overall levels of nuclear genetic differentiation were low, and there is no evidence for any major barriers to gene flow across their range. However, patterns of mtDNA differentiation are highly variable, with high FST values between most sample pairs (including between all western samples, between western and eastern samples, and between some eastern samples), while low mitochondrial differentiation was observed within two groups of samples found in central and eastern regions of North America. Furthermore, the Alaskan population was highly differentiated from all others, and western populations were characterized by isolation by distance while eastern populations were not. These data raise the possibility that the current patterns of spread of WNS observed in eastern North America may not apply to the entire range and that there may be broad-scale spatial variation in the risk of WNS transmission and occurrence if the disease continues to spread west.	[Vonhof, Maarten J.] Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA; [Vonhof, Maarten J.] Western Michigan Univ, Environm & Sustainabil Studies Program, Kalamazoo, MI 49008 USA; [Russell, Amy L.] Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA; [Miller-Butterworth, Cassandra M.] Penn State Beaver, Monaca, PA USA	Western Michigan University; Western Michigan University; Grand Valley State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Vonhof, MJ (corresponding author), Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA.	maarten.vonhof@wmich.edu	Russell, Amy L/B-2222-2010		Western Michigan University; Pennsylvania Game Commission State Wildlife Grant Program [231100]; Pennsylvania State University Research Development Grants	Western Michigan University; Pennsylvania Game Commission State Wildlife Grant Program; Pennsylvania State University Research Development Grants	Funding for this study was provided by Western Michigan University, the Pennsylvania Game Commission State Wildlife Grant Program (Cooperative Agreement No. 231100), and the Pennsylvania State University Research Development Grants.	Biek R, 2010, MOL ECOL, V19, P3515, DOI 10.1111/j.1365-294X.2010.04679.x; Bilgin R, 2008, ZOOL SCR, V37, P253, DOI 10.1111/j.1463-6409.2008.00326.x; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Bogdanowicz W, 2013, ACTA CHIROPTEROL, V15, P35, DOI 10.3161/150811013X667849; Bryja J, 2009, BIOL J LINN SOC, V96, P103, DOI 10.1111/j.1095-8312.2008.01093.x; Burns LE, 2014, ECOL EVOL, V4, P4130, DOI 10.1002/ece3.1266; Carstens BC, 2010, SYST BIOL, V59, P400, DOI 10.1093/sysbio/syq024; Castella V, 2000, MOL ECOL, V9, P1761, DOI 10.1046/j.1365-294x.2000.01069.x; Castella V, 2001, J EVOLUTION BIOL, V14, P708, DOI 10.1046/j.1420-9101.2001.00331.x; Cryan PM, 2013, J WILDLIFE DIS, V49, P398, DOI 10.7589/2012-04-121; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; Cullingham CI, 2011, EVOL APPL, V4, P116, DOI 10.1111/j.1752-4571.2010.00142.x; Davis W. H., 1965, Journal of Mammalogy, V46, P296, DOI 10.2307/1377850; Dixon MD, 2011, ECOL EVOL, V1, P191, DOI 10.1002/ece3.20; Dixon MD, 2011, J MAMMAL, V92, P1343, DOI 10.1644/10-MAMM-A-426.1; Duchesne P, 2009, MOL ECOL RESOUR, V9, P1333, DOI 10.1111/j.1755-0998.2009.02571.x; Duchesne P, 2012, J HERED, V103, P734, DOI 10.1093/jhered/ess038; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; FENTON M B, 1980, Mammalian Species, P1, DOI 10.2307/3503792; Fontaine MC, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-30; Frantz AC, 2009, J APPL ECOL, V46, P493, DOI 10.1111/j.1365-2664.2008.01606.x; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Furmankiewicz J, 2007, CONSERV GENET, V8, P913, DOI 10.1007/s10592-006-9246-2; Gibbs HL, 2000, MOL ECOL, V9, P2137, DOI 10.1046/j.1365-294X.2000.01136.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gray RR, 2012, PARASITOLOGY, V139, P1939, DOI 10.1017/S0031182012001102; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Irwin DE, 2011, MOL ECOL, V20, P3102, DOI 10.1111/j.1365-294X.2011.05159.x; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jones KL, 2005, MOL ECOL, V14, P2645, DOI 10.1111/j.1365-294X.2005.02622.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kerth G, 2003, CONSERV GENET, V4, P491, DOI 10.1023/A:1024771713152; Kerth G, 2002, MOL ECOL, V11, P1491, DOI 10.1046/j.1365-294X.2002.01528.x; Kerth G, 2008, MOL ECOL, V17, P2368, DOI 10.1111/j.1365-294X.2008.03768.x; Kimura M, 2002, MOL ECOL, V11, P1605, DOI 10.1046/j.1365-294X.2002.01551.x; Lack JB, 2010, ACTA CHIROPTEROL, V12, P401, DOI 10.3161/150811010X537981; Langwig KE, 2012, ECOL LETT, V15, P1050, DOI 10.1111/j.1461-0248.2012.01829.x; Lausen CL, 2008, CAN J ZOOL, V86, P700, DOI 10.1139/Z08-046; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Mcrae BH, 2005, MOL ECOL, V14, P1965, DOI 10.1111/j.1365-294X.2005.02571.x; Meirmans PG, 2012, J HERED, V103, P744, DOI 10.1093/jhered/ess047; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Miller-Butterworth CM, 2014, J HERED, V105, P354, DOI 10.1093/jhered/esu012; Moussy C, 2013, MAMMAL REV, V43, P183, DOI 10.1111/j.1365-2907.2012.00218.x; Norquay KJO, 2013, J MAMMAL, V94, P506, DOI 10.1644/12-MAMM-A-065.1; Oyler-McCance SJ, 2011, CONSERV GENET RESOUR, V3, P243, DOI 10.1007/s12686-010-9332-0; Piaggio AJ, 2009, MOL ECOL RESOUR, V9, P1191, DOI 10.1111/j.1755-0998.2009.02625.x; Piaggio AJ, 2009, MOL ECOL RESOUR, V9, P258, DOI 10.1111/j.1755-0998.2008.02243.x; Pritchard JK, 2000, GENETICS, V155, P945; Real LA, 2007, J R SOC INTERFACE, V4, P935, DOI 10.1098/rsif.2007.1041; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; Reid FA, 2006, MAMMALS N AM; Rivers NM, 2006, BIOL CONSERV, V127, P215, DOI 10.1016/j.biocon.2005.08.010; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Rousset F, 1997, GENETICS, V145, P1219; Schwartz MK, 2009, CONSERV GENET, V10, P441, DOI 10.1007/s10592-008-9622-1; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Stadelmann B, 2007, MOL PHYLOGENET EVOL, V43, P32, DOI 10.1016/j.ympev.2006.06.019; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thogmartin WE, 2012, J WILDLIFE DIS, V48, P876, DOI 10.7589/2011-06-176; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559; Trujillo RG, 2009, CONSERV GENET, V10, P1965, DOI 10.1007/s10592-009-9869-1; Turmelle AS, 2011, MOL ECOL, V20, P357, DOI 10.1111/j.1365-294X.2010.04947.x; Turner Gregory G., 2011, Bat Research News, V52, P13; U.S. Fish and Wildlife Service, 2014, CURR WNS OCC MAP; Veith M, 2004, HEREDITY, V93, P342, DOI 10.1038/sj.hdy.6800509; Verant ML, 2014, BMC PHYSL, V14, pe10; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Vollmer SA, 2011, ENVIRON MICROBIOL, V13, P184, DOI 10.1111/j.1462-2920.2010.02319.x; Vonhof MJ, 2008, J MAMMAL, V89, P1411, DOI 10.1644/08-MAMM-S-062.1; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilder AP, 2011, BIOL LETTERS, V7, P950, DOI 10.1098/rsbl.2011.0355; Willis CKR, 2011, INTEGR COMP BIOL, V51, P364, DOI 10.1093/icb/icr076; Wilmer Jessica Worthington, 1996, Bat Research News, V37, P1; Wilson D.E., 2005, MAMMAL SPECIES WORLD	89	20	21	0	189	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0128713	10.1371/journal.pone.0128713	http://dx.doi.org/10.1371/journal.pone.0128713			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154307	Green Published, gold			2022-12-27	WOS:000358159700009
J	Yang, LH; Jin, MJ; Du, PF; Chen, G; Zhang, C; Wang, J; Jin, F; Shao, H; She, YX; Wang, SS; Zheng, LF; Wang, J				Yang, Lihua; Jin, Maojun; Du, Pengfei; Chen, Ge; Zhang, Chan; Wang, Jian; Jin, Fen; Shao, Hua; She, Yongxin; Wang, Shanshan; Zheng, Lufei; Wang, Jing			Study on Enhancement Principle and Stabilization for the Luminol-H2O2-HRP Chemiluminescence System	PLOS ONE			English	Article							LUMINOL SIGNAL ENHANCER; HORSERADISH-PEROXIDASE; ENZYME IMMUNOASSAYS; HYDROGEN-PEROXIDE; DERIVATIVES; INTENSITY; OXIDATION; KINETICS	A luminol-H2O2-HRP chemiluminescence system with high relative luminescent intensity (RLU) and long stabilization time was investigated. First, the comparative study on the enhancement effect of ten compounds as enhancers to the luminol-H2O2-HRP chemiluminescence system was carried out, and the results showed that 4-(imidazol-1-yl) phenol (4-IMP), 4-iodophenol (4-IOP), 4-bromophenol (4-BOP) and 4-hydroxy-4'-iodobiphenyl (HIOP) had the best performance. Based on the experiment, the four enhancers were dissolved in acetone, acetonitrile, methanol, and dimethylformamide (DMF) with various concentrations, the results indicated that 4-IMP, 4-IOP, 4-BOP and HIOP dissolved in DMF with the concentrations of 0.2%, 3.2%, 1.6% and 3.2% could get the highest RLU values. Subsequently, the influences of pH, ionic strength, HRP, 4-IMP, 4-IOP, 4-BOP, HIOP, H(2)O(2)and luminol on the stabilization of the luminol-H2O2-HRP chemiluminescence system were studied, and we found that pH value, ionic strength, 4-IMP, 4-IOP, 4-BOP, HIOP, H(2)O(2)and luminol have little influence on luminescent stabilization, while HRP has a great influence. In different ranges of HRP concentration, different enhancers should be selected. When the concentration is within the range of 0 similar to 6 ng/mL, 4-IMP should be selected. When the concentration of HRP ranges from 6 to 25ng/mL, 4-IOP was the best choice. And when the concentration is within the range of 25 similar to 80 ng/mL, HIOP should be selected as the enhancer. Finally, the three well-performing chemiluminescent enhanced solutions (CESs) have been further optimized according to the three enhancers (4-IMP, 4-IOP and HIOP) in their utilized HRP concentration ranges.	[Yang, Lihua; Jin, Maojun; Du, Pengfei; Chen, Ge; Zhang, Chan; Wang, Jian; Jin, Fen; Shao, Hua; She, Yongxin; Wang, Shanshan; Zheng, Lufei; Wang, Jing] Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol AgroProd, Key Lab AgroProd Qual & Safety, Beijing 100081, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS	Jin, MJ (corresponding author), Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol AgroProd, Key Lab AgroProd Qual & Safety, Beijing 100081, Peoples R China.	katonking@163.com; w_jing2001@126.com		Jin, Maojun/0000-0002-9102-8572	International Science & Technology Cooperation Program of China [2012DFA31140]; Chinese Public Interest Industrial Science & Technology Project [201203094]; National Natural Science Foundation of China [31201371]	International Science & Technology Cooperation Program of China; Chinese Public Interest Industrial Science & Technology Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by International Science & Technology Cooperation Program of China (No. 2012DFA31140), the Chinese Public Interest Industrial Science & Technology Project (201203094) and National Natural Science Foundation of China (No. 31201371). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpeeva IS, 2003, J BIOL INORG CHEM, V8, P683, DOI 10.1007/s00775-003-0467-2; Chen FM, 2012, ANAL CHIM ACTA, V739, P77, DOI 10.1016/j.aca.2012.06.022; Chuang JC, 2005, TALANTA, V67, P658, DOI 10.1016/j.talanta.2005.04.063; Deftereos NT, 2000, ANAL CHIM ACTA, V403, P137, DOI 10.1016/S0003-2670(99)00643-1; Diaz AN, 1996, ANAL CHIM ACTA, V321, P219; Diaz AN, 1998, J BIOLUM CHEMILUM, V13, P75, DOI 10.1002/(SICI)1099-1271(199803/04)13:2<75::AID-BIO469>3.0.CO;2-7; Dotsikas Y, 2004, ANAL CHIM ACTA, V509, P103, DOI 10.1016/j.aca.2003.12.007; Dotsikas Y, 2002, ANAL CHIM ACTA, V459, P177, DOI 10.1016/S0003-2670(02)00133-2; Dotsikas Y, 2007, TALANTA, V71, P906, DOI 10.1016/j.talanta.2006.05.068; Gui WJ, 2006, ANAL BIOCHEM, V357, P9, DOI 10.1016/j.ab.2006.07.023; IWATA R, 1995, ANAL BIOCHEM, V231, P170, DOI 10.1006/abio.1995.1517; Jin MJ, 2009, THESIS ZHEJIANG U; Kricka JL, 1996, ANAL BIOCHEM, V240, P119, DOI 10.1006/abio.1996.0338; Kuroda N, 1999, LUMINESCENCE, V14, P361, DOI 10.1002/(SICI)1522-7243(199911/12)14:6<361::AID-BIO563>3.3.CO;2-A; Kuroda N, 2000, ANAL CHIM ACTA, V403, P131, DOI 10.1016/S0003-2670(99)00649-2; Liang YL, 2012, J LUMIN, V132, P1021, DOI 10.1016/j.jlumin.2011.11.029; Marquette CA, 2006, BIOSENS BIOELECTRON, V21, P1424, DOI 10.1016/j.bios.2004.09.037; Marquette CA, 2009, BIOANALYSIS, V1, P1259, DOI [10.4155/bio.09.69, 10.4155/BIO.09.69]; Roda A, 2012, ANAL BIOANAL CHEM, V402, P69, DOI 10.1007/s00216-011-5455-8; RONGEN HAH, 1994, J PHARMACEUT BIOMED, V12, P433, DOI 10.1016/0731-7085(94)80027-8; THORPE GHG, 1985, ANAL BIOCHEM, V145, P96, DOI 10.1016/0003-2697(85)90332-X; Vdovenko MM, 2010, APPL BIOCHEM MICRO+, V46, P65, DOI 10.1134/S0003683810010114; Vdovenko MM, 2009, ANAL BIOCHEM, V392, P54, DOI 10.1016/j.ab.2009.05.031; Wu YJ, 2013, LUMINESCENCE, V28, P905, DOI 10.1002/bio.2455; Yang XY, 2009, ANAL BIOCHEM, V393, P56, DOI 10.1016/j.ab.2009.06.008; Zhao LX, 2009, TRAC-TREND ANAL CHEM, V28, P404, DOI 10.1016/j.trac.2008.12.006	26	21	22	3	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131193	10.1371/journal.pone.0131193	http://dx.doi.org/10.1371/journal.pone.0131193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154162	gold, Green Submitted, Green Published			2022-12-27	WOS:000358159700057
J	Chen, YF; Zhao, WL; Lin, LD; Xiao, X; Zhou, XY; Ming, HX; Huang, TT; Liao, J; Li, YC; Zeng, XY; Huang, GW; Ye, WM; Zhang, Z				Chen, Yufeng; Zhao, Weilin; Lin, Longde; Xiao, Xue; Zhou, Xiaoying; Ming, Huixin; Huang, Tingting; Liao, Jian; Li, Yancheng; Zeng, Xiaoyun; Huang, Guangwu; Ye, Weimin; Zhang, Zhe			Nasopharyngeal Epstein-Barr Virus Load: An Efficient Supplementary Method for Population-Based Nasopharyngeal Carcinoma Screening	PLOS ONE			English	Article							DNA LOAD; PLASMA; EBV; BRUSHINGS; INFECTION; DIAGNOSIS; BLOOD; GENE	Serological detection of Epstein-Barr virus (EBV) antibodies is frequently used in nasopharyngeal carcinoma (NPC) mass screening. However, the large number of seropositive subjects who require close follow-up is still a big burden. The present study aimed to detect the nasopharyngeal EBV load in a high-risk population seropositive for antibodies against EBV, as well as to examine whether assay for nasopharyngeal EBV DNA load might reduce the number of high-risk subjects for follow-up and improve early detection of NPC. A prospective and population-based cohort study was conducted in southern China from 2006 through 2013. Among 22,186 participants, 1045 subjects with serum immunoglobulin A (IgA) antibodies against viral capsid antigen (VCA) titers >= 1: 5 were defined as high-risk group, and were then followed-up for NPC occurrence. Qualified nasopharyngeal swab specimens were available from 905 participants and used for quantitative PCR assay. Our study revealed that 89% (802/905) subjects showed positive EBV DNA in nasopharyngeal swab. The nasopharyngeal EBV load in females was higher than that in males. The nasopharyngeal EBV load increased with increasing serum VCA/IgA titers. Eight cases of newly diagnosed NPC showed an extremely elevated EBV load, and 87.5% (7 of 8 patients) were early-stage NPCs. The EBV loads of 8 NPCs were significantly higher than those of 897 NPC-free subjects (mean, 2.8x10(6) copies/swab [range 4.8x10(4)-1.1x10(8)] vs. 5.6x10(3) [range 0-3.8x10(6)]). Using mean EBV load in NPC-free population plus two standard deviations as cut-off value, a higher diagnostic performance was obtained for EBV load test than serum VCA/IgA test (area under ROC, 0.980 vs 0.895). In conclusion, in a prospective and population-based study we demonstrated that an additional assay of EBV load in the nasopharynx among high-risk individuals may reduce the number of subjects needed to be closely followed up and could serve as part of a NPC screening program in high-risk populations.	[Chen, Yufeng; Zhao, Weilin; Xiao, Xue; Zhou, Xiaoying; Ming, Huixin; Huang, Tingting; Huang, Guangwu; Zhang, Zhe] Guangxi Med Univ, Affiliated Hosp 1, Dept Otolaryngol Head & Neck Surg, Nanning, Guangxi, Peoples R China; [Chen, Yufeng; Lin, Longde; Huang, Tingting; Zeng, Xiaoyun; Huang, Guangwu; Zhang, Zhe] Guangxi Med Univ, Minist Educ, Key Lab High Incidence Tumor Prevent & Treatment, Nanning, Guangxi, Peoples R China; [Chen, Yufeng; Lin, Longde; Zeng, Xiaoyun] Guangxi Med Univ, Sch Publ Hlth, Dept Epidemiol, Nanning, Guangxi, Peoples R China; [Liao, Jian; Li, Yancheng] Canc Inst Cangwu Cty, Wuzhou, Guangxi, Peoples R China; [Ye, Weimin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Zhao, Weilin] Mie Univ, Grad Sch Med, Dept Environm & Mol Med, Tsu, Mie, Japan	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Karolinska Institutet; Mie University	Zhang, Z (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Otolaryngol Head & Neck Surg, Nanning, Guangxi, Peoples R China.	zhangzhe@gxmu.edu.cn	Zhou, Xiaoying/Y-4217-2019	Zhou, Xiaoying/0000-0003-3298-5089; Huang, Tingting/0000-0003-2314-4448	National Basic Research Program of China [2012CB526600, 2011CB504300]; Program for New Century Excellent Talents in University of the Ministry of Education of China [NCET-12-0654]; Natural Science Foundation of China [81272983]	National Basic Research Program of China(National Basic Research Program of China); Program for New Century Excellent Talents in University of the Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Basic Research Program of China (grant number: 2012CB526600, recipient: ZZ; grant number: 2011CB504300, recipient: GWH), Program for New Century Excellent Talents in University of the Ministry of Education of China (grant number: NCET-12-0654, recipient: ZZ) and Natural Science Foundation of China (grant number: 81272983, recipient: ZZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham M, 2013, CLIN CANCER RES, V19, P2175, DOI 10.1158/1078-0432.CCR-12-2897; Cao SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019100; Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chien YC, 2001, NEW ENGL J MED, V345, P1877, DOI 10.1056/NEJMoa011610; Fachiroh J, 2008, J CLIN MICROBIOL, V46, P1374, DOI 10.1128/JCM.01368-07; Fachiroh J, 2010, J VIROL METHODS, V169, P79, DOI 10.1016/j.jviromet.2010.07.001; Hao SP, 2003, CANCER, V97, P1909, DOI 10.1002/cncr.11312; Hatton OL, 2014, IMMUNOL RES, V58, P268, DOI 10.1007/s12026-014-8496-1; Ji MF, 2007, BRIT J CANCER, V96, P623, DOI 10.1038/sj.bjc.6603609; Ji MF, 2014, CANCER-AM CANCER SOC, V120, P1353, DOI 10.1002/cncr.28564; King AD, 2011, RADIOLOGY, V258, P531, DOI 10.1148/radiol.10101241; Kutok JL, 2006, ANNU REV PATHOL-MECH, V1, P375, DOI 10.1146/annurev.pathol.1.110304.100209; Lin JC, 2004, NEW ENGL J MED, V350, P2461, DOI 10.1056/NEJMoa032260; Lin SY, 2001, HEAD NECK-J SCI SPEC, V23, P194, DOI 10.1002/1097-0347(200103)23:3<194::AID-HED1018>3.0.CO;2-X; Liu ZW, 2013, AM J EPIDEMIOL, V177, P242, DOI 10.1093/aje/kws404; Lo YMD, 1999, CANCER RES, V59, P1188; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; MIDDELDORP JM, 1988, J VIROL METHODS, V21, P133, DOI 10.1016/0166-0934(88)90060-2; Ng RHW, 2014, OTOLARYNG HEAD NECK, V150, P602, DOI 10.1177/0194599813520136; Pak MW, 2009, LARYNGOSCOPE, V119, P523, DOI 10.1002/lary.20060; Paramita DK, 2009, CLIN VACCINE IMMUNOL, V16, P706, DOI 10.1128/CVI.00425-08; PATHMANATHAN R, 1995, NEW ENGL J MED, V333, P693, DOI 10.1056/NEJM199509143331103; Piazza C, 2008, ACTA OTORHINOLARYNGO, V28, P49; SHAM JST, 1989, CANCER, V64, P1838, DOI 10.1002/1097-0142(19891101)64:9<1838::AID-CNCR2820640914>3.0.CO;2-C; Stevens SJC, 2006, INT J CANCER, V119, P608, DOI 10.1002/ijc.21914; Wu HC, 2003, LAB INVEST, V83, P797, DOI 10.1097/01.LAB.0000074896.03561.FB; YI Z, 1980, INTERVIROLOGY, V13, P162, DOI 10.1159/000149121	28	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132669	10.1371/journal.pone.0132669	http://dx.doi.org/10.1371/journal.pone.0132669			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151639	Green Published, Green Submitted, gold			2022-12-27	WOS:000358158900052
J	Lunden, K; Danielsson, M; Durling, MB; Ihrmark, K; Gorriz, MN; Stenlid, J; Asiegbu, FO; Elfstrand, M				Lunden, Karl; Danielsson, Marie; Durling, Mikael Brandstrom; Ihrmark, Katarina; Gorriz, Miguel Nemesio; Stenlid, Jan; Asiegbu, Frederick O.; Elfstrand, Malin			Transcriptional Responses Associated with Virulence and Defence in the Interaction between Heterobasidion annosum s. s. and Norway Spruce	PLOS ONE			English	Article							GENE-EXPRESSION; BETA-GLUCOSIDASE; ACID DESATURASE; PICEA-ABIES; DROUGHT; STRESS; IDENTIFICATION; DEHYDRINS; BARK; PINE	Heterobasidion annosum sensu lato is a serious pathogen causing root and stem rot to conifers in the northern hemisphere and rendering the timber defective for sawing and pulping. In this study we applied next-generation sequencing to i) identify transcriptional responses unique to Heterobasidion-inoculated Norway spruce and ii) investigate the H. annosum transcripts to identify putative virulence factors. To address these objectives we wounded or inoculated 30-year-old Norway spruce clones with H. annosumand 454-sequenced the transcriptome of the interaction at 0, 5 and 15 days post inoculation. The 491860 high-quality reads were de novo assembled and the relative expression was analysed. Overall, very few H. annosum transcripts were represented in our dataset. Three delta-12 fatty acid desaturase transcripts and one Clavaminate synthase-like transcript, both associated with virulence in other pathosystems, were found among the significantly induced transcripts. The analysis of the Norway spruce transcriptional responses produced a handful of differentially expressed transcripts. Most of these transcripts originated from genes known to respond to H. annosum. However, three genes that had not previously been reported to respond to H. annosum showed specific induction to inoculation: an oxophytodienoic acid-reductase (OPR), a beta-glucosidaseand a germin-like protein (GLP2) gene. Even in a small data set like ours, five novel highly expressed Norway spruce transcripts without significant alignment to any previously annotated protein in Genbank but present in the P. abies (v1.0) gene catalogue were identified. Their expression pattern suggests a role in defence. Therefore a more complete survey of the transcriptional responses in the interactions between Norway spruce and its major pathogen H. annosumwould probably provide a better understanding of gymnosperm defence than accumulated until now.	[Lunden, Karl; Durling, Mikael Brandstrom; Ihrmark, Katarina; Gorriz, Miguel Nemesio; Stenlid, Jan; Elfstrand, Malin] Swedish Univ Agr Sci, Uppsala Bioctr, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden; [Danielsson, Marie] KTH Royal Inst Technol, Sch Chem Sci & Engn, Chem, Stockholm, Sweden; [Asiegbu, Frederick O.] Univ Helsinki, Dept Forest Sci, Helsinki, Finland	Swedish University of Agricultural Sciences; Royal Institute of Technology; University of Helsinki	Elfstrand, M (corresponding author), Swedish Univ Agr Sci, Uppsala Bioctr, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden.	Malin.Elfstrand@slu.se	Gorriz, Miguel Nemesio/S-6139-2019; Brandström Durling, Mikael/C-1213-2008; Stenlid, Jan/K-5909-2019	Gorriz, Miguel Nemesio/0000-0001-8052-8101; Brandström Durling, Mikael/0000-0001-6485-197X; Asiegbu, Fred O/0000-0003-0223-7194; Lunden, Karl/0000-0002-0817-2419; Stenlid, Jan/0000-0002-5344-2094; Elfstrand, Malin/0000-0002-0214-5284	Swedish Research council Formas [brg0312st2]; Swedish Foundation for Strategic Research (SSF) [R8b08-0011]	Swedish Research council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research)	Financial support was received from the Swedish Research council Formas, grant brg0312st2 (http://www.formas.se/en/), and from the Swedish Foundation for Strategic Research (SSF), grant number R8b08-0011 (www.stratresearch.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomas A, 2006, PHYSIOL MOL PLANT P, V69, P140, DOI 10.1016/j.pmpp.2007.04.001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arnerup J, 2013, PLANTA, V237, P1037, DOI 10.1007/s00425-012-1822-8; Bendz-Hellgren M, 1998, HETEROBASIDION ANNOSUM: BIOLOGY, ECOLOGY, IMPACT AND CONTROL, P333; Bottcher C, 2009, FEBS J, V276, P4693, DOI 10.1111/j.1742-4658.2009.07195.x; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Calvo AM, 2001, J BIOL CHEM, V276, P25766, DOI 10.1074/jbc.M100732200; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dalman K, 2010, MOL ECOL, V19, P4979, DOI 10.1111/j.1365-294X.2010.04873.x; Damude HG, 2006, P NATL ACAD SCI USA, V103, P9446, DOI 10.1073/pnas.0511079103; Danielsson M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-154; Deflorio G, 2011, PHYSIOL MOL PLANT P, V75, P180, DOI 10.1016/j.pmpp.2011.02.002; DHARMAWARDHANA DP, 1995, PLANT PHYSIOL, V107, P331, DOI 10.1104/pp.107.2.331; Eldhuset TD, 2013, PLANT SOIL, V366, P305, DOI 10.1007/s11104-012-1432-z; Fossdal CG, 2007, PHYSIOL MOL PLANT P, V70, P161, DOI 10.1016/j.pmpp.2007.09.002; Fossdal CG, 2012, TREE PHYSIOL, V32, P1137, DOI 10.1093/treephys/tps073; Franceschi VR, 2005, NEW PHYTOL, V167, P353, DOI 10.1111/j.1469-8137.2005.01436.x; Haas BJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-734; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Hietala AM, 2004, APPL ENVIRON MICROB, V70, P3948, DOI 10.1128/AEM.70.7.3948-3953.2004; Huang YS, 1999, LIPIDS, V34, P649, DOI 10.1007/s11745-999-0410-8; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Johnk N, 2005, TREE PHYSIOL, V25, P1533, DOI 10.1093/treephys/25.12.1533; Karlsson B., 1998, Forest Genetics, V5, P21; Karlsson M, 2003, FUNGAL GENET BIOL, V39, P51, DOI 10.1016/S1087-1845(02)00586-8; Koutaniemi S, 2007, PLANT MOL BIOL, V65, P311, DOI 10.1007/s11103-007-9220-5; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Marjamaa K, 2003, TREE PHYSIOL, V23, P977, DOI 10.1093/treephys/23.14.977; Minto RE, 2009, APPL ENVIRON MICROB, V75, P1156, DOI 10.1128/AEM.02049-08; Niemela T, 1998, HETEROBASIDION ANNOSUM: BIOLOGY, ECOLOGY, IMPACT AND CONTROL, P27; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Olson A, 2012, NEW PHYTOL, V194, P1001, DOI 10.1111/j.1469-8137.2012.04128.x; Otrosina WJ, 2010, FUNGAL BIOL-UK, V114, P16, DOI 10.1016/j.mycres.2009.09.001; Palovaara J, 2008, PLANT MOL BIOL, V66, P533, DOI 10.1007/s11103-008-9289-5; PARADKAR AS, 1995, J BACTERIOL, V177, P1307, DOI 10.1128/jb.177.5.1307-1314.1995; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Raacke IC, 2006, J PHYTOPATHOL, V154, P740, DOI 10.1111/j.1439-0434.2006.01191.x; Ralph SG, 2007, PHYTOCHEMISTRY, V68, P1975, DOI 10.1016/j.phytochem.2007.04.042; Richard S, 2000, PLANT MOL BIOL, V43, P1, DOI 10.1023/A:1006453811911; Sakuradani E, 1999, EUR J BIOCHEM, V261, P812, DOI 10.1046/j.1432-1327.1999.00333.x; STENLID J, 1991, MYCOL RES, V95, P1153, DOI 10.1016/S0953-7562(09)80004-X; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Swedjemark G, 1999, EUR J FOREST PATHOL, V29, P249; Urano D, 2014, ANNU REV PLANT BIOL, V65, P365, DOI 10.1146/annurev-arplant-050213-040133; Velasco-Conde T, 2012, TREE GENET GENOMES, V8, P957, DOI 10.1007/s11295-012-0476-9; Vestman D, 2011, TREE GENET GENOMES, V7, P347, DOI 10.1007/s11295-010-0336-4; Wilson RA, 2004, MICROBIOL-SGM, V150, P2881, DOI 10.1099/mic.0.27207-0; Yakovlev IA, 2008, PLANTA, V228, P459, DOI 10.1007/s00425-008-0750-0; Yaqoob N, 2012, PHYSIOL MOL PLANT P, V77, P10, DOI 10.1016/j.pmpp.2011.11.001; Zhang S, 2007, FEBS LETT, V581, P315, DOI 10.1016/j.febslet.2006.12.031; Zhang ZH, 2000, NAT STRUCT BIOL, V7, P127	53	20	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131182	10.1371/journal.pone.0131182	http://dx.doi.org/10.1371/journal.pone.0131182			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151363	Green Published, Green Submitted, gold			2022-12-27	WOS:000358158900019
J	Mizdrak, A; Scarborough, P; Waterlander, WE; Rayner, M				Mizdrak, Anja; Scarborough, Peter; Waterlander, Wilma E.; Rayner, Mike			Differential Responses to Food Price Changes by Personal Characteristic: A Systematic Review of Experimental Studies	PLOS ONE			English	Article							ENERGY-DENSE; CONSUMPTION; SUBSIDIES; OBESITY; POLICY; SUPERMARKET.; PURCHASES; TAXES; DIET	Background Fiscal interventions to improve population diet have been recommended for consideration by many organisations including the World Health Organisation and the United Nations and policies such as sugar-sweetened beverage taxes have been implemented at national and sub-national levels. However, concerns have been raised with respect to the differential impact of fiscal interventions on population sub-groups and this remains a barrier to implementation. Objective To examine how personal characteristics (such as socioeconomic status, sex, impulsivity, and income) moderate changes in purchases of targeted foods in response to food and beverage price changes in experimental settings. Design Systematic review Data Sources Online databases (PubMed, EMBASE, Web of Science, EconLit and PsycInfo), reference lists of previous reviews, and additional data from study authors. Study Selection We included randomised controlled trials where food and beverage prices were manipulated and reported differential effects of the intervention on participant sub-groups defined according to personal characteristics. Data Analysis Where possible, we extracted data to enable the calculation of price elasticities for the target foods by personal characteristic. Results 8 studies were included in the review. Across studies, the difference in price elasticity varied from 0.02 to 2.43 between groups within the same study. 11 out of the total of 18 comparisons of own-price elasticity estimates by personal characteristic differed by more than 0.2 between groups. Income related factors were the most commonly considered and there was an indication that own-price elasticity estimates do vary by income but the direction of this effect was not clear. Conclusion Experimental studies provide an opportunity to examine the differential effects of fiscal measures to improve population diets. Patterns in price sensitivity by personal characteristics are complex. General conclusions pertaining to the effects of personal characteristics on price sensitivity are not supported by the evidence, which shows heterogeneity between studies and populations.	[Mizdrak, Anja; Scarborough, Peter; Rayner, Mike] Univ Oxford, Nuffield Dept Populat Hlth, British Heart Fdn, Ctr Populat Approaches Noncommunicable Dis Preven, Oxford, England; [Waterlander, Wilma E.] Univ Auckland, Sch Populat Hlth, Natl Inst Hlth Innovat, Auckland 1, New Zealand	University of Oxford; University of Auckland	Mizdrak, A (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, British Heart Fdn, Ctr Populat Approaches Noncommunicable Dis Preven, Oxford, England.	anja.mizdrak@dph.ox.ac.uk	Scarborough, Peter/ABD-6111-2021	Scarborough, Peter/0000-0002-2378-2944; Waterlander, Wilma/0000-0003-0956-178X; Mizdrak, Anja/0000-0002-2897-3002	British Heart Foundation [FS/13/37/30295, 021/P&C/Core/2010/HPRG]; New Zealand National Heart Foundation [1570]; Health Research Council of New Zealand [HRC 13/724]	British Heart Foundation(British Heart Foundation); New Zealand National Heart Foundation; Health Research Council of New Zealand(Health Research Council of New Zealand)	AM is funded by a British Heart Foundation Non-Clinical Studentship (no. FS/13/37/30295). PS and MR are funded by the British Heart Foundation (Grant no. 021/P&C/Core/2010/HPRG). WW is funded by a Fellowship from the New Zealand National Heart Foundation (Grant 1570) and by a Programme Grant from the Health Research Council of New Zealand (HRC 13/724). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An RP, 2013, PUBLIC HEALTH NUTR, V16, P1215, DOI 10.1017/S1368980012004715; Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; Blakely T, 2011, J EPIDEMIOL COMMUN H, V65, P902, DOI 10.1136/jech.2010.118588; Chapman CD, 2013, OBESITY, V21, pE555, DOI 10.1002/oby.20579; Darmon N, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-66; Epstein LH, 2007, AM J CLIN NUTR, V86, P914, DOI 10.1093/ajcn/86.4.914; Epstein LH, 2012, AM J CLIN NUTR, V95, P789, DOI 10.3945/ajcn.111.024380; Epstein LH, 2010, PSYCHOL SCI, V21, P406, DOI 10.1177/0956797610361446; Eyles H, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001353; Food and Agriculture Organization of the United Nations, 2006, LIV LONG SHAD ENV IS; Giesen JCAH, 2012, APPETITE, V58, P6, DOI 10.1016/j.appet.2011.09.026; Green R, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3703; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Mhurchu CN, 2009, J EPIDEMIOL COMMUN H, V63, P850, DOI 10.1136/jech.2008.081109; MITTAL B, 1994, J MARKETING RES, V31, P533, DOI 10.2307/3151881; Nederkoorn C, 2011, APPETITE, V56, P760, DOI 10.1016/j.appet.2011.03.002; Raghubir P, 1998, J MARKETING RES, V35, P316, DOI 10.2307/3152030; Rao M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004277; Smed S, 2007, FOOD POLICY, V32, P624, DOI 10.1016/j.foodpol.2007.03.002; Thow AM, 2014, NUTR REV; Thow AM, 2010, B WORLD HEALTH ORGAN, V88, P609, DOI 10.2471/BLT.09.070987; United Nations General Assembly, 2012, POL DECL HIGH LEV M; Waterlander WE, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-11; World Health Organization, 2010, GLOBAL STATUS REPORT; Zhang Q, 2014, CURR OBES REP, V3, P171, DOI 10.1007/s13679-014-0099-6	25	12	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0130320	10.1371/journal.pone.0130320	http://dx.doi.org/10.1371/journal.pone.0130320			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EC	26151133	Green Published, gold, Green Submitted			2022-12-27	WOS:000358158900008
J	Barzenje, DA; Smastuen, MC; Liestol, K; Fossa, A; Delabie, J; Kolstad, A; Holte, H				Barzenje, Dlawer Abdulla; Smastuen, Milada Cvancarova; Liestol, Knut; Fossa, Alexander; Delabie, Jan; Kolstad, Arne; Holte, Harald			Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years	PLOS ONE			English	Article							NON-HODGKIN-LYMPHOMA; LOW-GRADE; RESPONSE CRITERIA; COMPETING RISKS; CLASSIFICATION; COMMITTEE; THERAPY; DISEASE; TRIAL	Purpose To investigate outcome for patients with follicular lymphoma (FL) stage I-II treated at a population-based referral institution with a median follow-up of 15 years. Overall and causespecific survival was compared to that of a sex, age and residency matched individuals from normal population. Material and Methods 404 patients with early stage FL treated between 1980 and 2005 were retrospectively analyzed. Two of three patients had stage I disease. Based on clinical characteristics, first line treatments were radiotherapy (RT) (48% of patients), chemotherapy (CT) (16%), combined chemo-and radiotherapy (CRT) (16%) or observation (OBS) (15%). Survival was modeled with Kaplan-Meier methodology. Multivariate analyses were performed with the Cox model. Results Fifteen years overall survival (OS), progression free survival (PFS) and time to next treatment (TNT) were 50% (95% confidence interval [CI]: 45-55), 42% (95% CI: 36-47) and 48% (95% CI, 42-54), respectively. For patients treated with RT 97% achieved a complete remission, and 15 year OS, PFS and TNT were 57% (95% CI, 50-64), 46% (95% CI, 3954) and 49% (95% CI, 42-57), respectively. Relapse rate after RT and CRT was 49% and 36%, respectively. Only 2% of patients who received RT or CRT relapsed inside the radiation field and 5% had isolated near-field relapse. No statistical differences were found between treatment groups regarding death from cardiovascular disease or incidence of second cancer. Compared to a matched normal population, non-lymphoma cancer mortality was higher among patients given RT, hazard ratio 1.66 (95% CI: 1.14-2.42; P<0.01). Compared to other treatment modalities, patients selected for observation without treatment did not have inferior outcome. Conclusions A differentiated treatment strategy in early stage FL results in long term survival for the majority of patients. OBS is a valid initial choice for selected patients without lymphoma-related symptoms.	[Barzenje, Dlawer Abdulla] Ostfold Hosp Trust, Dept Oncol, Fredrikstad, Norway; [Smastuen, Milada Cvancarova] Oslo Univ Hosp, Dept Biostat, Oslo, Norway; [Liestol, Knut] Univ Oslo, Ctr Canc Biomed, Oslo, Norway; [Liestol, Knut] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Fossa, Alexander; Kolstad, Arne; Holte, Harald] Oslo Univ Hosp, Dept Oncol, Oslo, Norway; [Delabie, Jan] Oslo Univ Hosp, Dept Pathol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Barzenje, DA (corresponding author), Ostfold Hosp Trust, Dept Oncol, Fredrikstad, Norway.	dlabar@so-hf.no	Holte, Harald/AAO-5647-2020	Delabie, Jan/0000-0001-5023-0689; Barzenje, Dlawer Abdulla/0000-0002-9364-6841	Ostfold Hospital Trust, Fredrikstad, Norway; Norwegian Cancer Society	Ostfold Hospital Trust, Fredrikstad, Norway; Norwegian Cancer Society(Norwegian Cancer Society)	Dlawer Abdulla Barzenje has been supported with grants from Ostfold Hospital Trust, Fredrikstad, Norway. Arne Kolstad and Harald Holte have both received a research grant from Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani R, 2004, J CLIN ONCOL, V22, P1454, DOI 10.1200/JCO.2004.10.086; Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213; Andre M, 2004, BLOOD, V103, P1222, DOI 10.1182/blood-2003-04-1124; Campbell BA, 2010, CANCER-AM CANCER SOC, V116, P3797, DOI 10.1002/cncr.25117; CARBONE PP, 1971, CANCER RES, V31, P1860; Chan WC, 1997, BLOOD, V89, P3909; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Cheson BD, 2014, J CLIN ONCOL, V32, P3059, DOI 10.1200/JCO.2013.54.8800; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Friedberg JW, 2012, J CLIN ONCOL, V30, P3368, DOI 10.1200/JCO.2011.40.6546; GALLAGHER CJ, 1986, J CLIN ONCOL, V4, P1470, DOI 10.1200/JCO.1986.4.10.1470; GOMEZ GA, 1986, AM J CLIN ONCOL-CANC, V9, P40, DOI 10.1097/00000421-198602000-00011; Guadagnolo BA, 2006, INT J RADIAT ONCOL, V64, P928, DOI 10.1016/j.ijrobp.2005.08.010; HARRIS NL, 1994, BLOOD, V84, P1361; HUDSON BV, 1994, BRIT J CANCER, V69, P1088, DOI 10.1038/bjc.1994.213; KELSEY SM, 1994, MED ONCOL, V11, P19, DOI 10.1007/BF02990087; LISTER TA, 1989, J CLIN ONCOL, V7, P1630, DOI 10.1200/JCO.1989.7.11.1630; Lowry L, 2011, RADIOTHER ONCOL, V100, P86, DOI 10.1016/j.radonc.2011.05.013; MacManus MP, 1996, J CLIN ONCOL, V14, P1282, DOI 10.1200/JCO.1996.14.4.1282; Martinelli G, 2010, J CLIN ONCOL, V28, P4480, DOI 10.1200/JCO.2010.28.4786; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; OLWENY CLM, 1990, J CLIN ONCOL, V8, P1598; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Seymour JF, 2003, J CLIN ONCOL, V21, P2115, DOI 10.1200/JCO.2003.07.111; Solal-Celigny P, 2004, BLOOD, V104, P1258, DOI 10.1182/blood-2003-12-4434; SOUBEYRAN P, 1988, RADIOTHER ONCOL, V13, P91, DOI 10.1016/0167-8140(88)90030-8; Soubeyran P, 1996, ANN ONCOL, V7, P713; STANSFELD AG, 1988, LANCET, V1, P292; Swerdlow SH, 2008, WHO CLASSIFICATION T; Wilder RB, 2001, INT J RADIAT ONCOL, V51, P1219, DOI 10.1016/S0360-3016(01)01747-3; YAHALOM J, 1993, CANCER, V71, P2342, DOI 10.1002/1097-0142(19930401)71:7<2342::AID-CNCR2820710728>3.0.CO;2-I	31	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131158	10.1371/journal.pone.0131158	http://dx.doi.org/10.1371/journal.pone.0131158			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147646	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600067
J	Dietrich, S; Hertrich, I; Ackermann, H				Dietrich, Susanne; Hertrich, Ingo; Ackermann, Hermann			Network Modeling for Functional Magnetic Resonance Imaging (fMRI) Signals during Ultra-Fast Speech Comprehension in Late-Blind Listeners	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; MACAQUE MONKEY; INFERIOR PULVINAR; MULTISENSORY CONVERGENCE; CORTICAL PROJECTIONS; ACTIVATION PATTERNS; SUPERIOR COLLICULUS; FUSIFORM GYRUS; RHESUS-MONKEY; AREA 17	In many functional magnetic resonance imaging (fMRI) studies blind humans were found to show cross-modal reorganization engaging the visual system in non-visual tasks. For example, blind people can manage to understand (synthetic) spoken language at very high speaking rates up to ca. 20 syllables/s (syl/s). FMRI data showed that hemodynamic activation within right-hemispheric primary visual cortex (V1), bilateral pulvinar (Pv), and left-hemispheric supplementary motor area (pre-SMA) covaried with their capability of ultra-fast speech (16 syllables/s) comprehension. It has been suggested that right V1 plays an important role with respect to the perception of ultra-fast speech features, particularly the detection of syllable onsets. Furthermore, left pre-SMA seems to be an interface between these syllabic representations and the frontal speech processing and working memory network. So far, little is known about the networks linking V1 to Pv, auditory cortex (A1), and (mesio-) frontal areas. Dynamic causal modeling (DCM) was applied to investigate (i) the input structure from A1 and Pv toward right V1 and (ii) output from right V1 and A1 to left pre-SMA. As concerns the input Pv was significantly connected to V1, in addition to A1, in blind participants, but not in sighted controls. Regarding the output V1 was significantly connected to pre-SMA in blind individuals, and the strength of V1-SMA connectivity correlated with the performance of ultra-fast speech comprehension. By contrast, in sighted controls, not understanding ultra-fast speech, pre-SMA did neither receive input from A1 nor V1. Taken together, right V1 might facilitate the "parsing" of the ultra-fast speech stream in blind subjects by receiving subcortical auditory input via the Pv (= secondary visual pathway) and transmitting this information toward contralateral pre-SMA.	[Dietrich, Susanne; Hertrich, Ingo; Ackermann, Hermann] Univ Tubingen, Dept Gen Neurol, Hertie Inst Clin Brain Res, Ctr Neurol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Dietrich, S (corresponding author), Univ Tubingen, Dept Gen Neurol, Hertie Inst Clin Brain Res, Ctr Neurol, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	susanne.dietrich@med.uni-tuebingen.de	Hertrich, Ingo/T-1154-2018	Hertrich, Ingo/0000-0001-8965-6249	German Research Foundation (DFG) [AC 55 9/01, HE 1573/4-1, HE 1573/6-2]; Hertie Institute for Clinical Brain Research, Tubingen	German Research Foundation (DFG)(German Research Foundation (DFG)); Hertie Institute for Clinical Brain Research, Tubingen	This study was supported by the German Research Foundation (DFG; AC 55 9/01, HE 1573/4-1, HE 1573/6-2) and Hertie Institute for Clinical Brain Research, Tubingen.	Abler B, 2006, MAGN RESON IMAGING, V24, P181, DOI 10.1016/j.mri.2005.10.022; Adams MM, 2000, J COMP NEUROL, V419, P377, DOI 10.1002/(SICI)1096-9861(20000410)419:3<377::AID-CNE9>3.0.CO;2-E; Amedi A, 2003, NAT NEUROSCI, V6, P758, DOI 10.1038/nn1072; Bar M, 2006, PSYCHOL SCI, V17, P645, DOI 10.1111/j.1467-9280.2006.01759.x; Bedny M, 2012, BRAIN LANG, V122, P162, DOI 10.1016/j.bandl.2011.10.005; Bedny M, 2011, P NATL ACAD SCI USA, V108, P4429, DOI 10.1073/pnas.1014818108; Bell AH, 2005, J NEUROPHYSIOL, V93, P3659, DOI 10.1152/jn.01214.2004; BENDER DB, 1988, PROG BRAIN RES, V75, P55; BENDER DB, 1981, J NEUROPHYSIOL, V46, P672, DOI 10.1152/jn.1981.46.3.672; BENEVENTO LA, 1976, BRAIN RES, V108, P1, DOI 10.1016/0006-8993(76)90160-8; Berman RA, 2011, J NEUROSCI, V31, P373, DOI 10.1523/JNEUROSCI.4738-10.2011; Berman RA, 2008, PROG BRAIN RES, V171, P467, DOI 10.1016/S0079-6123(08)00668-7; Bernstein L. E., 2004, HDB MULTISENSORY PRO, P203; Bolognini N, 2010, NEUROSCI LETT, V477, P109, DOI 10.1016/j.neulet.2010.04.044; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; Burr D, 2006, PROG BRAIN RES, V155, P243, DOI 10.1016/S0079-6123(06)55014-9; Burton H, 2006, HUM BRAIN MAPP, V27, P325, DOI 10.1002/hbm.20188; Clos M, 2014, HUM BRAIN MAPP, V35, P61, DOI 10.1002/hbm.22151; DIAMOND IT, 1969, SCIENCE, V164, P251, DOI 10.1126/science.164.3877.251; Dietrich S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00701; Dietrich S, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-74; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Foxe JJ, 2005, NEUROREPORT, V16, P419, DOI 10.1097/00001756-200504040-00001; Friederici AD, 2004, BRAIN LANG, V89, P267, DOI 10.1016/S0093-934X(03)00351-1; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gizewski ER, 2003, NEUROIMAGE, V19, P968, DOI 10.1016/S1053-8119(03)00114-9; Gray D, 1999, J COMP NEUROL, V409, P452, DOI 10.1002/(SICI)1096-9861(19990705)409:3<452::AID-CNE9>3.0.CO;2-I; Hertrich I, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00530; Hertrich I, 2013, BRAIN LANG, V124, P9, DOI 10.1016/j.bandl.2012.10.006; Hertrich I, 2009, NEUROCASE, V15, P163, DOI 10.1080/13554790802709054; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Kaas JH, 2007, BRAIN RES REV, V55, P285, DOI 10.1016/j.brainresrev.2007.02.008; Klinge C, 2010, J NEUROSCI, V30, P12798, DOI 10.1523/JNEUROSCI.2384-10.2010; Kotz SA, 2010, TRENDS COGN SCI, V14, P392, DOI 10.1016/j.tics.2010.06.005; Kotz SAE, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00086; Krumbholz K, 2000, J ACOUST SOC AM, V108, P1170, DOI 10.1121/1.1287843; Lambert S, 2004, COGNITIVE BRAIN RES, V20, P1; Leh SE, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/789539; Leo F, 2008, BRAIN, V131, P855, DOI 10.1093/brain/awn003; LEVITT JB, 1995, EXP BRAIN RES, V104, P419; LUND JS, 1975, J COMP NEUROL, V164, P287, DOI 10.1002/cne.901640303; Maleki N, 2012, HUM BRAIN MAPP, V33, P75, DOI 10.1002/hbm.21194; Martin E, 2002, MRI OF THE NEONATAL; OGREN MP, 1977, BRAIN RES, V137, P343, DOI 10.1016/0006-8993(77)90344-4; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Penny WD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000709; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; PETERSEN SE, 1985, J NEUROPHYSIOL, V54, P867, DOI 10.1152/jn.1985.54.4.867; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Poirier C, 2006, NEUROIMAGE, V31, P279, DOI 10.1016/j.neuroimage.2005.11.036; Raz N, 2005, CEREB CORTEX, V15, P1459, DOI 10.1093/cercor/bhi026; REZAK M, 1979, BRAIN RES, V167, P19, DOI 10.1016/0006-8993(79)90260-9; ROBINSON DL, 1993, PROG BRAIN RES, V95, P371, DOI 10.1016/S0079-6123(08)60382-9; Roder B, 2002, EUR J NEUROSCI, V16, P930, DOI 10.1046/j.1460-9568.2002.02147.x; Rosa MJ, 2010, NEUROIMAGE, V49, P217, DOI 10.1016/j.neuroimage.2009.08.051; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Sadato N, 2005, NEUROSCIENTIST, V11, P577, DOI 10.1177/1073858405277314; Schroeder CE, 2003, INT J PSYCHOPHYSIOL, V50, P5, DOI 10.1016/S0167-8760(03)00120-X; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Schwartze M, 2012, INT J PSYCHOPHYSIOL, V83, P200, DOI 10.1016/j.ijpsycho.2011.11.003; Shipp S, 2004, TRENDS COGN SCI, V8, P223, DOI 10.1016/j.tics.2004.03.004; Stephan KE, 2010, NEUROIMAGE, V49, P3099, DOI 10.1016/j.neuroimage.2009.11.015; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; Wong M, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00052	64	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132196	10.1371/journal.pone.0132196	http://dx.doi.org/10.1371/journal.pone.0132196			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148062	Green Submitted, gold, Green Published			2022-12-27	WOS:000358157600217
J	Kis, V; Barti, B; Lippai, M; Sass, M				Kis, Viktor; Barti, Benjamin; Lippai, Monika; Sass, Miklos			Specialized Cortex Glial Cells Accumulate Lipid Droplets in Drosophila melanogaster	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; MICE LACKING; STORAGE; GENES; FABP7; NEURODEGENERATION; LOCALIZATION; ORGANIZATION; HOMEOSTASIS; METABOLISM	Lipid droplets (LDs) are common organelles of the majority of eukaryotic cell types. Their biological significance has been extensively studied in mammalian liver cells and white adipose tissue. Although the central nervous system contains the highest relative amount and the largest number of different lipid species, neither the spatial nor the temporal distribution of LDs has been described. In this study, we used the brain of the fruitfly, Drosophila melanogaster, to investigate the neuroanatomy of LDs. We demonstrated that LDs are exclusively localised in glial cells but not in neurons in the larval nervous system. We showed that the brain's LD pool, rather than being constant, changes dynamically during development and reaches its highest value at the beginning of metamorphosis. LDs are particularly enriched in cortex glial cells located close to the brain surface. These specialized superficial cortex glial cells contain the highest amount of LDs among glial cell types and encapsulate neuroblasts and their daughter cells. Superficial cortex glial cells, combined with subperineurial glial cells, express the Drosophila fatty acid binding protein (Dfabp), as we have demonstrated through light-and electron microscopic immunocytochemistry. To the best of our best knowledge this is the first study that describes LD neuroanatomy in the Drosophila larval brain.	[Kis, Viktor; Barti, Benjamin; Lippai, Monika; Sass, Miklos] Eotvos Lorand Univ, Dept Anat Cell & Dev Biol, Budapest, Hungary	Eotvos Lorand University	Kis, V (corresponding author), Eotvos Lorand Univ, Dept Anat Cell & Dev Biol, Budapest, Hungary.	kis.viktor@gmail.com	Lippai, Monika/J-3740-2018	Lippai, Monika/0000-0002-7307-4233; Barti, Benjamin/0000-0002-1669-2246	Hungarian Scientific Research Funds [NK78012]; European Union; European Social Fund [TAMOP 4.2.1./B-09/KMR-2010-0003]	Hungarian Scientific Research Funds(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Union(European Commission); European Social Fund(European Social Fund (ESF))	This work was supported by grants from the Hungarian Scientific Research Funds provided to M. Sass (NK78012). The European Union and the European Social Fund have provided financial support to this project under grant agreement no. TAMOP 4.2.1./B-09/KMR-2010-0003 (http://www.otka.hu/en http://palyazat.gov.hu/doc/5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhein B, 2006, DEV BIOL, V296, P545, DOI 10.1016/j.ydbio.2006.04.460; ASHWORTH CT, 1960, AM J PHYSIOL, V198, P1326, DOI 10.1152/ajplegacy.1960.198.6.1326; Awasaki T, 2008, J NEUROSCI, V28, P13742, DOI 10.1523/JNEUROSCI.4844-08.2008; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648; CARLSON SD, 1990, ANNU REV ENTOMOL, V35, P597, DOI 10.1146/annurev.en.35.010190.003121; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Chang YY, 2010, FEBS LETT, V584, P1342, DOI 10.1016/j.febslet.2010.01.006; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; D'Alessandro Rosalba, 2010, Commun Integr Biol, V3, P576, DOI 10.4161/cib.3.6.13093; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Egger B, 2002, DEVELOPMENT, V129, P3295; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; FENG L, 1995, DEVELOPMENT, V121, P1719; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Gerstner JR, 2012, J NEUROSCI, V32, P1383, DOI 10.1523/JNEUROSCI.3228-11.2012; Greenberg AS, 2012, J CLIN INVEST, P121; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; GUYTON JR, 1989, AM J PATHOL, V134, P705; Kearney JB, 2004, DEV BIOL, V275, P473, DOI 10.1016/j.ydbio.2004.08.047; KEITH AD, 1967, COMP BIOCHEM PHYSIOL, V21, P587, DOI 10.1016/0010-406X(67)90455-0; Kretzschmar D, 2002, BRAIN RES BULL, V57, P121, DOI 10.1016/S0361-9230(01)00643-8; Kretzschmar Doris, 2005, Invertebrate Neuroscience, V5, P97, DOI 10.1007/s10158-005-0005-8; Kunte AS, 2006, CELL METAB, V3, P439, DOI 10.1016/j.cmet.2006.04.011; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; LANG PD, 1970, J CLIN INVEST, V49, P1479, DOI 10.1172/JCI106365; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; Liu RZ, 2010, INT J DEV BIOL, V54, P1229, DOI 10.1387/ijdb.092976rl; Matsumata M, 2012, STEM CELLS, V30, P1532, DOI 10.1002/stem.1124; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Muhlig-Versen M, 2005, J NEUROSCI, V25, P2865, DOI 10.1523/JNEUROSCI.5097-04.2005; Navarro JA, 2010, HUM MOL GENET, V19, P2828, DOI 10.1093/hmg/ddq183; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Owada Y, 2006, EUR J NEUROSCI, V24, P175, DOI 10.1111/j.1460-9568.2006.04855.x; Palm W, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002828; Pereanu W, 2005, DEV BIOL, V283, P191, DOI 10.1016/j.ydbio.2005.04.024; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Sandoval H, 2015, ELIFE; Schaap FG, 1999, CIRC RES, V85, P329, DOI 10.1161/01.RES.85.4.329; Siegrist SE, 2010, CURR BIOL, V20, P643, DOI 10.1016/j.cub.2010.01.060; Sousa-Nunes R, 2010, CURR OPIN NEUROBIOL, V20, P50, DOI 10.1016/j.conb.2009.12.005; Stork T, 2008, J NEUROSCI, V28, P587, DOI 10.1523/JNEUROSCI.4367-07.2008; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009; Tschape JA, 2002, EMBO J, V21, P6367, DOI 10.1093/emboj/cdf636; Unhavaithaya Y, 2012, GENE DEV, V26, P31, DOI 10.1101/gad.177436.111; WAKE K, 1974, J CELL BIOL, V63, P683, DOI 10.1083/jcb.63.2.683; Watanabe A, 2007, PLOS BIOL, V5, P2469, DOI 10.1371/journal.pbio.0050297; Welte MA, 2005, CURR BIOL, V15, P1266, DOI 10.1016/j.cub.2005.06.062; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; YANG SY, 1987, J BIOL CHEM, V262, P13027; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	56	30	30	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131250	10.1371/journal.pone.0131250	http://dx.doi.org/10.1371/journal.pone.0131250			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148013	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600074
J	Liu, HL; Osmani, AH; Osmani, SA				Liu, Hui-Lin; Osmani, Aysha H.; Osmani, Stephen A.			The Inner Nuclear Membrane Protein Src1 Is Required for Stable Post-Mitotic Progression into G1 in Aspergillus nidulans	PLOS ONE			English	Article							PORE-COMPLEX; ENVELOPE FORMATION; CELL-CYCLE; SCHIZOSACCHAROMYCES-JAPONICUS; CAENORHABDITIS-ELEGANS; ENDOPLASMIC-RETICULUM; CLOSED MITOSIS; CDC14 RELEASE; IN-VIVO; CHROMATIN	How membranes and associated proteins of the nuclear envelope (NE) are assembled specifically and inclusively around segregated genomes during exit from mitosis is incompletely understood. Inner nuclear membrane (INM) proteins play key roles by providing links between DNA and the NE. In this study we have investigated the highly conserved INM protein Src1 in Aspergillus nidulans and have uncovered a novel cell cycle response during post mitotic formation of G1 nuclei. Live cell imaging indicates Src1 could have roles during mitotic exit as it preferentially locates to the NE abscission points during nucleokinesis and to the NE surrounding forming daughter G1 nuclei. Deletion analysis further supported this idea revealing that although Src1 is not required for interphase progression or mitosis it is required for stable post-mitotic G1 nuclear formation. This conclusion is based upon the observation that in the absence of Src1 newly formed G1 nuclei are structurally unstable and immediately undergo architectural modifications typical of mitosis. These changes include NPC modifications that stop nuclear transport as well as disassembly of nucleoli. More intriguingly, the newly generated G1 nuclei then cycle between mitotic-and interphase- like states. The findings indicate that defects in post-mitotic G1 nuclear formation caused by lack of Src1 promote repeated failed attempts to generate stable G1 nuclei. To explain this unexpected phenotype we suggest a type of regulation that promotes repetition of defective cell cycle transitions rather than preventing progression past the defective cell cycle transition. We suggest the term "reboot regulation" to define this mode of cell cycle regulation. The findings are discussed in relationship to recent studies showing the Cdk1 master oscillator can entrain subservient oscillators that when uncoupled cause cell cycle transitions to be repeated.	[Liu, Hui-Lin; Osmani, Aysha H.; Osmani, Stephen A.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Osmani, SA (corresponding author), Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA.	osmani.2@osu.edu	Osmani, Stephen A./AAS-3904-2021		National Institutes of Health [GM042564]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (GM042564) to SAO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Anderson DJ, 2008, J CELL BIOL, V182, P911, DOI 10.1083/jcb.200805140; Anderson DJ, 2007, NAT CELL BIOL, V9, P1160, DOI 10.1038/ncb1636; Anderson DJ, 2009, J CELL BIOL, V186, P183, DOI 10.1083/jcb.200901106; Antonin W, 2005, MOL CELL, V17, P83, DOI 10.1016/j.molcel.2004.12.010; Antonin W, 2008, FEBS LETT, V582, P2004, DOI 10.1016/j.febslet.2008.02.067; Aoki K, 2011, GENES CELLS, V16, P911, DOI 10.1111/j.1365-2443.2011.01540.x; Bapteste E, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r85; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Brachner A, 2011, BIOCHEM SOC T, V39, P1735, DOI 10.1042/BST20110724; De Souza CP, 2011, EMBO J, V30, P2648, DOI 10.1038/emboj.2011.176; De Souza CP, 2009, TRENDS GENET, V25, P545, DOI 10.1016/j.tig.2009.10.005; De Souza CPC, 2007, EUKARYOT CELL, V6, P1521, DOI 10.1128/EC.00178-07; De Souza CPC, 2004, CURR BIOL, V14, P1973, DOI 10.1016/j.cub.2004.10.050; FIDDY C, 1976, J GEN MICROBIOL, V97, P169, DOI 10.1099/00221287-97-2-169; Field MC, 2014, TRAFFIC, V15, P141, DOI 10.1111/tra.12141; Gonzalez Y, 2012, NUCLEUS-PHILA, V3, P60, DOI 10.4161/nucl.18824; Grund SE, 2008, J CELL BIOL, V182, P897, DOI 10.1083/jcb.200803098; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Ibarra A, 2015, GENE DEV, V29, P337, DOI 10.1101/gad.256495.114; Ikegami K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r120; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Liu HL, 2009, MOL BIOL CELL, V20, P616, DOI 10.1091/mbc.E08-06-0628; Liu J, 2003, P NATL ACAD SCI USA, V100, P4598, DOI 10.1073/pnas.0730821100; Lu L, 2011, J CELL BIOL, V194, P425, DOI 10.1083/jcb.201012063; Lu Y, 2010, CELL, V141, P268, DOI 10.1016/j.cell.2010.03.021; Mans BJ, 2004, CELL CYCLE, V3, P1612; Manzoni R, 2010, J CELL BIOL, V190, P209, DOI 10.1083/jcb.201002026; Markossian S, 2015, MOL BIOL CELL, V26, P605, DOI 10.1091/mbc.E14-09-1359; Mekhail K, 2008, NATURE, V456, P667, DOI 10.1038/nature07460; OCONNELL MJ, 1992, EMBO J, V11, P2139, DOI 10.1002/j.1460-2075.1992.tb05273.x; Oikonomou C, 2010, CURR OPIN GENET DEV, V20, P605, DOI 10.1016/j.gde.2010.08.006; Osmani AH, 2006, NAT PROTOC, V1, P2517, DOI 10.1038/nprot.2006.406; Osmani AH, 2006, MOL BIOL CELL, V17, P4946, DOI 10.1091/mbc.E06-07-0657; OSMANI SA, 1987, J CELL BIOL, V104, P1495, DOI 10.1083/jcb.104.6.1495; Rasala BA, 2008, MOL BIOL CELL, V19, P3982, DOI 10.1091/mbc.E08-01-0012; Rodriguez-Navarro S, 2002, YEAST, V19, P43, DOI 10.1002/yea.803; Rotem A, 2009, MOL BIOL CELL, V20, P4031, DOI 10.1091/mbc.E09-02-0150; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Sazer S, 2014, CURR BIOL, V24, pR1099, DOI 10.1016/j.cub.2014.10.011; Smoyer CJ, 2014, CURR OPIN CELL BIOL, V26, P1, DOI 10.1016/j.ceb.2013.08.002; Steglich B, 2012, NUCLEUS-PHILA, V3, P77, DOI 10.4161/nucl.18825; Suelmann R, 1997, MOL MICROBIOL, V25, P757, DOI 10.1046/j.1365-2958.1997.5131873.x; Taddei A, 2004, ANNU REV GENET, V38, P305, DOI 10.1146/annurev.genet.37.110801.142705; Ukil L, 2009, MOL BIOL CELL, V20, P2132, DOI 10.1091/mbc.E08-10-1046; Ulbert S, 2006, FEBS LETT, V580, P6435, DOI 10.1016/j.febslet.2006.10.060; Ulbert S, 2006, J CELL BIOL, V173, P469, DOI 10.1083/jcb.200512078; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Webster M, 2009, J CELL SCI, V122, P1477, DOI 10.1242/jcs.037333; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Yam C, 2013, CURR BIOL, V23, P2303, DOI 10.1016/j.cub.2013.09.057; Yam C, 2011, CURR BIOL, V21, P1314, DOI 10.1016/j.cub.2011.06.052; Yewdell WT, 2011, MOL BIOL CELL, V22, P1375, DOI 10.1091/mbc.E10-06-0554	56	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132489	10.1371/journal.pone.0132489	http://dx.doi.org/10.1371/journal.pone.0132489			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147902	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600286
J	Rodrigues, AS; Correia, M; Gomes, A; Pereira, SL; Perestrelo, T; Sousa, MI; Ramalho-Santos, J				Rodrigues, Ana Sofia; Correia, Marcelo; Gomes, Andreia; Pereira, Sandro L.; Perestrelo, Tania; Sousa, Maria Ines; Ramalho-Santos, Joao			Dichloroacetate, the Pyruvate Dehydrogenase Complex and the Modulation of mESC Pluripotency	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; COLORECTAL-CANCER CELLS; TUMOR-SUPPRESSOR; KINASE M2; METABOLISM; DIFFERENTIATION; P53; INHIBITION; GLYCOLYSIS; APOPTOSIS	Introduction The pyruvate dehydrogenase (PDH) complex is localized in the mitochondrial matrix catalyzing the irreversible decarboxylation of pyruvate to acetyl-CoA and NADH. For proper complex regulation the E1-alpha subunit functions as an on/off switch regulated by phosphorylation/dephosphorylation. In different cell types one of the four-pyruvate dehydrogenase kinase isoforms (PDHK1-4) can phosphorylate this subunit leading to PDH inactivation. Our previous results with human Embryonic Stem Cells (hESC), suggested that PDHK could be a key regulator in the metabolic profile of pluripotent cells, as it is upregulated in pluripotent stem cells. Therefore, we wondered if metabolic modulation, via inexpensive pharmacological inhibition of PDHK, could impact metabolism and pluripotency. Methods/Results In order to assess the importance of the PDH cycle in mouse Embryonic Stem Cells (mESC), we incubated cells with the PDHK inhibitor dichloroacetate (DCA) and observed that in its presence ESC started to differentiate. Changes in mitochondrial function and proliferation potential were also found and protein levels for PDH (both phosphorylated and non-phosphorylated) and PDHK1 were monitored. Interestingly, we were also able to describe a possible pathway that involves Hif-1 alpha and p53 during DCA-induced loss of pluripotency. Results with ESCs treated with DCA were comparable to those obtained for cells grown without Leukemia Inhibitor Factor (LIF), used in this case as a positive control for differentiation. Conclusions DCA negatively affects ESC pluripotency by changing cell metabolism and elements related to the PDH cycle, suggesting that PDHK could function as a possible metabolic gatekeeper in ESC, and may be a good target to modulate metabolism and differentiation. Although further molecular biology-based experiments are required, our data suggests that inactive PDH favors pluripotency and that ESC have similar strategies as cancer cells to maintain a glycolytic profile, by using some of the signaling pathways found in the latter cells.	[Rodrigues, Ana Sofia; Correia, Marcelo; Gomes, Andreia; Perestrelo, Tania] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, PhD Programme Expt Biol & Biomed, Coimbra, Portugal; [Rodrigues, Ana Sofia; Correia, Marcelo; Pereira, Sandro L.; Perestrelo, Tania; Sousa, Maria Ines; Ramalho-Santos, Joao] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Correia, Marcelo; Gomes, Andreia; Perestrelo, Tania] Univ Coimbra, Inst Interdisciplinary Res IIIUC, Coimbra, Portugal; [Gomes, Andreia] Biocant Ctr Innovat Biotechnol, Cantanhede, Portugal; [Sousa, Maria Ines; Ramalho-Santos, Joao] Univ Coimbra, Dept Life Sci, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	Ramalho-Santos, J (corresponding author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal.	jramalho@ci.uc.pt	Santos, João/HHZ-5595-2022; Ramalho-Santos, João/F-8641-2012; Rodrigues, Ana Sofia/ABA-9042-2020; Correia, Marcelo/W-4213-2017; Perestrelo, Tânia Marisa Melim/ABC-5495-2020	Ramalho-Santos, João/0000-0002-1172-4018; Rodrigues, Ana Sofia/0000-0001-7060-879X; Correia, Marcelo/0000-0002-3163-9582; Perestrelo, Tânia Marisa Melim/0000-0001-8995-6620; Sousa, Maria Ines/0000-0001-5443-5868; Cardoso Pereira, Sandro Lino/0000-0001-9498-3965	Fundacao para a Ciencia e a Tecnologia (FCT) Portugal [PTDC/EBB-EBI/ 120634/2010, PDTC/QUI-BIQ/120652/2010]; Compete/FEDER/National Funds; QREN [Centro-01-0762-FEDER-00204]; FCT [PEst-C/SAU/LA0001/2011];  [SFRH/BD/33463/2008];  [SFRH/BD/51681/2011];  [SFRH/BD/51684/2011];  [SFRH/BD/51968/2012];  [SFRH/BPD/98995/2013]	Fundacao para a Ciencia e a Tecnologia (FCT) Portugal(Portuguese Foundation for Science and Technology); Compete/FEDER/National Funds; QREN; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); ; ; ; ; 	The authors thank Fundacao para a Ciencia e a Tecnologia (FCT) Portugal for grant support (PTDC/EBB-EBI/ 120634/2010 and PDTC/QUI-BIQ/120652/2010 co-funded by Compete/FEDER/National Funds; and scholarships attributed to ASR (SFRH/BD/33463/2008); to MC (SFRH/BD/51681/2011), to TP (SFRH/BD/51684/2011), AG (SFRH/BD/51968/2012) and SLP (SFRH/BPD/98995/2013) and also to QREN (Centro-01-0762-FEDER-00204). Center for Neuroscience and Cell Biology (CNC) funding is also supported by FCT (PEst-C/SAU/LA0001/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abildgaard C, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0247-5; Amaral S, 2009, MITOCHONDRION, V9, P41, DOI 10.1016/j.mito.2008.11.005; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Babu E, 2011, ONCOGENE, V30, P4026, DOI 10.1038/onc.2011.113; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Branco AF, 2011, CARDIOVASC TOXICOL, V11, P191, DOI 10.1007/s12012-011-9111-5; Chambers Kari T, 2011, J Biol Chem, V286, P11155, DOI 10.1074/jbc.M110.217349; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Dingley S, 2012, METHODS MOL BIOL, V837, P231, DOI 10.1007/978-1-61779-504-6_16; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Floryk D, 1999, BIOSCIENCE REP, V19, P27, DOI 10.1023/A:1020193906974; Folmes CDL, 2013, J CARDIOVASC TRANSL, V6, P10, DOI 10.1007/s12265-012-9431-2; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Lee S, 2009, AGING CELL, V8, P296, DOI 10.1111/j.1474-9726.2009.00477.x; Lin G, 2014, BRIT J CANCER, V111, P375, DOI 10.1038/bjc.2014.281; Luo WB, 2011, ONCOTARGET, V2, P551; Ma WZ, 2007, J BIOENERG BIOMEMBR, V39, P243, DOI 10.1007/s10863-007-9083-0; Madhok BM, 2010, BRIT J CANCER, V102, P1746, DOI 10.1038/sj.bjc.6605701; Mahler M, 2012, AUTOIMMUN REV, V11, P771, DOI 10.1016/j.autrev.2012.02.012; Manganelli G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029321; Mayers RM, 2005, BIOCHEM SOC T, V33, P367, DOI 10.1042/BST0330367; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Nair RP, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt186; Niewisch MR, 2012, CELL PHYSIOL BIOCHEM, V29, P373, DOI 10.1159/000338492; O'Connor MD, 2008, STEM CELLS, V26, P1109, DOI 10.1634/stemcells.2007-0801; O'Connor MD, 2011, METHODS MOL BIOL, V690, P67, DOI 10.1007/978-1-60761-962-8_4; Ohtsuka M, 2006, GENES GENET SYST, V81, P143, DOI 10.1266/ggs.81.143; Parnas D, 1998, BRAIN RES PROTOC, V2, P333, DOI 10.1016/S1385-299X(98)00009-9; Pereira SL, 2014, HUM REPROD UPDATE, V20, P924, DOI 10.1093/humupd/dmu034; Pereira SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082095; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Pistollato F, 2010, BIOCHEM PHARMACOL, V80, P1517, DOI 10.1016/j.bcp.2010.08.003; Prigione A, 2014, STEM CELLS, V32, P364, DOI 10.1002/stem.1552; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Roche TE, 2001, PROG NUCLEIC ACID RE, V70, P33, DOI 10.1016/S0079-6603(01)70013-X; Rodrigues AR, 2012, MOL CELL ENDOCRINOL, V361, P69, DOI 10.1016/j.mce.2012.03.011; Schieke SM, 2008, J BIOL CHEM, V283, P28506, DOI 10.1074/jbc.M802763200; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; STOCCHI V, 1985, ANAL BIOCHEM, V146, P118, DOI 10.1016/0003-2697(85)90405-1; Strumilo S, 2005, ACTA BIOCHIM POL, V52, P759; Sun RC, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-142; Sutendra G, 2013, ONCOGENE, V32, P1638, DOI 10.1038/onc.2012.198; Teslaa T, 2014, PLURIPOTENT STEM CEL; Varum S, 2009, STEM CELL RES, V3, P142, DOI 10.1016/j.scr.2009.07.002; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Venigalla RKC, 2013, EMBO J, V32, P1008, DOI 10.1038/emboj.2013.40; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wicks RT, 2015, NEURO-ONCOLOGY, V17, P70, DOI 10.1093/neuonc/nou143; Xie Y, 2014, STEM CELL REP, V3, P743, DOI 10.1016/j.stemcr.2014.09.021; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71	57	25	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131663	10.1371/journal.pone.0131663	http://dx.doi.org/10.1371/journal.pone.0131663			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147621	gold, Green Submitted, Green Published			2022-12-27	WOS:000358157600121
J	Wang, CY; Lai, MD; Phan, NN; Sun, ZD; Lin, YC				Wang, Chih-Yang; Lai, Ming-Derg; Phan, Nam Nhut; Sun, Zhengda; Lin, Yen-Chang			Meta-Analysis of Public Microarray Datasets Reveals Voltage-Gated Calcium Gene Signatures in Clinical Cancer Patients	PLOS ONE			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; PROSTATE-CANCER; BREAST-CANCER; CELL-GROWTH; EXPRESSION SIGNATURE; IN-VITRO; CHANNEL ANTAGONISTS; INTERNATIONAL-UNION; METASTATIC PATTERN; ANDROGEN RECEPTOR	Voltage-gated calcium channels (VGCCs) are well documented to play roles in cell proliferation, migration, and apoptosis; however, whether VGCCs regulate the onset and progression of cancer is still under investigation. The VGCC family consists of five members, which are L-type, N-type, T-type, R-type and P/Q type. To date, no holistic approach has been used to screen VGCC family genes in different types of cancer. We analyzed the transcript expression of VGCCs in clinical cancer tissue samples by accessing ONCOMINE (www.oncomine.org), a web-based microarray database, to perform a systematic analysis. Every member of the VGCCs was examined across 21 different types of cancer by comparing mRNA expression in cancer to that in normal tissue. A previous study showed that altered expression of mRNA in cancer tissue may play an oncogenic role and promote tumor development; therefore, in the present findings, we focus only on the overexpression of VGCCs in different types of cancer. This bioinformatics analysis revealed that different subtypes of VGCCs (CACNA1C, CACNA1D, CACNA1B, CACNA1G, and CACNA1I) are implicated in the development and progression of diverse types of cancer and show dramatic up-regulation in breast cancer. CACNA1F only showed high expression in testis cancer, whereas CACNA1A, CACNA1C, and CACNA1D were highly expressed in most types of cancer. The current analysis revealed that specific VGCCs likely play essential roles in specific types of cancer. Collectively, we identified several VGCC targets and classified them according to different cancer subtypes for prospective studies on the underlying carcinogenic mechanisms. The present findings suggest that VGCCs are possible targets for prospective investigation in cancer treatment.	[Wang, Chih-Yang] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Wang, Chih-Yang; Lai, Ming-Derg] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Wang, Chih-Yang; Lai, Ming-Derg] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Phan, Nam Nhut] Ton Duc Thang Univ, Fac Sci Appl, Ho Chi Minh, Vietnam; [Sun, Zhengda] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Lin, Yen-Chang] Chinese Culture Univ, Grad Inst Biotechnol, Taipei, Taiwan	University of California System; University of California San Francisco; National Cheng Kung University; National Cheng Kung University; Ton Duc Thang University; University of California System; University of California San Francisco; Chinese Culture University	Wang, CY (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	lycnthu@gmail.com	Lai, Ming-Derg/M-8028-2014; Phan, Nam Nhut/GLU-3273-2022	Wang, Chih-Yang/0000-0002-4137-5074	National Science Council (NSC) of the Executive Yuan, Taiwan [NSC 101-2320-B-034-001]; Ministry of Science and Technology [MOST103-2325-B006-012, 104-2917-I-006-002]; National Science Council, Taiwan	National Science Council (NSC) of the Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	Computational analyses and data mining were performed using the system provided by the Bioinformatics Core at the National Cheng Kung University, supported by the National Science Council, Taiwan. The authors thank the National Science Council (NSC) of the Executive Yuan, Taiwan [NSC 101-2320-B-034-001] for the grant. The authors also thank the Ministry of Science and Technology for the grants MOST103-2325-B006-012 and 104-2917-I-006-002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Aragon-Ching JB, 2007, CLIN CANCER RES, V13, P1644, DOI 10.1158/1078-0432.CCR-07-0096; Arredouani MS, 2009, CLIN CANCER RES, V15, P5794, DOI 10.1158/1078-0432.CCR-09-0911; Ayata C, 2000, NEUROSCIENCE, V95, P639; Azimi I, 2014, BRIT J PHARMACOL, V171, P945, DOI 10.1111/bph.12486; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Battistini S, 1999, NEUROLOGY, V53, P38, DOI 10.1212/WNL.53.1.38; BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bertolesi GE, 2002, MOL PHARMACOL, V62, P210, DOI 10.1124/mol.62.2.210; Bhat S, 2012, PROG NEUROBIOL, V99, P1, DOI 10.1016/j.pneurobio.2012.06.001; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bidaud I, 2006, BBA-MOL CELL RES, V1763, P1169, DOI 10.1016/j.bbamcr.2006.08.049; Bohn G, 2000, FEBS LETT, V481, P73, DOI 10.1016/S0014-5793(00)01979-7; BOLAND LM, 1993, J NEUROSCI, V13, P516; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; BORST MJ, 1993, SURGERY, V114, P637; Bourinet E, 1999, NAT NEUROSCI, V2, P407, DOI 10.1038/8070; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Cain SM, 2011, BIOFACTORS, V37, P197, DOI 10.1002/biof.158; Carlin KP, 2000, EUR J NEUROSCI, V12, P1635, DOI 10.1046/j.1460-9568.2000.00055.x; Catterall WA, 2003, PHARMACOL REV, V55, P579, DOI 10.1124/pr.55.4.8; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chambers KF, 2011, JOURNAL OF BIOMEDICA, V18, P1; Chaudhuri D, 2004, J NEUROSCI, V24, P6334, DOI 10.1523/JNEUROSCI.1712-04.2004; Chen Q, 2014, PHARMACOEPIDEM DR S, V23, P711, DOI 10.1002/pds.3645; Chen RB, 2014, UROL ONCOL-SEMIN ORI, V32, P524, DOI 10.1016/j.urolonc.2013.05.011; Cho JY, 2011, CLIN CANCER RES, V17, P1850, DOI 10.1158/1078-0432.CCR-10-2180; Choi DL, 2014, BIOORG MED CHEM LETT, V24, P1565, DOI 10.1016/j.bmcl.2014.01.071; CHUNG SC, 1994, BRIT J PHARMACOL, V113, P861, DOI 10.1111/j.1476-5381.1994.tb17072.x; CODIGNOLA A, 1993, J BIOL CHEM, V268, P26240; Coghlin C, 2010, J PATHOL, V222, P1, DOI 10.1002/path.2727; Coustan-Smith E, 2011, BLOOD, V117, P6267, DOI 10.1182/blood-2010-12-324004; Crabtree JS, 2009, CANCER RES, V69, P6171, DOI 10.1158/0008-5472.CAN-08-4471; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; Cui JA, 2011, NUCLEIC ACIDS RES, V39, P1197, DOI 10.1093/nar/gkq960; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Cutcliffe C, 2005, CLIN CANCER RES, V11, P7986, DOI 10.1158/1078-0432.CCR-05-1354; D'Ambrogio A, 2013, NAT REV CANCER, V13, P283, DOI 10.1038/nrc3485; D'Errico M, 2009, EUR J CANCER, V45, P461, DOI 10.1016/j.ejca.2008.10.032; Detwiller KY, 2005, CANCER RES, V65, P5881, DOI 10.1158/0008-5472.CAN-04-4078; DIVERSEPIERLUISSI M, 1995, NEURON, V14, P191, DOI 10.1016/0896-6273(95)90254-6; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Dziegielewska B, 2014, MOL CANCER RES, V12, P348, DOI 10.1158/1541-7786.MCR-13-0485; Dziegielewska B, 2014, PFLUG ARCH EUR J PHY, V466, P801, DOI 10.1007/s00424-014-1444-z; Enfissi A, 2004, CELL CALCIUM, V36, P459, DOI 10.1016/j.ceca.2004.04.004; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Ewald JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055414; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gazulla J, 2007, NEUROLOGIA, V22, P511; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Guida S, 2001, AM J HUM GENET, V68, P759, DOI 10.1086/318804; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Gyorffy B, 2012, BREAST CANCER RES TR, V132, P1025, DOI 10.1007/s10549-011-1676-y; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hahnfeldt P, 1999, CANCER RES, V59, P4770; Hall DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096866; Hao Y, 2006, GASTROENTEROLOGY, V131, P925, DOI 10.1053/j.gastro.2006.04.026; HARRIS M, 1984, BRIT J CANCER, V50, P23, DOI 10.1038/bjc.1984.135; Haverstick DM, 2000, CANCER RES, V60, P1002; Hoheisel JD, 2006, NAT REV GENET, V7, P200, DOI 10.1038/nrg1809; HUGUENARD JR, 1992, J NEUROSCI, V12, P3804, DOI 10.1523/jneurosci.12-10-03804.1992; JAVIER BV, 1967, DIS CHEST, V52, P481, DOI 10.1378/chest.52.4.481; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Kito M, 1996, SEIZURE, V5, P115; Kono S, 2014, BBA CLIN, V2, P56, DOI 10.1016/j.bbacli.2014.09.005; Krenek P, 2009, EUR J HEART FAIL, V11, P140, DOI 10.1093/eurjhf/hfn026; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; LaTulippe E, 2002, CANCER RES, V62, P4499; Lee JY, 2006, BIOORG MED CHEM LETT, V16, P5014, DOI 10.1016/j.bmcl.2006.07.046; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; LEE KS, 1983, NATURE, V302, P790, DOI 10.1038/302790a0; Lipskaia L, 2004, BIOL CELL, V96, P55, DOI 10.1016/j.biolcel.2003.11.001; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; Logsdon CD, 2003, CANCER RES, V63, P2649; Lory P, 2006, CELL CALCIUM, V40, P135, DOI 10.1016/j.ceca.2006.04.017; Loughlin KR, 2014, UROL ONCOL-SEMIN ORI, V32, P537, DOI 10.1016/j.urolonc.2013.08.001; Luo JH, 2002, MOL CARCINOGEN, V33, P25, DOI 10.1002/mc.10018; Luo WB, 2012, P NATL ACAD SCI USA, V109, pE3367, DOI 10.1073/pnas.1217394109; MACKIE K, 1992, P NATL ACAD SCI USA, V89, P3825, DOI 10.1073/pnas.89.9.3825; Magee JA, 2001, CANCER RES, V61, P5692; Mariot P, 2000, PROSTATE, V43, P205; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; Mermelstein PG, 1996, J NEUROSCI, V16, P595; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; Ni M, 2011, CANCER CELL, V20, P119, DOI 10.1016/j.ccr.2011.05.026; Nindl I, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-30; OLIVERA BM, 1994, ANNU REV BIOCHEM, V63, P823, DOI 10.1146/annurev.bi.63.070194.004135; Padera TP, 2002, SCIENCE, V296, P1883, DOI 10.1126/science.1071420; Panner A, 2006, CELL CALCIUM, V40, P253, DOI 10.1016/j.ceca.2006.04.029; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Pesch K, 2003, INVEST OPHTH VIS SCI, V44, P2260, DOI 10.1167/iovs.02-0115; Pierro C, 2014, J CELL SCI, V127, P1607, DOI 10.1242/jcs.141408; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Prevarskaya N, 2010, TRENDS MOL MED, V16, P107, DOI 10.1016/j.molmed.2010.01.005; Quade BJ, 2004, GENE CHROMOSOME CANC, V40, P97, DOI 10.1002/gcc.20018; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; RANDALL A, 1995, J NEUROSCI, V15, P2995; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Schreiber R, 2005, J MEMBRANE BIOL, V205, P129, DOI 10.1007/s00232-005-0778-z; Schuchert Matthew J, 2003, Curr Treat Options Oncol, V4, P65, DOI 10.1007/s11864-003-0033-8; Segarra NG, 2014, J NEUROL SCI, V342, P69, DOI 10.1016/j.jns.2014.04.027; Shinagare AB, 2011, AM J ROENTGENOL, V196, P117, DOI 10.2214/AJR.10.5036; Skotheim RI, 2005, CANCER RES, V65, P5588, DOI 10.1158/0008-5472.CAN-05-0153; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Storz MN, 2003, J INVEST DERMATOL, V120, P865, DOI 10.1046/j.1523-1747.2003.12142.x; Su AI, 2001, CANCER RES, V61, P7388; Su LJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-140; Szatkowski C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-156; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; TANG SQ, 1993, NEURON, V11, P1013, DOI 10.1016/0896-6273(93)90215-D; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Taylor JT, 2008, WORLD J GASTROENTERO, V14, P4984, DOI 10.3748/wjg.14.4984; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Triggle DJ, 2007, BIOCHEM PHARMACOL, V74, P1, DOI 10.1016/j.bcp.2007.01.016; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; UCHITEL OD, 1992, P NATL ACAD SCI USA, V89, P3330, DOI 10.1073/pnas.89.8.3330; Vanaja DK, 2003, CANCER RES, V63, P3877; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; WEISS JH, 1990, SCIENCE, V247, P1474, DOI 10.1126/science.2157282; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; Winston CB, 2000, AM J ROENTGENOL, V175, P795, DOI 10.2214/ajr.175.3.1750795; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; Zhai Y, 2007, CANCER RES, V67, P10163, DOI 10.1158/0008-5472.CAN-07-2056; Zhan FH, 2006, BLOOD, V108, p969A, DOI 10.1182/blood.V108.11.3393.3393; Zhuang LY, 2002, LAB INVEST, V82, P1755, DOI 10.1097/01.LAB.0000043910.41414.E7	141	68	69	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0125766	10.1371/journal.pone.0125766	http://dx.doi.org/10.1371/journal.pone.0125766			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147197	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600008
J	Xiong, B; Li, D; Wang, JL; Gyawali, L; Jing, JJ; Su, L				Xiong, Bin; Li, Dan; Wang, Jianling; Gyawali, Laxman; Jing, Jinjin; Su, Li			The Effect of Catheter Ablation on Left Atrial Size and Function for Patients with Atrial Fibrillation: An Updated Meta-Analysis	PLOS ONE			English	Article							TIME 3-DIMENSIONAL ECHOCARDIOGRAPHY; PULMONARY VEIN ISOLATION; TERM-FOLLOW-UP; ANTRUM ISOLATION; RHYTHM; ASSOCIATION; RECURRENCE; PREDICTOR; VOLUMES; IMPACT	Background Catheter ablation (CA) for atrial fibrillation (AF) is now an important therapeutic modality for patients with AF. However, data regarding changes in left atrial (LA) function after CA have indicated conflicting results depending on the AF types, follow-up period, and the analytical imaging tools. The objective of this review was to analyze the effect of CA on the LA size and function for patients with AF. Methods We searched for studies regarding LA size and function pre- and post-ablation in PubMed, Embase, the Cochrane Library, and Web of Knowledge through May 2014. LA function was measured by LA ejective fraction (LAEF), LA active ejective fraction (LAAEF), or both. Total and subgroup analyses were implemented using Cochrane Review Manager Version 5.2. Weighted mean differences with 95% confidence intervals were used to express the results of continuous outcomes using fixed or random effect models. I-2 was used to calculate heterogeneity. To assess publication bias, Egger's test and Begg's funnel plot were performed using Stata 12.0. Results Twenty-five studies (2040 enrolled patients) were selected for this meta-analysis. The LA diameter (LAD), maximum LA volume, and minimal LA volume were significantly decreased post-ablation, as compared with those at a pre-ablation visit. Compared with the pre-ablation outcomes, we found no significant differences in LAEF/LAAEF at a post-ablation follow-up. Decreases in LA volume and LAEF remained significant post-ablation for paroxysmal AF (PAF); however, the LAEF was insignificant changes in persistent AF (PeAF). Heterogeneity was significant in spite which individual study was excluded. A publication bias was not found. In a meta-regression analysis, we did not find any factor that contributed to the heterogeneity. Conclusion With CA, LA volumes and LAD were decreased significantly in patients with AF; LAEF was not significant changes in patients with PeAF but decreased in those with PAF.	[Xiong, Bin; Li, Dan; Wang, Jianling; Gyawali, Laxman; Jing, Jinjin; Su, Li] Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiol, Chongqing Cardiac Arrhythmias Serv Ctr, Chongqing, Peoples R China	Chongqing Medical University	Xiong, B (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiol, Chongqing Cardiac Arrhythmias Serv Ctr, Chongqing, Peoples R China.	sulicq@163.com						Arbelo E, 2012, EUROPACE, V14, P1094, DOI 10.1093/europace/eus153; Beukema WP, 2005, CIRCULATION, V112, P2089, DOI 10.1161/CIRCULATIONAHA.104.484766; Calkins H, 2007, HEART RHYTHM, V4, P816, DOI 10.1016/j.hrthm.2007.04.005; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Cheitlin MD, 2003, CIRCULATION, V108, P1146, DOI 10.1161/01.CIR.0000073597.57414.A9; Choi JI, 2008, CIRC J, V72, P2051, DOI 10.1253/circj.CJ-08-0428; Dagres N, 2009, ACTA CARDIOL, V64, P167, DOI 10.2143/AC.64.2.2035339; Delgado V, 2008, AM J CARDIOL, V101, P1285, DOI 10.1016/j.amjcard.2007.12.028; Erdei T, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-11; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Hesse B, 2004, Eur J Echocardiogr, V5, P86, DOI 10.1016/S1525-2167(03)00046-5; Hof IE, 2014, J INTERV CARD ELECTR, V39, P201, DOI 10.1007/s10840-013-9860-0; Jahnke C, 2011, INT J CARDIOL, V153, P42, DOI 10.1016/j.ijcard.2010.08.034; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Jeevanantham V, 2010, AM J CARDIOL, V105, P1317, DOI 10.1016/j.amjcard.2009.12.046; Lemola K, 2005, HEART RHYTHM, V2, P923, DOI 10.1016/j.hrthm.2005.06.026; Lemola K, 2004, HEART RHYTHM, V1, P576, DOI 10.1016/j.hrthm.2004.07.020; Liu ZH, 2008, J INTERV CARD ELECTR, V23, P167, DOI 10.1007/s10840-008-9301-7; Machino-Ohtsuka T, 2013, CIRC J, V77, P1695, DOI 10.1253/circj.CJ-12-1518; Marsan NA, 2008, AM J CARDIOL, V102, P847, DOI 10.1016/j.amjcard.2008.05.048; Masuda M, 2012, PACE, V35, P327, DOI 10.1111/j.1540-8159.2011.03284.x; McGann CJ, 2008, J AM COLL CARDIOL, V52, P1263, DOI 10.1016/j.jacc.2008.05.062; Miyasaka Y, 2007, J AM COLL CARDIOL, V49, P986, DOI 10.1016/j.jacc.2006.10.062; Miyazaki S, 2011, J CARDIOVASC ELECTR, V22, P621, DOI 10.1111/j.1540-8167.2010.01984.x; Montserrat S, 2011, AM J CARDIOL, V108, P1741, DOI 10.1016/j.amjcard.2011.07.041; Muller H, 2008, EUROPACE, V10, P1073, DOI 10.1093/europace/eun187; Nori D, 2009, J INTERV CARD ELECTR, V26, P109, DOI 10.1007/s10840-009-9409-4; Perea RJ, 2008, J CARDIOVASC ELECTR, V19, P374, DOI 10.1111/j.1540-8167.2007.01086.x; Reant P, 2005, CIRCULATION, V112, P2896, DOI 10.1161/CIRCULATIONAHA.104.523928; Rodrigues ACT, 2009, AM J CARDIOL, V103, P395, DOI 10.1016/j.amjcard.2008.09.094; Shin SH, 2008, J AM SOC ECHOCARDIOG, V21, P697, DOI 10.1016/j.echo.2007.10.022; Sohns C, 2013, EUR HEART J-CARD IMG, V14, P684, DOI 10.1093/ehjci/jet017; Teh AW, 2012, HEART RHYTHM, V9, P473, DOI 10.1016/j.hrthm.2011.11.013; Tops LF, 2007, HEART, V93, P1461, DOI 10.1136/hrt.2007.116467; Tops LF, 2011, J AM COLL CARDIOL, V57, P324, DOI 10.1016/j.jacc.2010.05.063; Tops LF, 2006, AM J CARDIOL, V97, P1220, DOI 10.1016/j.amjcard.2005.11.043; Tsao HM, 2005, J CARDIOVASC ELECTR, V16, P7, DOI 10.1046/j.1540-8167.2005.04407.x; Uchiyama T, 2013, CIRC J, V77, P2722, DOI 10.1253/circj.CJ-13-0468; Verma A, 2006, J CARDIOVASC ELECTR, V17, P741, DOI 10.1111/j.1540-8167.2006.00488.x; Wazni O, 2011, NEW ENGL J MED, V365, P2296, DOI 10.1056/NEJMct1109977; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yoshida N, 2013, ECHOCARDIOGR-J CARD, V30, P744, DOI 10.1111/echo.12143	42	19	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0129274	10.1371/journal.pone.0129274	http://dx.doi.org/10.1371/journal.pone.0129274			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147984	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600019
J	Zhang, SX; Wu, SH; Chen, YY; Tian, WM				Zhang, Shi-Xin; Wu, Shao-Hua; Chen, Yue-Yi; Tian, Wei-Min			Analysis of Differentially Expressed Genes Associated with Coronatine-Induced Laticifer Differentiation in the Rubber Tree by Subtractive Hybridization Suppression	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASES; BRASILIENSIS MUELL. ARG.; EXOGENOUS JASMONIC ACID; HEVEA-BRASILIENSIS; METHYL JASMONATE; ARABIDOPSIS-THALIANA; CALCIUM; STRESS; METALLOTHIONEIN; RESPONSES	The secondary laticifer in the secondary phloem is differentiated from the vascular cambia of the rubber tree (Hevea brasiliensis Muell. Arg.). The number of secondary laticifers is closely related to the rubber yield potential of Hevea. Pharmacological data show that jasmonic acid and its precursor linolenic acid are effective in inducing secondary laticifer differentiation in epicormic shoots of the rubber tree. In the present study, an experimental system of coronatine-induced laticifer differentiation was developed to perform SSH identification of genes with differential expression. A total of 528 positive clones were obtained by blue-white screening, of which 248 clones came from the forward SSH library while 280 clones came from the reverse SSH library. Approximately 215 of the 248 clones and 171 of the 280 clones contained cDNA inserts by colony PCR screening. A total of 286 of the 386 ESTs were detected to be differentially expressed by reverse northern blot and sequenced. Approximately 147 unigenes with an average length of 497 bp from the forward and 109 unigenes with an average length of 514 bp from the reverse SSH libraries were assembled and annotated. The unigenes were associated with the stress/defense response, plant hormone signal transduction and structure development. It is suggested that Ca2+ signal transduction and redox seem to be involved in differentiation, while PGA and EIF are associated with the division of cambium initials for COR-induced secondary laticifer differentiation in the rubber tree.	[Zhang, Shi-Xin] Hainan Univ, Coll Hort, Haikou 570228, Hainan, Peoples R China; [Zhang, Shi-Xin; Wu, Shao-Hua; Chen, Yue-Yi; Tian, Wei-Min] CATAS, Key Lab Biol & Genet Resources Rubber Tree, State Key Lab Incubat Base Cultivat & Physiol Tro, Minist Agr,Crops Rubber Res Inst, Danzhou 571737, Hainan, Peoples R China	Hainan University; Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Tian, WM (corresponding author), CATAS, Key Lab Biol & Genet Resources Rubber Tree, State Key Lab Incubat Base Cultivat & Physiol Tro, Minist Agr,Crops Rubber Res Inst, Danzhou 571737, Hainan, Peoples R China.	wmtian@163.com			Open Foundation of Key Laboratory of Rubber Biology and Genetic Resources of Rubber Tree, Ministry of Agriculture, China [KLOF0906]; Special Program for Key Basic Research of Ministry of Science and Technology, China [2012CB723005]; Earmarked Fund for China Agriculture Research System [CARS-34-GW1]	Open Foundation of Key Laboratory of Rubber Biology and Genetic Resources of Rubber Tree, Ministry of Agriculture, China; Special Program for Key Basic Research of Ministry of Science and Technology, China; Earmarked Fund for China Agriculture Research System	This work was supported by the Open Foundation of Key Laboratory of Rubber Biology and Genetic Resources of Rubber Tree, Ministry of Agriculture, China (KLOF0906), the Special Program for Key Basic Research of the Ministry of Science and Technology, China (2012CB723005) and the Earmarked Fund for China Agriculture Research System (CARS-34-GW1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananieva EA, 2008, PLANT PHYSIOL, V148, P1868, DOI 10.1104/pp.108.130575; BENEDETTI CE, 1995, PLANT PHYSIOL, V109, P567, DOI 10.1104/pp.109.2.567; Berardini TZ, 2004, PLANT PHYSIOL, V135, P745, DOI 10.1104/pp.104.040071; Bressan RA, 2001, PLANT PHYSIOL, V127, P1354, DOI 10.1104/pp.010752; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Fiorani M, 2013, J NUTR BIOCHEM, V24, P467, DOI 10.1016/j.jnutbio.2012.01.009; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Geng XQ, 2014, PLANTA, V240, P1149, DOI 10.1007/s00425-014-2151-x; Gl W, 1998, NATURE, V393, P365; Hao BZ, 2000, ANN BOT-LONDON, V85, P37, DOI 10.1006/anbo.1999.0995; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; ICHIHARA A, 1977, J AM CHEM SOC, V99, P636, DOI 10.1021/ja00444a067; Ivashuta S, 2005, PLANT CELL, V17, P2911, DOI 10.1105/tpc.105.035394; Kaye Y, 2011, PLANT PHYSIOL, V157, P229, DOI 10.1104/pp.111.176883; Kim J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9r87; Kim MC, 2009, MOL PLANT, V2, P13, DOI 10.1093/mp/ssn091; Lanciano P, 2013, BIOCHEMISTRY-US, V52, P7196, DOI 10.1021/bi400561e; Lanteri ML, 2006, J EXP BOT, V57, P1341, DOI 10.1093/jxb/erj109; Leferink NGH, 2008, FEBS J, V275, P713, DOI 10.1111/j.1742-4658.2007.06233.x; Li HP, 2011, PLANT SCI, V181, P132, DOI 10.1016/j.plantsci.2011.04.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mano J, 2004, ARCH BIOCHEM BIOPHYS, V429, P71, DOI 10.1016/j.abb.2004.05.022; Mehlmer N, 2010, PLANT J, V63, P484, DOI 10.1111/j.1365-313X.2010.04257.x; Milburn JA, 1996, J EXP BOT, V47, P135, DOI 10.1093/jxb/47.1.135; Munemasa S, 2007, PLANT PHYSIOL, V143, P1398, DOI 10.1104/pp.106.091298; Pandey N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-216; Qiu YJ, 2012, PLANT MOL BIOL, V79, P89, DOI 10.1007/s11103-012-9896-z; Rangaswamy V, 1998, P NATL ACAD SCI USA, V95, P15469, DOI 10.1073/pnas.95.26.15469; Tian WM, 2013, J PLANT PHYSIOL, V170, P723, DOI 10.1016/j.jplph.2012.12.019; Tian WM, 2003, ACTA BOT SIN, V45, P1366; Vadassery J, 2012, PLANT PHYSIOL, V159, P1159, DOI 10.1104/pp.112.198150; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Y, 2012, EURASIP J ADV SIG PR, P1, DOI 10.1186/1687-6180-2012-40; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Wasternack C, 2010, PLANT SIGNAL BEHAV, V5, P337, DOI 10.4161/psb.5.4.11574; Wong HL, 2004, PLANT PHYSIOL, V135, P1447, DOI 10.1104/pp.103.036384; Xia CA, 2010, PLANT J, V63, P189, DOI 10.1111/j.1365-313X.2010.04237.x; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu JY, 2011, PLANT MOL BIOL, V75, P167, DOI 10.1007/s11103-010-9716-2; Xue TT, 2009, J EXP BOT, V60, P339, DOI 10.1093/jxb/ern291; Yang DH, 2012, PLANT PHYSIOL, V159, P1591, DOI 10.1104/pp.112.199018; Zhao Y, 2011, J PLANT PHYSIOL, V168, P1649, DOI 10.1016/j.jplph.2011.02.010; Zhu JH, 2010, PLANT PHYSIOL BIOCH, V48, P710, DOI 10.1016/j.plaphy.2010.04.004	43	11	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132070	10.1371/journal.pone.0132070	http://dx.doi.org/10.1371/journal.pone.0132070			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147807	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600195
J	Zhou, YR; Sun, P; Wang, T; Chen, KX; Zhu, WL; Wang, HY				Zhou, Yuren; Sun, Peng; Wang, Ting; Chen, Kaixian; Zhu, Weiliang; Wang, Heyao			Inhibition of Calcium Influx Reduces Dysfunction and Apoptosis in Lipotoxic Pancreatic beta-Cells via Regulation of Endoplasmic Reticulum Stress	PLOS ONE			English	Article							FREE FATTY-ACIDS; INDUCED ER STRESS; INSULIN-SECRETION; GLUCOSE-INSENSITIVITY; GENE-EXPRESSION; PALMITATE; FAILURE; GPR40; ACTIVATION; MECHANISMS	Lipotoxicity plays an important role in pancreatic beta-cell failure during the development of type 2 diabetes. Prolonged exposure of beta-cells to elevated free fatty acids level could cause deterioration of beta-cell function and induce cell apoptosis. Therefore, inhibition of fatty acids-induced beta-cell dysfunction and apoptosis might provide benefit for the therapy of type 2 diabetes. The present study examined whether regulation of fatty acids-triggered calcium influx could protect pancreatic beta-cells from lipotoxicity. Two small molecule compounds, L-type calcium channel blocker nifedipine and potassium channel activator diazoxide were used to inhibit palmitic acid-induced calcium influx. And whether the compounds could reduce palmitic acid-induced beta-cell failure and the underlying mechanism were also investigated. It was found that both nifedipine and diazoxide protected MIN6 pancreatic beta-cells and primary cultured murine islets from palmitic acid-induced apoptosis. Meanwhile, the impaired insulin secretion was also recovered to varying degrees by these two compounds. Our results verified that nifedipine and diazoxide could reduce palmitic acid-induced endoplasmic reticulum stress to generate protective effects on pancreatic beta-cells. More importantly, it suggested that regulation of calcium influx by small molecule compounds might provide benefits for the prevention and therapy of type 2 diabetes.	[Zhou, Yuren; Sun, Peng; Wang, Ting; Chen, Kaixian; Zhu, Weiliang; Wang, Heyao] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Sun, Peng; Chen, Kaixian] Shanghai Univ Tradit Chinese Med, Sch Pharm, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai University of Traditional Chinese Medicine	Wang, HY (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.	hywang@simm.ac.cn	Sun, Peng/AAU-2124-2021	Sun, Peng/0000-0002-7820-712X	Shanghai Natural Science Foundation [14ZR1447700]; National Natural Science Foundation of China [81473262, 81072681]; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" [2012ZX09301001-001, 2013ZX09103001-001]	Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program"	This work was supported by grant from Shanghai Natural Science Foundation (14ZR1447700), National Natural Science Foundation of China (81473262, 81072681), National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" (2012ZX09301001-001, 2013ZX09103001-001).	Arora DK, 2013, APOPTOSIS, V18, P1, DOI 10.1007/s10495-012-0763-9; Casas S, 2008, DIABETOLOGIA, V51, P2252, DOI 10.1007/s00125-008-1111-z; Cernea S, 2013, BIOCHEM MEDICA, V23, P266; Chang I, 2004, J IMMUNOL, V172, P7008, DOI 10.4049/jimmunol.172.11.7008; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; Cnop M, 2010, DIABETES OBES METAB, V12, P76, DOI 10.1111/j.1463-1326.2010.01279.x; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Diakogiannaki E, 2008, BIOCHEM SOC T, V36, P959, DOI 10.1042/BST0360959; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; Giacca A, 2011, AM J PHYSIOL-ENDOC M, V300, pE255, DOI 10.1152/ajpendo.00416.2010; Gromada J, 2006, ENDOCRINOLOGY, V147, P672, DOI 10.1210/en.2005-1388; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hu H, 2009, BIOCHEM BIOPH RES CO, V390, P557, DOI 10.1016/j.bbrc.2009.10.004; Iglesias P, 2014, EUR J ENDOCRINOL, V170, pR147, DOI 10.1530/EJE-13-1012; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; Kaiser N, 2005, DIABETES, V54, pS137, DOI 10.2337/diabetes.54.suppl_2.S137; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kim YH, 2009, INT J TOXICOL, V28, P151, DOI 10.1177/1091581809336885; Kristinsson H, 2013, ENDOCRINOLOGY, V154, P4078, DOI 10.1210/en.2013-1352; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; Minami K, 2000, AM J PHYSIOL-ENDOC M, V279, pE773, DOI 10.1152/ajpendo.2000.279.4.E773; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Remizov O, 2003, MOL CELL ENDOCRINOL, V212, P1, DOI 10.1016/j.mce.2003.09.026; RORSMAN P, 1989, P NATL ACAD SCI USA, V86, P4505, DOI 10.1073/pnas.86.12.4505; Sargsyan E, 2008, J ENDOCRINOL, V199, P41, DOI 10.1677/JOE-08-0251; Sun P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066744; Choi E, 2007, MOL CELL ENDOCRINOL, V272, P50, DOI 10.1016/j.mce.2007.04.004; Tan C, 2013, PURINERG SIGNAL, V9, P67, DOI 10.1007/s11302-012-9331-6; Trus M, 2007, BIOCHEMISTRY-US, V46, P14461, DOI 10.1021/bi7016816; Wang T, 2014, J AGR FOOD CHEM, V62, P5038, DOI 10.1021/jf500387d; Wang W, 2003, J NEUROCYTOL, V32, P143, DOI 10.1023/B:NEUR.0000005599.10952.33; Wang Y, 2011, INT J MOL SCI, V12, P7569, DOI 10.3390/ijms12117569; Wu JW, 2012, J CELL BIOCHEM, V113, P1152, DOI 10.1002/jcb.23450; Yanagida K, 2002, PEPTIDES, V23, P135, DOI 10.1016/S0196-9781(01)00589-7; Zhang XD, 2010, BIOMED PHARMACOTHER, V64, P647, DOI 10.1016/j.biopha.2010.06.008	42	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132411	10.1371/journal.pone.0132411	http://dx.doi.org/10.1371/journal.pone.0132411			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147439	gold, Green Submitted, Green Published			2022-12-27	WOS:000358157600263
J	Wang, YQ; Momohara, A; Wang, L; Lebreton-Anberree, J; Zhou, ZK				Wang, Yuqing; Momohara, Arata; Wang, Li; Lebreton-Anberree, Julie; Zhou, Zhekun			Evolutionary History of Atmospheric CO2 during the Late Cenozoic from Fossilized Metasequoia Needles	PLOS ONE			English	Article							MIDDLE EOCENE; REVISED MODEL; ICE VOLUME; SW CHINA; CLIMATE; CARBON; PLIOCENE; ISOTOPE; GINKGO; LEAVES	The change in ancient atmospheric CO2 concentrations provides important clues for understanding the relationship between the atmospheric CO2 concentration and global temperature. However, the lack of CO2 evolution curves estimated from a single terrestrial proxy prevents the understanding of climatic and environmental impacts due to variations in data. Thus, based on the stomatal index of fossilized Metasequoia needles, we reconstructed a history of atmospheric CO2 concentrations from middle Miocene to late Early Pleistocene when the climate changed dramatically. According to this research, atmospheric CO2 concentration was stabile around 330-350 ppmv in the middle and late Miocene, then it decreased to 278-284 ppmv during the Late Pliocene and to 277-279 ppmv during the Early Pleistocene, which was almost the same range as in preindustrial time. According to former research, this is a time when global temperature decreased sharply. Our results also indicated that from middle Miocene to Pleistocene, global CO2 level decreased by more than 50 ppmv, which may suggest that CO2 decrease and temperature decrease are coupled.	[Wang, Yuqing; Wang, Li; Lebreton-Anberree, Julie; Zhou, Zhekun] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla 666303, Peoples R China; [Wang, Yuqing; Lebreton-Anberree, Julie] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhou, Zhekun] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming 650204, Peoples R China; [Momohara, Arata] Chiba Univ, Grad Sch Hort, Chiba 2718510, Japan; [Wang, Li] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Cent Lab, Mengla 666303, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chiba University; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Zhou, ZK (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla 666303, Peoples R China.	zhouzk@xtbg.ac.cn	Wang, yuqing/HIR-1604-2022; Zhou, Zhekun/G-5281-2011	Zhou, Zhekun/0000-0002-0710-2128	973 programme of Ministry of Science and Technology of the People's Republic of China [2012CB821901]; National Natural Science Foundation of China (NSFC) [1300188]; Chinese Academy of Sciences 135 program [XTBG-F01]; State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS) [123108]	973 programme of Ministry of Science and Technology of the People's Republic of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences 135 program; State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS)(Chinese Academy of Sciences)	The work was supported by the following: 1. 973 programme of Ministry of Science and Technology of the People's Republic of China (2012CB821901), Receiver: ZZK, URL: http://www.973.gov.cn/Default_3.aspx; 2. National Natural Science Foundation of China (NSFC, No. 1300188), Receiver: WL, URL: http://www.nsfc.gov.cn/; 3. Chinese Academy of Sciences 135 program (XTBG-F01), Receiver: ZZK, URL: http://www.xtbg.ac.cn/yisanwu/; and 4. State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS) (No. 123108),	Badger MPS, 2013, PALEOCEANOGRAPHY, V28, DOI 10.1002/palo.20015; Bai YJ, 2015, GLOBAL CHANGE BIOL, V21, P874, DOI 10.1111/gcb.12670; BASINGER JF, 1981, CAN J BOT, V59, P2379, DOI 10.1139/b81-291; Beerling DJ, 2011, NAT GEOSCI, V4, P418, DOI 10.1038/ngeo1186; Beerling DJ, 1999, FOSSIL PLANTS SPORES, P251; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; BERNER RA, 1994, AM J SCI, V294, P56, DOI 10.2475/ajs.294.1.56; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; De Schepper S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081508; Domingo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063739; Doria G, 2011, AM J SCI, V311, P63, DOI 10.2475/01.2011.03; Edenhofer O., 2014, CONTRIBUTION WORKING; FLOWER BP, 1994, PALAEOGEOGR PALAEOCL, V108, P537, DOI 10.1016/0031-0182(94)90251-8; Foster GL, 2012, EARTH PLANET SC LETT, V341, P243, DOI 10.1016/j.epsl.2012.06.007; Ge H-R., 1999, CENOZOIC COAL BEARIN; Grein M, 2013, PALAEOGEOGR PALAEOCL, V374, P41, DOI 10.1016/j.palaeo.2012.12.025; Henderiks J, 2008, EARTH PLANET SC LETT, V269, P575, DOI 10.1016/j.epsl.2008.03.016; Horiuchi J, 1996, NEOGENE FLORA KANTO, V17, P109; Jones TP., 1999, FOSSIL PLANTS SPORES; KERP H, 1990, Palaios, V5, P548, DOI 10.2307/3514861; Kimura T, 1984, T P PALEONTOLOGICAL, V122, P87; Knorr G, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048873; Kobayashi M, 2011, J GEOLOGICAL SOC JAP, V117, P632; Kurschner WM, 2008, P NATL ACAD SCI USA, V105, P449, DOI 10.1073/pnas.0708588105; Kurschner WM, 1996, MAR MICROPALEONTOL, V27, P299, DOI 10.1016/0377-8398(95)00067-4; Kurschner WM, 1996, THESIS UTRECHT U; Lacis AA, 2010, SCIENCE, V330, P356, DOI 10.1126/science.1190653; LePage BA., 2005, GEOBIOLOGY ECOLOGY M; Li L, 2011, EARTH PLANET SC LETT, V309, P10, DOI 10.1016/j.epsl.2011.04.016; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Mitamura Muneki, 1992, Quaternary Research (Tokyo), V31, P159; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Mosbrugger V, 2005, P NATL ACAD SCI USA, V102, P14964, DOI 10.1073/pnas.0505267102; Pagani M, 2005, GEOCHIM COSMOCHIM AC, V69, P953, DOI 10.1016/j.gca.2004.07.029; Pearson PN, 2001, NATURE, V414, P470, DOI 10.1038/35106617; Peng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095282; Quan C, 2009, CRETACEOUS RES, V30, P424, DOI 10.1016/j.cretres.2008.08.004; Raupach MR, 2010, CURR OPIN ENV SUST, V2, P210, DOI 10.1016/j.cosust.2010.04.003; RAYMO ME, 1994, ANNU REV EARTH PL SC, V22, P353, DOI 10.1146/annurev.ea.22.050194.002033; Retallack GJ, 2009, PALAEOGEOGR PALAEOCL, V281, P57, DOI 10.1016/j.palaeo.2009.07.011; Roth-Nebelsick A, 2014, REV PALAEOBOT PALYNO, V206, P1, DOI 10.1016/j.revpalbo.2014.03.001; Royer DL, 2006, GEOCHIM COSMOCHIM AC, V70, P5665, DOI 10.1016/j.gca.2005.11.031; Royer DL, 2001, REV PALAEOBOT PALYNO, V114, P1, DOI 10.1016/S0034-6667(00)00074-9; Royer DL, 2001, SCIENCE, V292, P2310, DOI 10.1126/science.292.5525.2310; Ruddiman WF, 2003, QUATERNARY SCI REV, V22, P1597, DOI 10.1016/S0277-3791(03)00087-8; Salisbury EJ, 1982, PHILOS T ROY SOC LON, V216, P1; Satoguchi Y, 2012, J GEOL SOC JPN S, V118, P70, DOI DOI 10.5575/geosoc.2012.0035; Satoguchi Y, 2012, ISL ARC, V21, P149, DOI 10.1111/j.1440-1738.2012.00816.x; Seki O, 2010, EARTH PLANET SC LETT, V292, P201, DOI 10.1016/j.epsl.2010.01.037; Shevenell AE, 2004, SCIENCE, V305, P1766, DOI 10.1126/science.1100061; Shevenell AE, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001736; Smith RY, 2010, PALAEOGEOGR PALAEOCL, V293, P120, DOI 10.1016/j.palaeo.2010.05.006; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stults DZ, 2011, PALAEOGEOGR PALAEOCL, V309, P327, DOI 10.1016/j.palaeo.2011.06.017; Sun BN, 2012, TURK J EARTH SCI, V21, P237, DOI 10.3906/yer-1003-42; Tomita Y, 1999, J GEOLOGICAL SOC JAP, V105, P63; Tripati AK, 2011, GEOCHIM COSMOCHIM AC, V75, P2582, DOI 10.1016/j.gca.2011.01.018; Tripati AK, 2009, SCIENCE, V326, P1394, DOI 10.1126/science.1178296; VANDERBURGH J, 1993, SCIENCE, V260, P1788, DOI 10.1126/science.260.5115.1788; Vincent E., 1985, CARBON CYCLE ATMOSPH, V32, P455, DOI [10.1029/GM032p0455, DOI 10.1029/GM032P0455]; Wagner F, 1999, SCIENCE, V284, P1971, DOI 10.1126/science.284.5422.1971; Wang L, 2012, JAPANESE J PALYNOLOG, V58, P251; Yanagisawa Y, 1985, QUATERNARY RES; Yoshikawa S., 1999, J GEOL SOC JPN, V105, P332; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zhang QQ, 2012, PALAEOGEOGR PALAEOCL, V363, P23, DOI 10.1016/j.palaeo.2012.08.009; Zhang YG, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2013.0096	68	19	23	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130941	10.1371/journal.pone.0130941	http://dx.doi.org/10.1371/journal.pone.0130941			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154449	gold, Green Published, Green Submitted			2022-12-27	WOS:000358159700048
J	Muraya, MM; Schmutzer, T; Ulpinnis, C; Scholz, U; Altmann, T				Muraya, Moses M.; Schmutzer, Thomas; Ulpinnis, Chris; Scholz, Uwe; Altmann, Thomas			Targeted Sequencing Reveals Large-Scale Sequence Polymorphism in Maize Candidate Genes for Biomass Production and Composition	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; WHOLE-GENOME; VARIANT DETECTION; READ ALIGNMENT; INDEL RATES; ARCHITECTURE; ASSOCIATION; DIVERSITY; INFERENCE; DISCOVERY	A major goal of maize genomic research is to identify sequence polymorphisms responsible for phenotypic variation in traits of economic importance. Large-scale detection of sequence variation is critical for linking genes, or genomic regions, to phenotypes. However, due to its size and complexity, it remains expensive to generate whole genome sequences of sufficient coverage for divergent maize lines, even with access to next generation sequencing (NGS) technology. Because methods involving reduction of genome complexity, such as genotyping-by-sequencing (GBS), assess only a limited fraction of sequence variation, targeted sequencing of selected genomic loci offers an attractive alternative. We therefore designed a sequence capture assay to target 29 Mb genomic regions and surveyed a total of 4,648 genes possibly affecting biomass production in 21 diverse inbred maize lines (7 flints, 14 dents). Captured and enriched genomic DNA was sequenced using the 454 NGS platform to 19.6-fold average depth coverage, and a broad evaluation of read alignment and variant calling methods was performed to select optimal procedures for variant discovery. Sequence alignment with the B73 reference and de novo assembly identified 383,145 putative single nucleotide polymorphisms (SNPs), of which 42,685 were non-synonymous alterations and 7,139 caused frameshifts. Presence/absence variation (PAV) of genes was also detected. We found that substantial sequence variation exists among genomic regions targeted in this study, which was particularly evident within coding regions. This diversification has the potential to broaden functional diversity and generate phenotypic variation that may lead to new adaptations and the modification of important agronomic traits. Further, annotated SNPs identified here will serve as useful genetic tools and as candidates in searches for phenotype-altering DNA variation. In summary, we demonstrated that sequencing of captured DNA is a powerful approach for variant discovery in maize genes.	[Muraya, Moses M.; Schmutzer, Thomas; Ulpinnis, Chris; Scholz, Uwe; Altmann, Thomas] Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, D-06466 Stadt Seeland, Germany; [Muraya, Moses M.] Chuka Univ, Dept Plant Sci, Chuka, Kenya	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Schmutzer, T (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, Corrensstr 3, D-06466 Stadt Seeland, Germany.	schmutzr@ipk-gatersleben.de	Schmutzer, Thomas/W-8705-2019	Schmutzer, Thomas/0000-0003-1073-6719; Scholz, Uwe/0000-0001-6113-3518; Ulpinnis, Chris/0000-0001-5444-9282; Altmann, Thomas/0000-0002-3759-360X	German Federal Ministry of Education and Research [FKZ 0315461C]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The KBBE-CornFed project and its research leading to these results have received funding by the German Federal Ministry of Education and Research (FKZ 0315461C); www.bmbf.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov ED, 2013, PLANT PHYSIOL, V161, P252, DOI 10.1104/pp.112.205161; Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; Andersen EC, 2012, NAT GENET, V44, P285, DOI 10.1038/ng.1050; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; Belo A, 2010, THEOR APPL GENET, V120, P355, DOI 10.1007/s00122-009-1128-9; Botstein D, 1980, CONSTRUCTION GENETIC, P314; Bouchet S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071377; Buckler ES, 2006, CURR OPIN PLANT BIOL, V9, P172, DOI 10.1016/j.pbi.2006.01.013; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cartwright RA, 2009, MOL BIOL EVOL, V26, P473, DOI 10.1093/molbev/msn275; Chen A. F, 2014, ASSESSING SINGLE NUC, P1; Cheng AY, 2014, BIOINFORMATICS, V30, P1707, DOI 10.1093/bioinformatics/btu067; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Clouse S.D, 1999, MOLE GENETICS BRASSI, P163; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cook JP, 2012, PLANT PHYSIOL, V158, P824, DOI 10.1104/pp.111.185033; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fu JJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3832; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Haseneyer G, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-131; Hirsch CN, 2014, PLANT CELL, V26, P121, DOI 10.1105/tpc.113.119982; Homer N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r99; Hu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086269; Jia PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038470; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee TH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-162; Li H., 2013, PREPRINT, P1, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Liu Q, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S8; Lunter G, 2007, BIOINFORMATICS, V23, pI289, DOI 10.1093/bioinformatics/btm185; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Mace ES, 2003, HIGH THROUGHPUT DNA; Monaco MK, 2014, NUCLEIC ACIDS RES, V42, pD1193, DOI 10.1093/nar/gkt1110; Monaco MK, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2012.09.0025; Morgulis A, 2006, BIOINFORMATICS, V22, P134, DOI 10.1093/bioinformatics/bti774; Nielsen R, 2004, GENETICS, V168, P2373, DOI 10.1534/genetics.104.031039; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; Olukolu BA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004562; Park MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086664; Pritchard JK, 2000, GENETICS, V155, P945; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Riedelsheimer C, 2012, GENOME WIDE ASSOCIAT, DOI [10.1073/pnas.1120813109/-/DCSupplemental, DOI 10.1073/PNAS.1120813109/-/DCSUPPLEMENTAL]; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Rincent R, 2014, THEOR APPL GENET, V127, P2313, DOI 10.1007/s00122-014-2379-7; Rincent R, 2014, GENETICS, V197, P375, DOI 10.1534/genetics.113.159731; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sedlazeck FJ, 2013, BIOINFORMATICS, V29, P2790, DOI 10.1093/bioinformatics/btt468; Sham PC, 2014, NAT REV GENET, V15, P335, DOI 10.1038/nrg3706; Shigemizu D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02161; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Swanson-Wagner RA, 2010, GENOME RES, V20, P1689, DOI 10.1101/gr.109165.110; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Vergara Ismael A, 2012, BMC Res Notes, V5, P615, DOI 10.1186/1756-0500-5-615; Wang WX, 2014, BIOINFORMATICS, V30, P2498, DOI 10.1093/bioinformatics/btu338; Wei FS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000715; Wei Z, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr599; Yu XQ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-274; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010	73	17	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132120	10.1371/journal.pone.0132120	http://dx.doi.org/10.1371/journal.pone.0132120			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151830	Green Submitted, gold, Green Published			2022-12-27	WOS:000358158900034
J	Pang, LX; Wang, XY; Tang, XD				Pang, Laixue; Wang, Xiaoying; Tang, Xinde			Ceria Nanotube Formed by Sacrificed Precursors Template through Oswald Ripening	PLOS ONE			English	Article							ENHANCED CATALYTIC-ACTIVITY; HYDROTHERMAL SYNTHESIS; CEO2 NANOWIRES; ASSISTED SYNTHESIS; ROOM-TEMPERATURE; CO OXIDATION; LARGE-SCALE; NANORODS; FACILE; OXYGEN	Controllable preparation of ceria nanotube was realized by hydrothermal treatment of Ce(OH)CO3 precursors. The gradually changing morphologies and microstructures of cerium oxide were characterized by X-ray powder diffraction, scanning electron microscopy and transmission electron microscopy. A top-down path is illuminated to have an insight to the morphological transformation from nanorod to nanotube by adjusting the reaction time. The growth process is investigated by preparing a series of intermediate morphologies during the shape evolution of CeO(2)nanostructure based on the scanning electron microscopy image observation. On the basis of the time-dependent experimental observation, the possible formation mechanism related to oriented attachment and Oswald ripening was proposed, which might afford some guidance for the synthesis of other inorganic nanotubes.	[Pang, Laixue; Wang, Xiaoying; Tang, Xinde] Shandong Jiaotong Univ, Sch Mat Sci & Engn, Jinan 250023, Peoples R China	Shandong Jiaotong University	Pang, LX (corresponding author), Shandong Jiaotong Univ, Sch Mat Sci & Engn, Jinan 250023, Peoples R China.	lxpang@sdjtu.edu.cn			Applied Basic Research Planning of Ministry of Transportation in China [2013319817050]; National Natural Science Foundation of China [21407098]; Project of Shandong Province Higher Educational Science and Technology Program [J12LA09]	Applied Basic Research Planning of Ministry of Transportation in China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Shandong Province Higher Educational Science and Technology Program	Funding provided by Applied Basic Research Planning of Ministry of Transportation in China (2013319817050), National Natural Science Foundation of China (Grant No. 21407098) and Project of Shandong Province Higher Educational Science and Technology Program (J12LA09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar MS, 2011, MATER LETT, V65, P3098, DOI 10.1016/j.matlet.2011.06.042; Boehme M, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/6/065602; Cao X, 2013, T NONFERR METAL SOC, V23, P725, DOI 10.1016/S1003-6326(13)62521-2; Chen GZ, 2008, INORG CHEM, V47, P723, DOI 10.1021/ic701867f; Chen GZ, 2009, INORG CHEM, V48, P1334, DOI 10.1021/ic801714z; Cui MY, 2010, MATER CHEM PHYS, V121, P314, DOI 10.1016/j.matchemphys.2010.01.041; Du N, 2007, J PHYS CHEM C, V111, P12677, DOI 10.1021/jp074011r; Elaheh K., 2011, J COLLOID INTERF SCI, V356, P473, DOI DOI 10.1016/J.JCIS.2011.01.063; Feng YJ, 2011, J MATER CHEM, V21, P15442, DOI 10.1039/c1jm12747k; Fu XQ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/14/145503; Hua GM, 2012, J MATER CHEM, V22, P6851, DOI 10.1039/c2jm13610d; Lin HL, 2010, J COLLOID INTERF SCI, V341, P12, DOI 10.1016/j.jcis.2009.04.047; Liu J, 2009, REACT KINET CATAL L, V98, P311, DOI 10.1007/s11144-009-0093-2; Liu XW, 2009, J AM CHEM SOC, V131, P3140, DOI 10.1021/ja808433d; Lu XW, 2013, POWDER TECHNOL, V239, P415, DOI 10.1016/j.powtec.2013.01.060; Lu XH, 2011, J MATER CHEM, V21, P5569, DOI 10.1039/c0jm04466k; Mai HX, 2005, J PHYS CHEM B, V109, P24380, DOI 10.1021/jp055584b; Pal P, 2013, RSC ADV, V3, P10837, DOI 10.1039/c3ra23485a; Pan CS, 2008, J SOLID STATE CHEM, V181, P1298, DOI 10.1016/j.jssc.2008.02.011; Shah V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047827; Sun CW, 2012, ENERG ENVIRON SCI, V5, P8475, DOI 10.1039/c2ee22310d; Sun ZY, 2010, J MATER CHEM, V20, P1947, DOI 10.1039/b921510g; Tana, 2009, CATAL TODAY, V148, P179, DOI 10.1016/j.cattod.2009.02.016; Tang ZR, 2011, RSC ADV, V1, P1772, DOI 10.1039/c1ra00518a; Vantomme A, 2005, LANGMUIR, V21, P1132, DOI 10.1021/la047751p; Wang GF, 2010, J ALLOY COMPD, V493, P202, DOI 10.1016/j.jallcom.2009.12.053; Wang ZL, 2003, J PHYS CHEM B, V107, P13563, DOI 10.1021/jp036815m; Wu MZ, 2010, INT J MIN MET MATER, V17, P470, DOI [10.1007/S12613-010-0343-3, 10.1007/s12613-010-0343-3]; Yang ZJ, 2010, J CRYST GROWTH, V312, P426, DOI 10.1016/j.jcrysgro.2009.11.027; Yuan Q, 2009, J COLLOID INTERF SCI, V335, P151, DOI 10.1016/j.jcis.2009.04.007; Zhang C, 2014, NEW J CHEM, V38, P2581, DOI 10.1039/c4nj00214h; Zhang DS, 2007, J SOLID STATE CHEM, V180, P654, DOI 10.1016/j.jssc.2006.11.025; Zhou KB, 2005, J CATAL, V229, P206, DOI 10.1016/j.jcat.2004.11.004	33	1	1	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132536	10.1371/journal.pone.0132536	http://dx.doi.org/10.1371/journal.pone.0132536			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151866	Green Published, Green Submitted, gold			2022-12-27	WOS:000358158900045
J	Albuquerque, FCA; Bueno, NB; Clemente, APG; Ferriolli, E; Florencio, TMMT; Hoffman, D; Sawaya, AL				Alves Albuquerque, Fabiana Cristina; Bueno, Nassib Bezerra; Grotti Clemente, Ana Paula; Ferriolli, Eduardo; Menezes Toledo Florencio, Telma Maria; Hoffman, Daniel; Sawaya, Ana Lydia			Association between Adult Stature and Energy Expenditure in Low-Income Women from Northeastern Brazil	PLOS ONE			English	Article							DOUBLY-LABELED-WATER; FAT-FREE MASS; METABOLIC-RATE; SAO-PAULO; OBESITY; POPULATION; UNDERNUTRITION; SHANTYTOWNS; DEUTERIUM; CHILDREN	Background Perinatal undernutrition may lead to important metabolic adaptations in adult life, short stature being the most visible. The present study aimed to evaluate the association between stature and total energy expenditure of low-income women. Method Women aged 19-45 years from low-income communities in Maceio-AL were recruited. A sample of 67 volunteers was selected and divided into either short stature (<= 152.4 cm; n = 34) or non-short stature (>= 158.7 cm; n = 33) group. Data on socioeconomic status, anthropometric variables, and hormonal profiles was collected. Total energy expenditure and body composition were assessed by the doubly labeled water technique with multiple points over 14 days. In addition, physical activity levels were measured with triaxial accelerometers and dietary intake data were collected using three 24-hour food records. Results The mean subject age was 30.94 years. Women of short stature had lower body weight and lean body mass compared to non-short women, but there were no differences in thyroid hormone concentrations or daily energy intake between the two groups. Short-stature women showed lower total energy expenditure (P = 0.01) and a significantly higher physical activity level (P = 0.01) compared to non-short women. However, the difference in total energy expenditure was no longer significant after statistical adjustment for age, lean body mass, and triiodothyronine concentrations. Conclusion Women with short stature present the same energy intake, but lower total energy expenditure than non-short women, even with a higher physical activity level, which suggests that they are more prone to weight gain.	[Alves Albuquerque, Fabiana Cristina; Grotti Clemente, Ana Paula; Menezes Toledo Florencio, Telma Maria] Univ Fed Alagoas, Dept Nutr, Maceio, Alagoas, Brazil; [Ferriolli, Eduardo] Univ Sao Paulo, Dept Clin Med, Fac Med Ribeirao Preto, Sao Paulo, Brazil; [Bueno, Nassib Bezerra; Sawaya, Ana Lydia] Univ Fed Sao Paulo, Dept Physiol, Sao Paulo, Brazil; [Hoffman, Daniel] Rutgers State Univ, Dept Nutr Sci, Newark, NJ 07102 USA	Universidade Federal de Alagoas; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Rutgers State University Newark; Rutgers State University New Brunswick	Florencio, TMMT (corresponding author), Univ Fed Alagoas, Dept Nutr, Maceio, Alagoas, Brazil.	telmatf_al@hotmail.com	Florencio, Telma/AAE-3394-2019; Ferriolli, Eduardo/AAZ-6594-2021; Bueno, Nassib Bezerra/P-8057-2018; CLEMENTE, ANA PAULA/N-6720-2019; Sawaya, Ana Lydia/D-3845-2014; Ferriolli, Eduardo/J-6258-2012	Ferriolli, Eduardo/0000-0002-5028-2451; Bueno, Nassib Bezerra/0000-0002-3286-0297; Sawaya, Ana Lydia/0000-0002-2580-9557; 	Brazilian National Council for Scientific and Technologic Development (CNPq) [552194/2011-5]	Brazilian National Council for Scientific and Technologic Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study is funded by the Brazilian National Council for Scientific and Technologic Development (CNPq) (http://www.cnpq.br/), process number 552194/2011-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTRUP A, 1992, J CLIN ENDOCR METAB, V74, P279, DOI 10.1210/jc.74.2.279; Barbosa JM, 2009, ARCH LATINOAM NUTR, V59, P22; Baretta E, 2007, CAD SAUDE PUBLICA, V23, P1595, DOI 10.1590/S0102-311X2007000700010; Bosy-Westphal A, 2009, BRIT J NUTR, V102, P453, DOI 10.1017/S0007114508190304; Britto RPA, 2009, PUBLISHER MOREIRA JU, V68, P71; Castinheiras-Neto AG, 2009, BRAZILIAN JOURNAL OF, V3, P96; dos Reis HFC, 2009, ARQ BRAS CARDIOL, V92, P203, DOI 10.1590/S0066-782X2009000300007; COWARD WA, 1988, P NUTR SOC, V47, P209, DOI 10.1079/PNS19880037; Disse-Mohamed R, 2012, PLOS ONE, V7, P1; Ferreira Haroldo da Silva, 2005, Rev. Nutr., V18, P209; Ferriolli E, 2008, NUTRITIONAL SCIENCES, P442; Ferriolli E, 2010, RAPID COMMUN MASS SP, V24, P506, DOI 10.1002/rcm.4333; Florencio TMDT, 2001, BRIT J NUTR, V86, P277, DOI 10.1079/BJN2001396; Florencio TT, 2004, NUTR METAB CARDIOVAS, V14, P26, DOI 10.1016/S0939-4753(04)80044-9; Florencio TT, 2003, EUR J CLIN NUTR, V57, P1437, DOI 10.1038/sj.ejcn.1601708; FORBES GB, 1974, AM J CLIN NUTR, V27, P595, DOI 10.1093/ajcn/27.6.595; Frainer DES, 2008, REV BRAS CIN DES HUM, V10, P197; Grillo LP, 2005, EUR J CLIN NUTR, V59, P835, DOI 10.1038/sj.ejcn.1602150; Clemente APG, 2011, J PEDIAT-BRAZIL, V87, P138, DOI 10.2223/JPED.2071; Hoffman DJ, 2000, AM J CLIN NUTR, V72, P1025; Hoffman DJ, 2000, AM J CLIN NUTR, V72, P702; Johnstone AM, 2005, AM J CLIN NUTR, V82, P941, DOI 10.1093/ajcn/82.5.941; LOHMAN TJ, 1992, MEDICINE SCIENCE IN, V24, P1; Martins VJB, 2011, INT J ENV RES PUB HE, V8, P1817, DOI 10.3390/ijerph8061817; Monteiro J.P., 2007, CONSUMO ALIMENTAR VI, V1st; NELSON KM, 1992, AM J CLIN NUTR, V56, P848, DOI 10.1093/ajcn/56.5.848; Prentice A, 2006, INT J EPIDEMIOL, V35, P24, DOI 10.1093/ije/dyi204; Rosa BPS, 2012, RENEFARA, V3, P16; Sartorelli D. S., 2003, CAD SAUDE PUBLICA, V19, P29, DOI DOI 10.1590/S0102-311X2003000700004; SAWAYA AL, 1995, OBES RES, V3, pS107, DOI 10.1002/j.1550-8528.1995.tb00453.x; Scagliusi Fernanda Baeza, 2005, Rev. Nutr., V18, P541, DOI 10.1590/S1415-52732005000400009; Scagliusi FB, 2008, BRIT J NUTR, V100, P1060, DOI 10.1017/S0007114508971300; Schoeller D.A., 1996, HUMAN BODY COMPOSITI, P25; SCHOELLER DA, 1995, OBES RES, V3, P15, DOI 10.1002/j.1550-8528.1995.tb00003.x; Schoeller DA, 2002, PUBLIC HEALTH NUTR, V5, P883, DOI 10.1079/PHN2002378; SCHOELLER DA, 1980, AM J CLIN NUTR, V33, P2686, DOI 10.1093/ajcn/33.12.2686; SCHOELLER DA, 1988, J NUTR, V118, P1278, DOI 10.1093/jn/118.11.1278; SCRIMGEOUR CM, 1993, BIOL MASS SPECTROM, V22, P383, DOI 10.1002/bms.1200220704; Speakman JR, 1998, AM J CLIN NUTR, V68, p932S, DOI 10.1093/ajcn/68.4.932S; Wong W, 1990, THE DOUBLY LABELED W, P20; WONG WW, 1987, AM J CLIN NUTR, V45, P905, DOI 10.1093/ajcn/45.5.905; World Health Organization, 2007, WORLD HEALTH ORGANIZ	42	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131891	10.1371/journal.pone.0131891	http://dx.doi.org/10.1371/journal.pone.0131891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147672	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600158
J	Braber, TL; Prakken, NHJ; Mosterd, A; Mali, WPTM; Doevendans, PAFM; Bots, ML; Velthuis, BK				Braber, Thijs L.; Prakken, Niek H. J.; Mosterd, Arend; Mali, Willem P. Th. M.; Doevendans, Pieter A. F. M.; Bots, Michiel L.; Velthuis, Birgitta K.			Identifying Coronary Artery Disease in Asymptomatic Middle-Aged Sportsmen: The Additional Value of Pulse Wave Velocity	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; CENTRAL BLOOD-PRESSURE; CARDIOVASCULAR EVENTS; COMPUTED-TOMOGRAPHY; GENERAL-POPULATION; SCIENTIFIC STATEMENT; INVASIVE VALIDATION; AORTIC STIFFNESS; CARDIAC-ARREST; ALL-CAUSE	Background Cardiovascular screening may benefit middle-aged sportsmen, as coronary artery disease (CAD) is the main cause of exercise-related sudden cardiac death. Arterial stiffness, as measured by pulse wave velocity (PWV), may help identify sportsmen with subclinical CAD. We examined the additional value of PWV measurements to traditional CAD risk factors for identifying CAD. Methods From the Measuring Athlete's Risk of Cardiovascular events (MARC) cohort of asymptomatic, middle-aged sportsmen who underwent low-dose Cardiac CT (CCT) after routine sports medical examination (SME), 193 consecutive sportsmen (aged 55 +/- 6.6 years) were included with additional PWV measurements before CCT. Sensitivity, specificity and predictive values of PWV values (>8.3 and >7.5m/s) assessed by Arteriograph were used to identify CAD (coronary artery calcium scoring >= 100 Agatston Units or coronary CT angiography luminal stenosis >= 50%) and to assess the additional diagnostic value of PWV to established cardiovascular risk factors. Results Forty-seven sportsmen (24%) had CAD on CCT. They were older (58.9 vs. 53.8 years, p<0.001), had more hypertension (17 vs. 4%, p=0.003), higher cholesterol levels (5.7 vs. 5.4mmol/l) p=0.048), and more often were (ever) smokers (55 vs. 34%, p=0.008). Mean PWV was higher in those with CAD (8.9 vs. 8.0 m/s, p=0.017). For PWV >8.3m/s respectively >7.5m/s sensitivity to detect CAD on CT was 43% and 74%, specificity 69% and 45%, positive predictive value 31% and 30%, and negative predictive value 79% and 84%. Adding PWV to traditional risk factor models did not change the area under the curve (from 0.78 (95% CI = 0.709-0.848)) to AUC 0.78 (95% CI 0.710-0.848, p = 0.99)) for prediction of CAD on CCT. Conclusions Limited additional value was found for PWV on top of established risk factors to identify CAD. PWV might still have a role to identify CAD in middle-aged sportsmen if risk factors such as cholesterol are unknown.	[Braber, Thijs L.; Mali, Willem P. Th. M.; Velthuis, Birgitta K.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Braber, Thijs L.; Doevendans, Pieter A. F. M.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Prakken, Niek H. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands; [Mosterd, Arend] Meander Med Ctr, Dept Cardiol, Amersfoort, Netherlands; [Bots, Michiel L.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen; Meander Medisch Centrum; Utrecht University; Utrecht University Medical Center	Braber, TL (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	thijsbraber@gmail.com		Prakken, Niek/0000-0001-7043-3336				Aagaard P, 2013, MED SCI SPORT EXER, V45, P130, DOI 10.1249/MSS.0b013e31826c5552; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Ben-Shlomo Y, 2014, J AM COLL CARDIOL, V63, P636, DOI 10.1016/j.jacc.2013.09.063; Berdowski J, 2013, EUR HEART J, V34, P3616, DOI 10.1093/eurheartj/eht401; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Borjesson M, 2010, EUR J CARDIOV PREV R, DOI [10.1097/HJR.0b013e32833b0969, DOI 10.1097/HJR.0B013E32833B0969]; Budoff MJ, 2010, JACC-CARDIOVASC IMAG, V3, P1229, DOI 10.1016/j.jcmg.2010.08.018; Coutinho T, 2011, JACC-CARDIOVASC IMAG, V4, P754, DOI 10.1016/j.jcmg.2011.04.011; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Exeter DJ, 2014, BRIT J SPORT MED, V48, P1167, DOI 10.1136/bjsports-2013-093360; Fletcher GF, 2013, CIRCULATION, V128, P873, DOI 10.1161/CIR.0b013e31829b5b44; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Guimaraes GV, 2010, HYPERTENS RES, V33, P627, DOI 10.1038/hr.2010.42; Hansen TW, 2008, J HUM HYPERTENS, V22, P214, DOI 10.1038/sj.jhh.1002295; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; Horvath IG, 2010, J HYPERTENS, V28, P2068, DOI 10.1097/HJH.0b013e32833c8a1a; Ikonomidis I, 2013, INT J CARDIOL, V168, P4890, DOI 10.1016/j.ijcard.2013.07.025; Jatoi NA, 2009, J HYPERTENS, V27, P2186, DOI 10.1097/HJH.0b013e32833057e8; Kim JH, 2012, NEW ENGL J MED, V366, P130, DOI 10.1056/NEJMoa1106468; Kullo IJ, 2006, HYPERTENSION, V47, P174, DOI 10.1161/01.HYP.0000199605.35173.14; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Marijon E, 2011, CIRCULATION, V124, P672, DOI 10.1161/CIRCULATIONAHA.110.008979; Marwan M, 2009, HEART, V95, P1056, DOI 10.1136/hrt.2008.153353; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Menafoglio A, 2015, BRIT J SPORT MED, V49, P757, DOI 10.1136/bjsports-2014-093857; Mohlenkamp S, 2008, EUR HEART J, V29, P1903, DOI 10.1093/eurheartj/ehn163; Mohlenkamp S, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-013-0391-8; Park JS, 2011, CLIN EXP HYPERTENS, V33, P501, DOI 10.3109/10641963.2011.601376; Pelliccia A, 2000, CIRCULATION, V102, P278; Polonsky TS, 2012, NAT REV CARDIOL, V9, P599, DOI 10.1038/nrcardio.2012.114; Rajzer MW, 2008, J HYPERTENS, V26, P2001, DOI 10.1097/HJH.0b013e32830a4a25; Rossen NB, 2014, AM J HYPERTENS, V27, P674, DOI 10.1093/ajh/hpt162; Silverman MG, 2014, EUR HEART J, V35, P2232, DOI 10.1093/eurheartj/eht508; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Thompson PD, 2007, CIRCULATION, V115, P2358, DOI 10.1161/CIRCULATIONAHA.107.181485; Thompson PD, 2005, CIRCULATION, V112, P2354, DOI 10.1161/CIRCULATIONAHA.104.502591; Trachet B, 2010, ANN BIOMED ENG, V38, P876, DOI 10.1007/s10439-010-9945-1; Verwoert GC, 2012, J HUM HYPERTENS, V26, P28, DOI 10.1038/jhh.2010.124; Vliegenthart R, 2002, EUR HEART J, V23, P1596, DOI 10.1053/euhj.2002.3240; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373	41	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131895	10.1371/journal.pone.0131895	http://dx.doi.org/10.1371/journal.pone.0131895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147752	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600159
J	Kenny, JD; Taylor, NE; Brown, EN; Solt, K				Kenny, Jonathan D.; Taylor, Norman E.; Brown, Emery N.; Solt, Ken			Dextroamphetamine (but Not Atomoxetine) Induces Reanimation from General Anesthesia: Implications for the Roles of Dopamine and Norepinephrine in Active Emergence	PLOS ONE			English	Article							ISOFLURANE ANESTHESIA; PROPOFOL ANESTHESIA; RATS; METHYLPHENIDATE; CHILDREN; POTENCY; MAC; REQUIREMENTS; AMPHETAMINE; SEVOFLURANE	Methylphenidate induces reanimation (active emergence) from general anesthesia in rodents, and recent evidence suggests that dopaminergic neurotransmission is important in producing this effect. Dextroamphetamine causes the direct release of dopamine and norepinephrine, whereas atomoxetine is a selective reuptake inhibitor for norepinephrine. Like methylphenidate, both drugs are prescribed to treat Attention Deficit Hyperactivity Disorder. In this study, we tested the efficacy of dextroamphetamine and atomoxetine for inducing reanimation from general anesthesia in rats. Emergence from general anesthesia was defined by return of righting. During continuous sevoflurane anesthesia, dextroamphetamine dose-dependently induced behavioral arousal and restored righting, but atomoxetine did not (n = 6 each). When the D1 dopamine receptor antagonist SCH-23390 was administered prior to dextroamphetamine under the same conditions, righting was not restored (n = 6). After a single dose of propofol (8 mg/kg IV), the mean emergence times for rats that received normal saline (vehicle) and dextroamphetamine (1 mg/kg IV) were 641 sec and 404 sec, respectively (n = 8 each). The difference was statistically significant. Although atomoxetine reduced mean emergence time to 566 sec (n = 8), this decrease was not statistically significant. Spectral analysis of electroencephalogram recordings revealed that dextroamphetamine and atomoxetine both induced a shift in peak power from delta (0.1-4 Hz) to theta (4-8 Hz) during continuous sevoflurane general anesthesia, which was not observed when animals were pre-treated with SCH-23390. In summary, dextroamphetamine induces reanimation from general anesthesia in rodents, but atomoxetine does not induce an arousal response under the same experimental conditions. This supports the hypothesis that dopaminergic stimulation during general anesthesia produces a robust behavioral arousal response. In contrast, selective noradrenergic stimulation causes significant neurophysiological changes, but does not promote behavioral arousal during general anesthesia. We hypothesize that dextroamphetamine is more likely than atomoxetine to be clinically useful for restoring consciousness in anesthetized patients, mainly due to its stimulation of dopaminergic neurotransmission.	[Kenny, Jonathan D.; Taylor, Norman E.; Brown, Emery N.; Solt, Ken] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Taylor, Norman E.; Brown, Emery N.; Solt, Ken] Harvard Univ, Sch Med, Dept Anaesthesia, Boston, MA 02115 USA; [Brown, Emery N.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Brown, Emery N.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Solt, K (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA.	ksolt@mgh.harvard.edu	Solt, Ken/AAX-8188-2020	Solt, Ken/0000-0001-5328-2062; Kenny, Jonathan/0000-0003-3745-3217; Taylor, Norman/0000-0001-5961-6641	National Institute of General Medical Sciences [TR01-GM104948, K08-GM094394]; Mentored Research Training Grant (NET) from the Foundation for Anesthesia Education and Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM094394, R01GM104948] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Mentored Research Training Grant (NET) from the Foundation for Anesthesia Education and Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants TR01-GM104948 (KS and ENB) and K08-GM094394 (KS) from the National Institute of General Medical Sciences (www.nigms.nih.gov), and a Mentored Research Training Grant (NET) from the Foundation for Anesthesia Education and Research (www.faer.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2007, ANESTHESIOLOGY, V107, P264, DOI 10.1097/01.anes.0000270741.33766.24; ANTOGNINI JF, 1993, ANESTHESIOLOGY, V79, P1244, DOI 10.1097/00000542-199312000-00015; Bari A, 2013, NEUROPHARMACOLOGY, V64, P53, DOI 10.1016/j.neuropharm.2012.07.020; Brown EN, 2011, ANNU REV NEUROSCI, V34, P601, DOI 10.1146/annurev-neuro-060909-153200; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Bymaster FP, 2002, NEUROPSYCHOPHARMACOL, V27, P699, DOI 10.1016/S0893-133X(02)00346-9; Chambers NA, 2012, PEDIATR ANESTH, V22, P341, DOI 10.1111/j.1460-9592.2011.03717.x; Chemali JJ, 2012, ANESTHESIOLOGY, V116, P998, DOI 10.1097/ALN.0b013e3182518bfc; Chidambaran V, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-8; Cole JW, 2002, PAEDIATR ANAESTH, V12, P442, DOI 10.1046/j.1460-9592.2002.00868.x; CROSS AJ, 1983, NEUROPHARMACOLOGY, V22, P1327, DOI 10.1016/0028-3908(83)90208-3; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Eger EI, 2001, ANESTH ANALG, V93, P947, DOI 10.1097/00000539-200110000-00029; EGER EI, 1965, ANESTHESIOLOGY, V26, P756, DOI 10.1097/00000542-196511000-00010; Fasting S, 2002, CAN J ANAESTH, V49, P545, DOI 10.1007/BF03017379; Fischer SP, 2006, ANESTH ANALG, V103, P203, DOI 10.1213/01.ane.0000221451.24482.11; Forsyth I, 2006, PEDIATR ANESTH, V16, P371, DOI 10.1111/j.1460-9592.2005.01830.x; Heal DJ, 2008, PHARMACOL BIOCHEM BE, V90, P184, DOI 10.1016/j.pbb.2008.03.016; Heal DJ, 2009, NEUROPHARMACOLOGY, V57, P608, DOI 10.1016/j.neuropharm.2009.08.020; Hudetz AG, 2003, ANESTHESIOLOGY, V99, P1125, DOI 10.1097/00000542-200311000-00019; JOHNSTON RR, 1974, ANESTHESIOLOGY, V41, P57, DOI 10.1097/00000542-197407000-00013; JOHNSTON RR, 1975, ANESTH ANALG, V54, P655; JOHNSTON RR, 1972, ANESTHESIOLOGY, V36, P357, DOI 10.1097/00000542-197204000-00010; Kasuga Takaho, 2008, Masui, V57, P748; Kelz MB, 2008, P NATL ACAD SCI USA, V105, P1309, DOI 10.1073/pnas.0707146105; Kirch C, 2011, ANN STAT, V39, P1427, DOI 10.1214/10-AOS868; Langsjo JW, 2012, J NEUROSCI, V32, P4935, DOI 10.1523/JNEUROSCI.4962-11.2012; Lepouse C, 2006, BRIT J ANAESTH, V96, P747, DOI 10.1093/bja/ael094; Luo T, 2011, ANESTHESIOLOGY, V115, P36, DOI 10.1097/ALN.0b013e3182207655; Luo T, 2009, ANESTHESIOLOGY, V111, P725, DOI 10.1097/ALN.0b013e3181b061a0; Mitra P, 2008, OBSERVED BRAIN DYNAM, Vxxii; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; Pillay S, 2011, ANESTHESIOLOGY, V115, P733, DOI 10.1097/ALN.0b013e31822c5ee1; RAMPIL IJ, 1993, ANESTHESIOLOGY, V78, P707, DOI 10.1097/00000542-199304000-00014; RAMPIL IJ, 1994, ANESTHESIOLOGY, V80, P606, DOI 10.1097/00000542-199403000-00017; Ririe DG, 1997, PAEDIATR ANAESTH, V7, P69, DOI 10.1046/j.1460-9592.1997.d01-34.x; Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923; Solt K, 2014, ANESTHESIOLOGY, V121, P311, DOI 10.1097/ALN.0000000000000117; Solt K, 2011, ANESTHESIOLOGY, V115, P791, DOI 10.1097/ALN.0b013e31822e92e5; Taylor NE, 2013, ANESTHESIOLOGY, V118, P30, DOI 10.1097/ALN.0b013e318278c896; Vazey EM, 2014, P NATL ACAD SCI USA, V111, P3859, DOI 10.1073/pnas.1310025111; Zecharia AY, 2009, J NEUROSCI, V29, P2177, DOI 10.1523/JNEUROSCI.4997-08.2009; Zhang LN, 2012, ANESTH ANALG, V115, P789, DOI 10.1213/ANE.0b013e3182645ea3	44	44	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131914	10.1371/journal.pone.0131914	http://dx.doi.org/10.1371/journal.pone.0131914			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148114	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600165
J	Mo, LH; Pospichalova, V; Huang, ZQ; Murphy, SK; Payne, S; Wang, F; Kennedy, M; Cianciolo, GJ; Bryja, V; Pizzo, SV; Bachelder, RE				Mo, Lihong; Pospichalova, Vendula; Huang, Zhiqing; Murphy, Susan K.; Payne, Sturgis; Wang, Fang; Kennedy, Margaret; Cianciolo, George J.; Bryja, Vitezslav; Pizzo, Salvatore V.; Bachelder, Robin E.			Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells	PLOS ONE			English	Article							SURVIVAL; GENE; TRANSPORTERS; CHEMOTHERAPY; KINASE; MDR1	Chemotherapy resistance is the major reason for the failure of ovarian cancer treatment. One mechanism behind chemo-resistance involves the upregulation of multidrug resistance (MDR) genes (ABC transporters) that effectively transport (efflux) drugs out of the tumor cells. As a common symptom in stage III/IV ovarian cancer patients, ascites is associated with cancer progression. However, whether ascites drives multidrug resistance in ovarian cancer cells awaits elucidation. Here, we demonstrate that when cultured with ascites derived from ovarian cancer-bearing mice, a murine ovarian cancer cell line became less sensitive to paclitaxel, a first line chemotherapeutic agent for ovarian cancer patients. Moreover, incubation of murine ovarian cancer cells in vitro with ascites drives efflux function in these cells. Functional studies show ascites-driven efflux is suppressible by specific inhibitors of either of two ABC transporters [Multidrug Related Protein (MRP1); Breast Cancer Related Protein (BCRP)]. To demonstrate relevance of our findings to ovarian cancer patients, we studied relative efflux in human ovarian cancer cells obtained from either patient ascites or from primary tumor. Immortalized cell lines developed from human ascites show increased susceptibility to efflux inhibitors (MRP1, BCRP) compared to a cell line derived from a primary ovarian cancer, suggesting an association between ascites and efflux function in human ovarian cancer. Efflux in ascites-derived human ovarian cancer cells is associated with increased expression of ABC transporters compared to that in primary tumor-derived human ovarian cancer cells. Collectively, our findings identify a novel activity for ascites in promoting ovarian cancer multidrug resistance.	[Mo, Lihong; Murphy, Susan K.; Payne, Sturgis; Wang, Fang; Kennedy, Margaret; Cianciolo, George J.; Pizzo, Salvatore V.; Bachelder, Robin E.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Pospichalova, Vendula; Bryja, Vitezslav] Masaryk Univ, Fac Sci, CS-61137 Brno, Czech Republic; [Huang, Zhiqing; Murphy, Susan K.] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA	Duke University; Masaryk University Brno; Duke University	Bachelder, RE (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	robin.bachelder@dm.duke.edu	Bryja, Vít?zslav/H-1925-2014; Pospichalova, Vendula/C-6126-2015; Bryja, Vítězslav/P-4217-2019; Murphy, Susan/R-3903-2019	Bryja, Vít?zslav/0000-0002-9136-5085; Pospichalova, Vendula/0000-0002-5957-2156; Bryja, Vítězslav/0000-0002-9136-5085; Murphy, Susan/0000-0001-8298-7272; Mo, Lihong/0000-0001-6701-0594	European Social Fund [CZ. 1.07/2.3.00/30.0009]; Department of Defense Ovarian Cancer Research Program Award [W81XWH-11-1-0469]; Gail Parkins Ovarian Cancer Research Fund; Internal Reserve Fund of the Department of Pathology; Duke University Medical Center	European Social Fund(European Social Fund (ESF)); Department of Defense Ovarian Cancer Research Program Award; Gail Parkins Ovarian Cancer Research Fund; Internal Reserve Fund of the Department of Pathology; Duke University Medical Center	This work was supported by CZ. 1.07/2.3.00/30.0009, European Social Fund (VP) (http://ec.europa.eu/esf/home.jsp), W81XWH-11-1-0469, Department of Defense Ovarian Cancer Research Program Award (SKM) (http://cdmrp.army.mil/ocrp/), Gail Parkins Ovarian Cancer Research Fund (SKM) (http://www.ovarianawareness.org), Internal Reserve Fund of the Department of Pathology, Duke University Medical Center (SVP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Cheng G, 2001, Zhonghua Zhong Liu Za Zhi, V23, P305; Couture L, 2006, PHARMACOL REV, V58, P244, DOI 10.1124/pr.58.2.7; George JA, 2005, CANCER RES, V65, P10381, DOI 10.1158/0008-5472.CAN-05-1822; Goncharenko-Khaider N, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-84; Hennessy BT, 2009, LANCET, V374, P1371, DOI 10.1016/S0140-6736(09)61338-6; Huang H, 2013, NEOPLASMA, V60, P546, DOI 10.4149/neo_2013_071; Jia P, 2005, INT J GYNECOL CANCER, V15, P1042, DOI 10.1111/j.1525-1438.2005.00260.x; Johnatty SE, 2013, GYNECOL ONCOL, V131, P8, DOI 10.1016/j.ygyno.2013.07.107; Kamazawa S, 2002, GYNECOL ONCOL, V86, P171, DOI 10.1006/gyno.2002.6738; Kasai T, 2002, J BIOL CHEM, V277, P5187, DOI 10.1074/jbc.M110295200; Kavallaris M, 1996, CANCER LETT, V102, P7, DOI 10.1016/0304-3835(96)04143-2; Kwon MJ, 2013, INT J MOL SCI, V14, P6624, DOI 10.3390/ijms14046624; Lan CY, 2013, TECHNOL CANCER RES T, V12, P259, DOI 10.7785/tcrt.2012.500312; Lane D, 2010, ONCOGENE, V29, P3519, DOI 10.1038/onc.2010.107; Loizzi V, 2003, AM J OBSTET GYNECOL, V189, P1301, DOI 10.1067/S0002-9378(03)00629-X; Luqmani YA, 2005, MED PRIN PRACT, V14, P35, DOI 10.1159/000086183; Maliepaard M, 1999, CANCER RES, V59, P4559; Markman M, 2000, Oncologist, V5, P26, DOI 10.1634/theoncologist.5-1-26; Penson RT, 2004, GYNECOL ONCOL, V93, P98, DOI 10.1016/j.ygyno.2003.11.053; Schmitz G, 2001, CURR OPIN LIPIDOL, V12, P129, DOI 10.1097/00041433-200104000-00006; Schondorf T, 2002, ANTICANCER RES, V22, P2199; Tangjitgamol S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006014.pub6; Wang Y, 2011, CYTOKINE, V56, P365, DOI 10.1016/j.cyto.2011.06.005; Wang Y, 2010, CANCER LETT, V295, P110, DOI 10.1016/j.canlet.2010.02.019; Yoh K, 2004, CLIN CANCER RES, V10, P1691, DOI 10.1158/1078-0432.CCR-0937-3; Zajchowski DA, 2012, MOL CANCER THER, V11, P492, DOI 10.1158/1535-7163.MCT-11-0746	27	21	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131579	10.1371/journal.pone.0131579	http://dx.doi.org/10.1371/journal.pone.0131579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148191	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600111
J	Shi, XN; Li, HJ; Yao, H; Liu, X; Li, L; Leung, KS; Kung, HF; Lu, D; Wong, MH; Lin, MCM				Shi, Xi-Nan; Li, Hongjian; Yao, Hong; Liu, Xu; Li, Ling; Leung, Kwong-Sak; Kung, Hsiang-fu; Lu, Di; Wong, Man-Hon; Lin, Marie Chia-mi			In Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer Drug	PLOS ONE			English	Article							METABOLISM; DOCKING; CELLS; ZINC	Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths worldwide. Surgical resection and conventional chemotherapy and radiotherapy ultimately fail due to tumor recurrence and HCC's resistance. The development of novel therapies against HCC is thus urgently required. The cyclin-dependent kinase (CDK) pathways are important and well-established targets for cancer treatment. In particular, CDK2 is a key factor regulating the cell cycle G1 to S transition and a hallmark for cancers. In this study, we utilized our free and open-source protein-ligand docking software, idock, prospectively to identify potential CDK2 inhibitors from 4,311 FDA-approved small molecule drugs using a repurposing strategy and an ensemble docking methodology. Sorted by average idock score, nine compounds were purchased and tested in vitro. Among them, the anti-psychotic drug fluspirilene exhibited the highest anti-proliferative effect in human hepatocellular carcinoma HepG2 and Huh7 cells. We demonstrated for the first time that fluspirilene treatment significantly increased the percentage of cells in G1 phase, and decreased the expressions of CDK2, cyclin E and Rb, as well as the phosphorylations of CDK2 on Thr160 and Rb on Ser795. We also examined the anti-cancer effect of fluspirilene in vivo in BALB/C nude mice subcutaneously xenografted with human hepatocellular carcinoma Huh7 cells. Our results showed that oral fluspirilene treatment significantly inhibited tumor growth. Fluspirilene (15 mg/kg) exhibited strong anti-tumor activity, comparable to that of the leading cancer drug 5-fluorouracil (10 mg/kg). Moreover, the cocktail treatment with fluspirilene and 5-fluorouracil exhibited the highest therapeutic effect. These results suggested for the first time that fluspirilene is a potential CDK2 inhibitor and a candidate anti-cancer drug for the treatment of human hepatocellular carcinoma. In view of the fact that fluspirilene has a long history of safe human use, our discovery of fluspirilene as a potential anti-HCC drug may present an immediately applicable clinical therapy.	[Shi, Xi-Nan; Liu, Xu; Li, Ling; Kung, Hsiang-fu; Lu, Di; Lin, Marie Chia-mi] Kunming Med Univ, Ctr Biotechnol, Kunming, Yunnan, Peoples R China; [Li, Hongjian; Leung, Kwong-Sak; Wong, Man-Hon] Chinese Univ Hong Kong, Dept Comp Sci & Engn, Hong Kong, Hong Kong, Peoples R China; [Shi, Xi-Nan] Southwest Guizhou Vocat & Tech Coll Nationalities, Dept Med, Xuzhou, Guizhou, Peoples R China; [Lin, Marie Chia-mi] Shenzhen Univ, Sch Med, Shenzhen Key Lab Translat Med Tumor, Shenzhen, Peoples R China; [Yao, Hong] Xuzhou Med Coll, Canc Biotherapy Inst Jiangsu Prov, Xuzhou, Peoples R China; [Yao, Hong; Kung, Hsiang-fu] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Kunming Medical University; Chinese University of Hong Kong; Shenzhen University; Xuzhou Medical University; Chinese University of Hong Kong	Leung, KS (corresponding author), Chinese Univ Hong Kong, Dept Comp Sci & Engn, Hong Kong, Hong Kong, Peoples R China.	ksleung@cse.cuhk.edu.hk; mcmlin@163.com	Wong, Man Hon/GOH-0560-2022; Shi, Xi-Nan/AAV-8400-2021		Hsiang-fu Kung academician workstation of Kunming Medical University; National Natural Science Foundation of China (NSFC) [81272549]; Key Lab project of Shenzhen from China [ZDSY20130329101130496]; Chinese University of Hong Kong; GRF Grant from Research Grants Council of Hong Kong [414413, 772910, 470911]	Hsiang-fu Kung academician workstation of Kunming Medical University; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Key Lab project of Shenzhen from China; Chinese University of Hong Kong(Chinese University of Hong Kong); GRF Grant from Research Grants Council of Hong Kong	~ This study was supported by grants from the Hsiang-fu Kung academician workstation of Kunming Medical University, National Natural Science Foundation of China (NSFC) 81272549, Key Lab project of Shenzhen (ZDSY20130329101130496) from China, the Direct Grant from the Chinese University of Hong Kong, the GRF Grant (Project References 414413, 772910, and 470911) from the Research Grants Council of Hong Kong.	Ballester PJ, 2007, J COMPUT CHEM, V28, P1711, DOI [10.1002/jcc.20681, 10.1002/JCC.20681]; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Craig IR, 2010, J CHEM INF MODEL, V50, P511, DOI 10.1021/ci900407c; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; GLAB N, 1994, FEBS LETT, V353, P207, DOI 10.1016/0014-5793(94)01035-8; HEYKANT.JPP, 1969, LIFE SCI PT 1 PHYSI, V8, P1029, DOI 10.1016/0024-3205(69)90154-4; Hongjian Li, 2012, 2012 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB), P77, DOI 10.1109/CIBCB.2012.6217214; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Huang SY, 2007, PROTEINS, V66, P399, DOI 10.1002/prot.21214; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Khedr MA, 2014, EUR J PHARM SCI, V65, P130, DOI 10.1016/j.ejps.2014.09.014; Korb O, 2012, J CHEM INF MODEL, V52, P1262, DOI 10.1021/ci2005934; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Li HJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-56; Li HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085678; Lin RX, 2005, ACTA PHARMACOL SIN, V26, P762, DOI 10.1111/j.1745-7254.2005.00762.x; Ma DL, 2013, CHEM SOC REV, V42, P2130, DOI 10.1039/c2cs35357a; Mariaule G, 2014, MOLECULES, V19, P14366, DOI 10.3390/molecules190914366; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Patil SP, 2015, J COMPUT AID MOL DES, V29, P155, DOI 10.1007/s10822-014-9811-6; Pihan E, 2012, BIOINFORMATICS, V28, P1540, DOI 10.1093/bioinformatics/bts186; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; Senderowicz AM, 1999, INVEST NEW DRUG, V17, P313, DOI 10.1023/A:1006353008903; Teo C.Y., 2013, METABOLOMICS, V3, P118; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Zhong HJ, 2014, BIOCHIMIE, V102, P211, DOI 10.1016/j.biochi.2014.03.005	31	61	62	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132072	10.1371/journal.pone.0132072	http://dx.doi.org/10.1371/journal.pone.0132072			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147897	gold, Green Submitted, Green Published			2022-12-27	WOS:000358157600196
J	Slocumb, ME; Regalado, JM; Yoshizawa, M; Neely, GG; Masek, P; Gibbs, AG; Keene, AC				Slocumb, Melissa E.; Regalado, Josue M.; Yoshizawa, Masato; Neely, Greg G.; Masek, Pavel; Gibbs, Allen G.; Keene, Alex C.			Enhanced Sleep Is an Evolutionarily Adaptive Response to Starvation Stress in Drosophila	PLOS ONE			English	Article							DESICCATION RESISTANCE; TRADE-OFF; MELANOGASTER; SELECTION; CONSERVATION; ACQUISITION; METABOLISM; MECHANISMS; BEHAVIOR	Animals maximize fitness by modulating sleep and foraging strategies in response to changes in nutrient availability. Wild populations of the fruit fly, Drosophila melanogaster, display highly variable levels of starvation and desiccation resistance that differ in accordance with geographic location, nutrient availability, and evolutionary history. Further, flies potently modulate sleep in response to changes in food availability, and selection for starvation resistance enhances sleep, revealing strong genetic relationships between sleep and nutrient availability. To determine the genetic and evolutionary relationship between sleep and nutrient deprivation, we assessed sleep in flies selected for desiccation or starvation resistance. While starvation resistant flies have higher levels of triglycerides, desiccation resistant flies have enhanced glycogen stores, indicative of distinct physiological adaptations to food or water scarcity. Strikingly, selection for starvation resistance, but not desiccation resistance, leads to increased sleep, indicating that enhanced sleep is not a generalized consequence of higher energy stores. Thermotolerance is not altered in starvation or desiccation resistant flies, providing further evidence for context-specific adaptation to environmental stressors. F-2 hybrid flies were generated by crossing starvation selected flies with desiccation selected flies, and the relationship between nutrient deprivation and sleep was examined. Hybrids exhibit a positive correlation between starvation resistance and sleep, while no interaction was detected between desiccation resistance and sleep, revealing that prolonged sleep provides an adaptive response to starvation stress. Therefore, these findings demonstrate context-specific evolution of enhanced sleep in response to chronic food deprivation, and provide a model for understanding the evolutionary relationship between sleep and nutrient availability.	[Slocumb, Melissa E.; Regalado, Josue M.; Yoshizawa, Masato; Masek, Pavel; Keene, Alex C.] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [Gibbs, Allen G.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89119 USA; [Yoshizawa, Masato] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA; [Neely, Greg G.] Garvan Inst, Div Neurosci, Sydney, NSW 2010, Australia	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Hawaii System; University of Hawaii Manoa; Garvan Institute of Medical Research	Keene, AC (corresponding author), Univ Nevada, Dept Biol, Reno, NV 89557 USA.	akeene@unr.edu	Neely, Greg/AAB-4642-2020; Gibbs, Allen G/G-6939-2014; Yoshizawa, Masato/AAE-9415-2022; Yoshizawa, Masato/AFD-8467-2022	Neely, Greg/0000-0002-1957-9732; Gibbs, Allen G/0000-0001-5233-2056; Yoshizawa, Masato/0000-0001-8455-8252; Yoshizawa, Masato/0000-0001-8455-8252	NIH [R15 NS080155, R01 NS0825152, R15-GM100395, P20 RR-016464]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM100395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS080155, R01NS085152] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants R15 NS080155 and R01 NS0825152 to ACK; R15-GM100395 to AG; and P20 RR-016464 supporting PM.	Allada R, 2008, CURR BIOL, V18, pR670, DOI 10.1016/j.cub.2008.06.033; Archer MA, 2007, PHYSIOL BIOCHEM ZOOL, V80, P386, DOI 10.1086/518354; Ballard JWO, 2008, J INSECT PHYSIOL, V54, P1371, DOI 10.1016/j.jinsphys.2008.07.009; BERGER RJ, 1995, BEHAV BRAIN RES, V69, P65, DOI 10.1016/0166-4328(95)00002-B; BORBELY AA, 1977, BRAIN RES, V124, P457, DOI 10.1016/0006-8993(77)90947-7; Burke MK, 2009, AM J PHYSIOL-REG I, V296, pR1847, DOI 10.1152/ajpregu.90551.2008; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; Capellini I, 2008, FUNCT ECOL, V22, P847, DOI 10.1111/j.1365-2435.2008.01449.x; Capellini I, 2008, EVOLUTION, V62, P1764, DOI 10.1111/j.1558-5646.2008.00392.x; Chippindale AK, 1998, EVOLUTION, V52, P1342, DOI 10.2307/2411304; Djawdan M, 1996, PHYSIOL ZOOL, V69, P1176, DOI 10.1086/physzool.69.5.30164252; Erion R, 2012, J BIOL CHEM, V287, P32406, DOI 10.1074/jbc.M112.360875; Folk DG, 2001, J EXP BIOL, V204, P3323; Gefen E, 2006, J EXP BIOL, V209, P3293, DOI 10.1242/jeb.02397; Gibbs AG, 2003, J EXP BIOL, V206, P1183, DOI 10.1242/jeb.00233; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Harbison ST, 2004, GENETICS, V166, P1807, DOI 10.1534/genetics.166.4.1807; Harbison ST, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006211; Harshman LG, 1999, J EVOLUTION BIOL, V12, P370, DOI 10.1046/j.1420-9101.1999.00024.x; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hoffmann AA, 2005, J EVOLUTION BIOL, V18, P804, DOI 10.1111/j.1420-9101.2004.00871.x; Kayser MS, 2014, SCIENCE, V344, P269, DOI 10.1126/science.1250553; Keene AC, 2010, CURR BIOL, V20, P1209, DOI 10.1016/j.cub.2010.05.029; Koh K, 2006, P NATL ACAD SCI USA, V103, P13843, DOI 10.1073/pnas.0605903103; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lehmann FO, 2000, J EXP BIOL, V203, P1613; Marron MT, 2003, J INSECT PHYSIOL, V49, P261, DOI 10.1016/S0022-1910(02)00287-1; Masek P, 2014, J EXP BIOL, V217, P3122, DOI 10.1242/jeb.103309; McDonald DM, 2010, AGING-US, V2, P519, DOI 10.18632/aging.100181; Parkash R, 2012, COMP BIOCHEM PHYS A, V161, P102, DOI 10.1016/j.cbpa.2011.09.010; Pfeiffenberger Cory, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5520; Pfeiffenberger Cory, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5518; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Rion S, 2007, J EVOLUTION BIOL, V20, P1655, DOI 10.1111/j.1420-9101.2007.01405.x; Sehgal A, 2011, CELL, V146, P194, DOI 10.1016/j.cell.2011.07.004; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; SIBLY RM, 1991, FUNCT ECOL, V5, P184, DOI 10.2307/2389256; Tu MP, 2003, AGING CELL, V2, P327, DOI 10.1046/j.1474-9728.2003.00064.x; Vieira C, 2000, GENETICS, V154, P213; Vijendravarma RK, 2012, P ROY SOC B-BIOL SCI, V279, P3540, DOI 10.1098/rspb.2012.0966; Williams AE, 2004, PHYSIOL BIOCHEM ZOOL, V77, P10, DOI 10.1086/381467; Yurgel M, 2014, J COMP PHYSL A	42	29	29	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131275	10.1371/journal.pone.0131275	http://dx.doi.org/10.1371/journal.pone.0131275			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147198	Green Submitted, gold, Green Published			2022-12-27	WOS:000358157600080
J	Valcarcel-Ocete, L; Alkorta-Aranburu, G; Iriondo, M; Fullaondo, A; Garcia-Barcina, M; Fernandez-Garcia, JM; Lezcano-Garcia, E; Losada-Domingo, JM; Ruiz-Ojeda, J; de Arcaya, AA; Perez-Ramos, JM; Roos, RAC; Nielsen, JE; Saft, C; Zubiaga, AM; Aguirre, A				Valcarcel-Ocete, Leire; Alkorta-Aranburu, Gorka; Iriondo, Mikel; Fullaondo, Asier; Garcia-Barcina, Maria; Manuel Fernandez-Garcia, Jose; Lezcano-Garcia, Elena; Maria Losada-Domingo, Jose; Ruiz-Ojeda, Javier; Alvarez de Arcaya, Amaia; Maria Perez-Ramos, Jose; Roos, Raymund A. C.; Nielsen, Jorgen E.; Saft, Carsten; Zubiaga, Ana M.; Aguirre, Ana		European Huntington's Dis Network	Exploring Genetic Factors Involved in Huntington Disease Age of Onset: E2F2 as a New Potential Modifier Gene	PLOS ONE			English	Article							CASPASE-ACTIVATED DNASE; NMDA RECEPTOR FUNCTION; CAG REPEAT LENGTH; MUTANT HUNTINGTIN; PGC-1-ALPHA; PROTEIN-1; PHOSPHORYLATION; TRANSCRIPTION; ASSOCIATION; APOPTOSIS	Age of onset (AO) of Huntington disease (HD) is mainly determined by the length of the CAG repeat expansion (CAGexp) in exon 1 of the HTT gene. Additional genetic variation has been suggested to contribute to AO, although the mechanism by which it could affect AO is presently unknown. The aim of this study is to explore the contribution of candidate genetic factors to HD AO in order to gain insight into the pathogenic mechanisms underlying this disorder. For that purpose, two AO definitions were used: the earliest age with unequivocal signs of HD (earliest AO or eAO), and the first motor symptoms age (motor AO or mAO). Multiple linear regression analyses were performed between genetic variation within 20 candidate genes and eAO or mAO, using DNA and clinical information of 253 HD patients from REGISTRY project. Gene expression analyses were carried out by RT-qPCR with an independent sample of 35 HD patients from Basque Country Hospitals. We found suggestive association signals between HD eAO and/or mAO and genetic variation within the E2F2, ATF7IP, GRIN2A, GRIN2B, LINC01559, HIP1 and GRIK2 genes. Among them, the most significant was the association between eAO and rs2742976, mapping to the promoter region of E2F2 transcription factor. Furthermore, rs2742976 T allele patient carriers exhibited significantly lower lymphocyte E2F2 gene expression, suggesting a possible implication of E2F2-dependent transcriptional activity in HD pathogenesis. Thus, E2F2 emerges as a new potential HD AO modifier factor.	[Valcarcel-Ocete, Leire; Iriondo, Mikel; Fullaondo, Asier; Zubiaga, Ana M.; Aguirre, Ana] Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain; [Alkorta-Aranburu, Gorka] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Garcia-Barcina, Maria] Basurto Univ Hosp, Genet Unit, Bilbao, Spain; [Manuel Fernandez-Garcia, Jose] Basurto Univ Hosp, Neurol Serv, Bilbao, Spain; [Lezcano-Garcia, Elena; Maria Losada-Domingo, Jose] Cruces Univ Hosp, Dept Neurol, Baracaldo, Spain; [Ruiz-Ojeda, Javier] Galdakao Usansolo Hosp, Dept Neurol, Galdakao, Spain; [Alvarez de Arcaya, Amaia; Maria Perez-Ramos, Jose] Alava Univ Hosp, Dept Neurol, Vitoria, Spain; [Roos, Raymund A. C.] Leiden Univ, Dept Neurol, Med Ctr, Leiden, Netherlands; [Nielsen, Jorgen E.] Rigshosp, Univ Copenhagen Hosp, Neurogenet Clin, Danish Dementia Res Ctr, DK-2100 Copenhagen, Denmark; [Saft, Carsten] Ruhr Univ Bochum, St Josef Hosp, Huntington Zentrum NRW Bochum, Bochum, Germany	University of Basque Country; University of Chicago; Basurto Hospital; Basurto Hospital; Hospital Universitario Cruces; Galdakao Hospital; University Hospital of Araba; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Rigshospitalet; University of Copenhagen; Ruhr University Bochum	Aguirre, A (corresponding author), Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain.	ana.aguirre@ehu.es	Fullaondo, Asier/G-7131-2019; Iriondo, Mikel/AAA-7997-2019; Romano, Silvia/P-7984-2015; zubiaga, ana/S-3457-2019; Fullaondo, Asier/L-2848-2019	Fullaondo, Asier/0000-0001-5387-4762; Iriondo, Mikel/0000-0001-7835-0041; Romano, Silvia/0000-0003-0499-8843; zubiaga, ana/0000-0002-2132-9708; Fullaondo, Asier/0000-0001-5387-4762; AGUIRRE ESCOBAL, ANA ISABEL/0000-0002-5624-443X; Saft, Carsten/0000-0002-3983-7292; Nielsen, Jorgen Erik/0000-0003-0453-5582	Basque Government [PE08UN78, 09+UEGV096/C01, IT634-13]; University of the Basque Country (UPV/EHU) [UFI 11/20]; CHDI Foundation, Inc.; Novo Nordisk Fonden [NNF11OC1014514] Funding Source: researchfish	Basque Government(Basque Government); University of the Basque Country (UPV/EHU); CHDI Foundation, Inc.; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by Basque Government grants (PE08UN78,09+UEGV096/C01 and IT634-13) received by AA and by University of the Basque Country (UPV/EHU) grant (UFI 11/20) received by AMZ. The European Huntington's Disease Network is funded by CHDI Foundation, Inc. (http://chdifoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberch J, 2005, NEUROLOGY, V65, P964, DOI 10.1212/01.wnl.0000175977.57661.b1; Andresen JM, 2007, J MED GENET, V44, P44, DOI 10.1136/jmg.2006.045153; Andresen JM, 2007, ANN HUM GENET, V71, P295, DOI 10.1111/j.1469-1809.2006.00335.x; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Anne SL, 2007, J NEUROSCI, V27, P7318, DOI 10.1523/JNEUROSCI.1831-07.2007; Arning L, 2005, NEUROGENETICS, V6, P25, DOI 10.1007/s10048-004-0198-8; Arning L, 2008, J MOL MED, V86, P485, DOI 10.1007/s00109-007-0299-6; Arning L, 2007, HUM GENET, V122, P175, DOI 10.1007/s00439-007-0393-4; Arning Larissa, 2004, BMC Med Genet, V5, P7, DOI 10.1186/1471-2350-5-7; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brinkman RR, 1997, AM J HUM GENET, V60, P1202; Chang KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046492; Chattopadhyay B, 2005, NEUROSCI LETT, V374, P81, DOI 10.1016/j.neulet.2004.10.018; Chattopadhyay B, 2003, NEUROSCI LETT, V345, P93, DOI 10.1016/S0304-3940(03)00436-1; Che HV, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-1; Chen-Plotkin AS, 2006, NEUROBIOL DIS, V22, P233, DOI 10.1016/j.nbd.2005.11.001; Dhaenens CM, 2009, NEUROBIOL DIS, V35, P474, DOI 10.1016/j.nbd.2009.06.009; Dimassi S, 2013, AM J MED GENET A, V161, P2564, DOI 10.1002/ajmg.a.36079; Djousse L, 2003, AM J MED GENET A, V119A, P279, DOI 10.1002/ajmg.a.20190; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fan MMY, 2007, PROG NEUROBIOL, V81, P272, DOI 10.1016/j.pneurobio.2006.11.003; Fontaine SN, 2012, FEBS LETT, V586, P3030, DOI 10.1016/j.febslet.2012.07.011; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gervais FG, 2002, NAT CELL BIOL, V4, P95, DOI 10.1038/ncb735; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Graham RK, 2010, J NEUROSCI, V30, P15019, DOI 10.1523/JNEUROSCI.2071-10.2010; Gusella JF, 2009, GENOME MED, V1, DOI 10.1186/gm80; Hackam AS, 2000, J BIOL CHEM, V275, P41299, DOI 10.1074/jbc.M008408200; Holbert S, 2001, P NATL ACAD SCI USA, V98, P1811, DOI 10.1073/pnas.041566798; Huettner JE, 2003, PROG NEUROBIOL, V70, P387, DOI 10.1016/S0301-0082(03)00122-9; Infante A, 2008, CELL CYCLE, V7, P3915, DOI 10.4161/cc.7.24.7379; Jeong H, 2012, NAT MED, V18, P159, DOI 10.1038/nm.2559; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kobal J, 2012, HUNTINGTON'S DISEASE - CORE CONCEPTS AND CURRENT ADVANCES, P101; Lee JM, 2012, NEUROLOGY, V78, P690, DOI 10.1212/WNL.0b013e318249f683; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Lu MX, 2012, MOL CARCINOGEN, V51, pE132, DOI 10.1002/mc.21882; Luo SQ, 2005, J CELL BIOL, V169, P647, DOI 10.1083/jcb.200412071; Majumder P, 2006, NEUROBIOL DIS, V22, P242, DOI 10.1016/j.nbd.2005.11.003; Marchina E, 2014, J NEUROL SCI, V337, P42, DOI 10.1016/j.jns.2013.11.014; Matute C, 2011, CNS NEUROSCI THER, V17, P661, DOI 10.1111/j.1755-5949.2010.00204.x; McGill JK, 2006, CELL, V127, P465, DOI 10.1016/j.cell.2006.10.023; Metzger S, 2008, HUM MOL GENET, V17, P1137, DOI 10.1093/hmg/ddn003; Metzger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068951; Metzger S, 2010, HUM GENET, V128, P453, DOI 10.1007/s00439-010-0873-9; Metzler M, 2007, J NEUROSCI, V27, P2298, DOI 10.1523/JNEUROSCI.5175-06.2007; Orth Michael, 2011, PLoS Curr, V3, pRRN1258, DOI 10.1371/currents.RRN1258; Paulsen JS, 2008, J NEUROL NEUROSUR PS, V79, P874, DOI 10.1136/jnnp.2007.128728; Persengiev SP, 2001, ONCOGENE, V20, P5124, DOI 10.1038/sj.onc.1204663; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Polager S, 2008, ONCOGENE, V27, P4860, DOI 10.1038/onc.2008.117; Ramos EM, 2012, HUM GENET, V131, P1833, DOI 10.1007/s00439-012-1205-z; Rangone H, 2004, EUR J NEUROSCI, V19, P273, DOI 10.1111/j.0953-816X.2003.03131.x; Roos RAC, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-40; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Rubinsztein DC, 1997, P NATL ACAD SCI USA, V94, P3872, DOI 10.1073/pnas.94.8.3872; Saft Carsten, 2011, PLoS Curr, V3, pRRN1247, DOI 10.1371/currents.RRN1247; Sassone J, 2009, EXP NEUROL, V219, P385, DOI 10.1016/j.expneurol.2009.05.012; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Taherzadeh-Fard E, 2010, NEUROGENETICS, V11, P435, DOI 10.1007/s10048-010-0248-3; Taherzadeh-Fard E, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-10; Trynka G, 2013, CURR OPIN GENET DEV, V23, P635, DOI 10.1016/j.gde.2013.10.009; U M, 2001, CELL DEATH DIFFER, V8, P377, DOI 10.1038/sj.cdd.4400819; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Warby SC, 2009, AM J HUM GENET, V84, P351, DOI 10.1016/j.ajhg.2009.02.003; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Weydt P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-3; Wu LLY, 2009, CELL ADHES MIGR, V3, P71, DOI 10.4161/cam.3.1.7511; Zeng WQ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-62; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	75	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131573	10.1371/journal.pone.0131573	http://dx.doi.org/10.1371/journal.pone.0131573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148071	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600110
J	Zhang, C; Zhang, LL; Liu, XH; Zhang, L; Zeng, ZY; Li, L; Liu, GJ; Jiang, H				Zhang, Chuan; Zhang, Lingli; Liu, Xinghui; Zhang, Li; Zeng, Zhiyou; Li, Lin; Liu, Guanjian; Jiang, Hong			Timing of Antibiotic Prophylaxis in Elective Caesarean Delivery: A Multi-Center Randomized Controlled Trial and Meta-Analysis	PLOS ONE			English	Article							SECTION; METRONIDAZOLE; ENDOMETRITIS; MORBIDITY; FLORA; GUT	Objective To compare the effectiveness of antibiotic prophylaxis before skin incision with that after umbilical cord clamping in elective caesarean delivery. Methods We conducted a randomized open-label controlled trial with two parallel arms at three hospitals in western China. Participants meeting the inclusion criteria received antibiotics 30-60 minutes before skin incision while others received antibiotics after umbilical cords clamping. For the meta-analysis, studies were identified from the database of PUBMED, Cochrane Library and EMbase and assessed using the Cochrane risk of bias tool. Results Four hundred and ten patients were randomized to receive antibiotics before skin incision (n = 205) or after umbilical cords clamping (n = 205). There was no difference in the incidence of postpartum endometritis (RR = 0.34, 95% CI 0.04 to 3.24), wound infection (RR = 3.06, 95% CI 0.13 to 74.69) and total puerperal morbidity (RR = 1.02, 95% CI 0.47 to 2.22). No increase in the incidence of neonatal sepsis (RR = 0.34, 95% CI 0.04 to 3.24), septic workup (RR = 0.41, 95% CI 0.08 to 2.07), or intermediate NICU admission (RR = 0.73, 95% CI 0.24 to 2.26) was observed. The meta-analysis involving nine RCTs showed that no statistically significant difference was found in terms of the risk of postpartum endometritis (RR = 0.73, 95% CI 0.39, 1.36), wound infection (RR = 0.80, 95% CI 0.55, 1.17), or puerperal morbidity (RR = 0.89, 95% CI 0.70, 1.13). No increase in the incidence of neonatal sepsis (RR = 0.65, 95% CI 0.35 to 1.20), septic workup (RR = 0.88, 95% CI 0.50 to 1.54), or intermediate NICU admission (RR = 0.91, 95% CI 0.70 to 1.18) was observed. Conclusion For elective caesarean delivery, the effects of antibiotic prophylaxis before skin incision and after umbilical cord clamping were equal. Both antibiotic prophylaxis before skin incision and that after umbilical cord clamping were recommended for elective caesarean delivery. The outcome of further studies should address both maternal and neonatal infectious morbidity as well as long-term neonatal follow up.	[Zhang, Chuan; Zhang, Lingli] Sichuan Univ, West China Univ Hosp 2, Evidence Based Pharm Ctr, Dept Pharm, Chengdu 610064, Sichuan, Peoples R China; [Liu, Xinghui; Zhang, Li] Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Chuan; Zhang, Lingli; Liu, Xinghui; Zhang, Li] Sichuan Univ, Minist Educ, Key Lab Birth Defects & Related Dis Women & Child, Chengdu 610064, Sichuan, Peoples R China; [Zeng, Zhiyou; Li, Lin] Nanchong Cent Hosp, Dept Pharm, Nanchong, Sichuan, Peoples R China; [Liu, Guanjian] West China Hosp, Chinese Cochrane Ctr, Chengdu, Sichuan, Peoples R China; [Jiang, Hong] Suining Cent Hosp, Dept Obstet & Gynecol, Suining, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; North Sichuan Medical University	Zhang, C (corresponding author), Sichuan Univ, West China Univ Hosp 2, Evidence Based Pharm Ctr, Dept Pharm, Chengdu 610064, Sichuan, Peoples R China.	zhlingli@sina.com; liu_xinghui2001@163.com	Li, Lin/ABD-9139-2021		Natural Science Foundation of China : Evidence based establishment of evaluation index system for pediatric rational drug use in China [81373381]	Natural Science Foundation of China : Evidence based establishment of evaluation index system for pediatric rational drug use in China	This research was supported by Natural Science Foundation of China : Evidence based establishment of evaluation index system for pediatric rational drug use in China (No. 81373381).	American College of Obstetricians and Gynecologists, 2003, OBSTET GYNECOL, V102; Andrews WW, 2003, OBSTET GYNECOL, V101, P1183, DOI 10.1016/S0029-7844(03)00016-4; [Anonymous], 2011, OBSTET GYNECOL, V117, P1472, DOI DOI 10.1097/AOG.0B013E3182238C31; Baaqeel H, 2013, BJOG-INT J OBSTET GY, V120, P661, DOI 10.1111/1471-0528.12036; Bashier Osman, 2013, BMC RES NOTES, V6, P57, DOI [10.1186/1756-0500-6-57, DOI 10.1186/1756-0500-6-57]; BURKE JF, 1961, SURGERY, V50, P161; Costantine MM, 2008, AM J OBSTET GYNECOL, V199; DexinXiong, 2003, MOD INT MICR; DUCLUZEAU R, 1983, ANN RECH VET, V14, P354; Elahi S, 2013, NATURE, V504, P158, DOI 10.1038/nature12675; ENKIN M, 1989, EFFECTIVE CARE PREGN; Francis C, 2013, J PERINATOL, V33, P759, DOI 10.1038/jp.2013.56; Hofmeyr GJ., 2010, COCHRANE DB SYST REV; Hopkins L, 2012, COCHRANE DB SYST REV, V1; Kalaranjini S, 2013, ARCH GYNECOL OBSTET, V288, P1263, DOI 10.1007/s00404-013-2906-9; Kandil M, 2014, J MATERN-FETAL NEO M, V27, P588, DOI 10.3109/14767058.2013.823938; Kelly D, 2007, MUTAT RES-FUND MOL M, V622, P58, DOI 10.1016/j.mrfmmm.2007.03.011; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P193, DOI 10.1111/j.1471-0528.2010.02729.x; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; Mackeen AD, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009516.pub2; Macones GA, 2012, AM J PERINAT, V29, P273, DOI 10.1055/s-0031-1295657; Marcollet A, 2002, AM J OBSTET GYNECOL, V186, P784, DOI 10.1067/mob.2002.122251; Meyer NL, 2003, SOUTH MED J, V96, P992, DOI 10.1097/01.SMJ.0000060570.51934.14; Nokiani F. A., 2009, IRAN J CLIN INFECT D, V4, P71; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Pitt C, 2001, OBSTET GYNECOL, V98, P745, DOI 10.1016/S0029-7844(01)01517-4; ROTIMI VO, 1981, J MED MICROBIOL, V14, P51, DOI 10.1099/00222615-14-1-51; van Schalkwyk J, 2010, J OBSTET GYNAECOL CA, V32, P878, DOI 10.1016/S1701-2163(16)34662-X; Witt A, 2011, ARCH SURG-CHICAGO, V146, P1404, DOI 10.1001/archsurg.2011.725; Yildirim G, 2009, ARCH GYNECOL OBSTET, V280, P13, DOI 10.1007/s00404-008-0845-7	30	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0129434	10.1371/journal.pone.0129434	http://dx.doi.org/10.1371/journal.pone.0129434			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148063	gold, Green Submitted, Green Published			2022-12-27	WOS:000358157600021
J	Zhuang, XT; Wang, LQ; Song, ZX; Xiao, W				Zhuang, Xiaotong; Wang, Lianqing; Song, Zixun; Xiao, Wei			A Novel Insertion Variant of CRYGD Is Associated with Congenital Nuclear Cataract in a Chinese Family	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT CATARACT; MISSENSE MUTATION; GENE; CRYBA1/A3; CRYAA	Objective To investigate a novel insertion variant of CRYGD identified in a Chinese family with nuclear congenital cataract. Methods A Chinese family with congenital nuclear cataract was recruited for the mutational screening of candidate genes by direct sequencing. Recombinant N-terminal Myc tagged wildtype or mutant CRYGD was expressed in HEK293T cells. The expression pattern, protein solubility and subcellular distribution were analyzed by western blotting and immunofluorescence. Principal Findings A novel insertion variant, c.451_452insGACT, in CRYGD was identified in the patients. It causes a frameshift and a premature termination of the polypeptide to become Y151*. A significantly reduced solubility was observed for this mutant. Unlike wildtype CRYGD, which existed mainly in the cytoplasm, Y151* was mis-located in the nucleus. Conclusions We have identified a novel mutation, c.451_452insGACT, in CRYGD, which is associated with nuclear cataract. This is the first insertion mutation of CRYGD found to cause autosomal dominant congenital cataract. The mutant protein, with loss of solubility and localization to the nucleus, is hypothesized to be the major cause of cataract in these patients.	[Zhuang, Xiaotong; Song, Zixun; Xiao, Wei] China Med Univ, Shengjing Hosp, Dept Ophthalmol, Shenyang, Peoples R China; [Zhuang, Xiaotong] Fourth Peoples Hosp Shenyang, Dept Ophthalmol, Shenyang, Peoples R China; [Wang, Lianqing] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Med Genet, Beijing 100730, Peoples R China; [Wang, Lianqing] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Lianqing] Cent Hosp Zibo, Cent Lab, Zibo, Peoples R China	China Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Xiao, W (corresponding author), China Med Univ, Shengjing Hosp, Dept Ophthalmol, Shenyang, Peoples R China.	xiaow@sj-hospital.org	Wang, Lianqing/AAX-5278-2020; Xiao, Wei/M-3847-2018	Wang, Lianqing/0000-0002-7161-4718; Xiao, Wei/0000-0001-5924-434X; Song, Zixun/0000-0003-0241-8518; song, zixun/0000-0002-6819-8178	National Natural Science Foundation of China [30973276]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation of China (No. 30973276). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basak A, 2003, J MOL BIOL, V328, P1137, DOI 10.1016/S0022-2836(03)00375-9; Brown AL, 1924, AM J OPHTHALMOL, V7, P1924; Chen JJ, 2011, AM J HUM GENET, V88, P827, DOI 10.1016/j.ajhg.2011.05.008; Cocquerel L, 2000, J VIROL, V74, P3623, DOI 10.1128/JVI.74.8.3623-3633.2000; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Gu ZS, 2010, MOL VIS, V16, P154; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Heon E, 1999, AM J HUM GENET, V65, P1261, DOI 10.1086/302619; Mackay DS, 2003, EUR J HUM GENET, V11, P784, DOI 10.1038/sj.ejhg.5201046; Messina-Baas O, 2006, MOL VIS, V12, P995; Nandrot E, 2003, J MED GENET, V40, P262, DOI 10.1136/jmg.40.4.262; Pauli S, 2007, MOL VIS, V13, P962; Qi YH, 2004, HUM GENET, V114, P192, DOI 10.1007/s00439-003-1049-7; Santana A, 2009, MOL VIS, V15, P793; SCOTT MH, 1994, OPHTHALMOLOGY, V101, P866; Su DM, 2012, MOL VIS, V18, P3057; Talla V, 2008, INVEST OPHTH VIS SCI, V49, P3483, DOI 10.1167/iovs.07-1114; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Vendra VPR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070336; Wang BB, 2011, HUM MUTAT, V32, pE1939, DOI 10.1002/humu.21386; Wang KJ, 2011, HUM MUTAT, V32, pE2050, DOI 10.1002/humu.21436; Weisschuh N, 2012, MOL VIS, V18, P174; Willoughby CE, 2005, MOL VIS, V11, P587; Yao K, 2008, MOL VIS, V14, P1272; Zhang LY, 2007, MOL VIS, V13, P2096; Zhang TX, 2009, HUM MUTAT, V30, pE603, DOI 10.1002/humu.20995	26	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131471	10.1371/journal.pone.0131471	http://dx.doi.org/10.1371/journal.pone.0131471			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147294	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600099
J	Ahmed, M; Kumar, G; Navarro, G; Wang, YG; Gourevitch, S; Moussa, MH; Rozenblum, N; Levchenko, T; Galun, E; Torchilin, VP; Goldberg, SN				Ahmed, Muneeb; Kumar, Gaurav; Navarro, Gemma; Wang, Yuanguo; Gourevitch, Svetlana; Moussa, Marwan H.; Rozenblum, Nir; Levchenko, Tatyana; Galun, Eithan; Torchilin, Vladimir P.; Goldberg, S. Nahum			Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy	PLOS ONE			English	Article							LIPOSOMAL DOXORUBICIN ACCUMULATION; COLORECTAL LIVER METASTASES; PULMONARY VEIN ISOLATION; BREAST-TUMOR MODEL; THERMAL ABLATION; ATRIAL-FIBRILLATION; HEPATOCELLULAR-CARCINOMA; GROWTH-FACTOR; DELIVERY; INCREASES	Purpose Radiofrequency thermal ablation (RFA) of hepatic and renal tumors can be accompanied by non-desired tumorigenesis in residual, untreated tumor. Here, we studied the use of micelle-encapsulated siRNA to suppress IL-6-mediated local and systemic secondary effects of RFA. Methods We compared standardized hepatic or renal RFA (laparotomy, 1 cm active tip at 70 +/- 2 degrees C for 5 min) and sham procedures without and with administration of 150nm micelle-like nanoparticle (MNP) anti-IL6 siRNA (DOPE-PEI conjugates, single IP dose 15 min post-RFA, C57Bl mouse: 3.5 ug/100ml, Fisher 344 rat: 20ug/200ul), RFA/scrambled siRNA, and RFA/empty MNPs. Outcome measures included: local periablational cellular infiltration (a-SMA+ stellate cells), regional hepatocyte proliferation, serum/tissue IL-6 and VEGF levels at 6-72hr, and distant tumor growth, tumor proliferation (Ki-67) and microvascular density (MVD, CD34) in subcutaneous R3230 and MATBIII breast adenocarcinoma models at 7 days. Results For liver RFA, adjuvant MNP anti-IL6 siRNA reduced RFA-induced increases in tissue IL-6 levels, alpha-SMA+stellate cell infiltration, and regional hepatocyte proliferation to baseline (p<0.04, all comparisons). Moreover, adjuvant MNP anti-IL6-siRNA suppressed increased distant tumor growth and Ki-67 observed in R3230 and MATBIII tumors post hepatic RFA (p<0.01). Anti-IL6 siRNA also reduced RFA-induced elevation in VEGF and tumor MVD (p<0.01). Likewise, renal RFA-induced increases in serum IL-6 levels and distant R3230 tumor growth was suppressed with anti-IL6 siRNA (p<0.01). Conclusions Adjuvant nanoparticle-encapsulated siRNA against IL-6 can be used to modulate local and regional effects of hepatic RFA to block potential unwanted pro-oncogenic effects of hepatic or renal RFA on distant tumor.	[Ahmed, Muneeb; Kumar, Gaurav; Wang, Yuanguo; Moussa, Marwan H.; Goldberg, S. Nahum] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Lab Minimally Invas Tumor Therapies,Dept Radiol, Boston, MA 02215 USA; [Navarro, Gemma; Levchenko, Tatyana; Torchilin, Vladimir P.] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Navarro, Gemma; Levchenko, Tatyana; Torchilin, Vladimir P.] Northeastern Univ, Ctr Pharmaceut Biotechnol & Nanomed, Boston, MA 02115 USA; [Gourevitch, Svetlana; Rozenblum, Nir; Galun, Eithan] Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel; [Goldberg, S. Nahum] Hadassah Hebrew Univ, Med Ctr, Dept Radiol, Div Image Guided Therapy & Intervent Oncol, IL-91120 Jerusalem, Israel	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Northeastern University; Northeastern University; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Ahmed, M (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Lab Minimally Invas Tumor Therapies,Dept Radiol, 1 Deaconess Rd WCC 308B, Boston, MA 02215 USA.	mahmed@bidmc.harvard.edu	Galun, Eithan/AAD-9117-2022; Ahmed, Muneeb/X-8479-2018; Goldberg, S. Nahum/AAV-4526-2020	Galun, Eithan/0000-0002-6243-6702; 	National Cancer Institute (CCNE) [1U54CA151881-01]; Radiological Society of North America Research and Education Foundation [RSD1215]; Harvard Medical Faculty Physicians Faculty Radiology Foundation; Deutsche Forschungsgemeinschaft [SF8841]; Israeli Center of Excellence I-CORE; Israel Science Foundation; NATIONAL CANCER INSTITUTE [U54CA151881] Funding Source: NIH RePORTER	National Cancer Institute (CCNE); Radiological Society of North America Research and Education Foundation; Harvard Medical Faculty Physicians Faculty Radiology Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Israeli Center of Excellence I-CORE; Israel Science Foundation(Israel Science Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute (CCNE 1U54CA151881-01 VPT, SNG, MA, TL), Radiological Society of North America Research and Education Foundation (RSD1215, MA), Harvard Medical Faculty Physicians Faculty Radiology Foundation (MA), Deutsche Forschungsgemeinschaft (SF8841, EG), the Israeli Center of Excellence I-CORE (EG), and the Israel Science Foundation (EG, SNG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanell AM, 2010, AM J PHYSIOL-HEART C, V298, pH1529, DOI 10.1152/ajpheart.01087.2009; Ahmed M, 2003, CANCER RES, V63, P6327; Ahmed M, 2014, RADIOLOGY, V13; Ahmed M, 2013, J VASC INTERV RADIOL, V24, pS44; Ahmed M, 2012, CHEM PHYS LIPIDS, V165, P424, DOI 10.1016/j.chemphyslip.2011.12.002; Ahmed M, 2011, RADIOLOGY, V258, P351, DOI 10.1148/radiol.10081634; Anower AKMM, 2012, EUR J PHARMACOL, V688, P76, DOI 10.1016/j.ejphar.2012.05.007; Chu KF, 2014, NAT REV CANCER, V14, P199, DOI 10.1038/nrc3672; Davila ML, 2013, THORAC SURG CLIN, V23, P479, DOI 10.1016/j.thorsurg.2013.07.010; de Baere T, 2015, EUR J ENDOCRINOL, V172, pR151, DOI 10.1530/EJE-14-0630; de Bethlenfalva-Hora CE, 2014, CLIN SCI, V126, P243, DOI 10.1042/CS20130089; de Martimprey H, 2009, EUR J PHARM BIOPHARM, V71, P490, DOI 10.1016/j.ejpb.2008.09.024; Deftereos S, 2012, J AM COLL CARDIOL, V60, P1790, DOI 10.1016/j.jacc.2012.07.031; Dewire J, 2010, NAT REV CARDIOL, V7, P129, DOI 10.1038/nrcardio.2009.232; Dong YZ, 2014, P NATL ACAD SCI USA, V111, P3955, DOI 10.1073/pnas.1322937111; Erinjeri JP, 2013, J VASC INTERV RADIOL, V24, P1105, DOI 10.1016/j.jvir.2013.02.015; Filgueiras-Rama D, 2013, J AM COLL CARDIOL, V61, P1464, DOI 10.1016/j.jacc.2012.12.042; Gao Y, 2011, INT J NANOMED, V6, P1017, DOI 10.2147/IJN.S17040; Gavrilov Kseniya, 2012, Yale Journal of Biology and Medicine, V85, P187; Gohell MS, 2009, PHLEBOLOGY, V24, P42, DOI 10.1258/phleb.2009.09s005; Goldberg SN, 2002, RADIOLOGY, V222, P797, DOI 10.1148/radiol.2223010861; Guo PX, 2010, ADV DRUG DELIVER REV, V62, P650, DOI 10.1016/j.addr.2010.03.008; Haen SP, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/160250; Hamamoto S, 2013, RADIOLOGY, V267, P405, DOI 10.1148/radiol.13120249; Hohenberger Peter, 2013, Am Soc Clin Oncol Educ Book, P457, DOI 10.1200/EdBook_AM.2013.33.457; Ishii H, 2001, ARCH ORAL BIOL, V46, P77, DOI 10.1016/S0003-9969(00)00081-9; Jeong JH, 2009, BIOCONJUGATE CHEM, V20, P5, DOI 10.1021/bc800278e; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Kong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037266; Kruskal JB, 2001, J VASC INTERV RADIOL, V12, P1193, DOI 10.1016/S1051-0443(07)61679-0; Kumar G, 2013, RAD SOC N AM P ANN M, P77; Lencioni R, 2005, RADIOLOGY, V234, P961, DOI 10.1148/radiol.2343040350; Lim HS, 2014, CIRC-ARRHYTHMIA ELEC, V7, P83, DOI 10.1161/CIRCEP.113.000876; Mao CP, 2007, J BIOMED SCI, V14, P15, DOI 10.1007/s11373-006-9131-5; Mittal S, 2013, J CLIN GASTROENTEROL, V47, pS2, DOI 10.1097/MCG.0b013e3182872f29; Monsky WL, 2002, RADIOLOGY, V224, P823, DOI 10.1148/radiol.2243011421; Moussa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102727; NAVARRO G, 2013, NANOMED-NANOTECHNOL, V10, P411; Navarro G, 2012, NANOMEDICINE-UK, V7, P65, DOI [10.2217/NNM.11.93, 10.2217/nnm.11.93]; Nijkamp MW, 2009, ANN SURG, V249, P814, DOI 10.1097/SLA.0b013e3181a38ef5; Nikfarjam M, 2006, SURGERY, V139, P73, DOI 10.1016/j.surg.2005.07.030; Niu J, 2008, J CANCER RES CLIN, V134, P503, DOI 10.1007/s00432-007-0314-x; Oh YK, 2009, ADV DRUG DELIVER REV, V61, P850, DOI 10.1016/j.addr.2009.04.018; Polimeni A, 2013, CIRC J, V77, P857, DOI 10.1253/circj.CJ-13-0297; Ponnappa BC, 2009, CURR OPIN INVEST DR, V10, P418; Ramanathan R, 2014, TRANSPLANTATION, V98, P100, DOI 10.1097/01.TP.0000441090.39840.b0; Resnier P, 2013, BIOMATERIALS, V34, P6429, DOI 10.1016/j.biomaterials.2013.04.060; Rozenblum N, 2011, P ANN M, P70; Rozenblum N, 2014, RADIOLOGY IN PRESS; Sawant RR, 2012, BIOMATERIALS, V33, P3942, DOI 10.1016/j.biomaterials.2011.11.088; Shim J, 2009, GENE THER, V16, P415, DOI 10.1038/gt.2008.180; Solazzo SA, 2010, RADIOLOGY, V255, P62, DOI 10.1148/radiol.09091196; Taylor MA, 2014, ACCELERATED GROWTH R; Thiel KW, 2012, NUCLEIC ACIDS RES, V40, P6319, DOI 10.1093/nar/gks294; Wang J, 2010, AAPS J, V12, P492, DOI 10.1208/s12248-010-9210-4; Wang XD, 2013, CARDIOVASC INTER RAD, V36, P166, DOI 10.1007/s00270-012-0377-1; Widenmeyer M, 2011, INT J CANCER, V128, P2653, DOI 10.1002/ijc.25601; Wood BJ, 2012, J VASC INTERV RADIOL, V23, P248, DOI 10.1016/j.jvir.2011.10.018; Wu N, 2013, INT J CARDIOL, V169, P62, DOI 10.1016/j.ijcard.2013.08.078; Yang W, 2011, INT J HYPERTHER, V27, P527, DOI 10.3109/02656736.2011.582474	60	20	20	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0128910	10.1371/journal.pone.0128910	http://dx.doi.org/10.1371/journal.pone.0128910			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154425	Green Published, Green Submitted, gold			2022-12-27	WOS:000358159700011
J	Benuzzi, F; Ballotta, D; Mirandola, L; Ruggieri, A; Vaudano, AE; Zucchelli, M; Ferrari, E; Nichelli, PF; Meletti, S				Benuzzi, Francesca; Ballotta, Daniela; Mirandola, Laura; Ruggieri, Andrea; Vaudano, Anna Elisabetta; Zucchelli, Micaela; Ferrari, Elisabetta; Nichelli, Paolo Frigio; Meletti, Stefano			An EEG-fMRI Study on the Termination of Generalized Spike-And-Wave Discharges in Absence Epilepsy	PLOS ONE			English	Article							NEGATIVE BOLD; NETWORK; ACTIVATION; SEIZURES; CONNECTIVITY; STATE; DEACTIVATION; RESPONSES; ARTIFACT; BEHAVIOR	Introduction Different studies have investigated by means of EEG-fMRI coregistration the brain networks related to generalized spike-and-wave discharges (GSWD) in patients with idiopathic generalized epilepsy (IGE). These studies revealed a widespread GSWD-related neural network that involves the thalamus and regions of the default mode network. In this study we investigated which brain regions are critically involved in the termination of absence seizures (AS) in a group of IGE patients. Methods Eighteen patients (6 male; mean age 25 years) with AS were included in the EEG-fMRI study. Functional data were acquired at 3T with continuous simultaneous video-EEG recording. Event-related analysis was performed with SPM8 software, using the following regressors: (1) GSWD onset and duration; (2) GSWD offset. Data were analyzed at single-subject and at group level with a second level random effect analysis. Results A mean of 17 events for patient was recorded (mean duration of 4.2 sec). Group-level analysis related to GSWD onset respect to rest confirmed previous findings revealing thalamic activation and a precuneus/posterior cingulate deactivation. At GSWD termination we observed a decrease in BOLD signal over the bilateral dorsolateral frontal cortex respect to the baseline (and respect to GSWD onset). The contrast GSWD offset versus onset showed a BOLD signal increase over the precuneus-posterior cingulate region bilaterally. Parametric correlations between electro-clinical variables and BOLD signal at GSWD offset did not reveal significant effects. Conclusion The role of the decreased neural activity of lateral prefrontal cortex at GSWD termination deserve future investigations to ascertain if it has a role in promoting the discharge offset, as well as in the determination of the cognitive deficits often present in patients with AS. The increased BOLD signal at precuneal/posterior cingulate cortex might reflect the recovery of neural activity in regions that are "suspended" during spike and waves activity, as previously hypothesized.	[Benuzzi, Francesca; Ballotta, Daniela; Mirandola, Laura; Ruggieri, Andrea; Vaudano, Anna Elisabetta; Nichelli, Paolo Frigio; Meletti, Stefano] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy; [Mirandola, Laura; Vaudano, Anna Elisabetta; Nichelli, Paolo Frigio; Meletti, Stefano] NOCSAE Hosp ASL, Neurol Unit, Modena, Italy; [Zucchelli, Micaela] Univ Bologna, Dept Psychol, Bologna, Italy; [Ferrari, Elisabetta] IIT, Genoa, Italy	Universita di Modena e Reggio Emilia; University of Bologna; Istituto Italiano di Tecnologia - IIT	Meletti, S (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy.	stefano.meletti@unimore.it	Ferrari, Elisabetta/AAA-4801-2020; Vaudano, Anna Elisabetta AE/O-2653-2015; Nichelli, Paolo/F-7336-2015; Meletti, Stefano/O-3622-2015	Ferrari, Elisabetta/0000-0002-4781-1367; Vaudano, Anna Elisabetta AE/0000-0002-6280-7526; Nichelli, Paolo/0000-0001-9756-6796; Meletti, Stefano/0000-0003-0334-539X; Benuzzi, Francesca/0000-0002-3498-3303	grant of Carismo Foundation [A.010@FCRMO RINT@MELFONINFO]	grant of Carismo Foundation	This work is part of a research program funded by a grant of Carismo Foundation (grant number: A.010@FCRMO RINT@MELFONINFO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghakhani Y, 2004, BRAIN, V127, P1127, DOI 10.1093/brain/awh136; Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Amzica F, 2009, ENCYCLOPEDIA OF BASIC EPILEPSY RESEARCH, VOLS 1-3, P1343; [Anonymous], 1981, Epilepsia, V22, P489; Archer JS, 2003, NEUROIMAGE, V20, P1915, DOI 10.1016/S1053-8119(03)00294-5; Avanzini P, 2014, CLIN NEUROPHYSIOL, V125, P239, DOI 10.1016/j.clinph.2013.07.009; Bai XX, 2010, J NEUROSCI, V30, P5884, DOI 10.1523/JNEUROSCI.5101-09.2010; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Benuzzi F, 2012, EPILEPSIA, V53, P622, DOI 10.1111/j.1528-1167.2011.03385.x; Berman R, 2010, EPILEPSIA, V51, P2011, DOI 10.1111/j.1528-1167.2010.02652.x; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Carney PW, 2012, NEUROLOGY, V78, P1157, DOI 10.1212/WNL.0b013e31824f801d; Carney PW, 2010, NEUROLOGY, V75, P904, DOI 10.1212/WNL.0b013e3181f11c06; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chatton JY, 2003, P NATL ACAD SCI USA, V100, P12456, DOI 10.1073/pnas.2132096100; Fahoum F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068038; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Gotman J, 2005, P NATL ACAD SCI USA, V102, P15236, DOI 10.1073/pnas.0504935102; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Halasz P, 2002, EPILEPSY RES, V51, P123, DOI 10.1016/S0920-1211(02)00123-7; Hamandi K, 2006, NEUROIMAGE, V31, P1700, DOI 10.1016/j.neuroimage.2006.02.016; Jacobs J, 2009, NEUROIMAGE, V45, P1220, DOI 10.1016/j.neuroimage.2009.01.014; Killory BD, 2011, NEUROIMAGE, V56, P2209, DOI 10.1016/j.neuroimage.2011.03.036; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Labate A, 2005, EPILEPTIC DISORD, V7, P373; Lado FA, 2008, EPILEPSIA, V49, P1651, DOI 10.1111/j.1528-1167.2008.01669.x; Laufs H, 2006, EPILEPSIA, V47, P444, DOI 10.1111/j.1528-1167.2006.00443.x; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Ltittjohann A, 2014, NEUROBIOL DIS, V70, P127, DOI 10.1016/j.nbd.2014.06.007; Luo C, 2011, HUM BRAIN MAPP, V32, P438, DOI 10.1002/hbm.21034; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Maneshi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050359; Meletti S, 2015, CLIN NEUROPHYSIOL, V126, P847, DOI 10.1016/j.clinph.2014.07.030; Moeller F, 2008, EPILEPSIA, V49, P1510, DOI 10.1111/j.1528-1167.2008.01626.x; Moeller F, 2008, NEUROIMAGE, V39, P1839, DOI 10.1016/j.neuroimage.2007.10.058; Moeller F, 2010, EPILEPSIA, V51, P2000, DOI 10.1111/j.1528-1167.2010.02698.x; Neckelmann D, 2000, NEUROSCIENCE, V96, P475, DOI 10.1016/S0306-4522(99)00571-0; Pittau F, 2013, BRAIN TOPOGR, V26, P627, DOI 10.1007/s10548-013-0302-1; Pugnaghi M, 2014, BRAIN TOPOGR, V27, P123, DOI 10.1007/s10548-013-0311-0; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rathakrishnan R, 2010, EPILEPSIA, V51, P1837, DOI 10.1111/j.1528-1167.2010.02643.x; Ruggieri A, 2015, J NEUROSCI METH, V239, P223, DOI 10.1016/j.jneumeth.2014.10.005; Salek-Haddadi A, 2003, ANN NEUROL, V53, P663, DOI 10.1002/ana.10586; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Stefanovic B, 2005, NEUROIMAGE, V28, P205, DOI 10.1016/j.neuroimage.2005.05.038; Talairach J., 1998, COPLANAR STEREOTAXIC; Truccolo W, 2011, NAT NEUROSCI, V14, P635, DOI 10.1038/nn.2782; Vaudano AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006475; Vaudano AE, 2014, ANN NEUROL, V76, P412, DOI 10.1002/ana.24236; Xue KQ, 2014, EPILEPSY RES, V108, P125, DOI 10.1016/j.eplepsyres.2013.10.002; Yang TH, 2013, HUM BRAIN MAPP, V34, P1761, DOI 10.1002/hbm.22025	53	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130943	10.1371/journal.pone.0130943	http://dx.doi.org/10.1371/journal.pone.0130943			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154563	Green Published, Green Submitted, gold			2022-12-27	WOS:000358159700049
J	Paiva, CE; Manfredini, LL; Paiva, BSR; Hui, D; Bruera, E				Paiva, Carlos Eduardo; Manfredini, Luciana Lopes; Ribeiro Paiva, Bianca Sakamoto; Hui, David; Bruera, Eduardo			The Brazilian Version of the Edmonton Symptom Assessment System (ESAS) Is a Feasible, Valid and Reliable Instrument for the Measurement of Symptoms in Advanced Cancer Patients	PLOS ONE			English	Article							EARLY PALLIATIVE CARE; ASSESSMENT SCALE; PSYCHOMETRIC PROPERTIES; SLEEPINESS; MEDICINE; QLQ-C30; SERVICE	Purposes To develop and validate a Portuguese version of the Edmonton Symptom Assessment System (ESAS) in Brazilian patients with advanced cancer. Methods The ESAS was translated and then back translated into Portuguese in accordance with international guidelines. The final version was approved by an Expert Committee after pilot testing on 24 advanced cancer patients. Subsequently, we evaluated the time to complete the assessment, the number of unanswered items, internal consistency, convergent validity, and known-group validity in a sample of 249 advanced cancer patients who completed the ESAS along with the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30), Hospital Anxiety and Depression Scale (HADS), and Epworth Sleepiness Scale (ESS). A total of 90 clinically stable patients were retested after 4 to 96 hours (test-retest reliability), and 80 patients answered the ESAS after 21 (+/- 7) days to measure scale responsiveness using an anchor-based method. Results The ESAS was completed in a mean time of only 2.2 minutes. The internal consistency was good (Cronbach's alpha = 0.861), and the removal of single items did not change the overall alpha value. For convergent validity, Spearman's correlation coefficients between the ESAS symptom scores and the corresponding EORTC QLQ-C30 and ESS symptom scores ranged between 0.520 (95% CI = 0.424-0.605) and 0.814 (95% CI = 0.760-0.856), indicating moderate to strong correlations. Test-retest reliability values were considered adequate, with intraclass correlation coefficients ranging from 0.758 (95% CI = 0.627-0.843) to 0.939 (95% CI = 0.905-0.960). Conclusions ESAS is a feasible, valid and reliable multi-symptom assessment instrument for use in Brazil.	[Paiva, Carlos Eduardo] Barretos Canc Hosp, Dept Clin Oncol, Barretos, SP, Brazil; [Paiva, Carlos Eduardo; Ribeiro Paiva, Bianca Sakamoto] Barretos Canc Hosp, Learning & Res Inst, Barretos, SP, Brazil; [Manfredini, Luciana Lopes] Barretos Canc Hosp, Canc Hosp Children & Youth President Luiz Inacio, Barretos, SP, Brazil; [Bruera, Eduardo] Univ Texas MD Anderson Canc Ctr, Dept Palliat Care & Rehabil Med, Houston, TX 77030 USA	Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; University of Texas System; UTMD Anderson Cancer Center	Paiva, CE (corresponding author), Barretos Canc Hosp, Dept Clin Oncol, Barretos, SP, Brazil.	caredupai@gmail.com	Paiva, Carlos E/F-4810-2012; Bruera, Eduardo/AAA-1550-2022; Lopes Manfredini, Luciana/Q-6747-2016	Paiva, Carlos Eduardo/0000-0002-7934-1451; Lopes Manfredini, Luciana/0000-0001-6015-5854				AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Barroso EM, 2015, BRAZ J OTOR IN PRESS; Bertolazi AN, 2009, J BRAS PNEUMOL, V35, P877, DOI 10.1590/S1806-37132009000900009; Bruera E, 1991, J Palliat Care, V7, P6; Carvajal A, 2011, EUR J CANCER, V47, P1863, DOI 10.1016/j.ejca.2011.03.027; Chang VT, 2000, CANCER, V88, P2164, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2164::AID-CNCR24>3.0.CO;2-5; Chinda M, 2011, J PAIN SYMPTOM MANAG, V42, P954, DOI 10.1016/j.jpainsymman.2011.02.020; Claessens P, 2011, AM J HOSP PALLIAT ME, V28, P475, DOI 10.1177/1049909111400724; Fayers PM, 2007, QUALITY LIFE ASSESSM; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Hearn J, 1997, J PUBLIC HEALTH MED, V19, P193, DOI 10.1093/oxfordjournals.pubmed.a024608; Homsi J, 2006, SUPPORT CARE CANCER, V14, P444, DOI 10.1007/s00520-005-0009-2; Homsi J, 2002, SUPPORT CARE CANCER, V10, P337, DOI 10.1007/s00520-002-0341-8; Hui D, 2012, ONCOLOGIST, V17, P1574, DOI 10.1634/theoncologist.2012-0192; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kang JH, 2013, J PAIN SYMPTOM MANAG, V46, P652, DOI 10.1016/j.jpainsymman.2012.11.009; Karnofsky D, 1949, EVALUATION OF CHEMOT; Kwon JH, 2013, J PAIN SYMPTOM MANAG, V46, P947, DOI 10.1016/j.jpainsymman.2013.01.012; Monteiro Daiane da Rosa, 2013, Rev Gaucha Enferm, V34, P163; Moro C, 2006, SUPPORT CARE CANCER, V14, P30, DOI 10.1007/s00520-005-0834-3; Pais-Ribeiro J, 2007, Psychol Health Med, V12, P225, DOI 10.1080/13548500500524088; Paiva CE, 2014, SUPPORT CARE CANCER, V22, P2151, DOI 10.1007/s00520-014-2206-3; Paiva CE, 2014, J PALLIAT MED, V17, P264, DOI 10.1089/jpm.2013.0603; Paiva CE, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-8; Paiva CE, 2014, PALLIAT SUPPORT CARE, P1; Partridge AH, 2014, J CLIN ONCOL, V32, P3330, DOI 10.1200/JCO.2013.54.8149; Pautex S, 2003, CRIT REV ONCOL HEMAT, V47, P281, DOI 10.1016/S1040-8428(03)00043-X; Philip J, 1998, SUPPORT CARE CANCER, V6, P539, DOI 10.1007/s005200050212; PORTENOY RK, 1994, QUAL LIFE RES, V3, P183, DOI 10.1007/BF00435383; Rangachari D, 2013, CANCER J, V19, P373, DOI 10.1097/PPO.0b013e3182a76b9c; Rugno FC, 2014, GYNECOL ONCOL, V135, P249, DOI 10.1016/j.ygyno.2014.08.030; Stromgren AS, 2002, CANCER, V94, P512, DOI 10.1002/cncr.10222; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Watanabe S, 2009, SUPPORT CARE CANCER, V17, P675, DOI 10.1007/s00520-008-0522-1; Watanabe SM, 2011, J PAIN SYMPTOM MANAG, V41, P456, DOI 10.1016/j.jpainsymman.2010.04.020; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmermann C, 2014, LANCET, V383, P1721, DOI 10.1016/S0140-6736(13)62416-2	38	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0132073	10.1371/journal.pone.0132073	http://dx.doi.org/10.1371/journal.pone.0132073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154288	gold, Green Published, Green Submitted			2022-12-27	WOS:000358159700085
J	Zhou, CL; Wu, YN; An, SL; Li, XJ				Zhou, Chunlan; Wu, Yanni; An, Shengli; Li, Xiaojin			Effect of Expressive Writing Intervention on Health Outcomes in Breast Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							WRITTEN EMOTIONAL DISCLOSURE; QUALITY-OF-LIFE; RHEUMATOID-ARTHRITIS; EARLY-STAGE; WOMEN; FEASIBILITY; SYMPTOMS; BENEFITS; PAIN; MINDFULNESS	Background Numerous randomized controlled trials (RCTs) have arrived at conflicting conclusions on expressive writing (EW) as an intervention for breast cancer (BC) patients, but there has been no meta-analysis of these studies to assess the effectiveness of EW in BC population. Methods PubMed, Web of Science, The Cochrane Library, EMBASE, and CINAHL and the www.clinicaltrial.gov database on ongoing clinical trials were searched to identify all the RCTs investigating efficacy of EW on the physical and psychological health in BC patients. The risk of bias of the original studies was assessed using the Cochrane Collaboration's tool. Our primary outcomes for physical and psychological health were respectively negative somatic symptoms and negative mood which were stratified by emotional, benefit-finding and multiple prompts in sub-group analyses. The data were analyzed using Review Manager 5.2 and Stata version 12.0 statistical software. Results Of the 5,232 titles screened, we identified 11 RCTs with a total of 1,178 participants. The pooled results showed a significant effect of EW using either an emotional prompt or a benefit-finding prompt on reducing negative somatic symptoms in BC patients in the <= 3-month follow-up group [Mean Difference (MD), -13.03, 95% CI, -19.23 to -6.83, P<0.0001; MD, -9.18, 95% CI, -15.57 to -2.79, P = 0.005]. There was no significant effect of EW on physical health in the >3-month follow-up group. There were no significant differences regarding psychological health indexes between EW intervention and control groups at any of the follow-up time-points (P>0.05). Conclusion This systematic review and meta-analysis reveals that EW intervention may have a significantly positive impact on the physical health but not the psychological health in BC patients, but this benefit may not last long. However, further high-quality studies with more homogeneity are needed to confirm the current findings.	[Zhou, Chunlan; Wu, Yanni; Li, Xiaojin] Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [An, Shengli] Southern Med Univ, Dept Biostat, Guangdong Prov Key Lab Trop Dis Res, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Zhou, CL (corresponding author), Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China.	lanchun200488@126.com; 379249275@qq.com			Guangdong Provincial Department of Science and Technology [2012B031800124]	Guangdong Provincial Department of Science and Technology	The research was supported by the Guangdong Provincial Department of Science and Technology. The grant number is 2012B031800124. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander F, 1950, PSYCHOSOMATIC MEDICI; Alexander F, 1939, PSYCHOSOM MED, V1, P173, DOI 10.1097/00006842-193901000-00013; American Cancer Society, 2010, CANCER FACTS AND FIG; Aranda S, 2005, EUR J CANCER CARE, V14, P211, DOI 10.1111/j.1365-2354.2005.00541.x; Bardwell WA, 2006, PSYCHO-ONCOL, V15, pS4; Bauer-Wu S, 2007, PSYCHO-ONCOL, V16, pS78; Bauer-Wu S, 2007, ONCOL NURS FORUM, V34, P202; Boinon D, 2011, PSYCHO-ONCOLOGIE, V5, P173, DOI 10.1007/s11839-011-0328-4; Broderick JE, 2005, PSYCHOSOM MED, V67, P326, DOI 10.1097/01.psy.0000156933.04566.bd; Broderick JE, 2004, ANN BEHAV MED, V27, P50, DOI 10.1207/s15324796abm2701_7; Burton CM, 2008, BRIT J HEALTH PSYCH, V13, P9, DOI 10.1348/135910707X250910; Carlson LE, 2013, J CLIN ONCOL, V31, P3119, DOI 10.1200/JCO.2012.47.5210; Cella D, 2008, BREAST CANCER RES TR, V107, P167, DOI 10.1007/s10549-007-9548-1; Cepeda MS, 2008, J PAIN SYMPTOM MANAG, V35, P623, DOI 10.1016/j.jpainsymman.2007.08.011; Cleeland Charles S, 2007, J Natl Cancer Inst Monogr, P16; Craft M, 2007, ONCOL NURS FORUM, V34, P507; Craft MA, 2013, J ADV NURS, V69, P305, DOI 10.1111/j.1365-2648.2012.06008.x; de Moor Janet S, 2008, J Soc Integr Oncol, V6, P59; Dubenko L, 2008, PSYCHO-ONCOL, V17, pS92; Earnhardt JL, 2002, J COLL STUDENT PSYCH, V17, P19, DOI DOI 10.1300/J035V17N01_04; Fallowfield L, 2004, J CLIN ONCOL, V22, P4261, DOI 10.1200/JCO.2004.08.029; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fernandez I, 2008, BRIT J HEALTH PSYCH, V13, P31, DOI 10.1348/135910707X251234; Frattaroli J, 2006, PSYCHOL BULL, V132, P823, DOI 10.1037/0033-2909.132.6.823; Frisina PG, 2004, J NERV MENT DIS, V192, P629, DOI 10.1097/01.nmd.0000138317.30764.63; Gellaitry G, 2010, PSYCHO-ONCOLOGY, V19, P77, DOI 10.1002/pon.1532; GOLDBERG JA, 1992, EUR J SURG ONCOL, V18, P327; GROSS J, 1989, SOC SCI MED, V28, P1239, DOI 10.1016/0277-9536(89)90342-0; Harris AHS, 2006, J CONSULT CLIN PSYCH, V74, P243, DOI 10.1037/0022-006X.74.2.243; Harris AHS, 2005, PSYCHOSOM MED, V67, P130, DOI 10.1097/01.psy.0000146345.73510.d5; Henry EA, 2010, ONCOL NURS FORUM, V37, P749, DOI 10.1188/10.ONF.749-757; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hunter MS, 2004, PSYCHO-ONCOL, V13, P769, DOI 10.1002/pon.793; Hunter MS, 2009, MATURITAS, V63, P336, DOI 10.1016/j.maturitas.2009.06.003; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jensen-Johansen MB, 2013, PSYCHO-ONCOLOGY, V22, P1492, DOI 10.1002/pon.3193; Jensen-Johansen MM, 2011, PSYCHO ONCOLOGY SUPP, V20, P30; Johansen MB, 2006, PSYCHO-ONCOLOGY, V15, pS278; Kain ZN, 2000, J PSYCHOSOM RES, V49, P417, DOI 10.1016/S0022-3999(00)00189-6; Kelley JE, 1997, HEALTH PSYCHOL, V16, P331, DOI 10.1037/0278-6133.16.4.331; King LA, 2001, PERS SOC PSYCHOL B, V27, P798, DOI 10.1177/0146167201277003; Kissane DW, 2004, AUST NZ J PSYCHIAT, V38, P320, DOI 10.1080/j.1440-1614.2004.01358.x; Klein K, 2001, J EXP PSYCHOL GEN, V130, P520, DOI 10.1037//0096-3445.130.3.520; Knobf M Tish, 2011, Semin Oncol Nurs, V27, pe1, DOI 10.1016/j.soncn.2011.05.001; Laccetti M, 2007, ONCOL NURS FORUM, V34, P1019, DOI 10.1188/07.ONF.1019-1024; Lee HS, 2010, STRESS HEALTH, V26, P250, DOI 10.1002/smi.1293; Low CA, 2006, HEALTH PSYCHOL, V25, P181, DOI 10.1037/0278-6133.25.2.181; Low CA, 2010, HEALTH PSYCHOL, V29, P460, DOI 10.1037/a0020153; Lu Q, 2012, HEALTH PSYCHOL, V31, P548, DOI 10.1037/a0026834; Lumley MA, 2014, J CONSULT CLIN PSYCH, V82, P644, DOI 10.1037/a0036958; Manzoni GM, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-51; Merz EL, 2014, HEALTH PSYCHOL REV, V8, P339, DOI 10.1080/17437199.2014.882007; Milbury K, 2014, J CLIN ONCOL, V32, P663, DOI 10.1200/JCO.2013.50.3532; Mogk Carolin, 2006, Psychosoc Med, V3, pDoc06; Mosher CE, 2012, PSYCHOL HEALTH, V27, P88, DOI 10.1080/08870446.2010.551212; Nyrop KA, 2014, J GERIATR ONCOL, V5, P148, DOI 10.1016/j.jgo.2013.12.002; Palesh OG, 2007, BIOL PSYCHOL, V75, P37, DOI 10.1016/j.biopsycho.2006.11.002; Paradisi A, 2010, EUR J DERMATOL, V20, P599, DOI 10.1684/ejd.2010.1018; Park EY, 2012, J KOREAN ACAD NURS, V42, P269, DOI 10.4040/jkan.2012.42.2.269; PENNEBAKER JW, 1990, J PERS SOC PSYCHOL, V58, P528, DOI 10.1037/0022-3514.58.3.528; PENNEBAKER JW, 1986, J ABNORM PSYCHOL, V95, P274, DOI 10.1037/0021-843X.95.3.274; Pennebaker JW, 1982, THE PSYCHOLOGY OF PH; RACHMAN S, 1980, BEHAV RES THER, V18, P51, DOI 10.1016/0005-7967(80)90069-8; Ridner SH, 2012, CANCER NURS, V35, pE18, DOI 10.1097/NCC.0b013e31821404c0; Rivkin ID, 2006, AIDS BEHAV, V10, P13, DOI 10.1007/s10461-005-9051-9; Servaes P, 1999, BEHAV MED, V25, P23, DOI 10.1080/08964289909596735; Sloan DM, 2004, J CONSULT CLIN PSYCH, V72, P165, DOI 10.1037/0022-006X.72.2.165; Smyth JM, 1998, J CONSULT CLIN PSYCH, V66, P174, DOI 10.1037/0022-006X.66.1.174; Smyth JM, 1999, JAMA-J AM MED ASSOC, V281, P1304, DOI 10.1001/jama.281.14.1304; SPIEGEL D, 1989, LANCET, V2, P1447; Stanton AL, 2002, J CLIN ONCOL, V20, P4160, DOI 10.1200/JCO.2002.08.521; Stefanic N, 2014, SUPPORT CARE CANCER, V22, P713, DOI 10.1007/s00520-013-2026-x; Tamagawa R, 2013, J CLIN PSYCHOL, V69, P264, DOI 10.1002/jclp.21939; Wagner LJ, 2010, AIDS BEHAV, V14, P410, DOI 10.1007/s10461-008-9427-8; Walker B L, 1999, Oncol Nurs Forum, V26, P1025; Zakowski SG, 2004, HEALTH PSYCHOL, V23, P555, DOI 10.1037/0278-6133.23.6.555; Zakowski SG, 2003, BRIT J HEALTH PSYCH, V8, P271, DOI 10.1348/135910703322370851	77	20	21	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131802	10.1371/journal.pone.0131802	http://dx.doi.org/10.1371/journal.pone.0131802			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EC	26151818	Green Published, gold, Green Submitted			2022-12-27	WOS:000358158900024
J	Jost, A; Tolstik, E; Feldmann, P; Wicker, K; Sentenac, A; Heintzmann, R				Jost, Aurelie; Tolstik, Elen; Feldmann, Polina; Wicker, Kai; Sentenac, Anne; Heintzmann, Rainer			Optical Sectioning and High Resolution in Single-Slice Structured Illumination Microscopy by Thick Slice Blind-SIM Reconstruction	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPY; LIGHT	The microscope image of a thick fluorescent sample taken at a given focal plane is plagued by out-of-focus fluorescence and diffraction limited resolution. In this work, we show that a single slice of Structured Illumination Microscopy (two or three beam SIM) data can be processed to provide an image exhibiting tight sectioning and high transverse resolution. Our reconstruction algorithm is adapted from the blind-SIM technique which requires very little knowledge of the illumination patterns. It is thus able to deal with illumination distortions induced by the sample or illumination optics. We named this new algorithm thick slice blind-SIM because it models a three-dimensional sample even though only a single two-dimensional plane of focus was measured.	[Jost, Aurelie; Tolstik, Elen; Feldmann, Polina; Wicker, Kai; Heintzmann, Rainer] Univ Jena, Inst Phys Chem, Abbe Ctr Photon, D-07743 Jena, Germany; [Jost, Aurelie; Tolstik, Elen; Feldmann, Polina; Wicker, Kai; Heintzmann, Rainer] Leibniz Inst Photon Technol, Jena, Germany; [Wicker, Kai] Carl Zeiss, Corp Res & Technol, Jena, Germany; [Sentenac, Anne] Aix Marseille Univ, CNRS, Inst Fresnel, Marseille, France; [Heintzmann, Rainer] Kings Coll London, Randall Div, London, England	Friedrich Schiller University of Jena; Leibniz Institut fur Photonische Technologien; Carl Zeiss AG; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of London; King's College London	Heintzmann, R (corresponding author), Univ Jena, Inst Phys Chem, Abbe Ctr Photon, D-07743 Jena, Germany.	heintzmann@gmail.com	Heintzmann, Rainer/AAY-4849-2020	Heintzmann, Rainer/0000-0002-4950-1936; Jost, Aurelie/0000-0002-6022-4327; Feldmann, Polina/0000-0002-9516-1899; Tolstik, Dr. Elen/0000-0003-0873-4335	Carl Zeiss AG	Carl Zeiss AG	Carl Zeiss AG provided support in the form of salaries for author KW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.	Ayuk R, 2013, OPT LETT, V38, P4723, DOI 10.1364/OL.38.004723; CARRINGTON WA, 1995, SCIENCE, V268, P1483, DOI 10.1126/science.7770772; Dong SY, 2014, OPT EXPRESS, V22, P20856, DOI 10.1364/OE.22.020856; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Heintzmann R, 1999, P SOC PHOTO-OPT INS, V3568, P185, DOI 10.1117/12.336833; Hoogendoorn E, 2015, FOC MISCR C ABSTR 20, P43; Keuper M, 2013, PROC CVPR IEEE, P2179, DOI 10.1109/CVPR.2013.283; Min J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02075; Mudry E, 2012, NAT PHOTONICS, V6, P312, DOI [10.1038/nphoton.2012.83, 10.1038/NPHOTON.2012.83]; Neil MAA, 1997, OPT LETT, V22, P1905, DOI 10.1364/OL.22.001905; Orieux F, 2012, IEEE T IMAGE PROCESS, V21, P601, DOI 10.1109/TIP.2011.2162741; Schmidt M., 2005, MINFUNC; Shao L, 2011, NAT METHODS, V1734, P1; Soulez F, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P1735, DOI 10.1109/ISBI.2012.6235915; Verveer PJ, 1999, J MICROSC-OXFORD, V193, P50, DOI 10.1046/j.1365-2818.1999.00421.x; Wicker K, 2013, OPT EXPRESS, V21, P2032, DOI 10.1364/OE.21.002032; Wright S., 1999, NUMERICAL OPTIMIZATI, V2	17	34	35	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132174	10.1371/journal.pone.0132174	http://dx.doi.org/10.1371/journal.pone.0132174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147644	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600211
J	Lee, YJ; Han, ME; Baek, SJ; Kim, SY; Oh, SO				Lee, Yong Joo; Han, Myoung-Eun; Baek, Su-Jin; Kim, Seon-Young; Oh, Sae-Ock			Roles of DPY30 in the Proliferation and Motility of Gastric Cancer Cells	PLOS ONE			English	Article							HISTONE H3; CHROMATIN MODIFICATIONS; COVALENT MODIFICATIONS; MOLECULAR REGULATION; METHYLATION; GENE; PROTEIN; TRIMETHYLATION; EXPRESSION; SUBUNIT	Various types of histone methylation have been associated with cancer progression. Depending on the methylation site in histone proteins, its effects on transcription are different. DPY30 is a common member of SET1/MLL histone H3K4 methyltransferase complexes. However, its expression and roles in gastric cancer have been poorly characterized. To determine whether DPY30 has pathophysiological roles in gastric cancer, its expression and roles were examined. Immunohistochemistry and real time PCR showed up-regulation of DPY30 expression in some gastric cancer cell lines and patients' tissues. Its knockdown by siRNA decreased the proliferation, migration, and invasion of gastric cancer cells, whereas its overexpression showed the opposite effects. These results indicate that DPY30 has critical roles in the proliferation, migration, and invasion of gastric cancer cells, and suggest DPY30 might be a therapeutic target in gastric cancer.	[Lee, Yong Joo; Han, Myoung-Eun; Oh, Sae-Ock] Pusan Natl Univ, Dept Anat, Sch Med, Busan, South Korea; [Han, Myoung-Eun] Pusan Natl Univ, Med Res Ctr Ischem Tissue Regenerat, Busan, South Korea; [Baek, Su-Jin; Kim, Seon-Young] KRIBB, Med Genom Res Ctr, Taejon, South Korea	Pusan National University; Pusan National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Oh, SO (corresponding author), Pusan Natl Univ, Dept Anat, Sch Med, Busan, South Korea.	hedgehog@pusan.ac.kr			Bio & Medical Technology Development Program [2012M3A9C6050213]; Basic Science Research Foundation of the National Research Foundation (NRF) - Korean government (MEST) [2012R1A1A3010521]; National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea [0920050]	Bio & Medical Technology Development Program; Basic Science Research Foundation of the National Research Foundation (NRF) - Korean government (MEST)(National Research Foundation of KoreaMinistry of Education, Science & Technology (MEST), Republic of Korea); National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the Bio & Medical Technology Development Program (#2012M3A9C6050213, OSO) and Basic Science Research Foundation (#2012R1A1A3010521, HME) of the National Research Foundation (NRF) funded by the Korean government (MEST), and by a grant from the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea (#0920050, OSO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chervona Y, 2012, AM J CANCER RES, V2, P589; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Ernst P, 2012, BRIEF FUNCT GENOMICS, V11, P217, DOI 10.1093/bfgp/els017; Guru SC, 1998, P NATL ACAD SCI USA, V95, P1630, DOI 10.1073/pnas.95.4.1630; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; Kim JY, 2014, MOL CELL, V54, P613, DOI 10.1016/j.molcel.2014.03.043; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Luscher-Firzlaff J, 2008, CANCER RES, V68, P749, DOI 10.1158/0008-5472.CAN-07-3158; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shi YQ, 2010, J SURG ONCOL, V101, P687, DOI 10.1002/jso.21455; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Simboeck E, 2013, EMBO J, V32, P2217, DOI 10.1038/emboj.2013.159; South PF, 2010, J BIOL CHEM, V285, P595, DOI 10.1074/jbc.M109.042697; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Takahashi Y, 2011, P NATL ACAD SCI USA, V108, P20526, DOI 10.1073/pnas.1109360108; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Yang ZH, 2014, BLOOD, V124, P2025, DOI 10.1182/blood-2014-01-549220; Yu M, 2005, ONCOGENE, V24, P1982, DOI 10.1038/sj.onc.1208410; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	27	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131863	10.1371/journal.pone.0131863	http://dx.doi.org/10.1371/journal.pone.0131863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147337	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600154
J	Toledano, MB; Smith, RB; Brook, JP; Douglass, M; Elliott, P				Toledano, Mireille B.; Smith, Rachel B.; Brook, James P.; Douglass, Margaret; Elliott, Paul			How to Establish and Follow up a Large Prospective Cohort Study in the 21st Century - Lessons from UK COSMOS	PLOS ONE			English	Article							RESPONSE RATES; RECRUITMENT; INTERNET; FACEBOOK; INTERVENTION; RETENTION	Large-scale prospective cohort studies are invaluable in epidemiology, but they are increasingly difficult and costly to establish and follow-up. More efficient methods for recruitment, data collection and follow-up are essential if such studies are to remain feasible with limited public and research funds. Here, we discuss how these challenges were addressed in the UK COSMOS cohort study where fixed budget and limited time frame necessitated new approaches to consent and recruitment between 2009-2012. Web-based e-consent and data collection should be considered in large scale observational studies, as they offer a streamlined experience which benefits both participants and researchers and save costs. Commercial providers of register and marketing data, smartphones, apps, email, social media, and the internet offer innovative possibilities for identifying, recruiting and following up cohorts. Using examples from UK COSMOS, this article sets out the dos and don'ts for today's cohort studies and provides a guide on how best to take advantage of new technologies and innovative methods to simplify logistics and minimise costs. Thus a more streamlined experience to the benefit of both research participants and researchers becomes achievable.	[Toledano, Mireille B.; Smith, Rachel B.; Brook, James P.; Douglass, Margaret; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, MRC PHE Ctr Environm & Hlth, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England	Imperial College London	Toledano, MB (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC PHE Ctr Environm & Hlth, Dept Epidemiol & Biostat, Sch Publ Hlth, St Marys Campus, London, England.	m.toledano@imperial.ac.uk		Elliott, Paul/0000-0002-7511-5684; Smith, Rachel/0000-0003-4000-2919	Department of Health Policy Research Programme; UK COSMOS Cohort Study of Mobile Phone Use and Health [PRST-0713-00003]; UK Department of Health Policy Research Programme (PRP) [PRST-0713-00003]; industry and government, via the independent Mobile Telecommunications & Health Research Programme (MTHR); Medical Research Council; Public Health England; NIHR Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London; MRC [MR/L01341X/1] Funding Source: UKRI; Medical Research Council [MR/L01341X/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10136] Funding Source: researchfish	Department of Health Policy Research Programme; UK COSMOS Cohort Study of Mobile Phone Use and Health; UK Department of Health Policy Research Programme (PRP); industry and government, via the independent Mobile Telecommunications & Health Research Programme (MTHR); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Public Health England; NIHR Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This report is independent research commissioned and funded by the Department of Health Policy Research Programme, UK COSMOS Cohort Study of Mobile Phone Use and Health, PRST-0713-00003. The views expressed in this publication are those of the author(s) and not necessarily those of the Department of Health. The UK COSMOS study is funded by the UK Department of Health Policy Research Programme (PRP) (http://www.prp-ccf.org.uk/)(project reference number PRST-0713-00003) and was formerly jointly funded by industry and government, via the independent Mobile Telecommunications & Health Research Programme (MTHR) (http://www.mthr.org.uk/)(project reference number RUM 27). PE is Director of the MRC-PHE Centre for Environment and Health and acknowledges support from the Medical Research Council and Public Health England. PE is a National Institute for Health Research (NIHR) senior investigator and acknowledges support from the NIHR Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen N, 2012, HEALTH POLICY TECHN, V1, P123, DOI 10.1016/j.hlpt.2012.07.003; Anhoj Jacob, 2004, J Med Internet Res, V6, pe42, DOI 10.2196/jmir.6.4.e42; Arnaud N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-826; Baker D., 2008, ENV EPIDEMIOLOGY STU; Bowling JM, 2006, EVAL PROGRAM PLANN, V29, P390, DOI 10.1016/j.evalprogplan.2006.08.011; Chu JL, 2013, J ADOLESCENT HEALTH, V52, P792, DOI 10.1016/j.jadohealth.2012.12.002; Davern M, 2013, HEALTH SERV RES, V48, P905, DOI 10.1111/1475-6773.12070; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; Doll R, 2004, BMJ-BRIT MED J, V328, P1529, DOI 10.1136/bmj.328.7455.1529; Duncan G. J., 2014, NATL CHILDRENS STUDY; Ip EJ, 2012, PHARMACOTHERAPY, V32, P910, DOI 10.1002/j.1875-9114.2012.01123; Johnson KJ, 2013, CONTEMP CLIN TRIALS, V34, P305, DOI 10.1016/j.cct.2012.12.002; Johnson TP, 2012, JAMA-J AM MED ASSOC, V307, P1805, DOI 10.1001/jama.2012.3532; Jones L, 2012, CONTEMP CLIN TRIALS, V33, P268, DOI 10.1016/j.cct.2011.10.011; Kapp JM, 2013, J CANCER EDUC, V28, P134, DOI 10.1007/s13187-012-0443-z; Khosropour CM, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2756; Koshy E, 2008, BMC OPHTHALMOL, V8, DOI 10.1186/1471-2415-8-9; Livingston EH, 2012, ARCH SURG-CHICAGO, V147, P110, DOI 10.1001/archsurg.2011.2169; Lohse B, 2013, JMIR RES PROTOC, V2, DOI 10.2196/resprot.2713; Medical Research Council, 2014, MAX VAL UK POP COH M; Mychasiuk R, 2012, CHILD CARE HLTH DEV, V38, P753, DOI 10.1111/j.1365-2214.2011.01326.x; Ofcom, COMM MARK REP 2014; Office for National Statistics, 2011, ETHN NAT ID ENGL WAL; Office for National Statistics, 2014, STAT B INT ACC HOUS; [Pew Research Center The Web at 25 in the U.S.], 2014, WEB 25 US; Ramo DE, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1878; Reaves AC, 2013, AM J MED GENET A, V161A, P951, DOI 10.1002/ajmg.a.35903; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Schuz J, 2011, CANCER EPIDEMIOL, V35, P37, DOI 10.1016/j.canep.2010.08.001; Sign-Up to, 2014, 2014 EMAIL MARKETING; Smith B, 2007, AM J EPIDEMIOL, V166, P1345, DOI 10.1093/aje/kwm212; Stopponi MA, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1086; Strandbygaard U, 2010, RESP MED, V104, P166, DOI 10.1016/j.rmed.2009.10.003; Tabor JA, 2011, J EXPO SCI ENV EPID, V21, P197, DOI 10.1038/jes.2009.67; The Nurses' Health Study, 2014, HIST WEBP; Ward H, 2012, OXFORD HDB EPIDEMIOL	36	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131521	10.1371/journal.pone.0131521	http://dx.doi.org/10.1371/journal.pone.0131521			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26147611	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600103
J	Wang, LF; Yokoyama, KK; Chen, TY; Hsiao, HW; Chiang, PC; Hsieh, YC; Lo, S; Hsu, C				Wang, Li-Fang; Yokoyama, Kazunari K.; Chen, Tzu-Yin; Hsiao, Hsiu-Wen; Chiang, Pei-Chi; Hsieh, Ya-Ching; Lo, Steven; Hsu, Chin			Male-Specific Alleviation of Iron-Induced Striatal Injury by Inhibition of Autophagy	PLOS ONE			English	Article							EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; BRAIN-INJURY; MICE; MORTALITY; DEATH	Men exhibit a worse survival rate than premenopausal women after intracerebral hemorrhage (ICH), however, no sex-specific management has been concerned. In a rat model involving infusion of ferrous citrate (FC) that simulates iron accumulation after hemorrhage, a higher degree of autophagy associated with higher injury severity was observed in striatum of males than in females. Since the imbalance between the levels of autophagy and energy demand may lead to cell death, we proposed that FC-induced autophagy is detrimental in a male specific manner and autophagy modulation affects injury severity in a sex-dependent manner. Rapamycin, an autophagy inducer, and conditional knockout gene of autophagy-related protein 7 (Atg7) in dopamine receptor D2 (DRD2) neurons were used to test our hypothesis using a mouse model with striatal FC infusion. The result showed that the levels of autophagic cell death and injury severity were higher in male than in female mice. Pre-treatment of FC-infused females with rapamycin increased the FC-induced behavioral deficit and DRD2 neuron death. However, DRD2 neuron-specific knockout of Atg7 decreased FC-induced injury severity and the number of TUNEL(+) DRD2 neurons in males. These results suggest that autophagy in FC-infusion males is overactive with maladaptive consequences and inhibition of autophagy decreases the severity of FC-induced striatal injury in males. These findings present prospects for male-specific therapeutic strategy that targets autophagy in patients suffering from iron overload.	[Wang, Li-Fang] Kaohsiung Med Univ, Coll Life Sci, Dept Med & Appl Chem, Kaohsiung, Taiwan; [Yokoyama, Kazunari K.] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Chen, Tzu-Yin; Hsiao, Hsiu-Wen; Chiang, Pei-Chi; Hsu, Chin] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Physiol, Kaohsiung, Taiwan; [Hsieh, Ya-Ching; Lo, Steven] I Shou Univ, E Da Hosp, Dept Med Res, Kaohsiung, Taiwan; [Lo, Steven] Royal Infirm, Canniesburn Plast Surg Unit, Glasgow G31 2ER, Lanark, Scotland	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; E-Da Hospital; I Shou University; Royal Infirmary of Edinburgh	Hsu, C (corresponding author), Kaohsiung Med Univ, Coll Med, Fac Med, Dept Physiol, Kaohsiung, Taiwan.	chinhsu@kmu.edu.tw		Wang, Li Fang/0000-0003-1593-4482; jiang, pei qi/0000-0002-9756-1044	National Science Council of Taiwan [101-2629-B-037-001, 102-2320-B-037-015, 103-2320-B-037028]; Kaohsiung Medical University [KMU-DT103007]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University	CH received research grants from the National Science Council of Taiwan (101-2629-B-037-001, 102-2320-B-037-015, and 103-2320-B-037028). LW received research grants from "Aim for the Top Journals Grant," grant No. KMU-DT103007 from Kaohsiung Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SS, 2006, AGING CELL, V5, P565, DOI 10.1111/j.1474-9726.2006.00252.x; Bhatia R, 2013, NEUROL INDIA, V61, P244, DOI 10.4103/0028-3886.115062; Chen CW, 2012, AUTOPHAGY, V8, P1510, DOI 10.4161/auto.21289; Chen TY, 2010, STROKE, V41, P160, DOI 10.1161/STROKEAHA.109.562850; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Gupta A, 2003, J ETHNOPHARMACOL, V89, P55, DOI 10.1016/S0378-8741(03)00262-9; Han Ning, 2008, Neurosci Bull, V24, P351, DOI 10.1007/s12264-008-0711-4; He Y, 2008, J CEREBR BLOOD F MET, V28, P897, DOI 10.1038/sj.jcbfm.9600578; Hu YZ, 2013, J ZHEJIANG UNIV-SC B, V14, P496, DOI 10.1631/jzus.B1200332; Hua Y, 2006, J NEUROSURG, V104, P305, DOI 10.3171/jns.2006.104.2.305; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; Inagawa T, 2003, NEUROSURGERY, V53, P1283, DOI 10.1227/01.NEU.0000093825.04365.F3; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Lewsey JD, 2009, STROKE, V40, P1038, DOI 10.1161/STROKEAHA.108.542787; Lofgren JLS, 2012, J AM ASSOC LAB ANIM, V51, P594; Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1; Mendelow AD, 2005, LANCET, V365, P387; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nakamura T, 2005, J NEUROSURG, V103, P97, DOI 10.3171/jns.2005.103.1.0097; Olivan S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/652817; Rangaraju S, 2010, J NEUROSCI, V30, P11388, DOI 10.1523/JNEUROSCI.1356-10.2010; Raz L, 2008, NEUROSIGNALS, V16, P140, DOI 10.1159/000111559; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Weis SN, 2014, NEUROSCIENCE, V256, P201, DOI 10.1016/j.neuroscience.2013.10.046; Weiss ES, 2009, ANN THORAC SURG, V88, P543, DOI 10.1016/j.athoracsur.2009.04.016; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zheng MZ, 2015, TRANSL STROKE RES, V6, P215, DOI 10.1007/s12975-015-0388-8; Zia E, 2009, STROKE, V40, P3567, DOI 10.1161/STROKEAHA.109.556324	32	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131224	10.1371/journal.pone.0131224	http://dx.doi.org/10.1371/journal.pone.0131224			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147959	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600071
J	Wu, SJ; Soulez, M; Yang, YH; Chu, CS; Shih, SC; Hebert, MJ; Kuo, MC; Hsieh, YJ				Wu, Shyh-Jong; Soulez, Mathilde; Yang, Ya-Hui; Chu, Chih-Sheng; Shih, Shih-Chuan; Hebert, Marie-Josee; Kuo, Mei-Chuan; Hsieh, Ya-Ju			Local Augmented Angiotensinogen Secreted from Apoptotic Vascular Endothelial Cells Is a Vital Mediator of Vascular Remodelling	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITORS; SMOOTH-MUSCLE-CELLS; RENAL ANGIOTENSINOGEN; HEART-DISEASE; INFLAMMATION; RENIN; ATHEROSCLEROSIS; HYPERTENSION; EXPRESSION; INJURY	Vascular remodelling is a critical vasculopathy found in atheromatous diseases and allograft failures. The local renin angiotensin system (RAS) has been implicated in vascular remodelling. However, the mechanisms by which the augmented local RAS is associated with the initial event of endothelial cell apoptosis in injured vasculature remain undefined. We induced the apoptosis of human umbilical vein endothelial cells (HUVECs) and vascular smooth muscle cells (VSMCs) through serum starvation (SS). After the cells were subjected to SS, we found that the mRNA expression of angiotensinogen (AGT) was increased by > 3-fold in HUVECs and by approximately 2.5-fold in VSMCs. In addition, the expression of angiotensin-converting enzyme (ACE) mRNA was increased in VSMCs but decreased to 50% in HUVECs during the same apoptotic process. Increases in the expression of AGT protein and angiotensin II (Ang II) were found in a serum-free medium conditioned by HUVECs (SSC). The increased Ang II was suppressed using lisinopril (an ACE inhibitor) treatment. Moreover, the activation of ERK1/2 induced by the SSC in VSMCs was also suppressed by losartan. In conclusion, we first demonstrated that the augmented AGT released from apoptotic endothelial cells acts as a vital progenitor of Ang II to accelerate vascular remodelling, and we suggest that blocking local augmented Ang II might be an effective strategy for restraining intimal hyperplasia.	[Wu, Shyh-Jong; Shih, Shih-Chuan] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Soulez, Mathilde] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Yang, Ya-Hui] Fooyin Univ, Dept Occupat Safety & Hyg, Kaohsiung, Taiwan; [Chu, Chih-Sheng] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Chu, Chih-Sheng] Kaohsiung Municipal Tatung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chu, Chih-Sheng] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Hebert, Marie-Josee] Univ Montreal CRCHUM, Ctr Hosp, Res Ctr, Hop Notre Dame, Montreal, PQ, Canada; [Hebert, Marie-Josee] Univ Montreal, Montreal, PQ, Canada; [Kuo, Mei-Chuan] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Hsieh, Ya-Ju] Kaohsiung Med Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan	Kaohsiung Medical University; Universite de Montreal; Fooyin University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Universite de Montreal; Universite de Montreal; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Hsieh, YJ (corresponding author), Kaohsiung Med Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan.	yjhsieh@kmu.edu.tw		Hsieh, Ya Ju/0000-0003-2082-9345	Kaohsiung Medical University [KMU-M099015]; National Science Council Taiwan [NSC98-2815-C-037-017-B, MOST 103-2314-B-037-007]	Kaohsiung Medical University; National Science Council Taiwan(Ministry of Science and Technology, Taiwan)	The sources of funding that supported this study were from the Kaohsiung Medical University (KMU-M099015; www.kmu.edu.tw) and National Science Council Taiwan (NSC98-2815-C-037-017-B; (www.most.gov.tw/mp.aspx)). Both grants were received by Shyh-Jong Wu. Another grant (MOST 103-2314-B-037-007) from National Science Council Taiwan was received by Ya-Ju Hsieh for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akishita M, 2000, PHYSIOL GENOMICS, V2, P13; Andujar-Sanchez M, 2007, FEBS LETT, V581, P3449, DOI 10.1016/j.febslet.2007.06.048; Aoki M, 2001, HYPERTENSION, V38, P48, DOI 10.1161/01.HYP.38.1.48; Brown NJ, 1998, CIRCULATION, V97, P1411, DOI 10.1161/01.CIR.97.14.1411; Cailhier JF, 2006, AM J TRANSPLANT, V6, P247, DOI 10.1111/j.1600-6143.2005.01165.x; CASSIS LA, 1988, CIRC RES, V62, P1259, DOI 10.1161/01.RES.62.6.1259; Costa MA, 2005, CIRCULATION, V111, P2257, DOI 10.1161/01.CIR.0000163587.36485.A7; Danilov SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025952; Diet F, 1996, CIRCULATION, V94, P2756, DOI 10.1161/01.CIR.94.11.2756; Ding YM, 2001, J BIOL CHEM, V276, P7431, DOI 10.1074/jbc.M003892200; Esper RJ, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-4; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Glicklich D, 2011, CLIN TRANSPLANT, V25, P843, DOI 10.1111/j.1399-0012.2010.01372.x; GOULD AB, 1971, CARDIOVASC RES, V5, P86, DOI 10.1093/cvr/5.1.86; Hillebrands Jan-Luuk, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S146239940300557X; Iwai N, 1997, HYPERTENSION, V29, P1044, DOI 10.1161/01.HYP.29.4.1044; Kang NL, 2002, J MOL MED, V80, P359, DOI 10.1007/s00109-002-0326-6; Kranzhofer R, 1999, ARTERIOSCL THROM VAS, V19, P1623, DOI 10.1161/01.ATV.19.7.1623; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu S, 2012, J BIOL CHEM, V287, P24739, DOI 10.1074/jbc.M112.340216; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Lonn EM, 2001, CIRCULATION, V103, P919; Morishita R, 2000, ARTERIOSCL THROM VAS, V20, P915, DOI 10.1161/01.ATV.20.4.915; Ohishi Mitsuru, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P111; Post MJ, 1997, CIRCULATION, V96, P996; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; RAKUGI H, 1994, J CLIN INVEST, V93, P339, DOI 10.1172/JCI116965; Raymond MA, 2002, BIOCHEM BIOPH RES CO, V291, P261, DOI 10.1006/bbrc.2002.6449; REID IA, 1978, ANNU REV PHYSIOL, V40, P377, DOI 10.1146/annurev.ph.40.030178.002113; Remko M, 2007, CHEM PAP, V61, P133, DOI 10.2478/s11696-007-0010-y; Solomon SD, 2009, CIRCULATION, V119, P530, DOI 10.1161/CIRCULATIONAHA.108.826214; Soulez M, 2012, CIRC RES, V110, P94, DOI 10.1161/CIRCRESAHA.111.250431; Wu L, 2001, CIRCULATION, V104, P2716, DOI 10.1161/hc4601.099404; Wu SJ, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.01.003; Wu SJ, 2004, PHYSIOL GENOMICS, V17, P79, DOI 10.1152/physiolgenomics.00133.2003; Yaghini FA, 2010, HYPERTENSION, V55, P1461, DOI 10.1161/HYPERTENSIONAHA.110.150029; Yao HL, 2012, MOL CELL BIOCHEM, V366, P355, DOI 10.1007/s11010-012-1315-x; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zhuo JL, 1997, CIRCULATION, V96, P174	39	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132583	10.1371/journal.pone.0132583	http://dx.doi.org/10.1371/journal.pone.0132583			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147666	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600302
J	Yan, S; Tian, SX; Kang, QW; Xia, YF; Li, CX; Chen, Q; Zhang, SK; Li, ZG				Yan, Shu; Tian, Shuxia; Kang, Qingwei; Xia, Yafei; Li, Caixia; Chen, Qing; Zhang, Shukun; Li, Zhigang			Rhizoma Paridis Saponins Suppresses Tumor Growth in a Rat Model of N-Nitrosomethylbenzylamine-Induced Esophageal Cancer by Inhibiting Cyclooxygenases-2 Pathway	PLOS ONE			English	Article							IN-VITRO; HEPATOCARCINOMA MICE; PENNOGENYL SAPONINS; EXPRESSION; APOPTOSIS; XENOGRAFTS; CHINA; CELLS; COX-2; VIVO	Rhizoma Paridis Saponins (RPS), a natural compound purified from Rhizoma Paridis, has been found to inhibit cancer growth in vitro and in animal models of cancer. However, its effects on esophageal cancer remain unexplored. The purpose of this study was to investigate the effects of RPS on tumor growth in a rat model of esophageal cancer and the molecular mechanism underlying the effects. A rat model of esophageal cancer was established by subcutaneous injection of N-nitrosomethylbenzylamine (NMBA, 1mg/kg) for 10 weeks. RPS (350 mg/kg or 100mg/kg) was administered by oral gavage once daily for 24 weeks starting at the first NMBA injection. RPS significantly reduced the size and number of tumors in the esophagus of rats exposed to NMBA and inhibited the viability, migration, and invasion of esophageal cancer cells EC9706 and KYSE150 in a dose dependent manner (all P < 0.01). Flow cytometry revealed that RPS induced apoptosis and cell cycle G2/M arrest in the esophageal cancer cells. The expression of cyclooxygenases-2 (COX-2) and Cyclin D1 in rat esophageal tissues and the esophageal cancer cells were also significantly reduced by RPS (all P < 0.01). Consistently, RPS also significantly decreased the release of prostaglandin E2, a downstream molecule of COX-2, in a dose-dependent manner (P < 0.01). Our study suggests that RPS inhibit esophageal cancer development by promoting apoptosis and cell cycle arrest and inhibiting the COX-2 pathway. RPS might be a promising therapeutic agent for esophageal cancer.	[Yan, Shu; Tian, Shuxia; Kang, Qingwei; Xia, Yafei] Nankai Hosp, Dept Pharmacol, Tianjin, Peoples R China; [Li, Caixia; Zhang, Shukun] Nankai Hosp, Inst Integrat Med Therapy Acute Abdominal Dis Tia, Tianjin, Peoples R China; [Li, Zhigang] Nankai Hosp, Dept Thorac Surg, Tianjin, Peoples R China; [Chen, Qing] Taizhou Hosp, Dept Pharmacol, Taizhou City, Zhejiang, Peoples R China		Li, ZG (corresponding author), Nankai Hosp, Dept Thorac Surg, Tianjin, Peoples R China.	zhigli38@hotmail.com		Li, Zhigang/0000-0001-7164-1049	Tianjin Science and Technology Plan Project of China [10JCYBJC15100]; National Natural Science Foundation of China [30973383]	Tianjin Science and Technology Plan Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	SY was supported by 2010 Tianjin Science and Technology Plan Project of China (10JCYBJC15100) ZL was supported by and the National Natural Science Foundation of China (No. 30973383 http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WQ, 2013, J THORAC DIS, V5, P19, DOI 10.3978/j.issn.2072-1439.2013.01.04; Chen YS, 2014, STEROIDS, V83, P39, DOI 10.1016/j.steroids.2014.01.014; D'Journo XB, 2014, J THORAC DIS, V6, pS253, DOI 10.3978/j.issn.2072-1439.2014.04.16; Jiang H, 2014, MOL MED REP, V9, P2265, DOI 10.3892/mmr.2014.2108; Li P, 2008, WORLD J INTEGRATED T, V3, P297; Lin YS, 2013, J EPIDEMIOL, V23, P233, DOI 10.2188/jea.JE20120162; Liu Z, 2014, ENVIRON TOXICOL PHAR, V38, P31, DOI 10.1016/j.etap.2014.04.026; Liu Z, 2012, J ETHNOPHARMACOL, V144, P67, DOI 10.1016/j.jep.2012.08.027; Man SL, 2014, STEROIDS, V84, P17, DOI 10.1016/j.steroids.2014.03.005; Man SL, 2014, STEROIDS, V80, P1, DOI 10.1016/j.steroids.2013.11.015; Man SL, 2014, J ETHNOPHARMACOL, V151, P407, DOI 10.1016/j.jep.2013.10.051; Man SL, 2011, J ETHNOPHARMACOL, V137, P1221, DOI 10.1016/j.jep.2011.07.045; Man SL, 2011, ARCH PHARM RES, V34, P43, DOI 10.1007/s12272-011-0105-4; Man SL, 2009, STEROIDS, V74, P1051, DOI 10.1016/j.steroids.2009.08.004; Misra S, 2014, CURR DRUG TARGETS, V15, P347, DOI 10.2174/1389450115666140127102915; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Sahin IH, 2014, CANCER LETT, V345, P249, DOI 10.1016/j.canlet.2013.09.001; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Xiao X, 2014, CANCER CHEMOTH PHARM, V73, P807, DOI 10.1007/s00280-014-2408-x; Xiao X, 2012, BIOSCI TRENDS, V6, P201, DOI 10.5582/bst.2012.v6.4.201; Xiao X, 2009, MOL CANCER THER, V8, P1179, DOI 10.1158/1535-7163.MCT-08-0939; Yan L. L., 2009, Experimental Oncology, V31, P27; Yu HP, 2004, J GASTROEN HEPATOL, V19, P638, DOI 10.1111/j.1440-1746.2004.03345.x; Zhang WJ, 2014, EUR J MED RES, V19, DOI 10.1186/2047-783X-19-41	24	14	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131560	10.1371/journal.pone.0131560	http://dx.doi.org/10.1371/journal.pone.0131560			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147856	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600106
J	Evans, DC; Ryan, MJ				Evans, David C.; Ryan, Michael J.			Cranial Anatomy of Wendiceratops pinhornensis gen. et sp nov., a Centrosaurine Ceratopsid (Dinosauria: Ornithischia) from the Oldman Formation (Campanian), Alberta, Canada, and the Evolution of Ceratopsid Nasal Ornamentation	PLOS ONE			English	Article							JUDITH RIVER FORMATION; HORNED DINOSAUR; AVACERATOPS; SKELETON; MONTANA; COUNTY	The fossil record of ceratopsid dinosaurs between the occurrence of their proximate sister taxa in the Turonian and the beginning of their well-documented radiation from the late Campanian of North America onwards (approximately 90 and 77 Ma) is poor, with only seven taxa described from this early period in their evolution. We describe a new taxon of a highly adorned basal centrosaurine, Wendiceratops pinhornensis gen. et sp. nov., from the lower part of the Oldman Formation (middle Campanian, approximately 78-79 Ma), Alberta, Canada. Over 200 bones derived from virtually all parts of the skeleton, including multiple well-preserved specimens of the diagnostic parietosquamosal frill, were collected from a medium-density monodominant bonebed, making the new taxon one of the best-represented early ceratopsids. The new taxon is apomorphic in having epiparietals at loci 2 and 3 developed as broad-based, pachyostotic processes that are strongly procurved anterodorsally to overhang the posterior and lateral parietal rami, and an ischium with a broad, rectangular distal terminus. Although the morphology of the nasal is incompletely known, Wendiceratops is inferred to have a large, upright nasal horn located close to the orbits, which represents the oldest occurrence of this feature in Ceratopsia. Given the phylogenetic position of the new taxon within Centrosaurinae, a enlarged nasal horn is hypothesized to have arisen independently at least twice in ceratopsid evolution.	[Evans, David C.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Evans, David C.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada; [Ryan, Michael J.] Cleveland Museum Nat Hist, Dept Vertebrate Paleontol, Cleveland, OH 44106 USA	Royal Ontario Museum; University of Toronto; Cleveland Museum of Natural History	Evans, DC (corresponding author), Royal Ontario Museum, Dept Nat Hist, 100 Queens Pk, Toronto, ON M5S 2C6, Canada.	d.evans@utoronto.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [355845]; Royal Ontario Museum Department of Natural History Fieldwork Grants; Dinosaur Research Institute	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Royal Ontario Museum Department of Natural History Fieldwork Grants; Dinosaur Research Institute	This research was supported by a Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) Discovery Grant to DCE (NSERC Grant File Number: RGPIN 355845, http://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=527922), Royal Ontario Museum Department of Natural History Fieldwork Grants to DCE, and research grants from the Dinosaur Research Institute to DCE and MJR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkman DB, 2004, PALAEOGEOGR PALAEOCL, V213, P295, DOI 10.1016/j.palaeo.2004.07.016; Brinkman DB, 1998, PALAIOS, V13, P160, DOI 10.2307/3515487; Brown B, 1917, B AM MUS NAT HIST, V37, P281; Brown CM, 2009, J VERTEBR PALEONTOL, V29, P132, DOI 10.1671/039.029.0119; Chinnery B, 2004, J VERTEBR PALEONTOL, V24, P591, DOI 10.1671/0272-4634(2004)024[0591:MAOETI]2.0.CO;2; Clayton K, 2009, J VERTEBR PALEONTOL, V29, p80A; Currie Philip J., 2008, P1; DODSON P, 1986, P ACAD NAT SCI PHILA, V138, P305; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Eberth DA, 2005, LIFE O PAST, P54; Eberth David A., 2007, P265; Fiorillo AR, 2012, ACTA PALAEONTOL POL, V57, P561, DOI 10.4202/app.2011.0033; FIORILLO AR, 1991, PALAEOGEOGR PALAEOCL, V81, P281, DOI 10.1016/0031-0182(91)90151-G; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; GOODWIN MB, 1989, CAN J EARTH SCI, V26, P1384, DOI 10.1139/e89-118; Holmes Robert, 2013, Kirtlandia, P5; Hone DWE, 2011, CRETACEOUS RES, V32, P495, DOI 10.1016/j.cretres.2011.03.005; Horner JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016574; HORNER JR, 1992, NATURE, V358, P59, DOI 10.1038/358059a0; Kirkland James I., 2010, P117; Lambe LM., 1915, CANADA GEOLOGICAL SU, V12, P1; Loewen Mark A., 2013, P488; Loewen Mark A., 2010, P99; Longrich NR, 2013, B PEABODY MUS NAT HI, V54, P51, DOI 10.3374/014.054.0103; Maiorino L, 2013, J VERTEBR PALEONTOL, V33, P1385, DOI 10.1080/02724634.2013.779922; Mallon JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067182; Mallon JC, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-14; Mallon JC, 2012, PALAEOGEOGR PALAEOCL, V350, P124, DOI 10.1016/j.palaeo.2012.06.024; Marsh O.C., 1890, AM J SCI, V39, P418, DOI DOI 10.2475/AJS.S3-39.233.418; Marsh OC., 1888, AM J SCI, V36, P477, DOI [10.2475/ajs.s3-36.216.477, DOI 10.2475/AJS.S3-36.216.477.]; Owen R., 1842, 11 M BRIT ASS ADV SC, P66; Penkalski P, 1999, J VERTEBR PALEONTOL, V19, P692, DOI 10.1080/02724634.1999.10011182; Roberts Eric M., 2013, P85; Ryan MJ, 2007, J PALEONTOL, V81, P376, DOI 10.1666/0022-3360(2007)81[376:ANBCCF]2.0.CO;2; Ryan MJ, 2012, CAN J EARTH SCI, V49, P1251, DOI 10.1139/e2012-056; Ryan Michael J., 2010, P181; Ryan MJ, 2005, LIFE O PAST, P312; Ryan MJ, 2005, CAN J EARTH SCI, V42, P1369, DOI 10.1139/E05-029; Sampson SD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1186; Sampson Scott D., 2010, P405; Sampson SD, 1997, ZOOLOGICAL J LINNEAN, V121, P292, DOI DOI 10.1111/J.1096-3642.1997.TB00340.X; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Wolfe Douglas G., 2010, P91; Xu X, 2010, CHINESE SCI BULL, V55, P1631, DOI 10.1007/s11434-009-3614-5; You Hailu, 2004, P478	46	22	22	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130007	10.1371/journal.pone.0130007	http://dx.doi.org/10.1371/journal.pone.0130007			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154293	gold, Green Published			2022-12-27	WOS:000358159700021
J	Jin, QW; Chen, H; Wang, XX; Zhao, LD; Xu, QC; Wang, HJ; Li, GY; Yang, XF; Ma, HM; Wu, HQ; Ji, XH				Jin, Qingwen; Chen, Hong; Wang, Xingxia; Zhao, Liandong; Xu, Qingchen; Wang, Huijuan; Li, Guanyu; Yang, Xiaofan; Ma, Hongming; Wu, Haoquan; Ji, Xiaohui			The Effects of the Recombinant CCR5 T4 Lysozyme Fusion Protein on HIV-1 Infection	PLOS ONE			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; CHEMOKINE RECEPTOR; COUPLED RECEPTOR; CRYSTAL-STRUCTURE; OPIOID RECEPTOR; STRUCTURAL INSIGHTS; CORECEPTOR CCR5; SMALL-MOLECULE; ANTAGONIST; COMPLEX	Background Insertion of T4 lysozyme (T4L) into the GPCR successfully enhanced GPCR protein stability and solubilization. However, the biological functions of the recombinant GPCR protein have not been analyzed. Methods We engineered the CCR5-T4L mutant and expressed and purified the soluble recombinant protein using an E. coli expression system. The antiviral effects of this recombinant protein in THP-1 cell lines, primary human macrophages, and PBMCs from different donors were investigated. We also explored the possible mechanisms underlying the observed antiviral effects. Results Our data showed the biphasic inhibitory and promotion effects of different concentrations of soluble recombinant CCR5-T4L protein on R5 tropic human immunodeficiency virus-1 (HIV-1) infection in THP-1 cell lines, human macrophages, and PBMCs from clinical isolates. We demonstrated that soluble recombinant CCR5-T4L acts as a HIV-1 co-receptor, interacts with wild type CCR5, down-regulates the surface CCR5 expression in human macrophages, and interacts with CCL5 to inhibit macrophage migration. Using binding assays, we further determined that recombinant CCR5-T4L and [I-125]-CCL5 compete for the same binding site on wild type CCR5. Conclusions Our results suggest that recombinant CCR5-T4L protein marginally promotes HIV-1 infection at low concentrations and markedly inhibits infection at higher concentrations. This recombinant protein may be helpful in the future development of anti-HIV-1 therapeutic agents.	[Jin, Qingwen; Wang, Huijuan; Yang, Xiaofan; Ji, Xiaohui] Nanjing Med Univ, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China; [Jin, Qingwen; Chen, Hong; Wang, Xingxia] Peoples Hosp Jiangsu Prov, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Zhao, Liandong] Second Hosp Huaian, Dept Neurol, Huaian, Jiangsu, Peoples R China; [Jin, Qingwen; Xu, Qingchen] Nanjing First Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Li, Guanyu] Mingji Hosp Nanjing, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Ma, Hongming; Wu, Haoquan] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, El Paso, TX USA	Nanjing Medical University; Texas Tech University System; Texas Tech University	Ji, XH (corresponding author), Nanjing Med Univ, Dept Microbiol & Immunol, 140 Hanzhong Rd, Nanjing, Jiangsu, Peoples R China.	immune@njmu.edu.cn	wang, hui/GRS-4730-2022	Wu, Haoquan/0000-0001-9386-3187	National Natural Science foundation of China [30870125]	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from National Natural Science foundation of China (#30870125) for QJ.	Aiamkitsumrit B, 2014, CURR HIV RES, V12, P132, DOI 10.2174/1570162X12666140526121746; Altenburg JD, 2010, J VIROL, V84, P2563, DOI 10.1128/JVI.00342-09; Arumugam K, 2014, J BIOMOL STRUCT DYN, V32, P1274, DOI 10.1080/07391102.2013.817952; Bozek K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002977; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; FDA notifications, 2007, AIDS ALERT, V22, P103; Garcia-Perez J, 2011, J BIOL CHEM, V286, P33409, DOI 10.1074/jbc.M111.279596; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Henrich TJ, 2013, CURR OPIN VIROL, V3, P51, DOI 10.1016/j.coviro.2012.12.002; Homan KT, 2014, CURR OPIN CELL BIOL, V27, P25, DOI 10.1016/j.ceb.2013.10.009; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Isgro M, 2013, MUCOSAL IMMUNOL, V6, P718, DOI 10.1038/mi.2012.109; Jin QW, 2011, VIROLOGY, V417, P449, DOI 10.1016/j.virol.2011.07.001; Jones KL, 2011, BRIT J PHARMACOL, V162, P1453, DOI 10.1111/j.1476-5381.2010.01147.x; Klasse PJ, 2012, CELL MICROBIOL, V14, P1183, DOI 10.1111/j.1462-5822.2012.01812.x; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mathew E, 2013, PROTEIN ENG DES SEL, V26, P59, DOI 10.1093/protein/gzs070; Moller M, 2014, ACTA NEUROL SCAND, V129, P27, DOI 10.1111/ane.12145; Mueller A, 2002, BRIT J PHARMACOL, V135, P1033, DOI 10.1038/sj.bjp.0704540; Nisius L, 2008, PROTEIN EXPRES PURIF, V61, P155, DOI 10.1016/j.pep.2008.06.001; Palani A, 2006, J MED CHEM, V49, P2851, DOI 10.1021/jm060009x; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Sohy D, 2009, J BIOL CHEM, V284, P31270, DOI 10.1074/jbc.M109.054809; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Venkatesan S, 2002, J BIOL CHEM, V277, P2287, DOI 10.1074/jbc.M108321200; Wiktor M, 2013, J BIOMOL NMR, V55, P79, DOI 10.1007/s10858-012-9688-4; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yang JP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-57	37	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131894	10.1371/journal.pone.0131894	http://dx.doi.org/10.1371/journal.pone.0131894			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154172	gold, Green Published, Green Submitted			2022-12-27	WOS:000358159700083
J	Apenteng, OO; Ismail, NA				Apenteng, Ofosuhene O.; Ismail, Noor Azina			A Markov Chain Monte Carlo Approach to Estimate AIDS after HIV Infection	PLOS ONE			English	Article							MODEL; TRANSMISSION; EPIDEMIC; DISEASE; SPREAD	The spread of human immunodeficiency virus (HIV) infection and the resulting acquired immune deficiency syndrome (AIDS) is a major health concern in many parts of the world, and mathematical models are commonly applied to understand the spread of the HIV epidemic. To understand the spread of HIV and AIDS cases and their parameters in a given population, it is necessary to develop a theoretical framework that takes into account realistic factors. The current study used this framework to assess the interaction between individuals who developed AIDS after HIV infection and individuals who did not develop AIDS after HIV infection (pre-AIDS). We first investigated how probabilistic parameters affect the model in terms of the HIV and AIDS population over a period of time. We observed that there is a critical threshold parameter, R-0, which determines the behavior of the model. If R-0 <= 1, there is a unique disease-free equilibrium; if R-0 < 1, the disease dies out; and if R-0 > 1, the disease-free equilibrium is unstable. We also show how a Markov chain Monte Carlo (MCMC) approach could be used as a supplement to forecast the numbers of reported HIV and AIDS cases. An approach using a Monte Carlo analysis is illustrated to understand the impact of model-based predictions in light of uncertain parameters on the spread of HIV. Finally, to examine this framework and demonstrate how it works, a case study was performed of reported HIV and AIDS cases from an annual data set in Malaysia, and then we compared how these approaches complement each other. We conclude that HIV disease in Malaysia shows epidemic behavior, especially in the context of understanding and predicting emerging cases of HIV and AIDS.	[Apenteng, Ofosuhene O.; Ismail, Noor Azina] Univ Malaya, Dept Appl Stat, Fac Econ & Adm, Kuala Lumpur, Malaysia	Universiti Malaya	Ismail, NA (corresponding author), Univ Malaya, Dept Appl Stat, Fac Econ & Adm, Kuala Lumpur, Malaysia.	nazina@um.edu.my	ISMAIL, NOOR AZINA/B-5341-2010	ISMAIL, NOOR AZINA/0000-0001-8032-2162; Apenteng, Ofosuhene O./0000-0001-9991-1709	University Malaya Research Grant, Demographic Network Modeling of The Spread of Infectious Diseases, under Social Network Dynamics Program, Equitable Society Research Cluster, University of Malaya [RP004J-13ICT]	University Malaya Research Grant, Demographic Network Modeling of The Spread of Infectious Diseases, under Social Network Dynamics Program, Equitable Society Research Cluster, University of Malaya	This work was supported by the University Malaya Research Grant, RP004J-13ICT: Demographic Network Modeling of The Spread of Infectious Diseases, under the Social Network Dynamics Program, Equitable Society Research Cluster, University of Malaya.	2012, 2012, MAL 2012 GLOB AIDS R; [Anonymous], 2013, TEXTS STAT SCI SERIE; Apenteng OO, 2009, DEMOGRAPHIC MODELLIN; Brun R, 2001, WATER RESOUR RES, V37, P1015, DOI 10.1029/2000WR900350; de Arazoza H, 2002, IMA J MATH APPL MED, V19, P221; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0; Hyman JM, 1989, MATH COMPUT MODEL, V12, P1180; Jones James Holland, 2007, NOTES R0; Kakehashi M, 1999, IMA J MATH APPL MED, V16, P111; Kim J-H, 2009, DYNAMIC PARTNERSHIPS; Laine M., 2008, ADAPTIVE MCMC METHOD; Merli MG, 2006, POP STUD-J DEMOG, V60, P1, DOI 10.1080/00324720500436060; Naresh R, 2006, APPL MATH COMPUT, V178, P262, DOI 10.1016/j.amc.2005.11.041; Nyabadza F, 2011, NONLINEAR ANAL-REAL, V12, P2091, DOI 10.1016/j.nonrwa.2010.12.024; Roberts MG, 2007, J MATH BIOL, V55, P803, DOI 10.1007/s00285-007-0112-8; ROMIEU I, 1991, HUM BIOL, V63, P683; Silva CJ, 2013, MATH BIOSCI, V244, P154, DOI 10.1016/j.mbs.2013.05.005; Slimi R, 2009, APPL MATH MODEL, V33, P1072, DOI 10.1016/j.apm.2007.12.028; Soetaert K, 2009, A PRACTICAL GUIDE TO; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; World Health Organization, 2014, GLOB SUMM HIV AIDS E	23	3	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131950	10.1371/journal.pone.0131950	http://dx.doi.org/10.1371/journal.pone.0131950			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147199	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600170
J	Cavalerie, L; Charron, MVP; Ezanno, P; Dommergues, L; Zumbo, B; Cardinale, E				Cavalerie, Lisa; Charron, Maud V. P.; Ezanno, Pauline; Dommergues, Laure; Zumbo, Betty; Cardinale, Eric			A Stochastic Model to Study Rift Valley Fever Persistence with Different Seasonal Patterns of Vector Abundance: New Insights on the Endemicity in the Tropical Island of Mayotte	PLOS ONE			English	Article							AEDES-ALBOPICTUS; CULEX-ZOMBAENSIS; VIRUS; COMPETENCE; TRANSMISSION; MOSQUITOS; DIPTERA; CULICIDAE; EPIDEMIOLOGY; TEMPERATURE	Rift Valley fever (RVF) is a zoonotic vector- borne disease causing abortion storms in cattle and human epidemics in Africa. Our aim was to evaluate RVF persistence in a seasonal and isolated population and to apply it to Mayotte Island (Indian Ocean), where the virus was still silently circulating four years after its last known introduction in 2007. We proposed a stochastic model to estimate RVF persistence over several years and under four seasonal patterns of vector abundance. Firstly, the model predicted a wide range of virus spread patterns, from obligate persistence in a constant or tropical environment (without needing vertical transmission or reintroduction) to frequent extinctions in a drier climate. We then identified for each scenario of seasonality the parameters that most influenced prediction variations. Persistence was sensitive to vector lifespan and biting rate in a tropical climate, and to host viraemia duration and vector lifespan in a drier climate. The first epizootic peak was primarily sensitive to viraemia duration and thus likely to be controlled by vaccination, whereas subsequent peaks were sensitive to vector lifespan and biting rate in a tropical climate, and to host birth rate and viraemia duration in arid climates. Finally, we parameterized the model according to Mayotte known environment. Mosquito captures estimated the abundance of eight potential RVF vectors. Review of RVF competence studies on these species allowed adjusting transmission probabilities per bite. Ruminant serological data since 2004 and three new cross- sectional seroprevalence studies are presented. Transmission rates had to be divided by more than five to best fit observed data. Five years after introduction, RVF persisted in more than 10% of the simulations, even under this scenario of low transmission. Hence, active surveillance must be maintained to better understand the risk related to RVF persistence and to prevent new introductions.	[Cavalerie, Lisa; Dommergues, Laure; Cardinale, Eric] Ctr Rech & Veille Malad Emergentes Ocean Indien, CRVOI, F-97490 St Clotilde, Reunion, France; [Cavalerie, Lisa; Dommergues, Laure; Cardinale, Eric] CIRAD, UMR CMAEE, F-97490 St Clotilde, Reunion, France; [Cavalerie, Lisa; Dommergues, Laure; Cardinale, Eric] INRA, UMR CMAEE 1309, F-34398 Montpellier, France; [Cavalerie, Lisa] AgroParisTech, F-75005 Paris, France; [Cavalerie, Lisa] Univ Reunion, F-97715 St Denis, Reunion, France; [Charron, Maud V. P.; Ezanno, Pauline] LUNAM Univ, INRA, BioEpAR UMR1300, Oniris,CS 40706, F-44307 Nantes, France; [Dommergues, Laure] GDS Mayotte Cooperat Agr Eleveurs Mahorais, F-97670 Coconi, Mayotte, France; [Zumbo, Betty] ARS OI, F-97600 Mamoudzou, Mayotte, France	CIRAD; INRAE; AgroParisTech; University of La Reunion; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE	Cavalerie, L (corresponding author), Ctr Rech & Veille Malad Emergentes Ocean Indien, CRVOI, F-97490 St Clotilde, Reunion, France.	lisa.cavalerie@gmail.com	Ezanno, Pauline/A-4699-2009; Cavalerie, Lisa/AAX-1587-2020	Ezanno, Pauline/0000-0002-0034-8950; Cavalerie, Lisa/0000-0001-7187-3800	French Ministry of Agriculture, Region Reunion, INRA; AnimalRisk program (Feder POCT)	French Ministry of Agriculture, Region Reunion, INRA; AnimalRisk program (Feder POCT)	Financial support was provided by the French Ministry of Agriculture, Region Reunion, INRA and the AnimalRisk program (Feder POCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo-Salem S, 2006, ANN NY ACAD SCI, V1081, P240, DOI 10.1196/annals.1373.028; Afssa, 2008, AFSSA OP RISK RIFT V, P156; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Andriamandimby SF, 2010, EMERG INFECT DIS, V16, P963, DOI 10.3201/eid1606.091266; Ba Y, 2005, J MED ENTOMOL, V42, P739, DOI 10.1603/0022-2585(2005)042[0739:AOBOTR]2.0.CO;2; Bagny L, 2009, J MED ENTOMOL, V46, P198, DOI 10.1603/033.046.0204; Balenghien T, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-78; Barakat, 2008, STUDENTS APPEAL RULI; Barker CM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002515; Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378; Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883; Breto C, 2009, ANN APPL STAT, V3, P319, DOI 10.1214/08-AOAS201; Cetre-Sossah C, 2012, EMERG INFECT DIS, V18, P969, DOI 10.3201/eid1806.110994; Cetre-Sossah C, 2012, EMERG INFECT DIS, V18, P972, DOI 10.3201/eid1806.111165; Chamchod F, 2014, B MATH BIOL, V76, P2052, DOI 10.1007/s11538-014-9998-7; Charron MVP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074213; Charron MVP, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-44; Charron MVP, 2011, J THEOR BIOL, V291, P1, DOI 10.1016/j.jtbi.2011.08.041; Chevalier V, 2010, RIFT VALLEY FEVER TH; Chitnis N, 2013, J BIOL DYNAM, V7, P11, DOI 10.1080/17513758.2012.733427; Clements AN, 2000, BIOL MOSQUITOES DEV; DAAF Direction de l'Alimentation de l'Agriculture et de la Foret de Mayotte, 2010, REC AGR 2010 MAYOTT; DAVIES FG, 1985, B WORLD HEALTH ORGAN, V63, P941; Dohoo I.R., 2003, VET EPIDEMIOLOGIC RE; Ezanno P, 2015, PREV VET MED, V120, P39, DOI 10.1016/j.prevetmed.2014.12.018; Ezanno P, 2012, NEW FRONTIERS OF MOLECULAR EPIDEMIOLOGY OF INFECTIOUS DISEASES, P79, DOI 10.1007/978-94-007-2114-2_5; FAO, 2008, EMPRES WATCH     SEP, P4; FARAN ME, 1987, AM J TROP MED HYG, V37, P403, DOI 10.4269/ajtmh.1987.37.403; Favier C, 2006, TROP MED INT HEALTH, V11, P1878, DOI 10.1111/j.1365-3156.2006.01746.x; Fischer EAJ, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-58; GAD AM, 1987, T ROY SOC TROP MED H, V81, P694, DOI 10.1016/0035-9203(87)90460-3; GAFF H, 2011, INT J ARTIFICIAL LIF, V2, P1, DOI DOI 10.4018/JALR.2011040101; Gaff H, 2007, ELECTRON J DIFFER EQ, V115, P1, DOI DOI 10.1155/2012/138757; Gerdes GH, 2004, REV SCI TECH OIE, V23, P613, DOI 10.20506/rst.23.2.1500; Gong HF, 2011, INT J BIOMETEOROL, V55, P435, DOI 10.1007/s00484-010-0354-9; InVS, 2012, 372 INVS, P3; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Kifaro EG, 2014, ONDERSTEPOORT J VET, V81, DOI 10.4102/ojvr.v81i2.717; Lagerqvist N, 2013, EID, V19; Lawpoolsri S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-159; Le Goff G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100696; Lernout T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074192; LINTHICUM KJ, 1985, J HYG-CAMBRIDGE, V95, P197, DOI 10.1017/S0022172400062434; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; Lumley T., 2011, COMPLEX SURVEYS GUID; Manore CA, 2015, TRANSBOUND EMERG DIS, V62, P13, DOI 10.1111/tbed.12082; Maquart M, 2016, TRANSBOUND EMERG DIS, V63, pE281, DOI 10.1111/tbed.12267; Maquart M, 2014, J VIROL METHODS, V195, P92, DOI 10.1016/j.jviromet.2013.10.001; MCINTOSH B M, 1973, Journal of the South African Veterinary Association, V44, P57; MCINTOSH BM, 1980, S AFR MED J, V58, P127; MCINTOSH BM, 1983, S AFR J SCI, V79, P61; Moore CG, 1993, MOSQUITOES PUBLIC HL; Moutailler S, 2008, VECTOR-BORNE ZOONOT, V8, P749, DOI 10.1089/vbz.2008.0009; Mpeshe SC, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/627586; Mpeshe SC, 2011, ACTA BIOTHEOR, V59, P231, DOI 10.1007/s10441-011-9132-2; Mweya CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108430; Owange NO, 2014, PREV VET MED, V117, P121, DOI 10.1016/j.prevetmed.2014.08.008; PATRICAN LA, 1989, AM J TROP MED HYG, V40, P534, DOI 10.4269/ajtmh.1989.40.534; Pepin M, 2010, VET RES, V41, P40; R Core Team, 2021, R LANGUAGE ENV STAT; Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921; Roger M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003045; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; Saltelli A., 2000, WILEY SERIES PROBABI; Scilab Enterprises, 2012, SCIL FREE OP SOURC S; Shoemaker T, 2002, EMERG INFECT DIS, V8, P1415, DOI 10.3201/eid0812.020195; Sissoko D, 2009, EMERG INFECT DIS, V15, P568, DOI 10.3201/eid1504.081045; Sumaye RD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002356; Tillard E, 2013, REFERENTIEL TECHNIQU, P90; Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698; Turell MJ, 2007, J AM MOSQUITO CONTR, V23, P378, DOI 10.2987/5645.1; Turell MJ, 2008, J MED ENTOMOL, V45, P102, DOI 10.1603/0022-2585(2008)45[102:VCOSAM]2.0.CO;2; Turell MJ, 2008, J AM MOSQUITO CONTR, V24, P502, DOI 10.2987/08-5791.1; TURELL MJ, 1988, J MED ENTOMOL, V25, P262, DOI 10.1093/jmedent/25.4.262; Turell MJ, 1998, J MED ENTOMOL, V35, P132, DOI 10.1093/jmedent/35.2.132; Turell MJ, 1996, AM J TROP MED HYG, V54, P136, DOI 10.4269/ajtmh.1996.54.136; TURELL MJ, 1988, J AM MOSQUITO CONTR, V4, P94; TURELL MJ, 1990, AM J TROP MED HYG, V43, P677, DOI 10.4269/ajtmh.1990.43.677; TURELL MJ, 1993, AM J TROP MED HYG, V49, P672, DOI 10.4269/ajtmh.1993.49.672; Xue L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062049; Xue L, 2012, J THEOR BIOL, V306, P129, DOI 10.1016/j.jtbi.2012.04.029	81	14	14	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130838	10.1371/journal.pone.0130838	http://dx.doi.org/10.1371/journal.pone.0130838			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147799	Green Submitted, gold, Green Published			2022-12-27	WOS:000358157600051
J	Chan, MC; Atasoylu, O; Hodson, E; Tumber, A; Leung, IKH; Chowdhury, R; Gomez-Perez, V; Demetriades, M; Rydzik, AM; Holt-Martyn, J; Tian, YM; Bishop, T; Claridge, TDW; Kawamura, A; Pugh, CW; Ratcliffe, PJ; Schofield, CJ				Chan, Mun Chiang; Atasoylu, Onur; Hodson, Emma; Tumber, Anthony; Leung, Ivanhoe K. H.; Chowdhury, Rasheduzzaman; Gomez-Perez, Veronica; Demetriades, Marina; Rydzik, Anna M.; Holt-Martyn, James; Tian, Ya-Min; Bishop, Tammie; Claridge, Timothy D. W.; Kawamura, Akane; Pugh, Christopher W.; Ratcliffe, Peter J.; Schofield, Christopher J.			Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain	PLOS ONE			English	Article							ANKYRIN REPEAT DOMAIN; FACTOR HIF; ASPARAGINYL HYDROXYLASE; BETA-HYDROXYLATION; STRUCTURAL BASIS; BINDING; SUBSTRATE; PROTEINS; TARGET; ALPHA	As part of the cellular adaptation to limiting oxygen availability in animals, the expression of a large set of genes is activated by the upregulation of the hypoxia-inducible transcription factors (HIFs). Therapeutic activation of the natural human hypoxic response can be achieved by the inhibition of the hypoxia sensors for the HIF system, i.e. the HIF prolyl-hydroxylases (PHDs). Here, we report studies on tricyclic triazole-containing compounds as potent and selective PHD inhibitors which compete with the 2-oxoglutarate co-substrate. One compound (IOX4) induces HIF alpha in cells and in wildtype mice with marked induction in the brain tissue, revealing that it is useful for studies aimed at validating the upregulation of HIF for treatment of cerebral diseases including stroke.	[Chan, Mun Chiang; Atasoylu, Onur; Leung, Ivanhoe K. H.; Chowdhury, Rasheduzzaman; Gomez-Perez, Veronica; Demetriades, Marina; Rydzik, Anna M.; Holt-Martyn, James; Claridge, Timothy D. W.; Kawamura, Akane; Schofield, Christopher J.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; [Chan, Mun Chiang; Hodson, Emma; Tian, Ya-Min; Bishop, Tammie; Pugh, Christopher W.; Ratcliffe, Peter J.] Univ Oxford, Ctr Cellular & Mol Physiol, Oxford OX1 3TA, England; [Tumber, Anthony] Univ Oxford, Target Discovery Inst, Oxford OX1 3TA, England	University of Oxford; University of Oxford; University of Oxford	Schofield, CJ (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England.	christopher.schofield@chem.ox.ac.uk	Rydzik, Anna/V-1178-2019; Claridge, Tim/A-8324-2018; Chan, Mun Chiang/T-4867-2019; Holt-Martyn, James/HGD-1452-2022; Leung, Ivanhoe/G-6168-2010; Kawamura, Akane/I-4047-2018; Atasoylu, Onur/J-8392-2019; Chowdhury, Rashed/I-7697-2014	Rydzik, Anna/0000-0003-3158-0493; Claridge, Tim/0000-0001-5583-6460; Chan, Mun Chiang/0000-0002-3162-6036; Leung, Ivanhoe/0000-0003-0633-6771; Kawamura, Akane/0000-0003-1169-5082; Chowdhury, Rashed/0000-0002-8058-6149; Pugh, Chris/0000-0002-5170-1662; Bishop, Tammie/0000-0003-3308-9139; Schofield, Christopher/0000-0002-0290-6565; Ratcliffe, Peter/0000-0002-2853-806X	Wellcome Trust [091857/Z.10/Z]; British Heart Foundation [PG/12/33/29546]; British Heart Foundation [RG/11/1/28684] Funding Source: researchfish; Cancer Research UK [18245] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK)	This work was funded by the Wellcome Trust, http://www.wellcome.ac.uk/, grant 091857/Z.10/Z to CJS, and the British Heart Foundation, https://www.bhf.org.uk/, grant PG/12/33/29546 to CJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aik W, 2013, J MED CHEM, V56, P3680, DOI 10.1021/jm400193d; Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Bertini I, 2008, ANGEW CHEM INT EDIT, V47, P4533, DOI 10.1002/anie.200800327; Bigge CF, 2004, PCT INT APPL, Patent No. 2003018553; Bishop T, 2013, J PHYSIOL-LONDON, V591, P3565, DOI 10.1113/jphysiol.2012.247254; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chowdhury R, 2013, ACS CHEM BIOL, V8, P1488, DOI 10.1021/cb400088q; Chowdhury R, 2009, STRUCTURE, V17, P981, DOI 10.1016/j.str.2009.06.002; Clark DE, 2011, FUTURE MED CHEM, V3, P469, DOI [10.4155/FMC.11.1, 10.4155/fmc.11.1]; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Cockman ME, 2009, MOL CELL PROTEOMICS, V8, P535, DOI 10.1074/mcp.M800340-MCP200; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Eltzschig HK, 2014, NAT REV DRUG DISCOV, V13, P852, DOI 10.1038/nrd4422; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ferguson JE, 2007, MOL CELL BIOL, V27, P6407, DOI 10.1128/MCB.00511-07; Hardy AP, 2009, J MOL BIOL, V392, P994, DOI 10.1016/j.jmb.2009.07.070; Harten SK, 2010, ANTIOXID REDOX SIGN, V12, P459, DOI 10.1089/ars.2009.2870; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hopkinson RJ, 2013, CHEM SCI, V4, P3110, DOI [10.1039/c3sc51122g, 10.1039/C3SC51122G]; Hsieh MM, 2007, BLOOD, V110, P2140, DOI 10.1182/blood-2007-02-073254; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Karuppagounder SS, 2012, J CEREBR BLOOD F MET, V32, P1347, DOI 10.1038/jcbfm.2012.28; Kelly L, 2009, MOL BIOSYST, V5, P52, DOI 10.1039/b815271c; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lau KW, 2007, BRIT J CANCER, V96, P1284, DOI 10.1038/sj.bjc.6603675; Lee SH, 2008, J BIOMOL SCREEN, V13, P494, DOI 10.1177/1087057108318800; LELAND JK, 1990, J ELECTROCHEM SOC, V137, P3127, DOI 10.1149/1.2086171; Leung IKH, 2013, J MED CHEM, V56, P547, DOI 10.1021/jm301583m; Leung IKH, 2010, J MED CHEM, V53, P867, DOI 10.1021/jm901537q; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Morton CJ, 1996, STRUCTURE, V4, P705, DOI 10.1016/S0969-2126(96)00076-7; Rabinowitz MH, 2013, J MED CHEM, V56, P9369, DOI 10.1021/jm400386j; Rose NR, 2012, J MED CHEM, V55, P6639, DOI 10.1021/jm300677j; Rose NR, 2011, CHEM SOC REV, V40, P4364, DOI 10.1039/c0cs00203h; Rydzik AM, 2012, CHEMBIOCHEM, V13, P1559, DOI 10.1002/cbic.201200256; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Stolze IP, 2004, J BIOL CHEM, V279, P42719, DOI 10.1074/jbc.M406713200; Thede K, 2008, PCT INT APPL, Patent No. 2008067871; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; van de Waterbeemd H, 1998, J DRUG TARGET, V6, P151, DOI 10.3109/10611869808997889; Webb JD, 2009, BIOCHEM J, V420, P327, DOI 10.1042/BJ20081905; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yan L, 2010, EXPERT OPIN THER PAT, V20, P1219, DOI 10.1517/13543776.2010.510836; Yang M, 2011, J BIOL CHEM, V286, P7648, DOI 10.1074/jbc.M110.193540; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105	54	45	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132004	10.1371/journal.pone.0132004	http://dx.doi.org/10.1371/journal.pone.0132004			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147748	Green Published, gold			2022-12-27	WOS:000358157600177
J	Dong, Y; Yang, LM; Ren, JM; Nair, DS; Parker, S; Jahnel, JL; Swanson-Devlin, TG; Beck, JM; Mathews, M; McNeil, CJ; Ling, YF; Cheng, X; Gao, Y; Dong, Q; Wang, DZ				Dong, Yi; Yang, Lumeng; Ren, Jinma; Nair, Deepak S.; Parker, Sarah; Jahnel, Jan L.; Swanson-Devlin, Teresa G.; Beck, Judith M.; Mathews, Maureen; McNeil, Clayton J.; Ling, Yifeng; Cheng, Xin; Gao, Yuan; Dong, Qiang; Wang, David Z.			Intravenous Tissue Plasminogen Activator Can Be Safely Given without Complete Blood Count Results Back	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; THROMBOLYSIS	Introduction It is well known that the efficacy of intravenous (IV) tissue plasminogen activator (tPA) is time-dependent when used to treat patients with acute ischemic strokes. Aim Our study examines the safety issue of giving IV tPA without complete blood count (CBC) resulted. Materials and Methods This is a retrospective observational study by examining the database from Huashan Hospital in China and OSF/INI Comprehensive Stroke Center in United States. Patient data collected included demographics, occurrence of symptomatic intracranial hemorrhage, door to needle intervals, National Institute of Health Stroke Scale scores on admission, CBC results on admission and follow-up modified Rankin Scale scores. Linear regression and multivariable logistic regression analysis were used to identify factors that would have an impact on door-to-needle intervals. Results Our study included120 patients from Huashan Hospital and 123 patients from INI. Among them, 36 in Huashan Hospital and 51in INI received IV tPA prior to their CBC resulted. Normal platelet count was found in 98.8% patients after tPA was given. One patient had thrombocytopenia but no hemorrhagic event. A significantly shorter door to needle interval (DTN) was found in the group without CBC resulted. There was also a difference in treatment interval between the two hospitals. Door to needle intervals had a strong correlation to onset to treatment intervals and NIHSS scores on admission. Conclusion In patients presented with acute ischemic stroke, the risk of developing hemorrhagic event is low if IV tPA is given before CBC has resulted. The door to needle intervals can be significantly reduced.	[Dong, Yi; Yang, Lumeng; Ling, Yifeng; Cheng, Xin; Dong, Qiang] Fudan Univ, Dept Neurol, Huashan Hosp, State Key Lab Neurobiol, Shanghai 200433, Peoples R China; [Ren, Jinma] Univ Illinois, Coll Med, Ctr Outcomes Res, Peoria, IL 61656 USA; [Dong, Yi; Nair, Deepak S.; Parker, Sarah; Jahnel, Jan L.; Swanson-Devlin, Teresa G.; Beck, Judith M.; Mathews, Maureen; McNeil, Clayton J.; Wang, David Z.] Univ Illinois, Coll Med, INI Stroke Network, OSF Healthcare Syst,Dept Neurol, Peoria, IL 61656 USA; [Gao, Yuan] Zhengzhou Univ Henan, Affiliated Hosp 1, Dept Neurol, Zhengzhou, Peoples R China	Fudan University; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Wang, DZ (corresponding author), Univ Illinois, Coll Med, INI Stroke Network, OSF Healthcare Syst,Dept Neurol, Peoria, IL 61656 USA.	dwang@uic.edu	Dong, Yi/AAF-6154-2019; Cheng, Xin/AAF-4744-2019; Dong, YI/B-9314-2019	Dong, Yi/0000-0001-6630-112X; Cheng, Xin/0000-0001-7816-0547; Dong, YI/0000-0001-6630-112X	Science and Technology Commission of Shanghai Municipality, China [1241119a8100]	Science and Technology Commission of Shanghai Municipality, China(Science & Technology Commission of Shanghai Municipality (STCSM))	Grant Support: Science and Technology Commission of Shanghai Municipality, China 1241119a8100 (X.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berrouschot J, 2005, STROKE, V36, P2421, DOI 10.1161/01.STR.0000185696.73938.e0; Fonarow GC, 2011, CIRCULATION, V123, P750, DOI 10.1161/CIRCULATIONAHA.110.974675; Gottesman RF, 2006, NEUROLOGY, V67, P1665, DOI 10.1212/01.wnl.0000244493.13898.5b; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; la Rosa FD, 2012, STROKE, V43, P1591, DOI 10.1161/STROKEAHA.111.645986; LAINO C, 2010, NEUROLOGY TODAY, V10, P8; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Marler JR, 2000, NEUROLOGY, V55, P1649, DOI 10.1212/WNL.55.11.1649; Meretoja A, 2013, NEUROLOGY, V81, P1071, DOI 10.1212/WNL.0b013e3182a4a4d2; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Tong D, 2011, NEUROLOGY, V76, P1780, DOI 10.1212/WNL.0b013e31821ccd60; Weber JE, 2013, NEUROLOGY, V80, P163, DOI 10.1212/WNL.0b013e31827b90e5	13	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131234	10.1371/journal.pone.0131234	http://dx.doi.org/10.1371/journal.pone.0131234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147994	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600073
J	Fang, L; Zhou, CJ; Bai, SJ; Huang, CL; Pan, JX; Wang, L; Wang, XF; Mao, Q; Sun, L; Xie, P				Fang, Liang; Zhou, Chanjuan; Bai, Shunjie; Huang, Chenglong; Pan, Junxi; Wang, Ling; Wang, Xinfa; Mao, Qiang; Sun, Lu; Xie, Peng			The C825T Polymorphism of the G-Protein beta 3 Gene as a Risk Factor for Depression: A Meta-Analysis	PLOS ONE			English	Article							SUBUNIT GENE; BIPOLAR DISORDER; ASSOCIATION; GNB3; LITHIUM; VARIANT; STRESS; SSRI	Background TheG-protein beta 3 gene (GN beta 3) has been implicated in psychiatric illness through its effects upon intracellular transduction of several neurotransmitter receptors. Multiple studies have investigated the relationship of the C825T polymorphism of the GN beta 3 gene (GN beta 3 C825T) to depression and antidepressant response. However, the relationship between GN beta 3 C825T and depression remains inconsistent. Therefore, here we performed a meta-analysis to investigate the role of GN beta 3 C825Tin depression risk. Methods Published case-control studies examining the association between GN beta 3 C825T and depression were systematically searched for through several electronic databases (PubMed, Scopus, Science Direct, Springer, Embase, psyINFO, and CNKI). The association between GN beta 3 C825T and depression risk were assessed by odd ratios (ORs) and their 95% confidence intervals (CIs) for each study. Pooled ORs were constructed for allele contrast (C versus T), homozygote (CC versus TT) model, heterozygote (CC versus CT) model, dominant model (CC + CT versus TT), and recessive (CC versus TT+ CT) model. In order to evaluate possible biases, a sensitivity analysis was conducted by sequential deletion of individual studies in an attempt to assess the contribution of each individual dataset to the pooled OR. Results Nine studies, including 1055 depressed patients and 1325 healthy controls, were included. A significant association between GN beta 3 C825Tand depression was found to exist, suggesting that the T-allele of GN beta 3 C825Tcan increase susceptibility to depression. After stratification by ethnicity, the same association was found in the Asian subpopulation, but not the Caucasian subpopulation. Conclusions This is the first meta-analysis to reveal a relationship between GN beta 3 C825T and depression. Asian T-allele carriers of GN beta 3 C825T appear to be more susceptible to depression.	[Fang, Liang] Chongqing Med Univ, Dept Neurol, Yongchuan Hosp, Chongqing, Peoples R China; [Zhou, Chanjuan; Bai, Shunjie; Huang, Chenglong; Pan, Junxi; Wang, Ling; Wang, Xinfa; Mao, Qiang; Sun, Lu; Xie, Peng] Chongqing Med Univ, Dept Neurol, Affiliated Hosp 1, Chongqing, Peoples R China; [Fang, Liang; Zhou, Chanjuan; Bai, Shunjie; Huang, Chenglong; Pan, Junxi; Wang, Ling; Wang, Xinfa; Mao, Qiang; Sun, Lu; Xie, Peng] Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Fang, Liang; Zhou, Chanjuan; Wang, Ling; Wang, Xinfa; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China; [Bai, Shunjie; Huang, Chenglong; Pan, Junxi; Sun, Lu] Chongqing Med Univ, Key Lab Lab Med Diagnost, Minist Educ, Dept Lab Med, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Xie, P (corresponding author), Chongqing Med Univ, Dept Neurol, Affiliated Hosp 1, Chongqing, Peoples R China.	xiepeng@cqmu.edu.cn	Mao, Qiang/HDL-6864-2022	Mao, Qiang/0000-0001-5645-2362	National Basic Research Program of China (973 Program) [2009CB918300]; Chongqing Postdoctoral Science Foundation [XM201103004]; Chongqing Postdoctoral Research Project [XM 201101003]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chongqing Postdoctoral Science Foundation; Chongqing Postdoctoral Research Project	This study was supported by the National Basic Research Program of China (973 Program, 2009CB918300), the Chongqing Postdoctoral Science Foundation (Grant No. XM201103004), and the Chongqing Postdoctoral Research Project (Grant No. XM 201101003).	Anttila S, 2007, J NEURAL TRANSM, V114, P461, DOI 10.1007/s00702-006-0583-6; Avissar S, 1999, Curr Psychiatry Rep, V1, P148, DOI 10.1007/s11920-999-0024-y; Avissar S, 1997, AM J PSYCHIAT, V154, P211; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Bishop JR, 2006, NEUROPSYCHOPHARMACOL, V31, P2281, DOI 10.1038/sj.npp.1301090; Bondy B, 2000, AM J MED GENET, V96, P466; Cao MQ, 2007, PSYCHIAT GENET, V17, P233, DOI 10.1097/YPG.0b013e3280c1e5de; Casiglia E, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/597034; Catapano LA, 2007, BBA-BIOMEMBRANES, V1768, P976, DOI 10.1016/j.bbamem.2006.09.025; Chang HH, 2010, J CLIN PSYCHOPHARM, V30, P512, DOI 10.1097/JCP.0b013e3181f03f50; Chen AM, 2011, J NEUROL, V44, P544; Chen PS, 2011, NEUROIMAGE, V56, P1526, DOI 10.1016/j.neuroimage.2010.10.082; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; Cohen-Woods S, 2013, PSYCHOL MED, V43, P673, DOI 10.1017/S0033291712001286; Eiden LE, 2013, ADV PHARMACOL, V68, P399, DOI 10.1016/B978-0-12-411512-5.00018-X; Exton MS, 2003, NEUROREPORT, V14, P531, DOI 10.1097/01.wnr.0000059998.23840.5f; GarciaSevilla JA, 1997, BIOL PSYCHIAT, V42, P704, DOI 10.1016/S0006-3223(96)00493-3; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hong X, 2003, CHINESE J CLIN  PHAR, V2, P000; Hosang GM, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-7; Hu Q, 2015, J AFFECT DISORDERS, V172, P103, DOI 10.1016/j.jad.2014.09.039; Johansson C, 2004, BIOL PSYCHIAT, V55, P317, DOI 10.1016/S0006-3223(03)00640-1; Kato M, 2008, PROG NEURO-PSYCHOPH, V32, P1041, DOI 10.1016/j.pnpbp.2008.01.019; Keers R, 2011, J PSYCHOPHARMACOL, V25, P867, DOI 10.1177/0269881110376683; Klenke S, 2011, PHARMACOGENET GENOM, V21, P594, DOI 10.1097/FPC.0b013e3283491153; Kunugi H, 2002, J NEURAL TRANSM, V109, P213, DOI 10.1007/s007020200018; Lee HJ, 2007, HUM PSYCHOPHARM CLIN, V22, P501, DOI 10.1002/hup.875; Lee HJ, 2004, PHARMACOGENOMICS J, V4, P29, DOI 10.1038/sj.tpj.6500217; Lin CN, 2001, NEUROPSYCHOBIOLOGY, V44, P118, DOI 10.1159/000054929; Mathews R, 1997, BIOL PSYCHIAT, V41, P649, DOI 10.1016/S0006-3223(96)00113-8; Muller DJ, 2005, EUR NEUROPSYCHOPHARM, V15, P525, DOI 10.1016/j.euroneuro.2005.02.001; Naert G, 2011, MOL CELL NEUROSCI, V46, P55, DOI 10.1016/j.mcn.2010.08.006; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Pacheco MA, 1996, BRAIN RES, V723, P37, DOI 10.1016/0006-8993(96)00207-7; Pellissier LP, 2011, J BIOL CHEM, V286, P9985, DOI 10.1074/jbc.M110.201939; Prestes AP, 2007, J NEURAL TRANSM, V114, P469, DOI 10.1007/s00702-006-0550-2; Rosskopf D, 2002, PHARMACOGENETICS, V12, P209, DOI 10.1097/00008571-200204000-00005; Serretti A, 2002, AM J MED GENET, V114, P370, DOI 10.1002/ajmg.10357; Serretti A, 2012, NEUROPSYCHOBIOLOGY, V65, P70, DOI 10.1159/000329553; Siffert W, 1998, NAT GENET, V18, P45, DOI 10.1038/ng0198-45; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Sullivan PF, 2010, NEURON, V68, P182, DOI 10.1016/j.neuron.2010.10.003; Tan JJ, 2014, AM J MED GENET B, V165, P438, DOI 10.1002/ajmg.b.32248; Wang HY, 1999, NEUROPHARMACOLOGY, V38, P403, DOI 10.1016/S0028-3908(98)00197-X; Wilkie MJ, PHARMACOGENET GENOMI, V17, P207; Willeit M, 2003, BIOL PSYCHIAT, V54, P682, DOI 10.1016/S0006-3223(03)00169-0; Zamponi GW, 2013, BBA-BIOMEMBRANES, V1828, P1629, DOI 10.1016/j.bbamem.2012.10.004; Zill P, 2000, NEUROREPORT, V11, P1893, DOI 10.1097/00001756-200006260-00018	48	10	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132274	10.1371/journal.pone.0132274	http://dx.doi.org/10.1371/journal.pone.0132274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147511	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600228
J	Gul, T; Islam, S; Shah, RA; Khalid, A; Khan, I; Shafie, S				Gul, Taza; Islam, Saeed; Shah, Rehan Ali; Khalid, Asma; Khan, Ilyas; Shafie, Sharidan			Unsteady MHD Thin Film Flow of an Oldroyd-B Fluid over an Oscillating Inclined Belt	PLOS ONE			English	Article							HOMOTOPY PERTURBATION METHOD; ASYMPTOTIC METHOD; NONLINEAR OSCILLATORS; STARTING SOLUTIONS; MOTIONS	This paper studies the unsteady magnetohydrodynamics (MHD) thin film flow of an incompressible Oldroyd-B fluid over an oscillating inclined belt making a certain angle with the horizontal. The problem is modeled in terms of non-linear partial differential equations with some physical initial and boundary conditions. This problem is solved for the exact analytic solutions using two efficient techniques namely the Optimal Homotopy Asymptotic Method (OHAM) and Homotopy Perturbation Method (HPM). Both of these solutions are presented graphically and compared. This comparison is also shown in tabular form. An excellent agreement is observed. The effects of various physical parameters on velocity have also been studied graphically.	[Gul, Taza; Islam, Saeed] Abdul Wali Khan Univ, Dept Math, Mardan, Kpk, Pakistan; [Shah, Rehan Ali] Univ Engn Technol, Dept Math, Peshawar, Kpk, Pakistan; [Khan, Ilyas] Majmaah Univ, Coll Engn, Dept Basic Sci, Majmaah 11952, Saudi Arabia; [Khalid, Asma; Shafie, Sharidan] Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Skudai Johor 81310, Malaysia	Abdul Wali Khan University; University of Engineering & Technology Peshawar; Majmaah University; Universiti Teknologi Malaysia	Gul, T (corresponding author), Abdul Wali Khan Univ, Dept Math, Mardan, Kpk, Pakistan.	sharidan@utm.my	Khan, Ilyas/C-8770-2019; Gul, Taza/R-7774-2019; Saeed, Islam/AAD-6067-2020	Khan, Ilyas/0000-0002-2056-9371; Gul, Taza/0000-0003-1376-8345; Saeed, Islam/0000-0001-5263-4871				Aksel N, 2006, Z ANGEW MATH PHYS, V57, P815, DOI 10.1007/s00033-006-0063-8; Anakira N. R., 2013, MATH PROBL ENG, V2013, P1; Anjum A, 2012, COMMUN NONLINEAR SCI, V17, P472, DOI 10.1016/j.cnsns.2011.05.004; Burdujan L, 2011, SERIES MATH ITS APPL, V3, P23; Fetecau C, 2007, APPL MATH MODEL, V31, P647, DOI 10.1016/j.apm.2005.11.032; Fetecau C, 2008, J NON-NEWTON FLUID, V153, P191, DOI 10.1016/j.jnnfm.2008.02.005; Ganji D.D., 2009, INT J NONLINEAR SCI, V7, P399; Ghosh AK, 2009, COMPUT APPL MATH, V28, P365, DOI 10.1590/S1807-03022009000300006; Ghosh AK, 2009, ACTA ASTRONAUT, V64, P272, DOI 10.1016/j.actaastro.2008.07.016; Ghosh AK, 2004, OPEN J FLUID DYNAMIC, V4, P226; Gul T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103843; Gul T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097552; Gul T, 2013, J APPL MATH, DOI 10.1155/2013/707286; Hayat T, 2001, INT J ENG SCI, V39, P135, DOI 10.1016/S0020-7225(00)00026-4; He JH, 2006, PHYS LETT A, V350, P87, DOI 10.1016/j.physleta.2005.10.005; He JH, 2005, CHAOS SOLITON FRACT, V26, P827, DOI 10.1016/j.chaos.2005.03.007; He JH, 2004, APPL MATH COMPUT, V151, P287, DOI 10.1016/S0096-3003(03)00341-2; He JH, 2005, CHAOS SOLITON FRACT, V26, P695, DOI 10.1016/j.chaos.2005.03.006; He JH, 2009, COMPUT MATH APPL, V57, P410, DOI 10.1016/j.camwa.2008.06.003; Ilyas K., 2011, INT J MATH MATH SCI, V2011, P408132, DOI [10.1155/2011/408132, DOI 10.1155/2011/408132]; Jamshad S., 2014, J APPL ENVIRON BIOL, V4, P41; Kashkari B.S., 2014, APPL MATH SCI, V8, P875, DOI [10.12988/ams.2014.312706, DOI 10.12988/AMS.2014.312706]; Khan I, 2012, SPEC TOP REV POROUS, V3, P89, DOI 10.1615/SpecialTopicsRevPorousMedia.v3.i1.80; Khan M, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/8/084701; Lie L, 2012, ADV MAT RES, V335, P83; Mabood F, 2014, COMPUT FLUIDS, V100, P72, DOI 10.1016/j.compfluid.2014.05.009; Mabood F, 2013, SAINS MALAYS, V42, P863; Marinca V.., 2013, SCI RES ESSAYS, V8, P161, DOI DOI 10.5897/SRE11.1630; Marinca V, 2008, CENT EUR J PHYS, V6, P648, DOI [10.2478/s11534-008-0061-x, 10.2478/S11534-008-0061-x]; Marinca V, 2014, ADV MATH PHYS, V2014, DOI 10.1155/2014/417643; Marinca V, 2009, APPL MATH LETT, V22, P245, DOI 10.1016/j.aml.2008.03.019; Nofel TA, 2014, APPL MATH, V5, P852; Qi HT, 2009, APPL MATH MODEL, V33, P4184, DOI 10.1016/j.apm.2009.03.002; Shah RA., 2011, INT J ADV RES COMPUT, V3, P1; Shahid N, 2012, BOUND VALUE PROBL, DOI 10.1186/1687-2770-2012-48; Siddiqui AM, 2008, CHAOS SOLITON FRACT, V35, P140, DOI 10.1016/j.chaos.2006.05.026	36	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0126698	10.1371/journal.pone.0126698	http://dx.doi.org/10.1371/journal.pone.0126698			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147287	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600009
J	Kemmler, J; Bindl, R; McCook, O; Wagner, F; Groger, M; Wagner, K; Scheuerle, A; Radermacher, P; Ignatius, A				Kemmler, Julia; Bindl, Ronny; McCook, Oscar; Wagner, Florian; Groeger, Michael; Wagner, Katja; Scheuerle, Angelika; Radermacher, Peter; Ignatius, Anita			Exposure to 100% Oxygen Abolishes the Impairment of Fracture Healing after Thoracic Trauma	PLOS ONE			English	Article							BLUNT CHEST TRAUMA; MESENCHYMAL STEM-CELLS; INDUCED LUNG INJURY; HYPERBARIC-OXYGEN; SEPTIC SHOCK; OSTEOGENIC DIFFERENTIATION; SYSTEMIC INFLAMMATION; FECAL PERITONITIS; TIBIAL SHAFT; HYPEROXIA	In polytrauma patients a thoracic trauma is one of the most critical injuries and an important trigger of post-traumatic inflammation. About 50% of patients with thoracic trauma are additionally affected by bone fractures. The risk for fracture malunion is considerably increased in such patients, the pathomechanisms being poorly understood. Thoracic trauma causes regional alveolar hypoxia and, subsequently, hypoxemia, which in turn triggers local and systemic inflammation. Therefore, we aimed to unravel the role of oxygen in impaired bone regeneration after thoracic trauma. We hypothesized that short-term breathing of 100% oxygen in the early post-traumatic phase ameliorates inflammation and improves bone regeneration. Mice underwent a femur osteotomy alone or combined with blunt chest trauma 100% oxygen was administered immediately after trauma for two separate 3 hour intervals. Arterial blood gas tensions, microcirculatory perfusion and oxygenation were assessed at 3, 9 and 24 hours after injury. Inflammatory cytokines and markers of oxidative/nitrosative stress were measured in plasma, lung and fracture hematoma. Bone healing was assessed on day 7, 14 and 21. Thoracic trauma induced pulmonary and systemic inflammation and impaired bone healing. Short-term exposure to 100% oxygen in the acute post-traumatic phase significantly attenuated systemic and local inflammatory responses and improved fracture healing without provoking toxic side effects, suggesting that hyperoxia could induce anti-inflammatory and pro-regenerative effects after severe injury. These results suggest that breathing of 100% oxygen in the acute post-traumatic phase might reduce the risk of poorly healing fractures in severely injured patients.	[Kemmler, Julia; Bindl, Ronny; Ignatius, Anita] Univ Ulm, Inst Orthopaed Res & Biomech, Ctr Musculoskeletal Res, D-89069 Ulm, Germany; [McCook, Oscar; Wagner, Florian; Groeger, Michael; Wagner, Katja; Radermacher, Peter] Univ Ulm, Med Ctr, Inst Pathophysiol Anaesthesiol & Proc Engn, D-89069 Ulm, Germany; [Scheuerle, Angelika] Univ Ulm, Dept Pathol, Med Ctr, D-89069 Ulm, Germany	Ulm University; Ulm University; Ulm University	Ignatius, A (corresponding author), Univ Ulm, Inst Orthopaed Res & Biomech, Ctr Musculoskeletal Res, D-89069 Ulm, Germany.	anita.ignatius@uni-ulm.de	Ignatius, Anita/M-6012-2013; McCook, Oscar/AAF-1647-2020	Ignatius, Anita/0000-0002-4782-1979; McCook, Oscar/0000-0001-7879-7695	German Research Foundation (DFG) [KFO200, IG18/13-1, RA396/11-1]; Collaborative Research Center [CRC 1149]	German Research Foundation (DFG)(German Research Foundation (DFG)); Collaborative Research Center	This project was funded by the German Research Foundation (DFG), in the frameworks of the Clinical Research Unit KFO200 (IG18/13-1, RA396/11-1) and the Collaborative Research Center (CRC 1149).	Albuszies G, 2005, CRIT CARE MED, V33, P2332, DOI 10.1097/01.CCM.0000182817.20977.E9; Alcaraz MJ, 2003, CURR PHARM DESIGN, V9, P2541, DOI 10.2174/1381612033453749; Barth E, 2008, CRIT CARE MED, V36, P495, DOI 10.1097/01.CCM.0B013E318161FC45; Bastian O, 2011, J LEUKOCYTE BIOL, V89, P669, DOI 10.1189/jlb.0810446; Benjamin S, 2013, TISSUE ENG PT A, V19, P748, DOI [10.1089/ten.TEA.2012.0298, 10.1089/ten.tea.2012.0298]; Bennett MH, 2012, COCHRANE DB SYST REV, V12, P1; Bhandari M, 2003, J ORTHOP TRAUMA, V17, P353, DOI 10.1097/00005131-200305000-00006; Bitterman H, 2007, ISR MED ASSOC J, V9, P874; Bitterman H, 2009, CRIT CARE, V13, DOI 10.1186/cc7151; Bouachour G, 1996, J TRAUMA, V41, P333, DOI 10.1097/00005373-199608000-00023; Brahimi-Horn MC, 2007, FEBS LETT, V581, P3582, DOI 10.1016/j.febslet.2007.06.018; Butler J, 2006, EMERG MED J, V23, P571, DOI 10.1136/emj.2006.038539; Butterfield TA, 2006, J ATHL TRAINING, V41, P457; Cakir E, 2011, APMIS, V119, P574, DOI 10.1111/j.1600-0463.2011.02778.x; Calzia E, 2010, CRIT CARE MED, V38, pS559, DOI 10.1097/CCM.0b013e3181f1fe70; Chao J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-54; Chen WJ, 2002, J TRAUMA, V52, P333, DOI 10.1097/00005373-200202000-00020; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Cortes DO, 2015, MICROVASC RES, V98, P23, DOI 10.1016/j.mvr.2014.11.006; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Distler JHW, 2003, Q J NUCL MED, V47, P149; Dyson A, 2012, INTENS CARE MED, V38, P1868, DOI 10.1007/s00134-012-2712-z; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Faller S, 2010, ANESTHESIOLOGY, V113, P104, DOI 10.1097/ALN.0b013e3181de7107; Flierl MA, 2008, SHOCK, V29, P25, DOI 10.1097/shk.0b013e3180556a0b; Fok TCO, 2008, ORAL SURG ORAL MED O, V105, P417, DOI 10.1016/j.tripleo.2007.07.015; Gebhard F, 2000, ARCH SURG-CHICAGO, V135, P291, DOI 10.1001/archsurg.135.3.291; GROGAARD B, 1990, ARCH ORTHOP TRAUM SU, V109, P268, DOI 10.1007/BF00419942; Groger M, 2005, MUTAT RES-FUND MOL M, V572, P167, DOI 10.1016/j.mrfmmm.2005.05.015; Hafner S, 2015, SHOCK, V43, P140, DOI 10.1097/SHK.0000000000000277; Hauser B, 2009, CRIT CARE MED, V37, P2465, DOI 10.1097/CCM.0b013e3181aee8ad; Hecke F, 1997, CRIT CARE MED, V25, P2015, DOI 10.1097/00003246-199712000-00019; Heilmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084232; Hensler T, 2002, J TRAUMA, V52, P962, DOI 10.1097/00005373-200205000-00023; Hou LC, 2009, SHOCK, V32, P451, DOI 10.1097/SHK.0b013e31819c391a; JAMIESON D, 1986, ANNU REV PHYSIOL, V48, P703, DOI 10.1146/annurev.ph.48.030186.003415; Karladani AH, 2001, ARCH ORTHOP TRAUM SU, V121, P325, DOI 10.1007/s004020000252; Knoferl MW, 2003, SHOCK, V19, P519, DOI 10.1097/01.shk.0000070739.34700.f6; Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI 10.1089/ten.TEB.2009.0687; Kolliputi N, 2010, J IMMUNOL, V184, P5819, DOI 10.4049/jimmunol.0902766; Lefering R, 2013, TRAUMAREGISTER ANN R, P29; Leijten J, 2014, P NATL ACAD SCI USA, V111, P13954, DOI 10.1073/pnas.1410977111; Lin SS, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-56; Lu CY, 2013, BONE, V52, P220, DOI 10.1016/j.bone.2012.09.037; Mak S, 2002, AM J PHYSIOL-HEART C, V282, pH2414, DOI 10.1152/ajpheart.00947.2001; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Pape HC, 2010, J ORTHOP TRAUMA, V24, P522, DOI 10.1097/BOT.0b013e3181ed1361; Quinn DA, 2002, J APPL PHYSIOL, V93, P517, DOI 10.1152/japplphysiol.00570.2001; Recknagel S, 2013, J TRAUMA ACUTE CARE, V74, P531, DOI 10.1097/TA.0b013e318278956d; Recknagel S, 2012, J ORTHOP RES, V30, P581, DOI 10.1002/jor.21561; Recknagel S, 2011, J ORTHOP RES, V29, P734, DOI 10.1002/jor.21299; Rontgen V, 2010, J ORTHOP RES, V28, P1456, DOI 10.1002/jor.21148; Seija M, 2012, SHOCK, V38, P403, DOI 10.1097/SHK.0b013e31826660f2; Seitz DH, 2011, J TRAUMA, V70, P189, DOI 10.1097/TA.0b013e3181d7693c; Shang J, 2014, CURR STEM CELL RES T, V9, P141, DOI 10.2174/1574888X09666131230142459; Simkova V, 2008, SHOCK, V30, P578, DOI 10.1097/SHK.0b013e31816a6e0f; Sinclair SE, 2004, CRIT CARE MED, V32, P2496, DOI 10.1097/01.CCM.0000148231.04642.8D; Stensballe J, 2009, ACTA ANAESTH SCAND, V53, P515, DOI 10.1111/j.1399-6576.2008.01801.x; Sugiura H, 2011, NITRIC OXIDE-BIOL CH, V25, P138, DOI 10.1016/j.niox.2011.03.079; Sukhotnik I, 2009, CRIT CARE MED, V37, P1054, DOI 10.1097/CCM.0b013e31819d0f5c; Tamura DY, 2002, SHOCK, V17, P269, DOI 10.1097/00024382-200204000-00005; Waisman D, 2003, AM J PHYSIOL-HEART C, V285, pH643, DOI 10.1152/ajpheart.00900.2002; Waisman D, 2012, SHOCK, V37, P95, DOI 10.1097/SHK.0b013e3182356fc3; Wang J, 2002, J Postgrad Med, V48, P226; Wehrle E, 2014, J ORTHOP RES, V32, P1006, DOI 10.1002/jor.22629; YABLON IG, 1968, J TRAUM, V8, P186, DOI 10.1097/00005373-196803000-00007	68	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131194	10.1371/journal.pone.0131194	http://dx.doi.org/10.1371/journal.pone.0131194			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147725	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600068
J	Khan, A; Prince, M; Brayne, C; Prina, AM				Khan, A.; Prince, M.; Brayne, C.; Prina, A. M.			Lifetime Prevalence and Factors Associated with Head Injury among Older People in Low and Middle Income Countries: A 10/66 Study	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; RISK-FACTORS; FOLLOW-UP; DEMENTIA; POPULATION; ADULTS; EPIDEMIOLOGY; DISABILITY	Introduction Traumatic brain injury (TBI) is a growing public health problem around the world, yet there is little information on the prevalence of head injury in low and middle income countries (LMICs). We utilised data collected by the 10/66 research group to investigate the lifetime prevalence of head injury in defined sites in low and middle income countries, its risk factors and its relationship with disability. Methods We analysed data from one-phase cross-sectional surveys of all residents aged 65 years and older (n = 16430) distributed across twelve sites in eight low and middle income countries (China, Cuba, Dominican Republic, India, Venezuela, Mexico, Peru, and Puerto Rico). Self-reported cases of head injury with loss of consciousness were identified during the interview. A sensitivity analysis including data provided by informants of people with dementia was also used to estimate the impact of this information on the estimates. Prevalence ratios (PR) from Poisson regressions were used to identify associated risk factors. Results The standardised lifetime prevalence of TBI ranged from 0.3% in China to 14.6% in rural Mexico and Venezuela. Being male (PR: 1.6, 95% CI: 1.29-1.82), younger (PR: 0.95, 95% CI: 0.92-0.99), with lower education (PR 0.91, 95% CI: 0.86-0.96), and having fewer assets (PR 0.92, 95% CI: 0.88-0.96), was associated with a higher prevalence of TBI when pooling estimates across sites. Discussion Our analysis revealed that the prevalence of TBI in LMICs is similar to that of developed nations. Considering the growing impact of TBI on health resources in these countries, there is an urgent need for further research.	[Khan, A.; Brayne, C.; Prina, A. M.] Univ Cambridge, Inst Publ Hlth, Cambridge CB2 0SR, England; [Prince, M.; Prina, A. M.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Global Mental Hlth, Hlth Serv & Populat Res Dept, London SE5 8AF, England	University of Cambridge; University of London; King's College London	Prina, AM (corresponding author), Univ Cambridge, Inst Publ Hlth, Forvie Site,Robinson Way, Cambridge CB2 0SR, England.	matthew.prina@kcl.ac.uk	Prina, Matthew/B-4188-2013; Brayne, Carol/AAA-4285-2020; Prince, Martin J/A-9170-2010	Prina, Matthew/0000-0001-6698-3263; Brayne, Carol/0000-0001-5307-663X; Prince, Martin J/0000-0003-1379-7146	Wellcome Trust (UK) [GR066133]; World Health Organization; US Alzheimer's Association [IIRG - 04 - 1286]; Fondo Nacional de Ciencia Y Tecnologia, Consejo de Desarrollo Cientifico Y Humanistico, Universidad Central de Venezuela (Venezuela); NIHR Specialist Biomedical Research Centre for Mental Health at the South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London; Medical Research Council [MR/K021907/1]; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish; MRC [MR/K021907/1] Funding Source: UKRI	Wellcome Trust (UK)(Wellcome Trust); World Health Organization(World Health Organization); US Alzheimer's Association(Alzheimer's Association); Fondo Nacional de Ciencia Y Tecnologia, Consejo de Desarrollo Cientifico Y Humanistico, Universidad Central de Venezuela (Venezuela); NIHR Specialist Biomedical Research Centre for Mental Health at the South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London(General Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The 10/66 Dementia Research Group population based surveys were supported by: the Wellcome Trust (UK) (GR066133); the World Health Organization; the US Alzheimer's Association (IIRG - 04 - 1286); and the Fondo Nacional de Ciencia Y Tecnologia, Consejo de Desarrollo Cientifico Y Humanistico, Universidad Central de Venezuela (Venezuela). RS is funded by the NIHR Specialist Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Matthew Prina is funded by the Medical Research Council (Grant number = MR/K021907/1).	Agrawal Amit, 2012, Int J Crit Illn Inj Sci, V2, P167, DOI 10.4103/2229-5151.100915; AMADUCCI LA, 1986, NEUROLOGY, V36, P922, DOI 10.1212/WNL.36.7.922; BROE GA, 1990, NEUROLOGY, V40, P1698, DOI 10.1212/WNL.40.11.1698; CHANDRA V, 1987, NEUROLOGY, V37, P1295, DOI 10.1212/WNL.37.8.1295; CHANDRA V, 1989, NEUROLOGY, V39, P1576, DOI 10.1212/WNL.39.12.1576; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fox WC, 2013, NEUROL RES, V35, P223, DOI 10.1179/1743132813Y.0000000162; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hsiao M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002621; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; Kalkonde YV, 2012, ALZHEIMERS DEMENT, V8, P204, DOI 10.1016/j.jalz.2011.03.011; Kraus J, 1996, EPIDEMIOLOGY OF BRAI; LI G, 1992, NEUROLOGY, V42, P1481, DOI 10.1212/WNL.42.8.1481; Lu TH, 2012, INJURY PREV, V18, P150, DOI 10.1136/injuryprev-2011-040135; Ma S, 2012, TRAFFIC INJ PREV, V13, P57, DOI 10.1080/15389588.2011.633945; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; MCDOWELL I, 1994, NEUROLOGY, V44, P2073; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; Nordstrom A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f723; Prina AM, 2011, PSYCHOL MED, V41, P2047, DOI 10.1017/S0033291711000444; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Smith K, 2010, AUST NZ J PSYCHIAT, V44, P888, DOI 10.3109/00048674.2010.491816; Sousa RM, 2010, INT J METH PSYCH RES, V19, P1, DOI 10.1002/mpr.299; Sousa RM, 2009, LANCET, V374, P1821, DOI 10.1016/S0140-6736(09)61829-8; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Timmons SD, 2012, J NEUROSURG SCI, V56, P191; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Wagner AK, 2011, HEALTH POLICY, V100, P151, DOI 10.1016/j.healthpol.2010.08.004; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; World Health Organization, 2006, NEUR DIS PUBL HLTH C	43	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132229	10.1371/journal.pone.0132229	http://dx.doi.org/10.1371/journal.pone.0132229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26146992	gold, Green Submitted, Green Published			2022-12-27	WOS:000358157600222
J	Mayer, S; Decaluwe, H; Ruol, M; Manodoro, S; Kramer, M; Till, H; Deprest, J				Mayer, Steffi; Decaluwe, Herbert; Ruol, Michele; Manodoro, Stefano; Kramer, Manuel; Till, Holger; Deprest, Jan			Diaphragm Repair with a Novel Cross-Linked Collagen Biomaterial in a Growing Rabbit Model	PLOS ONE			English	Article							SMALL-INTESTINAL SUBMUCOSA; ABDOMINAL-WALL DEFECTS; HERNIA REPAIR; PATCH REPAIR; TRACHEAL OCCLUSION; ANIMAL-MODEL; MESHES; RECONSTRUCTION; METAANALYSIS; MANAGEMENT	Background Neonates with congenital diaphragmatic hernia and large defects often require patch closure. Acellular collagen matrices (ACM) have been suggested as an alternative to synthetic durable patches as they are remodeled by the host or could also be used for tissue engineering purposes. Materials and Methods 2.0x1.0 cm diaphragmatic defects were created in 6-weeks old New-Zealand white rabbits. We compared reconstruction with a purpose-designed cross-linked ACM (Matricel) to 4-layer non-cross-linked small intestinal submucosa (SIS) and a 1-layer synthetic Dual Mesh (Gore-Tex). Unoperated animals or animals undergoing primary closure (4/0 polyglecaprone) served as age-matched controls. 60 (n = 25) resp. 90 (n = 17) days later, animals underwent chest x-ray and obduction for gross examination of explants, scoring of adhesion and inflammatory response. Also, uniaxial tensiometry was done, comparing explants to contralateral native diaphragmatic tissue. Results Overall weight nearly doubled from 1,554 +/- 242 g at surgery to 2,837 +/- 265 g at obduction (+ 84%). X-rays did show rare elevation of the left diaphragm (SIS = 1, Gore-Tex = 1, unoperated control = 1), but no herniation of abdominal organs. 56% of SIS and 10% of Matricel patches degraded with visceral bulging in four (SIS = 3, Matricel = 1). Adhesion scores were limited: 0.5 (Matricel) to 1 (SIS, Gore-Tex) to the left lung (p = 0.008) and 2.5 (Gore-Tex), 3 (SIS) and 4 (Matricel) to the liver (p<0.0001). Tensiometry revealed a reduced bursting strength but normal compliance for SIS. Compliance was reduced in Matricel and Gore-Tex (p<0.01). Inflammatory response was characterized by a more polymorphonuclear cell (SIS) resp. macrophage (Matricel) type of infiltrate (p<0.05). Fibrosis was similar for all groups, except there was less mature collagen deposited to Gore-Tex implants (p<0.05). Conclusions Matricel induced a macrophage-dominated inflammatory response, more adhesions, had appropriate strength but a lesser compliance compared to native tissue. The herein investigated ACM is not a viable option for CDH repair.	[Mayer, Steffi; Ruol, Michele; Manodoro, Stefano; Deprest, Jan] Katholieke Univ Leuven, Ctr Surg Technol & Organ Syst Cluster, Dept Dev & Regenerat, Fac Med, Leuven, Belgium; [Decaluwe, Herbert] Katholieke Univ Leuven, Dept Thorac Surg, Univ Hosp Gasthuisberg, Leuven, Belgium; [Ruol, Michele] Univ Hosp Padua, Dept Pediat Surg, Padua, Italy; [Manodoro, Stefano] Univ Hosp Monza, Dept Obstet & Gynecol, Monza, Italy; [Kramer, Manuel] Univ Erlangen Nurnberg, Dept Radiol, D-91054 Erlangen, Germany; [Till, Holger] Univ Hosp Leipzig, Dept Pediat Surg, Leipzig, Germany; [Deprest, Jan] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Obstet & Gynecol, Leuven, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Erlangen Nuremberg; Leipzig University; KU Leuven; University Hospital Leuven	Deprest, J (corresponding author), Katholieke Univ Leuven, Ctr Surg Technol & Organ Syst Cluster, Dept Dev & Regenerat, Fac Med, Leuven, Belgium.	jan.deprest@uzleuven.be	Decaluwe, Herbert/A-2436-2009	Decaluwe, Herbert/0000-0002-0877-7717; Manodoro, Stefano/0000-0002-1837-0806; Deprest, Jan/0000-0002-4920-945X	European Commission (EuroSTEC) [LSHC-CT-2006-037409]; Instituut voor Wetenschap en Technologie (I.W.T.); Flanders Research Foundation (FWO Vlaanderen) [1801207N]	European Commission (EuroSTEC)(European CommissionEuropean Commission Joint Research Centre); Instituut voor Wetenschap en Technologie (I.W.T.)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Flanders Research Foundation (FWO Vlaanderen)(FWO)	This work was supported by the European Commission in its 6th Framework Program (EuroSTEC, LSHC-CT-2006-037409) and the Instituut voor Wetenschap en Technologie (I.W.T.). Jan Deprest is a clinical researcher for the Flanders Research Foundation (FWO Vlaanderen; 1801207N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa M, 2013, SURG TODAY, V43, P1298, DOI 10.1007/s00595-012-0414-3; ATKINSON JB, 1992, J PEDIATR SURG, V27, P754, DOI 10.1016/S0022-3468(05)80109-5; BAX NMA, 1984, J PEDIATR SURG, V19, P484, DOI 10.1016/S0022-3468(84)80281-X; Bohm G, 2011, J BIOMATER APPL, V25, P721, DOI 10.1177/0885328210361543; Bozkurt A, 2007, TISSUE ENG, V13, P2971, DOI 10.1089/ten.2007.0116; Claerhout F, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.032; Dalla Vecchia LD, 1999, J PEDIATR SURG, V34, P167, DOI 10.1016/S0022-3468(99)90250-6; De Coppi P, 2012, EUR J PEDIATR SURG, V22, P393, DOI 10.1055/s-0032-1329410; DeKoninck P, 2011, EARLY HUM DEV, V87, P619, DOI 10.1016/j.earlhumdev.2011.08.001; Deprest J, 2006, INT UROGYNECOL J, V17, pS16, DOI 10.1007/s00192-006-0101-2; Deprest J, 2010, J UROLOGY, V183, P2249, DOI 10.1016/j.juro.2010.02.008; Deprest J, 2009, J UROLOGY, V182, P2362, DOI 10.1016/j.juro.2009.07.043; Fauza DO, 2014, SEMIN PEDIATR SURG, V23, P135, DOI 10.1053/j.sempedsurg.2014.04.004; Fauza DO, 2001, J PEDIATR SURG, V36, P146, DOI 10.1053/jpsu.2001.20034; Feola A, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.008; Gasior AC, 2012, PEDIATR SURG INT, V28, P327, DOI 10.1007/s00383-012-3059-9; Gonzalez R, 2011, J LAPAROENDOSC ADV S, V21, P449, DOI 10.1089/lap.2010.0409; Grethel EJ, 2006, J PEDIATR SURG, V41, P29, DOI 10.1016/j.jpedsurg.2005.10.005; Gucciardo L, 2014, J PEDIATR SURG, V49, P1458, DOI 10.1016/j.jpedsurg.2014.01.058; Gupta A, 2006, Hernia, V10, P419, DOI 10.1007/s10029-006-0130-2; Jones KA, 2009, INT UROGYNECOL J, V20, P847, DOI 10.1007/s00192-008-0781-x; Laituri CA, 2010, EUR J PEDIATR SURG, V20, P363, DOI 10.1055/s-0030-1261939; Lally KP, 2007, PEDIATRICS, V120, pE651, DOI 10.1542/peds.2006-3040; LALLY KP, 1992, ANN SURG, V216, P569, DOI 10.1097/00000658-199211000-00008; Lammers G, 2010, BIOMATERIALS, V31, P8299, DOI 10.1016/j.biomaterials.2010.07.055; Lantis JC, 2000, J INVEST SURG, V13, P319; Loff S, 2005, J PEDIATR SURG, V40, P1701, DOI 10.1016/j.jpedsurg.2005.07.007; Mayer S, 2011, PRENATAL DIAG, V31, P1086, DOI 10.1002/pd.2839; Mayer S, 2011, SEMIN PEDIATR SURG, V20, P161, DOI 10.1053/j.sempedsurg.2011.03.006; Montzka K, 2011, BJU INT, V107, P1974, DOI 10.1111/j.1464-410X.2010.09680.x; MOVAT HZ, 1955, ARCH PATHOL, V60, P289; Ozog Y, 2011, INT UROGYNECOL J, V22, P1099, DOI 10.1007/s00192-011-1440-1; Ozog Y, 2009, INT UROGYNECOL J, V20, P435, DOI 10.1007/s00192-008-0793-6; Peeters E, 2013, J SURG RES, V180, P274, DOI 10.1016/j.jss.2013.01.025; Raghavan D, 2005, J BIOMED MATER RES A, V73A, P90, DOI 10.1002/jbm.a.30268; Romao RLP, 2012, J PEDIATR SURG, V47, P1496, DOI 10.1016/j.jpedsurg.2012.01.009; Sandoval JA, 2006, J PEDIATR SURG, V41, P518, DOI 10.1016/j.jpedsurg.2005.11.068; Sinha CK, 2009, J PEDIATR SURG, V44, P312, DOI 10.1016/j.jpedsurg.2008.10.078; Slack M, 2012, INT UROGYNECOL J, V23, pS15, DOI 10.1007/s00192-012-1678-2; St Peter SD, 2007, J SURG RES, V140, P234, DOI 10.1016/j.jss.2007.03.018; Steinau G, 2010, BMC SURG, V10, DOI 10.1186/1471-2482-10-5; Tsai J, 2012, J PEDIATR SURG, V47, P637, DOI 10.1016/j.jpedsurg.2011.11.054; Tsao K, 2011, FETAL DIAGN THER, V29, P46, DOI 10.1159/000320244; TSUKADA T, 1986, ARTERIOSCLEROSIS, V6, P601, DOI 10.1161/01.ATV.6.6.601; Turner CG, 2011, J PEDIATR SURG, V46, P57, DOI 10.1016/j.jpedsurg.2010.09.063; Verbelen T, 2013, EUR J CARDIO-THORAC, V44, P263, DOI 10.1093/ejcts/ezt001; Zheng F, 2004, AM J OBSTET GYNECOL, V191, P1961, DOI 10.1016/j.ajog.2004.01.091; ZUHLKE HV, 1990, LANGENBECK ARCH CHIR, P1009	48	14	14	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132021	10.1371/journal.pone.0132021	http://dx.doi.org/10.1371/journal.pone.0132021			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147985	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600181
J	Pratumvinit, B; Wongkrajang, P; Wataganara, T; Hanyongyuth, S; Nimmannit, A; Chatsiricharoenkul, S; Manonukul, K; Reesukumal, K				Pratumvinit, Busadee; Wongkrajang, Preechaya; Wataganara, Tuangsit; Hanyongyuth, Sithikan; Nimmannit, Akarin; Chatsiricharoenkul, Somruedee; Manonukul, Kotchamol; Reesukumal, Kanit			Maternal Vitamin D Status and Its Related Factors in Pregnant Women in Bangkok, Thailand	PLOS ONE			English	Article							25-HYDROXYVITAMIN D LEVELS; D DEFICIENCY; D LEVEL; SEASONAL-VARIATION; D SUPPLEMENTATION; D INSUFFICIENCY; EARLY-CHILDHOOD; AIR-POLLUTION; PRETERM BIRTH; RISK	Background There are few data focusing on the prevalence of vitamin D deficiency in tropical countries. Objectives We determined the vitamin D status in pregnant women and examined the factors associated with vitamin D deficiency. Design and Methods A cross-sectional study of 147 pregnant Thai women aged 18-45 years at Siriraj Hospital (a university hospital in Bangkok, Thailand) was undertaken. Clinical data and plasma levels of 25-hydroxyvitamin D [25(OH) D], intact parathyroid hormone (iPTH), calcium, albumin, phosphate and magnesium were obtained in pregnant women at delivery. Results The prevalence of hypovitaminosis D [defined as 25(OH) D < 75 nmol/L] in pregnant women at delivery was 75.5%(95% confidence interval (CI), 67.7-82.2%). Of these, vitamin D insufficiency [defined as 25(OH) D 50-74.9 nmol/L] was found in 41.5%(95% CI, 33.4-49.9%) and vitamin D deficiency [25(OH) D < 50 nmol/L] was found in 34.0% (95% CI, 26.4-42.3%) of women. The mean 25(OH) D concentration was 61.6 +/- 19.3 nmol/L. The correlation between 25(OH) D and iPTH was weak (r = -0.29, P<0.01). Factors associated with vitamin D deficiency by multiple logistic regression were: pre-pregnancy body mass index (BMI in kg/m(2), odds ratio (OR), 0.88, 95% CI 0.80-0.97, P = 0.01) and season of blood collection (winter vs. rainy, OR, 2.62, 95% CI 1.18-5.85, P = 0.02). Conclusions Vitamin D deficiency is common among pregnant Thai women. The prevalence of vitamin D deficiency increased in women who had a lower pre-pregnancy BMI and whose blood was collected in the winter. Vitamin D supplementation may need to be implemented as routine antenatal care.	[Pratumvinit, Busadee; Wongkrajang, Preechaya; Hanyongyuth, Sithikan; Manonukul, Kotchamol; Reesukumal, Kanit] Mahidol Univ, Siriraj Hosp, Dept Clin Pathol, Fac Med, Bangkok 10700, Thailand; [Wataganara, Tuangsit] Mahidol Univ, Div Maternal Fetal Med, Dept Obstet & Gynecol, Fac Med,Siriraj Hosp, Bangkok 10700, Thailand; [Nimmannit, Akarin] Mahidol Univ, Siriraj Hosp, Fac Med, Off Res & Dev, Bangkok 10700, Thailand; [Chatsiricharoenkul, Somruedee] Mahidol Univ, Dept Pharmacol, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University	Reesukumal, K (corresponding author), Mahidol Univ, Siriraj Hosp, Dept Clin Pathol, Fac Med, Bangkok 10700, Thailand.	kanit.ree@mahidol.ac.th	Wataganara, Tuangsit/H-9956-2019	Wataganara, Tuangsit/0000-0001-7172-053X; Pratumvinit, Busadee/0000-0002-5220-0552	Siriraj Research Development Fund [R015432041]; Faculty of Medicine, Siriraj Hospital, Mahidol University	Siriraj Research Development Fund; Faculty of Medicine, Siriraj Hospital, Mahidol University	This study was supported by the Siriraj Research Development Fund (R015432041). BP, PW, TW, SC, AN, and KR each received Chalermprakiart grants from the Faculty of Medicine, Siriraj Hospital, Mahidol University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi P, 2014, MATERN CHILD NUTR, V10, P206, DOI 10.1111/mcn.12058; Achkar M, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.009; Agarwal KS, 2002, ARCH DIS CHILD, V87, P111, DOI 10.1136/adc.87.2.111; Aghajafari F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1169; Al Emadi Samar, 2013, Qatar Med J, V2013, P32, DOI 10.5339/qmj.2013.7; [Anonymous], 2012, PEDIATRICS, DOI [DOI 10.1542/peds.2011-3289, 10.1542/peds.2011-3289]; Aronsson CA, 2013, PUBLIC HEALTH NUTR, V16, P1390, DOI 10.1017/S1368980013000293; Bartoszewicz Z, 2013, GINEKOL POL, V84, P363; Bhattacharya S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-168; Bodnar LM, 2007, J NUTR, V137, P2437, DOI 10.1093/jn/137.11.2437; Bodnar LM, 2015, OBSTET GYNECOL, V125, P439, DOI 10.1097/AOG.0000000000000621; Bodnar LM, 2014, EPIDEMIOLOGY, V25, P207, DOI 10.1097/EDE.0000000000000039; Bodnar LM, 2014, AM J EPIDEMIOL, V179, P168, DOI 10.1093/aje/kwt237; Bolland MJ, 2007, AM J CLIN NUTR, V86, P959, DOI 10.1093/ajcn/86.4.959; Bowyer L, 2009, CLIN ENDOCRINOL, V70, P372, DOI 10.1111/j.1365-2265.2008.03316.x; Camargo CA, 2011, PEDIATRICS, V127, pE180, DOI 10.1542/peds.2010-0442; Chailurkit LO, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-853; Chaipraditkul N., 2013, ETHICS SCI ENV POLIT, V13, P27, DOI DOI 10.3354/ESEP00134; Charatcharoenwitthaya N, 2013, CLIN ENDOCRINOL, V78, P126, DOI 10.1111/j.1365-2265.2012.04470.x; Cho GJ, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.015; Dovnik A, 2014, EUR J OBSTET GYN R B, V181, P6, DOI 10.1016/j.ejogrb.2014.07.019; Dror DK, 2010, NUTR REV, V68, P465, DOI 10.1111/j.1753-4887.2010.00306.x; El Rifai NM, 2014, J MATERN-FETAL NEO M, V27, P1064, DOI 10.3109/14767058.2013.849240; Farrant HJW, 2009, EUR J CLIN NUTR, V63, P646, DOI 10.1038/ejcn.2008.14; Gernand AD, 2014, OBSTET GYNECOL, V123, P40, DOI 10.1097/AOG.0000000000000049; Gernand AD, 2013, J CLIN ENDOCR METAB, V98, P398, DOI 10.1210/jc.2012-3275; Ginde AA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.036; Grant WB, 2008, SOLAR RAD HUMAN HLTH, P167; Gur EB, 2014, J TURK-GER GYNECOL A, V15, P149, DOI 10.5152/jtgga.2014.13048; Gur EB, 2014, EUR J OBSTET GYN R B, V179, P110, DOI 10.1016/j.ejogrb.2014.05.017; Hanieh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099005; Hanna Bassam, 2009, Oman Med J, V24, P188, DOI 10.5001/omj.2009.37; Harvey NC, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18450; Heslehurst N, 2008, OBES REV, V9, P635, DOI 10.1111/j.1467-789X.2008.00511.x; Holick MF, 1995, AM J CLIN NUTR S, V61, p638S, DOI DOI 10.1093/ajcn/61.3.638S; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hosseinpanah F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-519; Jani Rati, 2014, Biomed Res Int, V2014, P892162, DOI 10.1155/2014/892162; Janjai S, 2010, INT J CLIMATOL, V30, P1893, DOI 10.1002/joc.2006; Karlsson T, 2015, CLIN NUTR, V34, P892, DOI 10.1016/j.clnu.2014.09.012; Kovacs CS, 2011, ENDOCRIN METAB CLIN, V40, P795, DOI 10.1016/j.ecl.2011.08.002; Lechtermann C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105558; Lehotay DC, 2013, CLIN BIOCHEM, V46, P1489, DOI 10.1016/j.clinbiochem.2013.05.051; Liu XM, 2011, ARCH GYNECOL OBSTET, V283, P65, DOI 10.1007/s00404-009-1288-5; Lund CC., SURG GYNECOL OBSTET, V79, P352; Luque-Fernandez MA, 2014, PAEDIATR PERINAT EP, V28, P166, DOI 10.1111/ppe.12103; Luxwolda MF, 2013, EUR J NUTR, V52, P1115, DOI 10.1007/s00394-012-0421-6; Magnus MC, 2013, PAEDIATR PERINAT EP, V27, P532, DOI 10.1111/ppe.12080; Manicourt DH, 2008, J CLIN ENDOCR METAB, V93, P3893, DOI 10.1210/jc.2007-2663; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; Mirzaei F, 2011, ANN NEUROL, V70, P30, DOI 10.1002/ana.22456; Mohamed HJJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100705; Molina PE, 2013, ENDOCRINE PHYSL; Napartivaumnuay Navaporn, 2013, Journal of the Medical Association of Thailand, V96, pS69; Nimitphong H, 2013, DERM-ENDOCRINOL, V5, DOI 10.4161/derm.24054; Nimitphong H, 2009, ENDOCRINE, V36, P205, DOI 10.1007/s12020-009-9216-9; Palacios C, 2014, J STEROID BIOCHEM, V144, P138, DOI 10.1016/j.jsbmb.2013.11.003; Robinson M, 2014, ARCH WOMEN MENT HLTH, V17, P213, DOI 10.1007/s00737-014-0422-y; Rojroongwasinkul N, 2013, BRIT J NUTR, V110, pS36, DOI 10.1017/S0007114513002110; Sachan A, 2005, AM J CLIN NUTR, V81, P1060; Seamans KM, 2009, AM J CLIN NUTR, V89, p1997S, DOI 10.3945/ajcn.2009.27230D; Shin Youn Ho, 2013, Korean J Pediatr, V56, P439, DOI 10.3345/kjp.2013.56.10.439; Song SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085081; Stelmach I, 2015, RESP MED, V109, P38, DOI 10.1016/j.rmed.2014.10.016; Tomedi LE, 2013, DIABETIC MED, V30, P1033, DOI 10.1111/dme.12229; van den Berg G, 2013, EUR J NUTR, V52, P273, DOI 10.1007/s00394-012-0327-3; Vandevijvere S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043868; Voorhees A. Scotr, 2008, Journal of Environmental Assessment Policy and Management, V10, P265, DOI 10.1142/S1464333208003093; Vu TTH, 2012, MATERN CHILD NUTR, V8, P533, DOI 10.1111/j.1740-8709.2011.00327.x; Wagner CL, 2015, J STEROID BIOCHEM, V148, P256, DOI 10.1016/j.jsbmb.2014.11.013; Watcharavitoon P, 2013, AEROSOL AIR QUAL RES, V13, P1741, DOI 10.4209/aaqr.2012.11.0305; Wei SQ, 2012, BJOG-INT J OBSTET GY, V119, P832, DOI 10.1111/j.1471-0528.2012.03307.x; Wei SQ, 2014, CURR OPIN OBSTET GYN, V26, P438, DOI 10.1097/GCO.0000000000000117; Wei SQ, 2013, J MATERN-FETAL NEO M, V26, P889, DOI 10.3109/14767058.2013.765849; Weinert LS, 2015, MATERN CHILD HLTH J, V19, P94, DOI 10.1007/s10995-014-1499-7; Willix C, 2015, AUST FAM PHYSICIAN, V44, P141; Xiao JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117748; Zhou J, 2014, EUR J CLIN NUTR, V68, P925, DOI 10.1038/ejcn.2014.99; Zipitis CS, 2008, ARCH DIS CHILD, V93, P512, DOI 10.1136/adc.2007.128579	81	26	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131126	10.1371/journal.pone.0131126	http://dx.doi.org/10.1371/journal.pone.0131126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147381	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600064
J	Rathi, PC; Jaeger, KE; Gohlke, H				Rathi, Prakash Chandra; Jaeger, Karl-Erich; Gohlke, Holger			Structural Rigidity and Protein Thermostability in Variants of Lipase A from Bacillus subtilis	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; CONFORMATIONAL FLEXIBILITY; THERMOPHILIC PROTEINS; THERMAL-STABILITY; CRYSTAL-STRUCTURE; PEBBLE GAME; B1 DOMAIN; ION-PAIRS; NETWORK; TEMPERATURE	Understanding the origin of thermostability is of fundamental importance in protein biochemistry. Opposing views on increased or decreased structural rigidity of the folded state have been put forward in this context. They have been related to differences in the temporal resolution of experiments and computations that probe atomic mobility. Here, we find a significant (p = 0.004) and fair (R-2 = 0.46) correlation between the structural rigidity of a well-characterized set of 16 mutants of lipase A from Bacillus subtilis (BsLipA) and their thermodynamic thermostability. We apply the rigidity theory-based Constraint Network Analysis (CNA) approach, analyzing directly and in a time-independent manner the statics of the BsLipA mutants. We carefully validate the CNA results on macroscopic and microscopic experimental observables and probe for their sensitivity with respect to input structures. Furthermore, we introduce a robust, local stability measure for predicting thermodynamic thermostability. Our results complement work that showed for pairs of homologous proteins that raising the structural stability is the most common way to obtain a higher thermostability. Furthermore, they demonstrate that related series of mutants with only a small number of mutations can be successfully analyzed by CNA, which suggests that CNA can be applied prospectively in rational protein design aimed at higher thermodynamic thermostability.	[Rathi, Prakash Chandra; Gohlke, Holger] Univ Dusseldorf, Inst Pharmaceut & Med Chem, Dusseldorf, Germany; [Jaeger, Karl-Erich] Univ Dusseldorf, Inst Mol Enzyme Technol, Dusseldorf, Germany; [Jaeger, Karl-Erich] Res Ctr Julich, Inst Bio & Geosci IBG Biotechnol 1, Julich, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich	Gohlke, H (corresponding author), Univ Dusseldorf, Inst Pharmaceut & Med Chem, Dusseldorf, Germany.	gohlke@uni-duesseldorf.de	jaeger, karl/ABB-1955-2020	Rathi, Prakash Chandra/0000-0002-2377-1479	Ministry of Innovation, Science, and Research of North Rhine-Westphalia; Heinrich-Heine-University Dusseldorf (HHU) within the Graduate Cluster Industrial Biotechnology [CLIB2021]	Ministry of Innovation, Science, and Research of North Rhine-Westphalia; Heinrich-Heine-University Dusseldorf (HHU) within the Graduate Cluster Industrial Biotechnology	The study was supported by the Ministry of Innovation, Science, and Research of North Rhine-Westphalia and Heinrich-Heine-University Dusseldorf (HHU) by a scholarship to PCR within the CLIB2021 Graduate Cluster Industrial Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham T, 2005, BIOCATAL BIOTRANSFOR, V23, P217, DOI 10.1080/10242420500193013; Acharya P, 2004, J MOL BIOL, V341, P1271, DOI 10.1016/j.jmb.2004.06.059; Ahmad S, 2008, J MOL BIOL, V381, P324, DOI 10.1016/j.jmb.2008.05.063; Ahmad S, 2009, PROTEIN SCI, V18, P1183, DOI 10.1002/pro.126; Augustyniak W, 2012, PROTEIN SCI, V21, P487, DOI 10.1002/pro.2031; Basu S, 2013, J CHEM INF MODEL, V53, P423, DOI 10.1021/ci300474h; Beermann B, 2007, BIOCHEMISTRY-US, V46, P4241, DOI 10.1021/bi0622423; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CASE DA, 1994, CURR OPIN STRUC BIOL, V4, P285, DOI 10.1016/S0959-440X(94)90321-2; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dahiyat BI, 1997, PROTEIN SCI, V6, P1333, DOI 10.1002/pro.5560060622; Danciulescu C, 2007, BIOCHEMISTRY-US, V46, P8537, DOI 10.1021/bi7004398; Demirjian DC, 2001, CURR OPIN CHEM BIOL, V5, P144, DOI 10.1016/S1367-5931(00)00183-6; Droge MJ, 2006, CHEMBIOCHEM, V7, P149, DOI 10.1002/cbic.200500308; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Fitter J, 2000, BIOPHYS J, V79, P1629, DOI 10.1016/S0006-3495(00)76413-7; Folch B, 2008, J CHEM INF MODEL, V48, P119, DOI 10.1021/ci700237g; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Friendly M, 2002, AM STAT, V56, P316, DOI 10.1198/000313002533; Friendly M, 2013, STAT SCI, V28, P1, DOI 10.1214/12-STS402; Fulle S, 2008, BIOPHYS J, V94, P4202, DOI 10.1529/biophysj.107.113415; Gohlke H, 2004, PROTEINS, V56, P322, DOI 10.1002/prot.20116; Graf J, 2007, J AM CHEM SOC, V129, P1179, DOI 10.1021/ja0660406; Gromiha MM, 2013, PROTEINS, V81, P715, DOI 10.1002/prot.24232; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hernandez G, 2001, BIOCHEMISTRY-US, V40, P14384, DOI 10.1021/bi0112560; Hernandez G, 2000, P NATL ACAD SCI USA, V97, P3166, DOI 10.1073/pnas.040569697; Hespenheide BM, 2004, J PHYS-CONDENS MAT, V16, pS5055, DOI 10.1088/0953-8984/16/44/003; Hespenheide BM, 2002, J MOL GRAPH MODEL, V21, P195, DOI 10.1016/S1093-3263(02)00146-8; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hung HC, 2001, BIOPHYS J, V81, P3456, DOI 10.1016/S0006-3495(01)75977-2; Ishima R, 2000, NAT STRUCT BIOL, V7, P740, DOI 10.1038/78963; JACOBS DJ, 1995, PHYS REV LETT, V75, P4051, DOI 10.1103/PhysRevLett.75.4051; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; Jacobs DJ, 1997, J COMPUT PHYS, V137, P346, DOI 10.1006/jcph.1997.5809; JAEGER KE, 1994, FEMS MICROBIOL REV, V15, P29, DOI 10.1016/0168-6445(94)90025-6; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; Jaenicke R, 2000, P NATL ACAD SCI USA, V97, P2962, DOI 10.1073/pnas.97.7.2962; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kalimeri M, 2013, J PHYS CHEM B, V117, P13775, DOI 10.1021/jp407078z; Kamal MZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035188; Kamal MZ, 2011, J MOL BIOL, V413, P726, DOI 10.1016/j.jmb.2011.09.002; Kamal MZ, 2010, BBA-PROTEINS PROTEOM, V1804, P1850, DOI 10.1016/j.bbapap.2010.06.014; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kawasaki K, 2002, ACTA CRYSTALLOGR D, V58, P1168, DOI 10.1107/S090744490200714X; Kayatekin C, 2008, J MOL BIOL, V384, P540, DOI 10.1016/j.jmb.2008.09.045; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kruger DM, 2013, NUCLEIC ACIDS RES, V41, pW340, DOI 10.1093/nar/gkt292; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Mamonova T, 2005, PHYS BIOL, V2, pS137, DOI 10.1088/1478-3975/2/4/S08; Marcos E, 2012, J CHEM THEORY COMPUT, V8, P1129, DOI 10.1021/ct200877z; O'Fagain C, 2011, METHODS MOL BIOL, V681, P103, DOI 10.1007/978-1-60761-913-0_7; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Oyeyemi OA, 2011, BIOCHEMISTRY-US, V50, P8251, DOI 10.1021/bi200640s; Pfleger C, 2013, STRUCTURE, V21, P1725, DOI 10.1016/j.str.2013.07.012; Pfleger C, 2013, J CHEM INF MODEL, V53, P1007, DOI 10.1021/ci400044m; Pfleger C, 2013, J COMPUT CHEM, V34, P220, DOI 10.1002/jcc.23122; Polizzi KM, 2007, CURR OPIN CHEM BIOL, V11, P220, DOI 10.1016/j.cbpa.2007.01.685; PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191; Querol E, 1996, PROTEIN ENG, V9, P265, DOI 10.1093/protein/9.3.265; Rader AJ, 2012, J BIOMOL STRUCT DYN, V30, P628, DOI 10.1080/07391102.2012.689696; Rader AJ, 2002, P NATL ACAD SCI USA, V99, P3540, DOI 10.1073/pnas.062492699; Radestock S, 2008, ENG LIFE SCI, V8, P507, DOI 10.1002/elsc.200800043; Radestock S, 2011, PROTEINS, V79, P1089, DOI 10.1002/prot.22946; Rajakumara E, 2008, BBA-PROTEINS PROTEOM, V1784, P302, DOI 10.1016/j.bbapap.2007.10.012; Rathi PC, 2011, MODELING OF MOLECULAR PROPERTIES, P281; Rathi PC, 2012, J BIOTECHNOL, V159, P135, DOI 10.1016/j.jbiotec.2012.01.027; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; Rees DC, 2001, PROTEIN SCI, V10, P1187, DOI 10.1110/ps.180101; Reetz MT, 2006, ANGEW CHEM INT EDIT, V45, P7745, DOI 10.1002/anie.200602795; Reynolds A.P., 2006, J MATH MODEL ALGORIT, V5, P475, DOI [DOI 10.1007/S10852-005-9022-1, 10.1007/s10852-005-9022-1]; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; RUSSELL RJM, 1994, STRUCTURE, V2, P1157, DOI 10.1016/S0969-2126(94)00118-9; Sapra KT, 2008, J MOL BIOL, V376, P1076, DOI 10.1016/j.jmb.2007.12.027; Seewald MJ, 2000, PROTEIN SCI, V9, P1177, DOI 10.1110/ps.9.6.1177; Stone MJ, 2001, J AM CHEM SOC, V123, P185, DOI 10.1021/ja003094l; Thorpe MF, 2000, J NON-CRYST SOLIDS, V266, P859, DOI 10.1016/S0022-3093(99)00856-X; van den Burg B, 2003, CURR OPIN MICROBIOL, V6, P213, DOI 10.1016/S1369-5274(03)00060-2; van Pouderoyen G, 2001, J MOL BIOL, V309, P215, DOI 10.1006/jmbi.2001.4659; VIHINEN M, 1987, PROTEIN ENG, V1, P477, DOI 10.1093/protein/1.6.477; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Whiteley W, 2005, PHYS BIOL, V2, pS116, DOI 10.1088/1478-3975/2/4/S06; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Yilmaz LS, 2000, J CHEM PHYS, V113, P4454, DOI 10.1063/1.1288512; ZHANG XJ, 1995, J MOL BIOL, V250, P527, DOI 10.1006/jmbi.1995.0396	91	49	52	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130289	10.1371/journal.pone.0130289	http://dx.doi.org/10.1371/journal.pone.0130289			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147762	Green Submitted, gold, Green Published			2022-12-27	WOS:000358157600033
J	ZeRuth, GT; Williams, JG; Cole, YC; Jetten, AM				ZeRuth, Gary T.; Williams, Jason G.; Cole, Yasemin C.; Jetten, Anton M.			HECT E3 Ubiquitin Ligase Itch Functions as a Novel Negative Regulator of Gli-Similar 3 (Glis3) Transcriptional Activity	PLOS ONE			English	Article							NEONATAL DIABETES-MELLITUS; PROLINE-RICH LIGANDS; BETA-CELL FUNCTION; ZINC-FINGER; WW-DOMAINS; CONGENITAL HYPOTHYROIDISM; KIDNEY-DISEASE; 26S PROTEASOME; NEDD4 FAMILY; PROTEIN	The transcription factor Gli-similar 3 (Glis3) plays a critical role in the generation of pancreatic B cells and the regulation insulin gene transcription and has been implicated in the development of several pathologies, including type 1 and 2 diabetes and polycystic kidney disease. However, little is known about the proteins and posttranslational modifications that regulate or mediate Glis3 transcriptional activity. In this study, we identify by mass-spectrometry and yeast 2-hybrid analyses several proteins that interact with the N-terminal region of Glis3. These include the WW-domain-containing HECT E3 ubiquitin ligases, Itch, Smurf2, and Nedd4. The interaction between Glis3 and the HECT E3 ubiquitin ligases was verified by co-immunoprecipitation assays and mutation analysis. All three proteins interact through their WW-domains with a PPxY motif located in the Glis3 N-terminus. However, only Itch significantly contributed to Glis3 polyubiquitination and reduced Glis3 stability by enhancing its proteasomal degradation. Itch-mediated degradation of Glis3 required the PPxY motif-dependent interaction between Glis3 and the WW-domains of Itch as well as the presence of the Glis3 zinc finger domains. Transcription analyses demonstrated that Itch dramatically inhibited Glis3-mediated transactivation and endogenous Ins2 expression by increasing Glis3 protein turnover. Taken together, our study identifies Itch as a critical negative regulator of Glis3-mediated transcriptional activity. This regulation provides a novel mechanism to modulate Glis3-driven gene expression and suggests that it may play a role in a number of physiological processes controlled by Glis3, such as insulin transcription, as well as in Glis3-associated diseases.	[ZeRuth, Gary T.; Cole, Yasemin C.; Jetten, Anton M.] NIEHS, Cell Biol Sect, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA; [Williams, Jason G.] NIEHS, Mass Spectrometry Grp, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Jetten, AM (corresponding author), NIEHS, Cell Biol Sect, Div Intramural Res, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	jetten@niehs.nih.gov	Jetten, Anton/C-3736-2019; Cole, Yasemin C/H-3875-2018	Jetten, Anton/0000-0003-0954-4445; Cole, Yasemin C/0000-0002-9492-5885	Intramural Research Program of the National Institute of Environmental Health Sciences, the National Institutes of Health [Z01-ES-100485]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES100485, ZICES102488, ZIAES100485] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Environmental Health Sciences, the National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Program of the National Institute of Environmental Health Sciences, the National Institutes of Health [Z01-ES-100485].	An H, 2014, MOL BIOSYST, V10, P1643, DOI 10.1039/c3mb70572b; Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Beak JY, 2008, NUCLEIC ACIDS RES, V36, P1690, DOI 10.1093/nar/gkn009; Beak JY, 2007, J BONE MINER RES; Bedford MT, 1997, EMBO J, V16, P2376, DOI 10.1093/emboj/16.9.2376; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Boesgaard TW, 2010, DIABETOLOGIA, V53, P1647, DOI 10.1007/s00125-010-1753-5; Bugliani M, 2013, MOL CELL ENDOCRINOL, V367, P1, DOI 10.1016/j.mce.2012.12.001; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Choi JH, 2007, J BIOL CHEM, V282, P30763, DOI 10.1074/jbc.M704655200; Di Marcotullio L, 2011, ONCOGENE, V30, P65, DOI 10.1038/onc.2010.394; Dimitri P, 2011, EUR J ENDOCRINOL, V164, P437, DOI 10.1530/EJE-10-0893; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guo SL, 2009, J BIOL CHEM, V284, P759, DOI 10.1074/jbc.M806314200; Hartmann-Petersen R, 2003, TRENDS BIOCHEM SCI, V28, P26, DOI 10.1016/S0968-0004(02)00002-6; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; HOU D, 1994, J BIOL CHEM, V269, P14244; Hu C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015542; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jennings MD, 2007, J BIOL CHEM, V282, P29032, DOI 10.1074/jbc.M703453200; Kang HS, 2009, MOL CELL BIOL, V29, P6366, DOI 10.1128/MCB.01259-09; Kang HS, 2009, MOL CELL BIOL, V29, P2556, DOI 10.1128/MCB.01620-08; Kato Y, 2004, J BIOL CHEM, V279, P31833, DOI 10.1074/jbc.M404719200; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Kim YS, 2012, MOL CELLS, V34, P193, DOI 10.1007/s10059-012-0109-z; Kim YS, 2003, NUCLEIC ACIDS RES, V31, P5513, DOI 10.1093/nar/gkg776; Komuro A, 1999, J BIOL CHEM, V274, P36513, DOI 10.1074/jbc.274.51.36513; Liao B, 2013, J CELL PHYSIOL, V228, P1443, DOI 10.1002/jcp.24297; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Marino A, 2014, DIABETES, V63, P550, DOI 10.2337/db13-0802; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sadowski M, 2012, IUBMB LIFE, V64, P136, DOI 10.1002/iub.589; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Santin I, 2013, DIABETES OBES METAB, V15, P71, DOI 10.1111/dom.12162; Scheffner M, 2014, BBA-MOL CELL RES, V1843, P61, DOI 10.1016/j.bbamcr.2013.03.024; Scialpi F, 2008, BIOCHEM PHARMACOL, V76, P1515, DOI 10.1016/j.bcp.2008.07.028; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Taha D, 2003, AM J MED GENET A, V122A, P269, DOI 10.1002/ajmg.a.20267; Wang CJ, 2012, BIOCHEM J, V444, P279, DOI 10.1042/BJ20111983; Watanabe N, 2009, FEBS LETT, V583, P2108, DOI 10.1016/j.febslet.2009.05.039; Winberg G, 2000, MOL CELL BIOL, V20, P8526, DOI 10.1128/MCB.20.22.8526-8535.2000; Yang Y, 2011, DIABETOLOGIA, V54, P2595, DOI 10.1007/s00125-011-2255-9; Yang YS, 2013, EMBO MOL MED, V5, P92, DOI 10.1002/emmm.201201398; Yang YS, 2009, NUCLEIC ACIDS RES, V37, P2529, DOI 10.1093/nar/gkp122; Yoshizawa T, 2014, CELL METAB, V19, P712, DOI 10.1016/j.cmet.2014.03.006; ZeRuth GT, 2013, MOL ENDOCRINOL, V27, P1692, DOI 10.1210/me.2013-1117; ZeRuth GT, 2011, J BIOL CHEM, V286, P22077, DOI 10.1074/jbc.M111.224964; Zhang HW, 2013, STEM CELLS, V31, P1574, DOI 10.1002/stem.1395; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhou GS, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00226	65	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131303	10.1371/journal.pone.0131303	http://dx.doi.org/10.1371/journal.pone.0131303			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147758	gold, Green Submitted, Green Published			2022-12-27	WOS:000358157600087
J	Skandrani, Z; Daniel, L; Jacquelin, L; Leboucher, G; Bovet, D; Prevot, AC				Skandrani, Zina; Daniel, Lucie; Jacquelin, Lauriane; Leboucher, Gerard; Bovet, Dalila; Prevot, Anne-Caroline			On Public Influence on People's Interactions with Ordinary Biodiversity	PLOS ONE			English	Article							CONSERVATION; MINDFULNESS	Besides direct impacts of urban biodiversity on local ecosystem services, the contact of city dwellers with urban nature in their everyday life could increase their awareness on conservation issues. In this paper, we focused on a particularly common animal urban species, the feral pigeon Columba livia. Through an observational approach, we examined behavioral interactions between city dwellers and this species in the Paris metropolis, France. We found that most people (mean: 81%) do not interact with pigeons. Further, interactions (either positive or negative) are context and age-dependent: children interact more than adults and the elderly, while people in tourist spots interact more than people in urban parks or in railway stations, a result that suggests that people interacting with pigeons are mostly tourists. We discuss these results in terms of public normative pressures on city dwellers' access to and reconnection with urban nature. We call for caution in how urban species are publically portrayed and managed, given the importance of interactions with ordinary biodiversity for the fate of nature conservation.	[Skandrani, Zina; Daniel, Lucie; Jacquelin, Lauriane; Prevot, Anne-Caroline] Univ Paris 04, MNHN, CNRS, UPMC,Ctr Ecol & Sci Conservat CESCO UMR7204, Paris, France; [Leboucher, Gerard; Bovet, Dalila] Univ Paris Ouest Def, LECC, Nanterre, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Skandrani, Z (corresponding author), Univ Paris 04, MNHN, CNRS, UPMC,Ctr Ecol & Sci Conservat CESCO UMR7204, Paris, France.	skandrani@mnhn.fr						ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2010, R LANG ENV STAT COMP; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Blake DE, 2001, ENVIRON BEHAV, V33, P708, DOI 10.1177/00139160121973205; Blechman AD, 2006, FASCINATING SAGA WOR; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Cialdini R.B., 2006, SOC INFLUENCE, V1, p3, DOI [10.1080/15534510500181459, DOI 10.1080/15534510500181459]; Cialdini RB, 2005, PSYCHOL INQ, V16, P158, DOI 10.1207/s15327965pli1604_03; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; Cialdini RB, 1995, ADV SOCIAL PSYCHOL, P256; Clayton S., 2009, CONSERVATION PSYCHOL; Colon PL, 2013, ETHNOLOGIE FRANCAISE, VXLIII, P153; Contassot Y, 2007, BIEN VIVRE AVEC ANIM; Dunn RR, 2006, CONSERV BIOL, V20, P1814, DOI 10.1111/j.1523-1739.2006.00533.x; Evans GW, 1998, J ENVIRON PSYCHOL, V18, P85, DOI 10.1006/jevp.1998.0089; Fuller R. A., 2010, URBAN ECOL, P134, DOI [DOI 10.1017/CBO9780511778483.008, 10.1017/CBO9780511778483.008]; Griskevicius V., 2008, INT J SUSTAIN COMMUN, V3, P5, DOI DOI 10.1007/S13398-014-0173-7.2; Haag-Wackernagel D, 2004, J INFECTION, V48, P307, DOI 10.1016/j.jinf.2003.11.001; Haag-Wackernagel D, 2002, SPECIE ORNITICHE PRO, P25; Hinds J, 2008, J ENVIRON PSYCHOL, V28, P109, DOI 10.1016/j.jenvp.2007.11.001; Jerolmack C, 2008, SOC PROBL, V55, P72, DOI 10.1525/sp.2008.55.1.72; Kang M, 2012, TOURISM MANAGE, V33, P440, DOI 10.1016/j.tourman.2011.05.005; Keenan PatrickJ., 2008, VANDERBILT J ENTERTA, V41, P327; Kellert SR, 2002, CHILDREN AND NATURE, P117; LANGER EJ, 1992, CONSCIOUS COGN, V1, P289, DOI 10.1016/1053-8100(92)90066-J; Miller JR, 2006, BIOL CONSERV, V127, P356, DOI 10.1016/j.biocon.2005.07.021; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Moscovici S, 2000, ECOLOGY SOC, V15, P31; Mugerauer R, 2010, THEORY INTEGRATED UR; Paris OTC (Office du Tourisme et des Congres), 2011, OFF TOUR C 2011 TOUR; Pergams ORW, 2008, P NATL ACAD SCI USA, V105, P2295, DOI 10.1073/pnas.0709893105; Pinheiro J, 2001, MIXED EFFECTS MODELS; Prevot-Julliard AC, 2011, ENVIRON MANAGE, V47, P315, DOI 10.1007/s00267-011-9615-6; Pyle RM, 2003, ORYX, V37, P206, DOI 10.1017/S0030605303000383; PYLE RM, 1977, HORTICULTURE, V55, P65; Schultz PW, 2007, PSYCHOL SCI, V18, P429, DOI 10.1111/j.1467-9280.2007.01917.x; Skandrani Z, 2014, ECOL PROCESS, V3, P1, DOI DOI 10.1186/2192-1709-3-3; Skandrani Z, ENV SCI POLICY; Thompson CW, 2013, J ENVIRON PSYCHOL, V34, P79, DOI 10.1016/j.jenvp.2013.01.003; United- Nations, 2011, WORLD URBANIZATION P	40	6	6	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130215	10.1371/journal.pone.0130215	http://dx.doi.org/10.1371/journal.pone.0130215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26154622	gold, Green Published, Green Submitted			2022-12-27	WOS:000358159700025
J	Crittenden, AN; Zes, DA				Crittenden, Alyssa N.; Zes, David A.			Food Sharing among Hadza Hunter-Gatherer Children	PLOS ONE			English	Article							RECIPROCAL ALTRUISM; KIN SELECTION; EVOLUTION; COOPERATION; EGALITARIANISM; SOCIETIES; TRANSFERS	Human prosociality is one of the defining characteristics of our species, yet the ontogeny of altruistic behavior remains poorly understood. The evolution of widespread food sharing in humans helped shape cooperation, family formation, life history, language, and the development of economies of scale. While the behavioral and ecological correlates of food sharing among adults are widely studied, very little is known about food sharing among children. Here, in the first study to analyze the food sharing patterns of hunter-gatherer children, we show that while sharing may be biased towards kin, reciprocity characterizes the majority of all sharing dyads, both related and unrelated. These data lend support to the recent claim that discrimination among kin might be linked with reciprocal altruism theory. Furthermore, we show that age positively correlates with an increase in sharing, both in frequency and amount, supporting recent suggestions that prosocial behaviors and egalitarianism develop strongly in middle childhood when children acquire the normative rules of their society.	[Crittenden, Alyssa N.] Univ Nevada, Dept Anthropol, Las Vegas, NV 89154 USA; [Zes, David A.] Univ Calif Los Angeles, Dept Ecol Stat, Los Angeles, CA USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of California System; University of California Los Angeles	Crittenden, AN (corresponding author), Univ Nevada, Dept Anthropol, Las Vegas, NV 89154 USA.	alyssa.crittenden@unlv.edu			National Science Foundation grant [0544751]; National Institutes of Health General Medical Sciences grant [8 P20 GM103440-11]; Department of Anthropology at the University of California, San Diego; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103440] Funding Source: NIH RePORTER	National Science Foundation grant(National Science Foundation (NSF)); National Institutes of Health General Medical Sciences grant; Department of Anthropology at the University of California, San Diego; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation grant #0544751 to Frank W. Marlowe, who paid for a portion of the field supplies and air travel of Alyssa N. Crittenden and assisted with research permit approval. Additional funding was received by Alyssa N. Crittenden from the Department of Anthropology at the University of California, San Diego, and National Institutes of Health General Medical Sciences grant #8 P20 GM103440-11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Arave W, 2008, EVOL HUM BEHAV, V29, P305, DOI 10.1016/j.evolhumbehav.2008.03.002; Almas I, 2010, SCIENCE, V328, P1176, DOI 10.1126/science.1187300; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Betzig L, CURR ANTHR, V27, P397; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; Conklin-Brittain Nancy Lou, 2006, P445; Crittenden AN, 2008, HUM NATURE-INT BIOS, V19, P249, DOI 10.1007/s12110-008-9043-3; Crittenden AN, 2013, EVOL HUM BEHAV, V34, P299, DOI 10.1016/j.evolhumbehav.2013.04.004; Crittenden AN, WILD PLANTS IN PRESS; Crittenden AN, SOCIAL LEAR IN PRESS; Crittenden AN, 2014, CUNA HUMANIDAD, P209; ENQUIST M, 1993, ANIM BEHAV, V45, P747, DOI 10.1006/anbe.1993.1089; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Fehr E, 2013, EUR ECON REV, V64, P369, DOI 10.1016/j.euroecorev.2013.09.006; Gintis H, 2001, J THEOR BIOL, V213, P103, DOI 10.1006/jtbi.2001.2406; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Gintis H, 1999, RECASTING EGALITARIA; Gurven M, 2004, BEHAV BRAIN SCI, V27, P543, DOI 10.1017/S0140525X04000123; Hames R, 2007, HUM NATURE-INT BIOS, V18, P1, DOI 10.1007/BF02820843; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hawkes K, 2002, EVOL ANTHROPOL, V11, P58, DOI 10.1002/evan.20005; HAWKES K, 1991, ETHOL SOCIOBIOL, V12, P29, DOI 10.1016/0162-3095(91)90011-E; HAWKES K, 1983, AM ETHNOL, V10, P345, DOI 10.1525/ae.1983.10.2.02a00090; Hewlett BS, 2011, PHILOS T R SOC B, V366, P1168, DOI 10.1098/rstb.2010.0373; Hill KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102806; Hoffman E, 1998, ECON INQ, V36, P335, DOI 10.1111/j.1465-7295.1998.tb01719.x; House BR, 2013, P NATL ACAD SCI USA, V110, P14586, DOI 10.1073/pnas.1221217110; ISAAC GL, 1978, J ANTHROPOL RES, V34, P311; Jaeggi AV, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1615; JELLIFFE DB, 1962, J PEDIATR-US, V60, P907, DOI 10.1016/S0022-3476(62)80176-0; KAPLAN H, 1985, CURR ANTHROPOL, V26, P223, DOI 10.1086/203251; Marlowe F., 2010, HADZA HUNTER GATHERE, DOI DOI 10.1152/physiol.00027.2018; O'Connell JF, 1999, J HUM EVOL, V36, P461, DOI 10.1006/jhev.1998.0285; Peterson D, 2012, LIGHT MILLION FIRES; Sahlins M., 1972, STONE AGE EC; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Winterhalder Bruce, 1996, Evolutionary Anthropology, V5, P46; Woodburn J, 2008, MAN HUNTER, P49	38	36	36	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131996	10.1371/journal.pone.0131996	http://dx.doi.org/10.1371/journal.pone.0131996			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EC	26151637	Green Published, gold, Green Submitted			2022-12-27	WOS:000358158900032
J	Gholami, M; Reimer, C; Erbe, M; Preisinger, R; Weigend, A; Weigend, S; Servin, B; Simianer, H				Gholami, Mahmood; Reimer, Christian; Erbe, Malena; Preisinger, Rudolf; Weigend, Annett; Weigend, Steffen; Servin, Bertrand; Simianer, Henner			Genome Scan for Selection in Structured Layer Chicken Populations Exploiting Linkage Disequilibrium Information	PLOS ONE			English	Article							POSITIVE SELECTION; GENE; ADAPTATION; POLYMORPHISM; ASSOCIATION; SIGNATURES; MODEL; TOOL	An increasing interest is being placed in the detection of genes, or genomic regions, that have been targeted by selection because identifying signatures of selection can lead to a better understanding of genotype-phenotype relationships. A common strategy for the detection of selection signatures is to compare samples from distinct populations and to search for genomic regions with outstanding genetic differentiation. The aim of this study was to detect selective signatures in layer chicken populations using a recently proposed approach, hapFLK, which exploits linkage disequilibrium information while accounting appropriately for the hierarchical structure of populations. We performed the analysis on 70 individuals from three commercial layer breeds (White Leghorn, White Rock and Rhode Island Red), genotyped for approximately 1 million SNPs. We found a total of 41 and 107 regions with outstanding differentiation or similarity using hapFLK and its single SNP counterpart FLK respectively. Annotation of selection signature regions revealed various genes and QTL corresponding to productions traits, for which layer breeds were selected. A number of the detected genes were associated with growth and carcass traits, including IGF-1R, AGRP and STAT5B. We also annotated an interesting gene associated with the dark brown feather color mutational phenotype in chickens (SOX10). We compared FST, FLK and hapFLK and demonstrated that exploiting linkage disequilibrium information and accounting for hierarchical population structure decreased the false detection rate.	[Gholami, Mahmood; Reimer, Christian; Erbe, Malena; Simianer, Henner] Univ Gottingen, Dept Anim Sci, Anim Breeding & Genet Grp, D-37073 Gottingen, Germany; [Preisinger, Rudolf] LOHMANN Tierzucht GMBH, Cuxhaven, Germany; [Weigend, Annett; Weigend, Steffen] FLI, Inst Farm Anim Genet ING, Neustadt, Germany; [Servin, Bertrand] INRA, Lab Genet Physiol & Syst Elevage, Castanet Tolosan, France	University of Gottingen; Friedrich Loeffler Institute; INRAE	Gholami, M (corresponding author), Univ Gottingen, Dept Anim Sci, Anim Breeding & Genet Grp, D-37073 Gottingen, Germany.	mgholam@gwdg.de	Servin, Bertrand/B-2206-2008; Simianer, Henner/A-6574-2015	Servin, Bertrand/0000-0001-5141-0913; Simianer, Henner/0000-0002-7551-3797	German Federal Ministry of Education and Research [0315528C]; German Research Foundation; Gottingen University	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); Gottingen University	This research was funded by the German Federal Ministry of Education and Research within the AgroClustEr "Synbreed - Synergistic plant and animal breeding" (Funding ID: 0315528C). We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University.	Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai YC, 2012, MOL BIOL REP, V39, P7533, DOI 10.1007/s11033-012-1587-y; Bassom F, 2009, MINI ENCYCLOPEDIA OF; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Bonhomme M, 2010, GENETICS, V186, P241, DOI 10.1534/genetics.104.117275; Brown WRA, 2003, NAT REV GENET, V4, P87, DOI 10.1038/nrg998; Browning SR, 2010, GENETICS, V185, P1337, DOI 10.1534/genetics.110.116681; Burt DW, 2005, GENOME RES, V15, P1692, DOI 10.1101/gr.4141805; Clarke BR, 2012, STAT PAP, V53, P1001, DOI 10.1007/s00362-011-0404-3; Crawford R, 1990, POULTRY BREEDING AND; Durinck S, R PACKAGE VERSION 26; Elferink MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032720; Eyras E, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-131; Fariello MI, 2013, GENETICS, V193, P929, DOI 10.1534/genetics.112.147231; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gautron J, 2011, BIOCHEM SOC T, V39, P971, DOI 10.1042/BST0390971; Gholami M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094509; Gunnarsson U, 2011, PIGM CELL MELANOMA R, V24, P268, DOI 10.1111/j.1755-148X.2011.00825.x; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Innan H, 2008, GENETICS, V179, P1713, DOI 10.1534/genetics.108.086835; Jiao S, 2013, MOL CELL BIOCHEM, V373, P107, DOI 10.1007/s11010-012-1479-4; Johansson AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001188; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KAPLAN NL, 1989, GENETICS, V123, P887; Kim S, 2009, MOL IMMUNOL, V47, P476, DOI 10.1016/j.molimm.2009.08.027; Kim Y, 2004, GENETICS, V167, P1513, DOI 10.1534/genetics.103.025387; Lei MM, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-70; LEWONTIN RC, 1973, GENETICS, V74, P175; Ma Y, 2015, HEREDITY, V115, P426, DOI 10.1038/hdy.2015.42; Muir Wi. M, 2003, POULTRY GENETICS BRE; Narum SR, 2011, MOL ECOL RESOUR, V11, P184, DOI 10.1111/j.1755-0998.2011.02987.x; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Nielsen R, 2013, AN INTRODUCTION TO P; Nuzhdin SV, 2013, CURR OPIN GENET DEV, V23, P694, DOI 10.1016/j.gde.2013.10.002; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qanbari S, LIVEST SCI; Qanbari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049525; Qanbari S, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-103; REYNOLDS J, 1983, GENETICS, V105, P767; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Xu PW, 2012, PHYSIOL BEHAV, V105, P276, DOI 10.1016/j.physbeh.2011.06.023; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhao XH, 2012, MOL BIOL REP, V39, P4177, DOI 10.1007/s11033-011-1202-7; Zhou H, 2011, STAT COMPUT, V21, P261, DOI 10.1007/s11222-009-9166-3	53	15	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0130497	10.1371/journal.pone.0130497	http://dx.doi.org/10.1371/journal.pone.0130497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151449	Green Published, gold, Green Submitted			2022-12-27	WOS:000358158900010
J	Lewandowski, D; Ruszkowski, P; Pinska, A; Schroeder, G; Kurczewska, J				Lewandowski, Dawid; Ruszkowski, Piotr; Pinska, Anita; Schroeder, Grzegorz; Kurczewska, Joanna			SBA-15 Mesoporous Silica Modified with Gallic Acid and Evaluation of Its Cytotoxic Activity	PLOS ONE			English	Article							SURFACE FUNCTIONALIZATION; ANTICANCER; NANOPARTICLES; ADSORPTION; PH; DELIVERY; INSIGHTS; RELEASE; AGENTS	Gallic acid has been covalently conjugated to SBA-15 mesoporous silica surface through different linkers. Cytotoxic activity of the hybrid organic-inorganic systems against HeLa and KB cell lines has been analyzed. Up to 67% of HeLa or KB tumor cells growth inhibition has been achieved at low silica concentration used (10 mu gmL(-1)).	[Lewandowski, Dawid; Schroeder, Grzegorz; Kurczewska, Joanna] Adam Mickiewicz Univ, Fac Chem, PL-60780 Poznan, Poland; [Ruszkowski, Piotr; Pinska, Anita] Poznan Univ Med Sci, Fac Pharm, Poznan, Poland	Adam Mickiewicz University; Poznan University of Medical Sciences	Lewandowski, D (corresponding author), Adam Mickiewicz Univ, Fac Chem, Grunwaldzka 6, PL-60780 Poznan, Poland.	dawid_le@amu.edu.pl	Kurczewska, Joanna/C-6259-2014	Kurczewska, Joanna/0000-0002-9046-3230; Ruszkowski, Piotr/0000-0002-5106-8510; Schroeder, Grzegorz/0000-0002-6626-9542	Polish National Science Center (NCN) [2011/03/B/ST5/01573]	Polish National Science Center (NCN)	This work was supported by the Polish National Science Center (NCN: www.ncn.gov.pl; grant no. 2011/03/B/ST5/01573). GS received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahrami Z, 2014, CHEM ENG RES DES, V92, P1296, DOI 10.1016/j.cherd.2013.11.007; Bhattarai SR, 2010, PHARM RES-DORDR, V27, P2556, DOI 10.1007/s11095-010-0245-0; Bian XL, 2013, BIOORGAN MED CHEM, V21, P5442, DOI 10.1016/j.bmc.2013.06.002; COREY EJ, 1969, J AM CHEM SOC, V91, P5675, DOI 10.1021/ja01048a062; Dauzonne D, 1997, EUR J MED CHEM, V32, P71, DOI 10.1016/S0223-5234(97)84363-2; Diaz I, 2001, APPL CATAL A-GEN, V205, P19, DOI 10.1016/S0926-860X(00)00808-5; Dorniani D, 2014, THESCIENTIFICWORLDJO, V416354, P11; Dorniani D, 2012, INT J NANOMED, V7, P5745, DOI 10.2147/IJN.S35746; Fan JQ, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/45/455102; Fresco P, 2006, MED RES REV, V26, P747, DOI 10.1002/med.20060; Ganesan V, 2004, LANGMUIR, V20, P3632, DOI 10.1021/la0364082; Hiyoshi N, 2005, MICROPOR MESOPOR MAT, V84, P357, DOI 10.1016/j.micromeso.2005.06.010; Johnson BJS, 2001, INORG CHEM, V40, P801, DOI 10.1021/ic991440y; Katiyar A, 2005, J CHROMATOGR A, V1069, P119, DOI 10.1016/j.chroma.2004.10.077; Khan HY, 2012, CURR DRUG TARGETS, V13, P1738; Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022; Locatelli C, 2013, EUR J MED CHEM, V60, P233, DOI 10.1016/j.ejmech.2012.10.056; Ma CM, 2005, EUR J MED CHEM, V40, P582, DOI 10.1016/j.ejmech.2005.01.001; Meng HA, 2010, J AM CHEM SOC, V132, P12690, DOI 10.1021/ja104501a; Mitsuhashi S, 2008, MOLECULES, V13, P2998, DOI 10.3390/molecules13122998; Perez-Quintanilla D, 2006, J MATER CHEM, V16, P1757, DOI 10.1039/b518157g; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Slowing I, 2006, J AM CHEM SOC, V128, P14792, DOI 10.1021/ja0645943; Song SW, 2005, LANGMUIR, V21, P9568, DOI 10.1021/la051167e; Subramanian V, 2014, FOOD CHEM TOXICOL, V66, P44, DOI 10.1016/j.fct.2014.01.017; Szegedi A, 2011, J SOLID STATE CHEM, V184, P1201, DOI 10.1016/j.jssc.2011.03.005; Vinu A, 2004, CHEM MATER, V16, P3056, DOI 10.1021/cm049718u; Wani A, 2012, PHARM RES-DORDR, V29, P2407, DOI 10.1007/s11095-012-0766-9; Xia Y, 2000, BIOORG MED CHEM LETT, V10, P699, DOI 10.1016/S0960-894X(00)00072-X; Ye JJ, 2010, LANGMUIR, V26, P1776, DOI 10.1021/la902497s	30	4	4	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132541	10.1371/journal.pone.0132541	http://dx.doi.org/10.1371/journal.pone.0132541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151908	Green Published, Green Submitted, gold			2022-12-27	WOS:000358158900046
J	Parker, VT				Parker, V. Thomas			Dispersal Mutualism Incorporated into Large-Scale, Infrequent Disturbances	PLOS ONE			English	Article							RANDOMLY VARYING ENVIRONMENT; SEED DISPERSAL; PLANT; FIRE; FOREST; TREE; FRAGMENTATION; REPRODUCTION; EVOLUTION; DYNAMICS	Because of their influence on succession and other community interactions, large-scale, infrequent natural disturbances also should play a major role in mutualistic interactions. Using field data and experiments, I test whether mutualisms have been incorporated into large-scale wildfire by whether the outcomes of a mutualism depend on disturbance. In this study a seed dispersal mutualism is shown to depend on infrequent, large-scale disturbances. A dominant shrubland plant (Arctostaphylos species) produces seeds that make up a persistent soil seed bank and requires fire to germinate. In post-fire stands, I show that seedlings emerging from rodent caches dominate sites experiencing higher fire intensity. Field experiments show that rodents (Perimyscus califomicus, P. boylii) do cache Arctostaphylos fruit and bury most seed caches to a sufficient depth to survive a killing heat pulse that a fire might drive into the soil. While the rodent dispersal and caching behavior itself has not changed compared to other habitats, the environmental transformation caused by wildfire converts the caching burial of seed from a dispersal process to a plant fire adaptive trait, and provides the context for stimulating subsequent life history evolution in the plant host.	San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	California State University System; San Francisco State University	Parker, VT (corresponding author), San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA.	parker@sfsu.edu		Parker, V. Thomas/0000-0002-6149-7140	National Science Foundation (USA) [0948627]	National Science Foundation (USA)(National Science Foundation (NSF))	This research was supported by a grant from the National Science Foundation (USA) #0948627. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; BOND WJ, 1994, PHILOS T R SOC B, V344, P83, DOI 10.1098/rstb.1994.0055; Borchert MI, 1995, BRUSHFIRES CALIFORNI, P91; Bronstein JL, 2003, AM NAT, V162, pS24, DOI 10.1086/378645; Bronstein JL, 2009, J ECOL, V97, P1160, DOI 10.1111/j.1365-2745.2009.01566.x; Chamberlain SA, 2014, ECOL LETT, V17, P881, DOI 10.1111/ele.12279; Chamberlain SA, 2009, ECOLOGY, V90, P2384, DOI 10.1890/08-1490.1; Chapman CA, 2003, BIOTROPICA, V35, P382, DOI 10.1111/j.1744-7429.2003.tb00592.x; Christian CE, 2001, NATURE, V413, P635, DOI 10.1038/35098093; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; COHEN D, 1968, J ECOL, V56, P219, DOI 10.2307/2258075; Cordeiro NJ, 2003, P NATL ACAD SCI USA, V100, P14052, DOI 10.1073/pnas.2331023100; CUSHMAN JH, 1989, ECOLOGY, V70, P1040, DOI 10.2307/1941372; Dale VH, 1998, ECOSYSTEMS, V1, P546, DOI 10.1007/s100219900050; Gray MA, 2007, CONSERV BIOL, V21, P133, DOI 10.1111/j.1523-1739.2006.00557.x; HANZAWA FM, 1988, AM NAT, V131, P1, DOI 10.1086/284769; Hirsch BT, 2012, ECOL LETT, V15, P1423, DOI 10.1111/ele.12000; Jordano P, 2000, ECOL MONOGR, V70, P591, DOI 10.1890/0012-9615(2000)070[0591:SDETQC]2.0.CO;2; Keeley J. E., 2012, FIRE MEDITERRANEAN E; Keeley JE, 2005, ECOL APPL, V15, P2109, DOI 10.1890/04-1222; KEELEY JE, 1976, OECOLOGIA, V24, P71, DOI 10.1007/BF00545488; KEELEY JE, 1977, ECOLOGY, V58, P820, DOI 10.2307/1936217; Keeley Jon E., 2006, Madrono, V53, P373, DOI 10.3120/0024-9637(2006)53[373:FSAPAI]2.0.CO;2; KELLY VR, 1990, AM MIDL NAT, V124, P114, DOI 10.2307/2426084; Kirika JM, 2008, CONSERV BIOL, V22, P318, DOI 10.1111/j.1523-1739.2007.00874.x; Leach MK, 1996, SCIENCE, V273, P1555, DOI 10.1126/science.273.5281.1555; Levey DJ, 2005, SCIENCE, V309, P146, DOI 10.1126/science.1111479; LONGLAND WS, 1995, J MAMMAL, V76, P1260, DOI 10.2307/1382621; Lugo AE, 1996, BIOTROPICA, V28, P585, DOI 10.2307/2389099; MORENO JM, 1989, ACTA OECOL-OEC PLANT, V10, P57; Odion DC, 2000, ECOL MONOGR, V70, P149, DOI 10.1890/0012-9615(2000)070[0149:FSHATF]2.0.CO;2; Parker V.T., 1989, ECOLOGY SOIL SEED BA, P231, DOI [10.1016/b978-0-12-440405-2.50016-6, DOI 10.1016/B978-0-12-440405-2.50016-6]; Parker V. T., 2009, FLORA N AM N MEXICO, V8, P406; Pickett S. T. A., 1985, ECOLOGY NATURAL DIST; PICKETT STA, 1987, VEGETATIO, V69, P109, DOI 10.1007/BF00038691; Prinzing A, 2007, OIKOS, V116, P1299, DOI [10.1111/j.2007.0030-1299.15738.x, 10.1111/j.0030-1299.2007.15738.x]; Rodriguez-Cabal MA, 2007, BIOL CONSERV, V139, P195, DOI 10.1016/j.biocon.2007.06.014; Thompson JN, 2013, P NATL ACAD SCI USA, V110, P11487, DOI 10.1073/pnas.1307451110; THOMPSON K, 1993, FUNCT ECOL, V7, P236, DOI 10.2307/2389893; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006; Wall SBV, 2010, PHILOS T R SOC B, V365, P989, DOI 10.1098/rstb.2009.0205; WELLS PV, 1969, EVOLUTION, V23, P264, DOI [10.2307/2406790, 10.1111/j.1558-5646.1969.tb03510.x]; Wootton JT, 1996, SCIENCE, V273, P1558, DOI 10.1126/science.273.5281.1558; Zelikova TJ, 2008, J TROP ECOL, V24, P309, DOI 10.1017/S0266467408004999	45	7	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132625	10.1371/journal.pone.0132625	http://dx.doi.org/10.1371/journal.pone.0132625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151560	gold, Green Submitted, Green Published			2022-12-27	WOS:000358158900051
J	Rais, R; Wozniak, K; Wu, Y; Niwa, M; Stathis, M; Alt, J; Giroux, M; Sawa, A; Rojas, C; Slusher, BS				Rais, Rana; Wozniak, Krystyna; Wu, Ying; Niwa, Minae; Stathis, Marigo; Alt, Jesse; Giroux, Marc; Sawa, Akira; Rojas, Camilo; Slusher, Barbara S.			Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration	PLOS ONE			English	Article							GLUTAMATE-CARBOXYPEPTIDASE-II; NAAG PEPTIDASE INHIBITOR; NASAL DRUG-DELIVERY; N-ACETYLASPARTYLGLUTAMATE; NAALADASE INHIBITION; COGNITIVE IMPAIRMENT; MEMBRANE ANTIGEN; NEUROPATHIC PAIN; GROWTH-FACTOR; SPINAL-CORD	Glutamate carboxypeptidase II (GCP-II) is a brain metallopeptidase that hydrolyzes the abundant neuropeptide N-acetyl-aspartyl-glutamate (NAAG) to NAA and glutamate. Small molecule GCP-II inhibitors increase brain NAAG, which activates mGluR3, decreases glutamate, and provide therapeutic utility in a variety of preclinical models of neurodegenerative diseases wherein excess glutamate is presumed pathogenic. Unfortunately no GCP-II inhibitor has advanced clinically, largely due to their highly polar nature resulting in insufficient oral bioavailability and limited brain penetration. Herein we report a non-invasive route for delivery of GCP-II inhibitors to the brain via intranasal (i.n.) administration. Three structurally distinct classes of GCP-II inhibitors were evaluated including DCMC (urea-based), 2-MPPA (thiol-based) and 2-PMPA (phosphonate-based). While all showed some brain penetration following i.n. administration, 2-PMPA exhibited the highest levels and was chosen for further evaluation. Compared to intraperitoneal (i.p.) administration, equivalent doses of i.n. administered 2-PMPA resulted in similar plasma exposures (AUC(0-t,) (i.n)./AUC(0-t), (i.p.) = 1.0) but dramatically enhanced brain exposures in the olfactory bulb (AUC(0-t, i.n)./AUC(0-t, i.p.) = 67), cortex (AUC(0-t, i.n)./AUC(0-t, i.p.) = 46) and cerebellum (AUC(0-t, i.n)./AUC(0-t, i.p.) = 6.3). Following i.n. administration, the brain tissue to plasma ratio based on AUC(0-t) in the olfactory bulb, cortex, and cerebellum were 1.49, 0.71 and 0.10, respectively, compared to an i.p. brain tissue to plasma ratio of less than 0.02 in all areas. Furthermore, i.n. administration of 2-PMPA resulted in complete inhibition of brain GCP-II enzymatic activity ex-vivo confirming target engagement. Lastly, because the rodent nasal system is not similar to humans, we evaluated i.n. 2-PMPA also in a non-human primate. We report that i.n. 2-PMPA provides selective brain delivery with micromolar concentrations. These studies support intranasal delivery of 2-PMPA to deliver therapeutic concentrations in the brain and may facilitate its clinical development.	[Rais, Rana; Wozniak, Krystyna; Wu, Ying; Stathis, Marigo; Alt, Jesse; Rojas, Camilo; Slusher, Barbara S.] Johns Hopkins Sch Med, Brain Sci Inst, Baltimore, MD 21205 USA; [Rais, Rana; Slusher, Barbara S.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Rojas, Camilo] Johns Hopkins Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD USA; [Sawa, Akira; Slusher, Barbara S.] Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Slusher, Barbara S.] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD USA; [Giroux, Marc] Kurve Technol Inc, Bothell, WA USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Slusher, BS (corresponding author), Johns Hopkins Sch Med, Brain Sci Inst, Baltimore, MD 21205 USA.	bslusher@jhmi.edu	Niwa, Minae/AAV-2639-2021; Niwa, Minae/G-5469-2011	Niwa, Minae/0000-0002-8784-7815; Niwa, Minae/0000-0002-8784-7815	Brain Science Institute; National Institutes of Health [RO1CA161056]; Kurve Technology, Inc.; NATIONAL CANCER INSTITUTE [R01CA161056] Funding Source: NIH RePORTER	Brain Science Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kurve Technology, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by Brain Science Institute and the National Institutes of Health, Grant #RO1CA161056 to B.S. Slusher. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Marc Giroux is employed by Kurve Technology, Inc. Kurve Technology, Inc. provided support in the form of salary for author M.G., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adedoyin MO, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-60; Bacich DJ, 2005, J NEUROCHEM, V95, P314, DOI 10.1111/j.1471-4159.2005.03361.x; Baker H, 2003, HDB OLFACTION GUSTAT; Barinka C, 2012, CURR MED CHEM, V19, P856, DOI 10.2174/092986712799034888; Berent-Spillson A, 2004, J NEUROCHEM, V89, P90, DOI 10.1111/j.1471-4159.2003.02321.x; Carozzi VA, 2010, NEUROTOX RES, V17, P380, DOI 10.1007/s12640-009-9114-1; Carpenter K J, 2001, Curr Opin Pharmacol, V1, P57, DOI 10.1016/S1471-4892(01)00009-1; Carpenter KJ, 2003, NEUROPEPTIDES, V37, P298, DOI 10.1016/j.npep.2003.08.001; Chen SR, 2002, J PHARMACOL EXP THER, V300, P662, DOI 10.1124/jpet.300.2.662; Chen Xue-Qing, 1998, J Alzheimers Dis, V1, P35; Chopra M, 2009, J PHARMACOL EXP THER, V330, P212, DOI 10.1124/jpet.109.152553; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Dhuria SV, 2009, J PHARM SCI-US, V98, P2501, DOI 10.1002/jps.21604; Farrell J, 2003, J PHARMACOL EXP THER, V306, P229, DOI 10.1124/jpet.103.050112; Febbraro F, 2013, EXP NEUROL, V247, P45, DOI 10.1016/j.expneurol.2013.03.017; Foss CA, 2005, CLIN CANCER RES, V11, P4022, DOI 10.1158/1078-0432.CCR-04-2690; Frey WH, 1997, DRUG DELIV, V4, P87, DOI 10.3109/10717549709051878; Ghadge GD, 2003, P NATL ACAD SCI USA, V100, P9554, DOI 10.1073/pnas.1530168100; Gibaldi M., 1982, PHARMACOKINETICS, V2nd ed., P409; Graham K, 2012, J MED CHEM, V55, P9510, DOI 10.1021/jm300710j; Guo C, 2013, NEUROBIOL AGING, V34, P562, DOI 10.1016/j.neurobiolaging.2012.05.009; Hanson LR, 2009, J PHARMACOL EXP THER, V330, P679, DOI 10.1124/jpet.108.149807; HUSSAIN A, 1980, J PHARM SCI, V69, P1411, DOI 10.1002/jps.2600691215; Illum L, 2002, DRUG DISCOV TODAY, V7, P1184, DOI 10.1016/S1359-6446(02)02529-1; Illum L, 2003, J CONTROL RELEASE, V87, P187, DOI 10.1016/S0168-3659(02)00363-2; Jackson PF, 2001, J MED CHEM, V44, P4170, DOI 10.1021/jm0001774; Janczura KJ, 2013, EUR J PHARMACOL, V701, P27, DOI 10.1016/j.ejphar.2012.11.027; Johnson NJ, 2010, MOL PHARMACEUT, V7, P884, DOI 10.1021/mp100029t; Kozikowski AP, 2004, J MED CHEM, V47, P1729, DOI 10.1021/jm0306226; Lochhead JJ, 2012, ADV DRUG DELIVER REV, V64, P614, DOI 10.1016/j.addr.2011.11.002; Long JB, 2005, EUR J PHARMACOL, V508, P115, DOI 10.1016/j.ejphar.2004.12.008; Luszczki JJ, 2006, EUR J PHARMACOL, V531, P66, DOI 10.1016/j.ejphar.2005.11.045; McKinzie DL, 2000, ADDICT BIOL, V5, P411, DOI 10.1111/j.1369-1600.2000.tb00209.x; Mesters JR, 2006, EMBO J, V25, P1375, DOI 10.1038/sj.emboj.7600969; Nagel J, 2006, NEUROPHARMACOLOGY, V51, P1163, DOI 10.1016/j.neuropharm.2006.07.018; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Neale JH, 2011, J NEUROCHEM, V119, P891, DOI 10.1111/j.1471-4159.2011.07380.x; Olszewski RT, 2012, SCHIZOPHR RES, V136, P160, DOI 10.1016/j.schres.2012.01.007; Olszewski RT, 2004, J NEUROCHEM, V89, P876, DOI 10.1111/j.1471-4159.2004.02358.x; Popik P, 2003, NEUROPSYCHOPHARMACOL, V28, P457, DOI 10.1038/sj.npp.1300048; Rahn KA, 2012, P NATL ACAD SCI USA, V109, P20101, DOI 10.1073/pnas.1209934109; Rais R, 2014, J PHARMACEUT BIOMED, V88, P162, DOI 10.1016/j.jpba.2013.08.028; Rais R, 2012, DRUG METAB DISPOS, V40, P2315, DOI 10.1124/dmd.112.046821; ROBINSON MB, 1987, J BIOL CHEM, V262, P14498; Rojas C, 2002, ANAL BIOCHEM, V310, P50, DOI 10.1016/S0003-2697(02)00286-5; Saito O, 2006, CAN J ANAESTH, V53, P891, DOI 10.1007/BF03022832; Sasson NJ, 2008, AUTISM RES, V1, P31, DOI 10.1002/aur.4; SCHATZ PL, 1989, CHEST, V95, P685, DOI 10.1378/chest.95.3.685; Shippenberg TS, 2000, SYNAPSE, V38, P161, DOI 10.1002/1098-2396(200011)38:2<161::AID-SYN7>3.0.CO;2-G; Slusher BS, 1999, NAT MED, V5, P1396, DOI 10.1038/70971; Stevens J, 2011, DRUG METAB DISPOS, V39, P2275, DOI 10.1124/dmd.111.040782; Thorne RG, 2008, NEUROSCIENCE, V152, P785, DOI 10.1016/j.neuroscience.2008.01.013; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Tortella FC, 2000, EUR J PHARMACOL, V402, P31, DOI 10.1016/S0014-2999(00)00519-7; Vaka SRK, 2009, J PHARM SCI-US, V98, P3640, DOI 10.1002/jps.21674; van der Post JP, 2005, BRIT J CLIN PHARMACO, V60, P128, DOI 10.1111/j.1365-2125.2005.02396.x; Vitharana D, 2002, TETRAHEDRON-ASYMMETR, V13, P1609, DOI 10.1016/S0957-4166(02)00412-3; Vornov JJ, 2013, J PHARMACOL EXP THER, V346, P406, DOI 10.1124/jpet.113.205039; Watkins JC, 2000, BIOCHEM SOC T, V28, P297, DOI 10.1042/0300-5127:0280297; Witkin JM, 2002, NEUROPHARMACOLOGY, V43, P348, DOI 10.1016/S0028-3908(02)00124-7; Wozniak KM, 2012, CURR MED CHEM, V19, P1323, DOI 10.2174/092986712799462630; Xi ZX, 2010, NEUROPHARMACOLOGY, V58, P304, DOI 10.1016/j.neuropharm.2009.06.016; Xi ZX, 2010, J NEUROCHEM, V112, P564, DOI 10.1111/j.1471-4159.2009.06478.x; Yamamoto T, 2004, EUR J NEUROSCI, V20, P483, DOI 10.1111/j.1460-9568.2004.03504.x; Yamamoto T, 2001, BRAIN RES, V909, P138, DOI 10.1016/S0006-8993(01)02650-6; Yamamoto T, 2001, NEUROSCIENCE, V102, P473, DOI 10.1016/S0306-4522(00)00502-9; Yamamoto T, 2007, EUR J NEUROSCI, V25, P147, DOI 10.1111/j.1460-9568.2006.05272.x; Yamamoto T, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-31; Zhang W, 2006, J NEUROL SCI, V247, P217, DOI 10.1016/j.jns.2006.05.052; Zhang W, 2002, J NEUROL SCI, V194, P21, DOI 10.1016/S0022-510X(01)00670-0; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x; Zhong CL, 2005, J NEUROTRAUM, V22, P266, DOI 10.1089/neu.2005.22.266	73	19	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131861	10.1371/journal.pone.0131861	http://dx.doi.org/10.1371/journal.pone.0131861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151906	Green Published, gold, Green Submitted			2022-12-27	WOS:000358158900026
J	Begat, C; Bailly, P; Chiaroni, J; Mazieres, S				Begat, Christophe; Bailly, Pascal; Chiaroni, Jacques; Mazieres, Stephane			Revisiting the Diego Blood Group System in Amerindians: Evidence for Gene-Culture Comigration	PLOS ONE			English	Article							Y-CHROMOSOME; NATIVE-AMERICANS; RED-CELL; POPULATION-STRUCTURE; SOUTH AMERINDIANS; MITOCHONDRIAL-DNA; HUMAN EXPANSION; AYOREO INDIANS; DIVERSITY; VARIABILITY	Six decades ago the DI*A allele of the Diego blood group system was instrumental in proving Native American populations originated from Siberia. Since then, it has received scant attention. The present study was undertaken to reappraise distribution of the DI*A allele in 144 Native American populations based on current knowledge. Using analysis of variance tests, frequency distribution was studied according to geographical, environmental, and cultural parameters. Frequencies were highest in Amazonian populations. In contrast, DI*A was undetectable in subarctic, Fuegian, Panamanian, Chaco and Yanomama populations. Closer study revealed a correlation that this unequal distribution was correlated with language, suggesting that linguistic divergence was a driving force in the expansion of DI*A among Native Americans. The absence of DI*A in circumpolar Eskimo-Aleut and Na-Dene speakers was consistent with a late migratory event confined to North America. Distribution of DI*A in subtropical areas indicated that gene and culture exchanges were more intense within than between ecozones. Bolstering the utility of classical genetic markers in biological anthropology, the present study of the expansion of Diego blood group genetic polymorphism in Native Americans shows strong evidence of gene-culture comigration.	[Begat, Christophe; Bailly, Pascal; Chiaroni, Jacques; Mazieres, Stephane] Aix Marseille Univ, CNRS, EFS, ADES UMR 7268, F-13916 Marseille, France; [Bailly, Pascal; Chiaroni, Jacques] Etab Francais Sang Alpes Mediterranee, F-13392 Marseille 5, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite	Mazieres, S (corresponding author), Aix Marseille Univ, CNRS, EFS, ADES UMR 7268, F-13916 Marseille, France.	stephane.mazieres@univ-amu.fr	Chiaroni, Jacques/ABA-2944-2021; Mazieres, Stephane/G-1702-2010; Mazières, Stéphane/R-2061-2019	Chiaroni, Jacques/0000-0002-3133-8990; Mazieres, Stephane/0000-0003-1266-4659; 				Anstee DJ, 2010, BLOOD, V115, P4635, DOI 10.1182/blood-2010-01-261859; Battaglia V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071390; Bernstein F., 1925, Z INDUKT ABSTAMM VER, V37, P237, DOI [DOI 10.1007/BF01763333, 10.1007/BF01763333]; Bisso-Machado R, 2012, GENET MOL BIOL, V35, P365, DOI 10.1590/S1415-47572012005000027; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; BOOTH PB, 1977, VOX SANG, V32, P99, DOI 10.1111/j.1423-0410.1977.tb00612.x; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Chiaroni J, 2009, P NATL ACAD SCI USA, V106, P20174, DOI 10.1073/pnas.0910803106; Diamond J, 2011, NATURE, V476, P291, DOI 10.1038/476291a; Dickau R, 2007, P NATL ACAD SCI USA, V104, P3651, DOI 10.1073/pnas.0611605104; Dornelles CL, 2004, AM J HUM BIOL, V16, P479, DOI 10.1002/ajhb.20038; Dugoujon JM, 2004, AM J PHYS ANTHROPOL, V125, P175, DOI 10.1002/ajpa.10405; Epps P, 2009, LANG LINGUIST COMPAS, V3, P581, DOI 10.1111/j.1749-818x.2009.00126.x; Estrada-Mena B, 2010, AM J PHYS ANTHROPOL, V142, P85, DOI 10.1002/ajpa.21204; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Galland M, 2013, PREMIER PEUPLEMENT A; Gilbert MTP, 2008, SCIENCE, V320, P1787, DOI 10.1126/science.1159750; Goebel T, 2003, SCIENCE, V301, P501, DOI 10.1126/science.1086555; Henn BM, 2012, P NATL ACAD SCI USA, V109, P17758, DOI 10.1073/pnas.1212380109; Hunemeier T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038862; Hunley KL, 2008, AM J PHYS ANTHROPOL, V135, P195, DOI 10.1002/ajpa.20720; JAROLIM P, 1991, P NATL ACAD SCI USA, V88, P11022, DOI 10.1073/pnas.88.24.11022; Jose RG, 2002, AM J HUM BIOL, V14, P308, DOI 10.1002/ajhb.10033; Junqueira Pedro C., 2002, Rev. Bras. Hematol. Hemoter., V24, P15, DOI 10.1590/S1516-84842002000100004; Koda Y, 2000, J MOL EVOL, V50, P243, DOI 10.1007/s002399910028; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; LAYRISSE M, 1958, Bibl Haematol, V7, P114; LAYRISSE M, 1961, SCIENCE, V134, P1077, DOI 10.1126/science.134.3485.1077; Leotard G, 2009, MOL PHYLOGENET EVOL, V53, P329, DOI 10.1016/j.ympev.2009.05.003; LEVINE P, 1956, NATURE, V177, P40, DOI 10.1038/177040b0; Matsuoka Y, 2002, THEOR APPL GENET, V104, P436, DOI 10.1007/s001220100694; Melton PE, 2008, GENETIC HIST PRECOLU; MOURANT A.E., 1958, ABO BLOOD GROUPS COM; NAM JM, 1976, ANN HUM GENET, V39, P361, DOI 10.1111/j.1469-1809.1976.tb00141.x; NEEL JV, 1967, AM J HUM GENET, V19, P554; NEEL JV, 1977, HUM GENET, V37, P207, DOI 10.1007/BF00393584; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Pritchard JK, 2000, GENETICS, V155, P945; Raghavan M, 2014, SCIENCE, V345, P1020, DOI 10.1126/science.1255832; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Regueiro M, 2013, AM J PHYS ANTHROPOL, V150, P333, DOI 10.1002/ajpa.22207; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rubicz R, 2002, HUM BIOL, V74, P743, DOI 10.1353/hub.2003.0011; RUHLEN M, 1987, GUIDE WORLDS LANGUAG, V1; Salzano FM, 2005, CURR ANTHROPOL, V46, pS121, DOI 10.1086/497667; SALZANO FM, 1978, HUM BIOL, V50, P121; Salzano FN, 2002, AN ACAD BRAS CIENC, V74, P223, DOI 10.1590/S0001-37652002000200005; Schroeder KB, 2007, BIOL LETTERS, V3, P218, DOI 10.1098/rsbl.2006.0609; Scliar MO, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0174-3; Shi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066102; Sicoli MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091722; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72; SLATKIN M, 1991, AM NAT, V138, P499, DOI 10.1086/285228; SMOUSE PE, 1981, GENETICS, V98, P179; SPRING FA, 1992, BIOCHEM J, V288, P713, DOI 10.1042/bj2880713; Steward J. H., 1963, HDB S AM INDIANS, V3; Steward JH, 1963, HDB S AM INDIANS, VII; Steward JH, 1963, HDB S AM INDIANS TOM, VVI; Steward JH, 1963, HDB S AM INDIANS, VI; Steward Julian H., 1963, HDB S AM INDIANS, V5; Storry JR, 2011, VOX SANG, V101, P77, DOI 10.1111/j.1423-0410.2010.01462.x; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Tarazona-Santos E, 2001, AM J HUM GENET, V68, P1485, DOI 10.1086/320601; THOMPSON EA, 1979, GENETICS, V93, P479; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; Underhill PA, 2015, EUR J HUM GENET, V23, P124, DOI 10.1038/ejhg.2014.50; Villanea FA, 2013, AM J PHYS ANTHROPOL, V151, P649, DOI 10.1002/ajpa.22292; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; WILLIAMS RC, 1985, AM J PHYS ANTHROPOL, V66, P1, DOI 10.1002/ajpa.1330660102; WOLFINGER R, 1993, COMMUN STAT-SIMUL C, V22, P1079, DOI 10.1080/03610919308813143; Yang NN, 2010, ANN HUM GENET, V74, P525, DOI 10.1111/j.1469-1809.2010.00608.x	78	10	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132211	10.1371/journal.pone.0132211	http://dx.doi.org/10.1371/journal.pone.0132211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148209	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600219
J	Boerlijst, MC; de Roos, AM				Boerlijst, Maarten C.; de Roos, Andre M.			Competition and Facilitation between a Disease and a Predator in a Stunted Prey Population	PLOS ONE			English	Article							LIGULA-INTESTINALIS CESTODA; ROACH RUTILUS-RUTILUS; PSEUDOPHYLLIDEA; PARASITES; ECOLOGY; HOST	The role of diseases and parasites has received relatively little attention in modelling ecological dynamics despite mounting evidence of their importance in structuring communities. In contrast to predators, parasites do not necessarily kill their host but instead they may change host life history. Here, we study the impact of a parasite that selectively infects juvenile prey individuals and prevents them from maturing into adults. The model is inspired by the Ligula intestinalis tape worm and its cyprinid fish host Rutilis rutilis. We demonstrate that the parasite can promote as well as demote the so-called stunting in its host population, that is, the accumulation of juvenile prey, which leads to strong exploitation competition and consequently to a bottleneck in maturation. If competition between infected and uninfected individuals is strong, stunting will be enhanced and bistability between a stunted and nonstunted prey population occurs. In this case, the disease competes with the predator of its host species, possibly leading to predator extinction. In contrast, if the competition between infected and uninfected individuals is weak, the stunting is relieved, and epi-zoonotic cycles will occur, with recurrent epidemic outbreaks. Here, the disease facilitates the predator, and predator density will be substantially increased. We discuss the implications of our results for the dynamics and structure of the natural Ligula-Roach system.	[Boerlijst, Maarten C.; de Roos, Andre M.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Theoret Ecol, NL-1090 GE Amsterdam, Netherlands	University of Amsterdam	Boerlijst, MC (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Theoret Ecol, POB 94248, NL-1090 GE Amsterdam, Netherlands.	M.C.Boerlijst@uva.nl	De Roos, Andre M./A-1590-2008	De Roos, Andre M./0000-0002-6944-2048				Amundsen PA, 2009, J ANIM ECOL, V78, P563, DOI 10.1111/j.1365-2656.2008.01518.x; Boerlijst MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062033; Carter V, 2005, REPRODUCTION, V130, P939, DOI 10.1530/rep.1.00742; Collinge SK, 2006, DIS ECOLOGY COMMUNIT; de Roos A.M., 2013, MONOGRAPHS POPULATIO; De Roos AM, 2002, P NATL ACAD SCI USA, V99, P12907, DOI 10.1073/pnas.192174199; de Roos AM, 2003, P ROY SOC B-BIOL SCI, V270, P611, DOI 10.1098/rspb.2002.2286; Dhooge A, 2003, ACM T MATH SOFTWARE, V29, P141, DOI 10.1145/779359.779362; Dobson AR, 2006, SFI S SCI C, P119; Grenfell B. T., 1995, ECOLOGY INFECT DIS N; Heins DC, 2011, J PARASITOL, V97, P371, DOI 10.1645/GE-2699.1; Hoole D, 2010, PARASITOLOGY, V137, P425, DOI 10.1017/S0031182010000107; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kennedy CR, 2009, PARASITOLOGY, V136, P1653, DOI 10.1017/S0031182009005794; Kennedy C. R., 1996, Field Studies, V8, P685; Kennedy CR, 2001, PARASITOLOGY, V123, P257, DOI 10.1017/S0031182001008538; Kuznetsov Yu. A., 2004, ELEMENTS APPL BIFURC, Vthird; Loot G, 2001, J PARASITOL, V87, P1002, DOI 10.1645/0022-3395(2001)087[1002:PMORRR]2.0.CO;2; Loot G, 2001, ARCH HYDROBIOL, V152, P511; Loot G, 2006, BIOL J LINN SOC, V89, P99, DOI 10.1111/j.1095-8312.2006.00661.x; Ohlberger J, 2011, ECOLOGY, V92, P2175, DOI 10.1890/11-0410.1; Osfeld RS, 2008, INFECT DIS ECOL EFFE; Thomas F., 2005, PARASITISM ECOSYSTEM; van Kooten T, 2005, J THEOR BIOL, V237, P67, DOI 10.1016/j.jtbi.2005.03.032; Ylikarjula J, 1999, EVOL ECOL, V13, P433, DOI 10.1023/A:1006755702230	25	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132251	10.1371/journal.pone.0132251	http://dx.doi.org/10.1371/journal.pone.0132251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147293	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600225
J	Cieza, A; Sabariego, C; Anczewska, M; Ballert, C; Bickenbach, J; Cabello, M; Giovannetti, A; Kaskela, T; Mellor, B; Pitkanen, T; Quintas, R; Raggi, A; Switaj, P; Chatterji, S				Cieza, Alarcos; Sabariego, Carla; Anczewska, Marta; Ballert, Carolina; Bickenbach, Jerome; Cabello, Maria; Giovannetti, Ambra; Kaskela, Teemu; Mellor, Blanca; Pitkanen, Tuuli; Quintas, Rui; Raggi, Alberto; Switaj, Piotr; Chatterji, Somnath		PARADISE Consortium	PARADISE 24: A Measure to Assess the Impact of Brain Disorders on People's Lives	PLOS ONE			English	Article							QUALITY-OF-LIFE; GLOBAL BURDEN; RASCH MODEL; EUROPE 2010; HEALTH; DISEASE; SF-36; EQ-5D; SIZE; FIT	Objective To construct a metric of the impact of brain disorders on people's lives, based on the psychosocial difficulties (PSDs) that are experienced in common across brain disorders. Study Design Psychometric study using data from a cross-sectional study with a convenience sample of 722 persons with 9 different brain disorders interviewed in four European countries: Italy, Poland, Spain and Finland. Questions addressing 64 PSDs were first reduced based on statistical considerations, patient's perspective and clinical expertise. Rasch analyses for polytomous data were also applied. Setting In and outpatient settings. Results A valid and reliable metric with 24 items was created. The infit of all questions ranged between 0.7 and 1.3. There were no disordered thresholds. The targeting between item thresholds and persons' abilities was good and the person-separation index was 0.92. Persons' abilities were linearly transformed into a more intuitive scale ranging from zero (no PSDs) to 100 (extreme PSDs). Conclusion The metric, called PARADISE 24, is based on the hypothesis of horizontal epidemiology, which affirms that people with brain disorders commonly experience PSDs. This metric is a useful tool to carry out cardinal comparisons over time of the magnitude of the psychosocial impact of brain disorders and between persons and groups in clinical practice and research.	[Cieza, Alarcos] Univ Southampton, Sch Psychol, Fac Social & Human Sci, Southampton, Hants, England; [Cieza, Alarcos; Sabariego, Carla] Univ Munich, Dept Med Informat Biometry & Epidemiol IBE, Chair Publ Hlth & Hlth Serv Res, Res Unit Biopsychosocial Hlth, Munich, Germany; [Cieza, Alarcos; Ballert, Carolina; Bickenbach, Jerome] Swiss Parapleg Res, Nottwil, Switzerland; [Anczewska, Marta; Switaj, Piotr] Inst Psychiat & Neurol, Dept Psychiat, Warsaw, Poland; [Cabello, Maria; Mellor, Blanca] Univ Autonoma Madrid, Inst Invest Hosp Univ La Princesa IIS IP, Ctr Invest Biomed Red Salud Mental CIBERSAM, Inst Salud Carlos III,Dept Psychiat,Psychiat Serv, E-28049 Madrid, Spain; [Cabello, Maria; Mellor, Blanca] Univ Autonoma Madrid, Dept Psychiat, E-28049 Madrid, Spain; [Giovannetti, Ambra; Quintas, Rui; Raggi, Alberto] IRCCS Fdn, Neurol Publ Hlth & Disabil, Sci Directorate, Neurol Inst Carlo Besta, Milan, Italy; [Kaskela, Teemu; Pitkanen, Tuuli] A Clin Fdn, Helsinki, Finland; [Chatterji, Somnath] World Hlth Org, Multicountry Studies, Dept Measurement & Hlth Informat Syst, Geneva, Switzerland	University of Southampton; University of Munich; Swiss Paraplegic Research; Institute of Psychiatry & Neurology; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Autonomous University of Madrid; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta; World Health Organization	Cieza, A (corresponding author), Univ Southampton, Sch Psychol, Fac Social & Human Sci, Southampton, Hants, England.	a.cieza@soton.ac.uk	Cabello, Maria/R-5665-2019; CHATTERJI, Somnath/ABE-6832-2020; leonardi, matilde/J-9997-2018; Quintas, Rui/AAJ-6630-2021; Cerniauskaite, Milda/AAS-2802-2021; Schiavolin, Silvia/K-6595-2016; Pitkänen, Tuuli/AAH-2204-2020; Raggi, Alberto/K-5787-2016	Cabello, Maria/0000-0003-2362-6092; leonardi, matilde/0000-0003-0552-8923; Quintas, Rui/0000-0002-9985-334X; Cerniauskaite, Milda/0000-0003-1871-3650; Schiavolin, Silvia/0000-0002-5391-7539; Raggi, Alberto/0000-0002-7433-7779; Coenen, Michaela/0000-0001-7492-7907; Anczewska, Marta/0000-0001-8816-930X; Giovannetti, Ambra Mara/0000-0002-7496-6727; Switaj, Piotr/0000-0002-0805-6696; Ayuso-Mateos, Jose Luis/0000-0002-7544-826X; Pitkanen, Tuuli/0000-0002-2381-9436	Coordination Theme 1 (Health) of the European Community's FP7 [HEALTH-F2-2009-241572]	Coordination Theme 1 (Health) of the European Community's FP7	The PARADISE project is supported by the Coordination Theme 1 (Health) of the European Community's FP7, Grant Agreement No. HEALTH-F2-2009-241572. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrich D, 1982, ED RES PERSPECTIVES, V9, P95; ANDRICH D, 2002, RUMM2020 RASCH UNIDI; Andrich David, 2003, J Appl Meas, V4, P205; Andrich D, 2005, EDUC ASIA PAC REG-IS, V4, P27; [Anonymous], 2013, BRAIN RES ADV INNOVA; Bond TG., 2020, APPL RASCH MODEL FUN; Brazier J, 2010, BRIT J PSYCHIAT, V197, P348, DOI 10.1192/bjp.bp.110.082453; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Choi SW, 2011, J STAT SOFTW, V39, P1; Cieza A, 2008, GESUNDHEITSWESEN, V70, P569, DOI 10.1055/s-2008-1080933; Cieza A, UNDERSTANDING BURDEN; Crane PK, 2006, MED CARE, V44, pS115, DOI 10.1097/01.mlr.0000245183.28384.ed; Ekstrom J., 2011, GENERALIZED DEFINITI; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Linacre John M, 2002, J Appl Meas, V3, P85; Mair P, 2007, J STAT SOFTW, V20, P1, DOI DOI 10.18637/JSS.V020.I09; Mathers Colin D, 2003, Popul Health Metr, V1, P6, DOI 10.1186/1478-7954-1-6; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Papaioannou D, 2011, VALUE HEALTH, V14, P907, DOI 10.1016/j.jval.2011.04.006; Pukrop R, 2000, EUR ARCH PSY CLIN N, V250, P120, DOI 10.1007/s004060070028; Rauch A, 2010, PHYS THER, V90, P1039, DOI 10.2522/ptj.20090327; Roscino A, 2006, STUD CLASS DATA ANAL, P135, DOI 10.1007/3-540-35978-8_16; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Smith AB, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-33; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; World Health Organization, 2006, NEUR DIS PUBL HLTH C; World Health Organization, 2001, INT CLASS FUNCT DIS	30	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132410	10.1371/journal.pone.0132410	http://dx.doi.org/10.1371/journal.pone.0132410			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147343	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000358157600262
J	Hobbs, JPA; Frisch, AJ; Newman, SJ; Wakefield, CB				Hobbs, Jean-Paul A.; Frisch, Ashley J.; Newman, Stephen J.; Wakefield, Corey B.			Selective Impact of Disease on Coral Communities: Outbreak of White Syndrome Causes Significant Total Mortality of Acropora Plate Corals	PLOS ONE			English	Article							GREAT-BARRIER-REEF; INDO-PACIFIC; BAND DISEASE; WATER-FLOW; AUSTRALIA; CONSERVATION; BIODIVERSITY; ISLANDS; TAXA	Coral diseases represent a significant and increasing threat to coral reefs. Among the most destructive diseases is White Syndrome (WS), which is increasing in distribution and prevalence throughout the Indo-Pacific. The aim of this study was to determine taxonomic and spatial patterns in mortality rates of corals following the 2008 outbreak of WS at Christmas Island in the eastern Indian Ocean. WS mainly affected Acropora plate corals and caused total mortality of 36% of colonies across all surveyed sites and depths. Total mortality varied between sites but was generally much greater in the shallows (0-96% of colonies at 5 m depth) compared to deeper waters (0-30% of colonies at 20 m depth). Site-specific mortality rates were a reflection of the proportion of corals affected by WS at each site during the initial outbreak and were predicted by the initial cover of live Acropora plate cover. The WS outbreak had a selective impact on the coral community. Following the outbreak, live Acropora plate coral cover at 5 m depth decreased significantly from 7.0 to 0.8%, while the cover of other coral taxa remained unchanged. Observations five years after the initial outbreak revealed that total Acropora plate cover remained low and confirmed that corals that lost all their tissue due to WS did not recover. These results demonstrate that WS represents a significant and selective form of coral mortality and highlights the serious threat WS poses to coral reefs in the Indo-Pacific.	[Hobbs, Jean-Paul A.] Curtin Univ, Dept Environm & Agr, Perth, WA 6845, Australia; [Frisch, Ashley J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Newman, Stephen J.; Wakefield, Corey B.] Govt Western Australia, Dept Fisheries, Western Australian Fisheries & Marine Res Labs, North Beach, WA, Australia	Curtin University; James Cook University; Government of Western Australia; Western Australian Fisheries & Marine Research Laboratories	Hobbs, JPA (corresponding author), Curtin Univ, Dept Environm & Agr, Perth, WA 6845, Australia.	jp.hobbs@curtin.edu.au	Hobbs, Jean-Paul/I-8743-2012; Newman, Stephen/C-4507-2016	Hobbs, Jean-Paul/0000-0003-0331-354X; Newman, Stephen/0000-0002-5324-5568	Parks Australia North; Wet 'n' Dry Adventures	Parks Australia North; Wet 'n' Dry Adventures	Logistical and financial support for this study was provided by Parks Australia North and Wet 'n' Dry Adventures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby GS, 2005, CORAL REEFS, V24, P481, DOI 10.1007/s00338-005-0493-3; ANTONIUS A, 1985, Marine Ecology, V6, P197, DOI 10.1111/j.1439-0485.1985.tb00322.x; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Ban SS, 2014, GLOBAL CHANGE BIOL, V20, P681, DOI 10.1111/gcb.12453; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Dalton SJ, 2006, CORAL REEFS, V25, P37, DOI 10.1007/s00338-005-0039-8; Green EP, 2000, BIOL CONSERV, V96, P347, DOI 10.1016/S0006-3207(00)00073-2; Haapkyla J, 2009, DIS AQUAT ORGAN, V87, P105, DOI 10.3354/dao02160; Hartfield M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003277; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Hobbs JPA, 2010, DIS AQUAT ORGAN, V89, P1, DOI 10.3354/dao02181; Hobbs JPA, 2014, MAR POLICY, V44, P149, DOI 10.1016/j.marpol.2013.08.020; Kuta KG, 2002, CORAL REEFS, V21, P393, DOI 10.1007/s00338-002-0261-6; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Luna GM, 2010, ENV MICROBIOL REP, V2, P120, DOI 10.1111/j.1758-2229.2009.00114.x; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Maynard JA, 2011, CORAL REEFS, V30, P485, DOI 10.1007/s00338-010-0708-0; McClanahan TR, 2005, MAR ECOL PROG SER, V298, P131, DOI 10.3354/meps298131; McClanahan TR, 2004, MAR POLLUT BULL, V48, P327, DOI 10.1016/j.marpolbul.2003.08.024; Miller MW, 2007, CORAL REEFS, V26, P97, DOI 10.1007/s00338-006-0165-y; Muller EM, 2009, CORAL REEFS, V28, P757, DOI 10.1007/s00338-009-0504-x; Nakamura T, 2001, MAR ECOL PROG SER, V212, P301, DOI 10.3354/meps212301; Porter JW, 2001, HYDROBIOLOGIA, V460, P1, DOI 10.1023/A:1013177617800; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Richards ZT, 2014, RAFFLES B ZOOL, P376; Richards ZT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083965; Richards ZT, 2013, CORAL REEFS, V32, P287, DOI 10.1007/s00338-012-0963-3; Richardson LL, 1998, TRENDS ECOL EVOL, V13, P438, DOI 10.1016/S0169-5347(98)01460-8; Roff G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026829; Ryan NM, 2014, RAFFLES B ZOOL, P399; SOONG KY, 1992, BIOL BULL, V183, P418, DOI 10.2307/1542018; Speed CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069863; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Veron J.E.N, 1986, CORALS AUSTR INDO PA; Williams GJ, 2011, DIS AQUAT ORGAN, V94, P89, DOI 10.3354/dao02323; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69	39	18	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132528	10.1371/journal.pone.0132528	http://dx.doi.org/10.1371/journal.pone.0132528			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147291	Green Published, gold, Green Accepted			2022-12-27	WOS:000358157600297
J	Mattioli, F; Stampatori, C; Bellomi, F; Scarpazza, C; Capra, R				Mattioli, Flavia; Stampatori, Chiara; Bellomi, Fabio; Scarpazza, Cristina; Capra, Ruggero			Natalizumab Significantly Improves Cognitive Impairment over Three Years in MS: Pattern of Disability Progression and Preliminary MRI Findings	PLOS ONE			English	Article							REMITTING MULTIPLE-SCLEROSIS; 3-YEAR FOLLOW-UP; TREATED-PATIENTS; BRAIN ATROPHY; CORTICAL PATHOLOGY; DISEASE-ACTIVITY; EFFICACY; LOBE	Previous studies reported that Multiple Sclerosis (MS) patients treated with natalizumab for one or two years exhibit a significant reduction in relapse rate and in cognitive impairment, but the long term effects on cognitive performance are unknown. This study aimed to evaluate the effects of natalizumab on cognitive impairment in a cohort of 24 consecutive patients with relapsing remitting MS treated for 3 years. The neuropsychological tests, as well as relapse number and EDSS, were assessed at baseline and yearly for three years. The impact on cortical atrophy was also considered in a subgroup of them, and are thus to be considered as preliminary. Results showed a significant reduction in the number of impaired neuropsychological tests after three years, a significant decrease in annualized relapse rate at each time points compared to baseline and a stable EDSS. In the neuropsychological assessment, a significant improvement in memory, attention and executive function test scores was detected. Preliminary MRI data show that, while GM volume did not change at 3 years, a significantly greater parahippocampal and prefrontal gray matter density was noticed, the former correlating with neuropsychological improvement in a memory test. This study showed that therapy with Natalizumab is helpful in improving cognitive performance, and is likely to have a protective role on grey matter, over a three years follow-up.	[Mattioli, Flavia; Stampatori, Chiara; Bellomi, Fabio; Scarpazza, Cristina] Spedali Civil Brescia, Neuropsychol Unit, I-25125 Brescia, Italy; [Capra, Ruggero] Spedali Civili Brescia, Multiple Sclerosis Ctr, Montichiari, Italy	Hospital Spedali Civili Brescia; Hospital Spedali Civili Brescia	Mattioli, F (corresponding author), Spedali Civil Brescia, Neuropsychol Unit, I-25125 Brescia, Italy.	flaviacaterina.mattioli@gmail.com	Mattioli, Flavia Caterina/AAM-8803-2020; Scarpazza, Cristina/AAA-2306-2022	Scarpazza, Cristina/0000-0002-4126-426X				Amato MP, 2010, MULT SCLER, V16, P1474, DOI 10.1177/1352458510380089; Amato MP, 2004, NEUROLOGY, V63, P89, DOI 10.1212/01.WNL.0000129544.79539.D5; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2009, NEUROIMAGE, V45, P333, DOI 10.1016/j.neuroimage.2008.12.008; Basso A, 1987, Funct Neurol, V2, P189; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Butzkueven H, 2014, J NEUROL NEUROSUR PS, V85, P1190, DOI 10.1136/jnnp-2013-306936; Caffarra P, 2002, NEUROL SCI, V22, P443, DOI 10.1007/s100720200003; Calabrese M, 2010, NEUROLOGY, V74, P321, DOI 10.1212/WNL.0b013e3181cbcd03; Calabrese M, 2011, EXPERT REV NEUROTHER, V11, P425, DOI 10.1586/ERN.10.155; Calabrese M, 2009, ARCH NEUROL-CHICAGO, V66, P1144, DOI 10.1001/archneurol.2009.174; de Renzi E., 1977, ARCH PSICOL NEUROL P, V38, P303; Eling P, 2008, BRAIN COGNITION, V67, P247, DOI 10.1016/j.bandc.2008.01.006; Filippi M, 2012, RADIOLOGY, V262, P932, DOI 10.1148/radiol.11111299; Ghezzi A, 2011, NEUROL SCI, V32, P351, DOI 10.1007/s10072-010-0469-0; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Havrdova E, 2009, LANCET NEUROL, V8, P254, DOI 10.1016/S1474-4422(09)70021-3; IAFFALDANO P, 2012, PLOS ONE, V7; Krysko KM, 2011, CAN J NEUROL SCI, V38, P422, DOI 10.1017/S0317167100011811; Lang C, 2012, EUR NEUROL, V67, P162, DOI 10.1159/000334722; Magraner M, 2012, EUR J RADIOL, V81, P3485, DOI 10.1016/j.ejrad.2012.01.028; Mattioli F, 2011, NEUROL SCI, V31, pS321, DOI 10.1007/s10072-010-0351-0; Mattioli F, 2011, NEUROL SCI, V32, P83, DOI 10.1007/s10072-010-0412-4; Mechelli A, 2005, CURR MED IMAGING, V1, P105, DOI 10.2174/1573405054038726; Morrow SA, 2010, MULT SCLER J, V16, P1385, DOI 10.1177/1352458510378021; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P278; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Portaccio E, 2013, EUR J NEUROL, V20, P986, DOI 10.1111/j.1468-1331.2012.03882.x; Prosperini L, 2012, J NEUROL SCI, V323, P104, DOI 10.1016/j.jns.2012.08.027; Raven J. C., 1978, MANUAL RAVENS PROGR; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rinaldi F, 2012, MULT SCLER J, V18, P1760, DOI 10.1177/1352458512447704; Rudick RA, 2009, MULT SCLER J, V15, P984, DOI 10.1177/1352458509106212; Sastre-Garriga J, 2015, MULT SCLER J, V21, P749, DOI 10.1177/1352458514556300; Sorensen PS, 2014, CURR OPIN NEUROL, V27, P246, DOI 10.1097/WCO.0000000000000096; Spinnler H., 1987, ITAL J NEUROL SCI, V58, P44; Spreen O., 1991, PROFILE TEST RESULTS; Weinstock-Guttman B, 2012, J NEUROL, V259, P898, DOI 10.1007/s00415-011-6275-7; Yassa MA, 2009, NEUROIMAGE, V44, P319, DOI 10.1016/j.neuroimage.2008.09.016	42	35	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131803	10.1371/journal.pone.0131803	http://dx.doi.org/10.1371/journal.pone.0131803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148120	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600147
J	Srilekha, S; Arokiasamy, T; Srikrupa, NN; Umashankar, V; Meenakshi, S; Sen, P; Kapur, S; Soumittra, N				Srilekha, Sundaramurthy; Arokiasamy, Tharigopala; Srikrupa, Natarajan N.; Umashankar, Vetrivel; Meenakshi, Swaminathan; Sen, Parveen; Kapur, Suman; Soumittra, Nagasamy			Homozygosity Mapping in Leber Congenital Amaurosis and Autosomal Recessive Retinitis Pigmentosa in South Indian Families	PLOS ONE			English	Article							GENOTYPE-PHENOTYPE CORRELATION; ONSET RETINAL DEGENERATION; GENE-THERAPY; AIPL1 MUTATIONS; COMMON-CAUSE; RPE65 GENE; DYSTROPHY; IDENTIFICATION; PREVALENCE; VISION	Leber congenital amaurosis (LCA) and retinitis pigmentosa (RP) are retinal degenerative diseases which cause severe retinal dystrophy affecting the photoreceptors. LCA is predominantly inherited as an autosomal recessive trait and contributes to 5% of all retinal dystrophies; whereas RP is inherited by all the Mendelian pattern of inheritance and both are leading causes of visual impairment in children and young adults. Homozygosity mapping is an efficient strategy for mapping both known and novel disease loci in recessive conditions, especially in a consanguineous mating, exploiting the fact that the regions adjacent to the disease locus will also be homozygous by descent in such inbred children. Here we have studied eleven consanguineous LCA and one autosomal recessive RP (arRP) south Indian families to know the prevalence of mutations in known genes and also to know the involvement of novel loci, if any. Complete ophthalmic examination was done for all the affected individuals including electroretinogram, fundus photograph, fundus autofluorescence, and optical coherence tomography. Homozygosity mapping using Affymetrix 250K HMA GeneChip on eleven LCA families followed by screening of candidate gene(s) in the homozygous block identified mutations in ten families; AIPL1 - 3 families, RPE65-2 families, GUCY2D, CRB1, RDH12, IQCB1 and SPATA7 in one family each, respectively. Six of the ten (60%) mutations identified are novel. Homozygosity mapping using Affymetrix 10K HMA GeneChip on the arRP family identified a novel nonsense mutation in MERTK. The mutations segregated within the family and was absent in 200 control chromosomes screened. In one of the eleven LCA families, the causative gene/mutation was not identified but many homozygous blocks were noted indicating that a possible novel locus/gene might be involved. The genotype and phenotype features, especially the fundus changes for AIPL1, RPE65, CRB1, RDH12 genes were as reported earlier.	[Srilekha, Sundaramurthy; Arokiasamy, Tharigopala; Srikrupa, Natarajan N.; Soumittra, Nagasamy] Vis Res Fdn, SNONGC Dept Genet & Mol Biol, Madras, Tamil Nadu, India; [Srilekha, Sundaramurthy; Srikrupa, Natarajan N.] BITS, Hyderabad, Andhra Pradesh, India; [Umashankar, Vetrivel] Vis Res Fdn, Ctr Bioinformat, Madras, Tamil Nadu, India; [Meenakshi, Swaminathan] Med Res Fdn, Dept Peadiatr Ophthalmol & Starbismus, Madras, Tamil Nadu, India; [Sen, Parveen] Med Res Fdn, Dept Vitreoretinal Serv, Madras, Tamil Nadu, India; [Kapur, Suman] BITS, Dept Biol Sci, Hyderabad, Andhra Pradesh, India	Birla Institute of Technology & Science Pilani (BITS Pilani); Birla Institute of Technology & Science Pilani (BITS Pilani)	Soumittra, N (corresponding author), Vis Res Fdn, SNONGC Dept Genet & Mol Biol, Madras, Tamil Nadu, India.	soumi_n@yahoo.co.uk	Sen, Parveen/W-4707-2019		Indian Council of Medical Research, Government of India [54/1/2010-BMS]	Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	This work was supported by the Indian Council of Medical Research, Government of India 54/1/2010-BMS (icmr.nic.in/) to NS.	Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alkuraya FS, 2010, GENET MED, V12, P236, DOI 10.1097/GIM.0b013e3181ceb95d; Allikmets Rando, 2004, Ophthalmic Genet, V25, P67, DOI 10.1080/13816810490514261; Asai-Coakwell M, 2013, HUM MOL GENET, V22, P1432, DOI 10.1093/hmg/dds560; Bertelsen M, 2014, OPHTHAL EPIDEMIOL, V21, P217, DOI 10.3109/09286586.2014.929710; Beryozkin A, 2013, INVEST OPHTH VIS SCI, V54, P2068, DOI 10.1167/iovs.12-11419; Chiang PW, 2012, NAT GENET, V44, P972, DOI 10.1038/ng.2370; Chinchore Y, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000377; Chung DC, 2009, J AAPOS, V13, P587, DOI 10.1016/j.jaapos.2009.10.004; Cideciyan AV, 2013, P NATL ACAD SCI USA, V110, pE517, DOI 10.1073/pnas.1218933110; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Cideciyan AV, 2009, NEW ENGL J MED, V361, P725, DOI 10.1056/NEJMc0903652; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; den Hollander AI, 2007, INVEST OPHTH VIS SCI, V48, P5690, DOI 10.1167/iovs.07-0610; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dhamaraj S, 2004, ARCH OPHTHALMOL-CHIC, V122, P1029, DOI 10.1001/archopht.122.7.1029; Dharmaraj S R, 2000, Ophthalmic Genet, V21, P135; Ehrenberg M, 2013, SEMIN OPHTHALMOL, V28, P397, DOI 10.3109/08820538.2013.825277; Estrada-Cuzcano A, 2011, INVEST OPHTH VIS SCI, V52, P834, DOI 10.1167/iovs.10-5221; Ferrari S, 2011, CURR GENOMICS, V12, P238, DOI 10.2174/138920211795860107; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Gallon VA, 2004, BBA-MOL BASIS DIS, V1690, P141, DOI 10.1016/j.bbadis.2004.06.012; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353; Huang XF, 2015, GENET MED, V17, P271, DOI 10.1038/gim.2014.138; Il LLN, 2010, HUM MUTAT, V31, pE1472, DOI 10.1002/humu.21268; Kannabiran C, 2012, MOL VIS, V18, P1165; Kaplan J, 2008, OPHTHALMIC GENET, V29, P92, DOI 10.1080/13816810802232768; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lalitha K, 2002, J GENET, V81, P59, DOI 10.1007/BF02715901; Mackay DS, 2010, MOL VIS, V16, P369; Mamatha G, 2008, OPHTHALMIC GENET, V29, P73, DOI 10.1080/13816810802008259; McKibbin M, 2010, ARCH OPHTHALMOL-CHIC, V128, P107, DOI 10.1001/archophthalmol.2010.309; Millán J.M., 2008, Arch Soc Esp Oftalmol, V83, P689; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Otto EA, 2008, HUM MUTAT, V29, P418, DOI 10.1002/humu.20669; Parmeggiani F, 2011, CURR GENOMICS, V12, P236, DOI 10.2174/138920211795860080; Ramprasad VL, 2008, MOL VIS, V14, P481; Rozen S, 2000, Methods Mol Biol, V132, P365; Schuster A, 2007, INVEST OPHTH VIS SCI, V48, P1824, DOI 10.1167/iovs.06-0628; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sergouniotis PI, 2011, AM J HUM GENET, V89, P183, DOI 10.1016/j.ajhg.2011.06.002; Singh HP, 2009, INVEST OPHTH VIS SCI, V50, P4065, DOI 10.1167/iovs.09-3479; Skjorringe T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018599; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Sohocki MM, 2000, MOL GENET METAB, V70, P142, DOI 10.1006/mgme.2000.3001; Stone EM, 2011, ARCH OPHTHALMOL-CHIC, V129, P81, DOI 10.1001/archophthalmol.2010.330; Sundaresan P, 2009, MOL VIS, V15, P1781; Testa F, 2011, INVEST OPHTH VIS SCI, V52, P5618, DOI 10.1167/iovs.10-6543; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Tsujikawa M, 2008, ARCH OPHTHALMOL-CHIC, V126, P337, DOI 10.1001/archopht.126.3.337; Venkata RA, 2012, RES J BIOTECHNOL, V7, P18; Verma A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073172; Wang X, 2013, J MED GENET, V50, P674, DOI 10.1136/jmedgenet-2013-101558; Wang X, 2011, HUM MUTAT, V32, P1450, DOI 10.1002/humu.21587; Woods CG, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016873; Woods CG, 2006, AM J HUM GENET, V78, P889, DOI 10.1086/503875	59	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131679	10.1371/journal.pone.0131679	http://dx.doi.org/10.1371/journal.pone.0131679			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147992	gold, Green Submitted, Green Published			2022-12-27	WOS:000358157600127
J	Trifonov, VA; Paoletti, A; Barucchi, VC; Kalinina, T; O'Brien, PCM; Ferguson-Smith, MA; Giovannotti, M				Trifonov, Vladimir A.; Paoletti, Alessio; Barucchi, Vincenzo Caputo; Kalinina, Tatiana; O'Brien, Patricia C. M.; Ferguson-Smith, Malcolm A.; Giovannotti, Massimo			Comparative Chromosome Painting and NOR Distribution Suggest a Complex Hybrid Origin of Triploid Lepidodactylus lugubris (Gekkonidae)	PLOS ONE			English	Article							PARTHENOGENETIC GECKO; HEMIDACTYLUS-FRENATUS; VIRGIN BIRTH; REPTILIA; LIZARDS; DIVERSITY; EVOLUTION; SQUAMATA	Parthenogenesis, unisexuality and triploidy are interesting but poorly studied phenomena occurring in some reptile species. The mourning gecko (Lepidodactylus lugubris) represents a complex of diploid and triploid parthenogenetic mostly all-female populations (males occur quite rarely) widely distributed in coastal areas of the Indian and Pacific Oceans. Here, we study karyotypes of a male and two female L. lugubris (LLU) triploid individuals (3n = 66) using comparative painting with Gekko japonicus, Hemidactylus turcicus and H. platyurus chromosome specific probes to visualize the homologous regions and to reveal genus specific rearrangements. Also, we applied a 28S ribosomal DNA probe and Ag-staining to detect nucleolus organizer regions (NORs). Our results suggest that the karyotype of L. lugubris underwent a chromosome fission and a fusion after its divergence from a common ancestor of the Gekko-Hemidactylus group. The NORs were found to be located on one out of three homologs on each of LLU8, LLU15 and LLU18, thus further confirming a hybrid origin of triploid individuals. It seems that three different bisexual populations might have contributed to the origin of this triploid parthenogenetic population. We postulate that the heterozygosity in NOR localization is maintained in the triploid clone studied by the absence of recombination as described in whiptail lizards. The pattern of NOR localizations and homologous regions in males and females, as well as the absence of other detectable karyotypic differences, suggest that males arise spontaneously in all female populations and do not arise from independent hybridizations with different species.	[Trifonov, Vladimir A.; Kalinina, Tatiana] Inst Mol & Cellular Biol SB RAS, Novosibirsk, Russia; [Trifonov, Vladimir A.; Kalinina, Tatiana] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Paoletti, Alessio; Barucchi, Vincenzo Caputo; Giovannotti, Massimo] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy; [O'Brien, Patricia C. M.; Ferguson-Smith, Malcolm A.] Univ Cambridge, Cambridge Resource Ctr Comparat Genom, Cambridge, England; [Barucchi, Vincenzo Caputo] CNR, Ist Sci Marine Sez Pesca Marittima, Ancona, Italy	Russian Academy of Sciences; Novosibirsk State University; Marche Polytechnic University; University of Cambridge; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Trifonov, VA (corresponding author), Inst Mol & Cellular Biol SB RAS, Novosibirsk, Russia.	vlad@mcb.nsc.ru	Trifonov, Vladimir/E-4907-2012; Kalinina, Tatiana/AAU-4594-2020; Giovannotti, Massimo/AAZ-3563-2020	Trifonov, Vladimir/0000-0003-0454-8359; Kalinina, Tatiana/0000-0002-2698-0866; Giovannotti, Massimo/0000-0001-7622-3583	MCB grant [6.13]; Universita Politecnica delle Marche	MCB grant; Universita Politecnica delle Marche	This work was funded by MCBNo6.13 grant to VAT and by funds (Ricerca Scientifica d'Ateneo 2012) provided by Universita Politecnica delle Marche to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booth W, 2012, BIOL LETTERS, V8, P983, DOI 10.1098/rsbl.2012.0666; Brown SG, 1996, HERPETOL J, V6, P69; Chapman DD, 2007, BIOL LETTERS, V3, P425, DOI 10.1098/rsbl.2007.0189; CUELLAR O, 1972, J GENET, V61, P14, DOI 10.1007/BF02984098; DAREVSKY IS, 1984, J HERPETOL, V18, P277, DOI 10.2307/1564081; Ezaz T, 2005, CHROMOSOME RES, V13, P763, DOI 10.1007/s10577-005-1010-9; Feldheim KA, 2010, J HERED, V101, P374, DOI 10.1093/jhered/esp129; Gamble T, 2008, ZOOL SCR, V37, P355, DOI 10.1111/j.1463-6409.2008.00330.x; Groot TVM, 2003, HEREDITY, V90, P130, DOI 10.1038/sj.hdy.6800210; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; INEICH I, 1988, CR ACAD SCI III-VIE, V307, P271; Kawai A, 2009, CHROMOSOMA, V118, P43, DOI 10.1007/s00412-008-0176-2; Lutes AA, 2010, NATURE, V464, P283, DOI 10.1038/nature08818; MORITZ C, 1993, BIOL J LINN SOC, V48, P113, DOI 10.1006/bijl.1993.1010; Neaves WB, 2011, TRENDS GENET, V27, P81, DOI 10.1016/j.tig.2010.12.002; OTA H, 1994, ECOL RES, V9, P121, DOI 10.1007/BF02347487; Ota H., 1993, Tropical Zoology, V6, P125; Ota H, 1996, GENETICA, V97, P81, DOI 10.1007/BF00132584; Pokorna MJ, 2015, CHROMOSOME RES, V23, P299, DOI 10.1007/s10577-015-9468-6; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; RADTKEY RR, 1995, P ROY SOC B-BIOL SCI, V259, P145, DOI 10.1098/rspb.1995.0022; Roell B, 2008, ZOOLOGY, V111, P385, DOI 10.1016/j.zool.2007.09.004; SCHMID M, 1988, CHROMOSOMA, V97, P101, DOI 10.1007/BF00327367; Shibaike Y, 2009, CYTOGENET GENOME RES, V127, P182, DOI 10.1159/000303334; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Trifonov VA, 2011, CHROMOSOME RES, V19, P843, DOI 10.1007/s10577-011-9241-4; VOLOBOUEV V, 1988, HEREDITY, V60, P463, DOI 10.1038/hdy.1988.65; VOLOBOUEV V, 1993, CYTOGENET CELL GENET, V63, P194, DOI 10.1159/000133533; Watts PC, 2006, NATURE, V444, P1021, DOI 10.1038/4441021a; Wilmhoff CD, 2003, MOL ECOL NOTES, V3, P400, DOI 10.1046/j.1471-8286.2003.00459.x; Yamashiro S, 2000, ZOOL SCI, V17, P1013, DOI 10.2108/zsj.17.1013; Yamashiro Saiko, 1998, Japanese Journal of Herpetology, V17, P152	32	22	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132380	10.1371/journal.pone.0132380	http://dx.doi.org/10.1371/journal.pone.0132380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148117	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600254
J	Zelasko-Leon, DC; Fuentes, CM; Messersmith, PB				Zelasko-Leon, Daria C.; Fuentes, Christina M.; Messersmith, Phillip B.			MUC1-Targeted Cancer Cell Photothermal Ablation Using Bioinspired Gold Nanorods	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; IN-VIVO; PLASMA-PROTEINS; MUC1 MUCIN; NANOPARTICLES; POLYDOPAMINE; CARCINOMA; THERAPY; MUSSEL; BSA	Recent studies have highlighted the overexpression of mucin 1 (MUC1) in various epithelial carcinomas and its role in tumorigenesis. These mucins present a novel targeting opportunity for nanoparticle-mediated photothermal cancer treatments due to their unique antenna-like extracellular extension. In this study, MUC1 antibodies and albumin were immobilized onto the surface of gold nanorods using a "primer" of polydopamine (PD), a molecular mimic of catechol-and amine-rich mussel adhesive proteins. PD forms an adhesive platform for the deposition of albumin and MUC1 antibodies, achieving a surface that is stable, bioinert and biofunctional. Two-photon luminescence confocal and darkfield scattering imaging revealed targeting of MUC1-BSA-PD-NRs to MUC1(+) MCF-7 breast cancer and SCC-15 squamous cell carcinoma cells lines. Treated cells were exposed to a laser encompassing the near-infrared AuNR longitudinal surface plasmon and assessed for photothermal ablation. MUC1-BSA-PD-NRs substantially decreased cell viability in photoirradiated MCF-7 cell lines vs. MUC1-MDA-MB-231 breast cancer cells (p < 0.005). Agents exhibited no cytotoxicity in the absence of photothermal treatment. The facile nature of the coating method, combined with targeting and photoablation efficacy, are attractive features of these candidate cancer nanotherapeutics.	[Zelasko-Leon, Daria C.; Fuentes, Christina M.; Messersmith, Phillip B.] Northwestern Univ, Dept Biomed Engn, Chem Life Proc Inst, Evanston, IL 60208 USA; [Zelasko-Leon, Daria C.; Fuentes, Christina M.; Messersmith, Phillip B.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Messersmith, Phillip B.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA	Northwestern University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Zelasko-Leon, DC (corresponding author), Northwestern Univ, Dept Biomed Engn, Chem Life Proc Inst, Evanston, IL 60208 USA.	philm@berkeley.edu		Messersmith, Phillip/0000-0002-1197-333X	NCI CCSG [P30 CA060553]; MRSEC program at the Material Research Center [NSF DMR-1121262]; International Institute for Nanotechnology (IIN); Keck Foundation; State of Illinois; Northwestern University High Throughput Analysis Laboratory (HTAL); Keck Biophysics Facility; Northwestern University Flow Cytometry Facility; Cancer Center [NCI CA060553]; National Science Foundation [DGE-0824162]; Robert H. Lurie Comprehensive Cancer Center (RHLCC) of Northwestern University; McCormick Summer Research Award; NIH [R01 EB005772, R37 DE014193]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE014193] Funding Source: NIH RePORTER	NCI CCSG; MRSEC program at the Material Research Center; International Institute for Nanotechnology (IIN); Keck Foundation(W.M. Keck Foundation); State of Illinois; Northwestern University High Throughput Analysis Laboratory (HTAL); Keck Biophysics Facility; Northwestern University Flow Cytometry Facility; Cancer Center; National Science Foundation(National Science Foundation (NSF)); Robert H. Lurie Comprehensive Cancer Center (RHLCC) of Northwestern University; McCormick Summer Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Imaging work was performed at the Northwestern University Center for Advanced Molecular Imaging (CAMI), generously supported by NCI CCSG P30 CA060553 awarded to the Robert H. Lurie Comprehensive Cancer Center. Portions of this research were performed at the Keck-II and EPIC cores of the Northwestern University Atomic and Nanoscale Characterization Experimental (NUANCE) Center. The NUANCE Center is supported by the MRSEC program (NSF DMR-1121262) at the Material Research Center, the International Institute for Nanotechnology (IIN), the Keck Foundation, and the State of Illinois. Additional material characterization experiments were carrieed out with the support of the Northwestern University High Throughput Analysis Laboratory (HTAL) and Keck Biophysics Facility. This work was further supported by the Northwestern University Flow Cytometry Facility and a Cancer Center Support Grant (NCI CA060553). DCZL was supported by a National Science Foundation Graduate Research Fellowship (DGE-0824162; http://www.fastlane.nsf.gov/grfp) and a Malkin Scholar Award from the Robert H. Lurie Comprehensive Cancer Center (RHLCC) of Northwestern University (http://cancer.northwestern.edu/research/research_programs/funding/). CMF was supported by a McCormick Summer Research Award (http://www.mccormick.northwestern.edu/students/undergraduate/research-opportunities/). Additional support was provided by NIH grants R01 EB005772 and R37 DE014193 (PBM; http://report.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkilany AM, 2012, ADV DRUG DELIVER REV, V64, P190, DOI 10.1016/j.addr.2011.03.005; Alkilany AM, 2009, SMALL, V5, P701, DOI 10.1002/smll.200801546; AMIJI M, 1992, J BIOMAT SCI-POLYM E, V3, P375, DOI 10.1163/156856292X00196; Apostolopoulos V, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1505; Ball V, 2012, J COLLOID INTERF SCI, V386, P366, DOI 10.1016/j.jcis.2012.07.030; Black KCL, 2014, SMALL, V10, P169, DOI 10.1002/smll.201301283; Black KCL, 2013, NANOMEDICINE-UK, V8, P17, DOI [10.2217/NNM.12.82, 10.2217/nnm.12.82]; Brewer SH, 2005, LANGMUIR, V21, P9303, DOI 10.1021/la050588t; Carpin LB, 2011, BREAST CANCER RES TR, V125, P27, DOI 10.1007/s10549-010-0811-5; d'Ischia M, 2014, ACCOUNTS CHEM RES, V47, P3541, DOI 10.1021/ar500273y; Dalsin JL, 2005, MATER TODAY, V8, P38, DOI 10.1016/S1369-7021(05)71079-8; Danysh BP, 2012, THERANOSTICS, V2, P777, DOI 10.7150/thno.4494; Dickerson EB, 2008, CANCER LETT, V269, P57, DOI 10.1016/j.canlet.2008.04.026; Ding YH, 2014, LANGMUIR, V30, P12258, DOI 10.1021/la5026608; Dreyer DR, 2012, LANGMUIR, V28, P6428, DOI 10.1021/la204831b; El-Sayed IH, 2006, CANCER LETT, V239, P129, DOI 10.1016/j.canlet.2005.07.035; Feng J, 2014, RSC ADV, V4, P28683, DOI 10.1039/c4ra03122a; Fessler SP, 2009, BREAST CANCER RES TR, V118, P113, DOI 10.1007/s10549-009-0412-3; Finn OJ, 2008, J IMMUNOL, V181, P1589, DOI 10.4049/jimmunol.181.3.1589; Francis GL, 2010, CYTOTECHNOLOGY, V62, P1, DOI 10.1007/s10616-010-9263-3; Gelamo EL, 2002, BBA-PROTEIN STRUCT M, V1594, P84, DOI 10.1016/S0167-4838(01)00287-4; Gole A, 2005, CHEM MATER, V17, P1325, DOI 10.1021/cm048297d; Govorov AO, 2007, NANO TODAY, V2, P30, DOI 10.1016/S1748-0132(07)70017-8; Hong S, 2012, ADV FUNCT MATER, V22, P4711, DOI 10.1002/adfm.201201156; Horiguchi Y, 2008, LANGMUIR, V24, P12026, DOI 10.1021/la800811j; Housni A, 2008, J PHYS CHEM C, V112, P12282, DOI 10.1021/jp803890a; Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a; Huang XH, 2007, NANO LETT, V7, P1591, DOI 10.1021/nl070472c; Kamps JAAM, 1997, P NATL ACAD SCI USA, V94, P11681, DOI 10.1073/pnas.94.21.11681; Kouchakzadeh Hasan, 2012, Human Antibodies, V21, P49, DOI 10.3233/HAB-2012-0261; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222; Lynge ME, 2011, NANOSCALE, V3, P4916, DOI 10.1039/c1nr10969c; Mamedova NN, 2001, NANO LETT, V1, P281, DOI 10.1021/nl015519n; Melancon MP, 2008, MOL CANCER THER, V7, P1730, DOI 10.1158/1535-7163.MCT-08-0016; Mitchell S, 2002, NEOPLASIA, V4, P9, DOI 10.1038/sj.neo.7900194; Mukai H, 2010, JPN J CLIN ONCOL, V40, P711, DOI 10.1093/jjco/hyq037; Mukhopadhyay P, 2011, BBA-REV CANCER, V1815, P224, DOI 10.1016/j.bbcan.2011.01.001; Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4; Nath N, 2004, SURF SCI, V570, P98, DOI 10.1016/j.susc.2004.06.182; Niidome T, 2006, J CONTROL RELEASE, V114, P343, DOI 10.1016/j.jconrel.2006.06.017; Nitta T, 2000, CANCER-AM CANCER SOC, V88, P245, DOI 10.1002/(SICI)1097-0142(20000115)88:2<245::AID-CNCR1>3.0.CO;2-T; Norde W, 2000, J BIOTECHNOL, V79, P259, DOI 10.1016/S0168-1656(00)00242-X; Ogawara K, 2004, J CONTROL RELEASE, V100, P451, DOI 10.1016/j.jconrel.2004.07.028; PACKHAM MA, 1969, J LAB CLIN MED, V73, P686; Pattani VP, 2015, J NANOPART RES, V17, DOI 10.1007/s11051-014-2822-3; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; Proks V, 2013, MACROMOL CHEM PHYS, V214, P499, DOI 10.1002/macp.201200505; Raina D, 2009, CANCER RES, V69, P5133, DOI 10.1158/0008-5472.CAN-09-0854; Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8; REED RG, 1986, J BIOL CHEM, V261, P5619; Sanavio B, 2007, BBA-PROTEINS PROTEOM, V1774, P781, DOI 10.1016/j.bbapap.2007.04.019; Sayari E, 2014, INT J PHARMACEUT, V473, P304, DOI 10.1016/j.ijpharm.2014.05.041; Sedo J, 2013, ADV MATER, V25, P653, DOI 10.1002/adma.201202343; Sileika TS, 2011, ACS APPL MATER INTER, V3, P4602, DOI 10.1021/am200978h; Singh AV, 2005, J MATER CHEM, V15, P5115, DOI 10.1039/b510398c; SLOCUM TL, 1991, ANAL BIOCHEM, V195, P14, DOI 10.1016/0003-2697(91)90287-4; Statz AR, 2009, BIOINTERPHASES, V4, pFA22, DOI 10.1116/1.3115103; Takahashi H, 2006, LANGMUIR, V22, P2, DOI 10.1021/la0520029; Technology NIoSa, 2012, NIST XRAY PHOTOELECT; Tenzer S, 2013, NAT NANOTECHNOL, V8, P772, DOI 10.1038/nnano.2013.181; Treuel L, 2010, CHEMPHYSCHEM, V11, P3093, DOI 10.1002/cphc.201000174; von Maltzahn G, 2011, NAT MATER, V10, P545, DOI [10.1038/nmat3049, 10.1038/NMAT3049]; VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5; WAITE JH, 1985, J MAR BIOL ASSOC UK, V65, P359, DOI 10.1017/S0025315400050487; Walsh MD, 1999, BREAST CANCER RES TR, V58, P255; Wang LM, 2013, J AM CHEM SOC, V135, P17359, DOI 10.1021/ja406924v; Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684; Whitney JR, 2013, SINGLE WALLED CARBON; Willets KA, 2007, ANNU REV PHYS CHEM, V58, P267, DOI 10.1146/annurev.physchem.58.032806.104607; Wiogo HTR, 2011, LANGMUIR, V27, P843, DOI 10.1021/la104278m; Wu P, 2012, ANAL CHEM, V84, P7692, DOI 10.1021/ac3015164; Zhao F, 2011, SMALL, V7, P1322, DOI 10.1002/smll.201100001; ZHOU NE, 1992, J BIOL CHEM, V267, P2664; Zhou WB, 2010, CHEM COMMUN, V46, P1479, DOI 10.1039/b915125g	77	24	24	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0128756	10.1371/journal.pone.0128756	http://dx.doi.org/10.1371/journal.pone.0128756			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147830	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600016
J	Di Giulio, A; Maurizi, E; Barbero, F; Sala, M; Fattorini, S; Balletto, E; Bonelli, S				Di Giulio, Andrea; Maurizi, Emanuela; Barbero, Francesca; Sala, Marco; Fattorini, Simone; Balletto, Emilio; Bonelli, Simona			The Pied Piper: A Parasitic Beetle's Melodies Modulate Ant Behaviours	PLOS ONE			English	Article							PAUSSUS-FAVIERI COLEOPTERA; GENUS PHEIDOLE; CARABIDAE; HYMENOPTERA; ORGAN	Ants use various communication channels to regulate their social organisation. The main channel that drives almost all the ants' activities and behaviours is the chemical one, but it is long acknowledged that the acoustic channel also plays an important role. However, very little is known regarding exploitation of the acoustical channel by myrmecophile parasites to infiltrate the ant society. Among social parasites, the ant nest beetles (Paussus) are obligate myrmecophiles able to move throughout the colony at will and prey on the ants, surprisingly never eliciting aggression from the colonies. It has been recently postulated that stridulatory organs in Paussus might be evolved as an acoustic mechanism to interact with ants. Here, we survey the role of acoustic signals employed in the Paussus beetle-Pheidole ant system. Ants parasitised by Paussus beetles produce caste-specific stridulations. We found that Paussus can "speak" three different "languages", each similar to sounds produced by different ant castes (workers, soldiers, queen). Playback experiments were used to test how host ants respond to the sounds emitted by Paussus. Our data suggest that, by mimicking the stridulations of the queen, Paussus is able to dupe the workers of its host and to be treated as royalty. This is the first report of acoustic mimicry in a beetle parasite of ants.	[Di Giulio, Andrea; Maurizi, Emanuela] Univ Roma Tre, Dept Sci, I-00146 Rome, Italy; [Barbero, Francesca; Sala, Marco; Balletto, Emilio; Bonelli, Simona] Univ Turin, Dept Life Sci & Syst Biol, I-10123 Turin, Italy; [Fattorini, Simone] Azorean Biodivers Grp, Ctr Ecol Evolut & Environm Changes CE3C, P-9700042 Angra Do Heroismo, Acores, Portugal; [Fattorini, Simone] Univ Acores, Dept Ciencias Agr, P-9700042 Angra Do Heroismo, Acores, Portugal	Italfarmaco; Roma Tre University; University of Turin; Universidade dos Acores	Di Giulio, A (corresponding author), Univ Roma Tre, Dept Sci, Viale G Marconi 446, I-00146 Rome, Italy.	andrea.digiulio@uniroma3.it	Fattorini, Simone/AAR-8028-2020; Di Giulio, Andrea/E-7064-2012; Fattorini, Simone/E-7075-2012; Barbero, Francesca/J-3555-2016	Fattorini, Simone/0000-0002-4517-2135; Di Giulio, Andrea/0000-0003-0508-0751; Fattorini, Simone/0000-0002-4517-2135; Barbero, Francesca/0000-0003-2667-0435; BALLETTO, Emilio/0000-0003-1168-2791; Bonelli, Simona/0000-0001-5185-8136	project CLIMIT funded through the FP6 BiodivERsA Eranet; German Federal Ministry of Education and Research; Italian Ministry of Education, University and Research (MIUR)	project CLIMIT funded through the FP6 BiodivERsA Eranet; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	Collecting field trip was possible thanks to ADG research grants (CLAR Di Giulio, University Roma Tre, Roma, IT) to ADG. Research was conducted within the project CLIMIT funded through the FP6 BiodivERsA Eranet and the German Federal Ministry of Education and Research. Part of the research was funded by the Italian Ministry of Education, University and Research (MIUR) within the project "A multitaxa approach to study the impact of climate change on the biodiversity of Italian ecosystems" to EB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbero F, 2009, J EXP BIOL, V212, P4084, DOI 10.1242/jeb.032912; Barbero F, 2009, SCIENCE, V323, P782, DOI 10.1126/science.1163583; Casacci LP, 2013, CURR BIOL, V23, P323, DOI 10.1016/j.cub.2013.01.010; Chiu YK, 2011, ANN ENTOMOL SOC AM, V104, P1012, DOI 10.1603/AN11027; Cushing P. E., 2012, PSYCHE-J ENTOMOL, V2012, P1, DOI DOI 10.1155/2012/151989; DARLINGTON P. J., 1950, TRANS AMER ENT SOC, V76, P47; de CARVALHO ED LUNA, 1951, MEM E ESTUD MUS ZOOL UNIV COIMBRA, V207, P1; Di Giulio A, 2008, ZOOTAXA, P37; Di Giulio A, 2014, EUR J ENTOMOL, V111, P692, DOI 10.14411/eje.2014.083; Di Giulio A, 2012, MICRON, V43, P705, DOI 10.1016/j.micron.2011.10.013; Di Giulio A, 2011, EUR J ENTOMOL, V108, P127, DOI 10.14411/eje.2011.016; Di Giulio A, 2009, ARTHROPOD STRUCT DEV, V38, P293, DOI 10.1016/j.asd.2009.01.001; Ferreira RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015363; Fiedler Konrad, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/153975; Geiselhardt SF, 2007, NATURWISSENSCHAFTEN, V94, P871, DOI 10.1007/s00114-007-0271-x; HOLLDOBLER B, 1985, BEHAV ECOL SOCIOBIOL, V18, P45; HOLLDOBLER B, 1985, Israel Journal of Entomology, V19, P89; Holldobler B., 1990, pi; Lenoir A., 1982, SOCIAL INSECTS TROPI, V1, P157; Luna de Carvalho E., 1989, MEMORIAS I INVESTIGA, V2, P1; MARKL H, 1965, SCIENCE, V149, P1392, DOI 10.1126/science.149.3690.1392; MARKL H, 1967, Z VERGL PHYSIOL, V57, P299, DOI 10.1007/BF00303001; Maurizi E., 2012, Psyche: A Journal of Entomology, V2012, P940315, DOI 10.1155/2012/940315; MENZEL JG, 1994, TISSUE CELL, V26, P735, DOI 10.1016/0040-8166(94)90056-6; Moore W, 2014, CURR BIOL, V24, P2435, DOI 10.1016/j.cub.2014.09.022; Parker J, 2014, CURR BIOL, V24, P2428, DOI 10.1016/j.cub.2014.08.068; Ruiz E, 2006, ANN SOC ENTOMOL FR, V42, P99, DOI 10.1080/00379271.2006.10697454; Sala M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094341; Sempo G, 2004, INSECT SOC, V51, P48, DOI 10.1007/s00040-003-0704-2; Sempo G, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.0301; TAUTZ J, 1995, SCIENCE, V267, P84, DOI 10.1126/science.267.5194.84; Thomas Jeremy A., 2005, P479, DOI 10.1079/9780851998121.0479; Westwood JO, 1874, THESAURUS ENTOMOLOGI, P72; WILSON EDWARD O., 1962, ANIMAL BEHAVIOR, V10, P134, DOI 10.1016/0003-3472(62)90141-0; WILSON EO, 1984, BEHAV ECOL SOCIOBIOL, V16, P89, DOI 10.1007/BF00293108	35	23	26	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130541	10.1371/journal.pone.0130541	http://dx.doi.org/10.1371/journal.pone.0130541			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154266	Green Submitted, Green Published, gold			2022-12-27	WOS:000358159700033
J	Hintz, F; Meyer, AS				Hintz, Florian; Meyer, Antje S.			Prediction and Production of Simple Mathematical Equations: Evidence from Visual World Eye-Tracking	PLOS ONE			English	Article							LANGUAGE COMPREHENSION; SPEECH PRODUCTION; LEXICAL ACCESS; SENTENCE PRODUCTION; COGNITIVE DOMAINS; TIME-COURSE; MOVEMENTS; BRAIN; SPEAKING; MODELS	The relationship between the production and the comprehension systems has recently become a topic of interest for many psycholinguists. It has been argued that these systems are tightly linked and in particular that listeners use the production system to predict upcoming content. In this study, we tested how similar production and prediction processes are in a novel version of the visual world paradigm. Dutch speaking participants (native speakers in Experiment 1; German-Dutch bilinguals in Experiment 2) listened to mathematical equations while looking at a clock face featuring the numbers 1 to 12. On alternating trials, they either heard a complete equation ("three plus eight is eleven") or they heard the first part ("three plus eight is") and had to produce the result ("eleven") themselves. Participants were encouraged to look at the relevant numbers throughout the trial. Their eye movements were recorded and analyzed. We found that the participants' eye movements in the two tasks were overall very similar. They fixated the first and second number of the equations shortly after they were mentioned, and fixated the result number well before they named it on production trials and well before the recorded speaker named it on comprehension trials. However, all fixation latencies were shorter on production than on comprehension trials. These findings suggest that the processes involved in planning to say a word and anticipating hearing a word are quite similar, but that people are more aroused or engaged when they intend to respond than when they merely listen to another person.	[Hintz, Florian; Meyer, Antje S.] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Hintz, Florian] Int Max Planck Res Sch Language Sci, Nijmegen, Netherlands; [Meyer, Antje S.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Max Planck Society; Max Planck Society; Radboud University Nijmegen	Hintz, F (corresponding author), Max Planck Inst Psycholinguist, Nijmegen, Netherlands.	florian.hintz@mpi.nl		Hintz, Florian/0000-0002-2444-3303	Max Planck Society for the Advancement of Science	Max Planck Society for the Advancement of Science(Max Planck Society)	This work was supported by the Max Planck Society for the Advancement of Science (www.mpg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allopenna PD, 1998, J MEM LANG, V38, P419, DOI 10.1006/jmla.1997.2558; Altmann GTM, 2009, COGNITIVE SCI, V33, P583, DOI 10.1111/j.1551-6709.2009.01022.x; Altmann GTM, 2009, COGNITION, V111, P55, DOI 10.1016/j.cognition.2008.12.005; Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, LME4 LINEAR MIXED EF; Bock K, 2003, J MEM LANG, V48, P653, DOI 10.1016/S0749-596X(03)00007-X; Bock K, 2007, ADV BEHAV BRAIN SCI, P21; Boersma P., 2002, PRAAT SYSTEM DOING P; Bonifacci P, 2011, DEVELOPMENTAL SCI, V14, P256, DOI 10.1111/j.1467-7687.2010.00974.x; Caramazza A, 1997, COGNITIVE NEUROPSYCH, V14, P177, DOI 10.1080/026432997381664; Chang F, 2006, PSYCHOL REV, V113, P234, DOI 10.1037/0033-295X.113.2.234; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Clark HH, 2004, J MEM LANG, V50, P62, DOI 10.1016/j.jml.2003.08.004; Costa A, 2000, J EXP PSYCHOL LEARN, V26, P1283, DOI 10.1037//0278-7393.26.5.1283; Dell GS, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0394; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; DeLong KA, 2005, NAT NEUROSCI, V8, P1117, DOI 10.1038/nn1504; Federmeier KD, 2007, PSYCHOPHYSIOLOGY, V44, P491, DOI 10.1111/j.1469-8986.2007.00531.x; Federmeier KD, 2010, BRAIN LANG, V115, P149, DOI 10.1016/j.bandl.2010.07.006; Federmeier KD, 1999, J MEM LANG, V41, P469, DOI 10.1006/jmla.1999.2660; Federmeier KD, 2002, PSYCHOPHYSIOLOGY, V39, P133, DOI 10.1111/1469-8986.3920133; Ferreira F, 2002, J MEM LANG, V46, P57, DOI 10.1006/jmla.2001.2797; Foucart A, 2014, J EXP PSYCHOL LEARN, V40, P1461, DOI 10.1037/a0036756; Gagnepain P, 2012, CURR BIOL, V22, P615, DOI 10.1016/j.cub.2012.02.015; Garrett M., 1980, LANGUAGE PRODUCTION, V1, P177; Gilbert DT, 2007, SCIENCE, V317, P1351, DOI 10.1126/science.1144161; Griffin ZM, 2000, PSYCHOL SCI, V11, P274, DOI 10.1111/1467-9280.00255; Hintz F, 2015, P 28 CUNY C HUM SENT; Huettig F, 2015, BRAIN RES, V1626, P118, DOI 10.1016/j.brainres.2015.02.014; Huettig F, 2011, ACTA PSYCHOL, V137, P151, DOI 10.1016/j.actpsy.2010.11.003; Knoeferle P, 2005, COGNITION, V95, P95, DOI 10.1016/j.cognition.2004.03.002; Korvorst M, 2007, EXP PSYCHOL, V54, P187, DOI 10.1027/1618-3169.54.3.187; Kroll J. F., 2005, HDB BILINGUALISM PSY, P289; Kubose TT, 2006, APPL COGNITIVE PSYCH, V20, P43, DOI 10.1002/acp.1164; Kuchinsky SE, 2011, J EXP PSYCHOL LEARN, V37, P748, DOI 10.1037/a0022637; Kukona A, 2011, COGNITION, V119, P23, DOI 10.1016/j.cognition.2010.12.002; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; Kutas M., 2011, PREDICTIONBRAIN US, P190, DOI DOI 10.1093/ACPROF:OSO/9780195395518.003.0065; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Levelt WJM, 1999, TRENDS COGN SCI, V3, P223, DOI 10.1016/S1364-6613(99)01319-4; MACDONALD MC, 2013, FRONT PSYCHOL, V0004; Mani N, 2012, J EXP PSYCHOL HUMAN, V38, P843, DOI 10.1037/a0029284; McCauley S, 2011, ANN C COGN SCI SOC; Meyer A, 2004, VIS COGN, V11, P553, DOI 10.1080/13506280344000248; Meyer AS, 1998, COGNITION, V66, pB25, DOI 10.1016/S0010-0277(98)00009-2; Pickering MJ, 2007, TRENDS COGN SCI, V11, P105, DOI 10.1016/j.tics.2006.12.002; Pickering MJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00132; Pickering MJ, 2013, BEHAV BRAIN SCI, V36, P329, DOI 10.1017/S0140525X12001495; R Core Team, 2012, R LANG ENV STAT COMP; Rapp B, 2013, LANG COGN NEUROSCI, V29, P24; Roelofs A, 1997, COGNITION, V64, P249, DOI 10.1016/S0010-0277(97)00027-9; Runnqvist E, 2013, COGNITION, V129, P256, DOI 10.1016/j.cognition.2013.07.008; Sadat J, 2012, J PSYCHOLINGUIST RES, V41, P159, DOI 10.1007/s10936-011-9183-1; SASLOW MG, 1967, J OPT SOC AM, V57, P1030, DOI 10.1364/JOSA.57.001030; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Scheepers C, 2014, Q J EXP PSYCHOL, V67, P1643, DOI 10.1080/17470218.2013.873815; Scheepers C, 2011, PSYCHOL SCI, V22, P1319, DOI 10.1177/0956797611416997; Sjerps MJ, 2015, COGNITION, V136, P304, DOI 10.1016/j.cognition.2014.10.008; Spalek K, 2014, COGNITION, V133, P226, DOI 10.1016/j.cognition.2014.06.016; Szewczyk JM, 2013, J MEM LANG, V68, P297, DOI 10.1016/j.jml.2012.12.002; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Van Berkum JJA, 2005, J EXP PSYCHOL LEARN, V31, P443, DOI 10.1037/0278-7393.31.3.443; Van Berkum JJA, 2010, ITAL J LINGUIST, V22, P181; van Heuven WJB, 2010, BRAIN RES REV, V64, P104, DOI 10.1016/j.brainresrev.2010.03.002; Wicha NYY, 2003, CORTEX, V39, P483, DOI 10.1016/S0010-9452(08)70260-0	68	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130766	10.1371/journal.pone.0130766	http://dx.doi.org/10.1371/journal.pone.0130766			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26154431	Green Published, gold, Green Submitted			2022-12-27	WOS:000358159700038
J	Bokka, KK; Jesudason, EC; Lozoya, OA; Guilak, F; Warburton, D; Lubkin, SR				Bokka, Kishore K.; Jesudason, Edwin C.; Lozoya, Oswaldo A.; Guilak, Farshid; Warburton, David; Lubkin, Sharon R.			Morphogenetic Implications of Peristalsis-Driven Fluid Flow in the Embryonic Lung	PLOS ONE			English	Article							PARTICLE-TRACKING MICRORHEOLOGY; FORCES; LIQUID	Epithelial organs are almost universally secretory. The lung secretes mucus of extremely variable consistency. In the early prenatal period, the secretions are of largely unknown composition, consistency, and flow rates. In addition to net outflow from secretion, the embryonic lung exhibits transient reversing flows from peristalsis. Airway peristalsis (AP) begins as soon as the smooth muscle forms, and persists until birth. Since the prenatal lung is liquid-filled, smooth muscle action can transport fluid far from the immediately adjacent tissues. The sensation of internal fluid flows has been shown to have potent morphogenetic effects, as has the transport of morphogens. We hypothesize that these effects play an important role in lung morphogenesis. To test these hypotheses in a quantitative framework, we analyzed the fluid-structure interactions between embryonic tissues and lumen fluid resulting from peristaltic waves that partially occlude the airway. We found that if the airway is closed, fluid transport is minimal; by contrast, if the trachea is open, shear rates can be very high, particularly at the stenosis. We performed a parametric analysis of flow characteristics' dependence on tissue stiffnesses, smooth muscle force, geometry, and fluid viscosity, and found that most of these relationships are governed by simple ratios. We measured the viscosity of prenatal lung fluid with passive bead microrheology. This paper reports the first measurements of the viscosity of embryonic lung lumen fluid. In the range tested, lumen fluid can be considered Newtonian, with a viscosity of 0.016 +/- 0.008 Pa-s. We analyzed the interaction between the internal flows and diffusion and conclude that AP has a strong effect on flow sensing away from the tip and on transport of morphogens. These effects may be the intermediate mechanisms for the enhancement of branching seen in occluded embryonic lungs.	[Bokka, Kishore K.] N Carolina State Univ, Dept Mech Engn, Raleigh, NC 27695 USA; [Jesudason, Edwin C.] Natl Hlth Serv NHS, Edinburgh, Midlothian, Scotland; [Lozoya, Oswaldo A.; Guilak, Farshid] Duke Univ, Med Ctr, Dept Orthopaed Surg, Orthopaed Res Labs, Durham, NC USA; [Warburton, David] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Lubkin, Sharon R.] N Carolina State Univ, Dept Math, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; Duke University; Children's Hospital Los Angeles; University of North Carolina; North Carolina State University	Lubkin, SR (corresponding author), N Carolina State Univ, Dept Math, Box 8205, Raleigh, NC 27695 USA.	lubkin@ncsu.edu	Guilak, Farshid/AAF-8558-2020; Warburton, David/AAD-5709-2020; Lubkin, Sharon/F-8802-2011	Guilak, Farshid/0000-0001-7380-0330; Lubkin, Sharon/0000-0003-2521-0699; Lozoya, Oswaldo/0000-0001-6779-7382	National Institutes of Health [R01 GM096195, T32 AI007217]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health (http://www.nih.gov/ R01 GM096195) (SRL, KKB, DW) and T32 AI007217 (OAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIS R, 1956, PROC R SOC LON SER-A, V235, P67, DOI 10.1098/rspa.1956.0065; Blewett CJ, 1996, J PEDIATR SURG, V31, P869, DOI 10.1016/S0022-3468(96)90400-5; Bokka KK, MORPHOGENETIC IMPLIC; Bokka KK, J THEOR BIO IN PRESS; BURNS JC, 1967, J FLUID MECH, V29, P731, DOI 10.1017/S0022112067001156; Fabry B, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.041914; Freund JB, 2012, DEVELOPMENT, V139, P1229, DOI 10.1242/dev.073593; George UZ, QUANTIFYING STRETCH; Harding R, 1996, J APPL PHYSIOL, V81, P209, DOI 10.1152/jappl.1996.81.1.209; HARDING R, 1984, RESP PHYSIOL, V57, P47, DOI 10.1016/0034-5687(84)90032-X; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; JAFFRIN MY, 1971, ANNU REV FLUID MECH, V3, P13, DOI 10.1146/annurev.fl.03.010171.000305; Jain R, 2010, AM J RESP CELL MOL, V43, P731, DOI 10.1165/rcmb.2009-0328OC; KING M, 1977, J APPL PHYSIOL, V42, P797, DOI 10.1152/jappl.1977.42.6.797; Mason TG, 1997, PHYS REV LETT, V79, P3282, DOI 10.1103/PhysRevLett.79.3282; McDermott KM, 2010, CURR BIOL, V20, P731, DOI 10.1016/j.cub.2010.02.048; Miller CJ, 2013, NAT REV GENET, V14, P733, DOI 10.1038/nrg3513; MOTTA C, 1985, CLIN CHIM ACTA, V153, P157, DOI 10.1016/0009-8981(85)90347-X; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Nelson CM, 2012, ANNU REV BIOMED ENG, V14, P129, DOI [10.1146/annurev-bioeng-071811-150043, 10.1146/annurev.bioeng-071811-150043]; Olver RE, 2004, ANNU REV PHYSIOL, V66, P77, DOI 10.1146/annurev.physiol.66.071702.145229; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; RATH HJ, 1982, INT J MECH SCI, V24, P359, DOI 10.1016/0020-7403(82)90069-8; Schittny JC, 2000, AM J RESP CELL MOL, V23, P11, DOI 10.1165/ajrcmb.23.1.3926; SHAPIRO AH, 1969, J FLUID MECH, V37, P799, DOI 10.1017/S0022112069000899; SPARROW MP, 1990, J APPL PHYSIOL, V68, P468, DOI 10.1152/jappl.1990.68.2.468; Tang N, 2011, SCIENCE, V333, P342, DOI 10.1126/science.1204831; TAYLOR G, 1953, PROC R SOC LON SER-A, V219, P186, DOI 10.1098/rspa.1953.0139; VILOS G A, 1982, Journal of Developmental Physiology (Eynsham), V4, P247; Wiebe C, 2005, J BIOMECH, V38, P2087, DOI 10.1016/j.jbiomech.2004.09.005; Wirtz D, 2009, ANNU REV BIOPHYS, V38, P301, DOI 10.1146/annurev.biophys.050708.133724; YIN FCP, 1971, J FLUID MECH, V47, P93, DOI 10.1017/S0022112071000958	32	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132015	10.1371/journal.pone.0132015	http://dx.doi.org/10.1371/journal.pone.0132015			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147967	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600180
J	Liang, XL; Chen, QF; Lei, Y; Li, H				Liang, Xiuling; Chen, Qingfei; Lei, Yi; Li, Hong			The Processing of Causal and Hierarchical Relations in Semantic Memory as Revealed by N400 and Frontal Negativity	PLOS ONE			English	Article							THEMATIC RELATIONS; OBJECT CATEGORIZATION; TIME-COURSE; KNOWLEDGE; COMPONENT; REPRESENTATIONS; POTENTIALS; SIMILARITY; DIFFERENCE; FMRI	Most current studies investigating semantic memory have focused on associative (ringemerald) or taxonomic relations (bird-sparrow). Little is known about the question of how causal relations (virus-epidemic) are stored and accessed in semantic memory. The goal of this study was to examine the processing of causally related, general associatively related and hierarchically related word pairs when participants were required to evaluate whether pairs of words were related in any way. The ERP data showed that the N400 amplitude (200-500ms) elicited by unrelated related words was more negative than all related words. Furthermore, the late frontal distributed negativity (500-700ms) elicited by causally related words was smaller than hierarchically related words, but not for general associated words. These results suggested the processing of causal relations and hierarchical relations in semantic memory recruited different degrees of cognitive resources, especially for role binding.	[Liang, Xiuling; Lei, Yi; Li, Hong] Shenzhen Univ, Res Ctr Brain Funct & Psychol Sci, Shenzhen, Peoples R China; [Chen, Qingfei] Shenzhen Univ, Res Ctr Special Econ Zone Res, Shenzhen, Peoples R China	Shenzhen University; Shenzhen University	Lei, Y (corresponding author), Shenzhen Univ, Res Ctr Brain Funct & Psychol Sci, Shenzhen, Peoples R China.	leiyi821@vip.sina.com			National Natural Science Foundation of China [31100740, 31271088, 31400961, 30370488]; MOE Project of Key Research Institute of Humanities and Social Sciences at Universities [11JJD190002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOE Project of Key Research Institute of Humanities and Social Sciences at Universities	This study was supported by the National Natural Science Foundation of China (31100740, 31271088, 31400961, and 30370488) and the MOE Project of Key Research Institute of Humanities and Social Sciences at Universities (11JJD190002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JE, 1995, PSYCHOPHYSIOLOGY, V32, P177, DOI 10.1111/j.1469-8986.1995.tb03310.x; Barr N, 2010, EXPLORING ASYMMETRIC; Blakemore SJ, 2001, NEUROREPORT, V12, P3741, DOI 10.1097/00001756-200112040-00027; Buehner MJ., 2005, CAUSAL LEARNING; Chen QF, 2015, ACTA PSYCHOL, V157, P176, DOI 10.1016/j.actpsy.2015.02.017; Chen QF, 2014, NEUROPSYCHOLOGIA, V64, P54, DOI 10.1016/j.neuropsychologia.2014.09.013; Chen QF, 2014, J COGN PSYCHOL, V26, P559, DOI 10.1080/20445911.2014.927877; Chen QF, 2013, INT J PSYCHOPHYSIOL, V90, P135, DOI 10.1016/j.ijpsycho.2013.06.015; Chwilla DJ, 2005, COGNITIVE BRAIN RES, V25, P589, DOI 10.1016/j.cogbrainres.2005.08.011; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Estes Z, 2011, PSYCHOL LEARN MOTIV, V54, P249, DOI 10.1016/B978-0-12-385527-5.00008-5; Fenker DB, 2010, J COGNITIVE NEUROSCI, V22, P2151, DOI 10.1162/jocn.2009.21387; Fenker DB, 2005, MEM COGNITION, V33, P1036, DOI 10.3758/BF03193211; Fugelsang JA, 2005, COGNITIVE BRAIN RES, V24, P41, DOI 10.1016/j.cogbrainres.2004.12.001; Fugelsang JA, 2005, NEUROPSYCHOLOGIA, V43, P1204, DOI 10.1016/j.neuropsychologia.2004.10.012; Fugelsang Jonathan, 2009, P269; Holcomb PJ, 2009, J NEUROLINGUIST, V22, P301, DOI 10.1016/j.jneuroling.2008.06.004; Hummel JE, 2003, PSYCHOL REV, V110, P220, DOI 10.1037/0033-295X.110.2.220; Keil A, 2014, PSYCHOPHYSIOLOGY, V51, P1, DOI 10.1111/psyp.12147; Khateb A, 2003, INT J PSYCHOPHYSIOL, V49, P41, DOI 10.1016/S0167-8760(03)00076-X; Kuperberg GR, 2011, J COGNITIVE NEUROSCI, V23, P1230, DOI 10.1162/jocn.2010.21452; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Large ME, 2004, COGNITIVE BRAIN RES, V20, P415, DOI 10.1016/j.cogbrainres.2004.03.013; Lin EL, 2001, J EXP PSYCHOL GEN, V130, P3, DOI 10.1037/0096-3445.130.1.3; Luck S.J., 2005, INTRO EVENT RELATED; Mason RA, 2004, PSYCHOL SCI, V15, P1, DOI 10.1111/j.0963-7214.2004.01501001.x; Paczynski M, 2012, J MEM LANG, V67, P426, DOI 10.1016/j.jml.2012.07.003; Rabovsky M, 2014, COGNITION, V132, P68, DOI 10.1016/j.cognition.2014.03.010; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; Rossell SL, 2003, NEUROPSYCHOLOGIA, V41, P550, DOI 10.1016/S0028-3932(02)00181-1; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Sass K, 2009, BRAIN RES, V1270, P78, DOI 10.1016/j.brainres.2009.03.013; Satpute AB, 2005, EUR J NEUROSCI, V22, P1233, DOI 10.1111/j.1460-9568.2005.04292.x; Simmons S, 2008, COGNITION, V108, P781, DOI 10.1016/j.cognition.2008.07.003; Tanaka J, 1999, NEUROREPORT, V10, P829, DOI 10.1097/00001756-199903170-00030; Turner DC, 2004, CEREB CORTEX, V14, P872, DOI 10.1093/cercor/bhh046	37	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132679	10.1371/journal.pone.0132679	http://dx.doi.org/10.1371/journal.pone.0132679			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26148338	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600310
J	Qu, Y; Han, BC; Yu, Y; Yao, WW; Bose, S; Karlan, BY; Giuliano, AE; Cui, XJ				Qu, Ying; Han, Bingchen; Yu, Yi; Yao, Weiwu; Bose, Shikha; Karlan, Beth Y.; Giuliano, Armando E.; Cui, Xiaojiang			Evaluation of MCF10A as a Reliable Model for Normal Human Mammary Epithelial Cells	PLOS ONE			English	Article							CANCER STEM-CELLS; BREAST-CANCER; IN-VITRO; MYOEPITHELIAL CELLS; GENE-EXPRESSION; GLAND; LINES; PROLIFERATION; MORPHOGENESIS; MARKERS	Breast cancer is the most common cancer in women and a leading cause of cancer-related deaths for women worldwide. Various cell models have been developed to study breast cancer tumorigenesis, metastasis, and drug sensitivity. The MCF10A human mammary epithelial cell line is a widely used in vitro model for studying normal breast cell function and transformation. However, there is limited knowledge about whether MCF10A cells reliably represent normal human mammary cells. MCF10A cells were grown in monolayer, suspension (mammosphere culture), three-dimensional (3D) "on-top" Matrigel, 3D "cell-embedded" Matrigel, or mixed Matrigel/collagen I gel. Suspension culture was performed with the MammoCult medium and low-attachment culture plates. Cells grown in 3D culture were fixed and subjected to either immunofluorescence staining or embedding and sectioning followed by immunohistochemistry and immunofluorescence staining. Cells or slides were stained for protein markers commonly used to identify mammary progenitor and epithelial cells. MCF10A cells expressed markers representing luminal, basal, and progenitor phenotypes in two-dimensional (2D) culture. When grown in suspension culture, MCF10A cells showed low mammosphere-forming ability. Cells in mammospheres and 3D culture expressed both luminal and basal markers. Surprisingly, the acinar structure formed by MCF10A cells in 3D culture was positive for both basal markers and the milk proteins beta-casein and alpha-lactalbumin. MCF10A cells exhibit a unique differentiated phenotype in 3D culture which may not exist or be rare in normal human breast tissue. Our results raise a question as to whether the commonly used MCF10A cell line is a suitable model for human mammary cell studies.	[Qu, Ying; Han, Bingchen; Yu, Yi; Giuliano, Armando E.; Cui, Xiaojiang] Cedars Sinai Med Ctr, Dept Surg, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Karlan, Beth Y.; Cui, Xiaojiang] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Womens Canc Program, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Bose, Shikha] Cedars Sinai Med Ctr, Dept Pathol, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Yao, Weiwu] Shanghai Jiao Tong Univ, Dept Radiol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Shanghai Jiao Tong University	Cui, XJ (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA.	Xiaojiang.cui@cshs.org			National Institutes of Health [CA151610]; Avon Foundation [02-2014-063]; David Salomon Translational Breast Cancer Research Fund; Fashion Footwear Charitable Foundation of New York, Inc.; Margie and Robert E. Petersen Foundation; NATIONAL CANCER INSTITUTE [R01CA151610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Avon Foundation; David Salomon Translational Breast Cancer Research Fund; Fashion Footwear Charitable Foundation of New York, Inc.; Margie and Robert E. Petersen Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (CA151610), the Avon Foundation (02-2014-063), David Salomon Translational Breast Cancer Research Fund to XC, and the Fashion Footwear Charitable Foundation of New York, Inc. and the Margie and Robert E. Petersen Foundation to AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Petersen BL, 2014, ONCOGENE, V33, P1306, DOI 10.1038/onc.2013.59; Batistatou A, 2003, IN VIVO, V17, P573; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Chimal-Ramirez GK, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/279505; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Duss S, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3673; Gerdes MJ, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00366; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gudjonsson T, 2005, J MAMMARY GLAND BIOL, V10, P261, DOI 10.1007/s10911-005-9586-4; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Keller PJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2755; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Knudsen KA, 2005, J CELL BIOCHEM, V95, P488, DOI 10.1002/jcb.20419; Krause S, 2008, TISSUE ENG PT C-METH, V14, P261, DOI 10.1089/ten.tec.2008.0030; Krause S, 2012, TISSUE ENG PT A, V18, P520, DOI [10.1089/ten.tea.2011.0317, 10.1089/ten.TEA.2011.0317]; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Liu SL, 2014, STEM CELL REP, V2, P78, DOI 10.1016/j.stemcr.2013.11.009; Liu Y, 2014, BRIT J CANCER, V110, P2063, DOI 10.1038/bjc.2014.105; Lombardo Y, 2012, P NATL ACAD SCI USA, V109, P16558, DOI 10.1073/pnas.1206268109; Maningat PD, 2009, PHYSIOL GENOMICS, V37, P12, DOI 10.1152/physiolgenomics.90341.2008; Manuel Iglesias J, 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0077281; Moriya T, 2009, PATHOLOGY, V41, P68, DOI 10.1080/00313020802563544; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Petersen OW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003160; Putti TC, 2005, MODERN PATHOL, V18, P26, DOI 10.1038/modpathol.3800255; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Sadlonova A, 2005, BREAST CANCER RES, V7, pR46, DOI 10.1186/bcr949; Santagata S, 2014, J CLIN INVEST, V124, P859, DOI 10.1172/JCI70941; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Sarrio D, 2012, STEM CELLS, V30, P292, DOI 10.1002/stem.791; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Sonnenschein C, 2008, SEMIN CANCER BIOL, V18, P372, DOI 10.1016/j.semcancer.2008.03.012; SOULE HD, 1990, CANCER RES, V50, P6075; Stingl J, 2005, J MAMMARY GLAND BIOL, V10, P49, DOI 10.1007/s10911-005-2540-7; Sung KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076373; TAYLORPAPADIMITRIOU J, 1989, J CELL SCI, V94, P403; TROYANOVSKY SM, 1989, J CELL SCI, V93, P419; Tulsyan S, 2014, CANCER CHEMOTH PHARM, V74, P1065, DOI 10.1007/s00280-014-2588-4; Vares G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077124; Vegfors J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053119; Vidi Pierre-Alexandre, 2013, Methods Mol Biol, V945, P193, DOI 10.1007/978-1-62703-125-7_13	45	118	121	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131285	10.1371/journal.pone.0131285	http://dx.doi.org/10.1371/journal.pone.0131285			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147507	Green Published, gold			2022-12-27	WOS:000358157600084
J	Richards, T; Musallam, KM; Nassif, J; Ghazeeri, G; Seoud, M; Gurusamy, KS; Jamali, FR				Richards, Toby; Musallam, Khaled M.; Nassif, Joseph; Ghazeeri, Ghina; Seoud, Muhieddine; Gurusamy, Kurinchi S.; Jamali, Faek R.			Impact of Preoperative Anaemia and Blood Transfusion on Postoperative Outcomes in Gynaecological Surgery	PLOS ONE			English	Article							30-DAY MORTALITY; CARDIAC-SURGERY; OLDER PATIENTS; MANAGEMENT; CONSERVATION; ASSOCIATION; PREVALENCE; LEVEL; COLON	Objective To evaluate the effect of preoperative anaemia and blood transfusion on 30-day postoperative morbidity and mortality in patients undergoing gynecological surgery. Study Design Data were analyzed from 12,836 women undergoing operation in the American College of Surgeons National Surgical Quality Improvement Program. Outcomes measured were; 30-day postoperative mortality, composite and specific morbidities (cardiac, respiratory, central nervous system, renal, wound, sepsis, venous thrombosis, or major bleeding). Multivariate logistic regression models were performed using adjusted odds ratios (ORadj) to assess the independent effects of preoperative anaemia (hematocrit <36.0%) on outcomes, effect estimates were performed before and after adjustment for perioperative transfusion requirement. Results The prevalence of preoperative anaemia was 23.9% (95% CI: 23.2-24.7). Adjusted for confounders by multivariate logistic regression; preoperative anaemia was independently and significantly associated with increased odds of 30-day mortality (OR: 2.40, 95% CI: 1.06-5.44) and composite morbidity (OR: 1.80, 95% CI: 1.45-2.24). This was reflected by significantly higher adjusted odds of almost all specific morbidities including; respiratory, central nervous system, renal, wound, sepsis, and venous thrombosis. Blood Transfusion increased the effect of preoperative anaemia on outcomes (61% of the effect on mortality and 16% of the composite morbidity). Conclusions Preoperative anaemia is associated with adverse post-operative outcomes in women undergoing gynecological surgery. This risk associated with preoperative anaemia did not appear to be corrected by use of perioperative transfusion.	[Richards, Toby; Gurusamy, Kurinchi S.] Univ Coll London Hosp, Div Surg & Intervent Sci, London, England; [Musallam, Khaled M.] Amer Univ Beirut, Med Ctr, Dept Internal Med, Beirut, Lebanon; [Nassif, Joseph; Ghazeeri, Ghina; Seoud, Muhieddine] Amer Univ Beirut, Med Ctr, Dept Obstet & Gynaecol, Beirut, Lebanon; [Jamali, Faek R.] Amer Univ Beirut, Med Ctr, Dept Surg, Beirut, Lebanon	University College London Hospitals NHS Foundation Trust; University of London; University College London; American University of Beirut; American University of Beirut; American University of Beirut	Jamali, FR (corresponding author), Amer Univ Beirut, Med Ctr, Dept Surg, Beirut, Lebanon.	fj03@aub.edu.lb	Richards, Toby/K-6547-2013	Gurusamy, Kurinchi/0000-0002-0313-9134; Musallam, Khaled/0000-0003-3935-903X; Nassif, Joseph/0000-0003-0937-6533	NIHR HTA; Health Foundation; Gideon Richter; Vifor Pharma Ltd; Pharmocosmos; National Institute for Health Research [10/104/06] Funding Source: researchfish	NIHR HTA; Health Foundation; Gideon Richter; Vifor Pharma Ltd; Pharmocosmos; National Institute for Health Research(National Institute for Health Research (NIHR))	UCL and the research program led by TR has received research funding from a variety of sources (19) including government, charity and industry sources for research into anaemia, blood transfusion and iron therapy including, NIHR HTA, Health Foundation, Gideon Richter, Vifor Pharma Ltd, Pharmocosmos. TR has also been the invited speaker at over 50 conferences on anaemia, blood transfusion and iron therapy in the last 5 years. KMM received consultancy fees and travel support from Vifor Pharma Ltd. ES received honoraria from Gideon Richter and Ethicon for provision of training to healthcare professionals. FRJ received research funding from Vifor Pharma Ltd. The remaining authors have no conflicts of interest to disclose. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	[Anonymous], 2009, AM COLL SURG; [Anonymous], 1968, WHO TECHN REP SER; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Bernard AC, 2009, J AM COLL SURGEONS, V208, P931, DOI 10.1016/j.jamcollsurg.2008.11.019; Carson JL, 1996, LANCET, V348, P1055, DOI 10.1016/S0140-6736(96)04330-9; CARSON JL, 1988, LANCET, V1, P727; Clevenger B, 2015, ANAESTHESIA, V70, DOI 10.1111/anae.12918; Dunne JR, 2002, AM SURGEON, V68, P582; Ferraris VA, 2012, ARCH SURG-CHICAGO, V147, P49, DOI 10.1001/archsurg.2011.790; Fink AS, 2002, ANN SURG, V236, P344, DOI 10.1097/00000658-200209000-00011; Glance LG, 2011, ANESTHESIOLOGY, V114, P283, DOI 10.1097/ALN.0b013e3182054d06; Goodnough LT, 2005, ANESTH ANALG, V101, P1858, DOI 10.1213/01.ANE.0000184124.29397.EB; Hofmann A, 2011, ONCOLOGIST, V16, P3, DOI 10.1634/theoncologist.2011-S3-3; Hogue CW, 1998, TRANSFUSION, V38, P924, DOI 10.1046/j.1537-2995.1998.381098440856.x; Hung M, 2011, ANAESTHESIA, V66, P812, DOI 10.1111/j.1365-2044.2011.06819.x; JPAC-Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee, 2014, PAT BLOOD MAN; Khuri SF, 2007, J AM COLL SURGEONS, V204, P1089, DOI 10.1016/j.jamcollsurg.2007.03.028; Lasocki S, 2015, EUR J ANAESTH, V32, P160, DOI 10.1097/EJA.0000000000000202; Leichtle SW, 2011, J AM COLL SURGEONS, V212, P187, DOI 10.1016/j.jamcollsurg.2010.09.013; Moskowitz DM, 2010, ANN THORAC SURG, V90, P451, DOI 10.1016/j.athoracsur.2010.04.089; Moskowitz DM, 2004, ANN THORAC SURG, V77, P626, DOI 10.1016/S0003-4975(03)01345-6; Musallam KM, 2011, LANCET, V378, P1396, DOI 10.1016/S0140-6736(11)61381-0; Napolitano LM, 2005, SURG CLIN N AM, V85, P1215, DOI 10.1016/j.suc.2005.10.012; Richards T, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0774-2; Sabry M, 2012, REPROD SCI, V19, P339, DOI 10.1177/1933719111432867; Spahn DR, 2012, BRIT J ANAESTH, V108, P889, DOI 10.1093/bja/aes166; Spahn DR, 2013, BEST PRACT RES-CLIN, V27, P37, DOI 10.1016/j.bpa.2013.02.003; Spahn DR, 2010, ANESTHESIOLOGY, V113, P482, DOI 10.1097/ALN.0b013e3181e08e97; Spahn DR, 2008, ANESTHESIOLOGY, V109, P951, DOI 10.1097/ALN.0b013e31818e3d75; SPENCE RK, 1990, AM J SURG, V159, P320, DOI 10.1016/S0002-9610(05)81227-9; van Klei WA, 2001, BRIT J ANAESTH, V87, P250, DOI 10.1093/bja/87.2.250; Wu WC, 2007, JAMA-J AM MED ASSOC, V297, P2481, DOI 10.1001/jama.297.22.2481; Wu WC, 2010, ANN SURG, V252, P11, DOI 10.1097/SLA.0b013e3181e3e43f	33	56	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130861	10.1371/journal.pone.0130861	http://dx.doi.org/10.1371/journal.pone.0130861			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147954	Green Published, gold			2022-12-27	WOS:000358157600053
J	Shang, CJ; Chen, QS; Dell, A; Haslam, SM; De Vos, WH; Van Damme, EJM				Shang, Chenjing; Chen, Qiushi; Dell, Anne; Haslam, Stuart M.; De Vos, Winnok H.; Van Damme, Els J. M.			The Cytotoxicity of Elderberry Ribosome-Inactivating Proteins Is Not Solely Determined by Their Protein Translation Inhibition Activity	PLOS ONE			English	Article							SAMBUCUS-NIGRA; COLOCALIZATION ANALYSIS; GLYCOSIDASE ACTIVITY; MOLECULAR-CLONING; HELA-CELLS; RICIN; LECTIN; APOPTOSIS; BINDING; TOXIN	Although the protein translation inhibition activity of ribosome inactivating proteins (RIPs) is well documented, little is known about the contribution of the lectin chain to the biological activity of these proteins. In this study, we compared the in vitro and intracellular activity of several S. nigra (elderberry) RIPs and non-RIP lectins. Our data demonstrate that RIPs from elderberry are much more toxic to HeLa cells than to primary fibroblasts. Differences in the cytotoxicity between the elderberry proteins correlated with differences in glycan specificity of their lectin domain, cellular uptake efficiency and intracellular destination. Despite the fact that the bulk of the RIPs accumulated in the lysosomes and partly in the Golgi apparatus, we could demonstrate effective inhibition of protein synthesis in cellula. As we also observed cytotoxicity for non-RIP lectins, it is clear that the lectin chain triggers additional pathways heralding cell death. Our data suggest that one of these pathways involves the induction of autophagy.	[Shang, Chenjing; De Vos, Winnok H.; Van Damme, Els J. M.] Univ Ghent, Fac Biosci Engn, Dept Mol Biotechnol, B-9000 Ghent, Belgium; [Chen, Qiushi; Dell, Anne; Haslam, Stuart M.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Fac Nat Sci, London, England; [De Vos, Winnok H.] Univ Antwerp, Fac Pharmaceut Biomed & Vet Sci, Dept Vet Sci, Antwerp, Belgium	Ghent University; Imperial College London; University of Antwerp	Van Damme, EJM (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Mol Biotechnol, B-9000 Ghent, Belgium.	ElsJM.VanDamme@ugent.be	Van Damme, Els/U-3904-2019; Chen, QIUSHI/AAA-6358-2022; Van Damme, Els J/B-4410-2015; de vos, winnok/A-6445-2012	Van Damme, Els/0000-0001-9848-766X; de vos, winnok/0000-0003-0960-6781; Chen, Qiushi/0000-0001-8355-2801; Dell, Anne/0000-0003-1380-2347	Fund for Scientific Research-Flanders (FWO) [G.0022.08]; Research Council of Ghent University [BOF10/GOA/003]; Biotechnology and Biological Sciences Research Council [BB/K016164/1, BB/F008309/1]; China Scholarship Council; Special Research Council of Ghent University; BBSRC [BB/K016164/1, BB/F008309/1] Funding Source: UKRI	Fund for Scientific Research-Flanders (FWO)(FWO); Research Council of Ghent University(Ghent University); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); China Scholarship Council(China Scholarship Council); Special Research Council of Ghent University(Ghent University); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded primarily by the Fund for Scientific Research-Flanders (FWO grants G.0022.08), the Research Council of Ghent University (project BOF10/GOA/003 to E.J.M.V.D.), and grants BB/K016164/1 and BB/F008309/1 from the Biotechnology and Biological Sciences Research Council (to A.D. and S.M.H.). C.S. is the recipient of China Scholarship Council and receives doctoral co-funding from the Special Research Council of Ghent University.	Barbieri L, 2004, FEBS LETT, V563, P219, DOI 10.1016/S0014-5793(04)00286-8; Battelli MG, 1997, FEBS LETT, V408, P355, DOI 10.1016/S0014-5793(97)00463-8; Battelli MG, 2004, CELL MOL LIFE SCI, V61, P1975, DOI 10.1007/s00018-004-4171-3; Battelli MG, 1997, ARCH TOXICOL, V71, P360, DOI 10.1007/s002040050399; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BROEKAERT WF, 1984, BIOCHEM J, V221, P163, DOI 10.1042/bj2210163; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Citores L, 2002, CANCER LETT, V184, P29, DOI 10.1016/S0304-3835(02)00169-6; Citores L, 1996, CELL MOL BIOL, V42, P473; Das MK, 2012, APPL BIOCHEM BIOTECH, V166, P1552, DOI 10.1007/s12010-012-9550-x; De Vos WH, 2010, CYTOM PART A, V77A, P64, DOI 10.1002/cyto.a.20807; EMMANUEL F, 1988, ANAL BIOCHEM, V173, P134, DOI 10.1016/0003-2697(88)90170-4; Fang EF, 2012, CANCER PREV RES, V5, P109, DOI 10.1158/1940-6207.CAPR-11-0203; Ferreras JM, 2011, TOXINS, V3, P420, DOI 10.3390/toxins3050420; Fu LL, 2011, INT J BIOCHEM CELL B, V43, P1442, DOI 10.1016/j.biocel.2011.07.004; Gadadhar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058304; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Jia N, 2014, J BIOL CHEM, V289, P28489, DOI 10.1074/jbc.M114.588541; Jimenez AS, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-26; Jimenez P, 2014, RIBOSOME-INACTIVATING PROTEINS: RICIN AND RELATED PROTEINS, P67; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Lei HY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-10; Lichtenstein RG, 2013, CELL DEATH DIFFER, V20, P976, DOI 10.1038/cdd.2013.50; Liu B, 2010, CANCER LETT, V287, P1, DOI 10.1016/j.canlet.2009.05.013; Lord JM, 1998, J CELL BIOL, V140, P733; MACH L, 1991, BIOCHEM J, V278, P667, DOI 10.1042/bj2780667; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Moriya K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037892; Narayanan S, 2005, FEBS LETT, V579, P1324, DOI 10.1016/j.febslet.2005.01.038; North SJ, 2010, METHOD ENZYMOL, V478, P27, DOI 10.1016/S0076-6879(10)78002-2; Oliveira C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/568932; Pascal JM, 2001, PROTEINS, V43, P319, DOI 10.1002/prot.1043; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Peumans WJ, 2001, FASEB J, V15, P1493, DOI 10.1096/fj.00-0751rev; Puri M, 2012, DRUG DISCOV TODAY, V17, P774, DOI 10.1016/j.drudis.2012.03.007; Rabinovich GA, 2005, BRIT J CANCER, V92, P1188, DOI 10.1038/sj.bjc.6602493; SANDVIG K, 1991, J CELL BIOL, V115, P971, DOI 10.1083/jcb.115.4.971; SANDVIG K, 1978, EUR J BIOCHEM, V82, P13, DOI 10.1111/j.1432-1033.1978.tb11992.x; SCHACHTER H, 1991, Glycobiology, V1, P453, DOI 10.1093/glycob/1.5.453; Shang CJ, 2014, GLYCOCONJUGATE J, V31, P345, DOI 10.1007/s10719-014-9527-9; Shibata M, 2010, BIOCHEM BIOPH RES CO, V393, P274, DOI 10.1016/j.bbrc.2010.01.121; Sikriwal D, 2010, PLANT CELL MONOGRAPH, P107; Stirpe F, 2006, CELL MOL LIFE SCI, V63, P1850, DOI 10.1007/s00018-006-6078-7; Svinth M, 1998, BIOCHEM BIOPH RES CO, V249, P637, DOI 10.1006/bbrc.1998.9207; Taylor ME, 2011, INTRO GLYCOBIOLOGY, P24; Tejero J, 2015, MOLECULES, V20, P2364, DOI 10.3390/molecules20022364; Van Damme EJM, 2001, CRIT REV PLANT SCI, V20, P395, DOI 10.1080/713608299; VanDamme EJM, 1997, J BIOL CHEM, V272, P8353, DOI 10.1074/jbc.272.13.8353; VanDamme EJM, 1996, EUR J BIOCHEM, V237, P505, DOI 10.1111/j.1432-1033.1996.0505k.x; VANDEURS B, 1987, EXP CELL RES, V171, P137, DOI 10.1016/0014-4827(87)90257-6; Verdoodt F, 2012, CELL BIOL INT, V36, P1251, DOI 10.1042/CBI20120187; Voss C, 2006, FASEB J, V20, P1194, DOI 10.1096/fj.05-5231fje; YOSHIDA T, 1991, EXP CELL RES, V192, P389, DOI 10.1016/0014-4827(91)90056-Z	56	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132389	10.1371/journal.pone.0132389	http://dx.doi.org/10.1371/journal.pone.0132389			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148207	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600255
J	Yang, TT; Lo, CP; Tsai, PS; Wu, SY; Wang, TF; Chen, YW; Jiang-Shieh, YF; Kuo, YM				Yang, Ting-Ting; Lo, Chen-Peng; Tsai, Pei-Shan; Wu, Shih-Ying; Wang, Tzu-Feng; Chen, Yun-Wen; Jiang-Shieh, Ya-Fen; Kuo, Yu-Min			Aging and Exercise Affect Hippocampal Neurogenesis via Different Mechanisms	PLOS ONE			English	Article							ADULT NEUROGENESIS; DENTATE GYRUS; NEURONS; CELLS; RAT; PROLIFERATION	The rate of neurogenesis is determined by 1) the number of neural stem/progenitor cells (NSCs), 2) proliferation of NSCs, 3) neuron lineage specification, and 4) survival rate of the newborn neurons. Aging lowers the rate of hippocampal neurogenesis, while exercise (Ex) increases this rate. However, it remains unclear which of the determinants are affected by aging and Ex. We characterized the four determinants in different age groups (3, 6, 9, 12, 21 months) of mice that either received one month of Ex training or remained sedentary. Bromodeoxyuridine (BrdU) was injected two hours before sacrificing the mice to label the proliferating cells. The results showed that the number of newborn neurons massively decreased (>95%) by the time the mice reached nine months of age. The number of NSC was mildly reduced during aging, while Ex delayed such decline. The proliferation rates were greatly decreased by the time the mice were 9-month-old and Ex could not improve the rates. The rates of neuron specification were decreased during aging, while Ex increased the rates. The survival rate was not affected by age or Ex. Aging greatly reduced newborn neuron maturation, while Ex potently enhanced it. In conclusion, age-associated decline of hippocampal neurogenesis is mainly caused by reduction of NSC proliferation. Although Ex increases the NSC number and neuron specification rates, it doesn't restore the massive decline of NSC proliferation rate. Hence, the effect of Ex on the rate of hippocampal neurogenesis during aging is limited, but Ex does enhance the maturation of newborn neurons.	[Yang, Ting-Ting; Wang, Tzu-Feng; Chen, Yun-Wen] I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan; [Lo, Chen-Peng; Wu, Shih-Ying; Kuo, Yu-Min] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Tsai, Pei-Shan; Wang, Tzu-Feng; Chen, Yun-Wen; Jiang-Shieh, Ya-Fen; Kuo, Yu-Min] Natl Cheng Kung Univ, Dept Cell Biol & Anat, Tainan 70101, Taiwan	I Shou University; National Cheng Kung University; National Cheng Kung University	Yang, TT (corresponding author), I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan.	tingting.taiwan@gmail.com; kuoym@mail.ncku.edu.tw	Kuo, Yu-Min/A-9050-2013; Ting-Ting, YANG/E-6009-2010	Kuo, Yu-Min/0000-0003-4867-2482; Ting-Ting, YANG/0000-0001-5975-8359; Wu, Shih-Ying/0000-0002-0439-0806	Ministry of Science and Technology of Taiwan, Republic of China [102-2314-B-214-006-MY3, 101-2320-B-006-006-MY3]	Ministry of Science and Technology of Taiwan, Republic of China	This work was supported by Ministry of Science and Technology 102-2314-B-214-006-MY3 (TTY) and 101-2320-B-006-006-MY3 (YMK) of Taiwan, Republic of China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; Aizawa K, 2011, NEUROBIOL AGING, V32, P140, DOI 10.1016/j.neurobiolaging.2008.12.011; Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; Amrein I, 2004, HIPPOCAMPUS, V14, P1000, DOI 10.1002/hipo.20018; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Christie BR, 2006, HIPPOCAMPUS, V16, P199, DOI 10.1002/hipo.20151; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Hattiangady B, 2008, NEUROBIOL AGING, V29, P129, DOI 10.1016/j.neurobiolaging.2006.09.015; Huang TY, 2012, J APPL PHYSIOL, V113, P889, DOI 10.1152/japplphysiol.01363.2011; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lazarov O, 2010, TRENDS NEUROSCI, V33, P569, DOI 10.1016/j.tins.2010.09.003; Leuner B, 2007, P NATL ACAD SCI USA, V104, P17169, DOI 10.1073/pnas.0708228104; Lin TW, 2012, NEUROBIOL LEARN MEM, V97, P140, DOI 10.1016/j.nlm.2011.10.006; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Nacher J, 2003, NEUROBIOL AGING, V24, P273, DOI 10.1016/S0197-4580(02)00096-9; Rao MS, 2006, AGING CELL, V5, P545, DOI 10.1111/j.1474-9726.2006.00243.x; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; Tsai SF, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00027; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Wu CW, 2008, J APPL PHYSIOL, V105, P1585, DOI 10.1152/japplphysiol.90775.2008; Wu SY, 2011, BRAIN BEHAV IMMUN, V25, P135, DOI 10.1016/j.bbi.2010.09.006	27	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132152	10.1371/journal.pone.0132152	http://dx.doi.org/10.1371/journal.pone.0132152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147302	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600207
J	Yap, S; Fanson, BG; Taylor, PW				Yap, Sarsha; Fanson, Benjamin G.; Taylor, Phillip W.			Mating Reverses Actuarial Aging in Female Queensland Fruit Flies	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; JUVENILE-HORMONE; LIFE-SPAN; DIETARY RESTRICTION; SEMINAL PROTEINS; HONEY-BEE; REPRODUCTION; PLASTICITY; INSECT; SENESCENCE	Animals that have a long pre-reproductive adult stage often employ mechanisms that minimize aging over this period in order to preserve reproductive lifespan. In a remarkable exception, one tephritid fruit fly exhibits substantial pre-reproductive aging but then mitigates this aging during a diet-dependent transition to the reproductive stage, after which life expectancy matches that of newly emerged flies. Here, we ascertain the role of nutrients, sexual maturation and mating in mitigation of previous aging in female Queensland fruit flies. Flies were provided one of three diets: 'sugar', 'essential', or 'yeast-sugar'. Essential diet contained sugar and micronutrients found in yeast but lacked maturation-enabling protein. At days 20 and 30, a subset of flies on the sugar diet were switched to essential or yeast-sugar diet, and some yeast-sugar fed flies were mated 10 days later. Complete mitigation of actuarial aging was only observed in flies that were switched to a yeast-sugar diet and mated, indicating that mating is key. Identifying the physiological processes associated with mating promise novel insights into repair mechanisms for aging.	[Yap, Sarsha; Fanson, Benjamin G.; Taylor, Phillip W.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia	Macquarie University	Taylor, PW (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	phil.taylor@mq.edu.au	Taylor, Phillip W/E-4620-2011	Taylor, Phillip W/0000-0002-7574-7737; Fanson, Ben/0000-0003-4246-4631; Yap, Sarsha/0000-0002-2049-6352	Macquarie University Research Excellence Scholarship	Macquarie University Research Excellence Scholarship	This work was supported by Macquarie University Research Excellence Scholarship awarded to Benjamin G. Fanson. Macquarie University's Department of Biological Sciences provided facilities and consumables. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2005, EXP GERONTOL, V40, P939, DOI 10.1016/j.exger.2005.08.004; Baker N, 2012, EXP GERONTOL, V47, P764, DOI 10.1016/j.exger.2012.05.011; BYRNE BM, 1989, PROG BIOPHYS MOL BIO, V53, P33, DOI 10.1016/0079-6107(89)90005-9; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Carey JR, 1998, SCIENCE, V281, P996, DOI 10.1126/science.281.5379.996; Collatz KG, 1997, ARCH GERONTOL GERIAT, V25, P83, DOI 10.1016/S0167-4943(96)00773-X; Fanson BG, 2012, P ROY SOC B-BIOL SCI, V279, P4893, DOI 10.1098/rspb.2012.2033; Fanson BG, 2012, J INSECT PHYSIOL, V58, P327, DOI 10.1016/j.jinsphys.2011.11.002; Flatt T, 2005, BIOESSAYS, V27, P999, DOI 10.1002/bies.20290; Flatt T, 2007, EVOLUTION, V61, P1980, DOI 10.1111/j.1558-5646.2007.00151.x; GIESEL JT, 1989, J INSECT PHYSIOL, V35, P893, DOI 10.1016/0022-1910(89)90106-6; Kang MA, 2008, J EXP BIOL, V211, P741, DOI 10.1242/jeb.012955; Kapelnikov A, 2008, P NATL ACAD SCI USA, V105, P13912, DOI 10.1073/pnas.0710997105; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Martinez RLMC, 2010, METRON, V68, P111, DOI 10.1007/BF03263529; McGraw LA, 2004, CURR BIOL, V14, P1509, DOI 10.1016/j.cub.2004.08.028; Moehrlin GS, 1998, OECOLOGIA, V115, P492, DOI 10.1007/s004420050546; Moshitzky P, 1996, ARCH INSECT BIOCHEM, V32, P363, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;363::AID-ARCH9&gt;3.0.CO;2-T; Munch D, 2008, FUNCT ECOL, V22, P407, DOI 10.1111/j.1365-2435.2008.01419.x; Munch D, 2010, FEBS LETT, V584, P2496, DOI 10.1016/j.febslet.2010.04.007; Nijhout H.F., 1998, INSECT HORMONES, P280; Partridge L, 2005, MECH AGEING DEV, V126, P35, DOI 10.1016/j.mad.2004.09.017; Partridge L, 2010, PHILOS T R SOC B, V365, P147, DOI 10.1098/rstb.2009.0222; Perez-Staples D, 2007, PHYSIOL ENTOMOL, V32, P225, DOI 10.1111/j.1365-3032.2007.00568.x; Radhakrishnan P, 2008, PHYSIOL ENTOMOL, V33, P302, DOI 10.1111/j.1365-3032.2008.00631.x; Radhakrishnan P, 2007, J INSECT PHYSIOL, V53, P741, DOI 10.1016/j.jinsphys.2006.10.009; Raghu S, 2003, AUST J ENTOMOL, V42, P281, DOI 10.1046/j.1440-6055.2003.00364.x; Rogina B, 2007, MECH AGEING DEV, V128, P477, DOI 10.1016/j.mad.2007.06.004; Romanyukha AA, 2004, P ROY SOC B-BIOL SCI, V271, P1319, DOI 10.1098/rspb.2004.2719; Tatar M, 2001, AM NAT, V158, P248, DOI 10.1086/321320; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; Wickens AP, 2001, RESP PHYSIOL, V128, P379, DOI 10.1016/S0034-5687(01)00313-9; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051; Wolfner MF, 2002, HEREDITY, V88, P85, DOI 10.1038/sj.hdy.6800017	35	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132486	10.1371/journal.pone.0132486	http://dx.doi.org/10.1371/journal.pone.0132486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147734	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600284
J	Beijbom, O; Edmunds, PJ; Roelfsema, C; Smith, J; Kline, DI; Neal, BP; Dunlap, MJ; Moriarty, V; Fan, TY; Tan, CJ; Chan, S; Treibitz, T; Gamst, A; Mitchell, BG; Kriegman, D				Beijbom, Oscar; Edmunds, Peter J.; Roelfsema, Chris; Smith, Jennifer; Kline, David I.; Neal, Benjamin P.; Dunlap, Matthew J.; Moriarty, Vincent; Fan, Tung-Yung; Tan, Chih-Jui; Chan, Stephen; Treibitz, Tali; Gamst, Anthony; Mitchell, B. Greg; Kriegman, David			Towards Automated Annotation of Benthic Survey Images: Variability of Human Experts and Operational Modes of Automation	PLOS ONE			English	Article							CORAL-REEFS; CLIMATE-CHANGE; CLASSIFICATION; KAPPA; COVER	Global climate change and other anthropogenic stressors have heightened the need to rapidly characterize ecological changes in marine benthic communities across large scales. Digital photography enables rapid collection of survey images to meet this need, but the subsequent image annotation is typically a time consuming, manual task. We investigated the feasibility of using automated point-annotation to expedite cover estimation of the 17 dominant benthic categories from survey-images captured at four Pacific coral reefs. Inter- and intra- annotator variability among six human experts was quantified and compared to semi- and fully- automated annotation methods, which are made available at coralnet.ucsd. edu. Our results indicate high expert agreement for identification of coral genera, but lower agreement for algal functional groups, in particular between turf algae and crustose coralline algae. This indicates the need for unequivocal definitions of algal groups, careful training of multiple annotators, and enhanced imaging technology. Semi-automated annotation, where 50% of the annotation decisions were performed automatically, yielded cover estimate errors comparable to those of the human experts. Furthermore, fully-automated annotation yielded rapid, unbiased cover estimates but with increased variance. These results show that automated annotation can increase spatial coverage and decrease time and financial outlay for image-based reef surveys.	[Beijbom, Oscar; Chan, Stephen; Kriegman, David] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; [Edmunds, Peter J.; Moriarty, Vincent] Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA; [Roelfsema, Chris] Univ Queensland, Sch Geog Planning & Environm Management, Biophys Remote Sensing Grp, St Lucia, Qld, Australia; [Smith, Jennifer; Kline, David I.; Neal, Benjamin P.; Mitchell, B. Greg] Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA; [Neal, Benjamin P.] Univ Queensland, Global Change Inst, Catlin Seaview Survey, St Lucia, Qld, Australia; [Dunlap, Matthew J.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Fan, Tung-Yung; Tan, Chih-Jui] Natl Museum Marine Biol & Aquarium, Checheng, Taiwan; [Treibitz, Tali] Univ Haifa, Charney Sch Marine Sci, IL-31999 Haifa, Israel; [Gamst, Anthony] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; California State University System; California State University Northridge; University of Queensland; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Queensland; University of Hawaii System; University of Hawaii Manoa; National Museum of Marine Biology & Aquarium; University of Haifa; University of California System; University of California San Diego	Beijbom, O (corresponding author), Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA.	obeijbom@ucsd.edu	Roelfsema, Chris/AAV-1277-2020; Roelfsema, Chris/B-1591-2015	Roelfsema, Chris/0000-0003-0182-1356; Kline, David/0000-0001-5128-9439; Mitchell, B. Greg/0000-0002-8550-4333; Treibitz, Tali/0000-0002-3078-282X; Edmunds, Peter/0000-0002-9039-9347	US National Science Foundation Division of Ocean Sciences (OCE) [0941760]; U.S. National Science Foundation's Long Term Ecological Research (LTER) program; Moorea Coral Reef (MCR) LTER Site (through OCE) [0417412, 1026851, 1236905]; Division Of Ocean Sciences [1236905] Funding Source: National Science Foundation	US National Science Foundation Division of Ocean Sciences (OCE); U.S. National Science Foundation's Long Term Ecological Research (LTER) program(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Moorea Coral Reef (MCR) LTER Site (through OCE); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the US National Science Foundation Division of Ocean Sciences (OCE) 0941760 to BGM. We gratefully acknowledge the support of the U.S. National Science Foundation's Long Term Ecological Research (LTER) program and the Moorea Coral Reef (MCR) LTER Site (through OCE 0417412, 1026851 and 1236905).	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Beijbom O., 2014, ARXIV14107074; Beijbom O, 2012, PROC CVPR IEEE, P1170, DOI 10.1109/CVPR.2012.6247798; Beijbom Oscar, 2012, ARXIV12114860; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bewley M., 2012, P AUSTR C ROB AUT; Branson S, 2013, PROC CVPR IEEE, P1806, DOI 10.1109/CVPR.2013.236; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Buskey EJ, 2006, HARMFUL ALGAE, V5, P685, DOI 10.1016/j.hal.2006.02.003; CARLETON JH, 1995, CORAL REEFS, V14, P35, DOI 10.1007/BF00304070; Carletta J, 1996, COMPUT LINGUIST, V22, P249; Cesar H. J. S., 2003, CESAR ENV EC CONSULT; Chatfield K, 2011, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2011, DOI 10.5244/C.25.76; Costanza R, 1998, ECOL ECON, V25, P3, DOI 10.1016/S0921-8009(98)00020-2; ELEFTHERIOU A, 2013, METHODS STUDY MARINE, DOI [10.2307/1467422, DOI 10.2307/1467422]; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Fleiss J. L., 1981, STAT METHODS RATES P, V2, P22; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gleason ACR, 2010, CORAL REEFS, V29, P253, DOI 10.1007/s00338-009-0544-2; Gonzalez-Rivero M, 2014, AQUAT CONSERV, V24, P184, DOI 10.1002/aqc.2505; Good P, 2005, PERMUTATION PARAMETR; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hopkins DJ, 2010, AM J POLIT SCI, V54, P229, DOI 10.1111/j.1540-5907.2009.00428.x; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jaffe J. S., 2001, OCEANOGRAPHY, V14, P66, DOI [10.5670/oceanog.2001.24, DOI 10.5670/OCEANOG.2001.24]; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lewis D.D., 1994, P 11 INT C MACH LEAR, V94, P148, DOI DOI 10.1016/B978-1-55860-335-6.50026-X; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Marcos MSAC, 2005, OPT EXPRESS, V13, P8766, DOI 10.1364/OPEX.13.008766; Miller I, 1999, CORAL REEFS, V18, P353, DOI 10.1007/s003380050212; Molloy PP, 2013, AQUAT CONSERV, V23, P820, DOI 10.1002/aqc.2372; MONSERUD RA, 1992, ECOL MODEL, V62, P275, DOI 10.1016/0304-3800(92)90003-W; Nicholson JW, 2008, MAR TECHNOL SOC J, V42, P44, DOI 10.4031/002533208786861272; Ninio R, 2003, MAR ECOL PROG SER, V265, P107, DOI 10.3354/meps265107; Olson RJ, 2007, LIMNOL OCEANOGR-METH, V5, P195, DOI 10.4319/lom.2007.5.195; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Pante Eric, 2012, Journal of Marine Biology, V2012, P1; Perronnin F., 2007, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/CVPR.2007.383266; Phinn SR, 2012, INT J REMOTE SENS, V33, P3768, DOI 10.1080/01431161.2011.633122; Porter James W., 2002, P749; Rifkin R, 2004, J MACH LEARN RES, V5, P101; Shihavuddin ASM, 2013, REMOTE SENS-BASEL, V5, P1809, DOI 10.3390/rs5041809; Solow A, 2001, MAR ECOL PROG SER, V216, P309, DOI 10.3354/meps216309; Sosik HM, 2007, LIMNOL OCEANOGR-METH, V5, P204, DOI 10.4319/lom.2007.5.204; Stokes MD, 2009, LIMNOL OCEANOGR-METH, V7, P157, DOI 10.4319/lom.2009.7.157; Torres, 2004, SUBSURFACE SENSING T, V5, P25, DOI DOI 10.1023/B:SSTA.0000018445.25977.F3; Treibitz T, 2015, SCI REP-UK, V5, DOI 10.1038/srep07694; Trygonis V, 2012, J EXP MAR BIOL ECOL, V424, P99, DOI 10.1016/j.jembe.2012.04.018; van Hooidonk R, 2013, NAT CLIM CHANGE, V3, P508, DOI [10.1038/NCLIMATE1829, 10.1038/nclimate1829]; Zawada DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084570	51	171	174	5	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130312	10.1371/journal.pone.0130312	http://dx.doi.org/10.1371/journal.pone.0130312			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154157	Green Submitted, Green Published, gold			2022-12-27	WOS:000358159700030
J	Johnsrud, I; Kulseth, MA; Rodningen, OK; Landro, L; Helsing, P; Nielsen, EW; Heimdal, K				Johnsrud, Irene; Kulseth, Mari Ann; Rodningen, Olaug Kristin; Landro, Linn; Helsing, Per; Nielsen, Erik Waage; Heimdal, Ketil			A Nationwide Study of Norwegian Patients with Hereditary Angioedema with C1 Inhibitor Deficiency Identified Six Novel Mutations in SERPING1	PLOS ONE			English	Article							EXON DELETIONS; GENE; SPECTRUM; FAMILIES; DIAGNOSIS	Hereditary angioedema with C1 inhibitor deficiency (C1-INH-HAE) is characterized by relapsing, non-pruritic swelling in skin and submucosal tissue. Symptoms can appear in early infancy when diagnosis is more difficult. In the absence of a correct diagnosis, treatment of abdominal attacks often lead to unnecessary surgery, and laryngeal edema can cause asphyxiation. A cohort study of 52 patients from 25 unrelated families in Norway was studied. Diagnosis of C1-INH-HAE was based on international consensus criteria including low functional and/or antigenic C1-INH values and antigenic C4. As SERPING1 mutations in Norwegian patients with C1-INH-HAE are largely undescribed and could help in diagnosis, we aimed to find and describe these mutations. Mutation analysis of the SERPING1 gene was performed by Sanger sequencing of all protein coding exons and exon-intron boundaries. Samples without detected mutation were further analyzed by multiplex ligation-dependent probe amplification to detect deletions and duplications. Novel mutations suspected to lead to splice defects were analyzed on the mRNA level. Fifty-two patients from 25 families were included. Forty-four (84,6%) suffered from C1-INH-HAE type I and eight (15,4%) suffered from C1-INH-HAE type II. Pathogenic or likely pathogenic mutations were found in 22/25 families (88%). Thirteen unique mutations were detected, including six previously undescribed. There were three missense mutations including one mutation affecting the reactive center loop at codon 466, three nonsense mutations, three small deletions/duplications, three gross deletions, and one splice mutation.	[Johnsrud, Irene; Landro, Linn; Helsing, Per] Oslo Univ Hosp, Rikshosp, Dept Dermatol, N-0027 Oslo, Norway; [Kulseth, Mari Ann; Rodningen, Olaug Kristin; Heimdal, Ketil] Oslo Univ Hosp, Dept Med Genet, N-0027 Oslo, Norway; [Nielsen, Erik Waage] Nordland Hosp, Dept Anesthesiol, N-8092 Bodo, Norway	University of Oslo; National Hospital Norway; University of Oslo	Johnsrud, I (corresponding author), Univ Oslo, Inst Clin Med, N-0316 Oslo, Norway.	iejohnsrud@gmail.com	Heimdal, Ketil Riddervold/H-3038-2019	Heimdal, Ketil Riddervold/0000-0002-8911-3508				Agostoni A, 2004, J ALLERGY CLIN IMMUN, V114, pS51, DOI 10.1016/j.jaci.2004.06.047; Bafunno V, 2014, ANN HUM GENET, V78, P73, DOI 10.1111/ahg.12052; BOCK SC, 1986, BIOCHEMISTRY-US, V25, P4292, DOI 10.1021/bi00363a018; Bos IGA, 2003, J BIOL CHEM, V278, P29463, DOI 10.1074/jbc.M302977200; Bos IGA, 2002, IMMUNOBIOLOGY, V205, P518, DOI 10.1078/0171-2985-00151; Bowen Tom, 2010, Allergy Asthma Clin Immunol, V6, P24, DOI 10.1186/1710-1492-6-24; Bygum A, 2011, ALLERGY, V66, P76, DOI 10.1111/j.1398-9995.2010.02456.x; Davis AE, 2007, IMMUNOBIOLOGY, V212, P313, DOI 10.1016/j.imbio.2006.10.003; Duponchel C, 2001, HUM MUTAT, V17, P61, DOI 10.1002/1098-1004(2001)17:1<61::AID-HUMU7>3.0.CO;2-9; Firinu D, 2013, CLIN IMMUNOL, V147, P129, DOI 10.1016/j.clim.2013.03.007; Freiberger T, 2002, HUM MUTAT, V19, DOI 10.1002/humu.9029; Gosswein T, 2008, CYTOGENET GENOME RES, V121, P181, DOI 10.1159/000138883; Kalmar L, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9202; Kesim B, 2011, INT ARCH ALLERGY IMM, V156, P443, DOI 10.1159/000323915; Longhurst H, 2012, LANCET, V379, P474, DOI 10.1016/S0140-6736(11)60935-5; Lopez-Lera A, 2011, MOL IMMUNOL, V49, P18, DOI 10.1016/j.molimm.2011.07.010; Nielsen EW, 1996, SCAND J IMMUNOL, V44, P185; NIELSEN EW, 1994, PEDIATR RES, V35, P184, DOI 10.1203/00006450-199402000-00012; Pappalardo E, 2000, J ALLERGY CLIN IMMUN, V106, P1147, DOI 10.1067/mai.2000.110471; Pappalardo E, 2008, MOL IMMUNOL, V45, P3536, DOI 10.1016/j.molimm.2008.05.007; Roche O, 2005, HUM MUTAT, V26, P135, DOI 10.1002/humu.20197; SKRIVER K, 1989, J BIOL CHEM, V264, P3066; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Stephan F, 2012, HAMOSTASEOLOGIE, V32, P51, DOI 10.5482/ha-1187; Tarzi MD, 2007, CLIN EXP IMMUNOL, V149, P513, DOI 10.1111/j.1365-2249.2007.03438.x; Verpy E, 1996, AM J HUM GENET, V59, P308; VERPY E, 1993, BEHR INST MITT, P120; Xu YY, 2012, ALLERGY, V67, P1430, DOI 10.1111/all.12024	29	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131637	10.1371/journal.pone.0131637	http://dx.doi.org/10.1371/journal.pone.0131637			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154504	gold, Green Published			2022-12-27	WOS:000358159700075
J	Barbosa-Ferreira, JM; Mady, C; Ianni, BM; Lopes, HF; Ramires, FJA; Salemi, VMC; Grupi, CJ; Hachul, DT; Fernandes, F				Barbosa-Ferreira, Joao Marcos; Mady, Charles; Ianni, Barbara Maria; Lopes, Heno Ferreira; Alvarez Ramires, Felix Jose; Cury Salemi, Vera Maria; Grupi, Cesar Jose; Hachul, Denise Tessariol; Fernandes, Fabio			Dysregulation of Autonomic Nervous System in Chagas' Heart Disease Is Associated with Altered Adipocytokines Levels	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI INFECTION; ADIPOSE-TISSUE; ADIPONECTIN CONCENTRATION; SYSTOLIC DYSFUNCTION; INSULIN-RESISTANCE; SERUM-LEVELS; LEPTIN; INFLAMMATION; FAILURE; GLUCOSE	Background Chagas disease (CD) induces autonomic dysfunction and inflammatory activity, which may promote metabolic abnormalities. We studied metabolism and his correlation with Autonomic Nervous System (ANS) and inflammation in CD. Methods and Results Sixty subjects were divided into 4 groups: control group (CG), IF (indeterminate form) group; ECG group (ECG abnormalities and normal left ventricular systolic function), and LVD group (left ventricular sistolic dysfunction). Levels of adiponectin, leptin, insulin, interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) were assayed in serum samples by ELISA. ANS was assessed by heart rate variability in frequency domain in 24-hour Holter and postural tilt test (rest and orthostatic position). High frequency (HFr) component values were used to estimate parasympathetic activity and low frequency (LFr) component, sympathetic activity. Analyzes were made of the correlations of each of the metabolic parameters (leptin and adiponectin) with the inflammatory cytokines (interleukin-6 and TNF-alpha) and with the ANS assessment measurements. No significant differences were observed in leptin and insulin levels. Adiponectin was higher in ECG and LVD groups: [CG = 4766.5 (5529.5), IF = 4003.5 (2482.5), ECG = 8376.5 (8388.5), LVD = 8798 (4188.0) ng/mL, p<0.001)]. IL-6 and TNF-alpha were higher in LVD group: [IL-6: CG = 1.85 (6.41); IF = 1.58 (1.91); ECG = 1.0 (1.57); LVD= 31.44 (72.19) pg/ml; p = 0.001. TNF-alpha: CG = 22.57 (88.2); IF = 19.31 (33.16); ECG = 12.45 (3.07); LVD = 75.15 (278.57) pg/ml; p = 0.04]. Adiponectin levels had a positive association with the HFr component (r = 0.539; p = 0.038) and an inverse association with the LFr component (r = -0.539; p = 0.038) in ECG group. Leptin levels had a negative association with the HFr component (r = -0.632; p = 0.011) and a positive association with the LFr component (r = 0.632; p = 0.011) in LVD group. Conclusions We found increased adiponectin levels in Chagas' heart disease with systolic dysfunction and in patients with ECG abnormalities and normal systolic function at rest. Adipocytokines levels (adiponectin and leptin) were associated with ANS parameters in Chagas' heart disease.	[Barbosa-Ferreira, Joao Marcos; Mady, Charles; Ianni, Barbara Maria; Alvarez Ramires, Felix Jose; Cury Salemi, Vera Maria; Fernandes, Fabio] Univ Sao Paulo, Fac Med, Hosp Clin, Cardiomyopathy Unit,Heart Inst InCor, Sao Paulo, Brazil; [Lopes, Heno Ferreira] Univ Sao Paulo, Fac Med, Hosp Clin, Hypertens Unit,Heart Inst InCor, Sao Paulo, Brazil; [Lopes, Heno Ferreira] Univ Nove Julho UNINOVE, Sao Paulo, Brazil; [Grupi, Cesar Jose] Univ Sao Paulo, Fac Med, Hosp Clin, Heart Inst InCor,Electrocardiol Unit, Sao Paulo, Brazil; [Hachul, Denise Tessariol] Univ Sao Paulo, Fac Med, Hosp Clin, Clin Arrhythmia Unit,Heart Inst InCor, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Nove de Julho; Universidade de Sao Paulo; Universidade de Sao Paulo	Barbosa-Ferreira, JM (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin, Cardiomyopathy Unit,Heart Inst InCor, Sao Paulo, Brazil.	jmbemfica@hotmail.com	Stefanadis, Christodoulos/ABH-2232-2020; Ramires, Felix JA/D-5996-2012; Ianni, Barbara Maria/C-7689-2012; Lopes, Heno/H-9825-2013; Salemi, Vera MC/C-9104-2013; Salemi, Vera/AAY-5024-2020; Ferreira, João/AAO-6824-2020; Mady, Charles/C-8870-2012	Stefanadis, Christodoulos/0000-0001-5974-6454; Ramires, Felix JA/0000-0003-2437-2485; Ianni, Barbara Maria/0000-0002-1588-5492; Lopes, Heno/0000-0002-9591-3093; Salemi, Vera MC/0000-0002-7152-1810; Mady, Charles/0000-0002-8838-199X; Tessariol Hachul, Denise/0000-0001-5338-3242	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/16887-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), grant number 2009/16887-9, and is part of the thesis of doctoral submitted by Joao Marcos Barbosa-Ferreira, from Faculdade de Medicina da Universidade de Sao Paulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniades C, 2009, OBES REV, V10, P269, DOI 10.1111/j.1467-789X.2009.00571.x; Barbosa-Ferreira Joao Marcos, 2013, Expert Opin Med Diagn, V7, P113, DOI 10.1517/17530059.2013.735229; Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; Bartness TJ, 2010, MOL CELL ENDOCRINOL, P318; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bloom HL, 2014, HEART INT, V9, P15, DOI 10.5301/HEART.2014.12496; Bobbert P, 2011, EUR HEART J, V32, P1134, DOI 10.1093/eurheartj/ehq498; Camm AJ, 1996, CIRCULATION, V93, P1043; Combs TP, 2005, J BIOL CHEM, V280, P24085, DOI 10.1074/jbc.M412802200; Davila DF, 1998, INT J CARDIOL, V66, P123, DOI 10.1016/S0167-5273(98)00212-5; Delporte ML, 2002, BIOCHEM J, V367, P677, DOI 10.1042/BJ20020610; Dieplinger B, 2009, CLIN BIOCHEM, V42, P1190, DOI 10.1016/j.clinbiochem.2009.02.023; Doehner W, 2014, J AM COLL CARDIOL, V64, P1388, DOI 10.1016/j.jacc.2014.04.083; Fasshauer M, 2001, FEBS LETT, V507, P142, DOI 10.1016/S0014-5793(01)02960-X; Fernandes F, 2007, BRAZ J MED BIOL RES, V40, P1631, DOI 10.1590/S0100-879X2007001200006; Filippatos GS, 2000, INT J CARDIOL, V76, P117, DOI 10.1016/S0167-5273(00)00397-1; Fu MQ, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-106; Gascon J, 2010, ACTA TROP, V115, P22, DOI 10.1016/j.actatropica.2009.07.019; George J, 2006, HEART, V92, P1420, DOI 10.1136/hrt.2005.083345; Goldstein DS, 2011, EXP PHYSIOL, V96, P1255, DOI 10.1113/expphysiol.2010.056259; Grassi G, 2002, J HYPERTENS, V20, P1487, DOI 10.1097/00004872-200208000-00008; GUARIENTO ME, 1993, BRAZ J MED BIOL RES, V26, P491; Guzik TJ, 2006, J PHYSIOL PHARMACOL, V57, P505; Hausberg M, 2002, J HYPERTENS, V20, P1633, DOI 10.1097/00004872-200208000-00027; Ianni B M, 2001, Arq Bras Cardiol, V77, P59; Imai J, 2006, OBESITY, V14, P1132, DOI 10.1038/oby.2006.130; Iwen KA, 2011, METABOLISM, V60, P430, DOI 10.1016/j.metabol.2010.03.011; Karki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028146; Khan RS, 2012, CIRC-HEART FAIL, V5, P340, DOI 10.1161/CIRCHEARTFAILURE.111.964031; Lam JCM, 2008, SLEEP, V31, P1721, DOI 10.1093/sleep/31.12.1721; Lieb DC, 2012, EXP DIABETES RES, DOI 10.1155/2012/878760; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; Ferreira AVM, 2011, MICROBES INFECT, V13, P1002, DOI 10.1016/j.micinf.2011.06.002; McEntegart MB, 2007, EUR HEART J, V28, P829, DOI 10.1093/eurheartj/ehm033; Molina RBG, 2006, INT J CARDIOL, V113, P188, DOI 10.1016/j.ijcard.2005.11.010; Moro C, 2007, DIABETOLOGIA, V50, P1038, DOI 10.1007/s00125-007-0614-3; Murdoch DR, 1999, HEART, V82, P352, DOI 10.1136/hrt.82.3.352; Nagajyothi F, 2008, OBESITY, V16, P1992, DOI 10.1038/oby.2008.331; Nagajyothi F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003118; Nagajyothi F, 2013, AM J PATHOL, V182, P886, DOI 10.1016/j.ajpath.2012.11.027; OLIVEIRA LCM, 1993, BRAZ J MED BIOL RES, V26, P1187; Paolisso G, 2000, J CLIN ENDOCR METAB, V85, P1810, DOI 10.1210/jc.85.5.1810; Paulo Araujo J, 2009, EUR J HEART FAIL, V11, P567, DOI 10.1093/eurjhf/hfp046; Prata A, 2001, LANCET INFECT DIS, V1, P92, DOI [10.1016/S1473-3099(01)00065-2, DOI 10.1016/S1473-3099(01)00065-2]; Ribeiro ALP, 2001, AM HEART J, V141, P260, DOI 10.1067/mhj.2001.111406; Sabino EC, 2013, CIRCULATION, V127, P1105, DOI 10.1161/CIRCULATIONAHA.112.123612; Schulze PC, 2011, J CARD FAIL, V17, P1004, DOI 10.1016/j.cardfail.2011.08.010; Schulze PC, 2003, EUR J HEART FAIL, V5, P33, DOI 10.1016/S1388-9842(02)00177-0; Simoes MV, 2000, AM J CARDIOL, V86, P975, DOI 10.1016/S0002-9149(00)01133-4; Skurk C, 2008, EUR HEART J, V29, P1168, DOI 10.1093/eurheartj/ehn136; Takahashi N, 2007, METABOLISM, V56, P919, DOI 10.1016/j.metabol.2007.02.005; Takano H, 2009, INT J CARDIOL, V132, P221, DOI 10.1016/j.ijcard.2007.11.040; Tanida M, 2007, EXP BIOL MED, V232, P390; Trayhurn P, 1998, P NUTR SOC, V57, P413, DOI 10.1079/PNS19980060; Tsukamoto O, 2009, J AM COLL CARDIOL, V53, P2070, DOI 10.1016/j.jacc.2009.02.038; Van Berendoncks An M, 2011, Curr Heart Fail Rep, V8, P113, DOI 10.1007/s11897-011-0056-6; Wajchenberg BL, 2009, ARQ BRAS ENDOCRINOL, V53, P145, DOI 10.1590/S0004-27302009000200005; Wakabayashi S, 2004, DIABETES CARE, V27, P2392, DOI 10.2337/diacare.27.10.2392; WHO, 2012, WORLD MALARIA REPORT 2012, P1	59	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131447	10.1371/journal.pone.0131447	http://dx.doi.org/10.1371/journal.pone.0131447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147101	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600097
J	Goldberg, BE; Mongodin, EF; Jones, CE; Chung, M; Fraser, CM; Tate, A; Zeichner, SL				Goldberg, Brittany E.; Mongodin, Emmanuel F.; Jones, Cheron E.; Chung, Michelle; Fraser, Claire M.; Tate, Anupama; Zeichner, Steven L.			The Oral Bacterial Communities of Children with Well-Controlled HIV Infection and without HIV Infection	PLOS ONE			English	Article							EARLY-CHILDHOOD CARIES; HEALTHY-CHILDREN; MICROBIOTA; DIVERSITY; CAVITY; DENTITION; PLAQUE; SURFACES; DISEASE	The oral microbial community (microbiota) plays a critical role in human health and disease. Alterations in the oral microbiota may be associated with disorders such as gingivitis, periodontitis, childhood caries, alveolar osteitis, oral candidiasis and endodontic infections. In the immunosuppressed population, the spectrum of potential oral disease is even broader, encompassing candidiasis, necrotizing gingivitis, parotid gland enlargement, Kaposi's sarcoma, oral warts and other diseases. Here, we used 454 pyrosequencing of bacterial 16S rRNA genes to examine the oral microbiome of saliva, mucosal and tooth samples from HIV-positive and negative children. Patient demographics and clinical characteristics were collected from a cross-section of patients undergoing routine dental care. Multiple specimens from different sampling sites in the mouth were collected for each patient. The goal of the study was to observe the potential diversity of the oral microbiota among individual patients, sample locations, HIV status and various dental characteristics. We found that there were significant differences in the microbiome among the enrolled patients, and between sampling locations. The analysis was complicated by uneven enrollment in the patient cohorts, with only five HIV-negative patients enrolled in the study and by the rapid improvement in the health of HIV-infected children between the time the study was conceived and completed. The generally good oral health of the HIV-negative patients limited the number of dental plaque samples that could be collected. We did not identify significant differences between well-controlled HIV-positive patients and HIV-negative controls, suggesting that well-controlled HIV-positive patients essentially harbor similar oral flora compared to patients without HIV. Nor were significant differences in the oral microbiota identified between different teeth or with different dental characteristics. Additional studies are needed to better characterize the oral microbiome in children and those with poorly-controlled HIV infections.	[Goldberg, Brittany E.] Childrens Natl Med Ctr, Div Pediat Infect Dis, Washington, DC 20010 USA; [Mongodin, Emmanuel F.; Jones, Cheron E.; Fraser, Claire M.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Mongodin, Emmanuel F.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Chung, Michelle; Tate, Anupama] Childrens Natl Med Ctr, Div Pediat Dent, Washington, DC 20010 USA; [Fraser, Claire M.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Zeichner, Steven L.] Childrens Natl Med Ctr, Ctr Canc & Immunol Res, Childrens Res Inst, Washington, DC 20010 USA; [Zeichner, Steven L.] George Washington Univ, Sch Med, Dept Pediat & Microbiol, Washington, DC USA; [Zeichner, Steven L.] George Washington Univ, Sch Med, Dept Immunol, Washington, DC USA; [Zeichner, Steven L.] George Washington Univ, Sch Med, Dept Trop Med, Washington, DC USA	Children's National Health System; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Children's National Health System; University System of Maryland; University of Maryland Baltimore; Children's National Health System; George Washington University; George Washington University; George Washington University	Zeichner, SL (corresponding author), Childrens Natl Med Ctr, Ctr Canc & Immunol Res, Childrens Res Inst, Washington, DC 20010 USA.	zeichner@gwu.org	Mongodin, Emmanuel/AAF-1850-2020	Mongodin, Emmanuel/0000-0003-3833-7437	National Institute of Dental and Craniofacial Research, National Institutes of Health [R56DE021570]; District of Columbia Developmental Center for AIDS Research (DC-CFAR); National Institute for Allergy and Infectious Diseases; National Institutes of Health [P30AI087714]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI087714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE021570] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); District of Columbia Developmental Center for AIDS Research (DC-CFAR); National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a grant, R56DE021570, from the National Institute of Dental and Craniofacial Research, National Institutes of Health, and in part by funding from the District of Columbia Developmental Center for AIDS Research (DC-CFAR), from the National Institute for Allergy and Infectious Diseases, with funding from other institutes of the National Institutes of Health, P30AI087714, and a gift from the Conner Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; [Anonymous], CARRANZAS CLIN PERIO; Becker MR, 2002, J CLIN MICROBIOL, V40, P1001, DOI 10.1128/JCM.40.3.1001-1009.2002; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Centers for Disease Prevention and Control, 1994, MMWR RECOMM REP, V43; Corby PM, 2005, J CLIN MICROBIOL, V43, P5753, DOI 10.1128/JCM.43.11.5753-5759.2005; Cortelli JR, 2008, J CLIN MICROBIOL, V46, P1322, DOI 10.1128/JCM.02051-07; Crielaard W, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-22; Dang AT, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-153; Del Toro Agnes, 1996, Pediatric Dentistry, V18, P114; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Griffen AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019051; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Jiang W, 2008, 15 C RETR OPP INF BO; Jiang W, 2013, CURR MICROBIOL, V67, P537, DOI 10.1007/s00284-013-0393-7; Kamma JJ, 2000, J PERIODONTAL RES, V35, P33, DOI 10.1034/j.1600-0765.2000.035001033.x; Kanasi E, 2010, J DENT RES, V89, P378, DOI 10.1177/0022034509360010; Kazor CE, 2003, J CLIN MICROBIOL, V41, P558, DOI 10.1128/JCM.41.2.558-563.2003; Kline MW, 1996, PEDIATRICS, V97, P380; Kumar PS, 2003, J DENT RES, V82, P338, DOI 10.1177/154405910308200503; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037919; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; Navazesh M, 2005, ORAL SURG ORAL MED O, V100, P701, DOI 10.1016/j.tripleo.2004.10.011; Nokta Mostafa, 2008, Curr HIV/AIDS Rep, V5, P5, DOI 10.1007/s11904-008-0002-8; Ooshima T, 2003, COMMUNITY DENT ORAL, V31, P417, DOI 10.1046/j.1600-0528.2003.00112.x; Papaioannou W, 2009, ORAL MICROBIOL IMMUN, V24, P183, DOI 10.1111/j.1399-302X.2008.00493.x; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Peterson SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058487; RAMBERG PW, 1994, J CLIN PERIODONTOL, V21, P490, DOI 10.1111/j.1600-051X.1994.tb00413.x; Ramos-Gomez F J, 1999, J Clin Pediatr Dent, V23, P85; Salako NO, 2004, MED PRIN PRACT, V13, P191, DOI 10.1159/000078314; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Signat B, 2011, CURR ISSUES MOL BIOL, V13, P25; Simon-Soro A, 2013, J DENT RES, V92, P616, DOI 10.1177/0022034513488119; Tanner ACR, 2011, J DENT RES, V90, P1298, DOI 10.1177/0022034511421201; Wang JF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01843; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wessel SW, 2014, J DENT RES, V93, P84, DOI 10.1177/0022034513511822; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zupancic ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043052	42	23	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131615	10.1371/journal.pone.0131615	http://dx.doi.org/10.1371/journal.pone.0131615			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146997	gold, Green Submitted, Green Published			2022-12-27	WOS:000358157600114
J	Henriques, A; Blasco, H; Fleury, MC; Corcia, P; Echaniz-Laguna, A; Robelin, L; Rudolf, G; Lequeu, T; Bergaentzle, M; Gachet, C; Pradat, PF; Marchioni, E; Andres, CR; Tranchant, C; de Aguilar, JLG; Loeffler, JP				Henriques, Alexandre; Blasco, Helene; Fleury, Marie-Celine; Corcia, Philippe; Echaniz-Laguna, Andoni; Robelin, Laura; Rudolf, Gabrielle; Lequeu, Thiebault; Bergaentzle, Martine; Gachet, Christian; Pradat, Pierre-Francois; Marchioni, Eric; Andres, Christian R.; Tranchant, Christine; de Aguilar, Jose-Luis Gonzalez; Loeffler, Jean-Philippe			Blood Cell Palmitoleate-Palmitate Ratio Is an Independent Prognostic Factor for Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							STEAROYL-COA DESATURASE; BODY-MASS INDEX; FATTY-ACIDS; PLASMA; SURVIVAL; DIET; ALS; HYPERMETABOLISM; PHOSPHOLIPIDS; DYSLIPIDEMIA	Growing evidence supports a link between fatty acid metabolism and amyotrophic lateral sclerosis (ALS). Here we determined the fatty acid composition of blood lipids to identify markers of disease progression and survival. We enrolled 117 patients from two clinical centers and 48 of these were age and gender matched with healthy volunteers. We extracted total lipids from serum and blood cells, and separated fatty acid methyl esters by gas chromatography. We measured circulating biochemical parameters indicative of the metabolic status. Association between fatty acid composition and clinical readouts was studied, including ALS functional rating scale-revised (ALSFRS-R), survival, disease duration, site of onset and body mass index. Palmitoleate (16:1) and oleate (18:1) levels, and stearoyl-CoA desaturase indices (16:1/16:0 and 18:1/18:0) significantly increased in blood cells from ALS patients compared to healthy controls. Palmitoleate levels and 16:1/16:0 ratio in blood cells, but not body mass index or leptin concentrations, negatively correlated with ALSFRS-R decline over a six-month period (p<0.05). Multivariate Cox analysis, with age, body mass index, site of onset and ALSFRS-R as covariables, showed that blood cell 16:1/16:0 ratio was an independent prognostic factor for survival (hazard ratio=0.1 per unit of ratio, 95% confidence interval=0.01-0.57, p=0.009). In patients with high 16:1/16:0 ratio, survival at blood collection was extended by 10 months, as compared to patients with low ratio. The 16:1/16:0 index is an easy-to-handle parameter that predicts survival of ALS patients independently of body mass index. It therefore deserves further validation in larger cohorts for being used to assess disease outcome and effects of disease-modifying drugs.	[Henriques, Alexandre; Echaniz-Laguna, Andoni; Robelin, Laura; Lequeu, Thiebault; de Aguilar, Jose-Luis Gonzalez; Loeffler, Jean-Philippe] INSERM, Mecanismes Centraux & Peripher Neurodegenerescenc, U1118, Strasbourg, France; [Henriques, Alexandre; Robelin, Laura; Lequeu, Thiebault; de Aguilar, Jose-Luis Gonzalez; Loeffler, Jean-Philippe] Univ Strasbourg, UMR S1118, Federat Med Translat, Strasbourg, France; [Blasco, Helene; Corcia, Philippe; Andres, Christian R.] Univ Tours, INSERM, U930, Neurogenet & Neurometab, Tours, France; [Blasco, Helene; Andres, Christian R.] CHRU Tours, Lab Biochim & Biol Mol, Tours, France; [Fleury, Marie-Celine; Echaniz-Laguna, Andoni; Rudolf, Gabrielle; Tranchant, Christine] Hop Univ Strasbourg, Serv Neurol, Federat Med Transrat, Strasbourg, France; [Corcia, Philippe] CHRU Tours, Ctr SLA, Tours, France; [Bergaentzle, Martine; Marchioni, Eric] Univ Strasbourg, Equipe Chim Analyt Mol BioAct, Illkirch Graffenstaden, France; [Bergaentzle, Martine; Marchioni, Eric] CNRS, UMR 7178, Strasbourg, France; [Gachet, Christian] Univ Strasbourg, INSERM, UMR S949, Etab Francais Sang Alsace, Strasbourg, France; [Pradat, Pierre-Francois] Hop La Pitie Salpetriere, AP HP, Ctr Referent Malad Rare SLA, Federat Malad Syst Nerveux, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Tours; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	de Aguilar, JLG (corresponding author), INSERM, Mecanismes Centraux & Peripher Neurodegenerescenc, U1118, Strasbourg, France.	gonzalez@unistra.fr; loeffler@unistra.fr	berg, tine/HGB-3621-2022; LOEFFLER, Jean-Philippe/AAS-4401-2020; Gachet, Christian/H-9156-2016	Rudolf, Gabrielle/0000-0002-2050-3911; Andres, Christian/0000-0002-5062-3156; blasco, helene/0000-0001-6107-0035; BERGAENTZLE, Martine/0000-0003-4238-3698; tranchant, christine/0000-0002-2895-1292	Thierry Latran Foundation; European Community's Health Seventh Framework Programme [259867]; "Association pour la Recherche sur la Sclerose Laterale Amyotrophique et autres Maladies du Motoneurone" (ARSLA); Andre combat la SLA; "Association pour la Recherche et le Developpement de Moyens de Lutte contre les Maladies Neurodegeneratives" (AREMANE)	Thierry Latran Foundation; European Community's Health Seventh Framework Programme; "Association pour la Recherche sur la Sclerose Laterale Amyotrophique et autres Maladies du Motoneurone" (ARSLA); Andre combat la SLA; "Association pour la Recherche et le Developpement de Moyens de Lutte contre les Maladies Neurodegeneratives" (AREMANE)	This work was supported by funds from Thierry Latran Foundation, European Community's Health Seventh Framework Programme under grant agreement No. 259867 (Euro-MOTOR), "Association pour la Recherche sur la Sclerose Laterale Amyotrophique et autres Maladies du Motoneurone" (ARSLA), "Andre combat la SLA" and "Association pour la Recherche et le Developpement de Moyens de Lutte contre les Maladies Neurodegeneratives" (AREMANE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Taan O, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-64; Arsic A, 2012, APPL PHYSIOL NUTR ME, V37, P40, DOI [10.1139/h11-125, 10.1139/H11-125]; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Chio A, 2009, NEUROLOGY, V73, P1681, DOI 10.1212/WNL.0b013e3181c1df1e; de Carvalho M, 2008, CLIN NEUROPHYSIOL, V119, P497, DOI 10.1016/j.clinph.2007.09.143; de Mello VDF, 2009, EUR J NUTR, V48, P447, DOI 10.1007/s00394-009-0033-y; Desport JC, 2001, AM J CLIN NUTR, V74, P328; Desport JC, 2005, NEURODEGENER DIS, V2, P202, DOI 10.1159/000089626; Dorst J, 2011, J NEUROL, V258, P613, DOI 10.1007/s00415-010-5805-z; Dorst J, 2013, AMYOTROPH LAT SCL FR, V14, P533, DOI 10.3109/21678421.2013.823999; Dube JJ, 2011, DIABETOLOGIA, V54, P1147, DOI 10.1007/s00125-011-2065-0; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; Falcao-Pires I, 2012, DRUG DISCOV TODAY, V17, P880, DOI 10.1016/j.drudis.2012.04.007; Friesen RW, 2009, J NUTR, V139, P2344, DOI 10.3945/jn.109.112565; Funalot B, 2009, AMYOTROPH LATERAL SC, V10, P113, DOI 10.1080/17482960802295192; Gordon PH, 2013, NEURODEGENER DIS, V12, P81, DOI 10.1159/000341316; HOLMAN RT, 1995, J NUTR, V125, P901; Hussain G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00144; Hussain G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064525; Jawaid A, 2010, AMYOTROPH LATERAL SC, V11, P542, DOI 10.3109/17482968.2010.482592; Lindauer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067783; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Manjaly ZR, 2010, AMYOTROPH LATERAL SC, V11, P439, DOI 10.3109/17482961003610853; Marin B, 2011, J NEUROL NEUROSUR PS, V82, P628, DOI 10.1136/jnnp.2010.211474; Matthan NR, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000764; Olivan S, 2014, J NUTR BIOCHEM, V25, P885, DOI 10.1016/j.jnutbio.2014.04.005; Paganoni S, 2011, MUSCLE NERVE, V44, P20, DOI 10.1002/mus.22114; Pupillo E, 2014, ANN NEUROL, V75, P287, DOI 10.1002/ana.24096; Reich-Slotky R, 2013, AMYOTROPH LAT SCL FR, V14, P212, DOI 10.3109/21678421.2013.770028; Sampath H, 2011, ANN NY ACAD SCI, V1243, P47, DOI 10.1111/j.1749-6632.2011.06303.x; Schmitt F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00025; Sutedja NA, 2011, J NEUROL NEUROSUR PS, V82, P638, DOI 10.1136/jnnp.2010.236752; Tepsic J, 2009, EUR J APPL PHYSIOL, V107, P359, DOI 10.1007/s00421-009-1131-5; Turner MR, 2012, BRAIN, V135, P2883, DOI 10.1093/brain/aws144; Turyn J, 2010, MOL CELL BIOCHEM, V345, P181, DOI 10.1007/s11010-010-0571-x; VANDENBOOM MAP, 1994, BBA-LIPID LIPID MET, V1215, P314, DOI 10.1016/0005-2760(94)90059-0; Vannice G, 2014, J ACAD NUTR DIET, V114, P136, DOI 10.1016/j.jand.2013.11.001; Vinknes KJ, 2013, OBESITY, V21, pE294, DOI 10.1002/oby.20011; Wills AM, 2014, LANCET, V383, P2065, DOI 10.1016/S0140-6736(14)60222-1; Wood KE, 2014, PROSTAG LEUKOTR ESS, V90, P133, DOI 10.1016/j.plefa.2013.12.010; Yun Jung-Mi, 2012, Prev Nutr Food Sci, V17, P158, DOI 10.3746/pnf.2012.17.2.158; Zak A, 2005, PHYSIOL RES, V54, P443, DOI 10.33549/physiolres.930643	46	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131512	10.1371/journal.pone.0131512	http://dx.doi.org/10.1371/journal.pone.0131512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147510	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600102
J	Hoffmann, U; Neudorfl, C; Daemen, K; Keil, J; Stevanovic-Meyer, M; Lehner, F; Haller, H; Blume, C; Falk, CS				Hoffmann, Ulrike; Neudoerfl, Christine; Daemen, Kerstin; Keil, Jana; Stevanovic-Meyer, Maja; Lehner, Frank; Haller, Hermann; Blume, Cornelia; Falk, Christine S.			NK Cells of Kidney Transplant Recipients Display an Activated Phenotype that Is Influenced by Immunosuppression and Pathological Staging	PLOS ONE			English	Article							ANTIBODY-MEDIATED REJECTION; DONOR-SPECIFIC ANTIBODIES; INNATE LYMPHOID-CELLS; NATURAL-KILLER-CELLS; CYCLOSPORINE-A; T-CELLS; EXPRESSION; CYTOKINE; RECOGNITION; CALCINEURIN	To explore phenotype and function of NK cells in kidney transplant recipients, we investigated the peripheral NK cell repertoire, capacity to respond to various stimuli and impact of immunosuppressive drugs on NK cell activity in kidney transplant recipients. CD56(dim) NK cells of kidney transplanted patients displayed an activated phenotype characterized by significantly decreased surface expression of CD16 (p=0.0003), CD226 (p<0.0001), CD161 (p=0.0139) and simultaneously increased expression of activation markers like HLA-DR (p=0.0011) and CD25 (p=0.0015). Upon in vitro stimulation via Ca++-dependent signals, down-modulation of CD16 was associated with induction of interferon (IFN)-gamma expression. CD16 modulation and secretion of NFAT-dependent cytokines such as IFN-gamma, TNF-alpha, IL-10 and IL-31 were significantly suppressed by treatment of isolated NK cells with calcineurin inhibitors but not with mTOR inhibitors. In kidney transplant recipients, IFN-gamma production was retained in response to HLA class I-negative target cells and to non-specific stimuli, respectively. However, secretion of other cytokines like IL-13, IL-17, IL-22 and IL-31 was significantly reduced compared to healthy donors. In contrast to suppression of cytokine expression at the transcriptional level, cytotoxin release, i.e. perforin, granzyme A/B, was not affected by immunosuppression in vitro and in vivo in patients as well as in healthy donors. Thus, immunosuppressive treatment affects NK cell function at the level of NFAT-dependent gene expression whereby calcineurin inhibitors primarily impair cytokine secretion while mTOR inhibitors have only marginal effects. Taken together, NK cells may serve as indicators for immunosuppression and may facilitate a personalized adjustment of immunosuppressive medication in kidney transplant recipients.	[Hoffmann, Ulrike; Neudoerfl, Christine; Daemen, Kerstin; Keil, Jana; Stevanovic-Meyer, Maja; Falk, Christine S.] Hannover Med Sch, IFB Tx, Inst Transplant Immunol, Hannover, Germany; [Lehner, Frank] Hannover Med Sch, Dept Visceral & Transplant Surg, Hannover, Germany; [Haller, Hermann; Blume, Cornelia] Hannover Med Sch, Dept Hypertens & Nephrol, Hannover, Germany; [Blume, Cornelia] Leibniz Univ Hannover, Inst Tech Chem, Hannover, Germany; [Falk, Christine S.] German Ctr Infect Dis, DZIF, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Leibniz University Hannover; German Center for Infection Research	Falk, CS (corresponding author), Hannover Med Sch, IFB Tx, Inst Transplant Immunol, Hannover, Germany.	falk.christine@mh-hannover.de	Falk, Christine/Q-4143-2016	Falk, Christine/0000-0003-1376-7318; Blume, Cornelia/0000-0001-7487-4884	German Research Foundation (DFG) [SFB738]; IFB-Tx of the German Ministry of Education and Research BMBF [BMBF 01EO1302]; DZIF (German Center for Infection Research) [TTU-IICH 8.3]	German Research Foundation (DFG)(German Research Foundation (DFG)); IFB-Tx of the German Ministry of Education and Research BMBF; DZIF (German Center for Infection Research)	This work was supported by the German Research Foundation (DFG), SFB738 project B3/B8, IFB-Tx of the German Ministry of Education and Research BMBF (BMBF 01EO1302) and DZIF (German Center for Infection Research) TTU-IICH 8.3.	Anfossi N, 2001, IMMUNOL REV, V181, P269, DOI 10.1034/j.1600-065X.2001.1810123.x; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; ARAMBURU J, 1995, J EXP MED, V182, P801, DOI 10.1084/jem.182.3.801; Bjorkstrom NK, 2013, IMMUNOLOGY, V139, P416, DOI 10.1111/imm.12098; Brandt C, 2010, CYTOM PART A, V77A, P607, DOI 10.1002/cyto.a.20928; Braun M, 2011, J INNATE IMMUN, V3, P420, DOI 10.1159/000322720; Brouard S, 2010, AM J TRANSPLANT, V10, P2604, DOI 10.1111/j.1600-6143.2010.03302.x; Crespo M, 2015, AM J TRANSPLANT, V15, P806, DOI 10.1111/ajt.13010; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Farkash EA, 2012, NAT REV NEPHROL, V8, P255, DOI 10.1038/nrneph.2012.61; Fauriat C, 2010, BLOOD, V115, P2167, DOI 10.1182/blood-2009-08-238469; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Haas M, 2014, AM J TRANSPLANT, V14, P272, DOI 10.1111/ajt.12590; Hadad U, 2014, IMMUNOL RES, V58, P259, DOI 10.1007/s12026-014-8493-4; Hidalgo LG, 2010, AM J TRANSPLANT, V10, P1812, DOI 10.1111/j.1600-6143.2010.03201.x; Juelke K, 2010, BLOOD, V116, P1299, DOI 10.1182/blood-2009-11-253286; Ke HM, 2003, BIOCHEM BIOPH RES CO, V311, P1095, DOI 10.1016/S0006-291X(03)01537-7; La Manna G, 2013, ANN TRANSPL, V18, P611, DOI 10.12659/AOT.889157; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Linkermann A, 2013, AM J TRANSPLANT, V13, P2797, DOI 10.1111/ajt.12448; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Marcard T, 2008, TRANSPL INT, V21, P1153, DOI 10.1111/j.1432-2277.2008.00731.x; Meehan AC, 2010, TRANSPLANTATION, V89, P756, DOI 10.1097/TP.0b013e3181cab17f; NeudoerfI C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00046; Pores-Fernando AT, 2009, CELL IMMUNOL, V254, P105, DOI 10.1016/j.cellimm.2008.07.004; Romee R, 2013, BLOOD, V121, P3599, DOI 10.1182/blood-2012-04-425397; Sagoo P, 2010, J CLIN INVEST, V120, P1848, DOI 10.1172/JCI39922; Sanchez-Correa B, 2012, IMMUNOL CELL BIOL, V90, P109, DOI 10.1038/icb.2011.15; Serfling E, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-16; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Tran TH, 2013, AM J TRANSPLANT, V13, P1063, DOI 10.1111/ajt.12134; Venner JM, 2015, AM J TRANSPLANT; Wai LE, 2008, TRANSPLANTATION, V85, P145, DOI 10.1097/01.tp.0000296817.28053.7b; Wang H, 2007, BLOOD, V110, P1530, DOI 10.1182/blood-2006-10-048173; Wood KJ, 2012, TRANSPLANTATION, V93, P1, DOI 10.1097/TP.0b013e31823cab44; Yu JH, 2013, TRENDS IMMUNOL, V34, P573, DOI 10.1016/j.it.2013.07.005; Yu JH, 2010, BLOOD, V115, P274, DOI 10.1182/blood-2009-04-215491; Zhang ZX, 2015, TRANSPLANTATION	38	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132484	10.1371/journal.pone.0132484	http://dx.doi.org/10.1371/journal.pone.0132484			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147651	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600283
J	Johnson, KL; Ramm, S; Kappel, C; Ward, S; Leyser, O; Sakamoto, T; Kurata, T; Bevan, MW; Lenhard, M				Johnson, Kim L.; Ramm, Sascha; Kappel, Christian; Ward, Sally; Leyser, Ottoline; Sakamoto, Tomoaki; Kurata, Tetsuya; Bevan, Michael W.; Lenhard, Michael			The Tinkerbell (Tink) Mutation Identifies the Dual-Specificity MAPK Phosphatase INDOLE-3-BUTYRIC ACID-RESPONSE5 (IBR5) as a Novel Regulator of Organ Size in Arabidopsis	PLOS ONE			English	Article							CLASS-I; PROTEIN PHOSPHATASE; AUXIN; RESPONSES; THALIANA; KINASE; GROWTH; INTERACTS; DISTINCT; PATHWAY	Mitogen-activated dual-specificity MAPK phosphatases are important negative regulators in the MAPK signalling pathways responsible for many essential processes in plants. In a screen for mutants with reduced organ size we have identified a mutation in the active site of the dual-specificity MAPK phosphatase INDOLE-3-BUTYRIC ACID-RESPONSE5 (IBR5) that we named tinkerbell (tink) due to its small size. Analysis of the tink mutant indicates that IBR5 acts as a novel regulator of organ size that changes the rate of growth in petals and leaves. Organ size and shape regulation by IBR5 acts independently of the KLU growth-regulatory pathway. Microarray analysis of tink/ibr5-6 mutants identified a likely role for this phosphatase in male gametophyte development. We show that IBR5 may influence the size and shape of petals through auxin and TCP growth regulatory pathways.	[Johnson, Kim L.] Univ Melbourne, ARC Ctr Excellence Plant Cell Walls, Sch Bot, Parkville, Vic 3010, Australia; [Ramm, Sascha; Kappel, Christian; Lenhard, Michael] Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany; [Ward, Sally; Leyser, Ottoline] Univ Cambridge, Sainsbury Lab, Cambridge CB2 1LR, England; [Sakamoto, Tomoaki; Kurata, Tetsuya] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300192, Japan; [Bevan, Michael W.] John Innes Ctr, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England	University of Melbourne; University of Potsdam; University of Cambridge; Nara Institute of Science & Technology; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Lenhard, M (corresponding author), Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany.	michael.lenhard@uni-potsdam.de	Johnson, Kim/AAB-5696-2022; Lenhard, Michael/J-1554-2015; Leyser, Ottoline/AAC-5577-2019	Johnson, Kim/0000-0001-6917-7742; Sakamoto, Tomoaki/0000-0002-1583-0993; Kappel, Christian/0000-0002-1450-1864; Leyser, Ottoline/0000-0003-2161-3829	Biotechnology and Biological Sciences Research Council; Australian Research Council, Centre of Excellence in Plant Cell Walls; BBSRC [BB/K017225/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K017225/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Australian Research Council, Centre of Excellence in Plant Cell Walls(Australian Research Council); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported in part by the Biotechnology and Biological Sciences Research Council grant and the Australian Research Council, Centre of Excellence in Plant Cell Walls (to KJ).	Aguilar-Martinez JA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00406; Anastasiou E, 2007, DEV CELL, V13, P843, DOI 10.1016/j.devcel.2007.10.001; Andreasson E, 2010, TRENDS PLANT SCI, V15, P106, DOI 10.1016/j.tplants.2009.12.001; Bennett T, 2006, CURR BIOL, V16, P553, DOI 10.1016/j.cub.2006.01.058; Bensmihen S, 2004, FEBS LETT, V561, P127, DOI 10.1016/S0014-5793(04)00148-6; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Disch S, 2006, CURR BIOL, V16, P272, DOI 10.1016/j.cub.2005.12.026; Gonzalez Besteiro MA, 2013, PLANT J, V73, P1034, DOI 10.1111/tpj.12095; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gupta R, 1998, PLANT J, V16, P581, DOI 10.1046/j.1365-313x.1998.00327.x; Hepworth J, 2014, CURR OPIN PLANT BIOL, V17, P36, DOI 10.1016/j.pbi.2013.11.005; Hu YX, 2003, PLANT CELL, V15, P1951, DOI 10.1105/tpc.013557; Jayaweera T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102301; Johnson K, 2011, NEW PHYTOL, V191, P319, DOI 10.1111/j.1469-8137.2011.03737.x; Kieffer M, 2011, PLANT J, V68, P147, DOI 10.1111/j.1365-313X.2011.04674.x; Krizek BA, 2003, NUCLEIC ACIDS RES, V31, P1859, DOI 10.1093/nar/gkg292; Lee JS, 2007, J BIOL CHEM, V282, P25020, DOI 10.1074/jbc.M701888200; Lee JS, 2009, PLANT J, V57, P975, DOI 10.1111/j.1365-313X.2008.03741.x; Li CX, 2005, P NATL ACAD SCI USA, V102, P12978, DOI 10.1073/pnas.0504039102; Lumbreras V, 2010, PLANT J, V63, P1017, DOI 10.1111/j.1365-313X.2010.04297.x; Mayank P, 2012, PLANT J, V72, P89, DOI 10.1111/j.1365-313X.2012.05061.x; Mizukami Y, 2000, P NATL ACAD SCI USA, V97, P942, DOI 10.1073/pnas.97.2.942; Mizukami Y, 2001, CURR OPIN PLANT BIOL, V4, P533, DOI 10.1016/S1369-5266(00)00212-0; Mockaitis K, 2000, PLANT J, V24, P785, DOI 10.1046/j.1365-313x.2000.00921.x; Monroe-Augustus M, 2003, PLANT CELL, V15, P2979, DOI 10.1105/tpc.017046; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pytela J, 2010, PLANTA, V231, P1311, DOI 10.1007/s00425-010-1135-8; Reina-Pinto JJ, 2010, PLANT J, V61, P166, DOI 10.1111/j.1365-313X.2009.04043.x; Sauret-Gueto S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001550; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Smekalova V, 2014, BIOTECHNOL ADV, V32, P2, DOI 10.1016/j.biotechadv.2013.07.009; Steiner E, 2012, PLANT CELL, V24, P96, DOI 10.1105/tpc.111.093518; Strader LC, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-41; Strader LC, 2008, GENETICS, V180, P2019, DOI 10.1534/genetics.108.091512; SUN H, 1994, TRENDS BIOCHEM SCI, V19, P480, DOI 10.1016/0968-0004(94)90134-1; Szecsi Judit, 2014, Methods Mol Biol, V1110, P191, DOI 10.1007/978-1-4614-9408-9_8; Uberti-Manassero NG, 2012, J EXP BOT, V63, P809, DOI 10.1093/jxb/err305; Valsecchi I, 2013, MOL BIOSYST, V9, P2282, DOI 10.1039/c3mb70128j; Viola IL, 2012, J BIOL CHEM, V287, P347, DOI 10.1074/jbc.M111.256271; Yoo JH, 2004, J BIOL CHEM, V279, P848, DOI 10.1074/jbc.M310709200	42	13	14	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131103	10.1371/journal.pone.0131103	http://dx.doi.org/10.1371/journal.pone.0131103			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147117	Green Published, gold			2022-12-27	WOS:000358157600061
J	Kraemer, BM; Hook, S; Huttula, T; Kotilainen, P; O'Reilly, CM; Peltonen, A; Plisnier, PD; Sarvala, J; Tamatamah, R; Vadeboncoeur, Y; Wehrli, B; McIntyre, PB				Kraemer, Benjamin M.; Hook, Simon; Huttula, Timo; Kotilainen, Pekka; O'Reilly, Catherine M.; Peltonen, Anu; Plisnier, Pierre-Denis; Sarvala, Jouko; Tamatamah, Rashid; Vadeboncoeur, Yvonne; Wehrli, Bernhard; McIntyre, Peter B.			Century-Long Warming Trends in the Upper Water Column of Lake Tanganyika	PLOS ONE			English	Article							CLIMATE-CHANGE; TEMPERATURE-DEPENDENCE; IMPACTS; LIPIDS	Lake Tanganyika, the deepest and most voluminous lake in Africa, has warmed over the last century in response to climate change. Separate analyses of surface warming rates estimated from in situ instruments, satellites, and a paleolimnological temperature proxy (TEX86) disagree, leaving uncertainty about the thermal sensitivity of Lake Tanganyika to climate change. Here, we use a comprehensive database of in situ temperature data from the top 100 meters of the water column that span the lake's seasonal range and lateral extent to demonstrate that long-term temperature trends in Lake Tanganyika depend strongly on depth, season, and latitude. The observed spatiotemporal variation in surface warming rates accounts for small differences between warming rate estimates from in situ instruments and satellite data. However, after accounting for spatiotemporal variation in temperature and warming rates, the TEX86 paleolimnological proxy yields lower surface temperatures (1.46 degrees C lower on average) and faster warming rates (by a factor of three) than in situ measurements. Based on the ecology of Thaumarchaeota (the microbes whose biomolecules are involved with generating the TEX86 proxy), we offer a reinterpretation of the TEX86 data from Lake Tanganyika as the temperature of the low-oxygen zone, rather than of the lake surface temperature as has been suggested previously. Our analyses provide a thorough accounting of spatiotemporal variation in warming rates, offering strong evidence that thermal and ecological shifts observed in this massive tropical lake over the last century are robust and in step with global climate change.	[Kraemer, Benjamin M.; McIntyre, Peter B.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Hook, Simon] NASA, Jet Prop Lab, Pasadena, CA USA; [Huttula, Timo] Finnish Environm Inst, Freshwater Ctr, Jyvaskyla, Finland; [Kotilainen, Pekka] Finnish Environm Inst, Ctr Marine Res, Helsinki, Finland; [O'Reilly, Catherine M.] Illinois State Univ, Dept Geog Geol, Normal, IL 61761 USA; [Peltonen, Anu] Ctr Econ Dev Transport & Environm Pirkanmaa, Tampere, Finland; [Plisnier, Pierre-Denis] Royal Museum Cent Africa, Tervuren, Belgium; [Sarvala, Jouko] Univ Turku, Dept Biol, SF-20500 Turku, Finland; [Tamatamah, Rashid] Univ Dar Es Salaam, Dept Aquat Sci & Fisheries, Dar Es Salaam, Tanzania; [Vadeboncoeur, Yvonne] Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA; [Wehrli, Bernhard] Swiss Fed Inst Aquat Sci & Technol Eawag, Surface Waters Dept, Kastanienbaum, Switzerland; [Wehrli, Bernhard] ETH, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland	University of Wisconsin System; University of Wisconsin Madison; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Finnish Environment Institute; Finnish Environment Institute; Illinois State University; Royal Museum for Central Africa; University of Turku; University of Dar es Salaam; University System of Ohio; Wright State University Dayton; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich	Kraemer, BM (corresponding author), Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA.	ben.m.kraemer@gmail.com	Hook, Simon J/D-5920-2016; Wehrli, Bernhard/A-4406-2013; Plisnier, Pierre-Denis/ABG-2933-2020; Wehrli, Bernhard/M-3847-2019; Sarvala, Jouko/J-8962-2019; Kraemer, Benjamin M/AAV-9299-2021; Wehrli, Bernhard/B-4420-2008	Hook, Simon J/0000-0002-0953-6165; Wehrli, Bernhard/0000-0001-7029-1972; Wehrli, Bernhard/0000-0001-7029-1972; Sarvala, Jouko/0000-0002-5016-3049; Wehrli, Bernhard/0000-0001-7029-1972	National Science Foundation (NSF) [DEB-1030242, DEB-0842253]; Global Lake Temperature Collaboration (National Aeronautics and Space Administration (NASA) Research Opportunities in Space and Earth Sciences (ROSES) Grant, Institute of Agricultural and Natural Resources (IANR), University of Nebraska-Lincoln) [DEB-1147666]	National Science Foundation (NSF)(National Science Foundation (NSF)); Global Lake Temperature Collaboration (National Aeronautics and Space Administration (NASA) Research Opportunities in Space and Earth Sciences (ROSES) Grant, Institute of Agricultural and Natural Resources (IANR), University of Nebraska-Lincoln)	The authors are grateful for field research funding from the National Science Foundation (NSF) (DEB-1030242 and DEB-0842253), and encouragement from the Global Lake Temperature Collaboration (DEB-1147666, National Aeronautics and Space Administration (NASA) Research Opportunities in Space and Earth Sciences (ROSES) Grant, Institute of Agricultural and Natural Resources (IANR), University of Nebraska-Lincoln).	Adrian R, 2009, LIMNOL OCEANOGR, V54, P2283, DOI 10.4319/lo.2009.54.6_part_2.2283; Austin JA, 2007, GEOPHYS RES LETT, V34; BEAUCHAMP R. S. A., 1939, INTERNAL REV GES HYDROBIOL U HYDROGR, V39, P316, DOI 10.1002/iroh.19390390303; Castaneda IS, 2011, QUATERNARY SCI REV, V30, P2851, DOI 10.1016/j.quascirev.2011.07.009; Chale F, 2006, TANZANIA JOURNAL OF, V32, P23; Coats R, 2006, CLIMATIC CHANGE, V76, P121, DOI 10.1007/s10584-005-9006-1; Corman JR, 2010, LIMNOL OCEANOGR, V55, P214, DOI 10.4319/lo.2010.55.1.0214; COULTER GW, 1968, LIMNOL OCEANOGR, V13, P385, DOI 10.4319/lo.1968.13.2.0385; Craig H, 1974, TANGANYIKA GEOCHEMIC; DAVISON W, 1983, GEOCHIM COSMOCHIM AC, V47, P67, DOI 10.1016/0016-7037(83)90091-1; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; DUBOIS J. T., 1958, HYDROBIOLOGIA, V10, P215, DOI 10.1007/BF00142188; Durisch-Kaiser E, 2011, J GEOPHYS RES-BIOGEO, V116; EDMOND JM, 1993, LIMNOL OCEANOGR, V38, P725, DOI 10.4319/lo.1993.38.4.0725; Finlay KP, 2001, CAN J FISH AQUAT SCI, V58, P609, DOI 10.1139/f01-017; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Huttula T, 1997, THERMAL REGIME AND S; Jacobs, 1914, ANN DER HYDROGR UND, V22; Jin ML, 2003, INT J REMOTE SENS, V24, P4543, DOI 10.1080/0143116031000095943; Kraemer B., 2015, CENTURY LONG TEMPERA, DOI [10.6073/pasta/59946ad9f1fefffd541d06054490b104, DOI 10.6073/PASTA/59946AD9F1FEFFFD541D06054490B104]; Livingstone DM, 2003, CLIMATIC CHANGE, V57, P205, DOI 10.1023/A:1022119503144; MacCallum SN, 2012, CAN J REMOTE SENS, V38, P25, DOI 10.5589/m12-010; MacIntyre S, 2013, CLIMATIC CHANGE AND, DOI [10.1002/9781118470596, DOI 10.1002/9781118470596]; MCARDLE BH, 1988, CAN J ZOOL, V66, P2329, DOI 10.1139/z88-348; Merchant CJ, 2005, Q J ROY METEOR SOC, V131, P2735, DOI 10.1256/qj.05.15; Narita T, 1986, VERTICAL DISTRIBUTIO; Ngai KLC, 2013, CLIMATIC CHANGE, V118, P841, DOI 10.1007/s10584-013-0695-6; O'Reilly CM, 2003, NATURE, V424, P766, DOI 10.1038/nature01833; Plisnier PD, 1999, HYDROBIOLOGIA, V407, P45, DOI 10.1023/A:1003762119873; Powers LA, 2004, GEOLOGY, V32, P613, DOI 10.1130/G20434.1; Roni N, 2013, ADV METEOROL; SCHNEIDER P, 1985, GEOPHYS RES LETT, V2010, P37, DOI DOI 10.1029/2010GL045059; Schouten S, 2012, ORG GEOCHEM, V53, P34, DOI 10.1016/j.orggeochem.2012.01.009; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051; Stappers L, 1913, REEPERTOIRE GEENEERA; Sumaila UR, 2011, NAT CLIM CHANGE, V1, P449, DOI 10.1038/NCLIMATE1301; Tierney JE, 2008, SCIENCE, V322, P252, DOI 10.1126/science.1160485; Tierney JE, 2010, NAT GEOSCI, V3, P422, DOI [10.1038/ngeo865, 10.1038/NGEO865]; Van Bocxlaer B, 2012, FRESHWATER BIOL, V57, P1733, DOI 10.1111/j.1365-2427.2012.02828.x; Van Meel Ludovic, 1987, CONTRIBUTION A LA LI; Verburg P, 2003, J GREAT LAKES RES, V29, P48, DOI 10.1016/S0380-1330(03)70538-3; Verburg P, 2003, SCIENCE, V301, P505, DOI 10.1126/science.1084846; Verburg P, 2011, LIMNOL OCEANOGR, V56, P910, DOI 10.4319/lo.2011.56.3.0910; Verburg P, 2009, LIMNOL OCEANOGR, V54, P2418, DOI 10.4319/lo.2009.54.6_part_2.2418; Wilson RC, 2013, J GEOPHYS RES-ATMOS, V118, P10332, DOI 10.1002/jgrd.50786; Wuchter C, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001041; Yvon-Durocher G, 2014, NATURE, V507, P488, DOI 10.1038/nature13164; Yvon-Durocher G, 2012, NATURE, V487, P472, DOI 10.1038/nature11205	49	38	39	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132490	10.1371/journal.pone.0132490	http://dx.doi.org/10.1371/journal.pone.0132490			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147964	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600287
J	Lee, TF; Chao, PJ; Chang, LY; Ting, HM; Huang, YJ				Lee, Tsair-Fwu; Chao, Pei-Ju; Chang, Liyun; Ting, Hui-Min; Huang, Yu-Jie			Developing Multivariable Normal Tissue Complication Probability Model to Predict the Incidence of Symptomatic Radiation Pneumonitis among Breast Cancer Patients	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; VOLUME HISTOGRAM ANALYSIS; LEAST ABSOLUTE SHRINKAGE; DOSE-VOLUME; CONFORMAL RADIOTHERAPY; SELECTION OPERATOR; RATED XEROSTOMIA; GRADING SYSTEM; STICKY SALIVA; NTCP MODELS	Purpose Symptomatic radiation pneumonitis (SRP), which decreases quality of life (QoL), is the most common pulmonary complication in patients receiving breast irradiation. If it occurs, acute SRP usually develops 4-12 weeks after completion of radiotherapy and presents as a dry cough, dyspnea and low-grade fever. If the incidence of SRP is reduced, not only the QoL but also the compliance of breast cancer patients may be improved. Therefore, we investigated the incidence SRP in breast cancer patients after hybrid intensity modulated radiotherapy (IMRT) to find the risk factors, which may have important effects on the risk of radiation-induced complications. Methods In total, 93 patients with breast cancer were evaluated. The final endpoint for acute SRP was defined as those who had density changes together with symptoms, as measured using computed tomography. The risk factors for a multivariate normal tissue complication probability model of SRP were determined using the least absolute shrinkage and selection operator (LASSO) technique. Results Five risk factors were selected using LASSO: the percentage of the ipsilateral lung volume that received more than 20-Gy (IV20), energy, age, body mass index (BMI) and T stage. Positive associations were demonstrated among the incidence of SRP, IV20, and patient age. Energy, BMI and T stage showed a negative association with the incidence of SRP. Our analyses indicate that the risk of SPR following hybrid IMRT in elderly or low-BMI breast cancer patients is increased once the percentage of the ipsilateral lung volume receiving more than 20-Gy is controlled below a limitation. Conclusions We suggest to define a dose-volume percentage constraint of IV20<37% (or AIV20<310cc) for the irradiated ipsilateral lung in radiation therapy treatment planning to maintain the incidence of SPR below 20%, and pay attention to the sequelae especially in elderly or low-BMI breast cancer patients. (AIV20: the absolute ipsilateral lung volume that received more than 20 Gy (cc).	[Lee, Tsair-Fwu; Chao, Pei-Ju; Ting, Hui-Min] Natl Kaohsiung Univ Appl Sci, Med Phys & Informat Lab Elect Engn, Kaohsiung 80778, Taiwan; [Lee, Tsair-Fwu] Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung 807, Taiwan; [Chao, Pei-Ju; Ting, Hui-Min; Huang, Yu-Jie] Kaohsiung Chang Gung Mem Hosp, Dept Radiat Oncol, Kaohsiung 83305, Taiwan; [Chao, Pei-Ju; Ting, Hui-Min; Huang, Yu-Jie] Chang Gung Univ, Coll Med, Kaohsiung 83305, Taiwan; [Chang, Liyun] I Shou Univ, Dept Med Imaging & Radiol Sci, Kaohsiung 82445, Taiwan	National Kaohsiung University of Science & Technology; Kaohsiung Medical University; Chang Gung Memorial Hospital; Chang Gung University; I Shou University	Huang, YJ (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Radiat Oncol, Kaohsiung 83305, Taiwan.	yjhuang5657@gmail.com	chao, P/GSD-8001-2022	Lee, Tsair-Fwu/0000-0002-3112-3594	Ministry of Science and Technology (MOST) of the Executive Yuan of the Republic of China [NSC-101-2221-E-151-007-MY3]	Ministry of Science and Technology (MOST) of the Executive Yuan of the Republic of China	This study was supported financially by a grant from the Ministry of Science and Technology (MOST) of the Executive Yuan of the Republic of China, (NSC-101-2221-E-151-007-MY3). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2012, AM J RESP CRIT CARE, V185, pA5727; Abe O, 2005, LANCET, V366, P2087; Allen AM, 2005, CANCER J, V11, P390, DOI 10.1097/00130404-200509000-00006; ARRIAGADA R, 1989, RADIOTHER ONCOL, V14, P1, DOI 10.1016/0167-8140(89)90002-9; Beetz I, 2012, RADIOTHER ONCOL, V105, P101, DOI 10.1016/j.radonc.2012.03.004; Beetz I, 2012, RADIOTHER ONCOL, V105, P94, DOI 10.1016/j.radonc.2011.11.006; Choi YW, 2004, RADIOGRAPHICS, V24, P985, DOI 10.1148/rg.244035160; Colombani C, 2013, J DAIRY SCI, V96, P575, DOI 10.3168/jds.2011-5225; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; El Naqa I, 2006, INT J RADIAT ONCOL, V64, P1275, DOI 10.1016/j.ijrobp.2005.11.022; Fu WH, 2004, BIO-MED MATER ENG, V14, P123; Gagliardi G, 2000, INT J RADIAT ONCOL, V46, P373, DOI 10.1016/S0360-3016(99)00420-4; Goldman Ulla Blom, 2010, RADIAT ONCOL, V5, P1; Graham MV, 1999, INT J RADIAT ONCOL, V45, P323, DOI 10.1016/S0360-3016(99)00183-2; HARDMAN PDJ, 1994, RADIOTHER ONCOL, V30, P33, DOI 10.1016/0167-8140(94)90007-8; Hassaballa HA, 2005, CHEST, V128, P1448, DOI 10.1378/chest.128.3.1448; Hernando ML, 2001, INT J RADIAT ONCOL, V51, P650, DOI 10.1016/S0360-3016(01)01685-6; Hooning MJ, 2006, INT J RADIAT ONCOL, V64, P1081, DOI 10.1016/j.ijrobp.2005.10.022; IKEZOE J, 1988, AM J ROENTGENOL, V150, P765, DOI 10.2214/ajr.150.4.765; Johansson S, 1998, RADIOTHER ONCOL, V49, P41, DOI 10.1016/S0167-8140(98)00064-4; Kahan Z, 2007, INT J RADIAT ONCOL, V68, P673, DOI 10.1016/j.ijrobp.2006.12.016; Lee TF, 2014, SCI REP-UK, V4, DOI 10.1038/srep06217; Lee TF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/143020; Lee TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089700; Lind PARM, 2000, EUR RADIOL, V10, P484; Lind PARM, 2001, BREAST CANCER RES TR, V68, P199, DOI 10.1023/A:1012292019599; Lind PARM, 1999, INT J RADIAT ONCOL, V43, P489, DOI 10.1016/S0360-3016(98)00414-3; Mansouri S, 2014, ASIAN PAC J CANCER P, V15, P4727, DOI 10.7314/APJCP.2014.15.11.4727; Mayo CS, 2005, INT J RADIAT ONCOL, V61, P922, DOI 10.1016/j.ijrobp.2004.10.033; McGale P, 2014, LANCET, V383, P2127, DOI 10.1016/S0140-6736(14)60488-8; Michalski A, 2014, MED DOSIM, V39, P163, DOI 10.1016/j.meddos.2013.12.003; Ramella S, 2010, INT J RADIAT ONCOL, V76, P110, DOI 10.1016/j.ijrobp.2009.01.036; Ramsey SD, 2000, CANCER-AM CANCER SOC, V88, P1294, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1294::AID-CNCR4>3.3.CO;2-D; Rancati T, 2007, RADIOTHER ONCOL, V82, P308, DOI 10.1016/j.radonc.2006.12.001; Taghian AG, 2001, J NATL CANCER I, V93, P1806, DOI 10.1093/jnci/93.23.1806; Teppola P, 2013, ANAL CHIM ACTA, V768, P57, DOI 10.1016/j.aca.2013.01.005; Theuws JCM, 1998, RADIOTHER ONCOL, V48, P33, DOI 10.1016/S0167-8140(98)00019-X; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; Tsougos I, 2005, PHYS MED BIOL, V50, P3535, DOI 10.1088/0031-9155/50/15/004; van der Schaaf A, 2012, RADIOTHER ONCOL, V105, P115, DOI 10.1016/j.radonc.2011.12.006; Wennberg B, 2002, INT J RADIAT ONCOL, V52, P1196, DOI 10.1016/S0360-3016(01)02770-5; Xu CJ, 2012, INT J RADIAT ONCOL, V84, pE123, DOI 10.1016/j.ijrobp.2012.02.022; Xu CJ, 2012, INT J RADIAT ONCOL, V82, pE677, DOI 10.1016/j.ijrobp.2011.09.036; Xu J, 2013, IET COMPUT VIS, V7, P48, DOI 10.1049/iet-cvi.2011.0193	46	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131736	10.1371/journal.pone.0131736	http://dx.doi.org/10.1371/journal.pone.0131736			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147496	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600137
J	Malvankar-Mehta, MS; Iordanous, Y; Chen, YN; Wang, WW; Patel, SS; Costella, J; Hutnik, CML				Malvankar-Mehta, Monali S.; Iordanous, Yiannis; Chen, Yufeng Nancy; Wang, Wan Wendy; Patel, Sangita Shantilal; Costella, John; Hutnik, Cindy M. L.			iStent with Phacoemulsification versus Phacoemulsification Alone for Patients with Glaucoma and Cataract: A Meta-Analysis	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; CLEAR CORNEAL PHACOEMULSIFICATION; INTRAOCULAR-LENS IMPLANTATION; MICRO-BYPASS STENT; OCULAR SURFACE; TRABECULAR MICROBYPASS; PRESSURE REDUCTION; SURGERY; EYES; ADHERENCE	Background Minimally invasive glaucoma surgeries (MIGS) have attracted significant attention, as they have been reported to lower intra-ocular pressure (IOP) and have an excellent safety profile. The iStent is an example of a minimally invasive glaucoma device that has received particular attention due to its early and wide spread utilization. There is a growing body of evidence supporting its use at the time of phacoemulsification to help lower IOP. However, it is still not clear how much of the IOP lowering effect can be attributed to the iStent, the crystalline lens extraction or both when inserted concurrently at the time of phacoemulsification. This has been an important issue in understanding its potential role in the glaucoma management paradigm. Purpose To conduct a systematic review and meta-analysis comparing the IOP lowering effect of iStent insertion at the time of phacoemulsification versus phacoemulsification alone for patients with glaucoma and cataracts. Methods A systematic review was conducted utilizing various databases. Studies examining the IOP lowering effect of iStent insertion in combination with phacoemulsification, as well as studies examining the IOP lowering effect of phacoemulsification alone were included. Thirty-seven studies, reporting on 2495 patients, met the inclusion criteria. The percentage reduction in IOP (IOPR%) and mean reduction in topical glaucoma medications after surgery were determined. The standardized mean difference (SMD) was computed as a measure of the treatment effect for continuous outcomes taking into account heterogeneity. Fixed-effect and random-effect models were applied. Results A 4% IOP reduction (IOPR%) from baseline occurred following phacoemulsification as a solo procedure compared to 9% following an iStent implant with phacoemulsification, and 27% following 2 iStents implants with phacoemulsification. Compared with cataract extraction alone, iStent with phacoemulsification resulted in significant reduction in the post-operative IOP (IOPR%) (SMD = -0.46, 95% CI: [-0.87, -0.06]). A weighted mean reduction in the number of glaucoma medications per patient was 1.01 following phacoemulsification alone compared to 1.33 after one iStent implant with phacoemulsification, and 1.1 after 2 iStent implants with phacoemulsification. Compared to cataract extraction alone, iStent with cataract extraction showed a significant decrease in the number of glaucoma medications (SMD = -0.65, 95% CI: [-1.18, -0.12]). Funnel plots suggested the absence of publication bias. Conclusion Both iStent implantation with concurrent phacoemulsification and phacoemulsification alone result in a significant decrease in IOP and topical glaucoma medications. In terms of both reductions, iStent with phacoemulsification significantly outperforms phacoemulsification alone.	[Malvankar-Mehta, Monali S.; Iordanous, Yiannis; Hutnik, Cindy M. L.] Univ Western Ontario, Dept Ophthalmol, Schulich Sch Med & Dent, London, ON, Canada; [Malvankar-Mehta, Monali S.] Univ Western Ontario, Dept Epidemiol & Biostat, Schulich Sch Med & Dent, London, ON, Canada; [Chen, Yufeng Nancy; Wang, Wan Wendy] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada; [Patel, Sangita Shantilal] Univ Western Ontario, Fac Hlth Sci, London, ON, Canada; [Costella, John] Univ Western Ontario, Ctr Nat Sci, Allyn & Betty Taylor Lib, London, ON N6A 5B7, Canada; [Hutnik, Cindy M. L.] Univ Western Ontario, Dept Pathol, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Malvankar-Mehta, MS (corresponding author), Univ Western Ontario, Dept Ophthalmol, Schulich Sch Med & Dent, London, ON, Canada.	Monali.Malvankar@schulich.uwo.ca	Costella, John/L-9241-2013	Costella, John/0000-0001-6542-6000				Administration USAFaD, 2010, US FDAS OPHTH DEV PA; Ahmed ASH, 2012, PROSPECTIVE RANDOMIZ; Altan-Yaycioglu R, 2009, J CATARACT REFR SURG, V35, P952, DOI 10.1016/j.jcrs.2009.01.015; Ammar DA, 2011, ADV THER, V28, P501, DOI 10.1007/s12325-011-0029-x; Arriola-Villalobos P, 2013, BRIT J OPHTHALMOLOGY; Arriola-Villalobos P, 2012, BRIT J OPHTHALMOL, V96, P645, DOI 10.1136/bjophthalmol-2011-300218; Baudouin C, 2008, OPHTHALMOLOGY, V115, P109, DOI 10.1016/j.ophtha.2007.01.036; Belovay GW, 2012, J CATARACT REFR SURG, V38, P1911, DOI 10.1016/j.jcrs.2012.07.017; Bowling Brad, 2009, J Cataract Refract Surg, V35, P406, DOI 10.1016/j.jcrs.2008.11.055; Buchacra O, 2011, CLIN OPHTHALMOL, V5, P321, DOI 10.2147/OPTH.S15025; Canadian National Institute for the Blind (CNIB), 2014, FAST FACTS VIS LOSS; Carrillo MM, 2005, ARCH OPHTHALMOL-CHIC, V123, P929, DOI 10.1001/archopht.123.7.929; Chang TC, 2012, J CATARACT REFR SURG, V38, P866, DOI 10.1016/j.jcrs.2012.01.016; Chihara E, 2011, JPN J OPHTHALMOL, V55, P107, DOI 10.1007/s10384-010-0923-9; Damji KF, 2006, BRIT J OPHTHALMOL, V90, P1014, DOI 10.1136/bjo.2006.091447; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Dreer LE, 2012, J GLAUCOMA, V21, P234, DOI 10.1097/IJG.0b013e31821dac86; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fea AM, 2012, INVEST OPHTHALMOL, V53, P3731; Fea AM, 2010, J CATARACT REFR SURG, V36, P407, DOI 10.1016/j.jcrs.2009.10.031; Fernandez-Barrientos Y, 2010, INVEST OPHTH VIS SCI, V51, P3327, DOI 10.1167/iovs.09-3972; Grue EV, 2009, J CLIN NURS, V18, P3037, DOI 10.1111/j.1365-2702.2009.02856.x; Guan H, 2013, OPTOMETRY VISION SCI, V90, P179, DOI 10.1097/OPX.0b013e31827ce224; Hayashi K, 2000, OPHTHALMOLOGY, V107, P698, DOI 10.1016/S0161-6420(00)00007-5; Hayashi K, 2001, J CATARACT REFR SURG, V27, P1779, DOI 10.1016/S0886-3350(01)01036-7; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Iordanous Y, 2013, J GLAUCOMA; Iskedjian M, 2003, J GLAUCOMA, V12, P456, DOI 10.1097/00061198-200312000-00002; Ismi T, 2013, TURK OFTALMOL DERG, V43, P167, DOI 10.4274/tjo.43.98852; KASS MA, 1987, AM J OPHTHALMOL, V103, P188, DOI 10.1016/S0002-9394(14)74225-4; Kholdebarin R, 2008, CAN J OPHTHALMOL, V43, P454, DOI [10.1139/i08-076, 10.3129/i08-076]; Khondkaryan AFB, 2012, COMBINED TRABECTOME; Kingman S, 2004, B WHO; Kingman S, 2004, GLAUCOMA IS 2 LEADIN; Klink J, 2005, BRIT J OPHTHALMOL, V89, P597, DOI 10.1136/bjo.2004.041988; Leung EW, 2008, J GLAUCOMA, V17, P350, DOI 10.1097/IJG.0b013e31815c5f4f; Malvankar-Mehta MS CY, 2015, PLOS ONE, V10; Mansberger SL, 2012, OPHTHALMOLOGY, V119, P1826, DOI 10.1016/j.ophtha.2012.02.050; Mathalone N, 2005, J CATARACT REFR SURG, V31, P479, DOI 10.1016/j.jcrs.2004.06.046; Merkur A, 2001, J CATARACT REFR SURG, V27, P528, DOI 10.1016/S0886-3350(00)00753-7; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Nichamin LD, 2009, MIDDLE EAST AFR J OP, V16, P138, DOI 10.4103/0974-9233.56227; Okeke CO, 2009, OPHTHALMOLOGY, V116, P191, DOI 10.1016/j.ophtha.2008.09.004; Park M, 2004, J GLAUCOMA, V13, P55, DOI 10.1097/00061198-200402000-00011; Patel I, 2013, CLIN EXP OPHTHALMOL, V41, P648, DOI 10.1111/ceo.12098; Pohjalainen T, 2001, ACTA OPHTHALMOL SCAN, V79, P313, DOI 10.1034/j.1600-0420.2001.790322.x; Poley BJ, 2010, PHACOEMULSIFICATION; Poley BJ, 2009, J CATARACT REFR SURG, V35, P1946, DOI 10.1016/j.jcrs.2009.05.061; Prevent Blindness America, 2013, COST VIS PROBL EC BU; Quality AfHRa, 2013, TREATM OP ANGL GLAUC; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Robin AL, 2005, OPHTHALMOLOGY, V112, P863, DOI 10.1016/j.ophtha.2004.12.026; Robin AL, 2007, AM J OPHTHALMOL, V144, P533, DOI 10.1016/j.ajo.2007.06.012; Rovner BW, 1998, J AM GERIATRICS SOC; Sacca S, 2001, BRIT J OPHTHALMOL, V85, P24, DOI 10.1136/bjo.85.1.24; Saheb H, 2012, CURR OPIN OPHTHALMOL, V23, P96, DOI 10.1097/ICU.0b013e32834ff1e7; Samuelson TW, 2011, OPHTHALMOLOGY, V118, P459, DOI 10.1016/j.ophtha.2010.07.007; Sharma TK, 2008, J CATARACT REFR SURG, V34, P831, DOI 10.1016/j.jcrs.2007.12.031; Shingleton B, 2008, J CATARACT REFR SURG, V34, P433, DOI 10.1016/j.jcrs.2007.11.029; Shingleton BJ, 2006, J GLAUCOMA, V15, P494, DOI 10.1097/01.ijg.0000212294.31411.92; Shingleton BJ, 2008, J CATARACT REFR SURG, V34, P1834, DOI 10.1016/j.jcrs.2008.07.025; Slabaugh MA, 2014, AM J OPHTHALMOL, V157, P26, DOI 10.1016/j.ajo.2013.08.023; Spiegel D, 2002, BRIT J OPHTHALMOL, V86, P1228, DOI 10.1136/bjo.86.11.1228; Spiegel D, 2008, ADV THER, V25, P453, DOI 10.1007/s12325-008-0062-6; Spiegel D, 2009, EUR J OPHTHALMOL, V19, P393, DOI 10.1177/112067210901900311; Stone JL, 2009, ARCH OPHTHALMOL-CHIC, V127, P732, DOI 10.1001/archophthalmol.2009.96; The National Coalition for Vision Health, 2010, VIS LOSS CAN 2011; Wood JM, 2011, INVEST OPHTH VIS SCI, V52, P5088, DOI 10.1167/iovs.10-6644; Zhang WY, 2001, BRIT J OPHTHALMOL, V85, P983, DOI 10.1136/bjo.85.8.983	69	47	49	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131770	10.1371/journal.pone.0131770	http://dx.doi.org/10.1371/journal.pone.0131770			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147908	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600142
J	Martinez-Garcia, R; Murgui, C; Hernandez-Garcia, E; Lopez, C				Martinez-Garcia, Ricardo; Murgui, Clara; Hernandez-Garcia, Emilio; Lopez, Cristobal			Pattern Formation in Populations with Density-Dependent Movement and Two Interaction Scales	PLOS ONE			English	Article							YOUNG MUSSEL BEDS; SPATIAL-PATTERNS; COLLECTIVE MOTION; SELF-ORGANIZATION; DECISION-MAKING; ECOSYSTEMS; MECHANISMS; VEGETATION; SYSTEMS; MODEL	We study the spatial patterns formed by a system of interacting particles where the mobility of any individual is determined by the population crowding at two different spatial scales. In this way we model the behavior of some biological organisms (like mussels) that tend to cluster at short ranges as a defensive strategy, and strongly disperse if there is a high population pressure at large ranges for optimizing foraging. We perform stochastic simulations of a particle-level model of the system, and derive and analyze a continuous density description (a nonlinear diffusion equation). In both cases we show that this interplay of scale-dependent-behaviors gives rise to a rich formation of spatial patterns ranging from labyrinths to periodic cluster arrangements. In most cases these clusters have the very peculiar appearance of ring-like structures, i.e., organisms arranging in the perimeter of the clusters, which we discuss in detail.	[Martinez-Garcia, Ricardo; Murgui, Clara; Hernandez-Garcia, Emilio; Lopez, Cristobal] CSIC UIB, IFISC, Palma De Mallorca, Spain; [Martinez-Garcia, Ricardo] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); University of Barcelona; Princeton University	Martinez-Garcia, R (corresponding author), CSIC UIB, IFISC, Campus UIB, Palma De Mallorca, Spain.	ricardom@princeton.edu	Martinez-Garcia, Ricardo/J-4836-2013; Hernandez-Garcia, Emilio/B-1271-2008; López, Cristóbal/R-5410-2018	Martinez-Garcia, Ricardo/0000-0003-2765-8147; Hernandez-Garcia, Emilio/0000-0002-9568-8287; López, Cristóbal/0000-0002-3445-4284	JAEPredoc program of Consejo Superior de Investigacion Cientificas; IFISC-Intro program of Instituto de Fisica Interdisciplinar y Sistemas Complejos; Ministerio de Economia y Competitividad and Fondo Europeo de Desarrollo Regional [FIS2012-30634, CTM2012-39025-C02-01]	JAEPredoc program of Consejo Superior de Investigacion Cientificas; IFISC-Intro program of Instituto de Fisica Interdisciplinar y Sistemas Complejos; Ministerio de Economia y Competitividad and Fondo Europeo de Desarrollo Regional	RMG was supported by the JAEPredoc program of Consejo Superior de Investigacion Cientificas. CM was supported by the IFISC-Intro program of Instituto de Fisica Interdisciplinar y Sistemas Complejos. EHG and CL are supported by Ministerio de Economia y Competitividad and Fondo Europeo de Desarrollo Regional through grant no. FIS2012-30634 (INTENSE@COSYP) and no. CTM2012-39025-C02-01 (ESCOLA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, INDIVIDUAL BASED MOD; Bialek W, 2012, P NATL ACAD SCI USA, V109, P4786, DOI 10.1073/pnas.1118633109; Bonachela JA, 2015, SCIENCE, V347, P651, DOI 10.1126/science.1261487; Borgogno F, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000256; Burger M, 2013, PHYSICA D, V260, P145, DOI 10.1016/j.physd.2012.11.003; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; de Jager M, 2011, SCIENCE, V332, P1551, DOI 10.1126/science.1201187; Dean DS, 1996, J PHYS A-MATH GEN, V29, pL613, DOI 10.1088/0305-4470/29/24/001; DeAngelis DL, 2005, ANNU REV ECOL EVOL S, V36, P147, DOI 10.1146/annurev.ecolsys.36.102003.152644; Fernandez-Oto C, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2014.0009; Flierl G, 1999, J THEOR BIOL, V196, P397, DOI 10.1006/jtbi.1998.0842; Heinsalu E, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/40011; Hernandez-Garcia E, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.016216; JUDSON OP, 1994, TRENDS ECOL EVOL, V9, P9, DOI 10.1016/0169-5347(94)90225-9; Juergens N, 2013, SCIENCE, V339, P1618, DOI 10.1126/science.1222999; Krapivsky P., 2010, KINETIC VIEW STAT PH; Krause J, 2002, LIVING GROUPS; Lefever R, 1997, B MATH BIOL, V59, P263, DOI 10.1007/BF02462004; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Liu QX, 2013, P NATL ACAD SCI USA, V110, P11905, DOI 10.1073/pnas.1222339110; Liu QX, 2012, P ROY SOC B-BIOL SCI, V279, P2744, DOI 10.1098/rspb.2012.0157; Lopez C, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.012102; Lopez U, 2012, INTERFACE FOCUS, V2, P693, DOI 10.1098/rsfs.2012.0033; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; Martinez-Garcia R, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2014.0068; Martinez-Garcia R, 2013, GEOPHYS RES LETT, V40, P6143, DOI 10.1002/2013GL058797; Martinez-Garcia R, 2013, J THEOR BIOL, V333, P156, DOI 10.1016/j.jtbi.2013.05.024; Martinez-Garcia R, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.248106; Medvinsky AB, 2002, SIAM REV, V44, P311, DOI 10.1137/S0036144502404442; Mendez V, 2014, SPRINGER SER SYNERG, P1, DOI 10.1007/978-3-642-39010-4; Mendez V, 2012, J THEOR BIOL, V309, P113, DOI 10.1016/j.jtbi.2012.06.015; Murray, 2002, MATH BIOL I INTRO IN; OKUBO A, 2001, DIFFUSION ECOLOGICAL; Pigolotti S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.258101; Raghib M, 2010, J THEOR BIOL, V264, P893, DOI 10.1016/j.jtbi.2010.02.030; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Schellinck J, 2011, ECOL MODEL, V222, P1897, DOI 10.1016/j.ecolmodel.2011.03.013; Sheffer E, 2011, J THEOR BIOL, V273, P138, DOI 10.1016/j.jtbi.2010.12.028; van de Koppel J, 2005, AM NAT, V165, pE66; van de Koppel J, 2008, SCIENCE, V322, P739, DOI 10.1126/science.1163952; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Viswanathan G. M., 2011, PHYS FORAGING; Wang RH, 2009, J R SOC INTERFACE, V6, P705, DOI 10.1098/rsif.2008.0439; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105; Young WR, 2001, NATURE, V412, P328, DOI 10.1038/35085561	46	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132261	10.1371/journal.pone.0132261	http://dx.doi.org/10.1371/journal.pone.0132261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147351	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600226
J	Montesi, M; Panseri, S; Iafisco, M; Adamiano, A; Tampieri, A				Montesi, Monica; Panseri, Silvia; Iafisco, Michele; Adamiano, Alessio; Tampieri, Anna			Coupling Hydroxyapatite Nanocrystals with Lactoferrin as a Promising Strategy to Fine Regulate Bone Homeostasis	PLOS ONE			English	Article							IN-VITRO; OSTEOBLAST DIFFERENTIATION; OSTEOCLAST DIFFERENTIATION; CELLS; RANKL; APOPTOSIS; BISPHOSPHONATES; EXPRESSION; PATHWAYS; DELIVERY	Lactoferrin (LF) is an interesting glycoprotein in the field of bone biology for its regulatory effect on cells involved in bone remodeling, that results compromised in several pathological conditions, as osteoporosis. In a previous study we observed that the coupling of LF and biomimetic hydroxyapatite nanocrystals (HA), a material well-known for its bioactivity and osteoconductive properties, leads to a combined effect in the induction of osteogenic differentiation of mesenchymal stem cells. On the basis of this evidence, the present study is an extension of our previous work aiming to investigate the synergistic effect of the coupling of HA and LF on bone homeostasis. Biomimetic HA nanocrystals were synthesized and functionalized with LF (HA-LF) and then pre-osteoblasts (MC3T3-E1) and monocyte/macrophage cells lines (RAW 264.7), using as osteoclastogenesis in vitro model, were cultured separately or in co-culture in presence of HA-LF. The results clearly revealed that HA and LF act in synergism in the regulation of the bone homeostasis, working as anabolic factor for osteoblasts differentiation and bone matrix deposition, and as inhibitor of the osteoclast formation and activity.	[Montesi, Monica; Panseri, Silvia; Iafisco, Michele; Adamiano, Alessio; Tampieri, Anna] CNR, Inst Sci & Technol Ceram, Faenza, Ravenna, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienza e Tecnologia dei Materiali Ceramici (ISTEC-CNR)	Montesi, M (corresponding author), CNR, Inst Sci & Technol Ceram, Faenza, Ravenna, Italy.	monica.montesi@istec.cnr.it	Adamiano, Alessio/K-2499-2018; Montesi, Monica/J-8861-2018; Iafisco, Michele/B-4597-2010; Panseri, Silvia/AAW-2856-2020; Iafisco, Michele/ABF-7752-2020	Adamiano, Alessio/0000-0002-2077-0411; Montesi, Monica/0000-0002-9192-8554; Iafisco, Michele/0000-0002-7813-8347; Panseri, Silvia/0000-0002-8099-7132; Iafisco, Michele/0000-0002-7813-8347; Panseri, Sara/0000-0001-6970-2009	National Research Program -National Research Council (PNRCNR) Aging Program	National Research Program -National Research Council (PNRCNR) Aging Program	This work has been supported by National Research Program -National Research Council (PNRCNR) Aging Program 2012-2014.	Amini AA, 2011, CURR MED CHEM, V18, P1220; Amini AA, 2014, TISSUE ENG PT A, V20, P2830, DOI [10.1089/ten.tea.2013.0506, 10.1089/ten.TEA.2013.0506]; Amini AA, 2014, ADV HEALTHC MATER, V3, P897, DOI 10.1002/adhm.201300496; Bouleftour W, 2015, J CELL PHYSIOL, V230, P568, DOI 10.1002/jcp.24772; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Collin-Osdoby P, 2003, METH MOLEC MED, V80, P153; Cornish J, 2006, BIOCHEM CELL BIOL, V84, P297, DOI 10.1139/O06-057; Cornish J, 2010, BIOMETALS, V23, P425, DOI 10.1007/s10534-010-9320-6; Goncalves MJ, 2013, ACTA MEDICA PORT, V26, P445; Hou JM, 2012, ACTA PHARMACOL SIN, V33, P1277, DOI 10.1038/aps.2012.83; Iafisco M, 2011, DALTON T, V40, P820, DOI 10.1039/c0dt00714e; Iafisco M, 2012, J INORG BIOCHEM, V117, P237, DOI 10.1016/j.jinorgbio.2012.06.004; Iafisco M, 2012, NANOSCALE, V4, P206, DOI 10.1039/c1nr11147g; Itoh T, 2014, BIOSCI BIOTECH BIOCH, V78, P92, DOI 10.1080/09168451.2014.877182; Kfoury Y, 2015, CELL STEM CELL, V16, P239, DOI 10.1016/j.stem.2015.02.019; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Kim SY, 2014, APPL SURF SCI, V321, P412, DOI 10.1016/j.apsusc.2014.09.177; Kirstein B, 2006, J CELL BIOCHEM, V98, P1085, DOI 10.1002/jcb.20835; Kiviranta R, 2005, BONE, V36, P159, DOI 10.1016/j.bone.2004.09.020; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Landi E, 2005, BIOMATERIALS, V26, P2835, DOI 10.1016/j.biomaterials.2004.08.010; LAZEBNIK YA, 1993, J CELL BIOL, V123, P7, DOI 10.1083/jcb.123.1.7; Liu XC, 2012, INT J NANOMED, V7, P1239, DOI 10.2147/IJN.S28098; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorget F, 2002, BIOCHEM BIOPH RES CO, V296, P261, DOI 10.1016/S0006-291X(02)00849-5; Martin A, 2015, BONE, V75, P96, DOI 10.1016/j.bone.2015.02.007; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Montesi M, 2015, J BIOMED MATER RES A, V103, P224, DOI 10.1002/jbm.a.35170; Munarin F, 2012, J APPL BIOMATER FUNC, V10, P67, DOI 10.5301/JABFM.2012.9418; Nakamura I, 1996, J BONE MINER RES, V11, P1873; PAPADOPOULOS NG, 1994, J IMMUNOL METHODS, V177, P101, DOI 10.1016/0022-1759(94)90147-3; Pistone A, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/42/425701; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Samarasinghe RM, 2014, BIOMATERIALS, V35, P7522, DOI 10.1016/j.biomaterials.2014.04.109; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Schaffler MB, 2014, CALCIFIED TISSUE INT, V94, P5, DOI 10.1007/s00223-013-9790-y; Sims NA, 2012, CURR OSTEOPOROS REP, V10, P109, DOI 10.1007/s11914-012-0096-1; Sinha KM, 2014, J BONE MINER RES, V29, P855, DOI 10.1002/jbmr.2103; Sinha KM, 2013, J CELL BIOCHEM, V114, P975, DOI 10.1002/jcb.24439; Sullivan MP, 2014, BONE JOINT J, V96B, P569, DOI 10.1302/0301-620X.96B5.33606; Do TNT, 2012, THER DELIV, V3, P623, DOI 10.4155/TDE.12.39; Tseng FJ, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-57; Uskokovic V, 2011, J BIOMED MATER RES B, V96B, P152, DOI 10.1002/jbm.b.31746; Vandrovcova M, 2015, J BIOMED MATER RES A, V103, P525, DOI 10.1002/jbm.a.35199; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4; Xu ZL, 2012, J APPL TOXICOL, V32, P429, DOI 10.1002/jat.1745; Zhang W, 2014, J BONE MINER RES, V29, P1232, DOI 10.1002/jbmr.2116	49	20	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132633	10.1371/journal.pone.0132633	http://dx.doi.org/10.1371/journal.pone.0132633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148296	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600309
J	Okamura, Y; Obayashi, T; Kinoshita, K				Okamura, Yasunobu; Obayashi, Takeshi; Kinoshita, Kengo			Comparison of Gene Coexpression Profiles and Construction of Conserved Gene Networks to Find Functional Modules	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; EXPRESSION; MICROARRAY; EVOLUTION; SEQUENCE; DATABASE	Background Computational approaches toward gene annotation are a formidable challenge, now that many genome sequences have been determined. Each gene has its own function, but complicated cellular functions are achieved by sets of genes. Therefore, sets of genes with strong functional relationships must be identified. For this purpose, the similarities of gene expression patterns and gene sequences have been separately utilized, although the combined information will provide a better solution. Result & Discussion We propose a new method to find functional modules, by comparing gene coexpression profiles among species. A coexpression pattern is represented as a list of coexpressed genes with each guide gene. We compared two coexpression lists, one from a human guide gene and the other from a homologous mouse gene, and defined a measure to evaluate the similarity between the lists. Based on this coexpression similarity, we detected the highly conserved genes, and constructed human gene networks with conserved coexpression between human and mouse. Some of the tightly coupled genes ( modules) showed clear functional enrichment, such as immune system and cell cycle, indicating that our method could identify functionally related genes without any prior knowledge. We also found a few functional modules without any annotations, which may be good candidates for novel functional modules. All of the comparisons are available at the http://v1.coxsimdb.info web database.	[Okamura, Yasunobu; Obayashi, Takeshi; Kinoshita, Kengo] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan; [Kinoshita, Kengo] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Kinoshita, Kengo] Tohoku Med Megabank Org, Sendai, Miyagi, Japan	Tohoku University; Tohoku University	Kinoshita, K (corresponding author), Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan.	kengo@ecei.tohoku.ac.jp	Kinoshita, Kengo/E-9688-2011; Obayashi, Takeshi/E-9663-2011	Kinoshita, Kengo/0000-0003-3453-2171; Obayashi, Takeshi/0000-0002-3106-722X; Okamura, Yasunobu/0000-0001-9847-9037	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [24570176]; MEXT [24114005]; CREST research project of Japan Science and Technology Agency [11102558]; Grants-in-Aid for Scientific Research [24114005, 24114001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST research project of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by for Scientific Research (24570176) to KK from Ministry of Education, Culture, Sports, Science, and Technology (MEXT, http://www.mext.go.jp/english/) and for Innovative Area (24114005) to TO from MEXT, and also supported by the CREST research project of the Japan Science and Technology Agency (http://www.jst.go.jp/EN/index.html) (11102558) to TO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Blake JA, 2013, NUCLEIC ACIDS RES, V41, pD530, DOI 10.1093/nar/gks1050; Bornholdt J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-65; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chen JC, 2006, BIOINFORMATICS, V22, P2283, DOI 10.1093/bioinformatics/btl370; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kanamori-Katayama M, 2011, GENOME RES, V21, P1150, DOI 10.1101/gr.115469.110; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Le HS, 2010, BIOINFORMATICS, V26, P2416, DOI 10.1093/bioinformatics/btq451; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Obayashi T, 2009, DNA RES, V16, P249, DOI 10.1093/dnares/dsp016; Okamura Y, 2015, NUCLEIC ACIDS RES, V43, pD82, DOI 10.1093/nar/gku1163; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pontius JU, 2007, GENOME RES, V17, P1675, DOI 10.1101/gr.6380007; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shi ZA, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-74; SIM GK, 1979, CELL, V18, P1303, DOI 10.1016/0092-8674(79)90241-1; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1633, DOI 10.1111/j.1365-3040.2009.02040.x; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wise A, 2012, BIOINFORMATICS, V28, pI258, DOI 10.1093/bioinformatics/bts205; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906	41	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132039	10.1371/journal.pone.0132039	http://dx.doi.org/10.1371/journal.pone.0132039			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147120	gold, Green Submitted, Green Published			2022-12-27	WOS:000358157600187
J	Ward, D; Edney-Browne, E				Ward, Darren; Edney-Browne, Emma			Poles Apart: Comparing Trends of Alien Hymenoptera in New Zealand with Europe (DAISIE)	PLOS ONE			English	Article							LINEPITHEMA-HUMILE; ARGENTINE ANTS; IMPACTS; CONSEQUENCES; DIVERSITY; INVASIONS; PATHWAYS	Developing generalisations of invasive species is an important part of invasion biology. However, trends and generalisations from one part of the world may not necessarily hold elsewhere. We present the first inventory and analysis of all Hymenoptera alien to New Zealand, and compare patterns from New Zealand with those previously published from Europe (DAISIE). Between the two regions there was broad correlation between families with the highest number of alien species (Braconidae, Encyrtidae, Pteromalidae, Eulophidae, Formicidae, Aphelinidae). However, major differences also existed. The number of species alien to New Zealand is higher than for Europe (334 vs 286), and major differences include: i) the much lower proportion of intentionally released species in New Zealand (21% vs 63% in Europe); and ii) the greater proportion of unintentionally introduced parasitoids in New Zealand (71.2% vs 22.6%). The disharmonic 'island' nature of New Zealand is shown, as a high proportion of families (36%) have no native representatives, and alien species also represent >10% of the native fauna for many other families. A much larger proportion of alien species are found in urban areas in New Zealand (60%) compared to Europe (similar to 30%), and higher numbers of alien species were present earlier in New Zealand (especially <1950). Differences in the origins of alien species were also apparent. Unlike Europe, the New Zealand data reveals a change in the origins of alien species over time, with an increasing dominance of alien species from Australasia (a regional neighbour) during the past 25 years. We recommend that further effort be made towards the formation, and analysis, of regional inventories of alien species. This will allow a wider range of taxa and regions to be examined for generalisations, and help assess and prioritise the risk posed by certain taxa towards the economy or environment.	[Ward, Darren] Landcare Res, New Zealand Arthropod Collect, Auckland, New Zealand; [Ward, Darren; Edney-Browne, Emma] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	Landcare Research - New Zealand; University of Auckland	Ward, D (corresponding author), Landcare Res, New Zealand Arthropod Collect, Private Bag 92170, Auckland, New Zealand.	wardda@landcareresearch.co.nz		Ward, Darren/0000-0002-4509-8553	New Zealand Ministry of Business, Innovation, and Employment through Crown Research Institute	New Zealand Ministry of Business, Innovation, and Employment through Crown Research Institute	This research was supported by the New Zealand Ministry of Business, Innovation, and Employment through Crown Research Institute core funding to Landcare Research within the "Defining New Zealand's Land Biota" and 'Managing Invasive Weeds, Pests and Diseases' Portfolios. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RB, 2006, ECOLOGICAL STUDIES, V186; Beggs J, 2001, BIOL CONSERV, V99, P17, DOI 10.1016/S0006-3207(00)00185-3; Beggs JR, 2011, BIOCONTROL, V56, P505, DOI 10.1007/s10526-011-9389-z; Berry JA, 2007, AUST J ENTOMOL, V46, P99, DOI 10.1111/j.1440-6055.2007.00575.x; Berry Jocelyn A., 2001, Entomofauna, V22, P41; Brockerhoff EG, 2010, NEW ZEAL J ECOL, V34, P158; Charles J. G., 1998, Biocontrol News and Information, V19, P47; Corin SE, 2007, DIVERS DISTRIB, V13, P510, DOI 10.1111/j.1472-4642.2007.00355.x; Crosby TK, 1998, NEW ZEAL J ZOOL, V25, P175, DOI 10.1080/03014223.1998.9518148; Diez JM, 2009, ECOL LETT, V12, P1174, DOI 10.1111/j.1461-0248.2009.01376.x; Donovan BJ, 2007, FAUNA NEW ZEALAND SE, V57; Early John W., 2000, New Zealand Entomologist, V23, P27; Early JW, 2001, INVERTEBR TAXON, V15, P341, DOI 10.1071/IT00053; Eschen R, 2015, ENVIRON SCI POLICY, V51, P228, DOI 10.1016/j.envsci.2015.04.021; Eschen R, 2014, FOREST ECOL MANAG, V315, P103, DOI 10.1016/j.foreco.2013.12.021; Essl F, 2011, P NATL ACAD SCI USA, V108, P203, DOI 10.1073/pnas.1011728108; Ferguson CM, 2007, BCANZ BIOL CONTROL A; Fernandez-Triana JL, 2011, ZOOTAXA, P24, DOI 10.11646/zootaxa.2932.1.2; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Gauld I., 1988, HYMENOPTERA, P1; Gordon, 2010, NEW ZEALAND INVENTOR, V2, P350; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Huang DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031734; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Kenis M, 2009, BIOL INVASIONS, V11, P21, DOI 10.1007/s10530-008-9318-y; Kumschick S, 2015, BIOSCIENCE, V65, P55, DOI 10.1093/biosci/biu193; LEATHWICK JR, 2004, CONSERV BIOL, V17, P1; Lester P., 2013, N SCI REV, V70, P56; LOCKWOOD JL, 2007, INVASION ECOLOGY, P1; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Ministry for the Environment, 2013, LAND CLASSIFICATION; Murray B. R., 2012, NeoBiota, P1; Noyes JS, 2014, WORLD WIDE WEB ELECT; Pimentel D., 2002, BIOL INVASIONS EC EN; Rabitsch Wolfgang, 2010, BioRisk, V4, P27; Rasplus Jean-Yves, 2010, BioRisk, V4, P669; Roques Alain, 2010, BioRisk, V4, P11; Roy HE, 2011, BIOCONTROL, V56, P375, DOI 10.1007/s10526-011-9388-0; Seabloom EW, 2006, ECOL APPL, V16, P1338, DOI 10.1890/1051-0761(2006)016[1338:HIPIAI]2.0.CO;2; Slippers B, 2012, SIREX WOODWASP FUNGA; Snyder WE, 2006, ANNU REV ECOL EVOL S, V37, P95, DOI 10.1146/annurev.ecolsys.37.091305.110107; Stanley M, 2008, SOCIOBIOLOGY, V51, P461; Stone GN, 2002, ANNU REV ENTOMOL, V47, P633, DOI 10.1146/annurev.ento.47.091201.145247; Suarez AV, 2010, ANT ECOLOGY, P233; Tscharntke T, 2007, BIOL CONTROL, V43, P294, DOI 10.1016/j.biocontrol.2007.08.006; Valentine EW, 1991, 4 DSIR; Ward D, 2011, NZ ENTOMOL, V34, P37, DOI 10.1080/00779962.2011.9722206; Ward D, 2011, NZ ENTOMOL, V34, P1; Ward DF, 2012, NZ ENTOMOL, V35, P116, DOI 10.1080/00779962.2012.686315; Ward DF, 2010, N Z ENTOMOL, V33, P68, DOI 10.1080/00779962.2010.9722193; Ward D, 2014, PEERJ, V2, DOI 10.7717/peerj.435; Ward Darren F., 2005, Weta, V30, P16; Ward DF, 2006, DIVERS DISTRIB, V12, P601, DOI 10.1111/j.1366-9516.2006.00270.x; Ward DF, 2013, ECOL EVOL, V3, P4408, DOI 10.1002/ece3.826; Ward DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050346; Ward DF, 2009, MYRMECOL NEWS, V12, P195; Withers TM, 2001, AUSTRAL ECOL, V26, P467, DOI 10.1046/j.1442-9993.2001.01140.x; Yu D.S., 2012, TAXONOMY BIOL MORPHO	58	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132264	10.1371/journal.pone.0132264	http://dx.doi.org/10.1371/journal.pone.0132264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147445	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600227
J	Xie, XY; Ling, CD; Mo, SJ; Luan, K				Xie, Xiao-Yun; Ling, Chu-Ding; Mo, Shen-Jiang; Luan, Kun			Linking Colleague Support to Employees' Promotive Voice: A Moderated Mediation Model	PLOS ONE			English	Article							GEOGRAPHICALLY DISPERSED TEAMS; CROSS-LEVEL; ORGANIZATIONAL IDENTIFICATION; DEMOGRAPHIC FAULTLINES; MULTILEVEL MEDIATION; DIVERSITY FAULTLINES; JOB DISSATISFACTION; WORK; BEHAVIOR; SUBGROUPS	Promotive voice is essential for improving team and organization performance. Yet in the current literature, less was known regarding the psychological reasons why people engage in promotive voice. Through the lens of social exchange, we proposed that employees who received support from colleagues may develop higher level of felt obligation for constructive change which leads to promotive voice. Analyses of multi-source data from 51 cross-functional sources (51 team supervisors and 162 employees) showed that employees' felt obligation for constructive change positively mediates the relationship between colleague support and promotive voice behavior. Moreover, the impact of colleague support on felt obligation for constructive change is stronger when there is a low level of subgroup formation in the team. Theoretical and practical implications of these findings are discussed.	[Xie, Xiao-Yun; Ling, Chu-Ding; Luan, Kun] Zhejiang Univ, Sch Management, Hangzhou 310003, Zhejiang, Peoples R China; [Mo, Shen-Jiang] Sun Yat Sen Univ, Lingnan Univ Coll, Guangzhou 510275, Guangdong, Peoples R China	Zhejiang University; Sun Yat Sen University	Mo, SJ (corresponding author), Sun Yat Sen Univ, Lingnan Univ Coll, Guangzhou 510275, Guangdong, Peoples R China.	moshenjiang@mail.sysu.edu.cn			Natural Social Science Foundation of China [71302102, 71372056]; Zhejiang Social Science Fund [09CGGL006YBQ]	Natural Social Science Foundation of China; Zhejiang Social Science Fund	This work was supported by the Natural Social Science Foundation of China, 71302102(SJM) & 71372056(XYX) http://www.nsfc.gov.cn/ and Zhejiang Social Science Fund (09CGGL006YBQ) (XYX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacharach SB, 2005, ACAD MANAGE J, V48, P619, DOI 10.2307/20159683; Bacharach SB, 2000, ADMIN SCI QUART, V45, P704, DOI 10.2307/2667017; Bauer DJ, 2006, PSYCHOL METHODS, V11, P142, DOI 10.1037/1082-989X.11.2.142; Bierstedt R., 1964, EXCHANGE POWER SOCIA; Bliese P.D., 2000, MULTILEVEL THEORY RE, P349; Bliese PD, 1998, ORGAN RES METHODS, V1, P355, DOI 10.1177/109442819814001; Brislin R., 1980, HDB CROSS CULTURAL P, P389, DOI DOI 10.3390/HEALTHCARE6030093; Caplan R, 1975, JOB DEMANDS AND WORK; Chiaburu DS, 2008, J APPL PSYCHOL, V93, P1082, DOI 10.1037/0021-9010.93.5.1082; Cohen J., 2003, APPL MULTIPLE REGRES; Colquitt JA, 2001, J APPL PSYCHOL, V86, P386, DOI 10.1037//0021-9010.86.3.386; Cronin MA, 2011, J ORGAN BEHAV, V32, P831, DOI 10.1002/job.707; Detert JR, 2007, ACAD MANAGE J, V50, P869; Edmondson AC, 2003, J MANAGE STUD, V40, P1419, DOI 10.1111/1467-6486.00386; Edwards JR, 2007, PSYCHOL METHODS, V12, P1, DOI 10.1037/1082-989X.12.1.1; FARRELL D, 1983, ACAD MANAGE J, V26, P596, DOI 10.2307/255909; Gibson C, 2003, ADMIN SCI QUART, V48, P202, DOI 10.2307/3556657; Gonzalez JA, 2009, J ORGAN BEHAV, V30, P21, DOI 10.1002/job.498; Gonzalez-Roma V, 2002, J APPL PSYCHOL, V87, P465, DOI 10.1037//0021-9010.87.3.465; GRAEN GB, 1995, LEADERSHIP QUART, V6, P219, DOI 10.1016/1048-9843(95)90036-5; Grant AM, 2009, ACAD MANAG ANN, V3, P317, DOI 10.1080/19416520903047327; Griffin MA, 2007, ACAD MANAGE J, V50, P327, DOI 10.5465/AMJ.2007.24634438; Hagedoorn M, 1999, J ORGAN BEHAV, V20, P309, DOI 10.1002/(SICI)1099-1379(199905)20:3<309::AID-JOB895>3.0.CO;2-P; Hirschman A. O., 1970, EXIT VOICE LOYALTY; JAMES LR, 1984, J APPL PSYCHOL, V69, P85, DOI 10.1037/0021-9010.69.1.85; Jehn KA, 2010, ORGAN BEHAV HUM DEC, V112, P24, DOI 10.1016/j.obhdp.2009.11.008; Li JT, 2005, ACAD MANAGE J, V48, P794, DOI 10.2307/20159698; Liang J, 2012, ACAD MANAGE J, V55, P71, DOI 10.5465/amj.2010.0176; Liu W, 2015, J APPL PSYCHOL, V100, P976, DOI 10.1037/a0038066; Liu W, 2010, LEADERSHIP QUART, V21, P189, DOI 10.1016/j.leaqua.2009.10.014; MacKenzie SB, 2011, PERS PSYCHOL, V64, P559, DOI 10.1111/j.1744-6570.2011.01219.x; MAEL F, 1992, J ORGAN BEHAV, V13, P103, DOI 10.1002/job.4030130202; Maynes TD, 2014, J APPL PSYCHOL, V99, P87, DOI 10.1037/a0034284; Molleman E, 2005, GROUP DECIS NEGOT, V14, P173, DOI 10.1007/s10726-005-6490-7; Morrison EW, 2014, ANNU REV ORGAN PSYCH, V1, P173, DOI 10.1146/annurev-orgpsych-031413-091328; Morrison EW, 2011, ACAD MANAG ANN, V5, P373, DOI 10.1080/19416520.2011.574506; Morrison EW, 2011, J APPL PSYCHOL, V96, P183, DOI 10.1037/a0020744; Morrison EW, 1999, ACAD MANAGE J, V42, P403, DOI 10.2307/257011; Muthen L, 2007, MUTH N MUTH N; Nahum-Shani I, 2011, ORGAN BEHAV HUM DEC, V114, P49, DOI 10.1016/j.obhdp.2010.09.002; Ng TWH, 2008, GROUP ORGAN MANAGE, V33, P243, DOI 10.1177/1059601107313307; O'Leary MB, 2010, ORGAN SCI, V21, P115, DOI 10.1287/orsc.1090.0434; Parker SK, 2010, J MANAGE, V36, P633, DOI 10.1177/0149206308321554; PEARCE JL, 1991, J APPL PSYCHOL, V76, P838, DOI 10.1037/0021-9010.76.6.838; Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452; Polzer JT, 2006, ACAD MANAGE J, V49, P679, DOI 10.2307/20159792; Preacher KJ, 2010, PSYCHOL METHODS, V15, P209, DOI 10.1037/a0020141; Qin X, 2014, J ORGAN BEHAV, V35, P1018, DOI 10.1002/job.1948; Rico R, 2007, J MANAGE, V33, P111, DOI 10.1177/0149206306295307; Shin J, 2013, THESIS U MARYLAND; Smidts A, 2001, ACAD MANAGE J, V44, P1051, DOI 10.2307/3069448; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Tangirala S, 2008, PERS PSYCHOL, V61, P37, DOI 10.1111/j.1744-6570.2008.00105.x; Thatcher SMB, 2011, J APPL PSYCHOL, V96, P1119, DOI 10.1037/a0024167; Thatcher SMB, 2003, GROUP DECIS NEGOT, V12, P217, DOI 10.1023/A:1023325406946; Van Dyne L, 1998, ACAD MANAGE J, V41, P108, DOI 10.2307/256902; Van Dyne L, 2008, J APPL PSYCHOL, V93, P1195, DOI 10.1037/0021-9010.93.6.1195; Xie XY, 2014, GROUP DYN-THEOR RES, V18, P87, DOI 10.1037/a0035689; Zhou J, 2001, ACAD MANAGE J, V44, P682, DOI 10.2307/3069410; Zhou L, 2012, J APPL PSYCHOL, V97, P668, DOI 10.1037/a0026305	60	7	8	6	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132123	10.1371/journal.pone.0132123	http://dx.doi.org/10.1371/journal.pone.0132123			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26148194	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600202
J	Muthalib, M; Re, R; Zucchelli, L; Perrey, S; Contini, D; Caffini, M; Spinelli, L; Kerr, G; Quaresima, V; Ferrari, M; Torricelli, A				Muthalib, Makii; Re, Rebecca; Zucchelli, Lucia; Perrey, Stephane; Contini, Davide; Caffini, Matteo; Spinelli, Lorenzo; Kerr, Graham; Quaresima, Valentina; Ferrari, Marco; Torricelli, Alessandro			Effects of Increasing Neuromuscular Electrical Stimulation Current Intensity on Cortical Sensorimotor Network Activation: A Time Domain fNIRS Study	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; PRIMARY SOMATOSENSORY CORTEX; DIFFUSE OPTICAL TOMOGRAPHY; PRIMARY MOTOR CORTEX; FUNCTIONAL MRI; WRIST EXTENSOR; BLOOD-FLOW; PAIN; BRAIN; RESPONSES	Neuroimaging studies have shown neuromuscular electrical stimulation (NMES)-evoked movements activate regions of the cortical sensorimotor network, including the primary sensorimotor cortex (SMC), premotor cortex (PMC), supplementary motor area (SMA), and secondary somatosensory area (S2), as well as regions of the prefrontal cortex (PFC) known to be involved in pain processing. The aim of this study, on nine healthy subjects, was to compare the cortical network activation profile and pain ratings during NMES of the right forearm wrist extensor muscles at increasing current intensities up to and slightly over the individual maximal tolerated intensity (MTI), and with reference to voluntary (VOL) wrist extension movements. By exploiting the capability of the multi-channel time domain functional near-infrared spectroscopy technique to relate depth information to the photon time-of-flight, the cortical and superficial oxygenated (O(2)Hb) and deoxygenated (HHb) hemoglobin concentrations were estimated. The O(2)Hb and HHb maps obtained using the General Linear Model (NIRS-SPM) analysis method, showed that the VOL and NMES-evoked movements significantly increased activation (i.e., increase in O(2)Hb and corresponding decrease in HHb) in the cortical layer of the contralateral sensorimotor network (SMC, PMC/SMA, and S2). However, the level and area of contralateral sensorimotor network (including PFC) activation was significantly greater for NMES than VOL. Furthermore, there was greater bilateral sensorimotor network activation with the high NMES current intensities which corresponded with increased pain ratings. In conclusion, our findings suggest that greater bilateral sensorimotor network activation profile with high NMES current intensities could be in part attributable to increased attentional/pain processing and to increased bilateral sensorimotor integration in these cortical regions.	[Muthalib, Makii; Perrey, Stephane] Univ Montpellier, Movement Hlth M2H, EuroMov, F-34059 Montpellier, France; [Muthalib, Makii; Kerr, Graham] Queensland Univ Technol, IHBI, Movement Neurosci, Brisbane, Qld 4001, Australia; [Re, Rebecca; Zucchelli, Lucia; Contini, Davide; Torricelli, Alessandro] Politecn Milan, Politecn Milan, I-20133 Milan, Italy; [Caffini, Matteo] Politecn Milan, Dipartimento Elettr Informaz & Bioingn, I-20133 Milan, Italy; [Spinelli, Lorenzo] Politecn Milan, CNR, Ist Foton & Nanotecnol, I-20133 Milan, Italy; [Quaresima, Valentina; Ferrari, Marco] Univ Aquila, Dipartimento Med Clin Sanita Pubbl Sci & Ambiente, I-67100 Laquila, Italy	Universite de Montpellier; Queensland University of Technology (QUT); Polytechnic University of Milan; Polytechnic University of Milan; Consiglio Nazionale delle Ricerche (CNR); Polytechnic University of Milan; University of L'Aquila	Muthalib, M (corresponding author), Univ Montpellier, Movement Hlth M2H, EuroMov, F-34059 Montpellier, France.	makii.muthalib@univ-montp1.fr	Ferrari, Marco/AAF-3486-2019; perrey, stephane/B-7483-2008; Quaresima, Valentina/AAQ-7387-2021; Caffini, Matteo/AAJ-8127-2020; Spinelli, Lorenzo/ABC-9163-2020; SPINELLI, LORENZO CLEMENTE/AAW-6564-2020	perrey, stephane/0000-0002-8741-629X; SPINELLI, LORENZO CLEMENTE/0000-0002-4414-4351; FERRARI, Marco/0000-0002-3041-2917; Torricelli, Alessandro/0000-0002-6878-8936; Muthalib, Makii/0000-0003-0073-9211; Kerr, Graham/0000-0002-1008-256X; Caffini, Matteo/0000-0003-0716-983X; quaresima, valentina/0000-0001-9884-0304; Re, Rebecca/0000-0002-9521-8066	LASERLAB-EUROPE (EC's Seventh Framework Programme) [284464]	LASERLAB-EUROPE (EC's Seventh Framework Programme)	The research leading to these results has received funding from LASERLAB-EUROPE (grant agreement no. 284464, EC's Seventh Framework Programme: http://www.laserlab-europe.eu/transnational-access/information-for-users).	Aletti F, 2012, COMPUT BIOL MED, V42, P282, DOI 10.1016/j.compbiomed.2011.06.001; Anwar AR, 2012, IEEE ENG MED BIO, P2287, DOI 10.1109/EMBC.2012.6346419; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Azar AA, 2009, IEEE ENG MED BIO, P1375, DOI 10.1109/IEMBS.2009.5334283; Bax L, 2005, SPORTS MED, V35, P191, DOI 10.2165/00007256-200535030-00002; Becerra L, 2008, NEUROIMAGE, V41, P252, DOI 10.1016/j.neuroimage.2008.01.047; Becerra L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008016; Becker W, 2005, ADV TIME CORRELATED; Blickenstorfer A, 2009, HUM BRAIN MAPP, V30, P963, DOI 10.1002/hbm.20559; Butti M, 2009, MED PHYS, V36, P4103, DOI 10.1118/1.3190557; Chiou SY, 2013, CLIN NEUROPHYSIOL, V124, P1353, DOI 10.1016/j.clinph.2013.02.001; Chipchase LS, 2011, CLIN NEUROPHYSIOL, V122, P456, DOI 10.1016/j.clinph.2010.07.025; Chipchase LS, 2011, ARCH PHYS MED REHAB, V92, P1423, DOI 10.1016/j.apmr.2011.01.011; Chul J, 2009, NEUROIMAGE, V44, P428, DOI 10.1016/j.neuroimage.2008.08.036; Contini D., 2009, P SOC PHOTO-OPT INS, V7369; Contini D, 2007, PROC SPIE, V6629, DOI 10.1117/12.728104; Contini D, 2006, OPT EXPRESS, V14, P5418, DOI 10.1364/OE.14.005418; Del Bianco S, 2002, PHYS MED BIOL, V47, P4131, DOI 10.1088/0031-9155/47/23/301; Derosiere G, 2014, NEUROIMAGE, V85, P471, DOI 10.1016/j.neuroimage.2013.02.006; Devor A, 2012, J CEREBR BLOOD F MET, V32, P1259, DOI 10.1038/jcbfm.2011.195; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Ellis H, 2012, SURGERY, V30, P99; Fazli S, 2012, NEUROIMAGE, V59, P519, DOI 10.1016/j.neuroimage.2011.07.084; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; Francis S, 2009, NEUROIMAGE, V44, P469, DOI 10.1016/j.neuroimage.2008.09.017; Friston KJ, 2006, STAT PARAMETRIC MAPP; Frot M, 2013, HUM BRAIN MAPP, V34, P2655, DOI 10.1002/hbm.22097; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Gondin J, 2011, J APPL PHYSIOL, V110, P433, DOI 10.1152/japplphysiol.00914.2010; Haeussinger FB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026377; Hallacoglu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064095; Han BS, 2003, AM J PHYS MED REHAB, V82, P17, DOI 10.1097/01.PHM.0000043516.69441.15; Hinkley LB, 2007, J NEUROPHYSIOL, V97, P1288, DOI 10.1152/jn.00733.2006; Hortobagyi T, 2011, EUR J APPL PHYSIOL, V111, P2439, DOI 10.1007/s00421-011-2012-2; Hoshi Y, 2011, PHILOS T R SOC A, V369, P4425, DOI 10.1098/rsta.2011.0262; Iftime-Nielsen SD, 2012, HUM BRAIN MAPP, V33, P40, DOI 10.1002/hbm.21191; Iwamura Y, 2000, PHILOS T R SOC B, V355, P267, DOI 10.1098/rstb.2000.0563; Jang KE, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3127204; Joa KL, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-48; Kirilina E, 2012, NEUROIMAGE, V61, P70, DOI 10.1016/j.neuroimage.2012.02.074; Leff DR, 2011, NEUROIMAGE, V54, P2922, DOI 10.1016/j.neuroimage.2010.10.058; Liebert A, 2004, APPL OPTICS, V43, P3037, DOI 10.1364/AO.43.003037; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Lorenz J, 2005, EUR J PAIN, V9, P163, DOI 10.1016/j.ejpain.2004.07.009; Molteni E, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.056005; Moreira-Gonzalez A, 2006, PLAST RECONSTR SURG, V117, P1964, DOI 10.1097/01.prs.0000209933.78532.a7; Muthalib M, 2013, CLIN NEUROPHYSIOL, V124, P2060, DOI 10.1016/j.clinph.2013.03.018; Muthalib M, 2012, ADV EXP MED BIOL, V737, P45, DOI 10.1007/978-1-4614-1566-4_7; Muthalib M, 2009, EUR J APPL PHYSIOL, V107, P235, DOI 10.1007/s00421-009-1118-2; Niddam DM, 2002, NEUROIMAGE, V17, P1437, DOI 10.1006/nimg.2002.1270; Nomura Y, 1997, PHYS MED BIOL, V42, P1009, DOI 10.1088/0031-9155/42/6/002; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paddon-Jones D, 2000, J Sci Med Sport, V3, P35, DOI 10.1016/S1440-2440(00)80046-8; Papaiordanidou M, 2010, MUSCLE NERVE, V41, P54, DOI 10.1002/mus.21427; Peake JM, 2006, EXERC IMMUNOL REV, V12, P72; Ridding MC, 1999, EXP BRAIN RES, V126, P536, DOI 10.1007/s002210050762; Rozzi S, 2006, CEREB CORTEX, V16, P1389, DOI 10.1093/cercor/bhj076; Sato C, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2136312; Schafer K, 2012, NEUROIMAGE, V59, P3119, DOI 10.1016/j.neuroimage.2011.11.085; Scholkmann F, 2014, NEUROIMAGE, V85, P6, DOI 10.1016/j.neuroimage.2013.05.004; Seifert F, 2013, HUM BRAIN MAPP, V34, P1768, DOI 10.1002/hbm.22035; Selb J, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1852553; Selb J, 2007, OPT EXPRESS, V15, P16400, DOI 10.1364/OE.15.016400; Sheffler LR, 2007, MUSCLE NERVE, V35, P562, DOI 10.1002/mus.20758; Singh AK, 2005, NEUROIMAGE, V27, P842, DOI 10.1016/j.neuroimage.2005.05.019; Smith GV, 2003, EXP BRAIN RES, V150, P33, DOI 10.1007/s00221-003-1405-9; Stefanovic B, 2004, NEUROIMAGE, V22, P771, DOI 10.1016/j.neuroimage.2004.01.036; Steinbrink J, 2001, PHYS MED BIOL, V46, P879, DOI 10.1088/0031-9155/46/3/320; Stippich C, 2007, NEUROIMAGE, V34, P1227, DOI 10.1016/j.neuroimage.2006.08.046; Storm H, 2008, CURR OPIN ANESTHESIO, V21, P796, DOI 10.1097/ACO.0b013e3283183fe4; Sutherland MT, 2006, NEUROIMAGE, V33, P1042, DOI 10.1016/j.neuroimage.2006.08.015; Takahashi T, 2011, NEUROIMAGE, V57, P991, DOI 10.1016/j.neuroimage.2011.05.012; Takeuchi M, 2009, BRAIN TOPOGR, V22, P197, DOI 10.1007/s10548-009-0109-2; Tanosaki M, 2003, NEUROSCI LETT, V352, P1, DOI 10.1016/j.neulet.2003.08.055; Torricelli A, 2014, NEUROIMAGE, V85, P28, DOI 10.1016/j.neuroimage.2013.05.106; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Vanderthommen M, 2007, EXERC SPORT SCI REV, V35, P180, DOI 10.1097/jes.0b013e318156e785; Wabnitz H, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.8.086012; Zhao Q, 2011, BIOMED OPT EXPRESS, V2, P705, DOI 10.1364/BOE.2.000705	82	27	27	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131951	10.1371/journal.pone.0131951	http://dx.doi.org/10.1371/journal.pone.0131951			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158464	Green Published, gold, Green Submitted			2022-12-27	WOS:000358161200043
J	Vidoni, ED; Johnson, DK; Morris, JK; Van Sciver, A; Greer, CS; Billinger, SA; Donnelly, JE; Burns, JM				Vidoni, Eric D.; Johnson, David K.; Morris, Jill K.; Van Sciver, Angela; Greer, Colby S.; Billinger, Sandra A.; Donnelly, Joseph E.; Burns, Jeffrey M.			Dose-Response of Aerobic Exercise on Cognition: A Community-Based, Pilot Randomized Controlled Trial	PLOS ONE			English	Article							LATE-LIFE FUNCTION; PHYSICAL-ACTIVITY; CARDIORESPIRATORY FITNESS; DISABILITY INSTRUMENT; OLDER-ADULTS; IMPAIRMENT; DEMENTIA; DECLINE; WOMEN; PREVENTION	Epidemiological studies suggest a dose-response relationship exists between physical activity and cognitive outcomes. However, no direct data from randomized trials exists to support these indirect observations. The purpose of this study was to explore the possible relationship of aerobic exercise dose on cognition. Underactive or sedentary participants without cognitive impairment were randomized to one of four groups: no-change control, 75, 150, and 225 minutes per week ofmoderate-intensity semi-supervised aerobic exercise for 26-weeks in a community setting. Cognitive outcomes were latent residual scores derived from a battery of 16 cognitive tests: Verbal Memory, Visuospatial Processing, Simple Attention, Set Maintenance and Shifting, and Reasoning. Other outcome measures were cardiorespiratory fitness (peak oxygen consumption) and measures of function functional health. In intent-to-treat (ITT) analyses (n = 101), cardiorespiratory fitness increased and perceived disability decreased in a dose-dependent manner across the 4 groups. No other exercise-related effects were observed in ITT analyses. Analyses restricted to individuals who exercised per-protocol (n = 77) demonstrated that Simple Attention improved equivalently across all exercise groups compared to controls and a dose-response relationship was present for Visuospatial Processing. A clear dose-response relationship exists between exercise and cardiorespiratory fitness. Cognitive benefits were apparent at low doses with possible increased benefits in visuospatial function at higher doses but only in those who adhered to the exercise protocol. An individual's cardiorespiratory fitness response was a better predictor of cognitive gains than exercise dose (i.e., duration) and thus maximizing an individual's cardiorespiratory fitness may be an important therapeutic target for achieving cognitive benefits.	[Vidoni, Eric D.; Johnson, David K.; Morris, Jill K.; Van Sciver, Angela; Greer, Colby S.; Burns, Jeffrey M.] Univ Kansas, Med Ctr, Alzheimers Dis Ctr, Fairway, KS 66205 USA; [Johnson, David K.] Univ Kansas, Dept Psychol, Lawrence, KS 66045 USA; [Billinger, Sandra A.] Univ Kansas, Med Ctr, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66103 USA; [Donnelly, Joseph E.] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Burns, JM (corresponding author), Univ Kansas, Med Ctr, Alzheimers Dis Ctr, Fairway, KS 66205 USA.	jburns2@kumc.edu		Burns, Jeffrey/0000-0001-7609-8954	National Institute on Aging [R01 AG034614]; Foundation for Physical Therapy New Investigator Fellowship Training Initiative [KL2 TR000119, K01 HD067318, F32 AG044953];  [UL1 TR000001];  [P30 AG035982]	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Foundation for Physical Therapy New Investigator Fellowship Training Initiative; ; 	This project was funded by the National Institute on Aging (R01 AG034614), registered on ClinicalTrials.gov [NCT01129115] as "Dose Response Study of Aerobic Exercise in Older Adults." Essential support and infrastructure was provided through UL1 TR000001 and P30 AG035982. Other sources of support include the Foundation for Physical Therapy New Investigator Fellowship Training Initiative, KL2 TR000119, K01 HD067318 and F32 AG044953. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Sports Medicine, 2009, Med Sci Sports Exerc, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Angevaren M, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005381.pub3, 10.1002/14651858.CD005381.pub2]; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Barnes DE, 2013, JAMA INTERN MED, V173, P797, DOI 10.1001/jamainternmed.2013.189; Billinger SA, 2011, ARCH PHYS MED REHAB, V92, P2000, DOI 10.1016/j.apmr.2011.07.194; Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010; Church TS, 2007, JAMA-J AM MED ASSOC, V297, P2081, DOI 10.1001/jama.297.19.2081; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Cole DA, 2003, J ABNORM PSYCHOL, V112, P558, DOI 10.1037/0021-843X.112.4.558; Day JR, 2003, J APPL PHYSIOL, V95, P1901, DOI 10.1152/japplphysiol.00024.2003; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Etnier JL, 2006, BRAIN RES REV, V52, P119, DOI 10.1016/j.brainresrev.2006.01.002; Fleg JL, 2005, CIRCULATION, V112, P674, DOI 10.1161/CIRCULATIONAHA.105.545459; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Haley SM, 2002, J GERONTOL A-BIOL, V57, pM217, DOI 10.1093/gerona/57.4.M217; Jette AM, 2002, J GERONTOL A-BIOL, V57, pM209, DOI 10.1093/gerona/57.4.M209; Johnson DK, 2009, ARCH NEUROL-CHICAGO, V66, P1254, DOI 10.1001/archneurol.2009.158; Kaminsky LA, 2013, CIRCULATION, V127, P652, DOI 10.1161/CIR.0b013e31827ee100; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Kryscio RJ, 2014, JAMA NEUROL, V71, P947, DOI 10.1001/jamaneurol.2014.1120; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Lee IM, 2007, JAMA-J AM MED ASSOC, V297, P2137, DOI 10.1001/jama.297.19.2137; Little T. D., 2013, LONGITUDINAL STRUCTU; Mayer Charles J, 2008, Prev Chronic Dis, V5, pA24; McArdle J. J., 2001, STRUCTURAL EQUATION; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morss GM, 2004, MED SCI SPORT EXER, V36, P336, DOI 10.1249/01.MSS.0000113738.06267.E5; National Institute on Aging, 2007, NIH PUBLICATION, V07-5757; National Institute on Aging, 2009, NIH PUBLICATION, V15-4258; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Preacher KJ, 2010, PSYCHOL METHODS, V15, P209, DOI 10.1037/a0020141; Saghaei Mahmood, 2004, BMC Med Res Methodol, V4, P26, DOI 10.1186/1471-2288-4-26; Shah KR, 2004, ALZ DIS ASSOC DIS, V18, P112, DOI 10.1097/01.wad.0000127441.77570.f3; Sparling PB, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h100; Stewart WH, 2000, STAT MED, V19, P913, DOI 10.1002/(SICI)1097-0258(20000415)19:7<913::AID-SIM397>3.3.CO;2-U; Varela S, 2012, CLIN REHABIL, V26, P442, DOI 10.1177/0269215511425835; WARE JE, 1995, MED CARE, V33, pAS264, DOI 10.1097/00005650-199501001-00005; Wendell CR, 2014, J GERONTOL A-BIOL, V69, P455, DOI 10.1093/gerona/glt144; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; Yaffe K, 2001, ARCH INTERN MED, V161, P1703, DOI 10.1001/archinte.161.14.1703	40	94	94	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131647	10.1371/journal.pone.0131647	http://dx.doi.org/10.1371/journal.pone.0131647			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EW	26158265	gold, Green Published, Green Submitted			2022-12-27	WOS:000358161200035
J	Woo, YM; Shin, Y; Lee, EJ; Lee, S; Jeong, SH; Kong, HK; Park, EY; Kim, HK; Han, J; Chang, M; Park, JH				Woo, Yu Mi; Shin, Yubin; Lee, Eun Ji; Lee, Sunyoung; Jeong, Seung Hun; Kong, Hyun Kyung; Park, Eun Young; Kim, Hyoung Kyu; Han, Jin; Chang, Minsun; Park, Jong-Hoon			Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1 alpha Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; HYPOXIA-INDUCIBLE FACTOR-1; ACTIVATED PROTEIN-KINASE; DRUG-RESISTANCE; GLUCOSE-METABOLISM; ENDOCRINE THERAPY; GROWTH; MTOR; EXPRESSION; PATHWAY	Tamoxifen resistance is often observed in the majority of estrogen receptor-positive breast cancers and it remains as a serious clinical problem in breast cancer management. Increased aerobic glycolysis has been proposed as one of the mechanisms for acquired resistance to chemotherapeutic agents in breast cancer cells such as adriamycin. Herein, we report that the glycolysis rates in LCC2 and LCC9-tamoxifen-resistant human breast cancer cell lines derived from MCF7-are higher than those in MCF7S, which is the parent MCF7 subline. Inhibition of key glycolytic enzyme such as hexokinase-2 resulted in cell growth retardation at higher degree in LCC2 and LCC9 than that in MCF7S. This implies that increased aerobic glycolysis even under O-2-rich conditions, a phenomenon known as the Warburg effect, is closely associated with tamoxifen resistance. We found that HIF-1 alpha is activated via an Akt/mTOR signaling pathway in LCC2 and LCC9 cells without hypoxic condition. Importantly, specific inhibition of hexokinase-2 suppressed the activity of Akt/mTOR/HIF-1 alpha axis in LCC2 and LCC9 cells. In addition, the phosphorylated AMPK which is a negative regulator of mTOR was decreased in LCC2 and LCC9 cells compared to MCF7S. Interestingly, either the inhibition of mTOR activity or increase in AMPK activity induced a reduction in lactate accumulation and cell survival in the LCC2 and LCC9 cells. Taken together, our data provide evidence that development of tamoxifen resistance may be driven by HIF-1 alpha hyperactivation via modulation of Akt/mTOR and/or AMPK signaling pathways. Therefore, we suggest that the HIF-1 alpha hyperactivation is a critical marker of increased aerobic glycolysis in accordance with tamoxifen resistance and thus restoration of aerobic glycolysis may be novel therapeutic target for treatment of tamoxifen-resistant breast cancer.	[Woo, Yu Mi; Shin, Yubin; Lee, Eun Ji; Lee, Sunyoung; Kong, Hyun Kyung; Park, Eun Young; Park, Jong-Hoon] Sookmyung Womens Univ, Dept Life Syst, Seoul, South Korea; [Jeong, Seung Hun; Kim, Hyoung Kyu; Han, Jin] Inje Univ, Natl Res Lab Mitochondrial Signaling Lab, Cardiovasc & Metab Dis Ctr, Dept Hlth Sci & Technol,Grad Sch,Coll Med,Dept Ph, Busan, South Korea; [Chang, Minsun] Sookmyung Womens Univ, Dept Med & Pharmaceut Sci, Seoul, South Korea	Sookmyung Women's University; Inje University; Sookmyung Women's University	Chang, M (corresponding author), Sookmyung Womens Univ, Dept Med & Pharmaceut Sci, 52 Hyochangwon Rd, Seoul, South Korea.	minsunchang@sookmyung.ac.kr; parkjh@sookmyung.ac.kr			 [2013R1A2A1A01011908]		2013R1A2A1A01011908, http://www.nrf.re.kr/nrf_tot_cms/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blancher C, 2001, CANCER RES, V61, P7349; BRUNNER N, 1993, CANCER RES, V53, P3229; Brunner N, 1997, CANCER RES, V57, P3486; BRUNNER N, 1993, CANCER RES, V53, P283; Chan CH, 2012, CELL, V149, P1098, DOI 10.1016/j.cell.2012.02.065; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cigler T, 2007, CANCER J, V13, P148, DOI 10.1097/PPO.0b013e318074d363; Clarke R, 2009, J STEROID BIOCHEM, V114, P8, DOI 10.1016/j.jsbmb.2008.12.023; DeGraffenried LA, 2004, CLIN CANCER RES, V10, P8059, DOI 10.1158/1078-0432.CCR-04-0035; Dodwell D, 2008, CANCER TREAT REV, V34, P137, DOI 10.1016/j.ctrv.2007.09.004; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Evans A, 2008, CANCER CHEMOTH PHARM, V61, P377, DOI 10.1007/s00280-007-0480-1; Fan P, 2007, CANCER RES, V67, P1352, DOI 10.1158/0008-5472.CAN-06-1020; FAN TWM, 1986, BIOCHIM BIOPHYS ACTA, V882, P154, DOI 10.1016/0304-4165(86)90150-9; FURMAN E, 1992, J STEROID BIOCHEM, V43, P189, DOI 10.1016/0960-0760(92)90207-Y; Ghayad SE, 2008, CANCER SCI, V99, P1992, DOI 10.1111/j.1349-7006.2008.00955.x; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kondoh H, 2005, CANCER RES, V65, P177; Leung E, 2011, CANCER BIOL THER, V11, P938, DOI 10.4161/cbt.11.11.15527; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; Lu CW, 2011, AM J PATHOL, V179, P1405, DOI 10.1016/j.ajpath.2011.05.050; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; LYON RC, 1988, CANCER RES, V48, P870; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Mayer Ingrid, 2013, Clin Adv Hematol Oncol, V11, P217; Milane L, 2011, J CONTROL RELEASE, V155, P237, DOI 10.1016/j.jconrel.2011.03.032; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Nahta R, 2010, CLIN BREAST CANCER, V10, pS72, DOI 10.3816/CBC.2010.s.015; NEEMAN M, 1989, CANCER RES, V49, P589; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Park SY, 2006, CANCER RES, V66, P5121, DOI 10.1158/0008-5472.CAN-05-1341; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Pelicano H, 2006, LEUKEMIA, V20, P610, DOI 10.1038/sj.leu.2404140; Ravi R, 2000, GENE DEV, V14, P34; Rivenzon-Segal D, 2003, INT J CANCER, V107, P177, DOI 10.1002/ijc.11387; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Rubio MP, 2003, EMBO J, V22, P3514, DOI 10.1093/emboj/cdg363; Semenza GL, 2007, J MOL MED-JMM, V85, P1293, DOI 10.1007/s00109-007-0285-z; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Sokolosky ML, 2011, ONCOTARGET, V2, P538, DOI 10.18632/oncotarget.302; Warburg OH, 1931, METABOLISM TUMOURS; Xu RH, 2005, CANCER RES, V65, P613; Zhao YH, 2011, CANCER RES, V71, P4585, DOI 10.1158/0008-5472.CAN-11-0127; Zhou M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-33	51	81	85	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0132285	10.1371/journal.pone.0132285	http://dx.doi.org/10.1371/journal.pone.0132285			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158266	Green Published, Green Submitted, gold			2022-12-27	WOS:000358161200049
J	Frese, S; Ruebner, M; Suhr, F; Konou, TM; Tappe, KA; Toigo, M; Jung, HH; Henke, C; Steigleder, R; Strissel, PL; Huebner, H; Beckmann, MW; van der Keylen, P; Schoser, B; Schiffer, T; Frese, L; Bloch, W; Strick, R				Frese, Sebastian; Ruebner, Matthias; Suhr, Frank; Konou, Thierry M.; Tappe, Kim A.; Toigo, Marco; Jung, Hans H.; Henke, Christine; Steigleder, Ruth; Strissel, Pamela L.; Huebner, Hanna; Beckmann, Matthias W.; van der Keylen, Piet; Schoser, Benedikt; Schiffer, Thorsten; Frese, Laura; Bloch, Wilhelm; Strick, Reiner			Long-Term Endurance Exercise in Humans Stimulates Cell Fusion of Myoblasts along with Fusogenic Endogenous Retroviral Genes In Vivo	PLOS ONE			English	Article							MUSCLE SATELLITE CELL; MYONUCLEAR DOMAIN SIZE; SKELETAL-MUSCLE; STEM-CELL; FUNCTIONAL-CHARACTERIZATION; MOLECULAR REGULATION; MYOGENESIS; EXPRESSION; RECEPTOR; NUCLEI	Myogenesis is defined as growth, differentiation and repair of muscles where cell fusion of myoblasts to multinucleated myofibers is one major characteristic. Other cell fusion events in humans are found with bone resorbing osteoclasts and placental syncytiotrophoblasts. No unifying gene regulation for natural cell fusions has been found. We analyzed skeletal muscle biopsies of competitive cyclists for muscle-specific attributes and expression of human endogenous retrovirus (ERV) envelope genes due to their involvement in cell fusion of osteoclasts and syncytiotrophoblasts. Comparing muscle biopsies from post- with the pre-competitive seasons a significant 2.25-fold increase of myonuclei/mm fiber, a 2.38-fold decrease of fiber area/nucleus and a 3.1-fold decrease of satellite cells (SCs) occurred. We propose that during the pre-competitive season SC proliferation occurred following with increased cell fusion during the competitive season. Expression of twenty-two envelope genes of muscle biopsies demonstrated a significant increase of putative muscle-cell fusogenic genes Syncytin-1 and Syncytin-3, but also for the non-fusogenic erv3. Immunohistochemistry analyses showed that Syncytin-1 mainly localized to the sarcolemma of myofibers positive for myosin heavy-chain isotypes. Cellular receptors SLC1A4 and SLC1A5 of Syncytin-1 showed significant decrease of expression in post-competitive muscles compared with the pre-competitive season, but only SLC1A4 protein expression localized throughout the myofiber. Erv3 protein was strongly expressed throughout the myofiber, whereas envK1-7 localized to SC nuclei and myonuclei. Syncytin-1 transcription factors, PPAR. and RXR alpha, showed no protein expression in the myofiber, whereas the pCREB-Ser133 activator of Syncytin-1 was enriched to SC nuclei and myonuclei. Syncytin-1, Syncytin-3, SLC1A4 and PAX7 gene regulations along with MyoD1 and myogenin were verified during proliferating or actively-fusing human primary myoblast cell cultures, resembling muscle biopsies of cyclists. Myoblast treatment with anti-Synycytin-1 abrogated cell fusion in vitro. Our findings support functional roles for ERV envelope proteins, especially Syncytin-1, contributing to cell fusion of myotubes.	[Frese, Sebastian; Suhr, Frank; Konou, Thierry M.; Tappe, Kim A.; Bloch, Wilhelm] German Sport Univ Cologne, Inst Cardiovasc Res & Sport Med, Dept Mol & Cellular Sport Med, Cologne, Germany; [Frese, Sebastian; Jung, Hans H.] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Frese, Sebastian; Toigo, Marco] ETH, Inst Human Movement Sci & Sport, Exercise Physiol, Zurich, Switzerland; [Ruebner, Matthias; Henke, Christine; Steigleder, Ruth; Strissel, Pamela L.; Huebner, Hanna; Beckmann, Matthias W.; Strick, Reiner] Univ Erlangen Nurnberg, Univ Clin Erlangen, Dept Obstet & Gynaecol, Mol Med Lab, D-91054 Erlangen, Germany; [Toigo, Marco] Univ Zurich, Balgrist Univ Hosp, Dept Orthopaed, Zurich, Switzerland; [van der Keylen, Piet] Univ Erlangen Nurnberg, Inst Anat, D-91054 Erlangen, Germany; [Schiffer, Thorsten] German Sport Univ Cologne, Outpatient Clin Sports Traumatol & Publ Hlth Cons, Cologne, Germany; [Frese, Laura] Univ Hosp, Zurich, Switzerland; [Frese, Laura] Univ Zurich, Div Surg Res, Zurich, Switzerland; [Bloch, Wilhelm] German Sport Univ Cologne, German Res Ctr Elite Sport, Cologne, Germany; [Schoser, Benedikt] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80539 Munich, Germany	German Sport University Cologne; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Erlangen Nuremberg; University of Zurich; University of Erlangen Nuremberg; German Sport University Cologne; University of Zurich; University Zurich Hospital; University of Zurich; German Sport University Cologne; University of Munich	Strick, R (corresponding author), Univ Erlangen Nurnberg, Univ Clin Erlangen, Dept Obstet & Gynaecol, Mol Med Lab, Univ Str, D-91054 Erlangen, Germany.	reiner.strick@uk-erlangen.de	Huebner, Hanna/U-1003-2019; Suhr, Frank/AAU-5080-2021; Schoser, Benedikt/AAH-6286-2020	Huebner, Hanna/0000-0001-6889-1493; Schoser, Benedikt/0000-0002-2757-8131; Suhr, Frank/0000-0002-9013-3944; van der Keylen, Piet/0000-0003-4191-7192	German Research Centre of Elite Sport (German Sport University Cologne, Cologne, Germany); German Research Foundation (DFG) [STR 923/3-1]	German Research Centre of Elite Sport (German Sport University Cologne, Cologne, Germany); German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by the German Research Centre of Elite Sport (German Sport University Cologne, Cologne, Germany) to WB and in part by the German Research Foundation (DFG) to RS (STR 923/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; ALLEN DL, 1995, J APPL PHYSIOL, V78, P1969, DOI 10.1152/jappl.1995.78.5.1969; Bae GU, 2008, J BIOL CHEM, V283, P8301, DOI 10.1074/jbc.M706730200; Bae GU, 2010, MOL BIOL CELL, V21, P2399, DOI 10.1091/mbc.E09-12-1011; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Bjerregard B, 2014, CELL TISSUE RES, V357, P355, DOI 10.1007/s00441-014-1930-9; Blaise S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-19; Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116; Buslei R, 2015, NEUROPATH APPL NEURO, V41, P180, DOI 10.1111/nan.12136; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Charifi N, 2003, MUSCLE NERVE, V28, P87, DOI 10.1002/mus.10394; Cheynet V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-41; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; D'Antona G, 2006, J PHYSIOL-LONDON, V570, P611, DOI 10.1113/jphysiol.2005.101642; de Parseval N, 2003, J VIROL, V77, P10414, DOI 10.1128/JVI.77.19.10414-10422.2003; Du M, 2008, MOL CELL BIOL, V28, P2952, DOI 10.1128/MCB.00248-08; Duan R, 2012, J CELL BIOL, V199, P169, DOI 10.1083/jcb.201204065; Esnault C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003400; Faenza I, 2012, FASEB J, V26, P3042, DOI 10.1096/fj.11-200337; Faria EW, 2005, SPORTS MED, V35, P313, DOI 10.2165/00007256-200535040-00003; Fluck M, 2003, REV PHYSIOL BIOCH P, V146, P159, DOI 10.1007/s10254-002-0004-7; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Frese S, 2011, ARCH TOXICOL, V85, P635, DOI 10.1007/s00204-010-0607-8; Gruenbaum-Cohen Y, 2012, P NATL ACAD SCI USA, V109, P11211, DOI 10.1073/pnas.1116065109; Gundersen K, 2008, J PHYSIOL-LONDON, V586, P2675, DOI 10.1113/jphysiol.2008.154369; Hamoud N, 2014, P NATL ACAD SCI USA, V111, P3745, DOI 10.1073/pnas.1313886111; Haralalka S, 2011, DEVELOPMENT, V138, P1551, DOI 10.1242/dev.057653; Hindi SM, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003832; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Horsley V, 2004, CELLS TISSUES ORGANS, V176, P67, DOI 10.1159/000075028; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Ishido M, 2009, ACTA PHYSIOL, V195, P459, DOI 10.1111/j.1748-1716.2008.01905.x; JAMES NT, 1981, BRIT J EXP PATHOL, V62, P600; Kadi F, 2005, PFLUG ARCH EUR J PHY, V451, P319, DOI 10.1007/s00424-005-1406-6; Kadi F, 2004, J PHYSIOL-LONDON, V558, P1005, DOI 10.1113/jphysiol.2004.065904; Kadi F, 1999, HISTOCHEM CELL BIOL, V111, P189, DOI 10.1007/s004180050348; Kawai M, 2010, NAT REV ENDOCRINOL, V6, P629, DOI 10.1038/nrendo.2010.155; Knerr I, 2005, FEBS LETT, V579, P3991, DOI 10.1016/j.febslet.2005.06.029; Kurosaka M, 2012, ACTA PHYSIOL, V205, P159, DOI 10.1111/j.1748-1716.2011.02381.x; Lagha M, 2008, GENE DEV, V22, P1828, DOI 10.1101/gad.477908; LAGORD C, 1993, BIOCHEM BIOPH RES CO, V191, P928, DOI 10.1006/bbrc.1993.1306; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Liu JX, 2009, EXP PHYSIOL, V94, P117, DOI 10.1113/expphysiol.2008.043877; Lochmuller H, 1999, EXP CELL RES, V248, P186, DOI 10.1006/excr.1999.4407; Mackey AL, 2007, SCAND J MED SCI SPOR, V17, P34, DOI 10.1111/j.1600-0838.2006.00534.x; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Moseley L, 2004, INT J SPORTS MED, V25, P374, DOI 10.1055/s-2004-815848; MOSS FP, 1971, ANAT REC, V170, P421, DOI 10.1002/ar.1091700405; Myer A, 1997, DEV BIOL, V185, P127, DOI 10.1006/dbio.1997.8565; Onel SF, 2009, DEV DYNAM, V238, P1513, DOI 10.1002/dvdy.21961; Oikawa T, 2013, CELL MOL LIFE SCI, V70, P3341, DOI 10.1007/s00018-012-1238-4; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Oluwole OSA, 2007, AMYOTROPH LATERAL SC, V8, P67, DOI 10.1080/17482960600864207; Otto A, 2009, J ANAT, V215, P477, DOI 10.1111/j.1469-7580.2009.01138.x; Prudhomme S, 2004, J VIROL, V78, P12157, DOI 10.1128/JVI.78.22.12157-12168.2004; Rios R, 2001, BIOCHEM BIOPH RES CO, V280, P561, DOI 10.1006/bbrc.2000.4159; Rosser BWC, 2002, INT J DEV BIOL, V46, P747; Rosser BWC, 2000, DEV DYNAM, V217, P50, DOI 10.1002/(SICI)1097-0177(200001)217:1<50::AID-DVDY5>3.0.CO;2-1; Ruebner M, 2012, J CELL BIOCHEM, V113, P2383, DOI 10.1002/jcb.24110; Ruebner M, 2010, J MOL MED, V88, P1143, DOI 10.1007/s00109-010-0656-8; SCHMALBRUCH H, 1977, ANAT REC, V189, P169, DOI 10.1002/ar.1091890204; SCHULTZ E, 1994, REV PHYSIOL BIOCH P, V123, P213, DOI 10.1007/BFb0030904; Seale P, 2001, DEV CELL, V1, P333, DOI 10.1016/S1534-5807(01)00049-1; Sens KL, 2010, J CELL BIOL, V191, P1013, DOI 10.1083/jcb.201006006; SHEFER G, 2013, FEBS J, V280, P4063, DOI DOI 10.1111/FEBS.12228; Simonds WF, 1999, TRENDS PHARMACOL SCI, V20, P66, DOI 10.1016/S0165-6147(99)01307-3; Soe K, 2011, BONE, V48, P837, DOI 10.1016/j.bone.2010.11.011; Sperlich B, 2010, EUR J APPL PHYSIOL, V110, P1029, DOI 10.1007/s00421-010-1586-4; Strick R, 2007, J MOL MED, V85, P23, DOI 10.1007/s00109-006-0104-y; Strissel PL, 2012, ONCOTARGET, V3, P1204; Toigo M, 2006, EUR J APPL PHYSIOL, V97, P643, DOI 10.1007/s00421-006-0238-1; Toufaily C, 2013, PLACENTA, V34, P85, DOI 10.1016/j.placenta.2012.10.012; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; Vargas A, 2008, PLACENTA, V29, P170, DOI 10.1016/j.placenta.2007.10.012; Vasyutina E, 2009, P NATL ACAD SCI USA, V106, P8935, DOI 10.1073/pnas.0902501106; Verney J, 2008, MUSCLE NERVE, V38, P1147, DOI 10.1002/mus.21054; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Xu C, 2013, CELL, V155, P909, DOI 10.1016/j.cell.2013.10.023; Yoshida N, 1998, J CELL SCI, V111, P769; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zammit PS, 2001, DIFFERENTIATION, V68, P193, DOI 10.1046/j.1432-0436.2001.680407.x	83	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0132099	10.1371/journal.pone.0132099	http://dx.doi.org/10.1371/journal.pone.0132099			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154387	gold, Green Published, Green Submitted			2022-12-27	WOS:000358159700087
J	Moisa, SJ; Shike, DW; Shoup, L; Rodriguez-Zas, SL; Loor, JJ				Moisa, Sonia J.; Shike, Daniel W.; Shoup, Lindsay; Rodriguez-Zas, Sandra L.; Loor, Juan J.			Maternal Plane of Nutrition during Late Gestation and Weaning Age Alter Angus x Simmental Offspring Longissimus Muscle Transcriptome and Intramuscular Fat	PLOS ONE			English	Article							NF-KAPPA-B; ADIPOSE-TISSUE; GLUCOCORTICOID-RECEPTOR; GLUCOSE-HOMEOSTASIS; GENE NETWORKS; CELL-CYCLE; EXPRESSION; COMPLEX; PROTEIN; GROWTH	In model organisms both the nutrition of the mother and the young offspring could induce long-lasting transcriptional changes in tissues. In livestock, such changes could have important roles in determining nutrient use and meat quality. The main objective was to evaluate if plane of maternal nutrition during late-gestation and weaning age alter the offspring's Longissimus muscle (LM) transcriptome, animal performance, and metabolic hormones. Whole-transcriptome microarray analysis was performed on LM samples of early (EW) and normal weaned (NW) Angus x Simmental calves born to grazing cows receiving no supplement [low plane of nutrition (LPN)] or 2.3 kg high-grain mix/day [medium plane of nutrition (MPN)] during the last 105 days of gestation. Biopsies of LM were harvested at 78 (EW), 187 (NW) and 354 (before slaughter) days of age. Despite greater feed intake in MPN offspring, blood insulin was greater in LPN offspring. Carcass intramuscular fat content was greater in EW offspring. Bioinformatics analysis of the transcriptome highlighted a modest overall response to maternal plane of nutrition, resulting in only 35 differentially expressed genes (DEG). However, weaning age and a high-grain diet (EW) strongly impacted the transcriptome (DEG = 167), especially causing a lipogenic program activation. In addition, between 78 and 187 days of age, EW steers had an activation of the innate immune system due presumably to macrophage infiltration of intramuscular fat. Between 187 and 354 days of age (the "finishing" phase), NW steers had an activation of the lipogenic transcriptome machinery, while EW steers had a clear inhibition through the epigenetic control of histone acetylases. Results underscored the need to conduct further studies to understand better the functional outcome of transcriptome changes induced in the offspring by pre- and post-natal nutrition. Additional knowledge on molecular and functional outcomes would help produce more efficient beef cattle.	[Moisa, Sonia J.; Loor, Juan J.] Univ Illinois, Dept Anim Sci, Mammalian NutriPhysioGen, Urbana, IL 61801 USA; [Shike, Daniel W.; Shoup, Lindsay; Rodriguez-Zas, Sandra L.; Loor, Juan J.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Loor, Juan J.] Univ Illinois, Div Nutr Sci, IIT, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Illinois Institute of Technology; University of Illinois System; University of Illinois Urbana-Champaign	Loor, JJ (corresponding author), Univ Illinois, Dept Anim Sci, Mammalian NutriPhysioGen, 328 Mumford Hall, Urbana, IL 61801 USA.	jloor@illinois.edu	Loor, Juan J./H-3760-2012	Loor, Juan J./0000-0003-1586-4365; MOISA, SONIA/0000-0003-1776-8721; Rodriguez-Zas, Sandra/0000-0003-1122-4758	Division of Nutritional Sciences Vision 20/20" (University of Illinois, Urbana-Champaign) interdisciplinary nutrition-related research program; National Institute of Food and Agriculture, USA [ILLU-971-352]	Division of Nutritional Sciences Vision 20/20" (University of Illinois, Urbana-Champaign) interdisciplinary nutrition-related research program; National Institute of Food and Agriculture, USA	This study was funded by the Division of Nutritional Sciences Vision 20/20" (University of Illinois, Urbana-Champaign) interdisciplinary nutrition-related research program, and project # ILLU-971-352 (National Institute of Food and Agriculture, USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflaki E, 2011, CELL MOL LIFE SCI, V68, P3933, DOI 10.1007/s00018-011-0688-4; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Attwooll C, 2005, J BIOL CHEM, V280, P1199, DOI 10.1074/jbc.M412509200; Benes H, 2013, CARDIOVASC TOXICOL, V13, P347, DOI 10.1007/s12012-013-9215-1; Bionaz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032455; Chen YQ, 2008, J BIOL CHEM, V283, P10048, DOI 10.1074/jbc.M708151200; Du M, 2010, J ANIM SCI, V88, pE51, DOI 10.2527/jas.2009-2311; Duffield JA, 2009, PEDIATR RES, V66, P59, DOI 10.1203/PDR.0b013e3181a7c121; Dzitoyeva S, 2013, J LIPIDS, V2013, DOI 10.1155/2013/297932; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Faou P, 2012, BBA-MOL CELL RES, V1823, P348, DOI 10.1016/j.bbamcr.2011.12.001; Feng M, 2014, BIOL CELL, V106, P294, DOI 10.1111/boc.201400004; Flores-Alcantar A, 2011, CELL TISSUE RES, V345, P137, DOI 10.1007/s00441-011-1182-x; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Gnanalingham MG, 2005, AM J PHYSIOL-REG I, V289, pR1407, DOI 10.1152/ajpregu.00375.2005; Grant RW, 2015, OBESITY SILVER SPRIN; Graugnard DE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-142; Greenwood PL, 2007, ANIMAL, V1, P1283, DOI 10.1017/S175173110700050X; Huang GH, 2009, CYTOKINE, V48, P161, DOI 10.1016/j.cyto.2009.08.002; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Jones GE, 2000, J LEUKOCYTE BIOL, V68, P593; Kelner MJ, 2000, J BIOL CHEM, V275, P13000, DOI 10.1074/jbc.275.17.13000; Khafipour E, 2009, J DAIRY SCI, V92, P1060, DOI 10.3168/jds.2008-1389; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; Lee YF, 1998, J BIOL CHEM, V273, P13437, DOI 10.1074/jbc.273.22.13437; Lewis MJ, 1996, CELL, V85, P205, DOI 10.1016/S0092-8674(00)81097-1; Liu Y, 2013, DIABETES, V62, P743, DOI 10.2337/db12-0687; Loor JJ, 2007, PHYSIOL GENOMICS, V32, P105, DOI 10.1152/physiolgenomics.00188.2007; Medina-Gomez G, 2009, J ENDOCRINOL, V56, P404, DOI [10.1016/S1575-0922(09)72710-X, DOI 10.1016/S1575-0922(09)72710-X]; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Moisa SJ, 2013, BIOINFORM BIOL INSIG, V7, P253, DOI 10.4137/BBI.S12328; Morishima Y, 2000, J BIOL CHEM, V275, P6894, DOI 10.1074/jbc.275.10.6894; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Naslavsky N, 2005, J CELL SCI, V118, P4093, DOI 10.1242/jcs.02595; Neels JG, 2009, J BIOL CHEM, V284, P20692, DOI 10.1074/jbc.M109.018556; Ortega FJ, 2013, HORM METAB RES, V45, P1009, DOI 10.1055/s-0033-1358690; Otten MA, 2004, IMMUNOL LETT, V92, P23, DOI 10.1016/j.imlet.2003.11.018; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Penagaricano F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1034; Psarra AMG, 2011, BBA-MOL CELL RES, V1813, P1814, DOI 10.1016/j.bbamcr.2011.05.014; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Raddatz JR, 2008, MEASUREMENT ADIPONEC; Ren Y, 2014, MOL CELL BIOCH; Robin MA, 2003, J BIOL CHEM, V278, P18960, DOI 10.1074/jbc.M301807200; Ronnov-Jessen L, 2002, AM J PATHOL, V161, P471, DOI 10.1016/S0002-9440(10)64203-4; Rozenfeld-Granot G, 2002, ONCOGENE, V21, P1469, DOI 10.1038/sj.onc.1205218; Saare M, 2012, EXP CELL RES, V318, P1767, DOI 10.1016/j.yexcr.2012.04.013; Shimba S, 2004, J BIOL CHEM, V279, P40946, DOI 10.1074/jbc.M400840200; Shoup L, 2014, EFFECTS PREPARTUM SU; SMITH SB, 1981, ARCH BIOCHEM BIOPHYS, V211, P192, DOI 10.1016/0003-9861(81)90444-6; Spang A, 2013, COLD SPRING HARB PER, V5; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Taga H, 2011, J ANIM SCI, V89, P711, DOI 10.2527/jas.2010-3234; Thamer C, 2004, DIABETOLOGIA, V47, P1303, DOI 10.1007/s00125-004-1430-7; Urao N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013440; Wang L, 2001, J BIOL CHEM, V276, P21405, DOI 10.1074/jbc.M102488200; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Welte MA, 2009, BIOCHEM SOC T, V37, P991, DOI 10.1042/BST0370991; Yan Xu, 2013, J Genomics, V1, P29, DOI 10.7150/jgen.3930; Yoon HY, 2008, TRAFFIC, V9, P2236, DOI 10.1111/j.1600-0854.2008.00839.x	62	18	20	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131478	10.1371/journal.pone.0131478	http://dx.doi.org/10.1371/journal.pone.0131478			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26153887	Green Submitted, Green Published, gold			2022-12-27	WOS:000358159700067
J	Ujjain, SK; Bhatia, R; Ahuja, P; Attri, P				Ujjain, Sanjeev K.; Bhatia, Rohit; Ahuja, Preety; Attri, Pankaj			Highly Conductive Aromatic Functionalized Multi-Walled Carbon Nanotube for Inkjet Printable High Performance Supercapacitor Electrodes	PLOS ONE			English	Article							ALL-SOLID-STATE; ENERGY-STORAGE; IONIC LIQUID	We report the functionalization of multiwalled carbon nanotubes (MWCNT) via the 1,3-dipolar [3+2] cycloaddition of aromatic azides, which resulted in a detangled CNT as shown by transmission electron microscopy (TEM). Carboxylic moieties (-COOH) on aromatic azide result in highly stable aqueous dispersion (max. conc. similar to 10 mg/mL H2O), making the suitable for inkjet printing. Printed patterns on polyethylene terephthalate (PET) flexible substrate exhibit low sheet resistivity similar to 65 Omega.cm, which is attributed to enhanced conductivity. Fabricated Supercapacitors (SC) assembled using these printed substrates exhibit good electrochemical performance in organic as well as aqueous electrolytes. High energy and power density (57.8 Wh/kg and 0.85 kW/kg) in 1M H2SO4 aqueous electrolyte demonstrate the excellent performance of the proposed supercapacitor. Capacitive retention varies from similar to 85-94% with columbic efficiency similar to 95% after 1000 charge/discharge cycles in different electrolytes, demonstrating the excellent potential of the device for futuristic power applications.	[Ujjain, Sanjeev K.] Indian Inst Technol, Dept Phys, Kanpur 208016, Uttar Pradesh, India; [Bhatia, Rohit] Inst Home Econ, Dept Chem, Delhi, India; [Bhatia, Rohit] Peoples Act Livelihood & Sustainabil Pals, Delhi, India; [Ahuja, Preety] Univ Delhi, Dept Chem, Delhi 110007, India; [Attri, Pankaj] Kwangwoon Univ, Plasma Biosci Res Ctr, Dept Elect & Biol Phys, Seoul, South Korea	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; University of Delhi; Kwangwoon University	Ujjain, SK (corresponding author), Indian Inst Technol, Dept Phys, Kanpur 208016, Uttar Pradesh, India.	drsanjeevkujjain@gmail.com; chem.pankaj@gmail.com	Attri, Pankaj/ABE-7522-2020; Kumar, Sanjeev/AAP-7938-2021	Attri, Pankaj/0000-0002-5036-7877; 	DST INSPIRE fellowship program; UGC; SRC program of National Research Foundation of Korea (NRF) Grant - the Korean Government (MEST) [20100029418]; Kwangwoon University	DST INSPIRE fellowship program; UGC(University Grants Commission, India); SRC program of National Research Foundation of Korea (NRF) Grant - the Korean Government (MEST); Kwangwoon University	SK Ujjain gratefully thanks DST INSPIRE fellowship program. PA acknowledges the Ph.D fellowship received from UGC. The authors gratefully acknowledge SRC program of National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MEST) (No. 20100029418) and in part by Kwangwoon University 2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja P, 2014, ELECTROCHIM ACTA, V146, P429, DOI 10.1016/j.electacta.2014.09.039; Ahuja P, 2014, RSC ADV, V4, P57192, DOI 10.1039/c4ra09027f; An KH, 2001, ADV MATER, V13, P497, DOI 10.1002/1521-4095(200104)13:7<497::AID-ADMA497>3.0.CO;2-H; Arico AS, 2005, NAT MATER, V4, P366, DOI 10.1038/nmat1368; Attri P, 2014, B KOREAN CHEM SOC, V35, P3035, DOI 10.5012/bkcs.2014.35.10.3035; Attri P, 2014, MATER RES BULL, V58, P6, DOI 10.1016/j.materresbull.2014.03.025; Baik KY, 2014, CARBON, V77, P302, DOI 10.1016/j.carbon.2014.05.033; Bao LH, 2011, NANO LETT, V11, P1215, DOI 10.1021/nl104205s; Che GL, 1998, NATURE, V393, P346, DOI 10.1038/30694; Chen PC, 2010, NANO RES, V3, P594, DOI 10.1007/s12274-010-0020-x; Futaba DN, 2006, NAT MATER, V5, P987, DOI 10.1038/nmat1782; Inamdar AI, 2011, J POWER SOURCES, V196, P2393, DOI 10.1016/j.jpowsour.2010.09.052; Kaempgen M, 2009, NANO LETT, V9, P1872, DOI 10.1021/nl8038579; Kordas K, 2006, SMALL, V2, P1021, DOI 10.1002/smll.200600061; Li L, 2006, J ELECTROCHEM SOC, V153, pA1823, DOI 10.1149/1.2234659; Li SD, 2004, NANO LETT, V4, P2003, DOI 10.1021/nl048687z; Lutz JF, 2007, ANGEW CHEM INT EDIT, V46, P1018, DOI 10.1002/anie.200604050; Ma JG, 2010, J POLYM SCI POL CHEM, V48, P5541, DOI 10.1002/pola.24365; Nuriel S, 2005, CHEM PHYS LETT, V404, P263, DOI 10.1016/j.cplett.2005.01.072; Paiva MC, 2010, ACS NANO, V4, P7379, DOI 10.1021/nn1022523; Pushparaj VL, 2007, P NATL ACAD SCI USA, V104, P13574, DOI 10.1073/pnas.0706508104; Qian Y, 2014, J MATER CHEM A, V2, P10917, DOI 10.1039/c4ta00988f; RUOFF RS, 1995, CARBON, V33, P925, DOI 10.1016/0008-6223(95)00021-5; Sharma M, 2011, SYNTHETIC MET, V161, P844, DOI 10.1016/j.synthmet.2011.02.011; Simon P, 2008, NAT MATER, V7, P845, DOI 10.1038/nmat2297; Tortorich RP, 2013, NANOMATERIALS-BASEL, V3, P453, DOI 10.3390/nano3030453; Troiani HE, 2003, NANO LETT, V3, P751, DOI 10.1021/nl0341640; Ujjain SK, 2015, J MATER CHEM A, V3, P9925, DOI 10.1039/c5ta00653h; Ujjain SK, 2015, ELECTROCHIM ACTA, V157, P245, DOI 10.1016/j.electacta.2015.01.061; Wei T, 2007, CARBON, V45, P2712, DOI 10.1016/j.carbon.2007.08.009; Xia H, 2009, NANOSCALE RES LETT, V4, P1035, DOI 10.1007/s11671-009-9352-4; Yang C, 2009, ANGEW CHEM INT EDIT, V48, P1592, DOI 10.1002/anie.200805228; Yang YK, 2010, APPL SURF SCI, V257, P1010, DOI 10.1016/j.apsusc.2010.08.009; Zhang LL, 2009, CHEM SOC REV, V38, P2520, DOI 10.1039/b813846j; Zhou Y, 2006, APPL PHYS LETT, V88	35	30	31	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131475	10.1371/journal.pone.0131475	http://dx.doi.org/10.1371/journal.pone.0131475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26153688	Green Published, gold, Green Submitted			2022-12-27	WOS:000358159700066
J	Fischer, S; Hirche, C; Reichenberger, MA; Kiefer, J; Diehm, Y; Mukundan, S; Alhefzi, M; Bueno, EM; Kneser, U; Pomahac, B				Fischer, Sebastian; Hirche, Christoph; Reichenberger, Matthias A.; Kiefer, Jurij; Diehm, Yannick; Mukundan, Srinivasan, Jr.; Alhefzi, Muayyad; Bueno, Ericka M.; Kneser, Ulrich; Pomahac, Bohdan			Silicone Implants with Smooth Surfaces Induce Thinner but Denser Fibrotic Capsules Compared to Those with Textured Surfaces in a Rodent Model	PLOS ONE			English	Article							SOFT-TISSUE RESPONSE; BREAST IMPLANT; CONTRACTED CAPSULES; MAMMARY IMPLANTS; AUGMENTATION; INFECTION; BIOFILM; OUTCOMES; THERAPY; POLYMER	Purpose Capsular contracture is the most frequent long-term complication after implant-based breast reconstruction or augmentation. The aim of this study was to evaluate the impact of implant surface properties on fibrotic capsule formation in an animal model. Materials and Methods Twenty-four rats received 1 scaled down silicone implant each; 12 of the rats received implants with textured surfaces, and the other 12 received implants with smooth surfaces. After 60 and 120 days, rats in each group underwent 7-Tesla Magnetic Resonance Imaging (MRI) and high-resolution ultrasound (HR-US), and specimens of the capsules were acquired and used to measure capsule thickness through histology, collagen density through picro sirius red staining, and analyses of expression of pro-fibrotic and inflammatory genes (Collagen1-4, TGFb1, TGFb3, Smad3, IL4, IL10, IL13, CD68) through qRT-PCR. Furthermore, MRI data were processed to obtain capsule volume and implant surface area. Results On day 60, histology and HR-US showed that fibrotic capsules were significantly thicker in the textured implant group with respect to the smooth implant group (p<0.05). However, this difference did not persist on day 120 (p=0.56). Capsule thickness decreased significantly over the study period in both smooth and textured implant groups (p<0.05). Thickness measurements were substantiated by MRI analysis and volumes changed accordingly. Implant surface area did not vary between study dates, but it was different between implant types. On day 60, the density of collagen in the fibrotic capsules was significantly lower in the textured implant group with respect to the smooth group (p<0.05), but again this difference did not persist on day 120 (p=0.67). Collagen 1 and CD68 were respectively over- and under expressed in the textured implant group on day 60. Significant differences in the expression of other genes were not observed. Conclusion Silicone implants with textured surfaces led to temporarily thicker but less dense fibrotic capsules compared with smooth surfaces. 7-Tesla MRI and HR-US are capable for non-invasive in-vivo assessment of capsular fibrosis in an animal model and can provide unique insights into the fibrotic process by 3D reconstruction and surface area measurement.	[Fischer, Sebastian; Alhefzi, Muayyad; Bueno, Ericka M.; Pomahac, Bohdan] Harvard Univ, Sch Med, Dept Surg, Div Plast Surg,Brigham & Womens Hosp, Boston, MA 02115 USA; [Fischer, Sebastian; Hirche, Christoph; Kiefer, Jurij; Diehm, Yannick; Kneser, Ulrich] Heidelberg Univ, BG Clin Ludwigshafen, Dept Hand Plast & Reconstruct Surg, Ludwigshafen, Germany; [Reichenberger, Matthias A.] Univ Heidelberg Hosp, Aesthet & Prevent Med, Clin Plast & Reconstruct Surg, Ethianum, Heidelberg, Germany; [Mukundan, Srinivasan, Jr.] Harvard Univ, Sch Med, Dept Radiol, Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Fischer, S (corresponding author), Harvard Univ, Sch Med, Dept Surg, Div Plast Surg,Brigham & Womens Hosp, Boston, MA 02115 USA.	sfischer@hotmail.de	Pomahac, Bohdan/AAH-1792-2019; Alhefzi, Muayyad/GRY-4287-2022	Pomahac, Bohdan/0000-0003-3703-8240; 				Adams WP, 2006, PLAST RECONSTR SURG, V118, p46S, DOI 10.1097/01.prs.0000185671.51993.7e; American Society of Plastic Surgeons, 2013, COMPL PLAST SURG STA; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Araco A, 2009, PLAST RECONSTR SURG, V124, P1808, DOI 10.1097/PRS.0b013e3181bf7f26; Asplund O, 1996, PLAST RECONSTR SURG, V97, P1200, DOI 10.1097/00006534-199605000-00015; Beranek JT, 2005, ANN RHEUM DIS, V64, P342; Bergmann PA, 2014, J PLAST RECONSTR AES, V67, P1364, DOI 10.1016/j.bjps.2014.05.040; Brody GS, 2015, PLAST RECONSTR SURG, V135, P695, DOI 10.1097/PRS.0000000000001033; BUCKY LP, 1994, PLAST RECONSTR SURG, V93, P1123, DOI 10.1097/00006534-199405000-00002; Bui JM, 2015, AESTHET PLAST SURG, V39, P306, DOI 10.1007/s00266-014-0439-7; CAFFEE HH, 1983, ANN PLAS SURG, V11, P412, DOI 10.1097/00000637-198311000-00008; CLUGSTON PA, 1994, ANN PLAS SURG, V33, P595, DOI 10.1097/00000637-199412000-00005; Fagrell D, 2001, PLAST RECONSTR SURG, V108, P2108, DOI 10.1097/00006534-200112000-00046; Fischer S, 2015, ULTRASOUND MED BIOL, V41, P781, DOI 10.1016/j.ultrasmedbio.2014.10.018; Food and Drug Administration, 2014, AN LARG CELL LYMPH A; GAYOU RM, 1979, PLAST RECONSTR SURG, V63, P700, DOI 10.1097/00006534-197905000-00015; Hakelius L, 1997, PLAST RECONSTR SURG, V100, P1566, DOI 10.1097/00006534-199711000-00030; Handel N, 2006, PLAST RECONSTR SURG, V117, P757, DOI 10.1097/01.prs.0000201457.00772.1d; Jacombs A, 2014, PLAST RECONSTR SURG, V133, p471E, DOI 10.1097/PRS.0000000000000020; James SJ, 1997, BIOMATERIALS, V18, P667, DOI 10.1016/S0142-9612(96)00189-5; JUNQUEIRA LCU, 1978, ARCH HISTOL JAPON, V41, P267, DOI 10.1679/aohc1950.41.267; Khan UD, 2010, AESTHET PLAST SURG, V34, P42, DOI 10.1007/s00266-009-9427-8; Kirkpatrick CJ, 2000, AM J PATHOL, V156, P1455, DOI 10.1016/S0002-9440(10)65014-6; Liu X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116071; Merzin M, 2008, THESIS U TARTU ESTON; Britez MEM, 2012, EUR J PLAST SURG, V35, P647, DOI 10.1007/s00238-012-0728-9; Minami E, 2006, PLAST RECONSTR SURG, V118, P874, DOI 10.1097/01.prs.0000240878.24213.b7; OPPENHEIMER E, 1961, CANCER RES, V21, P132; Pajkos A, 2003, PLAST RECONSTR SURG, V111, P1605, DOI 10.1097/01.PRS.0000054768.14922.44; Pan SY, 2012, INT J CANCER, V131, pE1148, DOI 10.1002/ijc.27603; Prantl L, 2006, HANDCHIR MIKROCHIR P, V38, P224, DOI 10.1055/s-2006-924420; ROSATO RM, 1994, ANN PLAS SURG, V32, P342, DOI 10.1097/00000637-199404000-00002; Rubino C, 2001, ANN PLAS SURG, V46, P95, DOI 10.1097/00000637-200102000-00001; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Siggelkow W, 2003, BIOMATERIALS, V24, P1101, DOI 10.1016/S0142-9612(02)00429-5; SMAHEL J, 1993, PLAST RECONSTR SURG, V92, P474, DOI 10.1097/00006534-199309000-00015; Tamboto H, 2010, PLAST RECONSTR SURG, V126, P835, DOI 10.1097/PRS.0b013e3181e3b456; TAYLOR SR, 1983, J BIOMED MATER RES, V17, P205, DOI 10.1002/jbm.820170202; Valencia-Lazcano AA, 2013, J MECH BEHAV BIOMED, V21, P133, DOI 10.1016/j.jmbbm.2013.02.005; van Heerden J, 2009, J PLAST RECONSTR AES, V62, P610, DOI 10.1016/j.bjps.2007.09.044; Wick G, 2010, TRENDS IMMUNOL, V31, P110, DOI 10.1016/j.it.2009.12.001; Wilflingseder P, 1983, Minerva Chir, V38, P877; Wyatt LE, 1998, PLAST RECONSTR SURG, V102, P1922, DOI 10.1097/00006534-199811000-00017; Xu DR, 2009, MAGN RESON IMAGING, V27, P311, DOI 10.1016/j.mri.2008.07.018; Zahavi A, 2006, ANN PLAS SURG, V57, P248, DOI 10.1097/01.sap.0000221614.32176.9a	45	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132131	10.1371/journal.pone.0132131	http://dx.doi.org/10.1371/journal.pone.0132131			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151888	Green Published, gold, Green Submitted			2022-12-27	WOS:000358158900035
J	Inoue, T; Sakuta, Y; Shimamura, K; Ichikawa, H; Kobayashi, M; Otani, R; Yamaguchi, MK; Kanazawa, S; Kakigi, R; Sakuta, R				Inoue, Takeshi; Sakuta, Yuiko; Shimamura, Keiichi; Ichikawa, Hiroko; Kobayashi, Megumi; Otani, Ryoko; Yamaguchi, Masami K.; Kanazawa, So; Kakigi, Ryusuke; Sakuta, Ryoichi			Differences in the Pattern of Hemodynamic Response to Self-Face and Stranger-Face Images in Adolescents with Anorexia Nervosa: A Near-Infrared Spectroscopic Study	PLOS ONE			English	Article							FUNCTIONAL NEUROANATOMY; PREFRONTAL CORTEX; INFANT BRAIN; BODY-IMAGE; PERCEPTION; REPRESENTATION; RECOGNITION; HEMOGLOBIN; ACTIVATION; AREA	There have been no reports concerning the self-face perception in patients with anorexia nervosa (AN). The purpose of this study was to compare the neuronal correlates of viewing self-face images (i.e. images of familiar face) and stranger-face images (i.e. images of an unfamiliar face) in female adolescents with and without AN. We used near-infrared spectroscopy (NIRS) to measure hemodynamic responses while the participants viewed full-color photographs of self-face and stranger-face. Fifteen females with AN (mean age, 13.8 years) and 15 age- and intelligence quotient (IQ)-matched female controls without AN (mean age, 13.1 years) participated in the study. The responses to photographs were compared with the baseline activation (response to white uniform blank). In the AN group, the concentration of oxygenated hemoglobin (oxy-Hb) significantly increased in the right temporal area during the presentation of both the self-face and stranger-face images compared with the baseline level. In contrast, in the control group, the concentration of oxy-Hb significantly increased in the right temporal area only during the presentation of the self-face image. To our knowledge the present study is the first report to assess brain activities during self-face and stranger-face perception among female adolescents with AN. There were different patterns of brain activation in response to the sight of the self-face and stranger-face images in female adolescents with AN and controls.	[Inoue, Takeshi; Shimamura, Keiichi; Otani, Ryoko; Sakuta, Ryoichi] Dokkyo Med Univ, Koshigaya Hosp, Dept Pediat, Ctr Child Dev & Psychosomat, Koshigaya, Saitama, Japan; [Sakuta, Yuiko] Jissen Womens Univ, Fac Human Life Sci, Hino, Tokyo, Japan; [Ichikawa, Hiroko] Tokyo Univ Sci, Fac Sci & Technol, Noda, Chiba 278, Japan; [Kobayashi, Megumi; Kakigi, Ryusuke] Natl Inst Physiol Sci, Dept Integrat Physiol, Okazaki, Aichi 444, Japan; [Yamaguchi, Masami K.] Chuo Univ, Dept Psychol, Hachioji, Tokyo, Japan; [Kanazawa, So] Japan Womens Univ, Dept Psychol, Kawasaki, Kanagawa, Japan	Dokkyo Medical University; Tokyo University of Science; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Chuo University; Japan Womens University	Sakuta, R (corresponding author), Dokkyo Med Univ, Koshigaya Hosp, Dept Pediat, Ctr Child Dev & Psychosomat, Koshigaya, Saitama, Japan.	sakuta@dokkyomed.ac.jp			Japan Society for the Promotion of Science [25285204]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by a Grant-in-Aid for Scientific Research (25285204 for SK) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html).	Cash TF, 1997, INT J EAT DISORDER, V22, P107, DOI 10.1002/(SICI)1098-108X(199709)22:2&lt;107::AID-EAT1&gt;3.0.CO;2-J; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Hoek HW, 2006, CURR OPIN PSYCHIATR, V19, P389, DOI 10.1097/01.yco.0000228759.95237.78; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; Ichikawa H, 2010, NEUROSCI LETT, V482, P90, DOI 10.1016/j.neulet.2010.06.086; Jayakar A, 2005, J CLIN NEUROPHYSIOL, V22, P415; Jellema T, 2000, BRAIN COGNITION, V44, P280, DOI 10.1006/brcg.2000.1231; Kameyama M, 2004, NEUROIMAGE, V22, P1715, DOI 10.1016/j.neuroimage.2004.03.050; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kobayashi M, 2012, NEUROREPORT, V23, P984, DOI 10.1097/WNR.0b013e32835a4b86; Kobayashi M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00153; Kusaka T, 2004, HUM BRAIN MAPP, V22, P122, DOI 10.1002/hbm.20020; Lauer CJ, 1999, J PSYCHIATR RES, V33, P129, DOI 10.1016/S0022-3956(98)00020-X; Lena SM, 2004, NEUROPSYCHOL REV, V14, P99, DOI 10.1023/B:NERV.0000028081.40907.de; Lloyd-Fox S, 2011, J COGNITIVE NEUROSCI, V23, P2521, DOI 10.1162/jocn.2010.21598; MALONEY MJ, 1988, J AM ACAD CHILD PSY, V27, P541, DOI 10.1097/00004583-198809000-00004; Matsuda G, 2006, NEUROIMAGE, V29, P706, DOI 10.1016/j.neuroimage.2005.08.019; Miyake Y, 2010, PSYCHIAT RES-NEUROIM, V181, P183, DOI 10.1016/j.pscychresns.2009.09.001; Mohr HM, 2010, PSYCHOL MED, V40, P1519, DOI 10.1017/S0033291709991826; Morita T, 2008, J COGNITIVE NEUROSCI, V20, P342, DOI 10.1162/jocn.2008.20024; Nagamitsu S, 2011, BRAIN DEV-JPN, V33, P35, DOI 10.1016/j.braindev.2009.12.010; Nakato E, 2009, HUM BRAIN MAPP, V30, P462, DOI 10.1002/hbm.20516; Nakato E, 2011, EARLY HUM DEV, V87, P1, DOI 10.1016/j.earlhumdev.2010.08.030; Nakato E, 2011, NEUROIMAGE, V54, P1600, DOI 10.1016/j.neuroimage.2010.09.021; Otsuka Y, 2007, NEUROIMAGE, V34, P399, DOI 10.1016/j.neuroimage.2006.08.013; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Pena M, 2003, P NATL ACAD SCI USA, V100, P11702, DOI 10.1073/pnas.1934290100; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; Schroeter ML, 2004, NEUROIMAGE, V21, P283, DOI 10.1016/j.neuroimage.2003.09.054; Schroeter ML, 2003, NEUROIMAGE, V19, P555, DOI 10.1016/S1053-8119(03)00155-1; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Shimada S, 2006, NEUROIMAGE, V32, P930, DOI 10.1016/j.neuroimage.2006.03.044; Sugiura M, 2005, NEUROIMAGE, V24, P143, DOI 10.1016/j.neuroimage.2004.07.063; Sugiura M, 2012, HUM BRAIN MAPP, V33, P1364, DOI 10.1002/hbm.21290; SZMUKLER GI, 1992, J CLIN EXP NEUROPSYC, V14, P347, DOI 10.1080/01688639208402834; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; Uher R, 2005, BIOL PSYCHIAT, V58, P990, DOI 10.1016/j.biopsych.2005.06.001; Vocks S, 2011, PSYCHOL MED, V41, P1651, DOI 10.1017/S0033291710002382; Vocks S, 2010, COGN AFFECT BEHAV NE, V10, P422, DOI 10.3758/CABN.10.3.422; Vocks S, 2010, PSYCHIAT RES-NEUROIM, V183, P114, DOI 10.1016/j.pscychresns.2010.05.011; Watanabe E, 1996, NEUROSCI LETT, V205, P41, DOI 10.1016/0304-3940(96)12376-4; Yamashita Y, 2001, MED PHYS, V28, P1108, DOI 10.1118/1.1373401	43	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132050	10.1371/journal.pone.0132050	http://dx.doi.org/10.1371/journal.pone.0132050			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151754	Green Published, gold, Green Submitted			2022-12-27	WOS:000358158900033
J	Chaftari, AM; Hachem, R; Reitzel, R; Jordan, M; Jiang, Y; Yousif, A; Garoge, K; Deshmukh, P; Al Hamal, Z; Jabbour, J; Hanania, A; Raad, S; Jamal, M; Raad, I				Chaftari, Anne-Marie; Hachem, Ray; Reitzel, Ruth; Jordan, Mary; Jiang, Ying; Yousif, Ammar; Garoge, Kumait; Deshmukh, Poonam; Al Hamal, Zanaib; Jabbour, Joseph; Hanania, Alexander; Raad, Sammy; Jamal, Mohamed; Raad, Issam			Role of Procalcitonin and Interleukin-6 in Predicting Cancer, and Its Progression Independent of Infection	PLOS ONE			English	Article							SERUM-LEVELS; EXPRESSION; GROWTH; FEVER; INFLAMMATION; DIAGNOSIS; BIOMARKER; MARKERS; SEPSIS; LIVER	Procalcitonin (PCT) and Interleukin-6 (IL-6) have emerged as biomarkers for different inflammatory conditions. The purpose of the study was to evaluate the role of PCT and IL-6 as biomarkers of cancer and its progression in a large cohort of patients. This cross-sectional study included residual plasma samples collected from cancer patients, and control subjects without cancer. Levels of PCT and IL-6 were determined by Kryptor compact bioanalyzer. We identified 575 febrile cancer patients, 410 non-febrile cancer patients, and 79 non-cancer individuals. The median PCT level was lower in control subjects (0.029 ng/ml) compared to cancer patients with stage I-III disease (0.127 ng/ml) (p<0.0001) and stage IV disease (0.190 ng/ml) (p<0.0001). It was also higher in febrile cancer patients (0.310 ng/ml) compared to non-febrile cancer patients (0.1 ng/ml) (p<0.0001). Median IL-6 level was significantly lower in the control group (0 pg/ml) than in non-febrile cancer patients with stages I-III (7.376 pg/ml) or stage IV (9.635 pg/ml) (p<0.0001). Our results suggest a potential role for PCT and IL-6 in predicting cancer in non-febrile patients. In addition, PCT is useful in detecting progression of cancer and predicting bacteremia or sepsis in febrile cancer patients.	[Chaftari, Anne-Marie; Hachem, Ray; Reitzel, Ruth; Jordan, Mary; Jiang, Ying; Yousif, Ammar; Garoge, Kumait; Deshmukh, Poonam; Al Hamal, Zanaib; Jabbour, Joseph; Hanania, Alexander; Raad, Sammy; Jamal, Mohamed; Raad, Issam] Univ Texas MD Anderson Canc Ctr, Div Internal Med, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chaftari, AM (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Internal Med, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA.	achaftar@mdanderson.org	Jamal, Mohamed A/AAE-4275-2019; Hanania, Alexander N./AAF-7207-2020	Hanania, Alexander N./0000-0002-4717-5057; Jamal, Mohamed/0000-0003-3404-2535				Al Shuaibi M, 2013, CLIN INFECT DIS, V56, P943, DOI 10.1093/cid/cis1029; Becker KL, 2004, J CLIN ENDOCR METAB, V89, P1512, DOI 10.1210/jc.2002-021444; Bele N, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-224; Bihan H, 2003, THYROID, V13, P819, DOI 10.1089/105072503768499716; Brahms, 2011, PCT SENSITIVE KRYPTO; Carnino L, 2010, J CANCER RES CLIN, V136, P611, DOI 10.1007/s00432-009-0699-9; Chang CY, 2005, J CLIN NEUROSCI, V12, P930, DOI 10.1016/j.jocn.2004.11.017; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; de Jong KP, 2001, SCAND J GASTROENTERO, V36, P636, DOI 10.1080/003655201750163132; Engel A, 1999, SCAND J INFECT DIS, V31, P185, DOI 10.1080/003655499750006254; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Gilbert DN, 2011, CLIN INFECT DIS, V52, pS346, DOI 10.1093/cid/cir050; HUTCHINS D, 1994, INT J CANCER, V58, P80, DOI 10.1002/ijc.2910580114; Kaczka K, 2010, ENDOKRYNOL POL, V61, P430; Keramidaris D, 2013, J BUON, V18, P623; Kretzschmar M, 2001, ACTA ANAESTH SCAND, V45, P1162, DOI 10.1034/j.1399-6576.2001.450918.x; KUTTEH WH, 1991, SCAND J IMMUNOL, V33, P607, DOI 10.1111/j.1365-3083.1991.tb02532.x; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Liu XH, 2002, BIOCHEM BIOPH RES CO, V290, P249, DOI 10.1006/bbrc.2001.6188; Massaro KSR, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-137; Matzaraki V, 2007, CLIN BIOCHEM, V40, P336, DOI 10.1016/j.clinbiochem.2006.10.027; Mauro MV, 2012, DIAGN MICR INFEC DIS, V73, P308, DOI 10.1016/j.diagmicrobio.2012.04.006; Mouawad R, 1996, CLIN CANCER RES, V2, P1405; Oberhoffer M, 1999, J CRIT CARE, V14, P29, DOI 10.1016/S0883-9441(99)90005-9; Oka M, 1996, CANCER RES, V56, P2776; Ruokonen E, 1999, EUR J CLIN MICROBIOL, V18, P283, DOI 10.1007/s100960050277; Scheller J, 2006, SCAND J IMMUNOL, V63, P321, DOI 10.1111/j.1365-3083.2006.01750.x; Schuetz P, 2011, ARCH INTERN MED, V171, P1322, DOI 10.1001/archinternmed.2011.318; Shomali W, 2012, CANCER-AM CANCER SOC, V118, P5823, DOI 10.1002/cncr.27602; TAMM I, 1994, P NATL ACAD SCI USA, V91, P4338, DOI 10.1073/pnas.91.10.4338; Vincent JL, 2009, CRIT CARE CLIN, V25, P665, DOI 10.1016/j.ccc.2009.07.001; Yaegashi H, 2014, INT J UROL, V21, P104, DOI 10.1111/iju.12178; Zhang GJ, 1999, ANTICANCER RES, V19, P1427	33	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130999	10.1371/journal.pone.0130999	http://dx.doi.org/10.1371/journal.pone.0130999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148092	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600056
J	Chalan, P; Bijzet, J; Huitema, MG; Kroesen, BJ; Brouwer, E; Boots, AMH				Chalan, Paulina; Bijzet, Johan; Huitema, Minke G.; Kroesen, Bart-Jan; Brouwer, Elisabeth; Boots, Annemieke M. H.			Expression of Lectin-Like Transcript 1, the Ligand for CD161, in Rheumatoid Arthritis	PLOS ONE			English	Article							KILLER GENE-COMPLEX; SYNOVIAL TISSUE; INTERFERON-GAMMA; DENDRITIC CELLS; HUMAN NKR-P1A; CUTTING EDGE; B-CELLS; ACTIVATION; LYMPHOCYTES; TOLL-LIKE-RECEPTOR-4	Objectives Precursor Th17 lineage cells expressing CD161 are implicated in Rheumatoid Arthritis (RA) pathogenesis. CD4+CD161+ T-cells accumulate in RA joints and may acquire a non classical Th1 phenotype. The endogenous ligand for CD161 is lectin-like transcript 1 (LLT1). CD161/LLT1 ligation may co-stimulate T-cell IFN-gamma production. We investigated the presence and identity of LLT1-expressing cells in RA synovial fluid (SF) and synovial tissue (ST). We also assessed levels of soluble LLT1 (sLLT1) in different phases of RA development. Methods Paired samples of peripheral blood mononuclear cells (MC) and SFMC (n = 14), digested ST cells (n = 4) and ST paraffin sections (n = 6) from late-stage RA were analyzed for LLT1 expression by flow cytometry and immunohistochemistry. sLLT1 was measured using a sandwich ELISA. Sera and SF from late-stage RA (n = 26), recently diagnosed RA patients (n = 39), seropositive arthralgia patients (SAP, n = 31), spondyloarthropathy patients (SpA, n = 26) and healthy controls (HC, n = 31) were assayed. Results In RA SF, LLT1 was expressed by a small proportion of monocytes. In RA ST, LLT1-expressing cells were detected in the lining, sublining layer and in areas with infiltrates. The LLT1 staining pattern overlapped with the CD68 staining pattern. FACS analysis of digested ST confirmed LLT1 expression by CD68+ cells. Elevated systemic sLLT1 was found in all patient groups. Conclusions In RA joints, LLT1 is expressed by cells of the monocyte/macrophage lineage. Serum levels of sLLT1 were increased in all patient groups (patients with early- and late-stage RA, seropositive arthralgia and spondyloarthropathy) when compared to healthy subjects.	[Chalan, Paulina; Bijzet, Johan; Huitema, Minke G.; Brouwer, Elisabeth; Boots, Annemieke M. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [Kroesen, Bart-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands	University of Groningen; University of Groningen	Boots, AMH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands.	m.boots@umcg.nl	Brouwer, Elisabeth/AAL-9029-2020; Brouwer, Elisabeth/A-3198-2015	Brouwer, Elisabeth/0000-0002-5652-4423; Brouwer, Elisabeth/0000-0002-5652-4423				Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; Arends S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099685; Bartel Y, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00362; Bos WH, 2010, ANN RHEUM DIS, V69, P490, DOI 10.1136/ard.2008.105759; Brennan FM, 2002, ARTHRITIS RES THER, V4, pS177, DOI 10.1186/ar556; Chalan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079370; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Cosmi L, 2011, ARTHRITIS RHEUM-US, V63, P2504, DOI 10.1002/art.30332; CUSH JJ, 1988, ARTHRITIS RHEUM-US, V31, P1230, DOI 10.1002/art.1780311003; DECLERCK LS, 1995, RES IMMUNOL, V146, P81, DOI 10.1016/0923-2494(96)80241-0; Eichler W, 2001, J CELL BIOCHEM, P201; Fergusson JR, 2014, CELL REP, V9, P1075, DOI 10.1016/j.celrep.2014.09.045; Germain C, 2011, J BIOL CHEM, V286, P37964, DOI 10.1074/jbc.M111.285312; Germain C, 2010, J BIOL CHEM, V285, P36207, DOI 10.1074/jbc.M110.179622; Hamann J, 1997, IMMUNOGENETICS, V45, P295, DOI 10.1007/s002510050208; Hreggvidsdottir HS, 2014, MOL IMMUNOL, V57, P28, DOI 10.1016/j.molimm.2013.07.016; IGUCHI T, 1986, ARTHRITIS RHEUM-US, V29, P600, DOI 10.1002/art.1780290504; Iwahashi M, 2004, ARTHRITIS RHEUM-US, V50, P1457, DOI 10.1002/art.20219; Kamishikiryo J, 2011, J BIOL CHEM, V286, P23823, DOI 10.1074/jbc.M110.214254; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Krenn V, 2006, HISTOPATHOLOGY, V49, P358, DOI 10.1111/j.1365-2559.2006.02508.x; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; Radstake TRDJ, 2004, ARTHRITIS RHEUM-US, V50, P3856, DOI 10.1002/art.20678; Reparon-Schuijt CC, 1998, ARTHRITIS RHEUM, V41, P2211, DOI 10.1002/1529-0131(199812)41:12<2211::AID-ART17>3.0.CO;2-O; RIDLEY MG, 1990, BRIT J RHEUMATOL, V29, P84; Roelofs MF, 2005, ARTHRITIS RHEUM, V52, P2313, DOI 10.1002/art.21278; Rosen DB, 2008, J IMMUNOL, V180, P6508, DOI 10.4049/jimmunol.180.10.6508; Rosen DB, 2005, J IMMUNOL, V175, P7796, DOI 10.4049/jimmunol.175.12.7796; RUBIN LA, 1985, J IMMUNOL, V135, P3172; Samson M, 2012, ARTHRITIS RHEUM-US, V64, P3788, DOI 10.1002/art.34647; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Satkunanathan S, 2013, J VIROL; Spreu J, 2007, IMMUNOGENETICS, V59, P903, DOI 10.1007/s00251-007-0263-1; STEINER G, 1995, J RHEUMATOL, V22, P406; van de Stadt LA, 2011, ANN RHEUM DIS, V70, P128, DOI 10.1136/ard.2010.132662; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055	37	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132436	10.1371/journal.pone.0132436	http://dx.doi.org/10.1371/journal.pone.0132436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147876	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600268
J	Fedewa, SA; Cullati, S; Bouchardy, C; Welle, I; Burton-Jeangros, C; Manor, O; Courvoisier, DS; Guessous, I				Fedewa, Stacey A.; Cullati, Stephane; Bouchardy, Christine; Welle, Ida; Burton-Jeangros, Claudine; Manor, Orly; Courvoisier, Delphine S.; Guessous, Idris			Colorectal Cancer Screening in Switzerland: Cross-Sectional Trends (2007-2012) in Socioeconomic Disparities	PLOS ONE			English	Article							LOWER GASTROINTESTINAL ENDOSCOPY; HEALTH INTERVIEW SURVEY; OCCULT BLOOD-TEST; FAMILY-HISTORY; UNITED-STATES; WOMEN; CARE; PARTICIPATION; DETERMINANTS; PREVALENCE	Background Despite universal health care coverage, disparities in colorectal cancer (CRC) screening by income in Switzerland have been reported. However, it is not known if these disparities have changed over time. This study examines the association between socioeconomic position and CRC screening in Switzerland between 2007 and 2012. Methods Data from the 2007 (n = 5,946) and 2012 (n = 7,224) population-based Swiss Health Interview Survey data (SHIS) were used to evaluate the association between monthly household income, education, and employment with CRC screening, defined as endoscopy in the past 10 years or fecal occult blood test (FOBT) in the past 2 years. Multivariable Poisson regression was used to estimate prevalence ratios (PR) and 95% Confidence Intervals (CI) adjusting for demographics, health status, and health utilization. Results CRC screening increased from 18.9% in 2007 to 22.2% in 2012 (padjusted: = 0.036). During the corresponding time period, endoscopy increased (8.2% vs. 15.0%, padjusted:<0.001) and FOBT decreased (13.0% vs. 9.8%, padjusted: 0.002). CRC screening prevalence was greater in the highest income (>$6,000) vs. lowest income (<=$ 2,000) group in 2007 (24.5% vs. 10.5%, PR: 1.37, 95% CI: 0.96-1.96) and in 2012 (28.6% vs. 16.0%, PR: 1.45, 95% CI: 1.09-1.92); this disparity did not significantly change over time. Conclusions While CRC screening prevalence in Switzerland increased from 2007 to 2012, CRC screening coverage remains low and disparities in CRC screening by income persisted over time. These findings highlight the need for increased access to CRC screening as well as enhanced awareness of the benefits of CRC screening in the Swiss population, particularly among low-income residents.	[Fedewa, Stacey A.; Guessous, Idris] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA; [Fedewa, Stacey A.] Amer Canc Soc, Atlanta, GA 30329 USA; [Cullati, Stephane; Manor, Orly; Guessous, Idris] Univ Hosp Geneva, Unit Populat Epidemiol, Dept Community Med Primary Care & Emergency Med, Geneva, Switzerland; [Bouchardy, Christine] Univ Geneva, Geneva Canc Registry, Global Hlth Inst, Geneva, Switzerland; [Welle, Ida] Univ Lausanne Hosp, Inst Social & Prevent Med, Lausanne, Switzerland; [Burton-Jeangros, Claudine] Univ Geneva, Dept Sociol, Geneva, Switzerland; [Manor, Orly] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Sch Publ Hlth & Community Med, Jerusalem, Israel; [Courvoisier, Delphine S.] Univ Hosp Geneva, Div Clin Epidemiol, Geneva, Switzerland; [Guessous, Idris] Univ Lausanne Hosp, Div Chron Dis, Univ Inst Social & Prevent Med, Lausanne, Switzerland	Emory University; American Cancer Society; University of Geneva; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Guessous, I (corresponding author), Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA.	idris.guessous@hcuge.ch	Cullati, Stephane/F-7991-2011	Cullati, Stephane/0000-0002-3881-446X; Fedewa, Stacey/0000-0002-3624-6382	Swiss Cancer League grant [KLS-3144-02-2013]	Swiss Cancer League grant	This work was supported by the Swiss Cancer League grant KLS-3144-02-2013.	American Cancer Society, 2015, CANC PREV EARL DET 2; Arditi C, 2009, ENDOSCOPY, V41, P200, DOI 10.1055/s-0028-1119626; Burla L, 2012, CORPS MED SUISSE EFF; Busato A, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-8; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Collet TH, 2011, J GEN INTERN MED, V26, P724, DOI 10.1007/s11606-011-1674-0; Coughlin SS, 2004, CANCER CAUSE CONTROL, V15, P159, DOI 10.1023/B:CACO.0000019496.30145.62; Cullati S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-118; Dutoit L, 2014, ETABLISSEMENT RECENS; ERIKSON R, 1979, BRIT J SOCIOL, V30, P415, DOI 10.2307/589632; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Ferlay J., 2013, INT AGENCY RES CANC; Fischer R, 2013, EUR J CANCER PREV, V22, P425, DOI 10.1097/CEJ.0b013e32835f3b87; Frederiksen BL, 2010, BRIT J CANCER, V103, P1496, DOI 10.1038/sj.bjc.6605962; Guessous I, 2012, PREV MED, V55, P521, DOI 10.1016/j.ypmed.2012.08.005; Guessous I, 2014, J AGING RES; JACCARD RUEDIN H., 2009, PERSONNEL SANTE SUIS; Jensen CD, 2015, CLIN GASTROENTEROL H, V13, P739, DOI 10.1016/j.cgh.2014.10.020; Kraft E, 2009, B MED SVIZZERI, V90, P1647; Mai PL, 2010, PUBLIC HEALTH GENOM, V13, P495, DOI 10.1159/000294469; Meissner HI, 2006, CANCER EPIDEM BIOMAR, V15, P389, DOI 10.1158/1055-9965.EPI-05-0678; Menvielle G, 2008, BRIT J CANCER, V98, P1012, DOI 10.1038/sj.bjc.6604274; Paccaud GFaF, 2007, MED SOCIALE PREVENTI; Phillips KA, 2007, MED CARE, V45, P160, DOI 10.1097/01.mlr.0000246612.35245.21; Pinsky PF, 2003, AM J EPIDEMIOL, V157, P792, DOI 10.1093/aje/kwg043; Rapiti E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-102; Rauscher GH, 2008, CANCER EPIDEM BIOMAR, V17, P748, DOI 10.1158/1055-9965.EPI-07-2629; Shapiro JA, 2008, CANCER EPIDEM BIOMAR, V17, P1623, DOI 10.1158/1055-9965.EPI-07-2838; Spaeth A, 2013, ENDOSCOPY, V45, P560, DOI 10.1055/s-0032-1326636; Stock C, 2010, ENDOSCOPY, V42, P546, DOI 10.1055/s-0029-1244127; Subramanian S, 2004, PREV MED, V38, P536, DOI 10.1016/j.ypmed.2003.12.011; Swiss Confederation Federal Authorities, 2014, MED STAT 2014; Swiss Federal Statistical Office, 2014, STAT ENC 2014; Valle L, 2007, J CLIN ONCOL, V25, P781, DOI 10.1200/JCO.2006.06.9781; Volken T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-167; von Wagner C, 2011, INT J EPIDEMIOL, V40, P712, DOI 10.1093/ije/dyr008; Walter P, 2014, INDICATEURS MARCHE T; Wanzenried G., 2008, SJES, V144, P247; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Zapka JG, 2002, AM J PREV MED, V23, P28, DOI 10.1016/S0749-3797(02)00444-0; Zorzi M, 2009, EPIDEMIOL PREV, V33, P57	41	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131205	10.1371/journal.pone.0131205	http://dx.doi.org/10.1371/journal.pone.0131205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147803	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600069
J	Gorbe, A; Eder, A; Varga, ZV; Paloczi, J; Hansen, A; Ferdinandy, P; Eschenhagen, T				Gorbe, A.; Eder, A.; Varga, Z. V.; Paloczi, J.; Hansen, A.; Ferdinandy, P.; Eschenhagen, T.			Protection by the NO-Donor SNAP and BNP against Hypoxia/Reoxygenation in Rat Engineered Heart Tissue	PLOS ONE			English	Article							EXOGENOUS NITRIC-OXIDE; ISCHEMIA-REPERFUSION; APOPTOSIS; INJURY; CARDIOPROTECTION; NECROSIS	In vitro assays could replace animal experiments in drug screening and disease modeling, but have shortcomings in terms of functional readout. Force-generating engineered heart tissues (EHT) provide simple automated measurements of contractile function. Here we evaluated the response of EHTs to hypoxia/reoxygenation (H/R) and the effect of known cardiocytoprotective molecules. EHTs from neonatal rat heart cells were incubated for 24 h in EHT medium. Then they were subjected to 180 min hypoxia (93% N-2, 7% CO2) and 120 min reoxygenation (40% O-2, 53% N-2, 7% CO2), change of medium and additional follow-up of 48 h. Time-matched controls (40% O-2, 53% N-2, 7% CO2) were run for comparison. The following conditions were applied during H/R: fresh EHT medium(positive control), the NO-donor S-nitroso-N-acetyl-D,L-penicillamine (SNAP, 10(-7), 10(-6), 10(-5) M) or the guanylate cyclase activator brain type natriuretic peptide (BNP, 10(-9), 10(-8), 10(-7) M). Frequency and force of contraction were repeatedly monitored over the entire experiment, pH, troponin I (cTnI), lactate dehydrogenase (LDH) and glucose concentrations measured in EHT medium. Beating activity of EHTs in 24 h-medium ceased during hypoxia, partially recovered during reoxygenation and reached time-control values during follow-up. H/R was accompanied by a small increase in LDH and non-significant increase in cTnI. In fresh medium, some EHTs continued beating during hypoxia and all EHTs recovered faster during reoxygenation. SNAP and BNP showed small but significant protective effects during reoxygenation. EHTs are applicable to test potential cardioprotective compounds in vitro, monitoring functional and biochemical endpoints, which otherwise could be only measured by using in vivo or ex vivo heart preparations. The sensitivity of the model needs improvement.	[Gorbe, A.; Varga, Z. V.; Paloczi, J.] Univ Szeged, Dept Biochem, Cardiovasc Res Grp, Szeged, Hungary; [Eder, A.; Eschenhagen, T.] DZHK German Ctr Cardiovasc Res, Dept Expt Pharmacol & Toxicol, Cardiovasc Res Ctr, Hamburg, Germany; [Varga, Z. V.; Ferdinandy, P.] Semmelweis Univ, Dept Pharmacol & Pharmacotherapy, H-1085 Budapest, Hungary; [Gorbe, A.; Paloczi, J.; Ferdinandy, P.] Pharmahungary Grp, Szeged, Hungary	Szeged University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; Semmelweis University; Pharmahungary Group	Gorbe, A (corresponding author), Univ Szeged, Dept Biochem, Cardiovasc Res Grp, Szeged, Hungary.	aniko.gorbe@pharmahungary.com	Ferdinandy, Péter/H-9181-2019; Varga, Zoltan V/J-9264-2017	Varga, Zoltan V/0000-0002-2758-0784	German Research Foundation [DFG Es/88-12]; European Commission; NKFP [07 1-ES2HEART-HU (OM-00202/2007)]; National Development Agency - New Hungary Development Plan [TAMOP-4.2.2-08/1/2008-0013, TAMOP-4.2.1/B-09/1]; OTKA [PD 106001]; Hungarian Academy of Sciences; National Excellence Program [TAMOP-4.2.4.A/2-11/1-2012-0001]; National Program of Excellence [TAMOP 4.2.4.A/2-11-1-2012-0001]; Pharmahungary Group	German Research Foundation(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); NKFP; National Development Agency - New Hungary Development Plan; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); National Excellence Program; National Program of Excellence; Pharmahungary Group	This study was supported by grants from the German Research Foundation (DFG Es/88-12), the European Commission (FP7 Angioscaff, FP7 Biodesign) (EA, HA, TE), NKFP 07 1-ES2HEART-HU (OM-00202/2007), National Development Agency - New Hungary Development Plan (TAMOP-4.2.2-08/1/2008-0013, TAMOP-4.2.1/B-09/1); OTKA PD 106001 (GA, PJ, VZV, FP). GA holds a "Janos Bolyai Fellowship" from the Hungarian Academy of Sciences. PJ holds a "Apaczai-Csere Janos Fellowship" from TAMOP-4.2.4.A/2-11/1-2012-0001 (National Excellence Program). PF was a Szentagothai Fellow of the National Program of Excellence (TAMOP 4.2.4.A/2-11-1-2012-0001). Pharmahungary Group provided support in the form of salaries for authors AG, JP, and PF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Andreadou I, 2015, BRIT J PHARMACOL, V172, P1587, DOI 10.1111/bph.12811; Bell RM, 2003, CARDIOVASC RES, V57, P405, DOI 10.1016/S0008-6363(02)00675-2; Bell RM, 2001, CARDIOVASC RES, V52, P274, DOI 10.1016/S0008-6363(01)00394-7; Burley DS, 2007, BASIC RES CARDIOL, V102, P529, DOI 10.1007/s00395-007-0672-1; Csont T, 2010, J MOL CELL CARDIOL, V48, P649, DOI 10.1016/j.yjmcc.2010.01.013; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; DUTOIT EF, 1992, CIRC RES, V70, P960, DOI 10.1161/01.RES.70.5.960; Eder A, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0436-7; Ferdinandy P, 2003, BRIT J PHARMACOL, V138, P532, DOI 10.1038/sj.bjp.0705080; Gorbe A, 2014, MOL BIOTECHNOL, V56, P258, DOI 10.1007/s12033-013-9704-2; Gorbe A, 2010, BASIC RES CARDIOL, V105, P643, DOI 10.1007/s00395-010-0097-0; Hansen A, 2010, CIRC RES, V107, P35, DOI 10.1161/CIRCRESAHA.109.211458; Hirt MN, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0307-z; Johnson WB, 2012, LIFE SCI, V90, P328, DOI 10.1016/j.lfs.2011.11.016; Katare RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009275; Maejima Y, 2003, CARDIOVASC RES, V59, P308, DOI 10.1016/S0008-6363(03)00425-5; Marshall KD, 2014, AM J PHYSIOL-CELL PH, V306, pC639, DOI 10.1152/ajpcell.00167.2013; Nakano A, 2000, J MOL CELL CARDIOL, V32, P1159, DOI 10.1006/jmcc.2000.1152; Pritchett-Corning KR, 2009, J AM ASSOC LAB ANIM, V48, P23; Qi LL, 2011, EUR J PHARMACOL, V668, P201, DOI 10.1016/j.ejphar.2011.06.020; Radisic M, 2008, J BIOMED MATER RES A, V86A, P713, DOI 10.1002/jbm.a.31578; Rakhit RD, 2000, AM J PHYSIOL-HEART C, V278, pH1211, DOI 10.1152/ajpheart.2000.278.4.H1211; Saraste A, 1999, HERZ, V24, P189, DOI 10.1007/BF03044961; Shinmura K, 1999, AM J PHYSIOL-HEART C, V277, pH2495, DOI 10.1152/ajpheart.1999.277.6.H2495; Stohr A, 2013, J MOL CELL CARDIOL, V63, P189, DOI 10.1016/j.yjmcc.2013.07.011; Takano H, 1998, CIRC RES, V83, P73, DOI 10.1161/01.RES.83.1.73; Takimoto E, 2012, CIRC J, V76, P1819, DOI 10.1253/circj.CJ-12-0664; Vandenburgh H, 2008, MUSCLE NERVE, V37, P438, DOI 10.1002/mus.20931; Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394; Zimmermann WH, 2000, BIOTECHNOL BIOENG, V68, P106	31	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132186	10.1371/journal.pone.0132186	http://dx.doi.org/10.1371/journal.pone.0132186			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147889	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600214
J	Gossmann, R; Langer, K; Mulac, D				Gossmann, Rebecca; Langer, Klaus; Mulac, Dennis			New Perspective in the Formulation and Characterization of Didodecyldimethylammonium Bromide (DMAB) Stabilized Poly(Lactic-co-Glycolic Acid) (PLGA) Nanoparticles	PLOS ONE			English	Article							DRUG-DELIVERY; ORAL DELIVERY; MODEL; SURFACTANTS; ESTRADIOL; CELLS	Over the last few decades the establishment of nanoparticles as suitable drug carriers with the transport of drugs across biological barriers such as the gastrointestinal barrier moved into the focus of many research groups. Besides drug transport such carrier systems are well suited for the protection of drugs against enzymatic and chemical degradation. The preparation of biocompatible and biodegradable nanoparticles based on poly(lactic-co-glycolic acid) (PLGA) is intensively described in literature, while especially nanoparticles with cationic properties show a promising increased cellular uptake. This is due to the electrostatic interaction between the cationic surface and the negatively charged lipid membrane of the cells. Even though several studies achieved the successful preparation of nanoparticles stabilized with the cationic surfactants such as didodecyldimethylammonium bromide (DMAB), in most cases insufficient attention was paid to a precise analytical characterization of the nanoparticle system. The aim of the present work was to overcome this deficit by presenting a new perspective in the formulation and characterization of DMAB-stabilized PLGA nanoparticles. Therefore these nanoparticles were carefully examined with regard to particle diameter, zeta potential, the effect of variation in stabilizer concentration, residual DMAB content, and electrolyte stability. Without any steric stabilization, the DMAB-modified nanoparticles were sensitive to typical electrolyte concentrations of biological environments due to compression of the electrical double layer in conjunction with a decrease in zeta potential. To handle this problem, the present study proposed two modifications to enable electrolyte stability. Both polyvinyl alcohol (PVA) and polyethylene glycol (PEG) modified DMAB-PLGA-nanoparticles were stable during electrolyte addition. Furthermore, in contrast to unmodified DMAB-PLGA-nanoparticles and free DMAB, such modifications led to a lower cytotoxic activity against Caco-2 cells. In conclusion this study offers a closer and critical point of view on preparation, in vitro and analytical evaluation of DMAB-stabilized PLGA nanoparticles for the physiological use.	[Gossmann, Rebecca; Langer, Klaus; Mulac, Dennis] Univ Munster, Inst Pharmaceut Technol & Biopharm, D-48149 Munster, Germany	University of Munster	Gossmann, R (corresponding author), Univ Munster, Inst Pharmaceut Technol & Biopharm, Corrensstr 48, D-48149 Munster, Germany.	mulac.dennis@wwu.de		Langer, Klaus/0000-0002-0203-7478				ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3578; Amidi M, 2006, J CONTROL RELEASE, V111, P107, DOI 10.1016/j.jconrel.2005.11.014; [Anonymous], 2004, REV ONCOL; ARTURSSON P, 1991, BIOCHEM BIOPH RES CO, V175, P880, DOI 10.1016/0006-291X(91)91647-U; Astete CE, 2006, J BIOMAT SCI-POLYM E, V17, P247, DOI 10.1163/156856206775997322; Bhardwaj V, 2009, PHARM RES-DORDR, V26, P2495, DOI 10.1007/s11095-009-9965-4; Borrego E, 1999, INT J ENVIRON AN CH, V75, P181, DOI 10.1080/03067319908047310; Chen HB, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9741-8; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; DERJAGUIN B, 1993, PROG SURF SCI, V43, P30, DOI 10.1016/0079-6816(93)90013-L; Fagerholm U, 2007, J PHARM PHARMACOL, V59, P905, DOI 10.1211/jpp.59.7.0001; Fay F, 2010, BIOMATERIALS, V31, P4214, DOI 10.1016/j.biomaterials.2010.01.143; Florence A. T., 2006, PHYSICOCHEMICAL PRIN; Hariharan S, 2006, PHARM RES-DORDR, V23, P184, DOI 10.1007/s11095-005-8418-y; JUMARIE C, 1991, J CELL PHYSIOL, V149, P24, DOI 10.1002/jcp.1041490105; Kagan L, 2008, EXPERT OPIN DRUG DEL, V5, P681, DOI [10.1517/17425247.5.6.681, 10.1517/17425247.5.6.681 ]; Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001; Kusumoto K, 2010, J CONTROL RELEASE, V147, P246, DOI 10.1016/j.jconrel.2010.07.114; LOWRY JB, 1979, J PHARM SCI, V68, P110, DOI 10.1002/jps.2600680138; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Muta H, 2001, POLYMER, V42, P6313, DOI 10.1016/S0032-3861(01)00098-2; Panyam J, 2012, ADV DRUG DELIVER REV, V64, P61, DOI 10.1016/j.addr.2012.09.023; PARRIS N, 1980, J LIQ CHROMATOGR, V3, P1743, DOI 10.1080/01483918008064765; Peetla C, 2009, LANGMUIR, V25, P2369, DOI 10.1021/la803361y; Ruddy K, 2009, CA-CANCER J CLIN, V59, P56, DOI 10.3322/caac.20004; Sahana DK, 2008, J PHARM SCI-US, V97, P1530, DOI 10.1002/jps.21158; Sahoo SK, 2002, J CONTROL RELEASE, V82, P105, DOI 10.1016/S0168-3659(02)00127-X; Shibukawa M, 1999, J CHROMATOGR A, V830, P321, DOI 10.1016/S0021-9673(98)00939-X; Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4; Tessmar JK, 2007, MACROMOL BIOSCI, V7, P23, DOI 10.1002/mabi.200600096; Xia T, 2008, ACS NANO, V2, P85, DOI 10.1021/nn700256c; Xu AR, 2012, INT J NANOMED, V7, P3547, DOI 10.2147/IJN.S32188	32	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0127532	10.1371/journal.pone.0127532	http://dx.doi.org/10.1371/journal.pone.0127532			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147338	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600010
J	Kohlscheen, S; Wintterle, S; Schwarzer, A; Kamp, C; Brugman, MH; Breuer, DC; Busche, G; Baum, C; Modlich, U				Kohlscheen, Saskia; Wintterle, Sabine; Schwarzer, Adrian; Kamp, Christel; Brugman, Martijn H.; Breuer, Daniel C.; Buesche, Guntram; Baum, Christopher; Modlich, Ute			Inhibition of Thrombopoietin/Mpl Signaling in Adult Hematopoiesis Identifies New Candidates for Hematopoietic Stem Cell Maintenance	PLOS ONE			English	Article							SEVERE APLASTIC-ANEMIA; C-MPL; GENE-EXPRESSION; SELF-RENEWAL; MICE LACKING; BONE-MARROW; RECEPTOR; THROMBOCYTOPENIA; MUTATIONS; MEGAKARYOCYTOPOIESIS	Thrombopoietin (Thpo) signals via its receptor Mpl and regulates megakaryopoiesis, hematopoietic stem cell (HSC) maintenance and post-transplant expansion. Mpl expression is tightly controlled and deregulation of Thpo/Mpl-signaling is linked to hematological disorders. Here, we constructed an intracellular-truncated, signaling-deficient Mpl protein which is presented on the cell surface (dnMpl). The transplantation of bone marrow cells retrovirally transduced to express dnMpl into wildtype mice induced thrombocytopenia, and a progressive loss of HSC. The aplastic BM allowed the engraftment of a second BM transplant without further conditioning. Functional analysis of the truncated Mpl in vitro and in vivo demonstrated no internalization after Thpo binding and the inhibition of Thpo/Mpl-signaling in wildtype cells due to dominant-negative (dn) effects by receptor competition with wildtype Mpl for Thpo binding. Intracellular inhibition of Mpl could be excluded as the major mechanism by the use of a constitutive-dimerized dnMpl. To further elucidate the molecular changes induced by Thpo/Mpl-inhibition on the HSC-enriched cell population in the BM, we performed gene expression analysis of Lin-Sca1+cKit+ (LSK) cells isolated from mice transplanted with dnMpl transduced BM cells. The gene expression profile supported the exhaustion of HSC due to increased cell cycle progression and identified new and known downstream effectors of Thpo/Mpl-signaling in HSC (namely TIE2, ESAM1 and EPCR detected on the HSC-enriched LSK cell population). We further compared gene expression profiles in LSK cells of dnMpl mice with human CD34+ cells of aplastic anemia patients and identified similar deregulations of important stemness genes in both cell populations. In summary, we established a novel way of Thpo/Mpl inhibition in the adult mouse and performed in depth analysis of the phenotype including gene expression profiling.	[Kohlscheen, Saskia; Modlich, Ute] LOEWE Ctr Cell & Gene Therapy Frankfurt Main, Res Grp Gene Modificat Stem Cells, Langen, Germany; [Kohlscheen, Saskia; Modlich, Ute] Paul Ehrlich Inst, Langen, Germany; [Kohlscheen, Saskia; Wintterle, Sabine; Schwarzer, Adrian; Breuer, Daniel C.; Baum, Christopher; Modlich, Ute] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany; [Kamp, Christel] Paul Ehrlich Inst, Dept Biostat, Langen, Germany; [Brugman, Martijn H.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Buesche, Guntram] Hannover Med Sch, Inst Pathol, Hannover, Germany	Paul Ehrlich Institute; Hannover Medical School; Paul Ehrlich Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Hannover Medical School	Modlich, U (corresponding author), LOEWE Ctr Cell & Gene Therapy Frankfurt Main, Res Grp Gene Modificat Stem Cells, Langen, Germany.	Ute.modlich@pei.de	Brugman, Martijn/F-3389-2011; Schwarzer, Adrian/AAA-2571-2022	Brugman, Martijn/0000-0003-2675-2705; Modlich, Ute/0000-0001-8018-4118; Kamp, Christel/0000-0001-9997-6772; Schwarzer, Adrian/0000-0001-5684-2280	Deutsche Forschungsgemeinschaft (Excellence Cluster REBIRTH) [MO860]; LOEWE Center for Cell and Gene Therapy, Frankfurt; Hannover Biomedical Research School stipend	Deutsche Forschungsgemeinschaft (Excellence Cluster REBIRTH)(German Research Foundation (DFG)); LOEWE Center for Cell and Gene Therapy, Frankfurt; Hannover Biomedical Research School stipend	This work was supported by Deutsche Forschungsgemeinschaft (MO860 and Excellence Cluster REBIRTH) and LOEWE Center for Cell and Gene Therapy, Frankfurt. S.K. was supported by a Hannover Biomedical Research School stipend.	Alexander W S, 1996, Stem Cells, V14 Suppl 1, P124; Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; ALEXANDER WS, 1995, EMBO J, V14, P5569, DOI 10.1002/j.1460-2075.1995.tb00244.x; Arai F, 2009, ANN NY ACAD SCI, V1176, P36, DOI 10.1111/j.1749-6632.2009.04561.x; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Ballmaier M, 2001, BLOOD, V97, P139, DOI 10.1182/blood.V97.1.139; Bradley HL, 2004, BLOOD, V103, P2965, DOI 10.1182/blood-2003-08-2963; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheung AMS, 2013, BLOOD, V122, P3129, DOI 10.1182/blood-2013-06-508432; Coers J, 2004, J BIOL CHEM, V279, P36397, DOI 10.1074/jbc.M401386200; Culhane AC, 2010, NUCLEIC ACIDS RES, V38, pD716, DOI 10.1093/nar/gkp1015; de Graaf CA, 2011, CELL CYCLE, V10, P1582, DOI 10.4161/cc.10.10.15619; de Graaf CA, 2010, P NATL ACAD SCI USA, V107, P21689, DOI 10.1073/pnas.1016166108; deSauvage FJ, 1996, J EXP MED, V183, P651, DOI 10.1084/jem.183.2.651; Desmond R, 2014, BLOOD, V123, P1818, DOI 10.1182/blood-2013-10-534743; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Fehse B, 2000, MOL THER, V1, P448, DOI 10.1006/mthe.2000.0068; Fischer U, 2012, HAEMATOL-HEMATOL J, V97, P1304, DOI 10.3324/haematol.2011.056705; Forsberg EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008785; Fox N, 2002, J CLIN INVEST, V110, P389, DOI 10.1172/JCI200215430; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gazit R, 2014, J EXP MED, V211, P1314, DOI 10.1084/jem.20130428; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Heckl D, 2011, BLOOD, V117, P3737, DOI 10.1182/blood-2010-09-308262; Ihara K, 1999, P NATL ACAD SCI USA, V96, P3132, DOI 10.1073/pnas.96.6.3132; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jaatinen T, 2006, STEM CELLS, V24, P631, DOI 10.1634/stemcells.2005-0185; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kaushansky K, 2005, J CLIN INVEST, V115, P3339, DOI 10.1172/JCI26674; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kimura S, 1998, P NATL ACAD SCI USA, V95, P1195, DOI 10.1073/pnas.95.3.1195; King S, 2005, BRIT J HAEMATOL, V131, P636, DOI 10.1111/j.1365-2141.2005.05819.x; KUTER DJ, 1995, BLOOD, V85, P2720, DOI 10.1182/blood.V85.10.2720.bloodjournal85102720; Lento W, 2014, GENE DEV, V28, P995, DOI 10.1101/gad.231944.113; Luis TC, 2010, BLOOD, V116, P496, DOI 10.1182/blood-2010-04-282624; Meyer J, 1998, BLOOD, V91, P1901, DOI 10.1182/blood.V91.6.1901.1901_1901_1908; Meyer J, 2002, GROWTH FACTORS, V20, P131, DOI 10.1080/0897719021000058139; Olnes MJ, 2012, NEW ENGL J MED, V367, P11, DOI 10.1056/NEJMoa1200931; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Qian SG, 1998, BLOOD, V92, P2189, DOI 10.1182/blood.V92.6.2189; Saur SJ, 2010, BLOOD, V115, P1254, DOI 10.1182/blood-2009-06-227033; Schambach A, 2006, GENE THER, V13, P1524, DOI 10.1038/sj.gt.3302807; Schambach A, 2006, MOL THER, V13, P391, DOI 10.1016/j.ymthe.2005.08.012; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sudo T, 2012, J IMMUNOL, V189, P200, DOI 10.4049/jimmunol.1200056; Townsley DM, 2013, INT J HEMATOL, V98, P48, DOI 10.1007/s12185-013-1352-6; Vainchenker W, 2011, NEW MUTATIONS AND PA; Walne AJ, 2012, HAEMATOL-HEMATOL J, V97, P524, DOI 10.3324/haematol.2011.052787; Wicke DC, 2010, MOL THER, V18, P343, DOI 10.1038/mt.2009.233; Yan XQ, 1999, EXP HEMATOL, V27, P1409, DOI 10.1016/S0301-472X(99)00069-7; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126	54	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131866	10.1371/journal.pone.0131866	http://dx.doi.org/10.1371/journal.pone.0131866			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147434	Green Submitted, gold, Green Published			2022-12-27	WOS:000358157600155
J	Peron, M; Lovisa, F; Poli, E; Basso, G; Bonvini, P				Peron, Marica; Lovisa, Federica; Poli, Elena; Basso, Giuseppe; Bonvini, Paolo			Understanding the Interplay between Expression, Mutation and Activity of ALK Receptor in Rhabdomyosarcoma Cells for Clinical Application of Small-Molecule Inhibitors	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; INFLAMMATORY MYOFIBROBLASTIC TUMOR; HEPATOCYTE GROWTH-FACTOR; FACTOR-I RECEPTOR; TYROSINE KINASE; LUNG-CANCER; C-MET; MONOCLONAL-ANTIBODIES; ACTIVATING MUTATIONS; ACQUIRED-RESISTANCE	Background Receptor tyrosine kinases (RTKs) have a central role in cancer initiation and progression, since changes in their expression and activity potentially results in cell transformation. This concept is essential from a therapeutic standpoint, as clinical evidence indicates that tumours carrying deregulated RTKs are particularly susceptible to their activity but also to their inhibition. Rhabdomyosarcoma (RMS) is an aggressive childhood cancer where emerging therapies rely on the use kinase inhibitors, and among druggable kinases ALK represents a potential therapeutic target to commit efforts against. However, the functional relevance of ALK in RMS is not known, likewise the multi-component deregulated RTK profile to which ALK belongs. Methods In this study we used RMS cell lines representative of the alveolar and embrional histotype and looked at ALK intracellular localization, activity and cell signalling. Results We found that ALK was properly located at the plasma membrane of RMS cells, though in an unphosphorylated and inactive state due to intracellular tyrosine phosphatases (PTPases) activity. Indeed, increase of ALK phosphorylation was observed upon PTPase inhibition, as well as after ligand binding or protein overexpression. In these conditions, ALK signalling proceeded through the MAPK/ERK and PI3K/AKT pathways, and it was susceptible to ATP-competitive inhibitors exposure. However, drug-induced growth inhibition, cell cycle arrest and apoptosis did not correlate with ALK expression only, but relied also on the expression of other RTKs with akin drug binding affinity. Indeed, analysis of baseline and inducible RTK phosphorylation confirmed that RMS cells were susceptible to ALK kinase inhibitors even in the absence of the primary intended target, due to the presence of compensatory RTKs signalling pathways. Conclusions These data, hence, provided evidences of a potentially active role of ALK in RMS cells, but also suggest caution in considering ALK a major therapeutic target in this malignancy, particularly if expression and activity cannot be accurately determined.	[Peron, Marica; Lovisa, Federica; Poli, Elena; Basso, Giuseppe; Bonvini, Paolo] Azienda Osped Univ Padova, Clin Oncoematol Pediat Padova, Padua, Italy; [Bonvini, Paolo] Ist Ric Pediat Citta Speranza, Padua, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova; Fondazione Citta della Speranza	Bonvini, P (corresponding author), Azienda Osped Univ Padova, Clin Oncoematol Pediat Padova, Padua, Italy.	paolo.bonvini@unipd.it	Bonvini, Paolo/J-9877-2018	Bonvini, Paolo/0000-0003-2889-108X; BASSO, GIUSEPPE/0000-0002-2634-9302; LOVISA, FEDERICA/0000-0001-9570-6150	Fondazione Citta della Speranza; MIUR (Ministero Istruzione Universita e Ricerca); AIRC (Associazione Italiana per la Ricerca sul Cancro)	Fondazione Citta della Speranza; MIUR (Ministero Istruzione Universita e Ricerca)(Ministry of Education, Universities and Research (MIUR)); AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Fondazione Citta della Speranza (PB and FL), MIUR (Ministero Istruzione Universita e Ricerca), and by AIRC (Associazione Italiana per la Ricerca sul Cancro). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasi S, 1997, J CELL BIOL, V137, P1057, DOI 10.1083/jcb.137.5.1057; Armistead PM, 2007, CANCER, V110, P2293, DOI 10.1002/cncr.23038; Bonvini P, 2002, CANCER RES, V62, P1559; Bonvini P, 2013, BRIT J CANCER, V109, P3084, DOI 10.1038/bjc.2013.653; Boutterin MC, 2013, CELL SIGNAL, V25, P1505, DOI 10.1016/j.cellsig.2013.02.020; Bresler SC, 2014, CANCER CELL, V26, P682, DOI 10.1016/j.ccell.2014.09.019; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Cao LA, 2010, CANCER RES, V70, P6497, DOI 10.1158/0008-5472.CAN-10-0582; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; Cessna MH, 2002, MODERN PATHOL, V15, P931, DOI 10.1097/01.MP.0000026615.04130.1F; Chen JY, 2013, J MED CHEM, V56, P5673, DOI 10.1021/jm401005u; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Christensen JG, 2007, MOL CANCER THER, V6, P3314, DOI 10.1158/1535-7163.MCT-07-0365; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Clayton AHA, 2007, BIOCHEMISTRY-US, V46, P4589, DOI 10.1021/bi700002b; Crose Lisa E. S., 2011, Sarcoma, V2011, P1, DOI 10.1155/2011/756982; Davicioni E, 2006, CANCER RES, V66, P6936, DOI 10.1158/0008-5472.CAN-05-4578; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Diomedi-Camassei F, 2008, CLIN CANCER RES, V14, P4119, DOI 10.1158/1078-0432.CCR-07-4446; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Ehnman M, 2013, CANCER RES, V73, P2139, DOI 10.1158/0008-5472.CAN-12-1646; ELBADRY OM, 1990, CELL GROWTH DIFFER, V1, P325; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Friboulet L, 2014, CANCER DISCOV, V4, P662, DOI 10.1158/2159-8290.CD-13-0846; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; Ganti R, 2006, MODERN PATHOL, V19, P1213, DOI 10.1038/modpathol.3800636; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Huang F, 2010, CANCER RES, V70, P7221, DOI 10.1158/0008-5472.CAN-10-0391; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Iwama E, 2014, ONCOTARGETS THER, V7, P375, DOI 10.2147/OTT.S38868; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Katayama R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003316; Knight JDR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000982; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lawrence B, 2000, AM J PATHOL, V157, P377, DOI 10.1016/S0002-9440(10)64550-6; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lennerz JK, 2011, J CLIN ONCOL, V29, P4803, DOI 10.1200/JCO.2011.35.4928; Li SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072220; Lovly CM, 2014, NAT MED, V20, P1027, DOI 10.1038/nm.3667; Lovly CM, 2011, CANCER RES, V71, P4920, DOI 10.1158/0008-5472.CAN-10-3879; Lukasiewicz E, 2009, FOLIA HISTOCHEM CYTO, V47, P485, DOI 10.2478/v10042-009-0108-x; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mathivet T, 2007, CELL SIGNAL, V19, P2434, DOI 10.1016/j.cellsig.2007.07.011; Mazot P, 2011, ONCOGENE, V30, P2017, DOI 10.1038/onc.2010.595; Mazot P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033581; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Moog-Lutz C, 2005, J BIOL CHEM, V280, P26039, DOI 10.1074/jbc.M501972200; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Motegi A, 2004, J CELL SCI, V117, P3319, DOI 10.1242/jcs.01183; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Niederst MJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004652; Nishimura R, 2013, CANCER SCI, V104, P856, DOI 10.1111/cas.12173; Okamoto W, 2012, MOL CANCER THER, V11, P1557, DOI 10.1158/1535-7163.MCT-11-0934; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Perez-Pinera P, 2007, J BIOL CHEM, V282, P28683, DOI 10.1074/jbc.M704505200; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Pulford K, 1997, BLOOD, V89, P1394, DOI 10.1182/blood.V89.4.1394; Rees H, 2006, GROWTH FACTORS, V24, P197, DOI 10.1080/08977190600759923; Rodig SJ, 2010, CURR OPIN INVEST DR, V11, P1477; Sabbatini P, 2009, MOL CANCER THER, V8, P2811, DOI 10.1158/1535-7163.MCT-09-0423; Schlessinger J, 2014, COLD SPRING HARB PER, P6; Seto T, 2013, LANCET ONCOL, V14, P590, DOI 10.1016/S1470-2045(13)70142-6; Shaw AT, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894; Shaw AT, 2011, CLIN CANCER RES, V17, P2081, DOI 10.1158/1078-0432.CCR-10-1591; Shern JF, 2014, CANCER DISCOV, V4, P216, DOI 10.1158/2159-8290.CD-13-0639; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sun Ke, 2007, Chinese Journal of Pathology, V36, P605; Taulli R, 2006, CANCER RES, V66, P4742, DOI 10.1158/0008-5472.CAN-05-4292; Taylor JG, 2009, J CLIN INVEST, V119, P3395, DOI 10.1172/JCI39703; van Gaal JC, 2012, J CLIN ONCOL, V30, P308, DOI 10.1200/JCO.2011.37.8588; Volinsky N, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009043; Wagner JP, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003994; Ward CW, 2007, TRENDS BIOCHEM SCI, V32, P129, DOI 10.1016/j.tibs.2007.01.001; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Yamada T, 2012, CLIN CANCER RES, V18, P3592, DOI 10.1158/1078-0432.CCR-11-2972; Yano S, 2012, CANCER SCI, V103, P1189, DOI 10.1111/j.1349-7006.2012.02279.x; Yeung CL, 2013, ONCOGENE, V32, P5429, DOI 10.1038/onc.2012.590; Yoshida A, 2013, MOD PATHOL; Zou HY, 2012, MOL CANCER THER, V11, P1036, DOI 10.1158/1535-7163.MCT-11-0839	84	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132330	10.1371/journal.pone.0132330	http://dx.doi.org/10.1371/journal.pone.0132330			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147305	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600243
J	Tang, H; Tang, YP; Li, NG; Lin, H; Li, WX; Shi, QP; Zhang, W; Zhang, PX; Dong, ZX; Shen, MZ; Gu, T; Duan, JA				Tang, Hao; Tang, Yuping; Li, Nian-Guang; Lin, Hang; Li, Weixia; Shi, Qianping; Zhang, Wei; Zhang, Pengxuan; Dong, Zexi; Shen, Minzhe; Gu, Ting; Duan, Jin-Ao			Comparative Metabolomic Analysis of the Neuroprotective Effects of Scutellarin and Scutellarein against Ischemic Insult	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS-SPECTROMETRY; POWERFUL TECHNOLOGY; ALZHEIMERS-DISEASE; CERAMIDE; METABONOMICS; REPERFUSION; THERAPY; HYPOXIA; DESIGN; PLASMA	For more than thirty years, scutellarin (Scu) has been used in China to clinically treat acute cerebral infarction and paralysis. Scutellarein (Scue), the major Scu metabolite in vivo, exhibits heightened neuroprotective effects when compared to Scu. To explore the neuroprotective role of these compounds, we performed ultra-high-performance liquid chromatography-quadrupole/time-of-flight mass spectrometry (UHPLC-QTOF/MS) coupled with a pattern recognition approach to investigate metabolomic differences in a rat model of ischemia after treatment with each compound. We examined metabolites in urine, hippocampal tissue, and plasma, and we tentatively identified 23 endogenous metabolites whose levels differed significantly between sham-operated and model groups. Upon pathway analysis, we found an additional 11 metabolic pathways in urine, 14 metabolic pathways in the hippocampal tissue, and 3 metabolic pathways in plasma. These endogenous metabolites were mainly involved in sphingolipid metabolism, lysine biosynthesis, and alanine, aspartate, and glutamate metabolism. We found that metabolic changes after ischemic injury returned to near-normal levels after Scue intervention, unlike Scu treatment, further validating the heightened protective effects exerted by Scue compared to Scu. These results demonstrate that Scue is a potential drug for treatment of ischemic insult.	[Tang, Hao; Tang, Yuping; Li, Nian-Guang; Lin, Hang; Li, Weixia; Shi, Qianping; Zhang, Wei; Zhang, Pengxuan; Dong, Zexi; Shen, Minzhe; Gu, Ting; Duan, Jin-Ao] Nanjing Univ Chinese Med, Jiangsu Collaborat Innovat Ctr Chinese Med Resour, Jiangsu Key Lab High Technol Res TCM Formulae, Natl & Local Collaborat Engn Ctr Chinese Med Reso, Nanjing 210023, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine	Tang, YP (corresponding author), Nanjing Univ Chinese Med, Jiangsu Collaborat Innovat Ctr Chinese Med Resour, Jiangsu Key Lab High Technol Res TCM Formulae, Natl & Local Collaborat Engn Ctr Chinese Med Reso, Nanjing 210023, Jiangsu, Peoples R China.	yupingtang@njucm.edu.cn; linianguang@njucm.edu.cn; dja@njucm.edu.cn	Tang, Huiru/F-9849-2011	Tang, Huiru/0000-0002-7139-2756	National Natural Science Foundation of China [81001382]; Program for New Century Excellent Talents by the Ministry of Education [NCET-12- 0741]; Six Talents Project Funded by Jiangsu Province [2013-YY-010]; Jiangsu Province, Technology Innovation Venture Fund by Nanjing University of Chinese Medicine [CX201301]; Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization [ZDXMHT-1-13]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents by the Ministry of Education(Program for New Century Excellent Talents in University (NCET)); Six Talents Project Funded by Jiangsu Province; Jiangsu Province, Technology Innovation Venture Fund by Nanjing University of Chinese Medicine; Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China (81001382), the Program for New Century Excellent Talents by the Ministry of Education (NCET-12- 0741), Six Talents Project Funded by Jiangsu Province (2013-YY-010), 333 High-level Talents Training Project Funded by Jiangsu Province, Technology Innovation Venture Fund by Nanjing University of Chinese Medicine (CX201301), Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization (ZDXMHT-1-13), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Aronowski J, 1997, J CEREBR BLOOD F MET, V17, P1048, DOI 10.1097/00004647-199710000-00006; Bogaert L, 2000, BRAIN RES, V887, P266, DOI 10.1016/S0006-8993(00)02959-0; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; BUTCHER SP, 1990, STROKE, V21, P1727, DOI 10.1161/01.STR.21.12.1727; Chen JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05855; Chen Y, 2001, J CEREBR BLOOD F MET, V21, P34, DOI 10.1097/00004647-200101000-00005; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; Chung EH, 2002, LIFE SCI, V72, P609, DOI 10.1016/S0024-3205(02)02269-5; Cuzzocrea S, 2001, PHARMACOL REV, V53, P135; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Han XL, 2002, J NEUROCHEM, V82, P809, DOI 10.1046/j.1471-4159.2002.00997.x; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; Hong H, 2004, LIFE SCI, V74, P2959, DOI 10.1016/j.lfs.2003.09.074; Jung JY, 2011, STROKE, V42, P1282, DOI 10.1161/STROKEAHA.110.598789; Kara I, 2011, BRAIN INJURY, V25, P113, DOI 10.3109/02699052.2010.531688; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Lenz EM, 2007, J PROTEOME RES, V6, P443, DOI 10.1021/pr0605217; Li F, 2011, BIOCHEM PHARMACOL, V81, P1043, DOI 10.1016/j.bcp.2011.01.024; Li J, 2013, J CHROMATOGR A, V1320, P103, DOI 10.1016/j.chroma.2013.10.064; Li NG, 2013, BIOORG MED CHEM LETT, V23, P102, DOI 10.1016/j.bmcl.2012.11.002; Li NG, 2012, BIOORGAN MED CHEM, V20, P6919, DOI 10.1016/j.bmc.2012.10.015; Li WX, 2014, J CHROMATOGR A, V1346, P49, DOI 10.1016/j.chroma.2014.04.042; Li XL, 2004, PLANTA MED, V70, P1039, DOI 10.1055/s-2004-832644; Liu H, 2005, PHARMACOL RES, V51, P205, DOI 10.1016/j.phrs.2004.09.001; Liu P, 2013, MOL BIOSYST, V9, P77, DOI 10.1039/c2mb25238d; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Oda M, 2007, STROKE, V38, P2157, DOI 10.1161/STROKEAHA.106.477026; Pan ZW, 2008, PHYTOTHER RES, V22, P1428, DOI 10.1002/ptr.2364; Patti GJ, 2012, NAT CHEM BIOL, V8, P232, DOI [10.1038/nchembio.767, 10.1038/NCHEMBIO.767]; Satoi H, 2005, NEUROSCIENCE, V130, P657, DOI 10.1016/j.neuroscience.2004.08.056; Small DL, 1996, J CARDIOTHOR VASC AN, V10, P139, DOI 10.1016/S1053-0770(96)80189-3; Su SL, 2013, J PROTEOME RES, V12, P852, DOI 10.1021/pr300935x; Sun LY, 2012, J PROTEOME RES, V11, P2937, DOI 10.1021/pr3000317; Tan GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034157; Tang H, 2014, PHARMACOL BIOCHEM BE, V118, P51, DOI 10.1016/j.pbb.2014.01.003; Tao YH, 2008, PHYTOMEDICINE, V15, P92, DOI 10.1016/j.phymed.2007.06.009; Vinaixa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029052; Wang XJ, 2012, J PROTEOMICS, V75, P1411, DOI 10.1016/j.jprot.2011.11.011; Wang XJ, 2012, ANAL CHEM, V84, P428, DOI 10.1021/ac202828r; Wang XJ, 2011, J SEP SCI, V34, P3451, DOI 10.1002/jssc.201100333; Wardlaw JM, 1997, LANCET, V350, P607, DOI 10.1016/S0140-6736(97)03022-5; Yu ZF, 2000, J MOL NEUROSCI, V15, P85, DOI 10.1385/JMN:15:2:85; Zaleska MM, 2009, NEUROPHARMACOLOGY, V56, P329, DOI 10.1016/j.neuropharm.2008.10.006; Zhang GL, 2011, PHARMACOL BIOCHEM BE, V99, P42, DOI 10.1016/j.pbb.2011.03.019; Zhao YY, 2014, CHEM-BIOL INTERACT, V220, P181, DOI 10.1016/j.cbi.2014.06.029; Zhao YY, 2014, CLIN BIOCHEM, V47, P16, DOI 10.1016/j.clinbiochem.2014.07.019; Zhao YY, 2014, CHEM-BIOL INTERACT, V215, P7, DOI 10.1016/j.cbi.2014.02.014; Zhu JTT, 2009, PLANTA MED, V75, P1489, DOI 10.1055/s-0029-1185776	48	18	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131569	10.1371/journal.pone.0131569	http://dx.doi.org/10.1371/journal.pone.0131569			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147971	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600108
J	Uddin, GMN; Larsen, MH; Christensen, H; Aarestrup, FM; Phu, TM; Dalsgaard, A				Uddin, Gazi Md Noor; Larsen, Marianne Halberg; Christensen, Henrik; Aarestrup, Frank M.; Tran Minh Phu; Dalsgaard, Anders			Identification and Antimicrobial Resistance of Bacteria Isolated from Probiotic Products Used in Shrimp Culture	PLOS ONE			English	Article							BACILLUS-CEREUS; MOLECULAR CHARACTERIZATION; SUSCEPTIBILITY; SEQUENCE; ANTHRACIS; MYCOIDES; STRAINS	Probiotics are increasingly used in aquaculture to control diseases and improve feed digestion and pond water quality; however, little is known about the antimicrobial resistance properties of such probiotic bacteria and to what extent they may contribute to the development of bacterial resistance in aquaculture ponds. Concerns have been raised that the declared information on probiotic product labels are incorrect and information on bacterial composition are often missing. We therefore evaluated seven probiotics commonly used in Vietnamese shrimp culture for their bacterial species content, phenotypic antimicrobial resistance and associated transferable resistance genes. The bacterial species was established by 16S rRNA sequence analysis of 125 representative bacterial isolates. MIC testing was done for a range of antimicrobials and whole genome sequencing of six multiple antimicrobial resistant Bacillus spp. used to identify resistance genes and genetic elements associated with horizontal gene transfer. Thirteen bacterial species declared on the probiotic products could not be identified and 11 non-declared Bacillus spp. were identified. Although our culture-based isolation and identification may have missed a few bacterial species present in the tested products this would represent minor bias, but future studies may apply culture independent identification methods like pyro sequencing. Only 6/60 isolates were resistant to more than four antimicrobials and whole genome sequencing showed that they contained macrolide (ermD), tetracycline (tetL), phenicol (fexA) and trimethoprim (dfrD, dfrG and dfrK) resistance genes, but not known structures associated with horizontal gene transfer. Probiotic bacterial strains used in Vietnamese shrimp culture seem to contribute with very limited types and numbers of resistance genes compared to the naturally occurring bacterial species in aquaculture environments. Approval procedures of probiotic products must be strengthened through scientific-based efficacy trials and product labels should allow identification of individual bacterial strains and inform the farmer on specific purpose, dosage and correct application measures.	[Uddin, Gazi Md Noor; Larsen, Marianne Halberg; Christensen, Henrik; Tran Minh Phu; Dalsgaard, Anders] Univ Copenhagen, Dept Vet Dis Biol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Aarestrup, Frank M.] Tech Univ Denmark, Natl Food Inst, DK-2800 Lyngby, Denmark	University of Copenhagen; Technical University of Denmark	Dalsgaard, A (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Fac Hlth & Med Sci, Copenhagen, Denmark.	adal@sund.ku.dk		Aarestrup, Frank/0000-0002-7116-2723; Christensen, Henrik/0000-0003-4238-4658; Tran, Minh Phu/0000-0002-2521-0667; Larsen, Marianne Halberg/0000-0001-6242-6937	University of Copenhagen through a PhD stipend; European Union funded project "Sustaining Ethical Aquaculture Trade" (SEAT project) [222889]	University of Copenhagen through a PhD stipend; European Union funded project "Sustaining Ethical Aquaculture Trade" (SEAT project)	This study was financially supported by the University of Copenhagen through a PhD stipend to G.M.N. Uddin. The work presented is further part of and received support through European Union funded project "Sustaining Ethical Aquaculture Trade" (SEAT project number 222889: www.seatglobal.eu).	Aguirre-Guzman G, 2012, AFR J MICROBIOL RES, V6, P4845, DOI 10.5897/AJMR11.1038; Altschul SF, 1990, J MOL BIOL, V138, P32; Aquilina G, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2740; CLSI, 2012, PERFORMANCE STANDARD, V7th; COWAN S T, 1974, P238; D'Arienzo R, 2006, RES MICROBIOL, V157, P891, DOI 10.1016/j.resmic.2006.06.001; FAO, 2012, STAT WORLD FISH AQ, P230; FAO/WHO, 2002, FOOD AGR ORG UN WHO; Flegel TW, 2012, J INVERTEBR PATHOL, V110, P166, DOI 10.1016/j.jip.2012.03.004; Gevers D, 2003, APPL ENVIRON MICROB, V69, P1270, DOI 10.1128/AEM.69.2.1270-1275.2003; GRYCZAN T, 1984, MOL GEN GENET, V194, P349, DOI 10.1007/BF00425543; Guinebretiere MH, 2008, ENVIRON MICROBIOL, V64, P2489; Hoa NT, 2000, APPL ENVIRON MICROB, V66, P5241, DOI 10.1128/AEM.66.12.5241-5247.2000; Hong HA, 2005, FEMS MICROBIOL REV, V29, P813, DOI 10.1016/j.femsre.2004.12.001; Hummel AS, 2007, APPL ENVIRON MICROB, V73, P730, DOI 10.1128/AEM.02105-06; Huys G, 2006, RES MICROBIOL, V157, P803, DOI 10.1016/j.resmic.2006.06.006; Irianto A, 2002, J FISH DIS, V25, P333, DOI 10.1046/j.1365-2761.2002.00375.x; Kallow W, 2010, MASS SPECTROMETRY MI, P255; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Tran L, 2013, DIS AQUAT ORGAN, V105, P45, DOI 10.3354/dao02621; Luna VA, 2007, J ANTIMICROB CHEMOTH, V60, P555, DOI 10.1093/jac/dkm213; Mai Van Tai, 2012, FAO Fisheries and Aquaculture Technical Paper, V547, P91; Mannanov RN, 2001, CHEM NAT COMPD, V37, P117, DOI 10.1023/A:1012314516354; Martinez JL, 2015, NAT REV MICROBIOL, V13, P116, DOI 10.1038/nrmicro3399; Mathur S, 2005, INT J FOOD MICROBIOL, V14, P123; Mazza P, 1992, Boll Chim Farm, V131, P401; Meier-Kolthoff JP, 2013, ARCH MICROBIOL, V195, P413, DOI 10.1007/s00203-013-0888-4; Moriarty DJW, 1997, AQUACULTURE, V151, P333, DOI 10.1016/S0044-8486(96)01487-1; Nick GHT, 2011, TRENDS ECOL ENVIRON, V26, P278; Oh MH, 2012, INT J FOOD MICROBIOL, V152, P1, DOI 10.1016/j.ijfoodmicro.2011.09.018; Padmavathi P., 2012, African Journal of Microbiology Research, V6, P7471; Park SH, 2007, J MICROBIOL BIOTECHN, V17, P1177; Phu TM, 2013, EUROPEAN AQUACULTURE, P9; Rico A, 2013, AQUACULTURE, V412, P231, DOI 10.1016/j.aquaculture.2013.07.028; Sandra A., 2012, International Food Research Journal, V19, P829; Senesi S, 2001, APPL ENVIRON MICROB, V67, P834, DOI 10.1128/AEM.67.2.834-839.2001; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vietnam Association of Seafood Exporters and Producers, 2013, WEEKLY NEWS 2011 201; Wang YB, 2007, AQUACULTURE, V269, P259, DOI 10.1016/j.aquaculture.2007.05.035; Wannaprasat W, 2009, SE ASIAN J TROP MED, V40, P1103; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yamada S, 1999, APPL ENVIRON MICROB, V65, P1483; Zankari E, 2013, J ANTIMICROB CHEMOTH, V68, P771, DOI 10.1093/jac/dks496	44	34	36	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132338	10.1371/journal.pone.0132338	http://dx.doi.org/10.1371/journal.pone.0132338			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147573	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600246
J	Dietrich, F; Martins, JP; Kaiser, S; Silva, RBM; Rockenbach, L; Edelweiss, MIA; Ortega, GG; Morrone, FB; Campos, MM; Battastini, AMO				Dietrich, Fabrcia; Martins, Jeronimo Pietrobon; Kaiser, Samuel; Madeira Silva, Rodrigo Braccini; Rockenbach, Liliana; Albano Edelweiss, Maria Isabel; Ortega, George Gonzalez; Morrone, Fernanda Bueno; Campos, Maria Martha; Oliveira Battastini, Ana Maria			The Quinovic Acid Glycosides Purified Fraction from Uncaria tomentosa Protects against Hemorrhagic Cystitis Induced by Cyclophosphamide in Mice	PLOS ONE			English	Article							CATS CLAW; ANTIINFLAMMATORY ACTIVITY; URINARY-BLADDER; RECEPTORS; EXPRESSION; MODEL; EXTRACTS	Uncaria tomentosa is widely used in folk medicine for the treatment of numerous diseases, such as urinary tract disease. Hemorrhagic cystitis (HE) is an inflammatory condition of the bladder associated with the use of anticancer drugs such as cyclophosphamide (CYP). Sodium 2-mercaptoethanesulfonate (Mesna) has been used to prevent the occurrence of HE, although this compound is not effective in established lesions. It has been demonstrated that the purinergic system is involved in several pathophysiological events. Among purinergic receptors, P2X7 deserves attention because it is involved in HE induced by CYP and, therefore, can be considered a therapeutic target. The objective of this study was to investigate the potential therapeutic effect of the quinovic acid glycosides purified fraction (QAPF) from U. tomentosa in the mouse model of CYP-induced HE. Pretreatment with QAPF not only had a protective effect on HE-induced urothelial damage (edema, hemorrhage and bladder wet weight) but was also able to control visceral pain, decrease IL-1 beta levels and down-regulates P2X7 receptors, most likely by inhibit the neutrophils migration to the bladder. This research clearly demonstrates the promising anti-inflammatory properties of QAPF, supporting its use as complementary therapy. QAPF represents a promising therapeutic option for this pathological condition.	[Dietrich, Fabrcia; Rockenbach, Liliana; Oliveira Battastini, Ana Maria] Univ Fed Rio Grande do Sul, ICBS, Programa Posgrad Ciencias Biol Bioquim, Porto Alegre, RS, Brazil; [Oliveira Battastini, Ana Maria] Univ Fed Rio Grande do Sul, ICBS, Dept Bioquim, Porto Alegre, RS, Brazil; [Martins, Jeronimo Pietrobon; Madeira Silva, Rodrigo Braccini; Morrone, Fernanda Bueno] Pontificia Univ Catolica Rio Grande do Sul, Fac Farm, Lab Farmacol Aplicada, Porto Alegre, RS, Brazil; [Kaiser, Samuel; Ortega, George Gonzalez] Univ Fed Rio Grande do Sul, Fac Farm, Programa Posgrad Ciencias Farmaceut, Porto Alegre, RS, Brazil; [Madeira Silva, Rodrigo Braccini; Morrone, Fernanda Bueno; Campos, Maria Martha] Pontificia Univ Catolica Rio Grande do Sul, Inst Toxicol & Farmacol, Porto Alegre, RS, Brazil; [Albano Edelweiss, Maria Isabel] Univ Fed Rio Grande do Sul, Fac Med, Porto Alegre, RS, Brazil; [Campos, Maria Martha] Pontificia Univ Catolica Rio Grande do Sul, Fac Odontol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Battastini, AMO (corresponding author), Univ Fed Rio Grande do Sul, ICBS, Programa Posgrad Ciencias Biol Bioquim, Porto Alegre, RS, Brazil.	abattastini@gmail.com	Battastini, Ana M/E-2809-2012; Morrone, Fernanda/AAH-6044-2020; Campos, Maria Martha M/J-8829-2015; Dietrich, Fabrícia/F-8658-2019; Kaiser, Samuel/L-7833-2019; Silva, Rodrigo BM/O-7441-2017; Morrone, Fernanda B/K-7703-2015	Battastini, Ana M/0000-0001-6068-3278; Morrone, Fernanda/0000-0002-2709-2801; Campos, Maria Martha M/0000-0002-1153-3633; Silva, Rodrigo BM/0000-0001-6284-7387; Morrone, Fernanda B/0000-0002-2709-2801; Dietrich, Fabricia/0000-0002-6458-2359; Campos, Maria/0000-0001-7738-9892	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); FINEP (Financiadora de Estudos e Projetos) research grant "Implantacao, Modernizacao e Qualificacao de Estrutura de Pesquisa da PUCRS" (PUCRSINFRA) [01.11.0014-00]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FINEP (Financiadora de Estudos e Projetos) research grant "Implantacao, Modernizacao e Qualificacao de Estrutura de Pesquisa da PUCRS" (PUCRSINFRA)	This study was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes), in addition to a FINEP (Financiadora de Estudos e Projetos) research grant "Implantacao, Modernizacao e Qualificacao de Estrutura de Pesquisa da PUCRS" (PUCRSINFRA) #01.11.0014-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar JL, 2002, J ETHNOPHARMACOL, V81, P271, DOI 10.1016/S0378-8741(02)00093-4; Allen-Hall L, 2007, J ETHNOPHARMACOL, V109, P312, DOI 10.1016/j.jep.2006.07.039; Allen-Hall L, 2010, J ETHNOPHARMACOL, V127, P685, DOI 10.1016/j.jep.2009.12.004; AQUINO R, 1991, J NAT PROD, V54, P453, DOI 10.1021/np50074a016; Batista CKLP, 2006, BRAZ J MED BIOL RES, V39, P1475; Dantas ACB, 2010, ACTA CIR BRAS, V25, P43, DOI 10.1590/S0102-86502010000100011; Bhatia K, 2008, FOOD CHEM TOXICOL, V46, P3368, DOI 10.1016/j.fct.2008.08.011; Burnstock G, 2004, CURR TOP MED CHEM, V4, P793, DOI 10.2174/1568026043451014; Cisneros FJ, 2005, J ETHNOPHARMACOL, V96, P355, DOI 10.1016/j.jep.2004.06.039; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Dietrich F, 2014, FOOD CHEM TOXICOL, V67, P222, DOI 10.1016/j.fct.2014.02.037; Fennell D, 2004, PREV MED, V39, P932, DOI 10.1016/j.ypmed.2004.03.031; GRAY KJ, 1986, J UROLOGY, V136, P497, DOI 10.1016/S0022-5347(17)44929-9; Heitzman ME, 2005, PHYTOCHEMISTRY, V66, P5, DOI 10.1016/j.phytochem.2004.10.022; Keplinger K, 1999, J ETHNOPHARMACOL, V64, P23, DOI 10.1016/S0378-8741(98)00096-8; Kiuchi H, 2009, J UROLOGY, V181, P2339, DOI 10.1016/j.juro.2009.01.015; Lee HY, 2000, J UROLOGY, V163, P2002, DOI 10.1016/S0022-5347(05)67618-5; Malykhina Anna P., 2012, BMC Physiology, V12, P15, DOI 10.1186/1472-6793-12-15; Manikandan R, 2010, INDIAN J UROL, V26, P159, DOI 10.4103/0970-1591.65380; Martins JP, 2012, BRIT J PHARMACOL, V165, P183, DOI 10.1111/j.1476-5381.2011.01535.x; Morais MM, 1999, BRAZ J MED BIOL RES, V32, P1211, DOI 10.1590/S0100-879X1999001000006; Negoro H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106269; O'Reilly BA, 2001, BJU INT, V87, P617, DOI 10.1046/j.1464-410x.2001.02179.x; Passos GF, 2004, J IMMUNOL, V172, P1839, DOI 10.4049/jimmunol.172.3.1839; Pavei C, 2012, J PHARMACEUT BIOMED, V62, P250, DOI 10.1016/j.jpba.2011.12.031; Phelps PT, 2006, EUR J PHARMACOL, V536, P28, DOI 10.1016/j.ejphar.2006.02.046; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rosenbaum CC, 2010, ALTERN THER HEALTH M, V16, P32; Sandoval M, 2002, PHYTOMEDICINE, V9, P325, DOI 10.1078/0944-7113-00117; Sandoval-Chacon M, 1998, ALIMENT PHARM THER, V12, P1279, DOI 10.1046/j.1365-2036.1998.00424.x; Santos AA, 2010, N-S ARCH PHARMACOL, V382, P399, DOI 10.1007/s00210-010-0555-0; Sheng YZ, 2000, J ETHNOPHARMACOL, V69, P115, DOI 10.1016/S0378-8741(99)00070-7; Traxer O, 2001, PROG UROL, V11, P591; Vial C, 2000, BRIT J PHARMACOL, V131, P1489, DOI 10.1038/sj.bjp.0703720; Wantuch C, 2007, NEUROSCI LETT, V421, P250, DOI 10.1016/j.neulet.2007.05.043	35	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131882	10.1371/journal.pone.0131882	http://dx.doi.org/10.1371/journal.pone.0131882			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154141	gold, Green Published, Green Submitted			2022-12-27	WOS:000358159700082
J	Simons, M; Brug, J; Chinapaw, MJM; de Boer, M; Seidell, J; de Vet, E				Simons, Monique; Brug, Johannes; Chinapaw, Mai J. M.; de Boer, Michiel; Seidell, Jaap; de Vet, Emely			Replacing Non-Active Video Gaming by Active Video Gaming to Prevent Excessive Weight Gain in Adolescents	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; HEALTH INDICATORS; CHILDHOOD OBESITY; GAMES; CHILDREN; OVERWEIGHT; PROMOTION; VIEWS; TIME	Objective The aim of the current study was to evaluate the effects of and adherence to an active video game promotion intervention on anthropometrics, sedentary screen time and consumption of sugar-sweetened beverages and snacks among non-active video gaming adolescents who primarily were of healthy weight. Methods We assigned 270 gaming (i.e. >= 2 hours/week non-active video game time) adolescents randomly to an intervention group (n = 140) (receiving active video games and encouragement to play) or a waiting-list control group (n = 130). BMI-SDS (SDS = adjusted for mean standard deviation score), waist circumference-SDS, hip circumference and sum of skinfolds were measured at baseline, at four and ten months follow-up (primary outcomes). Sedentary screen time, physical activity, consumption of sugar-sweetened beverages and snacks, and process measures (not at baseline) were assessed with self-reports at baseline, one, four and ten months follow-up. Multi-level-intention to treat-regression analyses were conducted. Results The control group decreased significantly more than the intervention group on BMI-SDS (beta = 0.074, 95% CI: 0.008; 0.14), and sum of skinfolds (beta = 3.22, 95% CI: 0.27; 6.17) (overall effects). The intervention group had a significantly higher decrease in self-reported nonactive video game time (beta = -1.76, 95% CI: -3.20;-0.32) and total sedentary screen time (Exp (beta = 0.81, 95% CI: 0.74; 0.88) than the control group (overall effects). The process evaluation showed that 14% of the adolescents played the Move video games every week >= 1 hour/week during the whole intervention period. Conclusions The active video game intervention did not result in lower values on anthropometrics in a group of 'excessive' non-active video gamers (mean similar to 14 hours/week) who primarily were of healthy weight compared to a control group throughout a ten-month-period. Even some effects in the unexpected direction were found, with the control group showing lower BMI-SDS and skin folds than the intervention group. The intervention did result in less selfreported sedentary screen time, although these results are likely biased by social desirability.	[Simons, Monique; de Boer, Michiel; Seidell, Jaap] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Hlth Sci, Amsterdam, Netherlands; [Simons, Monique; de Boer, Michiel; Seidell, Jaap] Vrije Univ Amsterdam, Fac Earth & Life Sci, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Simons, Monique; Chinapaw, Mai J. M.] Vrije Univ Amsterdam, Med Ctr, TNO VU VUmc, Res Ctr Phys Act Work & Hlth,Body Work, Amsterdam, Netherlands; [Simons, Monique] TNO, Expertise Ctr Life Style, Leiden, Netherlands; [Brug, Johannes] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Brug, Johannes; Chinapaw, Mai J. M.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Chinapaw, Mai J. M.] Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [de Vet, Emely] Wageningen Univ, Ctr Integrat Dev, Subdept Commun, Chairgroup Strateg Commun, NL-6700 AP Wageningen, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Netherlands Organization Applied Science Research; Vrije Universiteit Amsterdam; Netherlands Organization Applied Science Research; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Wageningen University & Research	Simons, M (corresponding author), Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Hlth Sci, Amsterdam, Netherlands.	m.simons@uu.nl	Brug, Johannes/A-8242-2018; Paw, Mai Chin A/N-1665-2019; De Vet, Emely/B-4896-2014; seidell, jacob/AAF-5362-2019	Brug, Johannes/0000-0002-1904-7349; Paw, Mai Chin A/0000-0001-6259-2441; De Vet, Emely/0000-0002-4452-2367; seidell, jacob/0000-0002-9262-9062	Netherlands Organization for Health Research and Development [120520012]	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	This work was supported by a grant from The Netherlands Organization for Health Research and Development (http://www.zonmw.nl/nl/)(grant number: 120520012). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sony Benelux provided the PlayStation Move packages and video games for the study participants, but did not have any role in the design, data collection, and analysis, decision to publish or preparation of the manuscript.	Alberga AS, 2012, PEDIATR OBES, V7, P261, DOI 10.1111/j.2047-6310.2011.00046.x; [Anonymous], 1994, PHYS ACTIVITY FITNES; Baranowski T, 2012, CHILD OBES, V8, P34, DOI 10.1089/chi.2011.0103; Baranowski T, 2012, PEDIATRICS, V129, pE636, DOI 10.1542/peds.2011-2050; Barnett A, 2011, J PHYS ACT HEALTH, V8, P724, DOI 10.1123/jpah.8.5.724; Brug J, 2012, PEDIATR OBES, V7, P399, DOI 10.1111/j.2047-6310.2012.00067.x; Brug J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034742; Chinapaw MJM, 2011, OBES REV, V12, pE621, DOI 10.1111/j.1467-789X.2011.00865.x; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cummings HM, 2007, ARCH PEDIAT ADOL MED, V161, P684, DOI 10.1001/archpedi.161.7.684; Daley AJ, 2009, PEDIATRICS, V124, P763, DOI 10.1542/peds.2008-2357; De Vet E, 2014, HEALTH PROMOT INT, V29, P235, DOI 10.1093/heapro/das064; Falbe J, 2013, PEDIATRICS, V132, pE1497, DOI 10.1542/peds.2013-0887; Gao Z, 2014, OBES REV, V15, P676, DOI 10.1111/obr.12164; Guy S, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/179124; Hildebrandt VH, 2010, TRENDRAPPORT BEWEGAN; LeBlanc AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065351; Livingstone M B, 2001, Public Health Nutr, V4, P109; Lyons EJ, 2012, AM J CLIN NUTR, V96, P234, DOI 10.3945/ajcn.111.028423; Maddison R, 2011, AM J CLIN NUTR, V94, P156, DOI 10.3945/ajcn.110.009142; Mellecker RR, 2010, APPETITE, V55, P343, DOI 10.1016/j.appet.2010.07.008; Must A, 2006, INT J OBESITY, V30, P590, DOI 10.1038/sj.ijo.0803300; NHS-NRG, 2007, PREV GEW RICHT GEW N; Nikken P, 2003, COMPUTERSPELLEN GEZI; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Paez S, 2009, PEDIATR PHYS THER, V21, P245, DOI 10.1097/PEP.0b013e3181b13a82; Paw MJMCA, 2008, J SCI MED SPORT, V11, P163, DOI 10.1016/j.jsams.2007.06.001; Peng W, 2013, HEALTH EDUC BEHAV, V40, P171, DOI 10.1177/1090198112444956; Philippaerts RM, 2006, INT J SPORTS MED, V27, P131, DOI 10.1055/s-2005-837619; Przybylski AK, 2014, PEDIATRICS, V134, pE716, DOI 10.1542/peds.2013-4021; Riddoch CJ, 2004, MED SCI SPORT EXER, V36, P86, DOI 10.1249/01.MSS.0000106174.43932.92; Rideout V. J., 2010, MEDIA LIVES 8 18 YEA; Schonbeck Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027608; Simons M, 2014, J SCI MED SPORT, V17, P597, DOI 10.1016/j.jsams.2013.10.250; Simons M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-275; Simons M, 2012, GAMES HEALTH J, V1, P211, DOI 10.1089/g4h.2011.0032; Simons M, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-118; Staiano AE, 2013, OBESITY, V21, P598, DOI 10.1002/oby.20282; Stettler N, 2004, OBES RES, V12, P896, DOI 10.1038/oby.2004.109; Straker LM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002629; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; Trost SG, 2014, JAMA PEDIATR, V168, P407, DOI 10.1001/jamapediatrics.2013.3436; van Assema P, 2001, J HUM NUTR DIET, V14, P377, DOI 10.1046/j.1365-277X.2001.00310.x; van der Horst K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-142; van Mechelen W, 2000, MED SCI SPORT EXER, V32, P1610	45	21	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0126023	10.1371/journal.pone.0126023	http://dx.doi.org/10.1371/journal.pone.0126023			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26153884	Green Published, gold, Green Submitted			2022-12-27	WOS:000358159700002
J	Shi, YF; Han, Y; Su, YT; Yang, JH; Yu, YQ				Shi, Yu-Feng; Han, Yong; Su, Yun-Ting; Yang, Jun-Hua; Yu, Yan-Qin			Silencing of Cholinergic Basal Forebrain Neurons Using Archaerhodopsin Prolongs Slow-Wave Sleep in Mice	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; ACETYLCHOLINE-RELEASE; ALZHEIMERS-DISEASE; PARADOXICAL SLEEP; WAKE TRANSITIONS; REM-SLEEP; WAKING; ACTIVATION; CONNECTIONS; CYCLE	The basal forebrain (BF) plays a crucial role in cortical activation. Our previous study showed that activation of cholinergic BF neurons alone is sufficient to suppress slow-wave sleep ( SWS) and promote wakefulness and rapid-eye-movement ( REM) sleep. However, the exact role of silencing cholinergic BF neurons in the sleep-wake cycle remains unclear. We inhibitied the cholinergic BF neurons genetically targeted with archaerhodopsin ( Arch) with yellow light to clarify the role of cholinergic BF neurons in the sleep-wake cycle. Bilateral inactivation of cholinergic BF neurons genetically targeted with archaerhodopsin prolonged SWS and decreased the probability of awakening from SWS in mice. However, silencing these neurons changed neither the duration of wakefulness or REM sleep, nor the probability of transitions to other sleep-wake episodes from wakefulness or REM sleep. Furthermore, silencing these neurons for 6 h within the inactive or active period increased the duration of SWS at the expense of the duration of wakefulness, as well as increasing the number of prolonged SWS episodes (120-240 s). The lost wakefulness was compensated by a delayed increase of wakefulness, so the total duration of SWS and wakefulness during 24 h was kept stable. Our results indicate that the main effect of these neurons is to terminate SWS, whereas wakefulness or REM sleep may be determined by co-operation of the cholinergic BF neurons with other arousal-sleep control systems.	[Shi, Yu-Feng; Han, Yong; Su, Yun-Ting; Yang, Jun-Hua; Yu, Yan-Qin] Zhejiang Univ, Sch Med, Key Lab Neurobiol,Minist Hlth China, Key Lab Med Neurobiol,Dept Neurobiol & Physiol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Yu, YQ (corresponding author), Zhejiang Univ, Sch Med, Key Lab Neurobiol,Minist Hlth China, Key Lab Med Neurobiol,Dept Neurobiol & Physiol, Hangzhou 310003, Zhejiang, Peoples R China.	yanqinyu@zju.edu.cn	Yang, Junhua/ADR-6060-2022	Yang, Junhua/0000-0003-4117-7569				Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Anaclet C, 2014, NAT NEUROSCI, V17, P1217, DOI 10.1038/nn.3789; BAGHDOYAN HA, 1993, J NEUROSCI, V13, P229; Berntson GG, 2002, EUR J NEUROSCI, V16, P2453, DOI 10.1046/j.1460-9568.2002.02310.x; Blanco-Centurion CA, 2006, EUR J NEUROSCI, V24, P2084, DOI 10.1111/j.1460-9568.2006.05074.x; Borbely A A, 1982, Hum Neurobiol, V1, P195; Boucetta S, 2009, J NEUROSCI, V29, P4664, DOI 10.1523/JNEUROSCI.5502-08.2009; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Cape EG, 2000, J NEUROSCI, V20, P8452, DOI 10.1523/JNEUROSCI.20-22-08452.2000; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; Carter ME, 2009, J NEUROSCI, V29, P10939, DOI 10.1523/JNEUROSCI.1205-09.2009; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Eggermann E, 2001, NEUROSCIENCE, V108, P177, DOI 10.1016/S0306-4522(01)00512-7; Fuller P, 2011, J COMP NEUROL, V519, P933, DOI 10.1002/cne.22559; Gerashchenko D, 2001, BRAIN RES, V913, P106, DOI 10.1016/S0006-8993(01)02792-5; GROVE EA, 1988, J COMP NEUROL, V277, P347, DOI 10.1002/cne.902770303; Han Y, 2014, CURR BIOL, V24, P693, DOI 10.1016/j.cub.2014.02.011; Hassani OK, 2009, J NEUROSCI, V29, P11828, DOI 10.1523/JNEUROSCI.1259-09.2009; Jones BE, 2008, ANN NY ACAD SCI, V1129, P26, DOI 10.1196/annals.1417.026; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; Kaur S, 2008, J NEUROSCI, V28, P491, DOI 10.1523/JNEUROSCI.1585-07.2008; Lazarus M, 2013, CURR OPIN NEUROBIOL, V23, P780, DOI 10.1016/j.conb.2013.02.001; Lee MG, 2005, J NEUROSCI, V25, P4365, DOI 10.1523/JNEUROSCI.0178-05.2005; LEHMANN J, 1980, NEUROSCIENCE, V5, P1161, DOI 10.1016/0306-4522(80)90195-5; LEWIS PR, 1967, BRAIN, V90, P521, DOI 10.1093/brain/90.3.521; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; MARROSU F, 1995, BRAIN RES, V671, P329, DOI 10.1016/0006-8993(94)01399-3; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; MCGINTY DJ, 1976, BRAIN RES, V101, P569, DOI 10.1016/0006-8993(76)90480-7; NISHINO S, 1995, J NEUROSCI, V15, P4806; Parmentier R, 2002, J NEUROSCI, V22, P7695; Platt B, 2011, BEHAV BRAIN RES, V221, P499, DOI 10.1016/j.bbr.2011.01.017; RYE DB, 1984, NEUROSCIENCE, V13, P627, DOI 10.1016/0306-4522(84)90083-6; SHAMMAHLAGNADO SJ, 1992, NEUROSCIENCE, V50, P403, DOI 10.1016/0306-4522(92)90433-3; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Steriade M, 2004, PROG BRAIN RES, V145, P179, DOI 10.1016/S0079-6123(03)45013-9; Vazquez J, 2001, AM J PHYSIOL-REG I, V280, pR598, DOI 10.1152/ajpregu.2001.280.2.R598; Wisor JP, 2005, NEUROSCIENCE, V131, P375, DOI 10.1016/j.neuroscience.2004.11.018; Wong CJH, 1997, J COMP NEUROL, V389, P49; Wu M, 2000, J NEUROSCI, V20, P3900, DOI 10.1523/JNEUROSCI.20-10-03900.2000; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	41	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0130130	10.1371/journal.pone.0130130	http://dx.doi.org/10.1371/journal.pone.0130130			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151909	gold, Green Submitted, Green Published			2022-12-27	WOS:000358158900006
J	Del Pozo, S; Lindenbergh, R; Rodriguez-Gonzalvez, P; Blom, JK; Gonzalez-Aguilera, D				Del Pozo, Susana; Lindenbergh, Roderik; Rodriguez-Gonzalvez, Pablo; Blom, Jan Kees; Gonzalez-Aguilera, Diego			Discrimination between Sedimentary Rocks from Close-Range Visible and Very-Near-Infrared Images	PLOS ONE			English	Article							TERRESTRIAL LIDAR; FRANCE; NOIRES; FIELD	Variation in the mineral composition of rocks results in a change of their spectral response capable of being studied by imaging spectroscopy. This paper proposes the use of a low-cost handy sensor, a calibrated visible-very near infrared (VIS-VNIR) multispectral camera for the recognition of different geological formations. The spectral data was recorded by a Tetracam Mini-MCA-6 camera mounted on a field-based platform covering six bands in the spectral range of 0.530-0.801 mu m. Twelve sedimentary formations were selected in the Rhone-Alpes region (France) to analyse the discrimination potential of this camera for rock types and close-range mapping applications. After proper corrections and data processing, a supervised classification of the multispectral data was performed trying to distinguish four classes: limestones, marlstones, vegetation and shadows. After a maximum-likelihood classification, results confirmed that this camera can be efficiently exploited to map limestone-marlstone alternations in geological formations with this mineral composition.	[Del Pozo, Susana; Rodriguez-Gonzalvez, Pablo; Gonzalez-Aguilera, Diego] Univ Salamanca, Polytech Sch Avila, Dept Cartog & Land Engn, Avila, Spain; [Lindenbergh, Roderik; Blom, Jan Kees] Delft Univ Technol, Dept Geosci & Remote Sensing, Delft, Netherlands	University of Salamanca; Delft University of Technology	Gonzalez-Aguilera, D (corresponding author), Univ Salamanca, Polytech Sch Avila, Dept Cartog & Land Engn, Avila, Spain.	daguilera@usal.es	Del Pozo Aguilera, Susana/L-2011-2017; Rodríguez-Gonzálvez, Pablo/H-8820-2015	Del Pozo Aguilera, Susana/0000-0003-4869-3742; Rodríguez-Gonzálvez, Pablo/0000-0002-2657-813X; Blom, Jan Kees/0000-0002-4573-8813; Gonzalez-Aguilera, Diego/0000-0002-8949-4216; Lindenbergh, Roderik/0000-0001-8655-5266				Antoine P, 1995, ENG GEOL, V40, P223, DOI 10.1016/0013-7952(95)00053-4; Bellian JA, 2005, J SEDIMENT RES, V75, P166, DOI 10.2110/jsr.2005.013; BHATIA MR, 1986, CONTRIB MINERAL PETR, V92, P181, DOI 10.1007/BF00375292; Boulila S, 2010, BASIN RES, V22, P717, DOI 10.1111/j.1365-2117.2009.00429.x; Buckley SJ, 2013, COMPUT GEOSCI-UK, V54, P249, DOI 10.1016/j.cageo.2013.01.018; Clark R.N., 1999, REMOTE SENSING EARTH, P3, DOI DOI 10.1111/J.1945-5100.2004.TB00079.X; Davis SM, 1978, REMOTE SENSING QUANT, P1; Del Pozo S, 2014, REMOTE SENS-BASEL, V6, P1918, DOI 10.3390/rs6031918; Dematte JAM, 1999, SOIL SCI SOC AM J, V63, P327, DOI 10.2136/sssaj1999.03615995006300020010x; Fardin N, 2004, INT J ROCK MECH MIN, V41, P329, DOI 10.1016/S1365-1609(03)00111-4; Franceschi M, 2009, ISPRS J PHOTOGRAMM, V64, P522, DOI 10.1016/j.isprsjprs.2009.03.003; Haneberg W., 2006, P 57 ANN HIGHW GEOL; Johnsson M.J., 1993, PROCESSES CONTROLLIN, V284, P1, DOI DOI 10.1130/SPE284-P1; Kobayashi C, 2010, ANDEAN GEOL, V37, P433, DOI 10.5027/andgeoV37n2-a09; Kurz TH, 2013, INT J REMOTE SENS, V34, P1798, DOI 10.1080/01431161.2012.727039; Kurz TH, 2012, SEDIMENTOLOGY, V59, P623, DOI 10.1111/j.1365-3091.2011.01269.x; Kurz TH, 2011, PHOTOGRAMM REC, V26, P212, DOI 10.1111/j.1477-9730.2011.00632.x; Lagacherie P, 2008, REMOTE SENS ENVIRON, V112, P825, DOI 10.1016/j.rse.2007.06.014; LeBissonnais Y, 1996, EUR J SOIL SCI, V47, P425, DOI 10.1111/j.1365-2389.1996.tb01843.x; Lillesand T.M., 2015, REMOTE SENSING IMAGE, V7th; Mccaffrey KJW, 2005, J GEOL SOC LONDON, V162, P927, DOI 10.1144/0016-764905-017; Moran MS, 2001, REMOTE SENS ENVIRON, V78, P71, DOI 10.1016/S0034-4257(01)00250-4; Olkkonen M, 2011, I-PERCEPTION, V2, P1014, DOI 10.1068/i0480; Phan TSH, 1993, PROPRIETES PHYS CARA; Rameil N, 2008, SEDIMENT GEOL, V212, P70, DOI 10.1016/j.sedgeo.2008.10.004; Reichelt K, 2005, LATE APTIAN ALBIAN V; Richards J.A., 2006, REMOTE SENSING DIGIT; ROSER BP, 1986, J GEOL, V94, P635, DOI 10.1086/629071; Rossel RAV, 2009, GEODERMA, V150, P253, DOI 10.1016/j.geoderma.2009.01.025; Smith GM, 1999, INT J REMOTE SENS, V20, P2653, DOI 10.1080/014311699211994; Tonon F., 2006, LASER PHOTOGRAMMETRI; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; van der Meer FD, 2012, INT J APPL EARTH OBS, V14, P112, DOI 10.1016/j.jag.2011.08.002; Xu X., 2000, LEAD EDGE, V19, P197, DOI [10.1190/1.1438576, DOI 10.1190/1.1438576]	34	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132471	10.1371/journal.pone.0132471	http://dx.doi.org/10.1371/journal.pone.0132471			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147309	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600279
J	Flynn, SP; Barrier, S; Scott, RC; Lenck-Santini, PP; Holmes, GL				Flynn, Sean P.; Barrier, Sylvain; Scott, Rod C.; Lenck-Santini, Pierre-Pascal; Holmes, Gregory L.			Status Epilepticus Induced Spontaneous Dentate Gyrus Spikes: In Vivo Current Source Density Analysis	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; MEDIAL ENTORHINAL CORTEX; CA3 NETWORK ACTIVITY; TREATED RATS; HIPPOCAMPAL EPILEPTOGENESIS; SYNAPTIC REORGANIZATION; ELECTRICAL STIMULATION; REDUCED INHIBITION; INTERICTAL SPIKES; SELECTIVE LOSS	The dentate gyrus is considered to function as an inhibitory gate limiting excitatory input to the hippocampus. Following status epilepticus (SE), this gating function is reduced and granule cells become hyper-excitable. Dentate spikes (DS) are large amplitude potentials observed in the dentate gyrus (DG) of normal animals. DS are associated with membrane depolarization of granule cells, increased activity of hilar interneurons and suppression of CA3 and CA1 pyramidal cell firing. Therefore, DS could act as an anti-excitatory mechanism. Because of the altered gating function of the dentate gyrus following SE, we sought to investigate how DS are affected following pilocarpine-induced SE. Two weeks following lithium-pilocarpine SE induction, hippocampal EEG was recorded in male Sprague-Dawley rats with 16-channel silicon probes under urethane anesthesia. Probes were placed dorsoventrally to encompass either CA1-CA3 or CA1-DG layers. Large amplitude spikes were detected from EEG recordings and subject to current source density analysis. Probe placement was verified histologically to evaluate the anatomical localization of current sinks and the origin of DS. In 9 of 11 pilocarpine-treated animals and two controls, DS were confirmed with large current sinks in the molecular layer of the dentate gyrus. DS frequency was significantly increased in pilocarpine-treated animals compared to controls. Additionally, in pilo-carpine-treated animals, DS displayed current sinks in the outer, middle and/ or inner molecular layers. However, there was no difference in the frequency of events when comparing between layers. This suggests that following SE, DS can be generated by input from medial and lateral entorhinal cortex, or within the dentate gyrus. DS were associated with an increase in multiunit activity in the granule cell layer, but no change in CA1. These results suggest that following SE there is an increase in DS activity, potentially arising from hyperexcitability along the hippocampal-entorhinal pathway or within the dentate gyrus itself.	[Flynn, Sean P.; Barrier, Sylvain; Scott, Rod C.; Lenck-Santini, Pierre-Pascal; Holmes, Gregory L.] Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA; [Scott, Rod C.] UCL, Inst Child Hlth, London, England	University of Vermont; University of London; University College London	Flynn, SP (corresponding author), Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA.	sean.p.flynn@uvm.edu	lenck-santini, pierre-pascal/N-3662-2016	lenck-santini, pierre-pascal/0000-0001-9925-9220; barriere, sylvain/0000-0002-3508-641X; Scott, Rod/0000-0002-8944-928X	National Institute of Health [NS074450, NS073083, NS075249]; Emmory R. Shapses Research Fund; Michael J. Pietroniro Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075249, R01NS074450, R01NS073083] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emmory R. Shapses Research Fund; Michael J. Pietroniro Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institute of Health grants NS074450 (GLH), NS073083 (GLH), NS075249 (RCS), the Emmory R. Shapses Research Fund and Michael J. Pietroniro Research Fund to GLH.	Bains JS, 1999, NAT NEUROSCI, V2, P720, DOI 10.1038/11184; Barbarosie M, 1997, J NEUROSCI, V17, P9308; Boido D, 2014, CEREB CORTEX, V24, P163, DOI 10.1093/cercor/bhs298; Bragin A, 1997, NEUROSCIENCE, V76, P1187, DOI 10.1016/S0306-4522(96)00446-0; BRAGIN A, 1995, J NEUROPHYSIOL, V73, P1691, DOI 10.1152/jn.1995.73.4.1691; Buckmaster PS, 1997, J NEUROPHYSIOL, V77, P2685, DOI 10.1152/jn.1997.77.5.2685; Bumanglag AV, 2008, J COMP NEUROL, V510, P561, DOI 10.1002/cne.21801; Canning KJ, 1997, HIPPOCAMPUS, V7, P643, DOI 10.1002/(SICI)1098-1063(1997)7:6<643::AID-HIPO6>3.0.CO;2-F; Cavazos JE, 2003, J COMP NEUROL, V458, P272, DOI 10.1002/cne.10581; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Coulter DA, 2007, PROG BRAIN RES, V163, P235, DOI 10.1016/S0079-6123(07)63014-3; de Curtis M, 2001, PROG NEUROBIOL, V63, P541, DOI 10.1016/S0301-0082(00)00026-5; DU F, 1995, J NEUROSCI, V15, P6301; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; Harvey BD, 2005, J COMP NEUROL, V488, P442, DOI 10.1002/cne.20594; HEINEMANN U, 1992, EPILEPSY RES, P273; Holmes GL, 1999, J COMP NEUROL, V404, P537, DOI 10.1002/(SICI)1096-9861(19990222)404:4<537::AID-CNE9>3.0.CO;2-#; HOUSER CR, 1992, EPILEPSY RES, P223; Hsu D, 2007, PROG BRAIN RES, V163, P601, DOI 10.1016/S0079-6123(07)63032-5; Isaev D, 2015, NEUROBIOL DIS, V78, P68, DOI 10.1016/j.nbd.2015.03.026; Kienzler F, 2009, J COMP NEUROL, V515, P181, DOI 10.1002/cne.22059; Kobayashi M, 2003, J NEUROSCI, V23, P8471; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Kumar SS, 2006, J NEUROSCI, V26, P4613, DOI 10.1523/JNEUROSCI.0064-06.2006; Lenck-Santini PP, 2008, J NEUROSCI, V28, P5053, DOI 10.1523/JNEUROSCI.5024-07.2008; Nadler JV, 2003, NEUROCHEM RES, V28, P1649, DOI 10.1023/A:1026004904199; Nagao T, 1996, NEUROSCIENCE, V72, P399, DOI 10.1016/0306-4522(95)00534-X; O'Dell CM, 2012, J NEUROSCI RES, V90, P913, DOI 10.1002/jnr.22829; Penttonen M, 1997, HIPPOCAMPUS, V7, P437, DOI 10.1002/(SICI)1098-1063(1997)7:4<437::AID-HIPO9>3.0.CO;2-F; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Richard GR, 2013, HIPPOCAMPUS, V23, P1269, DOI 10.1002/hipo.22164; RUTH RE, 1988, J COMP NEUROL, V270, P506, DOI 10.1002/cne.902700404; Salami P, 2014, NEUROBIOL DIS, V67, P97, DOI 10.1016/j.nbd.2014.03.012; Scharfman HE, 2001, NEUROSCIENCE, V104, P741, DOI 10.1016/S0306-4522(01)00132-4; Scharfman HE, 2007, PROG BRAIN RES, V163, P627, DOI 10.1016/S0079-6123(07)63034-9; Scharfman HE, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00106; Scorza FA, 2009, AN ACAD BRAS CIENC, V81, P345, DOI 10.1590/S0001-37652009000300003; Sloviter R S, 1991, Hippocampus, V1, P41, DOI 10.1002/hipo.450010106; Sloviter R S, 1991, Hippocampus, V1, P31, DOI 10.1002/hipo.450010105; Sloviter RS, 2013, NEUROPHARMACOLOGY, V69, P3, DOI 10.1016/j.neuropharm.2012.01.022; SLOVITER RS, 1994, ANN NEUROL, V35, P640, DOI 10.1002/ana.410350604; SLOVITER RS, 1992, NEUROSCI LETT, V137, P91, DOI 10.1016/0304-3940(92)90306-R; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; Spencer SS, 2002, EPILEPSIA, V43, P219, DOI 10.1046/j.1528-1157.2002.26901.x; Staley KJ, 1998, NAT NEUROSCI, V1, P201, DOI 10.1038/651; Sun CS, 2007, J COMP NEUROL, V500, P876, DOI 10.1002/cne.21207; Sutula TP, 2007, PROG BRAIN RES, V163, P541, DOI 10.1016/S0079-6123(07)63029-5; Wu K, 2001, NEUROSCIENCE, V104, P379, DOI 10.1016/S0306-4522(01)00043-4	48	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132630	10.1371/journal.pone.0132630	http://dx.doi.org/10.1371/journal.pone.0132630			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148195	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600308
J	Kerschan-Schindl, K; Thalmann, MM; Weiss, E; Tsironi, M; Foger-Samwald, U; Meinhart, J; Skenderi, K; Pietschmann, P				Kerschan-Schindl, Katharina; Thalmann, Markus M.; Weiss, Elisabeth; Tsironi, Maria; Foeger-Samwald, Ursula; Meinhart, Johann; Skenderi, Katerina; Pietschmann, Peter			Changes in Serum Levels of Myokines and Wnt-Antagonists after an Ultramarathon Race	PLOS ONE			English	Article							BONE TURNOVER MARKERS; HUMAN SKELETAL-MUSCLE; MESSENGER-RNA; PHYSICAL-ACTIVITY; MINERAL DENSITY; UP-REGULATION; MYOSTATIN; EXERCISE; SCLEROSTIN; EXPRESSION	Background Regular physical activities have a positive effect on the muscular skeletal system but over-strenuous exercise may be different. Transiently suppressed bone formation and increased bone resorption after participation in a 246-km ultradistance race has been demonstrated. Purpose The aim of this study was to analyze effects of the Spartathlon race on novel musculoskeletal markers. Methods Venous blood samples were obtained before and immediately after the race from 19 participants of the Spartathlon. From 9 runners who were available 3 days after the start blood was drawn for a third time. Serum levels of myostatin, an inhibitor of myogenic differentiation, and its opponent follistatin as well as sclerostin and dickkopf-1, both of them inhibitors of the wnt signaling pathway, and markers of bone turnover were determined. Results Serum levels of myostatin were significantly higher after the race. Serum follistatin only showed a transient increase. Sclerostin levels did not significantly differ before and after the race, whereas dickkopf-1 levels were significantly decreased. At follow-up a decrement of sclerostin and dickkopf-1 levels was seen. Serum cathepsin K levels did not change. Conclusion The increase of serum levels of myostatin appears to reflect muscle catabolic processes induced by overstrenuous exercise. After the short-term uncoupling of bone turnover participation in an ultradistance race seems to initiate a long-term positive effect on bone indicated by the low-level inhibition of the Wnt/beta-catenin signaling pathway.	[Kerschan-Schindl, Katharina] Med Univ Vienna, Dept Phys Med & Rehabil, Vienna, Austria; [Thalmann, Markus M.] Hosp Hietzing, Dept Cardiovasc Surg, Vienna, Austria; [Weiss, Elisabeth; Foeger-Samwald, Ursula; Pietschmann, Peter] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Tsironi, Maria] Univ Peloponnese, Sch Nursing, Sparta, Greece; [Meinhart, Johann] Karl Landsteiner Inst Cardiovasc Surg Res, Vienna, Austria; [Skenderi, Katerina] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece	Medical University of Vienna; Hietzing Hospital; Medical University of Vienna; University of Peloponnese; Harokopio University Athens	Kerschan-Schindl, K (corresponding author), Med Univ Vienna, Dept Phys Med & Rehabil, Vienna, Austria.	Katharina.Kerschan-Schindl@meduniwien.ac.at		Foger-Samwald, Ursula/0000-0002-3135-2194	Austrian Society of Rheumatology and Rheumatic Diseases; Karl Landsteiner Institute for Cardiovascular Surgical Research	Austrian Society of Rheumatology and Rheumatic Diseases; Karl Landsteiner Institute for Cardiovascular Surgical Research	This work was supported by the following grants: Austrian Society of Rheumatology and Rheumatic Diseases and the Karl Landsteiner Institute for Cardiovascular Surgical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2011, MED SCI SPORT EXER, V43, P1828, DOI 10.1249/MSS.0b013e3182178bb4; Amrein K, 2012, J CLIN ENDOCR METAB, V97, P148, DOI 10.1210/jc.2011-2152; Ardawi MSM, 2012, J CLIN ENDOCR METAB, V97, P3691, DOI 10.1210/jc.2011-3361; Bayod S, 2014, BRAIN RES, V1543, P38, DOI 10.1016/j.brainres.2013.10.048; Bergstrom I, 2012, J BONE MINER METAB, V30, P202, DOI 10.1007/s00774-011-0304-6; Costa AG, 2011, NAT REV RHEUMATOL, V7, P447, DOI 10.1038/nrrheum.2011.77; Crespo R, 1999, CALCIFIED TISSUE INT, V64, P287, DOI 10.1007/s002239900620; Dalbo VJ, 2013, EUR J NUTR, V52, P477, DOI 10.1007/s00394-012-0349-x; Dalbo VJ, 2011, J GERONTOL A-BIOL, V66, P855, DOI 10.1093/gerona/glr091; Drysdale IP, 2007, J CLIN DENSITOM, V10, P179, DOI 10.1016/j.jocd.2007.02.001; Fazeli PK, 2013, OSTEOPOROSIS INT, V24, P2433, DOI 10.1007/s00198-013-2353-2; Gorgens SW, 2013, ARCH PHYSIOL BIOCHEM, V119, P75, DOI 10.3109/13813455.2013.768270; Goussetis E, 2009, BLOOD CELL MOL DIS, V42, P294, DOI 10.1016/j.bcmd.2009.01.003; Hansen J, 2011, ENDOCRINOLOGY, V152, P164, DOI 10.1210/en.2010-0868; Hind K, 2006, BONE, V39, P880, DOI 10.1016/j.bone.2006.03.012; Hulmi JJ, 2007, MED SCI SPORT EXER, V39, P289, DOI 10.1249/01.mss.0000241650.15006.6e; Jensky NE, 2007, EUR J APPL PHYSIOL, V101, P473, DOI 10.1007/s00421-007-0521-9; Jeukendrup AE, 2000, CLIN SCI, V98, P47, DOI 10.1042/CS19990258; Ke HZ, 2012, ENDOCR REV, V33, P747, DOI 10.1210/er.2011-1060; Kerschan-Schindl K, 2009, BONE, V45, P1079, DOI 10.1016/j.bone.2009.07.088; Ma K, 2003, AM J PHYSIOL-ENDOC M, V285, pE363, DOI 10.1152/ajpendo.00487.2002; MALM HT, 1993, CALCIFIED TISSUE INT, V52, P209, DOI 10.1007/BF00298720; Margeli A, 2005, J CLIN ENDOCR METAB, V90, P3914, DOI 10.1210/jc.2004-2346; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mouzopoulos G, 2007, INT J SPORTS MED, V28, P576, DOI 10.1055/s-2007-964841; Ochi E, 2011, J STRENGTH COND RES, V25, P2283, DOI 10.1519/JSC.0b013e3181f1592e; Papassotiriou I, 2008, EUR J CLIN INVEST, V38, P276, DOI 10.1111/j.1365-2362.2008.01935.x; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pereira BC, 2014, INT J SPORTS MED, V35, P139, DOI 10.1055/s-0033-1349077; Pinho RA, 2010, CLIN J SPORT MED, V20, P306, DOI 10.1097/JSM.0b013e3181e413df; Schiffer T, 2011, INT J SPORTS MED, V32, P683, DOI 10.1055/s-0031-1279732; Sipos W, 2008, EXP GERONTOL, V43, P578, DOI 10.1016/j.exger.2008.03.008; Skenderi KP, 2006, MED SCI SPORT EXER, V38, P1054, DOI 10.1249/01.mss.0000222831.35897.5f; Walker KS, 2004, MED SCI SPORT EXER, V36, P787, DOI 10.1249/01.MSS.0000126384.04778.29; Wilks DC, 2009, BONE, V45, P91, DOI 10.1016/j.bone.2009.03.660; Willoughby DS, 2004, J SPORT SCI MED, V3, P226; Willoughby DS, 2004, MED SCI SPORT EXER, V36, P574, DOI 10.1249/01.MSS.0000121952.71533.EA; Zhu XY, 2004, CYTOKINE, V26, P262, DOI 10.1016/j.cyto.2004.03.007; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	39	35	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132478	10.1371/journal.pone.0132478	http://dx.doi.org/10.1371/journal.pone.0132478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147574	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600282
J	Lehmann, S; Hiller, J; van Bergenhenegouwen, J; Knippels, LMJ; Garssen, J; Traidl-Hoffmann, C				Lehmann, Sarah; Hiller, Julia; van Bergenhenegouwen, Jeroen; Knippels, Leon M. J.; Garssen, Johan; Traidl-Hoffmann, Claudia			In Vitro Evidence for Immune-Modulatory Properties of Non-Digestible Oligosaccharides: Direct Effect on Human Monocyte Derived Dendritic Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; CHAIN GALACTO-OLIGOSACCHARIDES; HUMAN-MILK; CYTOKINE PRODUCTION; ATOPIC-DERMATITIS; INFANTS; SYNBIOTICS; MIXTURE; RISK; METAANALYSIS	Infant formulas containing non-digestible oligosaccharides (NDO) similar to the composition in breast milk or a combination of lactic acid bacteria (LAB) and NDO have been shown to harbor preventive effects towards immune-regulatory disorders. The aim of this study was to investigate the immune-modulatory potential of non-digestible short chain galacto-and long chain fructo-oligosaccharides (scGOS/lcFOS) mimicking the natural distribution of oligosaccharides in human breast milk in presence or absence of certain LAB strains in human monocyte derived dendritic cells (MoDC). Immature human MoDC prepared from peripheral blood of healthy non-atopic volunteers were screened in vitro after stimulation with specific scGOS/lcFOS in presence or absence of LAB. IL-10 and IL-12p70 release was analyzed after 24 hours in cell-free supernatants by enzyme-linked immunosorbent assay (ELISA). A luminex-based assay was conducted to assess further cytokine and chemokine release by MoDC. To investigate the resulting T cell response, stimulated MoDC were co-incubated with naive T cells in allogeneic stimulation assays and intracellular Foxp3 expression, as well as immune-suppressive capacity was determined. Oligosaccharides did not induce relevant amounts of IL-12p70 production, but did promote IL-10 release by MoDC. Furthermore, scGOS/lcFOS mixtures exerted a significant enhancing effect on LAB induced IL-10 secretion by MoDC while no increase in IL-12p70 production was observed. Blocking toll like receptor (TLR)4 abrogated the increase in IL-10 in both the direct stimulation and the LAB stimulation of MoDC, suggesting that scGOS/lcFOS act via TLR4. Finally, scGOS/lcFOS-treated MoDC were shown to upregulate the number of functional suppressive Foxp3 positive T cells following allogeneic stimulation. Our results indicate anti-inflammatory and direct, microbiota independent, immune-modulatory properties of scGOS/lcFOS mixtures on human MoDC suggesting a possible induction of regulatory T cells (Tregs). The tested combinations of LAB and scGOS/lcFOS might represent a useful dietary ingredient for the maintenance of intestinal homeostasis via the induction of Tregs.	[Lehmann, Sarah; Hiller, Julia; Traidl-Hoffmann, Claudia] Tech Univ Munich, Inst Environm Med, UNIKA T, Augsburg, Germany; [Lehmann, Sarah; Hiller, Julia] Tech Univ Munich, Ctr Allergy & Environm ZAUM, D-80290 Munich, Germany; [Lehmann, Sarah; Hiller, Julia] Helmholtz Zentrum Munchen, Munich, Germany; [van Bergenhenegouwen, Jeroen; Knippels, Leon M. J.; Garssen, Johan] Nutricia Res, Dept Immunol, Utrecht, Netherlands; [van Bergenhenegouwen, Jeroen; Knippels, Leon M. J.; Garssen, Johan] Univ Utrecht, Div Pharmacol, Utrecht Inst Pharmaceut Sci, Fac Sci, Utrecht, Netherlands; [Traidl-Hoffmann, Claudia] CK CARE Christine Kuhne Ctr Allergy Res & Educ, Davos, Switzerland	Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Danone Nutricia; Utrecht University	Traidl-Hoffmann, C (corresponding author), Tech Univ Munich, Inst Environm Med, UNIKA T, Augsburg, Germany.	claudia.traidl-hoffmann@tum.de	garssen, johan/I-7159-2016	Traidl-Hoffmann, Claudia/0000-0001-5085-5179	Graduiertenstipendium der Universitat Bayern e.V. nach dem Bayerischen Eliteforderungsgesetz; Christine-Kuhne-Center for Allergy Research and Education (CK Care) and Nutricia Research	Graduiertenstipendium der Universitat Bayern e.V. nach dem Bayerischen Eliteforderungsgesetz; Christine-Kuhne-Center for Allergy Research and Education (CK Care) and Nutricia Research	This work was supported by a Graduiertenstipendium der Universitat Bayern e.V. nach dem Bayerischen Eliteforderungsgesetz (SL), Christine-Kuhne-Center for Allergy Research and Education (CK Care) and Nutricia Research. The funder Nutricia Research provided support in the form of salaries for authors JvB, LK and JG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of	Arslanoglu S, 2012, J Biol Regul Homeost Agents, V26, P49; Arslanoglu S, 2008, J NUTR, V138, P1091, DOI 10.1093/jn/138.6.1091; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Boks MA, 2012, CLIN IMMUNOL, V142, P332, DOI 10.1016/j.clim.2011.11.011; Capitan-Canadas F, 2014, MOL NUTR FOOD RES, V58, P1098, DOI 10.1002/mnfr.201300497; Cavani A, 2001, TRENDS IMMUNOL, V22, P118, DOI 10.1016/S1471-4906(00)01815-9; Dang D, 2013, J INT MED RES, V41, P1426, DOI 10.1177/0300060513493692; de Kivita S, 2013, J INNATE IMMUN, V5, P625, DOI 10.1159/000350515; Duijts L, 2009, MATERN CHILD NUTR, V5, P199, DOI 10.1111/j.1740-8709.2008.00176.x; Field CJ, 2005, J NUTR, V135, P1; Fyhrquist N, 2012, J INVEST DERMATOL, V132, P1672, DOI 10.1038/jid.2012.40; Gibson G, 1995, J NUTR; Gruber C, 2010, J ALLERGY CLIN IMMUN, V126, P791, DOI 10.1016/j.jaci.2010.07.022; Haarman M, 2005, APPL ENVIRON MICROB, V71, P2318, DOI 10.1128/AEM.71.5.2318-2324.2005; Hoppu U, 2001, ALLERGY, V56, P23, DOI 10.1034/j.1398-9995.2001.00908.x; Hubo M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00082; Jeurink PV, 2013, AM J CLIN NUTR, V98, p572S, DOI 10.3945/ajcn.112.038596; Karczewski J, 2014, AUTOIMMUNITY, P1; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kurakevich E, 2013, P NATL ACAD SCI USA, V110, P17444, DOI 10.1073/pnas.1306322110; Latvala S, 2008, WORLD J GASTROENTERO, V14, P5570, DOI 10.3748/wjg.14.5570; Lin CC, 2014, MOLECULES, V19, P5325, DOI 10.3390/molecules19045325; Liston A, 2014, NAT REV IMMUNOL, V14, P154, DOI 10.1038/nri3605; M'Rabet L, 2008, J NUTR, V138, p1782S, DOI 10.1093/jn/138.9.1782S; Macia L, 2012, IMMUNOL REV, V245, P164, DOI 10.1111/j.1600-065X.2011.01080.x; Maldonado RA, 2010, ADV IMMUNOL, V108, P111, DOI [10.1016/B978-0-12-380995-7.00004-5, 10.1016/S0065-2776(10)08004_1]; Martin R, 2010, BENEF MICROBES, V1, P367, DOI 10.3920/BM2010.0027; Moro G, 2006, ARCH DIS CHILD, V91, P814, DOI 10.1136/adc.2006.098251; Naarding MA, 2005, J CLIN INVEST, V115, P3256, DOI 10.1172/JCI25105; Nauta AJ, 2013, CARBOHYD POLYM, V93, P263, DOI 10.1016/j.carbpol.2012.02.021; Ortega-Gonzalez M, 2014, MOL NUTR FOOD RES, V58, P384, DOI 10.1002/mnfr.201300296; Osborn D, 2013, COCHRANE COLLABORATI, P1; Palomares O, 2014, GENES IMMUN, V15, P511, DOI 10.1038/gene.2014.45; Peterson RA, 2012, TOXICOL PATHOL, V40, P186, DOI 10.1177/0192623311430693; Plantinga TS, 2011, CLIN VACCINE IMMUNOL, V18, P621, DOI 10.1128/CVI.00498-10; Rijnierse A, 2011, EUR J PHARMACOL, V668, pS117, DOI 10.1016/j.ejphar.2011.07.009; Rolfe RD, 2000, J NUTR, V130, p396S, DOI 10.1093/jn/130.2.396S; Romagnani S, 2006, ALLERGY, V61, P3, DOI 10.1111/j.1398-9995.2006.01005; Romeo J, 2010, NUTR HOSP, V25, P341, DOI 10.3305/nh.2010.25.3.4517; Rutella S, 2004, IMMUNOL LETT, V94, P11, DOI 10.1016/j.imlet.2004.04.015; Scholtens PAMJ, 2008, J NUTR, V138, P1141, DOI 10.1093/jn/138.6.1141; Schouten B, 2012, BRIT J NUTR, V107, P96, DOI 10.1017/S0007114511002637; Schouten B, 2011, PEDIAT ALLERG IMM-UK, V22, P537, DOI 10.1111/j.1399-3038.2010.01132.x; Schouten B, 2010, J NUTR, V140, P835, DOI 10.3945/jn.109.116061; Schouten B, 2009, J NUTR, V139, P1398, DOI 10.3945/jn.109.108514; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Snel J, 2011, CLIN EXP ALLERGY, V41, P232, DOI 10.1111/j.1365-2222.2010.03650.x; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; Traidl-Hoffmann C, 2002, J ALLERGY CLIN IMMUN, V109, P831, DOI 10.1067/mai.2002.124655; Vael C, 2009, CURR OPIN PEDIATR, V21, P794, DOI 10.1097/MOP.0b013e328332351b; van der Aa LB, 2011, ALLERGY, V66, P170, DOI 10.1111/j.1398-9995.2010.02416.x; van Hoffen E, 2009, ALLERGY, V64, P484, DOI 10.1111/j.1398-9995.2008.01765.x; van Odijk J, 2003, ALLERGY, V58, P833, DOI 10.1034/j.1398-9995.2003.00264.x; van't Land B, 2010, VACCINE, V28, P5711, DOI 10.1016/j.vaccine.2010.06.046; Vogt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068367	55	58	59	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132304	10.1371/journal.pone.0132304	http://dx.doi.org/10.1371/journal.pone.0132304			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148091	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600237
J	Li, HQ; Hedmer, M; Karedal, M; Bjork, J; Stockfelt, L; Tinnerberg, H; Albin, M; Broberg, K				Li, Huiqi; Hedmer, Maria; Karedal, Monica; Bjork, Jonas; Stockfelt, Leo; Tinnerberg, Hakan; Albin, Maria; Broberg, Karin			A Cross-Sectional Study of the Cardiovascular Effects of Welding Fumes	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; ISCHEMIC-HEART-DISEASE; INCREASES ARTERIAL STIFFNESS; WORKPLACE PROTECTION FACTORS; SHORT-TERM EXPOSURE; ENDOTHELIAL FUNCTION; ULTRAFINE PARTICLES; VASCULAR FUNCTION; RATE-VARIABILITY; OCCUPATIONAL-EXPOSURE	Objectives Occupational exposure to particulate air pollution has been associated with an increased risk of cardiovascular disease. However, the risk to welders working today remains unclear. We aimed to elucidate the cardiovascular effects of exposure to welding fumes. Methods In a cross-sectional study, structured interviews and biological sampling were conducted for 101 welders and 127 controls (all non-smoking males) from southern Sweden. Personal breathing zone sampling of respirable dust was performed. Blood pressure (BP) and endothelial function (using peripheral arterial tonometry) were measured. Plasma and serum samples were collected from peripheral blood for measurement of C-reactive protein, low-density lipoprotein, homocysteine, serum amyloid A, and cytokines. Results Welders were exposed to 10-fold higher levels of particles than controls. Welders had significantly higher BP compared to controls, an average of 5 mm Hg higher systolic and diastolic BP (P <= 0.001). IL-8 was 3.4 ng/L higher in welders (P=0.010). Years working as a welder were significantly associated with increased BP (beta=0.35, 95%CI 0.13 - 0.58, P=0.0024 for systolic BP; beta=0.32, 95%CI 0.16-0.48, P<0.001 for diastolic BP, adjusted for BMI) but exposure to respirable dust was not associated with BP. No clear associations occurred between welding and endothelial function, or other effect markers. Conclusions A modest increase in BP was found among welders compared to controls suggesting that low-to-moderate exposure to welding fumes remains a risk factor for cardiovascular disease.	[Li, Huiqi; Hedmer, Maria; Karedal, Monica; Tinnerberg, Hakan; Albin, Maria; Broberg, Karin] Lund Univ, Div Occupat & Environm Med, Lab Med, Lund, Sweden; [Bjork, Jonas] Lund Univ, Competence Ctr Clin Res, Lund, Sweden; [Stockfelt, Leo] Univ Gothenburg, Sahlgrenska Univ Hosp & Acad, Dept Occupat & Environm Med, Gothenburg, Sweden; [Broberg, Karin] Karolinska Inst, Inst Environm Med, Unit Met & Hlth, S-10401 Stockholm, Sweden	Lund University; Lund University; Sahlgrenska University Hospital; University of Gothenburg; Karolinska Institutet	Broberg, K (corresponding author), Lund Univ, Div Occupat & Environm Med, Lab Med, Lund, Sweden.	karin.broberg@ki.se	Li, Huiqi/GRF-0591-2022; Li, Huiqi/AAE-7786-2019	Li, Huiqi/0000-0002-1127-0829; Hedmer, Maria/0000-0002-7422-2621; Broberg, Karin/0000-0002-5862-468X; Bjork, Jonas/0000-0003-1883-2000; Karedal, Monica/0000-0002-5936-2829	Swedish Council for Working Life and Social Research [2009-1888]	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This work was supported by The Swedish Council for Working Life and Social Research [2009-1888]. http://www.forte.se/. KB received the funding.	Allen RW, 2011, AM J RESP CRIT CARE, V183, P1222, DOI 10.1164/rccm.201010-1572OC; Andujar P, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-23; Antonini JM, 2003, CRIT REV TOXICOL, V33, P61, DOI 10.1080/713611032; Auchincloss AH, 2008, ENVIRON HEALTH PERSP, V116, P486, DOI 10.1289/ehp.10899; Barregard L, 2006, INHAL TOXICOL, V18, P845, DOI 10.1080/08958370600685798; Bonetti PO, 2011, ATHEROSCLEROSIS, V215, P218, DOI 10.1016/j.atherosclerosis.2010.12.011; Brauner EV, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-13; Brauner EV, 2008, AM J RESP CRIT CARE, V177, P419, DOI 10.1164/rccm.200704-632OC; Brauner EV, 2007, ENVIRON HEALTH PERSP, V115, P1177, DOI 10.1289/ehp.9984; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brook RD, 2009, J AM SOC HYPERTENS, V3, P332, DOI 10.1016/j.jash.2009.08.005; Chen LH, 2005, ENVIRON HEALTH PERSP, V113, P1723, DOI 10.1289/ehp.8190; de Ruijter W, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3083; Delfino RJ, 2008, ENVIRON HEALTH PERSP, V116, P898, DOI 10.1289/ehp.11189; Delfino RJ, 2005, ENVIRON HEALTH PERSP, V113, P934, DOI 10.1289/ehp.7938; Egan BM, 2008, CURR HYPERTENS REP, V10, P359, DOI 10.1007/s11906-008-0068-0; Fang SC, 2008, EPIDEMIOLOGY, V19, P217, DOI 10.1097/EDE.0b013e31816334dc; Forchhammer L, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-7; Gidhagen L, 2013, J EXPO SCI ENV EPID, V23, P306, DOI 10.1038/jes.2012.122; GOLLER JW, 1985, AM IND HYG ASSOC J, V46, P89, DOI 10.1202/0002-8894(1985)046<0089:ACOIOF>2.3.CO;2; Han DH, 2002, IND HEALTH, V40, P328, DOI 10.2486/indhealth.40.328; Hedmer M, 2014, INT ARCH OCC ENV HEA, V87, P623, DOI 10.1007/s00420-013-0896-3; Ibfelt E, 2010, OCCUP ENVIRON MED, V67, P772, DOI 10.1136/oem.2009.051086; Janssen LL, 2007, J OCCUP ENVIRON HYG, V4, P698, DOI 10.1080/15459620701517764; Jarvela M, 2013, INT J OCCUP MED ENV, V26, P220, DOI 10.2478/s13382-013-0097-z; Johnson BD, 2004, CIRCULATION, V109, P726, DOI 10.1161/01.CIR.0000115516.54550.B1; Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1183, DOI 10.1289/ehp.10851; Kim JY, 2005, OCCUP ENVIRON MED, V62, P157, DOI 10.1136/oem.2004.014795; Konttinen J, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-83; Kuvin JT, 2003, AM HEART J, V146, P168, DOI 10.1016/S0002-8703(03)00094-2; Lehnert M, 2012, ANN OCCUP HYG, V56, P557, DOI 10.1093/annhyg/mes025; Lin CP, 2009, FRONT BIOSCI-LANDMRK, V14, P3836, DOI [10.2735/3492, 10.2741/3492]; Lundback M, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-7; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; Meier R, 2014, ENVIRON HEALTH PERSP, V122, P726, DOI 10.1289/ehp.1307100; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Mocevic E, 2015, INT ARCH OCC ENV HEA, V88, P259, DOI 10.1007/s00420-014-0965-2; Myers GL, 2009, CLIN CHEM, V55, P378, DOI 10.1373/clinchem.2008.115899; Nurkiewicz TR, 2009, TOXICOL SCI, V110, P191, DOI 10.1093/toxsci/kfp051; O'Neill MS, 2005, CIRCULATION, V111, P2913, DOI 10.1161/CIRCULATIONAHA.104.517110; Park SK, 2008, AM J RESP CRIT CARE, V178, P283, DOI 10.1164/rccm.200708-1286OC; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Pope CA, 2011, J AIR WASTE MANAGE, V61, P858, DOI 10.3155/1047-3289.61.8.858; Pope CA, 2004, ENVIRON HEALTH PERSP, V112, P339, DOI 10.1289/ehp.6588; Robinson SC, 1939, ARCH INTERN MED, V62, P409, DOI 10.1001/archinte.1939.00190030002001; Romieu I, 2005, AM J RESP CRIT CARE, V172, P1534, DOI 10.1164/rccm.200503-372OC; Scharrer E, 2007, INT ARCH OCC ENV HEA, V80, P265, DOI 10.1007/s00420-006-0127-2; Schneider A, 2008, ENVIRON HEALTH PERSP, V116, P1666, DOI 10.1289/ehp.11666; Shah ASV, 2013, LANCET, V382, P1039, DOI 10.1016/S0140-6736(13)60898-3; Simkhovich BZ, 2008, J AM COLL CARDIOL, V52, P719, DOI 10.1016/j.jacc.2008.05.029; Sjogren B, 2002, INT J OCCUP ENV HEAL, V8, P309; St-Pierre AC, 2005, ATHEROSCLEROSIS, V182, P315, DOI 10.1016/j.atherosclerosis.2005.02.009; Stark M, 2009, CYTOKINE, V46, P290, DOI 10.1016/j.cyto.2009.02.012; Suadicani P, 2002, J CARDIOVASC RISK, V9, P191, DOI 10.1097/00043798-200208000-00003; Swedish Work Environment Authority, 2011, OCC EXP LIM, V2011, P18; Tornqvist H, 2007, AM J RESP CRIT CARE, V176, P395, DOI 10.1164/rccm.200606-872OC; Unosson J, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-20; Vinzents PS, 2005, ENVIRON HEALTH PERSP, V113, P1485, DOI 10.1289/ehp.7562; Wiebert P, 2012, OCCUP ENVIRON MED, V69, P651, DOI 10.1136/oemed-2011-100285; Xu Y, 2014, EUR HEART J-CARD IMG, V15, P736, DOI 10.1093/ehjci/jet256	60	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131648	10.1371/journal.pone.0131648	http://dx.doi.org/10.1371/journal.pone.0131648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147298	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600117
J	Li, Z; Zheng, WL; Li, HK; Li, CX; Gong, ZY				Li, Zhen; Zheng, Weiling; Li, Hankun; Li, Caixia; Gong, Zhiyuan			Synergistic Induction of Potential Warburg Effect in Zebrafish Hepatocellular Carcinoma by Co-Transgenic Expression of Myc and xmrk Oncogenes	PLOS ONE			English	Article							COMPARATIVE FUNCTIONAL GENOMICS; GROWTH-FACTOR-ALPHA; PYRUVATE-KINASE M2; ENERGY-METABOLISM; MOUSE MODELS; LIVER-CANCER; TUMORIGENESIS; BIOGENESIS; ACTIVATION; ADDICTION	Previously we have generated inducible liver tumor models by transgenic expression of Myc or xmrk (activated EGFR homolog) oncogenes in zebrafish. To investigate the interaction of the two oncogenes, we crossed the two transgenic lines and observed more severe and faster hepatocarcinogenesis in Myc/xmrk double transgenic zebrafish than either single transgenic fish. RNA-Seq analyses revealed distinct changes in many molecular pathways among the three types of liver tumors. In particular, we found dramatic alteration of cancer metabolism based on the uniquely enriched pathways in the Myc/xmrk tumors. Critical glycolytic genes including hk2, pkm and ldha were significantly up-regulated in Myc/xmrk tumors but not in either single oncogene-induced tumors, suggesting a potential Warburg effect. In RT-qPCR analyses, the specific pkm2 isoformin Warburg effect was found to be highly enriched in the Myc/xmrk tumors but not in Myc or xmrk tumors, consistent with the observations in many human cancers with Warburg effect. Moreover, the splicing factor genes (hnrnpa1, ptbp1a, ptbp1b and sfrs3b) responsible for generating the pkm isoform were also greatly up-regulated in the Myc/xmrk tumors. As Pkm2 isoform is generally inactive and causes incomplete glycolysis to favor anabolism and tumor growth, by treatment with a Pkm2-specific activator, TEPP-46, we further demonstrated that activation of Pkm2 suppressed the growth of oncogenic liver as well as proliferation of liver cells. Collectively, our Myc/xmrk zebrafish model suggests synergetic effect of EGFR and MYC in triggering Warburg effect in the HCC formation and may provide a promising in vivo model for Warburg effect.	[Li, Zhen; Zheng, Weiling; Li, Hankun; Li, Caixia; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	National University of Singapore	Gong, ZY (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.	dbsgzy@nus.edu.sg	Gong, Zhiyuan/H-8794-2012	Gong, Zhiyuan/0000-0002-9660-5260; Li, Caixia/0000-0003-2190-655X	National Medical Research Council of Singapore	National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This work was supported by a grant from National Medical Research Council of Singapore. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouElella A, 1996, MODERN PATHOL, V9, P95; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Nguyen AT, 2012, DIS MODEL MECH, V5, P63, DOI 10.1242/dmm.008367; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Berasain C, 2009, EXP BIOL MED, V234, P713, DOI 10.3181/0901-MR-12; Beyoglu D, 2013, J HEPATOL, V59, P842, DOI 10.1016/j.jhep.2013.05.030; Beyoglu D, 2013, HEPATOLOGY, V58, P229, DOI 10.1002/hep.26350; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Budhu A, 2013, GASTROENTEROLOGY, V144, P1066, DOI 10.1053/j.gastro.2013.01.054; Calvisi DF, 2005, J HEPATOL, V42, P842, DOI 10.1016/j.jhep.2005.01.029; Conner EA, 2003, BIOCHEM BIOPH RES CO, V302, P114, DOI 10.1016/S0006-291X(03)00125-6; Cortes-Cros M, 2013, P NATL ACAD SCI USA, V110, P489, DOI 10.1073/pnas.1212780110; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Desai S, 2013, ONCOTARGET; Dhanasekaran R, 2012, HEPATIC MED-EVID RES, V4, P19, DOI 10.2147/HMER.S16316; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Huang XQ, 2012, FUTURE ONCOL, V8, P21, DOI [10.2217/FON.11.137, 10.2217/fon.11.137]; Ito Y, 2001, BRIT J CANCER, V84, P1377, DOI 10.1054/bjoc.2000.1580; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lee JS, 2005, CARCINOGENESIS, V26, P1013, DOI 10.1093/carcin/bgi030; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Li J, 2013, STAT METHODS MED RES, V22, P519, DOI 10.1177/0962280211428386; Li Z, 2012, J HEPATOL, V56, P419, DOI 10.1016/j.jhep.2011.07.025; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; MURAKAMI H, 1993, CANCER RES, V53, P1719; Nguyen VTT, 2009, J VIRAL HEPATITIS, V16, P453, DOI 10.1111/j.1365-2893.2009.01117.x; Nilsson LM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002573; Reebye V, 2014, HEPATOLOGY, V59, P216, DOI 10.1002/hep.26669; SANDGREN EP, 1989, ONCOGENE, V4, P715; SantoniRugiu E, 1996, AM J PATHOL, V149, P407; Shachaf CM, 2005, CANCER RES, V65, P4471, DOI 10.1158/0008-5472.CAN-05-1172; Sun LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117249; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Wu CH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000090; Yang WW, 2013, CANCER LETT, V339, P153, DOI 10.1016/j.canlet.2013.06.008; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yang YX, 2007, J PROTEOME RES, V6, P2605, DOI 10.1021/pr070063h; Zheng WL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091179	45	11	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132319	10.1371/journal.pone.0132319	http://dx.doi.org/10.1371/journal.pone.0132319			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147004	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600240
J	Liefaard, MC; Ligthart, S; Vitezova, A; Hofman, A; Uitterlinden, AG; Kiefte-de Jong, JC; Franco, OH; Zillikens, MC; Dehghan, A				Liefaard, Marte C.; Ligthart, Symen; Vitezova, Anna; Hofman, Albert; Uitterlinden, Andre G.; Kiefte-de Jong, Jessica C.; Franco, Oscar H.; Zillikens, M. Carola; Dehghan, Abbas			Vitamin D and C-Reactive Protein: A Mendelian Randomization Study	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; D SUPPLEMENTATION; DISEASE; DETERMINANTS; ASSOCIATION; MECHANISMS; RECEPTORS; GENOTYPE; MARKERS	Vitamin D deficiency is widely prevalent and has been associated with many diseases. It has been suggested that vitamin D has effects on the immune system and inhibits inflammation. The aim of our study was to investigate whether vitamin D has an inhibitory effect on systemic inflammation by assessing the association between serum levels of vitamin D and C-reactive protein. We studied the association between serum 25-hydroxyvitamin D and C-reactive protein through linear regression in 9,649 participants of the Rotterdam Study, an observational, prospective population-based cohort study. We used genetic variants related to vitamin D and CRP to compute a genetic risk score and perform bi-directional Mendelian randomization analysis. In linear regression adjusted for age, sex, cohort and other confounders, natural log-transformed CRP decreased with 0.06 (95% CI: -0.08, -0.03) unit per standard deviation increase in 25-hydroxyvitamin D. Bi-directional Mendelian randomization analyses showed no association between the vitamin D genetic risk score and lnCRP (Beta per SD = -0.018; p = 0.082) or the CRP genetic risk score and 25-hydroxyvitamin D (Beta per SD = 0.001; p = 0.998). In conclusion, higher levels of Vitamin D are associated with lower levels of C-reactive protein. In this study we did not find evidence for this to be the result of a causal relationship.	[Liefaard, Marte C.; Ligthart, Symen; Vitezova, Anna; Hofman, Albert; Uitterlinden, Andre G.; Kiefte-de Jong, Jessica C.; Franco, Oscar H.; Dehghan, Abbas] Erasmus Univ, Dept Epidemiol, Med Ctr, Rotterdam, Netherlands; [Liefaard, Marte C.] Netherlands Inst Hlth Sci, Rotterdam, Netherlands; [Uitterlinden, Andre G.; Zillikens, M. Carola] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Dehghan, A (corresponding author), Erasmus Univ, Dept Epidemiol, Med Ctr, Rotterdam, Netherlands.	a.dehghan@erasmusmc.nl	Dehghan, Abbas/ABE-7377-2020; Ligthart, Symen/AAF-7185-2020; Kiefte-de Jong, Jessica/GLV-3216-2022; Franco, Óscar H/ABE-2305-2020; Dehghan, Abbas/B-9896-2008	Kiefte-de Jong, Jessica/0000-0002-8136-0918; Franco, Óscar H/0000-0002-4606-4929; Dehghan, Abbas/0000-0001-6403-016X	Erasmus Medical Center; Erasmus University Rotterdam; Netherlands Organization for Scientific Research (NWO); Netherlands Organization for Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Netherlands Heart Foundation; Ministry of Education, Culture and Science; Ministry of Health Welfare and Sports; European Commission; Municipality of Rotterdam; NWO grant (veni) [916.12.154]; EUR Fellowship; Nestle Nutrition (Nestec Ltd.); Metagenics Inc.; AXA	Erasmus Medical Center; Erasmus University Rotterdam; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Netherlands Heart Foundation(Netherlands Heart Foundation); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health Welfare and Sports; European Commission(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; NWO grant (veni); EUR Fellowship; Nestle Nutrition (Nestec Ltd.)(Nestle SA); Metagenics Inc.; AXA	The Rotterdam Study is supported by the Erasmus Medical Center and Erasmus University Rotterdam; the Netherlands Organization for Scientific Research (NWO); the Netherlands Organization for Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Netherlands Heart Foundation; the Ministry of Education, Culture and Science; the Ministry of Health Welfare and Sports; the European Commission; and the Municipality of Rotterdam. DSM Nutritional Products AG, Kaiseraugst, Switzerland, sponsored the Vitamin D serum analyses. Abbas Dehghan is supported by NWO grant (veni, 916.12.154) and the EUR Fellowship. O.H. Franco works in ErasmusAGE, a center for aging research across the life course funded by Nestle Nutrition (Nestec Ltd.); Metagenics Inc.; and AXA. Nestle Nutrition (Nestec Ltd.); Metagenics Inc.; and AXA had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review or approval of the manuscript. DSM Nutritional Products AG had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amer M, 2012, AM J CARDIOL, V109, P226, DOI 10.1016/j.amjcard.2011.08.032; BHALLA AK, 1983, J CLIN ENDOCR METAB, V57, P1308, DOI 10.1210/jcem-57-6-1308; Bjorkman MP, 2009, J NUTR HEALTH AGING, V13, P435, DOI 10.1007/s12603-009-0080-3; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; BURGER H, 1994, BONE MINER, V25, P1, DOI 10.1016/S0169-6009(08)80203-6; Cantorna MT, 2004, AM J CLIN NUTR, V80, p1717S, DOI 10.1093/ajcn/80.6.1717S; Chen N, 2014, NUTRIENTS, V6, P2206, DOI 10.3390/nu6062206; Coussens AK, 2012, P NATL ACAD SCI USA, V109, P15449, DOI 10.1073/pnas.1200072109; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Dickie LJ, 2010, RHEUMATOLOGY, V49, P1466, DOI 10.1093/rheumatology/keq124; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Guillot X, 2010, JOINT BONE SPINE, V77, P552, DOI 10.1016/j.jbspin.2010.09.018; Hewison M, 2004, MOL CELL ENDOCRINOL, V215, P31, DOI 10.1016/j.mce.2003.11.017; Hofman A, 2013, EUR J EPIDEMIOL, V28, P889, DOI 10.1007/s10654-013-9866-z; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Holick MF., 2002, CURR OPIN ENDOCRINOL, V9, P87, DOI DOI 10.1097/00060793-200202000-00011; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Mahon BD, 2003, J CELL BIOCHEM, V89, P922, DOI 10.1002/jcb.10580; Michos ED, 2009, CALCIFIED TISSUE INT, V84, P195, DOI 10.1007/s00223-008-9209-3; Patel S, 2007, ARTHRITIS RHEUM, V56, P2143, DOI 10.1002/art.22722; Pittas AG, 2007, DIABETES CARE, V30, P980, DOI 10.2337/dc06-1994; PROVVEDINI DM, 1983, SCIENCE, V221, P1181, DOI 10.1126/science.6310748; Schleithoff SS, 2006, AM J CLIN NUTR, V83, P754, DOI 10.1093/ajcn/83.4.754; Shea MK, 2008, AM J EPIDEMIOL, V167, P313, DOI 10.1093/aje/kwm306; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Timms PM, 2002, QJM-INT J MED, V95, P787, DOI 10.1093/qjmed/95.12.787; United Nations Educational SaCOU, 1976, INT STAND CLASS ED I; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Zhang Y, 2012, J IMMUNOL, V188, P2127, DOI 10.4049/jimmunol.1102412	36	48	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131740	10.1371/journal.pone.0131740	http://dx.doi.org/10.1371/journal.pone.0131740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147588	Green Submitted, gold, Green Published			2022-12-27	WOS:000358157600138
J	Lim, JR; Gandhi, NR; Mthiyane, T; Mlisana, K; Moodley, J; Jaglal, P; Ramdin, N; Brust, JCM; Ismail, N; Rustomjee, R; Shah, NS				Lim, Jennifer R.; Gandhi, Neel R.; Mthiyane, Thuli; Mlisana, Koleka; Moodley, Julie; Jaglal, Prenika; Ramdin, Neeshan; Brust, James C. M.; Ismail, Nazir; Rustomjee, Roxana; Shah, N. Sarita			Incidence and Geographic Distribution of Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal Province, South Africa	PLOS ONE			English	Article							OUTCOMES	South Africa is experiencing a widespread drug-resistant tuberculosis epidemic, although data are limited regarding the current situation. This study finds that the extensively drugr-esistant tuberculosis (XDR-TB) incidence in KwaZulu-Natal increased to 3.5 cases/100,000 (776 cases) in 2011-2012. XDR-TB cases are widely distributed geographically, with the majority of districts experiencing a rise in incidence.	[Lim, Jennifer R.; Gandhi, Neel R.; Brust, James C. M.; Shah, N. Sarita] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Lim, Jennifer R.; Gandhi, Neel R.; Brust, James C. M.; Shah, N. Sarita] Montefiore Med Ctr, Bronx, NY 10467 USA; [Gandhi, Neel R.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Mthiyane, Thuli; Mlisana, Koleka] Univ KwaZulu Natal, Durban, South Africa; [Mlisana, Koleka; Moodley, Julie; Jaglal, Prenika] Natl Hlth Lab Serv, Durban, South Africa; [Ramdin, Neeshan; Ismail, Nazir] Natl Inst Communicable Dis, Ctr TB, Natl Hlth Lab Serv, Johannesburg, South Africa; [Ismail, Nazir] Univ Pretoria, Dept Med Microbiol, ZA-0002 Pretoria, South Africa; [Rustomjee, Roxana] MRC, Cape Town, South Africa	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Emory University; Rollins School Public Health; University of Kwazulu Natal; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Pretoria	Gandhi, NR (corresponding author), Albert Einstein Coll Med, Bronx, NY 10467 USA.	neelgandhi@alumni.williams.edu	Mlisana, Koleka/N-6204-2013	Mlisana, Koleka/0000-0002-8436-3268; Mthiyane, Thuli/0000-0002-1782-5485	National Institutes of Health [R01 AI089349, K23 AI083088]; Doris Duke Charitable Foundation Clinical Scientist Development Award [2007071, 2007070]; Career Development Award from National Institute of Allergy and Infectious Diseases [K24 114444]; Emory University Center for AIDS Research [P30 AI050409]; EinsteinMontefiore Center for AIDS Research [P30 AI051519]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, R01AI089349, R01AI087465, K23AI083088, K24AI114444, P30AI051519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation Clinical Scientist Development Award(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); Career Development Award from National Institute of Allergy and Infectious Diseases; Emory University Center for AIDS Research; EinsteinMontefiore Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by: R01 AI089349, National Institutes of Health, NRG NSS (http://www.nih.gov/); 2007071, Doris Duke Charitable Foundation Clinical Scientist Development Award, NSS (http://www.ddcf.org/); 2007070, Doris Duke Charitable Foundation Clinical Scientist Development Award, NRG (http://www.ddcf.org/); K24 114444, K24 Career Development Award from the National Institute of Allergy and Infectious Diseases, NRG (http://www.niaid.nih.gov/Pages/default.aspx); P30 AI050409, Emory University Center for AIDS Research, NRG (http://www.cfar.emory.edu/); K23 AI083088, National Institutes of Health, JCMB (http://www.nih.gov/); and P30 AI051519, EinsteinMontefiore Center for AIDS Research, JCMB (http://www.einstein.yu.edu/centers/center-for-aidsresearch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, ANN REP 2009; Chihota VN, 2012, J CLIN MICROBIOL, V50, P995, DOI 10.1128/JCM.05832-11; Department of Health RoSA, 2007, TUB STRAT PLAN S AFR; Dye C, 2009, NAT REV MICROBIOL, V7, P81, DOI 10.1038/nrmicro2048; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Gupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034156; Ihekweazu C, 2012, COMMUNICABLE DIS SUR, V10, P79; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Moodley P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017513; Ndjeka N., 2014, MULT RESISTANT TUBER; O'Donnell MR, 2013, EMERG INFECT DIS, V19, P416, DOI 10.3201/eid1903.120998; Office of the Premier, 2012, MULT PROV STRAT PLAN; Pietersen E, 2014, LANCET, V383, P1230, DOI 10.1016/S0140-6736(13)62675-6; Shah N, 2006, MMWR-MORBID MORTAL W, V55, P301; Statistics South Africa RoSA, 2012, 0301 STAT S AFR ROSA; Wallengren K, 2011, EMERG INFECT DIS, V17, P1913, DOI 10.3201/eid1710.100952; WEYER K, 2004, SURVEY TUBERCULOSIS; WHO, 2014, WHO PUBL, VWHO/HTM/TB/2014.08; WHO, 2013, WHO PUBL, VWHO/HTM/TB/2013.2	21	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132076	10.1371/journal.pone.0132076	http://dx.doi.org/10.1371/journal.pone.0132076			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147963	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600197
J	Mo, C; Sun, G; Wang, YZ; Lu, ML; Yang, YS				Mo, Chen; Sun, Gang; Wang, Yan-Zhi; Lu, Ming-Liang; Yang, Yun-Sheng			PPI versus Histamine H2 Receptor Antagonists for Prevention of Upper Gastrointestinal Injury Associated with Low-Dose Aspirin: Systematic Review and Meta-analysis	PLOS ONE			English	Article							PROTON PUMP INHIBITORS; DUAL-ANTIPLATELET THERAPY; PEPTIC-ULCERS; ACETYLSALICYLIC-ACID; INTRAGASTRIC PH; GASTRIC-ULCERS; FAMOTIDINE; RISK; LANSOPRAZOLE; OMEPRAZOLE	This study compared proton pump inhibitors (PPIs) and histamine H2 receptor antagonists (H2RAs) for prevention of low-dose aspirin (LDA)-related gastrointestinal (GI) erosion, ulcer and bleeding. Electronic databases including PubMed, Embase, Cochrane Central Register of Controlled Trials, Chinese National Knowledge Infrastructure, Chinese Biomedical Literature Database, and WanFang Data were searched from the date of their establishment to December 31, 2013. Randomized controlled trials comparing PPIs and H2RAs for prevention of GI injury associated with low-dose aspirin (LDA) were collected. Two reviewers independently abstracted studies and patient characteristics and appraised study quality using the Cochrane risk-of-bias tool. Meta-analysis was performed using RevMan 5.1 software. We included nine RCTs involving 1047 patients. The meta-analysis showed that PPIs were superior to H2RAs for prevention of LDA-associated GI erosion/ulcer [odds ratio (OR=0.28, 95% confidence interval (CI): 0.16-0.50] and bleeding (OR=0.28, 95% CI: 0.14-0.59). In conclusion, PPIs were superior to H2RAs for prevention of LDA-related GI erosion/ulcer and bleeding. Higher quality, large, multicenter RCTs are needed to demonstrate the preventive effect of the two acid-suppressive drugs.	[Mo, Chen; Sun, Gang; Wang, Yan-Zhi; Lu, Ming-Liang; Yang, Yun-Sheng] Chinese Peoples Liberat Army Gen Hosp, Inst Digest Dis, Beijing 100853, Peoples R China; [Mo, Chen] Chinese Armed Police Force, Gen Hosp, Cadre Ward 2, Beijing 100039, Peoples R China	Chinese People's Liberation Army General Hospital	Yang, YS (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Inst Digest Dis, Beijing 100853, Peoples R China.	sunny301ddc@126.com		Wang, Yan-Zhi/0000-0003-4620-5012				Abraham NS, 2010, CIRCULATION, V122, P2619, DOI 10.1161/CIR.0b013e318202f701; Arbel Y, 2013, CLIN CARDIOL, V36, P342, DOI 10.1002/clc.22117; Bersenas AME, 2005, AM J VET RES, V66, P425, DOI 10.2460/ajvr.2005.66.425; Brophy GM, 2010, NEUROCRIT CARE, V13, P176, DOI 10.1007/s12028-010-9397-3; Cao YZ, 2001, J 4 MIL MED U, V22, P790; [杜瑜 Du Yu], 2013, [中国新药杂志, Chinese Journal New Drugs], V22, P975; Forgacs I, 2008, BMJ-BRIT MED J, V336, P2, DOI 10.1136/bmj.39406.449456.BE; Fraser LA, 2013, OSTEOPOROSIS INT, V24, P1161, DOI 10.1007/s00198-012-2112-9; Furuta T, 2005, ALIMENT PHARM THER, V22, P67, DOI 10.1111/j.1365-2036.2005.02523.x; Rodriguez LAG, 2007, CLIN GASTROENTEROL H, V5, P1418, DOI 10.1016/j.cgh.2007.09.010; [郭敏 GUO Min], 2009, [中华消化杂志, Chinese Journal of Digestion], V29, P481; Hu L, 2012, MMJC, V14, P100; Iida H, 2009, HEPATO-GASTROENTEROL, V56, P551; Ji CY, 2011, PRACT GERIATR, V25, P128; Kim YJ, 2010, J KOREAN MED SCI, V25, P583, DOI 10.3346/jkms.2010.25.4.583; Lai KC, 2002, NEW ENGL J MED, V346, P2033, DOI 10.1056/NEJMoa012877; Lanas A, 2002, ALIMENT PHARM THER, V16, P779, DOI 10.1046/j.1365-2036.2002.01230.x; Lanas A, 2007, AM J GASTROENTEROL, V102, P507, DOI 10.1111/j.1572-0241.2006.01062.x; Lanas A, 2011, CLIN GASTROENTEROL H, V9, P762, DOI 10.1016/j.cgh.2011.05.020; Li M, 2011, CLI MED, V31, P56; Li Y, 2013, SHAANXI MED J, V42, P1186; Lin KJ, 2011, GASTROENTEROLOGY, V141, P71, DOI 10.1053/j.gastro.2011.03.049; Lu BJ, 2013, CHIN J PRAC MED, V40, P87; Luk HH, 2009, J CHIN MED ASSOC, V72, P356, DOI 10.1016/S1726-4901(09)70387-9; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nagata Y, 2013, CARDIOVASC INTERV TH, V28, P22, DOI 10.1007/s12928-012-0123-2; Nakashima S, 2009, WORLD J GASTROENTERO, V15, P727, DOI 10.3748/wjg.15.727; Nema H, 2010, WORLD J GASTROENTERO, V16, P5342, DOI 10.3748/wjg.v16.i42.5342; Ng FH, 2008, DIGESTION, V77, P173, DOI 10.1159/000141264; Ng FH, 2012, AM J GASTROENTEROL, V107, P389, DOI 10.1038/ajg.2011.385; Ng FH, 2010, GASTROENTEROLOGY, V138, P82, DOI 10.1053/j.gastro.2009.09.063; Nishino M, 2011, J CLIN PHARMACOL, V51, P1079, DOI 10.1177/0091270010376194; Parkman HP, 1998, GUT, V42, P243, DOI 10.1136/gut.42.2.243; Ramsay EN, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-82; ROSTOM A, 2002, COCHRANE DB SYST REV, V2002, DOI [DOI 10.1002/14651858.CD002296, 10.1002/14651858.CD002296]; SAKAGUCHI M, 1995, J CLIN GASTROENTEROL, V20, pS27, DOI 10.1097/00004836-199506002-00008; Sakurada T, 2012, DIGEST ENDOSC, V24, P93, DOI 10.1111/j.1443-1661.2011.01176.x; Sakurai K, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-42; Sanuki T, 2012, J GASTROENTEROL, V47, P1186, DOI 10.1007/s00535-012-0588-x; Scheiman JM, 2011, HEART, V97, P797, DOI 10.1136/hrt.2010.217547; Sener-Muratoglu G, 2001, DIGEST DIS SCI, V46, P318, DOI 10.1023/A:1005652815921; Sugano K, 2011, J GASTROENTEROL, V46, P724, DOI 10.1007/s00535-011-0397-7; Sun RR, 2012, CHIN J MOD DRUG, V06, P79; Taha AS, 2009, LANCET, V374, P119, DOI 10.1016/S0140-6736(09)61246-0; Takahashi Y, 2006, J GASTROEN HEPATOL, V21, P1664, DOI 10.1111/j.1440-1746.2006.04270.x; Tamura Akira, 2013, BMC Res Notes, V6, P116, DOI 10.1186/1756-0500-6-116; Tanaka S, 2008, J CARDIOL, V52, P39, DOI 10.1016/j.jjcc.2008.05.004; [田笑笑 Tian Xiaoxiao], 2013, [中国全科医学, Chinese General Practice], V16, P2407; Tolbert K, 2011, J VET INTERN MED, V25, P47, DOI 10.1111/j.1939-1676.2010.0651.x; Tunggal P, 2011, AM HEART J, V162, DOI 10.1016/j.ahj.2011.08.007; Wang J, 2012, CHIN J CARD RES, V10, P191; Wang Y., 2012, THESIS; Wang YP, STRAIT PHARM J, V24, P114; Wang Z, 2013, CHINESE J MED, V48, P20; Wu CY, 2010, GASTROENTEROLOGY, V139, P1165, DOI 10.1053/j.gastro.2010.06.067; Wu G, 2012, THESIS; Yano H, 2012, CIRC J, V76, P2673, DOI 10.1253/circj.CJ-12-0511; Yasuda H, 2009, INTERNAL MED, V48, P1725, DOI 10.2169/internalmedicine.48.2031; Yeomans N, 2008, AM J GASTROENTEROL, V103, P2465, DOI 10.1111/j.1572-0241.2008.01995.x; Zhu LL, 2012, WORLD J GASTROENTERO, V18, P3167, DOI 10.3748/wjg.v18.i24.3167	60	21	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131558	10.1371/journal.pone.0131558	http://dx.doi.org/10.1371/journal.pone.0131558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147767	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600105
J	Xu, LZ; Paterson, AD; Turpin, W; Xu, W				Xu, Lizhen; Paterson, Andrew D.; Turpin, Williams; Xu, Wei			Assessment and Selection of Competing Models for Zero-Inflated Microbiome Data	PLOS ONE			English	Article							COUNT DATA; GUT MICROBIOTA; ABUNDANCE DATA; HURDLE MODELS; EXTRA ZEROS; REGRESSION; TESTS	Typical data in a microbiome study consist of the operational taxonomic unit (OTU) counts that have the characteristic of excess zeros, which are often ignored by investigators. In this paper, we compare the performance of different competing methods to model data with zero inflated features through extensive simulations and application to a microbiome study. These methods include standard parametric and non-parametric models, hurdle models, and zero inflated models. We examine varying degrees of zero inflation, with or without dispersion in the count component, as well as different magnitude and direction of the covariate effect on structural zeros and the count components. We focus on the assessment of type I error, power to detect the overall covariate effect, measures of model fit, and bias and effectiveness of parameter estimations. We also evaluate the abilities of model selection strategies using Akaike information criterion (AIC) or Vuong test to identify the correct model. The simulation studies show that hurdle and zero inflated models have well controlled type I errors, higher power, better goodness of fit measures, and are more accurate and efficient in the parameter estimation. Besides that, the hurdle models have similar goodness of fit and parameter estimation for the count component as their corresponding zero inflated models. However, the estimation and interpretation of the parameters for the zero components differs, and hurdle models are more stable when structural zeros are absent. We then discuss the model selection strategy for zero inflated data and implement it in a gut microbiome study of > 400 independent subjects.	[Xu, Lizhen; Paterson, Andrew D.; Xu, Wei] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada; [Paterson, Andrew D.] Hosp Sick Children Toronto, Program Genet & Genome Biol, Toronto, ON M5G 0A4, Canada; [Turpin, Williams] Mt Sinai Hosp, Zane Cohen Ctr Digest Dis, Div Gastroenterol, Toronto, ON M5T 3L9, Canada; [Xu, Wei] Princess Margaret Hosp, Dept Biostat, Toronto, ON M5G 2M9, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Xu, LZ (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada.	wxu@uhnres.utoronto.ca	xu, wei/HHD-2891-2022; Paterson, Andrew/AAQ-7511-2020; Paterson, Andrew D/A-4088-2011; Williams, Turpin/H-3255-2019	Paterson, Andrew/0000-0002-9169-118X; Paterson, Andrew D/0000-0002-9169-118X; Williams, Turpin/0000-0001-9364-5868	CIHR STAGE fellowship; Crohn's and Colitis Canada (CCC); CAG/CIHR Ferring Pharmaceuticals Inc. award; Leona M. and Harry B. Helmsley Charitable Trust	CIHR STAGE fellowship; Crohn's and Colitis Canada (CCC); CAG/CIHR Ferring Pharmaceuticals Inc. award; Leona M. and Harry B. Helmsley Charitable Trust	All authors disclose no potential conflicts (financial, professional, or personal) that are relevant to the manuscript. Williams Turpin acknowledges a CAG/CIHR Ferring Pharmaceuticals Inc. award; Lizhen Xu is a recipient of a CIHR STAGE fellowship. The authors would like to acknowledge the GEM Project Steering Committee, Recruitment Site Directors and Global Project Office members supported by Crohn's and Colitis Canada (CCC) and the Leona M. and Harry B. Helmsley Charitable Trust. The GEM Project Research Team is composed of i) Steering Committee: Paul Beck, Charles Bernstein, Alain Bitton, Kenneth Croitoru, Leo Dieleman, Brian Faegan, Anne Griffiths, David Guttman, Kevan Jacobson, Gil Kaplan, Karen Madsen, John Marshall, Paul Moayyedi, Mark Ropeleski, Ernest Seidman, Mark Silverberg, Kathy Siminovitch, Andy Stadnyk, Hilary Steinhart, Michael Surette, Dan Turner, Tom Walters, and Bruce Vallance; ii) Recruitment Center Directors: Guy Aumais, Paul Beck, Charles Bernstein, Alain Bitton, Brian Bressler, Herbert Brill, Maria Cino, Jeff Critch, Lee Denson, Colette Deslandres, Leo Dieleman, Martha Dirks, Wael El-Matary, Brian Feagan, Anne Griffiths, Hans Herfarth, Peter Higgins, Hien Huynh, Jeff Hyams, Kevan Jacobson, Gilaad Kaplan, Desmond Leddin, David Mack, John Marshall, Jerry McGrath, Anthony Otley, Remo Panancionne, Sophie Plamondon, Mark Ropeleski, Fred Saibil, Ernie Seidman, Corey Siegel, Mark Silverberg, Scott Snapper, Hillary Steinhart, and Dan Turner; and iii) The Global Project Office: Nellie Allam, Kenneth Croitoru, Alexandra Keludjian, Ana Olteanu, Kevin Ow and Isabelle Yeadon.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Balint M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053987; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Charles KF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0102451, DOI 10.1371/JOURNAL.PONE.0102451]; Desjardins CD, 2013, THESIS U MINNESOTA U; Dickson RP, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-28; Dominianni C, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-103; Duan N, 1983, J BUS ECON STAT, V1, P115, DOI DOI 10.2307/1391852; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Famoye F., 2006, J DATA SCI, V4, P117, DOI [DOI 10.6339/JDS.2006.04(1).257, 10.6339/JDS.2006.04(1).257]; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Fletcher D, 2005, ENVIRON ECOL STAT, V12, P45, DOI 10.1007/s10651-005-6817-1; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hauser LJ, 2014, INT FORUM ALLERGY RH, DOI [10.1002/alr.21428.2014/2/10, DOI 10.1002/ALR.21428.2014/2/10]; Hu MC, 2011, AM J DRUG ALCOHOL AB, V37, P367, DOI 10.3109/00952990.2011.597280; Jespers V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-83; Lachenbruch PA, 2002, STAT METHODS MED RES, V11, P297, DOI 10.1191/0962280202sm289ra; Lachenbruch PA, 2001, STAT MED, V20, P1215, DOI 10.1002/sim.790; Lambert D, 1992, AM STAT ASS AM SOC Q, V34, P1, DOI DOI 10.2307/1269547; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Loeys T, 2012, BRIT J MATH STAT PSY, V65, P163, DOI 10.1111/j.2044-8317.2011.02031.x; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Miller JM, 2007, THESIS U FLORIDA US; Min YY, 2005, STAT MODEL, V5, P1, DOI 10.1191/1471082X05st084oa; MULLAHY J, 1986, J ECONOMETRICS, V33, P341, DOI 10.1016/0304-4076(86)90002-3; Pearce MM, 2014, MBIO, V5, DOI 10.1128/mBio.01283-14; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rose CE, 2006, J BIOPHARM STAT, V16, P463, DOI 10.1080/10543400600719384; Sileshi G, 2009, ECOL MODEL, V220, P1764, DOI 10.1016/j.ecolmodel.2009.03.024; Stefansson G, 1996, ICES J MAR SCI, V53, P577, DOI 10.1006/jmsc.1996.0079; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Wagner BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020296; Warton DI, 2005, ENVIRONMETRICS, V16, P275, DOI 10.1002/env.702; Welsh AH, 1996, ECOL MODEL, V88, P297, DOI 10.1016/0304-3800(95)00113-1; Xia YL, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/593569; Yildirim S, 2014, ISME J, V8, P2431, DOI 10.1038/ismej.2014.90	38	58	58	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0129606	10.1371/journal.pone.0129606	http://dx.doi.org/10.1371/journal.pone.0129606			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148172	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600022
J	Gonzalez-Beltran, A; Li, P; Zhao, J; Avila-Garcia, MS; Roos, M; Thompson, M; van der Horst, E; Kaliyaperumal, R; Luo, R; Lee, TL; Lam, TW; Edmunds, SC; Sansone, SA; Rocca-Serra, P				Gonzalez-Beltran, Alejandra; Li, Peter; Zhao, Jun; Avila-Garcia, Maria Susana; Roos, Marco; Thompson, Mark; van der Horst, Eelke; Kaliyaperumal, Rajaram; Luo, Ruibang; Lee, Tin-Lap; Lam, Tak-wah; Edmunds, Scott C.; Sansone, Susanna-Assunta; Rocca-Serra, Philippe			From Peer-Reviewed to Peer-Reproduced in Scholarly Publishing: The Complementary Roles of Data Models and Workflows in Bioinformatics	PLOS ONE			English	Article							NATIONAL CENTER; SEQUENCE; ONTOLOGIES; RESOURCES; STANDARDS; SERVICES; GENOMES	Motivation Reproducing the results from a scientific paper can be challenging due to the absence of data and the computational tools required for their analysis. In addition, details relating to the procedures used to obtain the published results can be difficult to discern due to the use of natural language when reporting how experiments have been performed. The Investigation/Study/Assay (ISA), Nanopublications (NP), and Research Objects (RO) models are conceptual data modelling frameworks that can structure such information from scientific papers. Computational workflow platforms can also be used to reproduce analyses of data in a principled manner. We assessed the extent by which ISA, NP, and RO models, together with the Galaxy workflow system, can capture the experimental processes and reproduce the findings of a previously published paper reporting on the development of SOAPdenovo2, a de novo genome assembler. Results Executable workflows were developed using Galaxy, which reproduced results that were consistent with the published findings. A structured representation of the information in the SOAPdenovo2 paper was produced by combining the use of ISA, NP, and RO models. By structuring the information in the published paper using these data and scientific workflow modelling frameworks, it was possible to explicitly declare elements of experimental design, variables, and findings. The models served as guides in the curation of scientific information and this led to the identification of inconsistencies in the original published paper, thereby allowing its authors to publish corrections in the form of an errata. Availability SOAPdenovo2 scripts, data, and results are available through the GigaScience Database: http://dx.doi.org/10.5524/100044; the workflows are available from GigaGalaxy: http://galaxy.cbiit.cuhk.edu.hk; and the representations using the ISA, NP, and RO models are available through the SOAPdenovo2 case study website http://isa-tools.github.io/soapdenovo2/. Contact: philippe.rocca-serra@oerc.ox.ac.uk and susanna-assunta.sansone@oerc.ox.ac.uk.	[Gonzalez-Beltran, Alejandra; Sansone, Susanna-Assunta; Rocca-Serra, Philippe] Univ Oxford, Oxford E Res Ctr, Oxford OX1 3QG, England; [Li, Peter; Edmunds, Scott C.] GigaScience, BGI HK Res Inst, Hong Kong, Hong Kong, Peoples R China; [Zhao, Jun] Univ Lancaster, InfoLab21, Lancaster LA1 4WA, England; [Avila-Garcia, Maria Susana] John Radcliffe Hosp, Nuffield Dept Med, Div Expt Med, Oxford OX3 9DU, England; [Roos, Marco; Thompson, Mark; van der Horst, Eelke; Kaliyaperumal, Rajaram] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands; [Luo, Ruibang; Lam, Tak-wah] Univ Hong Kong, HKU BGI Bioinformat Algorithms & Core Technol Res, Hong Kong, Hong Kong, Peoples R China; [Luo, Ruibang; Lam, Tak-wah] Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China; [Lee, Tin-Lap] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Lee, Tin-Lap] Chinese Univ Hong Kong, CUHK BGI Innovat Inst Transom, Shatin, Hong Kong, Peoples R China	University of Oxford; Lancaster University; University of Oxford; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Sansone, SA (corresponding author), Univ Oxford, Oxford E Res Ctr, 7 Keble Rd, Oxford OX1 3QG, England.	susanna.assunta-sansone@oerc.ox.ac.uk; philippe.rocca-serra@oerc.ox.ac.uk	Lee, Tin-Lap/A-7853-2009; Lee, Tin-Lap/W-6595-2019; Edmunds, Scott/H-2735-2019	Lee, Tin-Lap/0000-0002-6654-0988; Lee, Tin-Lap/0000-0002-6654-0988; Edmunds, Scott/0000-0001-6444-1436; Zhao, Jun/0000-0001-6935-9028; Luo, Ruibang/0000-0001-9711-6533; Lam, Tak-Wah/0000-0003-4676-8587; Roos, Marco/0000-0002-8691-772X; Sansone, Susanna-Assunta/0000-0001-5306-5690	European Union [FP7 E9RXDC00, 270129, EU-FP7 ICT-2009.4.1, 305,444]; British Biotechnology and Biological Science Research Council [BB/L024101/1, BB/I025840/1]; University of Oxford e-Research Centre; Joint Chinese University of Hong Kong (CUHK)/The Beijing Genome Institute (BGI) Innovation Institute of Transomics and School of Biomedical Sciences; Chinese University of Hong Kong (CUHK); China National GeneBank (CNGB); Innovative Medicines Initiative Joint Undertaking (IMI-JU) project Open PHACTS [115191]; State Key Development Program for Basic Research of China-973 Program [2011CB809203]; National High Technology Research and Development Program of China-863 program [2012AA02A201]; National Natural Science Foundation of China [90612019]; Shenzhen Key Laboratory of Transomics Biotechnologies [CXB201108250096A]; Shenzhen Municipal Government of China [CXB201108250096A, JC201005260191A]; RGC General Research Fund [10612042]; BBSRC [BB/I025840/1, BB/L024101/1, BB/J020265/1, BB/H024921/1, BB/I000771/1, BB/E025080/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J020265/1, BB/L024101/1, BB/I000771/1, BB/E025080/1, BB/I025840/1, BB/H024921/1] Funding Source: researchfish	European Union(European Commission); British Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Oxford e-Research Centre; Joint Chinese University of Hong Kong (CUHK)/The Beijing Genome Institute (BGI) Innovation Institute of Transomics and School of Biomedical Sciences; Chinese University of Hong Kong (CUHK)(Chinese University of Hong Kong); China National GeneBank (CNGB); Innovative Medicines Initiative Joint Undertaking (IMI-JU) project Open PHACTS; State Key Development Program for Basic Research of China-973 Program(National Basic Research Program of ChinaState Key Development Program for Basic Research of China); National High Technology Research and Development Program of China-863 program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Key Laboratory of Transomics Biotechnologies; Shenzhen Municipal Government of China; RGC General Research Fund; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	SAS, PRS, and AGB received funding from the European Union Coordination of Standards in Metabolomics (COSMOS) FP7 E9RXDC00, the British Biotechnology and Biological Science Research Council BB/L024101/1, BB/I025840/1, and the University of Oxford e-Research Centre. The work done by PL, SCE, and TLL on GigaGalaxy and the implementation of the SOAPdenovo2 workflows were supported by funding from the Joint Chinese University of Hong Kong (CUHK)/The Beijing Genome Institute (BGI) Innovation Institute of Transomics and School of Biomedical Sciences, The Chinese University of Hong Kong (CUHK) and the China National GeneBank (CNGB). MSAG and JZ are supported by the European Union Workflow4ever project (EU Wf4Ever STREP, 270129), funded under European Union Framework Program 7 (EU-FP7 ICT-2009.4.1). MR, MT, EH, and RK are supported by the European Union Workflow4ever project (EU Wf4Ever STREP, 270129) funded under European Union Framework Program 7 (EU-FP7 ICT-2009.4.1), the Innovative Medicines Initiative Joint Undertaking (IMI-JU) project Open PHACTS (grant agreement no. 115191), and the European Union RD-Connect (EU FP7/2007-2013, grant agreement no. 305,444). SOAPdenovo2 was developed with the support of the State Key Development Program for Basic Research of China-973 Program (2011CB809203); National High Technology Research and Development Program of China-863 program (2012AA02A201); the National Natural Science Foundation of China (90612019); the Shenzhen Key Laboratory of Transomics Biotechnologies (CXB201108250096A); and the Shenzhen Municipal Government of China (JC201005260191A and CXB201108250096A). Tak-Wah Lam was partially supported by RGC General Research Fund 10612042.	Allen IE, 2007, SUPERIORITY EQUIVALE; Anderson C., 2008, WIRED MAGAZINE, V16; [Anonymous], 2013, NAT METHODS, V10, P367, DOI 10.1038/nmeth.2471; [Anonymous], 2013, RESOURCE DESCRIPTION; [Anonymous], 2012, BIOINFORMATICS, V29, P525; [Anonymous], 2014, BIOINFORMATICS; Barr R. S., 1995, Journal of Heuristics, V1, P9, DOI 10.1007/BF02430363; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Belhajjame K, 2015, J WEB SEMANT, V32, P16, DOI 10.1016/j.websem.2015.01.003; Bloom T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001607; Brinkman Ryan R, 2010, J Biomed Semantics, V1 Suppl 1, pS7, DOI 10.1186/2041-1480-1-S1-S7; Brownlee J., 2011, NAT INSPIRED PROGRAM; Candela L., 2013, DATA SCI J, V12, pGRDI75, DOI 10.2481/dsj.GRDI-013; Casadevall A, 2010, INFECT IMMUN, V78, P4972, DOI 10.1128/IAI.00908-10; Cokol Murat, 2008, EMBO Rep, V9, P2, DOI 10.1038/sj.embor.7401143; Dumontier M, 2014, J BIOMED SEMANT, V5, DOI 10.1186/2041-1480-5-14; GAGE, 2012, GENOME RES, V22, P557; Garijo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080278; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gonzalez-Beltran A, 2013, EMBNET J, V19, P46, DOI DOI 10.14806/EJ.19.B.728; Gonzalez-Beltran A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S14-S4; Gonzalez-Beltran A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S1-S11; Groth Paul, 2010, Information Services & Use, V30, P51, DOI 10.3233/ISU-2010-0613; Hakala J, PERSISTENT IDENTIFIE; Haug K, 2013, NUCLEIC ACIDS RES, V41, pD781, DOI 10.1093/nar/gks1004; Ince DC, 2012, NATURE, V482, P485, DOI 10.1038/nature10836; Institute SS Curtis+ Cartwrigh, 2010, SOFTW PRES BEN FRAM; Ioannidis JPA, 2009, NAT GENET, V41, P149, DOI 10.1038/ng.295; Juty N, 2012, NUCLEIC ACIDS RES, V40, pD580, DOI 10.1093/nar/gkr1097; Kettner Carsten, 2010, Stand Genomic Sci, V3, P259, DOI 10.4056/sigs.147362; Kohonen P, 2013, MOL INFORM, V32, P47, DOI 10.1002/minf.201200114; Leinonen R, 2010, NUCLEIC ACIDS RES, V38, pD39, DOI 10.1093/nar/gkp998; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Luo R, CORRECTION SOAPDENOV; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Mons B, 2011, NAT GENET, V43, P281, DOI 10.1038/ng0411-281; Naik G, 2011, WALL STREET J; National Institutes of Health, PLAN INCR ACC SCI PU; OECD, 2008, REP DOS 90 DAY OR TO; Oinn T, 2004, BIOINFORMATICS, V20, P3045, DOI 10.1093/bioinformatics/bth361; Page K., 2012, P 2 INT WORKSH LINK; Peng RD, 2011, SCIENCE, V334, P1226, DOI 10.1126/science.1213847; Pigliucci M, 2009, EMBO REP, V10, P534, DOI 10.1038/embor.2009.111; Ribeiro FJ, 2012, GENOME RES, V22, P2270, DOI 10.1101/gr.141515.112; Rocca-Serra P, 2010, BIOINFORMATICS, V26, P2354, DOI 10.1093/bioinformatics/btq415; Royal Society-Science as an open enterprise, SCI OP ENT; Sansone SA, 2012, NAT GENET, V44, P121, DOI 10.1038/ng.1054; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Smith R, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2742; Sneddon TP, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau018; Stodden V, 2014, J OPEN RES SOFTWARE, V2, pe21, DOI DOI 10.5334/J0RS.AY; Sui SJH, 2012, NUCLEIC ACIDS RES, V40, pD984, DOI 10.1093/nar/gkr1051; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Vandenbussche PY, 2014, ERCIM NEWS, P21; Vasilevsky NA, 2013, PEERJ, V1, DOI 10.7717/peerj.148; Wang J, 2012, GIGASCIENCE DATABASE; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Whetzel PL, 2011, NUCLEIC ACIDS RES, V39, pW541, DOI 10.1093/nar/gkr469; Zhao J, 2012, LINK SCI WORKSH; Zhao J, 2013, P 3 INT WORKSH LINK; Zhao J, 2012, P IEEE INT C E-SCI, DOI 10.1109/eScience.2012.6404482	64	25	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0127612	10.1371/journal.pone.0127612	http://dx.doi.org/10.1371/journal.pone.0127612			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154165	Green Published, gold, Green Submitted			2022-12-27	WOS:000358159700005
J	Kurilshikov, A; Livanova, NN; Fomenko, NV; Tupikin, AE; Rar, VA; Kabilov, MR; Livanov, SG; Tikunova, NV				Kurilshikov, Alexander; Livanova, Natalya N.; Fomenko, Nataliya V.; Tupikin, Alexey E.; Rar, Vera A.; Kabilov, Marsel R.; Livanov, Stanislav G.; Tikunova, Nina V.			Comparative Metagenomic Profiling of Symbiotic Bacterial Communities Associated with Ixodes persulcatus, Ixodes pavlovskyi and Dermacentor reticulatus Ticks	PLOS ONE			English	Article							BORNE ENCEPHALITIS-VIRUS; BURGDORFERI SENSU-LATO; WESTERN SIBERIA; TOMSK CITY; RICKETTSIA; DISEASES; REGION; SURVEILLANCE; MITOCHONDRIA; DIVERSITY	Ixodes persulcatus, Ixodes pavlovskyi, and Dermacentor reticulatus ticks inhabitingWestern Siberia are responsible for the transmission of a number of etiological agents that cause human and animal tick-borne diseases. Because these ticks are abundant in the suburbs of large cities, agricultural areas, and popular tourist sites and frequently attack people and livestock, data regarding the microbiomes of these organisms are required. Using metagenomic 16S profiling, we evaluate bacterial communities associated with I. persulcatus, I. pavlovskyi, and D. reticulatus ticks collected from the Novosibirsk region of Russia. A total of 1214 ticks were used for this study. DNA extracted fromthe ticks was pooled according to tick species and sex. Sequencing of the V3-V5 domains of 16S rRNA genes was performed using the Illumina Miseq platform. The following bacterial genera were prevalent in the examined communities: Acinetobacter (all three tick species), Rickettsia (I. persulcatus and D. reticulatus) and Francisella (D. reticulatus). B. burgdorferi sensu lato and B. miyamotoi sequences were detected in I. persulcatus and I. pavlovskyi but not in D. reticulatus ticks. The pooled samples of all tick species studied contained bacteria from the Anaplasmataceae family, although their occurrence was low. DNA from A. phagocytophilumand Candidatus Neoehrlichia mikurensis was first observed in I. pavlovskyi ticks. Significant inter-species differences in the number of bacterial taxa as well as intra-species diversity related to tick sex were observed. The bacterial communities associated with the I. pavlovskyi ticks displayed a higher biodiversity compared with those of the I. persulcatus and D. reticulatus ticks. Bacterial community structure was also diverse across the studied tick species, as shown by permutational analysis of variance using the Bray-Curtis dissimilarity metric (p = 0.002). Between-sex variation was confirmed by PERMANOVA testing in I. persulcatus (p = 0.042) and I. pavlovskyi (p = 0.042) ticks. Our study indicated that 16S metagenomic profiling could be used for rapid assessment of the occurrence ofmedically important bacteria in tick populations inhabiting different natural biotopes and therefore the epidemic danger of studied foci.	[Kurilshikov, Alexander; Livanova, Natalya N.; Fomenko, Nataliya V.; Tupikin, Alexey E.; Rar, Vera A.; Kabilov, Marsel R.; Tikunova, Nina V.] Inst Chem Biol & Fundamental Med SB RAS, Novosibirsk, Russia; [Livanova, Natalya N.; Livanov, Stanislav G.] Inst Systemat & Ecol Anim SB RAS, Novosibirsk, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Kurilshikov, A (corresponding author), Inst Chem Biol & Fundamental Med SB RAS, Novosibirsk, Russia.	alexa.kur@gmail.com	Kabilov, Marsel R./B-6669-2013; Tupikin, Alexey/AAE-9025-2021; Tikunova, Nina/J-5701-2014; Rar, Vera/AAE-7959-2019; Tupikin, Alexey E/G-1660-2015; Kurilshikov, Alexander/GWC-1519-2022	Kabilov, Marsel R./0000-0003-2777-0833; Tupikin, Alexey/0000-0002-8194-0322; Rar, Vera/0000-0002-5930-5306; Tupikin, Alexey E/0000-0002-8194-0322; Kurilshikov, Alexander/0000-0003-2541-5627	Russian Foundation for Basic Research [14-04-31549]; Russian Ministry of Education and Science Projects [VI.55.1.1]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Ministry of Education and Science Projects	This work was funded by the Russian Foundation for Basic Research (14-04-31549), http://www.rfbr.ru, and the Russian Ministry of Education and Science Projects (VI.55.1.1), http://mon.gov.ru. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberdi MP, 2012, TICKS TICK-BORNE DIS, V3, P348, DOI 10.1016/j.ttbdis.2012.10.020; Bakhvalova VN, 2000, VIRUS RES, V70, P1, DOI 10.1016/S0168-1702(00)00174-X; Beklemishev AB, 2003, FEMS MICROBIOL LETT, V227, P157, DOI 10.1016/S0378-1097(03)00581-0; Beninati T, 2004, APPL ENVIRON MICROB, V70, P2596, DOI 10.1128/AEM.70.5.2596-2602.2004; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carpi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025604; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Chausov EV, 2010, VECTOR-BORNE ZOONOT, V10, P365, DOI 10.1089/vbz.2009.0064; Cordaux R, 2007, APPL ENVIRON MICROB, V73, P5045, DOI 10.1128/AEM.00378-07; Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eremeeva ME, 2007, VECTOR-BORNE ZOONOT, V7, P426, DOI 10.1089/vbz.2007.0112; Fomenko N V, 2011, Mol Gen Mikrobiol Virusol, P12; Fomenko NV, 2008, INT J MED MICROBIOL, V298, P139, DOI 10.1016/j.ijmm.2007.11.008; Goethert HK, 2010, TICKS TICK-BORNE DIS, V1, P66, DOI 10.1016/j.ttbdis.2010.01.001; Heyman P, 2010, EXPERT REV ANTI-INFE, V8, P33, DOI 10.1586/ERI.09.118; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Karan LS, 2014, J MED VIROL, V86, P1181, DOI 10.1002/jmv.23856; Korenberg EI, 2010, VECTOR-BORNE ZOONOT, V10, P453, DOI 10.1089/vbz.2009.0033; Livanova N. N., 2011, Parazitologiya (St. Petersburg), V45, P94; Lledo L, 2014, INT J ENV RES PUB HE, V11, P1661, DOI 10.3390/ijerph110201661; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Mediannikov O Iu, 2004, Zh Mikrobiol Epidemiol Immunobiol, P7; Mediannikov O, 2008, INT J SYST EVOL MICR, V58, P1635, DOI 10.1099/ijs.0.64952-0; Menchaca AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067129; Michelet L, 2013, VET MICROBIOL, V163, P399, DOI 10.1016/j.vetmic.2013.01.014; Mikryukova TP, 2014, TICKS TICK-BORNE DIS, V5, P145, DOI 10.1016/j.ttbdis.2013.10.004; Morozova OV, 2004, VECTOR-BORNE ZOONOT, V4, P306, DOI 10.1089/vbz.2004.4.306; Murrell A, 2003, PARASITOL RES, V89, P326, DOI 10.1007/s00436-002-0722-4; Nakao R, 2013, ISME J, V7, P1003, DOI 10.1038/ismej.2012.171; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Parola P, 2001, CLIN INFECT DIS, V32, P897, DOI 10.1086/319347; Qiu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103961; Rar VA, 2014, INFECT GENET EVOL, V28, P270, DOI 10.1016/j.meegid.2014.10.010; Rar VA, 2005, EMERG INFECT DIS, V11, P1708, DOI 10.3201/eid1111.041195; Rar VA, 2010, TICKS TICK-BORNE DIS, V1, P57, DOI 10.1016/j.ttbdis.2010.01.002; Richter D, 2013, PARASITOL RES, V112, P107, DOI 10.1007/s00436-012-3110-8; Romanenko V. N., 2005, Parazitologiya (St. Petersburg), V39, P365; Romanenko V, 2015, EXP APPL ACAROL, V66, P103, DOI 10.1007/s10493-015-9879-2; Rymaszewska A, 2007, PARASITOL RES, V100, P917, DOI 10.1007/s00436-006-0412-8; Shpynov S, 2003, ANN NY ACAD SCI, V990, P162, DOI 10.1111/j.1749-6632.2003.tb07358.x; Shpynov S, 2006, ANN NY ACAD SCI, V1078, P378, DOI 10.1196/annals.1374.075; Takano A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104532; Tkachev S, 2014, TICKS TICK-BORNE DIS, V5, P494, DOI 10.1016/j.ttbdis.2014.03.003; Vayssier-Taussat M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081439; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang YF, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0005368, 10.1371/journal.pone.0007401]; Williams-Newkirk AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102130	49	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131413	10.1371/journal.pone.0131413	http://dx.doi.org/10.1371/journal.pone.0131413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154300	Green Submitted, Green Published, gold			2022-12-27	WOS:000358159700061
J	Murray, J; Cohen, A; Walaza, S; Groome, M; Madhi, S; Variava, E; Kahn, K; Dawood, H; Tempia, S; Tshangela, A; Venter, M; Feikin, D; Cohen, C				Murray, Jillian; Cohen, Adam; Walaza, Sibongile; Groome, Michelle; Madhi, Shabir; Variava, Ebrahim; Kahn, Kathleen; Dawood, Halima; Tempia, Stefano; Tshangela, Akhona; Venter, Marietje; Feikin, Daniel; Cohen, Cheryl			Determining the Provincial and National Burden of Influenza-Associated Severe Acute Respiratory Illness in South Africa Using a Rapid Assessment Methodology	PLOS ONE			English	Article							SEASONAL INFLUENZA; TRACT INFECTIONS; SURVEILLANCE; VIRUS; EPIDEMIOLOGY; PREVALENCE; PNEUMONIA; MORTALITY; CHILDREN	Local disease burden data are necessary to set national influenza vaccination policy. In 2010 the population of South Africa was 50 million and the HIV prevalence was 11%. We used a previously developed methodology to determine severe influenza burden in South Africa. Hospitalized severe acute respiratory illness (SARI) incidence was calculated, stratified by HIV status, for four age groups using data from population-based surveillance in one site situated in Gauteng Province for 2009-2011. These rates were adjusted for each of the remaining 8 provinces based on their prevalence of risk factors for pneumonia and healthcare-seeking behavior. We estimated non-hospitalized influenza-associated SARI from healthcare utilization surveys at two sites and used the percent of SARI cases positive for influenza from sentinel surveillance to derive the influenza-associated SARI rate. We applied rates of hospitalized and non-hospitalized influenza-associated SARI to census data to calculate the national number of cases. The percent of SARI cases that tested positive for influenza ranged from 7-17% depending on age group, year, province and HIV status. In 2010, there were an estimated 21,555 total severe influenza cases in HIV-uninfected individuals and 13,876 in HIV-infected individuals. In 2011, there were an estimated 29,892 total severe influenza cases in HIV-uninfected individuals and 17,289 in HIV-infected individuals. The incidence of influenza-associated SARI was highest in children <5 years and was higher in HIV-infected than HIV-uninfected persons in all age groups. Influenza virus was associated with a substantial amount of severe disease, especially in young children and HIV-infected populations in South Africa.	[Murray, Jillian; Feikin, Daniel] Johns Hopkins Int Vaccine Access Ctr, Baltimore, MD 21205 USA; [Cohen, Adam; Tempia, Stefano] Ctr Dis Control & Prevent, Pretoria, South Africa; [Cohen, Adam; Venter, Marietje; Feikin, Daniel] Ctr Dis Control & Prevent, Atlanta, GA USA; [Walaza, Sibongile; Madhi, Shabir; Tempia, Stefano; Tshangela, Akhona; Venter, Marietje; Cohen, Cheryl] Natl Inst Communicable Dis, Johannesburg, South Africa; [Groome, Michelle; Madhi, Shabir] MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Madhi, Shabir; Kahn, Kathleen; Cohen, Cheryl] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Madhi, Shabir; Kahn, Kathleen; Cohen, Cheryl] Univ Witwatersrand, Sch Pathol, Johannesburg, South Africa; [Variava, Ebrahim] Klerksdorp Tshepong Hosp, Klerksdorp, South Africa; [Kahn, Kathleen; Dawood, Halima] Univ KwaZulu Natal, Durban, South Africa; [Kahn, Kathleen] Umea Univ, Umea, Sweden; [Kahn, Kathleen] INDEPTH Network, Accra, Ghana; [Dawood, Halima] Pietermaritzburg Metropolitan Hosp Complex, Pietermaritzburg, South Africa; [Venter, Marietje] Univ Pretoria, Dept Med Virol, Zoonoses Res Unit, ZA-0002 Pretoria, South Africa	Johns Hopkins University; Centers for Disease Control & Prevention - USA; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand; University of Kwazulu Natal; Umea University; INDEPTH Network; University of Pretoria	Murray, J (corresponding author), Johns Hopkins Int Vaccine Access Ctr, Baltimore, MD 21205 USA.	jmurra35@jhu.edu	Dawood, Halima/AAF-6045-2020; Groome, Michelle Jennifer/AAI-9967-2021; Dawood, Halima/AAO-6963-2020; Variava, Ebrahim/AAO-5717-2020; Venter, Marietjie/P-9604-2016	Groome, Michelle Jennifer/0000-0001-5893-3725; Dawood, Halima/0000-0001-8180-6791; Variava, Ebrahim/0000-0003-2888-789X; Venter, Marietjie/0000-0003-2696-824X; Kahn, Kathleen/0000-0003-3339-3931; Cohen, Cheryl/0000-0003-0376-2302	Global Health Research Graduate Student Award, Centre for Global Health, Johns Hopkins Bloomberg School of Public Health	Global Health Research Graduate Student Award, Centre for Global Health, Johns Hopkins Bloomberg School of Public Health	This work was supported by the Global Health Research Graduate Student Award, Centre for Global Health, Johns Hopkins Bloomberg School of Public Health: http://www.hopkinsglobalhealth.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellei N.C.J., 2006, Braz J Infect Dis, V10, P269, DOI 10.1590/S1413-86702006000400011; Besselaar TG, 2004, J MED VIROL, V73, P71, DOI 10.1002/jmv.20063; Besselaar TG, 1999, J MED VIROL, V59, P561, DOI 10.1002/(SICI)1096-9071(199912)59:4&lt;561::AID-JMV22&gt;3.0.CO;2-5; Cohen C, 2013, EMERG INFECT DIS, V19, P1766, DOI 10.3201/eid1911.130546; Cohen C, 2012, CLIN INFECT DIS, V55, P996, DOI 10.1093/cid/cis549; Day C, 2012, S AFRICAN HLTH REV, V17, P208; Fuller JA, 2012, PLOS ONE; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Iwuji CC, 2011, HIV MED, V12, P553, DOI 10.1111/j.1468-1293.2011.00923.x; Jambo KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038628; Johnstone-Robertson SP, 2011, AM J EPIDEMIOL, V174, P1246, DOI 10.1093/aje/kwr251; Kyeyagalire R, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0694-x; Lin JC, 2001, ARCH INTERN MED, V161, P441, DOI 10.1001/archinte.161.3.441; Louria DB, 2007, CLIN INFECT DIS, V45, P470, DOI 10.1086/520026; Madhi SA, 2002, PEDIATR INFECT DIS J, V21, P291, DOI 10.1097/00006454-200204000-00007; Madhi SA, 2000, J PEDIATR-US, V137, P78, DOI 10.1067/mpd.2000.105350; MCANERNEY JM, 1994, S AFR MED J, V84, P473; McAnerney JM, 2012, J INFECT DIS, V206, pS153, DOI 10.1093/infdis/jis575; Medical Research Council DoH, 2007, S AFR DEM HLTH SURV; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; Ramkrishna W, 2013, COVERAGE HIGH RISK G; Roca A, 2010, VACCINE, V28, P4851, DOI 10.1016/j.vaccine.2010.03.060; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Schoub BD, 2013, SAMJ S AFR MED J, V103, P80, DOI [10.7196/samj.6435, 10.7196/SAMJ.6435]; Schoub BD, 2011, FUTURE VIROL, V6, P1143, DOI 10.2217/FVL.11.92; SCHOUB BD, 1986, S AFR MED J, V70, P815; Schoub BD, 2002, VACCINE, V20, pS45, DOI 10.1016/S0264-410X(02)00129-9; Shisana O., 2009, S AFRICAN NATL HIV P; World Health Organization, 2014, WHO GLOBAL EPIDEMIOL	31	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0132078	10.1371/journal.pone.0132078	http://dx.doi.org/10.1371/journal.pone.0132078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154306	Green Published, gold, Green Submitted			2022-12-27	WOS:000358159700086
J	Naze, F; Desvars, A; Picardeau, M; Bourhy, P; Michault, A				Naze, Florence; Desvars, Amelie; Picardeau, Mathieu; Bourhy, Pascale; Michault, Alain			Use of a New High Resolution Melting Method for Genotyping Pathogenic Leptospira spp.	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; CURVE ANALYSIS; RAPID IDENTIFICATION; INDIAN-OCEAN; DIFFERENTIATION; CLASSIFICATION; EPIDEMIOLOGY; POLYMORPHISM; VALIDATION	Background Leptospirosis is a worldwide zoonosis that is endemic in tropical areas, such as Reunion Island. The species Leptospira interrogans is the primary agent in human infections, but other pathogenic species, such as L. kirschner and L. borgpetersenii, are also associated with human leptospirosis. Methods and Findings In this study, a melting curve analysis of the products that were amplified with the primer pairs lfb1 F/R and G1/G2 facilitated an accurate species classification of Leptospira reference strains. Next, we combined an unsupervised high resolution melting (HRM) method with a new statistical approach using primers to amplify a two variable-number tandemrepeat (VNTR) for typing at the subspecies level. The HRM analysis, which was performed with ScreenClust Software, enabled the identification of genotypes at the serovar level with high resolution power (Hunter-Gaston index 0.984). This method was also applied to Leptospira DNA from blood samples that were obtained from Reunion Island after 1998. We were able to identify a unique genotype that is identical to that of the L. interrogans serovars Copenhageni and Icterohaemorrhagiae, suggesting that this genotype is the major cause of leptospirosis on Reunion Island. Conclusions Our simple, rapid, and robust genotyping method enables the identification of Leptospira strains at the species and subspecies levels and supports the direct genotyping of Leptospira in biological samples without requiring cultures.	[Naze, Florence; Desvars, Amelie; Michault, Alain] CHU La Reunion, Dept Microbiol, St Pierre, France; [Picardeau, Mathieu; Bourhy, Pascale] Inst Pasteur, Natl Reference Ctr, Unie Biol Spirochetes, Paris, France; [Picardeau, Mathieu; Bourhy, Pascale] WHO, Collaborating Ctr Leptospirosis, Inst Pasteur, Paris, France	CHU Reunion; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; World Health Organization	Michault, A (corresponding author), CHU La Reunion, Dept Microbiol, St Pierre, France.	alain.michault@chu-reunion.fr		Desvars-Larrive, Amelie/0000-0001-7671-696X				Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Ahmed A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007093; Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Boonsilp S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001954; Bourhy P, 2012, J CLIN MICROBIOL, V50, P307, DOI 10.1128/JCM.05931-11; Bourhy P, 2014, INT J SYST EVOL MICR, V64, P4061, DOI 10.1099/ijs.0.066597-0; Bourhy P, 2011, J CLIN MICROBIOL, V49, P2154, DOI 10.1128/JCM.02452-10; Brenner DJ, 1999, INT J SYST BACTERIOL, V49, P839, DOI 10.1099/00207713-49-2-839; Caimi K, 2012, MEM I OSWALDO CRUZ, V107, P644, DOI 10.1590/S0074-02762012000500011; Cerqueira GM, 2009, J MED MICROBIOL, V58, P1173, DOI 10.1099/jmm.0.009175-0; Chan WF, 2009, J MICROBIOL METH, V77, P326, DOI 10.1016/j.mimet.2009.03.007; CORNEY BG, 1993, J CLIN MICROBIOL, V31, P2927, DOI 10.1128/JCM.31.11.2927-2932.1993; Desvars A, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-80; Desvars A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020377; Erali M, 2006, CLIN CHEM, V52, P1443, DOI 10.1373/clinchem.2006.068510; Ferreira AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112312; Fortini D, 2007, CLIN CHEM, V53, P1377, DOI 10.1373/clinchem.2007.085993; Galloway RL, 2008, AM J TROP MED HYG, V78, P628, DOI 10.4269/ajtmh.2008.78.628; GRAVEKAMP C, 1993, J GEN MICROBIOL, V139, P1691, DOI 10.1099/00221287-139-8-1691; Gundry CN, 2003, CLIN CHEM, V49, P396, DOI 10.1373/49.3.396; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jeffery N, 2007, MICROBIOL-SGM, V153, P2679, DOI 10.1099/mic.0.2006/005140-0; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Kositanont U, 2007, J MICROBIOL METH, V69, P288, DOI 10.1016/j.mimet.2007.01.012; Levett PN, 2005, J MED MICROBIOL, V54, P45, DOI 10.1099/jmm.0.45860-0; Majed Z, 2005, J CLIN MICROBIOL, V43, P539, DOI 10.1128/JCM.43.2.539-545.2005; Merien F, 2005, FEMS MICROBIOL LETT, V249, P139, DOI 10.1016/j.femsle.2005.06.011; MERIEN F, 1992, J CLIN MICROBIOL, V30, P2219; Morey RE, 2006, J CLIN MICROBIOL, V44, P3510, DOI 10.1128/JCM.00670-06; Naze F, 2010, J CLIN MICROBIOL, V48, P3146, DOI 10.1128/JCM.00402-10; OLIVEIRA MAA, 1995, DIAGN MICR INFEC DIS, V22, P343, DOI 10.1016/0732-8893(95)00145-3; Picardeau M, 2013, MED MALADIES INFECT, V43, P1, DOI 10.1016/j.medmal.2012.11.005; Postic D, 2000, RES MICROBIOL, V151, P333, DOI 10.1016/S0923-2508(00)00156-X; Reja V, 2010, METHODS, V50, pS10, DOI 10.1016/j.ymeth.2010.02.006; Robertson T, 2009, J APPL MICROBIOL, V107, P2017, DOI 10.1111/j.1365-2672.2009.04388.x; Salaun L, 2006, J CLIN MICROBIOL, V44, P3954, DOI 10.1128/JCM.00336-06; Schwartz SB, 2009, J CLIN MICROBIOL, V47, P4117, DOI 10.1128/JCM.01696-09; Shukla J, 2002, INDIAN J MED RES, V116, P192; Steer PA, 2009, J CLIN MICROBIOL, V47, P311, DOI 10.1128/JCM.01567-08; Stephens AJ, 2008, CLIN CHEM, V54, P432, DOI 10.1373/clinchem.2007.093658; Struelens M. J., 1996, Clin Microbiol Infect, V2, P2, DOI 10.1111/j.1469-0691.1996.tb00193.x; Talmi-Frank D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000581; TAYLOR KA, 1991, INFECT IMMUN, V59, P323, DOI 10.1128/IAI.59.1.323-329.1991; Tulsiani SM, 2010, ANN TROP MED PARASIT, V104, P151, DOI 10.1179/136485910X12607012374037; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Vezenegho SB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-282; Vijayachari P, 2004, J CLIN MICROBIOL, V42, P3575, DOI [10.1128/JCM.42.8.3575-3580.2004, 10.1128/jcm.42.8.3575-3580.2004]; Waggoner JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112356; Winchell JM, 2010, J CLIN MICROBIOL, V48, P697, DOI 10.1128/JCM.02021-09; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; ZUERNER RL, 1993, J CLIN MICROBIOL, V31, P578, DOI 10.1128/JCM.31.3.578-583.1993	53	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0127430	10.1371/journal.pone.0127430	http://dx.doi.org/10.1371/journal.pone.0127430			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154161	Green Submitted, Green Published, gold			2022-12-27	WOS:000358159700004
J	Rohde, S; Nietzer, S; Schupp, PJ				Rohde, Sven; Nietzer, Samuel; Schupp, Peter J.			Prevalence and Mechanisms of Dynamic Chemical Defenses in Tropical Sponges	PLOS ONE			English	Article							SECONDARY METABOLITES; CARIBBEAN SPONGES; MARINE-INVERTEBRATES; HERBIVORE-RESISTANCE; ECOLOGY; PLANT; APLYSINA; LOCALIZATION; ALLOCATION; PATTERNS	Sponges and other sessile invertebrates are lacking behavioural escape or defense mechanisms and rely therefore on morphological or chemical defenses. Studies from terrestrial systems and marine algae demonstrated facultative defenses like induction and activation to be common, suggesting that sessile marine organisms also evolved mechanisms to increase the efficiency of their chemical defense. However, inducible defenses in sponges have not been investigated so far and studies on activated defenses are rare. We investigated whether tropical sponge species induce defenses in response to artificial predation and whether wounding triggers defense activation. Additionally, we tested if these mechanisms are also used to boost antimicrobial activity to avoid bacterial infection. Laboratory experiments with eight pacific sponge species showed that 87% of the tested species were chemically defended. Two species, Stylissa massa and Melophlus sarasinorum, induced defenses in response to simulated predation, which is the first demonstration of induced antipredatory defenses in marine sponges. One species, M. sarasinorum, also showed activated defense in response to wounding. Interestingly, 50% of the tested sponge species demonstrated induced antimicrobial defense. Simulated predation increased the antimicrobial defenses in Aplysinella sp., Cacospongia sp., M. sarasinorum, and S. massa. Our results suggest that wounding selects for induced antimicrobial defenses to protect sponges from pathogens that could otherwise invade the sponge tissue via feeding scars.	[Rohde, Sven; Nietzer, Samuel; Schupp, Peter J.] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, Wilhelmshaven, Germany	Carl von Ossietzky Universitat Oldenburg	Rohde, S (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, Wilhelmshaven, Germany.	sven.rohde@uni-oldenburg.de	Rohde, Sven/T-1255-2017; Schupp, Peter j/D-3296-2015	Rohde, Sven/0000-0002-1796-6384; Schupp, Peter Josef/0000-0003-4831-2751	German Academic Exchange Service; National Institutes of Health MBRS SCORE grant [S06-GM-44796]	German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); National Institutes of Health MBRS SCORE grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the German Academic Exchange Service to SR and the National Institutes of Health MBRS SCORE grant S06-GM-44796 to PJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amesbury SS, 1982, U GUAM MAR LAB C 173, V1, P1; Aoki S, 2000, TETRAHEDRON, V56, P1833, DOI 10.1016/S0040-4020(00)00092-2; Assmann M, 2000, MAR ECOL PROG SER, V207, P255, DOI 10.3354/meps207255; BALDWIN IT, 1990, TRENDS ECOL EVOL, V5, P91, DOI 10.1016/0169-5347(90)90237-8; Becerro MA, 2003, OECOLOGIA, V135, P91, DOI 10.1007/s00442-002-1138-7; BERGMANN W, 1950, J AM CHEM SOC, V72, P2809, DOI 10.1021/ja01162a543; Bewley CA, 1996, EXPERIENTIA, V52, P716, DOI 10.1007/BF01925581; BRYANT JP, 1991, ANNU REV ECOL SYST, V22, P431, DOI 10.1146/annurev.es.22.110191.002243; Burns E, 2003, MAR ECOL PROG SER, V252, P105, DOI 10.3354/meps252105; Cetrulo GL, 2000, MAR ECOL PROG SER, V207, P243, DOI 10.3354/meps207243; Chanas B, 1997, J EXP MAR BIOL ECOL, V208, P185, DOI 10.1016/S0022-0981(96)02653-6; Coleman RA, 2007, FUNCT ECOL, V21, P101, DOI 10.1111/j.1365-2435.2006.01210.x; Conn E. E., 1979, Herbivores: their interaction with secondary plant metabolites, P387; Cronin G, 2001, CRC MAR SCI, P325; Cronin G, 1996, ECOLOGY, V77, P1531, DOI 10.2307/2265549; Cronin G, 1996, OECOLOGIA, V105, P361, DOI 10.1007/BF00328739; Ebel R, 1997, J CHEM ECOL, V23, P1451, DOI 10.1023/B:JOEC.0000006475.10310.3a; Haber M, 2011, MAR ECOL PROG SER, V422, P113, DOI 10.3354/meps08921; Harvell CD, 1998, ECOLOGY AND EVOLUTION OF INDUCIBLE DEFENSES, P3; Hay ME, 1996, J EXP MAR BIOL ECOL, V200, P103, DOI 10.1016/S0022-0981(96)02659-7; HAY ME, 1994, ECOLOGY, V75, P1714, DOI 10.2307/1939631; Heil M, 2002, TRENDS PLANT SCI, V7, P61, DOI 10.1016/S1360-1385(01)02186-0; Jung V, 2001, TETRAHEDRON, V57, P7169, DOI 10.1016/S0040-4020(01)00692-5; KARBAN R, 1989, ANNU REV ECOL SYST, V20, P331, DOI 10.1146/annurev.es.20.110189.001555; Karban R, 1997, INDUCED RESPONSE HER; Kelly SR, 2005, AQUAT MICROB ECOL, V40, P191, DOI 10.3354/ame040191; KINNEL RB, 1993, J AM CHEM SOC, V115, P3376, DOI 10.1021/ja00061a065; KOBAYASHI J, 1986, EXPERIENTIA, V42, P1176, DOI 10.1007/BF01941300; KRISCHIK VA, 1991, OECOLOGIA, V85, P562, DOI 10.1007/BF00323769; Lindel T, 2000, J CHEM ECOL, V26, P1477, DOI 10.1023/A:1005591826613; Lindquist N, 2002, J NAT PROD, V65, P681, DOI 10.1021/np010339e; McClintock JB, 2010, INTEGR COMP BIOL, V50, P967, DOI 10.1093/icb/icq035; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Mohammed R, 2006, J NAT PROD, V69, P1739, DOI 10.1021/np060006n; Morrison WE, 2011, OECOLOGIA, V165, P427, DOI 10.1007/s00442-010-1791-1; Muller WEG, 2004, MAR BIOL, V144, P19, DOI 10.1007/s00227-003-1184-7; Newbold RW, 1999, AQUAT MICROB ECOL, V19, P279, DOI 10.3354/ame019279; Paul V.J., 1992, ECOLOGICAL ROLES MAR; Paul VJ, 2006, NAT PROD REP, V23, P153, DOI 10.1039/b404735b; PAUL VJ, 1992, J EXP MAR BIOL ECOL, V160, P191, DOI 10.1016/0022-0981(92)90237-5; Paul VJ, 2004, NAT PROD REP, V21, P189, DOI 10.1039/b302334f; Pavia H, 2000, ECOLOGY, V81, P3212; Pavia H, 2002, ECOLOGY, V83, P891; Pawlik JR, 2008, MAR ECOL PROG SER, V368, P137, DOI 10.3354/meps07615; Pawlik JR, 2002, INTEGR COMP BIOL, V42, P1292; PAWLIK JR, 1995, MAR ECOL PROG SER, V127, P183, DOI 10.3354/meps127183; Peters KJ, 2009, MAR ECOL PROG SER, V385, P77, DOI 10.3354/meps08026; PFISTER CA, 1992, ECOLOGY, V73, P1586, DOI 10.2307/1940012; Piel J, 2009, NAT PROD REP, V26, P338, DOI 10.1039/b703499g; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Pohnert G, 2004, TOP CURR CHEM, V239, P179, DOI 10.1007/b95453; Puglisi MP, 2014, NAT PROD REP, V31, P1510, DOI 10.1039/c4np00017j; Puyana M, 2003, MAR ECOL PROG SER, V246, P127, DOI 10.3354/meps246127; RAFFA KF, 1995, OECOLOGIA, V102, P285, DOI 10.1007/BF00329795; RANDALL JE, 1968, MAR BIOL, V1, P216, DOI 10.1007/BF00347115; Richelle-Maurer E, 2003, BIOCHEM SYST ECOL, V31, P1073, DOI 10.1016/S0305-1978(03)00072-3; Rohde S, 2004, J ECOL, V92, P1011, DOI 10.1111/j.0022-0477.2004.00936.x; Rohde S, 2008, J PHYCOL, V44, P85, DOI 10.1111/j.1529-8817.2007.00451.x; Rohde S, 2012, J CHEM ECOL, V38, P463, DOI 10.1007/s10886-012-0124-8; Rohde S, 2011, J EXP MAR BIOL ECOL, V399, P76, DOI 10.1016/j.jembe.2011.01.012; Salomon CE, 2001, MAR BIOL, V139, P313; Schupp P, 1999, MAR BIOL, V135, P573, DOI 10.1007/s002270050658; Sinko J, 2012, VET MED-CZECH, V57, P177, DOI 10.17221/5914-VETMED; Slattery M, 2012, HDB MARINE NATURAL P, V1; Swearingen DC, 1998, MAR BIOL, V131, P619, DOI 10.1007/s002270050354; Tasdemir D, 2002, J MED CHEM, V45, P529, DOI 10.1021/jm0102856; TEEYAPANT R, 1993, NATURWISSENSCHAFTEN, V80, P369, DOI 10.1007/BF01138794; THOMPSON JE, 1983, ACTA ZOOL-STOCKHOLM, V64, P199, DOI 10.1111/j.1463-6395.1983.tb00801.x; Thoms C, 2006, J CHEM ECOL, V32, P97, DOI 10.1007/s10886-006-9355-x; Thoms C, 2007, SERIE LIVROS MUSEO N, V28; Thoms Carsten, 2007, V28, P627; Thoms C, 2008, J CHEM ECOL, V34, P1242, DOI 10.1007/s10886-008-9518-z; Toth GB, 2007, J ECOL, V95, P425, DOI 10.1111/j.1365-2745.2007.01224.x; UNSON MD, 1993, EXPERIENTIA, V49, P349, DOI 10.1007/BF01923420; VACELET J, 1975, J MICROSC BIOL CELL, V23, P271; Van Alstyne KL, 2001, MAR ECOL PROG SER, V213, P53, DOI 10.3354/meps213053; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; WULFF JL, 1994, SPONGES IN TIME AND SPACE, P265; Xu JZ, 2006, CHEM PHARM BULL, V54, P852, DOI 10.1248/cpb.54.852	79	29	29	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0132236	10.1371/journal.pone.0132236	http://dx.doi.org/10.1371/journal.pone.0132236			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154741	Green Published, gold, Green Submitted			2022-12-27	WOS:000358159700091
J	Groene, O; Arah, OA; Klazinga, NS; Wagner, C; Bartels, PD; Kristensen, S; Saillour, F; Thompson, A; Thompson, CA; Pfaff, H; DerSarkissian, M; Sunol, R				Groene, Oliver; Arah, Onyebuchi A.; Klazinga, Niek S.; Wagner, Cordula; Bartels, Paul D.; Kristensen, Solvejg; Saillour, Florence; Thompson, Andrew; Thompson, Caroline A.; Pfaff, Holger; DerSarkissian, Maral; Sunol, Rosa			Patient Experience Shows Little Relationship with Hospital Quality Management Strategies	PLOS ONE			English	Article							IMPROVEMENT IMPLEMENTATION; HEALTH LITERACY; CARE; SYSTEMS; IMPACT; COMMUNICATION; CENTEREDNESS; PERFORMANCE	Objectives Patient-reported experience measures are increasingly being used to routinely monitor the quality of care. With the increasing attention on such measures, hospital managers seek ways to systematically improve patient experience across hospital departments, in particular where outcomes are used for public reporting or reimbursement. However, it is currently unclear whether hospitals with more mature quality management systems or stronger focus on patient involvement and patient-centered care strategies perform better on patient-reported experience. We assessed the effect of such strategies on a range of patient-reported experience measures. Materials and Methods We employed a cross-sectional, multi-level study design randomly recruiting hospitals from the Czech Republic, France, Germany, Poland, Portugal, Spain, and Turkey between May 2011 and January 2012. Each hospital contributed patient level data for four conditions/pathways: acute myocardial infarction, stroke, hip fracture and deliveries. The outcome variables in this study were a set of patient-reported experience measures including a generic 6-item measure of patient experience (NORPEQ), a 3-item measure of patient-perceived discharge preparation (Health Care Transition Measure) and two single item measures of perceived involvement in care and hospital recommendation. Predictor variables included three hospital management strategies: maturity of the hospital quality management system, patient involvement in quality management functions and patient-centered care strategies. We used directed acyclic graphs to detail and guide the modeling of the complex relationships between predictor variables and outcome variables, and fitted multivariable linear mixed models with random intercept by hospital, and adjusted for fixed effects at the country level, hospital level and patient level. Results Overall, 74 hospitals and 276 hospital departments contributed data on 6,536 patients to this study (acute myocardial infarction n = 1,379, hip fracture n = 1,503, deliveries n = 2,088, stroke n = 1,566). Patients admitted for hip fracture and stroke had the lowest scores across the four patient-reported experience measures throughout. Patients admitted after acute myocardial infarction reported highest scores on patient experience and hospital recommendation; women after delivery reported highest scores for patient involvement and health care transition. We found no substantial associations between hospital-wide quality management strategies, patient involvement in quality management, or patient-centered care strategies with any of the patient-reported experience measures. Conclusion This is the largest study so far to assess the complex relationship between quality management strategies and patient experience with care. Our findings suggest absence of and wide variations in the institutionalization of strategies to engage patients in quality management, or implement strategies to improve patient-centeredness of care. Seemingly counter-intuitive inverse associations could be capturing a scenario where hospitals with poorer quality management were beginning to improve their patient experience. The former suggests that patient-centered care is not yet sufficiently integrated in quality management, while the latter warrants a nuanced assessment of the motivation and impact of involving patients in the design and assessment of services.	[Groene, Oliver] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England; [Arah, Onyebuchi A.; DerSarkissian, Maral] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA; [Klazinga, Niek S.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Wagner, Cordula] Netherlands Inst Hlth Serv Res, Utrecht, Netherlands; [Wagner, Cordula] Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Bartels, Paul D.; Kristensen, Solvejg] Danish Clin Registries, Aalborg, Denmark; [Bartels, Paul D.; Kristensen, Solvejg] Aalborg Univ, Dept Clin Med, Aalborg, Denmark; [Saillour, Florence] Ctr Hosp Univ Bordeaux, Unite Methodes Evaluat Sante, Bordeaux, France; [Thompson, Andrew] Univ Edinburgh, Sch Social & Polit Sci, Edinburgh, Midlothian, Scotland; [Thompson, Caroline A.] PAMFRI, Palo Alto, CA USA; [Pfaff, Holger] Univ Cologne, Inst Med Sociol Hlth Serv Res & Rehabil Sci, D-50931 Cologne, Germany; [Sunol, Rosa] Univ Autonoma Barcelona, Avedis Donabedian Res Inst FAD, E-08193 Barcelona, Spain; [Groene, Oliver; Sunol, Rosa] Red Invest Serv Salud Enfermedades Cron REDISSEC, Barcelona, Spain	University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California Los Angeles; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Institute for Health Services Research; Vrije Universiteit Amsterdam; Aalborg University; CHU Bordeaux; University of Edinburgh; University of Cologne; Autonomous University of Barcelona	Groene, O (corresponding author), London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England.	oliver.groene@lshtm.ac.uk	Pfaff, Holger/D-2630-2009; Sunol, Rosa/AAS-7276-2021; Pfaff, Holger/AAT-6014-2020	Pfaff, Holger/0000-0001-9154-6575; Sunol, Rosa/0000-0003-1902-833X; Pfaff, Holger/0000-0001-9154-6575; Thompson, Caroline/0000-0001-9990-9756; Arah, Onyebuchi/0000-0002-9067-1697	European Commission's Seventh Framework Program FP7 [241822]	European Commission's Seventh Framework Program FP7	This work was supported by the European Commission's Seventh Framework Program FP7/2007-2013 [ec.europa.eu/index_en.htm] under the grant agreement number 241822. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding to pay the Open Access publication charges for this article was provided under grant agreement no. 241822.	Alexander Jeffrey A, 2006, Hosp Top, V84, P11, DOI 10.3200/HTPS.84.1.11-21; Arah OA, 2004, QUAL SAF HEALTH CARE, V13, P226, DOI 10.1136/qshc.2003.007070; Balik B, 2011, ACHEIVING EXCEPTIONA; Balint E, 1969, J R Coll Gen Pract, V17, P269; Berwick DM, 2009, HEALTH AFFAIR, V28, pW555, DOI 10.1377/hlthaff.28.4.w555; Black N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f167; Black N, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2495; Centre for Medicare & Medicaid Services, 2012, HOSP VAL BAS PURCH P; Coleman EA, 2005, MED CARE, V43, P246, DOI 10.1097/00005650-200503000-00007; Coulter A, 2005, EUR J PUBLIC HEALTH, V15, P355, DOI 10.1093/eurpub/cki004; Coulter A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2225; De Vries AMM, 2014, PSYCHO-ONCOLOGY, V23, P375, DOI 10.1002/pon.3445; Department of Health, 2008, HIGH QUALITY CARE AL; Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570; Edwards A, 2003, PATIENT EDUC COUNS, V50, P311, DOI 10.1016/S0738-3991(03)00055-7; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Gerteis M., 1993, PATIENTS EYES UNDERS; GREAVES F, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F4986; Greenfield D, 2008, INT J QUAL HEALTH C, V20, P172, DOI 10.1093/intqhc/mzn005; Groene O, 2009, QUAL SAF HEALTH CARE, V18, pI44, DOI 10.1136/qshc.2008.029397; Groene O, 2014, INT J QUAL HEALTH C, V26, P81, DOI 10.1093/intqhc/mzu022; Groene O, 2011, INT J QUAL HEALTH C, V23, P531, DOI 10.1093/intqhc/mzr058; Groene O, 2011, J HEALTH SERV RES PO, V16, P131, DOI 10.1258/jhsrp.2011.011022; Groene O, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-281; Health Foundation, 2014, PERS CTR CAR MAD SIM; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 2001, ENV NAT HLTH CAR QUA; Lewin S, 2001, COCHRANE DATABASE SY; McCarthy DM, 2012, MED CARE, V50, P277, DOI 10.1097/MLR.0b013e318241e8e1; McClelland LE, 2014, HEALTH SERV RES, V49, P1670, DOI 10.1111/1475-6773.12186; National Institute for Health and Care Excellence (NICE), 2012, PAT EXP AD NHS SERV; Oltedal S, 2007, SCAND J PUBLIC HEALT, V35, P540, DOI 10.1080/14034940701291724; ORTON JD, 1990, ACAD MANAGE REV, V15, P203, DOI 10.2307/258154; Parand A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005055; Pearl J, 1995, BIOMETRIKA, V82, P669, DOI 10.2307/2337329; Pearl J, 2009, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Reader TW, 2014, BMJ QUAL SAF, V23, P678, DOI 10.1136/bmjqs-2013-002437; Renedo A, 2014, PUBLIC MANAGEMENT RE, V17, P1, DOI DOI 10.1177/0038038514544208; Roter D, 2002, PATIENT EDUC COUNS, V46, P243, DOI 10.1016/S0738-3991(02)00012-5; Rozenblum R, 2013, BMJ QUAL SAF, V22, P242, DOI 10.1136/bmjqs-2012-001045; Rudd RE, 2013, REV CALID ASSIST, V28, P188, DOI 10.1016/j.cali.2013.03.003; Schoen Cathy, 2005, Health Aff (Millwood), VSuppl Web Exclusives, pW5; Secanell M, 2014, INT J QUAL HEALTH C, V26, P5, DOI 10.1093/intqhc/mzu025; Skudal KE, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000864; Sunol R, 2009, QUAL SAF HEALTH CARE, V18, pI62, DOI 10.1136/qshc.2008.029439; Szablowski Katarzyna M, 2014, Conn Med, V78, P49; Taylor A, 2015, J HLTH MANA IN PRESS, P29; Wagner C, 2014, INT J QUAL HEALTH C, V26, P74, DOI 10.1093/intqhc/mzu027; Wagner C, 2014, INT J QUAL HEALTH C, V26, P16, DOI 10.1093/intqhc/mzu021; Weick KE, 1999, ANNU REV PSYCHOL, V50, P361, DOI 10.1146/annurev.psych.50.1.361; Weiner BJ, 2006, HEALTH SERV RES, V41, P307, DOI 10.1111/j.1475-6773.2005.00483.x; Weiner BJ, 2006, MED CARE RES REV, V63, P29, DOI 10.1177/1077558705283122; Westbrook Kevin W, 2014, Health Mark Q, V31, P97, DOI 10.1080/07359683.2014.907114	53	22	22	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131805	10.1371/journal.pone.0131805	http://dx.doi.org/10.1371/journal.pone.0131805			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EC	26151864	Green Accepted, Green Published, gold			2022-12-27	WOS:000358158900025
J	Mailhiot, SE; Zignego, DL; Prigge, JR; Wardwell, ER; Schmidt, EE; June, RK				Mailhiot, Sarah E.; Zignego, Donald L.; Prigge, Justin R.; Wardwell, Ella R.; Schmidt, Edward E.; June, Ronald K.			Non-Invasive Quantification of Cartilage Using a Novel In Vivo Bioluminescent Reporter Mouse	PLOS ONE			English	Article							OSTEOARTHRITIC CARTILAGE; CHONDROCYTE HYPERTROPHY; JOINT DAMAGE; MODEL; MICE; HISTOPATHOLOGY; MORPHOLOGY; DELIVERY	Mouse models are common tools for examining post-traumatic osteoarthritis (OA), which involves cartilage deterioration following injury or stress. One challenge to current mouse models is longitudinal monitoring of the cartilage deterioration in vivoin the same mouse during an experiment. The objective of this study was to assess the feasibility for using a novel transgenic mouse for non-invasive quantification of cartilage. Chondrocytes are defined by expression of the matrix protein aggrecan, and we developed a novel mouse containing a reporter luciferase cassette under the inducible control of the endogenous aggrecan promoter. We generated these mice by crossing a Cre-dependent luciferase reporter allele with an aggrecan creERT2 knockin allele. The advantage of this design is that the targeted knockin retains the intact endogenous aggrecan locus and expresses the tamoxifen-inducible CreERT2 protein from a second IRES-driven open reading frame. These mice display bioluminescence in the joints, tail, and trachea, consistent with patterns of aggrecan expression. To evaluate this mouse as a technology for non-invasive quantification of cartilage loss, we characterized the relationship between loss of bioluminescence and loss of cartilage after induction with (i) ex vivo collagenase digestion, (ii) an in vivo OA model utilizing treadmill running, and (iii) age. Ex vivo experiments revealed that collagenase digestion of the femur reduced both luciferase signal intensity and pixel area, demonstrating a link between cartilage degradation and bioluminescence. In an in vivo model of experimental OA, we found decreased bioluminescent signal and pixel area, which correlated with pathological disease. We detected a decrease in both bioluminescent signal intensity and area with natural aging from 2 to 13 months of age. These results indicate that the bioluminescent signal from this mouse may be used as a non-invasive quantitative measure of cartilage. Future studies may use this reporter mouse to advance basic and preclinical studies of murine experimental OA with applications in synovial joint biology, disease pathogenesis, and drug delivery.	[Mailhiot, Sarah E.; Schmidt, Edward E.; June, Ronald K.] Montana State Univ, Mol Biosci Program, Bozeman, MT 59717 USA; [Prigge, Justin R.; Schmidt, Edward E.] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Mailhiot, Sarah E.; Zignego, Donald L.; Wardwell, Ella R.; June, Ronald K.] Montana State Univ, Dept Mech & Ind Engn, Bozeman, MT 59717 USA; [June, Ronald K.] Montana State Univ, Affiliate Fac, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	June, RK (corresponding author), Montana State Univ, Mol Biosci Program, Bozeman, MT 59717 USA.	rjune@me.montana.edu		Mailhiot, Sarah/0000-0001-7303-0751	Montana State University Vice President for Research; NIH [P20GM10339405S1]; NATIONAL INSTITUTE ON AGING [R01AG040020] Funding Source: NIH RePORTER	Montana State University Vice President for Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by awards from the Montana State University Vice President for Research and NIH P20GM10339405S1 to RKJ.	Arden N, 2006, BEST PRACT RES CL RH, V20, P3, DOI 10.1016/j.berh.2005.09.007; Bowles RD, 2014, ARTHRITIS RHEUMATOL, V66, P637, DOI 10.1002/art.38279; Chen JQ, 2013, J BONE MINER RES, V28, P1160, DOI 10.1002/jbmr.1834; Christiansen BA, 2012, OSTEOARTHR CARTILAGE, V20, P773, DOI 10.1016/j.joca.2012.04.014; Edwards SHR, 2011, VET J, V190, P15, DOI 10.1016/j.tvjl.2010.09.019; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Glasson SS, 2004, ARTHRITIS RHEUM-US, V50, P2547, DOI 10.1002/art.20558; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Gui YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046076; Henry SP, 2009, GENESIS, V47, P805, DOI 10.1002/dvg.20564; Hosaka Y, 2013, P NATL ACAD SCI USA, V110, P1875, DOI 10.1073/pnas.1207458110; Hutchinson ID, 2014, INT J RADIAT BIOL, V90, P821, DOI 10.3109/09553002.2014.927935; June RK, 2010, J AM CHEM SOC, V132, P10680, DOI 10.1021/ja1040418; KAEDING C C, 1990, Arthroscopy, V6, P33, DOI 10.1016/0749-8063(90)90094-T; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Kim BJ, 2013, OSTEOARTHR CARTILAGE, V21, P2013, DOI 10.1016/j.joca.2013.09.012; Kotwal N, 2012, OSTEOARTHR CARTILAGE, V20, P887, DOI 10.1016/j.joca.2012.04.012; Leahy AA, 2015, ARTHRITIS RHEUMATOL, V67, P442, DOI 10.1002/art.38957; Li W, 2015, J ORTHOP RES; Lim NH, 2014, ARTHRITIS RHEUMATOL, V66, P589, DOI 10.1002/art.38295; Little CB, 2009, ARTHRITIS RHEUM-US, V60, P3723, DOI 10.1002/art.25002; Little CB, 2013, NAT REV RHEUMATOL, V9, P485, DOI 10.1038/nrrheum.2013.72; MUNDLOS S, 1991, MATRIX, V11, P339, DOI 10.1016/S0934-8832(11)80205-2; Palmer AW, 2006, P NATL ACAD SCI USA, V103, P19255, DOI 10.1073/pnas.0606406103; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Renders GAP, 2014, DENTOMAXILLOFAC RAD, V43, DOI 10.1259/dmfr.20130098; Ruan MZC, 2013, ARTHRITIS RHEUM-US, V65, P388, DOI 10.1002/art.37766; Rudolphi K, 2003, OSTEOARTHR CARTILAGE, V11, P738, DOI 10.1016/S1063-4584(03)00153-5; Safran Michal, 2003, Mol Imaging, V2, P297, DOI 10.1162/153535003322750637; Sgariglia F, 2013, BONE, V57, P220, DOI 10.1016/j.bone.2013.08.012; Siebelt M, 2011, J ORTHOP RES, V29, P1788, DOI 10.1002/jor.21444; STERNBERG SR, 1983, COMPUTER, V16, P22, DOI 10.1109/MC.1983.1654163; Stock M, 2015, OSTEOARTHRITIS CARTI; Thomas N, 2015, J ORTHOP RES; Ushiku C, 2010, J ORTHOP RES, V28, P1338, DOI 10.1002/jor.21105; VANDERKRAAN PM, 1990, J EXP PATHOL, V71, P19; VANOSCH GJVM, 1994, J ORTHOP RES, V12, P168, DOI 10.1002/jor.1100120204; Wagner SC, 2001, J COMPUT ASSIST TOMO, V25, P661, DOI 10.1097/00004728-200109000-00001	39	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0130564	10.1371/journal.pone.0130564	http://dx.doi.org/10.1371/journal.pone.0130564			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151638	Green Published, gold, Green Submitted			2022-12-27	WOS:000358158900012
J	Sanguankeo, A; Upala, S; Cheungpasitporn, W; Ungprasert, P; Knight, EL				Sanguankeo, Anawin; Upala, Sikarin; Cheungpasitporn, Wisit; Ungprasert, Patompong; Knight, Eric L.			Effects of Statins on Renal Outcome in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							PROGRESSION; THERAPY; PRAVASTATIN; PEOPLE; ROSUVASTATIN; ATORVASTATIN; CARE	Background HMG CoA reductase inhibitors (statins) are known to prevent cardiovascular disease and improve lipid profiles. However, the effects of statins on renal outcomes, including decline in estimated glomerular filtration rate (eGFR) and proteinuria in patients with chronic kidney disease (CKD), are controversial. This meta-analysis evaluated the impact of statins on renal outcomes in patients with CKD. Materials and Methods We comprehensively searched the databases of MEDLINE, EMBASE, and Cochrane Databases. The inclusion criteria were published RCT and cohort studies comparing statin therapy to placebo or active controls in patients with CKD (eGFR <60 ml/min/1.73 m(2)) not requiring dialysis. The primary outcome was the differences in the change of eGFR. We also examined change of protein concentration in urine as a secondary outcome. A meta-analysis comparing statin and its control groups and a subgroup analysis examining intensity of statin were performed. Results From 142 full-text articles, 10 studies were included in the meta-analysis. Overall, there was a significant difference in rate of eGFR change per year favoring statin group (mean difference (MD) = 0.10 ml/min/1.73 m(2), 95% CI: 0.09 to 0.12). In our subgroup analysis, those who received high-intensity statins had a significant difference in eGFR with a MD of 3.35 (95% CI: 0.91 to 5.79) ml/min/1.73 m(2) compared to control. No significant change in eGFR was found with moderate-and low-intensity statin therapy. Compared with the control group, the statin group did not have a difference in reduction of proteinuria with MD in change of proteinuria of 0.19 gm/day (95% CI: -0.02 to 0.40). Conclusion Overall, there was a difference in change of eGFR between the statin and control group. High-intensity statins were found to improve a decline in eGFR in population with CKD not requiring dialysis compared with control, but moderate- and low-intensity statins were not. Statins were not found to decrease proteinuria in patients with CKD.	[Sanguankeo, Anawin; Upala, Sikarin] Columbia Univ Coll Phys & Surg, Bassett Med Ctr, Dept Internal Med, Cooperstown, NY USA; [Sanguankeo, Anawin; Upala, Sikarin] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Prevent & Social Med, Bangkok 10700, Thailand; [Sanguankeo, Anawin] Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA; [Cheungpasitporn, Wisit] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA; [Ungprasert, Patompong] Mayo Clin, Div Rheumatol, Rochester, MN USA; [Knight, Eric L.] Columbia Univ Coll Phys & Surg, Bassett Med Ctr, Div Nephrol, Cooperstown, NY USA	Columbia University; Mahidol University; Johns Hopkins University; Mayo Clinic; Mayo Clinic; Columbia University	Sanguankeo, A (corresponding author), Columbia Univ Coll Phys & Surg, Bassett Med Ctr, Dept Internal Med, Cooperstown, NY USA.	anawin.sanguankeo@bassett.org	Cheungpasitporn, Wisit/H-8194-2019	Cheungpasitporn, Wisit/0000-0001-9954-9711				Bianchi S, 2003, AM J KIDNEY DIS, V41, P565, DOI 10.1053/ajkd.2003.50140; Cases A, 2005, KIDNEY INT, V68, P87; Douglas K, 2006, ANN INTERN MED, V145, P117, DOI 10.7326/0003-4819-145-2-200607180-00009; Fried LF, 2001, KIDNEY INT, V59, P260, DOI 10.1046/j.1523-1755.2001.00487.x; Geng Q, 2014, AM J CARDIOL, V114, P562, DOI 10.1016/j.amjcard.2014.05.033; Haynes R, 2014, J AM SOC NEPHROL, V25, P1825, DOI 10.1681/ASN.2013090965; Higgins JPT, 2008, COCHRANE HDB SYSTEMA, Vxxi, DOI DOI 10.1002/9780470712184; Hou WY, 2013, EUR HEART J, V34, P1807, DOI 10.1093/eurheartj/eht065; James MT, 2010, LANCET, V375, P1296, DOI 10.1016/S0140-6736(09)62004-3; Kendrick J, 2010, AM J KIDNEY DIS, V55, P42, DOI 10.1053/j.ajkd.2009.09.020; Koren MJ, 2009, AM J KIDNEY DIS, V53, P741, DOI 10.1053/j.ajkd.2008.11.025; Lee HS, 1997, KIDNEY INT, V51, P1151, DOI 10.1038/ki.1997.158; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Natsuaki M, 2012, AM J CARDIOL, V110, P1568, DOI 10.1016/j.amjcard.2012.07.021; Palmer SC, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007784.pub2, 10.1590/1516-3180.20141325T1]; Palmer SC, 2014, SAO PAULO MED J, V132, P314, DOI 10.1590/1516-3180.20141325T1; Rahman M, 2008, AM J KIDNEY DIS, V52, P412, DOI 10.1053/j.ajkd.2008.05.027; Ruan XZ, 2009, NAT REV NEPHROL, V5, P713, DOI 10.1038/nrneph.2009.184; Sawara Y, 2008, INTERNAL MED, V47, P1505, DOI 10.2169/internalmedicine.47.1159; Sharma K, 2008, J CLIN INVEST, V118, P1645, DOI 10.1172/JCI32691; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tonelli M, 2005, CIRCULATION, V112, P171, DOI 10.1161/CIRCULATIONAHA.104.517565; Tonelli M, 2003, J AM SOC NEPHROL, V14, P1605, DOI 10.1097/01.ASN.0000068461.45784.2F; Vidt DG, 2006, AM J CARDIOL, V97, P1602, DOI 10.1016/j.amjcard.2005.12.052; Yasuda G, 2004, RENAL FAILURE, V26, P411, DOI 10.1081/JDI-120039826; Zoja C, 2002, KIDNEY INT, V61, P1635, DOI 10.1046/j.1523-1755.2002.00332.x	29	61	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132970	10.1371/journal.pone.0132970	http://dx.doi.org/10.1371/journal.pone.0132970			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151753	Green Submitted, Green Published, gold			2022-12-27	WOS:000358158900053
J	Choi, E; Byeon, SJ; Kim, SH; Lee, HJ; Kwon, HJ; Ahn, H; Kim, DH; Chang, MS				Choi, Euno; Byeon, Sun-ju; Kim, Soo Hee; Lee, Hyun Ju; Kwon, Hyeong Ju; Ahn, HyeSeong; Kim, Dong Ha; Chang, Mee Soo			Implication of Leptin-Signaling Proteins and Epstein-Barr Virus in Gastric Carcinomas	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; RECEPTOR OB-R; GROWTH-FACTOR; EXPRESSION; CELL; OVEREXPRESSION; PROLIFERATION; ACTIVATION; PROGNOSIS; PATHWAY	We investigated the clinicopathological implications of leptin-signaling proteins and Epstein-Barr virus (EBV)-infection status in gastric carcinomas. Immunohistochemistry for leptin signalling-related proteins (leptin, leptin-receptor, pSTAT3, ERK, pAkt, mTOR and HIF-1 alpha), and in situ hybridization for EBV-encoded small RNAs was performed in 343 cases of gastric carcinomas. The siRNA against leptin-receptor was transfected into three stomach cancer cell lines, and western blot for caspase 3 was performed. The TNM stage was a prognostic factor in all 343 patients, and was negatively correlated with expression of leptin, pSTAT3, ERK, pAkt, mTOR and HIF-1 alpha (P < 0.05). Leptin-receptor expression was correlated with poor survival in 207 patients of the advanced gastric cancer (AGC) subgroup, 139 of the Lauren diffuse group, and in 160 patients with lymph node metastasis (P < 0.05, respectively). Additionally, in stomach cancer cells, cleaved caspase 3 level increased by leptin-receptor inhibition, that is, apoptosis increased. Interestingly, EBV-positive AGC (n = 29) tended to show better survival of patients than EBV-negative AGC (n = 178) (P = 0.06). pAkt expression was related with a good survival of 32 patients (9%) in the EBV-positive subgroup, but was not an independent prognostic factor. Among, leptin signalingrelated proteins, expressions of leptin-receptor and mTOR were different between EBVpositive subgroup and EBV-negative subgroup (P < 0.05, respectively). In conclusion, leptin- signaling proteins and EBV status show different significance on patient survival, according to subsets of gastric carcinomas. The leptin-receptor may predict poor patient prognosis in the AGC, Lauren diffuse and lymph node metastasis subgroups, while EBV-positive status can show a good prognosis in the AGC. Each leptin signaling-related protein may be differently involved in carcinogenesis of EBV-negative and EBV-positive subsets.	[Choi, Euno; Kim, Soo Hee; Lee, Hyun Ju; Kwon, Hyeong Ju; Kim, Dong Ha; Chang, Mee Soo] Seoul Natl Univ, Coll Med, Dept Pathol, Boramae Hosp, Seoul 151, South Korea; [Byeon, Sun-ju; Ahn, HyeSeong] Seoul Natl Univ, Boramae Hosp, Dept Surg, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Chang, MS (corresponding author), Seoul Natl Univ, Coll Med, Dept Pathol, Boramae Hosp, Seoul 151, South Korea.	meesooch@snu.ac.kr		Byeon, Sun-ju/0000-0002-9599-4970	SNUH Research Fund [0420140350 (2014-1167)]	SNUH Research Fund	This work was funded by grant number 0420140350 (2014-1167) from the SNUH Research Fund (https://cris.snuh.org/ncris/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballinger A, 1999, GUT, V44, P153, DOI 10.1136/gut.44.2.153; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bjorbaek C, 1997, J BIOL CHEM, V272, P32686, DOI 10.1074/jbc.272.51.32686; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Cabuk D, 2007, ONCOLOGY-BASEL, V72, P111, DOI 10.1159/000111118; Camargo MC, 2014, GUT, V63, P236, DOI 10.1136/gutjnl-2013-304531; Cammisotto PG, 2007, HISTOL HISTOPATHOL, V22, P199, DOI 10.14670/HH-22.199; Chang Mee Soo, 2005, Cancer Res Treat, V37, P257, DOI 10.4143/crt.2005.37.5.257; Chang MS, 2013, J VIROL, V87, P10515, DOI 10.1128/JVI.00955-13; Chang MS, 2001, PATHOL RES PRACT, V197, P395, DOI 10.1078/0344-0338-00052; Chen Jiezhong, 2012, World J Virol, V1, P154, DOI 10.5501/wjv.v1.i6.154; Cho JY, 2013, J GASTRIC CANCER, V13, P129, DOI 10.5230/jgc.2013.13.3.129; Edge SB, 2010, AJCC CANC STAGING MA, P117, DOI DOI 10.1007/978-0-387-88441-7; Fukayama M, 2010, PATHOL INT, V60, P337, DOI 10.1111/j.1440-1827.2010.02533.x; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; Griffiths EA, 2007, BRIT J CANCER, V96, P95, DOI 10.1038/sj.bjc.6603524; Hegyi K, 2004, CELL BIOL INT, V28, P159, DOI 10.1016/j.cellbi.2003.12.003; Iizasa H, 2012, VIRUSES-BASEL, V4, P3420, DOI 10.3390/v4123420; Ishikawa M, 2006, WORLD J GASTROENTERO, V12, P5517, DOI 10.3748/wjg.v12.i34.5517; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Kaneda A, 2012, CANCER RES, V72, P3445, DOI 10.1158/0008-5472.CAN-11-3919; Kang GH, 2002, AM J PATHOL, V160, P787, DOI 10.1016/S0002-9440(10)64901-2; Kim B, 2010, PATHOLOGY, V42, P58, DOI 10.3109/00313020903356392; Lang K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-27; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee HS, 2004, CLIN CANCER RES, V10, P1698, DOI 10.1158/1078-0432.CCR-1122-3; Lee S, 2010, KOREAN J PATHOL, V44, P252, DOI 10.4132/KoreanJPathol.2010.44.3.252; Mizokami K, 2006, J SURG ONCOL, V94, P149, DOI 10.1002/jso.20568; Procaccini C, 2012, MOL ASPECTS MED, V33, P35, DOI 10.1016/j.mam.2011.10.012; Ren H, 2014, CANCER LETT, V354, P172, DOI 10.1016/j.canlet.2014.08.001; Sasaki T, 2013, PATHOBIOLOGY, V81, P36, DOI 10.1159/000351721; Schneider R, 2001, HORM METAB RES, V33, P1, DOI 10.1055/s-2001-12617; Sukawa Y, 2014, DIGESTION, V89, P12, DOI 10.1159/000356201; Sukawa Y, 2012, WORLD J GASTROENTERO, V18, P6577, DOI 10.3748/wjg.v18.i45.6577; Sweeney G, 2002, CELL SIGNAL, V14, P655, DOI 10.1016/S0898-6568(02)00006-2; Uddin S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-74; Woo S, 2011, PATHOBIOLOGY, V78, P295, DOI 10.1159/000321696; Yarandi SS, 2011, NUTRITION, V27, P269, DOI 10.1016/j.nut.2010.07.004	39	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130839	10.1371/journal.pone.0130839	http://dx.doi.org/10.1371/journal.pone.0130839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147886	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600052
J	Guarino, F; Cicatelli, A; Brundu, G; Heinze, B; Castiglione, S				Guarino, Francesco; Cicatelli, Angela; Brundu, Giuseppe; Heinze, Berthold; Castiglione, Stefano			Epigenetic Diversity of Clonal White Poplar (Populus alba L.) Populations: Could Methylation Support the Success of Vegetative Reproduction Strategy?	PLOS ONE			English	Article							DNA-METHYLATION; STRESS; CONSERVATION; BIODIVERSITY; MYCORRHIZAL; HOTSPOTS; GENOMES; ORIGIN; MEMORY	The widespread poplar populations of Sardinia are vegetatively propagated and live in different natural environments forming large monoclonal stands. The main goals of the present study were: i) to investigate/measure the epigenetic diversity of the poplar populations by determining their DNA methylation status; ii) to assess if and how methylation status influences population clustering; iii) to shed light on the changes that occur in the epigenome of ramets of the same poplar clone. To these purposes, 83 white poplar trees were sampled at different locations on the island of Sardinia. Methylation sensitive amplified polymorphism analysis was carried out on the genomic DNA extracted from leaves at the same juvenile stage. The study showed that the genetic biodiversity of poplars is quite limited but it is counterbalanced by epigenetic inter-population molecular variability. The comparison between MspI and HpaII DNA fragmentation profiles revealed that environmental conditions strongly influence hemi-methylation of the inner cytosine. The variable epigenetic status of Sardinian white poplars revealed a decreased number of population clusters. Landscape genetics analyses clearly demonstrated that ramets of the same clone were differentially methylated in relation to their geographic position. Therefore, our data support the notion that studies on plant biodiversity should no longer be restricted to genetic aspects, especially in the case of vegetatively propagated plant species.	[Guarino, Francesco; Cicatelli, Angela; Castiglione, Stefano] Univ Salerno, Dipartimento Chim & Biol, Fisciano, Italy; [Brundu, Giuseppe] Univ Sassari, Dipartimento Agr, I-07100 Sassari, Italy; [Heinze, Berthold] Austrian Fed Res Ctr Forests, Dept Forest Genet, Vienna, Austria	University of Salerno; University of Sassari	Castiglione, S (corresponding author), Univ Salerno, Dipartimento Chim & Biol, Fisciano, Italy.	scastiglione@unisa.it	Heinze, Berthold/A-8734-2011; Brundu, Giuseppe/C-6772-2012; Guarino, Francesco/AAB-3663-2019	Heinze, Berthold/0000-0002-7571-9138; Brundu, Giuseppe/0000-0003-3076-4098; Guarino, Francesco/0000-0001-8536-4257; Castiglione, Stefano/0000-0002-0632-4677; Cicatelli, Angela/0000-0001-6996-3495	Italian Ministry of Environment, Land and Sea Protection; People's Republic of China; Italian Ministry for Education, University and Research [PRIN 2003077418]; EC under the Trees4Future project [284181]	Italian Ministry of Environment, Land and Sea Protection; People's Republic of China; Italian Ministry for Education, University and Research(Ministry of Education, Universities and Research (MIUR)); EC under the Trees4Future project	The research was financed by the Italian Ministry of Environment, Land and Sea Protection within the project "Research and development in biotechnology applied to the protection of the environment" in collaboration with the People's Republic of China to SC, and by the Italian Ministry for Education, University and Research (PRIN 2003077418) to SC and to FG for the PhD course in System biology of University of Salerno. Financial support by the Transnational Access to Research Infrastructures activity in the 7th Framework Programme of the EC under the Trees4Future project (no. 284181) for conducting the research is gratefully acknowledged to FG.	Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Aina R, 2004, PHYSIOL PLANTARUM, V121, P472, DOI 10.1111/j.1399-3054.2004.00343.x; Alvarez ME, 2010, MOL PLANT PATHOL, V11, P563, DOI [10.1111/J.1364-3703.2010.00621.X, 10.1111/j.1364-3703.2010.00621.x]; Ashikawa I, 2001, PLANT MOL BIOL, V45, P31, DOI 10.1023/A:1006457321781; Brundu G, 2008, ANN BOT-LONDON, V102, P997, DOI 10.1093/aob/mcn192; Chen M, 2010, DEV GROWTH DIFFER, V52, P555, DOI 10.1111/j.1440-169X.2010.01192.x; Chen TP, 2004, CURR TOP DEV BIOL, V60, P55; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Cicatelli A, 2014, ENVIRON SCI POLLUT R, V21, P1723, DOI 10.1007/s11356-013-2072-4; Cicatelli A, 2012, ENVIRON EXP BOT, V75, P25, DOI 10.1016/j.envexpbot.2011.08.012; Darwin C., 1872, ORIGIN SPECIES MEANS, V144, P971; Dickmann DI, 2001, POPLAR CULTURE N AM, p1e42; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Du QZ, 2012, J HERED, V103, P853, DOI 10.1093/jhered/ess061; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2011, INTEGRATED SOFTWARE; Foret S, 2012, P NATL ACAD SCI USA, V109, P4968, DOI 10.1073/pnas.1202392109; Fussi B, 2012, EUR J FOREST RES, V131, P347, DOI 10.1007/s10342-011-0506-4; Fussi B, 2010, TREE GENET GENOMES, V6, P439, DOI 10.1007/s11295-009-0262-5; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guillot G., 2011, POPULATION GENETICS; Hauben M, 2009, P NATL ACAD SCI USA, V106, P20109, DOI 10.1073/pnas.0908755106; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Kovarik A, 1997, GENE, V204, P25, DOI 10.1016/S0378-1119(97)00503-9; Labra M, 2004, CHEMOSPHERE, V54, P1049, DOI 10.1016/j.chemosphere.2003.10.024; Labra M, 2002, PLANT BIOSYST, V136, P269, DOI 10.1080/11263500212331351179; Labra M, 2002, PLANT BIOLOGY, V4, P694, DOI 10.1055/s-2002-37398; Lantuejoul C, 2002, GEOSTATISTICAL SIMULATION, P1; Latzel V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3875; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Lukens LN, 2007, CURR OPIN PLANT BIOL, V10, P317, DOI 10.1016/j.pbi.2007.04.012; Ma KF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063977; Ma KF, 2012, TREE GENET GENOMES, V8, P1407, DOI 10.1007/s11295-012-0527-2; Medail F, 1997, ANN MO BOT GARD, V84, P112, DOI 10.2307/2399957; Michalakis Y, 1996, GENETICS, V142, P1061; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PEAKALL R, 1995, MOL ECOL, V4, P135, DOI 10.1111/j.1365-294X.1995.tb00203.x; Perez-Figueroa A, 2013, MOL ECOL RESOUR, V13, P522, DOI 10.1111/1755-0998.12064; Peterson Chris J., 1997, P263; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pritchard JK, 2000, GENETICS, V155, P945; Putiri EL, 2011, CLIN EPIGENETICS, V2, P299, DOI 10.1007/s13148-010-0017-z; QUEZEL P, 1985, PLANT CONSERVATION M, P9; Santos-del-Blanco L, 2013, TREE GENET GENOMES, V9, P499, DOI 10.1007/s11295-012-0574-8; Saze H, 2008, SEMIN CELL DEV BIOL, V19, P527, DOI 10.1016/j.semcdb.2008.07.017; Stolting KN, 2013, MOL ECOL, V22, P842, DOI 10.1111/mec.12011; Suter L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060364; Teyssier E, 2008, PLANTA, V228, P391, DOI 10.1007/s00425-008-0743-z; Thellier M, 2013, PLANT BIOLOGY, V15, P1, DOI 10.1111/j.1438-8677.2012.00674.x; Trewavas A, 2003, ANN BOT-LONDON, V92, P1, DOI 10.1093/aob/mcg101; Van Oosten MJ, 2014, CRIT REV PLANT SCI, V33, P64, DOI 10.1080/07352689.2014.852920; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WAGNER I, 1981, BIOCHIM BIOPHYS ACTA, V654, P52, DOI 10.1016/0005-2787(81)90135-0; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275; Yaish MW, 2011, J EXP BOT, V62, P3727, DOI 10.1093/jxb/err177; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769; Zhao Y, 2012, J GENET GENOMICS, V39, P307, DOI 10.1016/j.jgg.2012.02.009	62	34	34	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131480	10.1371/journal.pone.0131480	http://dx.doi.org/10.1371/journal.pone.0131480			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147352	gold, Green Submitted, Green Published			2022-12-27	WOS:000358157600100
J	Keenan, SW; Hill, CA; Kandoth, C; Buck, LT; Warren, DE				Keenan, Sarah W.; Hill, Craig A.; Kandoth, Cyriac; Buck, Leslie T.; Warren, Daniel E.			Transcriptomic Responses of the Heart and Brain to Anoxia in the Western Painted Turtle	PLOS ONE			English	Article							GENE-EXPRESSION; CARDIOVASCULAR-RESPONSES; HYPOXIA TOLERANCE; NUCLEAR RECEPTORS; VITAMIN-C; OXYGEN; SURVIVAL; CYR61; CYCLOOXYGENASE-2; IDENTIFICATION	Painted turtles are the most anoxia-tolerant tetrapods known, capable of surviving without oxygen for more than four months at 3 degrees C and 30 hours at 20 degrees C. To investigate the transcriptomic basis of this ability, we used RNA-seq to quantify mRNA expression in the painted turtle ventricle and telencephalon after 24 hours of anoxia at 19 degrees C. Reads were obtained from 22,174 different genes, 13,236 of which were compared statistically between treatments for each tissue. Total tissue RNA contents decreased by 16% in telencephalon and 53% in ventricle. The telencephalon and ventricle showed >= 2x expression (increased expression) in 19 and 23 genes, respectively, while only four genes in ventricle showed <= 0.5x changes (decreased expression). When treatment effects were compared between anoxic and normoxic conditions in the two tissue types, 31 genes were increased (>= 2x change) and 2 were decreased (<= 0.5x change). Most of the effected genes were immediate early genes and transcription factors that regulate cellular growth and development; changes that would seem to promote transcriptional, translational, and metabolic arrest. No genes related to ion channels, synaptic transmission, cardiac contractility or excitation-contraction coupling changed. The generalized expression pattern in telencephalon and across tissues, but not in ventricle, correlated with the predicted metabolic cost of transcription, with the shortest genes and those with the fewest exons showing the largest increases in expression.	[Keenan, Sarah W.; Hill, Craig A.; Warren, Daniel E.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA; [Kandoth, Cyriac] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA; [Buck, Leslie T.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada	Saint Louis University; Washington University (WUSTL); University of Toronto	Warren, DE (corresponding author), St Louis Univ, Dept Biol, St Louis, MO 63103 USA.	dwarren4@slu.edu		Keenan, Sarah W./0000-0002-2905-7823	National Science Foundation [IOS 1253939]; Natural Sciences and Engineering Research Council of Canada	National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by National Science Foundation (IOS 1253939) to DEW, and Natural Sciences and Engineering Research Council of Canada to LTB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Bailey DJ, 2003, MOL BRAIN RES, V116, P147, DOI 10.1016/S0169-328X(03)00288-2; BELKIN DA, 1968, RESP PHYSIOL, V4, P1, DOI 10.1016/0034-5687(68)90002-9; BELKIN DA, 1963, SCIENCE, V139, P492, DOI 10.1126/science.139.3554.492; Bickler PE, 1998, J EXP BIOL, V201, P1141; Bickler PE, 2000, J NEUROSCI, V20, P3522, DOI 10.1523/JNEUROSCI.20-10-03522.2000; Bickler PE, 2007, ANNU REV PHYSIOL, V69, P145, DOI 10.1146/annurev.physiol.69.031905.162529; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Boutilier RG, 1997, J EXP BIOL, V200, P387; Buck LT, 2012, ADV EXP MED BIOL, V758, P71, DOI 10.1007/978-94-007-4584-1_10; Buck LT, 1998, J EXP BIOL, V201, P289; Burzle M, 2012, CURR TOP MEMBR, V70, P357, DOI 10.1016/B978-0-12-394316-3.00011-9; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200; Cho Y, 2009, MOL PHARMACOL, V76, P1360, DOI 10.1124/mol.109.057000; Dwyer J, 2007, ANN NY ACAD SCI, V1114, P36, DOI 10.1196/annals.1396.022; Dwyer JM, 2010, CLIN EXP PHARMACOL P, V37, P83, DOI 10.1111/j.1440-1681.2009.05236.x; Feliciano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076247; Geiger K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026465; Gofflot F, 2007, CELL, V131, P405, DOI 10.1016/j.cell.2007.09.012; GOLDENBERG H, 1994, J BIOENERG BIOMEMBR, V26, P359, DOI 10.1007/BF00762776; Gracey AY, 2001, P NATL ACAD SCI USA, V98, P1993, DOI 10.1073/pnas.98.4.1993; Greenway SC, 2000, J EXP ZOOL, V287, P477, DOI 10.1002/1097-010X(20001201)287:7<477::AID-JEZ3>3.0.CO;2-4; Healy S, 2013, PHARMACOL THERAPEUT, V137, P64, DOI 10.1016/j.pharmthera.2012.09.001; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Hicks JMT, 2000, J EXP BIOL, V203, P3775; Hicks JMT, 2000, J EXP BIOL, V203, P3765; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Ishiguro H, 2001, ONCOGENE, V20, P5062, DOI 10.1038/sj.onc.1204603; Jackson DC, 2002, J PHYSIOL-LONDON, V543, P731, DOI 10.1113/jphysiol.2002.024729; Ji YS, 1998, CIRC RES, V83, P295, DOI 10.1161/01.RES.83.3.295; Johlin JM, 1933, J BIOL CHEM, V103, P107; Latinkic BV, 2001, ENDOCRINOLOGY, V142, P2549, DOI 10.1210/en.142.6.2549; Liang GS, 1996, J BIOL CHEM, V271, P1695, DOI 10.1074/jbc.271.3.1695; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu C, 2009, BIOINFORMATICS, V25, P2020, DOI 10.1093/bioinformatics/btp360; Lutz PL, 2002, INTEGR COMP BIOL, V42, P463, DOI 10.1093/icb/42.3.463; Mohan HM, 2012, CLIN CANCER RES, V18, P3223, DOI 10.1158/1078-0432.CCR-11-2953; Neyns B, 1996, ONCOGENE, V12, P1247; NORTH AJ, 1994, CIRC RES, V75, P33, DOI 10.1161/01.RES.75.1.33; Noshiro M, 2009, GENES CELLS, V14, P29, DOI 10.1111/j.1365-2443.2008.01247.x; Overgaard J, 2004, J EXP BIOL, V207, P655, DOI 10.1242/jeb.00791; Pamenter ME, 2011, P NATL ACAD SCI USA, V108, P11274, DOI 10.1073/pnas.1102429108; Pamenter ME, 2008, AM J PHYSIOL-REG I, V294, pR606, DOI 10.1152/ajpregu.00433.2007; Park J, 2007, BIOCHEM BIOPH RES CO, V360, P447, DOI 10.1016/j.bbrc.2007.06.077; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; PEREZPINZON MA, 1992, AM J PHYSIOL, V262, pR712, DOI 10.1152/ajpregu.1992.262.4.R712; Ramaglia V, 2004, J EXP BIOL, V207, P3775, DOI 10.1242/jeb.01211; Regard JB, 2004, J NEUROSCI, V24, P4092, DOI 10.1523/JNEUROSCI.4252-03.2004; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Schmedtje JF, 1997, J BIOL CHEM, V272, P601; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shaffer HB, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r28; Shin DSH, 2003, PHYSIOL BIOCHEM ZOOL, V76, P41, DOI 10.1086/374274; Sjostrom M, 2007, P NATL ACAD SCI USA, V104, P16922, DOI 10.1073/pnas.0706838104; Stecyk JAW, 2012, COMP BIOCHEM PHYS D, V7, P59, DOI 10.1016/j.cbd.2011.11.001; Stecyk JAW, 2009, AM J PHYSIOL-REG I, V297, pR756, DOI 10.1152/ajpregu.00102.2009; Stepp MW, 2014, BBA-MOL CELL RES, V1843, P1076, DOI 10.1016/j.bbamcr.2014.02.003; Ten Vadim S, 2002, Curr Opin Crit Care, V8, P242, DOI 10.1097/00075198-200206000-00008; Tonini T, 2003, ONCOGENE, V22, P6549, DOI 10.1038/sj.onc.1206816; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ueki I, 2011, AM J PHYSIOL-ENDOC M, V301, pE668, DOI 10.1152/ajpendo.00151.2011; ULTSCH GR, 1982, J EXP BIOL, V96, P11; Warren DE, 2007, J COMP PHYSL; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; You JJ, 2010, EXP EYE RES, V91, P825, DOI 10.1016/j.exer.2010.10.006	70	15	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131669	10.1371/journal.pone.0131669	http://dx.doi.org/10.1371/journal.pone.0131669			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147940	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600125
J	Park, HYL; Kim, SE; Park, CK				Park, Hae-Young Lopilly; Kim, Sung Eum; Park, Chan Kee			Optic Disc Change during Childhood Myopic Shift: Comparison between Eyes with an Enlarged Cup-To-Disc Ratio and Childhood Glaucoma Compared to Normal Myopic Eyes	PLOS ONE			English	Article							CORNEAL BIOMECHANICAL PROPERTIES; INTRAOCULAR-PRESSURE; NERVE HEAD; HYSTERESIS; THICKNESS; REVERSAL; SCLERA; AGE	Background Progressive disc tilting and the development or enlargement of peripapillary atrophy (PPA) are observed during a myopic shift in children. This could be related to the changes around the optic nerve head during eyeball elongation. If the biomechanical properties at or around the optic nerve head are changed after exposure to elevated intraocular pressure (IOP) in glaucoma eyes, different response of the disc tilting and PPA changes could take place during eyeball elongation by myopic shift. On the basis of this background, the aim of this study was to compare the morphological changes in the optic disc induced by a myopic shift during childhood between normal control eyes, eyes from disc suspects with an enlarged cup-to-disc ratio (CDR), and eyes with childhood glaucoma. Methods Total of 82 eyes from 82 subjects younger than 14 years of age were included in the study. Serial disc photographs were classified into one of two groups: eyes with an optic nerve head (ONH) or peripapillary atrophy (PPA) change or without an ONH/PPA change. Using ImageJ software, the outlines of the optic disc and PPA were plotted, and the vertical disc diameter (VDD), horizontal disc diameter (HDD), and maximum PPA width (PPW) were measured. The changes in the ratios of these parameters and the relationships between the degree of myopic shift or the ONH/PPA change were analyzed. Results Twenty-five eyes with normal optic disc appearance, 36 eyes with enlarged cup-to-disc ratio, and 21 eyes of glaucoma patients were analyzed. The initial intraocular pressure (IOP) at diagnosis was significantly different among the groups (P<0.001). The degree of myopic shift during follow-up period was not significantly different among the groups (P=0.612). However, the changes in the HDD/VDD and PPW/VDD ratios were significantly greater in the disc suspect group and significantly smaller in the glaucoma group. Among the 42 eyes with an ONH/PPA change, 16 (38.1%) were from the normal control group, 24 (57.1%) were from the disc suspect group, and 2 (4.8%) were from the glaucoma group (P < 0.001). Conclusions and Relevance The optic disc change during childhood myopic shift was different in eyes with various conditions. Eyes of childhood glaucoma showed less change in the disc morphology during myopic shift compared to eyes with normal disc or enlarged cup-to-disc ratio.	[Park, Hae-Young Lopilly; Kim, Sung Eum; Park, Chan Kee] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Park, CK (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	ckpark@catholic.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2014R1A1A3049403]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. NRF-2014R1A1A3049403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cone-Kimball E, 2013, MOL VIS, V19, P2023; Congdon NG, 2006, AM J OPHTHALMOL, V141, P868, DOI 10.1016/j.ajo.2005.12.007; Coudrillier B, 2013, BIOMECH MODEL MECHAN, V12, P941, DOI 10.1007/s10237-012-0455-y; Danford FL, 2013, INVEST OPHTH VIS SCI, V54, P7922, DOI 10.1167/iovs.13-12262; Grytz R, 2011, BIOMECH MODEL MECHAN, V10, P371, DOI 10.1007/s10237-010-0240-8; Huang WB, 2013, MED SCI MONIT BASIC, V19, P237, DOI 10.12659/MSMBR.889061; Hyman L, 2005, ARCH OPHTHALMOL-CHIC, V123, P977, DOI 10.1001/archopht.123.7.977; Jonas JB, 2013, ACTA OPHTHALMOL; Kaushik S, 2012, AM J OPHTHALMOL, V153, P840, DOI 10.1016/j.ajo.2011.10.032; Kim TW, 2012, OPHTHALMOLOGY, V119, P21, DOI 10.1016/j.ophtha.2011.07.051; Lesk MR, 1999, OPHTHALMOLOGY, V106, P1013, DOI 10.1016/S0161-6420(99)00526-6; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; Mochizuki H, 2011, OPHTHALMOLOGY, V118, P2008, DOI 10.1016/j.ophtha.2011.02.041; Park HYL, 2014, INVEST OPHTH VIS SCI, V55, P233, DOI 10.1167/iovs.12-10329; Pijanka JK, 2012, INVEST OPHTH VIS SCI, V53, P5258, DOI 10.1167/iovs.12-9705; Prata TS, 2012, CLIN EXP OPHTHALMOL, V40, P682, DOI 10.1111/j.1442-9071.2012.02790.x; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Meirelles SHS, 2008, J GLAUCOMA, V17, P470, DOI 10.1097/IJG.0b013e3181650f6e; Sullivan-Mee M, 2012, OPTOMETRY VISION SCI, V89, pE803, DOI 10.1097/OPX.0b013e3182504214; Wells AP, 2008, INVEST OPHTH VIS SCI, V49, P3262, DOI 10.1167/iovs.07-1556; Yan DM, 2011, INVEST OPHTH VIS SCI, V52, P821, DOI 10.1167/iovs.09-4651	21	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131781	10.1371/journal.pone.0131781	http://dx.doi.org/10.1371/journal.pone.0131781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147983	Green Published, gold			2022-12-27	WOS:000358157600144
J	Roberts-Crowley, ML; Rittenhouse, AR				Roberts-Crowley, Mandy L.; Rittenhouse, Ann R.			Characterization of ST14A Cells for Studying Modulation of Voltage-Gated Calcium Channels	PLOS ONE			English	Article							MEDIUM SPINY NEURONS; ARACHIDONIC-ACID RELEASE; RAT SYMPATHETIC NEURONS; D-2 DOPAMINE-RECEPTORS; HUNTINGTONS-DISEASE; PARKINSONS-DISEASE; PROGENITOR CELLS; COORDINATED EXPRESSION; MUSCARINIC INHIBITION; STRIATAL ASTROCYTES	In medium spiny neurons (MSNs) of the striatum, dopamine D-2 receptors (D(2)Rs) specifically inhibit the Ca(v)1.3 subtype of L-type Ca2+ channels (LTCs). MSNs are heterogeneous in their expression of dopamine receptors making the study of D2R pathways difficult in primary neurons. Here, we employed the ST14A cell line, derived from embryonic striatum and characterized to have properties of MSNs, to study Ca(v)1.3 current and its modulation by neurotransmitters. Round, undifferentiated ST14A cells exhibited little to no endogenous Ca2+ current while differentiated ST14A cells expressed endogenous Ca2+ current. Transfection with LTC subunits produced functional Ca(v)1.3 current from round cells, providing a homogeneous model system compared to native MSNs for studying D2R pathways. However, neither endogenous nor recombinant Ca(v)1.3 current was modulated by the D2R agonist quinpirole. We confirmed D2R expression in ST14A cells and also detected D(1)Rs, D(4)Rs, D(5)Rs, G(q), calcineurin and phospholipase A(2) using RT-PCR and/or Western blot analysis. Phospholipase C beta-1 (PLC beta-1) expression was not detected by Western blot analysis which may account for the lack of LTC modulation by D(2)Rs. These findings raise caution about the assumption that the presence of G-protein coupled receptors in cell lines indicates the presence of complete signaling cascades. However, exogenous arachidonic acid inhibited recombinant Ca(v)1.3 current indicating that channels expressed in ST14A cells are capable of modulation since they respond to a known signaling molecule downstream of D(2)Rs. Thus, ST14A cells provide a MSN-like cell line for studying channel modulation and signaling pathways that do not involve activation of PLC beta-1.	[Roberts-Crowley, Mandy L.; Rittenhouse, Ann R.] Univ Massachusetts, Sch Med, Dept Physiol, Program Neurosci, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester	Rittenhouse, AR (corresponding author), Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Program Neurosci, Worcester, MA 01655 USA.	Ann.Rittenhouse@umassmed.edu			National Institute of Health [R01-NS34195]; American Heart Association [9940225N]; University of Massachusetts Medical School; National Institute of Health Ruth L. Kirschstein National Research Service Award (NRSA) [5 TS32 NS07366-09]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034195] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Massachusetts Medical School; National Institute of Health Ruth L. Kirschstein National Research Service Award (NRSA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health (http://www.nih.gov/) grant #R01-NS34195, and American Heart Association (http://www.heart.org/HEARTORG/) grant #9940225N, and funding from the University of Massachusetts Medical School (umassmed.edu) to ARR. Also the National Institute of Health Ruth L. Kirschstein National Research Service Award (NRSA) (http://grants.nih.gov/training/nrsa.htm) grant #5 TS32 NS07366-09 to MLR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren-Beekendorf JA, 2004, J RECEPT SIG TRANSD, V24, P117, DOI 10.1081/LRST-200029953; AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; Bajorat R, 2005, J NEUROSCI RES, V82, P206, DOI 10.1002/jnr.20643; Bari M, 2013, FEBS J, V280, P3376, DOI 10.1111/febs.12329; Basselin M, 2008, NEUROCHEM RES, V33, P1373, DOI 10.1007/s11064-008-9595-y; Bell DC, 2001, J NEUROPHYSIOL, V85, P816, DOI 10.1152/jn.2001.85.2.816; Bhattacharjee AK, 2006, J CEREBR BLOOD F MET, V26, P1378, DOI 10.1038/sj.jcbfm.9600290; Bhattacharjee AK, 2007, NEUROIMAGE, V37, P1112, DOI 10.1016/j.neuroimage.2007.06.012; Bhattacharjee AK, 2005, PSYCHOPHARMACOLOGY, V180, P735, DOI 10.1007/s00213-005-2208-4; Bitner RS, 2006, NEUROPHARMACOLOGY, V50, P521, DOI 10.1016/j.neuropharm.2005.10.009; Blanchet F, 1999, SYNAPSE, V31, P140, DOI 10.1002/(SICI)1098-2396(199902)31:2<140::AID-SYN7>3.3.CO;2-U; Bosch M, 2004, EXP NEUROL, V190, P42, DOI 10.1016/j.expneurol.2004.06.027; Bottcher T, 2003, J NEUROSCI RES, V73, P42, DOI 10.1002/jnr.10624; Cattaneo E, 1996, J BIOL CHEM, V271, P23374, DOI 10.1074/jbc.271.38.23374; Cattaneo E, 1998, J NEUROSCI RES, V53, P223, DOI 10.1002/(SICI)1097-4547(19980715)53:2<223::AID-JNR11>3.0.CO;2-7; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Cocco L, 2011, ADV ENZYME REGUL, V51, P2, DOI 10.1016/j.advenzreg.2010.09.015; Cocco L, 2010, ADV ENZYME REGUL, V50, P2, DOI 10.1016/j.advenzreg.2009.10.007; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Ehrlich ME, 2001, EXP NEUROL, V167, P215, DOI 10.1006/exnr.2000.7551; Ehrlich ME, 2012, NEUROTHERAPEUTICS, V9, P270, DOI 10.1007/s13311-012-0112-2; Ermak G, 2009, J BIOL CHEM, V284, P11845, DOI 10.1074/jbc.M900639200; FISHBURN CS, 1995, J BIOL CHEM, V270, P29819; Gao L, 2006, J NEUROSCI, V26, P6259, DOI 10.1523/JNEUROSCI.0481-06.2006; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; HernandezLopez S, 1997, J NEUROSCI, V17, P3334; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; Hirota K, 1997, NEUROSCI LETT, V223, P169, DOI 10.1016/S0304-3940(97)13434-6; Ilijic E, 2011, NEUROBIOL DIS, V43, P364, DOI 10.1016/j.nbd.2011.04.007; Kang S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2149; KANTERMAN RY, 1991, MOL PHARMACOL, V39, P364; Kuppers E, 2000, MOL BRAIN RES, V81, P19, DOI 10.1016/S0169-328X(00)00156-X; Lange C, 2006, NEURODEGENER DIS, V3, P76, DOI 10.1159/000092097; Levant B, 2002, LIFE SCI, V71, P2691, DOI 10.1016/S0024-3205(02)02109-4; Lin JY, 2004, EUR J NEUROSCI, V20, P1219, DOI 10.1111/j.1460-9568.2004.03576.x; Lin ZX, 1996, J MOL NEUROSCI, V7, P257, DOI 10.1007/BF02737063; Liu LW, 2006, J NEUROSCI, V26, P11588, DOI 10.1523/JNEUROSCI.2102-06.2006; Liu LW, 2000, J PHYSIOL-LONDON, V525, P391, DOI 10.1111/j.1469-7793.2000.00391.x; Liu LW, 2004, EUR BIOPHYS J BIOPHY, V33, P255, DOI 10.1007/s00249-003-0387-7; Liu LW, 2003, P NATL ACAD SCI USA, V100, P295, DOI 10.1073/pnas.0136826100; Liu LW, 2001, AM J PHYSIOL-CELL PH, V280, pC1293, DOI 10.1152/ajpcell.2001.280.5.C1293; Martella G, 2011, NEUROSCIENCE, V177, P240, DOI 10.1016/j.neuroscience.2010.12.057; Mink J W, 2001, Adv Neurol, V85, P113; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Moreland RB, 2004, BIOCHEM PHARMACOL, V68, P761, DOI 10.1016/j.bcp.2004.05.019; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; Roberts-Crowley ML, 2009, CELL CALCIUM, V45, P589, DOI 10.1016/j.ceca.2009.03.015; Roberts-Crowley ML, 2009, J GEN PHYSIOL, V133, P387, DOI 10.1085/jgp.200810047; Rouach N, 2002, P NATL ACAD SCI USA, V99, P1023, DOI 10.1073/pnas.022257499; SCHINELLI S, 1994, J NEUROCHEM, V62, P944; SPECTOR AA, 1975, J LIPID RES, V16, P165; Strauss U, 2003, HIDDEN SODIUM CURREN; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; TENCE M, 1994, J PHARMACOL EXP THER, V269, P646; Torres JM, 2003, MOL CELL BIOCHEM, V250, P125, DOI 10.1023/A:1024902419502; Varani K, 2001, FASEB J, V15, P1245, DOI 10.1096/fj.00-0730fje; Weinelt S, 2003, J NEUROSCI RES, V71, P228, DOI 10.1002/jnr.10477; Wu L, 2002, NATURE, V419, P947, DOI 10.1038/nature01118; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yan Z, 2001, NEUROSCIENCE, V103, P1017, DOI 10.1016/S0306-4522(01)00039-2; YUE DT, 1990, SCIENCE, V250, P1735, DOI 10.1126/science.2176745; Zanassi P, 1998, NEUROSCI LETT, V247, P83, DOI 10.1016/S0304-3940(98)00262-6; Zhang H, 2005, J NEUROSCI, V25, P1037, DOI 10.1523/JNEUROSCI.4554-04.2005; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	69	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132469	10.1371/journal.pone.0132469	http://dx.doi.org/10.1371/journal.pone.0132469			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147123	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600277
J	Schwarz, KA; Buchel, C				Schwarz, Katharina A.; Buechel, Christian			Cognition and the Placebo Effect - Dissociating Subjective Perception and Actual Performance	PLOS ONE			English	Article							STEREOTYPE THREAT; CONFIDENCE-INTERVALS; METHYLPHENIDATE; EXPECTATION; MECHANISMS; ANALGESIA; NOCEBO; PAIN; ENHANCEMENT; PEOPLE	The influence of positive or negative expectations on clinical outcomes such as pain relief or motor performance in patients and healthy participants has been extensively investigated for years. Such research promises potential benefit for patient treatment by deliberately using expectations as means to stimulate endogenous regulation processes. Especially regarding recent interest and controversies revolving around cognitive enhancement, the question remains whether mere expectancies might also yield enhancing or impairing effects in the cognitive domain, i.e., can we improve or impair cognitive performance simply by creating a strong expectancy in participants about their performance? Moreover, previous literature suggests that especially subjective perception is highly susceptible to expectancy effects, whereas objective measures can be affected in certain domains, but not in others. Does such a dissociation of objective measures and subjective perception also apply to cognitive placebo and nocebo effects? In this study, we sought to investigate whether placebo and nocebo effects can be evoked in cognitive tasks, and whether these effects influence objective and subjective measures alike. To this end, we instructed participants about alleged effects of different tone frequencies (high, intermediate, low) on brain activity and cognitive functions. We paired each tone with specific success rates in a Flanker task paradigm as a preliminary conditioning procedure, adapted from research on placebo hypoalgesia. In a subsequent test phase, we measured reaction times and success rates in different expectancy conditions (placebo, nocebo, and control) and then asked participants how the different tone frequencies affected their performance. Interestingly, we found no effects of expectation on objective measures, but a strong effect on subjective perception, i.e., although actual performance was not affected by expectancy, participants strongly believed that the placebo tone frequency improved their performance.	[Schwarz, Katharina A.; Buechel, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Schwarz, KA (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany.	k.schwarz@uke.de	Schwarz, Katharina/AAQ-1427-2021	Schwarz, Katharina/0000-0001-8714-790X	European Research Council [ERC-2010AdG_20100407]; Deutsche Forschungsgemeinschaft [FOR 1328, SFB 936, SFB TRR 58]	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	K.A.S. and C.B. are supported by the European Research Council, ERC-2010AdG_20100407. C.B. is also supported by the Deutsche Forschungsgemeinschaft (Research group FOR 1328, SFB 936 and SFB TRR 58). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Beilock SL, 2007, J EXP PSYCHOL GEN, V136, P256, DOI 10.1037/0096-3445.136.2.256; Bingel U, 2014, JAMA-J AM MED ASSOC, V312, P693, DOI 10.1001/jama.2014.8342; Boot WR, 2013, PERSPECT PSYCHOL SCI, V8, P445, DOI 10.1177/1745691613491271; Chatterjee A, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1956; Colloca L, 2005, NAT REV NEUROSCI, V6, P545, DOI 10.1038/nrn1705; Colloca L, 2006, PAIN, V124, P126, DOI 10.1016/j.pain.2006.04.005; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; Dijksterhuis A, 2014, PERSPECT PSYCHOL SCI, V9, P72, DOI 10.1177/1745691613513472; Eippert F, 2009, NEURON, V63, P533, DOI 10.1016/j.neuron.2009.07.014; Enck P, 2013, NAT REV DRUG DISCOV, V12, P191, DOI 10.1038/nrd3923; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Geers AL, 2006, J BEHAV MED, V29, P171, DOI 10.1007/s10865-005-9040-5; Geuter S, 2013, J NEUROSCI, V33, P13784, DOI 10.1523/JNEUROSCI.2191-13.2013; Green CS, 2012, CURR BIOL, V22, pR197, DOI 10.1016/j.cub.2012.02.012; Harris J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1955; Hyman SE, 2011, NEURON, V69, P595, DOI 10.1016/j.neuron.2011.02.012; Kirsch W, 2014, ATTEN PERCEPT PSYCHO, V76, P1752, DOI 10.3758/s13414-014-0685-4; Krendl AC, 2008, PSYCHOL SCI, V19, P168, DOI 10.1111/j.1467-9280.2008.02063.x; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Looby A, 2011, EXP CLIN PSYCHOPHARM, V19, P434, DOI 10.1037/a0025252; Mora MS, 2011, PHILOS T R SOC B, V366, P1879, DOI 10.1098/rstb.2010.0394; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Pajares F, 1996, REV EDUC RES, V66, P543, DOI 10.2307/1170653; Pfister R, 2013, ADV COGN PSYCHOL, V9, P74, DOI [10.5709/acp-0133-x, 10.2478/v10053-008-0133-x]; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Proffitt DR, 2013, ACTION SCIENCE: FOUNDATIONS OF AN EMERGING DISCIPLINE, P171; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; Sahakian BJ, 2011, J PSYCHOPHARMACOL, V25, P197, DOI 10.1177/0269881109106926; Schmader T, 2008, PSYCHOL REV, V115, P336, DOI 10.1037/0033-295X.115.2.336; Schwarz KA, TOUGHER SEX ST UNPUB; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Stewart-Williams S, 2004, PSYCHOL BULL, V130, P324, DOI 10.1037/0033-2909.130.2.324; Tracey I, 2010, NAT MED, V16, P1277, DOI 10.1038/nm.2229; Volkow ND, 2006, NEUROIMAGE, V32, P1782, DOI 10.1016/j.neuroimage.2006.04.192; Wechsler ME, 2011, NEW ENGL J MED, V365, P119, DOI 10.1056/NEJMoa1103319; Wraga M, 2006, PSYCHON B REV, V13, P813, DOI 10.3758/BF03194002	40	28	28	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130492	10.1371/journal.pone.0130492	http://dx.doi.org/10.1371/journal.pone.0130492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26148009	Green Published, gold			2022-12-27	WOS:000358157600038
J	Watabe, M; Arjunan, SNV; Fukushima, S; Iwamoto, K; Kozuka, J; Matsuoka, S; Shindo, Y; Ueda, M; Takahashi, K				Watabe, Masaki; Arjunan, Satya N. V.; Fukushima, Seiya; Iwamoto, Kazunari; Kozuka, Jun; Matsuoka, Satomi; Shindo, Yuki; Ueda, Masahiro; Takahashi, Koichi			A Computational Framework for Bioimaging Simulation	PLOS ONE			English	Article							SYSTEMS BIOLOGY; MODEL; VALIDATION; SPACE; GAPS	Using bioimaging technology, biologists have attempted to identify and document analytical interpretations that underlie biological phenomena in biological cells. Theoretical biology aims at distilling those interpretations into knowledge in the mathematical form of biochemical reaction networks and understanding how higher level functions emerge from the combined action of biomolecules. However, there still remain formidable challenges in bridging the gap between bioimaging and mathematical modeling. Generally, measurements using fluorescence microscopy systems are influenced by systematic effects that arise from stochastic nature of biological cells, the imaging apparatus, and optical physics. Such systematic effects are always present in all bioimaging systems and hinder quantitative comparison between the cell model and bioimages. Computational tools for such a comparison are still unavailable. Thus, in this work, we present a computational framework for handling the parameters of the cell models and the optical physics governing bioimaging systems. Simulation using this framework can generate digital images of cell simulation results after accounting for the systematic effects. We then demonstrate that such a framework enables comparison at the level of photon-counting units.	[Watabe, Masaki; Arjunan, Satya N. V.; Iwamoto, Kazunari; Shindo, Yuki; Takahashi, Koichi] RIKEN, Lab Biochem Simulat, Quantitat Biol Ctr, Suita, Osaka, Japan; [Fukushima, Seiya; Kozuka, Jun; Matsuoka, Satomi; Ueda, Masahiro] RIKEN, Quantitat Biol Ctr, Lab Cell Signaling Dynam, Suita, Osaka, Japan; [Takahashi, Koichi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Fukushima, Seiya; Shindo, Yuki; Ueda, Masahiro] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan	RIKEN; RIKEN; Keio University; Osaka University	Takahashi, K (corresponding author), RIKEN, Lab Biochem Simulat, Quantitat Biol Ctr, Suita, Osaka, Japan.	ktakahashi@riken.jp	Arjunan, Satya N. V./B-3441-2008; Arjunan, Satya/AAL-2433-2020	Arjunan, Satya N. V./0000-0002-2913-3347; Arjunan, Satya/0000-0002-2913-3347; Ueda, Masahiro/0000-0002-9354-3404; Iwamoto, Kazunari/0000-0001-9794-9420; Shindo, Yuki/0000-0001-5313-5492; Matsuoka, Satomi/0000-0002-4552-4460				Andrews SS, 2004, PHYS BIOL, V1, P137, DOI 10.1088/1478-3967/1/3/001; Arjunan S.N.V., 2009, BMC SYST BIOL, V3, P211; Arjunan Satya Nanda Vel, 2010, Syst Synth Biol, V4, P35, DOI 10.1007/s11693-009-9047-2; Bevington P. R, 2003, DATA REDUCTION AND E; Cvijovic M, 2014, MOL GENET GENOMICS, V289, P727, DOI 10.1007/s00438-014-0843-3; Fullerton S, 2012, PROC SPIE, V8228, DOI 10.1117/12.906336; Fullerton S, 2012, PROC SPIE, V8228, DOI 10.1117/12.906346; Gaskill JD, 1987, LINEAR SYSTEMS FOURI; Hollinger M.A., 1997, INTRO PHARM; Huang F, 2013, NAT METHODS, V10, P653, DOI [10.1038/NMETH.2488, 10.1038/nmeth.2488]; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Kerr RA, 2008, SIAM J SCI COMPUT, V30, P3126, DOI 10.1137/070692017; Kirshner H, 2013, J MICROSC-OXFORD, V249, P13, DOI 10.1111/j.1365-2818.2012.03675.x; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Lakowicz J. R., 2006, PRINCIPLES OF FLUORE; Mansuripur M, 2009, CLASSICAL OPTICS AND; Moraru II, 2008, IET SYST BIOL, V2, P352, DOI 10.1049/iet-syb:20080102; Oberkampf W. L., 2004, Applied Mechanics Review, V57, P345, DOI 10.1115/1.1767847; Pawley J, 2008, HANDBOOK OF BIOLOGIC; Qu ZL, 2011, PROG BIOPHYS MOL BIO, V107, P21, DOI 10.1016/j.pbiomolbio.2011.06.004; Sanghvi JC, 2013, NAT METHODS, V10, P1192, DOI [10.1038/NMETH.2724, 10.1038/nmeth.2724]; Sornette D, 2007, P NATL ACAD SCI USA, V104, P6562, DOI 10.1073/pnas.0611677104; Jr T, 2014, COMPUT STRUCT BIOTEC, V12, P14, DOI 10.1016/j.csbj.2014.10.003; Takahashi K, 2005, FEBS LETT, V579, P1783, DOI 10.1016/j.febslet.2005.01.072; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P2473, DOI 10.1073/pnas.0906885107; Trucano TG, 2006, RELIAB ENG SYST SAFE, V91, P1331, DOI 10.1016/j.ress.2005.11.031; Valeur B., 2012, MOLECULAR FLUORESCEN; van Zon JS, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2137716	30	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130089	10.1371/journal.pone.0130089	http://dx.doi.org/10.1371/journal.pone.0130089			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147508	gold, Green Submitted, Green Published			2022-12-27	WOS:000358157600030
J	Yoon, JW; Jang, IH; Heo, SC; Kwon, YW; Choi, EJ; Bae, KH; Suh, DS; Kim, SC; Han, S; Haam, S; Jung, J; Kim, K; Ryu, SH; Kim, JH				Yoon, Jung Won; Jang, Il Ho; Heo, Soon Chul; Kwon, Yang Woo; Choi, Eun Jung; Bae, Kwang-Hee; Suh, Dong-Soo; Kim, Seung-Chul; Han, Seungmin; Haam, Seungjoo; Jung, Jongha; Kim, Kiseok; Ryu, Sung Ho; Kim, Jae Ho			Isolation of Foreign Material-Free Endothelial Progenitor Cells Using CD31 Aptamer and Therapeutic Application for Ischemic Injury	PLOS ONE			English	Article							BONE-MARROW; IN-VIVO; PECAM-1; NEOVASCULARIZATION; SELECTION; DISEASE	Endothelial progenitor cells (EPCs) can be isolated from human bone marrow or peripheral blood and reportedly contribute to neovascularization. Aptamers are 40-120-mer nucleotides that bind to a specific target molecule, as antibodies do. To utilize apatmers for isolation of EPCs, in the present study, we successfully generated aptamers that recognize human CD31, an endothelial cell marker. CD31 aptamers bound to human umbilical cord blood-derived EPCs and showed specific interaction with human CD31, but not with mouse CD31. However, CD31 aptamers showed non-specific interaction with CD31-negative 293FT cells and addition of polyanionic competitor dextran sulfate eliminated non-specific interaction without affecting cell viability. From the mixture of EPCs and 293FT cells, CD31 aptamers successfully isolated EPCs with 97.6% purity and 94.2% yield, comparable to those from antibody isolation. In addition, isolated EPCs were decoupled from CD31 aptamers with a brief treatment of high concentration dextran sulfate. EPCs isolated with CD31 aptamers and subsequently decoupled from CD31 aptamers were functional and enhanced the restoration of blood flow when transplanted into a murine hindlimb ischemia model. In this study, we demonstrated isolation of foreign material-free EPCs, which can be utilized as a universal protocol in preparation of cells for therapeutic transplantation.	[Yoon, Jung Won; Jang, Il Ho; Heo, Soon Chul; Kwon, Yang Woo; Choi, Eun Jung; Kim, Jae Ho] Pusan Natl Univ, Sch Med, Dept Physiol, Yangsan 626870, South Korea; [Bae, Kwang-Hee] Korea Res Inst Biosci & Biotechnol, Funct Genom Res Ctr, Taejon, South Korea; [Suh, Dong-Soo; Kim, Seung-Chul] Pusan Natl Univ, Sch Med, Dept Obstet & Gynecol, Yangsan 626870, South Korea; [Han, Seungmin; Haam, Seungjoo] Yonsei Univ, Dept Chem & Biomol Engn, Coll Engn, Seoul 120749, South Korea; [Jung, Jongha; Kim, Kiseok] Aptamer Sci Inc, Postech Biotech Ctr, Pohang 790784, South Korea; [Ryu, Sung Ho] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; [Kim, Jae Ho] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan 626770, Gyeongsangnam D, South Korea	Pusan National University; Pusan National University Hospital; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Pusan National University; Pusan National University Hospital; Yonsei University; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pusan National University; Pusan National University Hospital	Kim, JH (corresponding author), Pusan Natl Univ, Sch Med, Dept Physiol, Yangsan 626870, South Korea.	jhkimst@pusan.ac.kr		Bae, Kwang-Hee/0000-0002-5868-2556; Jang, Il Ho/0000-0002-0820-3035; Ryu, Sung Ho/0000-0003-0913-3048	programs of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012M3A9C7050184, 2010-0020274]	programs of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	Aptamer Sciences Inc. provided support in the form of salaries for authors JJ and KK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was also supported by the programs of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012M3A9C7050184; 2010-0020274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alev C, 2011, ANTIOXID REDOX SIGN, V15, P949, DOI 10.1089/ars.2010.3872; Arnau J, 2006, PROTEIN EXPRES PURIF, V48, P1, DOI 10.1016/j.pep.2005.12.002; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asahara T, 2011, STEM CELLS, V29, P1650, DOI 10.1002/stem.745; Avci-Adali M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068810; Bauer SM, 2006, J VASC SURG, V43, P134, DOI 10.1016/j.jvs.2005.08.038; Cibiel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087002; EATON BE, 1995, CHEM BIOL, V2, P633, DOI 10.1016/1074-5521(95)90023-3; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Germer Katherine, 2013, Int J Biochem Mol Biol, V4, P27; Gilles JGG, 2000, SEMIN THROMB HEMOST, V26, P151, DOI 10.1055/s-2000-9817; Gold L, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003582; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Hamula CLA, 2006, TRAC-TREND ANAL CHEM, V25, P681, DOI 10.1016/j.trac.2006.05.007; Heo SC, 2014, STEM CELLS, V32, P779, DOI 10.1002/stem.1578; Ii M, 2005, CIRCULATION, V111, P1114, DOI 10.1161/01.CIR.0000157144.24888.7E; Jager S, 2005, J AM CHEM SOC, V127, P15071, DOI 10.1021/ja051725b; Jefferis R, 2009, MABS, V1, P332, DOI 10.4161/mabs.1.4.9122; Jujo K, 2008, J MOL CELL CARDIOL, V45, P530, DOI 10.1016/j.yjmcc.2008.08.003; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Karbach J, 2012, CANCER RES, V72, P4304, DOI 10.1158/0008-5472.CAN-12-0257; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kim H, 2010, CIRC RES, V107, P602, DOI 10.1161/CIRCRESAHA.110.218396; Kim K, 2014, BIOCHEM BIOPH RES CO, V448, P114, DOI 10.1016/j.bbrc.2014.04.086; Kim SW, 2011, REGEN MED, V6, P335, DOI [10.2217/RME.11.24, 10.2217/rme.11.24]; Kim SW, 2010, J AM COLL CARDIOL, V56, P593, DOI 10.1016/j.jacc.2010.01.070; Kim WS, 2013, BLOOD RES, V48, P76, DOI 10.5045/br.2013.48.2.76; Mayer G, 2010, NAT PROTOC, V5, P1993, DOI 10.1038/nprot.2010.163; Nakada MT, 2000, J IMMUNOL, V164, P452, DOI 10.4049/jimmunol.164.1.452; Napoli C, 2011, ATHEROSCLEROSIS, V215, P9, DOI 10.1016/j.atherosclerosis.2010.10.039; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Privratsky JR, 2010, LIFE SCI, V87, P69, DOI 10.1016/j.lfs.2010.06.001; Raval Z, 2013, CIRC RES, V112, P1288, DOI 10.1161/CIRCRESAHA.113.300565; Soontornworajit B, 2011, ANAL BIOANAL CHEM, V399, P1591, DOI 10.1007/s00216-010-4559-x; Sun W, 2011, CURR PHARM DESIGN, V17, P80, DOI 10.2174/138161211795049769; Sundaram P, 2013, EUR J PHARM SCI, V48, P259, DOI 10.1016/j.ejps.2012.10.014; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tiwari A, 2003, CELL BIOL TOXICOL, V19, P265, DOI 10.1023/B:CBTO.0000004929.37511.ed; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Wakelin MW, 1996, J EXP MED, V184, P229, DOI 10.1084/jem.184.1.229; Woodfin A, 2007, ARTERIOSCL THROM VAS, V27, P2514, DOI 10.1161/ATVBAHA.107.151456; Wu Y, 2005, J IMMUNOL, V175, P3484, DOI 10.4049/jimmunol.175.6.3484; Xu JY, 2014, CURR STEM CELL RES T, V9, P401, DOI 10.2174/1574888X09666140619121318; Zhang L, 2014, ARTERIOSCL THROM VAS, V34, P1114, DOI 10.1161/ATVBAHA.114.303809; Zichi D, 2008, CURR OPIN CHEM BIOL, V12, P78, DOI 10.1016/j.cbpa.2008.01.016; Zubair AC, 2010, CYTOTHERAPY, V12, P178, DOI 10.3109/14653240903493409	47	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131785	10.1371/journal.pone.0131785	http://dx.doi.org/10.1371/journal.pone.0131785			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148001	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600145
J	Zebracki, K; Koper, P; Marczak, M; Skorupska, A; Mazur, A				Zebracki, Kamil; Koper, Piotr; Marczak, Malgorzata; Skorupska, Anna; Mazur, Andrzej			Plasmid-Encoded RepA Proteins Specifically Autorepress Individual repABC Operons in the Multipartite Rhizobium leguminosarum bv. trifolii Genome	PLOS ONE			English	Article							AGROBACTERIUM-TUMEFACIENS; ANTISENSE RNA; SYMBIOTIC PLASMID; PARTITIONING SITE; COPY NUMBER; REPLICATION; INCOMPATIBILITY; P1; IDENTIFICATION; TRANSCRIPTION	Rhizobia commonly have very complex genomes with a chromosome and several large plasmids that possess genes belonging to the repABC family. RepA and RepB are members of the ParA and ParB families of partitioning proteins, respectively, whereas RepC is crucial for plasmid replication. In the repABC replicons, partitioning and replication functions are transcriptionally linked resulting in complex regulation of rep gene expression. The genome of R. leguminosarum bv. trifolii TA1 (RtTA1) consists of a chromosome and four plasmids (pRleTA1a-d), equipped with functional repABC genes. In this work, the regulation of transcription of the individual repABC cassettes of the four RtTA1 plasmids was studied. The involvement of the RepA and RepB as well as parS-like centromere sites in this process was depicted, demonstrating some dissimilarity in expression of respective rep regions. RtTA1 repABC genes of individual plasmids formed operons, which were negatively regulated by RepA and RepB. Individual RepA were able to bind to DNA without added nucleotides, but in the presence of ADP, bound specifically to their own operator sequences containing imperfect palindromes, and caused operon autorepression, whereas the addition of ATP stimulated non-specific binding of RepA to DNA. The RepA proteins were able to dimerize/oligomerize: in general dimers formed independently of ATP or ADP, although ATP diminished the concentration of oligomers that were produced. By the comprehensive approach focusing on a set of plasmids instead of individual replicons, the work highlighted subtle differences between the organization and regulation of particular rep operons as well as the structures and specificity of RepA proteins, which contribute to the fine-tuned coexistence of several replicons with similar repABC cassettes in the complex bacterial genome.	[Zebracki, Kamil; Koper, Piotr; Marczak, Malgorzata; Skorupska, Anna; Mazur, Andrzej] Marie Curie Sklodowska Univ, Dept Genet & Microbiol, Inst Microbiol & Biotechnol, Fac Biol & Biotechnol, Lublin, Poland	Maria Curie-Sklodowska University	Mazur, A (corresponding author), Marie Curie Sklodowska Univ, Dept Genet & Microbiol, Inst Microbiol & Biotechnol, Fac Biol & Biotechnol, Lublin, Poland.	mazur@hektor.umcs.lublin.pl	Koper, Piotr/ABG-8618-2020	Koper, Piotr/0000-0001-5709-443X; Koper, Piotr/0000-0002-0386-3544; Zebracki, Kamil/0000-0001-7250-4492				Bartosik D, 2001, J BACTERIOL, V183, P6234, DOI 10.1128/JB.183.21.6234-6243.2001; Bartosik D, 1998, MICROBIOL-UK, V144, P3149, DOI 10.1099/00221287-144-11-3149; Bignell C, 2001, J BIOTECHNOL, V91, P1, DOI 10.1016/S0168-1656(01)00293-0; BROWN CM, 1975, J GEN MICROBIOL, V86, P39, DOI 10.1099/00221287-86-1-39; Campbell CS, 2007, J CELL BIOL, V179, P1059, DOI 10.1083/jcb.200708206; Castaing JP, 2008, MOL MICROBIOL, V70, P1000, DOI 10.1111/j.1365-2958.2008.06465.x; Castillo-Ramirez S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-536; Cervantes-Rivera R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-158; Cervantes-Rivera R, 2010, J BACTERIOL, V192, P3268, DOI 10.1128/JB.00118-10; Cevallos MA, 2008, PLASMID, V60, P19, DOI 10.1016/j.plasmid.2008.03.001; Chai YR, 2005, MOL MICROBIOL, V58, P1114, DOI 10.1111/j.1365-2958.2005.04886.x; Chai YR, 2005, MOL MICROBIOL, V56, P1574, DOI 10.1111/j.1365-2958.2005.04636.x; CHAKRAVORTY A K, 1982, Journal of Molecular and Applied Genetics, V1, P585; DAVEY MJ, 1994, J BIOL CHEM, V269, P29908; Dunham TD, 2009, EMBO J, V28, P1792, DOI 10.1038/emboj.2009.120; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Erdmann N, 1999, P NATL ACAD SCI USA, V96, P14905, DOI 10.1073/pnas.96.26.14905; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Howard M, 2010, MOL MICROBIOL, V78, P9, DOI 10.1111/j.1365-2958.2010.07316.x; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Krol JE, 2007, GENOMICS, V89, P237, DOI 10.1016/j.ygeno.2006.08.015; MacLellan SR, 2006, MOL MICROBIOL, V59, P1559, DOI 10.1111/j.1365-2958.2006.05040.x; MacLellan SR, 2005, MOL MICROBIOL, V55, P611, DOI 10.1111/j.1365-2958.2004.04412.x; Mazur A, 2011, PLASMID, V66, P53, DOI 10.1016/j.plasmid.2011.04.002; Miller JH., 1972, EXPERIMENTS IN MOLEC; Narasimhan G, 2002, J COMPUT BIOL, V9, P707, DOI 10.1089/106652702761034145; Pappas KM, 2008, PLASMID, V60, P89, DOI 10.1016/j.plasmid.2008.05.003; Pappas KM, 2003, MOL MICROBIOL, V49, P441, DOI 10.1046/j.1365-2958.2003.03560.x; Pappas KM, 2003, MOL MICROBIOL, V48, P1059, DOI 10.1046/j.1365-2958.2003.03488.x; Perez-Oseguera A, 2013, PLASMID, V70, P362, DOI 10.1016/j.plasmid.2013.08.001; Pinto UM, 2012, NAT REV MICROBIOL, V10, P755, DOI 10.1038/nrmicro2882; Pinto UM, 2011, MOL MICROBIOL, V81, P1593, DOI 10.1111/j.1365-2958.2011.07789.x; Ramirez-Romero MA, 2000, J BACTERIOL, V182, P3117, DOI 10.1128/JB.182.11.3117-3124.2000; Ramirez-Romero MA, 2001, MOL MICROBIOL, V42, P195, DOI 10.1046/j.1365-2958.2001.02621.x; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Rivera-Urbalejo A, 2015, PLASMID, V78, P48, DOI 10.1016/j.plasmid.2015.01.004; ROSENBERG C, 1984, MOL GEN GENET, V196, P533, DOI 10.1007/BF00436205; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schumacher MA, 2012, CURR OPIN STRUC BIOL, V22, P72, DOI 10.1016/j.sbi.2011.11.001; Sengupta M, 2010, J BACTERIOL, V192, P1175, DOI 10.1128/JB.01245-09; Slavcev RA, 2005, J BACTERIOL, V187, P1227, DOI 10.1128/JB.187.4.1227-1237.2005; Soberon N, 2004, PLASMID, V51, P203, DOI 10.1016/j.plasmid.2004.01.005; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; Thomas CM, 2000, MOL MICROBIOL, V37, P485, DOI 10.1046/j.1365-2958.2000.02006.x; Vecchiarelli AG, 2010, MOL MICROBIOL, V78, P78, DOI 10.1111/j.1365-2958.2010.07314.x; Venkova-Canova T, 2004, MOL MICROBIOL, V54, P1431, DOI 10.1111/j.1365-2958.2004.04366.x; VINCENT J. M., 1970, A Manual for the Practical Study of the Root- Bacteria.; Yip CB, 2015, PLASMID, V78, P37, DOI 10.1016/j.plasmid.2014.12.003	51	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131907	10.1371/journal.pone.0131907	http://dx.doi.org/10.1371/journal.pone.0131907			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147968	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600162
J	Brewin, RJW; de Mora, L; Jackson, T; Brewin, TG; Shutler, J				Brewin, Robert J. W.; de Mora, Lee; Jackson, Thomas; Brewin, Thomas G.; Shutler, Jamie			On the Potential of Surfers to Monitor Environmental Indicators in the Coastal Zone	PLOS ONE			English	Article							CITIZEN-SCIENCE; OCEAN ACIDIFICATION; CLIMATE-CHANGE; TEMPERATURE; MARINE; WATERS; BLOOMS; ESTUARIES; IMPACTS; FRONTS	The social and economic benefits of the coastal zone make it one of the most treasured environments on our planet. Yet it is vulnerable to increasing anthropogenic pressure and climate change. Coastal management aims to mitigate these pressures while augmenting the socio-economic benefits the coastal region has to offer. However, coastal management is challenged by inadequate sampling of key environmental indicators, partly due to issues relating to cost of data collection. Here, we investigate the use of recreational surfers as platforms to improve sampling coverage of environmental indicators in the coastal zone. We equipped a recreational surfer, based in the south west United Kingdom (UK), with a temperature sensor and Global Positioning System (GPS) device that they used when surfing for a period of one year (85 surfing sessions). The temperature sensor was used to derive estimates of sea-surface temperature (SST), an important environmental indicator, and the GPS device used to provide sample location and to extract information on surfer performance. SST data acquired by the surfer were compared with data from an oceanographic station in the south west UK and with satellite observations. Our results demonstrate: (i) high-quality SST data can be acquired by surfers using low cost sensors; and (ii) GPS data can provide information on surfing performance that may help motivate data collection by surfers. Using recent estimates of the UK surfing population, and frequency of surfer participation, we speculate around 40 million measurements on environmental indicators per year could be acquired at the UK coastline by surfers. This quantity of data is likely to enhance coastal monitoring and aid UK coastal management. Considering surfing is a world-wide sport, our results have global implications and the approach could be expanded to other popular marine recreational activities for coastal monitoring of environmental indicators.	[Brewin, Robert J. W.; de Mora, Lee; Jackson, Thomas] Plymouth Marine Lab, Plymouth, Devon, England; [Brewin, Robert J. W.] Plymouth Marine Lab, Natl Ctr Earth Observat, Plymouth, Devon, England; [Brewin, Thomas G.] Chatham & Clarendon Grammar Sch, Ramsgate, Kent, England; [Shutler, Jamie] Univ Exeter, Coll Life & Environm Sci, Penryn, Cornwall, England	Plymouth Marine Laboratory; Plymouth Marine Laboratory; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC National Centre for Earth Observation; University of Exeter	Brewin, RJW (corresponding author), Plymouth Marine Lab, Plymouth, Devon, England.	robr@pml.ac.uk	/AAL-3738-2021; de Mora, Lee/AAP-5456-2020	de Mora, Lee/0000-0002-5080-3149; Jackson, Thomas/0000-0003-4336-1597; Brewin, Robert/0000-0001-5134-8291	Plymouth Marine Laboratory; UK National Centre for Earth Observation; Changing Earth Science Network initiative of the STSE program of the European Space Agency; Natural Environment Research Council [pml010008, pml010009, pml010010, nceo020006, pml010007] Funding Source: researchfish; NERC [pml010008, pml010009, pml010007, pml010010, nceo020006] Funding Source: UKRI	Plymouth Marine Laboratory(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK National Centre for Earth Observation; Changing Earth Science Network initiative of the STSE program of the European Space Agency; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was supported by a Research Project (RP) funded by Plymouth Marine Laboratory. The lead author is also supported by the UK National Centre for Earth Observation, and by the Changing Earth Science Network initiative of the STSE program of the European Space Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarninkhof SGJ, 2003, COAST ENG, V49, P275, DOI 10.1016/S0378-3839(03)00064-4; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Bailey SW, 2006, REMOTE SENS ENVIRON, V102, P12, DOI 10.1016/j.rse.2006.01.015; Barbier EB, 2014, SCIENCE, V345, P1250, DOI 10.1126/science.1254629; Barlow MJ, 2014, J STRENGTH COND RES, V28, P2946, DOI 10.1519/JSC.0000000000000491; Beaton AD, 2011, SENSOR ACTUAT B-CHEM, V156, P1009, DOI 10.1016/j.snb.2011.02.042; Bibby R, 2008, AQUAT BIOL, V2, P67, DOI 10.3354/ab00037; Borja A, 2005, CONT SHELF RES, V25, P1768, DOI 10.1016/j.csr.2005.05.004; Brewin RJW, 2015, ANN TIME SERIES SEA; Brossard D, 2005, INT J SCI EDUC, V27, P1099, DOI 10.1080/09500690500069483; Butt Tony, 2004, SURF SCI INTRO WAVES; Chickadel CC, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001774; Cicin-Sain B., 1998, INTEGRATED COASTAL O; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; Dally WR, 2001, J COASTAL RES, V29, P33; Davidson M, 2007, COAST ENG, V54, P463, DOI 10.1016/j.coastaleng.2007.01.007; Davis CO, 2002, OPT EXPRESS, V10, P210, DOI 10.1364/OE.10.000210; Defeo O, 2009, ESTUAR COAST SHELF S, V81, P1, DOI 10.1016/j.ecss.2008.09.022; DEFRA. UK Department for Environment Food & Rural Affairs (DEFRA), 2007, CHART PROGR LEIS REC; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; Farley ORL, 2012, J STRENGTH COND RES, V26, P1887, DOI 10.1519/JSC.0b013e3182392c4b; Ferreira JG, 2007, ENVIRON MONIT ASSESS, V135, P195, DOI 10.1007/s10661-007-9643-0; Gill AB, 2005, J APPL ECOL, V42, P605, DOI 10.1111/j.1365-2664.2005.01060.x; GOREAU TJ, 1994, AMBIO, V23, P176; Graham E., 2011, EOS T AM GEOPHYS UN, V92, DOI [10.1029/2011EO380002, DOI 10.1029/2011EO380002, DOI 10.1029/2011E0380002]; Groom S, 2009, J MARINE SYST, V77, P278, DOI 10.1016/j.jmarsys.2007.12.015; Gura Trisha, 2013, Nature, V496, P259; Halberda J, 2012, P NATL ACAD SCI USA, V109, P11116, DOI 10.1073/pnas.1200196109; Handeland SO, 2008, AQUACULTURE, V283, P36, DOI 10.1016/j.aquaculture.2008.06.042; Harris R, 2010, J PLANKTON RES, V32, P577, DOI 10.1093/plankt/fbq021; Holman R.A., 1993, J OCEANOGAPHY, V6, P78, DOI [DOI 10.5670/0CEAN0G.1993.02, DOI 10.5670/OCEANOG.1993.02]; Hu CM, 2000, REMOTE SENS ENVIRON, V74, P195, DOI 10.1016/S0034-4257(00)00080-8; Hutt J., 2001, J COASTAL RES, P66; IOCCG, 2000, REPORTS INT OCEAN CO; Irish JL, 1998, COAST ENG, V35, P47, DOI 10.1016/S0378-3839(98)00022-2; Jeong SJ, 2013, GEOPHYS RES LETT, V40, P359, DOI [10.1029/2012GL054431, 10.1029/2012Gl054431]; Jickells TD, 1998, SCIENCE, V281, P217, DOI 10.1126/science.281.5374.217; Kappel CV, 2005, FRONT ECOL ENVIRON, V3, P275, DOI 10.2307/3868490; Keller AA, 1999, LIMNOL OCEANOGR, V44, P344, DOI 10.4319/lo.1999.44.2.0344; Lafleur JP, 2010, TALANTA, V81, P722, DOI 10.1016/j.talanta.2009.12.001; Land PE, 2013, BIOGEOSCIENCES, V10, P8109, DOI 10.5194/bg-10-8109-2013; Lapowsky, 2014, NEXT BIG THING YOU M; Lauro FM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001947; LIPPMANN TC, 1989, J GEOPHYS RES-OCEANS, V94, P995, DOI 10.1029/JC094iC01p00995; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Mason P. J., 2010, C PART COP; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; Mendez-Villanueva A, 2006, J STRENGTH COND RES, V20, P477; Mills B., 2013, WHEAL KITT WORKSH ST; Monk K, 2013, COAST ENG, V73, P115, DOI 10.1016/j.coastaleng.2012.10.004; MORRIS AW, 1978, NATURE, V274, P678, DOI 10.1038/274678a0; NEWELL RE, 1979, AM SCI, V67, P405; Newman G, 2012, FRONT ECOL ENVIRON, V10, P298, DOI 10.1890/110294; Nobre AM, 2011, MAR ECOL PROG SER, V434, P279, DOI 10.3354/meps09250; Norse E.A., 1993, GLOBAL MARINE BIOL D; Nov O, 2011, P 2011 ICONFERENCE, P68, DOI [DOI 10.1145/1940761.1940771, 10.1145/1940761.1940771]; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; PEPIN P, 1991, CAN J FISH AQUAT SCI, V48, P503, DOI 10.1139/f91-065; PINGREE RD, 1975, NATURE, V258, P672, DOI 10.1038/258672a0; Platt T, 2008, REMOTE SENS ENVIRON, V112, P3426, DOI 10.1016/j.rse.2007.10.016; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Roc T, 2013, RENEW ENERG, V51, P448, DOI 10.1016/j.renene.2012.09.039; Schwartz MD, 2012, FRONT ECOL ENVIRON, V10, P324, DOI 10.1890/110281; SIMPSON JH, 1981, PHILOS T R SOC A, V302, P531, DOI 10.1098/rsta.1981.0181; Small C, 2003, J COASTAL RES, V19, P584; Smyth TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098709; Smyth TJ, 2010, J PLANKTON RES, V32, P585, DOI 10.1093/plankt/fbp128; Stewart KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014451; Thomas A, 2002, REMOTE SENS ENVIRON, V81, P262, DOI 10.1016/S0034-4257(02)00004-4; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Trumbull DJ, 2000, SCI EDUC, V84, P265, DOI 10.1002/(SICI)1098-237X(200003)84:2<265::AID-SCE7>3.0.CO;2-5; Wiggins Andrea, 2011, P HICSS, P1, DOI DOI 10.1109/HICSS.2011.207	78	28	28	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0127706	10.1371/journal.pone.0127706	http://dx.doi.org/10.1371/journal.pone.0127706			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154173	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000358159700006
J	Costa, B; Kendall, MS; Parrish, FA; Rooney, J; Boland, RC; Chow, M; Lecky, J; Montgomery, A; Spalding, H				Costa, Bryan; Kendall, Matthew S.; Parrish, Frank A.; Rooney, John; Boland, Raymond C.; Chow, Malia; Lecky, Joey; Montgomery, Anthony; Spalding, Heather			Identifying Suitable Locations for Mesophotic Hard Corals Offshore of Maui, Hawai'i	PLOS ONE			English	Article							SPECIES DISTRIBUTION; REEF ACCRETION; AUAU CHANNEL; HABITAT; DISTRIBUTIONS; PREDICTION; ECOLOGY; COMMUNITIES; PERFORMANCE; DIVERSITY	Mesophotic hard corals (MHC) are increasingly threatened by a growing number of anthropogenic stressors, including impacts from fishing, land-based sources of pollution, and ocean acidification. However, little is known about their geographic distributions (particularly around the Pacific islands) because it is logistically challenging and expensive to gather data in the 30 to 150 meter depth range where these organisms typically live. The goal of this study was to begin to fill this knowledge gap by modelling and predicting the spatial distribution of three genera of mesophotic hard corals offshore of Maui in the Main Hawaiian Islands. Maximum Entropy modeling software was used to create separate maps of predicted probability of occurrence and uncertainty for: (1) Leptoseris, (2) Montipora, and (3) Porites. Genera prevalence was derived from the in situ presence/absence data, and used to convert relative habitat suitability to probability of occurrence values. Approximately 1,300 georeferenced records of the occurrence of MHC, and 34 environmental predictors were used to train the model ensembles. Receiver Operating Characteristic (ROC) Area Under the Curve (AUC) values were between 0.89 and 0.97, indicating excellent overall model performance. Mean uncertainty and mean absolute error for the spatial predictions ranged from 0.006% to 0.05% and 3.73% to 17.6%, respectively. Depth, distance from shore, euphotic depth (mean and standard deviation) and sea surface temperature (mean and standard deviation) were identified as the six most influential predictor variables for partitioning habitats among the three genera. MHC were concentrated between Hanaka' o' o and Papawai Points offshore of western Maui most likely because this area hosts warmer, clearer and calmer water conditions almost year round. While these predictions helped to fill some knowledge gaps offshore of Maui, many information gaps remain in the Hawaiian Archipelago and Pacific Islands. This approach may be used to identify other potentially suitable areas for MHCs, helping scientists and resource managers prioritize sites, and focus their limited resources on areas that may be of higher scientific or conservation value.	[Costa, Bryan; Kendall, Matthew S.] NOAA, Natl Ctr Coastal Ocean Sci, Biogeog Branch, Silver Spring, MD 20910 USA; [Costa, Bryan] CSS Dynamac, Fairfax, VA USA; [Parrish, Frank A.; Rooney, John; Boland, Raymond C.] NOAA, Pacific Islands Fisheries Sci Ctr, Honolulu, HI USA; [Chow, Malia; Lecky, Joey] NOAA, Off Natl Marine Sanctuaries, Honolulu, HI USA; [Montgomery, Anthony] US Fish & Wildlife Serv, Pacific Islands Fish & Wildlife Off, Honolulu, HI USA; [Spalding, Heather] Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Centers for Coastal Ocean Science (NOOCS); National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior; US Fish & Wildlife Service; University of Hawaii System; University of Hawaii Manoa	Costa, B (corresponding author), NOAA, Natl Ctr Coastal Ocean Sci, Biogeog Branch, Silver Spring, MD 20910 USA.	bryan.costa@noaa.gov	Montgomery, Anthony/AAK-8138-2020; /AAL-3738-2021	Montgomery, Anthony/0000-0002-3430-3451; Lecky, Joey/0000-0001-9364-4793	National Oceanic and Atmospheric Administration's (NOAA) Office of National Marine Sanctuaries (ONMS) Hawaiian Islands Humpback Whale National Marine Sanctuary (HIHWNMS); NOAA's Office of Marine and Aviation Operations (OMAO); NOAA's National Centers for Coastal Ocean Science's Center for Sponsored Coastal Ocean Research (CSCOR) [NA07NOS4780188, NA07NOS4780187, NA07NOS478190, NA07NOS4780189]; NOAA Undersea Research Program's Hawai'i Undersea Research Laboratory [NA05OAR4301108]	National Oceanic and Atmospheric Administration's (NOAA) Office of National Marine Sanctuaries (ONMS) Hawaiian Islands Humpback Whale National Marine Sanctuary (HIHWNMS); NOAA's Office of Marine and Aviation Operations (OMAO); NOAA's National Centers for Coastal Ocean Science's Center for Sponsored Coastal Ocean Research (CSCOR); NOAA Undersea Research Program's Hawai'i Undersea Research Laboratory	Funding for this spatial modeling effort was provided by the National Oceanic and Atmospheric Administration's (NOAA) Office of National Marine Sanctuaries (ONMS) Hawaiian Islands Humpback Whale National Marine Sanctuary (HIHWNMS). This modeling effort was made possible because of research funded by the NOAA's Office of Marine and Aviation Operations (OMAO) and NOAA's National Centers for Coastal Ocean Science's Center for Sponsored Coastal Ocean Research (CSCOR) under award NA07NOS4780188 to the Bishop Museum, NA07NOS4780187 and NA07NOS478190 to the University of Hawai'i, NA07NOS4780189 to the State of Hawai'i's Division of Aquatic Resources and to the NOAA Pacific Islands Fisheries Science Center (PIFSC). Submersible support was provided by the NOAA Undersea Research Program's Hawai'i Undersea Research Laboratory under award NA05OAR4301108.	Aeby GS, 2011, PLOS ONE, V6, P1; Barry S, 2006, J APPL ECOL, V43, P413, DOI 10.1111/j.1365-2664.2006.01136.x; Beever EA, 2006, DIVERS DISTRIB, V12, P229, DOI 10.1111/j.1366-9516.2006.00260.x; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Carter G, 2012, TIDE MODEL OUTPUT MA; Carter GS, 2008, J PHYS OCEANOGR, V38, P2205, DOI 10.1175/2008JPO3860.1; Costa BM, 2012, 149 NOAA NOS NCCOS, P1; Dolan MFJ, 2008, DEEP-SEA RES PT I, V55, P1564, DOI 10.1016/j.dsr.2008.06.010; Dollar S.J., 1982, Coral Reefs, V1, P71, DOI 10.1007/BF00301688; DOLLAR SJ, 1993, CORAL REEFS, V12, P223, DOI 10.1007/BF00334481; DUSTAN P, 1975, MAR BIOL, V33, P101, DOI 10.1007/BF00390714; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Engels MS, 2004, J SEDIMENT RES, V74, P255, DOI 10.1306/073003740255; Falkowski P.G., 1990, P89; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fletcher Charles H., 2008, V1, P435, DOI 10.1007/978-1-4020-6847-8_11; Franklin EC, 2013, MAR ECOL PROG SER, V481, P121, DOI 10.3354/meps10252; FRICKE HW, 1987, OECOLOGIA, V73, P371, DOI 10.1007/BF00385253; GRIGG RICHARD W., 1965, PACIFIC SCI, V19, P244; Grigg RW, 1998, CORAL REEFS, V17, P263, DOI 10.1007/s003380050127; Grigg RW, 2006, CORAL REEFS, V25, P77, DOI 10.1007/s00338-005-0073-6; GRIGG RW, 1983, MAR ECOL PROG SER, V11, P1, DOI 10.3354/meps011001; Guinan J, 2009, ECOL INFORM, V4, P83, DOI 10.1016/j.ecoinf.2009.01.004; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; Howell KL, 2011, BIOL CONSERV, V144, P2656, DOI 10.1016/j.biocon.2011.07.025; Jenness JS, 2011, DEM SURFACE TOOLS AR; Jokiel P.L., 2006, P 10 INT COR REEF S, P390; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Kahng S., 2012, P 12 INT COR REEF S; Kahng SE, 2007, CORAL REEFS, V26, P679, DOI 10.1007/s00338-007-0253-7; Kahng SE, 2014, CURR OPIN ENV SUST, V7, P72, DOI 10.1016/j.cosust.2013.11.019; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Kahng SE, 2006, CORAL REEFS, V25, P254, DOI 10.1007/s00338-006-0098-5; Kahng SE, 2005, CORAL REEFS, V24, P556, DOI 10.1007/s00338-005-0026-0; Kleypas JA, 1999, AM ZOOL, V39, P146; KUHLMANN DHH, 1983, HELGOLANDER MEERESUN, V36, P183; Leathwick JR, 2001, FUNCT ECOL, V15, P233, DOI 10.1046/j.1365-2435.2001.00504.x; Leclercq N, 2000, GLOB CHANGE BIOL, V6, P329, DOI 10.1046/j.1365-2486.2000.00315.x; Lemeshow, 2000, APPL LOGISTIC REGRES, P375, DOI [10.1002/0471722146, DOI 10.1002/0471722146]; Lesser MP, 2011, BIOL INVASIONS, V13, P1855, DOI 10.1007/s10530-011-0005-z; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Liddell W.D., 1988, PALAIOS, V3, P413, DOI DOI 10.2307/3514787; Liu C, 2009, 18 WORLD IMACS MODSI; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Luck DG, 2013, PEERJ, V132, P1; Menza C, 2008, REV BIOL TROP, V56, P11; Miller J, 2007, ECOL MODEL, V202, P225, DOI 10.1016/j.ecolmodel.2006.12.012; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips S., 2012, BRIEF TUTORIAL MAXEN; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; PIFSC (Pacific Islands Fisheries Science Center), 2014, OPTICAL ANAL OVERVIE; Piniak GA, 2007, MAR ENVIRON RES, V64, P456, DOI 10.1016/j.marenvres.2007.04.001; Pittman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020583; Pittman SJ, 2009, J COASTAL RES, V25, P27, DOI [10.2112/SI53-004.1, 10.2112/S153-004.1]; Pontius RG, 2001, AGR ECOSYST ENVIRON, V85, P239, DOI 10.1016/S0167-8809(01)00187-6; Rengstorf AM, 2013, J BIOGEOGR, V40, P1702, DOI 10.1111/jbi.12123; Rooney J, 2010, CORAL REEFS, V29, P361, DOI 10.1007/s00338-010-0596-3; Rudnick DL, 2003, SCIENCE, V301, P355, DOI 10.1126/science.1085837; Slattery M, 2011, J EXP MAR BIOL ECOL, V408, P32, DOI 10.1016/j.jembe.2011.07.024; Spalding H, 2012, THESIS U HAWAII M NO; Storlazzi CD, 2005, CORAL REEFS, V24, P43, DOI 10.1007/s00338-004-0430-x; Storlazzi CD, 2004, 21 PACLIM P, P36; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Vermeij M, 2008, CORAL REEFS MAUI STA; Wells J. W., 1957, Memoirs Geological Society of America, V67, P609; Wiley E. O., 2003, OCEANOGRAPHY, V16, P120, DOI [http://dx.doi.org/10.5670/oceanog.2003.42, DOI 10.5670/OCEANOG.2003.42, 10.5670/oceanog.2003.42]; Woodby D, 2009, MAR ECOL PROG SER, V397, P227, DOI 10.3354/meps08358; Wright D.J., 2005, ARCGIS BENTHIC TERRA	76	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130285	10.1371/journal.pone.0130285	http://dx.doi.org/10.1371/journal.pone.0130285			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26153883	Green Published, gold, Green Submitted			2022-12-27	WOS:000358159700028
J	Lieberman, DE; Castillo, ER; Otarola-Castillo, E; Sang, MK; Sigei, TK; Ojiambo, R; Okutoyi, P; Pitsiladis, Y				Lieberman, Daniel E.; Castillo, Eric R.; Otarola-Castillo, Erik; Sang, Meshack K.; Sigei, Timothy K.; Ojiambo, Robert; Okutoyi, Paul; Pitsiladis, Yannis			Variation in Foot Strike Patterns among Habitually Barefoot and Shod Runners in Kenya	PLOS ONE			English	Article							REARFOOT STRIKE; FEMALE RUNNERS; STANCE PHASE; ROAD RACE; FOREFOOT; KINEMATICS; ECONOMY; LEVEL	Runners are often categorized as forefoot, midfoot or rearfoot strikers, but how much and why do individuals vary in foot strike patterns when running on level terrain? This study used general linear mixed-effects models to explore both intra-and inter-individual variations in foot strike pattern among 48 Kalenjin-speaking participants from Kenya who varied in age, sex, body mass, height, running history, and habitual use of footwear. High speed video was used to measure lower extremity kinematics at ground contact in the sagittal plane while participants ran down 13 meter-long tracks with three variables independently controlled: speed, track stiffness, and step frequency. 72% of the habitually barefoot and 32% of the habitually shod participants used multiple strike types, with significantly higher levels of foot strike variation among individuals who ran less frequently and who used lower step frequencies. There was no effect of sex, age, height or weight on foot strike angle, but individuals were more likely to midfoot or forefoot strike when they ran on a stiff surface, had a high preferred stride frequency, were habitually barefoot, and had more experience running. It is hypothesized that strike type variation during running, including a more frequent use of forefoot and midfoot strikes, used to be greater before the introduction of cushioned shoes and paved surfaces.	[Lieberman, Daniel E.; Castillo, Eric R.; Otarola-Castillo, Erik] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Sang, Meshack K.; Ojiambo, Robert] Moi Univ, Sch Med, Dept Med Physiol, Eldoret, Kenya; [Sigei, Timothy K.] Moi Univ, Dept Stat & Comp Sci, Eldoret, Kenya; [Okutoyi, Paul] Moi Univ, Sch Med, Dept Orthopaed & Rehabil, Eldoret, Kenya; [Pitsiladis, Yannis] Univ Brighton, Ctr Sport & Exercise Sci & Med, Brighton, E Sussex, England	Harvard University; Moi University; Moi University; Moi University; University of Brighton	Lieberman, DE (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA.	danlieb@fas.harvard.edu		Otarola-Castillo, Erik/0000-0002-7806-494X; Pitsiladis, Yannis/0000-0001-6210-2449	American School of Prehistoric Research, Harvard University	American School of Prehistoric Research, Harvard University	This work was supported by the American School of Prehistoric Research, Harvard University (DEL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn AN, 2014, J SPORT HEALTH SCI, V3, P102, DOI 10.1016/j.jshs.2014.03.007; Altman AR, 2012, CURR SPORT MED REP, V11, P244, DOI 10.1249/JSR.0b013e31826c9bb9; Altman AR, 2012, GAIT POSTURE, V35, P298, DOI 10.1016/j.gaitpost.2011.09.104; ARDIGO LP, 1995, ACTA PHYSIOL SCAND, V155, P17, DOI 10.1111/j.1748-1716.1995.tb09943.x; BUCZEK FL, 1990, MED SCI SPORT EXER, V22, P669, DOI 10.1249/00005768-199010000-00019; Cunningham CB, 2010, J EXP BIOL, V213, P790, DOI 10.1242/jeb.038984; De Wit B, 2000, J BIOMECH, V33, P269, DOI 10.1016/S0021-9290(99)00192-X; Divert C, 2008, INT J SPORTS MED, V29, P512, DOI 10.1055/s-2007-989233; Gibson AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066552; Gruber AH, 2013, FOOTWEAR SCI, V5, P39, DOI 10.1080/19424280.2012.742141; Gruber AH, 2013, J APPL PHYSIOL, V115, P194, DOI 10.1152/japplphysiol.01437.2012; Hamill J, 2011, FOOTWEAR SCI, V3, P33, DOI 10.1080/19424280.2010.542187; Hasegawa H, 2007, J STRENGTH COND RES, V21, P888, DOI 10.1519/R-22096.1; Hatala KG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052548; Hayes P, 2012, J SPORT SCI, V30, P1275, DOI 10.1080/02640414.2012.707326; Hreljac A, 2000, MED SCI SPORT EXER, V32, P1635; Kasmer ME, 2014, J SPORT HEALTH SCI, V3, P122, DOI 10.1016/j.jshs.2014.03.005; Keller TS, 1996, CLIN BIOMECH, V11, P253, DOI 10.1016/0268-0033(95)00068-2; Larson P, 2014, J SPORT HEALTH SCI, V3, P137, DOI 10.1016/j.jshs.2014.03.003; Larson P, 2011, J SPORT SCI, V29, P1665, DOI 10.1080/02640414.2011.610347; Lieberman D., 2013, STORY HUMAN BODY EVO; Lieberman DE, 2014, J SPORT HEALTH SCI, V3, P86, DOI 10.1016/j.jshs.2014.03.009; Lieberman DE, 2012, EXERC SPORT SCI REV, V40, P63, DOI 10.1097/JES.0b013e31824ab210; Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; Manly B.F.J., 2006, RANDOMIZATION BOOTST, V3rd, DOI DOI 10.1201/9781315273075; MCCULLOCH CE, 2001, GENERALIZED LINEAR M; Meredith MD., 2010, FITNESSGRAM ACTIVITY; Miller EE, 2014, J SPORT HEALTH SCI, V3, P74, DOI 10.1016/j.jshs.2014.03.011; Milner CE, 2006, MED SCI SPORT EXER, V38, P323, DOI 10.1249/01.mss.0000183477.75808.92; Nigg B. M., 2010, BIOMECHANICS SPORTS; Nigg BM, 1997, CURR OPIN ORTHOP, DOI [10.1097/00001433-199712000-00007., DOI 10.1097/00001433-199712000-00007]; Ojiambo R, 2013, ANN HUM BIOL, V40, P318, DOI 10.3109/03014460.2013.775344; Padulo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069006; Perl DP, 2012, MED SCI SPORT EXER, V44, P1335, DOI 10.1249/MSS.0b013e318247989e; Pitsiladis Y. P., 2004, Equine and Comparative Exercise Physiology, V1, P285, DOI 10.1079/ECP200433; Pohl MB, 2009, CLIN J SPORT MED, V19, P372, DOI 10.1097/JSM.0b013e3181b8c270; Pontzer H, 2014, J SPORT HEALTH SCI, V3, P95, DOI 10.1016/j.jshs.2014.03.010; Sears E., 2001, RUNNING AGES; Squadrone R, 2009, J SPORT MED PHYS FIT, V49, P6; Williams DS, 2000, J APPL BIOMECH, V16, P210, DOI 10.1123/jab.16.2.210	40	38	41	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131354	10.1371/journal.pone.0131354	http://dx.doi.org/10.1371/journal.pone.0131354			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154285	Green Submitted, gold, Green Published			2022-12-27	WOS:000358159700060
J	Walker, CG; Solis-Trapala, I; Holzapfel, C; Ambrosini, GL; Fuller, NR; Loos, RJF; Hauner, H; Caterson, ID; Jebb, SA				Walker, Celia G.; Solis-Trapala, Ivonne; Holzapfel, Christina; Ambrosini, Gina L.; Fuller, Nicholas R.; Loos, Ruth J. F.; Hauner, Hans; Caterson, Ian D.; Jebb, Susan A.			Modelling the Interplay between Lifestyle Factors and Genetic Predisposition on Markers of Type 2 Diabetes Mellitus Risk	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; WEIGHT-LOSS; SUSCEPTIBILITY LOCI; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; GLYCEMIC TRAITS; INTERVENTION; FAT; VARIANTS; REPLICATION	The risk of developing type 2 diabetes mellitus (T2DM) is determined by a complex interplay involving lifestyle factors and genetic predisposition. Despite this, many studies do not consider the relative contributions of this complex array of factors to identify relationships which are important in progression or prevention of complex diseases. We aimed to describe the integrated effect of a number of lifestyle changes (weight, diet and physical activity) in the context of genetic susceptibility, on changes in glycaemic traits in overweight or obese participants following 12-months of a weight management programme. A sample of 353 participants from a behavioural weight management intervention were included in this study. A graphical Markov model was used to describe the impact of the intervention, by dividing the effects into various pathways comprising changes in proportion of dietary saturated fat, physical activity and weight loss, and a genetic predisposition score (T2DM-GPS), on changes in insulin sensitivity (HOMA-IR), insulin secretion (HOMA-B) and short and long term glycaemia (glucose and HbA1c). We demonstrated the use of graphical Markov modelling to identify the importance and interrelationships of a number of possible variables changed as a result of a lifestyle intervention, whilst considering fixed factors such as genetic predisposition, on changes in traits. Paths which led to weight loss and change in dietary saturated fat were important factors in the change of all glycaemic traits, whereas the T2DM-GPS only made a significant direct contribution to changes in HOMA-IR and plasma glucose after considering the effects of lifestyle factors. This analysis shows that modifiable factors relating to body weight, diet, and physical activity are more likely to impact on glycaemic traits than genetic predisposition during a behavioural intervention.	[Walker, Celia G.; Solis-Trapala, Ivonne; Ambrosini, Gina L.; Jebb, Susan A.] MRC Human Nutr Res, Elsie Widdowson Lab, Cambridge, England; [Holzapfel, Christina; Hauner, Hans] Tech Univ Munich, Fac Med, Else Kroener Fresenius Ctr Nutr Med, D-80290 Munich, Germany; [Fuller, Nicholas R.; Caterson, Ian D.] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, Charles Bronfman Inst Personalized Med, Genet Obes & Related Metab Traits Programme, New York, NY 10029 USA	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Technical University of Munich; University of Sydney; Icahn School of Medicine at Mount Sinai	Walker, CG (corresponding author), MRC Human Nutr Res, Elsie Widdowson Lab, Cambridge, England.	celia.walker@mrc-hnr.cam.ac.uk; Ivonne.Solis-Trapala@mrc-hnr.cam.ac.uk	Loos, Ruth J F/Q-2862-2016; Loos, Ruth/GON-5877-2022; Holzapfel, Christina/AAO-5928-2020; Solis-Trapala, Ivonne/D-8144-2011; Solis-Trapala, Ivonne/AAZ-2105-2021; Ambrosini, Gina/E-7107-2010	Loos, Ruth J F/0000-0002-8532-5087; Holzapfel, Christina/0000-0002-0155-9338; Solis-Trapala, Ivonne/0000-0002-1264-1396; Solis-Trapala, Ivonne/0000-0002-1264-1396; Ambrosini, Gina/0000-0003-1001-4265; Jebb, Susan/0000-0001-9190-2920	UK Medical Research Council [U105960389]; Weight Watchers International; MRC [G0701642, MC_EX_G0701642/2, MC_U105960389] Funding Source: UKRI; Medical Research Council [MC_EX_G0701642/2, G0701642, MC_U105960389] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541, P60DK020541] Funding Source: NIH RePORTER	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Weight Watchers International; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This analysis was funded by the participating centres including UK Medical Research Council (grant code U105960389). The intervention trial was funded by Weight Watchers International through a grant to the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An P, 2014, METABOLISM, V63, P461, DOI 10.1016/j.metabol.2013.11.018; Andersson EA, 2013, DIABETES, V62, P3610, DOI 10.2337/db13-0362; Belalcazar LM, 2010, DIABETES CARE, V33, P2297, DOI 10.2337/dc10-0728; Berrington A, 2008, J R STAT SOC A STAT, V171, P89; Borgoni R, 2012, QUAL QUANT, V46, P715, DOI 10.1007/s11135-010-9407-8; Corder K, 2007, CURR OPIN CLIN NUTR, V10, P597, DOI 10.1097/MCO.0b013e328285d883; Cox D.R., 1996, MULTIVARIATE DEPENDE; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fitt E, 2015, PUBLIC HEALTH NUTR, V18, P234, DOI 10.1017/S1368980014000342; FSANZ, 2006, NUTR TABLES USE AUST; Fuller NR, 2014, CLIN OBES, V4, P127, DOI 10.1111/cob.12057; Hivert MF, 2011, DIABETES, V60, P1340, DOI 10.2337/db10-1119; Hornbak M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104837; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; Hung T, 2003, CURR OPIN CLIN NUTR, V6, P165, DOI 10.1097/00075197-200303000-00005; Jebb SA, 2011, LANCET, V378, P1485, DOI 10.1016/S0140-6736(11)61344-5; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Li SX, 2010, AM J CLIN NUTR, V91, P184, DOI 10.3945/ajcn.2009.28403; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Mason C, 2011, AM J PREV MED, V41, P366, DOI 10.1016/j.amepre.2011.06.042; Merlotti C, 2014, DIABETES OBES METAB, V16, P719, DOI 10.1111/dom.12270; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Peter I, 2012, OBESITY, V20, P1675, DOI 10.1038/oby.2012.11; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Riccardi G, 2004, CLIN NUTR, V23, P447, DOI 10.1016/j.clnu.2004.02.006; Ruggeri M, 2004, INT J METH PSYCH RES, V13, P10, DOI 10.1002/mpr.160; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vessby B, 2001, DIABETOLOGIA, V44, P312, DOI 10.1007/s001250051620; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Walker CG, 2012, GENES NUTR, V7, P529, DOI 10.1007/s12263-012-0284-8; Wermuth N, 2012, INT STAT REV, V80, P415, DOI 10.1111/j.1751-5823.2012.00195.x; Wermuth N, 2012, TEST-SPAIN, V21, P215, DOI 10.1007/s11749-012-0290-6; WHO, 2003, WHO TECHN REP SER, V916, P54; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	41	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131681	10.1371/journal.pone.0131681	http://dx.doi.org/10.1371/journal.pone.0131681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154605	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000358159700076
J	Bertolini, F; Scimone, C; Geraci, C; Schiavo, G; Utzeri, VJ; Chiofalo, V; Fontanesi, L				Bertolini, Francesca; Scimone, Concetta; Geraci, Claudia; Schiavo, Giuseppina; Utzeri, Valerio Joe; Chiofalo, Vincenzo; Fontanesi, Luca			Next Generation Semiconductor Based Sequencing of the Donkey (Equus asinus) Genome Provided Comparative Sequence Data against the Horse Genome and a Few Millions of Single Nucleotide Polymorphisms	PLOS ONE			English	Article							COPY NUMBER VARIANTS; ION TORRENT; GENETIC DIVERSITY; COMPARATIVE MAP; ANCIENT DNA; MILK; CHROMOSOME; EVOLUTION; INSIGHT; BREEDS	Few studies investigated the donkey (Equus asinus) at the whole genome level so far. Here, we sequenced the genome of two male donkeys using a next generation semiconductor based sequencing platform (the Ion Proton sequencer) and compared obtained sequence information with the available donkey draft genome (and its Illumina reads from which it was originated) and with the EquCab2.0 assembly of the horse genome. Moreover, the Ion Torrent Personal Genome Analyzer was used to sequence reduced representation libraries (RRL) obtained from a DNA pool including donkeys of different breeds (Grigio Siciliano, Ragusano and Martina Franca). The number of next generation sequencing reads aligned with the EquCab2.0 horse genome was larger than those aligned with the draft donkey genome. This was due to the larger N50 for contigs and scaffolds of the horse genome. Nucleotide divergence between E. caballus and E. asinus was estimated to be similar to 0.52-0.57%. Regions with low nucleotide divergence were identified in several autosomal chromosomes and in the whole chromosome X. These regions might be evolutionally important in equids. Comparing Y-chromosome regions we identified variants that could be useful to track donkey paternal lineages. Moreover, about 4.8 million of single nucleotide polymorphisms (SNPs) in the donkey genome were identified and annotated combining sequencing data from Ion Proton (whole genome sequencing) and Ion Torrent (RRL) runs with Illumina reads. A higher density of SNPs was present in regions homologous to horse chromosome 12, in which several studies reported a high frequency of copy number variants. The SNPs we identified constitute a first resource useful to describe variability at the population genomic level in E. asinus and to establish monitoring systems for the conservation of donkey genetic resources.	[Bertolini, Francesca; Geraci, Claudia; Schiavo, Giuseppina; Utzeri, Valerio Joe; Fontanesi, Luca] Univ Bologna, Div Anim Sci, Dept Agr & Food Sci, Bologna, Italy; [Bertolini, Francesca; Scimone, Concetta; Chiofalo, Vincenzo] Polo Univ Annunziata, Univ Messina, Dept Vet Sci, Anim Prod Unit, Messina, Italy; [Chiofalo, Vincenzo] Polo Univ Annunziata, Meat Res Consortium, Messina, Italy	University of Bologna; University of Messina	Fontanesi, L (corresponding author), Univ Bologna, Div Anim Sci, Dept Agr & Food Sci, Viale Fanin 46, Bologna, Italy.	luca.fontanesi@unibo.it	Scimone, Concetta/P-4366-2015; bertolini, francesca/AAX-3836-2021; Fontanesi, Luca/L-1770-2014	Fontanesi, Luca/0000-0001-7050-3760; Geraci, Claudia/0000-0002-4948-0725; Bertolini, Francesca/0000-0003-4181-3895; UTZERI, VALERIO JOE/0000-0001-5320-4216	University of Bologna RFO (Ricerca Fondamentale Orientata); University of Messina; Corfilcarni; PanLab Project [PONa3_00166/F1]	University of Bologna RFO (Ricerca Fondamentale Orientata); University of Messina; Corfilcarni; PanLab Project	This study was supported by University of Bologna RFO (Ricerca Fondamentale Orientata), University of Messina, Corfilcarni and PanLab Project PONa3_00166/F1 funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitbol M, 2014, ANIM GENET, V45, P878, DOI 10.1111/age.12207; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Amati L, 2010, CURR PHARM DESIGN, V16, P864, DOI 10.2174/138161210790883651; [Anonymous], 2014, R LANG ENV STAT COMP; Aranguren-Mendez J, 2004, J ANIM BREED GENET, V121, P319, DOI 10.1111/j.1439-0388.2004.00464.x; Aranguren-Mendez J, 2001, GENET SEL EVOL, V33, P433, DOI 10.1051/gse:2001126; Ballestra F, 2005, French Patent Application, Patent No. [FR 2 707 877 Al. 6, 2707877]; Beja-Pereira A, 2004, SCIENCE, V304, P1781, DOI 10.1126/science.1096008; Bell CC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1002; Bertolini F, 2014, ANIM GENET, V45, P304, DOI 10.1111/age.12121; Blench RM., 2004, THE HISTORY AND SPRE; Boland JF, 2013, HUM GENET, V132, P1153, DOI 10.1007/s00439-013-1321-4; Bordonaro S, 2012, SCI WORLD J, DOI 10.1100/2012/648427; Bovo S, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/950737; Carroccio A, 2000, CLIN EXP ALLERGY, V30, P1597, DOI 10.1046/j.1365-2222.2000.00925.x; Choi JW, 2013, MOL CELLS, V36, P203, DOI 10.1007/s10059-013-2347-0; Colli L, 2013, ANIM GENET, V44, P69, DOI 10.1111/j.1365-2052.2012.02356.x; Cosenza G, 2010, ITAL J ANIM SCI, V9, P206, DOI 10.4081/ijas.2010.e40; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Doan R, 2012, GENOME RES, V22, P899, DOI 10.1101/gr.128991.111; Fantini E, 2015, METHODS MOL BIOL, V1231, P77, DOI 10.1007/978-1-4939-1720-4_5; Fontanesi L, 2011, GENOMICS, V97, P158, DOI 10.1016/j.ygeno.2010.11.005; Fontanesi L, 2015, ANIM BIOTECHNOL, V26, P92, DOI 10.1080/10495398.2014.881369; Fontanesi L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-639; Ghosh S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004712; Han L, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0246-4; Henry M., 1995, BIOL REPROD, V52, P273, DOI [10.1093/biolreprod/52.monograph_series1.273, DOI 10.1093/BIOLREPROD/52.MONOGRAPH_SERIES1.273]; Homer N, TMAP THE TORRENT MAP; Huang JL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04958; IACONO G, 1992, J PEDIATR GASTR NUTR, V14, P177, DOI 10.1097/00005176-199202000-00010; Kimura B, 2011, P ROY SOC B-BIOL SCI, V278, P50, DOI 10.1098/rspb.2010.0708; Kugler W, REPORT 2007 2008; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WH, 2002, CURR OPIN GENET DEV, V12, P650, DOI 10.1016/S0959-437X(02)00354-4; Liu Q, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S8; Lopez CL, 2005, TROP ANIM HEALTH PRO, V37, P173, DOI 10.1007/s11250-005-9001-6; Martemucci G, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-113; McCue ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002451; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Merriman B, 2012, ELECTROPHORESIS, V33, P3397, DOI 10.1002/elps.201200424; Metzger J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-487; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Molnar J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-761; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Parson W, 2013, FORENSIC SCI INT-GEN, V7, P543, DOI 10.1016/j.fsigen.2013.06.003; Payseur BA, 2004, EVOLUTION, V58, P2064; Polidori P, 2008, MEAT SCI, V80, P1222, DOI 10.1016/j.meatsci.2008.05.027; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Raudsepp T, 2001, CYTOGENET CELL GENET, V94, P180, DOI 10.1159/000048812; Raudsepp T, 1999, CHROMOSOME RES, V7, P103, DOI 10.1023/A:1009234814635; Rizzi R, 2011, J ANIM SCI, V89, P1304, DOI 10.2527/jas.2010-3379; RONG R, 1988, CYTOGENET CELL GENET, V47, P134, DOI 10.1159/000132531; Rosenbom S, 2015, ANIM GENET, V46, P30, DOI 10.1111/age.12256; Rossel S, 2008, P NATL ACAD SCI USA, V105, P3715, DOI 10.1073/pnas.0709692105; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; RYDER OA, 1985, J HERED, V76, P379; Selvaggi M, 2011, AFR J BIOTECHNOL, V10, P5118; Starkey P, 2000, DONKEYS PEOPLE DEV R, P219; Stoddard JL, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00531; Tesse R, 2009, ITAL J PEDIATR, V35, DOI 10.1186/1824-7288-35-19; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wallner B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060015; Wang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086860; Yang FT, 2004, CHROMOSOME RES, V12, P65, DOI 10.1023/B:CHRO.0000009298.02689.8a; Zenebe S, 2000, DONKEYS PEOPLE AND D, P71	67	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131925	10.1371/journal.pone.0131925	http://dx.doi.org/10.1371/journal.pone.0131925			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151450	Green Published, gold, Green Submitted			2022-12-27	WOS:000358158900030
J	do Bonfim, CM; Sobrinho, JS; Nogueira, RL; Kupper, DS; Valera, FCP; Nogueira, ML; Villa, LL; Rahal, P; Sichero, L				do Bonfim, Caroline Measso; Sobrinho, Joao Simao; Nogueira, Rodrigo Lacerda; Kupper, Daniel Salgado; Pereira Valera, Fabiana Cardoso; Nogueira, Maurcio Lacerda; Villa, Luisa Lina; Rahal, Paula; Sichero, Laura			Differences in Transcriptional Activity of Human Papillomavirus Type 6 Molecular Variants in Recurrent Respiratory Papillomatosis	PLOS ONE			English	Article							CERVICAL-CANCER; UPSTREAM; THERAPY; REGION; DNA; SUSCEPTIBILITY; LESIONS; SITES; HPV-6; RISK	A significant proportion of recurrent respiratory papillomatosis (RRP) is caused by human papillomavirus type 6 (HPV-6). The long control region (LCR) contains cis-elements for regulation of transcription. Our aim was to characterize LCR HPV-6 variants in RRP cases, compare promoter activity of these isolates and search for cellular transcription factors (TFs) that could explain the differences observed. The complete LCR from 13 RRP was analyzed. Transcriptional activity of 5 variants was compared using luciferase assays. Differences in putative TFs binding sites among variants were revealed using the TRANSFAC database. Chromatin immunoprecipation (CHIP) and luciferase assays were used to evaluate TF binding and impact upon transcription, respectively. Juvenile-onset RRP cases harbored exclusively HPV-6vc related variants, whereas among adult-onset cases HPV-6a variants were more prevalent. The HPV-6vc reference was more transcriptionally active than the HPV-6a reference. Active FOXA1, ELF1 and GATA1 binding sites overlap variable nucleotide positions among isolates and influenced LCR activity. Furthermore, our results support a crucial role for ELF1 on transcriptional downregulation. We identified TFs implicated in the regulation of HPV-6 early gene expression. Many of these factors are mutated in cancer or are putative cancer biomarkers, and must be further studied.	[do Bonfim, Caroline Measso; Rahal, Paula] UNESP, Lab Genom Studies, Sao Jose Do Rio Preto, SP, Brazil; [Sobrinho, Joao Simao; Villa, Luisa Lina; Sichero, Laura] ICESP, Ctr Translat Oncol, Mol Biol Lab, Sao Paulo, Brazil; [Nogueira, Rodrigo Lacerda; Kupper, Daniel Salgado; Pereira Valera, Fabiana Cardoso] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Ophthalmol Otorhinolaryngol & Head Neck Surg, Discipline Otorhinolaryngol, Sao Paulo, Brazil; [Nogueira, Maurcio Lacerda] FAMERP, Fac Med Sao Jose Rio Preto, Lab Res Virol, Sao Jose Do Rio Preto, Brazil; [Villa, Luisa Lina] Univ Sao Paulo, Sch Med, Dept Radiol & Oncol, Sao Paulo, Brazil; [Villa, Luisa Lina] Santa Casa Sao Paulo & HPV Inst, Sch Med, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Universidade de Sao Paulo	Sichero, L (corresponding author), ICESP, Ctr Translat Oncol, Mol Biol Lab, Sao Paulo, Brazil.	lsichero@gmail.com	Valera, Fabiana Cardoso Pereira/D-3787-2012; Rahal, Paula/D-3871-2012; Nogueira, Mauricio L/B-7599-2012; Sichero, Laura/AAT-4228-2021; VILLA, LUISA/AAH-4761-2019	Valera, Fabiana Cardoso Pereira/0000-0002-6605-5317; Rahal, Paula/0000-0001-5693-6148; Nogueira, Mauricio L/0000-0003-1102-2419; Sichero, Laura/0000-0002-7999-5818; VILLA, LUISA/0000-0003-4074-2335	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [10/00029-0, 08/57889-1]; Conselho Nacional de Desenvolvimento Cientifico e Tencnologico (CNPq) [573799/2008-3]; Ludwig Institute for Cancer Research	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tencnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Ludwig Institute for Cancer Research	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (grant numbers 10/00029-0 to CMB and 08/57889-1 to LLV); Conselho Nacional de Desenvolvimento Cientifico e Tencnologico (CNPq) (grant number 573799/2008-3 to LLV); and Ludwig Institute for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Matos RPA, 2013, INFECT GENET EVOL, V16, P282, DOI 10.1016/j.meegid.2012.12.033; Bernard HU, 2002, ANTIVIR THER, V7, P219; Berumen J, 2001, JNCI-J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325; Bishai D, 2000, ARCH OTOLARYNGOL, V126, P935, DOI 10.1001/archotol.126.8.935; Buchinsky FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002263; Burk Robert D, 2011, Acta Dermatovenerol Alp Pannonica Adriat, V20, P113; Combrinck CE, 2012, EPIDEMIOL INFECT, V140, P1095, DOI 10.1017/S0950268811001580; Danielewski JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063892; Derkay CS, 2008, LARYNGOSCOPE, V118, P1236, DOI 10.1097/MLG.0b013e31816a7135; Derkay CS, 1998, LARYNGOSCOPE, V108, P935, DOI 10.1097/00005537-199806000-00026; DEVILLIERS EM, 1981, J VIROL, V40, P932, DOI 10.1128/JVI.40.3.932-935.1981; Donne AJ, 2010, INT J STD AIDS, V21, P381, DOI 10.1258/ijsa.2010.010073; Donne AJ, 2010, INT J PEDIATR OTORHI, V74, P7, DOI 10.1016/j.ijporl.2009.09.004; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Gall T, 2011, ANTIVIR RES, V92, P356, DOI 10.1016/j.antiviral.2011.09.007; Gallant S, 2006, ARCH IMMUNOL THER EX, V54, P149, DOI 10.1007/s00005-006-0017-z; Garcia-Vallve S, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-20; Gelder CM, 2003, J VIROL, V77, P1927, DOI 10.1128/JVI.77.3.1927-1939.2003; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HEINZEL PA, 1995, J CLIN MICROBIOL, V33, P1746, DOI 10.1128/JCM.33.7.1746-1754.1995; Hildesheim A, 2001, JNCI-J NATL CANCER I, V93, P315, DOI 10.1093/jnci/93.4.315; Hubert WG, 2005, J VIROL, V79, P5914, DOI 10.1128/JVI.79.10.5914-5922.2005; Jelen MM, 2014, J VIROL, V88, P7307, DOI 10.1128/JVI.00621-14; Kammer C, 2000, J GEN VIROL, V81, P1975, DOI 10.1099/0022-1317-81-8-1975; KASHIMA H, 1993, ANN OTO RHINOL LARYN, V102, P580, DOI 10.1177/000348949310200802; Katsumura KR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015412; Kocjan BJ, 2013, J INFECT DIS, V207, P583, DOI 10.1093/infdis/jis733; Kocjan BJ, 2009, VIROLOGY, V391, P274, DOI 10.1016/j.virol.2009.06.030; Komlos KF, 2012, J MED VIROL, V84, P1233, DOI 10.1002/jmv.23318; Larson DA, 2010, APMIS, V118, P450, DOI 10.1111/j.1600-0463.2010.02619.x; Lizano M, 2006, GYNECOL ONCOL, V102, P230, DOI 10.1016/j.ygyno.2005.12.002; Lucs AV, 2012, MOL MED, V18, P244, DOI 10.2119/molmed.2011.00447; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; OBALEK S, 1990, J AM ACAD DERMATOL, V23, P205, DOI 10.1016/0190-9622(90)70200-2; Rainis L, 2003, BLOOD, V102, P981, DOI 10.1182/blood-2002-11-3599; RANDO RF, 1986, J VIROL, V57, P353, DOI 10.1128/JVI.57.1.353-356.1986; ROMANCZUK H, 1991, J VIROL, V65, P2739, DOI 10.1128/JVI.65.5.2739-2744.1991; Sichero L, 2005, J INFECT DIS, V191, P739, DOI 10.1086/427825; Sichero L, 2007, INT J CANCER, V120, P1763, DOI 10.1002/ijc.22481; Sichero L, 2012, J INFECT DIS, V206, P867, DOI 10.1093/infdis/jis430; Thomas-Chollier M, 2011, NAT PROTOC, V6, P1860, DOI 10.1038/nprot.2011.409; Thompson D I, 1994, Healthc Inf Manage, V8, P45; Yuan H, 2012, NEW ENGL J MED, V367, P1220, DOI 10.1056/NEJMoa1203055	43	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132325	10.1371/journal.pone.0132325	http://dx.doi.org/10.1371/journal.pone.0132325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151558	Green Published, Green Submitted, gold			2022-12-27	WOS:000358158900041
J	Hasegawa, H; Sato, M; Tanaka, H				Hasegawa, Hiroaki; Sato, Masanori; Tanaka, Hiroshi			Evaluation of an X-Ray Dose Profile Derived from an Optically Stimulated Luminescent Dosimeter during Computed Tomographic Fluoroscopy	PLOS ONE			English	Article							CT-FLUOROSCOPY; RADIATION-EXPOSURE; INTERVENTIONAL PROCEDURES; GUIDED INTERVENTIONS; PHYSICIANS HAND; PATIENT; PARAMETERS; RADIOLOGY; SCANNER; SYSTEM	The purpose of this study was to evaluate scatter radiation dose to the subject surface during X-ray computed tomography (CT) fluoroscopy using the integrated dose ratio (IDR) of an X-ray dose profile derived from an optically stimulated luminescent (OSL) dosimeter. We aimed to obtain quantitative evidence supporting the radiation protection methods used during previous CT fluoroscopy. A multislice CT scanner was used to perform this study. OSL dosimeters were placed on the top and the lateral side of the chest phantom so that the longitudinal direction of dosimeters was parallel to the orthogonal axis-to-slice plane for measurement of dose profiles in CT fluoroscopy. Measurement of fluoroscopic conditions was performed at 120 kVp and 80 kVp. Scatter radiation dose was evaluated by calculating the integrated dose determined by OSL dosimetry. The overall percent difference of the integrated doses between OSL dosimeters and ionization chamber was 5.92%. The ratio of the integrated dose of a 100-mm length area to its tails (-50 to -6 mm, 50 to 6 mm) was the lowest on the lateral side at 80 kVp and the highest on the top at 120 kVp. The IDRs for different measurement positions were larger at 120 kVp than at 80 kVp. Similarly, the IDRs for the tube voltage between the primary X-ray beam and scatter radiation was larger on the lateral side than on the top of the phantom. IDR evaluation suggested that the scatter radiation dose has a high dependence on the position and a low dependence on tube voltage relative to the primary X-ray beam for constant dose rate fluoroscopic conditions. These results provided quantitative evidence supporting the radiation protection methods used during CT fluoroscopy in previous studies.	[Hasegawa, Hiroaki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Bioinformat, Bunkyo Ku, Tokyo, Japan; [Sato, Masanori] Komazawa Univ, Dept Radiol Sci, Grad Sch Hlth Sci, Setagaya Ku, Tokyo, Japan; [Tanaka, Hiroshi] Tokyo Med & Dent Univ, Div Gen Med, Med Res Inst, Dept Bioinformat,Bunkyo ku, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Hasegawa, H (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Bioinformat, Bunkyo Ku, Tokyo, Japan.	hasegawah-rad@h.u-tokyo.ac.jp		Hasegawa, Hiroaki/0000-0002-8244-8911	Foundation for Promotion of Cancer Research in Japan	Foundation for Promotion of Cancer Research in Japan	This work was supported in part by Foundation for Promotion of Cancer Research in Japan.	Al-Haj A, 2010, RADIAT PROT DOSIM, V142, P228, DOI 10.1093/rpd/ncq220; [Anonymous], 2008, 96 AAPM DIAGN IM COU; Bauhs JA, 2008, RADIOGRAPHICS, V28, P245, DOI 10.1148/rg.281075024; Beganovic A, 2013, RADIAT PROT DOSIM, V153, P106, DOI 10.1093/rpd/ncs100; Boone JM, 2007, MED PHYS, V34, P1364, DOI 10.1118/1.2713240; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Buls N, 2003, HEALTH PHYS, V85, P165, DOI 10.1097/00004032-200308000-00005; Chintapalli KN, 2012, AM J ROENTGENOL, V198, pW347, DOI 10.2214/AJR.11.7958; Hamberg LM, 2003, RADIOLOGY, V226, P762, DOI 10.1148/radiol.2263020205; HOROWITZ YS, 1990, RADIAT PROT DOSIM, V30, P219; IAEA, 2007, TECHNICAL REPORTS SE, V475; International Atomic Energy Agency, 2011, 457 TRS; International Atomic Energy Agency, 2008, 1585 IAEA TECDOC; International Electrotechnical Commission, 2006, EV ROUT TEST MED I 2; International Organization for Standardization, 2008, GUID EXPR UNC MEAS; Irie T, 2001, J VASC INTERV RADIOL, V12, P1417, DOI 10.1016/S1051-0443(07)61701-1; Irie T, 2000, J VASC INTERV RADIOL, V11, P359, DOI 10.1016/S1051-0443(07)61430-4; Jackson SR, 2013, J APPL CLIN MED PHYS, V14, P227, DOI 10.1120/jacmp.v14i4.4122; JANECZEK J, 1995, RADIAT PROT DOSIM, V60, P231; Katada K, 1996, RADIOLOGY, V200, P851, DOI 10.1148/radiology.200.3.8756943; Katada Kazuhiro, 1994, Nippon Acta Radiologica, V54, P1172; Kato R, 1996, RADIOLOGY, V201, P576, DOI 10.1148/radiology.201.2.8888264; Martin CJ, 2011, J RADIOL PROT, V31, P389, DOI 10.1088/0952-4746/31/4/001; Nawfel RD, 2000, RADIOLOGY, V216, P180, DOI 10.1148/radiology.216.1.r00jl39180; Ruan C, 2010, MED PHYS, V37, P3560, DOI 10.1118/1.3455285; Saidatul A, 2010, Biomed Imaging Interv J, V6, pe1, DOI 10.2349/biij.6.1.e2; Sanchez R, 2011, RADIAT PROT DOSIM, V147, P94, DOI 10.1093/rpd/ncr281; Sarti M, 2012, RADIOGRAPHICS, V32, P1109, DOI 10.1148/rg.324115072; SHOPE TB, 1981, MED PHYS, V8, P488, DOI 10.1118/1.594995; Silverman SG, 1999, RADIOLOGY, V212, P673, DOI 10.1148/radiology.212.3.r99se36673; Theocharopoulos N, 2006, EUR RADIOL, V16, P2575, DOI 10.1007/s00330-006-0251-0; Vrieze TJ, 2012, MED PHYS, V39, P6580, DOI 10.1118/1.4754591; Yamao Y, 2013, CLIN RADIOL, V68, P162, DOI 10.1016/j.crad.2012.05.020; Yamao Y, 2010, RADIOLOGY, V255, P233, DOI 10.1148/radiol.09090733; Yukihara EG, 2008, PHYS MED BIOL, V53, pR351, DOI 10.1088/0031-9155/53/20/R01; Yukihara EG, 2010, RADIAT MEAS, V45, P658, DOI 10.1016/j.radmeas.2009.12.034; Yukihara EG, 2009, PHYS MED BIOL, V54, P6337, DOI 10.1088/0031-9155/54/20/020; Zanca F, 2014, MED PHYS, V41, DOI 10.1118/1.4884231	38	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132154	10.1371/journal.pone.0132154	http://dx.doi.org/10.1371/journal.pone.0132154			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151914	Green Published, gold, Green Submitted			2022-12-27	WOS:000358158900036
J	Kim, JE; Park, SH; Kwak, MH; Go, J; Koh, EK; Song, SH; Sung, JE; Lee, HS; Hong, JT; Hwang, DY				Kim, Ji Eun; Park, So Hae; Kwak, Moon Hwa; Go, Jun; Koh, Eun Kyoung; Song, Sung Hwa; Sung, Ji Eun; Lee, Hee Seob; Hong, Jin Tae; Hwang, Dae Youn			Characterization of Changes in Global Genes Expression in the Distal Colon of Loperamide-Induced Constipation SD Rats in Response to the Laxative Effects of Liriope platyphylla	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; FIBROBLAST-GROWTH-FACTOR; AQUEOUS EXTRACTS; INHIBITION; HYPERMETHYLATION; IDENTIFICATION; MODULATION; KALLIKREIN; SECRETION; OXIDATION	To characterize the changes in global gene expression in the distal colon of constipated SD rats in response to the laxative effects of aqueous extracts of Liriope platyphylla (AEtLP), including isoflavone, saponin, oligosaccharide, succinic acid and hydroxyproline, the total RNA extracted from the distal colon of AEtLP-treated constipation rats was hybridized to oligonucleotide microarrays. The AEtLP treated rats showed an increase in the number of stools, mucosa thickness, flat luminal surface thickness, mucin secretion, and crypt number. Overall, compared to the controls, 581 genes were up-regulated and 216 genes were down-regulated by the constipation induced by loperamide in the constipated rats. After the AEtLP treatment, 67 genes were up-regulated and 421 genes were down-regulated. Among the transcripts up-regulated by constipation, 89 were significantly down-regulated and 22 were recovered to the normal levels by the AEtLP treatment. The major genes in the down-regulated categories included Slc9a5, klk10, Fgf15, and Alpi, whereas the major genes in the recovered categories were Cyp2b2, Ace, G6pc, and Setbp1. On the other hand, after the AEtLP treatment, ten of these genes down-regulated by constipation were up-regulated significantly and five were recovered to the normal levels. The major genes in the up-regulated categories included Serpina3n, Lcn2 and Slc5a8, whereas the major genes in the recovered categories were Tmem45a, Rerg and Rgc32. These results indicate that several gene functional groups and individual genes as constipation biomarkers respond to an AEtLP treatment in constipated model rats.	[Kim, Ji Eun; Kwak, Moon Hwa; Go, Jun; Koh, Eun Kyoung; Song, Sung Hwa; Sung, Ji Eun; Hwang, Dae Youn] Pusan Natl Univ, Life & Ind Convergence Res Inst, Coll Nat Resources & Life Sci, Dept Biomat Sci, Miryang 627706, South Korea; [Park, So Hae; Lee, Hee Seob] Pusan Natl Univ, Coll Human Ecol, Dept Food Sci & Nutr, Busan 609735, South Korea; [Hong, Jin Tae] Chungbuk Natl Univ, Coll Pharm, Chungju 361763, South Korea; [Hong, Jin Tae] Chungbuk Natl Univ, Med Res Ctr, Chungju 361763, South Korea	Pusan National University; Pusan National University; Chungbuk National University; Chungbuk National University	Hong, JT (corresponding author), Chungbuk Natl Univ, Coll Pharm, Chungju 361763, South Korea.	jinthong@chungbuk.ac.kr; dyhwang@pusan.ac.kr			National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [MRC-2008-0062275]; Regional Innovation System (RIS) of the Ministry of Knowledge Economy in Korea	National Research Foundation of Korea (NRF) grant - Korea government (MSIP); Regional Innovation System (RIS) of the Ministry of Knowledge Economy in Korea	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. MRC-2008-0062275). Also, this research was supported by a grant from the Regional Innovation System (RIS) of the Ministry of Knowledge Economy in Korea.	Altabas K, 2003, COLLEGIUM ANTROPOL, V27, P197; Beltran-Ramirez O, 2012, TOXICOL PATHOL, V40, P466, DOI 10.1177/0192623311431947; Bharucha AE, 2007, BEST PRACT RES CL GA, V21, P709, DOI 10.1016/j.bpg.2007.07.001; Bolignano D, 2009, REJUV RES, V12, P7, DOI 10.1089/rej.2008.0803; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Bousserouel S, 2011, PATHOL INT, V61, P80, DOI 10.1111/j.1440-1827.2010.02621.x; Byrnes JJ, 2009, INFLAMM RES, V58, P819, DOI 10.1007/s00011-009-0053-3; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Choi SB, 2004, LIFE SCI, V75, P2653, DOI 10.1016/j.lfs.2004.04.039; Choi SI, 2012, MOL MED REP, V6, P1160, DOI 10.3892/mmr.2012.1024; Colman RW, 1997, P ASSOC AM PHYSICIAN, V109, P10; DIGNASS AU, 1994, GASTROENTEROLOGY, V106, P1254, DOI 10.1016/0016-5085(94)90017-5; Emmanuel AV, 2009, NEUROGASTROENT MOTIL, V21, P41, DOI 10.1111/j.1365-2982.2009.01403.x; Erasto P, 2005, AFR J BIOTECHNOL, V4, P1458; Flower DR, 1996, BIOCHEM J, V318, P1; Goo JS, 2013, MOL NEUROBIOL, V48, P232, DOI 10.1007/s12035-013-8453-3; Goyal J, 1998, CANCER RES, V58, P4782; Gronborg M, 2004, J PROTEOME RES, V3, P1042, DOI 10.1021/pr0499085; Hoogerwerf WA, 1996, AM J PHYSIOL, V270, P29; Hou XiangYu, 2013, Journal of China Medical University, V42, P348; Houchen CW, 1999, AM J PHYSIOL-GASTR L, V276, pG249, DOI 10.1152/ajpgi.1999.276.1.G249; Hur J, 2009, EUR J PHARMACOL, V620, P9, DOI 10.1016/j.ejphar.2009.08.016; Imamura T, 2014, BIOL PHARM BULL, V37, P1081, DOI 10.1248/bpb.b14-00265; Imig JD, 2004, HYPERTENSION, V43, P533, DOI 10.1161/01.HYP.0000118054.86193.ce; Izzo AA, 2009, DRUGS, V69, P1777, DOI 10.2165/11317010-000000000-00000; Jeong S, 2008, J ETHNOPHARMACOL, V119, P245, DOI 10.1016/j.jep.2008.06.037; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Kakino M, 2010, BIOSCI BIOTECH BIOCH, V74, P1550, DOI 10.1271/bbb.100122; Kim JE, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-333; Kim Ji Eun, 2010, Laboratory Animal Research, V26, P377; Kim JE, 2011, BIOMOL THER, V19, P348, DOI 10.4062/biomolther.2011.19.3.348; 김형진, 2010, Laboratory Animal Research, V26, P7; Kim SD, 2001, J KOREAN SOC FOOD SC, V30, P20; Kim SW, 2002, BIOSCI BIOTECH BIOCH, V66, P2751, DOI 10.1271/bbb.66.2751; Kim WR, 2000, GASTROENTEROLOGY, V119, P1631, DOI 10.1053/gast.2000.20197; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Koga H, 2008, SURGERY, V144, P259, DOI 10.1016/j.surg.2008.03.043; Kwak MH, 2013, J ETHNOPHARMACOL, V148, P880, DOI 10.1016/j.jep.2013.05.036; Lazartigues E, 2007, CURR PHARM DESIGN, V13, P1231, DOI 10.2174/138161207780618911; Lee C, 2014, LIFE SCI, V95, P29, DOI 10.1016/j.lfs.2013.11.005; Lee HY, 2012, FOOD CHEM TOXICOL, V50, P895, DOI 10.1016/j.fct.2011.12.001; Lee YC, 2005, J ETHNOPHARMACOL, V101, P144, DOI 10.1016/j.jep.2005.04.030; Leung FW, 2007, DIGEST DIS SCI, V52, P313, DOI 10.1007/s10620-006-9298-7; Linz D, 2012, HYPERTENSION, V60, P1560, DOI 10.1161/HYPERTENSIONAHA.112.201590; Martin P, 2010, ACTA PHARMACOL SIN, V31, P51, DOI 10.1038/aps.2009.187; McCallum IJD, 2009, BMJ-BRIT MED J, V338, P831; Meda A, 2005, FOOD CHEM, V91, P571, DOI 10.1016/j.foodchem.2004.10.006; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Morita R, 2011, ARCH TOXICOL, V85, P1475, DOI 10.1007/s00204-011-0696-z; Nebert DW, 2000, PHARMACOLOGY, V61, P124, DOI 10.1159/000028393; Neri F, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/896162; Niwa T, 2009, CURR DRUG METAB, V10, P700, DOI 10.2174/138920009789895525; Nyam DCNK, 1997, DIS COLON RECTUM, V40, P273, DOI 10.1007/BF02050415; Ostvik AE, 2013, CLIN EXP IMMUNOL, V173, P502, DOI 10.1111/cei.12136; Parker Lynn P., 2009, Cancer Genomics & Proteomics, V6, P189; PODOLSKY DK, 1993, AM J PHYSIOL, V264, pG179, DOI 10.1152/ajpgi.1993.264.2.G179; Poniatowski B, 2009, KIDNEY BLOOD PRESS R, V32, P77, DOI 10.1159/000208989; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Roman-Gomez J, 2004, LEUKEMIA, V18, P362, DOI 10.1038/sj.leu.2403223; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; Schwartz N, 2007, ANN NY ACAD SCI, V1109, P265, DOI 10.1196/annals.1398.032; Shankaran H, 2007, PLOS COMPUT BIOL, V3, P986, DOI 10.1371/journal.pcbi.0030101; Sidiropoulos M, 2005, TUMOR BIOL, V26, P324, DOI 10.1159/000089290; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Sui Haixia, 2010, Wei Sheng Yan Jiu, V39, P693; VLODAVSKY I, 1991, TRENDS BIOCHEM SCI, V16, P268, DOI 10.1016/0968-0004(91)90102-2; Walia R, 2009, CURR OPIN PEDIATR, V21, P661, DOI 10.1097/MOP.0b013e32832ff241; Wintola OA, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-95; Xu H, 2005, AM J PHYSIOL-GASTR L, V289, pG36, DOI 10.1152/ajpgi.00552.2004; Yang ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003348; Ye Xu-ying, 2008, Zhongguo Zhong Xi Yi Jie He Za Zhi, V28, P824; Yu HR, 2000, HYPERTENSION, V35, P135, DOI 10.1161/01.HYP.35.1.135; ZEITLIN IJ, 1973, GUT, V14, P133, DOI 10.1136/gut.14.2.133; Zhang JH, 2013, AM J PHYSIOL-GASTR L, V304, pG940, DOI 10.1152/ajpgi.00398.2012; Zhang R, 2004, ANAL BIOCHEM, V280, P286	77	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0129664	10.1371/journal.pone.0129664	http://dx.doi.org/10.1371/journal.pone.0129664			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151867	Green Published, gold, Green Submitted			2022-12-27	WOS:000358158900005
J	Catalan, A; Simons, CJP; Bustamante, S; Olazabal, N; Ruiz, E; de Artaza, MG; Penas, A; Maurottolo, C; Gonzalez, A; van Os, J; Gonzalez-Torres, MA				Catalan, Ana; Simons, Claudia J. P.; Bustamante, Sonia; Olazabal, Nora; Ruiz, Eduardo; Gonzalez de Artaza, Maider; Penas, Alberto; Maurottolo, Claudio; Gonzalez, Andrea; van Os, Jim; Angel Gonzalez-Torres, Miguel			Data Gathering Bias: Trait Vulnerability to Psychotic Symptoms?	PLOS ONE			English	Article							DELUSIONAL CONVICTION; LIBERAL ACCEPTANCE; REASONING BIASES; CONCLUSIONS BIAS; DECISION-MAKING; WORKING-MEMORY; LIFE EVENTS; PEOPLE; SCHIZOPHRENIA; RELIABILITY	Background Jumping to conclusions (JTC) is associated with psychotic disorder and psychotic symptoms. If JTC represents a trait, the rate should be (i) increased in people with elevated levels of psychosis proneness such as individuals diagnosed with borderline personality disorder (BPD), and (ii) show a degree of stability over time. Methods The JTC rate was examined in 3 groups: patients with first episode psychosis (FEP), BPD patients and controls, using the Beads Task. PANSS, SIS-R and CAPE scales were used to assess positive psychotic symptoms. Four WAIS III subtests were used to assess IQ. Results A total of 61 FEP, 26 BPD and 150 controls were evaluated. 29 FEP were revaluated after one year. 44% of FEP (OR = 8.4, 95% CI: 3.9-17.9) displayed a JTC reasoning bias versus 19% of BPD (OR = 2.5, 95% CI: 0.8-7.8) and 9% of controls. JTC was not associated with level of psychotic symptoms or specifically delusionality across the different groups. Differences between FEP and controls were independent of sex, educational level, cannabis use and IQ. After one year, 47.8% of FEP with JTC at baseline again displayed JTC. Conclusions JTC in part reflects trait vulnerability to develop disorders with expression of psychotic symptoms.	[Catalan, Ana; Bustamante, Sonia; Olazabal, Nora; Ruiz, Eduardo; Gonzalez de Artaza, Maider; Maurottolo, Claudio; Angel Gonzalez-Torres, Miguel] Univ Basque Country, Dept Neurosci, Basque Country, Spain; [Catalan, Ana; Bustamante, Sonia; Olazabal, Nora; Ruiz, Eduardo; Penas, Alberto; Angel Gonzalez-Torres, Miguel] Basurto Univ Hosp, Dept Psychiat, Bilbao, Spain; [Simons, Claudia J. P.; van Os, Jim] Maastricht Univ, Dept Psychiat & Psychol, South Limburg Mental Hlth Res & Teaching Network, EURON,Med Ctr, Maastricht, Netherlands; [Simons, Claudia J. P.] GGzE, Eindhoven, Netherlands; [Maurottolo, Claudio; Gonzalez, Andrea] Clin Serv Med AMSA, Bilbao, Vizcaya, Spain; [van Os, Jim] Kings Coll London, Inst Psychiat, Kings Hlth Partners, Dept Psychosis Studies, London WC2R 2LS, England	University of Basque Country; Basurto Hospital; Maastricht University; University of London; King's College London	Catalan, A (corresponding author), Univ Basque Country, Dept Neurosci, Basque Country, Spain.	ana.catalanalcantara@osakidetza.eus	Catalan, Ana/AAL-2224-2020; González Ríos, Andrea/HGU-7618-2022; van Os, Jim/C-2113-2014; van Os, Jim/V-8884-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022	Catalan, Ana/0000-0002-0418-7904; van Os, Jim/0000-0002-7245-1586; Gonzalez-Torres, Miguel Angel/0000-0002-4017-2785; Bustamante, Sonia/0000-0002-7226-2910				Andreou D, 2012, 20 EUR C PSYCH; Bentall RP, 1999, BRIT J CLIN PSYCHOL, V38, P323, DOI 10.1348/014466599162809; Blyler CR, 2000, SCHIZOPHR RES, V46, P209, DOI 10.1016/S0920-9964(00)00017-7; Broome MR, 2007, BRIT J PSYCHIAT, V191, pS38, DOI 10.1192/bjp.191.51.s38; Buchy L, 2007, SCHIZOPHR RES, V90, P334, DOI 10.1016/j.schres.2006.11.012; Colbert SM, 2002, J NERV MENT DIS, V190, P27, DOI 10.1097/00005053-200201000-00007; Colbert SM, 2010, COGN NEUROPSYCHIATRY, V15, P422, DOI 10.1080/13546800903495684; Craddock N, 1996, BRIT J PSYCHIAT, V169, P58, DOI 10.1192/bjp.169.1.58; Dudley REJ, 1997, BRIT J CLIN PSYCHOL, V36, P243, DOI 10.1111/j.2044-8260.1997.tb01410.x; Dudley REJ, 2003, CLIN PSYCHOL PSYCHOT, V10, P263, DOI 10.1002/cpp.376; Dudley R, 2011, EARLY INTERV PSYCHIA, V5, P50, DOI 10.1111/j.1751-7893.2010.00258.x; ENDICOTT J, 1976, ARCH GEN PSYCHIAT, V33, P766; Falcone MA, 2015, SCHIZOPHRENIA BULL, V41, P411, DOI 10.1093/schbul/sbu104; Fear CF, 1997, PSYCHOL MED, V27, P199, DOI 10.1017/S0033291796004175; Fine Cordelia, 2007, Cogn Neuropsychiatry, V12, P46, DOI 10.1080/13546800600750597; Freeman D, 2014, PSYCHOL MED, V44, P3017, DOI 10.1017/S0033291714000592; Freeman D, 2002, BRIT J CLIN PSYCHOL, V41, P331, DOI 10.1348/014466502760387461; Freeman D, 2008, SCHIZOPHR RES, V102, P254, DOI 10.1016/j.schres.2008.03.020; FREESTON MH, 1994, PERS INDIV DIFFER, V17, P791, DOI 10.1016/0191-8869(94)90048-5; Garety PA, 2005, J ABNORM PSYCHOL, V114, P373, DOI 10.1037/0021-843X.114.3.373; Garety PA, 1999, BRIT J CLIN PSYCHOL, V38, P113, DOI 10.1348/014466599162700; Gaweda L, 2012, PSYCHIAT RES, V195, P1, DOI 10.1016/j.psychres.2011.07.035; Good KP, 2002, BRIT J PSYCHIAT, V181, pS45, DOI 10.1192/bjp.181.43.s45; HUQ SF, 1988, Q J EXP PSYCHOL-A, V40, P801, DOI 10.1080/14640748808402300; Jacobsen P, 2012, BRIT J CLIN PSYCHOL, V51, P84, DOI 10.1111/j.2044-8260.2011.02014.x; John C. H., 1994, J MENTAL HLTH, V3, P31; Jolley S, 2014, PSYCHIAT RES, V219, P275, DOI 10.1016/j.psychres.2014.05.051; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kinderman P, 1997, J ABNORM PSYCHOL, V106, P341, DOI 10.1037/0021-843X.106.2.341; Langdon R, 2014, COGN NEUROPSYCHIATRY, V19, P241, DOI 10.1080/13546805.2013.854198; Langdon R, 2010, SCHIZOPHRENIA BULL, V36, P321, DOI 10.1093/schbul/sbn069; Lincoln TM, 2010, COGNITIVE THER RES, V34, P297, DOI 10.1007/s10608-009-9284-4; Lincoln TM, 2010, SCHIZOPHRENIA BULL, V36, P1140, DOI 10.1093/schbul/sbp029; Linney YM, 1998, BRIT J CLIN PSYCHOL, V37, P285, DOI 10.1111/j.2044-8260.1998.tb01386.x; Mckay R, 2006, J NERV MENT DIS, V194, P422, DOI 10.1097/01.nmd.0000221353.44132.25; McKenna G, 2014, EUR EAT DISORD REV, V22, P352, DOI 10.1002/erv.2310; Menon M, 2013, EUR PSYCHIAT, V28, P71, DOI 10.1016/j.eurpsy.2011.03.005; Menon M, 2008, SCHIZOPHR RES, V98, P225, DOI 10.1016/j.schres.2007.08.021; Moritz S, 2008, PSYCHOL MED, V38, P825, DOI 10.1017/S0033291707002553; Moritz S, 2005, BRIT J CLIN PSYCHOL, V44, P193, DOI 10.1348/014466505X35678; Moritz S, 2009, PSYCHOL MED, V39, P1821, DOI 10.1017/S0033291709005923; Moritz Steffen, 2006, Curr Psychiatry Rep, V8, P184, DOI 10.1007/s11920-006-0022-2; Moritz S, 2012, SCHIZOPHR RES TREAT, V2012, DOI 10.1155/2012/384039; Moritz S, 2011, J BEHAV THER EXP PSY, V42, P349, DOI 10.1016/j.jbtep.2011.02.003; Mortimer A, 1996, COGNITIVE NEUROPSYCH, V1, P303; Myin-Germeys I, 2003, SOC PSYCH PSYCH EPID, V38, P262, DOI 10.1007/s00127-003-0633-4; Myin-Germeys I, 2003, PSYCHOL MED, V33, P327, DOI 10.1017/S0033291702006785; Ormrod J, 2012, COGN NEUROPSYCHIATRY, V17, P97, DOI 10.1080/13546805.2011.569372; Park S, 2003, SCHIZOPHR RES, V59, P261, DOI 10.1016/S0920-9964(02)00209-8; Peralta Martin V, 1994, Actas Luso Esp Neurol Psiquiatr Cienc Afines, V22, P171; PHILLIPS LD, 1966, J EXP PSYCHOL, V72, P346, DOI 10.1037/h0023653; Randjbar S, 2011, PSYCHOSIS, V3, P74, DOI 10.1080/17522431003717675; Reese HE, 2011, J BEHAV THER EXP PSY, V42, P270, DOI 10.1016/j.jbtep.2010.11.005; Ross K, 2011, SCHIZOPHRENIA BULL, V37, P324, DOI 10.1093/schbul/sbn165; Sanford N, 2013, SCHIZOPHR RES, V147, P207, DOI 10.1016/j.schres.2013.02.042; Schroeder K, 2013, CURR OPIN PSYCHIATR, V26, P113, DOI 10.1097/YCO.0b013e32835a2ae7; So SH, 2012, J ABNORM PSYCHOL, V121, P129, DOI 10.1037/a0025297; Speechley WJ, 2010, J PSYCHIATR NEUROSCI, V35, P7, DOI 10.1503/jpn.090025; StatCorp, 2011, STAT STAT SOFTW REL; Stefanis NC, 2002, PSYCHOL MED, V32, P347, DOI 10.1017/S0033291701005141; Van Dael F, 2006, SCHIZOPHRENIA BULL, V32, P341, DOI 10.1093/schbul/sbj021; Van Os J, 1998, SOC PSYCH PSYCH EPID, V33, P596, DOI 10.1007/s001270050099; van Os Jim, 2003, Epidemiol Psichiatr Soc, V12, P242; Veckenstedt R, 2011, COGN NEUROPSYCHIATRY, V16, P174, DOI 10.1080/13546805.2010.536084; Verdoux H, 2002, SCHIZOPHR RES, V54, P59, DOI 10.1016/S0920-9964(01)00352-8; Vollema MG, 2000, SCHIZOPHRENIA BULL, V26, P619, DOI 10.1093/oxfordjournals.schbul.a033482; Wagner M, 2011, EUR C SCH RES; White LO, 2009, CLIN PSYCHOL PSYCHOT, V16, P111, DOI 10.1002/cpp.607; Williams J, 1996, PSYCHOL MED, V26, P775, DOI 10.1017/S003329170003779X; Woodward TS, 2009, PSYCHIAT RES, V170, P119, DOI 10.1016/j.psychres.2008.10.018; Woodward TS, 2009, SCHIZOPHRENIA BULL, V35, P249; Wozniak JR, 2008, EARLY INTERV PSYCHIA, V2, P169, DOI 10.1111/j.1751-7893.2008.00075.x; Young H, 1997, PSYCHOLOGICALMEDICIN, V27, P465; Ziegler M, 2008, PSYCHOL PSYCHOTHER-T, V81, P237, DOI 10.1348/147608308X297104	74	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132442	10.1371/journal.pone.0132442	http://dx.doi.org/10.1371/journal.pone.0132442			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26147948	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600269
J	Dominiak-Felden, G; Gobbo, C; Simondon, F				Dominiak-Felden, Geraldine; Gobbo, Corrado; Simondon, Francois			Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; ANOGENITAL WARTS; UNITED-STATES; IMPACT; HEALTH; WOMEN; POPULATION; MANAGEMENT; GERMANY; BURDEN	Genital warts (GWs) are common, with about 5% to 10% of people having at least one episode in their lifetime. They develop about 2-3 months after infection with human papillomavirus (HPV) genotypes 6 and 11. The prophylactic quadrivalent HPV vaccine (qHPV), protects against HPV6/11 infections and diseases. In Belgium, HPV vaccines started to be reimbursed in 2007 and have been fully reimbursed since December 2008 for women 12 to 18 years old. This study aimed at evaluating the real-life benefit of qHPV vaccine introduction in Belgium on GWs by measuring both vaccine impact (VI) at a population level and the direct effect of the qHPV vaccine at an individual level (vaccine effectiveness (VE)), using data from a large sick-fund (MLOZ) reimbursement database. A first reimbursement for imiquimod (most common first-line GWs treatment in Belgium) was used as a surrogate for a first GWs episode; reimbursement of qHPV vaccine was used as surrogate for vaccination. VI was estimated by comparing the incidence of GWs before and after qHPV vaccine introduction in Belgium (ecologic evaluation). VE was assessed by comparing GWs incidences in vaccinated vs. unvaccinated women, among women eligible for HPV vaccination. VI was evaluated in 9,223,384 person-years. Overall, GWs incidence rates decreased significantly between the pre- and post-vaccination periods (-8.1% (95% CI: -15.3; -0.3) for men and women aged 18-59 years. This decrease was highest in women targeted by the HPV vaccination programme (-72.1% (95% CI: -77.9; -64.7) in women aged 16-22 years, with a 43% vaccine uptake in 2013). A significant decrease was also observed in men aged 16-22 years (-51.1%, 95% CI: -67.6; -26.2), suggesting herd-protection. VE was evaluated in 369,881 person-years. Age-adjusted VE for fully vaccinated women was 88.0% (95% CI: 79.4; 93.0). VE was higher when the first dose was given younger and remained high for over 4 years post-vaccination in all ages. High VI and VE of the qHPV vaccine were observed in a real-life setting in Belgium.	[Dominiak-Felden, Geraldine; Simondon, Francois] Sanofi Pasteur MSD, Franchise Dev Dept, Lyon, France; [Gobbo, Corrado] Sanofi Pasteur MSD, Diegem, Belgium	Sanofi-Aventis; Sanofi France	Dominiak-Felden, G (corresponding author), Sanofi Pasteur MSD, Franchise Dev Dept, Lyon, France.	gdominiak@spmsd.com		Simondon, Francois/0000-0003-0395-1314	Sanofi Pasteur MSD	Sanofi Pasteur MSD	This study was funded by Sanofi Pasteur MSD who commercialise the quadrivalent HPV vaccine in Europe. All authors work for Sanofi Pasteur MSD. The funder provided support in the form of salaries for all authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2032; Annemans Lieven, 2008, J Med Econ, V11, P135, DOI 10.3111/13696990801961611; Baandrup L, 2013, SEX TRANSM DIS, V40, P130, DOI 10.1097/OLQ.0b013e31827bd66b; Beutner KR, 1999, CLIN INFECT DIS, V28, pS37, DOI 10.1086/514722; Blomberg M, 2012, J INFECT DIS, V205, P1544, DOI 10.1093/infdis/jis228; Cutts FT, 2007, B WORLD HEALTH ORGAN, V85, P719, DOI 10.2471/BLT.06.038414; Desai S, 2011, SEX TRANSM INFECT, V87, P464, DOI 10.1136/sti.2010.048421; Dillner J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3493; Dinh TH, 2008, SEX TRANSM DIS, V35, P357, DOI 10.1097/OLQ.0b013e3181632d61; Dominiak-Felden G, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1065; European Medicines Agency, GARDASIL SUMMARY PRO; Fairley CK, 2009, SEX TRANSM INFECT, V85, P499, DOI 10.1136/sti.2009.037788; Flagg EW, 2013, AM J PUBLIC HEALTH, V103, P1428, DOI 10.2105/AJPH.2012.301182; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Garland SM, 2009, J INFECT DIS, V199, P805, DOI 10.1086/597071; Hanquet G, 2013, VACCINE, V31, P5634, DOI 10.1016/j.vaccine.2013.07.006; Hillemanns P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-76; Kjaer SK, 2007, J INFECT DIS, V196, P1447, DOI 10.1086/522863; Kraut AA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-360; Lacey CJN, 2006, VACCINE, V24, P35, DOI 10.1016/j.vaccine.2006.06.015; Lawrence S, 2009, INT J STD AIDS, V20, P696, DOI 10.1258/ijsa.2009.009120; Leval A, 2013, JNCI-J NATL CANCER I, V105, P469, DOI 10.1093/jnci/djt032; Leval A, 2012, J INFECT DIS, V206, P860, DOI 10.1093/infdis/jis405; Liu B, 2014, SEX TRANSM INFECT, V90, P532, DOI 10.1136/sextrans-2013-051307; Mariani L, 2015, ADV THER, V32, P10, DOI 10.1007/s12325-015-0178-4; Marra F, 2009, SEX TRANSM INFECT, V85, P111, DOI 10.1136/sti.2008.030999; Mikolajczyk RT, 2013, SEX TRANSM DIS, V40, P28, DOI 10.1097/OLQ.0b013e3182756efd; Moreau N, 2013, SECONDARY SCH CHILDR; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Oliphant J, 2011, NEW ZEAL MED J, V124, P51; Oriel JD, 1971, SEXUALLY TRANSMIT S1, V76, pS21; Read TRH, 2011, SEX TRANSM INFECT, V87, P544, DOI 10.1136/sextrans-2011-050234; Verbrugge R, 2014, SEXUALLY TRANSMITTED; Von Krogh G, 2001, EUR J DERMATOL, V11, P598; von Krogh G, 2001, EJD, V11, P4; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	37	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132404	10.1371/journal.pone.0132404	http://dx.doi.org/10.1371/journal.pone.0132404			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147096	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600259
J	Gonzalez, R; Augusto, OJ; Munguambe, K; Pierrat, C; Pedro, EN; Sacoor, C; De Lazzari, E; Aponte, JJ; Macete, E; Alonso, PL; Menendez, C; Naniche, D				Gonzalez, Raquel; Augusto, Orvalho J.; Munguambe, Khatia; Pierrat, Charlotte; Pedro, Elpidia N.; Sacoor, Charfudin; De Lazzari, Elisa; Aponte, John J.; Macete, Eusebio; Alonso, Pedro L.; Menendez, Clara; Naniche, Denise			HIV Incidence and Spatial Clustering in a Rural Area of Southern Mozambique	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; PREVALENCE DATA; INFECTION; ZIMBABWE; TRENDS; RISK	Background Monitoring the HIV epidemic in a defined population is critical for planning treatment and preventive strategies. This is especially important in sub-Saharan Africa, which harbours the highest burden of the disease. Objective To estimate HIV incidence in adults aged 18-47 years old and to investigate spatial variations of HIV prevalence in Manhica, a semi-rural area of southern Mozambique. Methods Two cross-sectional community-based surveys were conducted in 2010 and 2012 to determine HIV prevalence. Individual participants were randomly selected from the demographic surveillance system in place in the area and voluntary HIV counselling and testing was offered at the household level. HIV incidence was calculated using prevalence estimates from the two sero-surveys. Each participant's household was geocoded using a global information system. The Spatial Scan Statistics programme was used to identify areas with disproportionate excess in HIV prevalence. Results A total of 1511 adults were tested. The estimated HIV prevalence in the community was 39.9% in 2010 and 39.7% in 2012. The overall HIV incidence was 3.6 new infections per 100 person-years at risk (PYAR) [95CI 1.56; 7.88], assuming stable epidemic conditions, and tended to be higher in women (4.9/100 PYAR [95CI 1.74; 11.85]) than in men (3.2/PYAR [95CI 1.36; 9.92]). One cluster with significant excess HIV prevalence was identified at the same geographic location in both surveys. This cluster had an HIV prevalence of 79.0% in 2010 and 52.3% in 2012. Conclusions The findings of these first individually-randomised community-HIV sero-surveys conducted in Mozambique reinforce the need to combine HIV incidence estimates and research on micro geographical infection patterns to guide and consolidate effective prevention strategies.	[Gonzalez, Raquel; Pierrat, Charlotte; De Lazzari, Elisa; Aponte, John J.; Alonso, Pedro L.; Menendez, Clara; Naniche, Denise] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Heath Res CRESIB, Barcelona, Spain; [Gonzalez, Raquel; Augusto, Orvalho J.; Munguambe, Khatia; Pedro, Elpidia N.; Sacoor, Charfudin; Aponte, John J.; Macete, Eusebio; Alonso, Pedro L.; Menendez, Clara; Naniche, Denise] Ctr Invest Saude Manhica CISM, Maputo, Mozambique; [Macete, Eusebio] Minist Saude, Direcao Nacl Saude DNS, Maputo, Mozambique; [Alonso, Pedro L.] World Hlth Org WHO, Geneva, Switzerland	ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica; World Health Organization	Gonzalez, R (corresponding author), Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Heath Res CRESIB, Barcelona, Spain.	Raquel.gonzalez@cresib.cat	Gonzalez, Raquel/J-3604-2017; Alonso, Pedro L/AAZ-3645-2020; Menéndez, Clara/Q-3446-2016; Augusto, Orvalho/J-8767-2019; Naniche, Denise S/S-1814-2018	Gonzalez, Raquel/0000-0001-5487-801X; Alonso, Pedro L/0000-0003-3292-3443; Menéndez, Clara/0000-0002-2641-6907; Augusto, Orvalho/0000-0002-0005-3968; Naniche, Denise S/0000-0002-4495-6325; De Lazzari, Elisa/0000-0003-2614-6545	European and Developing Countries Clinical Trials Partnership (EDCTP), AfrEVacc consortium [CT.2006.33111.001]; Fondo de Investigacion Sanitaria from Spanish Ministry of Health; Spanish Agency for International Cooperation (AECI); Agencia de Cooperacio Catalana; EDCTP grant [IP.07.31080.002]	European and Developing Countries Clinical Trials Partnership (EDCTP), AfrEVacc consortium; Fondo de Investigacion Sanitaria from Spanish Ministry of Health; Spanish Agency for International Cooperation (AECI); Agencia de Cooperacio Catalana; EDCTP grant	This work was supported by the European and Developing Countries Clinical Trials Partnership (EDCTP; http://www.edctp.org/) as part of the AfrEVacc consortium (grant: CT.2006.33111.001) and co-funded by the Fondo de Investigacion Sanitaria from the Spanish Ministry of Health. The CISM receives core funding from the Spanish Agency for International Cooperation (AECI) and the HIV VCT units were in part supported by the Agencia de Cooperacio Catalana. RG was partially supported by an EDCTP grant (IP.07.31080.002).	Abdool Karim Q, 2010, INT J EPIDEMIOL; [Anonymous], 2012, REP MOZ GLOB AIDS RE; [Anonymous], 2012, GLOB REP UNAIDS REP; Coffee M, 2007, AIDS, V21, P343, DOI 10.1097/QAD.0b013e328011dac9; Cuadros DF, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-28; Dube K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084979; Eaton JW, 2014, AIDS, V28, pS507, DOI 10.1097/QAD.0000000000000412; Feldacker C, 2011, SOC SCI MED, V72, P717, DOI 10.1016/j.socscimed.2011.01.003; Feldacker C, 2010, HEALTH PLACE, V16, P996, DOI 10.1016/j.healthplace.2010.06.004; Feldblum PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097547; Gonzalez R, 2012, HIV MED; Gregson S, 1998, AIDS, V12, P2049, DOI 10.1097/00002030-199815000-00017; Hallett T, 2009, JAMA-J AM MED ASSOC, V301, P159, DOI 10.1001/jama.2008.953; Hallett TB, 2008, PLOS MED, V5, P611, DOI 10.1371/journal.pmed.0050080; Hallett TB, 2014, AIDS, V28, pS523, DOI 10.1097/QAD.0000000000000488; Hallett TB, 2010, AIDS, V24, P147, DOI 10.1097/QAD.0b013e32833062dc; Instituto Nacional de Estadistica, 2007, TERC REC GER POP HAB; Instituto-Nacional-de-Saude, 2010, INQUERITO NACIONAL D; Jeque J., 2012, C NORD MOC; Joint United Nations Programme on HIV/AIDS, 2021, UNAIDS GLOB AIDS UPD; Kim AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017535; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Lopman BA, 2009, SEX TRANSM INFECT, V85, pI41, DOI 10.1136/sti.2008.033043; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; Merson MH, 2008, LANCET, V372, P475, DOI 10.1016/S0140-6736(08)60884-3; Ministerio da Saude-Republica de Mocambique, 2013, INTR NO SEG PAC HIV; Mossong J, 2013, AIDS, V27, P2471, DOI 10.1097/01.aids.0000432475.14992.da; Msisha WM, 2008, AIDS, V22, P741, DOI 10.1097/QAD.0b013e3282f3947f; Nel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035278; Nhacolo AQ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-291; Perez-Hoyos S, 2011, HIV MED, V12, P500, DOI 10.1111/j.1468-1293.2010.00908.x; Rehle TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011094; Sacoor C, 2013, INT J EPIDEMIOL, V42, P1309, DOI 10.1093/ije/dyt148; Sartorius B, 2010, GLOBAL HEALTH ACTION, V3, P50, DOI 10.3402/gha.v3i0.5225; Stata-Corp-LP, 2009, STATA SURB DAT REF M; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; UNGASS, 2010, UN GEN ASS SPEC SESS; Wand H, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-41; *WHO UNAIDS, 2003, REC ANT CLIN BAS SUR; Wong KF, 2006, STAT MED, V25, P2441, DOI 10.1002/sim.2371; Zaidi J, 2013, AIDS, V27, P2301, DOI 10.1097/QAD.0b013e328362e832; Zango A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063427	42	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132053	10.1371/journal.pone.0132053	http://dx.doi.org/10.1371/journal.pone.0132053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147473	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600191
J	Ikeda, K; Takahashi, M; Sato, S; Igarashi, H; Ishizuka, T; Yawo, H; Arata, S; Southard-Smith, EM; Kawakami, K; Onimaru, H				Ikeda, Keiko; Takahashi, Masanori; Sato, Shigeru; Igarashi, Hiroyuki; Ishizuka, Toru; Yawo, Hiromu; Arata, Satoru; Southard-Smith, E. Michelle; Kawakami, Kiyoshi; Onimaru, Hiroshi			A Phox2b BAC Transgenic Rat Line Useful for Understanding Respiratory Rhythm Generator Neural Circuitry	PLOS ONE			English	Article							CENTRAL HYPOVENTILATION SYNDROME; STEM-SPINAL-CORD; HOMEOBOX GENE PHOX2B; CRE RECOMBINASE ACTIVITY; CENTRAL-NERVOUS-SYSTEM; RETROTRAPEZOID NUCLEUS; NEWBORN RATS; PREBOTZINGER COMPLEX; VENTRAL MEDULLA; CAROTID-BODY	The key role of the respiratory neural center is respiratory rhythm generation to maintain homeostasis through the control of arterial blood pCO(2)/pH and pO(2) levels. The neuronal network responsible for respiratory rhythm generation in neonatal rat resides in the ventral side of the medulla and is composed of two groups; the parafacial respiratory group (pFRG) and the pre-Botzinger complex group (preBotC). The pFRG partially overlaps in the retrotrapezoid nucleus (RTN), which was originally identified in adult cats and rats. Part of the pre-inspiratory (Pre-I) neurons in the RTN/pFRG serves as central chemoreceptor neurons and the CO2 sensitive Pre-I neurons express homeobox gene Phox2b. Phox2b encodes a transcription factor and is essential for the development of the sensory-motor visceral circuits. Mutations in human PHOX2B cause congenital hypoventilation syndrome, which is characterized by blunted ventilatory response to hypercapnia. Here we describe the generation of a novel transgenic (Tg) rat harboring fluorescently labeled Pre-I neurons in the RTN/pFRG. In addition, the Tg rat showed fluorescent signals in autonomic enteric neurons and carotid bodies. Because the Tg rat expresses inducible Cre recombinase in PHOX2B-positive cells during development, it is a potentially powerful tool for dissecting the entire picture of the respiratory neural network during development and for identifying the CO2/O-2 sensor molecules in the adult central and peripheral nervous systems.	[Ikeda, Keiko] Hyogo Coll Med, Div Biol, Nishinomiya, Hyogo 6638501, Japan; [Ikeda, Keiko; Takahashi, Masanori; Sato, Shigeru; Kawakami, Kiyoshi] Jichi Med Univ, Ctr Mol Med, Div Biol, Shimotsuke, Tochigi, Japan; [Igarashi, Hiroyuki; Yawo, Hiromu] Tohoku Univ, Grad Sch Med, Dept Physiol & Pharmacol, Sendai, Miyagi 980, Japan; [Ishizuka, Toru; Yawo, Hiromu] Tohoku Univ, Grad Sch Med, Dept Dev Biol & Neurosci, Sendai, Miyagi 980, Japan; [Ishizuka, Toru; Yawo, Hiromu] JST CREST, Sendai, Miyagi, Japan; [Arata, Satoru] Showa Univ, Ctr Biotechnol, Shinagawa Ku, Tokyo, Japan; [Southard-Smith, E. Michelle] Vanderbilt Univ, Sch Med, Dept Med, Div Med Genet, Nashville, TN 37212 USA; [Onimaru, Hiroshi] Showa Univ, Sch Med, Dept Physiol, Shinagawa Ku, Tokyo 142, Japan	Hyogo College of Medicine; Jichi Medical University; Tohoku University; Tohoku University; Showa University; Vanderbilt University; Showa University	Ikeda, K (corresponding author), Hyogo Coll Med, Div Biol, Nishinomiya, Hyogo 6638501, Japan.	kiikeda@hyo-med.ac.jp	Yawo, Hiromu/I-4871-2015; Ishizuka, Toru/L-8191-2017; Sato, Shigeru/ABE-2090-2020	Yawo, Hiromu/0000-0002-4299-3288; Ishizuka, Toru/0000-0003-4405-8792; Southard-Smith, E Michelle/0000-0003-4718-5869	MEXT (Ministry of Education, Culture, Sports, Science and Technology); Grants-in-Aid for Scientific Research [15K15025, 25430012, 15H01413] Funding Source: KAKEN	MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Naito Foundation, https://www.naito-f.or.jp/jp/joseikn/jo_index.php?data = detail&grant_id=KEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MEXT (Ministry of Education, Culture, Sports, Science and Technology)-Supported Program for the Strategic Research Foundation at Private Universities 2012-2015 (Showa University of Medicine, Jichi Medical University, Hyogo College of Medicine), preparation of reagent, equipments, performing experiments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SBG, 2011, J NEUROSCI, V31, P16410, DOI 10.1523/JNEUROSCI.3280-11.2011; Abe K, 2004, EXP ANIM TOKYO, V53, P311, DOI 10.1538/expanim.53.311; Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Ballanyi K, 1999, PROG NEUROBIOL, V59, P583, DOI 10.1016/S0301-0082(99)00009-X; Bayliss DA, 2015, PFLUG ARCH EUR J PHY, V467, P917, DOI 10.1007/s00424-014-1633-9; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Cinelli E, 2013, J NEUROSCI, V33, P9104, DOI 10.1523/JNEUROSCI.0299-13.2013; CONNELLY CA, 1990, AM J PHYSIOL, V258, pL33, DOI 10.1152/ajplung.1990.258.2.L33; Corpening JC, 2008, DEV DYNAM, V237, P1119, DOI 10.1002/dvdy.21498; D'Autreaux F, 2011, P NATL ACAD SCI USA, V108, P20018, DOI 10.1073/pnas.1110416108; Dauger S, 2003, DEVELOPMENT, V130, P6635, DOI 10.1242/dev.00866; Dercksen VJ, 2008, MATH VIS, P3, DOI 10.1007/978-3-540-72630-2_1; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Dubreuil V, 2008, P NATL ACAD SCI USA, V105, P1067, DOI 10.1073/pnas.0709115105; Dubreuil V, 2009, J NEUROSCI, V29, P14836, DOI 10.1523/JNEUROSCI.2623-09.2009; Dubreuil V, 2009, PHILOS T R SOC B, V364, P2477, DOI 10.1098/rstb.2009.0085; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feldman JL, 2013, ANNU REV PHYSIOL, V75, P423, DOI 10.1146/annurev-physiol-040510-130049; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gaultier C, 2004, PEDIATR RES, V55, P729, DOI 10.1203/01.PDR.0000115677.78759.C5; Gestreau C, 2010, P NATL ACAD SCI USA, V107, P2325, DOI 10.1073/pnas.0910059107; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GONZALEZ C, 1979, BRAIN RES, V172, P572, DOI 10.1016/0006-8993(79)90591-2; Goridis C, 2010, RESP PHYSIOL NEUROBI, V173, P312, DOI 10.1016/j.resp.2010.03.014; Gottgens B, 2000, NAT BIOTECHNOL, V18, P181, DOI 10.1038/72635; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Gourine AV, 2005, NATURE, V436, P108, DOI 10.1038/nature03690; Gozal D, 1998, PEDIATR PULM, V26, P273; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Guyenet PG, 2008, J APPL PHYSIOL, V105, P404, DOI 10.1152/japplphysiol.90452.2008; Guyenet PG, 2010, J COMP NEUROL, V518, P3883, DOI 10.1002/cne.22435; Guyenet PG, 2010, RESP PHYSIOL NEUROBI, V173, P244, DOI 10.1016/j.resp.2010.02.005; Guyenet PG, 2009, RESP PHYSIOL NEUROBI, V168, P59, DOI 10.1016/j.resp.2009.02.001; Guyenet PG, 2005, J NEUROSCI, V25, P8938, DOI 10.1523/JNEUROSCI.2415-05.2005; Haming D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026543; HELLSTROM S, 1975, ACTA PHYSIOL SCAND, V93, P540, DOI 10.1111/j.1748-1716.1975.tb05846.x; Hirsch MR, 2013, GENESIS, V51, P506, DOI 10.1002/dvg.22393; Hoekstra EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052118; Igarashi H, 2014, PROGRAM NO 657 18 20; Ikeda K, 2007, DEV BIOL, V311, P53, DOI 10.1016/j.ydbio.2007.08.020; Imayoshi I, 2006, GENESIS, V44, P233, DOI 10.1002/dvg.20212; Janczewski WA, 2006, J PHYSIOL-LONDON, V570, P407, DOI 10.1113/jphysiol.2005.098848; Kang BJ, 2007, J COMP NEUROL, V503, P627, DOI 10.1002/cne.21409; Kawai A, 2006, J PHYSIOL-LONDON, V572, P525, DOI 10.1113/jphysiol.2005.102533; Kawai A, 1996, J PHYSIOL-LONDON, V492, P277, DOI 10.1113/jphysiol.1996.sp021308; McGaughey DM, 2008, GENOME RES, V18, P252, DOI 10.1101/gr.6929408; McGaughey DM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-8; Mellen NM, 2003, NEURON, V37, P821, DOI 10.1016/S0896-6273(03)00092-8; MILLER AD, 1994, FRONT NEUROENDOCRIN, V15, P301, DOI 10.1006/frne.1994.1012; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; Mutolo D, 2007, NEUROSCIENCE, V150, P720, DOI 10.1016/j.neuroscience.2007.09.028; Mutolo D, 2010, NEUROSCIENCE, V169, P1136, DOI 10.1016/j.neuroscience.2010.06.004; Mutolo D, 2011, J NEUROSCI, V31, P13323, DOI 10.1523/JNEUROSCI.2764-11.2011; Muyrers JPP, 2000, EMBO REP, V1, P239, DOI 10.1093/embo-reports/kvd049; Nattie E, 1999, PROG NEUROBIOL, V59, P299, DOI 10.1016/S0301-0082(99)00008-8; Nattie EE, 2002, J PHYSIOL-LONDON, V544, P603, DOI 10.1113/jphysiol.2002.020032; Onimaru H, 2012, NEUROSCIENCE, V212, P131, DOI 10.1016/j.neuroscience.2012.03.037; ONIMARU H, 1988, BRAIN RES, V445, P314, DOI 10.1016/0006-8993(88)91194-8; Onimaru H, 2003, J NEUROSCI, V23, P1478, DOI 10.1523/JNEUROSCI.23-04-01478.2003; Onimaru H, 2008, ADV EXP MED BIOL, V605, P104; Onimaru H, 2007, J PHYSIOL-LONDON, V584, P271, DOI 10.1113/jphysiol.2007.136572; Onimaru H, 2006, J NEUROPHYSIOL, V96, P55, DOI 10.1152/jn.01175.2005; Onimaru H, 2014, PROG BRAIN RES, V209, P57, DOI 10.1016/B978-0-444-63274-6.00004-7; Onimaru H, 2012, J PHYSIOL-LONDON, V590, P1615, DOI 10.1113/jphysiol.2011.222687; Onimaru H, 2009, RESP PHYSIOL NEUROBI, V168, P13, DOI 10.1016/j.resp.2009.03.007; Onimaru H, 2008, J NEUROSCI, V28, P12845, DOI 10.1523/JNEUROSCI.3625-08.2008; Pagliardini S, 2011, J NEUROSCI, V31, P2895, DOI 10.1523/JNEUROSCI.5338-10.2011; Pan TCF, 2010, COMP BIOCHEM PHYS A, V157, P382, DOI [10.1016/J.cbpa.2010.08.018, 10.1016/j.cbpa.2010.08.018]; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; PEARCE RA, 1989, NEUROSCI LETT, V101, P138, DOI 10.1016/0304-3940(89)90520-X; Putnam RW, 2010, J APPL PHYSIOL, V108, P1796, DOI 10.1152/japplphysiol.01169.2009; Richerson GB, 2005, EXP PHYSIOL, V90, P259, DOI 10.1113/expphysiol.2005.029843; Rosin DL, 2006, J COMP NEUROL, V499, P64, DOI 10.1002/cne.21105; Shimizu S, 2014, HANDB EXP PHARMACOL, V223, P767, DOI 10.1007/978-3-319-05161-1_3; Smith CA, 2006, J APPL PHYSIOL, V100, P13, DOI 10.1152/japplphysiol.00926.2005; SMITH JC, 1989, J COMP NEUROL, V281, P69, DOI 10.1002/cne.902810107; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Spengler CM, 2001, RESP PHYSIOL, V129, P247, DOI 10.1016/S0034-5687(01)00294-8; Stornetta RL, 2006, J NEUROSCI, V26, P10305, DOI 10.1523/JNEUROSCI.2917-06.2006; Stranahan AM, 2011, BEHAV NEUROSCI, V125, P791, DOI 10.1037/a0025133; Szymczak-Workman Andrea L, 2012, Cold Spring Harb Protoc, V2012, P199, DOI 10.1101/pdb.ip067876; Takahashi M, 2011, MECH DEVELOP, V128, P289, DOI 10.1016/j.mod.2011.04.001; Takahashi N, 2011, NAT CHEM BIOL, V7, P701, DOI [10.1038/NCHEMBIO.640, 10.1038/nchembio.640]; Takakura ACT, 2006, J PHYSIOL-LONDON, V572, P503, DOI 10.1113/jphysiol.2005.103788; Thoby-Brisson M, 2009, NAT NEUROSCI, V12, P1028, DOI 10.1038/nn.2354; Vicario I, 2000, AM J PHYSIOL-CELL PH, V278, pC490, DOI 10.1152/ajpcell.2000.278.3.C490; Weese-Mayer DE, 2005, RESP PHYSIOL NEUROBI, V149, P73, DOI 10.1016/j.resp.2005.06.010; Wenker IC, 2010, J NEUROPHYSIOL, V104, P3042, DOI 10.1152/jn.00544.2010; Whishaw IQ, 1996, PHYSIOL BEHAV, V60, P1191, DOI 10.1016/S0031-9384(96)00176-X; Wong-Riley MTT, 2013, RESP PHYSIOL NEUROBI, V185, P156, DOI 10.1016/j.resp.2012.05.026; Young HM, 2003, J COMP NEUROL, V456, P1, DOI 10.1002/cne.10448	93	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132475	10.1371/journal.pone.0132475	http://dx.doi.org/10.1371/journal.pone.0132475			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147470	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600281
J	Kurbatova, N; Mason, JC; Morgan, H; Meehan, TF; Karp, NA				Kurbatova, Natalja; Mason, Jeremy C.; Morgan, Hugh; Meehan, Terrence F.; Karp, Natasha A.			PhenStat: A Tool Kit for Standardized Analysis of High Throughput Phenotypic Data	PLOS ONE			English	Article							KNOCKOUT MICE; RAT GENETICS; MOUSE; CONSORTIUM; GENOME; RESOURCES; PROJECT; POINT	The lack of reproducibility with animal phenotyping experiments is a growing concern among the biomedical community. One contributing factor is the inadequate description of statistical analysis methods that prevents researchers from replicating results even when the original data are provided. Here we present PhenStat - a freely available R package that provides a variety of statistical methods for the identification of phenotypic associations. The methods have been developed for high throughput phenotyping pipelines implemented across various experimental designs with an emphasis on managing temporal variation. PhenStat is targeted to two user groups: small-scale users who wish to interact and test data from large resources and large-scale users who require an automated statistical analysis pipeline. The software provides guidance to the user for selecting appropriate analysis methods based on the dataset and is designed to allow for additions and modifications as needed. The package was tested on mouse and rat data and is used by the International Mouse Phenotyping Consortium (IMPC). By providing raw data and the version of PhenStat used, resources like the IMPC give users the ability to replicate and explore results within their own computing environment.	[Kurbatova, Natalja; Mason, Jeremy C.; Meehan, Terrence F.] EMBL European Bioinformat Inst, Hinxton, Cambs, England; [Morgan, Hugh] Med Res Council Harwell, Harwell, Oxon, England; [Karp, Natasha A.] Wellcome Trust Sanger Inst, Mouse Informat Grp, Hinxton, Cambs, England	European Molecular Biology Laboratory (EMBL); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Wellcome Trust Sanger Institute	Kurbatova, N (corresponding author), EMBL European Bioinformat Inst, Wellcome Trust Genome Campus, Hinxton, Cambs, England.	natalja@ebi.ac.uk		Mason, Justin/0000-0001-7783-1660; /0000-0002-2796-5123; Karp, Natasha/0000-0002-8404-2907; Kurbatova, Natalja/0000-0002-3973-2909; Meehan, Terrence/0000-0003-1980-3228	Wellcome Trust [WT098051]; National Institutes of Health [1 U54 HG006370-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006370] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Wellcome Trust (grant number: WT098051, http:/www.wellcome.ac.ukFundingindex.htm) and the National Institutes of Health (grant number: 1 U54 HG006370-01, http:/grants.nih.govgrantsoer.htm).	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; [Anonymous], 2012, NATURE, V483, P509, DOI DOI 10.1038/483509A; Ayadi A, 2012, MAMM GENOME, V23, P600, DOI 10.1007/s00335-012-9418-y; Baker D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001756; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brown SDM, 2012, MAMM GENOME, V23, P632, DOI 10.1007/s00335-012-9427-x; Clark RA, 2012, J PSYCHOPHARMACOL, V26, P1136, DOI 10.1177/0269881111420313; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Cook MN, 2007, MAMM GENOME, V18, P559, DOI 10.1007/s00335-007-9035-3; Deans AR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002033; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Flanagan KL, 2014, T ROY SOC TROP MED H, V108, P385, DOI 10.1093/trstmh/tru079; Hahne F, 2008, USE R, P1, DOI 10.1007/978-0-387-77240-0_1; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Karp NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111239; Karp NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052410; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Koscielny G, 2014, NUCLEIC ACIDS RES, V42, pD802, DOI 10.1093/nar/gkt977; Lees H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100916; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; R Development Core Team, R LANG ENV STAT COMP; Reed DR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-4; Ringwald M, 2011, NUCLEIC ACIDS RES, V39, pD849, DOI 10.1093/nar/gkq879; Simon MM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r82; Valdar W, 2006, GENETICS, V174, P959, DOI 10.1534/genetics.106.060004; West B. T., 2014, LINEAR MIXED MODELS; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022	31	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131274	10.1371/journal.pone.0131274	http://dx.doi.org/10.1371/journal.pone.0131274			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147094	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600079
J	Sun, L; Chen, FJ; Peng, G				Sun, Liu; Chen, Fengjiao; Peng, Gang			Conserved Noncoding Sequences Regulate lhx5 Expression in the Zebrafish Forebrain	PLOS ONE			English	Article							LIM-HOMEOBOX GENE; IN-SITU HYBRIDIZATION; DORSAL SPINAL-CORD; PROSOMERIC MODEL; CELL DIFFERENTIATION; BINDING-SITES; GLI PROTEINS; HOMEODOMAIN; EVOLUTION; GENOME	The LIM homeobox family protein Lhx5 plays important roles in forebrain development in the vertebrates. The lhx5 gene exhibits complex temporal and spatial expression patterns during early development but its transcriptional regulation mechanisms are not well understood. Here, we have used transgenesis in zebrafish in order to define regulatory elements that drive lhx5 expression in the forebrain. Through comparative genomic analysis we identified 10 non-coding sequences conserved in five teleost species. We next examined the enhancer activities of these conserved non-coding sequences with Tol2 transposon mediated transgenesis. We found a proximately located enhancer gave rise to robust reporter EGFP expression in the forebrain regions. In addition, we identified an enhancer located at approximately 50 kb upstream of lhx5 coding region that is responsible for reporter gene expression in the hypothalamus. We also identify an enhancer located approximately 40 kb upstream of the lhx5 coding region that is required for expression in the prethalamus (ventral thalamus). Together our results suggest discrete enhancer elements control lhx5 expression in different regions of the forebrain.	[Sun, Liu; Chen, Fengjiao; Peng, Gang] Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Sun, Liu; Chen, Fengjiao; Peng, Gang] Fudan Univ, Collaborat Innovat Ctr Brain Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Peng, G (corresponding author), Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China.	gangpeng@fudan.edu.cn	sun, liu/U-5553-2019	sun, liu/0000-0002-1459-9478; peng, gang/0000-0001-6625-5426	National Natural Science Foundation of China [30970948, 31371099]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant 30970948 and 31371099 to GP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aday AW, 2011, DEV BIOL, V357, P450, DOI 10.1016/j.ydbio.2011.03.007; Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Asakawa K, 2009, METHODS, V49, P275, DOI 10.1016/j.ymeth.2009.01.004; Bachy I, 2001, J NEUROSCI, V21, P7620, DOI 10.1523/JNEUROSCI.21-19-07620.2001; Brohl D, 2008, DEV BIOL, V322, P381, DOI 10.1016/j.ydbio.2008.08.002; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Ericson J, 1998, DEVELOPMENT, V125, P1005; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gao JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036516; Green EK, 2003, PSYCHIAT GENET, V13, P97, DOI 10.1097/00041444-200306000-00007; Hare EE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000106; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Herzog W, 2004, DEVELOPMENT, V131, P3681, DOI 10.1242/dev.01235; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Houston DW, 2003, DEVELOPMENT, V130, P2695, DOI 10.1242/dev.00509; Inoue J, 2013, DEV GROWTH DIFFER, V55, P668, DOI 10.1111/dgd.12074; Jeong JY, 2007, DEVELOPMENT, V134, P127, DOI 10.1242/dev.02705; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kiecker C, 2004, NAT NEUROSCI, V7, P1242, DOI 10.1038/nn1338; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koyabu Y, 2001, J BIOL CHEM, V276, P6889, DOI 10.1074/jbc.C000773200; Langeland JA, 2006, INT J BIOL SCI, V2, P110; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CH, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-2; Lim LS, 2010, STEM CELLS, V28, P1961, DOI 10.1002/stem.527; Liu F, 2013, DEVELOPMENT, V140, P1111, DOI 10.1242/dev.080226; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Makki N, 2011, DEV BIOL, V357, P295, DOI 10.1016/j.ydbio.2011.06.042; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Miquelajauregui A, 2010, J NEUROSCI, V30, P10551, DOI 10.1523/JNEUROSCI.5563-09.2010; Mizugishi K, 2001, J BIOL CHEM, V276, P2180, DOI 10.1074/jbc.M004430200; Nakagawa Y, 2001, J NEUROSCI, V21, P2711, DOI 10.1523/JNEUROSCI.21-08-02711.2001; Okada T, 2008, DEV BIOL, V320, P92, DOI 10.1016/j.ydbio.2008.04.034; Osorio J, 2005, DEV BIOL, V288, P100, DOI 10.1016/j.ydbio.2005.08.042; Paylor R, 2001, PHYSIOL BEHAV, V73, P781, DOI 10.1016/S0031-9384(01)00515-7; Pearson CA, 2011, DEVELOPMENT, V138, P2613, DOI 10.1242/dev.062794; Peng G, 2006, DEVELOPMENT, V133, P3191, DOI 10.1242/dev.02485; Pillai A, 2007, DEVELOPMENT, V134, P357, DOI 10.1242/dev.02717; Puelles L, 2003, TRENDS NEUROSCI, V26, P469, DOI 10.1016/S0166-2236(03)00234-0; Puelles L, 2013, TRENDS NEUROSCI, V36, P570, DOI 10.1016/j.tins.2013.06.004; RUBENSTEIN JLR, 1994, SCIENCE, V266, P578, DOI 10.1126/science.7939711; Sanek NA, 2008, DEV BIOL, V317, P325, DOI 10.1016/j.ydbio.2008.02.029; Scholpp S, 2006, DEVELOPMENT, V133, P855, DOI 10.1242/dev.02248; Sheng HZ, 1997, DEV DYNAM, V208, P266, DOI 10.1002/(SICI)1097-0177(199702)208:2<266::AID-AJA13>3.0.CO;2-1; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; TOYAMA R, 1995, DEV BIOL, V170, P583, DOI 10.1006/dbio.1995.1238; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Winata CL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003852; Zhang CW, 2012, J NEUROSCI, V32, P12589, DOI 10.1523/JNEUROSCI.6518-11.2012; Zhao Y, 2007, P NATL ACAD SCI USA, V104, P13182, DOI 10.1073/pnas.0705464104; Zhao YG, 2000, GENE, V260, P95, DOI 10.1016/S0378-1119(00)00466-2; Zhao YU, 1999, SCIENCE, V284, P1155, DOI 10.1126/science.284.5417.1155	59	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132525	10.1371/journal.pone.0132525	http://dx.doi.org/10.1371/journal.pone.0132525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147098	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600295
J	Tougaard, J				Tougaard, Jakob			Underwater Noise from a Wave Energy Converter Is Unlikely to Affect Marine Mammals	PLOS ONE			English	Article							HARBOR SEALS; KHZ	Underwater noise was recorded from the Wavestar wave energy converter; a full-scale hydraulic point absorber, placed on a jack-up rig on the Danish North Sea coast. Noise was recorded 25 m from the converter with an autonomous recording unit (10 Hz to 20 kHz bandwidth). Median sound pressure levels (L-eq) in third-octave bands during operation of the converter were 106-109 dB re. 1 mu Pa in the range 125-250 Hz, 1-2 dB above ambient noise levels (statistically significant). Outside the range 125-250 Hz the noise from the converter was undetectable above the ambient noise. During start and stop of the converter a more powerful tone at 150 Hz (sound pressure level (L-eq) 121-125 dB re 1 mu Pa) was easily detectable. This tone likely originated from the hydraulic pump which was used to lower the absorbers into the water and lift them out of the water at shutdown. Noise levels from the operating wave converter were so low that they would barely be audible to marine mammals and the likelihood of negative impact from the noise appears minimal. A likely explanation for the low noise emissions is the construction of the converter where all moving parts, except for the absorbers themselves, are placed above water on a jack-up rig. The results may thus not be directly transferable to other wave converter designs but do demonstrate that it is possible to harness wave energy without noise pollution to the marine environment.	Aarhus Univ, Dept Biosci, DK-4000 Roskilde, Denmark	Aarhus University	Tougaard, J (corresponding author), Aarhus Univ, Dept Biosci, DK-4000 Roskilde, Denmark.	jat@bios.au.dk	Tougaard, Jakob/G-4948-2011	Tougaard, Jakob/0000-0002-4422-7800	Wavestar A/S	Wavestar A/S	This study was commissioned and funded by Wavestar A/S. Field work was conducted on request from the funders and with assistance from company employees but the funders had no role in data analysis, writing of the manuscript or had any power to deny publication of results.	Azzellino A, 2013, INT J MAR ENERGY, V3-4, pE11, DOI 10.1016/j.ijome.2013.11.008; Bassett C, 2011, UNDERWATER NOISE MEA; Betke K., 2006, MEASUREMENT UNDERWAT; Chozas JF, 2012, 4 INT C OC EN DUBL; Drew B, 2009, P I MECH ENG A-J POW, V223, P887, DOI 10.1243/09576509JPE782; Frid C, 2012, ENVIRON IMPACT ASSES, V32, P133, DOI 10.1016/j.eiar.2011.06.002; Gill AB, 2005, J APPL ECOL, V42, P605, DOI 10.1111/j.1365-2664.2005.01060.x; Haikonen K, 2013, ENERGIES, V6, P2562, DOI 10.3390/en6052562; Kastelein RA, 2010, J ACOUST SOC AM, V128, P3211, DOI 10.1121/1.3493435; Kastelein RA, 2009, J ACOUST SOC AM, V126, P476, DOI 10.1121/1.3132522; Kramer MM, 9 EUR WAV TID C SOUT; Madsen PT, 2006, MAR ECOL PROG SER, V309, P279, DOI 10.3354/meps309279; Marquis L, 2012, 4 INT C OC EN DUBL; Patricio S, 8 EUR WAV TID EN C, P1020; Scheidat M, 2011, GEOPHYS RES LETT, V6, DOI [10.1088/1748-9326/6/2/025102, DOI 10.1088/1748-9326/6/2/025102]; Tougaard J, 2009, J ACOUST SOC AM, V125, P3766, DOI 10.1121/1.3117444	16	11	11	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132391	10.1371/journal.pone.0132391	http://dx.doi.org/10.1371/journal.pone.0132391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148299	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600256
J	Zheng, GH; Lan, XL; Li, MY; Ling, K; Lin, H; Chen, LD; Tao, J; Li, JZ; Zheng, X; Chen, B; Fang, QY				Zheng, Guohua; Lan, Xiulu; Li, Moyi; Ling, Kun; Lin, Hui; Chen, Lidian; Tao, Jing; Li, Junzhe; Zheng, Xin; Chen, Bai; Fang, Qianying			Effectiveness of Tai Chi on Physical and Psychological Health of College Students: Results of a Randomized Controlled Trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; MENTAL-HEALTH; RISK-FACTORS; CARDIOVASCULAR-DISEASE; UNIVERSITY-STUDENTS; SELF-ESTEEM; EXERCISE; BADUANJIN; ADULTS; BEHAVIORS	Objective To investigate the effectiveness and safety of Tai Chi Chuan (TCC) on physical and psychological health of college students. Methods Two hundred six college students were recruited and randomly allocated to a control group or a TCC exercise group in an equal ratio. Participants in the control group were instructed to maintain their original activity level and those in the TCC exercise group received 12 weeks of TCC exercise training based on their original activity level. Physical and psychological outcomes were evaluated at baseline, 13 weeks and 25 weeks. Intention-to-treat analysis was performed for the above outcomes. Results Compared with the control group, the TCC exercise group showed significant improvements at the end of the 12-week intervention period for flexibility (length of Sit and Reach (cm): TCC group 14.09 +/- 7.40 versus control 12.88 +/- 6.57, P = 0.039 adjusted for its baseline measures using a general linear model) and balance ability (open eyes perimeter: TCC group 235.6(191 similar to 314) versus control 261(216 similar to 300); closed eyes perimeter: TCC group 370.5 (284 similar to 454) versus control 367 (293 similar to 483); P = 0.0414, 0.008, respectively, adjusted for corresponding baseline measures using a general linear model). No significant changes in other physical and mental outcomes were found between the two groups. No adverse events were reported during the study period. Conclusion TCC exercise was beneficial in college students for improving flexibility and balance capability to some extent, compared with usual exercise.	[Zheng, Guohua; Lan, Xiulu; Li, Moyi; Tao, Jing; Li, Junzhe; Zheng, Xin; Chen, Bai; Fang, Qianying] Fujian Univ Tradit Chinese Med, Coll Rehabil Med, Fuzhou 350122, Peoples R China; [Ling, Kun; Lin, Hui] Fujian Univ Tradit Chinese Med, Dept Phys Educ, Fuzhou 350122, Peoples R China; [Chen, Lidian] Fujian Univ Tradit Chinese Med, Fuzhou 350122, Peoples R China	Fujian University of Traditional Chinese Medicine; Fujian University of Traditional Chinese Medicine; Fujian University of Traditional Chinese Medicine	Chen, LD (corresponding author), Fujian Univ Tradit Chinese Med, Fuzhou 350122, Peoples R China.	lidianchen87@163.com		Tao, Jing/0000-0001-9751-5294; Chen, Lidian/0000-0002-6454-7932	Special Scientific Research Fund of Public Welfare Profession of China from Ministry of finance of the People's Republic of China [201307004]	Special Scientific Research Fund of Public Welfare Profession of China from Ministry of finance of the People's Republic of China	This project was supported by 'the Special Scientific Research Fund of Public Welfare Profession of China (Grant No. 201307004)' from Ministry of finance of the People's Republic of China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College Health Association, 2009, J Am Coll Health, V57, P477, DOI 10.3200/JACH.57.5.477-488; Bagnato S, 2009, NEUROL SCI, V30, P107, DOI 10.1007/s10072-009-0031-0; Barnes AS, 2013, TEX HEART I J, V40, P293; Beili Z., 1995, J TIANJIN I PHYS ED, V10, P35, DOI DOI 10.13297/j.cnki.issn1005-0000.1995.01.007; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Brevard PB, 1996, J AM DIET ASSOC, V96, P35, DOI 10.1016/S0002-8223(96)00011-9; BROOKS JH, 1995, J COLL STUDENT DEV, V36, P347; Caldwell K, 2011, J ALTERN COMPLEM MED, V17, P931, DOI 10.1089/acm.2010.0645; Cheng FK, 2015, J BODYW MOV THER, V19, P138, DOI 10.1016/j.jbmt.2014.11.001; Converse AK, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00013; Cook LJ, 2007, J PSYCHOSOC NURS, V45, P40, DOI 10.3928/02793695-20070401-09; Eisenberg D, 2013, J NERV MENT DIS, V201, P60, DOI 10.1097/NMD.0b013e31827ab077; Fang JQ, 2000, QUALITY LIFE MEASURE, P228; Folsom AR, 1996, AM J EPIDEMIOL, V144, P235, DOI 10.1093/oxfordjournals.aje.a008918; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Haase A, 2004, PREV MED, V39, P182, DOI 10.1016/j.ypmed.2004.01.028; [胡建平 Hu Jianping], 2012, [中华物理医学与康复杂志, Chinese Journal of Physical Medicine and Rehabilitation], V34, P34; Hunt J, 2010, J ADOLESCENT HEALTH, V46, P3, DOI 10.1016/j.jadohealth.2009.08.008; Jahnke Roger, 2010, Am J Health Promot, V24, pe1, DOI 10.4278/ajhp.081013-LIT-248; Ji YF., 1993, CHINESE MENTAL HLTH, V7, P251; Kitzrow MA., 2003, NASPA J, V41, P167, DOI [10.2202/1949-6605.1310, DOI 10.2202/1949-6605.1310]; KOH TC, 1982, AM J CHINESE MED, V10, P14, DOI 10.1142/S0192415X8200004X; Kwan MY, 2012, AM J PREV MED, V42, P14, DOI 10.1016/j.amepre.2011.08.026; Lan C, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/502131; Lee LYK, 2007, J CLIN NURS, V16, P1580, DOI 10.1111/j.1365-2702.2007.02061.x; Li FZ, 2001, STRUCT EQU MODELING, V8, P53, DOI 10.1207/S15328007SEM0801_4; Liu JY, 1975, TAMKANG, V13, P217; Luepker RV, 1996, JAMA-J AM MED ASSOC, V276, P241; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Mikolajczyk RT, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-215; Mustian KM, 2004, SUPPORT CARE CANCER, V12, P871, DOI 10.1007/s00520-004-0682-6; Norman JE, 2003, INT J OBESITY, V27, P369, DOI 10.1038/sj.ijo.0802243; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Seo DC, 2012, INT J BEHAV MED, V19, P316, DOI 10.1007/s12529-011-9167-4; Tong Y, 2009, CHINESE NATL STANDAR; Tosevski DL, 2010, CURR OPIN PSYCHIATR, V23, P48, DOI 10.1097/YCO.0b013e328333d625; Valois RF, 2004, J SCHOOL HEALTH, V74, P59, DOI 10.1111/j.1746-1561.2004.tb04201.x; Verhagen AP, 2004, FAM PRACT, V21, P107, DOI 10.1093/fampra/cmh122; Wang CC, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-23; [王盛 Wang Sheng], 2011, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V26, P1035; Wang XD, 1993, CHIN MENT HLTH J S, P31; Wang Y, 2004, AM J CHINESE MED, V32, P453, DOI 10.1142/S0192415X04002107; Xiong XJ, 2015, MATURITAS, V80, P370, DOI 10.1016/j.maturitas.2015.01.002; Yang Ting-zhong, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P760; Yeh GY, 2009, J CARDIOPULM REHABIL, V29, P152, DOI 10.1097/HCR.0b013e3181a33379; ZHANG JX, 1995, PSYCHOLOGIA, V38, P174; Zheng GH, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-129; Zheng GH, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-422	50	17	17	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132605	10.1371/journal.pone.0132605	http://dx.doi.org/10.1371/journal.pone.0132605			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26147842	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600304
J	Zizzari, IG; Martufi, P; Battisti, F; Rahimi, H; Caponnetto, S; Bellati, F; Nuti, M; Rughetti, A; Napoletano, C				Zizzari, Ilaria Grazia; Martufi, Paola; Battisti, Federico; Rahimi, Hassan; Caponnetto, Salvatore; Bellati, Filippo; Nuti, Marianna; Rughetti, Aurelia; Napoletano, Chiara			The Macrophage Galactose-Type C-Type Lectin (MGL) Modulates Regulatory T Cell Functions	PLOS ONE			English	Article							CD45	Regulatory T cells (Tregs) are physiologically designed to prevent autoimmune disease and maintain self-tolerance. In tumour microenvironments, their presence is related to a poor prognosis, and they influence the therapeutic outcome due to their capacity to suppress the immune response by cell-cell contact and to release immunosuppressive cytokines. In this study, we demonstrate that Treg immunosuppressive activity can be modulated by the cross-linking between the CD45RA expressed by Tregs and the C-type lectin MGL. This specific interaction strongly decreases the im-munosuppressive activity of Tregs, restoring the proliferative capacity of co-cultured T lymphocytes. This effect can be attributed to changes in CD45RA and TCR signalling through the inhibition of Lck and inactivation of Zap-70, an increase in the Foxp3 methylation status and, ultimately, the reduced production of suppressive cytokines. These results indicate a role of MGL as an immunomodulator within the tumour microenvironment interfering with Treg functions, suggesting its possible use in the design of anticancer vaccines.	[Zizzari, Ilaria Grazia; Martufi, Paola; Battisti, Federico; Rahimi, Hassan; Caponnetto, Salvatore; Nuti, Marianna; Rughetti, Aurelia; Napoletano, Chiara] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Bellati, Filippo] Univ Roma La Sapienza, Dept Obstet & Gynecol, I-00185 Rome, Italy	Sapienza University Rome; Sapienza University Rome	Nuti, M (corresponding author), Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy.	marianna.nuti@uniroma1.it	ZIZZARI, ILARIA GRAZIA/K-7958-2016; Napoletano, Chiara/AAO-1691-2021	Bellati, Filippo/0000-0002-2036-9951; BATTISTI, FEDERICO/0000-0001-9495-5905; Napoletano, Chiara/0000-0001-5449-5430; Caponnetto, Salvatore/0000-0003-2906-449X; RAHIMI KOSHKAKI, HASSAN/0000-0001-6701-1263	Associazione Italiana per la Ricerca sul Cancro (AIRC), Ricerche Universitarie (Ateneo)	Associazione Italiana per la Ricerca sul Cancro (AIRC), Ricerche Universitarie (Ateneo)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Associazione Italiana per la Ricerca sul Cancro (MN: AIRC 2009), Ricerche Universitarie (CN: Ateneo 2012, 2013; IGZ: Ateneo "Start up" 2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MR, 2014, J NEUROIMMUNE PHARM, V9, P522, DOI 10.1007/s11481-014-9547-z; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Beissert S, 2006, J INVEST DERMATOL, V126, P15, DOI 10.1038/sj.jid.5700004; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gregori S, 2005, J EXP MED, V201, P1293, DOI 10.1084/jem.20040912; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Hoffmann P, 2006, BLOOD, V108, P4260, DOI 10.1182/blood-2006-06-027409; Hori S, 2011, TRENDS IMMUNOL, V32, P295, DOI 10.1016/j.it.2011.04.004; Leitenberg D, 2007, IMMUNOLOGY, V121, P545, DOI 10.1111/j.1365-2567.2007.02602.x; Luke PP, 2011, CURR MOL MED, V1, P533; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Mkrtichyan M, 2011, EUR J IMMUNOL, V41, P2977, DOI 10.1002/eji.201141639; Napoletano C, 2007, CANCER RES, V67, P8358, DOI 10.1158/0008-5472.CAN-07-1035; Napoletano C, 2012, EUR J IMMUNOL, V42, P936, DOI 10.1002/eji.201142086; O'Mahony D, 2007, CLIN CANCER RES, V13, P958, DOI 10.1158/1078-0432.CCR-06-1974; Pen JJ, 2013, J IMMUNOL, V191, P1976, DOI 10.4049/jimmunol.1201008; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Senovilla L, 2012, ONCOIMMUNOLOGY, V1, P1323, DOI 10.4161/onci.22009; Shimizu J, 2005, J IMMUNOL, V174, P4090, DOI 10.4049/jimmunol.174.7.4090; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Stone JD, 1997, J IMMUNOL, V158, P5773; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; van Vliet SJ, 2008, TRENDS IMMUNOL, V29, P83, DOI 10.1016/j.it.2007.10.010; van Vliet SJ, 2006, NAT IMMUNOL, V7, P1200, DOI 10.1038/ni1390	26	17	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132617	10.1371/journal.pone.0132617	http://dx.doi.org/10.1371/journal.pone.0132617			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147970	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600306
J	Aryal, UK; Ross, ARS; Krochko, JE				Aryal, Uma K.; Ross, Andrew R. S.; Krochko, Joan E.			Enrichment and Analysis of Intact Phosphoproteins in Arabidopsis Seedlings	PLOS ONE			English	Article							ION AFFINITY-CHROMATOGRAPHY; LARGE-SCALE ANALYSIS; PHOSPHORYLATION SITES; SEED-GERMINATION; PLASMA-MEMBRANE; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; REVEALS; THALIANA	Protein phosphorylation regulates diverse cellular functions and plays a key role in the early development of plants. To complement and expand upon previous investigations of protein phosphorylation in Arabidopsis seedlings we used an alternative approach that combines protein extraction under non-denaturing conditions with immobilized metal-ion affinity chromatography (IMAC) enrichment of intact phosphoproteins in Rubisco-depleted extracts, followed by identification using two-dimensional gel electrophoresis (2-DE) and liquid chromatography-tandem mass spectrometry (LC-MS/MS). In-gel trypsin digestion and analysis of selected gel spots identified 144 phosphorylated peptides and residues, of which only18 phosphopeptides and 8 phosphosites were found in the PhosPhAt 4.0 and (PDB)-D-3 Arabidopsis thaliana phosphorylation site databases. More than half of the 82 identified phosphoproteins were involved in carbohydrate metabolism, photosynthesis/respiration or oxidative stress response mechanisms. Enrichment of intact phosphoproteins prior to 2-DE and LC-MS/MS appears to enhance detection of phosphorylated threonine and tyrosine residues compared with methods that utilize peptide-level enrichment, suggesting that the two approaches are somewhat complementary in terms of phosphorylation site coverage. Comparing results for young seedlings with those obtained previously for mature Arabidopsis leaves identified five proteins that are differentially phosphorylated in these tissues, demonstrating the potential of this technique for investigating the dynamics of protein phosphorylation during plant development.	[Aryal, Uma K.; Ross, Andrew R. S.; Krochko, Joan E.] Natl Res Council Canada, Saskatoon, SK S7N 0W9, Canada	National Research Council Canada	Ross, ARS (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.	andrew.ross@dfo-mpo.gc.ca			National Research Council (NRC); Saskatchewan Provincial Government; NRC	National Research Council (NRC); Saskatchewan Provincial Government; NRC(National Research Centre (NRC))	UKA also acknowledges the generous support from the National Research Council (NRC) for a postdoctoral Visiting Fellowship. Funding for protein mass spectrometry equipment was provided by the Saskatchewan Provincial Government and NRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This article is contribution number 54680 from the National Research Council of Canada.	Alexandersson E, 2004, PLANT CELL PHYSIOL, V45, P1543, DOI 10.1093/pcp/pch209; AOYAGI K, 1985, PLANT PHYSIOL, V78, P661, DOI 10.1104/pp.78.3.661; Aryal UK, 2012, J PROTEOME RES, V11, P425, DOI 10.1021/pr200917t; BEEVERS H, 1956, PLANT PHYSIOL, V31, P440, DOI 10.1104/pp.31.6.440; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; Cellar NA, 2008, J CHROMATOGR B, V861, P29, DOI 10.1016/j.jchromb.2007.11.024; Cellar NA, 2009, J CHROMATOGR B, V877, P79, DOI 10.1016/j.jchromb.2008.11.020; Cernac A, 2006, PLANT PHYSIOL, V141, P745, DOI 10.1104/pp.106.079574; Chen M, 2010, PLANT CELL, V22, P77, DOI 10.1105/tpc.109.071837; van Bentem SDF, 2006, NUCLEIC ACIDS RES, V34, P3267, DOI 10.1093/nar/gkl429; Durek P, 2010, NUCLEIC ACIDS RES, V38, pD828, DOI 10.1093/nar/gkp810; Eastmond PJ, 2001, TRENDS PLANT SCI, V6, P72, DOI 10.1016/S1360-1385(00)01835-5; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Ghelis T, 2011, PLANT SIGNAL BEHAV, V6, P942, DOI 10.4161/psb.6.7.15261; Graham IA, 2008, ANNU REV PLANT BIOL, V59, P115, DOI 10.1146/annurev.arplant.59.032607.092938; Grimsrud PA, 2010, PLANT PHYSIOL, V152, P19, DOI 10.1104/pp.109.149625; He Y, 2011, NEW PHYTOL, V189, P160, DOI 10.1111/j.1469-8137.2010.03460.x; Heazlewood JL, 2008, NUCLEIC ACIDS RES, V36, pD1015, DOI 10.1093/nar/gkm812; Horvath DP, 2003, TRENDS PLANT SCI, V8, P534, DOI 10.1016/j.tplants.2003.09.013; Jebanathirajah JA, 1998, PLANTA, V204, P177, DOI 10.1007/s004250050244; Jones AME, 2009, J PROTEOMICS, V72, P439, DOI 10.1016/j.jprot.2009.02.004; Kress W, 2009, RES MICROBIOL, V160, P618, DOI 10.1016/j.resmic.2009.08.006; Lapik YR, 2003, PLANT CELL, V15, P1578, DOI 10.1105/tpc.011890; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Liu CC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-158; Lohrig K, 2009, PLANTA, V229, P1123, DOI 10.1007/s00425-009-0901-y; Machida M, 2007, FEBS J, V274, P1576, DOI 10.1111/j.1742-4658.2007.05705.x; Mann M, 2002, TRENDS BIOTECHNOL, V20, P261, DOI 10.1016/S0167-7799(02)01944-3; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.010475; Marx C, 2003, PLANTA, V216, P454, DOI 10.1007/s00425-002-0857-7; Mazzitelli L, 2007, J EXP BOT, V58, P1035, DOI 10.1093/jxb/erl266; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Nuhse TS, 2003, MOL CELL PROTEOMICS, V2, P1234, DOI 10.1074/mcp.T300006-MCP200; O'Neill CM, 2003, PHYTOCHEMISTRY, V64, P1077, DOI 10.1016/S0031-9422(03)00351-0; Patnaik Debasis, 2001, Indian Journal of Experimental Biology, V39, P191; Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x; Rajjou L, 2006, PLANT PHYSIOL, V141, P910, DOI 10.1104/pp.106.082057; Rao RSP, 2012, BBA-PROTEINS PROTEOM, V1824, P405, DOI 10.1016/j.bbapap.2011.12.001; Reiland S, 2009, PLANT PHYSIOL, V150, P889, DOI 10.1104/pp.109.138677; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; Tang GL, 1999, PROTEIN EXPRES PURIF, V16, P432, DOI 10.1006/prep.1999.1087; Tang WQ, 2008, MOL CELL PROTEOMICS, V7, P728, DOI 10.1074/mcp.M700358-MCP200; Teng NJ, 2006, NEW PHYTOL, V172, P92, DOI 10.1111/j.1469-8137.2006.01818.x; Wan LL, 2007, BIOCHEM J, V404, P247, DOI 10.1042/BJ20061569; Wang X, 2013, J PROTEOMICS, V78, P486, DOI 10.1016/j.jprot.2012.10.018; Waterworth WM, 2005, J EXP BOT, V56, P1545, DOI 10.1093/jxb/eri149; Yao QM, 2014, NUCLEIC ACIDS RES, V42, pD1206, DOI 10.1093/nar/gkt1135	51	6	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0130763	10.1371/journal.pone.0130763	http://dx.doi.org/10.1371/journal.pone.0130763			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158488	Green Published, Green Submitted, gold			2022-12-27	WOS:000358161200016
J	Kovacevic, N; Ritter, P; Tays, W; Moreno, S; McIntosh, AR				Kovacevic, Natasha; Ritter, Petra; Tays, William; Moreno, Sylvain; McIntosh, Anthony Randal			'My Virtual Dream': Collective Neurofeedback in an Immersive Art Environment	PLOS ONE			English	Article							EEG-NEUROFEEDBACK; BRAIN; PERFORMANCE; MEMORY; SLEEP	While human brains are specialized for complex and variable real world tasks, most neuroscience studies reduce environmental complexity, which limits the range of behaviours that can be explored. Motivated to overcome this limitation, we conducted a large-scale experiment with electroencephalography (EEG) based brain-computer interface (BCI) technology as part of an immersive multi-media science-art installation. Data from 523 participants were collected in a single night. The exploratory experiment was designed as a collective computer game where players manipulated mental states of relaxation and concentration with neurofeedback targeting modulation of relative spectral power in alpha and beta frequency ranges. Besides validating robust time-of-night effects, gender differences and distinct spectral power patterns for the two mental states, our results also show differences in neurofeedback learning outcome. The unusually large sample size allowed us to detect unprecedented speed of learning changes in the power spectrum (similar to 1 min). Moreover, we found that participants' baseline brain activity predicted subsequent neurofeedback beta training, indicating state-dependent learning. Besides revealing these training effects, which are relevant for BCI applications, our results validate a novel platform engaging art and science and fostering the understanding of brains under natural conditions.	[Kovacevic, Natasha; Tays, William; Moreno, Sylvain; McIntosh, Anthony Randal] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada; [Ritter, Petra] Max Planck Inst Cognit & Brain Sci, Leipzig, Germany; [Ritter, Petra] Charite, Dept Neurol, D-13353 Berlin, Germany; [Moreno, Sylvain; McIntosh, Anthony Randal] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Baycrest; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Toronto	Kovacevic, N (corresponding author), Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada.	nkovacevic@research.baycrest.org	; Ritter, Petra/B-6953-2008	McIntosh, Anthony/0000-0002-1784-5662; Ritter, Petra/0000-0002-4643-4782	James S. McDonnel Foundation [JSMF22002082]; German Ministry of Education and Research [01GQ0971]; Max-Planck Society (Minerva Program)	James S. McDonnel Foundation; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Max-Planck Society (Minerva Program)	The authors especially thank Mr. Max and Mrs. Gianna Glassman for their financial support, as well as to the University of Toronto for their logistical and financial support of the event. They also acknowledge funding by the James S. McDonnel Foundation (Brain Network Recovery Group JSMF22002082), the German Ministry of Education and Research (Bernstein Focus State Dependencies of Learning 01GQ0971) and the Max-Planck Society (Minerva Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagdasaryan J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00680; Bangert M, 2001, ANN NY ACAD SCI, V930, P425, DOI 10.1111/j.1749-6632.2001.tb05760.x; Becker R, 2011, J NEUROSCI, V31, P11016, DOI 10.1523/JNEUROSCI.0210-11.2011; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; BRENNER RP, 1995, ELECTROEN CLIN NEURO, V94, P1, DOI 10.1016/0013-4694(94)00234-C; CORSICABRERA M, 1992, SLEEP, V15, P550, DOI 10.1093/sleep/15.6.550; Freyer F, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00144; Gramann K, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00444; Griffiths MJ, 2005, MED APPL SIGNAL PROC; Gruzelier J, 1999, INT J PSYCHOPHYSIOL, V34, P341, DOI 10.1016/S0167-8760(99)00091-4; Gruzelier JH, 2014, NEUROSCI BIOBEHAV R, V44, DOI [10.1016/j.neubiorev.2014.05.003, DOI 10.1016/J.NEUBI0REV.2014.05.003]; Gruzelier JH, 2014, NEUROSCI BIOBEHAV R, V44, P142, DOI 10.1016/j.neubiorev.2013.11.004; Gwin JT, 2010, J NEUROPHYSIOL, V103, P3526, DOI 10.1152/jn.00105.2010; Hanslmayr S, 2005, APPL PSYCHOPHYS BIOF, V30, P1, DOI 10.1007/s10484-005-2169-8; HARDT JV, 1978, SCIENCE, V201, P79, DOI 10.1126/science.663641; HARTIKAINEN P, 1992, ACTA NEUROL SCAND, V86, P148, DOI 10.1111/j.1600-0404.1992.tb05057.x; Hasson U, 2012, NEUROIMAGE, V62, P1272, DOI 10.1016/j.neuroimage.2012.02.004; Kovacevic N, 2013, SPRINGER P MATH STAT, V56, P159, DOI 10.1007/978-1-4614-8283-3_10; Leon PS, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00010; McDowell K, 2013, REAL WORLD NEUROIMAG, V1; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; Niedermeyer E., 1999, ELECTROENCEPHALOGRAP; Reinacher M, 2009, J NEUROSCI METH, V183, P49, DOI 10.1016/j.jneumeth.2009.06.036; Reiner M, 2014, BIOL PSYCHOL, V95, P45, DOI 10.1016/j.biopsycho.2013.10.010; Ritter P, 2013, BRAIN CONNECT, V3, P121, DOI 10.1089/brain.2012.0120; Ros T, 2013, NEUROIMAGE, V65, P324, DOI 10.1016/j.neuroimage.2012.09.046; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; SAXBY E, 1995, J CLIN PSYCHOL, V51, P685, DOI 10.1002/1097-4679(199509)51:5<685::AID-JCLP2270510514>3.0.CO;2-K; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Sigala R, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00036; Spiers HJ, 2006, NEUROIMAGE, V31, P1826, DOI 10.1016/j.neuroimage.2006.01.037; Staufenbiel SM, 2014, BIOL PSYCHOL, V95, P74, DOI 10.1016/j.biopsycho.2013.05.020; Sterman MB, 2000, CLIN ELECTROENCEPHAL, V31, P45, DOI 10.1177/155005940003100111; Taubert M, 2010, J NEUROSCI, V30, P11670, DOI 10.1523/JNEUROSCI.2567-10.2010; Vernon D, 2003, INT J PSYCHOPHYSIOL, V47, P75, DOI 10.1016/S0167-8760(02)00091-0; Vernon DJ, 2005, APPL PSYCHOPHYS BIOF, V30, P347, DOI 10.1007/s10484-005-8421-4; Volosyak I, 2009, REHABILITATION ROBOT; Woodman MM, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00036; Yuan-Pin L, 2013, LECT NOTES COMPUTER, V8008; Zoefel B, 2011, NEUROIMAGE, V54, P1427, DOI 10.1016/j.neuroimage.2010.08.078	40	38	40	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130129	10.1371/journal.pone.0130129	http://dx.doi.org/10.1371/journal.pone.0130129			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26154513	Green Published, gold, Green Submitted			2022-12-27	WOS:000358159700024
J	McKenzie, AJ; Robertson, PA				McKenzie, Ailsa J.; Robertson, Peter A.			Which Species Are We Researching and Why? A Case Study of the Ecology of British Breeding Birds	PLOS ONE			English	Article							H-INDEX; BEHAVIOR	Our ecological knowledge base is extensive, but the motivations for research are many and varied, leading to unequal species representation and coverage. As this evidence is used to support a wide range of conservation, management and policy actions, it is important that gaps and biases are identified and understood. In this paper we detail a method for quantifying research effort and impact at the individual species level, and go on to investigate the factors that best explain between-species differences in outputs. We do this using British breeding birds as a case study, producing a ranked list of species based on two scientific publication metrics: total number of papers (a measure of research quantity) and h-index (a measure of the number of highly cited papers on a topic - an indication of research quality). Widespread, populous species which are native, resident and in receipt of biodiversity action plans produced significantly higher publication metrics. Guild was also significant, birds of prey the most studied group, with pigeons and doves the least studied. The model outputs for both metrics were very similar, suggesting that, at least in this example, research quantity and quality were highly correlated. The results highlight three key gaps in the evidence base, with fewer citations and publications relating to migrant breeders, introduced species and species which have experienced contractions in distribution. We suggest that the use of publication metrics in this way provides a novel approach to understanding the scale and drivers of both research quantity and impact at a species level and could be widely applied, both taxonomically and geographically.	[McKenzie, Ailsa J.; Robertson, Peter A.] Newcastle Univ, Sch Biol, Ctr Wildlife Management, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Robertson, Peter A.] Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, York, N Yorkshire, England	Newcastle University - UK; Animal & Plant Health Agency UK	McKenzie, AJ (corresponding author), Newcastle Univ, Sch Biol, Ctr Wildlife Management, Ridley Bldg,Claremont Rd, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	ailsa.mckenzie@ncl.ac.uk	Robertson, Peter/H-1614-2013	Robertson, Peter/0000-0003-1567-8677	AHVLA; Newcastle University	AHVLA; Newcastle University	This work was funded by the Technology Strategy Board as part of a Knowledge Transfer Partnership between AHVLA and Newcastle University [http://www.ktponline.org.uk/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmer D., 2013, BIRD ATLAS 2007 11 B; Bar-Ilan J, 2008, SCIENTOMETRICS, V74, P257, DOI 10.1007/s11192-008-0216-y; Baxter AT, 2007, INT J PEST MANAGE, V53, P341, DOI 10.1080/09670870701245231; Bonnet X, 2002, TRENDS ECOL EVOL, V17, P1, DOI 10.1016/S0169-5347(01)02381-3; Brito D, 2009, TROP CONSERV SCI, V2, P353, DOI 10.1177/194008290900200305; Brodie JF, 2009, BIODIVERS CONSERV, V18, P2927, DOI 10.1007/s10531-009-9617-3; Brooke ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093195; BTO, BTO BIRDFACTS; Clark JA, 2002, SCIENCE, V297, P191; Ducatez S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089955; Dunn JC, 2012, BIRD STUDY, V59, P394, DOI 10.1080/00063657.2012.725710; EOL, TRAITBANK ENCY LIFE; Fera, 2010, OVERVIEW CONFLICTS H; Harrop AHJ, 2013, IBIS, V155, P635, DOI 10.1111/ibi.12069; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; IUCN, IUCN RED LIST THREAT; JNCC, UK BAP PRIORITY SPEC; Langston RHW, 2007, IBIS, V149, P250, DOI 10.1111/j.1474-919X.2007.00709.x; Mackay B, 2014, J WILDLIFE MANAGE, V78, P671, DOI 10.1002/jwmg.711; Malesios CC, 2014, QUAL QUANT, V48, P521, DOI 10.1007/s11135-012-9785-1; Manchester SJ, 2000, J APPL ECOL, V37, P845, DOI 10.1046/j.1365-2664.2000.00538.x; Peck HL, 2014, BEHAV ECOL, V25, P582, DOI 10.1093/beheco/aru025; Robertson PA, 2015, MAMMAL REV, V9; Rodriguez-Pastor R, 2012, ANIM BIODIV CONSERV, V35, P107; Smith GC, 2005, J APPL ECOL, V42, P546, DOI 10.1111/j.1365-2664.2005.00977.x; Wilkin TA, 2006, J ANIM ECOL, V75, P604, DOI 10.1111/j.1365-2656.2006.01078.x	26	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131004	10.1371/journal.pone.0131004	http://dx.doi.org/10.1371/journal.pone.0131004			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154759	gold, Green Submitted, Green Published			2022-12-27	WOS:000358159700051
J	Yu, HM; Wang, XC; He, RL; Liang, RF; Zhou, LY				Yu, Hongmei; Wang, Xiaocheng; He, Runlian; Liang, Ruifeng; Zhou, Liye			Measuring the Caregiver Burden of Caring for Community-Residing People with Alzheimer's Disease	PLOS ONE			English	Article							FAMILY CAREGIVERS; PSYCHOLOGICAL SYMPTOMS; DEMENTIA BPSD; CARE; HEALTH; RELATIVES; FEELINGS	Objectives To assess the direct and indirect effects of patient or caregiver factors on caregiver burden of caring for community-residing people with mild Alzheimer's disease (AD). Methods We conducted a cross-sectional study of patients diagnosed with AD from two hospitals and three communities in Taiyuan, China and their caregivers. For this survey, 200 patients with mild AD and their caregivers were selected. Caregivers were asked to provide sociodemographic information including age, gender, relationship with the patient, level of education, and number of contact hours per week with the patient. Caregiver burden was assessed using the Caregivers Burden Inventory. The caregivers also completed other measures including the Positive Aspects of Caregiving, the Family Adaptation, Partnership, Growth, Affection, and Resolve, and the Social Support Rating Scale. The patients with AD completed the Montreal Cognitive Assessment; their caregivers completed the Activities of Daily Living Scale and a questionnaire about the patients' Behavioral and Psychological symptoms of Dementia. The main outcome in this study was caregiver burden. The care receivers' level of cognitive function, physical function, and behavioral problems were treated as original stress; the primary appraisal variable was measured as the number of hours of caregiving in the previous week reported by the caregiver. Mediator variables included perceived social support, family function, and caregiving experience. Path analysis was used to build the interrelationship among caregiver burden and patient or caregiver factors. Results A lower level of cognitive function in patients (r = -0.28, p<0.001) and longer hours of caregiving (r = 0.17, p = 0.019) were related to increased caregiver burden. Greater social support (r = -0.23, p<0.001), family function (r = -0.17, p = 0.015) and caregiving experience (r = -0.16, p = 0.012) were related to decreased caregiver burden. Social support (r = 0.16, p = 0.040) and family function (r = 0.25, p = 0.002) were directly related to patients' level of cognitive functioning, but were mediator factors between level of cognitive function in patients and caregiver burden. Similarly, social support was a mediator factor between patients' daily function (r = -0.23, p = 0.004) and caregiver burden; while caregiving experience mediated the link between behavioral and psychological symptoms in patients (r = 0.36, p<0.001) and caregiver burden. Conclusion Level of cognitive function and hours of caregiving were directly related to caregiver's burden. Social support, family function and caregiving experience could mediate the relationship between patient factors and caregiver burden. Focusing on patient factors and promoting caregiver care will be helpful in lowering the perceived burden of caregiving.	[Yu, Hongmei] Shanxi Med Univ, Sch Publ Hlth, Dept Hlth Stat, Taiyuan, Peoples R China; [Wang, Xiaocheng] Shanxi Prov Peoples Hosp, Dept Med Record Management, Taiyuan, Peoples R China; [He, Runlian] Taiyuan Cent Hosp, Dept Nursing, Taiyuan, Shanxi, Peoples R China; [Liang, Ruifeng] Shanxi Med Univ, Sch Publ Hlth, Dept Environm Hlth, Taiyuan, Peoples R China; [Zhou, Liye] Shanxi Med Univ, Sch Basic Med Sci, Dept Math, Taiyuan, Peoples R China	Shanxi Medical University; Shanxi People's Hospital; Shanxi Medical University; Shanxi Medical University; Shanxi Medical University	Yu, HM (corresponding author), Shanxi Med Univ, Sch Publ Hlth, Dept Hlth Stat, Taiyuan, Peoples R China.	yu_hongmei@hotmail.com		Yu, Hongmei/0000-0002-9852-2485	National Natural Science Foundation of China [81373106]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Hongmei Yu was supported by grant No. 81373106 from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahpour I, 2014, J GERIATR PSYCH NEUR, V27, P172, DOI 10.1177/0891988714524627; Aguglia E, 2004, Am J Alzheimers Dis Other Demen, V19, P248, DOI 10.1177/153331750401900403; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Arai Y, 2004, PSYCHIAT CLIN NEUROS, V58, P396, DOI 10.1111/j.1440-1819.2004.01274.x; Beeri MS, 2002, INT J GERIATR PSYCH, V17, P403, DOI 10.1002/gps.490; Chappell NL, 2002, GERONTOLOGIST, V42, P772, DOI 10.1093/geront/42.6.772; CHAU T-T, 1991, Kaohsiung Journal of Medical Sciences, V7, P27; Choo Wan-Yuen, 2003, Asia Pac J Public Health, V15, P23, DOI 10.1177/101053950301500105; Chou KR, 2002, NURS RES, V51, P324, DOI 10.1097/00006199-200209000-00009; Chou KR, 1999, NURS RES, V48, P206, DOI 10.1097/00006199-199907000-00003; Cox C, 2013, CURR GERIATR REP, V2, P31, DOI 10.1007/s13670-012-0033-2; Ericson I, 2001, Br J Nurs, V10, P710; GEORGE LK, 1986, GERONTOLOGIST, V26, P253, DOI 10.1093/geront/26.3.253; Gonyea Judith G, 2005, Am J Alzheimers Dis Other Demen, V20, P273, DOI 10.1177/153331750502000505; Heru AM, 2006, B MENNINGER CLIN, V70, P222, DOI 10.1521/bumc.2006.70.3.222; Heru AM, 2004, INT J GERIATR PSYCH, V19, P533, DOI 10.1002/gps.1119; Huang SS, 2012, ARCH GERONTOL GERIAT, V55, P55, DOI 10.1016/j.archger.2011.04.009; Ji P, 2010, J NURS ADMIN, V10, P787; Kasuya RT, 2000, POSTGRAD MED, V108, P119, DOI 10.3810/pgm.2000.12.1324; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kramer BJ, 1997, GERONTOLOGIST, V37, P218, DOI 10.1093/geront/37.2.218; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Li Y, 2002, ILLNESS CRISIS LOSS, V10, P318, DOI DOI 10.1177/105413702236512; Lu J, 2011, J GERIATR PSYCH NEUR, V24, P184, DOI 10.1177/0891988711422528; Maestre GE, 2012, CURR NEUROL NEUROSCI, V12, P511, DOI 10.1007/s11910-012-0300-9; Padierna A, 2013, SOC PSYCH PSYCH EPID, V48, P151, DOI 10.1007/s00127-012-0525-6; Perlick DA, 2005, BIPOLAR DISORD, V7, P126, DOI 10.1111/j.1399-5618.2004.00172.x; Reisberg B, 1996, Int Psychogeriatr, V8 Suppl 3, P301; Rinaldi P, 2005, INT J GERIATR PSYCH, V20, P168, DOI 10.1002/gps.1267; Schulz R, 2003, NEW ENGL J MED, V349, P1936, DOI 10.1056/NEJMsa035373; Schulz R, 2002, GERONTOLOGIST, V42, P589, DOI 10.1093/geront/42.5.589; Shaji K S, 2009, Indian J Psychiatry, V51, P45, DOI 10.4103/0019-5545.44905; Shurgot GR, 2005, J GERONTOL B-PSYCHOL, V60, pP331, DOI 10.1093/geronb/60.6.P331; Sink KM, 2005, JAMA-J AM MED ASSOC, V293, P596, DOI 10.1001/jama.293.5.596; Smith M, 2004, J AM GERIATR SOC, V52, P1755, DOI 10.1111/j.1532-5415.2004.52473.x; STULL DE, 1994, GERONTOLOGIST, V34, P88, DOI 10.1093/geront/34.1.88; Tanji H., 2005, GERIATR GERONTOL INT, V5, P94, DOI DOI 10.1111/J.1447-0594.2005.00274.X; Tarlow BJ, 2004, RES AGING, V26, P429, DOI 10.1177/0164027504264493; Torti FM, 2004, ALZ DIS ASSOC DIS, V18, P99, DOI 10.1097/01.wad.0000126902.37908.b2; Tremont G, 2006, DEMENT GERIATR COGN, V21, P170, DOI 10.1159/000090699; Xiao S., 1994, J CLIN PSYCHIAT, V4, P98, DOI DOI 10.1186/S12913-016-1423-5; Yates ME, 1999, J GERONTOL B-PSYCHOL, V54, pP12, DOI 10.1093/geronb/54B.1.P12; Zarit SH, 1998, J GERONTOL B-PSYCHOL, V53, pS267, DOI 10.1093/geronb/53B.5.S267; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	45	46	47	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0132168	10.1371/journal.pone.0132168	http://dx.doi.org/10.1371/journal.pone.0132168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26154626	Green Submitted, Green Published, gold			2022-12-27	WOS:000358159700090
J	Zhao, BW; Chen, YM; Jiang, SS; Chen, YB; Zhou, ZW; Li, YF				Zhao, Bai-Wei; Chen, Yong-Ming; Jiang, Shan-Shan; Chen, Yin-Bo; Zhou, Zhi-Wei; Li, Yuan-Fang			Lymph Node Metastasis, a Unique Independent Prognostic Factor in Early Gastric Cancer	PLOS ONE			English	Article							DISTAL GASTRECTOMY; PREDICTIVE FACTORS; DISSECTION; RECURRENCE; RESECTION; INVASION	Background Lymph node metastasis (LNM) has been shown to be related to the prognosis of early gastric cancer (EGC). The choice of optimal treatment depends on an accurate pre-operative assessment of LNM status in EGC patients. However, in China, where EGC cases account for only a small part of gastric cancer (GC) cases, there are not enough data to make an accurate assessment. Therefore, this study, which involved a relatively large number of EGC patients, aimed to explore the relationship between clinicopathological characteristics and LNM in EGC. Methods Clinicopathological data from 205 EGC patients who underwent surgical resection at Sun Yat-Sen University Cancer Center from January 2000 to December 2011 were retrospectively analyzed. Clinicopathological characteristics were assessed to identify effective predictive factors for LNM and overall survival. Results LNM occurred in 52 (25.37%) EGC cases; of these cases, 18 occurred in intra-mucosal cancers (13 N1, 4 N2 and 1 N3), and 34 occurred in sub-mucosal cancers (22 N1, 7 N2 and 5 N3). Logistic regression analysis demonstrated that tumor differentiation (P=0.002), depth of tumor infiltration (P=0.004), vessel invasion (P=0.012), tumor size (P=0.020) and gender (P=0.022) were risk factors associated with LNM in EGC, listed in order of priority. The overall survival rate was 90.2%. Kaplan-Meier survival analysis showed that overall survival of EGC patients was significantly correlated with LNM (P=0.001), N staging (P<0.001) and invasion of lymphatic or blood vessels (P=0.010), but it was not correlated with tumor size, depth of tumor infiltration or tumor cell differentiation. Moreover, a multiple Cox regression analysis demonstrated that only N staging (P=0.001) could serve as an independent prognostic predictor in EGC patients. Conclusions Because LNM independently predicts the prognosis of EGC, endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) and laparoscopic partial gastrectomy should be cautiously used in high-risk EGC patients. A pre-operative assessment of LNM status based on clinicopathological factors may be useful for therapy planning.	[Zhao, Bai-Wei; Chen, Yong-Ming; Jiang, Shan-Shan; Chen, Yin-Bo; Zhou, Zhi-Wei; Li, Yuan-Fang] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China; [Zhao, Bai-Wei; Chen, Yong-Ming; Chen, Yin-Bo; Zhou, Zhi-Wei; Li, Yuan-Fang] Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510060, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Li, YF (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China.	liyuanf@sysucc.org.cn	Li, Yuan/GXV-1310-2022; Chen, Yongming/E-3656-2015	Chen, Yongming/0000-0003-2843-5543				Adachi Y, 2002, DIGEST SURG, V19, P333, DOI 10.1159/000065829; Du XH, 2009, CHINESE MED J-PEKING, V122, P1404, DOI 10.3760/cma.j.issn.0366-6999.2009.12.009; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jung HY, 2012, DIGEST ENDOSC, V24, P159, DOI 10.1111/j.1443-1661.2012.01275.x; Kikuchi S, 2000, ANTICANCER RES, V20, P3695; Kim H, 2011, ONCOL REP, V25, P1589, DOI 10.3892/or.2011.1242; Kwee RM, 2008, GASTRIC CANCER, V11, P134, DOI 10.1007/s10120-008-0476-5; Li H, 2008, WORLD J GASTROENTERO, V14, P4222, DOI 10.3748/wjg.14.4222; Milhomem LM, 2012, ABCD-ARQ BRAS CIR DI, V25, P235, DOI 10.1590/S0102-67202012000400005; Namieno T, 1996, WORLD J SURG, V20, P996; Narumiya K, 2011, ANN SURG, V253, P840, DOI [10.1097/10.1097/SLA.0b013e318211d91b, 10.1097/SLA.0b013e318211d91b]; Nonaka S, 2011, GASTRIC CANCER, V14, P56, DOI 10.1007/s10120-011-0008-6; Park IS, 2000, YONSEI MED J, V41, P607, DOI 10.3349/ymj.2000.41.5.607; Park YD, 2008, ENDOSCOPY, V40, P7, DOI 10.1055/s-2007-966750; Saka M, 2008, GASTRIC CANCER, V11, P214, DOI 10.1007/s10120-008-0485-4; SANO T, 1993, CANCER, V72, P3174, DOI 10.1002/1097-0142(19931201)72:11<3174::AID-CNCR2820721107>3.0.CO;2-H; Suzuki H, 2013, ENDOSCOPY, V45, P93, DOI 10.1055/s-0032-1325929; Tamura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049251; Wang Li, 2013, Zhonghua Wei Chang Wai Ke Za Zhi, V16, P147; Yasuda K, 1999, CANCER, V85, P2119, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2119::AID-CNCR4>3.0.CO;2-M; Zeng YK, 2012, ANN SURG, V256, P39, DOI 10.1097/SLA.0b013e3182583e2e; Zilberstein B, 2012, ABCD-ARQ BRAS CIR DI, V25, P161, DOI 10.1590/S0102-67202012000300005	22	28	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0129531	10.1371/journal.pone.0129531	http://dx.doi.org/10.1371/journal.pone.0129531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154617	Green Submitted, gold, Green Published			2022-12-27	WOS:000358159700013
J	Muhanna, N; Amer, J; Salhab, A; Sichel, JY; Safadi, R				Muhanna, Nidal; Amer, Johnny; Salhab, Ahmad; Sichel, Jean-Yves; Safadi, Rifaat			The Immune Interplay between Thyroid Papillary Carcinoma and Hepatic Fibrosis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NATURAL-KILLER-CELL; LYMPH-NODE METASTASIS; C-VIRUS-INFECTION; MIXED CRYOGLOBULINEMIA; INCREASED EXPRESSION; LIVER FIBROSIS; STELLATE CELLS; CANCER-CELLS; NK CELLS	Background A high prevalence of thyroid papillary cancer was reported in hepatitis-C-virus (HCV) positive patients. However, the mechanistic role of hepatic-fibrosis in thyroid malignancy progressions is still unclear. Aim We aimed to study the immune-modulatory interactions between thyroid papillary carcinoma and hepatic-fibrosis. Methods Hepatic-fibrosis was induced in nude-nu-male mice by intra-peritoneal administration of carbon-tetrachloride. To induce thyroid-tumor, a thyroid papillary carcinoma cell line (NPA) was injected subcutaneously in the backs. Fibrotic profile was estimated by alpha-smooth-muscle- actin (alpha SMA) expression in liver tissue extracts using western-blots and RT-PCR. Intra-hepatic NK cells were isolated and stained for NK activity (CD107a) by flow cytometry. Liver histopathology (H&E staining), thyroid tumor mass and serum alanine aminotransferase (ALT), serum vascular endothelial growth factor (VEGF) and free-T4 levels were also assessed. Results Ex-vivo: NPA cells were co-cultured with intra-hepatic NK cells isolated from fibrotic mice with/without the tumor were analyzed for CFSE-proliferations. Both tumor groups (with/without hepatic-fibrosis) excreted higher serum free T4 levels. Hepatic-fibrosis increased tumor weight and size and serum free-T4 levels. In addition, tumor induction increased liver injury (both hepatic-fibrosis, necro-inflammation and serum ALT levels). In addition, tumor-bearing animals with hepatic-fibrosis had increased NK activity. NPA tumor-bearing animals increased fibrosis in spite of increased NK activity; probably due to a direct effect through increased serum free-T4 excretions. Serum VEGF levels were significantly increased in the fibrotic-bearing tumor groups compared to the non-fibrotic groups. In-vitro, NK cells from fibrotic tumor-bearing animals reduced proliferation of NPA cells. This decrease is attributed to increase NK cells activity in the fibrotic animals with the NPA tumors. Conclusions Our results propose that NK cells although were stimulated in advanced fibrosis with tumor, they lost their anti-tumor and anti-fibrotic activity probably due to secretions of T4 and VEFG and may explain increased risk of thyroid tumors in chronic HCV patients.	[Muhanna, Nidal; Amer, Johnny; Salhab, Ahmad; Safadi, Rifaat] Hadassah Univ Med Ctr, Div Med, Liver & Gastroenterol Units, Jerusalem, Israel; [Muhanna, Nidal; Sichel, Jean-Yves] Shaare Zedek Med Ctr, Dept Otolaryngol Head & Neck Surg, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Amer, J (corresponding author), Hadassah Univ Med Ctr, Div Med, Liver & Gastroenterol Units, Jerusalem, Israel.	johnnyamer@hotmail.com						Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Antonelli A, 2004, QJM-INT J MED, V97, P499, DOI 10.1093/qjmed/hch088; Antonelli A, 1999, JAMA-J AM MED ASSOC, V281, P1588, DOI 10.1001/jama.281.17.1588; Antonelli A, 2002, CLIN EXP RHEUMATOL, V20, P693; Antonelli A, 2007, THYROID, V17, P447, DOI 10.1089/thy.2006.0194; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Briseis A, 2011, THYROID, V21, P1996; Brito JP, 2014, CURR OPIN ENDOCRINOL, V21, P405, DOI 10.1097/MED.0000000000000094; Bruck R, 2007, J GASTROEN HEPATOL, V22, P2189, DOI 10.1111/j.1440-1746.2006.04777.x; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cramer JD, 2010, SURGERY, V148, P1147, DOI 10.1016/j.surg.2010.10.016; Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97; Enewold L, 2009, CANCER EPIDEM BIOMAR, V18, P784, DOI 10.1158/1055-9965.EPI-08-0960; Ferri C, 1997, INT J CANCER, V71, P1113, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1113::AID-IJC31>3.0.CO;2-B; Ferri C, 2004, SEMIN ARTHRITIS RHEU, V33, P355, DOI 10.1016/j.semarthrit.2003.10.001; FERRI C, 1994, BRIT J HAEMATOL, V88, P392, DOI 10.1111/j.1365-2141.1994.tb05036.x; Fiorino S, 2013, J PANCREAS, V14, P603, DOI 10.6092/1590-8577/1948; Foresta C, 2008, J ENDOCRINOL INVEST, V31, P470, DOI 10.1007/BF03346393; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Graubardt N, 2013, HEPATOLOGY, V57, P1969, DOI 10.1002/hep.26008; HOOFNAGLE JH, 1997, HEPATOLOGY S1, V26, P15; Horn-Ross PL, 2011, CANCER EPIDEM BIOMAR, V20, P1751, DOI 10.1158/1055-9965.EPI-11-0381; Kim HJ, 2009, INT J ONCOL, V35, P49, DOI 10.3892/ijo_00000312; Koike K, 2006, THYROID, V16, P333, DOI 10.1089/thy.2006.16.333; Lai CW, 2011, GROWTH FACTORS, V29, P57, DOI 10.3109/08977194.2011.557373; Lubina A, 2006, THYROID, V16, P1033, DOI 10.1089/thy.2006.16.1033; Lutchman G, 2009, CURRENT HEPATITIS RE, V8, P141; Melhem A, 2006, J HEPATOL, V45, P60, DOI 10.1016/j.jhep.2005.12.025; Montella M, 2003, ONCOL REP, V10, P133; Montella M, 2001, LIVER, V21, P335, DOI 10.1034/j.1600-0676.2001.210506.x; Moretta A, 2002, NAT IMMUNOL, V3, P6, DOI 10.1038/ni0102-6; Muhanna N, 2007, CLIN EXP IMMUNOL, V148, P338, DOI 10.1111/j.1365-2249.2007.03353.x; Muhanna N, 2008, HEPATOLOGY, V48, P963, DOI 10.1002/hep.22413; Muhanna N, 2011, GUT, V60, P90, DOI 10.1136/gut.2010.211136; Nakamura Y, 2006, J CLIN ENDOCR METAB, V91, P1582, DOI 10.1210/jc.2005-1790; Oren R, 1996, HEPATOLOGY, V24, P419; Safadi R, 2004, GASTROENTEROLOGY, V127, P870, DOI 10.1053/j.gastro.2004.04.062; Sarlis N J, 2000, Rev Endocr Metab Disord, V1, P183, DOI 10.1023/A:1010079031162; Scarpino S, 2007, J PATHOL, V212, P411, DOI 10.1002/path.2183; Segev DL, 2003, SURG ONCOL, V12, P69, DOI 10.1016/S0960-7404(03)00037-9; Textor S, 2011, CANCER RES, V71, P5998, DOI 10.1158/0008-5472.CAN-10-3211; Tuttle RM, 2002, J CLIN ENDOCR METAB, V87, P1737, DOI 10.1210/jc.87.4.1737; Yasuoka H, 2005, MODERN PATHOL, V18, P1127, DOI 10.1038/modpathol.3800402; Yokoyama WM, 2002, MICROBES INFECT, V4, P1513, DOI 10.1016/S1286-4579(02)00034-5; Yu XM, 2005, CLIN CANCER RES, V11, P8063, DOI 10.1158/1078-0432.CCR-05-0646; Zvibel I, 2010, LAB INVEST, V90, P674, DOI 10.1038/labinvest.2010.48	49	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132463	10.1371/journal.pone.0132463	http://dx.doi.org/10.1371/journal.pone.0132463			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151749	gold, Green Published, Green Submitted			2022-12-27	WOS:000358158900043
J	Slobodkin, A; Gavrilov, S; Ionov, V; Iliyin, V				Slobodkin, Alexander; Gavrilov, Sergey; Ionov, Victor; Iliyin, Vyacheslav			Spore-Forming Thermophilic Bacterium within Artificial Meteorite Survives Entry into the Earth's Atmosphere on FOTON-M4 Satellite Landing Module	PLOS ONE			English	Article							NATURAL TRANSFER; VIABLE MICROBES; SP NOV.; MARS; LITHOPANSPERMIA; SPACE; ALH84001; PLANETS; SEARCH	One of the key conditions of the lithopanspermia hypothesis is that microorganisms situated within meteorites could survive hypervelocity entry from space through the Earth's atmosphere. So far, all experimental proof of this possibility has been based on tests with sounding rockets which do not reach the transit velocities of natural meteorites. We explored the survival of the spore-forming thermophilic anaerobic bacterium, Thermoanaerobacter siderophilus, placed within 1.4-cm thick basalt discs fixed on the exterior of a space capsule (the METEORITE experiment on the FOTON-M4 satellite). After 45 days of orbital flight, the landing module of the space vehicle returned to Earth. The temperature during the atmospheric transit was high enough to melt the surface of basalt. T. siderophilus survived the entry; viable cells were recovered from 4 of 24 wells loaded with this microorganism. The identity of the strain was confirmed by 16S rRNA gene sequence and physiological tests. This is the first report on the survival of a lifeform within an artificial meteorite after entry from space orbit through Earth's atmosphere at a velocity that closely approached the velocities of natural meteorites. The characteristics of the artificial meteorite and the living object applied in this study can serve as positive controls in further experiments on testing of different organisms and conditions of interplanetary transport.	[Slobodkin, Alexander; Gavrilov, Sergey] Russian Acad Sci, Winogradsky Inst Microbiol, Moscow 117312, Russia; [Ionov, Victor; Iliyin, Vyacheslav] Russian Acad Sci, Russian Federat State Res Ctr, Inst Biomed Problems, Moscow 123007, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences	Slobodkin, A (corresponding author), Russian Acad Sci, Winogradsky Inst Microbiol, Prospect 60-Letiya Oktyabrya 7-2, Moscow 117312, Russia.	aslobodkin@hotmail.com			Russian Academy of Sciences program entitled "Evolution of the Organic World and Planetary Processes"	Russian Academy of Sciences program entitled "Evolution of the Organic World and Planetary Processes"	This work was supported by the Russian Academy of Sciences program entitled "Evolution of the Organic World and Planetary Processes."	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BALASHOVA VV, 1979, MICROBIOLOGY+, V48, P635; Benson DA, 1999, NUCLEIC ACIDS RES, V27, P12, DOI 10.1093/nar/27.1.12; Brandstatter F, 2008, PLANET SPACE SCI, V56, P976, DOI 10.1016/j.pss.2007.12.014; Bronshten V. A., 1983, PHYS METEORIC PHENOM; Byrer DE, 2000, ARCH MICROBIOL, V174, P334, DOI 10.1007/s002030000211; Clark BC, 2001, ORIGINS LIFE EVOL B, V31, P185, DOI 10.1023/A:1006757011007; Cockell CS, 2007, ASTROBIOLOGY, V7, P1, DOI 10.1089/ast.2006.0038; de la Torre R, 2010, ICARUS, V208, P735, DOI 10.1016/j.icarus.2010.03.010; Dobretsov Nikolay, 2008, BIOSPHERE ORIGIN EVO; Fajardo-Cavazos P, 2005, ASTROBIOLOGY, V5, P726, DOI 10.1089/ast.2005.5.726; Fajardo-Cavazos P, 2009, ASTROBIOLOGY, V9, P647, DOI 10.1089/ast.2008.0326; Foucher F, 2010, ICARUS, V207, P616, DOI 10.1016/j.icarus.2009.12.014; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Horneck G, 1994, ADV SPACE RES; Horneck G, 2008, ASTROBIOLOGY, V8, P17, DOI 10.1089/ast.2007.0134; Horneck G, 2010, MICROBIOL MOL BIOL R, V74, P121, DOI 10.1128/MMBR.00016-09; Lane D., 1991, NUCL ACID TECHNIQUES, V1991, P115; Lunine JI, 2006, PHILOS T R SOC B, V361, P1721, DOI 10.1098/rstb.2006.1900; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; Mileikowsky C, 2000, ICARUS, V145, P391, DOI 10.1006/icar.1999.6317; Nicholson WL, 2009, TRENDS MICROBIOL, V17, P243, DOI 10.1016/j.tim.2009.03.004; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; O'Sullivan LA, 2015, ISME J, V9, P922, DOI 10.1038/ismej.2014.190; Papike J., 1991, LUNAR SOURCEBOOK USE, P121; Price MC, 2013, ICARUS, V222, P263, DOI 10.1016/j.icarus.2012.10.035; Slobodkin AI, 2014, MICROBIOLOGY+, V83, P169, DOI 10.1134/S0026261714030151; Slobodkin AI, 2012, INT J SYST EVOL MICR, V62, P2565, DOI 10.1099/ijs.0.034397-0; Slobodkin AI, 2005, MICROBIOLOGY+, V74, P501, DOI 10.1007/s11021-005-0096-6; Slobodkin AI, 1999, INT J SYST BACTERIOL, V49, P1471, DOI 10.1099/00207713-49-4-1471; Thiel CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112979; Valtonen M, 2009, ASTROPHYS J, V690, P210, DOI 10.1088/0004-637X/690/1/210; Weiss BP, 2000, SCIENCE, V290, P791, DOI 10.1126/science.290.5492.791; WOLIN EA, 1963, J BIOL CHEM, V238, P2882; Yanai K, 1997, MINERAL J, V19, P65; Zahnle K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004895	37	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132611	10.1371/journal.pone.0132611	http://dx.doi.org/10.1371/journal.pone.0132611			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151136	Green Published, Green Submitted, gold			2022-12-27	WOS:000358158900048
J	Anastasiou, O; Sydor, S; Sowa, JP; Manka, P; Katsounas, A; Syn, WK; Fuhrer, D; Gieseler, RK; Bechmann, LP; Gerken, G; Moeller, LC; Canbay, A				Anastasiou, Olympia; Sydor, Svenja; Sowa, Jan-Peter; Manka, Paul; Katsounas, Antonios; Syn, Wing-Kin; Fuehrer, Dagmar; Gieseler, Robert K.; Bechmann, Lars P.; Gerken, Guido; Moeller, Lars C.; Canbay, Ali			Higher Thyroid-Stimulating Hormone, Triiodothyronine and Thyroxine Values Are Associated with Better Outcome in Acute Liver Failure	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; ISCHEMIA-REPERFUSION; NONTHYROIDAL ILLNESS; BINDING GLOBULIN; SERUM; DISEASE; INJURY; RAT; THYROTROPIN; METABOLISM	Introduction Changes in thyroid hormone levels, mostly as non-thyroidal illness syndrome (NTIS), have been described in many diseases. However, the relationship between acute liver failure (ALF) and thyroid hormone levels has not yet been clarified. The present study evaluates potential correlations of select thyroid functional parameters with ALF. Methods 84 consecutively recruited ALF patients were grouped according to the outcome of ALF (spontaneous recovery: SR; transplantation or death: NSR). TSH, free thyroxine (fT4), free triiodothyronine (fT3), T4, and T3 were determined. Results More than 50% of patients with ALF presented with abnormal thyroid parameters. These patients had greater risk for an adverse outcome than euthyroid patients. SR patients had significantly higher TSH, T4, and T3 concentrations than NSR patients. Albumin concentrations were significantly higher in SR than in NSR. In vitro T3 treatment was not able to rescue primary human hepatocytes from acetaminophen induced changes in mRNA expression. Conclusions In patients with ALF, TSH and total thyroid hormone levels differed significantly between SR patients and NSR patients. This might be related to diminished liver-derived transport proteins, such as albumin, in more severe forms of ALF. Thyroid parameters may serve as additional indicators of ALF severity.	[Anastasiou, Olympia; Sydor, Svenja; Sowa, Jan-Peter; Manka, Paul; Katsounas, Antonios; Gieseler, Robert K.; Bechmann, Lars P.; Gerken, Guido; Canbay, Ali] Univ Duisburg, Univ Hosp, Dept Gastroenterol & Hepatol, D-45122 Essen, Germany; [Manka, Paul; Syn, Wing-Kin] Inst Hepatol, Regenerat & Repair Grp, London WC1E 6HX, England; [Syn, Wing-Kin] Barts Hlth NHS Trust, Liver Unit, London, England; [Fuehrer, Dagmar; Moeller, Lars C.] Univ Duisburg, Univ Hosp, Dept Endocrinol & Metab, D-45122 Essen, Germany; [Gieseler, Robert K.] Rodos BioTarget GmbH, D-30625 Hannover, Germany	University of Duisburg Essen; University of London; University College London; Barts Health NHS Trust; University of Duisburg Essen	Canbay, A (corresponding author), Univ Duisburg, Univ Hosp, Dept Gastroenterol & Hepatol, D-45122 Essen, Germany.	ali.Canbay@uni-due.de	Manka, Paul/AAN-1261-2021; Bechmann, Lars/AAZ-7141-2020; Manka, Paul/ABH-2421-2020; Syn, Wing-Kin/AAB-8406-2020; Anastasiou, Olympia/AAV-6338-2020; Canbay, Ali/AAL-9620-2020; Sydor, Svenja/AAV-9951-2021; Sydor, Svenja/ABG-6622-2020; Katsounas, Antonios/AAA-7947-2022; Sowa, Jan-Peter/AAQ-6318-2020	Manka, Paul/0000-0001-8589-7280; Sydor, Svenja/0000-0002-1349-8309; Katsounas, Antonios/0000-0002-5179-0327; Canbay, Ali/0000-0001-6069-7899; Moeller, Lars/0000-0002-9330-9036; Sowa, Jan-Peter/0000-0003-2943-0015; Gieseler, Robert/0000-0002-3064-8516; Bechmann, Lars/0000-0003-3487-9810; Anastasiou, Olympia/0000-0003-2178-3182	Deutsche Forschungsgemeinschaft [267/8-1, 267/13-1]; Wilhelm Laupitz Foundation; Rodos BioTarget GmbH	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm Laupitz Foundation; Rodos BioTarget GmbH	This work was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/, grants 267/8-1, 267/13-1) and the Wilhelm Laupitz Foundation (no URL) to A.C. Dr Gieseler is employed by Rodos BioTarget GmbH. Rodos BioTarget GmbH provided support in the form of salary for Dr Gieseler but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section	ATTWOOD EC, 1982, ANN CLIN BIOCHEM, V19, P101, DOI 10.1177/000456328201900207; BACCI V, 1982, J CLIN ENDOCR METAB, V54, P1229, DOI 10.1210/jcem-54-6-1229; Bantel H, 2001, HEPATOLOGY, V34, P758, DOI 10.1053/jhep.2001.28229; Bechmann LP, 2010, J HEPATOL, V53, P639, DOI 10.1016/j.jhep.2010.04.029; BECKER U, 1988, ACTA MED SCAND, V224, P367; Bernal W, 2013, NEW ENGL J MED, V369, P2525, DOI 10.1056/NEJMra1208937; BRENT GA, 1986, AM J MED, V81, P463, DOI 10.1016/0002-9343(86)90300-1; Bruck R, 1998, HEPATOLOGY, V27, P1013, DOI 10.1002/hep.510270417; Canbay A, 2011, DTSCH ARZTEBL INT, V108, P714, DOI 10.3238/arztebl.2011.0714; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; Chi HC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/601361; Mazo DFD, 2013, CLIN EXP GASTROENTER, V6, P9, DOI 10.2147/CEG.S39358; den Brinker M, 2005, J CLIN ENDOCR METAB, V90, P5613, DOI 10.1210/jc.2005-0888; DOCTER R, 1993, CLIN ENDOCRINOL, V39, P499, DOI 10.1111/j.1365-2265.1993.tb02401.x; Fernandez V, 2007, HEPATOLOGY, V45, P170, DOI 10.1002/hep.21476; Friberg L, 2002, ARCH INTERN MED, V162, P1388, DOI 10.1001/archinte.162.12.1388; Gaitan E, 1997, Curr Ther Endocrinol Metab, V6, P94; Gerdes AM, 2010, CIRCULATION, V122, P385, DOI 10.1161/CIRCULATIONAHA.109.917922; HEPNER GW, 1979, ARCH INTERN MED, V139, P1117, DOI 10.1001/archinte.139.10.1117; Iervasi G, 2003, CIRCULATION, V107, P708, DOI 10.1161/01.CIR.0000048124.64204.3F; Imberti R, 1998, ANESTH ANALG, V86, P1187, DOI 10.1097/00000539-199806000-00009; ISRAEL Y, 1979, GASTROENTEROLOGY, V76, P116; KANO T, 1987, Gastroenterologia Japonica, V22, P344; Kibirige D, 2012, THYROID RES, V5, DOI 10.1186/1756-6614-5-6; Kostopanagiotou G, 2009, ENDOCRINE, V36, P198, DOI 10.1007/s12020-009-9210-2; Malik R, 2003, HEPATOLOGY, V37, P79, DOI 10.1053/jhep.2003.50001; Malik R, 2006, DIGEST DIS SCI, V51, P2235, DOI 10.1007/s10620-006-9275-1; Melchert H-U, 2003, SCHILDDRUSENHORMONE; Moeller LC, 2009, THYROID, V19, P639, DOI 10.1089/thy.2008.0293; OREN R, 1995, DIGEST DIS SCI, V40, P1941, DOI 10.1007/BF02208661; Oren R, 1998, J CLIN GASTROENTEROL, V27, P339, DOI 10.1097/00004836-199812000-00012; ORREGO H, 1987, NEW ENGL J MED, V317, P1421, DOI 10.1056/NEJM198712033172301; PAGLIACCI MC, 1989, J ENDOCRINOL INVEST, V12, P149, DOI 10.1007/BF03349947; Papatheodoridis GV, 2010, J CLIN GASTROENTEROL, V44, pE87, DOI 10.1097/MCG.0b013e3181c0945a; Ray DC, 2002, INTENS CARE MED, V28, P1301, DOI 10.1007/s00134-002-1427-y; Redkar Neelam, 2012, J Assoc Physicians India, V60, P70; SHIMADA T, 1988, ENDOCRINOL JAPON, V35, P357; Tapia G, 1997, FREE RADICAL RES, V26, P267, DOI 10.3109/10715769709097805; Tas A, 2012, AM J MED SCI, V344, P175, DOI 10.1097/MAJ.0b013e318239a666; VANTHIEL DH, 1985, HEPATOLOGY, V5, P862, DOI 10.1002/hep.1840050526; Warner MH, 2010, J ENDOCRINOL, V205, P1, DOI 10.1677/JOE-09-0412; Wree A, 2014, METABOLISM, V63, P1542, DOI 10.1016/j.metabol.2014.09.001; Youssef Wael I, 2002, Clin Liver Dis, V6, P879, DOI 10.1016/S1089-3261(02)00049-1	44	11	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132189	10.1371/journal.pone.0132189	http://dx.doi.org/10.1371/journal.pone.0132189			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147961	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600215
J	Chau, PH; Leung, AYM; Li, HLH; Sea, M; Chan, R; Woo, J				Chau, P. H.; Leung, Angela Y. M.; Li, Holly L. H.; Sea, Mandy; Chan, Ruth; Woo, Jean			Development and Validation of Chinese Health Literacy Scale for Low Salt Consumption - Hong Kong Population (CHLSalt-HK)	PLOS ONE			English	Article							REDUCE SALT; KNOWLEDGE	Globally, sodium intake far exceeds the level recommended by the World Health Organization. Assessing health literacy related to salt consumption among older adults could guide the development of interventions that target their knowledge gaps, misconceptions, or poor dietary practices. This study aimed to develop and validate the Chinese Health Literacy Scale for Low Salt Consumption - Hong Kong population (CHLSalt-HK). Based on previous studies on salt intake and nutrition label reading in other countries, we developed similar questions that were appropriate for the Chinese population in Hong Kong. The questions covered the following eight broad areas: functional literacy (term recognition and nutrition label reading), knowledge of the salt content of foods, knowledge of the diseases related to high salt intake, knowledge of international standards, myths about salt intake, attitudes toward salt intake, salty food consumption practices, and nutrition label reading practices. Eight professionals, including doctors, nurses, and dietitians, provided feedback on the scale. The psychometric properties of the scale were assessed based on data collected from a convenience sample of 603 Chinese elderly adults recruited from Elderly Health Centres in Hong Kong. The 49-item CHLSalt-HK had a possible score range of 0 to 98, with a higher score indicating higher health literacy related to salt intake. The CHLSalt-HK had acceptable content validity; the item-level Content Validity Index ranged from 0.857 to 1.000, and the scale-level Content Validity Index was 0.994. Additionally, it had good internal consistency (Cronbach's alpha of 0.799) and good test-retest reliability (intraclass correlation coefficient of 0.846). The mean CHLSalt-HK score among those who were aware of the public education slogan about nutrition labels and sodium intake was higher by 3.928 points (95% confidence interval: 1.742 to 6.115) than that among those who were not aware of the slogan, which supports adequate discriminant validity. The validated CHLSalt-HK had acceptable content validity, acceptable construct validity, good internal consistency, good test-retest reliability, and adequate discriminant validity. The scale could be completed in 10-15 minutes and is easy to administer compared with the collection of biomarkers or food diaries. Further research should investigate its concurrent validity and predictive validity. The development of this scale supports the first step in salt intake reduction among older Chinese adults in Hong Kong by enabling the assessment of their health literacy related to salt consumption in health screenings or health assessments, and it can be used to evaluate salt reduction interventions.	[Chau, P. H.; Leung, Angela Y. M.] Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [Li, Holly L. H.] Dept Hlth, Elderly Hlth Serv, Hong Kong, Hong Kong, Peoples R China; [Sea, Mandy] Chinese Univ Hong Kong, Ctr Nutr Studies, Hong Kong, Hong Kong, Peoples R China; [Chan, Ruth; Woo, Jean] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Chau, PH (corresponding author), Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China.	phchau@graduate.hku.hk	Chan, Ruth/K-4995-2014; Woo, Jean/K-2625-2014; Leung, Angela Yee Man/X-4415-2019; Chau, Pui Hing/A-2290-2010	Woo, Jean/0000-0001-7593-3081; Leung, Angela Yee Man/0000-0002-9836-1925; Chan, Ruth/0000-0002-5725-4066; Chau, Pui Hing/0000-0003-0287-8020				Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Centers for Disease Control and Prevention, 2014, HLTH LITERACY; Chau PH, 2011, CEREBROVASC DIS, V31, P138, DOI 10.1159/000321734; Claro RM, 2012, REV PANAM SALUD PUBL, V32, P265, DOI 10.1590/S1020-49892012001000004; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cutilli CC, 2011, ORTHOP NURS, V30, P281, DOI 10.1097/NOR.0b013e3182247c8f; Department of Health of HKSAR Department of Community Medicine of The University of Hong Kong, 2005, REPORT POPULATION HL; Freedman DA, 2009, AM J PREV MED, V36, P446, DOI 10.1016/j.amepre.2009.02.001; Frisch AL, 2012, HEALTH PROMOT INT, V27, P117, DOI 10.1093/heapro/dar043; He F. J., 2013, BMJ, V346; He FJ, 2010, PROG CARDIOVASC DIS, V52, P363, DOI 10.1016/j.pcad.2009.12.006; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Janus ED, 1997, HONG KONG CARDIOVASC; Jay M, 2009, PREV MED, V48, P25, DOI 10.1016/j.ypmed.2008.10.011; Ji C, 2012, REV PANAM SALUD PUBL, V32, P307, DOI 10.1590/S1020-49892012001000010; Kim MK, 2012, J FOOD SCI, V77, pS307, DOI 10.1111/j.1750-3841.2012.02843.x; Leung AYM, 2013, J HEALTH COMMUN, V18, P205, DOI 10.1080/10810730.2013.829138; Liu ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104018; Moshfegh Alanna J., 2012, Morbidity and Mortality Weekly Report, V61, P92; Ngan MHR, 1996, RES REPORT; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Okuda N, 2014, J HYPERTENS, V32, P2385, DOI 10.1097/HJH.0000000000000341; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Polit DF, 2006, RES NURS HEALTH, V29, P489, DOI 10.1002/nur.20147; Sarmugam R, 2014, PUBLIC HEALTH NUTR, V17, P1061, DOI 10.1017/S1368980013000517; Tavakol M, 2011, INT J MED EDUC, V2, P1, DOI 10.5116/ijme.4d27.32ff; Temple NJ, 2014, NUTRITION, V30, P257, DOI 10.1016/j.nut.2013.06.012; Webster J, 2014, NUTRIENTS, V6, P3274, DOI 10.3390/nu6083274; Woo J, 1998, J EPIDEMIOL COMMUN H, V52, P631, DOI 10.1136/jech.52.10.631	30	18	21	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132303	10.1371/journal.pone.0132303	http://dx.doi.org/10.1371/journal.pone.0132303			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26148008	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600236
J	Cozma, C; Eichler, S; Wittmann, G; Bonet, AF; Kramp, GJ; Giese, AK; Rolfs, A				Cozma, Claudia; Eichler, Sabrina; Wittmann, Gyula; Bonet, Alba Flores; Kramp, Guido Johannes; Giese, Anne-Katrin; Rolfs, Arndt			Diagnosis of Morquio Syndrome in Dried Blood Spots Based on a New MRM-MS Assay	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; LYSOSOMAL STORAGE DISORDERS; N-ACETYLGALACTOSAMINE-6-SULFATE SULFATASE GENE; MUCOPOLYSACCHARIDOSIS IVA MORQUIO; ENZYME ASSAY; IDENTIFICATION; MUTATIONS; SAMPLES; REVEALS; DISEASE	Background Mucopolysaccharidosis IVA (MPS IVA; Morquio A disease) is an autosomal recessive disease caused and characterized by a decreased activity of N-acetylgalactosamine-6-sulfate sulfatase (GALNS), resulting in accumulation of keratan sulfate and chondroitin-6-sulfate in tissues and secondary organ damage. Recently approved enzyme replacement therapy renders the easy and early identification of MPS IVA of out-most importance. Methodology We propose a completely new assay for the stable and reproducible detection of GALNS deficiency in dry blood spots (DBS). For the validation blood samples were taken from 59 healthy individuals and 24 randomly selected genetically confirmed MPS IVA patients. The material extracted from DBS was incubated with a 4-methylumbelliferyl-beta-D-galactopyranoside-6-sulfate as a specific substrate. Final enzymatic product, 4-methylumbelliferone, obtained after adding exogenous beta-galactosidase, was quantified by LC/MRM-MS (liquid-chromatography/multiple-reaction-monitoring mass-spectrometry). 4-propyl-5-hydroxy-7-methyl-2h-chromen-2-one was used as internal standard, a compound with a similar molecular structure and fragmentation pattern in negative ion mode as 4-methylumbelliferone. Findings The enzymatic assay yielded a positive and negative predictive value of 1.0 for genetically confirmed MPS IVA patients (GALNS activity of 0.35 +/- 0.21 mu mol/L/h) and for controls with normal GALNS activity (23.1 +/- 5.3 mu mol/L /h). With present enzymatic conditions, the reaction yield in dried blood spots is at least 20 fold higher than any previously reported data with other assays. Interpretation The present LC/MRM-MS based assay for MPS IVA diagnosis provides an easy, highly-standardized, accurate and innovative quantification of the enzymatic product in vitro and distinguishes perfectly between MPS IVA affected patients and normal controls. This technique will significantly simplify the early detection of MPS IVA patients.	[Cozma, Claudia; Eichler, Sabrina; Wittmann, Gyula; Bonet, Alba Flores; Kramp, Guido Johannes; Rolfs, Arndt] Centogene AG, Rostock, Germany; [Giese, Anne-Katrin; Rolfs, Arndt] Univ Rostock, Albrecht Kossel Inst, D-18055 Rostock, Germany	CENTOGENE AG; University of Rostock	Rolfs, A (corresponding author), Centogene AG, Rostock, Germany.	arndt.rolfs@med.uni-rostock.de		Giese, A.K./0000-0002-8500-2376	Centogene AG, Rostock, Germany	Centogene AG, Rostock, Germany	This study has been financially supported by Centogene AG, Rostock, Germany. The company had a role in this study in study design, data collection and analysis, decision to publish and preparation of the manuscript.	[Anonymous], 2015, CENTOGENES MUT DAT C; Baehner F, 2005, J INHERIT METAB DIS, V28, P1011, DOI 10.1007/s10545-005-0112-z; BOBEY DG, 1981, J CLIN MICROBIOL, V13, P393, DOI 10.1128/JCM.13.2.393-394.1981; Bunge S, 1997, HUM MUTAT, V10, P223; Camelier MV, 2011, CLIN CHIM ACTA, V412, P1805, DOI 10.1016/j.cca.2011.06.001; Chen M, 2012, J CHROMATOGR B, V904, P73, DOI 10.1016/j.jchromb.2012.07.022; Civallero G, 2006, CLIN CHIM ACTA, V372, P98, DOI 10.1016/j.cca.2006.03.029; Fukuda S, 1996, HUM MUTAT, V7, P123, DOI 10.1002/(SICI)1098-1004(1996)7:2<123::AID-HUMU6>3.3.CO;2-V; Khaliq T, 2011, CLIN CHEM, V57, P128, DOI 10.1373/clinchem.2010.149880; Muller KB, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-65; OGAWA T, 1995, HUM MOL GENET, V4, P341, DOI 10.1093/hmg/4.3.341; Prasain JK, 2010, J CHROMATOGR B, V878, P994, DOI 10.1016/j.jchromb.2010.02.032; Reuser AJ, 2011, MOL GENET METAB, V104, P144, DOI 10.1016/j.ymgme.2011.07.014; Rivera-Colon Y, 2012, J MOL BIOL, V423, P736, DOI 10.1016/j.jmb.2012.08.020; Scott CR, 2013, J PEDIATR-US, V163, P498, DOI 10.1016/j.jpeds.2013.01.031; Terzioglu M, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9088; Tomatsu S, 2004, J HUM GENET, V49, P490, DOI 10.1007/s10038-004-0178-8; VANDIGGELEN OP, 1990, CLIN CHIM ACTA, V187, P131, DOI 10.1016/0009-8981(90)90339-T; Wang Z, 2010, J HUM GENET, V55, P534, DOI 10.1038/jhg.2010.65; Wittmann J, 2012, JIMD REP, V6, P117, DOI 10.1007/8904_2012_130; Wood TC, 2013, J INHERIT METAB DIS, V36, P293, DOI 10.1007/s10545-013-9587-1; Zhang XK, 2008, CLIN CHEM, V54, P1725, DOI 10.1373/clinchem.2008.104711; Zheng XG, 2010, J PHARMACEUT BIOMED, V51, P599, DOI 10.1016/j.jpba.2009.09.030	23	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131228	10.1371/journal.pone.0131228	http://dx.doi.org/10.1371/journal.pone.0131228			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147980	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600072
J	Dodson, JA; Wang, Y; Murugiah, K; Dharmarajan, K; Cooper, Z; Hashim, S; Nuti, SV; Spatz, E; Desai, N; Krumholz, HM				Dodson, John A.; Wang, Yun; Murugiah, Karthik; Dharmarajan, Kumar; Cooper, Zack; Hashim, Sabet; Nuti, Sudhakar V.; Spatz, Erica; Desai, Nihar; Krumholz, Harlan M.			National Trends in Hospital Readmission Rates among Medicare Fee-for-Service Survivors of Mitral Valve Surgery, 1999-2010	PLOS ONE			English	Article							30-DAY MORTALITY-RATES; BYPASS GRAFT-SURGERY; HEART-FAILURE; BENEFICIARIES; OUTCOMES; CARE; RACE	Background Older patients who undergo mitral valve surgery (MVS) have high 1-year survival rates, but little is known about the experience of survivors. Our objective was to determine trends in 1-year hospital readmission rates and length of stay (LOS) in these individuals. Methods We included 100% of Medicare Fee-for-Service patients >= 65 years of age who underwent MVS between 1999-2010 and survived to 1 year (N = 146,877). We used proportional hazards regression to analyze the post-MVS 1-year readmission rate in each year, mean hospital LOS (after index admission), and readmission rates by subgroups (age, sex, race). Results The 1-year survival rate among patients undergoing MVS was 81.3%. Among survivors, 49.1% experienced a hospital readmission within 1 year. The post-MVS 1-year readmission rate declined from 1999-2010 (49.5% to 46.9%, P<0.01), and mean hospital LOS decreased from 6.2 to 5.3 (P<0.01). Readmission rates were highest in oldest patients, but declined in all age subgroups (65-74: 47.4% to 44.4%; 75-84: 51.4% to 49.2%, >= 85: 56.4% to 50.0%, all P<0.01). There were declines in women and men (women: 51.7% to 50.8%, P<0.01; men: 46.9% to 43.0%, P<0.01), and in whites and patients of other race, but not in blacks (whites: 49.0% to 46.2%, P<0.01; other: 55.0% to 48.9%, P<0.01; blacks: 58.1% to 59.0%, P = 0.18). Conclusions Among older adults surviving MVS to 1 year, slightly fewer than half experience a hospital readmission. There has been a modest decline in both the readmission rate and LOS over time, with worse outcomes in women and blacks.	[Dodson, John A.] NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol, New York, NY 11201 USA; [Wang, Yun; Murugiah, Karthik; Dharmarajan, Kumar; Nuti, Sudhakar V.; Spatz, Erica; Desai, Nihar; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Wang, Yun] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Dharmarajan, Kumar; Spatz, Erica; Desai, Nihar; Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT USA; [Cooper, Zack; Krumholz, Harlan M.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA; [Hashim, Sabet] Yale Univ, Sch Med, Dept Surg, Sect Cardiac Surg, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, RWJ Clin Scholars Program, New Haven, CT USA	New York University; Yale University; Harvard University; Harvard T.H. Chan School of Public Health; Yale University; Yale University; Yale University; Yale University	Dodson, JA (corresponding author), NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol, New York, NY 11201 USA.	John.Dodson@nyumc.org	, Harlan/AAI-2875-2020	Murugiah, Karthik/0000-0001-7932-382X	NHLBI in Bethesda, Maryland [1U01HL105270-03]; NIH National Institute of Aging (NIA) [R03AG045067]; T. Franklin Williams Scholarship Award (Atlantic Philanthropies, Inc); T. Franklin Williams Scholarship Award (John A. Hartford Foundation); T. Franklin Williams Scholarship Award (Alliance for Academic Internal Medicine); T. Franklin Williams Scholarship Award (American College of Cardiology); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG045067] Funding Source: NIH RePORTER	NHLBI in Bethesda, Maryland; NIH National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); T. Franklin Williams Scholarship Award (Atlantic Philanthropies, Inc); T. Franklin Williams Scholarship Award (John A. Hartford Foundation); T. Franklin Williams Scholarship Award (Alliance for Academic Internal Medicine); T. Franklin Williams Scholarship Award (American College of Cardiology); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported by grant 1U01HL105270-03 from the NHLBI in Bethesda, Maryland. Dr. Dodson is additionally supported the NIH National Institute of Aging (NIA) grant R03AG045067 and a T. Franklin Williams Scholarship Award (funding provided by: Atlantic Philanthropies, Inc, the John A. Hartford Foundation, the Alliance for Academic Internal Medicine-Association of Specialty Professors, and the American College of Cardiology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouza E, 2008, CHEST, V134, P938, DOI 10.1378/chest.08-0103; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Bueno H, 2010, JAMA-J AM MED ASSOC, V303, P2141, DOI 10.1001/jama.2010.748; Chen J, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.06.011; Courtney M, 2009, J AM GERIATR SOC, V57, P395, DOI 10.1111/j.1532-5415.2009.02138.x; Dodson JA, 2012, CIRC-CARDIOVASC QUAL, V5, P298, DOI 10.1161/CIRCOUTCOMES.112.966077; Gammie JS, 2009, ANN THORAC SURG, V87, P1431, DOI 10.1016/j.athoracsur.2009.01.064; Hannan EL, 2011, JACC-CARDIOVASC INTE, V4, P569, DOI 10.1016/j.jcin.2011.01.010; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Kaiser Family Foundation, MEDICARE ADVANTAGE 2; Kassin MT, 2012, J AM COLL SURGEONS, V215, P322, DOI 10.1016/j.jamcollsurg.2012.05.024; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Krumholz HM, 1997, ARCH INTERN MED, V157, P99, DOI 10.1001/archinte.157.1.99; Lee R, 2011, ANN THORAC SURG, V91, P677, DOI 10.1016/j.athoracsur.2010.11.009; NKOMO VT, 2006, LANCET, V368, P1005, DOI DOI 10.1016/S0140-6736(06)69208-8; Philbin EF, 1999, J AM COLL CARDIOL, V33, P1560, DOI 10.1016/S0735-1097(99)00059-5; Swaminathan M, 2009, CIRC-CARDIOVASC QUAL, V2, P305, DOI 10.1161/CIRCOUTCOMES.108.831016; Taylor NE, 2005, CIRCULATION, V111, P1305, DOI 10.1161/01.CIR.0000157737.92938.D8; Walsh EE, 2011, ARCH INTERN MED, V171, P68, DOI 10.1001/archinternmed.2010.326; Williams MV, 2013, JAMA-J AM MED ASSOC, V309, P394, DOI 10.1001/jama.2012.233964; Yeh RW, 2012, CIRC-CARDIOVASC INTE, V5, P227, DOI 10.1161/CIRCINTERVENTIONS.111.967638	24	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132470	10.1371/journal.pone.0132470	http://dx.doi.org/10.1371/journal.pone.0132470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147225	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600278
J	Duwadi, K; Chen, L; Menassa, R; Dhaubhadel, S				Duwadi, Kishor; Chen, Ling; Menassa, Rima; Dhaubhadel, Sangeeta			Identification, Characterization and Down-Regulation of Cysteine Protease Genes in Tobacco for Use in Recombinant Protein Production	PLOS ONE			English	Article							NICOTIANA-TABACUM L.; RNA INTERFERENCE; PHARMACEUTICAL PROTEINS; MONOCLONAL-ANTIBODY; TRANSGENIC TOBACCO; SECRETORY PATHWAY; PLANTS; EXPRESSION; ARABIDOPSIS; INTERLEUKIN-10	Plants are an attractive host system for pharmaceutical protein production. Many therapeutic proteins have been produced and scaled up in plants at a low cost compared to the conventional microbial and animal-based systems. The main technical challenge during this process is to produce sufficient levels of recombinant proteins in plants. Low yield is generally caused by proteolytic degradation during expression and downstream processing of recombinant proteins. The yield of human therapeutic interleukin (IL)-10 produced in transgenic tobacco leaves was found to be below the critical level, and may be due to degradation by tobacco proteases. Here, we identified a total of 60 putative cysteine protease genes (CysP) in tobacco. Based on their predicted expression in leaf tissue, 10 candidate CysPs (CysP1-CysP10) were selected for further characterization. The effect of CysP gene silencing on IL-10 accumulation was examined in tobacco. It was found that the recombinant protein yield in tobacco could be increased by silencing CysP6. Transient expression of CysP6 silencing construct also showed an increase in IL-10 accumulation in comparison to the control. Moreover, CysP6 localizes to the endoplasmic reticulum (ER), suggesting that ER may be the site of IL-10 degradation. Overall results suggest that CysP6 is important in determining the yield of recombinant IL-10 in tobacco leaves.	[Duwadi, Kishor; Menassa, Rima; Dhaubhadel, Sangeeta] Univ Western Ontario, Dept Biol, London, ON, Canada; [Chen, Ling; Menassa, Rima; Dhaubhadel, Sangeeta] Agr & Agri Food Canada, London, ON, Canada	Western University (University of Western Ontario); Agriculture & Agri Food Canada	Dhaubhadel, S (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	sangeeta.dhaubhadel@agr.gc.ca		Menassa, Rima/0000-0003-3536-0332	Agriculture and Agri-Food Canada's Abase [J-000158]	Agriculture and Agri-Food Canada's Abase	Agriculture and Agri-Food Canada's Abase grant number J-000158.	Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; BARTA A, 1986, PLANT MOL BIOL, V6, P347, DOI 10.1007/BF00034942; Bernoux M, 2008, PLANT CELL, V20, P2252, DOI 10.1105/tpc.108.058685; Bertazzon N, 2012, PLANT CELL REP, V31, P133, DOI 10.1007/s00299-011-1147-2; Beyene G, 2006, J EXP BOT, V57, P1431, DOI 10.1093/jxb/erj123; Chen L, 2013, ARABIDOPSIS THALIANA; Conley AJ, 2011, PLANT BIOTECHNOL J, V9, P434, DOI 10.1111/j.1467-7652.2010.00563.x; DENEVE M, 1993, TRANSGENIC RES, V2, P227, DOI 10.1007/BF01977353; Dickinson DP, 2002, CRIT REV ORAL BIOL M, V13, P238, DOI 10.1177/154411130201300304; Doran PM, 2006, TRENDS BIOTECHNOL, V24, P426, DOI 10.1016/j.tibtech.2006.06.012; Faye L, 2005, VACCINE, V23, P1770, DOI 10.1016/j.vaccine.2004.11.003; Fischer R, 2004, CURR OPIN PLANT BIOL, V7, P152, DOI 10.1016/j.pbi.2004.01.007; Fischer R, 2013, CURR PHARM DESIGN, V19, P5471, DOI 10.2174/1381612811319310002; Fischer R, 2012, BIOTECHNOL ADV, V30, P434, DOI 10.1016/j.biotechadv.2011.08.007; GAN SS, 1995, SCIENCE, V270, P1986, DOI 10.1126/science.270.5244.1986; Garcia-Lorenzo M, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-30; Gietl C, 2001, NATURWISSENSCHAFTEN, V88, P49, DOI 10.1007/s001140000203; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Grzonka Z, 2001, ACTA BIOCHIM POL, V48, P1; Gu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032422; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Hehle VK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-128; Ho SL, 2000, PLANT PHYSIOL, V122, P57, DOI 10.1104/pp.122.1.57; KARRER KM, 1993, P NATL ACAD SCI USA, V90, P3063, DOI 10.1073/pnas.90.7.3063; Kerschen A, 2004, FEBS LETT, V566, P223, DOI 10.1016/j.febslet.2004.04.043; Khoudi H, 1999, BIOTECHNOL BIOENG, V64, P135, DOI 10.1002/(SICI)1097-0290(19990720)64:2&lt;135::AID-BIT2&gt;3.0.CO;2-Q; Kim NS, 2008, PLANT MOL BIOL, V68, P263, DOI 10.1007/s11103-008-9367-8; KOIZUMI M, 1993, GENE, V129, P175, DOI 10.1016/0378-1119(93)90266-6; Kolotilin I, 2014, VET RES, V45, P375; Lee S, 2004, PLANT MOL BIOL, V54, P755, DOI 10.1023/B:PLAN.0000040904.15329.29; Leitch IJ, 2008, ANN BOT-LONDON, V101, P805, DOI 10.1093/aob/mcm326; LINTHORST HJM, 1993, PLANT MOL BIOL, V21, P685, DOI 10.1007/BF00014551; Ma JKC, 2003, NAT REV GENET, V4, P794, DOI 10.1038/nrg1177; Matzke AJM, 1998, CURR OPIN PLANT BIOL, V1, P142, DOI 10.1016/S1369-5266(98)80016-2; Menassa R, 2004, J BIOTECHNOL, V108, P179, DOI 10.1016/j.jbiotec.2003.11.009; Menassa R, 2001, MOL BREEDING, V8, P177, DOI 10.1023/A:1013376407362; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Outchkourov NS, 2003, PLANT PHYSIOL, V133, P379, DOI 10.1104/pp.102.017293; Russell DA, 2005, BIOTECHNOL BIOENG, V89, P775, DOI 10.1002/bit.20366; Russell DA, 1999, CURR TOP MICROBIOL, V240, P119; Sack M, 2015, CURR OPIN BIOTECH, V32, P163, DOI 10.1016/j.copbio.2014.12.008; SCHAFFER MA, 1988, PLANT PHYSIOL, V87, P431, DOI 10.1104/pp.87.2.431; Schiermeyer A, 2005, BIOTECHNOL BIOENG, V89, P848, DOI 10.1002/bit.20410; Sharp JM, 2001, BIOTECHNOL BIOENG, V73, P338, DOI 10.1002/bit.1067; Stevens LH, 2000, PLANT PHYSIOL, V124, P173, DOI 10.1104/pp.124.1.173; Stoger E, 2014, ANNU REV PLANT BIOL, V65, P743, DOI 10.1146/annurev-arplant-050213-035850; Tolkatchev D, 2001, J PEPT RES, V57, P227, DOI 10.1046/j.1397-002X.2000.00828.x; Ueda T, 2000, PLANT MOL BIOL, V44, P649, DOI 10.1023/A:1026546004942; VANENGELEN FA, 1994, PLANT MOL BIOL, V26, P1701, DOI 10.1007/BF00019485; Westerhof LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046460; Wiederanders B, 2003, CURR PROTEIN PEPT SC, V4, P309, DOI 10.2174/1389203033487081; Zhang XM, 2009, J EXP BOT, V60, P1569, DOI 10.1093/jxb/erp022; Zhao P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001655	54	30	30	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130556	10.1371/journal.pone.0130556	http://dx.doi.org/10.1371/journal.pone.0130556			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148064	Green Submitted, gold, Green Published			2022-12-27	WOS:000358157600039
J	Ferrarini, A; Xumerle, L; Griggio, F; Garonzi, M; Cantaloni, C; Centomo, C; Vargas, SM; Descombes, P; Marquis, J; Collino, S; Franceschi, C; Garagnani, P; Salisbury, BA; Harvey, JM; Delledonne, M				Ferrarini, Alberto; Xumerle, Luciano; Griggio, Francesca; Garonzi, Marianna; Cantaloni, Chiara; Centomo, Cesare; Vargas, Sergio Marin; Descombes, Patrick; Marquis, Julien; Collino, Sebastiano; Franceschi, Claudio; Garagnani, Paolo; Salisbury, Benjamin A.; Harvey, John Max; Delledonne, Massimo			The Use of Non-Variant Sites to Improve the Clinical Assessment of Whole-Genome Sequence Data	PLOS ONE			English	Article							RARE VARIANTS; GENETIC-VARIATION; WIDE ASSOCIATION; MUTATIONS; DISEASE; COMMON; EXOME; CANCER; SCN10A; SNP	Genetic testing, which is now a routine part of clinical practice and disease management protocols, is often based on the assessment of small panels of variants or genes. On the other hand, continuous improvements in the speed and per-base costs of sequencing have now made whole exome sequencing (WES) and whole genome sequencing (WGS) viable strategies for targeted or complete genetic analysis, respectively. Standard WGS/WES data analytical workflows generally rely on calling of sequence variants respect to the reference genome sequence. However, the reference genome sequence contains a large number of sites represented by rare alleles, by known pathogenic alleles and by alleles strongly associated to disease by GWAS. It's thus critical, for clinical applications of WGS and WES, to interpret whether non-variant sites are homozygous for the reference allele or if the corresponding genotype cannot be reliably called. Here we show that an alternative analytical approach based on the analysis of both variant and non-variant sites from WGS data allows to genotype more than 92% of sites corresponding to known SNPs compared to 6% genotyped by standard variant analysis. These include homozygous reference sites of clinical interest, thus leading to a broad and comprehensive characterization of variation necessary to an accurate evaluation of disease risk. Altogether, our findings indicate that characterization of both variant and non-variant clinically informative sites in the genome is necessary to allow an accurate clinical assessment of a personal genome. Finally, we propose a highly efficient extended VCF (eVCF) file format which allows to store genotype calls for sites of clinical interest while remaining compatible with current variant interpretation software.	[Ferrarini, Alberto; Griggio, Francesca; Garonzi, Marianna; Cantaloni, Chiara; Centomo, Cesare; Vargas, Sergio Marin; Delledonne, Massimo] Univ Verona, Dept Biotechnol, Funct Genom Ctr, I-37134 Verona, Italy; [Xumerle, Luciano; Griggio, Francesca; Cantaloni, Chiara; Franceschi, Claudio; Garagnani, Paolo; Delledonne, Massimo] Personal Genom Srl, I-37134 Verona, Italy; [Descombes, Patrick; Marquis, Julien] Nestle Inst Hlth Sci SA, Funct Genom, CH-1015 Lausanne, Switzerland; [Collino, Sebastiano] Nestle Inst Hlth Sci SA, Mol Biomarkers, CH-1015 Lausanne, Switzerland; [Franceschi, Claudio; Garagnani, Paolo] Univ Bologna, Dept Expt Diagnost & Specialty Med Expt Pathol, I-40126 Bologna, Italy; [Franceschi, Claudio; Garagnani, Paolo] Univ Bologna, Interdept Ctr L Galvani CIG, I-40126 Bologna, Italy; [Franceschi, Claudio] Osped Bellaria, Inst Neurol Sci Bologna, IRCCS, I-40139 Bologna, Italy; [Garagnani, Paolo] St Orsola Malpighi Univ Hosp, Ctr Appl Biomed Res, I-40138 Bologna, Italy; [Salisbury, Benjamin A.; Harvey, John Max] Knome Inc, Waltham, MA 02451 USA	University of Verona; Nestle SA; Nestle SA; University of Bologna; University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); IRCCS Azienda Ospedaliero-Universitaria di Bologna	Delledonne, M (corresponding author), Univ Verona, Dept Biotechnol, Funct Genom Ctr, I-37134 Verona, Italy.	massimo.delledonne@univr.it	Delledonne, Massimo/O-8685-2017; Franceschi, Claudio/L-4484-2017	Franceschi, Claudio/0000-0001-9841-6386; Delledonne, Massimo/0000-0002-7100-4581; Garagnani, Paolo/0000-0002-4161-3626; Xumerle, Luciano/0000-0003-4518-3958	Personal Genomics s.r.l; Nestle Institute of Health Sciences SA; Knome Inc	Personal Genomics s.r.l; Nestle Institute of Health Sciences SA(Nestle SA); Knome Inc	Personal Genomics s.r.l, Nestle Institute of Health Sciences SA, and Knome Inc provided support in the form of salaries for authors FG, CC, PD, JM, SC, CF, PG, BAS, JMH, and MD but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Ajay SS, 2011, GENOME RES, V21, P1498, DOI 10.1101/gr.123638.111; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bakker E, 2006, CLIN CHEM, V52, P557, DOI 10.1373/clinchem.2005.066068; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Bezzina CR, 2013, NAT GENET, V45, P1044, DOI 10.1038/ng.2712; Biliczki P, 2008, HEART RHYTHM, V5, P1159, DOI 10.1016/j.hrthm.2008.04.016; Chambers JC, 2010, NAT GENET, V42, P149, DOI 10.1038/ng.516; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Drilon A, 2013, CANCER DISCOV, V3, P630, DOI 10.1158/2159-8290.CD-13-0035; Easton DF, 2008, HUM MOL GENET, V17, pR109, DOI 10.1093/hmg/ddn287; Fang H, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0089-z; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Grupe A, 2006, AM J HUM GENET, V78, P78, DOI 10.1086/498851; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lee H, 2012, BIOINFORMATICS, V28, P2097, DOI 10.1093/bioinformatics/bts330; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MLJ, 2012, NUCLEIC ACIDS RES, V40, pD1047, DOI 10.1093/nar/gkr1182; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; Pallante BA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P186, DOI 10.1161/CIRCEP.109.928820; Pant S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00078; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Raczy C, 2013, BIOINFORMATICS, V29, P2041, DOI 10.1093/bioinformatics/btt314; Rehm HL, 2013, NAT REV GENET, V14, P295, DOI 10.1038/nrg3463; Richards CS, 2002, GENET MED, V4, P471; Saint Pierre A, 2014, BRIEF FUNCT GENOMICS, V13, P353, DOI 10.1093/bfgp/elu025; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sequeiros J, 2012, J COMMUN GENET, V3, P113, DOI 10.1007/s12687-012-0084-2; Simon R, 2013, NAT REV DRUG DISCOV, V12, P359, DOI 10.1038/nrd3979; Strom CM, 2011, GENET MED, V13, P166, DOI 10.1097/GIM.0b013e3181fa24c4; Subbiah V, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-8; Tester DJ, 2005, HEART RHYTHM, V2, P507, DOI 10.1016/j.hrthm.2005.01.020; Van Limbergen J, 2009, ANNU REV GENOM HUM G, V10, P89, DOI 10.1146/annurev-genom-082908-150013; Veal CD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-455; Verkerk AO, 2012, CIRC RES, V111, P333, DOI 10.1161/CIRCRESAHA.112.274035; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Yang T, 2012, CIRC RES, V111, P322, DOI 10.1161/CIRCRESAHA.112.265173; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835	55	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132180	10.1371/journal.pone.0132180	http://dx.doi.org/10.1371/journal.pone.0132180			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147798	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600213
J	Gupta, R; Sadhale, PP; Vijayraghavan, U				Gupta, Ritu; Sadhale, Parag P.; Vijayraghavan, Usha			SUB1 Plays a Negative Role during Starvation Induced Sporulation Program in Saccharomyces cerevisiae	PLOS ONE			English	Article							RNA-POLYMERASE-II; TRANSCRIPTIONAL REPRESSOR; HISTONE DEACETYLASE; CALORIE RESTRICTION; HUMAN COACTIVATOR; UME6; EXPRESSION; REGULATOR; MEIOSIS; COMPLEX	Saccharomyces cerevisiae Sub1 is involved in several cellular processes such as, transcription initiation, elongation, mRNA processing and DNA repair. It has also been reported to provide cellular resistance during conditions of oxidative DNA damage and osmotic stress. Here, we report a novel role of SUB1 during starvation stress-induced sporulation, which leads to meiosis and spore formation in diploid yeast cells. Deletion of SUB1 gene significantly increased sporulation efficiency as compared to the wild-type cells in S288c genetic background. Whereas, the sporulation functions of the sub1(Y66A) missense mutant were similar to Sub1. SUB1 transcript and protein levels are downregulated during sporulation, in highly synchronized and sporulation proficient wild-type SK1 cells. The changes in Sub1 levels during sporulation cascade correlate with the induction of middle sporulation gene expression. Deletion of SUB1 increased middle sporulation gene transcript levels with no effect on their induction kinetics. In wild-type cells, Sub1 associates with chromatin at these loci in a temporal pattern that correlates with their enhanced gene expression seen in sub1. cells. We show that SUB1 genetically interacts with HOS2, which led us to speculate that Sub1 might function with Set3 repressor complex during sporulation. Positive Cofactor 4, human homolog of Sub1, complemented the sub1. sporulation phenotype, suggesting conservation of function. Taken together, our results suggest that SUB1 acts as a negative regulator of sporulation.	[Gupta, Ritu; Sadhale, Parag P.; Vijayraghavan, Usha] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Vijayraghavan, U (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	uvr@mcbl.iisc.ernet.in		GUPTA, RITU/0000-0002-0563-6599	Council of Scientific and Industrial Research	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was funded by a fellowship from Council of Scientific and Industrial Research to RG. DBT grant-in-aid program funding to Indian Institute of Science provided phosphor imager, real time PCR and other instrumentation facilities for the study.	Ahmed NT, 2009, MOL CELL BIOL, V29, P4352, DOI 10.1128/MCB.00305-09; ANDERSON SF, 1995, PROTEIN SCI, V4, P1832, DOI 10.1002/pro.5560040918; Arevalo-Rodriguez M, 2005, EUKARYOT CELL, V4, P17, DOI 10.1128/EC.4.1.17-29.2005; Beltrao P, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000134; Ben-Ari G, 2006, PLOS GENET, V2, P1815, DOI 10.1371/journal.pgen.0020195; Calvo O, 2005, EMBO J, V24, P1009, DOI 10.1038/sj.emboj.7600575; Calvo O, 2001, MOL CELL, V7, P1013, DOI 10.1016/S1097-2765(01)00236-2; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Cohen TJ, 2008, EUKARYOT CELL, V7, P1191, DOI 10.1128/EC.00059-08; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Corbi D, 2014, MOL CELL BIOL, V34, P2249, DOI 10.1128/MCB.01413-13; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399; ESPOSITO MS, 1969, J BACTERIOL, V100, P180, DOI 10.1128/JB.100.1.180-186.1969; FREESE EB, 1982, J BACTERIOL, V149, P840, DOI 10.1128/JB.149.3.840-851.1982; Frydlova I, 2007, CURR GENET, V52, P87, DOI 10.1007/s00294-007-0141-2; Garcia A, 2012, MOL BIOL CELL, V23, P4297, DOI 10.1091/mbc.E12-04-0331; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Goldmark JP, 2000, CELL, V103, P423, DOI 10.1016/S0092-8674(00)00134-3; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guisbert KSK, 2012, RNA, V18, P1142, DOI 10.1261/rna.030510.111; Harbison CT, 2004, NATURE, V431, P1; Henry NL, 1996, J BIOL CHEM, V271, P21842, DOI 10.1074/jbc.271.36.21842; Hepworth SR, 1998, MOL CELL BIOL, V18, P5750, DOI 10.1128/MCB.18.10.5750; Huang JG, 2012, ACTA CRYSTALLOGR D, V68, P1071, DOI 10.1107/S0907444912019932; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; KASSIR Y, 1991, METHOD ENZYMOL, V194, P94; Knaus R, 1996, EMBO J, V15, P1933, DOI 10.1002/j.1460-2075.1996.tb00544.x; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Koyama H, 2008, GENES CELLS, V13, P1113, DOI 10.1111/j.1365-2443.2008.01229.x; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lindgren A, 2000, EMBO J, V19, P6489, DOI 10.1093/emboj/19.23.6489; Lo HC, 2012, MOL CELL BIOL, V32, P541, DOI 10.1128/MCB.06032-11; Mallory MJ, 2003, J BIOL CHEM, V278, P44727, DOI 10.1074/jbc.M308632200; MITCHELL AP, 1994, MICROBIOL REV, V58, P56, DOI 10.1128/MMBR.58.1.56-70.1994; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; ROMAN H, 1955, GENETICS, V40, P546; Rosonina E, 2009, MOL CELL BIOL, V29, P2308, DOI 10.1128/MCB.01841-08; RubinBejerano I, 1996, MOL CELL BIOL, V16, P2518; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; STRICH R, 1994, GENE DEV, V8, P796, DOI 10.1101/gad.8.7.796; Tavenet A, 2009, P NATL ACAD SCI USA, V106, P14265, DOI 10.1073/pnas.0900162106; Wang JY, 2004, MOL CELL BIOL, V24, P6084, DOI 10.1128/MCB.24.13.6084-6093.2004; Washburn BK, 2001, MOL CELL BIOL, V21, P2057, DOI 10.1128/MCB.21.6.2057-2069.2001; Zheng JS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.77	52	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132350	10.1371/journal.pone.0132350	http://dx.doi.org/10.1371/journal.pone.0132350			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147804	gold, Green Submitted, Green Published			2022-12-27	WOS:000358157600249
J	Lissner, MM; Thomas, BJ; Wee, K; Tong, AJ; Kollmann, TR; Smale, ST				Lissner, Michelle M.; Thomas, Brandon J.; Wee, Kathleen; Tong, Ann-Jay; Kollmann, Tobias R.; Smale, Stephen T.			Age-Related Gene Expression Differences in Monocytes from Human Neonates, Young Adults, and Older Adults	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; DENDRITIC CELLS; RNA-SEQ; RESPONSES; TRANSCRIPTION; IMMUNITY; FETAL; INDUCTION; BINDING; DEFECT	A variety of age-related differences in the innate and adaptive immune systems have been proposed to contribute to the increased susceptibility to infection of human neonates and older adults. The emergence of RNA sequencing (RNA-seq) provides an opportunity to obtain an unbiased, comprehensive, and quantitative view of gene expression differences in defined cell types from different age groups. An examination of ex vivo human monocyte responses to lipopolysaccharide stimulation or Listeria monocytogenes infection by RNA-seq revealed extensive similarities between neonates, young adults, and older adults, with an unexpectedly small number of genes exhibiting statistically significant age-dependent differences. By examining the differentially induced genes in the context of transcription factor binding motifs and RNA-seq data sets from mutant mouse strains, a previously described deficiency in interferon response factor-3 activity could be implicated in most of the differences between newborns and young adults. Contrary to these observations, older adults exhibited elevated expression of inflammatory genes at baseline, yet the responses following stimulation correlated more closely with those observed in younger adults. Notably, major differences in the expression of constitutively expressed genes were not observed, suggesting that the age-related differences are driven by environmental influences rather than cell-autonomous differences in monocyte development.	[Lissner, Michelle M.; Thomas, Brandon J.; Tong, Ann-Jay; Smale, Stephen T.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Wee, Kathleen; Kollmann, Tobias R.] Univ British Columbia, Dept Pediat, Div Infect & Immunol Dis, Vancouver, BC V6T 1W5, Canada	University of California System; University of California Los Angeles; University of British Columbia	Kollmann, TR (corresponding author), Univ British Columbia, Dept Pediat, Div Infect & Immunol Dis, Vancouver, BC V6T 1W5, Canada.	tkollmann@cw.bc.ca; smale@mednet.ucla.edu		Kollmann, Tobias/0000-0003-2403-9762	National Institutes of Health [R01GM086372, P50AR063030, T32GM008042, T32CA009120]; Canadian Institutes of Health Research; Burroughs Wellcome Fund; British Columbia Children's Hospital Foundation; Michael Smith Foundation for Health Research; NATIONAL CANCER INSTITUTE [T32CA009120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR063020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086372, T32GM008042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); British Columbia Children's Hospital Foundation; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by National Institutes of Health (www.nih.gov) grants R01GM086372 (S.T.S.), P50AR063030 (S.T.S.), T32GM008042 (B.J.T.), and T32CA009120 (A.J.T.), and also by grants from the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca) (K.W., T.R.K.), Burroughs Wellcome Fund (www.bwfund.org) (T.R.K.), British Columbia Children's Hospital Foundation (www.bcchf.ca) (T.R.K.), and the Michael Smith Foundation for Health Research (www.msfhr.org) (T.R.K.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy E, 2007, BLOOD, V109, P2887, DOI 10.1182/blood-2006-06-027862; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Corbett NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015041; Danis B, 2008, EUR J IMMUNOL, V38, P507, DOI 10.1002/eji.200737760; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; De Wit D, 2004, BLOOD, V103, P1030, DOI 10.1182/blood-2003-04-1216; De Wit D, 2003, J AUTOIMMUN, V21, P277, DOI 10.1016/j.jaut.2003.08.003; Fortin CF, 2008, REJUV RES, V11, P873, DOI 10.1089/rej.2008.0750; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goriely S, 2001, J IMMUNOL, V166, P2141, DOI 10.4049/jimmunol.166.3.2141; Goriely S, 2004, J EXP MED, V199, P1011, DOI 10.1084/jem.20031272; HALL JM, 1995, BLOOD, V86, P2829; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Kollmann TR, 2013, FEIGIN CHERRYS TXB P, P1329; Krow-Lucal ER, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00314; Krow-Lucal ER, 2014, BLOOD, V123, P1897, DOI 10.1182/blood-2013-11-536094; Lavoie PM, 2010, J INFECT DIS, V202, P1754, DOI 10.1086/657143; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Levy O, 2013, VACCINE, V31, P2500, DOI 10.1016/j.vaccine.2012.10.016; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509; Pettengill M, 2013, J BIOL CHEM, V288, P27315, DOI 10.1074/jbc.M113.484212; Plackett TP, 2004, J LEUKOCYTE BIOL, V76, P291, DOI 10.1189/jlb.1103592; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van Duin D, 2007, J IMMUNOL, V178, P970, DOI 10.4049/jimmunol.178.2.970; Vanden Eijnden S, 2006, EUR J IMMUNOL, V36, P21, DOI 10.1002/eji.200535467; Way SS, 2003, J IMMUNOL, V171, P533, DOI 10.4049/jimmunol.171.2.533; Wilson CB, 2008, NESTLE NUTR WORKS SE, V61, P183, DOI 10.1159/0000113493; Witte CE, 2012, ADV IMMUNOL, V113, P135, DOI 10.1016/B978-0-12-394590-7.00002-6; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464	35	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132061	10.1371/journal.pone.0132061	http://dx.doi.org/10.1371/journal.pone.0132061			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147648	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600193
J	Marcsa, B; Denes, R; Voros, K; Racz, G; Sasvari-Szekely, M; Ronai, Z; Toro, K; Keszler, G				Marcsa, Boglarka; Denes, Reka; Voeroes, Krisztina; Racz, Gergely; Sasvari-Szekely, Maria; Ronai, Zsolt; Toero, Klara; Keszler, Gergely			A Common Polymorphism of the Human Cardiac Sodium Channel Alpha Subunit (SCN5A) Gene Is Associated with Sudden Cardiac Death in Chronic Ischemic Heart Disease	PLOS ONE			English	Article							VENTRICULAR-ARRHYTHMIAS; VARIANTS; PROMOTER; MUTATION; PHENOTYPES; MORTALITY; RISK	Cardiac death remains one of the leading causes of mortality worldwide. Recent research has shed light on pathophysiological mechanisms underlying cardiac death, and several genetic variants in novel candidate genes have been identified as risk factors. However, the vast majority of studies performed so far investigated genetic associations with specific forms of cardiac death only (sudden, arrhythmogenic, ischemic etc.). The aim of the present investigation was to find a genetic marker that can be used as a general, powerful predictor of cardiac death risk. To this end, a case-control association study was performed on a heterogeneous cohort of cardiac death victims (n=360) and age-matched controls (n=300). Five single nucleotide polymorphisms (SNPs) from five candidate genes (beta2 adrenergic receptor, nitric oxide synthase 1 adaptor protein, ryanodine receptor 2, sodium channel type V alpha subunit and transforming growth factor-beta receptor 2) that had previously been shown to associate with certain forms of cardiac death were genotyped using sequence-specific real-time PCR probes. Logistic regression analysis revealed that the CC genotype of the rs11720524 polymorphism in the SCN5A gene encoding a subunit of the cardiac voltage-gated sodium channel occurred more frequently in the highly heterogeneous cardiac death cohort compared to the control population (p=0.019, odds ratio: 1.351). A detailed subgroup analysis uncovered that this effect was due to an association of this variant with cardiac death in chronic ischemic heart disease (p=0.012, odds ratio = 1.455). None of the other investigated polymorphisms showed association with cardiac death in this context. In conclusion, our results shed light on the role of this non-coding polymorphism in cardiac death in ischemic cardiomyopathy. Functional studies are needed to explore the pathophysiological background of this association.	[Marcsa, Boglarka; Denes, Reka; Voeroes, Krisztina; Sasvari-Szekely, Maria; Ronai, Zsolt; Keszler, Gergely] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary; [Toero, Klara] Semmelweis Univ, Dept Forens & Insurance Med, H-1085 Budapest, Hungary; [Racz, Gergely] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary	Semmelweis University; Semmelweis University; Semmelweis University	Keszler, G (corresponding author), Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary.	keszler.gergely@med.semmelweis-univ.hu	Ronai, Zsolt/A-2473-2008	Ronai, Zsolt/0000-0002-0909-7932	Hungarian Scientific Research Fund [OTKA K-83766]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The present study was supported financially by the OTKA K-83766 research grant from the Hungarian Scientific Research Fund (www.otka.hu) (receiving author: Zsolt Ronai). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse AJLHJ, 2007, CIRCULATION, V116, P10, DOI 10.1161/CIRCULATIONAHA.106.676783; Albert CM, 2010, CIRC-ARRHYTHMIA ELEC, V3, P222, DOI 10.1161/CIRCEP.110.944934; Arakawa J, 2014, HEART VESSELS; Baas AF, 2010, EUR J HUM GENET, V18, P240, DOI 10.1038/ejhg.2009.141; Becker ML, 2009, BRIT J CLIN PHARMACO, V67, P61, DOI 10.1111/j.1365-2125.2008.03325.x; Bezzina CR, 2006, CIRCULATION, V113, P338, DOI 10.1161/CIRCULATIONAHA.105.580811; Blayney LM, 2009, PHARMACOL THERAPEUT, V123, P151, DOI 10.1016/j.pharmthera.2009.03.006; Boehringer T, 2014, MOL MED REP, V10, P2039, DOI 10.3892/mmr.2014.2401; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Choi Yu Mi, 2012, Korean J Pediatr, V55, P18, DOI 10.3345/kjp.2012.55.1.18; Cutler MJ, 2011, TRENDS PHARMACOL SCI, V32, P174, DOI 10.1016/j.tips.2010.12.001; Earle N, 2014, HEART RHYTHM, V11, P76, DOI 10.1016/j.hrthm.2013.10.005; Fishman GI, 2010, CIRCULATION, V122, P2335, DOI 10.1161/CIRCULATIONAHA.110.976092; Flevari P, 2012, AM HEART J, V164, P530, DOI 10.1016/j.ahj.2012.07.006; Francia P, 2013, J INTERV CARD ELECTR, V38, P169, DOI 10.1007/s10840-013-9827-1; Gavin MC, 2011, HEART RHYTHM, V8, P704, DOI 10.1016/j.hrthm.2011.01.003; Han PD, 2011, AM J PHYSIOL-HEART C, V301, pH1588, DOI 10.1152/ajpheart.01153.2010; Imamichi Y, 2014, BBA-GENE REGUL MECH, V1839, P33, DOI 10.1016/j.bbagrm.2013.11.005; Israel Carsten W, 2014, Indian Heart J, V66 Suppl 1, pS10, DOI 10.1016/j.ihj.2014.01.005; Jamshidi Y, 2012, J AM COLL CARDIOL, V60, P841, DOI 10.1016/j.jacc.2012.03.031; Kelly BB, 2012, MT SINAI J MED, V79, P632, DOI 10.1002/msj.21345; Klaver EC, 2011, INT J CARDIOL, V152, P162, DOI 10.1016/j.ijcard.2010.12.051; Kolettis TM, 2013, CURR OPIN PHARMACOL, V13, P210, DOI 10.1016/j.coph.2013.01.001; Kotyuk E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080613; Kulminski AM, 2010, REJUV RES, V13, P13, DOI 10.1089/rej.2009.0905; Lakatos K, 2002, MOL PSYCHIATR, V7, P27, DOI 10.1038/sj/mp/4000986; Maekawa K, 2005, ANN HUM GENET, V69, P413, DOI 10.1046/j.1529-8817.2005.00167.x; Miller Dori, 2014, Adv Pharmacol, V70, P367, DOI 10.1016/B978-0-12-417197-8.00012-2; Morita H, 2005, J CLIN INVEST, V115, P518, DOI 10.1172/JCI200524351; Nakajima S, 2013, INTERNAL MED, V52, P1805, DOI 10.2169/internalmedicine.52.0085; Park JK, 2012, HEART RHYTHM, V9, P1090, DOI 10.1016/j.hrthm.2012.02.023; Petersen M, 2011, BRIT J CLIN PHARMACO, V71, P556, DOI 10.1111/j.1365-2125.2010.03868.x; Ran YQ, 2010, CLIN SCI, V119, P215, DOI 10.1042/CS20090656; Schwark T, 2011, INT J LEGAL MED, V125, P891, DOI 10.1007/s00414-010-0537-2; Son MK, 2013, J KOREAN MED SCI, V28, P1021, DOI 10.3346/jkms.2013.28.7.1021; Treuer Adriana V, 2014, Int J Physiol Pathophysiol Pharmacol, V6, P37; Tseng ZH, 2009, HEART RHYTHM, V6, P1745, DOI 10.1016/j.hrthm.2009.08.031; Yang P, 2008, EUR J HUM GENET, V16, P350, DOI 10.1038/sj.ejhg.5201952; Zeng ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078382; Zhang YM, 2014, PEDIATR CARDIOL, V35, P295, DOI 10.1007/s00246-013-0773-6	40	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132137	10.1371/journal.pone.0132137	http://dx.doi.org/10.1371/journal.pone.0132137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146998	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600204
J	Mennitti, LV; Oyama, LM; de Oliveira, JL; Hachul, ACL; Santamarina, AB; de Santana, AA; Okuda, MH; Ribeiro, EB; do Nascimento, CMDO; Pisani, LP				Mennitti, Lais Vales; Oyama, Lila Missae; de Oliveira, Juliana Lopez; Losinskas Hachul, Ana Claudia; Santamarina, Aline Boveto; de Santana, Aline Alves; Okuda, Marcos Hiromu; Ribeiro, Eliane Beraldi; da Penha Oller do Nascimento, Claudia Maria; Pisani, Luciana Pellegrini			Maternal Supplementation with Oligofructose (10%) during Pregnancy and Lactation Leads to Increased Pro-Inflammatory Status of the 21-D-Old Offspring	PLOS ONE			English	Article							HYDROGENATED FAT INTAKE; KAPPA-B PATHWAY; METABOLIC ENDOTOXEMIA; ADIPOSE-TISSUE; GUT MICROBIOTA; HUMAN-MILK; ADIPONECTIN; PREBIOTICS; DISEASE; ACIDS	Previously, we showed that oligofructose (10%) supplementation during pregnancy and lactation increased endotoxemia in 21-d-old pups. The present study evaluated the effect of 10% oligofructose diet supplementation during pregnancy and lactation in the presence or absence of hydrogenated vegetable fat on the pro-inflammatory status of 21-d-old offspring. On the first day of pregnancy, female Wistar rats were divided into the following groups: control diet (C), control diet supplemented with 10% oligofructose (CF), diet enriched with hydrogenated vegetable fat (T) or diet enriched with hydrogenated vegetable fat supplemented with 10% oligofructose (TF). Diets were maintained during pregnancy and lactation. Serum TNF-alpha (tumor necrosis factor alpha) was assessed using a specific kit. Protein expression was determined by Western Blotting, and the relative mRNA levels were analyzed by RTPCR (real-time polymerase chain reaction). We observed that 10% oligofructose supplementation during pregnancy and lactation increased offspring's IL-6R (interleukin-6 receptor) mRNA levels in the liver and RET (retroperitoneal white adipose tissue) and decreased (adiponectin receptor 2) and ADIPOR1 (adiponectin receptor 1) gene expression in liver and EDL (extensor digital longus)/SOL (soleus) muscles of CF group. Additionally, TF group presented with increased serum TNF-alpha, protein expression of p-NF kappa Bp65 (phosphorylated form of nuclear factor kappa B p65 subunit) in liver and IL-6R mRNA levels in RET. These findings were accompanied by decreased levels of ADIPOR1 mRNA in the EDL and SOL muscles of the TF group. In conclusion, supplementing the dam's diet with 10% of oligofructose during pregnancy and lactation, independent of hydrogenated vegetable fat addition, contributes to the increased pro-inflammatory status of 21-d-old offspring, possibly through the activation of the TLR4 (toll like receptor 4) pathway.	[Mennitti, Lais Vales] Univ Fed Sao Paulo, Programa Pos Grad Interdisciplinar Ciencias Saude, Santos, SP, Brazil; [Pisani, Luciana Pellegrini] Univ Fed Sao Paulo, Inst Saude Sociedade, Dept Biociencias, Santos, SP, Brazil; [Oyama, Lila Missae; de Oliveira, Juliana Lopez; Losinskas Hachul, Ana Claudia; Santamarina, Aline Boveto; de Santana, Aline Alves; Okuda, Marcos Hiromu; Ribeiro, Eliane Beraldi; da Penha Oller do Nascimento, Claudia Maria] Univ Fed Sao Paulo, Dept Fisiol, Disciplina Fisiol Nutr, Escola Paulista Med, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Pisani, LP (corresponding author), Univ Fed Sao Paulo, Inst Saude Sociedade, Dept Biociencias, Rua Silva Jardim 136, Santos, SP, Brazil.	lucianapisani@gmail.com	Pisani, Luciana Pellegrini/B-3038-2015; Oyama, Lila M/B-7609-2012; Santamarina, Aline/AAI-7639-2020; Ribeiro, Eliane B/C-8124-2012; Hachul, Ana C. L./N-4082-2017	Ribeiro, Eliane B/0000-0002-3071-9134; Hachul, Ana C. L./0000-0003-4044-9382; Lopez de Oliveira, Juliana/0000-0003-2841-5980; Pisani, Luciana/0000-0001-6579-6167; Mennitti, Lais Vales/0000-0002-9326-7649	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2011/19426-2]; CAPES; CNPq; FAPESP	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, no 2011/19426-2). CAPES and CNPq granted scholarships and FAPESP has financed the research.	Ajuwon KM, 2005, AM J PHYSIOL-REG I, V288, pR1220, DOI 10.1152/ajpregu.00397.2004; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213; Caesar R, 2010, J INTERN MED, V268, P320, DOI 10.1111/j.1365-2796.2010.02270.x; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Champ M, 2009, CURR OPIN CLIN NUTR, V12, P565, DOI 10.1097/MCO.0b013e328331b4aa; Cummings JH, 2002, BRIT J NUTR, V87, pS145, DOI 10.1079/BJN/2002530; Damaskos D, 2008, BRIT J CLIN PHARMACO, V65, P453, DOI 10.1111/j.1365-2125.2008.03096.x; de Oliveira JL, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-22; Dehghan P, 2014, NUTRITION, V30, P418, DOI 10.1016/j.nut.2013.09.005; Fernandez L, 2013, PHARMACOL RES, V69, P1, DOI 10.1016/j.phrs.2012.09.001; Fessler MB, 2009, CURR OPIN LIPIDOL, V20, P379, DOI 10.1097/MOL.0b013e32832fa5c4; Gebauer SK, 2007, LIPIDS, V42, P787, DOI 10.1007/s11745-007-3095-8; Godfrey KM, 2002, PLACENTA, V23, pS20, DOI 10.1053/plac.2002.0773; Godfrey KM, 1998, EUR J OBSTET GYN R B, V78, P141, DOI 10.1016/S0301-2115(98)00060-8; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kelly G, 2008, ALTERN MED REV, V13, P315; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; Leonel AJ, 2012, CURR OPIN CLIN NUTR, V15, P474, DOI 10.1097/MCO.0b013e32835665fa; Lira FS, 2012, CYTOKINE, V57, P98, DOI 10.1016/j.cyto.2011.10.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Hachul ACL, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-59; Macfarlane GT, 2011, J CLIN GASTROENTEROL, V45, pS120, DOI 10.1097/MCG.0b013e31822fecfe; Mennitti LV, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-26; Morley R, 2001, CLIN EXP PHARMACOL P, V28, P962, DOI 10.1046/j.1440-1681.2001.03557.x; Mozaffarian D, 2004, AM J CLIN NUTR, V79, P606, DOI 10.1093/ajcn/79.4.606; Nakamura YK, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-60; Pan XD, 2009, J ZHEJIANG UNIV-SC B, V10, P258, DOI 10.1631/jzus.B0820261; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Pimentel GD, 2012, J NUTR BIOCHEM, V23, P265, DOI 10.1016/j.jnutbio.2010.12.003; Pisani LP, 2008, NUTRITION, V24, P255, DOI 10.1016/j.nut.2007.12.001; Reeves P G, 1997, J Nutr, V127, p838S, DOI 10.1093/jn/127.5.838S; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Roberfroid MB, 1998, ANNU REV NUTR, V18, P117, DOI 10.1146/annurev.nutr.18.1.117; Rudloff S, 2012, ADV NUTR, V3, p398S, DOI 10.3945/an.111.001594; Sauert M, 2015, BIOCHIMIE, V114, P39, DOI 10.1016/j.biochi.2014.12.011; Semova I, 2012, CELL HOST MICROBE, V12, P277, DOI 10.1016/j.chom.2012.08.003; Takeuchi O, 2001, INT IMMUNOPHARMACOL, V1, P625, DOI 10.1016/S1567-5769(01)00010-8; Villarreal-Molina MT, 2012, BIOCHIMIE, V94, P2143, DOI 10.1016/j.biochi.2012.06.030; Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130; Zhou YA, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-2	43	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132038	10.1371/journal.pone.0132038	http://dx.doi.org/10.1371/journal.pone.0132038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147005	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600186
J	Xu, WL; Cardenes, N; Corey, C; Erzurum, SC; Shiva, S				Xu, Weiling; Cardenes, Nayra; Corey, Catherine; Erzurum, Serpil C.; Shiva, Sruti			Platelets from Asthmatic Individuals Show Less Reliance on Glycolysis	PLOS ONE			English	Article							ALLERGIC-ASTHMA; NITRIC-OXIDE; UNCOUPLING PROTEIN-2; PROGENITOR CELLS; MURINE MODEL; P-SELECTIN; MITOCHONDRIAL; ACTIVATION; INFLAMMATION; RECRUITMENT	Asthma, a chronic inflammatory airway disease, is typified by high levels of T(H)2-cytokines and excessive generation of reactive nitrogen and oxygen species, which contribute to bronchial epithelial injury and airway remodeling. While immune function plays a major role in the pathogenesis of the disease, accumulating evidence suggests that altered cellular metabolism is a key determinant in the predisposition and disease progression of asthma. Further, several studies demonstrate altered mitochondrial function in asthmatic airways and suggest that these changes may be systemic. However, it is unknown whether systemic metabolic changes can be detected in circulating cells in asthmatic patients. Platelets are easily accessible blood cells that are known to propagate airway inflammation in asthma. Here we perform a bioenergetic screen of platelets from asthmatic and healthy individuals and demonstrate that asthmatic platelets show a decreased reliance on glycolytic processes and have increased tricarboxylic acid cycle activity. These data demonstrate a systemic alteration in asthma and are consistent with prior reports suggesting that oxidative phosphorylation is more efficient asthmatic individuals. The implications for this potential metabolic shift will be discussed in the context of increased oxidative stress and hypoxic adaptation of asthmatic patients. Further, these data suggest that platelets are potentially a good model for the monitoring of bioenergetic changes in asthma.	[Xu, Weiling] Lerner Res Inst, Cleveland, OH USA; [Cardenes, Nayra; Corey, Catherine] Univ Pittsburgh, Sch Med, Vasc Med Inst, Pittsburgh, PA USA; [Erzurum, Serpil C.] Cleveland Clin, Resp Inst, Lerner Res Inst, Cleveland, OH 44106 USA; [Shiva, Sruti] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Vasc Med Inst,Ctr Metab & Mitochondrial Med, Pittsburgh, PA 15260 USA	Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shiva, S (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Vasc Med Inst,Ctr Metab & Mitochondrial Med, Pittsburgh, PA 15260 USA.	sss43@pitt.edu			National Institutes of Health [HL081064, HL103453]; National Center for Advancing Translational Sciences [UL1TR000439]; Hemophilia Center of Western Pennsylvania; Intsitute for Transfusion Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081064, R24HL123767, P01HL103453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Hemophilia Center of Western Pennsylvania; Intsitute for Transfusion Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (HL081064, HL103453 to SCE), in part by National Center for Advancing Translational Sciences (UL1TR000439 to SCE), the Hemophilia Center of Western Pennsylvania (SS) and the Intsitute for Transfusion Medicine (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKKERMAN JWN, 1978, THROMB HAEMOSTASIS, V39, P712; AKKERMAN JWN, 1978, BIOCHIM BIOPHYS ACTA, V541, P241, DOI 10.1016/0304-4165(78)90397-5; [Anonymous], 2000, Am J Respir Crit Care Med, V162, P2341; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; AVERILL FJ, 1992, AM REV RESPIR DIS, V145, P571, DOI 10.1164/ajrccm/145.3.571; Barnes PJ, 1995, RES IMMUNOL, V146, P698, DOI 10.1016/0923-2494(96)84921-2; Bolanos JP, 2008, BBA-BIOENERGETICS, V1777, P789, DOI 10.1016/j.bbabio.2008.04.011; BOLOGNA E, 1990, Bollettino Societa Italiana Biologia Sperimentale, V66, P343; Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008; Cardenes N, 2014, BLOOD, V123, P2864, DOI 10.1182/blood-2013-09-529420; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Comhair SAA, 2010, ANTIOXID REDOX SIGN, V12, P93, DOI [10.1089/ars.2008.2425, 10.1089/ARS.2008.2425]; Cottrell L, 2011, AM J RESP CRIT CARE, V183, P441, DOI 10.1164/rccm.201004-0603OC; Dixon Anne E, 2010, Proc Am Thorac Soc, V7, P325, DOI 10.1513/pats.200903-013ST; Dudek AZ, 2003, BLOOD, V101, P4687, DOI 10.1182/blood-2002-08-2363; Erzurum SC, 2007, P NATL ACAD SCI USA, V104, P17593, DOI 10.1073/pnas.0707462104; Falkowski PG, 2005, SCIENCE, V309, P2202, DOI 10.1126/science.1116047; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gourgoulianis K, 2001, ARCH MED RES, V32, P429, DOI 10.1016/S0188-4409(01)00302-2; GRESELE P, 1985, LANCET, V1, P347; GRESELE P, 1993, J ALLERGY CLIN IMMUN, V91, P894, DOI 10.1016/0091-6749(93)90347-I; Helenius I, 2000, J ALLERGY CLIN IMMUN, V106, P444, DOI 10.1067/mai.2000.107749; Holguin F, 2011, J ALLERGY CLIN IMMUN, V127, P1486, DOI 10.1016/j.jaci.2011.03.036; Hunt JF, 2002, AM J RESP CRIT CARE, V165, P101, DOI 10.1164/ajrccm.165.1.2104131; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Johansson MW, 2012, AM J RESP CRIT CARE, V185, P498, DOI 10.1164/rccm.201109-1712OC; Johnson JB, 2007, FREE RADICAL BIO MED, V42, P665, DOI 10.1016/j.freeradbiomed.2006.12.005; JOSEPH M, 1983, NATURE, V303, P810, DOI 10.1038/303810a0; JOSEPH M, 1986, EUR J IMMUNOL, V16, P306, DOI 10.1002/eji.1830160318; Jung J, 2013, CLIN EXP ALLERGY, V43, P425, DOI 10.1111/cea.12089; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; KAMEYOSHI Y, 1992, J EXP MED, V176, P587, DOI 10.1084/jem.176.2.587; Klinger MHF, 1997, ANAT EMBRYOL, V196, P1, DOI 10.1007/s004290050075; Kornerup KN, 2010, J APPL PHYSIOL, V109, P758, DOI 10.1152/japplphysiol.01086.2009; Kramer PA, 2014, REDOX BIOL, V2, P206, DOI 10.1016/j.redox.2013.12.026; Mabalirajan U, 2008, J IMMUNOL, V181, P3540, DOI 10.4049/jimmunol.181.5.3540; Mabalirajan U, 2009, J IMMUNOL, V183, P2059, DOI 10.4049/jimmunol.0900342; Matarrese P, 2009, FEBS J, V276, P845, DOI 10.1111/j.1742-4658.2008.06829.x; MCKEEHAN WL, 1982, CELL BIOL INT REP, V6, P635, DOI 10.1016/0309-1651(82)90125-4; Picado C, 1999, ALLERGY, V54, P569, DOI 10.1034/j.1398-9995.1999.00024.x; Pitchford SC, 2006, CLIN EXP ALLERGY, V36, P399, DOI 10.1111/j.1365-2222.2006.02462.x; Pitchford SC, 2005, BLOOD, V105, P2074, DOI 10.1182/blood-2004-06-2282; Pitchford SC, 2008, AM J RESP CRIT CARE, V177, P604, DOI 10.1164/rccm.200702-214OC; Ravi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123597; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shiva S, 2001, P NATL ACAD SCI USA, V98, P7212, DOI 10.1073/pnas.131128898; Sivitz WI, 2009, ANTIOXID REDOX SIGNA; Sullivan PJ, 2000, RESPIRATION, V67, P514, DOI 10.1159/000067466; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Taylor B, 2008, THORAX, V63, P14, DOI 10.1136/thx.2007.082784; Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956; VANLEEUWEN WS, 1924, KLIN WOCHENSCHR, V3, P520; Varady KA, 2007, AM J CLIN NUTR, V86, P7, DOI 10.1093/ajcn/86.1.7; Vargas MH, 1999, J ASTHMA, V36, P511, DOI 10.3109/02770909909054557; Weiler JM, 2000, J ALLERGY CLIN IMMUN, V106, P267, DOI 10.1067/mai.2000.108605; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu WL, 2007, P NATL ACAD SCI USA, V104, P1342, DOI 10.1073/pnas.0605080104; Xu WL, 2003, AM J PHYSIOL-LUNG C, V285, pL137, DOI 10.1152/ajplung.00441.2002; Yamagishi S, 2001, DIABETES, V50, P1491, DOI 10.2337/diabetes.50.6.1491; Zernecke A, 2005, CIRC RES, V96, P784, DOI 10.1161/01.RES.0000162100.52009.38; Zernecke A, 2008, CIRC RES, V102, P209, DOI 10.1161/CIRCRESAHA.107.160697	61	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132007	10.1371/journal.pone.0132007	http://dx.doi.org/10.1371/journal.pone.0132007			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147848	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000358157600178
J	Ozaki, CY; Silveira, CRF; Andrade, FB; Nepomuceno, R; Silva, A; Munhoz, DD; Yamamoto, BB; Luz, D; Abreu, PAE; Horton, DSPQ; Elias, WP; Ramos, OHP; Piazza, RMF				Ozaki, Christiane Y.; Silveira, Caio R. F.; Andrade, Fernanda B.; Nepomuceno, Roberto; Silva, Anderson; Munhoz, Danielle D.; Yamamoto, Bruno B.; Luz, Daniela; Abreu, Patricia A. E.; Horton, Denise S. P. Q.; Elias, Waldir P.; Ramos, Oscar H. P.; Piazza, Roxane M. F.			Single Chain Variable Fragments Produced in Escherichia coli against Heat-Labile and Heat-Stable Toxins from Enterotoxigenic E-coli	PLOS ONE			English	Article							COLONIZATION FACTOR ANTIGENS; HIGH-LEVEL EXPRESSION; ANTIBODY FRAGMENT; PHAGE-DISPLAY; RECOMBINANT ANTIBODIES; PROTEINS; PURIFICATION; ADHERENCE; INTIMIN; CELLS	Background Diarrhea is a prevalent pathological condition frequently associated to the colonization of the small intestine by enterotoxigenic Escherichia coli (ETEC) strains, known to be endemic in developing countries. These strains can produce two enterotoxins associated with the manifestation of clinical symptoms that can be used to detect these pathogens. Although several detection tests have been developed, minimally equipped laboratories are still in need of simple and cost-effective methods. With the aim to contribute to the development of such diagnostic approaches, we describe here two mouse hybridoma-derived single chain fragment variable (scFv) that were produced in E. coli against enterotoxins of ETEC strains. Methods and Findings Recombinant scFv were developed against ETEC heat-labile toxin (LT) and heat-stable toxin (ST), from previously isolated hybridoma clones. This work reports their design, construction, molecular and functional characterization against LT and ST toxins. Both antibody fragments were able to recognize the cell-interacting toxins by immunofluorescence, the purified toxins by ELISA and also LT-, ST-and LT/ST-producing ETEC strains. Conclusion The developed recombinant scFvs against LT and ST constitute promising starting point for simple and cost-effective ETEC diagnosis.	[Ozaki, Christiane Y.; Silveira, Caio R. F.; Andrade, Fernanda B.; Nepomuceno, Roberto; Silva, Anderson; Munhoz, Danielle D.; Yamamoto, Bruno B.; Luz, Daniela; Abreu, Patricia A. E.; Horton, Denise S. P. Q.; Elias, Waldir P.; Piazza, Roxane M. F.] Inst Butantan, Bacteriol Lab, Sao Paulo, SP, Brazil; [Ramos, Oscar H. P.] CEA, iBiTecs, SIMOPRO, Gif Sur Yvette, France	Instituto Butantan; CEA; UDICE-French Research Universities; Universite Paris Saclay	Piazza, RMF (corresponding author), Inst Butantan, Bacteriol Lab, Sao Paulo, SP, Brazil.	roxane@butantan.gov.br	Ramos, Oscar HP/E-1862-2013; Piazza, Roxane MF/A-9915-2018; Elias, Waldir P/B-9890-2013; Piazza, Roxane Maria F/K-9807-2016; Piazza, Roxane/ABD-9196-2020; Munhoz, Danielle/AAB-2587-2022; Abreu, Patricia/C-4682-2012; Luz, Daniela/C-2374-2019	Ramos, Oscar HP/0000-0002-5788-4500; Piazza, Roxane MF/0000-0003-0068-8506; Piazza, Roxane/0000-0003-0068-8506; Munhoz, Danielle/0000-0001-5228-8163; Abreu, Patricia/0000-0002-7541-0341; Silveira, Caio/0000-0001-5778-7789; Elias, Waldir/0000-0003-3470-5706; Ozaki, Christiane Yumi/0000-0001-9234-8378; Luz, Daniela/0000-0001-9622-0320	Sao Paulo Research Foundation (FAPESP) [11/12928-2, 04/08297-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [301302/2013-8]; FAPESP fellowships [06/60258-8, 10/14659-6, 11/24111-0, 11/22108-2]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP fellowships(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by grants 11/12928-2 from Sao Paulo Research Foundation (FAPESP) and from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - 301302/2013-8) to RMFP and by grants 04/08297-3 from Sao Paulo Research Foundation (FAPESP) to OHPR. CYO, CRFS, DDM and FBA were recipients of FAPESP fellowships (06/60258-8, 10/14659-6, 11/24111-0 and 11/22108-2, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad ZA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/980250; Akiyoshi DE, 2010, INFECT IMMUN, V78, P1376, DOI 10.1128/IAI.00867-09; Arakawa T, 2014, ANTIBODIES, V3, P232, DOI 10.3390/antib3020232; Arbabi-Ghahroudi M, 2005, CANCER METAST REV, V24, P501, DOI 10.1007/s10555-005-6193-1; Bowman CC, 2001, INFECT IMMUN, V69, P1528, DOI 10.1128/IAI.69.3.1528-1535.2001; Bu DW, 2013, PROTEIN EXPRES PURIF, V92, P203, DOI 10.1016/j.pep.2013.10.002; Buc E, 2005, EUR J CANCER, V41, P1618, DOI 10.1016/j.ejca.2005.02.031; Caravelli A, 2013, DIAGN MICR INFEC DIS, V77, P301, DOI 10.1016/j.diagmicrobio.2013.08.021; Chung WY, 2008, J IMMUNOL METHODS, V339, P115, DOI 10.1016/j.jim.2008.08.005; Dorsey FC, 2006, CELL MICROBIOL, V8, P1516, DOI 10.1111/j.1462-5822.2006.00736.x; EVANS DJ, 1973, INFECT IMMUN, V8, P322, DOI 10.1128/IAI.8.3.322-328.1973; Golchin M, 2008, VET IMMUNOL IMMUNOP, V121, P321, DOI 10.1016/j.vetimm.2007.10.005; Guion CE, 2008, J CLIN MICROBIOL, V46, P1752, DOI 10.1128/JCM.02341-07; Guo JQ, 2003, J BIOTECHNOL, V102, P177, DOI 10.1016/S0168-1656(03)00020-8; GUTH BEC, 1994, MICROBIOL IMMUNOL, V38, P695, DOI 10.1111/j.1348-0421.1994.tb01844.x; Hill DR, 2010, CURR OPIN INFECT DIS, V23, P481, DOI 10.1097/QCO.0b013e32833dfca5; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Joosten V, 2003, MICROB CELL FACT, V2, DOI 10.1186/1475-2859-2-1; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kortt AA, 1997, PROTEIN ENG, V10, P423, DOI 10.1093/protein/10.4.423; Kramer K, 2002, BIOSENS BIOELECTRON, V17, P305, DOI 10.1016/S0956-5663(01)00292-5; Kuhne SA, 2004, J CLIN MICROBIOL, V42, P2966, DOI 10.1128/JCM.42.7.2966-2976.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamberski JA, 2006, PROTEIN EXPRES PURIF, V47, P82, DOI 10.1016/j.pep.2005.08.024; Leong MK, 2008, MED CHEM, V4, P396, DOI 10.2174/157340608784872226; Luz D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120481; Ma Y, 2008, IMMUNOL LETT, V121, P110, DOI 10.1016/j.imlet.2008.09.008; Martineau P, 1998, J MOL BIOL, V280, P117, DOI 10.1006/jmbi.1998.1840; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Menezes CA, 2006, MEM I OSWALDO CRUZ, V101, P875, DOI 10.1590/S0074-02762006000800009; Menezes Marcio A, 2011, BMC Res Notes, V4, P30, DOI 10.1186/1756-0500-4-30; Mousli M, 2007, J VIROL METHODS, V146, P246, DOI 10.1016/j.jviromet.2007.07.015; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Piazza RMF, 2010, PATHOGENIC ESCHERICH, P95; Pleckaityte M, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-100; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Rocha LB, 2013, TOXINS, V5, P2384, DOI 10.3390/toxins5122384; Rouet R, 2012, NAT PROTOC, V7, P364, DOI 10.1038/nprot.2011.448; Sack D A, 1980, Compr Ther, V6, P50; Sambrook J, 2001, MOL CLONIN; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Song HN, 2014, INT J MOL SCI, V15, P23658, DOI 10.3390/ijms151223658; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tremblay JM, 2013, INFECT IMMUN, V81, P4592, DOI 10.1128/IAI.01033-13; Tsumoto K, 2003, PROTEIN EXPRES PURIF, V28, P1, DOI 10.1016/S1046-5928(02)00641-1; Umetsu M, 2003, J BIOL CHEM, V278, P8979, DOI 10.1074/jbc.M212247200; Weisser NE, 2009, BIOTECHNOL ADV, V27, P502, DOI 10.1016/j.biotechadv.2009.04.004; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569, DOI 10.1128/CMR.10.4.569; World Health Organization, 2013, DIARRHOEA DIS; ZDANOV A, 1994, P NATL ACAD SCI USA, V91, P6423, DOI 10.1073/pnas.91.14.6423; Zhang T, 2010, VACCINE, V28, P3949, DOI 10.1016/j.vaccine.2010.03.045	52	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131484	10.1371/journal.pone.0131484	http://dx.doi.org/10.1371/journal.pone.0131484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154103	Green Submitted, Green Published, gold			2022-12-27	WOS:000358159700068
J	Rocca, CH; Kimport, K; Roberts, SCM; Gould, H; Neuhaus, J; Foster, DG				Rocca, Corinne H.; Kimport, Katrina; Roberts, Sarah C. M.; Gould, Heather; Neuhaus, John; Foster, Diana G.			Decision Rightness and Emotional Responses to Abortion in the United States: A Longitudinal Study	PLOS ONE			English	Article							PSYCHOLOGICAL RESPONSES; WOMEN; PARTICIPATION	Background Arguments that abortion causes women emotional harm are used to regulate abortion, particularly later procedures, in the United States. However, existing research is inconclusive. We examined women's emotions and reports of whether the abortion decision was the right one for them over the three years after having an induced abortion. Methods We recruited a cohort of women seeking abortions between 2008-2010 at 30 facilities across the United States, selected based on having the latest gestational age limit within 150 miles. Two groups of women (n=667) were followed prospectively for three years: women having first-trimester procedures and women terminating pregnancies within two weeks under facilities' gestational age limits at the same facilities. Participants completed semiannual phone surveys to assess whether they felt that having the abortion was the right decision for them; negative emotions (regret, anger, guilt, sadness) about the abortion; and positive emotions (relief, happiness). Multivariable mixed-effects models were used to examine changes in each outcome over time, to compare the two groups, and to identify associated factors. Results The predicted probability of reporting that abortion was the right decision was over 99% at all time points over three years. Women with more planned pregnancies and who had more difficulty deciding to terminate the pregnancy had lower odds of reporting the abortion was the right decision (aOR=0.71 [0.60, 0.85] and 0.46 [0.36, 0.64], respectively). Both negative and positive emotions declined over time, with no differences between women having procedures near gestational age limits versus first-trimester abortions. Higher perceived community abortion stigma and lower social support were associated with more negative emotions (b=0.45 [0.31, 0.58] and b=-0.61 [-0.93, -0.29], respectively). Conclusions Women experienced decreasing emotional intensity over time, and the overwhelming majority of women felt that termination was the right decision for them over three years. Emotional support may be beneficial for women having abortions who report intended pregnancies or difficulty deciding.	[Rocca, Corinne H.; Kimport, Katrina; Roberts, Sarah C. M.; Gould, Heather; Foster, Diana G.] Univ Calif San Francisco, Sch Med, Bixby Ctr Global Reprod Hlth, Adv Stand Reprod Hlth ANSIRH,Dept Obstet Gynecol, San Francisco, CA 94143 USA; [Neuhaus, John] Univ Calif San Francisco, Dept Epidemiol & Biostat, Div Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rocca, CH (corresponding author), Univ Calif San Francisco, Sch Med, Bixby Ctr Global Reprod Hlth, Adv Stand Reprod Hlth ANSIRH,Dept Obstet Gynecol, San Francisco, CA 94143 USA.	roccac@obgyn.ucsf.edu			Wallace Alexander Gerbode Foundation; David and Lucile Packard Foundation	Wallace Alexander Gerbode Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This study was supported by a gift from the Wallace Alexander Gerbode Foundation (http://foundationcenter.org/grantmaker/gerbode/, to DGF), a research grant from an anonymous foundation (to DGF), and an institutional grant from the David and Lucile Packard Foundation (http://www.packard.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Academy of Medical Royal Colleges, 2011, INDUCED ABORTION MEN; ADLER NE, 1990, SCIENCE, V248, P41, DOI 10.1126/science.2181664; ADLER NE, 1975, AM J ORTHOPSYCHIAT, V45, P446, DOI 10.1111/j.1939-0025.1975.tb02555.x; American Psychological Association, 2008, REP TASK FORC MENT H, DOI [10.1037/a0017497, DOI 10.1037/A0017497]; Barrett G, 2004, J EPIDEMIOL COMMUN H, V58, P426, DOI 10.1136/jech.2003.014787; Biggs MA, 2014, QUAL LIFE RES, V23, P2505, DOI 10.1007/s11136-014-0687-7; Biggs MA, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-29; Broen AN, 2004, PSYCHOSOM MED, V66, P265, DOI 10.1097/01.psy.0000118028.32507.9d; Broen AN, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-18; Dobkin LM, 2014, WOMEN HEALTH ISS, V24, pE115, DOI 10.1016/j.whi.2013.10.004; Fernandes-Taylor S, 2011, PSYCHO-ONCOLOGY, V20, P506, DOI 10.1002/pon.1749; Finer LB, 2011, CONTRACEPTION, V84, P478, DOI 10.1016/j.contraception.2011.07.013; Foster DG, 2015, PSYCHOL MED, V45, P2073, DOI 10.1017/S0033291714003213; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Gould H, 2012, WOMEN HEALTH ISS, V22, pE359, DOI 10.1016/j.whi.2012.04.003; Harris LF, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-76; Hillis SD, 1999, OBSTET GYNECOL, V93, P889, DOI 10.1016/S0029-7844(98)00539-0; Kero A, 2004, SOC SCI MED, V58, P2559, DOI 10.1016/j.socscimed.2003.09.004; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Keys J, 2010, SYMB INTERACT, V33, P41, DOI 10.1525/si.2010.33.1.41; Kimport K, 2012, SYMB INTERACT, V35, P105, DOI 10.1002/symb.11; Kimport K, 2011, PERSPECT SEX REPRO H, V43, P103, DOI 10.1363/4310311; LAZARUS A, 1985, Journal of Psychosomatic Obstetrics and Gynecology, V4, P141, DOI 10.3109/01674828509019579; Major B, 2000, ARCH GEN PSYCHIAT, V57, P777, DOI 10.1001/archpsyc.57.8.777; Morton LM, 2006, AM J EPIDEMIOL, V163, P197, DOI 10.1093/aje/kwj036; Paul M, 2009, MANAGEMENT UNINTENDE; Pazol Karen, 2009, Morbidity and Mortality Weekly Report, V58, P1; Rabe-Hesketh S., 2007, HDB STAT ANAL USING, V4th ed.; Rabe-Hesketh S.S.A., 2005, MULTILEVEL LONGITUDI; Raiten JM, 2012, NEW ENGL J MED, V367, P1779, DOI 10.1056/NEJMp1209698; Roberts SCM, 2015, MATERN CHILD HLTH J, V19, P438, DOI 10.1007/s10995-014-1515-y; Roberts SCM, 2014, DRUG ALCOHOL DEPEN, V134, P63, DOI 10.1016/j.drugalcdep.2013.09.013; Rocca CH, 2013, PERSPECT SEX REPRO H, V45, P122, DOI 10.1363/4512213; Siegel RB, 2008, DUKE LAW J, V57, P1641; SMITH EM, 1973, AM J ORTHOPSYCHIAT, V43, P574, DOI 10.1111/j.1939-0025.1973.tb00826.x; Soderberg H, 1998, EUR J OBSTET GYN R B, V79, P173, DOI 10.1016/S0301-2115(98)00084-0; Watson K, 2014, JAMA-J AM MED ASSOC, V311, P27, DOI 10.1001/jama.2013.283739; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	38	71	71	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0128832	10.1371/journal.pone.0128832	http://dx.doi.org/10.1371/journal.pone.0128832			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26154386	Green Published, Green Submitted, gold			2022-12-27	WOS:000358159700010
J	Aurelius, O; Johansson, R; Bagenholm, V; Lundin, D; Tholander, F; Balhuizen, A; Beck, T; Sahlin, M; Sjoberg, BM; Mulliez, E; Logan, DT				Aurelius, Oskar; Johansson, Renzo; Bagenholm, Viktoria; Lundin, Daniel; Tholander, Fredrik; Balhuizen, Alexander; Beck, Tobias; Sahlin, Margareta; Sjoberg, Britt-Marie; Mulliez, Etienne; Logan, Derek T.			The Crystal Structure of Thermotoga maritima Class III Ribonucleotide Reductase Lacks a Radical Cysteine Pre-Positioned in the Active Site	PLOS ONE			English	Article							PYRUVATE FORMATE-LYASE; SUBSTRATE-SPECIFICITY REGULATION; IRON-SULFUR CENTER; ESCHERICHIA-COLI; DIPHOSPHATE REDUCTASE; ALLOSTERIC REGULATION; LACTOCOCCUS-LACTIS; REACTION-MECHANISM; ACTIVATING ENZYME; PROTEIN R1	Ribonucleotide reductases (RNRs) catalyze the reduction of ribonucleotides to deoxyribonucleotides, the building blocks for DNA synthesis, and are found in all but a few organisms. RNRs use radical chemistry to catalyze the reduction reaction. Despite RNR having evolved several mechanisms for generation of different kinds of essential radicals across a large evolutionary time frame, this initial radical is normally always channelled to a strictly conserved cysteine residue directly adjacent to the substrate for initiation of substrate reduction, and this cysteine has been found in the structures of all RNRs solved to date. We present the crystal structure of an anaerobic RNR from the extreme thermophile Thermotoga maritima (tmNrdD), alone and in several complexes, including with the allosteric effector dATP and its cognate substrate CTP. In the crystal structure of the enzyme as purified, tmNrdD lacks a cysteine for radical transfer to the substrate pre-positioned in the active site. Nevertheless activity assays using anaerobic cell extracts from T. maritima demonstrate that the class III RNR is enzymatically active. Other genetic and microbiological evidence is summarized indicating that the enzyme is important for T. maritima. Mutation of either of two cysteine residues in a disordered loop far from the active site results in inactive enzyme. We discuss the possible mechanisms for radical initiation of substrate reduction given the collected evidence from the crystal structure, our activity assays and other published work. Taken together, the results suggest either that initiation of substrate reduction may involve unprecedented conformational changes in the enzyme to bring one of these cysteine residues to the expected position, or that alternative routes for initiation of the RNR reduction reaction may exist. Finally, we present a phylogenetic analysis showing that the structure of tmNrdD is representative of a new RNR subclass IIIh, present in all Thermotoga species plus a wider group of bacteria from the distantly related phyla Firmicutes, Bacteroidetes and Proteobacteria.	[Aurelius, Oskar; Johansson, Renzo; Bagenholm, Viktoria; Balhuizen, Alexander; Logan, Derek T.] Lund Univ, Dept Biochem & Struct Biol, S-22100 Lund, Sweden; [Lundin, Daniel; Sahlin, Margareta; Sjoberg, Britt-Marie] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Tholander, Fredrik] Karolinska Inst, Dept Med Biochem & Biophys, Solna, Sweden; [Beck, Tobias] Univ Gottingen, Dept Inorgan Chem, D-37073 Gottingen, Germany; [Mulliez, Etienne] CEA Grenoble, Inst Rech Technol & Sci Vivant iRTSV, Grp Biocatalyse, LCBM, F-38054 Grenoble 09, France	Lund University; Stockholm University; Karolinska Institutet; University of Gottingen; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Aurelius, O (corresponding author), Lund Univ, Dept Biochem & Struct Biol, Box 124, S-22100 Lund, Sweden.	derek.logan@biochemistry.lu.se	Beck, Tobias/K-3738-2014; Logan, Derek T/A-1114-2011; Logan, Derek/O-2497-2019	Beck, Tobias/0000-0001-7398-3982; Logan, Derek T/0000-0002-0098-8560; Logan, Derek/0000-0002-0098-8560; Balhuizen, Alexander/0000-0001-7581-121X; Lundin, Daniel/0000-0002-8779-6464; Sjoberg, Britt-Marie/0000-0001-5953-3360	Swedish Research Council [2011-5770, 2013-2978]; Carl Trygger Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Trygger Foundation	The work was funded by grants from the Swedish Research Council (www.vr.se) to DTL (2011-5770) and BMS (2013-2978), as well the Carl Trygger Foundation (www.carltryggersstiftelse.se) to BMS.	ABERG A, 1989, J BIOL CHEM, V264, P12249; Ahmad MF, 2012, J MOL BIOL, V419, P315, DOI 10.1016/j.jmb.2012.03.014; Andersson J, 2001, J BIOL CHEM, V276, P40457, DOI 10.1074/jbc.M106863200; Becker A, 2002, J BIOL CHEM, V277, P40036, DOI 10.1074/jbc.M205821200; Becker A, 1999, NAT STRUCT BIOL, V6, P969; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; Eriksson M, 1997, STRUCTURE, V5, P1077, DOI 10.1016/S0969-2126(97)00259-1; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; Funk MA, 2014, P NATL ACAD SCI USA, V111, P10161, DOI 10.1073/pnas.1405983111; Himo F, 2000, CHEM PHYS LETT, V328, P270, DOI 10.1016/S0009-2614(00)00932-5; Hioe J, 2011, CHEM-EUR J, V17, P3781, DOI 10.1002/chem.201002620; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880; Johansson R, 2010, FEBS J, V277, P4265, DOI 10.1111/j.1742-4658.2010.07815.x; Johnson MR, 2006, APPL ENVIRON MICROB, V72, P811, DOI 10.1128/AEM.72.1.811-818.2006; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Larsson KM, 2010, ACS CHEM BIOL, V5, P933, DOI 10.1021/cb1000845; Larsson KM, 2004, NAT STRUCT MOL BIOL, V11, P1142, DOI 10.1038/nsmb838; Larsson KM, 2001, STRUCTURE, V9, P739, DOI 10.1016/S0969-2126(01)00627-X; Latif H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003485; Logan DT, 2003, P NATL ACAD SCI USA, V100, P3826, DOI 10.1073/pnas.0736456100; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; Logan DT, 2008, RIBONUCLEOTIDE REDUC, P185; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; Luttringer F, 2009, J BIOL INORG CHEM, V14, P923, DOI 10.1007/s00775-009-0505-9; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9733, DOI 10.1021/bi00155a029; Martins BM, 2011, J AM CHEM SOC, V133, P14666, DOI 10.1021/ja203344x; Montero CI, 2007, APPL ENVIRON MICROB, V73, P5058, DOI 10.1128/AEM.00453-07; MULLIEZ E, 1995, P NATL ACAD SCI USA, V92, P8759, DOI 10.1073/pnas.92.19.8759; MULLIEZ E, 1993, J BIOL CHEM, V268, P2296; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pD111, DOI 10.1093/nar/gkp894; Nurizzo D, 2006, J SYNCHROTRON RADIAT, V13, P227, DOI 10.1107/S0909049506004341; O'Brien JR, 2004, BIOCHEMISTRY-US, V43, P4635, DOI 10.1021/bi035930k; Ollagnier S, 1997, J BIOL CHEM, V272, P24216, DOI 10.1074/jbc.272.39.24216; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; PETERSSON L, 1980, J BIOL CHEM, V255, P6706; Pieper U, 2014, NUCLEIC ACIDS RES, V42, pD336, DOI 10.1093/nar/gkt1144; Sintchak MD, 2002, NAT STRUCT BIOL, V9, P293, DOI 10.1038/nsb774; STUBBE J, 1983, J BIOL CHEM, V258, P1625; Sun XY, 1996, J BIOL CHEM, V271, P6827, DOI 10.1074/jbc.271.12.6827; SUN XY, 1995, J BIOL CHEM, V270, P2443, DOI 10.1074/jbc.270.6.2443; TAMAO Y, 1973, BIOCHEMISTRY-US, V12, P24, DOI 10.1021/bi00725a005; THELANDER L, 1974, J BIOL CHEM, V249, P4858; Torrents E, 2000, J BIOL CHEM, V275, P2463, DOI 10.1074/jbc.275.4.2463; Torrents E, 2001, J BIOL CHEM, V276, P33488, DOI 10.1074/jbc.M103743200; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; Uppsten M, 2003, J MOL BIOL, V330, P87, DOI 10.1016/S0022-2836(03)00538-2; Ursby T, 2013, J SYNCHROTRON RADIAT, V20, P648, DOI 10.1107/S0909049513011734; Vey JL, 2008, P NATL ACAD SCI USA, V105, P16137, DOI 10.1073/pnas.0806640105; WAGNER AFV, 1992, P NATL ACAD SCI USA, V89, P996, DOI 10.1073/pnas.89.3.996; Wei YF, 2014, P NATL ACAD SCI USA, V111, pE3756, DOI 10.1073/pnas.1414396111; Wei YF, 2014, J AM CHEM SOC, V136, P9001, DOI 10.1021/ja5030194; Xu H, 2006, P NATL ACAD SCI USA, V103, P4022, DOI 10.1073/pnas.0600443103; Young P, 1996, J BIOL CHEM, V271, P20770, DOI 10.1074/jbc.271.34.20770	55	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0128199	10.1371/journal.pone.0128199	http://dx.doi.org/10.1371/journal.pone.0128199			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147435	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600011
J	Ban, L; Fleming, KM; Doyle, P; Smeeth, L; Hubbard, RB; Fiaschi, L; Tata, LJ				Ban, Lu; Fleming, Kate M.; Doyle, Pat; Smeeth, Liam; Hubbard, Richard B.; Fiaschi, Linda; Tata, Laila J.			Congenital Anomalies in Children of Mothers Taking Antiepileptic Drugs with and without Periconceptional High Dose Folic Acid Use: A Population-Based Cohort Study	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; IN-UTERO EXPOSURE; FETAL MALFORMATIONS; PREGNANCY OUTCOMES; UK-EPILEPSY; WOMEN; RISK; ANTAGONISTS; VALPROATE; INFANTS	Background Antenatal antiepileptic drug (AED) use has been found to be associated with increased major congenital anomaly (CA) risks. However whether such AED-associated risks were different according to periconceptional high dose (5mg daily) folic acid supplementation is still unclear. Methods We included 258,591 singleton live-born children ofmothers aged 15-44 years in 1990-2013 from The Health Improvement Network, a large UK primary care database. We identified all major CAs according to the European Surveillance of Congenital Anomalies classification. Absolute risks and adjusted odds ratios (aOR) were calculated comparing children of mothers prescribed AEDs to those without such prescriptions, stratified by folic acid prescriptions around the time of conception (one month before conception to two months post-conception). Results CA risk was 476/10,000 in children of mothers with first trimester AEDs compared with 269/10,000 in those without AEDs equating to an aOR of 1.82, 95% confidence interval 1.30-2.56. The highest system-specific risks were for heart anomalies (198/10,000 and 79/10,000 respectively, aOR 2.49,1.47-4.21). Sodium valproate and lamotrigine were both associated with increased risks of any CA (aOR 2.63,1.46-4.74 and aOR 2.01,1.12-3.59 respectively) and system-specific risks. Stratification by folic acid supplementation did not show marked reductions in AED-associated risks (e.g. for CAs overall aOR 1.75, 1.01-3.03 in the high dose folic acid group and 1.94, 95% CI 1.21-3.13 in the low dose or no folic acid group); however, the majority of mothers taking AEDs only initiated high dose folic acid from the second month of pregnancy. Conclusions Children of mothers with AEDs in the first trimester of pregnancy have a 2-fold increased risk of major CA compared to those unexposed. We found no evidence that prescribed high dose folic acid supplementation reduced such AED-associated risks. Although statistical power was limited, prescribing of folic acid too late for it to be effective during the organogenic period or selective prescribing to those with more severe morbidity may explain these findings.	[Ban, Lu; Fleming, Kate M.; Hubbard, Richard B.; Fiaschi, Linda; Tata, Laila J.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Doyle, Pat; Smeeth, Liam] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England	University of Nottingham; University of London; London School of Hygiene & Tropical Medicine	Tata, LJ (corresponding author), Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England.	laila.tata@nottingham.ac.uk	Fiaschi, Linda/AAB-4905-2022; Fleming, Kate M/A-6475-2010; Smeeth, Liam/X-5862-2018; Tata, Laila/J-5227-2012	Fiaschi, Linda/0000-0002-3780-5895; Fleming, Kate M/0000-0002-6572-5016; Smeeth, Liam/0000-0002-9168-6022; Ban, Lu/0000-0001-9388-9141; Tata, Laila/0000-0002-6404-8658	Wellcome Trust [86101/Z/08/Z]; Medical Research Council [MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by a grant from Wellcome Trust, http://www.wellcome.ac.uk/ (PI: LJT; grant number: 86101/Z/08/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2012, INVESTIGATING USE ME; [Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A; Ban L, 2015, BJOG-INT J OBSTET GY, V122, P1833, DOI 10.1111/1471-0528.13102; BINOCAR, 2012, CONG AN STAT 2010 EN; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2459, DOI 10.1001/jama.2011.1823; Cassina M, 2013, REPROD TOXICOL, V39, P50, DOI 10.1016/j.reprotox.2013.04.002; Chen YH, 2009, ARCH NEUROL-CHICAGO, V66, P979, DOI 10.1001/archneurol.2009.142; Confidential Enquiry into Maternal and Child Health ( CEMACH), 2009, PER MORT 2007 UK; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Department of Health, 2011, AB STAT ENGL WAL 201; Diav-Citrin O, 2008, CNS DRUGS, V22, P325, DOI 10.2165/00023210-200822040-00004; EUR-Lex, 2012, CHART FUND RIGHTS EU; European Surveillance of Congenital Anomalies, 2015, EUROCAT PREV TABL; Grosse SD, 2007, BIRTH DEFECTS RES A, V79, P737, DOI 10.1002/bdra.20394; Harden CL, 2009, NEUROLOGY, V73, P133, DOI 10.1212/WNL.0b013e3181a6b312; Hernandez-Diaz S, 2012, NEUROLOGY, V78, P1692, DOI 10.1212/WNL.0b013e3182574f39; Hernandez-Diaz S, 2001, AM J EPIDEMIOL, V153, P961, DOI 10.1093/aje/153.10.961; Hernandez-Diaz S, 2000, NEW ENGL J MED, V343, P1608, DOI 10.1056/NEJM200011303432204; Holmes LB, 2001, NEW ENGL J MED, V344, P1132, DOI 10.1056/NEJM200104123441504; Jentink J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6581; Jentink J, 2010, PHARMACOEPIDEM DR S, V19, P803, DOI 10.1002/pds.1975; Jentink J, 2010, NEW ENGL J MED, V362, P2185, DOI 10.1056/NEJMoa0907328; Joint Formulary Committee, 2012, BRITISH NATIONAL FOR; Kaaja E, 2003, NEUROLOGY, V60, P575, DOI 10.1212/01.WNL.0000044157.28073.DC; Kulaga S, 2011, SEIZURE-EUR J EPILEP, V20, P667, DOI 10.1016/j.seizure.2011.06.012; LEPPIK IE, 1990, POSTGRAD MED, V88, P253, DOI 10.1080/00325481.1990.11716375; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Linnebank M, 2011, ANN NEUROL, V69, P352, DOI 10.1002/ana.22229; Man SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052339; Mawhinney E, 2012, SEIZURE-EUR J EPILEP, V21, P215, DOI 10.1016/j.seizure.2012.01.005; Mawhinney E, 2013, NEUROLOGY, V80, P400, DOI 10.1212/WNL.0b013e31827f0874; Meador K, 2008, EPILEPSY RES, V81, P1, DOI 10.1016/j.eplepsyres.2008.04.022; Molgaard-Nielsen D, 2011, JAMA-J AM MED ASSOC, V305, P1996, DOI 10.1001/jama.2011.624; Morrow J, 2006, J NEUROL NEUROSUR PS, V77, P193, DOI 10.1136/jnnp.2005.074203; Morrow JI, 2009, J NEUROL NEUROSUR PS, V80, P506, DOI 10.1136/jnnp.2008.156109; NICE, 2011, CG62 ANT CAR NICE GU; NICE, CG137 EP FULL GUID; Prajapati B, OPTOMETRY TODAY 0716; QueisserLuft A, 1996, AM J MED GENET, V63, P268, DOI 10.1002/(SICI)1096-8628(19960503)63:1<268::AID-AJMG45>3.0.CO;2-J; Say Lale, 2006, Reprod Health, V3, P1, DOI 10.1186/1742-4755-3-1; Sokal R, 2013, BIRTH DEFECTS RES A, V97, P546, DOI 10.1002/bdra.23150; Thomas SV, 2008, PEDIATR CARDIOL, V29, P604, DOI 10.1007/s00246-007-9161-4; Tomson T, 2011, LANCET NEUROL, V10, P609, DOI 10.1016/S1474-4422(11)70107-7; Vajda FJE, 2006, EUR J NEUROL, V13, P645, DOI 10.1111/j.1468-1331.2006.01359.x; Vajda FJ, 2013, NEUROLOGY, V81, P999, DOI 10.1212/WNL.0b013e3182a43e81; van Gelder MMHJ, 2010, HUM REPROD UPDATE, V16, P378, DOI 10.1093/humupd/dmp052; Wallace H, 1998, LANCET, V352, P1970, DOI 10.1016/S0140-6736(98)04512-7; World Health Organization(WHO), BMI CLASS	48	28	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131130	10.1371/journal.pone.0131130	http://dx.doi.org/10.1371/journal.pone.0131130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147467	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000358157600065
J	Dhanya, R; Arun, KB; Nisha, VM; Syama, HP; Nisha, P; Kumar, TRS; Jayamurthy, P				Dhanya, R.; Arun, K. B.; Nisha, V. M.; Syama, H. P.; Nisha, P.; Kumar, T. R. Santhosh; Jayamurthy, P.			Preconditioning L6 Muscle Cells with Naringin Ameliorates Oxidative Stress and Increases Glucose Uptake	PLOS ONE			English	Article							INSULIN-RESISTANCE; MYOCARDIAL-INFARCTION; DIABETES-MELLITUS; VITAMIN-C; PREVENTION; ANTIOXIDANTS; LIPIDS; MICE	Enhanced oxidative stress contributes to pathological changes in diabetes and its complications. Thus, strategies to reduce oxidative stress may alleviate these pathogenic processes. Herein, we have investigated Naringin mediated regulation of glutathione (GSH) & intracellular free radical levels and modulation of glucose uptake under oxidative stress in L6 cell lines. The results from the study demonstrated a marked decrease in glutathione with a subsequent increase in free radical levels, which was reversed by the pretreatment of Naringin. We also observed that the increased malondialdehyde level, the marker of lipid peroxidation on induction of oxidative stress was retrieved on Naringin pretreatment. Addition of Naringin (100 mu M) showed approximately 40% reduction in protein glycation in vitro. Furthermore, we observed a twofold increase in uptake of fluorescent labeled glucose namely 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl) Amino)-2-Deoxyglucose (2 - NBDG) on Naringin treatment in differentiated L6 myoblast. The increased uptake of 2-NBDG by L6 myotubes may be attributed due to the enhanced translocation of GLUT4. Our results demonstrate that Naringin activate GSH synthesis through a novel antioxidant defense mechanism against excessive Reactive Oxygen Species (ROS) production, contributing to the prevention of oxidative damage in addition to its effect on glycemic control.	[Dhanya, R.; Arun, K. B.; Nisha, V. M.; Syama, H. P.; Nisha, P.; Jayamurthy, P.] CSIR, Agroproc & Nat Prod Div, Natl Inst Interdisciplinary Sci & Technol NIIST, Thiruvananthapuram 695019, Kerala, India; [Kumar, T. R. Santhosh] Rajiv Gandhi Ctr Biotechnol, Thiruvananthapuram 695019, Kerala, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute Interdisciplinary Science & Technology (NIIST); Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Jayamurthy, P (corresponding author), CSIR, Agroproc & Nat Prod Div, Natl Inst Interdisciplinary Sci & Technol NIIST, Ind Estate, Thiruvananthapuram 695019, Kerala, India.	jayamurthy@live.com	P, Nisha/G-3519-2013; B, Arun K/ABA-5008-2020; HP, Syama/GOV-6372-2022	B, Arun K/0000-0002-8292-5933; r, dhanya/0000-0003-3916-3547	Kerala State Council for Science, Technology and Environment, Government of Kerala	Kerala State Council for Science, Technology and Environment, Government of Kerala	RD is supported by Kerala State Council for Science, Technology and Environment, Government of Kerala in the form of a fellowship.	Abiko T, 2003, DIABETES, V52, P829, DOI 10.2337/diabetes.52.3.829; Atli T, 2004, ARCH GERONTOL GERIAT, V39, P269, DOI 10.1016/j.archger.2004.04.065; Beckman JA, 2003, AM J PHYSIOL-HEART C, V285, pH2392, DOI 10.1152/ajpheart.00403.2003; Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; CATHCART R, 1983, ANAL BIOCHEM, V134, P111, DOI 10.1016/0003-2697(83)90270-1; Ceriello A, 2000, METABOLISM, V49, P27, DOI 10.1016/S0026-0495(00)80082-7; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Dhanya R, 2014, FOOD CHEM, V158, P546, DOI 10.1016/j.foodchem.2014.02.151; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Gaede P, 2001, DIABETIC MED, V18, P756, DOI 10.1046/j.0742-3071.2001.00574.x; Hilmi Y, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-149; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Jagetia GC, 2003, NAHRUNG, V47, P181, DOI 10.1002/food.200390042; Jedsadayanmata A., 2013, NARESUAN U J SCI TEC, V13, P35; Jeon SM, 2004, CLIN NUTR, V23, P1025, DOI 10.1016/j.clnu.2004.01.006; Jeon SM, 2002, CLIN CHIM ACTA, V317, P181, DOI 10.1016/S0009-8981(01)00778-1; Jia J, 2009, FOOD CHEM, V115, P32, DOI 10.1016/j.foodchem.2008.11.043; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kowluru RA, 2001, EXPERT OPIN INV DRUG, V10, P1665, DOI 10.1517/13543784.10.9.1665; Likidlilid Atip, 2010, Journal of the Medical Association of Thailand, V93, P682; Mahmoud AM, 2012, J DIABETES COMPLICAT, V26, P483, DOI 10.1016/j.jdiacomp.2012.06.001; Moore K, 1998, FREE RADICAL RES, V28, P659, DOI 10.3109/10715769809065821; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Osawa T, 2005, ANN NY ACAD SCI, V1043, P440, DOI 10.1196/annals.1333.050; Otero P, 2005, ATHEROSCLEROSIS, V182, P259, DOI 10.1016/j.atherosclerosis.2005.02.024; Packer L, 2001, NUTRITION, V17, P888, DOI 10.1016/S0899-9007(01)00658-X; Pari L, 2010, INT J PHARM BIOL ARC, V1, P280; Punithavathi VR, 2008, J APPL TOXICOL, V28, P806, DOI 10.1002/jat.1343; Rajadurai M, 2009, PHYTOTHER RES, V23, P358, DOI 10.1002/ptr.2632; Sathish V, 2003, MOL CELL BIOCHEM, V243, P133, DOI 10.1023/A:1021612230000; Shen X, 2006, DIABETES, V55, P798, DOI 10.2337/diabetes.55.03.06.db05-1039; Thornalley PJ, 2003, ARCH BIOCHEM BIOPHYS, V419, P31, DOI 10.1016/j.abb.2003.08.013; Topic A, 2010, BIOL TRACE ELEM RES, V134, P296, DOI 10.1007/s12011-009-8474-y; Vincent AM, 2007, EXP NEUROL, V208, P216, DOI 10.1016/j.expneurol.2007.07.017; Zatalia St Rabiul, 2013, Acta Med Indones, V45, P141	35	22	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132429	10.1371/journal.pone.0132429	http://dx.doi.org/10.1371/journal.pone.0132429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147673	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600266
J	Granich, R; Gupta, S; Hersh, B; Williams, B; Montaner, J; Young, B; Zuniga, JM				Granich, Reuben; Gupta, Somya; Hersh, Bradley; Williams, Brian; Montaner, Julio; Young, Benjamin; Zuniga, Jose M.			Trends in AIDS Deaths, New Infections and ART Coverage in the Top 30 Countries with the Highest AIDS Mortality Burden; 1990-2013	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; HIV; TUBERCULOSIS; EMPLOYMENT; CHILDREN; IMPACT; ADULTS; MODEL; RISK	Background Antiretroviral therapy (ART) prevents human immunodeficiency virus (HIV) disease progression, mortality and transmission. We assess the impact of expanded HIV treatment for the prevention of Acquired Immunodeficiency Syndrome (AIDS)-related deaths and simulate four treatment scenarios for Nigeria and South Africa. Methods For 1990-2013, we used the Joint United Nations Programme on HIV/AIDS (UNAIDS) database to examine trends in AIDS deaths, HIV incidence and prevalence, ART coverage, annual AIDS death rate, AIDS death-to-treatment and HIV infections to treatment ratios for the top 30 countries with the highest AIDS mortality burden and compare them with data from high-income countries. We projected the 1990-2020 AIDS deaths for Nigeria and South Africa using four treatment scenarios: 1) no ART; 2) maintaining current ART coverage; 3) 90% ART coverage based on 2013 World Health Organization (WHO) ART guidelines by 2020; and 4) reaching the United Nations 90-90-90 Target by 2020. Findings In 2013, there were 1.3 million (1.1 million-1.6 million) AIDS deaths in the top 30 countries representing 87% of global AIDS deaths. Eight countries accounted for 58% of the global AIDS deaths; Nigeria and South Africa accounted for 27% of global AIDS deaths. The highest death rates per 1000 people living with HIV were in Central African Republic (91), South Sudan (82), Cote d'Ivoire (75), Cameroon (72) and Chad (71), nearly 8-10 times higher than the high-income countries. ART access in 2013 has averted as estimated 1,051,354 and 422,448 deaths in South Africa and Nigeria, respectively. Increasing ART coverage in these two countries to meet the proposed UN 90-90-90 Target by 2020 could avert 2.2 and 1.2 million deaths, respectively. Interpretation Over the past decade the expansion of access to ART averted millions of deaths. Reaching the proposed UN 90-90-90 Target by 2020 will prevent additional morbidity, mortality and HIV transmission. Despite progress, high-burden countries will need to accelerate access to ART treatment to avert millions of premature AIDS deaths and new HIV infections.	[Granich, Reuben; Gupta, Somya; Young, Benjamin; Zuniga, Jose M.] Int Assoc Providers AIDS Care, Washington, DC 20036 USA; [Hersh, Bradley] Joint UN Programme HIV AIDS UNAIDS, Geneva, Switzerland; [Williams, Brian] Univ Witwatersrand, Wits Reprod Hlth Inst, Johannesburg, South Africa; [Montaner, Julio] British Columbia Ctr HIV AIDS Excellence, Vancouver, BC, Canada	UNAIDS; University of Witwatersrand	Granich, R (corresponding author), Int Assoc Providers AIDS Care, Washington, DC 20036 USA.	rgranich@iapac.org		Williams, Brian/0000-0002-3174-4876	British Columbia Ministry of Health; US National Institutes of Health [R01DA036307]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036307] Funding Source: NIH RePORTER	British Columbia Ministry of Health; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	JM is supported with grants paid to his institution by the British Columbia Ministry of Health and by the US National Institutes of Health (R01DA036307).	[Anonymous], 2012, PEPFAR BLUEPRINT CRE; Becker ML, 2012, INT J STD AIDS, V23, P36, DOI 10.1258/ijsa.2011.011017; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Bor J, 2012, HEALTH AFFAIR, V31, P1459, DOI 10.1377/hlthaff.2012.0407; Botswana Central Statistics Office Botswana National AIDS Coordinating Agency UNDP ACHAP, 2005, BOTSWANA AIDS IMPACT; Ciaranello A, 2014, PEDIATR INFECT DIS J, V33, P623, DOI 10.1097/INF.0000000000000223; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Granich R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030216; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grinsztejn B, 2014, LANCET INFECT DIS; Gupta S, 2014, CURR HIV AIDS REP; Houle B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100420; IAPAC-UNAIDS-UN HABITAT, ABOUT THE FAST TRACK; Ingle SM, 2014, CLIN INFECT DIS, V59, P287, DOI 10.1093/cid/ciu261; International Association of Providers of AIDS Care (IAPAC), 2015, GLOBAL DATABASE OF H; Johnson LF, 2012, PEDIATR INFECT DIS J, V31, P474, DOI 10.1097/INF.0b013e3182456ba2; Johnson LF, 2012, THE SOUTHERN AFRICAN; Lodi S, 2011, CLIN INFECT DIS, V53, P817, DOI 10.1093/cid/cir494; MAY RM, 1988, PHILOS T ROY SOC B, V321, P565, DOI 10.1098/rstb.1988.0108; Miller V, 2014, AIDS, V28, P273, DOI 10.1097/QAD.0000000000000079; Ministry of Health of the Republic of Botswana, 2011, 2011 BOTSWANA SECOND; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Montaner JSG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087872; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Stoneburner R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100431; Stover J, 2012, SEX TRANSM INFECT, V88, pI11, DOI 10.1136/sextrans-2012-050640; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Thirumurthy H, 2013, AIDS, V27, P627, DOI 10.1097/QAD.0b013e32835c54d8; UNAIDS, THE GAP REPORT 2014; UNAIDS, 2014, BRICS HEALTH MINISTE; UNAIDS, 2014, 20TH INTERNATIONAL A; UNAIDS, 2014, UNAIDS WORLD AIDS DA; UNAIDS, 2015, TREATMENT 2015; UNAIDS, 2013, UNAIDS REPORT ON THE; UNAIDS, 2011, AIDS AT 30 NATIONS A; UNAIDS, 2014, 90 90 90 AN AMBITIOU; UNAIDS, AIDSINFO DATA TOOL; WHO, 2013, CONSOLIDATED GUIDELI; Williams B, R0 AND THE ELIMINATI; World Health O, 2012, ANTIRETROVIRAL TREAT; Yan HJ, 2014, AIDS BEHAV, V18, pS5, DOI 10.1007/s10461-013-0520-2	44	85	89	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131353	10.1371/journal.pone.0131353	http://dx.doi.org/10.1371/journal.pone.0131353			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147987	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600091
J	Hu, X; Song, XP; Li, EF; Liu, JJ; Yuan, YG; Liu, WG; Liu, YJ				Hu, Xiao; Song, Xiaopeng; Li, Erfeng; Liu, Jiajia; Yuan, Yonggui; Liu, Weiguo; Liu, Yijun			Altered Resting-State Brain Activity and Connectivity in Depressed Parkinson's Disease	PLOS ONE			English	Article							NONMOTOR SYMPTOMS; ACTIVATION; NETWORKS	Depressive symptoms are common in Parkinson's disease (PD), but the neurophysiological mechanisms of depression in PD are poorly understood. The current study attempted to examine disrupted spontaneous local brain activities and functional connectivities that underlie the depression in PD. We recruited a total of 20 depressed PD patients (DPD), 40 non-depressed PD patients (NDPD) and 43 matched healthy controls (HC). All the subjects underwent neuropsychological tests and resting-state fMRI scanning. The between-group differences in the amplitude of low frequency fluctuations (ALFF) of BOLD signals were examined using post-hoc tests after the analysis of covariance. Compared with the NDPD and HC, the DPD group showed significantly increased ALFF in the left median cingulated cortex (MCC). The functional connectivity (FC) between left MCC and all the other voxels in the brain were then calculated. Compared with the HC and NDPD group, the DPD patients showed stronger FC between the left MCC and some of the major nodes of the default mode network (DMN), including the post cingulated cortex/precuneus, medial prefrontal cortex, inferior frontal gyrus, and cerebellum. Correlation analysis revealed that both the ALFF values in the left MCC and the FC between the left MCC and the nodes of DMN were significantly correlated with the Hamilton Depression Rating Scale score. Moreover, higher local activities in the left MCC were associated with increased functional connections between the MCC and the nodes of DMN in PD. These abnormal activities and connectivities of the limbic-cortical circuit may indicate impaired high-order cortical control or uncontrol of negative mood in DPD, which suggested a possible neural mechanism of the depression in PD.	[Hu, Xiao; Li, Erfeng; Liu, Jiajia; Liu, Weiguo] Nanjing Med Univ, Dept Neurol, Affiliated Brain Hosp, Nanjing 210029, Jiangsu, Peoples R China; [Song, Xiaopeng; Liu, Yijun] Peking Univ, Dept Biomed Engn, Coll Engn, Beijing 10087, Peoples R China; [Yuan, Yonggui] Southeast Univ, Affiliated ZhongDa Hosp, Dept Psychiat & Psychosomat, Inst Neuropsychiat, Nanjing 210009, Jiangsu, Peoples R China	Nanjing Medical University; Peking University; Southeast University - China	Liu, WG (corresponding author), Nanjing Med Univ, Dept Neurol, Affiliated Brain Hosp, Nanjing 210029, Jiangsu, Peoples R China.	wgliunbh@sina.com; yijunliu@ufl.edu	Yuan, Yonggui/AFA-0807-2022; hu, xiao/HDO-5404-2022	Yuan, Yonggui/0000-0001-6496-3998; Song, Xiaopeng/0000-0003-0074-6489	National Natural Science Foundation of China [61131003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China under Grant No. 61131003.	Aarsland D, 2012, NAT REV NEUROL, V8, P35, DOI 10.1038/nrneurol.2011.189; Cerullo MA, 2014, BIPOLAR DISORD, V16, P703, DOI 10.1111/bdi.12225; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Dutta A, 2014, PSYCHIAT RES-NEUROIM, V224, P139, DOI 10.1016/j.pscychresns.2014.10.003; Ford KA, 2013, J AFFECT DISORDERS, V150, P1174, DOI 10.1016/j.jad.2013.05.088; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Hu X, 2015, MOVEMENT DISORD, V30, P238, DOI 10.1002/mds.26087; Khoo TK, 2013, NEUROLOGY, V80, P276, DOI 10.1212/WNL.0b013e31827deb74; Kong LT, 2013, J PSYCHIATR NEUROSCI, V38, P417, DOI 10.1503/jpn.120117; Leentjens AFG, 2000, INT J GERIATR PSYCH, V15, P644, DOI 10.1002/1099-1166(200007)15:7<644::AID-GPS167>3.0.CO;2-L; Luo CY, 2014, J NEUROL NEUROSUR PS, V85, P675, DOI 10.1136/jnnp-2013-306237; Ma ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053148; Martin WRW, 2009, MOVEMENT DISORD, V24, P1949, DOI 10.1002/mds.22680; Nuti A, 2004, EUR J NEUROL, V11, P315, DOI 10.1111/j.1468-1331.2004.00781.x; Pankratz N, 2008, MOVEMENT DISORD, V23, P2216, DOI 10.1002/mds.22285; Pickut BA, 2013, CLIN NEUROL NEUROSUR, V115, P2419, DOI 10.1016/j.clineuro.2013.10.002; Qiao PF, 2012, NEUROSCIENCES, V17, P256; Rive MM, 2013, NEUROSCI BIOBEHAV R, V37, P2529, DOI 10.1016/j.neubiorev.2013.07.018; Shin LM, 2009, ARCH GEN PSYCHIAT, V66, P1099, DOI 10.1001/archgenpsychiatry.2009.138; Skidmore FM, 2013, NEUROIMAGE, V81, P484, DOI 10.1016/j.neuroimage.2011.07.012; Skidmore FM, 2013, NEUROIMAGE, V75, P249, DOI 10.1016/j.neuroimage.2011.06.056; Surdhar I, 2012, PARKINSONISM RELAT D, V18, P809, DOI 10.1016/j.parkreldis.2012.03.008; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Valente KDR, 2013, ARQ NEURO-PSIQUIAT, V71, P183, DOI 10.1590/S0004-282X2013000300011; Vogt BA, 2003, EUR J NEUROSCI, V18, P3134, DOI 10.1111/j.1460-9568.2003.03034.x; Wang L, 2014, PSYCHOL MED, V44, P1417, DOI 10.1017/S0033291713002031; Wang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048658; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Xia JG, 2013, NEURAL REGEN RES, V8, P2557, DOI 10.3969/j.issn.1673-5374.2013.27.007; Yang H, 2013, NEUROSCI LETT, V549, P24, DOI 10.1016/j.neulet.2013.05.080; Zarei M, 2013, J NEUROL NEUROSUR PS, V84, P875, DOI 10.1136/jnnp-2012-304126	32	44	45	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131133	10.1371/journal.pone.0131133	http://dx.doi.org/10.1371/journal.pone.0131133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147571	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600066
J	King, TZ; Wang, LY; Mao, H				King, Tricia Z.; Wang, Liya; Mao, Hui			Disruption of White Matter Integrity in Adult Survivors of Childhood Brain Tumors: Correlates with Long-Term Intellectual Outcomes	PLOS ONE			English	Article							MEDULLOBLASTOMA SURVIVORS; NEUROCOGNITIVE DEFICITS; CANCER SURVIVOR; ANISOTROPY; RADIATION; MODEL; IRRADIATION; CHILDREN	Background Although chemotherapy and radiation treatment have contributed to increased survivorship, treatment-induced brain injury has been a concern when examining long-term intellectual outcomes of survivors. Specifically, disruption of brain white matter integrity and its relationship to intellectual outcomes in adult survivors of childhood brain tumors needs to be better understood. Methods Fifty-four participants underwent diffusion tensor imaging in addition to structural MRI and an intelligence test (IQ). Voxel-wise group comparisons of fractional anisotropy calculated from DTI data were performed using Tract Based Spatial Statistics (TBSS) on 27 survivors (14 treated with radiation with and without chemotherapy and 13 treated without radiation treatment on average over 13 years since diagnosis) and 27 healthy comparison participants. Whole brain white matter fractional anisotropy (FA) differences were explored between each group. The relationships between IQ and FA in the regions where statistically lower FA values were found in survivors were examined, as well as the role of cumulative neurological factors. Results The group of survivors treated with radiation with and without chemotherapy had lower IQ relative to the group of survivors without radiation treatment and the healthy comparison group. TBSS identified white matter regions with significantly different mean fractional anisotropy between the three different groups. A lower level of white matter integrity was found in the radiation with or without chemotherapy treated group compared to the group without radiation treatment and also the healthy control group. The group without radiation treatment had a lower mean FA relative to healthy controls. The white matter disruption of the radiation with or without chemotherapy treated survivors was positively correlated with IQ and cumulative neurological factors. Conclusions Lower long-term intellectual outcomes of childhood brain tumor survivors are associated with lower white matter integrity. Radiation and adjunct chemotherapy treatment may play a role in greater white matter disruption. The relationships between white matter integrity and IQ, as well as cumulative neurological risk factors exist in young adult survivors of childhood brain tumors.	[King, Tricia Z.] Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA; [King, Tricia Z.] Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA; [Wang, Liya; Mao, Hui] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Atlanta, GA USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Emory University	King, TZ (corresponding author), Georgia State Univ, Dept Psychol, Univ Plaza, Atlanta, GA 30303 USA.	tzking@gsu.edu			American Cancer Society [RSGPB-CPPB-114044]	American Cancer Society(American Cancer Society)	This research was supported by a Research Scholar Grant from the American Cancer Society to TZK (#RSGPB-CPPB-114044). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong GT, 2009, JNCI-J NATL CANCER I, V101, P946, DOI 10.1093/jnci/djp148; Aukema EJ, 2009, INT J RADIAT ONCOL, V74, P837, DOI 10.1016/j.ijrobp.2008.08.060; Brinkman TM, 2012, NEURO-ONCOLOGY, V14, P25, DOI 10.1093/neuonc/nos214; First MB, 2002, STRUCTURED CLIN INTE; Gurney JG, 2003, CANCER-AM CANCER SOC, V97, P663, DOI 10.1002/cncr.11095; Hoppenbrouwers SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072375; Jayakar R, 2015, NEUROPSYCHO IN PRESS; Khong PL, 2006, J CLIN ONCOL, V24, P884, DOI 10.1200/JCO.2005.02.4505; Khong PL, 2003, AM J NEURORADIOL, V24, P734; King TZ, CHILD NEURO IN PRESS; Kurita H, 2001, NEUROL RES, V23, P869, DOI 10.1179/016164101101199324; Law N, 2011, NEUROIMAGE, V56, P2238, DOI 10.1016/j.neuroimage.2011.03.065; Leung LHT, 2004, NEUROIMAGE, V21, P261, DOI 10.1016/j.neuroimage.2003.09.020; Mabbott DJ, 2006, NEURO-ONCOLOGY, V8, P244, DOI 10.1215/15228517-2006-002; Micklewright JL, 2008, J CHILD NEUROL, V23, P455, DOI 10.1177/0883073807309241; Mori S, 2007, INTRO DIFFUSION TENS; Mulhern RK, 1999, ANN NEUROL, V46, P834, DOI 10.1002/1531-8249(199912)46:6<834::AID-ANA5>3.0.CO;2-M; Palmer SL, 2001, J CLIN ONCOL, V19, P2302, DOI 10.1200/JCO.2001.19.8.2302; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Prabhu SP, 2011, CHILD NERV SYST, V27, P11, DOI 10.1007/s00381-010-1323-7; Qiu D, 2007, INT J RADIAT ONCOL, V69, P846, DOI 10.1016/j.ijrobp.2007.04.041; Reddick WE, 2003, CANCER-AM CANCER SOC, V97, P2512, DOI 10.1002/cncr.11355; Ris MD, 2007, J PEDIATR PSYCHOL, V32, P1029, DOI 10.1093/jpepsy/jsm018; Rueckriegel SM, 2010, INT J RADIAT ONCOL, V76, P859, DOI 10.1016/j.ijrobp.2009.02.054; Smith KM, 2014, NEUROPSYCHOLOGY, V28, P448, DOI 10.1037/neu0000056; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stepens A, 2010, BRAIN, V133, P3676, DOI 10.1093/brain/awq281; Wang SL, 2009, CANCER RES, V69, P1190, DOI 10.1158/0008-5472.CAN-08-2661; Wechsler D., 2011, WASI 2 WECHSLER ABBR	31	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131744	10.1371/journal.pone.0131744	http://dx.doi.org/10.1371/journal.pone.0131744			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147736	Green Submitted, gold, Green Published			2022-12-27	WOS:000358157600140
J	Kuijper, SJM; Hartman, CA; Hendriks, P				Kuijper, Sanne J. M.; Hartman, Catharina A.; Hendriks, Petra			Who Is He? Children with ASD and ADHD Take the Listener into Account in Their Production of Ambiguous Pronouns	PLOS ONE			English	Article							ATTENTION-DEFICIT HYPERACTIVITY; SPECTRUM DISORDERS; AUTISM; LANGUAGE; ADULTS; INFORMATION; ABILITIES; CHOICE; MODEL	During conversation, speakers constantly make choices about how specific they wish to be in their use of referring expressions. In the present study we investigate whether speakers take the listener into account or whether they base their referential choices solely on their own representation of the discourse. We do this by examining the cognitive mechanisms that underlie the choice of referring expression at different discourse moments. Furthermore, we provide insights into how children with Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD) use referring expressions and whether their use differs from that of typically developing (TD) children. Children between 6 and 12 years old (ASD: n=46; ADHD: n=37; TD: n=38) were tested on their production of referring expressions and on Theory of Mind, response inhibition and working memory. We found support for the view that speakers take the listener into account when choosing a referring expression: Theory of Mind was related to referential choice only at those moments when speakers could not solely base their choice on their own discourse representation to be understood. Working memory appeared to be involved in keeping track of the different referents in the discourse. Furthermore, we found that TD children as well as children with ASD and children with ADHD took the listener into account in their choice of referring expression. In addition, children with ADHD were less specific than TD children in contexts with more than one referent. The previously observed problems with referential choice in children with ASD may lie in difficulties in keeping track of longer and more complex discourses, rather than in problems with taking into account the listener.	[Kuijper, Sanne J. M.; Hendriks, Petra] Univ Groningen, Ctr Language & Cognit Groningen, Groningen, Netherlands; [Hartman, Catharina A.] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol Emot Regulat I, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen	Kuijper, SJM (corresponding author), Univ Groningen, Ctr Language & Cognit Groningen, Groningen, Netherlands.	s.j.m.kuijper@rug.nl		Hendriks, Petra/0000-0002-7584-4078	Netherlands Organisation for Scientific Research (NWO) [277-70-005]; NWO	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO(Netherlands Organization for Scientific Research (NWO))	This investigation was supported by a grant from the Netherlands Organisation for Scientific Research (NWO grant no. 277-70-005, URL: http://www.nwo.nl/). SK and PH both received funding from NWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ARIEL M, 1988, J LINGUIST, V24, P65, DOI 10.1017/S0022226700011567; Arnold J. E., 1998, THESIS; Arnold JE, 2004, J MEM LANG, V51, P55, DOI 10.1016/j.jml.2004.03.006; Arnold JE, 2000, COGNITION, V76, pB13, DOI 10.1016/S0010-0277(00)00073-1; Arnold JE, 2009, COGNITION, V110, P131, DOI [10.1016/j.cognition.2008.10.016, DOI 10.1016/J.C0GNITION.2008.10.016]; Arnold JE, 2007, J MEM LANG, V56, P521, DOI 10.1016/j.jml.2006.09.007; Baltaxe CAM, 1996, EUR J DISORDER COMM, V31, P245; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Baron-Cohen S., 1993, UNDERSTANDING OTHER; Brennan S. E., 1987, 25th Annual Meeting of the Association for Computational Linguistics. Proceedings of the Conference, P155; Buitelaar JK, 1999, DEV PSYCHOPATHOL, V11, P39, DOI 10.1017/S0954579499001947; Charman T., 2001, EMOT BEHAV DIFFICULT, V6, P31, DOI [10.1080/13632750100507654, DOI 10.1080/13632750100507654]; Colle L, 2008, J AUTISM DEV DISORD, V38, P28, DOI 10.1007/s10803-007-0357-5; Dunn L.M., 1981, PEABODY PICTURE VOCA; Dyck MJ, 2001, EUR CHILD ADOLES PSY, V10, P105, DOI 10.1007/s007870170033; Geurts HM, 2004, J CHILD PSYCHOL PSYC, V45, P1437, DOI 10.1111/j.1469-7610.2004.00326.x; Givon Talmy, 1983, TOPIC CONTINUITY DIS, P1, DOI [10.1075/tsl.3, DOI 10.1075/TSL.3.01GIV]; Grice Herbert Paul, 1975, SPEECH ACTS, P41, DOI DOI 10.1163/9789004368811_003; GROSZ BJ, 1995, COMPUT LINGUIST, V21, P203; Gundel J. K., 2007, ZAS PAPERS LINGUISTI, V48, P1; GUNDEL JK, 1993, LANGUAGE, V69, P274, DOI 10.2307/416535; Heck RH, 2012, QUANT METH SER; Hendriks P., 2008, J LOGIC LANG INFORM, V17, P443, DOI [DOI 10.1007/S10849-008-9065-6, DOI 10.1080/13825585.2011.607228]; Hendriks P, 2011, PICTURE STORYBOOKS A; Hendriks P, 2014, LANG COGN NEUROSCI, V29, P391, DOI 10.1080/01690965.2013.766356; Hill EL, 2004, DEV REV, V24, P189, DOI 10.1016/j.dr.2004.01.001; Hollebrandse B, 2014, SYNTHESE, V191, P321, DOI 10.1007/s11229-012-0169-9; Ickowicz A, 2006, CAN J PSYCHIAT, V51, P325, DOI 10.1177/070674370605100508; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Kaiser Elsi, 2011, PROCESSING ACQUISITI, P323; Karmiloff-Smith Annette, 1985, LANG COGNITIVE PROC, V1, P61, DOI DOI 10.1080/01690968508402071; Kort W., 2002, WISC 3 NL; Kuijper SJ, 2014, PRONOUN PROCES UNPUB; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lord C., 1999, ADOS AUTISM DIAGNOST; Martinussen R, 2005, J AM ACAD CHILD PSY, V44, P377, DOI 10.1097/01.chi.0000153228.72591.73; Novogrodsky R, 2013, CLIN LINGUIST PHONET, V27, P85, DOI 10.3109/02699206.2012.742567; Nyden A, 2001, DEV MED CHILD NEUROL, V43, P165, DOI 10.1017/S0012162201000329; Purvis KL, 1997, J ABNORM CHILD PSYCH, V25, P133, DOI 10.1023/A:1025731529006; Risi S, 2006, J AM ACAD CHILD PSY, V45, P1094, DOI 10.1097/01.chi.0000227880.42780.0e; Rutter M., 2003, AUTISM DIAGNOSTIC IN, DOI DOI 10.1002/aur.1329; TAGERFLUSBERG H, 1995, BRIT J DEV PSYCHOL, V13, P45, DOI 10.1111/j.2044-835X.1995.tb00663.x; TANNOCK R, 1993, J ABNORM CHILD PSYCH, V21, P103, DOI 10.1007/BF00910492; Tannock R, 2002, COMMUNICATION, P1; van den Wildenberg WPM, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00145; van Rij J, 2013, TOP COGN SCI, V5, P564, DOI 10.1111/tops.12029; van Rij J, 2010, J CHILD LANG, V37, P731, DOI 10.1017/S0305000909990560; Vogels J, 2014, THESIS TILBURG U TIL; Wigglesworth G, 1997, J CHILD LANG, V24, P279, DOI 10.1017/S0305000997003048; Wubs Ellen., 2009, P 3 C GENERATIVE APP, P313; ZENTALL SS, 1988, J ABNORM CHILD PSYCH, V16, P657, DOI 10.1007/BF00913476	54	32	32	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132408	10.1371/journal.pone.0132408	http://dx.doi.org/10.1371/journal.pone.0132408			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26147200	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600260
J	Lecocq, A; Kryger, P; Vejsnaes, F; Jensen, AB				Lecocq, Antoine; Kryger, Per; Vejsnaes, Flemming; Jensen, Annette Bruun			Weight Watching and the Effect of Landscape on Honeybee Colony Productivity: Investigating the Value of Colony Weight Monitoring for the Beekeeping Industry	PLOS ONE			English	Article							POLLINATION SERVICES; BEES; ABUNDANCE; MAIZE; CITY	Over the last few decades, a gradual departure away from traditional agricultural practices has resulted in alterations to the composition of the countryside and landscapes across Europe. In the face of such changes, monitoring the development and productivity of honey bee colonies from different sites can give valuable insight on the influence of landscape on their productivity and might point towards future directions for modernized beekeeping practices. Using data on honeybee colony weights provided by electronic scales spread across Denmark, we investigated the effect of the immediate landscape on colony productivity. In order to extract meaningful information, data manipulation was necessary prior to analysis as a result of different management regimes or scales malfunction. Once this was carried out, we were able to show that colonies situated in landscapes composed of more than 50% urban areas were significantly more productive than colonies situated in those with more than 50% agricultural areas or those in mixed areas. As well as exploring some of the potential reasons for the observed differences, we discuss the value of weight monitoring of colonies on a large scale.	[Lecocq, Antoine; Jensen, Annette Bruun] Univ Copenhagen, Dept Plants & Environm Sci PLEN, DK-1871 Frederiksberg C, Denmark; [Kryger, Per] Aarhus Univ, Dept Agroecol Entomol & Plant Pathol, DK-4200 Slagelse, Denmark; [Vejsnaes, Flemming] Danish Beekeepers Assoc, DK-4180 Soro, Denmark	University of Copenhagen; Aarhus University	Lecocq, A (corresponding author), Univ Copenhagen, Dept Plants & Environm Sci PLEN, DK-1871 Frederiksberg C, Denmark.	antoine@plen.ku.dk	Jensen, Annette Bruun/AAH-1732-2021; Jensen, Annette B/G-7558-2014; Kryger, Per/C-1773-2013; Kryger, Per/H-4600-2019	Jensen, Annette Bruun/0000-0002-2044-2274; Jensen, Annette B/0000-0002-2044-2274; Kryger, Per/0000-0001-5306-3230; Kryger, Per/0000-0001-5306-3230; Lecocq, Antoine/0000-0002-8013-0221				Ahrne K., 2008, THESIS SWEDISH U AGR; Banaszak-Cibicka W, 2012, J INSECT CONSERV, V16, P331, DOI 10.1007/s10841-011-9419-2; Bates AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023459; Breeze TD, 2011, AGR ECOSYST ENVIRON, V142, P137, DOI 10.1016/j.agee.2011.03.020; Breeze TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082996; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; BURRILL RM, 1981, APIDOLOGIE, V12, P319, DOI 10.1051/apido:19810402; Couvillon MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093495; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Di Pasquale G., 2013, PLOS ONE, V8, DOI DOI 10.1371/journal.pone.0072016; Fairbrother A, 2014, ENVIRON TOXICOL CHEM, V33, P719, DOI 10.1002/etc.2527; Fortel L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104679; Geslin B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063421; Hein Lars, 2009, Open Ecology Journal, V2, P74, DOI 10.2174/1874213000902010074; Hernandez JL, 2009, CITIES ENV, V2, P1, DOI DOI 10.15365/cate.2132009; Hocherl N, 2012, J INSECT PHYSIOL, V58, P278, DOI 10.1016/j.jinsphys.2011.12.001; Human H, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.10; Khoury DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059084; Kluser S, 2010, GLOBAL HONEY BEE COL; Kryger P., 2011, 150 DJF AARH U, P65; Le Feon V, 2010, AGR ECOSYST ENVIRON, V137, P143, DOI 10.1016/j.agee.2010.01.015; Lowenstein DM, 2014, BIODIVERS CONSERV, V23, P2857, DOI 10.1007/s10531-014-0752-0; Matteson KC, 2008, ANN ENTOMOL SOC AM, V101, P140, DOI 10.1603/0013-8746(2008)101[140:BRAAIN]2.0.CO;2; MCLELLAN AR, 1977, J APPL ECOL, V14, P401, DOI 10.2307/2402553; Meikle WG, 2008, APIDOLOGIE, V39, P694, DOI 10.1051/apido:2008055; Odgaard MV, 2011, AGR ECOSYST ENVIRON, V142, P291, DOI 10.1016/j.agee.2011.05.026; Odoux JF, 2014, J APICULT RES, V53, P57, DOI 10.3896/IBRA.1.53.1.05; Pardee GL, 2014, URBAN ECOSYST, V17, P641, DOI 10.1007/s11252-014-0349-0; PETERS KA, 2012, DRAKE J AGR L, V17, P597; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Riessberger U, 1997, APIDOLOGIE, V28, P411, DOI 10.1051/apido:19970608; Ritter W., 2006, 4 FAO AGR FOOD ENG; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Russell S, 2013, ECOL MODEL, V265, P158, DOI 10.1016/j.ecolmodel.2013.06.005; Schneider A, 2003, PHOTOGRAMM ENG REM S, V69, P1377, DOI 10.14358/PERS.69.12.1377; Schofield H., 2010, BBC; Simon-Delso N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103073; Staveley JP, 2014, HUM ECOL RISK ASSESS, V20, P566, DOI 10.1080/10807039.2013.831263; Tommasi D, 2004, CAN ENTOMOL, V136, P851; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Wang NA, 2011, J EXP BOT, V62, P5641, DOI 10.1093/jxb/err249; Wray MK, 2011, ANIM BEHAV, V81, P559, DOI 10.1016/j.anbehav.2010.11.027; Zheng HQ, 2014, J ECON ENTOMOL, V107, P2037, DOI 10.1603/EC13520	43	27	28	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132473	10.1371/journal.pone.0132473	http://dx.doi.org/10.1371/journal.pone.0132473			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147392	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600280
J	Reis, GSM; de Almeida, AAF; de Almeida, NM; de Castro, AV; Mangabeira, PAO; Pirovani, CP				Monteiro Reis, Graciele Santos; Furtado de Almeida, Alex-Alan; de Almeida, Nicolle Moreira; de Castro, Andressa Vieira; Oliveira Mangabeira, Pedro Antonio; Pirovani, Carlos Priminho			Molecular, Biochemical and Ultrastructural Changes Induced by Pb Toxicity in Seedlings of Theobroma cacao L.	PLOS ONE			English	Article							LIPID-PEROXIDATION; MONILIOPHTHORA-PERNICIOSA; ANTIOXIDATIVE ENZYMES; PROTEIN EXTRACTION; LEAD TOLERANCE; EXCESS LEAD; PLANTS; STRESS; ACCUMULATION; LEAVES	Pb is a metal which is highly toxic to plants and animals, including humans. High concentrations of Pb have been observed in beans of T. cacao, as well as in its products. In this work, we evaluated the molecular, biochemical, and ultrastructural alterations in mature leaves and primary roots of seedlings of two progenies of T. cacao, obtained from seed germination in different concentrations of Pb (0, 0.05, 0.1, 0.2, 0.4, 0.8 g L-1), in the form of Pb(NO3)(2). The progenies resulted from self-fertilization of Catongo and a cross of CCN-10 x SCA-6. The Pb, supplied via seminal, caused alterations in the ultrastructures of the mesophyll cells and in the amount of starch grains in the chloroplasts. The dosage of substances reactive to thiobarbituric acid showed that Pb induced lipid peroxidation. The activity of guaiacol peroxidases and the expression of genes associated to synthetase of phytochelatin, SOD-cyt and PER increased in response to Pb. In addition, there was alteration in the expression of stress-related proteins. The progeny of CCN-10 x SCA-6 was more tolerant to Pb stress when compared to Catongo, since: (i) it accumulated more Pb in the roots, preventing its translocation to the shoot; (ii) it presented higher activity of peroxidases in the roots, which are enzymes involved in the elimination of excess of reactive oxygen species; and (iii) increased expression of the gene in the phytochelatin biosynthesis route. The results of the proteomic analysis were of paramount importance to differentiate the defense mechanisms used by both progenies of T. cacao.	[Monteiro Reis, Graciele Santos; Furtado de Almeida, Alex-Alan; de Almeida, Nicolle Moreira; de Castro, Andressa Vieira; Oliveira Mangabeira, Pedro Antonio; Pirovani, Carlos Priminho] Univ Estadual Santa Cruz, Dept Biol Sci, BR-45662900 Ilheus, BA, Brazil	Universidade Estadual de Santa Cruz	Reis, GSM (corresponding author), Univ Estadual Santa Cruz, Dept Biol Sci, Campus Soane Nazare Andrade,Rodovia Jorge Amado, BR-45662900 Ilheus, BA, Brazil.	alexalan@uesc.br	Mangabeira, Pedro A O/I-7742-2014; Pirovani, Carlos Priminho/N-1153-2019; Pirovani, Carlos P/J-3426-2017	Mangabeira, Pedro A O/0000-0001-6563-4539; Pirovani, Carlos Priminho/0000-0002-6176-4069; Pirovani, Carlos P/0000-0002-6176-4069	CAPES; Universidad e Estadual de Santa Cruz (UESC); Conselho Nacional de Desenvolvimento CientIfico and Tecnologico (CNPq), Brazil	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Universidad e Estadual de Santa Cruz (UESC); Conselho Nacional de Desenvolvimento CientIfico and Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We gratefully acknowledge the financial support provided by CAPES and Universidad e Estadual de Santa Cruz (UESC). The second author gratefully acknowledges the Conselho Nacional de Desenvolvimento CientIfico and Tecnologico (CNPq), Brazil, for the concession of a scientific productivity fellowship. We thank Dr. Claudia Fortes Ferreira for their excellent review and constructive comments.	Anjum NA, 2010, ASCORBATE-GLUTATHIONE PATHWAY AND STRESS TOLERANCE IN PLANTS, P1, DOI 10.1007/978-90-481-9404-9; Anjum NA, 2012, ENVIRON EXP BOT, V75, P307, DOI 10.1016/j.envexpbot.2011.07.002; Anunciacao DS, 2011, FOOD ANAL METHOD, V4, P286, DOI 10.1007/s12161-010-9172-2; Aravind Parameswaran, 2005, Braz. J. Plant Physiol., V17, P3, DOI 10.1590/S1677-04202005000100002; Austin JR, 2006, PLANT CELL, V18, P1693, DOI 10.1105/tpc.105.039859; Basile A, 2013, ENVIRON POLLUT, V182, P209, DOI 10.1016/j.envpol.2013.07.014; Benavides María P., 2005, Braz. J. Plant Physiol., V17, P21, DOI 10.1590/S1677-04202005000100003; Bertolde FZ, 2014, GENET MOL RES, V13, P5036, DOI 10.4238/2014.July.4.19; Bovenkamp GL, 2013, ENVIRON SCI TECHNOL, V47, P4375, DOI 10.1021/es302408m; Brandazza A, 2004, FEBS LETT, V572, P3, DOI 10.1016/j.febslet.2004.07.003; Brunet J, 2009, CHEMOSPHERE, V77, P1113, DOI 10.1016/j.chemosphere.2009.07.058; Camillo LR, 2013, PLANT PHYSIOL BIOCH, V73, P254, DOI 10.1016/j.plaphy.2013.10.009; Cenkci S, 2010, ENVIRON EXP BOT, V67, P467, DOI 10.1016/j.envexpbot.2009.10.001; Cobbett CS, 2000, PLANT PHYSIOL, V123, P825, DOI 10.1104/pp.123.3.825; Cosio C, 2005, J EXP BOT, V56, P765, DOI 10.1093/jxb/eri062; DANTAS NA, 2005, PHYTOPATHOLOGY, V30, P380; Almeida Alex-Alan F. de, 2007, Braz. J. Plant Physiol., V19, P83, DOI 10.1590/S1677-04202007000200001; Freeman JL, 2004, PLANT CELL, V16, P2176, DOI 10.1105/tpc.104.023036; Gopal R, 2008, CHEMOSPHERE, V70, P1539, DOI 10.1016/j.chemosphere.2007.08.043; Gramacho I.C.P., 1992, CULTIVO BENEFICIAMEN; Gupta DK, 2013, ENVIRON SCI POLLUT R, V20, P2150, DOI 10.1007/s11356-013-1485-4; Gupta DK, 2010, J HAZARD MATER, V177, P437, DOI 10.1016/j.jhazmat.2009.12.052; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hu JZ, 2007, RUSS J PLANT PHYSL+, V54, P414, DOI 10.1134/S1021443707030181; International Cocoa Organization (ICCO), 2013, WORLD COC EC PRES; Islam E, 2007, J HAZARD MATER, V147, P806, DOI 10.1016/j.jhazmat.2007.01.117; Jung C, 2003, PLANT SOIL, V252, P301, DOI 10.1023/A:1024775803759; Kieffer P, 2008, PROTEOMICS, V8, P2514, DOI 10.1002/pmic.200701110; Kim YY, 2002, PHYSIOL PLANTARUM, V116, P368, DOI 10.1034/j.1399-3054.2002.1160312.x; Koca H, 2007, ENVIRON EXP BOT, V60, P344, DOI 10.1016/j.envexpbot.2006.12.005; Kotchoni SO, 2006, PLANT CELL ENVIRON, V29, P1033, DOI 10.1111/j.1365-3040.2005.01458.x; Kramer U, 2010, ANNU REV PLANT BIOL, V61, P517, DOI 10.1146/annurev-arplant-042809-112156; Krzeslowska M, 2011, ACTA PHYSIOL PLANT, V33, P35, DOI 10.1007/s11738-010-0581-z; Kupper H, 2017, METAL IONS LIFE SCI, V17, P491, DOI [10.1590/S1677-04202005000100004, 10.1515/9783110434330-015]; Lamhamdi M, 2011, CR BIOL, V334, P118, DOI 10.1016/j.crvi.2010.12.006; Lee SM, 2002, FREE RADICAL BIO MED, V32, P1185, DOI 10.1016/S0891-5849(02)00815-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malecka A, 2008, ACTA PHYSIOL PLANT, V30, P629, DOI 10.1007/s11738-008-0159-1; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; McLaughlin M.J., 1999, CADMIUM SOIL PLANTS; Medeiros AG, 1965, COMBATE PODRIDAO PAR; Menu-Bouaouiche L, 2003, BIOCHIMIE, V85, P123, DOI 10.1016/S0300-9084(03)00058-0; Monteiro WR, 2012, GENETIC IMPROVEMENT; Moraes CL, 2011, THESIS U FEDERAL PEL; Nautiyal N, 2012, ACTA PHYSIOL PLANT, V34, P977, DOI 10.1007/s11738-011-0894-6; Paivoke AEA, 2002, ENVIRON EXP BOT, V48, P61, DOI 10.1016/S0098-8472(02)00011-4; Piechalak A, 2008, BIOL PLANTARUM, V52, P565, DOI 10.1007/s10535-008-0112-6; Piechalak A, 2002, PHYTOCHEMISTRY, V60, P153, DOI 10.1016/S0031-9422(02)00067-5; Pirovani CP, 2008, ELECTROPHORESIS, V29, P2391, DOI 10.1002/elps.200700743; Pourrut B., 2013, HEAVY METAL STRESS P, P121, DOI DOI 10.1007/978-3-642-38469-1_7; Qureshi MI, 2005, ENVIRON EXP BOT, V53, P185, DOI 10.1016/j.envexpbot.2004.03.014; Rankin CW, 2005, ENVIRON HEALTH PERSP, V113, P1344, DOI 10.1289/ehp.8009; Rascio N, 2011, PLANT SCI, V180, P169, DOI 10.1016/j.plantsci.2010.08.016; Reddy AM, 2005, CHEMOSPHERE, V60, P97, DOI 10.1016/j.chemosphere.2004.11.092; Rehem BC, 2011, PHOTOSYNTHETICA, V49, P127, DOI 10.1007/s11099-011-0021-3; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Romanowska E, 2008, BIOL PLANTARUM, V52, P80, DOI 10.1007/s10535-008-0012-9; Rossato VL, 2010, PLUCHEASAGITTALIS HA; Rucinska-Sobkowiak R, 2013, ENVIRON EXP BOT, V87, P100, DOI 10.1016/j.envexpbot.2012.09.012; Semane B, 2007, PHYSIOL PLANTARUM, V129, P519, DOI 10.1111/j.1399-3054.2006.00822.x; Shahid M, 2012, J HAZARD MATER, V219, P1, DOI 10.1016/j.jhazmat.2012.01.060; Silva FAC, 2013, GENET MOL RES, V12, P4855, DOI 10.4238/2013.October.22.5; Silva LF, 1969, P 2 INT COC RES C, P412; Singh RP, 1997, CHEMOSPHERE, V34, P2467, DOI 10.1016/S0045-6535(97)00087-8; Sinha P, 2006, CHEMOSPHERE, V65, P651, DOI 10.1016/j.chemosphere.2006.01.068; Tian SK, 2011, ENVIRON POLLUT, V159, P782, DOI 10.1016/j.envpol.2010.11.020; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; VANASSCHE F, 1990, PLANT CELL ENVIRON, V13, P195, DOI 10.1111/j.1365-3040.1990.tb01304.x; Verma S, 2003, PLANT SCI, V164, P645, DOI 10.1016/S0168-9452(03)00022-0; Walliwalagedara C, 2010, PHYTOCHEMISTRY, V71, P1460, DOI 10.1016/j.phytochem.2010.05.018; Wang C, 2011, ECOTOX ENVIRON SAFE, V74, P1297, DOI 10.1016/j.ecoenv.2011.03.005; Weis JS, 2004, ENVIRON INT, V30, P685, DOI 10.1016/j.envint.2003.11.002; Wierzbicka M, 1999, ENVIRON POLLUT, V104, P41, DOI 10.1016/S0269-7491(98)00156-0; Xiong ZT, 1997, ENVIRON POLLUT, V97, P275, DOI 10.1016/S0269-7491(97)00086-9; Yadav SK, 2010, S AFR J BOT, V76, P167, DOI 10.1016/j.sajb.2009.10.007; Yan ZZ, 2010, AQUAT BOT, V92, P112, DOI 10.1016/j.aquabot.2009.10.014; Yang YL, 2010, ECOTOX ENVIRON SAFE, V73, P1982, DOI 10.1016/j.ecoenv.2010.08.041; Ytterberg AJ, 2006, PLANT PHYSIOL, V140, P984, DOI 10.1104/pp.105.076083; Zaier H, 2010, ANAL CHIM ACTA, V671, P48, DOI 10.1016/j.aca.2010.04.054; Zhang FQ, 2007, CHEMOSPHERE, V67, P44, DOI 10.1016/j.chemosphere.2006.10.007; Zhao FJ, 2000, PLANT CELL ENVIRON, V23, P507, DOI 10.1046/j.1365-3040.2000.00569.x; Zou TJ, 2011, J HAZARD MATER, V186, P683, DOI 10.1016/j.jhazmat.2010.11.053	82	19	20	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0129696	10.1371/journal.pone.0129696	http://dx.doi.org/10.1371/journal.pone.0129696			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146994	gold, Green Submitted, Green Published			2022-12-27	WOS:000358157600024
J	Pappano, WN; Guo, J; He, YP; Ferguson, D; Jagadeeswaran, S; Osterling, DJ; Gao, WQ; Spence, JK; Pliushchev, M; Sweis, RF; Buchanan, FG; Michaelides, MR; Shoemaker, AR; Tse, C; Chiang, GG				Pappano, William N.; Guo, Jun; He, Yupeng; Ferguson, Debra; Jagadeeswaran, Sujatha; Osterling, Donald J.; Gao, Wenqing; Spence, Julie K.; Pliushchev, Marina; Sweis, Ramzi F.; Buchanan, Fritz G.; Michaelides, Michael R.; Shoemaker, Alexander R.; Tse, Chris; Chiang, Gary G.			The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia	PLOS ONE			English	Article							DNA METHYLATION; DRUG DISCOVERY; CHEMICAL PROBE; G9A; CELLS; GLP; TRANSFORMATION; REVERSAL	Histone methyltransferases are epigenetic regulators that modify key lysine and arginine residues on histones and are believed to play an important role in cancer development and maintenance. These epigenetic modifications are potentially reversible and as a result this class of enzymes has drawn great interest as potential therapeutic targets of small molecule inhibitors. Previous studies have suggested that the histone lysine methyltransferase G9a (EHMT2) is required to perpetuate malignant phenotypes through multiple mechanisms in a variety of cancer types. To further elucidate the enzymatic role of G9a in cancer, we describe herein the biological activities of a novel peptide-competitive histone methyltransferase inhibitor, A-366, that selectively inhibits G9a and the closely related GLP (EHMT1), but not other histone methyltransferases. A-366 has significantly less cytotoxic effects on the growth of tumor cell lines compared to other known G9a/GLP small molecule inhibitors despite equivalent cellular activity on methylation of H3K9me2. Additionally, the selectivity profile of A-366 has aided in the discovery of a potentially important role for G9a/GLP in maintenance of leukemia. Treatment of various leukemia cell lines in vitro resulted in marked differentiation and morphological changes of these tumor cell lines. Furthermore, treatment of a flank xenograft leukemia model with A-366 resulted in growth inhibition in vivo consistent with the profile of H3K9me2 reduction observed. In summary, A-366 is a novel and highly selective inhibitor of G9a/GLP that has enabled the discovery of a role for G9a/GLP enzymatic activity in the growth and differentiation status of leukemia cells.	[Pappano, William N.; Guo, Jun; He, Yupeng; Ferguson, Debra; Jagadeeswaran, Sujatha; Osterling, Donald J.; Gao, Wenqing; Spence, Julie K.; Pliushchev, Marina; Sweis, Ramzi F.; Buchanan, Fritz G.; Michaelides, Michael R.; Shoemaker, Alexander R.; Tse, Chris; Chiang, Gary G.] AbbVie Inc, Discovery Res, N Chicago, IL 60064 USA	AbbVie	Chiang, GG (corresponding author), AbbVie Inc, Discovery Res, 1 North Waukegan Rd, N Chicago, IL 60064 USA.	gary.chiang@abbvie.com		Chiang, Gary/0000-0003-3004-7400; Pappano, William/0000-0003-2848-2219	AbbVie	AbbVie(AbbVie)	All authors are employees of AbbVie. The design, study conduct, and financial support for this research were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the publication.	Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; de Narvajas AAM, 2013, MOL CELL BIOL, V33, P3983, DOI 10.1128/MCB.00813-13; Degos L, 2001, ONCOGENE, V20, P7140, DOI 10.1038/sj.onc.1204763; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Imai K, 2010, J BIOL CHEM, V285, P16538, DOI 10.1074/jbc.M110.103531; Jenuwein T, 2006, FEBS J, V273, P3121, DOI 10.1111/j.1742-4658.2006.05343.x; Kaminskas E, 2005, CLIN CANCER RES, V11, P3604, DOI 10.1158/1078-0432.CCR-04-2135; Kondo Y, 2007, HEPATOL RES, V37, P974, DOI 10.1111/j.1872-034X.2007.00141.x; Kondo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002037; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Lehnertz B, 2014, GENE DEV, V28, P317, DOI 10.1101/gad.236794.113; Lehnertz B, 2010, J EXP MED, V207, P915, DOI 10.1084/jem.20100363; Liu F, 2013, J MED CHEM, V56, P8931, DOI 10.1021/jm401480r; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Pappano WN, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-314; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Schaefer A, 2009, NEURON, V64, P678, DOI 10.1016/j.neuron.2009.11.019; Sweis RF, 2014, ACS MED CHEM LETT, V5, P205, DOI 10.1021/ml400496h; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Watanabe H, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-15	31	55	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131716	10.1371/journal.pone.0131716	http://dx.doi.org/10.1371/journal.pone.0131716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147105	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600133
J	Schnitzler, F; Friedrich, M; Wolf, C; Stallhofer, J; Angelberger, M; Diegelmann, J; Olszak, T; Tillack, C; Beigel, F; Goke, B; Glas, J; Lohse, P; Brand, S				Schnitzler, Fabian; Friedrich, Matthias; Wolf, Christiane; Stallhofer, Johannes; Angelberger, Marianne; Diegelmann, Julia; Olszak, Torsten; Tillack, Cornelia; Beigel, Florian; Goeke, Burkhard; Glas, Juergen; Lohse, Peter; Brand, Stephan			The NOD2 Single Nucleotide Polymorphism rs72796353 (IVS4+10 A > C) Is a Predictor for Perianal Fistulas in Patients with Crohn's Disease in the Absence of Other NOD2 Mutations	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; FRAMESHIFT MUTATION; SUSCEPTIBILITY LOCI; INSERTION MUTATION; GENE; VARIANTS; GASTROENTEROLOGY; CLASSIFICATION; METAANALYSIS	Background A previous study suggested an association of the single nucleotide polymorphism (SNP) rs72796353 (IVS4+ 10 A>C) in the NOD2 gene with susceptibility to Crohn's disease (CD). However, this finding has not been confirmed. Given that NOD2 variants still represent the most important predictors for CD susceptibility and phenotype, we evaluated the association of rs72796353 with inflammatory bowel disease (IBD) susceptibility and the IBD phenotype. Methodology Genomic DNA from 2256 Caucasians, including 1073 CD patients, 464 patients with ulcerative colitis (UC), and 719 healthy controls, was genotyped for the NOD2 SNP rs72796353 and the three main CD-associated NOD2 mutations rs2066844, rs2066845, and rs2066847. Subsequently, IBD association and genotype-phenotype analyses were conducted. Results In contrast to the strong associations of the NOD2 SNPs rs2066844 (p=3.51 x 10(-3)), rs2066845 (p=1.54 x 10(-2)), and rs2066847 (p=1.61 x 10(-20)) with CD susceptibility, no significant association of rs72796353 with CD or UC susceptibility was found. However, in CD patients without the three main CD-associated NOD2 mutations, rs72796353 was significantly associated with the development of perianal fistulas (p=2.78 x 10(-7), OR 5.27, [95% CI 2.75-10.12] vs. NOD2 wild-type carriers). Conclusion/Significance Currently, this study represents the largest genotype-phenotype analysis of the impact of the NOD2 variant rs72796353 on the disease phenotype in IBD. Our data demonstrate that in CD patients the IVS4+ 10 A>C variant is strongly associated with the development of perianal fistulas. This association is particularly pronounced in patients who are not carriers of the three main CD-associated NOD2 mutations, suggesting rs72796353 as additional genetic marker for the CD disease behaviour.	[Schnitzler, Fabian; Friedrich, Matthias; Stallhofer, Johannes; Angelberger, Marianne; Olszak, Torsten; Tillack, Cornelia; Beigel, Florian; Goeke, Burkhard; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Friedrich, Matthias; Diegelmann, Julia] Univ Munich, Dept Prevent Dent & Periodontol, Munich, Germany; [Wolf, Christiane] Max Planck Inst Psychiat, Biostat Grp, D-80804 Munich, Germany; [Glas, Juergen] Rhein Westfal TH Aachen, Dept Human Genet, D-52062 Aachen, Germany; [Lohse, Peter] Univ Munich, Dept Clin Chem Grosshadern, Munich, Germany	University of Munich; University of Munich; Max Planck Society; RWTH Aachen University; University of Munich	Schnitzler, F (corresponding author), Univ Munich, Dept Med Grosshadern 2, Munich, Germany.	stephan.brand@med.uni-muenchen.de		Stallhofer, Johannes/0000-0001-8698-6103	Deutsche Forschungsgemeinschaft (DFG) [BR 1912/6-1, OL/324-1]; Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium) [2010_EKES.32]; Ludwig-Maximilians-University Munich (FoFoLe program)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium); Ludwig-Maximilians-University Munich (FoFoLe program)	S. Brand was supported by grants from the Deutsche Forschungsgemeinschaft (DFG, BR 1912/6-1) and the Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium 2010; 2010_EKES.32). C. Tillack was supported by a grant of the Ludwig-Maximilians-University Munich (FoFoLe program). T. Olszak was supported by a grant of the Deutsche Forschungsgemeinschaft (DFG OL/324-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2011, AM J GASTROENTEROL, V106, P699, DOI 10.1038/ajg.2011.19; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Brand S, 2013, GUT, V62, P1531, DOI 10.1136/gutjnl-2012-304151; Chamaillard M, 2003, P NATL ACAD SCI USA, V100, P3455, DOI 10.1073/pnas.0530276100; Cleynen I, 2013, GUT, V62, P1556, DOI 10.1136/gutjnl-2011-300777; Cosnes J, 2002, INFLAMM BOWEL DIS, V8, P244, DOI 10.1097/00054725-200207000-00002; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Glas J, 2008, AM J GASTROENTEROL, V103, P682, DOI 10.1111/j.1572-0241.2007.01694.x; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Loppalainen M, 2008, INFLAMM BOWEL DIS, V14, P176, DOI 10.1002/ibd.20287; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Radlmayr M, 2002, GASTROENTEROLOGY, V122, P2091, DOI 10.1053/gast.2002.34020; Russell RK, 2004, ARCH DIS CHILD, V89, P598, DOI 10.1136/adc.2003.041046; Schnitzler F, 2006, IMMUNOGENETICS, V58, P99, DOI 10.1007/s00251-005-0073-2; Schnitzler F, 2012, INFLAMM BOWEL DIS, V18, P395, DOI 10.1002/ibd.21882; Seiderer J, 2006, SCAND J GASTROENTERO, V41, P1421, DOI 10.1080/00365520600703900; Seiderer J, 2006, INFLAMM BOWEL DIS, V12, P1114, DOI 10.1097/01.mib.0000235836.32176.5e; Shanahan F, 2002, LANCET, V359, P62, DOI 10.1016/S0140-6736(02)07284-7; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Torok HP, 2005, GUT, V54, P1421, DOI 10.1136/gut.2005.066340; Tukel T, 2004, AM J HUM GENET, V74, P623, DOI 10.1086/382226	30	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0116044	10.1371/journal.pone.0116044	http://dx.doi.org/10.1371/journal.pone.0116044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147989	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600001
J	Wu, CC; Huang, KF; Yang, TY; Li, YL; Wen, CL; Hsu, SL; Chen, TH				Wu, Chun-Chi; Huang, Keh-Feng; Yang, Tsung-Ying; Li, Ya-Ling; Wen, Chi-Luan; Hsu, Shih-Lan; Chen, Tzu-Hsiu			The Topoisomerase 1 Inhibitor Austrobailignan-1 Isolated from Koelreuteria henryi Induces a G2/M-Phase Arrest and Cell Death Independently of p53 in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							CYCLE ARREST; COLORECTAL-CANCER; INDUCED APOPTOSIS; DNA-DAMAGE; CARCINOMA; CHEMOTHERAPY; IRINOTECAN; CISPLATIN; PATHWAYS; PROTEIN	Koelreuteria henryi Dummer, an endemic plant of Taiwan, has been used as a folk medicine for the treatment of hepatitis, enteritis, cough, pharyngitis, allergy, hypertension, hyperlipidemia, and cancer. Austrobailignan-1, a natural lignan derivative isolated from Koelreuteria henryi Dummer, has anti-oxidative and anti-cancer properties. However, the effects of austrobailignan-1 on human cancer cells have not been studied yet. Here, we showed that austrobailignan-1 inhibited cell growth of human non-small cell lung cancer A549 and H1299 cell lines in both dose- and time-dependent manners, the IC50 value (48 h) of austrobailignan-1 were 41 and 22 nM, respectively. Data from flow cytometric analysis indicated that treatment with austrobailignan-1 for 24 h retarded the cell cycle at the G2/M phase. The molecular event of austrobailignan-1-mediated G2/M phase arrest was associated with the increase of p21(Waf1/Cip1) and p27(Kip1) expression, and decrease of Cdc25C expression. Moreover, treatment with 100 nM austrobailignan-1 for 48 h resulted in a pronounced release of cytochrome c followed by the activation of caspase-2, -3, and -9, and consequently induced apoptosis. These events were accompanied by the increase of PUMA and Bax, and the decrease of Mcl-1 and Bcl-2. Furthermore, our study also showed that austrobailignan-1 was a topoisomerase 1 inhibitor, as evidenced by a relaxation assay and induction of a DNA damage response signaling pathway, including ATM, and Chk1, Chk2,YH2AX phosphorylated activation. Overall, our results suggest that austrobailignan-1 is a novel DNA damaging agent and displays a topoisomerase I inhibitory activity, causes DNA strand breaks, and consequently induces DNA damage response signaling for cell cycle G2/M arrest and apoptosis in a p53 independent manner.	[Wu, Chun-Chi] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Wu, Chun-Chi] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Huang, Keh-Feng] Providence Univ, Dept Appl Chem, Taichung 43309, Taiwan; [Yang, Tsung-Ying] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Yang, Tsung-Ying] Natl Yang Ming Univ, Sch Med, Dept Med, Taipei 112, Taiwan; [Li, Ya-Ling; Hsu, Shih-Lan] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Wen, Chi-Luan] Taiwan Seed Improvement & Propagat Stn, Council Agr, Propagat Technol Sect, Taichung, Taiwan; [Chen, Tzu-Hsiu] Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Providence University - Taiwan; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Chia Nan University of Pharmacy & Science	Chen, TH (corresponding author), Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan.	hsiu@mail.cnu.edu.tw			Taichung Veterans General Hospital [TCVGH1033209C, TCVGH-1027305D, TCVGH-1027319D]	Taichung Veterans General Hospital	This work was supported in part by grants from the Taichung Veterans General Hospital (TCVGH1033209C) to Tsung-Ying Yang, MD, PhD, as well as from the Taichung Veterans General Hospital (TCVGH-1027305D), and TCVGH-1027319D to Dr. Shih-Lan Hsu.	Agarwal C, 2006, MOL CANCER THER, V5, P3294, DOI 10.1158/1535-7163.MCT-06-0483; Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Barni S, 2013, REV RECENT CLIN TRIA, V8, P101, DOI 10.2174/15748871113089990042; Beretta GL, 2008, MINI-REV MED CHEM, V8, P856, DOI 10.2174/138955708785132774; Beretta GL, 2008, TARGETING TOPOISOMER; Bo S, 2014, FOOD CHEM TOXICOL, V68, P61, DOI 10.1016/j.fct.2014.03.007; Boohaker Rebecca J, 2014, Biomed J, V37, P3, DOI 10.4103/2319-4170.125655; Bouchier-Hayes L, 2012, CELL DEATH DIFFER, V19, P51, DOI 10.1038/cdd.2011.157; Cao Y, 2010, ANTICANCER RES, V30, P3911; Chen KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097888; Chen MC, 2012, CANCER SCI, V103, P80, DOI 10.1111/j.1349-7006.2011.02103.x; Cheng SB, 2012, J AGR FOOD CHEM, V60, P9620, DOI 10.1021/jf301882b; Chiang YY, 2013, INT J MOL MED, V32, P577, DOI 10.3892/ijmm.2013.1441; Chuang CY, 2010, J AGR FOOD CHEM, V58, P2943, DOI 10.1021/jf9043265; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; DARPA P, 1989, BIOCHIM BIOPHYS ACTA, V989, P163, DOI 10.1016/0304-419X(89)90041-3; Department of Health T, 2005, VIT STAT VIT STAT; Du Z, 2012, TUMORI, V99, P57; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; El-Deiry WS, 1998, SEMINARS CANC BIOL; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; FONSECA SF, 1980, PHYTOCHEMISTRY, V19, P1527, DOI 10.1016/S0031-9422(00)82115-9; Fu YR, 2006, MITOCHONDRION, V6, P211, DOI 10.1016/j.mito.2006.07.005; Fukuda M, 1996, CANCER RES, V56, P789; Grossi F, 2001, CRIT REV ONCOL HEMAT, V37, P61, DOI 10.1016/S1040-8428(00)00098-6; Haug K, 2008, ANTICANCER RES, V28, P583; He HY, 2011, MOLECULES, V16, P10685, DOI 10.3390/molecules161210685; Hsieh YC, 2010, CHEM RES TOXICOL, V23, P1256, DOI 10.1021/tx100116a; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kamal A, 2013, BIOORGAN MED CHEM, V21, P5198, DOI 10.1016/j.bmc.2013.06.033; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Khadka DB, 2011, BIOORGAN MED CHEM, V19, P724, DOI 10.1016/j.bmc.2010.10.057; Kocher S, 2013, RADIOTHER ONCOL, V108, P409, DOI 10.1016/j.radonc.2013.06.024; Korbakis D, 2009, TUMOR BIOL, V30, P100, DOI 10.1159/000218160; Kumler I, 2013, BREAST CANCER RES TR, V138, P347, DOI 10.1007/s10549-013-2476-3; Lai JM, 2009, EUR J PHARMACOL, V623, P1, DOI 10.1016/j.ejphar.2009.08.031; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Le Treut J, 2013, ANN ONCOL, V24, P1548, DOI 10.1093/annonc/mdt009; Lee JG, 2013, FOOD CHEM TOXICOL, V55, P214, DOI 10.1016/j.fct.2012.12.026; Lee TH, 2009, J NAT MED-TOKYO, V63, P209, DOI 10.1007/s11418-009-0314-z; Legarza K, 2006, ANTICANCER RES, V26, P3301; Letai A, 2009, J CELL BIOL, V185, P189, DOI 10.1083/jcb.200903134; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li G, 2004, BIOL PHARM BULL, V27, P1147, DOI 10.1248/bpb.27.1147; Lien JC, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/453679; Lin CB, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/326096; Lin CY, 2014, MOL MED REPORTS; MacKenzie SH, 2012, ADV EXP MED BIOL, V747, P55, DOI 10.1007/978-1-4614-3229-6_4; Mizutani H, 2002, J BIOL CHEM, V277, P30684, DOI 10.1074/jbc.M204353200; Mukherjee T, 2012, NAT PROD COMMUN, V7, P767; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Provinciali M, 2013, CURR PHARM DESIGN, V19, P1699; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rios J.L., 2002, STUDIES NATURAL PROD, V26, P183, DOI DOI 10.1016/S1572-5995(02)80008-4); Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; SONG YN, 1994, J NAT PROD, V57, P1670, DOI 10.1021/np50114a008; Su YT, 2005, BIOCHEM PHARMACOL, V70, P229, DOI 10.1016/j.bcp.2005.04.026; Sun HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036808; Takeba Y, 2007, BIOL PHARM BULL, V30, P1400, DOI 10.1248/bpb.30.1400; Thomas A, 2014, ONCOGENE; Turner T, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140008; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Wang T, 2004, WORLD J GASTROENTERO, V10, P2205; Wesierska-Gadek J, 2011, CURR PHARM DESIGN, V17, P256; White Y, 2011, ANTICANCER RES, V31, P4251; Wu CC, 2011, BIOCHEM BIOPH RES CO, V405, P168, DOI 10.1016/j.bbrc.2011.01.001; Wu J, 2010, ACTA PHARMACOL SIN, V31, P93, DOI 10.1038/aps.2009.183; Wu SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112220; YANG CS, 1993, J NATL CANCER I, V85, P1038, DOI 10.1093/jnci/85.13.1038; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhao Y, 2013, CANCER SCI, V104, P1062, DOI 10.1111/cas.12182	75	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132052	10.1371/journal.pone.0132052	http://dx.doi.org/10.1371/journal.pone.0132052			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147394	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600190
J	Xu, JL; Jin, B; Ren, ZH; Lou, YQ; Zhou, ZR; Yang, QZ; Han, BH				Xu, J. L.; Jin, B.; Ren, Z. H.; Lou, Y. Q.; Zhou, Z. R.; Yang, Q. Z.; Han, B. H.			Chemotherapy plus Erlotinib versus Chemotherapy Alone for Treating Advanced Non-Small Cell Lung Cancer: A Meta-Analysis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; RANDOMIZED PHASE-II; 1ST-LINE TREATMENT; 2ND-LINE TREATMENT; OPEN-LABEL; COMBINATION; TRIAL; GEMCITABINE; MULTICENTER; CARBOPLATIN	Background Whether a combination of chemotherapy and erlotinib is beneficial for advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to summarize the currently available evidence and compare the efficacy and safety of chemotherapy plus erlotinib versus chemotherapy alone for treating advanced NSCLC. Methods EMBASE, PubMed, and the Cochrane Central Register of Controlled Trials were searched for relevant studies. Our protocol was registered in PROSPERO (CRD42014015015). Results Nine randomized controlled trials with a total of 3599 patients were included. Compared to chemotherapy alone, chemotherapy plus erlotinib was superior in PFS (HR = 0.76 [95% CI 0.62, 0.92], P = 0.006), and no statistically significant difference was observed in OS (HR = 0.94 [95% CI 0.86, 1.03], P = 0.16). Intercalated erlotinib plus chemotherapy demonstrated improvements in PFS (HR = 0.67 [95% CI 0.50, 0.91], P = 0.009) and OS (HR = 0.82 [95% CI 0.69, 0.98], P = 0.03). Continuous erlotinib plus chemotherapy treatment failed to demonstrate improvements in PFS (HR = 0.91 [95% CI 0.80, 1.04], P = 0.16) and OS (HR = 0.98 [95% CI 0.89, 1.09], P = 0.75). The association of chemotherapy plus erlotinib with improvement in PFS was significant in never smoking patients (HR = 0.46 [95% CI 0.37, 0.56], P < 0.00001) but not in smoking patients (HR = 0.70 [95% CI 0.49, 1.00], P = 0.05). Among patients with EGFR mutant tumors, chemotherapy plus erlotinib demonstrated significant improvements in PFS (HR = 0.31 [95% CI 0.17, 0.58], P = 0.0002) and OS (HR = 0.52 [95% CI 0.30, 0.88], P = 0.01). Among patients with EGFR wild-type tumors, no statistically significant difference was observed with respect to PFS (HR = 0.87 [95% CI 0.70, 1.08], P = 0.21) and OS (HR = 0.78 [95% CI 0.59, 1.01], P = 0.06). Conclusion Combination of chemotherapy and erlotinib is a viable treatment option for patients with NSCLC, especially for patients who never smoked and patients with EGFR mutation-positive disease. In addition, intercalated administration is an effective combinatorial strategy.	[Xu, J. L.; Jin, B.; Lou, Y. Q.; Han, B. H.] Shanghai Jiao Tong Univ, Dept Pulm, Shanghai Chest Hosp, Shanghai 200030, Peoples R China; [Jin, B.] Shanghai Jiao Tong Univ, Ninth Peoples Hosp Shanghai, Shanghai 200030, Peoples R China; [Zhou, Z. R.] Fudan Univ, Dept Oncol, Shanghai Canc Ctr, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Yang, Q. Z.] Women & Child Care Heyuan, Dept Gynecol, Guangzhou, Guangdong, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University	Han, BH (corresponding author), Shanghai Jiao Tong Univ, Dept Pulm, Shanghai Chest Hosp, Shanghai 200030, Peoples R China.	xkyyhan@gmail.com			Key projects of Biomedicine Department, Science and Technology Commission of Shanghai Municipality [11411951200]	Key projects of Biomedicine Department, Science and Technology Commission of Shanghai Municipality	The study was supported by Key projects of Biomedicine Department, Science and Technology Commission of Shanghai Municipality (Project No11411951200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JG, 2013, ANN ONCOL, V24, P2860, DOI 10.1093/annonc/mdt341; Ahn MJ, 2010, J THORAC ONCOL, V5, P1185, DOI 10.1097/JTO.0b013e3181e2f624; Auliac JB, 2014, LUNG CANCER, V85, P415, DOI 10.1016/j.lungcan.2014.07.006; Boutsikou E, 2013, ONCOTARGETS THER, V6, P125, DOI 10.2147/OTT.S42245; Cataldo VD, 2011, NEW ENGL J MED, V364, P947, DOI 10.1056/NEJMct0807960; Dittrich C, 2014, EUR J CANCER, V50, P1571, DOI 10.1016/j.ejca.2014.03.007; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Feld R, 2006, J THORAC ONCOL, V1, P367, DOI 10.1097/01243894-200605000-00018; Gatzemeier U, 2007, J CLIN ONCOL, V25, P1545, DOI 10.1200/JCO.2005.05.1474; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lee DH, 2013, EUR J CANCER, V49, P3111, DOI 10.1016/j.ejca.2013.06.035; Li T, 2013, J CLIN ONCOL, P31; Li TH, 2007, CLIN CANCER RES, V13, P3413, DOI 10.1158/1078-0432.CCR-06-2923; Michael M, 2014, ASIA PAC J CLIN ONCO; Minami S, 2013, LUNG CANCER, V82, P271, DOI 10.1016/j.lungcan.2013.07.022; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mok TSK, 2009, J CLIN ONCOL, V27, P5080, DOI 10.1200/JCO.2008.21.5541; Qi WX, 2012, ASIAN PAC J CANCER P, V13, P5177, DOI 10.7314/APJCP.2012.13.10.5177; Reck M, 2014, ANN ONCOL, V25, P27, DOI 10.1093/annonc/mdu199; Rossi A, 2014, LANCET ONCOL, V15, P1254, DOI 10.1016/S1470-2045(14)70402-4; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stinchcombe TE, 2013, J THORAC ONCOL, V8, P443, DOI 10.1097/JTO.0b013e3182835577; Stinchcombe TE, 2011, J THORAC ONCOL, V6, P1569, DOI 10.1097/JTO.0b013e3182210430; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Wu YL, 2013, LANCET ONCOL, V14, P777, DOI 10.1016/S1470-2045(13)70254-7; Xu J, 2014, PROSPERO; Zhang WS, 2014, DRUG DES DEV THER, V8, P735, DOI 10.2147/DDDT.S60672; Zheng YL, 2013, LANCET ONCOL, V14, pE438, DOI 10.1016/S1470-2045(13)70412-1; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Zhou JG, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0471-0; Zwitter M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/185646	33	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131278	10.1371/journal.pone.0131278	http://dx.doi.org/10.1371/journal.pone.0131278			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147288	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600081
J	Yang, XY; Zheng, KD; Lin, K; Zheng, GF; Zou, H; Wang, JM; Lin, YY; Chuka, CM; Ge, RS; Zhai, WT; Wang, JG				Yang, Xin Yu; Zheng, Kai Di; Lin, Ke; Zheng, Guifeng; Zou, Hai; Wang, Jian Min; Lin, Yao Yao; Chuka, Chifundo Martha; Ge, Ren Shan; Zhai, Weitao; Wang, Jian Guang			Energy Metabolism Disorder as a Contributing Factor of Rheumatoid Arthritis: A Comparative Proteomic and Metabolomic Study	PLOS ONE			English	Article							SYNOVIAL-FLUID; HYPOXIA; ANGIOGENESIS; PATHOGENESIS; PROFILES	Objectives To explore the pathogenesis of rheumatoid arthritis (RA), the different metabolites were screened in synovial fluid by metabolomics. Methods Synovial fluid from 25 RA patients and 10 normal subjects were analyzed by GC/TOF MS analysis so as to give a broad overview of synovial fluid metabolites. The metabolic profiles of RA patients and normal subjects were compared using multivariate statistical analysis. Different proteins were verified by qPCR and western blot. Different metabolites were verified by colorimetric assay kit in 25 inactive RA patients, 25 active RA patients and 20 normal subjects. The influence of hypoxia-inducible factor (HIF)-1 alpha pathway on catabolism was detected by HIF-1 alpha knockdown. Results A subset of 58 metabolites was identified, in which the concentrations of 7 metabolites related to energy metabolism were significantly different as shown by importance in the projection (VIP) (VIP >= 1) and Student's t-test (p<0.05). In the 7 metabolites, the concentration of glucose was decreased, and the concentration of lactic acid was increased in the synovial fluid of RA patients than normal subjects verified by colorimetric assay Kit. Receiver operator characteristic (ROC) analysis shows that the concentration of glucose and lactic acid in synovial fluid could be used as dependable biomarkers for the diagnosis of active RA, provided an AUC of 0.906 and 0.922. Sensitivity and specificity, which were determined by cut-off points, reached 84% and 96% in sensitivity and 95% and 85% in specificity, respectively. The verification of different proteins identified in our previous proteomic study shows that the enzymes of anaerobic catabolism were up-regulated (PFKP and LDHA), and the enzymes of aerobic oxidation and fatty acid oxidation were down-regulated (CS, DLST, PGD, ACSL4, ACADVL and HADHA) in RA patients. The expression of HIF-1 alpha and the enzymes of aerobic oxidation and fatty acid oxidation were decreased and the enzymes of anaerobic catabolism were increased in FLS cells after HIF-1 alpha knockdown. Conclusion It was found that enhanced anaerobic catabolism and reduced aerobic oxidation regulated by HIF pathway are newly recognized factors contributing to the progression of RA, and low glucose and high lactic acid concentration in synovial fluid may be the potential biomarker of RA.	[Yang, Xin Yu] Wenzhou Med Univ, Sch Pharmaceut Sci, Dept Med Chem, Wenzhou, Peoples R China; [Zheng, Kai Di; Lin, Ke; Zheng, Guifeng; Zou, Hai; Lin, Yao Yao; Chuka, Chifundo Martha; Ge, Ren Shan; Wang, Jian Guang] Wenzhou Med Univ, Sch Basic Med Sci, Dept Biochem, Wenzhou, Peoples R China; [Wang, Jian Min] Jiamusi Cent Hosp, Dept Rheumatol, Jiamusi, Peoples R China; [Zhai, Weitao] Shanghai Guanghua Special Hosp Rheumatoid Arthrit, Dept Orthopaed Surg, Shanghai, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Zhai, WT (corresponding author), Shanghai Guanghua Special Hosp Rheumatoid Arthrit, Dept Orthopaed Surg, Shanghai, Peoples R China.	wtzhai@yahoo.com.cn; wz_wjg@163.com	wang, jian/GVS-0711-2022		Natural Science Foundations; Health Bureau funding of Zhejiang Province [R13H060001, LY12H28003, 2012KYB123, 2013KYB170]; National Natural Science Foundation of China [81201375, 81472055]; Zhejiang College Student Innovative Research Team [2015R413064]	Natural Science Foundations; Health Bureau funding of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang College Student Innovative Research Team	This project was supported by The Natural Science Foundations and the Health Bureau funding of Zhejiang Province (Grant No. R13H060001, LY12H28003 and 2012KYB123, 2013KYB170), the National Natural Science Foundation of China (Grant No. 81201375 and 81472055), Zhejiang College Student Innovative Research Team (Grant No. 2015R413064).	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bodamyali T, 1998, ANN RHEUM DIS, V57, P703, DOI 10.1136/ard.57.12.703; Distler JHW, 2004, ARTHRITIS RHEUM-US, V50, P10, DOI 10.1002/art.11425; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Gaber T, 2005, ANN RHEUM DIS, V64, P971, DOI 10.1136/ard.2004.031641; Giatromanolaki A, 2003, ARTHRITIS RES THER, V5, pR193, DOI 10.1186/ar756; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Gu Y, 2012, MOL BIOSYST, V8, P1535, DOI 10.1039/c2mb25022e; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HENDERSON B, 1979, ANN RHEUM DIS, V38, P63, DOI 10.1136/ard.38.1.63; Hitchon CA, 2009, RHEUMATOL INT, V29, P1205, DOI 10.1007/s00296-009-0865-z; Hollander AP, 2001, ARTHRITIS RHEUM-US, V44, P1540, DOI 10.1002/1529-0131(200107)44:7<1540::AID-ART277>3.0.CO;2-7; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Kapoor SR, 2013, ARTHRITIS RHEUM-US, V65, P1448, DOI 10.1002/art.37921; Kim S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097501; KONDO S, 1974, J INVEST DERMATOL, V62, P503; Li X, 2010, METABOLOMICS, V6, P109, DOI 10.1007/s11306-009-0184-0; Mobasheri A, 2005, HISTOL HISTOPATHOL, V20, P1327, DOI 10.14670/HH-20.1327; MOSSMAN SS, 1981, NEW ZEAL MED J, V93, P115; NAUGHTON D, 1993, FEBS LETT, V317, P135, DOI 10.1016/0014-5793(93)81508-W; NAUGHTON DP, 1993, FEBS LETT, V332, P221, DOI 10.1016/0014-5793(93)80636-9; Okamoto H, 2008, FEBS J, V275, P4463, DOI 10.1111/j.1742-4658.2008.06582.x; Pan XY, 2011, J PROTEOME RES, V10, P3493, DOI 10.1021/pr200114v; Pap T, 2000, ARTHRITIS RHEUM, V43, P2531, DOI 10.1002/1529-0131(200011)43:11<2531::AID-ANR21>3.0.CO;2-V; Procaccini C, 2012, TRENDS IMMUNOL, V33, P1, DOI 10.1016/j.it.2011.09.002; Salaffi F, 2000, RHEUMATOLOGY, V39, P90, DOI 10.1093/rheumatology/39.1.90; SEWELL KL, 1993, LANCET, V341, P283, DOI 10.1016/0140-6736(93)92627-6; Spies CM, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3885; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stobbe MD, 2012, FASEB J, V26, P3625, DOI 10.1096/fj.11-203091; Tak PP, 2000, IMMUNOL TODAY, V21, P78, DOI 10.1016/S0167-5699(99)01552-2; Taylor PC, 2005, CURR OPIN RHEUMATOL, V17, P293, DOI 10.1097/01.bor.0000155361.83990.5b; Tobon GJ, 2010, J AUTOIMMUN, V35, P10, DOI 10.1016/j.jaut.2009.12.009; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Wang JG, 2012, ARTHRITIS RHEUM-US, V64, P993, DOI 10.1002/art.33425; Wang ZG, 2012, EXP THER MED, V4, P165, DOI 10.3892/etm.2012.567; Wietmarschen H. van, 2012, British Journal of Medicine and Medical Research, V2, P469; Young SP, 2013, ARTHRITIS RHEUM-US, V65, P2015, DOI 10.1002/art.38021	39	62	70	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132695	10.1371/journal.pone.0132695	http://dx.doi.org/10.1371/journal.pone.0132695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147000	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600312
J	Elliott, MA; Kelly, J; Friedel, J; Brodsky, J; Mulcahy, P				Elliott, Mark A.; Kelly, Joy; Friedel, Jonas; Brodsky, Jennifer; Mulcahy, Paul			The Golden Section as Optical Limitation	PLOS ONE			English	Article							COGNITIVE-PROCESSES; SIZE ADAPTATION; FRACTIONS; DELTA; THETA; TRANSFORMATIONS; SYNCHRONIZATION; MAGNITUDES; AESTHETICS; GAMMA	The golden section, phi = (1 + root 5)/2 = 1.618 ... and its companion phi = 1/phi = phi -1 = 0.618 ..., are irrational numbers which for centuries were believed to confer aesthetic appeal. In line with the presence of golden sectioning in natural growth patterns, recent EEG recordings show an absence of coherence between brain frequencies related by the golden ratio, suggesting the potential relevance of the golden section to brain dynamics. Using Mondriantype patterns comprising a number of paired sections in a range of five section-section areal ratios (including golden-sectioned pairs), participants were asked to indicate as rapidly and accurately as possible the polarity (light or dark) of the smallest section in the patterns. They were also asked to independently assess the aesthetic appeal of the patterns. No preference was found for golden-sectioned patterns, while reaction times (RTs) tended to decrease overall with increasing ratio independently of each pattern's fractal dimensionality. (Fractal dimensionality was unrelated to ratio and measured in terms of the Minkowski-Bouligand box-counting dimension). The ease of detecting the smallest section also decreased with increasing ratio, although RTs were found to be substantially slower for golden-sectioned patterns under 8-paired sectioned conditions. This was confirmed by a significant linear relationship between RT and ratio (p < .001) only when the golden-sectioned RTs were excluded [the relationship was non-significant for the full complement of ratios (p = .217)]. Image analysis revealed an absence of spatial frequencies between 4 and 8 cycles-perdegree that was exclusive to the 8-paired (golden)-sectioned patterns. The significance of this was demonstrated in a subsequent experiment by addition of uniformly distributed random noise to the patterns. This provided a uniform spatial-frequency profile for all patterns, which did not influence the decrease in RT with increasing ratio but abolished the elevated RTs to golden-sectioned patterns. This suggests that optical limitation in the form of reduced inter-neural synchronization during spatial-frequency coding may be the foundation for the perceptual effects of golden sectioning.	[Elliott, Mark A.; Kelly, Joy; Mulcahy, Paul] Natl Univ Ireland Galway, Sch Psychol, Galway, Ireland; [Friedel, Jonas] Salzburg Univ, Dept Psychol, A-5020 Salzburg, Austria; [Brodsky, Jennifer] Union Coll, Dept Psychol, Schenectady, NY 12308 USA	Ollscoil na Gaillimhe-University of Galway; Salzburg University; Union College	Elliott, MA (corresponding author), Natl Univ Ireland Galway, Sch Psychol, Galway, Ireland.	mark.elliott@nuigalway.ie		Mulcahy, Paul/0000-0002-4005-1588; Elliott, Mark/0000-0003-2560-8760				ANSTIS SM, 1974, AM J PSYCHOL, V87, P261, DOI 10.2307/1422020; Barraza P, 2014, NEUROSCI LETT, V567, P40, DOI 10.1016/j.neulet.2014.03.021; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Basar E, 1999, NEUROSCI LETT, V259, P165, DOI 10.1016/S0304-3940(98)00934-3; Basar E., 1998, BRAIN FUNCTION OSCIL; BASAREROGLU C, 1992, INT J PSYCHOPHYSIOL, V13, P161, DOI 10.1016/0167-8760(92)90055-G; Bejan A., 2009, INT J DES NATURE ECO, V4, P97, DOI [10.2495/DNE-V4-N2-97-104, DOI 10.2495/DNE-V4-N2-97-104]; BLAKEMOR.C, 1969, SCIENCE, V166, P245, DOI 10.1126/science.166.3902.245; BLAKEMORE C, 1970, J PHYSIOL-LONDON, V210, P727, DOI 10.1113/jphysiol.1970.sp009238; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BOX GEP, 1982, J AM STAT ASSOC, V77, P209, DOI 10.2307/2287791; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V197, P551, DOI 10.1113/jphysiol.1968.sp008574; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Cohen MX, 2008, J NEUROSCI METH, V168, P494, DOI 10.1016/j.jneumeth.2007.10.012; Elul R, 1971, Int Rev Neurobiol, V15, P227; Fechner, 1865, ARCH ZEICHNENDEN KUN, V11, P100; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; FOWLER DH, 1982, FIBONACCI QUART, V20, P146; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Ganor-Stern D, 2011, EXP PSYCHOL, V58, P201, DOI 10.1027/1618-3169/a000086; Ghyka Matila, 1977, GEOMETRY ART LIFE; GODKEWITSCH M, 1974, AM J PSYCHOL, V87, P269, DOI 10.2307/1422021; GREEN CD, 1995, PERCEPTION, V24, P937, DOI 10.1068/p240937; Hambridge J, 1920, DYNAMIC SYMMETRY GRE; HINTZ JM, 1970, AM J PSYCHOL, V83, P126, DOI 10.2307/1420863; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; Jacob SN, 2012, TRENDS COGN SCI, V16, P157, DOI 10.1016/j.tics.2012.02.002; Livio M., 2008, GOLDEN RATIO STORY P; Lopes da Silva F H, 1976, Prog Brain Res, V45, P281; Lynch JW, 1993, J QUANT ANTHR, V4, P211; MCMANUS IC, 1980, BRIT J PSYCHOL, V71, P505, DOI 10.1111/j.2044-8295.1980.tb01763.x; Ogden RM, 1937, AM J PSYCHOL, V49, P198, DOI 10.2307/1416290; Pacioli di Borgo L, DIVINA PROPORTIONE; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pletzer B, 2010, BRAIN RES, V1335, P91, DOI 10.1016/j.brainres.2010.03.074; PRESSEY AW, 1972, PERCEPT PSYCHOPHYS, V11, P28, DOI 10.3758/BF03212677; Redies C, 2008, SPATIAL VISION, V21, P97, DOI 10.1163/156856808782713780; Restle F, 1971, ADAPTATION LEVEL THE, P55; Restle F, 1978, FORMAL THEORIES VISU, P247; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schneider M, 2010, J EXP PSYCHOL HUMAN, V36, P1227, DOI 10.1037/a0018170; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Spehar B, 2003, COMPUT GRAPH-UK, V27, P813, DOI 10.1016/S0097-8493(03)00154-7; STONE LA, 1965, AM J PSYCHOL, V78, P503, DOI 10.2307/1420591; Thurstone LL, 1927, PSYCHOL REV, V34, P273, DOI 10.1037/h0070288; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Zeising, 1855, AESTHETISCHE FORSCHU; Zeising A, 1854, NEUE LEHRE PROPORTIO	48	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131045	10.1371/journal.pone.0131045	http://dx.doi.org/10.1371/journal.pone.0131045			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154761	Green Submitted, Green Published, gold			2022-12-27	WOS:000358159700052
J	Kingdon, C; O'Donnell, E; Givens, J; Turner, M				Kingdon, Carol; O'Donnell, Emer; Givens, Jennifer; Turner, Mark			The Role of Healthcare Professionals in Encouraging Parents to See and Hold Their Stillborn Baby: A Meta-Synthesis of Qualitative Studies	PLOS ONE			English	Article							PERINATAL LOSS; NEONATAL DEATH; STILLBIRTH; EXPERIENCES; MOTHERS; BIRTH; MANAGEMENT; MEMORIES; BABIES; QUESTIONNAIRE	Background Globally, during 2013 there were three million recorded stillbirths. Where clinical guidelines exist some recommend that professionals do not encourage parental contact. The guidance is based on quantitative evidence that seeing and holding the baby is not beneficial for everyone, but has been challenged by bereaved parents' organisations. We aim to inform future guideline development through a synthesis of qualitative studies reporting data relevant to the research question; how does the approach of healthcare professionals to seeing and holding the baby following stillbirth impact parents views and experiences? Methods/Findings Using a predetermined search strategy of PubMed and PsychINFO we identified robust qualitative studies reporting bereaved parental views and/or experiences relating to seeing and holding their stillborn baby (final search 24 February, 2014). Eligible studies were English language, reporting parental views, with gestational loss >20weeks. Quality was independently assessed by three authors using a validated tool. We used meta-ethnographic techniques to identify key themes and a line of argument synthesis. We included 12 papers, representing the views of 333 parents (156 mothers, 150 fathers, and 27 couples) from six countries. The final themes were: "[Still] birth: Nature of care is paramount", "Real babies: Perfect beauties, monsters and spectres", and "Opportunity of a lifetime lost." Our line-of-argument synthesis highlights the contrast between all parents need to know their baby, with the time around birth being the only time memories can be made, and the variable ability that parents have to articulate their preferences at that time. Thus, we hypothesised that how health professionals approach contact between parents and their stillborn baby demands a degree of active management. An important limitation of this paper is all included studies originated from high income, westernised countries raising questions about the findings transferability to other cultural contexts. We do not offer new evidence to answer the question "Should parents see and hold their stillborn baby?", instead our findings advance understanding of how professionals can support parents to make appropriate decisions in a novel, highly charged and dynamic situation. Conclusions Guidelines could be more specific in their recommendations regarding parental contact. The role of healthcare professionals in encouraging parents to see and hold their stillborn baby is paramount. Parental choice not to see their baby, apprehension, or uncertainty should be continuously revisited in the hours after birth as the opportunity for contact is fleeting and final.	[Kingdon, Carol] Univ Cent Lancashire, Sch Hlth, Preston PR1 2HE, Lancs, England; [O'Donnell, Emer; Givens, Jennifer; Turner, Mark] Univ Liverpool, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England	University of Central Lancashire; University of Liverpool	Kingdon, C (corresponding author), Univ Cent Lancashire, Sch Hlth, Preston PR1 2HE, Lancs, England.	ckingdon@uclan.ac.uk		Turner, Mark/0000-0002-5299-8656; Kingdon, Carol/0000-0002-5958-9257				American College of Obstetricians and Gynecologists, 2009, OBSTET GYNECOL, V113, P478, DOI [10.1097/AOG.0b013e31819698fe, DOI 10.1097/AOG.0B013E31819698FE]; [Anonymous], 2011, SUPPLEMENTARY GUIDAN; Bennett SM, 2005, PROF PSYCHOL-RES PR, V36, P180, DOI 10.1037/0735-7028.36.2.180; Bonanno GA, 2002, J PERS SOC PSYCHOL, V83, P1150, DOI 10.1037//0022-3514.83.5.1150; Cacciatore J, 2013, INT J NURS STUD, V50, P664, DOI 10.1016/j.ijnurstu.2012.10.014; Cacciatore J, 2007, J SOC WORK END-LIFE, V3, P59, DOI 10.1300/J457v03n03_06; Cacciatore J, 2011, STILLBIRTH: PREDICTION, PREVENTION AND MANAGEMENT, P203; Cacciatore J, 2010, SOC WORK HEALTH CARE, V49, P134, DOI 10.1080/00981380903158078; Cacciatore J, 2008, BIRTH-ISS PERINAT C, V35, P313, DOI 10.1111/j.1523-536X.2008.00258.x; Chan MF, 2007, MIDWIFERY, V23, P309, DOI 10.1016/j.midw.2006.05.005; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Crawley R, 2013, J REPROD INFANT PSYC, V31, P195, DOI 10.1080/02646838.2013.795216; Cunningham KA, 2012, MED J AUSTRALIA, V196, P558, DOI 10.5694/mja11.11417; Dixon-Woods Mary, 2005, J Health Serv Res Policy, V10, P45, DOI 10.1258/1355819052801804; Downe S, 2007, J ADV NURS, V57, P127, DOI 10.1111/j.1365-2648.2006.04079.x; Downe S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002237; Downe S, 2012, EUR J OBSTET GYN R B, V162, P33, DOI 10.1016/j.ejogrb.2012.02.002; Erlandsson K, 2013, MIDWIFERY, V29, P246, DOI 10.1016/j.midw.2012.01.007; Finlayson K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001373; Flenady V, 2009, PSANZ CLIN PRACTICE; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Flenady VJ, 2012, MED J AUSTRALIA, V197, P276, DOI 10.5694/mja12.10982; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Glenton C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010414.pub2; Gold KJ, 2008, OBSTET GYNECOL, V112, P29, DOI 10.1097/AOG.0b013e31817d0582; Hughes P, 2002, LANCET, V360, P114, DOI 10.1016/S0140-6736(02)09410-2; Jensen LA, 1996, QUAL HEALTH RES, V6, P553, DOI 10.1177/104973239600600407; Joanna Briggs Institute Levels of Evidence and Grades of Recommendation Working Party, 2014, SUPP DOC JOANN BRIGG; Jonas-Simpson C, 2013, SAGE OPEN, V3, DOI 10.1177/2158244013486116; KENNELL JH, 1970, NEW ENGL J MED, V283, P344, DOI 10.1056/NEJM197008132830706; Kingdon C., 2013, BRIT J MIDWIFERY, V13, P622; Kohner N, 2001, BABY DIES EXPERIENCE; Lathrop A, 2011, BIRTH-ISS PERINAT C, V38, P256, DOI 10.1111/j.1523-536X.2011.00478.x; Lee, 2014, BRIT J HEALTH PSYCH, DOI [10.1111/bjhp.12121, DOI 10.1111/BJHP.12121]; Lee C, 2012, J REPROD INFANT PSYC, V30, P62, DOI 10.1080/02646838.2012.661849; LEON IG, 1992, CLIN PEDIATR, V31, P366, DOI 10.1177/000992289203100611; LEWIS E, 1979, BRIT MED J, V2, P27, DOI 10.1136/bmj.2.6181.27; LEWIS E, 1976, LANCET, V2, P619; LEWIS E, 1979, ARCH DIS CHILD, V54, P303, DOI 10.1136/adc.54.4.303; Li Z., 2011, Perinatal Statistics Series; LOVELL A, 1983, SOC SCI MED, V17, P755, DOI 10.1016/0277-9536(83)90264-2; Lunde A, 2013, J MIX METHOD RES, V7, P197, DOI 10.1177/1558689812471087; National Institute for Health and Clinical Excellence, 2014, ANT POSTN MENT HLTH; National Institute for Health and Clinical Excellence, 2007, ANT POSTN MENT HLTH; Noblit G. W., 1988, METAETHNOGRAPHY SYNT; Nuzum D, 2014, BJOG-INT J OBSTET GY, V121, P1020, DOI 10.1111/1471-0528.12695; Population Reference Bureau, 2013 WORLD POP DAT S; Radestad I, 1996, BRIT MED J, V312, P1505, DOI 10.1136/bmj.312.7045.1505; Radestad I, 2009, MIDWIFERY, V25, P422, DOI 10.1016/j.midw.2007.03.005; Redshaw M, 2010, BIRTH-ISS PERINAT C, V37, P150, DOI 10.1111/j.1523-536X.2010.00395.x; Ring N, 2010, GUIDE SYNTHESISING Q; Roehrs C, 2008, JOGNN-J OBST GYN NEO, V37, P631, DOI 10.1111/j.1552-6909.2008.00290.x; Roose RE, 2011, J PERINAT NEONAT NUR, V25, P77, DOI 10.1097/JPN.0b013e318208cb74; Royal College of Obstetricians and Gynaecologists, 1995, REP RCOG WORK PART M; Royal College of Obstetricians and Gynaecologists, 2010, GREEN TOP GUID 55 LA; Saflund K, 2004, BIRTH-ISS PERINAT C, V31, P132, DOI 10.1111/j.0730-7659.2004.00291.x; Samuelsson M, 2001, BIRTH-ISS PERINAT C, V28, P124, DOI 10.1046/j.1523-536X.2001.00124.x; Sandelowski M, 1997, RES NURS HEALTH, V20, P365, DOI 10.1002/(SICI)1098-240X(199708)20:4<365::AID-NUR9>3.0.CO;2-E; Simkin P., 1981, BIRTH-ISS PERINAT C, V19, P64; Stillbirth Foundation Australia and The Joanna Briggs Institute, 2014, BEST PRACT EV BAS GU; Trulsson O, 2004, BIRTH-ISS PERINAT C, V31, P189, DOI 10.1111/j.0730-7659.2004.00304.x; Turton P, 2009, J CHILD PSYCHOL PSYC, V50, P1451, DOI 10.1111/j.1469-7610.2009.02111.x; Turton P, 2009, ARCH WOMEN MENT HLTH, V12, P35, DOI 10.1007/s00737-008-0040-7; Wallbank S, 2013, INT J NURS STUD, V50, P1090, DOI 10.1016/j.ijnurstu.2012.11.022; Walsh D, 2005, J ADV NURS, V50, P204, DOI 10.1111/j.1365-2648.2005.03380.x; Walsh D, 2006, MIDWIFERY, V22, P108, DOI 10.1016/j.midw.2005.05.004; Wong G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-20; World Health Organisation, 2014, STILLB; Worth N J, 1997, Clin Nurs Res, V6, P71, DOI 10.1177/105477389700600107; Yamazaki A, 2010, HEALTH CARE WOMEN IN, V31, P921, DOI 10.1080/07399332.2010.503289	70	24	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130059	10.1371/journal.pone.0130059	http://dx.doi.org/10.1371/journal.pone.0130059			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26154302	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000358159700022
J	Witvorapong, N; Muttarak, R; Pothisiri, W				Witvorapong, Nopphol; Muttarak, Raya; Pothisiri, Wiraporn			Social Participation and Disaster Risk Reduction Behaviors in Tsunami Prone Areas	PLOS ONE			English	Article							SOCIOECONOMIC DIFFERENCES; MOBILITY INTENTIONS; CLIMATE-CHANGE; PREPAREDNESS; HEALTH; HAZARD; POPULATION; PREDICTORS; MIGRATION; RECOVERY	This paper examines the relationships between social participation and disaster risk reduction actions. A survey of 557 households in tsunami prone areas in Phang Nga, Thailand was conducted following the 2012 Indian Ocean earthquakes. We use a multivariate probit model to jointly estimate the likelihood of undertaking three responses to earthquake and tsunami hazards (namely, (1) following disaster-related news closely, (2) preparing emergency kits and/or having a family emergency plan, and (3) having an intention to migrate) and community participation. We find that those who experienced losses from the 2004 tsunami are more likely to participate in community activities and respond to earthquake hazards. Compared to men, women are more likely to prepare emergency kits and/or have an emergency plan and have a greater intention to migrate. Living in a community with a higher proportion of women with tertiary education increases the probability of engaging in community activities and carrying out disaster risk reduction measures. Individuals who participate in village-based activities are 5.2% more likely to undertake all three risk reduction actions compared to those not engaging in community activities. This implies that encouraging participation in community activities can have positive externalities in disaster mitigation.	[Witvorapong, Nopphol] Chulalongkorn Univ, Fac Econ, Bangkok, Thailand; [Muttarak, Raya] Austrian Acad Sci, Vienna Inst Demog, Wittgenstein Ctr Demog & Human Capital, IIASA,VID OAW,WU, A-1010 Vienna, Austria; [Muttarak, Raya] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Pothisiri, Wiraporn] Chulalongkorn Univ, Coll Populat Studies, Bangkok, Thailand	Chulalongkorn University; Austrian Academy of Sciences; International Institute for Applied Systems Analysis (IIASA); International Institute for Applied Systems Analysis (IIASA); Chulalongkorn University	Muttarak, R (corresponding author), Austrian Acad Sci, Vienna Inst Demog, Wittgenstein Ctr Demog & Human Capital, IIASA,VID OAW,WU, A-1010 Vienna, Austria.	muttarak@iiasa.ac.at	Witvorapong, Nopphol/J-4360-2019	Witvorapong, Nopphol/0000-0002-7926-381X; Muttarak, Raya/0000-0003-0627-4451; Pothisiri, Wiraporn/0000-0001-7279-9999	Advanced Grant of the European Research Council, "Forecasting Societies Adaptive Capacities to Climate Change" [ERC-2008-AdG 230195-FutureSoc]; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University for the project "Understanding Social Barriers to Coping with and Adapting to Extreme Climate Events" [RES560530150-CC]	Advanced Grant of the European Research Council, "Forecasting Societies Adaptive Capacities to Climate Change"; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University for the project "Understanding Social Barriers to Coping with and Adapting to Extreme Climate Events"	Funding for this work was made possible by an Advanced Grant of the European Research Council, "Forecasting Societies Adaptive Capacities to Climate Change" (grant agreement ERC-2008-AdG 230195-FutureSoc) and Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University for the project "Understanding Social Barriers to Coping with and Adapting to Extreme Climate Events" (Grant agreement number: RES560530150-CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2003, ECON GEOGR, V79, P387; Agrawal S., 2006, General Technical Report - USDA Forest Service, P163; Aldrich DP, 2011, J CIV SOC, V7, P81, DOI 10.1080/17448689.2011.553441; Aldrich DP, 2011, NAT HAZARDS, V56, P595, DOI 10.1007/s11069-010-9577-7; Beggs J., 1996, INT J MASS EMERGENCI, V14, P57; Bethel JW, 2011, AM J PREV MED, V40, P139, DOI 10.1016/j.amepre.2010.10.020; Bihari M, 2012, LANDSCAPE URBAN PLAN, V106, P253, DOI 10.1016/j.landurbplan.2012.03.011; Bradley DE, 2008, GERONTOLOGIST, V48, P190, DOI 10.1093/geront/48.2.190; Cappellari L, 2003, STATA J, V3, P278, DOI 10.1177/1536867X0300300305; Chamlee-Wright E., 2010, CULTURAL POLITICAL E; Chola L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071085; Crabbe P, 2006, CLIMATIC CHANGE, V78, P103, DOI 10.1007/s10584-006-9087-5; Cutter S.L., 1992, IND CRISIS Q, V6, P5, DOI DOI 10.1177/108602669200600102; Dasgupta P, 2000, SOCIAL CAPITAL, P325; Doocy Shannon, 2007, Am J Public Health, V97 Suppl 1, pS146; DOOLEY D, 1992, J APPL SOC PSYCHOL, V22, P451, DOI 10.1111/j.1559-1816.1992.tb00984.x; Dynes RR., 2002, IMPORTANCE SOCIAL CA; Dynes RR, 2005, COMMUNITY SOCIAL CAP; Edwards M.L., 1993, INT J MASS EMERG DIS, V11, P293; Eisenman David P, 2009, Disaster Med Public Health Prep, V3, P33, DOI 10.1097/DMP.0b013e318193be89; Ford JD, 2006, GLOBAL ENVIRON CHANG, V16, P145, DOI 10.1016/j.gloenvcha.2005.11.007; Fothergill A., 1996, INT J MASS EMERGENCI, V14, P33; Heller K, 2005, J APPL SOC PSYCHOL, V35, P399, DOI 10.1111/j.1559-1816.2005.tb02127.x; Henry S, 2004, POPUL ENVIRON, V25, P423, DOI 10.1023/B:POEN.0000036928.17696.e8; Huppert HE, 2006, PHILOS T R SOC A, V364, P1875, DOI 10.1098/rsta.2006.1803; Hyyppa MT, 2003, HEALTH EDUC RES, V18, P770, DOI 10.1093/her/cyf044; Ichida Y, 2013, SOC SCI MED, V94, P83, DOI 10.1016/j.socscimed.2013.05.006; JACKSON EL, 1981, ENVIRON BEHAV, V13, P387, DOI 10.1177/0013916581134001; KANIASTY K, 1993, J PERS SOC PSYCHOL, V64, P395, DOI 10.1037/0022-3514.64.3.395; Kawai M, 2010, ASIAN TSUNAMI: AID AND RECONSTRUCTION AFTER A DISASTER, P171; Klinenberg E., 2002, HEAT WAVE SOCIAL AUT; Knodel JE, 2009, 5 UNFPA THAIL; Kohn S, 2012, DISASTER MED PUBLIC, V6, P217, DOI 10.1001/dmp.2012.47; Lin N., 2008, HDB SOCIAL CAPITAL, P50, DOI DOI 10.4337/9781789907285.00009; Lindell MK, 2000, RISK ANAL, V20, P13, DOI 10.1111/0272-4332.00002; Lindstrom M, 2001, SOC SCI MED, V52, P441, DOI 10.1016/S0277-9536(00)00153-2; Lindstrom M, 2000, SCAND J PUBLIC HEALT, V28, P200, DOI 10.1177/14034948000280030901; Lu M, 1998, ENVIRON PLANN A, V30, P1473, DOI 10.1068/a301473; Maier Heiner, 2005, Eur J Ageing, V2, P31, DOI 10.1007/s10433-005-0018-5; MILETI DS, 1992, RISK ANAL, V12, P393, DOI 10.1111/j.1539-6924.1992.tb00691.x; Mishra S, 2007, PSYCHOL DEV SOC, V19, P143, DOI 10.1177/097133360701900201; Mulilis JP, 2000, J APPL SOC PSYCHOL, V30, P1310, DOI 10.1111/j.1559-1816.2000.tb02522.x; Nakagawa Y., 2004, INT J MASS EMERGENCI, V22, P5; Natural Sciences Sector, 2012, INDIAN OCEAN TSUNAMI; Nishikiori N, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-73; O'Brien P, 1992, INT J MASS EMERG DIS, V10, P71, DOI DOI 10.1007/S11069-011-9842-4; Pollitz FF, 2012, NATURE, V490, P250, DOI 10.1038/nature11504; PUTNAM RD, 1995, J DEMOCRACY, V0006; PUTNAM RD, 1995, PS, V28, P664, DOI 10.2307/420517; Reininger BM, 2013, SOC SCI MED, V83, P50, DOI 10.1016/j.socscimed.2013.01.037; Renzulli LA, 2000, SOC FORCES, V79, P523, DOI 10.2307/2675508; Riad JK, 1999, J APPL SOC PSYCHOL, V29, P918, DOI 10.1111/j.1559-1816.1999.tb00132.x; RUSSELL LA, 1995, ENVIRON BEHAV, V27, P744, DOI 10.1177/0013916595276002; Sharma U, 2012, NAT HAZARDS, V60, P409, DOI 10.1007/s11069-011-0023-2; Shaw R, 2012, COMM ENV DISAST RISK, V10, P3, DOI 10.1108/S2040-7262(2012)0000010007; Singh D., 2012, INDIAN OCEAN TSUNAMI; Siri JG, 2014, ECOL SOC, V19, DOI 10.5751/ES-06134-190133; Striessnig E, 2013, ECOL SOC, V18, DOI 10.5751/ES-05252-180116; Tierney K.J., 2001, FACING UNEXPECTED DI; Tompkins EL, 2005, GLOBAL ENVIRON CHANG, V15, P139, DOI 10.1016/j.gloenvcha.2004.11.002; Turner R.H, 1986, WAITING DISASTERS EA; UNISDR (United Nations International Strategy for Disaster Reduction), 2007, HYOGO FRAMEWORK ACTI; Uscher-Pines L, 2009, AM J PREV MED, V37, P227, DOI 10.1016/j.amepre.2009.04.028; USGS (U.S. Geological Survey), 2012, MAGNITUDE 8 6 W COAS; Varda DM, 2009, POPUL RES POLICY REV, V28, P11, DOI 10.1007/s11113-008-9110-9; Wamsler C, 2012, ECOL SOC, V17, DOI 10.5751/ES-04645-170202; Yamamura E., 2013, NATURAL DISASTERS SO; Yamamura E, 2010, REG STUD, V44, P1019, DOI 10.1080/00343400903365144	68	26	26	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130862	10.1371/journal.pone.0130862	http://dx.doi.org/10.1371/journal.pone.0130862			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26153891	gold, Green Accepted, Green Published			2022-12-27	WOS:000358159700041
J	Andersson, E; Dahmcke, CM; Steven, K; Larsen, LK; Guldberg, P				Andersson, Elin; Dahmcke, Christina M.; Steven, Kenneth; Larsen, Louise K.; Guldberg, Per			Filtration Device for On-Site Collection, Storage and Shipment of Cells from Urine and Its Application to DNA-Based Detection of Bladder Cancer	PLOS ONE			English	Article							FGFR3 MUTATION ASSAY; METHYLATION ASSAY; VOIDED URINE; BIOMARKERS; MARKERS; HYBRIDIZATION	Molecular analysis of cells from urine provides a convenient approach to non-invasive detection of bladder cancer. The practical use of urinary cell-based tests is often hampered by difficulties in handling and analyzing large sample volumes, the need for rapid sample processing to avoid degradation of cellular content, and low sensitivity due to a high background of normal cells. We present a filtration device, designed for home or point-of-care use, which enables collection, storage and shipment of urinary cells. A special feature of this device is a removable cartridge housing a membrane filter, which after filtration of urine can be transferred to a storage unit containing an appropriate preserving solution. In spiking experiments, the use of this device provided efficient recovery of bladder cancer cells with elimination of >99% of excess smaller-sized cells. The performance of the device was further evaluated by DNA-based analysis of urinary cells collected from 57 patients subjected to transurethral resection following flexible cystoscopy indicating the presence of a tumor. All samples were tested for FGFR3 mutations and seven DNA methylation markers (BCL2, CCNA1, EOMES, HOXA9, POU4F2, SALL3 and VIM). In the group of patients where a transitional cell tumor was confirmed at histopathological evaluation, urine DNA was positive for one or more markers in 29 out of 31 cases (94%), including 19 with FGFR3 mutation (61%). In the group of patients with benign histopathology, urine DNA was positive for methylation markers in 13 out of 26 cases (50%). Only one patient in this group was positive for a FGFR3 mutation. This patient had a stage Ta tumor resected 6 months later. The ability to easily collect, store and ship diagnostic cells from urine using the presented device may facilitate non-invasive testing for bladder cancer.	[Andersson, Elin; Dahmcke, Christina M.; Larsen, Louise K.; Guldberg, Per] Res Ctr, Danish Canc Soc, Copenhagen, Denmark; [Dahmcke, Christina M.] Copenhagen Univ Hosp, Dept Pathol, Herlev, Denmark; [Steven, Kenneth] Copenhagen Univ Hosp, Dept Urol, Herlev, Denmark	Danish Cancer Society; University of Copenhagen; University of Copenhagen	Guldberg, P (corresponding author), Res Ctr, Danish Canc Soc, Copenhagen, Denmark.	perg@cancer.dk			Candy Foundation	Candy Foundation	This study received grant support from The Candy Foundation.	Andersson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094023; Beukers W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077657; Birkhahn M, 2013, EUR J CANCER, V49, P3159, DOI 10.1016/j.ejca.2013.04.033; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315, DOI 10.1007/BF03262330; Cairns P, 2007, NAT REV CANCER, V7, P531, DOI 10.1038/nrc2170; Cheng L., 2012, BLADDER PATHOLOGY; Costa VL, 2010, CLIN CANCER RES, V16, P5842, DOI 10.1158/1078-0432.CCR-10-1312; Coumans FAW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061774; Coumans FAW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061770; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Falke J, 2011, NAT REV UROL, V8, P42, DOI 10.1038/nrurol.2010.208; Hedelin H, 2002, SCAND J UROL NEPHROL, V36, P344, DOI 10.1080/003655902320783845; Kandimalla R, 2013, CLIN CANCER RES, V19, P4760, DOI 10.1158/1078-0432.CCR-12-3276; Kandimalla R, 2013, NAT REV UROL, V10, P327, DOI 10.1038/nrurol.2013.89; Kipp BR, 2006, DIAGN CYTOPATHOL, V34, P479, DOI 10.1002/dc.20488; Meiers I, 2007, ARCH PATHOL LAB MED, V131, P1574; Mitra AP, 2010, NAT REV UROL, V7, P11, DOI 10.1038/nrurol.2009.236; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898; Reinert T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046297; Reinert T, 2011, CLIN CANCER RES, V17, P5582, DOI 10.1158/1078-0432.CCR-10-2659; Rubin EH, 2014, CLIN CANCER RES, V20, P1419, DOI 10.1158/1078-0432.CCR-14-0091; Serizawa RR, 2011, INT J CANCER, V129, P78, DOI 10.1002/ijc.25651; Taly V, 2012, TRENDS MOL MED, V18, P405, DOI 10.1016/j.molmed.2012.05.001; Thurner B, 1999, J IMMUNOL METHODS, V223, P1, DOI 10.1016/S0022-1759(98)00208-7; van Rhijn BWG, 2005, EUR UROL, V47, P736, DOI 10.1016/j.eururo.2005.03.014; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; WIENER HG, 1993, ACTA CYTOL, V37, P163; Wolff EM, 2010, CANCER RES, V70, P8169, DOI 10.1158/0008-5472.CAN-10-1335; Yap TA, 2014, CLIN CANCER RES, V20, P2553, DOI 10.1158/1078-0432.CCR-13-2664; Yu J, 2007, CLIN CANCER RES, V13, P7296, DOI 10.1158/1078-0432.CCR-07-0861; Zuiverloon TCM, 2012, BJU INT, V109, P941, DOI 10.1111/j.1464-410X.2011.10428.x; Zuiverloon TCM, 2011, J UROLOGY, V186, P707, DOI 10.1016/j.juro.2011.03.141	32	15	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131889	10.1371/journal.pone.0131889	http://dx.doi.org/10.1371/journal.pone.0131889			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151138	Green Submitted, gold, Green Published			2022-12-27	WOS:000358158900028
J	Al-Amiery, AA; Al-Majedy, YK; Kadhum, AAH; Mohamad, AB				Al-Amiery, Ahmed A.; Al-Majedy, Yasameen K.; Kadhum, Abdul Amir H.; Mohamad, Abu Bakar			Hydrogen Peroxide Scavenging Activity of Novel Coumarins Synthesized Using Different Approaches	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; DERIVATIVES	New derivatives of 7-hydroxy-4-methylcoumarin were synthesized using a chemical method and a microwave-assisted method to compare the feasibility, reaction times, and yields of the product. The newly synthesized coumarins were characterized by different spectroscopic techniques (FT-IR and NMR) and micro-elemental analysis (CHNS). In vitro antioxidant activities of these compounds were evaluated against hydrogen peroxide and were compared with standard natural antioxidant, vitamin C. Our results reveal that these compounds exhibit excellent radical scavenging activities.	[Al-Amiery, Ahmed A.] Univ Kebangsaan Malaysia, Dept Chem & Proc Engn, Bangi 43000, Selangor, Malaysia; [Al-Amiery, Ahmed A.; Al-Majedy, Yasameen K.; Kadhum, Abdul Amir H.; Mohamad, Abu Bakar] Univ Technol UOT, Environm Res Ctr, Baghdad 10001, Iraq; [Mohamad, Abu Bakar] Univ Kebangsaan Malaysia, Fuel Cell Inst, Bangi 43000, Selangor, Malaysia	Universiti Kebangsaan Malaysia; University of Technology- Iraq; Universiti Kebangsaan Malaysia	Al-Amiery, AA (corresponding author), Univ Kebangsaan Malaysia, Dept Chem & Proc Engn, Bangi 43000, Selangor, Malaysia.	dr.ahmed1975@gmail.com	, Abu Bakar Mohamad/J-5638-2014; Kadhum, Abdul Amir/AAB-7234-2021; Almajedy, yasameen Kadhim H./AAX-3695-2021; Al-Amiery, Ahmed/C-1520-2013	, Abu Bakar Mohamad/0000-0001-5135-7956; Kadhum, Abdul Amir/0000-0003-4074-9123; Al-Amiery, Ahmed/0000-0003-1033-4904	Universiti Kebangsaan Malaysia [DIP-2012-02]	Universiti Kebangsaan Malaysia	This study was supported by the Universiti Kebangsaan Malaysia under the DIP-2012-02 grant.	Abramovich R. A, 1991, ORG PREP P INT, V23, P683; Al-Amiery A.A, 2012, ORG MED CHEM LETT, V2, P1, DOI [DOI 10.1186/2191-2858-2-1, DOI 10.1186/2191-2858-2-4]; Al-Amiery AA, 2012, RES CHEM INTERMEDIAT, V38, P745, DOI 10.1007/s11164-011-0414-8; ALAMIERY A, 2013, BIOINORG CHEM APPL, V2013, P1; [Anonymous], 2012, J CHEM PHARM; BOSE AK, 1990, HETEROCYCLES, V30, P741; Cacic M, 2006, MOLECULES, V11, P134, DOI 10.3390/11010134; Chen Y, 1999, J AGR FOOD CHEM, V47, P2226, DOI 10.1021/jf990092f; Duh PD, 2012, LWT-FOOD SCI TECHNOL, V32, P269; ELAbd-All MM, 2013, J ATOMS MOL, V3, P537; Hamid A.A., 2010, AFR J PURE APPL CHEM, V4, P142, DOI [DOI 10.5897/AJPAC.9000020, 10.5897/AJPAC.9000020]; Hoult JRS, 1996, GEN PHARMACOL-VASC S, V27, P713, DOI 10.1016/0306-3623(95)02112-4; Kadhum AAH, 2011, INT J MOL SCI, V12, P5747, DOI 10.3390/ijms12095747; Khan MSY, 2003, INDIAN J CHEM B, V42, P900; Kotla V. V., 2013, Der Pharmacia Sinica, V4, P103; Kotla V. V., 2012, Der Pharma Chemica, V4, P2003; Lacova M, 1996, TETRAHEDRON, V52, P14995, DOI 10.1016/0040-4020(96)00922-2; Lin M.H., 2011, J EXP CLIN MED, V3, P126, DOI DOI 10.1016/J.JECM.2011.04.006; MITRA AK, 1980, SYNTHETIC COMMUN, V10, P915, DOI 10.1080/00397918008061851; Mladenovic M, 2009, MOLECULES, V14, P1495, DOI 10.3390/molecules14041495; Naama JH, 2013, RES CHEM INTERMEDIAT, V39, P4047, DOI 10.1007/s11164-012-0921-2; Pal R, 2012, IJPCBS, V2, P500; PUCIOVA M, 1994, COLLECT CZECH CHEM C, V59, P175, DOI 10.1135/cccc19940175; Satyanarayana VSV, 2008, ARKIVOC, P221; SCHONBERG A, 1954, J AM CHEM SOC, V76, P6208, DOI 10.1021/ja01652a112; Shankar KR, 2013, INT J BIOL PHARMACEU, V4, P862; Varma RS, 2002, TETRAHEDRON, V58, P1235, DOI 10.1016/S0040-4020(01)01216-9; VILLEMIN D, 1993, PHOSPHORUS SULFUR, V79, P33, DOI 10.1080/10426509308034395; Zahradnik M., 1992, PRODUCTION APPLICATI	29	27	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132175	10.1371/journal.pone.0132175	http://dx.doi.org/10.1371/journal.pone.0132175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147722	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600212
J	Archary, D; Liebenberg, LJ; Werner, L; Tulsi, S; Majola, N; Naicker, N; Dlamini, S; Hope, TJ; Samsunder, N; Karim, SSA; Morris, L; Passmore, JAS; Garrett, NJ				Archary, Derseree; Liebenberg, Lenine J.; Werner, Lise; Tulsi, Sahil; Majola, Nelisile; Naicker, Nivashnee; Dlamini, Sarah; Hope, Thomas J.; Samsunder, Natasha; Karim, Salim S. Abdool; Morris, Lynn; Passmore, Jo-Ann S.; Garrett, Nigel J.			Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage	PLOS ONE			English	Article							T-CELL RESPONSES; VAGINAL SECRETIONS; IMMUNE MARKERS; HIGH-RISK; MUCOSAL; TRACT; WOMEN; IGA; IMMUNOGLOBULINS; INFLAMMATION	Introduction Optimizing methods for genital specimen collection to accurately characterize mucosal immune responses is a priority for the HIV prevention field. The menstrual cup (MC) has been proposed as an alternative to other methods including cervicovaginal lavage (CVL), but no study has yet formally compared these two methods. Methods Forty HIV-infected, antiretroviral therapy-naive women from the CAPRISA 002 acute HIV infection cohort study were randomized to have genital fluid collected using the MC with subsequent CVL, or by CVL alone. Qualitative data, which assessed levels of comfort and acceptability of MC using a 5-point Likert scale, was collected. Luminex multiplex assays were used to measure HIV-specific IgG against multiple gene products and 48 cytokines. Results The majority (94%) of participants indicated that insertion, wearing and removal of the MC was comfortable. Nineteen MCs with 18 matching, subsequent CVLs and 20 randomized CVLs were available for analysis. Mucosal IgG responses against four HIV-antigens were detected in 99% of MCs compared to only 80% of randomized CVLs (p = 0.029). Higher specific antibody activity and total antibodies were observed in MCs compared to CVL (all p<0.001). In MCs, 42/48 (88%) cytokines were in the detectable range in all participants compared to 27/48 (54%) in CVL (p<0.001). Concentrations of 22/41 cytokines (53.7%) were significantly higher in fluid collected by MC. Both total IgG (r = 0.63; p = 0.005) and cytokine concentrations (r = 0.90; p<0.001) correlated strongly between MC and corresponding post-MC CVL. Conclusions MC sampling improves the detection of mucosal cytokines and antibodies, particularly those present at low concentrations. MC may therefore represent an ideal tool to assess immunological parameters in genital secretions, without interfering with concurrent collection of conventional CVL samples.	[Archary, Derseree; Liebenberg, Lenine J.; Werner, Lise; Tulsi, Sahil; Majola, Nelisile; Naicker, Nivashnee; Dlamini, Sarah; Samsunder, Natasha; Karim, Salim S. Abdool; Morris, Lynn; Passmore, Jo-Ann S.; Garrett, Nigel J.] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa, Nelson R Mandela Sch Med, Durban, South Africa; [Hope, Thomas J.] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA; [Karim, Salim S. Abdool] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Morris, Lynn] Natl Inst Communicable Dis, Johannesburg, South Africa; [Passmore, Jo-Ann S.] Univ Cape Town, Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Passmore, Jo-Ann S.] Natl Hlth Lab Serv, Cape Town, South Africa	University of Kwazulu Natal; Northwestern University; Feinberg School of Medicine; Columbia University; National Institute for Communicable Diseases (NICD); University of Cape Town	Archary, D (corresponding author), Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa, Nelson R Mandela Sch Med, Durban, South Africa.	desh.archary@caprisa.org	Karim, Salim Abdool/AAE-7118-2019; Liebenberg, Lenine/AAV-5224-2021; Karim, Salim Abdool/P-3117-2019; Morris, Lynn/V-3941-2018	Karim, Salim Abdool/0000-0002-4986-2133; Morris, Lynn/0000-0003-3961-7828; Liebenberg, Lenine Julie Phillips/0000-0001-6768-8776	Medical Research Council of South Africa Self-Initiated Grant (MRC SIR); National Research Foundation (NRF) of South Africa; CAPRISA; National Institute of Allergy and infectious Disease (NIAID), National Institutes of Health (NIH); US Department of Health and Human Services (DHHS) [AI51794]; National Research Foundation, South Africa [67385]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094584, R33AI094584, U19AI051794, P01AI082971] Funding Source: NIH RePORTER	Medical Research Council of South Africa Self-Initiated Grant (MRC SIR); National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa); CAPRISA; National Institute of Allergy and infectious Disease (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US Department of Health and Human Services (DHHS); National Research Foundation, South Africa(National Research Foundation - South Africa); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	DA was funded through the Medical Research Council of South Africa Self-Initiated Grant (MRC SIR), and DA and LL were supported through the National Research Foundation (NRF) of South Africa training funds to carry out this study. This research was supported by CAPRISA. CAPRISA is part of the Comprehensive International Program of Research on AIDS (CIPRA) which is funded by the National Institute of Allergy and infectious Disease (NIAID), National Institutes of Health (NIH) and the US Department of Health and Human Services (DHHS) (grant# AI51794), and the National Research Foundation, South Africa, under grant # 67385.	Alimonti JB, 2006, IMMUNOL CELL BIOL, V84, P482, DOI 10.1111/j.1440-1711.2006.01455.x; Bebell LM, 2008, J INFECT DIS, V198, P710, DOI 10.1086/590503; BELEC L, 1995, CLIN DIAGN LAB IMMUN, V2, P57; Belec L, 2001, J INFECT DIS, V184, P1412, DOI 10.1086/324375; Birse KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079505; Boskey ER, 2003, SEX TRANSM DIS, V30, P107, DOI 10.1097/00007435-200302000-00002; Castle PE, 2004, CLIN DIAGN LAB IMMUN, V11, P399, DOI 10.1128/CDLI.11.2.399-405.2004; Chappell CA, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.041; Chernesky M, 2006, J CLIN MICROBIOL, V44, P1084, DOI 10.1128/JCM.44.3.1084-1086.2006; Choi RY, 2012, AIDS, V26, P2155, DOI 10.1097/QAD.0b013e328359b99b; Clerici M, 2002, AIDS, V16, P1731, DOI 10.1097/00002030-200209060-00004; Cummins JE, 2009, SEX TRANSM DIS, V36, pS84, DOI 10.1097/OLQ.0b013e3181994191; Devito C, 2000, AIDS, V14, P1917, DOI 10.1097/00002030-200009080-00006; Dezzutti CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023136; Erickson AL, 2008, CLIN VACCINE IMMUNOL, V15, P1745, DOI 10.1128/CVI.00247-08; Hordnes K, 1998, J IMMUNOL METHODS, V220, P151, DOI 10.1016/S0022-1759(98)00165-3; Jespers V, 2011, AM J REPROD IMMUNOL, V65, P368, DOI 10.1111/j.1600-0897.2010.00938.x; Jespers V, 2010, EXPERT REV VACCINES, V9, P381, DOI [10.1586/erv.10.21, 10.1586/ERV.10.21]; Kaul R, 2001, AIDS, V15, P431, DOI 10.1097/00002030-200102160-00026; Keller MJ, 2009, SEX TRANSM DIS, V36, pS92, DOI 10.1097/OLQ.0b013e318199417d; Krech T, 2009, J VIROL METHODS, V162, P291, DOI 10.1016/j.jviromet.2009.08.011; Liu PH, 2011, J VIROL, V85, P11196, DOI 10.1128/JVI.05601-11; Marks MA, 2012, J IMMUNOL METHODS, V382, P211, DOI 10.1016/j.jim.2012.05.012; Mazzoli S, 1997, NAT MED, V3, P1250, DOI 10.1038/nm1197-1250; Mitchell C, 2011, J CLIN MICROBIOL, V49, P735, DOI 10.1128/JCM.00991-10; Mlisana K, 2012, J INFECT DIS, V206, P6, DOI 10.1093/infdis/jis298; Ndayisaba G, 2013, SEX TRANSM DIS, V40, P552, DOI 10.1097/OLQ.0b013e31828e5aa5; Omosa-Manyonyi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110228; Patel MV, 2014, AM J REPROD IMMUNOL, V72, P22, DOI 10.1111/aji.12218; Price CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024095; Quesnel A, 1997, J IMMUNOL METHODS, V202, P153, DOI 10.1016/S0022-1759(97)00003-3; Rowland-Jones SL, 1998, J CLIN INVEST, V102, P1758, DOI 10.1172/JCI4314; ROWLANDJONES S, 1995, NAT MED, V1, P59, DOI 10.1038/nm0195-59; Seaton KE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101863; Shukair SA, 2013, MUCOSAL IMMUNOL, V6, P427, DOI 10.1038/mi.2012.87; Snowhite IV, 2002, J IMMUNOL METHODS, V263, P85, DOI 10.1016/S0022-1759(02)00038-8; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; van Loggerenberg F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001954; Yates NL, 2011, AIDS, V25, P2089, DOI 10.1097/QAD.0b013e32834b348e; Zolla-Pazner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087572	40	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131906	10.1371/journal.pone.0131906	http://dx.doi.org/10.1371/journal.pone.0131906			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147923	Green Published, gold			2022-12-27	WOS:000358157600161
J	De Meester, N; Dos Santos, GAP; Rigaux, A; Valdes, Y; Derycke, S; Moens, T				De Meester, Nele; Dos Santos, Giovanni A. P.; Rigaux, Annelien; Valdes, Yirina; Derycke, Sofie; Moens, Tom			Daily Temperature Fluctuations Alter Interactions between Closely Related Species of Marine Nematodes	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; FREE-LIVING MARINE; FOOD AVAILABILITY; COEXISTENCE; GROWTH; ENVIRONMENT; COMPETITION; COMPLEX; FITNESS; FACILITATION	In addition to an increase in mean temperature, climate change models predict decreasing amplitudes of daily temperature fluctuations. In temperate regions, where daily and seasonal fluctuations are prominent, such decreases in daily temperature fluctuations can have a pronounced effect on the fitness of species and on the outcome of species interactions. In this study, the effect of a temperature regime with daily fluctuations versus a constant temperature on the fitness and interspecific interactions of three cryptic species of the marine nematode species complex of Litoditis marina (Pm I, Pm III and Pm IV) were investigated. In a lab experiment, different combinations of species (monospecific treatment: Pm I and Pm IV and Pm III alone; two-species treatment: Pm I + Pm IV; three-species treatment: Pm I + Pm IV + Pm III) were subjected to two different temperature regimes: one constant and one fluctuating temperature. Our results showed that fluctuating temperature had minor or no effects on the population fitness of the three species in monocultures. In contrast, interspecific interactions clearly influenced the fitness of all three species, both positively and negatively. Temperature regime did have a substantial effect on the interactions between the species. In the two-species treatment, temperature regime altered the interaction from a sort of mutualism to commensalism. In addition, the strength of the interspecific interactions changed depending on the temperature regime in the three-species treatment. This experiment confirms that interactions between the species can change depending on the abiotic environment; these results show that it is important to incorporate the effect of fluctuations on interspecific interactions to predict the effect of climate change on biodiversity.	[De Meester, Nele; Rigaux, Annelien; Derycke, Sofie; Moens, Tom] Univ Ghent, Dept Biol, Marine Biol Unit, B-9000 Ghent, Belgium; [De Meester, Nele; Rigaux, Annelien; Derycke, Sofie] Univ Ghent, Ctr Mol Phylogeny & Evolut, B-9000 Ghent, Belgium; [Dos Santos, Giovanni A. P.; Valdes, Yirina] Univ Fed Pernambuco, UFPE, CCB, Dept Zool, Recife, PE, Brazil	Ghent University; Ghent University; Universidade Federal de Pernambuco	De Meester, N (corresponding author), Univ Ghent, Dept Biol, Marine Biol Unit, B-9000 Ghent, Belgium.	nele.demeester@ugent.be	Moens, Tom/AAB-8701-2019; dos Santos, Giovanni/I-6539-2015	dos Santos, Giovanni/0000-0003-4761-7182	Flemish Fund for Scientific Research (FWO) [3G040407]; Ghent University [011060002, 01GA1911 W]	Flemish Fund for Scientific Research (FWO)(FWO); Ghent University(Ghent University)	Funding for this research was obtained from the Flemish Fund for Scientific Research (FWO) through project 3G040407, and from Ghent University through projects 011060002 and 01GA1911 W.	Amarasekare P, 2002, P ROY SOC B-BIOL SCI, V269, P2541, DOI 10.1098/rspb.2002.2181; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ATKINSON D, 1996, ANIMALS TEMPERATURE, P183; Begon M., 2009, POPULATION ECOLOGY U; Benton TG, 2000, EVOL ECOL RES, V2, P769; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Brakefield PM, 1997, P ROY SOC B-BIOL SCI, V264, P717, DOI 10.1098/rspb.1997.0102; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Colinet H, 2007, INSECT BIOCHEM MOLEC, V37, P1177, DOI 10.1016/j.ibmb.2007.07.004; Cossins A. R., 1987, TEMPERATURE BIOL ANI; Darwin C, 1859, ORIGIN SPECIES MEANS; De Meester N, 2011, MAR BIOL, V158, P2717, DOI 10.1007/s00227-011-1769-5; De Meester N, TEMPERATURE SA UNPUB; De Meester N, 2015, OIKOS, V124, P561, DOI 10.1111/oik.01779; Derycke S, 2008, MOL ECOL, V17, P3306, DOI 10.1111/j.1365-294X.2008.03846.x; Derycke S, 2008, ZOOL J LINN SOC-LOND, V152, P1, DOI 10.1111/j.1096-3642.2007.00365.x; Derycke S, 2007, MAR BIOL, V151, P1799, DOI 10.1007/s00227-007-0609-0; Derycke S, 2006, GENETICA, V128, P307, DOI 10.1007/s10709-006-6944-0; Derycke S, 2012, MOL ECOL RESOUR, V12, P607, DOI 10.1111/j.1755-0998.2012.03128.x; Derycke S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-1; Descamps-Julien B, 2005, ECOLOGY, V86, P2815, DOI 10.1890/04-1700; dos Santos GAP, 2008, J EXP MAR BIOL ECOL, V355, P27, DOI 10.1016/j.jembe.2007.11.015; dos Santos GAP, 2009, MAR BIOL, V156, P629, DOI 10.1007/s00227-008-1114-9; DUNSON WA, 1991, AM NAT, V138, P1067, DOI 10.1086/285270; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fischer K, 2011, OECOLOGIA, V166, P23, DOI 10.1007/s00442-011-1917-0; Fonseca G, 2008, BIOL J LINN SOC, V94, P737, DOI 10.1111/j.1095-8312.2008.01015.x; HANSKI I, 1983, J ANIM ECOL, V52, P263, DOI 10.2307/4599; HIGASHI M, 1989, AM NAT, V133, P288, DOI 10.1086/284919; JOHNSON LL, 1977, J EXP MAR BIOL ECOL, V28, P141, DOI 10.1016/0022-0981(77)90113-7; Jolliffe PA, 2000, J ECOL, V88, P371, DOI 10.1046/j.1365-2745.2000.00470.x; Litchman E, 2001, AM NAT, V157, P170, DOI 10.1086/318628; Martinez JG, 2012, APPL SOIL ECOL, V56, P10, DOI 10.1016/j.apsoil.2012.02.001; Moens T, 2005, AQUAT MICROB ECOL, V40, P77, DOI 10.3354/ame040077; Moens T, 1998, HELGOLANDER MEERESUN, V52, P115, DOI 10.1007/BF02908742; Molbo D, 2003, P NATL ACAD SCI USA, V100, P5867, DOI 10.1073/pnas.0930903100; Mougi A, 2005, ECOL RES, V20, P581, DOI 10.1007/s11284-005-0070-9; Ortells R, 2003, FRESHWATER BIOL, V48, P2194, DOI 10.1046/j.1365-2427.2003.01159.x; Peng YQ, 2008, SYMBIOSIS, V45, P9; Petavy G, 2001, PHYSIOL ENTOMOL, V26, P351, DOI 10.1046/j.0307-6962.2001.00255.x; Postma-Blaauw MB, 2005, OECOLOGIA, V142, P428, DOI 10.1007/s00442-004-1741-x; R Core Team, 2018, R LANG ENV STAT COMP; Rojas-Echenique J, 2011, ECOLOGY, V92, P1174; Sudhaus W., 2011, Journal of Nematode Morphology and Systematics, V14, P113; Valiente-Banuet A, 2008, J ECOL, V96, P489, DOI 10.1111/j.1365-2745.2008.01357.x; Vanfleteren JR, 1980, NEMATODES BIOL MODEL, V2, P47; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Zhang DY, 2004, ECOL LETT, V7, P165, DOI 10.1111/j.1461-0248.2004.00569.x	48	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131625	10.1371/journal.pone.0131625	http://dx.doi.org/10.1371/journal.pone.0131625			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147103	Green Published, gold			2022-12-27	WOS:000358157600115
J	Leung, EY; Askarian-Amiri, M; Finlay, GJ; Rewcastle, GW; Baguley, BC				Leung, Euphemia Y.; Askarian-Amiri, Marjan; Finlay, Graeme J.; Rewcastle, Gordon W.; Baguley, Bruce C.			Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines	PLOS ONE			English	Article							ADVANCED SOLID TUMORS; VIVO ANTITUMOR-ACTIVITY; MAMMALIAN TARGET; IN-VIVO; RAPAMYCIN INHIBITOR; PATHWAY INHIBITORS; KINASE INHIBITOR; AKT; SENSITIVITY; NVP-BEZ235	The mammalian target of rapamycin (mTOR), a vital component of signaling pathways involving PI3K/AKT, is an attractive therapeutic target in breast cancer. Everolimus, an allosteric mTOR inhibitor that inhibits the mTOR functional complex mTORC1, is approved for treatment of estrogen receptor positive (ER+) breast cancer. Other mTOR inhibitors show interesting differences in target specificities: BEZ235 and GSK2126458 are ATP competitive mTOR inhibitors targeting both PI3K and mTORC1/2; AZD8055, AZD2014 and KU-0063794 are ATP competitive mTOR inhibitors targeting both mTORC1 and mTORC2; and GDC-0941 is a pan-PI3K inhibitor. We have addressed the question of whether mTOR inhibitors may be more effective in combination than singly in inhibiting the proliferation of breast cancer cells. We selected a panel of 30 human breast cancer cell lines that included ER and PR positive, HER2 over-expressing, and "triple negative" variants, and determined whether signaling pathway utilization was related to drug-induced inhibition of proliferation. A significant correlation (p = 0.005) was found between everolimus IC50 values and p70S6K phosphorylation, but not with AKT or ERK phosphorylation, consistent with the mTOR pathway being a principal target. We then carried out combination studies with four everolimus resistant triple-negative breast cancer cell lines, and found an unexpectedly high degree of synergy between everolimus and the other inhibitors tested. The level of potentiation of everolimus inhibitory activity (measured by IC50 values) was found to be cell line-specific for all the kinase inhibitors tested. The results suggest that judicious combination of mTOR inhibitors with different modes of action could have beneficial effects in the treatment of breast cancer.	[Leung, Euphemia Y.; Askarian-Amiri, Marjan; Finlay, Graeme J.; Rewcastle, Gordon W.; Baguley, Bruce C.] Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1, New Zealand; [Leung, Euphemia Y.; Askarian-Amiri, Marjan; Finlay, Graeme J.] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand	University of Auckland; University of Auckland	Leung, EY (corresponding author), Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1, New Zealand.	e.leung@auckland.ac.nz; b.baguley@auckland.ac.nz	Askarian-Amiri, Marjan E./F-7910-2010	Askarian-Amiri, Marjan E./0000-0003-3524-9626	New Zealand Breast Cancer Foundation; Robert McClelland Trust; Auckland Cancer Society Research Centre	New Zealand Breast Cancer Foundation; Robert McClelland Trust; Auckland Cancer Society Research Centre	Funding for this work was obtained from the New Zealand Breast Cancer Foundation (http://www.nzbcf.org.nz/), and the Robert McClelland Trust (administered by http://www.cancernz.org.nz). This work is also supported by Auckland Cancer Society Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlund M, 2000, CANCER RES, V60, P5340; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Baselga J, 2011, ONCOLOGIST, V16, P12, DOI 10.1634/theoncologist.2011-S1-12; Beaver JA, 2012, FUTURE ONCOL, V8, P651, DOI [10.2217/fon.12.49, 10.2217/FON.12.49]; BERENBAUM MC, 1981, ADV CANCER RES, V35, P269, DOI 10.1016/S0065-230X(08)60912-4; Breuleux M, 2009, MOL CANCER THER, V8, P742, DOI 10.1158/1535-7163.MCT-08-0668; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Crowder RJ, 2005, BREAST CANCER RES, V7, P212, DOI 10.1186/bcr1307; Garcia-Echeverria C., 2006, PCT International Application, Patent No. [WO 2006122806 A2, 2006122806]; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Gonzalez-Angulo AM, 2013, CANCER TREAT REV, V39, P313, DOI 10.1016/j.ctrv.2012.11.002; Huo YL, 2011, BIOCHEM SOC T, V39, P446, DOI 10.1042/BST0390446; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Kirstein MM, 2013, LIVER INT, V33, P780, DOI 10.1111/liv.12126; Knight SD, 2010, ACS MED CHEM LETT, V1, P39, DOI 10.1021/ml900028r; Kuntzer J, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-43; Leung E, 2013, MTOR SIGNALING ENDOC; Leung E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/836769; Leung E, 2012, INVEST NEW DRUG, V30, P2103, DOI 10.1007/s10637-011-9768-4; Leung E, 2011, CANCER BIOL THER, V11, P938, DOI 10.4161/cbt.11.11.15527; Leung E, 2010, CANCER BIOL THER, V9, P717, DOI 10.4161/cbt.9.9.11432; Leung EY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105792; Leung EY, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00221; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Massarweh S, 2014, BREAST CANCER RES TR, V143, P325, DOI 10.1007/s10549-013-2810-9; Naing A, 2012, BRIT J CANCER, V107, P1093, DOI 10.1038/bjc.2012.368; Nyfeler B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048548; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; O'Brien NA, 2014, CLIN CANCER RES, V20, P3507, DOI 10.1158/1078-0432.CCR-13-2769; O'Donnell A, 2008, J CLIN ONCOL, V26, P1588, DOI 10.1200/JCO.2007.14.0988; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pike KG, 2015, J MED CHEM, V58, P2326, DOI 10.1021/jm501778s; Pike KG, 2013, BIOORG MED CHEM LETT, V23, P1212, DOI 10.1016/j.bmcl.2013.01.019; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Rosen N, 2006, CANCER CELL, V10, P254, DOI 10.1016/j.ccr.2006.10.001; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Soares HP, 2015, MOL CANCER THER, V14, P1014, DOI 10.1158/1535-7163.MCT-14-0669; Stowasser F., 2008, PCT Int. Appl., Patent No. [WO 2008064093 A2 20080529, 2008064093]; Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482; Thomas HE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003923; Wallin JJ, 2012, CLIN CANCER RES, V18, P3901, DOI 10.1158/1078-0432.CCR-11-2088; WHITEHEAD RH, 1983, J NATL CANCER I, V71, P1193; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675	45	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131400	10.1371/journal.pone.0131400	http://dx.doi.org/10.1371/journal.pone.0131400			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148118	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600094
J	Mergl, R; Koburger, N; Heinrichs, K; Szekely, A; Toth, MD; Coyne, J; Quintao, S; Arensman, E; Coffey, C; Maxwell, M; Varnik, A; van Audenhove, C; McDaid, D; Sarchiapone, M; Schmidtke, A; Genz, A; Gusmao, R; Hegerl, U				Mergl, Roland; Koburger, Nicole; Heinrichs, Katherina; Szekely, Andras; Toth, Monika Ditta; Coyne, James; Quintao, Sonia; Arensman, Ella; Coffey, Claire; Maxwell, Margaret; Vaernik, Airi; van Audenhove, Chantal; McDaid, David; Sarchiapone, Marco; Schmidtke, Armin; Genz, Axel; Gusmao, Ricardo; Hegerl, Ulrich			What Are Reasons for the Large Gender Differences in the Lethality of Suicidal Acts? An Epidemiological Analysis in Four European Countries	PLOS ONE			English	Article							CASE-FATALITY RATES; DEATHS; MULTICENTER; ALLIANCE; BEHAVIOR; STATES	Background In Europe, men have lower rates of attempted suicide compared to women and at the same time a higher rate of completed suicides, indicating major gender differences in lethality of suicidal behaviour. The aim of this study was to analyse the extent to which these gender differences in lethality can be explained by factors such as choice of more lethal methods or lethality differences within the same suicide method or age. In addition, we explored gender differences in the intentionality of suicide attempts. Methods and Findings Methods. Design: Epidemiological study using a combination of self-report and official data. Setting: Mental health care services in four European countries: Germany, Hungary, Ireland, and Portugal. Data basis: Completed suicides derived from official statistics for each country (767 acts, 74.4% male) and assessed suicide attempts excluding habitual intentional self-harm (8,175 acts, 43.2% male). Main Outcome Measures and Data Analysis. We collected data on suicidal acts in eight regions of four European countries participating in the EU-funded "OSPI-Europe"-project (www.ospi-europe.com). We calculated method-specific lethality using the number of completed suicides per method * 100 /(number of completed suicides per method + number of attempted suicides per method). We tested gender differences in the distribution of suicidal acts for significance by using the chi(2)-test for two-by-two tables. We assessed the effect sizes with phi coefficients (phi). We identified predictors of lethality with a binary logistic regression analysis. Poisson regression analysis examined the contribution of choice of methods and method-specific lethality to gender differences in the lethality of suicidal acts. Findings Main Results Suicidal acts (fatal and non-fatal) were 3.4 times more lethal in men than in women (lethality 13.91% (regarding 4106 suicidal acts) versus 4.05% (regarding 4836 suicidal acts)), the difference being significant for the methods hanging, jumping, moving objects, sharp objects and poisoning by substances other than drugs. Median age at time of suicidal behaviour (35-44 years) did not differ between males and females. The overall gender difference in lethality of suicidal behaviour was explained by males choosing more lethal suicide methods (odds ratio (OR) = 2.03; 95% CI = 1.65 to 2.50; p < 0.000001) and additionally, but to a lesser degree, by a higher lethality of suicidal acts for males even within the same method (OR = 1.64; 95% CI = 1.32 to 2.02; p = 0.000005). Results of a regression analysis revealed neither age nor country differences were significant predictors for gender differences in the lethality of suicidal acts. The proportion of serious suicide attempts among all non-fatal suicidal acts with known intentionality (NFSAi) was significantly higher in men (57.1%; 1,207 of 2,115 NFSAi) than in women (48.6%; 1,508 of 3,100 NFSAi) (chi(2) = 35.74; p < 0.000001). Main limitations of the study Due to restrictive data security regulations to ensure anonymity in Ireland, specific ages could not be provided because of the relatively low absolute numbers of suicide in the Irish intervention and control region. Therefore, analyses of the interaction between gender and age could only be conducted for three of the four countries. Attempted suicides were assessed for patients presenting to emergency departments or treated in hospitals. An unknown rate of attempted suicides remained undetected. This may have caused an overestimation of the lethality of certain methods. Moreover, the detection of attempted suicides and the registration of completed suicides might have differed across the four countries. Some suicides might be hidden and misclassified as undetermined deaths. Conclusions Men more often used highly lethal methods in suicidal behaviour, but there was also a higher method-specific lethality which together explained the large gender differences in the lethality of suicidal acts. Gender differences in the lethality of suicidal acts were fairly consistent across all four European countries examined. Males and females did not differ in age at time of suicidal behaviour. Suicide attempts by males were rated as being more serious independent of the method used, with the exceptions of attempted hanging, suggesting gender differences in intentionality associated with suicidal behaviour. These findings contribute to understanding of the spectrum of reasons for gender differences in the lethality of suicidal behaviour and should inform the development of gender specific strategies for suicide prevention.	[Mergl, Roland; Koburger, Nicole; Heinrichs, Katherina; Hegerl, Ulrich] Univ Leipzig, Dept Psychiat & Psychotherapy, D-04109 Leipzig, Saxonia, Germany; [Szekely, Andras; Toth, Monika Ditta] Semmelweis Univ, Inst Behav Sci, H-1085 Budapest, Hungary; [Coyne, James] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Psychol, NL-9713 AV Groningen, Netherlands; [Quintao, Sonia] Univ Nova Lisboa, Dept Psychiat & Mental Hlth, CEDOC, P-1200 Lisbon, Portugal; [Arensman, Ella; Coffey, Claire] Natl Univ Ireland Univ Coll Cork, Natl Suicide Res Fdn, Cork, Ireland; [Arensman, Ella; Coffey, Claire] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Maxwell, Margaret] Univ Stirling, Nursing Midwifery & Allied Hlth Profess Res Unit, Stirling FK9 4LA, Scotland; [Vaernik, Airi] Estonian Swedish Mental Hlth & Suicidol Inst, Tallinn, Estonia; [Vaernik, Airi] Tallinn Univ, EE-10120 Tallinn, Estonia; [van Audenhove, Chantal] Katholieke Univ Leuven, LUCAS Ctr Care Res & Consultancy, Leuven, Belgium; [McDaid, David] London Sch Econ, London WC2A 2AE, England; [Sarchiapone, Marco] Univ Molise, Dept Med & Hlth Sci, Campobasso, Italy; [Sarchiapone, Marco] Natl Inst Hlth Migrat & Poverty, Rome, Italy; [Sarchiapone, Marco] Univ Gabriele dAnnunzio Fdn, Chieti, Italy; [Schmidtke, Armin] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, D-97070 Wurzburg, Germany; [Genz, Axel] Univ Magdeburg, Dept Psychiat Psychotherapy & Psychosomat Med, D-39106 Magdeburg, Germany; [Gusmao, Ricardo] Univ Nova Lisboa, Dept Psychiat & Mental Hlth, CEDOC, P-1200 Lisbon, Portugal; [Gusmao, Ricardo] Univ Porto, Inst Publ Hlth, ISPUP, P-4100 Oporto, Portugal	Leipzig University; Semmelweis University; University of Groningen; Universidade Nova de Lisboa; University College Cork; University College Cork; University of Stirling; Tallinn University; KU Leuven; University of London; London School Economics & Political Science; University of Molise; G d'Annunzio University of Chieti-Pescara; University of Wurzburg; Otto von Guericke University; Universidade Nova de Lisboa; Universidade do Porto	Mergl, R (corresponding author), Univ Leipzig, Dept Psychiat & Psychotherapy, D-04109 Leipzig, Saxonia, Germany.	Ulrich.Hegerl@medizin.uni-leipzig.de	Gusmao, Ricardo/AAT-5016-2020; McDaid, David/E-5959-2014; Sarchiapone, Marco/F-6402-2018; Toth, Monika Ditta/K-5265-2017	Gusmao, Ricardo/0000-0002-6334-4607; McDaid, David/0000-0003-0744-2664; Sarchiapone, Marco/0000-0001-9583-3117; Heinrichs, Katherina/0000-0003-0775-0528; Van Audenhove, Chantal/0000-0002-5504-5439; Toth, Monika Ditta/0000-0001-8903-4802; Hegerl, Ulrich/0000-0002-3039-7470; Arensman, Ella/0000-0003-0376-1203; Maxwell, Margaret/0000-0003-3318-9500	European Commission [223138]; German Research Foundation (DFG); Universitat Leipzig; Chief Scientist Office [NMAHP1] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); German Research Foundation (DFG)(German Research Foundation (DFG)); Universitat Leipzig; Chief Scientist Office	The research leading to these results has received funding from the European Commission (ec.europa.eu) within the Seventh Framework Programme under grant agreement No 223138. The following authors received the funding: NK KH A. Szekely MT RG SQ EA CC MM AV CVA DMcD MS A. Schmidtke AG JC UH. The authors also acknowledge support from the German Research Foundation (DFG) and Universitat Leipzig within the program of Open Access Publishing. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdacic-Gross V, 2008, B WORLD HEALTH ORGAN, V86, P726, DOI 10.2471/BLT.07.043489; Althaus D, 2007, NERVENARZT, V78, P272, DOI 10.1007/s00115-005-2031-5; [Anonymous], 2019, BURGERLICHES GESETZB; Boenisch S, 2010, EUR PSYCHIAT, V25, P414, DOI 10.1016/j.eurpsy.2009.11.007; Bogdanovica I, 2011, SOC PSYCH PSYCH EPID, V46, P1103, DOI 10.1007/s00127-010-0282-3; Callanan VJ, 2012, SOC PSYCH PSYCH EPID, V47, P857, DOI 10.1007/s00127-011-0393-5; Carli V, 2014, NORD J PSYCHIAT, V68, P44, DOI 10.3109/08039488.2013.767934; Chen VCH, 2009, SOC PSYCH PSYCH EPID, V44, P1005, DOI 10.1007/s00127-009-0021-9; Cibis A, 2012, J AFFECT DISORDERS, V136, P9, DOI 10.1016/j.jad.2011.08.032; Elnour AA, 2008, INJURY PREV, V14, P39, DOI 10.1136/ip.2007.016246; Feuerlein W, 1971, Nervenarzt, V42, P127; Giner L, 2014, J CLIN PSYCHIAT, V75, pE191, DOI 10.4088/JCP.13m08524; Hawton K, 2000, BRIT J PSYCHIAT, V177, P484, DOI 10.1192/bjp.177.6.484; Hegerl U, 2008, WORLD J BIOL PSYCHIA, V9, P51, DOI 10.1080/15622970701216681; Hegerl U, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-428; Houle J, 2008, J AFFECT DISORDERS, V107, P37, DOI 10.1016/j.jad.2007.07.016; KILLIAS M, 1993, CAN MED ASSOC J, V148, P1721; Krug EG, 1998, INT J EPIDEMIOL, V27, P214, DOI 10.1093/ije/27.2.214; Miller M, 2004, ANN EMERG MED, V43, P723, DOI 10.1016/j.annemergmed.2004.01.018; Moller-Leimkuhler AM, 2003, EUR ARCH PSY CLIN N, V253, P1, DOI 10.1007/s00406-003-0397-6; Perry IJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031663; PLATT S, 1992, ACTA PSYCHIAT SCAND, V85, P97, DOI 10.1111/j.1600-0447.1992.tb01451.x; Racette S, 2007, J FORENSIC SCI, V52, P449, DOI 10.1111/j.1556-4029.2007.00387.x; Schmidtke A, 1997, SUICIDE LIFE-THREAT, V27, P127; Schmidtke A, 1999, PSYCHOL REP, V84, P157, DOI 10.2466/PR0.84.1.157-166; Shenassa ED, 2003, J EPIDEMIOL COMMUN H, V57, P120, DOI 10.1136/jech.57.2.120; Sher L, 2009, J PSYCHIATR RES, V43, P901, DOI 10.1016/j.jpsychires.2009.01.005; Spicer RS, 2000, AM J PUBLIC HEALTH, V90, P1885, DOI 10.2105/AJPH.90.12.1885; Stack S, 2009, SUICIDE LIFE-THREAT, V39, P13, DOI 10.1521/suli.2009.39.1.13; Toero K, 2009, FORENSIC SCI INT, V184, P6, DOI 10.1016/j.forsciint.2008.10.020; Toth M, 2014, 15 EUR S SUIC BEH TA; Varnik A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-61; Varnik P, 2012, INJURY PREV, V18, P321, DOI 10.1136/injuryprev-2011-040070; Varnik P, 2012, INT J ENV RES PUB HE, V9, P760, DOI 10.3390/ijerph9030760; Varnik A, 2008, J EPIDEMIOL COMMUN H, V62, P545, DOI 10.1136/jech.2007.065391; Varnik P, 2010, SCAND J PUBLIC HEALT, V38, P395, DOI 10.1177/1403494809354360; World Health Organization, 2014, PREV SUIC PREV SUIC	37	108	109	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0129062	10.1371/journal.pone.0129062	http://dx.doi.org/10.1371/journal.pone.0129062			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26147965	Green Published, Green Accepted, gold			2022-12-27	WOS:000358157600018
J	Tinnesand, HV; Buesching, CD; Noonan, MJ; Newman, C; Zedrosser, A; Rosell, F; Macdonald, DW				Tinnesand, Helga V.; Buesching, Christina D.; Noonan, Michael J.; Newman, Chris; Zedrosser, Andreas; Rosell, Frank; Macdonald, David W.			Will Trespassers Be Prosecuted or Assessed According to Their Merits? A Consilient Interpretation of Territoriality in a Group-Living Carnivore, the European Badger (Meles meles)	PLOS ONE			English	Article							RESOURCE DISPERSION HYPOTHESIS; SCENT-MARKING BEHAVIOR; EXTRA-GROUP PATERNITY; EURASIAN BADGER; INDIVIDUAL RECOGNITION; NASTY NEIGHBORS; DEAR ENEMIES; INFORMATION; POPULATION; MOVEMENT	Socio-spatial interactions of Carnivores have traditionally been described using the vocabulary of territoriality and aggression, with scent marks interpreted as 'scent fences'. Here, we investigate the role of olfactory signals in assumed territorial marking of group-living solitary foragers using European badgers Meles meles as a model. We presented anal gland secretions (n = 351) from known individuals to identifiable recipients (n = 187), to assess response-variation according to familiarity (own-group, neighbours, strangers) and spatial context (in-context: at a shared border; out-of-context: at an unshared border/the main sett). Sniffing and over-marking (with subcaudal gland secretion) responses were strongest to anal gland secretions from strangers, intermediate to neighbouring-group and weakest to own-group members. Secretions from both, strangers and neighbours, were sniffed for longer than were own-group samples, although neighbour-secretion presented out-of-context evoked no greater interest than in-context. On an individual level, responses were further moderated by the relevance of individual-specific donor information encoded in the secretion, as it related to the physiological state of the responder. There was a trend bordering on significance for males to sniff for longer than did females, but without sex-related differences in the frequency of subcaudal over-marking responses, and males over-marked oestrous female secretions more than non-oestrous females. There were no age-class related differences in sniff-duration or in over-marking. Evaluating these results in the context of the Familiarity hypothesis, the Threat-level hypothesis, and the Individual advertisement hypothesis evidences that interpretations of territorial scent-marks depicting rigid and potentially agonistic discrimination between own-and foreign-group conspecifics are overly simplistic. We use our findings to advance conceptual understanding of badger socio-spatial ecology, and the general context of territoriality and group-range dynamics.	[Tinnesand, Helga V.; Zedrosser, Andreas; Rosell, Frank] Telemark Univ Coll, Fac Arts & Sci, Dept Environm & Hlth Studies, N-3800 Bo I Telemark, Norway; [Buesching, Christina D.; Noonan, Michael J.; Newman, Chris; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Abingdon OX13 5QL, Oxon, England; [Zedrosser, Andreas] Univ Nat Resources & Life Sci, Inst Wildlife Biol & Game Management, Dept Integrat Biol, A-1180 Vienna, Austria	University College of Southeast Norway; University of Oxford; University of Natural Resources & Life Sciences, Vienna	Buesching, CD (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Tubney House,Abingdon Rd, Abingdon OX13 5QL, Oxon, England.	christina.buesching@zoo.ox.ac.uk	Noonan, Michael J/H-9613-2019		People's Trust for Endangered Species; Rhodes Scholarship for DPhil students	People's Trust for Endangered Species; Rhodes Scholarship for DPhil students	The People's Trust for Endangered Species provided core funding for the long-term badger population study (grant). MN was supported by a Rhodes Scholarship for DPhil students. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annavi G, 2014, J EVOLUTION BIOL, V27, P2191, DOI 10.1111/jeb.12473; Annavi G, 2012, THESIS U OXFORD OXFO; Apps PJ, 2013, NATURWISSENSCHAFTEN, V100, P487, DOI 10.1007/s00114-013-1054-1; Bates D.M., 2010, LME4 MIXED EFFECTS M; BOSSERT WH, 1968, J THEOR BIOL, V18, P157, DOI 10.1016/0022-5193(68)90158-6; BRINCK C, 1983, J CHEM ECOL, V9, P727, DOI 10.1007/BF00988779; Buesching C. D., SMALL CARNIVORES SPA; Buesching CD, 2004, ACTA THERIOL, V49, P235, DOI 10.1007/BF03192523; Buesching CD, 2001, CHEM SIGNAL, V9, P321; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Byrne AW, 2014, J ANIM ECOL, V83, P991, DOI 10.1111/1365-2656.12197; Carazo P, 2008, ANIM BEHAV, V76, P1953, DOI 10.1016/j.anbehav.2008.08.018; Carpenter PJ, 2005, MOL ECOL, V14, P273, DOI 10.1111/j.1365-294X.2004.02401.x; Carter SP, 2007, P ROY SOC B-BIOL SCI, V274, P2769, DOI 10.1098/rspb.2007.0998; Christian SF, 1995, J ZOOL, V237, P668, DOI 10.1111/j.1469-7998.1995.tb05024.x; Clutton-Brock T, 2009, PHILOS T R SOC B, V364, P3229, DOI 10.1098/rstb.2009.0120; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; DAVIES JM, 1988, J ZOOL, V216, P455, DOI 10.1111/j.1469-7998.1988.tb02441.x; Delahay RJ, 2000, MAMMAL REV, V30, P73, DOI 10.1046/j.1365-2907.2000.00058.x; Dugdale HL, 2007, MOL ECOL, V16, P5294, DOI 10.1111/j.1365-294X.2007.03571.x; Fell RJ, 2006, BEHAVIOUR, V143, P683, DOI 10.1163/156853906777791315; Fisher J., 1954, P71; GALEF BG, 1983, ANIM BEHAV, V31, P748, DOI 10.1016/S0003-3472(83)80232-2; GOSLING LM, 1990, CHEM SIGNAL, V5, P315; Gosling LM, 1996, BEHAVIOUR, V133, P491, DOI 10.1163/156853996X00170; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Hutchings MR, 2000, MAMMAL REV, V30, P157, DOI 10.1046/j.1365-2907.2000.00065.x; Johnson DDP, 2002, TRENDS ECOL EVOL, V17, P563, DOI 10.1016/S0169-5347(02)02619-8; Johnston RE, 2008, ADV STUD BEHAV, V38, P439, DOI 10.1016/S0065-3454(08)00009-0; Jordan NR, 2010, J ZOOL, V280, P72, DOI 10.1111/j.1469-7998.2009.00646.x; Kelly CD, 2008, BEHAV ECOL SOCIOBIOL, V62, P855, DOI 10.1007/s00265-007-0518-8; Kilshaw K, 2009, J MAMMAL, V90, P1188, DOI 10.1644/08-MAMM-A-200.1; Krause J, 2007, BEHAV ECOL SOCIOBIOL, V62, P15, DOI 10.1007/s00265-007-0445-8; KRUUK H, 1978, J ZOOL, V184, P1; Lewis MA, 2001, J THEOR BIOL, V210, P449, DOI 10.1006/jtbi.2001.2323; Lups P., 1993, HDB SAUGETIERE EUROP, V5, P856; Macdonald DW, 2015, J ZOOL, V295, P75, DOI 10.1111/jzo.12202; Macdonald DW, 2008, J MAMMAL, V89, P1077, DOI 10.1644/07-MAMM-A-185.1; Macdonald DW, 2009, J MAMMAL, V90, P1392, DOI 10.1644/08-MAMM-A-356R1.1; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; Macdonald DW, FARMING IN PRESS; MATSON PA, 1992, ECOLOGY, V73, P723, DOI 10.2307/1940151; Mayeaux DJ, 2002, ANIM BEHAV, V64, P269, DOI 10.1006/anbe.2002.3053; Muller CA, 2007, P ROY SOC B-BIOL SCI, V274, P959, DOI 10.1098/rspb.2006.0222; Noonan MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083156; OSTFELD RS, 1985, AM NAT, V126, P1, DOI 10.1086/284391; Palphramand KL, 2007, ANIM BEHAV, V74, P429, DOI 10.1016/j.anbehav.2006.10.026; Perkins SE, 2009, J ANIM ECOL, V78, P1015, DOI 10.1111/j.1365-2656.2009.01557.x; Potts JR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0231; Powell RA, 2000, METH C CONS, P65; RICHARDSON PRK, 1993, T ROY SOC S AFR, V48, P195, DOI 10.1080/00359199309520270; ROPER TJ, 1986, BEHAVIOUR, V97, P94, DOI 10.1163/156853986X00333; ROPER TJ, 1993, BEHAVIOUR, V127, P289, DOI 10.1163/156853993X00074; Schradin C, 2004, BEHAV ECOL SOCIOBIOL, V55, P439, DOI 10.1007/s00265-003-0733-x; SCHUTTE JJE, 1991, COMMON MKT LAW REV, V28, P549; Schwarzenberger F, 1996, ANIM REPROD SCI, V42, P515, DOI 10.1016/0378-4320(96)01561-8; Sliwa A, 1998, ANIM BEHAV, V56, P137, DOI 10.1006/anbe.1998.0757; SMITH JM, 1976, ANIM BEHAV, V24, P159, DOI 10.1016/S0003-3472(76)80110-8; Stephens PA, 2005, J APPL ECOL, V42, P4, DOI 10.1111/j.1365-2664.2005.01002.x; Stewart PD, 1999, ANIM BEHAV, V57, P153, DOI 10.1006/anbe.1998.0935; Stewart PD, 1997, J THEOR BIOL, V184, P279, DOI 10.1006/jtbi.1996.0248; Stewart PD, 2003, ETHOLOGY, V109, P751, DOI 10.1046/j.1439-0310.2003.00910.x; Stewart PD, 2001, J ZOOL, V255, P191, DOI 10.1017/S0952836901001261; Stewart PD, 1997, J ZOOL, V241, P543, DOI 10.1111/j.1469-7998.1997.tb04846.x; Sun LX, 1998, ANIM BEHAV, V55, P1529, DOI 10.1006/anbe.1997.0709; TEMELES EJ, 1994, ANIM BEHAV, V47, P339, DOI 10.1006/anbe.1994.1047; WOODROFFE R, 1995, J ZOOL, V235, P237; YDENBERG RC, 1988, ANIM BEHAV, V36, P343, DOI 10.1016/S0003-3472(88)80004-6; Zhang JX, 2003, CHEM SENSES, V28, P381, DOI 10.1093/chemse/28.5.381	70	16	16	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132432	10.1371/journal.pone.0132432	http://dx.doi.org/10.1371/journal.pone.0132432			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147753	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600267
J	Wei, YQ; Wang, DG; Yang, H; Cao, H				Wei, You-quan; Wang, Dian-gang; Yang, Hao; Cao, Heng			Cytochrome P450 CYP 2C19*2 Associated with Adverse 1-Year Cardiovascular Events in Patients with Acute Coronary Syndrome	PLOS ONE			English	Article							CLOPIDOGREL RESPONSIVENESS; PLATELET-AGGREGATION; INTERVENTION; POLYMORPHISM; INHIBITION; REACTIVITY; GENOTYPE; OUTCOMES; DISEASE; RISK	Background The cytochrome P450 (CYP450) 2C19 681 genotypes affect the antiplatelet activity of clopidogrel. We investigated the correlation of CYP 2C19 681G > A mutation with clopidogrel resistance (CR). Additionally, we studied the effect of CR on clinical prognosis of patients with acute coronary syndrome (ACS). Methods One hundred ten ACS patients undergoing percutaneous coronary intervention, who were followed-up for 1 year, were included in the study. The patients were co-administered aspirin 100 mg/d and clopidogrel 75mg/d following a loading dose of 300 mg. CR was assessed on the basis of polymorphism observed in the CYP2C19 subgroup. Results Patients in GG genotype group exhibited greater inhibition of platelet aggregation than patients in GA and AA genotype groups (16.2 +/- 10.1%; 10.2 +/- 9.9%; 8.0 +/- 5.9%, respectively, p < 0.01). CYP2C19 681GG genotype group was associated with lower CR than CYP2C19 681A allele (GA + AA) group (9/59 vs. (12+ 5)/51; p = 0.009). Over a follow-up of 12 months, the incidence of recurrent angina, acute myocardial infarction, and intra-stent thrombosis in CYP2C19 681 GG carriers was significantly lower than that in CYP2C19 681A allele (GA + AA) group (2/59 vs. 8/51, 1/59 vs. 6/51, 0 vs. 4/51, respectively, p < 0.05). Conclusion CYP 2C19*2 is associated with reduced clopidogrel antiplatelet activity and might be an important marker for poor prognosis of ACS.	[Wei, You-quan; Yang, Hao; Cao, Heng] Wannan Med Coll, Affiliated Hosp 1, Dept Cardiol, Wuhu, Peoples R China; [Wang, Dian-gang] Second Peoples Hosp Huangchuan Cty, Dept Cardiol, Xinyang, Peoples R China	Wannan Medical College	Cao, H (corresponding author), Wannan Med Coll, Affiliated Hosp 1, Dept Cardiol, Wuhu, Peoples R China.	ablationer@aliyun.com			Natural Science Research of Anhui Province College, Anhui, China, HC [kj2011A263]	Natural Science Research of Anhui Province College, Anhui, China, HC	This work was supported by grants from the Key Project of Natural Science Research of Anhui Province College (kj2011A263), Anhui, China, HC.	Bhatt DL, 2012, EUR HEART J, V33, P2143, DOI 10.1093/eurheartj/ehs059; Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0; Guengerich FP, 2006, AAPS J, V8, pE101, DOI 10.1208/aapsj080112; Gurbel PA, 2005, J AM COLL CARDIOL, V45, P1392, DOI 10.1016/j.jacc.2005.01.030; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Hulot JS, 2010, J AM COLL CARDIOL, V56, P134, DOI 10.1016/j.jacc.2009.12.071; Jaremo P, 2002, J INTERN MED, V252, P233, DOI 10.1046/j.1365-2796.2002.01027.x; Kazui M, 2010, DRUG METAB DISPOS, V38, P92, DOI 10.1124/dmd.109.029132; Muller I, 2003, THROMB HAEMOSTASIS, V89, P783, DOI 10.1055/s-0037-1613462; Nelson David R., 2009, Human Genomics, V4, P59; Price MJ, 2012, J AM COLL CARDIOL, V59, P1928, DOI 10.1016/j.jacc.2011.11.068; Price MJ, 2011, CIRCULATION, V124, P1132, DOI 10.1161/CIRCULATIONAHA.111.029165; Rothenbacher D, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-61; Serebruany VL, 2005, J AM COLL CARDIOL, V45, P246, DOI 10.1016/j.jacc.2004.09.067; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Smith SMG, 2007, J AM COLL CARDIOL, V49, p375A; Speed WC, 2009, PHARMACOGENOMICS J, V9, P283, DOI 10.1038/tpj.2009.10; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056	19	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132561	10.1371/journal.pone.0132561	http://dx.doi.org/10.1371/journal.pone.0132561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147597	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600301
J	Telfer, EJ; Stovold, GT; Li, YJ; Silva, OB; Grattapaglia, DG; Dungey, HS				Telfer, Emily J.; Stovold, Grahame T.; Li, Yongjun; Silva Junior, Orzenil B.; Grattapaglia, Dario G.; Dungey, Heidi S.			Parentage Reconstruction in Eucalyptus nitens Using SNPs and Microsatellite Markers: A Comparative Analysis of Marker Data Power and Robustness	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GENETIC DIVERSITY; LINKAGE MAP; SELECTION; GRANDIS; ASSIGNMENT; MANAGEMENT; GLOBULUS; REGNANS; GROWTH	Pedigree reconstruction using molecular markers enables efficient management of inbreeding in open-pollinated breeding strategies, replacing expensive and time-consuming controlled pollination. This is particularly useful in preferentially outcrossed, insect pollinated Eucalypts known to suffer considerable inbreeding depression from related matings. A single nucleotide polymorphism (SNP) marker panel consisting of 106 markers was selected for pedigree reconstruction from the recently developed high-density Eucalyptus Infinium SNP chip (EuCHIP60K). The performance of this SNP panel for pedigree reconstruction in open-pollinated progenies of two Eucalyptus nitens seed orchards was compared with that of two microsatellite panels with 13 and 16 markers respectively. The SNP marker panel out-performed one of the microsatellite panels in the resolution power to reconstruct pedigrees and out-performed both panels with respect to data quality. Parentage of all but one offspring in each clonal seed orchard was correctly matched to the expected seed parent using the SNP marker panel, whereas parentage assignment to less than a third of the expected seed parents were supported using the 13-microsatellite panel. The 16-microsatellite panel supported all but one of the recorded seed parents, one better than the SNP panel, although there was still a considerable level of missing and inconsistent data. SNP marker data was considerably superior to microsatellite data in accuracy, reproducibility and robustness. Although microsatellites and SNPs data provide equivalent resolution for pedigree reconstruction, microsatellite analysis requires more time and experience to deal with the uncertainties of allele calling and faces challenges for data transferability across labs and over time. While microsatellite analysis will continue to be useful for some breeding tasks due to the high information content, existing infrastructure and low operating costs, the multi-species SNP resource available with the EuCHIP60k, opens a whole new array of opportunities for high-throughput, genome-wide or targeted genotyping in species of Eucalyptus.	[Telfer, Emily J.; Stovold, Grahame T.; Li, Yongjun; Dungey, Heidi S.] Sc New Zealand Forest Res Inst Ltd, Rotorua, New Zealand; [Silva Junior, Orzenil B.; Grattapaglia, Dario G.] EMBRAPA Recursos Genet & Biotecnol, Lab Genet Vegetal, Brasilia, DF, Brazil; [Silva Junior, Orzenil B.; Grattapaglia, Dario G.] Univ Catolica Brasilia, Programa Ciencias Genom & Biotecnol, Brasilia, DF, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Catolica de Brasilia	Telfer, EJ (corresponding author), Sc New Zealand Forest Res Inst Ltd, Rotorua, New Zealand.	Emily.Telfer@scionresearch.com	Silva-Junior, Orzenil/B-3488-2013; Grattapaglia, Dario/AAB-6805-2020; Grattapaglia, Dario/B-5864-2014	Silva-Junior, Orzenil/0000-0002-2104-2010; Grattapaglia, Dario/0000-0002-0050-970X; Grattapaglia, Dario/0000-0002-0050-970X; Li, Yongjun/0000-0001-6937-3540; Telfer, Emily/0000-0001-5269-6589; Dungey, Heidi/0000-0003-2589-3928	Diverse Forests Ministry of Business Innovation and Employment [C04X0805]; Scion CORE funding	Diverse Forests Ministry of Business Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Scion CORE funding	This study was funded by C04X0805 Diverse Forests Ministry of Business Innovation and Employment (http://www.mbie.govt.nz/), and by Scion CORE funding (www.scionresearch.com). Authors EJT, GTS, YL and HSD are employed by Scion (New Zealand Forest research Institute Ltd.). Scion provided support in the form of salaries for these authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], GENOMESTUDIO DAT AN; Borralho NMG, 1996, ROLLING FRONT STRATE, P317; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Brondani RPV, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-20; Brondani RPV, 1998, THEOR APPL GENET, V97, P816, DOI 10.1007/s001220050961; Brondani RPV, 2001, BIOTECHNIQUES, V31, P793; Bush D, 2011, TREE GENET GENOMES, V7, P23, DOI 10.1007/s11295-010-0312-z; Chaix G, 2010, J TROP FOR SCI, V22, P271; Correia L, 2011, BMC P, V5, pP41, DOI [10.1186/1753-6561-5-S8-P41, DOI 10.1186/1753-6561-5-S8-P41]; Crawley MJ, 2005, STAT INTRO USING R; Emanuelli F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-39; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Faria DA, 2011, TREE GENET GENOMES, V7, P63, DOI 10.1007/s11295-010-0315-9; Garcia-Lor A, 2013, ANN BOT-LONDON, V111, P1, DOI 10.1093/aob/mcs227; Gea L. D., 2007, New Zealand Journal of Forestry Science, V37, P23; Gomory D., 2000, Forest Genetics, V7, P65; Grattapaglia D, 2004, THEOR APPL GENET, V109, P192, DOI 10.1007/s00122-004-1617-9; Grattapaglia D, 2011, TREE GENET GENOMES, P1; Grattapaglia D, 2012, TREE GENET GENOMES, V8, P463, DOI 10.1007/s11295-012-0491-x; Grattapaglia D, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-65; GRIFFIN AR, 1988, SILVAE GENET, V37, P124; GRIFFIN AR, 1987, AUST J BOT, V35, P465, DOI 10.1071/BT9870465; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Hamilton M, 2008, AUST FORESTRY, V71, P82, DOI 10.1080/00049158.2008.10676274; Hansen OK, 2006, CAN J FOREST RES, V36, P1054, DOI 10.1139/X05-299; Hauser L, 2011, MOL ECOL RESOUR, V11, P150, DOI 10.1111/j.1755-0998.2010.02961.x; JAMIESON A, 1994, ANIM GENET, V25, P37, DOI 10.1111/j.1365-2052.1994.tb00401.x; Jamieson A, 1997, ANIM GENET, V28, P397, DOI 10.1111/j.1365-2052.1997.00186.x; Kirst M, 2005, J HERED, V96, P161, DOI 10.1093/jhered/esi023; Kulheim C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-452; Mammadov J, 2012, INT J PLANT GENOMICS, V2012; Moncur MW, 1992, AFOCEL IUFRO S BORD, P107; Moriguchi Y., 2005, Journal of the Japanese Forest Society, V87, P161; Myburg AA, 2014, NATURE ADV ONLINE PU; Nei M., 1987, MOL EVOLUTIONARY GEN; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Resende MDV, 2012, NEW PHYTOL, V194, P116, DOI 10.1111/j.1469-8137.2011.04038.x; Sansaloni CP, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-16; Sedgley M, 1989, SEXUAL REPROD TREE C; Silva JCE, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2010018; Silva OB, 2015, NEW PHYTOL, V206, P1527, DOI 10.1111/nph.13322; Steane DA, 2011, MOL PHYLOGENET EVOL, V59, P206, DOI 10.1016/j.ympev.2011.02.003; Telfer E, 2013, NEW ZEAL J FOR SCI, V43, DOI 10.1186/1179-5395-43-3; Thavamanikumar S, 2011, AUST FORESTRY, V74, P23, DOI 10.1080/00049158.2011.10676342; Tokarska M, 2009, HEREDITY, V103, P326, DOI 10.1038/hdy.2009.73; Unterseer S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-823; Van Inghelandt D, 2010, THEOR APPL GENET, V120, P1289, DOI 10.1007/s00122-009-1256-2; VOLKER PW, 1990, SILVAE GENET, V39, P18; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Wurschum T, 2013, THEOR APPL GENET, P1; Yang XH, 2011, GENETICA, V139, P1045, DOI 10.1007/s10709-011-9606-9; Yu JM, 2009, PLANT GENOME-US, V2, P63, DOI 10.3835/plantgenome2008.09.0009	52	27	28	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0130601	10.1371/journal.pone.0130601	http://dx.doi.org/10.1371/journal.pone.0130601			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158446	Green Published, Green Submitted, gold			2022-12-27	WOS:000358161200015
J	Feller, C; Favre, P; Janka, A; Zeeman, SC; Gabriel, JP; Reinhardt, D				Feller, Chrystel; Favre, Patrick; Janka, Ales; Zeeman, Samuel C.; Gabriel, Jean-Pierre; Reinhardt, Didier			Mathematical Modeling of the Dynamics of Shoot-Root Interactions and Resource Partitioning in Plant Growth	PLOS ONE			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; PHOSPHATE-STARVATION; BIOMASS ALLOCATION; PHLOEM TRANSPORT; STARCH DEGRADATION; CARBON ALLOCATION; CIRCADIAN CLOCKS; LEAF STRUCTURE; ARABIDOPSIS; LIGHT	Plants are highly plastic in their potential to adapt to changing environmental conditions. For example, they can selectively promote the relative growth of the root and the shoot in response to limiting supply of mineral nutrients and light, respectively, a phenomenon that is referred to as balanced growth or functional equilibrium. To gain insight into the regulatory network that controls this phenomenon, we took a systems biology approach that combines experimental work with mathematical modeling. We developed a mathematical model representing the activities of the root (nutrient and water uptake) and the shoot (photosynthesis), and their interactions through the exchange of the substrates sugar and phosphate (Pi). The model has been calibrated and validated with two independent experimental data sets obtained with Petunia hybrida. It involves a realistic environment with a day-and-night cycle, which necessitated the introduction of a transitory carbohydrate storage pool and an endogenous clock for coordination of metabolism with the environment. Our main goal was to grasp the dynamic adaptation of shoot: root ratio as a result of changes in light and Pi supply. The results of our study are in agreement with balanced growth hypothesis, suggesting that plants maintain a functional equilibrium between shoot and root activity based on differential growth of these two compartments. Furthermore, our results indicate that resource partitioning can be understood as the emergent property of many local physiological processes in the shoot and the root without explicit partitioning functions. Based on its encouraging predictive power, the model will be further developed as a tool to analyze resource partitioning in shoot and root crops.	[Feller, Chrystel; Janka, Ales; Gabriel, Jean-Pierre] Univ Fribourg, Dept Math, CH-1700 Fribourg, Switzerland; [Favre, Patrick; Reinhardt, Didier] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; [Zeeman, Samuel C.] ETH, Inst Agr Sci, Zurich, Switzerland	University of Fribourg; University of Fribourg; Swiss Federal Institutes of Technology Domain; ETH Zurich	Reinhardt, D (corresponding author), Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland.	didier.reinhardt@unifr.ch	Reinhardt, Didier/M-8508-2014	Reinhardt, Didier/0000-0003-3495-6783; Zeeman, Samuel/0000-0002-2791-0915	SystemsX.ch	SystemsX.ch	This work was supported by SystemsX.ch, http://www.systemsx.ch. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acock B, 1991, MODELING CROP PHOTOS, V19, P41; Adams SR, 2008, J HORTIC SCI BIOTECH, V83, P609, DOI 10.1080/14620316.2008.11512431; Agren GI, 2003, ANN BOT-LONDON, V92, P795, DOI 10.1093/aob/mcg203; Ainsworth EA, 2011, PLANT PHYSIOL, V155, P64, DOI 10.1104/pp.110.167684; Amthor JS, 2000, ANN BOT-LONDON, V86, P1, DOI 10.1006/anbo.2000.1175; Beutler H. O., 1984, METHOD ENZYMAT AN, P321; Bove JM, 2002, PLANT SCI, V163, P1083, DOI 10.1016/S0168-9452(02)00276-5; Braun DM, 2014, J EXP BOT, V65, P1713, DOI 10.1093/jxb/ert416; BROUWER R., 1962, NETHERLANDS JOUR AGRIC SCI, V10, P399; Bucher M, 2007, NEW PHYTOL, V173, P11, DOI 10.1111/j.1469-8137.2006.01935.x; CAKMAK I, 1994, J EXP BOT, V45, P1245, DOI 10.1093/jxb/45.9.1245; Cannell MGR, 2000, ANN BOT-LONDON, V85, P45, DOI 10.1006/anbo.1999.0996; Chen YF, 2008, J INTEGR PLANT BIOL, V50, P835, DOI 10.1111/j.1744-7909.2008.00707.x; Coello CAC., 2007, EVOLUTIONARY ALGORIT, V5; Cruz-Ramirez A, 2006, P NATL ACAD SCI USA, V103, P6765, DOI 10.1073/pnas.0600863103; De Schepper V, 2013, J EXP BOT, V64, P4839, DOI 10.1093/jxb/ert302; DEWAR RC, 1993, FUNCT ECOL, V7, P356, DOI 10.2307/2390216; Dinant S, 2010, CR BIOL, V333, P307, DOI 10.1016/j.crvi.2010.01.006; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Flugge UI, 1998, CURR OPIN PLANT BIOL, V1, P201, DOI 10.1016/S1369-5266(98)80105-2; Forde B, 2001, PLANT SOIL, V232, P51, DOI 10.1023/A:1010329902165; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; GARNIER E, 1991, TRENDS ECOL EVOL, V6, P126, DOI 10.1016/0169-5347(91)90091-B; Geigenberger P, 2011, PLANT PHYSIOL, V155, P1566, DOI 10.1104/pp.110.170399; Gibon Y, 2004, PLANT J, V39, P847, DOI 10.1111/j.1365-313X.2004.02173.x; Graf A, 2010, P NATL ACAD SCI USA, V107, P9458, DOI 10.1073/pnas.0914299107; Guo WB, 2008, PLANT SCI, V175, P574, DOI 10.1016/j.plantsci.2008.06.007; HAEHNEL W, 1984, ANNU REV PLANT PHYS, V35, P659, DOI 10.1146/annurev.pp.35.060184.003303; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hendriks JHM, 2003, PLANT PHYSIOL, V133, P838, DOI 10.1104/pp.103.024513; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; HESKETH JD, 1971, CROP SCI, V11, P394, DOI 10.2135/cropsci1971.0011183X001100030025x; Hodge A, 1997, J EXP BOT, V48, P1797, DOI 10.1093/jexbot/48.315.1797; IWASA Y, 1984, THEOR POPUL BIOL, V25, P78, DOI 10.1016/0040-5809(84)90007-8; James SA, 2000, TREE PHYSIOL, V20, P1007; Jensen KH, 2012, PLANT CELL ENVIRON, V35, P1065, DOI 10.1111/j.1365-3040.2011.02472.x; JOHNSON IR, 1987, ANN BOT-LONDON, V60, P133, DOI 10.1093/oxfordjournals.aob.a087429; Kang MZ, 2007, WAG UR FRON, V22, P65; Kim HK, 2014, J EXP BOT, V65, P1895, DOI 10.1093/jxb/eru075; Kleemola J, 1996, PLANT SOIL, V185, P101, DOI 10.1007/BF02257567; Knoblauch M, 2012, PLANT J, V70, P147, DOI 10.1111/j.1365-313X.2012.04931.x; Kotting O, 2009, PLANT CELL, V21, P334, DOI 10.1105/tpc.108.064360; Kunst A., 1984, METHOD ENZYMAT AN, VVI, P163; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; Lu Y, 2005, PLANT PHYSIOL, V138, P2280, DOI 10.1104/pp.105.061903; Marcelis LFM, 2007, WAG UR FRON, V22, P103; Marcelis LFM, 1998, SCI HORTIC-AMSTERDAM, V74, P83, DOI 10.1016/S0304-4238(98)00083-1; Mauseth J., 1988, PLANT ANATOMY; McCarthy MC, 2007, FUNCT ECOL, V21, P713, DOI 10.1111/j.1365-2435.2007.01276.x; McCREE K. J., 1970, Prediction and measurement of photosynthetic productivity. Proceedings of the IBP/PP Technical Meeting, Trebon, [Czechoslovakia], 14-21 September, 1969, P221; Mengel K, 1982, Principles of plant nutrition.; Minchin PEH, 2007, WAG UR FRON, V22, P113; MINCHIN PEH, 1993, J EXP BOT, V44, P947, DOI 10.1093/jxb/44.5.947; Muller LM, 2014, J EXP BOT, V65, P2915, DOI 10.1093/jxb/eru117; Munch E., 1930, STOFFBEWEGUNGEN PFLA; Murchie EH, 2009, NEW PHYTOL, V181, P532, DOI 10.1111/j.1469-8137.2008.02705.x; Neumann G, 2002, TRENDS PLANT SCI, V7, P162, DOI 10.1016/S1360-1385(02)02241-0; NIKLAS KJ, 1988, EVOLUTION, V42, P1, DOI 10.1111/j.1558-5646.1988.tb04103.x; Nouri E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090841; Ogren E, 2000, PHYSIOL PLANTARUM, V108, P295, DOI 10.1034/j.1399-3054.2000.108003295.x; Oguchi R, 2003, PLANT CELL ENVIRON, V26, P505, DOI 10.1046/j.1365-3040.2003.00981.x; Patrick JW, 1997, ANNU REV PLANT PHYS, V48, P191, DOI 10.1146/annurev.arplant.48.1.191; Paul MJ, 2001, J EXP BOT, V52, P1383, DOI 10.1093/jexbot/52.360.1383; Peret B, 2011, TRENDS PLANT SCI, V16, P442, DOI 10.1016/j.tplants.2011.05.006; Peuke AD, 2010, J EXP BOT, V61, P635, DOI 10.1093/jxb/erp352; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P1191, DOI 10.1071/PP99173; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Rains DW, 1976, PLANT BIOCH, P561; Rasse DP, 2006, NEW PHYTOL, V172, P500, DOI 10.1111/j.1469-8137.2006.01848.x; Rausch C, 2002, PLANTA, V216, P23, DOI 10.1007/s00425-002-0921-3; REYNOLDS JF, 1982, ANN BOT-LONDON, V49, P585, DOI 10.1093/oxfordjournals.aob.a086286; Schnepf A, 2006, NEW PHYTOL, V171, P669, DOI 10.1111/j.1469-8137.2006.01771.x; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shachar-Hill Y, 2013, CURR OPIN BIOTECH, V24, P247, DOI 10.1016/j.copbio.2013.01.004; SHEEHY JE, 1995, ANN BOT-LONDON, V76, P263, DOI 10.1006/anbo.1995.1095; Shipley B, 2002, FUNCT ECOL, V16, P326, DOI 10.1046/j.1365-2435.2002.00626.x; Smith AM, 2007, PLANT CELL ENVIRON, V30, P1126, DOI 10.1111/j.1365-3040.2007.01708.x; Smith AM, ANN REV PLANT BIOL, P73; STITT M, 1991, PLANT CELL ENVIRON, V14, P741, DOI 10.1111/j.1365-3040.1991.tb01440.x; Stitt M, 2012, CURR OPIN PLANT BIOL, V15, P282, DOI 10.1016/j.pbi.2012.03.016; Stitt M, 2010, PLANT J, V61, P1067, DOI 10.1111/j.1365-313X.2010.04142.x; Sulpice R, 2014, MOL PLANT, V7, P137, DOI 10.1093/mp/sst127; Thornley HM, 2002, PLANT CROP MODELLING; Thornley J. H. M., 2007, Mathematical models in agriculture: quantitative methods for the plant, animal and ecological sciences, DOI 10.1079/9780851990101.0000; THORNLEY JH, 1972, ANN BOT-LONDON, V36, P431, DOI 10.1093/oxfordjournals.aob.a084602; THORNLEY JH, 1970, NATURE, V227, P304, DOI 10.1038/227304b0; Thornley JHM, 1998, ANN BOT-LONDON, V81, P165, DOI 10.1006/anbo.1997.0529; Thornley JHM, 2002, ANN BOT-LONDON, V89, P451, DOI 10.1093/aob/mcf071; THORNLEY JHM, 1995, ANN BOT-LONDON, V75, P391, DOI 10.1006/anbo.1995.1037; Thornley JHM., 1990, PLANT CROP MODELLING; Thornley JHM, 1998, GRASSLAND DYNAMICS; Thornley JHM, 2014, J THEOR BIOL, V342, P1, DOI 10.1016/j.jtbi.2013.10.003; Thykjaer T, 1997, PLANT MOL BIOL, V35, P523, DOI 10.1023/A:1005865600319; vonArnim A, 1996, ANNU REV PLANT PHYS, V47, P215, DOI 10.1146/annurev.arplant.47.1.215; Walter Achim, 2006, Plant Signal Behav, V1, P225, DOI 10.4161/psb.1.5.3447; Wentworth M, 2006, J EXP BOT, V57, P699, DOI 10.1093/jxb/erj061; WIT C. T. DE, 1970, Prediction and measurement of photosynthetic productivity. Proceedings of the IBP/PP Technical Meeting, Tfebon, [Czechoslovakia], 14-21 September, 1969., P47; Wu P, 2003, PLANT PHYSIOL, V132, P1260, DOI 10.1104/pp.103.021022; Wyka TP, 2012, OECOLOGIA, V170, P11, DOI 10.1007/s00442-012-2279-y; Yingshan Hsu P, 2013, TRENDS PLAN IN PRESS	100	20	22	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0127905	10.1371/journal.pone.0127905	http://dx.doi.org/10.1371/journal.pone.0127905			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154262	Green Published, Green Submitted, gold			2022-12-27	WOS:000358159700007
J	Zilhao, J; Banks, WE; d'Errico, F; Gioia, P				Zilhao, Joao; Banks, William E.; d'Errico, Francesco; Gioia, Patrizia			Analysis of Site Formation and Assemblage Integrity Does Not Support Attribution of the Uluzzian to Modern Humans at Grotta del Cavallo	PLOS ONE			English	Article							HUMAN-CLIMATE INTERACTION; PROTO-AURIGNACIAN; FUMANE CAVE; NEANDERTHAL REMAINS; ADAPTIVE SHIFT; CHRONOLOGY; EUROPE; MIDDLE; GREECE; HYPOTHESIS	Based on the morphology of two deciduous molars and radiocarbon ages from layers D and E of the Grotta del Cavallo (Lecce, Italy), assigned to the Uluzzian, it has been proposed that modern humans were the makers of this Early Upper Paleolithic culture and that this finding considerably weakens the case for an independent emergence of symbolism among western European Neandertals. Reappraisal of the new dating evidence, of the finds curated in the Taranto Antiquities depot, and of coeval publications detailing the site's 1963-66 excavations shows that (a) Protoaurignacian, Aurignacian and Early Epigravettian lithics exist in the assemblages from layers D and E, (b) even though it contains both inherited and intrusive items, the formation of layer D began during Protoaurignacian times, and (c) the composition of the extant Cavallo assemblages is influenced in a non-negligible manner by the post-hoc assignment of items to stratigraphic units distinct fromthat of original discovery. In addition, a major disturbance feature affected the 1960s excavation trench down to Mousterian layer F, this feature went unrecognized until 1964, the human remains assigned to the Uluzzian were discovered that year and/or the previous year, and there are contradictions between field reports and the primary anthropological description of the remains as to their morphology and level of provenience. Given these major contextual uncertainties, the Cavallo teeth cannot be used to establish the authorship of the Uluzzian. Since this technocomplex's start date is ca. 45,000 calendar years ago, a number of Neandertal fossils are dated to this period, and the oldest diagnostic European modern human fossil is the <41,400 year-old Oase 1 mandible, Neandertal authorship of the Uluzzian remains the parsimonious reading of the evidence.	[Zilhao, Joao] Univ Barcelona, Fac Geog & Hist, Dept Prehist Hist Antiga & Arqueol, Seminari Estudis & Recerques Prehi, Barcelona 08001, Spain; [Zilhao, Joao] ICREA, Barcelona 08010, Spain; [Banks, William E.; d'Errico, Francesco] Univ Bordeaux, CNRS, UMR PACEA 5199, CS 50023, F-33615 Pessac, France; [Banks, William E.] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [d'Errico, Francesco] Univ Bergen, Dept Archaeol Hist Cultural Studies & Relig, N-5007 Bergen, Norway; [Gioia, Patrizia] Univ Roma La Sapienza, Dipartimento Sci Antichita Facolta Lettere & Filo, I-00185 Rome, Italy	University of Barcelona; ICREA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; University of Kansas; University of Bergen; Sapienza University Rome	d'Errico, F (corresponding author), Univ Bordeaux, CNRS, UMR PACEA 5199, CS 50023, Batiment B18,Allee Geoffroy St Hilaire, F-33615 Pessac, France.	francesco.derrico@u-bordeaux.fr	Banks, William E./H-3494-2019; Zilhão, João/L-5670-2014	Banks, William E./0000-0003-1835-6315; Zilhão, João/0000-0001-5937-3061	European Research Council [249587]; Agence Nationale de la Recherche [ANR-10-LABX-52]; LaScArBx Cluster of Excellence; ICREA Funding Source: Custom; Fundação para a Ciência e a Tecnologia [PTDC/HIS-ARQ/121592/2010] Funding Source: FCT	European Research Council(European Research Council (ERC)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); LaScArBx Cluster of Excellence; ICREA(ICREA); Fundação para a Ciência e a Tecnologia	This work was supported by European Research Council (FP7/2007-2013 grant no. 249587), http://erc.europa.eu/; Agence Nationale de la Recherche (ANR-10-LABX-52), LaScArBx Cluster of Excellence, http://lascarbx.labex.u-bordeaux.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks WE, 2013, J HUM EVOL, V65, P810, DOI 10.1016/j.jhevol.2013.08.004; Banks WE, 2013, J HUM EVOL, V64, P39, DOI 10.1016/j.jhevol.2012.10.001; Bar-Yosef O, 2010, J HUM EVOL, V59, P586, DOI 10.1016/j.jhevol.2010.06.009; Benazzi S, 2007, IMAGE ANAL MORPHOLOG; Benazzi S, 2014, J HUM EVOL, V70, P61, DOI 10.1016/j.jhevol.2014.03.001; Benazzi S, 2014, J HUM EVOL, V66, P89, DOI 10.1016/j.jhevol.2013.09.009; Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; Bordes J-G, 2002, INTERSTRATIFIC UNPUB; Borzatti von Lowenstern E, 1965, RIV SCI PREISTORICHE, P1; Borzatti von Lowenstern E, 1963, RIV SCI PREISTORICHE, P75; Borzatti von Lowenstern E, 1964, RIV SCI PREISTORICHE, P41; Broglio A, 2002, MEMORIE MUSEO CIVICO, P29; Broglio A., 2005, 14 C UISPP LIEG 2 8, P415; Caron F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021545; Churchill SE, 2000, YEARB PHYS ANTHROPOL, V43, P61; D'Errico F, 2003, EVOL ANTHROPOL, V12, P188, DOI 10.1002/evan.10113; d'Errico F, 2012, QUATERN INT, V259, P59, DOI 10.1016/j.quaint.2011.03.039; Dayer L, 2014, J ARCHAEOL SCI, V44, P180, DOI 10.1016/j.jas.2014.01.032; De Stefani M., 2012, WISSENSCHAFTLICHE SC, V5, P135; De Vivo B, 2001, MINER PETROL, V73, P47, DOI 10.1007/s007100170010; DICESNOLA AP, 1989, ANTHROPOLOGIE, V93, P783; Dorale JA, 2010, SCIENCE, V327, P860, DOI 10.1126/science.1181725; Douka K, 2014, J HUM EVOL, V68, P1, DOI 10.1016/j.jhevol.2013.12.007; Douka K, 2012, J HUM EVOL, V62, P286, DOI 10.1016/j.jhevol.2011.11.009; Finlayson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045927; Gambassini P, 2005, PROCESSO UMANIZZAZIO; Gioia P., 1988, HOMME NEANDERTAL, V8, P71; Gioia P., 1990, MEMOIRES MUSEE PREHI, V3, P241; Gioia P, 1987, THESIS U ROME LA SAP; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Harvati K, 2003, J HUM EVOL, V45, P465, DOI 10.1016/j.jhevol.2003.09.005; Higham T, 2012, J HUM EVOL, V62, P664, DOI 10.1016/j.jhevol.2012.03.003; Higham T, 2010, P NATL ACAD SCI USA, V107, P20234, DOI 10.1073/pnas.1007963107; Higham T, 2009, QUATERNARY SCI REV, V28, P1257, DOI 10.1016/j.quascirev.2008.12.018; Higham T, 2014, NATURE, V512, P306, DOI 10.1038/nature13621; Higham T, 2011, NATURE, V479, P521, DOI 10.1038/nature10484; Hublin JJ, 2012, P NATL ACAD SCI USA, V109, P18743, DOI 10.1073/pnas.1212924109; Koumouzelis M, 2001, ANTHROPOLOGIE, V105, P469; Koumouzelis M, 2001, J ARCHAEOL SCI, V28, P515, DOI 10.1006/jasc.2000.0599; Laplace G, 1966, RECHERCHES ORIGINE E; Laplace G., 1966, QUARTAR, V17, P117; Messeri P, 1976, ZEPHYRUS, P26; Morin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032856; Moroni A, 2013, QUATERN INT, V316, P27, DOI 10.1016/j.quaint.2012.10.051; Mussi M., 2006, TRABALHOS ARQUEOLOGI, V45, P189; Palma di Cesnola A, 1993, PALEOLITICO SUPERIOR; Palma di Cesnola A, 1969, RIV SCI PREISTORICHE, P341; Palma di Cesnola A, 1966, RIV SCI PREISTORICHE, P289; Palma di Cesnola A, 1966, RIV SCI PREISTORICHE, V21, P419; Palma di Cesnola A, 1967, ANTHROPOLOGIE, V71, P249; Palma di Cesnola A, 1965, RIV SCI PREISTORICHE, P33; Palma di Cesnola A, 1987, PALEOLITHIQUE SUPERI, P203; Palma di Cesnola A, 1982, AURIGNACIEN GRAVETTI, VIII, P271; Palma di Cesnola A, 1972, RIV SCI PREISTORICHE, P51; Palma di Cesnola A, 1965, RIV SCI PREISTORICHE, P291; Palma di Cesnola A, 1966, RIV SCI PREISTORICHE, P3; Palma di Cesnola A, 1983, AURIGNACIEN GRAVETTI, VII, P119; Palma di Cesnola PA., 1964, RIV SCI PREISTORICHE, V19, P23; Palma di Cesnola PA., 1963, RIV SCI PREISTORICHE, V18, P41; Peresani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068572; Peresani M, 2011, P NATL ACAD SCI USA, V108, P3888, DOI 10.1073/pnas.1016212108; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Riel-Salvatore J, 2009, SOURCEBOOK OF PALEOLITHIC TRANSITIONS, P377, DOI 10.1007/978-0-387-76487-0_25; Ronchitelli A, 2014, J HUM EVOL, V73, P107, DOI 10.1016/j.jhevol.2013.12.010; Sarti L, 1998, ORIGINI, V22, P45; Sarti L., 2008, RIV SCI PREIST, V58, P421; Sarti L, 2002, RIV SCI PREISTORICHE, V52, P21; Schmitz RW, 2002, P NATL ACAD SCI USA, V99, P13342, DOI 10.1073/pnas.192464099; Trinkaus E, 2005, ANNU REV ANTHROPOL, V34, P207, DOI 10.1146/annurev.anthro.34.030905.154913; Trinkaus E, 2003, P NATL ACAD SCI USA, V100, P11231, DOI 10.1073/pnas.2035108100; Vanhaeren M, 2002, THESIS U BORDEAUX 1; Vanhaeren M, 2006, J ARCHAEOL SCI, V33, P1105, DOI 10.1016/j.jas.2005.11.017; White M, 2012, EUR J ARCHAEOL, V15, P392, DOI 10.1179/1461957112Y.0000000019; Zanolli C, 2013, XRAY MICROTOMOGRAPHY; Zilhao J, 1999, FACIES LEPTOLITHIQUE, P165; Zilhao J, 2013, DYNAMICS LEARNING NE, V1, P21; Zilhao J., 2008, PALEOANTHROPOLOGY, P1; Zilhao J, 2007, J ARCHAEOL RES, V15, P1, DOI 10.1007/s10814-006-9008-1; Zilhao J, 2006, P NATL ACAD SCI USA, V103, P12643, DOI 10.1073/pnas.0605128103; Zilhao J, 2011, VERTEBR PALEOBIOL PA, P331, DOI 10.1007/978-94-007-0492-3_25; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107	82	51	51	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131181	10.1371/journal.pone.0131181	http://dx.doi.org/10.1371/journal.pone.0131181			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CN1EJ	26154139	gold, Green Published, Green Submitted			2022-12-27	WOS:000358159700056
J	Bila, DCA; Boullosa, LT; Vubil, AS; Mabunda, NJ; Abreu, CM; Ismael, N; Jani, IV; Tanuri, A				Adolfo Bila, Dulce Celina; Boullosa, Lidia Teodoro; Vubil, Adolfo Salvador; Mabunda, Nedio Jonas; Abreu, Celina Monteiro; Ismael, Nalia; Jani, Ilesh Vinodrai; Tanuri, Amilcar			Trends in Prevalence of HIV-1 Drug Resistance in a Public Clinic in Maputo, Mozambique	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; REVERSE-TRANSCRIPTASE INHIBITORS; NAIVE PATIENTS; SUBTYPE-C; HIV-1-INFECTED PATIENTS; VIROLOGICAL FAILURE; K65R RESISTANCE; HEALTH APPROACH; 1ST YEAR; MUTATIONS	Background An observational study was conducted in Maputo, Mozambique, to investigate trends in prevalence of HIV drug resistance (HIVDR) in antiretroviral (ART) naive subjects initiating highly active antiretroviral treatment (HAART). Methodology/Principal Findings To evaluate the pattern of drug resistance mutations (DRMs) found in adults on ART failing first- line HAART [patients with detectable viral load (VL)]. Untreated subjects [Group 1 (G1;n= 99)] and 274 treated subjects with variable length of exposure to ARV's [6- 12 months, Group 2 (G2;n= 93); 12- 24 months, Group 3 (G3;n= 81); >24 months (G4;n= 100)] were enrolled. Virological and immunological failure (VF and IF) were measured based on viral load (VL) and T lymphocyte CD4+ cells (TCD4+) count and genotypic resistance was also performed. Major subtype found was C (untreated: n= 66, 97,06%;treated: n= 36, 91.7%). Maximum virological suppression was observed in G3, and significant differences intragroup were observed between VF and IF in G4 (p= 0.022). Intergroup differences were observed between G3 and G4 for VF (p= 0.023) and IF between G2 and G4 (p= 0.0018). Viral suppression (<50 copies/ml) ranged from 84.9% to 90.1%, and concordant VL and DRM ranged from 25% to 57%. WHO cut- off for determining VF as given by 2010 guidelines (>5000 copies/ml) identified 50% of subjects carrying DRM compared to 100% when lower VL cut- off was used (<50 copies/ml). Length of exposure to ARVs was directly proportional to the complexity of DRM patterns. In Mozambique, VL suppression was achieved in 76% of individuals after 24 months on HAART. This is in agreement with WHO target for HIVDR prevention target (70%). Conclusions We demonstrated that the best way to determine therapeutic failure is VL compared to CD4 counts. The rationalized use of VL testing is needed to ensure timely detection of treatment failures preventing the occurrence of TDR and new infections.	[Adolfo Bila, Dulce Celina; Vubil, Adolfo Salvador; Mabunda, Nedio Jonas; Ismael, Nalia; Jani, Ilesh Vinodrai] Natl Inst Hlth Mozambique, Maputo, Mozambique; [Adolfo Bila, Dulce Celina; Boullosa, Lidia Teodoro; Abreu, Celina Monteiro; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Dept Genet, Mol Virol Lab, Rio De Janeiro, Brazil; [Adolfo Bila, Dulce Celina] Univ Fed Rio de Janeiro, Dept Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Tanuri, A (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Mol Virol Lab, Rio De Janeiro, Brazil.	atanuri@biologia.ufrj.br	Abreu, Celina Monteiro/AAT-7447-2020; Tanuri, Amilcar/AAM-8601-2021	Jani, Ilesh/0000-0002-6880-6655	CAPES/Ministry of Education, Brazil	CAPES/Ministry of Education, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Dulce Bila is a PhD student at the Laboratorio de Virologia Molecular, Universidade Federal do Rio de Janeiro, Brazil, and receives a fellowship from CAPES/Ministry of Education, Brazil. We are grateful to the study participants and work done by the health care providers and administrative staff at Centro de Saude do Alto Mae. We would like to acknowledge the work done by laboratory staff at reference laboratory and Mussagy Mahomed at surveillance department at national health institute in Mozambique at Laboratorio de AIDS in FIOCRUZ Brazil.	Abreu CM, 2008, ARCH VIROL, V153, P2013, DOI 10.1007/s00705-008-0215-6; [Anonymous], 2015, MEGA SOFTWARE; [Anonymous], 2015, HIV REC AN; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Autran B, 1999, IMMUNOL LETT, V66, P207, DOI 10.1016/S0165-2478(98)00159-X; BEBENEK K, 1993, J BIOL CHEM, V268, P10324; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Borroto-Esoda K, 2007, AIDS RES HUM RETROV, V23, P988, DOI 10.1089/aid.2006.0310; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brenner B, 2003, AIDS, V17, pF1, DOI 10.1097/00002030-200301030-00001; Brenner BG, 2006, AIDS, V20, pF9, DOI 10.1097/01.aids.0000232228.88511.0b; Chunduri H, 2011, VIROLOGY, V414, P34, DOI 10.1016/j.virol.2011.03.007; Comite Nacional de Assistencia Medica e Colaboradores, GUIA TRAT ANT INF OP; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Fourati S, 2013, J ANTIMICROB CHEMOTH, V68, P2199, DOI 10.1093/jac/dkt200; Gaardbo JC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/670957; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Granados JMS, 2003, PEDIATR INFECT DIS J, V22, P863, DOI 10.1097/01.inf.0000091282.70253.5f; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Jordan MR, 2008, ANTIVIR THER, V13, P15; Kuritzkes DR, 2004, AIDS PATIENT CARE ST, V18, P259, DOI 10.1089/108729104323076007; Marconi VC, 2008, CLIN INFECT DIS, V46, P1589, DOI 10.1086/587109; Miiro G, 2009, TROP MED INT HEALTH, V14, P556, DOI 10.1111/j.1365-3156.2009.02259.x; Mouroux M, 2001, ANTIVIR THER, V6, P179; National Institute of Health NI of S (Mozambique) and C for DC (US), 2009, NAT SURV PREV BEH RI; Orrell C, 2009, ANTIVIR THER, V14, P523; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; RICHMAN DD, 1994, J VIROL, V68, P1660, DOI 10.1128/JVI.68.3.1660-1666.1994; Shafer RW, 2008, AIDS REV, V10, P67; Shafer RW, 2008, ANTIVIR THER, V13, P59; Soares MA, 2003, AIDS, V17, P11, DOI 10.1097/00002030-200301030-00004; Stanford University, 2015, DRUG RES AN; Sunpath H, 2012, AIDS, V26, P1679, DOI 10.1097/QAD.0b013e328356886d; Tiba Fabrice, 2012, Open AIDS J, V6, P16, DOI 10.2174/1874613601206010016; Turner D, 2009, J MED VIROL, V81, P1509, DOI 10.1002/jmv.21567; Wallis CL, 2010, JAIDS-J ACQ IMM DEF, V53, P480, DOI 10.1097/QAI.0b013e3181bc478b; WHO, 2010, ANT THER HIV INF AD	38	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0130580	10.1371/journal.pone.0130580	http://dx.doi.org/10.1371/journal.pone.0130580			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151752	Green Submitted, gold, Green Published			2022-12-27	WOS:000358158900013
J	Jing, LK; Fan, JX; Wang, Y; Li, HY; Wang, SZ; Yang, XJ; Zhang, Y				Jing, Linkai; Fan, Jixing; Wang, Yang; Li, Haiyun; Wang, Shengzhang; Yang, Xinjian; Zhang, Ying			Morphologic and Hemodynamic Analysis in the Patients with Multiple Intracranial Aneurysms: Ruptured versus Unruptured	PLOS ONE			English	Article							WALL SHEAR-STRESS; COMPUTATIONAL FLUID-DYNAMICS; CEREBRAL ANEURYSMS; RISK-FACTORS; DEFINED POPULATION; ASPECT RATIO; ARTERY; INDEX; ASSOCIATION; SIMULATION	Background and Purpose The authors evaluated the impact of morphologic and hemodynamic factors on multiple intracranial aneurysms and aimed to identify which parameters can be reliable indexes as one aneurysm ruptured, and the others did not. Methods Between June 2011 and May 2014, 69 patients harboring multiple intracranial aneurysms (69 ruptured and 86 unruptured) were analyzed from 3D-digital subtraction angiography (DSA) images and computational fluid dynamics (CFD). Morphologic and hemodynamic parameters were evaluated for significance with respect to rupture. Receiver operating characteristic (ROC) analysis identified area under the curve (AUC) and optimal thresholds separating ruptured from unruptured intracranial aneurysms for each parameter. Significant parameters were examined by binary logistic regression analysis to identify independent discriminators. Results Nine morphologic (size, neck width, surface area, volume, diameter of parent arteries, aspect ratio, size ratio, lateral/bifurcation type and regular/irregular type) and 6 hemodynamic (WSSmean, WSSmin, OSI, LSA, flow stability and flow complexity) parameters achieved statistical significance (p<0.05). Six morphologic (size, surface area, volume, aspect ratio, size ratio and regular/irregular type) and five hemodynamic (WSSmean, WSSmin, LSA, flow stability and flow complexity) parameters had high AUC values (AUC>0.7). By binary logistic regression analysis, large aspect ratio and low WSSmean were the independently significant rupture factors (AUC, 0.924; 95% CI, 0.883-0.965). Conclusions Large aspect ratio and low WSSmean were independently associated with the rupture status of multiple intracranial aneurysms.	[Jing, Linkai; Fan, Jixing; Wang, Yang; Yang, Xinjian; Zhang, Ying] Capital Med Univ, Beijing Tiantan Hosp, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, Beijing, Peoples R China; [Li, Haiyun] Capital Med Univ, Dept Biomed Engn, Beijing, Peoples R China; [Wang, Shengzhang] Fudan Univ, Dept Mech & Engn Sci, Shanghai 200433, Peoples R China	Beijing Neurosurgical Institute; Capital Medical University; Capital Medical University; Fudan University	Yang, XJ (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, Beijing, Peoples R China.	yang-xj@163.net; yingzhang829@163.com		Yang, Xinjian/0000-0001-7306-0125	National Natural Science Foundation of China [81220108007, 81301003, 81171079]; Special Research Project for Capital Health Development [2014-1-1071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Research Project for Capital Health Development	This work was supported by the National Natural Science Foundation of China (grant nos. 81220108007, 81301003 and 81171079) and Special Research Project for Capital Health Development (grant no. 2014-1-1071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backes D, 2014, STROKE, V45, P1299, DOI 10.1161/STROKEAHA.113.004421; Baharoglu MI, 2012, J NEUROSURG, V116, P871, DOI 10.3171/2011.11.JNS11311; Baumann F, 2008, ACT NEUR S, V103, P19; Byrne G, 2014, AM J NEURORADIOL, V35, P333, DOI 10.3174/ajnr.A3678; Cebral JR, 2011, AM J NEURORADIOL, V32, P145, DOI 10.3174/ajnr.A2419; Cebral JR, 2011, AM J NEURORADIOL, V32, P264, DOI 10.3174/ajnr.A2274; Cebral JR, 2005, AM J NEURORADIOL, V26, P2550; CRAWFORD T, 1959, J NEUROL NEUROSUR PS, V22, P259, DOI 10.1136/jnnp.22.4.259; CROMPTON MR, 1966, BRIT MED J, V1, P1138, DOI 10.1136/bmj.1.5496.1138; Ellamushi HE, 2001, J NEUROSURG, V94, P728, DOI 10.3171/jns.2001.94.5.0728; Frosen J, 2004, STROKE, V35, P2287, DOI 10.1161/01.STR.0000140636.30204.da; He XJ, 1996, J BIOMECH ENG-T ASME, V118, P74, DOI 10.1115/1.2795948; Hino A, 2000, NEUROSURGERY, V46, P825, DOI 10.1097/00006123-200004000-00011; Hoh BL, 2007, NEUROSURGERY, V61, P716, DOI 10.1227/01.NEU.0000298899.77097.BF; Jeon HJ, 2014, NEUROL RES, V36, P1056, DOI 10.1179/1743132814Y.0000000393; Jou LD, 2008, AM J NEURORADIOL, V29, P1761, DOI 10.3174/ajnr.A1180; Juvela S, 2000, STROKE, V31, P392, DOI 10.1161/01.STR.31.2.392; Kaminogo M, 2003, STROKE, V34, P16, DOI 10.1161/01.STR.0000046763.48330.AD; Kataoka K, 1999, STROKE, V30, P1396, DOI 10.1161/01.STR.30.7.1396; Kawaguchi T, 2012, J NEUROSURG, V117, P774, DOI 10.3171/2012.7.JNS111991; Lauric A, 2014, J NEUROINTERV SURG, V6, P466, DOI 10.1136/neurintsurg-2013-010871; Li CH, 2012, J NEUROSURG, V117, P276, DOI 10.3171/2012.5.JNS111558; Lu G, 2011, AM J NEURORADIOL, V32, P1255, DOI 10.3174/ajnr.A2461; Lu HT, 2013, CLIN NEUROL NEUROSUR, V115, P690, DOI 10.1016/j.clineuro.2012.08.011; Luo B, 2011, STROKE, V42, P745, DOI 10.1161/STROKEAHA.110.593517; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; Omodaka S, 2012, CEREBROVASC DIS, V34, P121, DOI 10.1159/000339678; Rahman M, 2011, NEUROSURGERY, V68, P155, DOI 10.1227/NEU.0b013e3181ff357c; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; RINNE J, 1994, NEUROSURGERY, V35, P803, DOI 10.1227/00006123-199411000-00001; Shojima M, 2004, STROKE, V35, P2500, DOI 10.1161/01.STR.0000144648.89172.0f; Tulamo R, 2010, J NEUROINTERV SURG, V2, P120, DOI 10.1136/jnis.2009.002055; Ujiie H, 2001, NEUROSURGERY, V48, P495, DOI 10.1097/00006123-200103000-00007; Ujiie H, 1999, NEUROSURGERY, V45, P119, DOI 10.1097/00006123-199907000-00028; Wang SZ, 2010, J HYDRODYN, V22, P639, DOI 10.1016/S1001-6058(09)60098-6; Xiang J, 2014, AM J NEURORADIOL, V35, P1849, DOI 10.3174/ajnr.A3710; Xiang JP, 2011, STROKE, V42, P144, DOI 10.1161/STROKEAHA.110.592923	38	46	55	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132494	10.1371/journal.pone.0132494	http://dx.doi.org/10.1371/journal.pone.0132494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147995	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600289
J	Kauffman, L; Balatti, V; Cascione, L; Fadda, P; Racke, F; Santhanam, R; Costinean, S				Kauffman, Lauren; Balatti, Veronica; Cascione, Luciano; Fadda, Paolo; Racke, Frederick; Santhanam, Ramasamy; Costinean, Stefan			RETRACTED: Gradual Rarefaction of Hematopoietic Precursors and Atrophy in a Depleted microRNA 29a, b and c Environment (Retracted article. See vol. 12, art no E0187454, 2017)	PLOS ONE			English	Article; Retracted Publication								Background The self-renewing ability of HSCs is fundamental for the maintenance of a pool of bone marrow precursors throughout the life of an individual. The genetic mechanisms underlying such a complex process are still poorly understood. Results and Significance Here, we show that constitutive in vivo deletion of miR29ab1 leads to reduced number of HSCs and that miR29ab1 deficient bone marrow cannot repopulate the bone marrow of irradiated mice. An Affymetrix analysis of the miR29ab1 knockout mice identifies key proteins that could be responsible for this phenotype, as DNMT3a and b. Moreover, our findings reveal that whereas miR29b2c knockout mice do not exhibit any spontaneous abnormality, the double knock out - miR29ab1b2c - has marked generalized atrophy, raising the possibility that the two bi-cistrons might cooperate in order to maintain the stem cell number in general, not only limited to the bone marrow.	[Racke, Frederick; Costinean, Stefan] Ohio State Wexner Med Ctr, Dept Pathol, Columbus, OH 43210 USA; [Kauffman, Lauren; Balatti, Veronica; Fadda, Paolo; Santhanam, Ramasamy] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Cascione, Luciano] Oncol Res Inst, Bellinzona, Switzerland	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Institute of Oncology Research (IOR)	Costinean, S (corresponding author), Ohio State Wexner Med Ctr, Dept Pathol, Columbus, OH 43210 USA.	stefan.costinean@unmc.edu	Cascione, Luciano/X-3115-2019	Cascione, Luciano/0000-0002-4606-0637	Ohio State University funds	Ohio State University funds	This study was supported by the Ohio State University funds.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Han YC, 2010, J EXP MED, V207, P475, DOI 10.1084/jem.20090831; Hu WH, 2015, BLOOD, V125, P2206, DOI 10.1182/blood-2014-06-585273; Kamran F, 2015, MOL ENDOCRINOL, V29, P921, DOI 10.1210/me.2015-1047; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Smith KM, 2012, J IMMUNOL, V189, P1567, DOI 10.4049/jimmunol.1103171; Steiner DF, 2011, IMMUNITY, V35, P169, DOI 10.1016/j.immuni.2011.07.009; Zhou Q, 2015, GASTROENTEROLOGY	12	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131981	10.1371/journal.pone.0131981	http://dx.doi.org/10.1371/journal.pone.0131981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147501	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600174
J	Kinney, SRM; Carlson, L; Ser-Dolansky, J; Thompson, C; Shah, S; Gambrah, A; Xing, W; Schneider, SS; Mathias, CB				Kinney, Shannon R. M.; Carlson, Logan; Ser-Dolansky, Jennifer; Thompson, Chelsea; Shah, Sagar; Gambrah, Amos; Xing, Wei; Schneider, Sallie S.; Mathias, Clinton B.			Curcumin Ingestion Inhibits Mastocytosis and Suppresses Intestinal Anaphylaxis in a Murine Model of Food Allergy	PLOS ONE			English	Article							MAST-CELLS; AIRWAY INFLAMMATION; ACTIVATION; COLITIS; HYPERRESPONSIVENESS; INDUCTION; PATHWAYS; MEDIATE; CURRY; TRIAL	IgE antibodies and mast cells play critical roles in the establishment of allergic responses to food antigens. Curcumin, the active ingredient of the curry spice turmeric, has anti-inflammatory properties, and thus may have the capacity to regulate Th2 cells and mucosal mast cell function during allergic responses. We assessed whether curcumin ingestion during oral allergen exposure can modulate the development of food allergy using a murine model of ovalbumin (OVA)-induced intestinal anaphylaxis. Herein, we demonstrate that frequent ingestion of curcumin during oral OVA exposure inhibits the development of mastocytosis and intestinal anaphylaxis in OVA-challenged allergic mice. Intragastric (i.g.) exposure to OVA in sensitized BALB/c mice induced a robust IgE-mediated response accompanied by enhanced OVA-IgE levels, intestinal mastocytosis, elevated serum mMCP-1, and acute diarrhea. In contrast, mice exposed to oral curcumin throughout the experimental regimen appeared to be normal and did not exhibit intense allergic diarrhea or a significant enhancement of OVA-IgE and intestinal mast cell expansion and activation. Furthermore, allergic diarrhea, mast cell activation and expansion, and Th2 responses were also suppressed in mice exposed to curcumin during the OVA-challenge phase alone, despite the presence of elevated levels of OVA-IgE, suggesting that curcumin may have a direct suppressive effect on intestinal mast cell activation and reverse food allergy symptoms in allergen-sensitized individuals. This was confirmed by observations that curcumin attenuated the expansion of both adoptively transferred bone marrow-derived mast cells (BMMCs), and inhibited their survival and activation during cell culture. Finally, the suppression of intestinal anaphylaxis by curcumin was directly linked with the inhibition of NF-kappa B activation in curcumin-treated allergic mice, and curcumin inhibited the phosphorylation of the p65 subunit of NF-kappa B in BMMCs. In summary, our data demonstrates a protective role for curcumin during allergic responses to food antigens, suggesting that frequent ingestion of this spice may modulate the outcome of disease in susceptible individuals.	[Kinney, Shannon R. M.; Carlson, Logan; Thompson, Chelsea; Shah, Sagar; Gambrah, Amos; Mathias, Clinton B.] Western New England Univ, Dept Pharmaceut & Adm Sci, Coll Pharm, Springfield, MA 01119 USA; [Ser-Dolansky, Jennifer; Schneider, Sallie S.] Baystate Med Ctr, Pioneer Valley Life Sci Inst, Springfield, MA 01199 USA; [Xing, Wei] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA	Western New England University; Baystate Medical Center; University of Massachusetts System; University of Massachusetts Worcester	Mathias, CB (corresponding author), Western New England Univ, Dept Pharmaceut & Adm Sci, Coll Pharm, Springfield, MA 01119 USA.	clinton.mathias@wne.edu	Kinney, Shannon/AAW-5301-2021	Mathias, Clinton/0000-0002-0223-4842	National Institutes of Health [NIAID R15AI107668]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI107668] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health NIAID R15AI107668 (www.NIH.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal DK, 2010, MED RES REV, V30, P818, DOI 10.1002/med.20188; Baum L, 2008, J CLIN PSYCHOPHARM, V28, P110, DOI 10.1097/jcp.0b013e318160862c; Bayet-Robert M, 2010, CANCER BIOL THER, V9, P8, DOI 10.4161/cbt.9.1.10392; Bischoff S, 2004, CURR OPIN GASTROEN, V20, P156, DOI 10.1097/00001574-200403000-00018; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; Brandt EB, 2009, J ALLERGY CLIN IMMUN, V123, P53, DOI 10.1016/j.jaci.2008.10.001; Bryce PJ, 2009, EXPERT REV CLIN IMMU, V5, P225, DOI 10.1586/ECI.09.6; Burton OT, 2013, MUCOSAL IMMUNOL, V6, P740, DOI 10.1038/mi.2012.112; Burton OT, 2014, IMMUNITY, V41, P141, DOI 10.1016/j.immuni.2014.05.017; Burton OT, 2011, IMMUNOL REV, V242, P128, DOI 10.1111/j.1600-065X.2011.01024.x; Choi YH, 2010, ANAT CELL BIOL, V43, P36, DOI 10.5115/acb.2010.43.1.36; Chung SH, 2012, MOL VIS, V18, P1966; Cong YZ, 2009, EUR J IMMUNOL, V39, P3134, DOI 10.1002/eji.200939052; Eigenmann PA, 2002, PEDIAT ALLERG IMM-UK, V13, P162, DOI 10.1034/j.1399-3038.2002.01015.x; Forbes EE, 2008, J EXP MED, V205, P897, DOI 10.1084/jem.20071046; Ganeshan K, 2009, J ALLERGY CLIN IMMUN, V123, P231, DOI 10.1016/j.jaci.2008.10.011; Jagetia GC, 2007, J CLIN IMMUNOL, V27, P19, DOI 10.1007/s10875-006-9066-7; Jian YT, 2005, WORLD J GASTROENTERO, V11, P1747, DOI 10.3748/wjg.v11.i12.1747; Jobin C, 1999, J IMMUNOL, V163, P3474; Johnston LK, 2014, J IMMUNOL, V192, P2529, DOI 10.4049/jimmunol.1303026; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; Karaman M, 2011, ARCH MED RES, V42, P79, DOI 10.1016/j.arcmed.2011.01.011; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Kliem C, 2012, J BIOL CHEM, V287, P10200, DOI 10.1074/jbc.M111.318733; Knight AK, 2007, AM J PHYSIOL-GASTR L, V293, pG1234, DOI 10.1152/ajpgi.00323.2007; Kurup VP, 2008, MOL NUTR FOOD RES, V52, P1031, DOI 10.1002/mnfr.200700293; Kurup Viswanath P, 2007, Clin Mol Allergy, V5, P1, DOI 10.1186/1476-7961-5-1; Kurup VP, 2006, J ALLERGY CLIN IMMUN, V117, pS203, DOI 10.1016/j.jaci.2005.12.802; Lack G, 2008, J ALLERGY CLIN IMMUN, V121, P1331, DOI 10.1016/j.jaci.2008.04.032; Larmonier CB, 2008, AM J PHYSIOL-GASTR L, V295, pG1079, DOI 10.1152/ajpgi.90365.2008; Lee JH, 2008, J ALLERGY CLIN IMMUN, V121, P1225, DOI 10.1016/j.jaci.2007.12.1160; Li XM, 2000, J ALLERGY CLIN IMMUN, V106, P150, DOI 10.1067/mai.2000.107395; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Ma CH, 2013, FITOTERAPIA, V87, P57, DOI 10.1016/j.fitote.2013.02.014; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Mathias CB, 2014, CLIN EXP ALLERGY, V44, P589, DOI 10.1111/cea.12271; Mathias CB, 2011, J ALLERGY CLIN IMMUN, V127, P795, DOI 10.1016/j.jaci.2010.11.009; Mathias CB, 2009, J IMMUNOL, V182, P2416, DOI 10.4049/jimmunol.0801569; Oh SW, 2011, J ETHNOPHARMACOL, V136, P414, DOI 10.1016/j.jep.2010.07.026; Oyoshi MK, 2014, J ALLERGY CLIN IMMUN, V133, P309, DOI 10.1016/j.jaci.2013.12.1045; Prescott S, 2011, PEDIAT ALLERG IMM-UK, V22, P155, DOI 10.1111/j.1399-3038.2011.01145.x; Ram A, 2003, BIOL PHARM BULL, V26, P1021, DOI 10.1248/bpb.26.1021; Rogers NM, 2010, CLIN EXP IMMUNOL, V162, P460, DOI 10.1111/j.1365-2249.2010.04232.x; Salh B, 2003, AM J PHYSIOL-GASTR L, V285, pG235, DOI 10.1152/ajpgi.00449.2002; Sicherer SH, 2011, J ALLERGY CLIN IMMUN, V127, P594, DOI 10.1016/j.jaci.2010.11.044; Sicherer SH, 2009, ANNU REV MED, V60, P261, DOI 10.1146/annurev.med.60.042407.205711; Singla V, 2014, J CROHNS COLITIS, V8, P208, DOI 10.1016/j.crohns.2013.08.006; Taylor Rebecca A, 2011, Altern Med Rev, V16, P152; Thakare VN, 2013, INT IMMUNOPHARMACOL, V17, P18, DOI 10.1016/j.intimp.2013.04.025; West CE, 2010, CURR OPIN PEDIATR, V22, P635, DOI 10.1097/MOP.0b013e32833d96ef	50	25	29	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132467	10.1371/journal.pone.0132467	http://dx.doi.org/10.1371/journal.pone.0132467			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147007	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600276
J	Klein, V; Schmidt, AF; Turner, D; Briken, P				Klein, Verena; Schmidt, Alexander F.; Turner, Daniel; Briken, Peer			Are Sex Drive and Hypersexuality Associated with Pedophilic Interest and Child Sexual Abuse in a Male Community Sample?	PLOS ONE			English	Article							PORNOGRAPHY USE; OFFENDERS; RECIDIVISM	Although much is currently known about hypersexuality (in the form of excessive sexual behavior) among sexual offenders, the degree to which hypersexual behavior is linked to paraphilic and especially pedophilic interests in non-forensic populations has not been established. The purpose of the present study was to elucidate the associations between total sexual outlets (TSO) and other sex drive indicators, antisocial behavior, pedophilic interests, and sexual offending behavior in a large population-based community sample of males. The sample included 8,718 German men who participated in an online study. Hypersexual behavior as measured by self-reported TSO, self-reported sex drive, criminal history, and pedophilic interests were assessed. In moderated hierarchical logistic regression analyses self-reported contact sexual offending against children was linked to sexual fantasizing about children and antisociality. There was no association between aggregated sex drive, and sexual abusive behaviour in the multivariate analyses. In contrast, self-reported child pornography consumption was associated with sex drive, sexual fantasies involving children, and antisociality. Nevertheless, in clinical practice an assessment of criminal history and pedophilic interests in hypersexual individuals and vice versa hypersexuality in antisocial or pedophilic men should be considered as particularly antisociality and pedophilic interest are important predictors of sexual offending against prepubescent children.	[Klein, Verena; Turner, Daniel; Briken, Peer] Univ Med Ctr Hamburg Eppendorf, Inst Sex Res & Forens Psychiat, Hamburg, Germany; [Schmidt, Alexander F.] Univ Luxembourg, Inst Hlth & Behav, Integrat Res Unit, Social & Individual Dev INSIDE,Hlth Promot & Aggr, Walferdange, Luxembourg	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Luxembourg	Klein, V (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Sex Res & Forens Psychiat, Hamburg, Germany.	vklein@uke.de	Schmidt, Alexander F/A-2912-2009	Schmidt, Alexander F/0000-0001-6449-2946	German Federal Ministry of Family Affairs, Senior Citizens, Women, and Youth	German Federal Ministry of Family Affairs, Senior Citizens, Women, and Youth	This research was supported by funding from the German Federal Ministry of Family Affairs, Senior Citizens, Women, and Youth.	Atwood J.D., 1987, J SEX EDUC THER, V13, P35, DOI [10.1080/01614576.1987.11074907, DOI 10.1080/01614576.1987.11074907]; Banse R, 2010, CRIM JUSTICE BEHAV, V37, P319, DOI 10.1177/0093854809357598; Cohen J., 2003, APPL MULTIPLE REGRES; Dombert B, 2015, J SEX RES; Hanson R. K., 2007, ASSESSING RISK SEXUA, P2007; Hanson RK, 2000, CRIM JUSTICE BEHAV, V27, P6, DOI 10.1177/0093854800027001002; Hanson RK, 2005, J CONSULT CLIN PSYCH, V73, P1154, DOI 10.1037/0022-006X.73.6.1154; Kafka MP, 1997, ARCH SEX BEHAV, V26, P505, DOI 10.1023/A:1024507922470; Kafka MP, 2012, 12 INT ASS TREATM SE; Kafka MP, 2010, ARCH SEX BEHAV, V39, P940; Kingston DA, 2008, AGGRESSIVE BEHAV, V34, P341, DOI 10.1002/ab.20250; Kingston DA, 2013, SEX ADDICT COMPULS, V20, P91, DOI 10.1080/10720162.2013.768131; Kingston DA, 2008, SEX ADDICT COMPULS, V15, P284, DOI 10.1080/10720160802289249; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Kjellgren C, 2010, ARCH SEX BEHAV, V39, P1161, DOI 10.1007/s10508-009-9572-9; Knight RA, 2003, ANN NY ACAD SCI, V989, P72, DOI 10.1111/j.1749-6632.2003.tb07294.x; Langstrom N, 2006, ARCH SEX BEHAV, V35, P37; Laumann EO, 1994, SOCIAL ORG SEXUALITY; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; MALAMUTH NM, 1995, J PERS SOC PSYCHOL, V69, P353, DOI 10.1037/0022-3514.69.2.353; Mann RE, 2010, SEX ABUSE-J RES TR, V22, P191, DOI 10.1177/1079063210366039; Marshall LE, 2008, SEX ADDICT COMPULS, V15, P271, DOI 10.1080/10720160802516328; Marshall LE, 2006, SEX ADDICT COMPULS, V13, P377, DOI 10.1080/10720160601011281; Ray JV, 2014, SEX ABUSE, V26, P523, DOI 10.1177/1079063213502678; Schmidt AF, 2014, SEX ABUSE-J RES TR, V26, P107, DOI 10.1177/1079063213480817; Schmidt AF, 2013, PSYCHOL ASSESSMENT, V25, P1146, DOI 10.1037/a0033326; Seigfried-Spellar KC, 2013, COMPUT HUM BEHAV, V29, P1997, DOI 10.1016/j.chb.2013.04.018; Seto MC, 2008, AM PSYCHOL; Seto MC, 2014, ARCH SEX BEHAV; Seto MC, 2006, J ABNORM PSYCHOL, V115, P610, DOI 10.1037/0021-843X.115.3.610; Svedin CG, 2011, J ADOLESCENCE, V34, P779, DOI 10.1016/j.adolescence.2010.04.010; Yildirim BO, 2012, PSYCHIAT RES, V200, P984, DOI 10.1016/j.psychres.2012.07.044	32	36	36	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0129730	10.1371/journal.pone.0129730	http://dx.doi.org/10.1371/journal.pone.0129730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26147099	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600025
J	Liu, AA; Su, YT; Nie, WZ; Yang, ZX				Liu, An-An; Su, Yu-Ting; Nie, Wei-Zhi; Yang, Zhao-Xuan			Jointly Learning Multiple Sequential Dynamics for Human Action Recognition	PLOS ONE			English	Article							RANDOM-FIELDS; SEGMENTATION	Discovering visual dynamics during human actions is a challenging task for human action recognition. To deal with this problem, we theoretically propose the multi-task conditional random fields model and explore its application on human action recognition. For visual representation, we propose the part-induced spatiotemporal action unit sequence to represent each action sample with multiple partwise sequential feature subspaces. For model learning, we propose the multi-task conditional random fields (MTCRFs) model to discover the sequence-specific structure and the sequence-shared relationship. Specifically, the multi-chain graph structure and the corresponding probabilistic model are designed to represent the interaction among multiple part-induced action unit sequences. Moreover we propose the model learning and inference methods to discover temporal context within individual action unit sequence and the latent correlation among different body parts. Extensive experiments are implemented to demonstrate the superiority of the proposed method on two popular RGB human action datasets, KTH & TJU, and the depth dataset in MSR Daily Activity 3D.	[Liu, An-An; Su, Yu-Ting; Nie, Wei-Zhi; Yang, Zhao-Xuan] Tianjin Univ, Sch Elect Informat Engn, Tianjin 300072, Peoples R China	Tianjin University	Liu, AA (corresponding author), Tianjin Univ, Sch Elect Informat Engn, Tianjin 300072, Peoples R China.	liuanan@tju.edu.cn; weizhinie@tju.edu.cn	Nie, Weizhi/ABF-5316-2021		National Natural Science Foundation of China 573 [61472275, 61170239]; Tianjin Research Program of Application Foundation; 574 Advanced Technology [15JCYBJC16200]; grant of Elite Scholar Program of 575 Tianjin University [2014XRG-0046]	National Natural Science Foundation of China 573; Tianjin Research Program of Application Foundation; 574 Advanced Technology; grant of Elite Scholar Program of 575 Tianjin University	This work was supported in part by the National Natural Science Foundation of China 573 (61472275, 61170239), the Tianjin Research Program of Application Foundation, and 574 Advanced Technology (15JCYBJC16200), the grant of Elite Scholar Program of 575 Tianjin University (2014XRG-0046).	Aggarwal JK, 2011, ACM COMPUT SURV, V43, DOI 10.1145/1922649.1922653; Ballan L, 2012, IEEE T MULTIMEDIA; Chen X, 2009, IEEE DATA MINING, P746, DOI 10.1109/ICDM.2009.128; Fathi A., 2008, CVPR 08; Felzenszwalb P. F., 2010, IEEE T PATTERN ANAL; Gilbert A, 2009, ICCV 09; Hamid R, 2009, ARTIF INTELL, V173, P1221, DOI 10.1016/j.artint.2009.05.002; Han L, 2010, IMAGE VISION COMPUT, V28, P836, DOI 10.1016/j.imavis.2009.08.003; Ivanov YA, 2000, IEEE T PATTERN ANAL, V22, P852, DOI 10.1109/34.868686; Jhuang H, 2007, IEEE I CONF COMP VIS, P1253; Ji SW, 2013, IEEE T PATTERN ANAL, V35, P221, DOI 10.1109/TPAMI.2012.59; Klaser A., 2008, BMVC, V275, P1; Klaser A., 2008, BMVC 08; Kovashka A, 2010, PROC CVPR IEEE, P2046, DOI 10.1109/CVPR.2010.5539881; Lafferty J., 2001, ICML 01; Laptev I, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P432, DOI 10.1109/iccv.2003.1238378; Laptev I., 2008, CVPR 08; Le QV, 2011, CVPR 11; Liu AA, 2012, ELECTRON LETT, V48, P262, DOI 10.1049/el.2011.3530; Liu AA, 2011, ELECTRON LETT, V47, P651, DOI 10.1049/el.2011.0880; Liu AA, 2015, IEEE T CYBERNETICS, V45, P1194, DOI 10.1109/TCYB.2014.2347057; Liu AA, 2015, SIGNAL PROCESS, V112, P74, DOI 10.1016/j.sigpro.2014.08.038; Liu AA, 2015, NEUROCOMPUTING, V151, P544, DOI 10.1016/j.neucom.2014.04.090; Liu AA, 2012, IEEE T MED IMAGING, V31, P359, DOI 10.1109/TMI.2011.2169495; Lv F, 2006, LECT NOTES COMPUT SC, V3954, P359; Ma AJ, 2013, IEEE T CIRC SYST VID, V23, P1447, DOI 10.1109/TCSVT.2013.2248494; Minhas R, 2012, IEEE T CIRC SYST VID, V22, P1529, DOI 10.1109/TCSVT.2011.2177182; Morency L. -P., 2007, P I C COMP VI PATT R, P1, DOI DOI 10.1109/CVPR.2007.383299; Niebles JC, 2008, INT J COMPUT VISION, V79, P299, DOI 10.1007/s11263-007-0122-4; Oreifej O., 2013, CVPR 13; Pei MT, 2011, IEEE I CONF COMP VIS, P487, DOI 10.1109/ICCV.2011.6126279; Quattoni A, 2007, IEEE T PATTERN ANAL, V29, P1848, DOI 10.1109/TPAMI.2007.1124; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Ryoo MS, 2006, 2006 IEEE COMPUTER S, V2, P1709, DOI DOI 10.1109/CVPR.2006.242; Schuldt C, 2004, INT C PATT RECOG, P32, DOI 10.1109/ICPR.2004.1334462; Scovanner P, 2007, ACM MULT 07; Su YT, 2014, ELECTRON LETT, V50, P870, DOI 10.1049/el.2014.1027; Taylor GW, 2010, LECT NOTES COMPUT SC, V6316, P140, DOI 10.1007/978-3-642-15567-3_11; Tian Y, 2013, CVPR 13; Wang H., 2009, BMVC 09; Wang J, 2012, PROC CVPR IEEE, P1290, DOI 10.1109/CVPR.2012.6247813; Wang J, 2011, PROC CVPR IEEE, DOI 10.1109/CVPR.2011.5995493; Wang Y, 2012, J MACHINE LEARNING R; Wang Y, 2011, IEEE T PATTERN ANAL; Weinland D, 2007, IEEE I CONF COMP VIS, P170; Welling M., 2004, P 20 C UNCERTAINTY A, P585; Willems G, 2008, LECT NOTES COMPUT SC, V5303, P650, DOI 10.1007/978-3-540-88688-4_48; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Xia L, 2013, CVPR 13; Zhang L, 2011, ICCV 11; Zhang Z, 2012, IEEE T PATTERN ANAL, V34, P436, DOI 10.1109/TPAMI.2011.157	51	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130884	10.1371/journal.pone.0130884	http://dx.doi.org/10.1371/journal.pone.0130884			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147979	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600054
J	Moustafa, DA; Scarff, JM; Garcia, PP; Cassidy, SKB; DiGiandomenico, A; Waag, DM; Inzana, TJ; Goldberg, JB				Moustafa, Dina A.; Scarff, Jennifer M.; Garcia, Preston P.; Cassidy, Sara K. B.; DiGiandomenico, Antonio; Waag, David M.; Inzana, Thomas J.; Goldberg, Joanna B.			Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; LIVE VECTOR VACCINES; ATTENUATED SALMONELLA; PSEUDOMONAS-AERUGINOSA; BALB/C MICE; CAPSULAR POLYSACCHARIDE; MONOCLONAL-ANTIBODIES; IMMUNE-RESPONSES; PSEUDOMALLEI LIPOPOLYSACCHARIDE; INTRANASAL IMMUNIZATION	Burkholderia pseudomallei and Burkholderia mallei are the etiologic agents of melioidosis and glanders, respectively. These bacteria are highly infectious via the respiratory route and can cause severe and often fatal diseases in humans and animals. Both species are considered potential agents of biological warfare; they are classified as category B priority pathogens. Currently there are no human or veterinary vaccines available against these pathogens. Consequently efforts are directed towards the development of an efficacious and safe vaccine. Lipopolysaccharide (LPS) is an immunodominant antigen and potent stimulator of host immune responses. B. mallei express LPS that is structurally similar to that expressed by B. pseudomallei, suggesting the possibility of constructing a single protective vaccine against melioidosis and glanders. Previous studies of others have shown that antibodies against B. mallei or B. pseudomallei LPS partially protect mice against subsequent lethal virulent Burkholderia challenge. In this study, we evaluated the protective efficacy of recombinant Salmonella enterica serovar Typhimurium SL3261 expressing B. mallei O antigen against lethal intranasal infection with Burkholderia thailandensis, a surrogate for biothreat Burkholderia spp. in a murine model that mimics melioidosis and glanders. All vaccine-immunized mice developed a specific antibody response to B. mallei and B. pseudomallei O antigen and to B. thailandensis and were significantly protected against challenge with a lethal dose of B. thailandensis. These results suggest that live-attenuated SL3261 expressing B. mallei O antigen is a promising platform for developing a safe and effective vaccine.	[Moustafa, Dina A.; Scarff, Jennifer M.; Garcia, Preston P.; Cassidy, Sara K. B.; DiGiandomenico, Antonio; Goldberg, Joanna B.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA; [DiGiandomenico, Antonio] MedImmune LLC, Dept Infect Dis, Gaithersburg, MD USA; [Waag, David M.] US Army Med Res Inst Infect Dis USAMRIID, Bacteriol Div, Ft Detrick, MD USA; [Inzana, Thomas J.] Virginia Tech, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA USA; [Inzana, Thomas J.] Virginia Tech, Virginia Tech Caril Sch Med, Blacksburg, VA USA; [Moustafa, Dina A.; Goldberg, Joanna B.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Moustafa, Dina A.; Goldberg, Joanna B.] Childrens Hosp Atlanta Inc, Atlanta, GA USA	University of Virginia; AstraZeneca; Medimmune; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Emory University	Goldberg, JB (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA.	joanna.goldberg@emory.edu	Scarff, Jennifer/M-7594-2019	Scarff, Jennifer/0000-0001-5419-5534; DiGiandomenico, Antonio/0000-0003-1745-647X	National Institutes of Health (NIH) [R21-AI073923, R21-AI081130]; NIH Infectious Disease Training Grant [T32-AI007046]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007046, R21AI081130, R21AI073923] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Infectious Disease Training Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) Grants R21-AI073923 to JBG and R21-AI081130 to TJI. JMS, PG, and SKBC were supported in part on an NIH Infectious Disease Training Grant (T32-AI007046) awarded to the University of Virginia.	Abilek K HSB, 1998, BIOHAZARD CHILLING T; Amemiya K, 2002, INFECT IMMUN, V70, P2319, DOI 10.1128/IAI.70.5.2319-2325.2002; Anuntagool N, 2006, AM J TROP MED HYG, V74, P348, DOI 10.4269/ajtmh.2006.74.348; Anuntagool N, 2002, MICROBIOL IMMUNOL, V46, P143, DOI 10.1111/j.1348-0421.2002.tb02679.x; Atkins T, 2002, INFECT IMMUN, V70, P5290, DOI 10.1128/IAI.70.9.5290-5294.2002; AuCoin DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035386; Avery O T, 1932, J Exp Med, V55, P769, DOI 10.1084/jem.55.5.769; Benitez AJ, 2009, CLIN VACCINE IMMUNOL, V16, P1272, DOI 10.1128/CVI.00089-09; Bondi SK, 2008, EXPERT REV VACCINES, V7, P1357, DOI 10.1586/14760584.7.9.1357; Bottex C, 2005, IMMUNOPHARM IMMUNOT, V27, P565, DOI 10.1080/08923970500493995; Brett PJ, 2011, INFECT IMMUN, V79, P961, DOI 10.1128/IAI.01023-10; Brett PJ, 2003, FEMS MICROBIOL LETT, V218, P323, DOI 10.1111/j.1574-6968.2003.tb11536.x; Brett PJ, 1996, INFECT IMMUN, V64, P2824, DOI 10.1128/IAI.64.7.2824-2828.1996; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Bryan L E, 1994, Can J Infect Dis, V5, P170; Burtnick MN, 2002, J BACTERIOL, V184, P849, DOI 10.1128/JB.184.3.849-852.2002; CARTER PB, 1974, INFECT IMMUN, V10, P816, DOI 10.1128/IAI.10.4.816-822.1974; Charuchaimontri C, 1999, CLIN INFECT DIS, V29, P813, DOI 10.1086/520441; Chen K, 2010, IMMUNITY, V33, P479, DOI 10.1016/j.immuni.2010.09.013; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cheng A C, 2005, Euro Surveill, V10, P11, DOI 10.2807/esm.10.03.00528-en; Conlan JW, 2005, VACCINE, V23, P2477, DOI 10.1016/j.vaccine.2004.10.034; Currie BJ, 2004, TROP MED INT HEALTH, V9, P1167, DOI 10.1111/j.1365-3156.2004.01328.x; Currie BJ, 2003, EUR RESPIR J, V22, P542, DOI 10.1183/09031936.03.00006203; Damron FH, 2013, APPL ENVIRON MICROB, V79, P4149, DOI 10.1128/AEM.00640-13; DeShazer D, 2004, J BACTERIOL, V186, P3938, DOI 10.1128/JB.186.12.3938-3950.2004; DeShazer D, 1998, MOL MICROBIOL, V30, P1081, DOI 10.1046/j.1365-2958.1998.01139.x; DiGiandomenico A, 2004, INFECT IMMUN, V72, P7012, DOI 10.1128/IAI.72.12.7012-7021.2004; DiGiandomenico A, 2007, P NATL ACAD SCI USA, V104, P4624, DOI 10.1073/pnas.0608657104; DiGiandomenico A, 2012, J EXP MED, V209, P1273, DOI 10.1084/jem.20120033; Estes DM, 2010, EXPERT REV ANTI-INFE, V8, P325, DOI [10.1586/eri.10.4, 10.1586/ERI.10.4]; Felgner PL, 2009, P NATL ACAD SCI USA, V106, P13499, DOI 10.1073/pnas.0812080106; Galen JE, 1997, VACCINE, V15, P700, DOI 10.1016/S0264-410X(96)00227-7; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; GERMANIER R, 1975, J INFECT DIS, V131, P553, DOI 10.1093/infdis/131.5.553; Goldblatt D, 2000, CLIN EXP IMMUNOL, V119, P1, DOI 10.1046/j.1365-2249.2000.01109.x; Hall LJ, 2009, VACCINE, V27, P6894, DOI 10.1016/j.vaccine.2009.09.007; Healey GD, 2005, INFECT IMMUN, V73, P5945, DOI 10.1128/IAI.73.9.5945-5951.2005; Ho M, 1997, INFECT IMMUN, V65, P3648, DOI 10.1128/IAI.65.9.3648-3653.1997; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Jones SM, 2002, J MED MICROBIOL, V51, P1055, DOI 10.1099/0022-1317-51-12-1055; Kespichayawattana W, 2004, MICROB PATHOGENESIS, V36, P287, DOI 10.1016/j.micpath.2004.01.001; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Makela P. Helena, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P249; Mastroeni P, 2003, J MED MICROBIOL, V52, P453, DOI 10.1099/jmm.0.05173-0; Meumann EM, 2012, CLIN INFECT DIS, V54, P362, DOI 10.1093/cid/cir808; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; Morici LA, 2010, MICROB PATHOGENESIS, V48, P9, DOI 10.1016/j.micpath.2009.10.004; Nardelli-Haefliger D, 2005, VACCINE, V23, P3634, DOI 10.1016/j.vaccine.2005.02.019; Nelson M, 2004, J MED MICROBIOL, V53, P1177, DOI 10.1099/jmm.0.45766-0; Ngugi SA, 2010, VACCINE, V28, P7551, DOI 10.1016/j.vaccine.2010.08.058; Norris MH, 2011, INFECT IMMUN, V79, P4010, DOI 10.1128/IAI.05044-11; OBRIEN AD, 1982, INFECT IMMUN, V38, P948, DOI 10.1128/IAI.38.3.948-952.1982; Osorio M, 2009, INFECT IMMUN, V77, P1475, DOI 10.1128/IAI.00828-08; Pace D, 2013, EXPERT OPIN BIOL TH, V13, P11, DOI 10.1517/14712598.2012.725718; Pasetti MF, 2000, VACCINE, V18, P3208, DOI 10.1016/S0264-410X(00)00142-0; Pasetti MF, 2003, VACCINE, V21, P401, DOI 10.1016/S0264-410X(02)00472-3; Patel N, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00198; Pavot V, 2012, VACCINE, V30, P142, DOI 10.1016/j.vaccine.2011.11.003; Peacock SJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001488; Perrone LA, 2009, J VIROL, V83, P5726, DOI 10.1128/JVI.00207-09; PERRY MB, 1995, INFECT IMMUN, V63, P3348, DOI 10.1128/IAI.63.9.3348-3352.1995; PIER GB, 1995, INFECT IMMUN, V63, P2818, DOI 10.1128/IAI.63.8.2818-2825.1995; Qazi Omar, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS58, DOI 10.1016/S0035-9203(08)70016-6; REED L. J., 1938, AMER JOUR HYG, V27, P493; Salerno-Goncalves R, 2003, J IMMUNOL, V170, P2734, DOI 10.4049/jimmunol.170.5.2734; Santosuosso M, 2006, INFECT IMMUN, V74, P4634, DOI 10.1128/IAI.00517-06; SCHLAGETER AM, 1990, INFECT IMMUN, V58, P1914, DOI 10.1128/IAI.58.6.1914-1918.1990; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Schweizer HP, 2008, EMERG INFECT DIS, V14, P1689, DOI [10.3201/eid1411.080431, 10.3201/eid1407.071501]; Silva EB, 2013, INFECT IMMUN, V81, P4626, DOI 10.1128/IAI.00915-13; Sirard JC, 1999, IMMUNOL REV, V171, P5, DOI 10.1111/j.1600-065X.1999.tb01340.x; Smith MD, 1997, INFECT IMMUN, V65, P4319, DOI 10.1128/IAI.65.10.4319-4321.1997; Stevens MP, 2004, MICROBIOL-SGM, V150, P2669, DOI 10.1099/mic.0.27146-0; Stone JK, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-250; Suwannasaen D, 2011, J INFECT DIS, V203, P1002, DOI 10.1093/infdis/jiq142; SZTEIN MB, 1994, J INFECT DIS, V170, P1508, DOI 10.1093/infdis/170.6.1508; Trevino SR, 2006, INFECT IMMUN, V74, P1958, DOI 10.1128/IAI.74.3.1958-1961.2006; Tuanyok A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001453; Uppington H, 2006, IMMUNOLOGY, V119, P147, DOI 10.1111/j.1365-2567.2006.02416.x; Varga JJ, 2012, VIRULENCE, V3, P510, DOI 10.4161/viru.22056; Warner Jeffrey M., 2010, Papua New Guinea Medical Journal, V53, P176; West T Eoin, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS119, DOI 10.1016/S0035-9203(08)70028-2; Wheelis M, 1998, NATURE, V395, P213, DOI 10.1038/26089; Wick MJ, 2011, J INNATE IMMUN, V3, P543, DOI 10.1159/000330771; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Woods DE, 1999, MICROBES INFECT, V1, P157, DOI 10.1016/S1286-4579(99)80007-0; Wuthiekanun V, 1996, J MED MICROBIOL, V45, P408, DOI 10.1099/00222615-45-6-408; Zhang SM, 2011, CLIN VACCINE IMMUNOL, V18, P825, DOI 10.1128/CVI.00533-10; Zhao ZP, 2009, VACCINE, V27, P5214, DOI 10.1016/j.vaccine.2009.06.075	92	12	13	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132032	10.1371/journal.pone.0132032	http://dx.doi.org/10.1371/journal.pone.0132032			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148026	Green Submitted, Green Published, gold			2022-12-27	WOS:000358157600183
J	Sheng, H; Nakamura, K; Kanno, T; Sasaki, K; Niwano, Y				Sheng, Hong; Nakamura, Keisuke; Kanno, Taro; Sasaki, Keiichi; Niwano, Yoshimi			Bactericidal Effect of Photolysis of H2O2 in Combination with Sonolysis of Water via Hydroxyl Radical Generation	PLOS ONE			English	Article							LOW-INTENSITY ULTRASOUND; ELECTRON-SPIN-RESONANCE; HYDROGEN-PEROXIDE; DISINFECTION SYSTEM; ANTIBIOTIC ACTION; ENHANCEMENT; OH	The bactericidal effect of hydroxyl radical (center dot OH) generated by combination of photolysis of hydrogen peroxide (H2O2) and sonolysis of water was examined under the condition in which the yield of center dot OH increased additively when H2O2 aqueous solution was concomitantly irradiated with laser and ultrasound. The suspension of Staphylococcus aureus mixed with the different concentrations of H2O2 was irradiated simultaneously with a laser light (wavelength: 405 nm, irradiance: 46 and 91 mW/cm(2)) and ultrasound (power: 30 w, frequency: 1.65 MHz) at 20 +/- 1 degrees C of the water bulk temperature for 2 min. The combination of laser and ultrasound irradiation significantly reduced the viable bacterial count in comparison with the laser irradiation of H2O2 alone. By contrast, the ultrasound irradiation alone exerted almost no bactericidal effect. These results suggested that the combination effect of photolysis of H2O2 and sonolysis of water on bactericidal activity was synergistic. A multi-way analysis of variance also revealed that the interaction of H2O2 concentration, laser power and ultrasound irradiation significantly affected the bactericidal activity. Since the result of oxidative DNA damage evaluation demonstrated that the combination of laser and ultrasound irradiation significantly induced oxidative damage of bacterial DNA in comparison with the laser irradiation of H2O2 alone, it was suggested that the combination effect of photolysis of H2O2 and sonolysis of water on bactericidal activity would be exerted via oxidative damage of cellular components such as DNA.	[Sheng, Hong; Sasaki, Keiichi] Tohoku Univ, Grad Sch Dent, Div Adv Prosthet Dent, Sendai, Miyagi 980, Japan; [Nakamura, Keisuke; Niwano, Yoshimi] Tohoku Univ, Grad Sch Dent, Lab Redox Regulat, Sendai, Miyagi 980, Japan; [Kanno, Taro] Tohoku Univ, Grad Sch Dent, Div Mol & Regenerat Prosthodont, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Sheng, H (corresponding author), Tohoku Univ, Grad Sch Dent, Div Adv Prosthet Dent, Sendai, Miyagi 980, Japan.	dentistseikou@dent.tohoku.ac.jp	Niwnao, Yoshimi/Z-3593-2019		Ministry of Education, Science, Sports and Culture, Japan [26460116]	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Ministry of Education, Science, Sports and Culture, Japan, Grant-in-Aid for Scientific Research (C), 26460116,2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augusto O., 2012, PRINCIPLES FREE RADI, P19; BADWEY JA, 1980, ANNU REV BIOCHEM, V49, P695, DOI 10.1146/annurev.bi.49.070180.003403; Buege J A, 1978, Methods Enzymol, V52, P302; BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3; CLIFFORD DP, 1982, MOL CELL BIOCHEM, V49, P143, DOI 10.1007/BF00231175; Fukuda S, 2001, JPN J APPL PHYS 1, V40, P3493, DOI 10.1143/JJAP.40.3493; GLAZE WH, 1987, OZONE-SCI ENG, V9, P335; Guo QQ, 2011, CHEM COMMUN, V47, P11906, DOI 10.1039/c1cc14699h; Halliwell B., 2007, FREE RADICALS BIOL M; HARBOUR JR, 1974, CAN J CHEM, V52, P3549, DOI 10.1139/v74-527; Hayashi E, 2012, J BIOSCI BIOENG, V114, P193, DOI 10.1016/j.jbiosc.2012.03.020; Ikai H, 2010, ANTIMICROB AGENTS CH, V54, P5086, DOI 10.1128/AAC.00751-10; Iwasawa A, 2009, J CLIN BIOCHEM NUTR, V45, P214, DOI 10.3164/jcbn.08-261; Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5; Kim JO, 1999, APPL ACOUST, V58, P211, DOI 10.1016/S0003-682X(98)00039-5; Kobayashi Y, 2014, J ORAL SCI, V56, P35, DOI 10.2334/josnusd.56.35; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohno M, 2011, J CLIN BIOCHEM NUTR, V49, P96, DOI 10.3164/jcbn.10-130; KONDO T, 1988, INT J RADIAT BIOL, V54, P955, DOI 10.1080/09553008814552351; Liu B, 2011, ULTRASON SONOCHEM, V18, P1052, DOI 10.1016/j.ultsonch.2011.02.001; MAKINO K, 1982, J AM CHEM SOC, V104, P3537, DOI 10.1021/ja00376a064; Maverakis E, 2010, J AUTOIMMUN, V34, pJ247, DOI 10.1016/j.jaut.2009.11.011; Munter R., 2001, P EST ACAD SCI, V50, P59, DOI DOI 10.1002/CHIN.200141291; Nakamura K, J AGR FOOD CHEM; Nakamura K, 2012, J AGR FOOD CHEM, V60, P10048, DOI 10.1021/jf303177p; Nakamura K, 2010, B CHEM SOC JPN, V83, P1037, DOI 10.1246/bcsj.20100078; Norihisa T, 2008, J SOC AUTO ENG JPN, V62, P92; Odashima Y, 2014, J CHEMOTHERAPY, V26, P92, DOI 10.1179/1973947813Y.0000000114; PITT WG, 1994, ANTIMICROB AGENTS CH, V38, P2577, DOI 10.1128/AAC.38.11.2577; Piyasena P, 2003, INT J FOOD MICROBIOL, V87, P207, DOI 10.1016/s0168-1605(03)00075-8; Qian Z, 1996, BIOMATERIALS, V17, P1975, DOI 10.1016/0142-9612(96)00022-1; Rediske AM, 1998, J GEN APPL MICROBIOL, V44, P283, DOI 10.2323/jgam.44.283; Redmond RW, 2006, PHOTOCHEM PHOTOBIOL, V82, P1178, DOI 10.1562/2006-04-14-IR-874; RIESZ P, 1992, FREE RADICAL BIO MED, V13, P247, DOI 10.1016/0891-5849(92)90021-8; ROOTS R, 1975, RADIAT RES, V64, P306, DOI 10.2307/3574267; Rutala WA, 1996, INFECT CONTROL, V24, P313; Sakai K, 2007, LASER PHYS, V17, P1062, DOI 10.1134/S1054660X07080075; Shirai A, 2014, J PHOTOCH PHOTOBIO B, V130, P226, DOI 10.1016/j.jphotobiol.2013.11.027; Shirato M, 2012, ANTIMICROB AGENTS CH, V56, P295, DOI 10.1128/AAC.05158-11; Tachibana K, 2008, ULTRASONICS, V48, P253, DOI 10.1016/j.ultras.2008.02.003; Takahashi Hiroshi, 2005, Journal of Nippon Medical School, V72, P4, DOI 10.1272/jnms.72.4; Takahashi M, 2007, J PHYS CHEM B, V111, P1343, DOI 10.1021/jp0669254; Toki T, 2015, J BIOSCI BIOENG, V119, P358, DOI 10.1016/j.jbiosc.2014.08.015; Usui M, 2011, JON J CONSERVATIVE D, V54, P424; Wright GD, 2007, CELL, V130, P781, DOI 10.1016/j.cell.2007.08.023; Yu H, 2012, ULTRASON SONOCHEM, V19, P377, DOI 10.1016/j.ultsonch.2011.11.010	46	21	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132445	10.1371/journal.pone.0132445	http://dx.doi.org/10.1371/journal.pone.0132445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148024	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600272
J	Stockdale, SR; Collins, B; Spinelli, S; Douillard, FP; Mahony, J; Cambillau, C; van Sinderen, D				Stockdale, Stephen R.; Collins, Barry; Spinelli, Silvia; Douillard, Franois P.; Mahony, Jennifer; Cambillau, Christian; van Sinderen, Douwe			Structure and Assembly of TP901-1 Virion Unveiled by Mutagenesis	PLOS ONE			English	Article							LACTOCOCCAL BACTERIOPHAGE TP901-1; MULTIPLE SEQUENCE ALIGNMENT; PROTEIN HOMOLOGY DETECTION; TAIL-TERMINATOR PROTEIN; PHAGE-LAMBDA; CRYSTAL-STRUCTURE; BINDING PROTEIN; 3-DIMENSIONAL STRUCTURE; LENGTH DETERMINATION; ELECTRON-MICROSCOPY	Bacteriophages of the Siphoviridae family represent the most abundant viral morphology in the biosphere, yet many molecular aspects of their virion structure, assembly and associated functions remain to be unveiled. In this study, we present a comprehensive mutational and molecular analysis of the temperate Lactococcus lactis-infecting phage TP901-1. Fourteen mutations located within the structural module of TP901-1 were created; twelve mutations were designed to prevent full length translation of putative proteins by non-sense mutations, while two additional mutations caused aberrant protein production. Electron microscopy and Western blot analysis of mutant virion preparations, as well as in vitro assembly of phage mutant combinations, revealed the essential nature of many of the corresponding gene products and provided information on their biological function(s). Based on the information obtained, we propose a functional and assembly model of the TP901-1 Siphoviridae virion.	[Stockdale, Stephen R.; Collins, Barry; Douillard, Franois P.; Mahony, Jennifer; van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Spinelli, Silvia; Cambillau, Christian] Aix Marseille Univ, Architecture & Fonct Macromol Biol, F-13288 Marseille 09, France; [Cambillau, Christian] CNRS, AFMB, F-13288 Marseille 09, France; [van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland	University College Cork; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); University College Cork	van Sinderen, D (corresponding author), Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Western Rd, Cork, Ireland.	d.vansinderen@ucc.ie	Van Sinderen, Douwe/A-6778-2015; mahony, jennifer/AAG-8357-2020	Van Sinderen, Douwe/0000-0003-1823-7957; mahony, jennifer/0000-0001-5846-6303; Stockdale, Stephen/0000-0002-0044-3878	Science Foundation Ireland (SFI) [08/IN.1/B1909]; French National Research Agency (ANR) [ANR-11-BSV8-004-01 Lacto-Phages]	Science Foundation Ireland (SFI)(Science Foundation Ireland); French National Research Agency (ANR)(French National Research Agency (ANR))	Work in the team of DVS was funded by Science Foundation Ireland (SFI; http://www.sfi.ie/) Principal Investigatorship award (Ref. No. 08/IN.1/B1909). Work in the team of CC was funded by a French National Research Agency (ANR; http://www.agence-nationale-recherche.fr/) grant (ANR-11-BSV8-004-01 Lacto-Phages). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth S, 2013, APPL ENVIRON MICROB; Aksyuk AA, 2011, VIRUSES-BASEL, V3, P172, DOI 10.3390/v3030172; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BAZINET C, 1988, J MOL BIOL, V202, P77, DOI 10.1016/0022-2836(88)90520-7; Bebeacua C, 2013, J VIROL, V87, P12302, DOI 10.1128/JVI.02033-13; Bebeacua C, 2013, J VIROL, V87, P1061, DOI 10.1128/JVI.02836-12; Bebeacua C, 2010, J BIOL CHEM, V285, P39079, DOI 10.1074/jbc.M110.175646; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Boulanger P, 2008, J BIOL CHEM, V283, P13556, DOI 10.1074/jbc.M800052200; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Brondsted L, 2001, VIROLOGY, V283, P93, DOI 10.1006/viro.2001.0871; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Campanacci V, 2010, J STRUCT BIOL, V172, P75, DOI 10.1016/j.jsb.2010.02.007; Cardarelli L, 2010, J MOL BIOL, V395, P754, DOI 10.1016/j.jmb.2009.10.067; CASJENS SR, 1974, J MOL BIOL, V88, P535, DOI 10.1016/0022-2836(74)90500-2; Chagot B, 2012, PROTEINS, V80, P319, DOI 10.1002/prot.23191; Chatterjee S, 2012, VIRUSES-BASEL, V4, P3162, DOI 10.3390/v4113162; Collins B, 2013, J VIROL, V87, P8429, DOI 10.1128/JVI.00907-13; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Dokland T, 1999, CELL MOL LIFE SCI, V56, P580, DOI 10.1007/s000180050455; Dorscht J, 2009, J BACTERIOL, V191, P7206, DOI 10.1128/JB.01041-09; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Douillard FP, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-66; Droge A, 2000, J MOL BIOL, V296, P117, DOI 10.1006/jmbi.1999.3450; Edmonds L, 2007, J MOL BIOL, V365, P175, DOI 10.1016/j.jmb.2006.09.068; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Goulet A, 2011, J BIOL CHEM, V286, P25397, DOI 10.1074/jbc.M111.243360; GUO PX, 1991, VIROLOGY, V183, P366, DOI 10.1016/0042-6822(91)90149-6; Hendrix RW, 2012, ADV EXP MED BIOL, V726, P351, DOI 10.1007/978-1-4614-0980-9_15; Johnson JE, 2007, CURR OPIN STRUC BIOL, V17, P237, DOI 10.1016/j.sbi.2007.03.011; Johnson JE, 2010, CURR OPIN STRUC BIOL, V20, P210, DOI 10.1016/j.sbi.2010.01.004; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KATSURA I, 1976, J MOL BIOL, V107, P307, DOI 10.1016/S0022-2836(76)80007-1; KATSURA I, 1977, VIROLOGY, V76, P129, DOI 10.1016/0042-6822(77)90290-2; KATSURA I, 1984, CELL, V39, P691, DOI 10.1016/0092-8674(84)90476-8; Kenny JG, 2004, J BACTERIOL, V186, P3480, DOI 10.1128/JB.186.11.3480-3491.2004; Koch B, 1997, APPL ENVIRON MICROB, V63, P2439, DOI 10.1128/AEM.63.6.2439-2441.1997; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Letarov A, 2009, J APPL MICROBIOL, V107, P1, DOI 10.1111/j.1365-2672.2009.04143.x; Lhuillier S, 2009, P NATL ACAD SCI USA, V106, P8507, DOI 10.1073/pnas.0812407106; Lillehaug D, 1997, J APPL MICROBIOL, V83, P85, DOI 10.1046/j.1365-2672.1997.00193.x; Mahony J, 2013, APPL ENVIRON MICROB, V79, P4385, DOI 10.1128/AEM.00653-13; Mateu MG, 2013, ARCH BIOCHEM BIOPHYS, V531, P65, DOI 10.1016/j.abb.2012.10.015; Mc Grath S, 2006, J BACTERIOL, V188, P3972, DOI 10.1128/JB.00024-06; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Newcomb WW, 2003, J VIROL, V77, P9862, DOI 10.1128/JVI.77.18.9862-9871.2003; Olia AS, 2011, NAT STRUCT MOL BIOL, V18, P597, DOI 10.1038/nsmb.2023; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Pedersen M, 2000, VIROLOGY, V276, P315, DOI 10.1006/viro.2000.0497; Pell LG, 2013, J MOL BIOL, V425, P2436, DOI 10.1016/j.jmb.2013.03.035; Pell LG, 2009, J MOL BIOL, V389, P938, DOI 10.1016/j.jmb.2009.04.072; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; Popovic A, 2012, J BIOL CHEM, V287, P32085, DOI 10.1074/jbc.M112.378349; PREVELIGE PE, 1993, BIOPHYS J, V64, P824, DOI 10.1016/S0006-3495(93)81443-7; Roces C, 2013, J GEN VIROL, V94, P2814, DOI 10.1099/vir.0.057182-0; Rost B, 2001, J STRUCT BIOL, V134, P204, DOI 10.1006/jsbi.2001.4336; Sambrook J, 1998, MOL CLONING LAB MANU, V2nd; Sassi M, 2013, J VIROL, V87, P8099, DOI 10.1128/JVI.01209-13; Sciara G, 2008, J BIOL CHEM, V283, P2716, DOI 10.1074/jbc.M707533200; Sciara G, 2010, P NATL ACAD SCI USA, V107, P6852, DOI 10.1073/pnas.1000232107; Seegers JFML, 2004, VIROLOGY, V329, P40, DOI 10.1016/j.virol.2004.07.003; Shepherd DA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009787; Siponen M, 2009, J BACTERIOL, V191, P728, DOI 10.1128/JB.01363-08; Siponen M, 2009, J BACTERIOL, V191, P3220, DOI 10.1128/JB.01637-08; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Spinelli S, 2006, NAT STRUCT MOL BIOL, V13, P85, DOI 10.1038/nsmb1029; Spinelli S, 2006, J BIOL CHEM, V281, P14256, DOI 10.1074/jbc.M600666200; Stiege AC, 2003, MOL MICROBIOL, V49, P1201, DOI 10.1046/j.1365-2958.2003.03631.x; Stockdale SR, 2013, J BIOL CHEM, V288, P5581, DOI 10.1074/jbc.M112.444901; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; ThumanCommike PA, 1996, J MOL BIOL, V260, P85, DOI 10.1006/jmbi.1996.0383; Van Pijkeren JP, 2012, BIOENGINEERED, V3, P209, DOI 10.4161/bioe.21049; van Pijkeren JP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks147; vanSinderen D, 1996, MOL MICROBIOL, V19, P1343, DOI 10.1111/j.1365-2958.1996.tb02478.x; Veesler D, 2012, P NATL ACAD SCI USA, V109, P8954, DOI 10.1073/pnas.1200966109; Veesler D, 2011, MICROBIOL MOL BIOL R, V75, P423, DOI 10.1128/MMBR.00014-11; Veesler D, 2010, J BIOL CHEM, V285, P36666, DOI 10.1074/jbc.M110.157529; Vegge CS, 2006, APPL ENVIRON MICROB, V72, P6815, DOI 10.1128/AEM.01033-06; Vegge CS, 2006, J BACTERIOL, V188, P55, DOI 10.1128/JB.188.1.55-63.2006; Vegge CS, 2005, J BACTERIOL, V187, P4187, DOI 10.1128/JB.187.12.4187-4197.2005; Ventura M, 2007, APPL ENVIRON MICROB, V73, P7771, DOI 10.1128/AEM.01273-07; Vinga I, 2006, MOL MICROBIOL, V61, P1609, DOI 10.1111/j.1365-2958.2006.05327.x; WEIGLE J, 1966, P NATL ACAD SCI USA, V55, P1462, DOI 10.1073/pnas.55.6.1462; White HE, 2012, J VIROL, V86, P6768, DOI 10.1128/JVI.00412-12; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; Xu J, 2004, MOL CELL, V16, P11, DOI 10.1016/j.molcel.2004.09.006; Xu J, 2014, J MOL BIOL, V426, P1004, DOI 10.1016/j.jmb.2013.06.040; Xu J, 2013, J MOL BIOL, V425, P3476, DOI 10.1016/j.jmb.2013.07.002; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485; Zivanovic Y, 2014, J VIROL, V88, P1162, DOI 10.1128/JVI.02262-13	94	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131676	10.1371/journal.pone.0131676	http://dx.doi.org/10.1371/journal.pone.0131676			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147978	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600126
J	Torres, DJ; Ricoy, UM; Roybal, S				Torres, David J.; Ricoy, Ulises M.; Roybal, Shanae			Modeling Honey Bee Populations	PLOS ONE			English	Article							APIS-MELLIFERA L.; BEHAVIORAL MATURATION; PRIMER PHEROMONE; WORKER; DYNAMICS; COLONIES; FAILURE; POLYETHISM; COLLAPSE; GROWTH	Eusocial honey bee populations (Apis mellifera) employ an age stratification organization of egg, larvae, pupae, hive bees and foraging bees. Understanding the recent decline in honey bee colonies hinges on understanding the factors that impact each of these different age castes. We first perform an analysis of steady state bee populations given mortality rates within each bee caste and find that the honey bee colony is highly susceptible to hive and pupae mortality rates. Subsequently, we study transient bee population dynamics by building upon the modeling foundation established by Schmickl and Crailsheim and Khoury et al. Our transient model based on differential equations accounts for the effects of pheromones in slowing the maturation of hive bees to foraging bees, the increased mortality of larvae in the absence of sufficient hive bees, and the effects of food scarcity. We also conduct sensitivity studies and show the effects of parameter variations on the colony population.	[Torres, David J.] Northern New Mexico Coll, Dept Math & Phys Sci, Espanola, NM 87532 USA; [Ricoy, Ulises M.; Roybal, Shanae] Northern New Mexico Coll, Dept Biol, Espanola, NM USA		Torres, DJ (corresponding author), Northern New Mexico Coll, Dept Math & Phys Sci, Espanola, NM 87532 USA.	davytorres@nnmc.edu	Torres, David/ABB-9663-2021	Torres, David/0000-0003-2469-5284; Ricoy, Ulises/0000-0002-8545-0865	NSF NMSU Alliance for Minority Participation Grant [HRD-1305011]; Direct For Education and Human Resources [1305011] Funding Source: National Science Foundation	NSF NMSU Alliance for Minority Participation Grant; Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	This work was supported by NSF NMSU Alliance for Minority Participation Grant, HRD-1305011. The grant supports faculty mentored student research projects.	Anderson J., 1931, BEE WORLD, V12, P25; Becher MA, 2014, J APPL ECOL, V51, P470, DOI 10.1111/1365-2664.12222; Becher MA, 2013, J APPL ECOL, V50, P868, DOI 10.1111/1365-2664.12112; Bodenheimer FS, 1937, Q REV BIOL, V12, P406, DOI 10.1086/394540; BRETSCHKO J, 1995, NATURGEMASSE BIENENZ, P292; Buhlmann G., 1985, Mitteilungen der Deutschen Gesellschaft fuer Allgemeine und Angewandte Entomologie, V4, P312; Castillo C, 2012, INSECT BIOCHEM MOLEC, V42, P404, DOI 10.1016/j.ibmb.2012.02.002; Chauzat MP, 2014, 10 COLOSS C 2014 SEP, P7; DEGRANDIHOFFMAN G, 1989, ECOL MODEL, V45, P133, DOI 10.1016/0304-3800(89)90088-4; EISCHEN FA, 1984, J APICULT RES, V23, P90, DOI 10.1080/00218839.1984.11100615; Evans EC, 2010, WHY DO BEES BUZZ FAS; Evans JD, 2010, J INVERTEBR PATHOL, V103, pS62, DOI 10.1016/j.jip.2009.06.019; Free J. B., 1959, Proceedings of the Royal Entomological Society of London (A), V34, P141; Fukuda H., 1968, Researches on Population Ecology Kyoto University, V10, P31, DOI 10.1007/BF02514731; FUKUDA H, 1983, RES POPUL ECOL, V25, P249, DOI 10.1007/BF02515602; FUKUDA HIROMI, 1966, JAP J ECOL, V16, P206; HARBO JR, 1993, J APICULT RES, V32, P11, DOI 10.1080/00218839.1993.11101282; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Imdorf A., 2008, ALP FORUM, V68, P1; Johnson BR, 2008, BEHAV ECOL SOCIOBIOL, V62, P777, DOI 10.1007/s00265-007-0503-2; Johnson BR, 2010, BEHAV ECOL SOCIOBIOL, V64, P305, DOI 10.1007/s00265-009-0874-7; Johnson RM, 2015, ANNU REV ENTOMOL, V60, P415, DOI 10.1146/annurev-ento-011613-162005; Khoury DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059084; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; KUNERT K, 1988, J APICULT RES, V27, P13, DOI 10.1080/00218839.1988.11100775; Leoncini I, 2004, P NATL ACAD SCI USA, V101, P17559, DOI 10.1073/pnas.0407652101; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; MORITZ B, 1987, J INSECT PHYSIOL, V33, P923, DOI 10.1016/0022-1910(87)90004-7; OMHOLT SW, 1986, J APICULT RES, V25, P9, DOI 10.1080/00218839.1986.11100686; Perry CJ, 2015, P NATL ACAD SCI USA, V112, P3427, DOI 10.1073/pnas.1422089112; Remolina SC, 2008, AGE, V30, P177, DOI 10.1007/s11357-008-9061-4; Rueppell O, 2008, BEHAV ECOL SOCIOBIOL, V62, P1621, DOI 10.1007/s00265-008-0591-7; Rueppell O, 2007, EXP GERONTOL, V42, P1020, DOI 10.1016/j.exger.2007.06.002; Rueppell O, 2009, EXP GERONTOL, V44, P447, DOI 10.1016/j.exger.2009.04.003; Russell S, 2013, ECOL MODEL, V265, P158, DOI 10.1016/j.ecolmodel.2013.06.005; Sagili RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016785; SAKAGAMI S F, 1968, Researches on Population Ecology (Tokyo), V10, P127, DOI 10.1007/BF02510869; Schmickl T, 2007, ECOL MODEL, V204, P219, DOI 10.1016/j.ecolmodel.2007.01.001; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Stabe HA, 1930, J ECON ENTOMOL, V23, P447, DOI 10.1093/jee/23.2.447; The White House, 2014, FACT SHEET EC CHALL; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; WANG DER-I, 1965, J APICULT RES, V4, P3	43	28	28	9	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130966	10.1371/journal.pone.0130966	http://dx.doi.org/10.1371/journal.pone.0130966			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148010	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600055
J	Wisman, PP; Teraa, M; de Borst, GJ; Verhaar, MC; Roest, M; Moll, FL				Wisman, Peter Paul; Teraa, Martin; de Borst, Gert Jan; Verhaar, Marianne C.; Roest, Mark; Moll, Frans L.			Baseline Platelet Activation and Reactivity in Patients with Critical Limb Ischemia	PLOS ONE			English	Article							DISEASE; ADHESION; MATRIX-METALLOPROTEINASE-9; MECHANISMS; LIGAND	Background Patients with critical limb ischemia (CLI) have a high risk to develop cardiovascular events (CVE). We hypothesized that in CLI patients platelets would display increased baseline activation and reactivity. Objectives We investigated baseline platelet activation and platelet reactivity in patients with CLI. Patients/Methods In this study baseline platelet activation and platelet reactivity in response to stimulation of all major platelet activation pathways were determined in 20 CLI patients (11 using aspirin and 9 using vitamin K-antagonists) included in the Juventas-trial (clinicaltrials.gov NCT00371371) and in 17 healthy controls. Platelet activation was quantified with flow cytometric measurement of platelet P-selectin expression and fibrinogen binding. Results CLI patients not using aspirin showed higher baseline platelet activation compared to healthy controls. Maximal reactivity to stimulation of the collagen and thrombin activation pathway was decreased in CLI patients compared to healthy controls. In line, attenuated platelet reactivity to stimulation of multiple activation pathways was associated with several traditional risk factors for cardiovascular disease. Conclusions Baseline platelet activation was increased in CLI patients, whereas the reactivity of circulating platelets to several stimulatory agents is decreased. Reactivity of platelets was inversely correlated with cardiovascular risk factors.	[Wisman, Peter Paul; Teraa, Martin; de Borst, Gert Jan; Moll, Frans L.] Univ Med Ctr Utrecht, Dept Vasc Surg, NL-3584 CX Utrecht, Netherlands; [Wisman, Peter Paul; Roest, Mark] Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, NL-3584 CX Utrecht, Netherlands; [Teraa, Martin] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Roest, M (corresponding author), Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, NL-3584 CX Utrecht, Netherlands.	m.roest@umcutrecht.nl	Teraa, Martin/A-2508-2012; Verhaar, Marianne/AAM-6788-2020	Teraa, Martin/0000-0002-6751-6752; Verhaar, Marianne/0000-0002-3276-6428				Andrews RK, 2007, ARTERIOSCL THROM VAS, V27, P1511, DOI 10.1161/ATVBAHA.107.141390; Becker DM, 2006, JAMA-J AM MED ASSOC, V295, P1420, DOI 10.1001/jama.295.12.1420; Bergmeier W, 2006, P NATL ACAD SCI USA, V103, P16900, DOI 10.1073/pnas.0608207103; Cassar K, 2003, J VASC SURG, V38, P99, DOI 10.1016/S0741-5214(03)00129-0; Fateh-Moghadam S, 2007, THROMB HAEMOSTASIS, V97, P974, DOI 10.1160/TH06-12-0725; Ferroni P, 2012, ANTIOXID REDOX SIGN, V17, P1447, DOI 10.1089/ars.2011.4324; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; GALT SW, 1991, J VASC SURG, V14, P747, DOI 10.1067/mva.1991.33419; Grodin JL, 2011, VASC MED, V16, P339, DOI 10.1177/1358863X11422110; Jackson SP, 2011, NAT MED, V17, P1423, DOI 10.1038/nm.2515; Koksch M, 2001, EUR J VASC ENDOVASC, V21, P147, DOI 10.1053/ejvs.2000.1294; Lindemann S, 2007, J THROMB HAEMOST, V5, P203, DOI 10.1111/j.1538-7836.2007.02517.x; Lopez-Farre AJ, 2011, PROTEOMICS, V11, P3335, DOI 10.1002/pmic.201000708; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Rajagopalan S, 2007, J VASC SURG, V46, P485, DOI 10.1016/j.jvs.2007.05.039; Ramacciotti E, 2009, THROMB HAEMOSTASIS, V101, P748, DOI 10.1160/TH08-09-0620; Reinboldt S, 2009, PLATELETS, V20, P441, DOI 10.1080/09537100903096684; Reininger CB, 1996, THROMB RES, V82, P523, DOI 10.1016/0049-3848(96)00102-8; Robless PA, 2003, EUR J VASC ENDOVASC, V25, P16, DOI 10.1053/ejvs.2002.1794; Sprengers RW, 2010, J VASC SURG, V51, P1564, DOI 10.1016/j.jvs.2010.02.020; Stephens G, 2005, BLOOD, V105, P186, DOI 10.1182/blood-2004-07-2842; Tretjakovs P, 2012, CLIN CHIM ACTA, V413, P25, DOI 10.1016/j.cca.2011.10.009; Van Holten TC, 2012, J THROMB HAEMOST, V10, P1177, DOI 10.1111/j.1538-7836.2012.04703.x; Violi Francesco, 2012, Handb Exp Pharmacol, P547, DOI 10.1007/978-3-642-29423-5_22; Wisman PP, 2014, J THROMB HAEMOST, V12, P736, DOI 10.1111/jth.12538	26	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131356	10.1371/journal.pone.0131356	http://dx.doi.org/10.1371/journal.pone.0131356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148006	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600092
J	Zhao, MM; San Leon, D; Mesel, F; Garcia, JA; Simion-Mateo, C				Zhao, Mingmin; San Leon, David; Mesel, Frida; Antonio Garcia, Juan; Simion-Mateo, Carmen			Assorted Processing of Synthetic Trans-Acting siRNAs and Its Activity in Antiviral Resistance	PLOS ONE			English	Article							PLUM-POX-VIRUS; SMALL INTERFERING RNAS; DOUBLE-STRANDED RNAS; FUNCTIONAL DIVERSIFICATION; ARTIFICIAL MICRORNAS; BIOGENESIS; SECONDARY; PLANTS; 22-NUCLEOTIDE; GENERATION	The use of syn-tasiRNAs has been proposed as an RNA interference technique alternative to those previously described: hairpin based, virus induced gene silencing or artificial miRNAs. In this study we engineered the TAS1c locus to impair Plum pox virus (PPV) infection by replacing the five native siRNAs with two 210-bp fragments from the CP and the 3'NCR regions of the PPV genome. Deep sequencing analysis of the small RNA species produced by both constructs in planta has shown that phased processing of the syn-tasiRNAs is construct-specific. While in syn-tasiR-CP construct the processing was as predicted 21-nt phased in register with miR173-guided cleavage, the processing of syn-tasiR-3NCR is far from what was expected. A 22-nt species from the miR173-guided cleavage was a guide of two series of phased small RNAs, one of them in an exact 21-nt register, and the other one in a mixed of 21-/22-nt frame. In addition, both constructs produced abundant PPV-derived small RNAs in the absence of miR173 as a consequence of a strong sense post-transcriptional gene silencing induction. The antiviral effect of both constructs was also evaluated in the presence or absence of miR173 and showed that the impairment of PPV infection was not significantly higher when miR173 was present. The results show that syn-tasiRNAs processing depends on construct-specific factors that should be further studied before the so-called MIGS (miRNA-induced gene silencing) technology can be used reliably.	[Zhao, Mingmin; San Leon, David; Mesel, Frida; Antonio Garcia, Juan; Simion-Mateo, Carmen] Campus Univ Autonoma Madrid, Dept Genet Mol Plantas, Ctr Nacl Biotecnol CNB CSIC, Madrid 28049, Spain; [Simion-Mateo, Carmen] Yangtze Univ, Coll Agr, Jingzhou 434025, Hubei, Peoples R China	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Yangtze University	Simion-Mateo, C (corresponding author), Campus Univ Autonoma Madrid, Dept Genet Mol Plantas, Ctr Nacl Biotecnol CNB CSIC, Madrid 28049, Spain.	csimon@cnb.csic.es	Garcia, Juan Antonio/N-3723-2014; Simon Mateo, Carmen/D-4878-2013	Garcia, Juan Antonio/0000-0002-4861-9609; Simon Mateo, Carmen/0000-0002-4251-0821; San Leon Granado, David/0000-0001-8138-500X	Spanish Ministerio de Economia and Competitividad [BIO2010-18541, BIO2013-49053-R]; European Union [KBBE-204429]	Spanish Ministerio de Economia and Competitividad; European Union(European Commission)	Support was provided by grant numbers BIO2010-18541 and BIO2013-49053-R from the Spanish Ministerio de Economia and Competitividad (http://www.mineco.gob.es/) and grant number KBBE-204429 from the European Union (http://www.plantkbbe-submission.net/).	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Garcia JA, 2006, NAT BIOTECHNOL, V24, P1358, DOI 10.1038/nbt1106-1358; Garcia JA, 2014, MOL PLANT PATHOL, V15, P226, DOI 10.1111/mpp.12083; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Baulcombe D, 2005, TRENDS BIOCHEM SCI, V30, P290, DOI 10.1016/j.tibs.2005.04.012; Baulcombe DC, 2007, SCIENCE, V315, P199, DOI 10.1126/science.1138030; Beclin C, 2002, CURR BIOL, V12, P684, DOI 10.1016/S0960-9822(02)00792-3; Boccara M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003883; Carbonell A, 2014, PLANT PHYSIOL, V165, P15, DOI 10.1104/pp.113.234989; Carbonell A, 2013, MOL PLANT MICROBE IN, V26, P1211, DOI 10.1094/MPMI-04-13-0093-R; Carbonell A, 2012, PLANT CELL, V24, P3613, DOI 10.1105/tpc.112.099945; Chen HM, 2007, P NATL ACAD SCI USA, V104, P3318, DOI 10.1073/pnas.0611119104; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Chitwood DH, 2007, DEVELOPMENT, V134, P813, DOI 10.1242/dev.000497; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; de Felippes FF, 2012, PLANT J, V70, P541, DOI 10.1111/j.1365-313X.2011.04896.x; Duan CG, 2008, J VIROL, V82, P11084, DOI 10.1128/JVI.01377-08; Eamens A, 2008, PLANT PHYSIOL, V147, P456, DOI 10.1104/pp.108.117275; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Fei QL, 2013, PLANT CELL, V25, P2400, DOI 10.1105/tpc.113.114652; Felippes FF, 2009, EMBO REP, V10, P264, DOI 10.1038/embor.2008.247; Fernandez-Fernandez MR, 2001, VIROLOGY, V280, P283, DOI 10.1006/viro.2000.0762; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Gutierrez-Nava MD, 2008, PLANT PHYSIOL, V147, P543, DOI 10.1104/pp.108.118307; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Manavella PA, 2012, P NATL ACAD SCI USA, V109, P2461, DOI 10.1073/pnas.1200169109; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Montgomery TA, 2008, P NATL ACAD SCI USA, V105, P20055, DOI 10.1073/pnas.0810241105; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Qu Jing, 2012, Methods Mol Biol, V894, P209, DOI 10.1007/978-1-61779-882-5_14; Rajeswaran R, 2012, NUCLEIC ACIDS RES, V40, P6241, DOI 10.1093/nar/gks242; Schwab R, 2010, P NATL ACAD SCI USA, V107, P14945, DOI 10.1073/pnas.1009416107; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Simon-Mateo C, 2006, J VIROL, V80, P2429, DOI 10.1128/JVI.80.5.2429-2436.2006; Simon-Mateo C, 2011, BBA-GENE REGUL MECH, V1809, P722, DOI 10.1016/j.bbagrm.2011.05.011; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Tiwari M, 2014, PLANT MOL BIOL, V86, P1, DOI 10.1007/s11103-014-0224-7; Toedling J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032724; Valli A, 2006, J VIROL, V80, P10055, DOI 10.1128/JVI.00985-06; Valli A, 2011, RNA, V17, P1148, DOI 10.1261/rna.2510611; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Voinnet O, 2008, TRENDS PLANT SCI, V13, P317, DOI 10.1016/j.tplants.2008.05.004; Wang XB, 2011, PLANT CELL, V23, P1625, DOI 10.1105/tpc.110.082305; Wei KF, 2012, J CELL BIOCHEM, V113, P2576, DOI 10.1002/jcb.24133; Yoshikawa M, 2013, GENES GENET SYST, V88, P77, DOI 10.1266/ggs.88.77; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111	56	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132281	10.1371/journal.pone.0132281	http://dx.doi.org/10.1371/journal.pone.0132281			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147769	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600231
J	Baron, S; van der Merwe, NA; Madder, M; Maritz-Olivier, C				Baron, Samantha; van der Merwe, Nicolaas A.; Madder, Maxime; Maritz-Olivier, Christine			SNP Analysis Infers that Recombination Is Involved in the Evolution of Amitraz Resistance in Rhipicephalus microplus	PLOS ONE			English	Article							SOUTHERN CATTLE TICK; SODIUM-CHANNEL GENE; PYRETHROID RESISTANCE; BOOPHILUS; ACARI; IDENTIFICATION; OCTOPAMINE; MUTATION; POPULATIONS; STRAINS	Rhipicephalus microplus, better known as the Asiatic cattle tick, is a largely invasive ectoparasite of great economic importance due to the negative effect it has on agricultural livestock on a global scale, particularly cattle. Tick-borne diseases (babesiosis and anaplasmosis) transmitted by R. microplus are alarming as they decrease the quality of livestock health and production. In sub-Saharan Africa, cattle represent a major source of meat and milk, but this region of the world is severely affected by the Rhipicephalus microplus tick. The principal method for tick control is the use of chemical acaricides, notably amitraz, which was implemented in the 1990's after resistance to other acaricides surfaced. However, the efficiency of chemical control is hindered by an increase in the frequency of mutant resistance alleles to amitraz in tick populations. Presently, the only way to assess amitraz resistance is by means of larval packet tests, but this technique is time-consuming and not particularly cost effective. The main aims of this study were three-fold. First, we attempted to correlate two known SNPs in the octopamine/tyramine (OCT/Tyr) receptor with amitraz resistance in South African field samples of R. microplus. Second, we calculated gametic disequilibrium for these SNPs to determine whether they are randomly associated. Lastly, we conducted a study to assess the evolutionary effects of recombination within the OCT/Tyr receptor. Our results confirmed that the two SNPs are associated with amitraz resistance in the South African tick strain, and that they are in gametic disequilibrium. Additionally, recombination was detected in the OCT/Tyr receptor generating two recombinant haplotypes. These results are of concern to farmers in sub-Saharan Africa, and the emergence of amitraz resistance should be closely monitored in future. Therefore, we present a quick and affordable RFLP based diagnostic technique to assess amitraz resistance in field samples of R. microplus.	[Baron, Samantha; van der Merwe, Nicolaas A.; Maritz-Olivier, Christine] Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa; [Madder, Maxime] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Madder, Maxime] Univ Pretoria, Dept Vet Trop Dis, ZA-0002 Pretoria, South Africa	University of Pretoria; Institute of Tropical Medicine (ITM); University of Pretoria	Maritz-Olivier, C (corresponding author), Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa.	Christine.maritz@up.ac.za	Van der Merwe, Nicolaas A/A-9096-2008; Baron, Samantha/Y-3674-2019	Baron, Samantha/0000-0002-7709-9032; van der Merwe, Albe/0000-0003-3185-348X; Maritz-Olivier, Christine/0000-0002-4697-3719	Gauteng Department of Agriculture and Rural Development; Zoetis South Africa (Pty) Ltd.; National Research Foundation, THRIP grant [83890]; Belgium Development Cooperation (DGD)	Gauteng Department of Agriculture and Rural Development; Zoetis South Africa (Pty) Ltd.; National Research Foundation, THRIP grant; Belgium Development Cooperation (DGD)	Funding was provided by (a) Gauteng Department of Agriculture and Rural Development, C Maritz-Olivier. (b) Zoetis South Africa (Pty) Ltd., C Maritz-Olivier (c) National Research Foundation, THRIP grant nr: 83890, C Maritz-Olivier and (d) Belgium Development Cooperation (DGD) FA3 project, M Madder and C Maritz-Olivier. 2. Zoetis South Africa assisted with sample collection but had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Aguilar-Tipacamu G, 2008, PARASITOL RES, V103, P633, DOI 10.1007/s00436-008-1024-2; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Balfanz S, 2005, J NEUROCHEM, V93, P440, DOI 10.1111/j.1471-4159.2005.03034.x; Baxter GD, 1999, INSECT BIOCHEM MOLEC, V29, P461, DOI 10.1016/S0965-1748(99)00023-5; Chen AC, 2007, VET PARASITOL, V148, P379, DOI 10.1016/j.vetpar.2007.06.026; Chen AC, 2009, J ECON ENTOMOL, V102, P373, DOI 10.1603/029.102.0148; Corley SW, 2013, P NATL ACAD SCI USA, V110, P16772, DOI 10.1073/pnas.1309072110; Corley SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032480; Estrada-Pena A, 2012, J MED ENTOMOL, V49, P794, DOI 10.1603/ME11223; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; Farooqui Tahira, 2012, Open Access Insect Physiology, V4, P1; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandez-Salas A, 2012, VET PARASITOL, V183, P338, DOI 10.1016/j.vetpar.2011.07.028; Fernandez-Salasa A, 2012, VET PARASITOL; Fragoso-Sanchez H., 2011, Journal of Entomology, V8, P218, DOI 10.3923/je.2011.218.228; Gibson G., 2009, PRIMER GENOME SCI; Guerrero FD, 2002, EXP APPL ACAROL, V28, P257, DOI 10.1023/A:1025319104529; Guerrero FD, 2012, REV BRAS PARASITOL V, V21, P1, DOI 10.1590/S1984-29612012000100002; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Halliburton R, 2003, INTRO POPULATION GEN; Hartl D., 1989, PRINCIPLES POPULATIO; He HQ, 1999, BIOCHEM BIOPH RES CO, V261, P558, DOI 10.1006/bbrc.1999.1076; Hernandez R, 2002, INSECT BIOCHEM MOLEC, V32, P1009, DOI 10.1016/S0965-1748(02)00037-1; Horak IG, 2007, ONDERSTEPOORT J VET, V74, P231; Jonsson NN, 2007, VET PARASITOL, V146, P193, DOI 10.1016/j.vetpar.2007.03.006; Jonsson NN, 2010, INT J PARASITOL, V40, P1659, DOI 10.1016/j.ijpara.2010.07.006; Jonsson NN, 2010, VET PARASITOL, V169, P157, DOI 10.1016/j.vetpar.2009.12.026; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kliot A, 2012, PEST MANAG SCI, V68, P1431, DOI 10.1002/ps.3395; Labruna MB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-46; Lees Kristin, 2007, Invertebrate Neuroscience, V7, P183, DOI 10.1007/s10158-007-0060-4; Lempereur L, 2010, ACTA TROP, V114, P55, DOI 10.1016/j.actatropica.2010.01.004; Li AY, 2005, EXP APPL ACAROL, V37, P183, DOI 10.1007/s10493-005-3260-9; Li AY, 2005, J ECON ENTOMOL, V98, P552, DOI 10.1603/0022-0493-98.2.552; Li AY, 2004, J MED ENTOMOL, V41, P193, DOI 10.1603/0022-2585-41.2.193; Lyngso RB, 2005, LECT NOTES COMPUT SC, V3692, P239; M'DIAYE K, 1991, Biomedical and Environmental Sciences, V4, P376; Madder M., 2010, TICK PHOTODATABASE T; Maqueira B, 2005, J NEUROCHEM, V94, P547, DOI 10.1111/j.1471-4159.2005.03251.x; Morgan JAT, 2009, INT J PARASITOL, V39, P775, DOI 10.1016/j.ijpara.2008.12.006; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Nachman Michael W., 2006, P103; Paris M, 2008, HEREDITY, V101, P499, DOI 10.1038/hdy.2008.92; Pohl PC, 2011, INT J PARASITOL, V41, P1323, DOI 10.1016/j.ijpara.2011.08.004; Price EW, 2005, BIOINFORMATICS, V21, P402, DOI 10.1093/bioinformatics/bti003; ROBB S, 1994, EMBO J, V13, P1325, DOI 10.1002/j.1460-2075.1994.tb06385.x; Rosado-Aguilar JA, 2008, VET PARASITOL, V152, P349, DOI 10.1016/j.vetpar.2007.12.026; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saldivar L, 2008, INSECT MOL BIOL, V17, P597, DOI 10.1111/j.1365-2583.2008.00831.x; SCHNITZERLING HJ, 1983, PESTIC SCI, V14, P64, DOI 10.1002/ps.2780140110; SHIN DH, 1994, TOXICOL APPL PHARM, V128, P45, DOI 10.1006/taap.1994.1178; Soberanes Cespedes N., 2002, Tecnica Pecuaria en Mexico, V40, P81; STONE B. F., 1962, Bulletin of Entomological Research, V53, Pt. 3, P563, DOI 10.1017/S000748530004832X; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsagkarakou A, 2009, INSECT MOL BIOL, V18, P583, DOI 10.1111/j.1365-2583.2009.00900.x; Van Leeuwen T, 2010, INSECT BIOCHEM MOLEC, V40, P563, DOI 10.1016/j.ibmb.2010.05.008; Walker AR, 2003, TICKS DOMESTIC ANIMA, P149	60	31	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131341	10.1371/journal.pone.0131341	http://dx.doi.org/10.1371/journal.pone.0131341			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158272	gold, Green Published, Green Submitted			2022-12-27	WOS:000358161200028
J	Haklay, G; Gopher, A				Haklay, Gil; Gopher, Avi			A New Look at Shelter 131/51 in the Natufian Site of Eynan (Ain-Mallaha), Israel	PLOS ONE			English	Article								In the past 25 years since the reconstruction of Shelter 131 of Eynan was suggested by Francois Valla, its image has become almost iconic-a highly cited symbol of early sedentism constituting a significant part of our knowledge on early stone constructions and the people behind them. A new look at the architectural remains and the stratigraphy resulted in an alternative reconstruction, essentially different than the one we have come to know. We used spatial (architectural-geometrical) analysis in order to study the relationships between the different architectural elements and to test our hypothesis that the series of postholes may have not pertained to the upper floor 131 of Layer IV as suggested by Perrot and Valla, but rather to the successive occupational and architectural episode. The association of the postholes with Wall 51 of Layer III sheds new light on the architectural remains revealing their geometric design, an important characteristic of Early Natufian Architecture, the meaning and implications of which we shortly discuss.	[Haklay, Gil; Gopher, Avi] Tel Aviv Univ, Sonia & Marco Nadler Inst Archaeol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Haklay, G (corresponding author), Tel Aviv Univ, Sonia & Marco Nadler Inst Archaeol, IL-69978 Tel Aviv, Israel.	gilhaklay@mail.tau.ac.il						Bar-Yosef O, 1998, EVOL ANTHROPOL, V6, P159, DOI 10.1002/(SICI)1520-6505(1998)6:5<159::AID-EVAN4>3.0.CO;2-7; Bar-Yosef O, 2012, BIODIVERSITY IN AGRICULTURE: DOMESTICATION, EVOLUTION, AND SUSTAINABILITY, P57; Boyd B., 1995, ARCHAEOLOGY DEATH AN, P17; Flannery K.V., 1972, ORIGINS VILLAGE SETT; Goring-Morris A. N., 2003, PERCEIVED LANDSCAPES, P65; Goring-Morris AN, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P239, DOI 10.1007/978-1-4020-8539-0_10; Goring-Morris N, 2002, LIFE NEOLITHIC FARMI, P103; Maher LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031447; Maher LA, 2012, EVOL ANTHROPOL, V21, P69, DOI 10.1002/evan.21307; Marx C., 1887, CAPITAL, VI; Nadel D, 1999, ANTIQUITY, V73, P755, DOI 10.1017/S0003598X00065509; Nadel D., 2004, BAR INT SERIES, V1320, P95; Nadel D, 2006, DOMESTICATING SPACE, P25; Perrot J., 1976, COURRIER CNRS, V22, P13; Perrot J., 1993, STERN EPHRAIM NEW EN, P389; Perrot J, 1988, MODELISATION ECOULEM, P1; Perrot J., 1966, ANTHROPOLOGIE, V70, P437; Perrot J., 1960, ISRAEL EXPLOR J, V10, P14; Perrot J, 1974, PALEORIENT, V2, P485; Samuelian N., 2006, DOMESTICATING SPACE, P35; Samuelian N, 2010, BAR INT SER, V2097, P19; Stordeur D., 2000, PALE ORIENT, V26, P29, DOI DOI 10.3406/paleo.2000.4696; Valla F. R., 1988, PALEORIENT, V14, P283, DOI DOI 10.3406/PALEO.1988.4475; Valla F.R., 2004, J ISR PREHIST SOC, V34, P49; Valla F. R., 1998, J ISRAEL PREHISTORIC, V28, P105; Valla F.R., 2010, J ISRAEL PREHISTORIC, V40, P131; VALLA FR, 2001, J ISRAEL PREHISTORIC, V31, P43; Valla R. F., 2007, J ISRAEL PREHISTORIC, V37, P135	28	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130121	10.1371/journal.pone.0130121	http://dx.doi.org/10.1371/journal.pone.0130121			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154433	gold, Green Submitted, Green Published			2022-12-27	WOS:000358159700023
J	Joly, Y; Dalpe, G; So, D; Birko, S				Joly, Yann; Dalpe, Gratien; So, Derek; Birko, Stanislav			Fair Shares and Sharing Fairly: A Survey of Public Views on Open Science, Informed Consent and Participatory Research in Biobanking	PLOS ONE			English	Article							GENETIC RESEARCH; ETHICS; SOCIETY; TRENDS; MODEL	Context Biobanks are important resources which enable large-scale genomic research with human samples and data, raising significant ethical concerns about how participants' information is managed and shared. Three previous studies of the Canadian public's opinion about these topics have been conducted. Building on those results, an online survey representing the first study of public perceptions about biobanking spanning all Canadian provinces was conducted. Specifically, this study examined qualitative views about biobank objectives, governance structure, control and ownership of samples and data, benefit sharing, consent practices and data sharing norms, as well as additional questions and ethical concerns expressed by the public. Results Over half the respondents preferred to give a one-time general consent for the future sharing of their samples among researchers. Most expressed willingness for their data to be shared with the international scientific community rather than used by one or more Canadian institutions. Whereas more respondents indicated a preference for one-time general consent than any other model of consent, they constituted less than half of the total responses, revealing a lack of consensus among survey respondents regarding this question. Respondents identified biobank objectives, governance structure and accountability as the most important information to provide participants. Respondents' concerns about biobanking generally centred around the control and ownership of biological samples and data, especially with respect to potential misuse by insurers, the government and other third parties. Although almost half the respondents suggested that these should be managed by the researchers' institutions, results indicate that the public is interested in being well-informed about these projects and suggest the importance of increased involvement from participants. In conclusion, the study discusses the viability of several proposed models for informed consent, including e-governance, independent trustees and the use of exclusion clauses, in the context of these new findings about the views of the Canadian public.	[Joly, Yann; Dalpe, Gratien; So, Derek; Birko, Stanislav] McGill Univ, Ctr Genom & Policy, Montreal, PQ, Canada; [Birko, Stanislav] Univ Montreal, Sch Publ Hlth, Montreal, PQ, Canada	McGill University; Universite de Montreal	So, D (corresponding author), McGill Univ, Ctr Genom & Policy, Montreal, PQ, Canada.	derek.so@mail.mcgill.ca		Dalpe, Gratien/0000-0002-3049-3315	Reseau de Medecine Genetique Appliquee (RMGA); Fonds de Recherche du Quebec Sante (FRQS) [24463]; Canadian Institutes of Health Research (CIHR) [TGF-96109]	Reseau de Medecine Genetique Appliquee (RMGA); Fonds de Recherche du Quebec Sante (FRQS); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Funding for this research was provided by the Reseau de Medecine Genetique Appliquee (RMGA), the Fonds de Recherche du Quebec Sante (FRQS, Grant #24463) and the Canadian Institutes of Health Research (CIHR, Grant #TGF-96109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2013, MCGILL J LAW HEALTH, V7, P85; [Anonymous], 2015, SHAR RES DAT IMPR PU; Arzberger P., 2004, DATA SCI J, V3, P135, DOI DOI 10.2481/DSJ.3.135; Austin Melissa A, 2003, Community Genet, V6, P37, DOI 10.1159/000069544; Boggio A, 2010, CRIT PUBLIC HEALTH, V20, P85, DOI 10.1080/09581590902780590; Boggio A, 2013, ETHICAL ISSUES GOVER, P197; Cambon-Thomsen A, 2007, EUR RESPIR J, V30, P373, DOI 10.1183/09031936.00165006; Cambon-Thomsen A, 2004, NAT REV GENET, V5, P866, DOI 10.1038/nrg1473; Campbell I, 2007, STAT MED, V26, P3661, DOI 10.1002/sim.2832; Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada Social Sciences and Humanities Research Council of Canada, 2010, TRI COUNCIL POLICY S; Caulfield T, 2003, BMC MED ETHICS, V4, P1, DOI [10.1186/1472-6939-4-1, DOI 10.1186/1472-6939-4-1]; Caulfield T, 2012, BIOPRESERV BIOBANK, V10, P433, DOI 10.1089/bio.2012.0029; COCHRAN WG, 1952, ANN MATH STAT, V23, P315, DOI 10.1214/aoms/1177729380; Dove ES, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-158; Gitter Donna M., 2013, COMP ISSUES GOVERNAN, P165; Godard B, 2007, COMMUNITY GENET, V10, P147, DOI 10.1159/000101756; Gottweis H, 2011, HUM GENET, V130, P433, DOI 10.1007/s00439-011-1065-y; Granados Moreno P, 2015, CONSENT PRA IN PRESS; Hansson MG, 2009, BRIT J CANCER, V100, P8, DOI 10.1038/sj.bjc.6604795; Hansson SO, 2004, CAMB Q HEALTHC ETHIC, V13, P319; Hawkins Naomi, 2013, COMP ISSUES GOVERNAN, P77; Hoeyer K, 2010, PUBLIC HEALTH GENOM, V13, P345, DOI 10.1159/000262329; Hoover RS, 2011, IEEE T PROF COMMUN, V54, P68, DOI 10.1109/TPC.2009.2036896; Klein JP, 2005, ENCY BIOSTATISTICS; Knoppers BM, 2005, NAT REV GENET, V6, P75, DOI 10.1038/nrg1505; Mascalzoni D, 2008, PLOS MED, V5, P1302, DOI 10.1371/journal.pmed.0050192; Master Z, 2015, EUR J HUM GENET, V23, P569, DOI 10.1038/ejhg.2014.143; Master Z, 2013, CAMB Q HEALTHC ETHIC, V22, P203, DOI 10.1017/S0963180112000576; Master Z, 2012, NAT METHODS, V9, P885, DOI 10.1038/nmeth.2142; O'Doherty KC, 2009, PUBLIC HEALTH GENOM, V12, P203, DOI 10.1159/000167801; O'Doherty KC, 2012, SOC SCI MED, V75, P1604, DOI 10.1016/j.socscimed.2012.06.026; Petrini C, 2010, SOC SCI MED, V70, P217, DOI 10.1016/j.socscimed.2009.10.004; Rachul C, 2012, STUD ETHICS LAW TECH, V6, P3, DOI DOI 10.1515/1941-6008.1177; Saha K, 2011, NATURE, V478, P312, DOI 10.1038/478312a; Salvaterra E, 2008, EMBO REP, V9, P307, DOI 10.1038/embor.2008.41; Simon CM, 2011, GENET MED, V13, P821, DOI 10.1097/GIM.0b013e31821d2f88; Skloot R., 2010, IMMORTAL LIFE HENRIE; Steinsbekk KS, 2013, EUR J HUM GENET, V21, P897, DOI 10.1038/ejhg.2012.282; Trinidad SB, 2011, SCIENCE, V331, P287, DOI 10.1126/science.1199000; Wilson PM, 2010, IMPLEMENT SCI, V5, P1, DOI [10.1186/1748-5908-5-91, 10.1186/1748-5908-5-61]; Winickoff DE, 2003, NEW ENGL J MED, V349, P1180, DOI 10.1056/NEJMsb030036; World Medical Association, DECL HELS ETH PRINC; Zawati MH, 2014, HLTH LAW REV, V21, P97	43	27	27	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0129893	10.1371/journal.pone.0129893	http://dx.doi.org/10.1371/journal.pone.0129893			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26154134	Green Published, Green Submitted, gold			2022-12-27	WOS:000358159700017
J	Jurdak, R; Zhao, K; Liu, JJ; AbouJaoude, M; Cameron, M; Newth, D				Jurdak, Raja; Zhao, Kun; Liu, Jiajun; AbouJaoude, Maurice; Cameron, Mark; Newth, David			Understanding Human Mobility from Twitter	PLOS ONE			English	Article							IMPACT	Understanding human mobility is crucial for a broad range of applications from disease prediction to communication networks. Most efforts on studying human mobility have so far used private and low resolution data, such as call data records. Here, we propose Twitter as a proxy for human mobility, as it relies on publicly available data and provides high resolution positioning when users opt to geotag their tweets with their current location. We analyse a Twitter dataset with more than six million geotagged tweets posted in Australia, and we demonstrate that Twitter can be a reliable source for studying human mobility patterns. Our analysis shows that geotagged tweets can capture rich features of human mobility, such as the diversity of movement orbits among individuals and of movements within and between cities. We also find that short-and long-distance movers both spend most of their time in large metropolitan areas, in contrast with intermediate-distance movers' movements, reflecting the impact of different modes of travel. Our study provides solid evidence that Twitter can indeed be a useful proxy for tracking and predicting human movement.	[Jurdak, Raja; Zhao, Kun; Liu, Jiajun] CSIRO, Brisbane, Qld, Australia; [AbouJaoude, Maurice] Amer Univ Beirut, Beirut, Lebanon; [Cameron, Mark; Newth, David] CSIRO, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); American University of Beirut; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Jurdak, R (corresponding author), CSIRO, Brisbane, Qld, Australia.	raja.jurdak@csiro.au	Jurdak, Raja/B-7637-2011; Newth, David/A-1848-2011	Jurdak, Raja/0000-0001-7517-0782; Newth, David/0000-0001-6882-7440; Abou Jaoude, Maurice/0000-0001-9270-7043				Austin D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090256; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Bernard A, 2014, POPUL DEV REV, V40, P213, DOI 10.1111/j.1728-4457.2014.00671.x; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Cameron M. A., 2012, PROC 21 INT C WORLD, P698; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Chaintreau A, 2007, IEEE T MOBILE COMPUT, V6, P606, DOI 10.1109/TMC.2007.1060; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; FANO RM, 1961, TRANSMISSION INFORMA; Fournet J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107878; Frank MR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02625; Frisch U, 1997, J PHYS I, V7, P1155, DOI 10.1051/jp1:1997114; Gambs S., 2012, P 1 WORKSH MEAS PRIV, V3, P1, DOI [10.1145/2181196.2181199, DOI 10.1145/2181196.2181199]; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Hawelkaa B, 2013, ARXIV PREPRINT; Ikawa Yohei, 2012, P 21 INT C COMP WORL, P687; Isaacman S., 2012, ACM, P239, DOI DOI 10.1145/2307636.2307659; Ji Y, 2011, THESIS MIT; Jiang Shan, 2013, P 2 ACM SIGKDD INT W; Jurdak R, 2013, ACM T SENSOR NETWORK, V9, DOI 10.1145/2422966.2422980; Laherrere J, 1998, EUR PHYS J B, V2, P525, DOI 10.1007/s100510050276; Liang X, 2013, SCI REP-UK, V3, DOI 10.1038/srep02983; Liu J, 2015, P 1 INT WORKSH BIG D; Lu X, 2013, SCI REP-UK, V3, DOI 10.1038/srep02923; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Palchykov V, 2014, SCI REP-UK, V4, DOI 10.1038/srep06174; Rhee I, 2011, IEEE ACM T NETWORK, V19, P630, DOI 10.1109/TNET.2011.2120618; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Storey K, 2001, AUST GEOGR, V32, P133, DOI 10.1080/00049180120066616; Tizzoni M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003716; Treiber M., 2013, TRAFFIC FLOW DYNAMIC; Wang P, 2009, SCIENCE, V324, P1071, DOI 10.1126/science.1167053; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112608; Wesolowski A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0986; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; Wilson T, 2004, J POPULATION RES, V21, P127, DOI [10.1007/BF03031895, DOI 10.1007/BF03031895]; Wu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097010; Yan XY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02678; Zhang Y, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/68002; Zhao K, 2014, ARXIV14084910; Zhao K, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056109; Zheng Y, 2008, PROCEEDINGS OF THE 10TH INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING (UBICOMP 2008), P312, DOI 10.1145/1409635.1409677; Zipf GK, 1946, AM SOCIOL REV, V11, P677, DOI 10.2307/2087063	44	178	180	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131469	10.1371/journal.pone.0131469	http://dx.doi.org/10.1371/journal.pone.0131469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26154597	gold, Green Published, Green Submitted			2022-12-27	WOS:000358159700064
J	Mikuni, S; Kodama, K; Sasaki, A; Kohira, N; Maki, H; Munetomo, M; Maenaka, K; Kinjo, M				Mikuni, Shintaro; Kodama, Kota; Sasaki, Akira; Kohira, Naoki; Maki, Hideki; Munetomo, Masaharu; Maenaka, Katsumi; Kinjo, Masataka			Screening for FtsZ Dimerization Inhibitors Using Fluorescence Cross-Correlation Spectroscopy and Surface Resonance Plasmon Analysis	PLOS ONE			English	Article							CELL-DIVISION; ANTISTAPHYLOCOCCAL EFFICACY; IN-VIVO; PROTEIN; PRODRUG; CONSTANT	FtsZ is an attractive target for antibiotic research because it is an essential bacterial cell division protein that polymerizes in a GTP-dependent manner. To find the seed chemical structure, we established a high-throughput, quantitative screening method combining fluorescence cross-correlation spectroscopy (FCCS) and surface plasmon resonance (SPR). As a new concept for the application of FCCS to polymerization-prone protein, Staphylococcus aureus FtsZ was fragmented into the N-terminal and C-terminal, which were fused with GFP and mCherry (red fluorescent protein), respectively. By this fragmentation, the GTP-dependent head-to-tail dimerization of each fluorescent labeled fragment of FtsZ could be observed, and the inhibitory processes of chemicals could be monitored by FCCS. In the first round of screening by FCCS, 28 candidates were quantitatively and statistically selected from 495 chemicals determined by in silico screening. Subsequently, in the second round of screening by FCCS, 71 candidates were also chosen from 888 chemicals selected via an in silico structural similarity search of the chemicals screened in the first round of screening. Moreover, the dissociation constants between the highest inhibitory chemicals and Staphylococcus aureus FtsZ were determined by SPR. Finally, by measuring the minimum inhibitory concentration, it was confirmed that the screened chemical had antibacterial activity against Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA).	[Mikuni, Shintaro; Kinjo, Masataka] Hokkaido Univ, Fac Adv Life Sci, Lab Mol Cell Dynam, Sapporo, Hokkaido, Japan; [Kodama, Kota] Hokkaido Univ, Creat Res Inst, Sapporo, Hokkaido, Japan; [Sasaki, Akira] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Bioanalyt Res Grp, Tsukuba, Japan; [Kohira, Naoki; Maki, Hideki] Shionogi & Co Ltd, Discovery Res Lab, Core Therapeut Areas, Toyonaka, Osaka, Japan; [Munetomo, Masaharu] Hokkaido Univ, Informat Initiat Ctr, Sapporo, Hokkaido, Japan; [Munetomo, Masaharu] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido, Japan; [Maenaka, Katsumi] Hokkaido Univ, Fac Pharmaceut Sci, Lab Biomol Sci, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; National Institute of Advanced Industrial Science & Technology (AIST); Shionogi & Company Limited; Hokkaido University; Hokkaido University; Hokkaido University	Kinjo, M (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Lab Mol Cell Dynam, Sapporo, Hokkaido, Japan.	kinjo@sci.hokudai.ac.jp	Sasaki, Akira/M-3025-2018; Kodama, Kota/ABG-8274-2020; Kinjo, Masataka/F-5267-2011	Sasaki, Akira/0000-0002-8021-9437; Kodama, Kota/0000-0002-2360-2034; Kinjo, Masataka/0000-0001-8889-8369	Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Ministry of Education, Culture, Sports, Science and Technology, Japan; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labor and Welfare, Japan; collaborative research program of the Information Initiative Center, Hokkaido University, Sapporo, Japan; Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Co., Ltd.	Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); collaborative research program of the Information Initiative Center, Hokkaido University, Sapporo, Japan; Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Co., Ltd.	This work was partially supported by the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program (http://www.jst.go.jp/shincho/en/), Ministry of Education, Culture, Sports, Science and Technology, Japan, the Platform for Drug Discovery, Informatics, and Structural Life Science (http://pford.jp/) from the Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labor and Welfare, Japan and the 2014 collaborative research program of the Information Initiative Center, Hokkaido University, Sapporo, Japan. Discovery Research Laboratory for Core Therapeutic Areas, Shionogi & Co., Ltd. provided support in the form of salaries for authors NK and HM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Andreu JM, 2010, J BIOL CHEM, V285, P14239, DOI 10.1074/jbc.M109.094722; Bacia K, 2007, NAT PROTOC, V2, P2842, DOI 10.1038/nprot.2007.410; Chan FY, 2014, J ANTIBIOT TOKYO, P1, DOI DOI 10.1177/1359105314530451; Clinical and Laboratory Standards Institute, 2006, APPROVED STANDARD, pM7; Czaplewski LG, 2009, BIOORG MED CHEM LETT, V19, P524, DOI 10.1016/j.bmcl.2008.11.021; Duggirala S, 2014, APPL BIOCHEM BIOTECH, V174, P283, DOI 10.1007/s12010-014-1056-2; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; Elsen NL, 2012, J AM CHEM SOC, V134, P12342, DOI 10.1021/ja303564a; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Kaul M, 2014, BIOCHEM PHARMACOL, V89, P321, DOI 10.1016/j.bcp.2014.03.002; Kaul M, 2013, BIOCHEM PHARMACOL, V86, P1699, DOI 10.1016/j.bcp.2013.10.010; Kaul M, 2013, ANTIMICROB AGENTS CH, V57, P5860, DOI 10.1128/AAC.01016-13; Kaul M, 2013, BIOCHIMIE, V95, P1880, DOI 10.1016/j.biochi.2013.06.010; Kogure T, 2008, METHODS, V45, P223, DOI 10.1016/j.ymeth.2008.06.009; Koppelman CM, 2004, MOL MICROBIOL, V51, P645, DOI 10.1046/j.1365-2958.2003.03876.x; Kumar K, 2011, J MED CHEM, V54, P374, DOI 10.1021/jm1012006; Li N, 2010, J BIOL CHEM, V285, P6922, DOI 10.1074/jbc.M109.069286; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Matsui T, 2014, J BIOL CHEM, V289, P3501, DOI 10.1074/jbc.M113.514901; Mitsuhashi M, 2011, J BIOCHEM, V149, P253, DOI 10.1093/jb/mvq134; Miura K, 2010, ANTIMICROB AGENTS CH, V54, P960, DOI 10.1128/AAC.00927-09; Mukherjee S, 2007, BIOORG MED CHEM LETT, V17, P6651, DOI 10.1016/j.bmcl.2007.09.010; Muto H, 2006, PLANT CELL PHYSIOL, V47, P1095, DOI 10.1093/pcp/pcj080; Ohrt T, 2008, NUCLEIC ACIDS RES, V36, P6439, DOI 10.1093/nar/gkn693; Oyama R, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl477; Park B, 2014, BIOORGAN MED CHEM, V22, P2602, DOI 10.1016/j.bmc.2014.03.035; Park HC, 2014, APPL BIOCHEM BIOTECH, V172, P3263, DOI 10.1007/s12010-014-0752-2; Perike S, 2014, EXP CELL RES, V324, P13, DOI 10.1016/j.yexcr.2014.03.005; Reija B, 2011, ANAL BIOCHEM, V418, P89, DOI 10.1016/j.ab.2011.07.001; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Ruan QQ, 2008, ANAL BIOCHEM, V374, P182, DOI 10.1016/j.ab.2007.11.007; Sadamoto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020285; Saito K, 2004, BIOCHEM BIOPH RES CO, V324, P849, DOI 10.1016/j.bbrc.2004.09.126; Sasaki A, 2010, J CONTROL RELEASE, V143, P104, DOI 10.1016/j.jconrel.2009.12.013; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; SHOJI J, 1988, J ANTIBIOT, V41, P713, DOI 10.7164/antibiotics.41.713; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Stokes NR, 2005, J BIOL CHEM, V280, P39709, DOI 10.1074/jbc.M506741200; Sun F, 2011, BIOCHEM BIOPH RES CO, V404, P706, DOI 10.1016/j.bbrc.2010.12.047; Tiwari M, 2013, BIOCHEM BIOPH RES CO, V436, P430, DOI 10.1016/j.bbrc.2013.05.121; Wang J, 2003, J BIOL CHEM, V278, P44424, DOI 10.1074/jbc.M307625200; White EL, 2002, J ANTIMICROB CHEMOTH, V50, P111, DOI 10.1093/jac/dkf075; Yamada M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3033; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhou XM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008074	49	8	8	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130933	10.1371/journal.pone.0130933	http://dx.doi.org/10.1371/journal.pone.0130933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154290	Green Published, Green Submitted, gold			2022-12-27	WOS:000358159700046
J	Gansel, LC; Plew, DR; Endresen, PC; Olsen, AI; Misimi, E; Guenther, J; Jensen, O				Gansel, Lars Christian; Plew, David R.; Endresen, Per Christian; Olsen, Anna Ivanova; Misimi, Ekrem; Guenther, Jana; Jensen, Osten			Drag of Clean and Fouled Net Panels - Measurements and Parameterization of Fouling	PLOS ONE			English	Article							AQUACULTURE; EFFICACY; CAGES; FORCE	Biofouling is a serious problem in marine aquaculture and it has a number of negative impacts including increased forces on aquaculture structures and reduced water exchange across nets. This in turn affects the behavior of fish cages in waves and currents and has an impact on the water volume and quality inside net pens. Even though these negative effects are acknowledged by the research community and governmental institutions, there is limited knowledge about fouling related effects on the flow past nets, and more detailed investigations distinguishing between different fouling types have been called for. This study evaluates the effect of hydroids, an important fouling organism in Norwegian aquaculture, on the forces acting on net panels. Drag forces on clean and fouled nets were measured in a flume tank, and net solidity including effect of fouling were determined using image analysis. The relationship between net solidity and drag was assessed, and it was found that a solidity increase due to hydroids caused less additional drag than a similar increase caused by change in clean net parameters. For solidities tested in this study, the difference in drag force increase could be as high as 43% between fouled and clean nets with same solidity. The relationship between solidity and drag force is well described by exponential functions for clean as well as for fouled nets. A method is proposed to parameterize the effect of fouling in terms of an increase in net solidity. This allows existing numerical methods developed for clean nets to be used to model the effects of biofouling on nets. Measurements with other types of fouling can be added to build a database on effects of the accumulation of different fouling organisms on aquaculture nets.	[Gansel, Lars Christian] Norwegian Univ Sci & Technol, Dept Marine Technol, N-7034 Trondheim, Norway; [Gansel, Lars Christian; Endresen, Per Christian; Misimi, Ekrem; Guenther, Jana] SINTEF Fisheries & Aquaculture, Aquaculture Technol Dept, Trondheim, Norway; [Plew, David R.] NIWA, Christchurch, New Zealand; [Olsen, Anna Ivanova] Den Norske Veritas, Trondheim, Norway; [Jensen, Osten] STATOIL, Stjordal, Norway	Norwegian University of Science & Technology (NTNU); SINTEF; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Gansel, LC (corresponding author), Norwegian Univ Sci & Technol, Dept Marine Technol, Otto Nielsens Vei 10, N-7034 Trondheim, Norway.	lars.gansel@sintef.no	Bannister, Jana/ABE-3695-2020	Bannister, Jana/0000-0002-5281-7800; Gansel, Lars Christian/0000-0003-3316-5277; Olsen, Anna/0000-0002-5381-584X; Plew, David/0000-0001-6714-4904; Misimi, Ekrem/0000-0003-2489-7759	Research Council of Norway [174842]	Research Council of Norway(Research Council of Norway)	The work was funded by The Research Council of Norway (www.forskningsradet.no) through a phd fellowship from the Faculty of Engineering Science and Technology at the Norwegian University of Science and Technology and through the Centre for Research-based Innovation in Aquaculture Technology, CREATE (Grant number: 174842), at SINTEF Fisheries and Aquaculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARSNES JV, 1990, ENGINEERING FOR OFFSHORE FISH FARMING, P137; Balash C, 2009, AQUACULT ENG, V41, P14, DOI 10.1016/j.aquaeng.2009.04.003; Baldwin KC, 2003, OCEANS 2003 MTS/IEEE: CELEBRATING THE PAST...TEAMING TOWARD THE FUTURE, P1454, DOI 10.1109/OCEANS.2003.178076; Bloecher N, 2013, AQUACULTURE, V416, P302, DOI 10.1016/j.aquaculture.2013.09.025; Braithwaite RA, 2007, AQUACULTURE, V262, P219, DOI 10.1016/j.aquaculture.2006.11.027; de Nys R, 2009, WOODHEAD PUBL MATER, P177, DOI 10.1533/9781845696313.1.177; Demtroder W., 2002, EXPERIMETNALPHYSIC 1, P32; Duerr S, 2010, BIOFOULING; Fitridge I, 2012, BIOFOULING, V28, P649, DOI 10.1080/08927014.2012.700478; Food and Agriculture Organization of the United Nations (FAO), 2010, STAT WORLD FISH AQ; Fredheim A., 2005, THESIS NORWEGIAN U S; Gansel L. C., 2011, J OFFSHORE MECH ARCT, V134; Guenther J, 2010, AQUACULTURE, V300, P120, DOI 10.1016/j.aquaculture.2010.01.005; Hodson SL, 2000, AQUACULTURE, V184, P277, DOI 10.1016/S0044-8486(99)00328-2; Jensen O, 2010, AQUACULT ENV INTERAC, V1, P71, DOI 10.3354/aei00008; Jensen O, 2013, P 32 INT C OC OFFSH; Klebert P, 2013, OCEAN ENG, V58, P260, DOI 10.1016/j.oceaneng.2012.11.006; Lader P, 2008, AQUACULT ENG, V38, P52, DOI 10.1016/j.aquaeng.2007.11.001; Loland G., 1991, THESIS NORWEGIAN I T; Milne P.H, 1972, FISH SHELLFISH FARMI; Milne P.H., 1970, FISH FARMING GUIDE D; Plew DR, 2009, AQUACULT ENG, V40, P55, DOI 10.1016/j.aquaeng.2008.12.003; PYEFINCH KA, 1949, J MAR BIOL ASSOC UK, V28, P21, DOI 10.1017/S0025315400055223; Standard Norge, 2009, 9415E2009 NS; Swift MR, 2006, AQUACULT ENG, V35, P292, DOI 10.1016/j.aquaeng.2006.03.002; Walpole R.E., 2007, PROBABILITY STAT ENG; Yamamoto K, 1988, JAPAN SOC SCI FISHER; Zhan JM, 2006, AQUACULT ENG, V35, P91, DOI 10.1016/j.aquaeng.2005.08.013	28	35	36	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131051	10.1371/journal.pone.0131051	http://dx.doi.org/10.1371/journal.pone.0131051			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151907	gold, Green Published, Green Submitted			2022-12-27	WOS:000358158900016
J	Chen, MJZ; Liang, DC; Zuo, AJ; Shao, H; Kaplan, HJ; Sun, DM				Chen, Mingjiazi; Liang, Dongchun; Zuo, Aijun; Shao, Hui; Kaplan, Henry J.; Sun, Deming			An A2B Adenosine Receptor Agonist Promotes Th17 Autoimmune Responses in Experimental Autoimmune Uveitis (EAU) via Dendritic Cell Activation	PLOS ONE			English	Article							DELTA T-CELLS; IMMUNE-RESPONSE; IL-23; DIFFERENTIATION; GENERATION; INDUCTION; MICE; INFLAMMATION; LYMPHOCYTES; METABOLISM	We have recently reported that, although adenosine receptor (AR) agonists have a suppressive effect on Th1 autoreactive T cells, their effect on Th17 autoreactive T cells and gamma delta T cells is stimulatory and this effect is mainly mediated via A2A adenosine receptors (A2ARs). In this study, we further demonstrate that treatment of C57BL/6 (B6) mice with a selective A2B adenosine receptor (A2BR) agonist greatly enhanced the development of experimental autoimmune uveitis (EAU), whereas treatment with an A2BR antagonist significantly ameliorated severity of EAU. The A2BR agonist-treated mice showed augmented Th17, but not Th1, responses. Mechanistic studies showed that the A2BR agonist-induced enhancement of the Th17 response was significantly lower when TCR-delta(-/-) mice received the same treatment and that transfer of gamma delta T cells into TCR-delta(-/-) mice partially restored this effect. We also showed that dendritic cells (DCs) from A2BR agonist-treated mice showed a significantly increased ability to activate gamma delta T cells and Th17 autoreactive T cells. Thus, our previous studies have shown that, in EAU, activated gamma delta T cells possess greatly increased ability to enhance Th17 autoimmune responses. In the present study, we showed that exposure of DCs to A2BR agonist facilitated gamma delta T cell activation, leading to augmented Th17 responses and progressive EAU development. Our results further support our previous finding that AR agonists have distinct effects on Th1 and Th17 autoimmune responses.	[Chen, Mingjiazi; Liang, Dongchun; Zuo, Aijun; Sun, Deming] Univ Calif Los Angeles, Doheny Eye Inst, Los Angeles, CA 90033 USA; [Chen, Mingjiazi; Liang, Dongchun; Zuo, Aijun; Sun, Deming] Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Shao, Hui; Kaplan, Henry J.] Univ Louisville, Dept Ophthalmol & Visual Sci, Kentucky Lions Eye Ctr, Louisville, KY 40202 USA	Doheny Eye Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Louisville	Sun, DM (corresponding author), Univ Calif Los Angeles, Doheny Eye Inst, Los Angeles, CA 90033 USA.	Dsun@doheny.org			National Institutes of Health [EY 0022403, EY018827, EY003040]; NATIONAL EYE INSTITUTE [R01EY018827, R01EY022403, P30EY003040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grants EY 0022403 (DS), EY018827 (DS), and EY003040 (DS).	Ben Addi A, 2008, EUR J IMMUNOL, V38, P1610, DOI 10.1002/eji.200737781; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; CASPI RR, 1988, J IMMUNOL, V140, P1490; Chen JF, 2013, NAT REV DRUG DISCOV, V12, P265, DOI 10.1038/nrd3955; Csoka B, 2012, FASEB J, V26, P376, DOI 10.1096/fj.11-190934; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Cui Y, 2009, J IMMUNOL, V183, P560, DOI 10.4049/jimmunol.0900241; Cui Y, 2009, INVEST OPHTH VIS SCI, V50, P5811, DOI 10.1167/iovs.09-3389; Di Virgilio Francesco, 2005, Purinergic Signal, V1, P205, DOI 10.1007/s11302-005-6312-z; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Ehrentraut H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032416; Eltzschig HK, 2008, TRENDS CARDIOVAS MED, V18, P103, DOI 10.1016/j.tcm.2008.01.006; Feoktistov I, 1997, PHARMACOL REV, V49, P381; Ferber IA, 1996, J IMMUNOL, V156, P5; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Granstein RD, 2005, J IMMUNOL, V174, P7725, DOI 10.4049/jimmunol.174.12.7725; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 2009, TRENDS IMMUNOL, V30, P263, DOI 10.1016/j.it.2009.04.001; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Jin DC, 2010, CANCER RES, V70, P2245, DOI 10.1158/0008-5472.CAN-09-3109; Jones LS, 1997, J IMMUNOL, V158, P5997; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kolachala VL, 2008, BRIT J PHARMACOL, V155, P127, DOI 10.1038/bjp.2008.227; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liang DC, 2014, J IMMUNOL, V193, P5498, DOI 10.4049/jimmunol.1401959; Liang DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108932; Liang DC, 2013, J IMMUNOL, V191, P1118, DOI 10.4049/jimmunol.1300626; Liang DC, 2013, INVEST OPHTH VIS SCI, V54, P3493, DOI 10.1167/iovs.12-11432; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; MANDLER R, 1982, P NATL ACAD SCI-BIOL, V79, P7542, DOI 10.1073/pnas.79.23.7542; Mills JH, 2008, P NATL ACAD SCI USA, V105, P9325, DOI 10.1073/pnas.0711175105; Nian H, 2011, INVEST OPHTH VIS SCI, V52, P5920, DOI 10.1167/iovs.10-6758; Nian H, 2010, INVEST OPHTH VIS SCI, V51, P4661, DOI 10.1167/iovs.09-5045; Niederkorn J Y, 1990, Adv Immunol, V48, P191, DOI 10.1016/S0065-2776(08)60755-5; Niemela J, 2008, EUR J IMMUNOL, V38, P2718, DOI 10.1002/eji.200838437; Novitskiy SV, 2008, BLOOD, V112, P1822, DOI 10.1182/blood-2008-02-136325; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Peng Y, 2007, INVEST OPHTH VIS SCI, V48, P4153, DOI 10.1167/iovs.07-0251; Ramlackhansingh AF, 2011, NEUROLOGY, V76, P1811, DOI 10.1212/WNL.0b013e31821ccce4; Sauer AV, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00265; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Sitkovsky MV, 2005, TRENDS IMMUNOL, V26, P299, DOI 10.1016/j.it.2005.04.004; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Stummvoll GH, 2008, J IMMUNOL, V181, P1908, DOI 10.4049/jimmunol.181.3.1908; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Thurau SR, 1997, CLIN EXP IMMUNOL, V109, P370, DOI 10.1046/j.1365-2249.1997.4571356.x; Wei W, 2013, J IMMUNOL, V190, P138, DOI 10.4049/jimmunol.1103721; Wilson JM, 2011, J IMMUNOL, V186, P6746, DOI 10.4049/jimmunol.1100117; Yip L, 2009, FASEB J, V23, P1685, DOI 10.1096/fj.08-126458; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	57	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132348	10.1371/journal.pone.0132348	http://dx.doi.org/10.1371/journal.pone.0132348			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147733	gold, Green Published			2022-12-27	WOS:000358157600248
J	Cohen, S; Innes, S; Geelen, SPM; Wells, JCK; Smit, C; Wolfs, TFW; van Eck-Smit, BLF; Kuijpers, TW; Reiss, P; Scherpbier, HJ; Pajkrt, D; Bunders, MJ				Cohen, Sophie; Innes, Steve; Geelen, Sibyl P. M.; Wells, Jonathan C. K.; Smit, Colette; Wolfs, Tom F. W.; van Eck-Smit, Berthe L. F.; Kuijpers, Taco W.; Reiss, Peter; Scherpbier, Henriette J.; Pajkrt, Dasja; Bunders, Madeleine J.			Long-Term Changes of Subcutaneous Fat Mass in HIV-Infected Children on Antiretroviral Therapy: A Retrospective Analysis of Longitudinal Data from Two Pediatric HIV-Cohorts	PLOS ONE			English	Article							BONE-MINERAL DENSITY; BODY-COMPOSITION; INSULIN-RESISTANCE; CROSS-CALIBRATION; LIPODYSTROPHY; STAVUDINE; ABNORMALITIES; LIPOATROPHY; INHIBITOR; SUBSTITUTION	Objective Longitudinal studies objectively evaluating changes in regional fat distribution of HIV-infected children assessed by whole body dual energy X-ray absorptiometry (DEXA) are scarce, whilst this long-term effect of HIV and antiretroviral therapy (cART) is an important issue in infected children in need for lifelong treatment. Methods We assessed regional fat distribution over time, measured with sequential DEXA-scans in HIV-infected children on cART in cohorts from South Africa (SA) and the Netherlands (NL), and in healthy controls (SA). Limb and trunk fat Z-scores were calculated with the lambda-mu-sigma (LMS) method. Multivariable linear regression models with mixed effects were used to investigate the effect of cART compounds on body fat distribution over time. Results In total, 218 children underwent 445 DEXA assessments with a median follow-up of 3.5 years. Fat mass in all limbs was decreased in HIV-infected children compared to controls (arm fat Z-score: coefficient -0.4813; P = 0.006, leg fat Z-score: coefficient -0.4345; P = 0.013). In the HIV-infected group, stavudine treatment was associated with lower subcutaneous fat mass (arm fat Z-score: coefficient -0.5838; P = 0.001), with an additional cumulative exposure effect (arm fat Z-score: coefficient -0.0867; P = 0.003). Conclusions Our study shows that subcutaneous fat loss is still prevalent in HIV-infected children on cART, and is strongly associated with cumulative stavudine exposure. These results underline the need for early detection of subcutaneous fat loss and alternative treatment options for HIV-infected children globally.	[Cohen, Sophie; Kuijpers, Taco W.; Scherpbier, Henriette J.; Pajkrt, Dasja; Bunders, Madeleine J.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Paediat Haematol Immunol & Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [Innes, Steve] Tygerberg Childrens Hosp, KID CRU Childrens Infect Dis Clin Res Unit, Cape Town, South Africa; [Innes, Steve] Univ Stellenbosch, Cape Town, South Africa; [Geelen, Sibyl P. M.; Wolfs, Tom F. W.] Univ Utrecht, Dept Paediat, Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Utrecht, Netherlands; [Wells, Jonathan C. K.] UCL, Childhood Nutr Res Ctr, Inst Child Hlth, London, England; [Smit, Colette; Reiss, Peter] Stichting HIV Monitoring, Amsterdam, Netherlands; [van Eck-Smit, Berthe L. F.] Univ Amsterdam, Acad Med Ctr, Dept Nucl Med, NL-1105 AZ Amsterdam, Netherlands; [Reiss, Peter] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Reiss, Peter] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Stellenbosch University; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; University of London; University College London; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Cohen, S (corresponding author), Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Paediat Haematol Immunol & Infect Dis, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.cohen@amc.nl	Wells, Jonathan/A-4604-2009	Wells, Jonathan/0000-0003-0411-8025; Innes, Steve/0000-0003-3969-8680	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI036214] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam N, 2012, JAIDS-J ACQ IMM DEF, V59, P314, DOI 10.1097/QAI.0b013e31824330cb; Arpadi S, 2013, ARCH DIS CHILD, V98, P258, DOI 10.1136/archdischild-2012-302633; Aurpibul L, 2012, PEDIATR INFECT DIS J, V31, P384, DOI 10.1097/INF.0b013e31823f0e11; Barlow-Mosha L, 2013, J INT AIDS SOC, V16, P1, DOI [10.7448/IAS.16.1.18567, DOI 10.7448/IAS.16.1.18567]; Bockhorst JL, 2003, PEDIATR INFECT DIS J, V22, P463, DOI 10.1097/00006454-200305000-00017; Bunders MJ, 2013, CLIN INFECT DIS, V56, P583, DOI 10.1093/cid/cis917; Cohen S, 2013, AIDS, V27, P2567, DOI 10.1097/01.aids.0000432451.75980.1b; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Dangerous Drugs England Dangerous Drugs Scotland., 2013, CONTROLLED DRUGS SUP; Ramalho LCD, 2011, INT J STD AIDS, V22, P453, DOI 10.1258/ijsa.2011.010516; Drechsler H, 2002, CLIN INFECT DIS, V35, P1219, DOI 10.1086/343050; Fabiano V, 2013, EUR J PEDIATR, V172, P1089, DOI 10.1007/s00431-013-2018-3; Giralt M, 2006, ANTIVIR THER, V11, P729; Goran MI, 1996, AM J CLIN NUTR, V63, P299, DOI 10.1093/ajcn/63.3.299; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Hartman K, 2006, PEDIATR INFECT DIS J, V25, P427, DOI 10.1097/01.inf.0000215003.32256.aa; Innes S, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-183; Kakuda TN, 1999, AIDS, V13, P2311, DOI 10.1097/00002030-199911120-00019; La Rovere, 2004, AIDS, V18, P1443, DOI 10.1097/01.aids.0000131334.38172.01; Madhi SA, 2010, J INFECT DIS, V202, P355, DOI 10.1086/653704; Martin A, 2004, AIDS, V18, P1029, DOI 10.1097/00002030-200404300-00011; Maynard LM, 2001, PEDIATRICS, V107, P344, DOI 10.1542/peds.107.2.344; Oh J, 2007, LANCET INFECT DIS, V7, P787, DOI 10.1016/S1473-3099(07)70287-6; Palmer M, 2013, AIDS, V27, P781, DOI 10.1097/QAD.0b013e32835c54b8; Pearson D, 2011, J CLIN DENSITOM, V14, P294, DOI 10.1016/j.jocd.2011.03.008; Rao D, 2007, AIDS CARE, V19, P28, DOI 10.1080/09540120600652303; Safrin S, 1999, AIDS, V13, P2493, DOI 10.1097/00002030-199912240-00002; Sauvageot D, 2010, PEDIATRICS, V125, pE1039, DOI 10.1542/peds.2009-1062; Soler-Palacin P, 2011, AIDS, V25, P171, DOI 10.1097/QAD.0b013e328340fdca; Technau KG, 2014, PEDIATR INFECT DIS J, V33, P617, DOI 10.1097/INF.0000000000000222; Vigano A, 2003, JAIDS-J ACQ IMM DEF, V32, P482, DOI 10.1097/00126334-200304150-00003; Vigano A, 2011, CURR HIV RES, V9, P321, DOI 10.2174/157016211797635946; Vigano A, 2007, ANTIVIR THER, V12, P297; Wells JCK, 2006, ARCH DIS CHILD, V91, P612, DOI 10.1136/adc.2005.085522; Wells JCK, 2012, AM J CLIN NUTR, V96, P1316, DOI 10.3945/ajcn.112.036970; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930	36	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0120927	10.1371/journal.pone.0120927	http://dx.doi.org/10.1371/journal.pone.0120927			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148119	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600003
J	da Costa, G; Ribeiro-Silva, C; Ribeiro, R; Gilberto, S; Gomes, RA; Ferreira, A; Mateus, E; Barroso, E; Coelho, AV; Freire, AP; Cordeiro, C				da Costa, Goncalo; Ribeiro-Silva, Cristina; Ribeiro, Raquel; Gilberto, Samuel; Gomes, Ricardo A.; Ferreira, Antonio; Mateus, Elia; Barroso, Eduardo; Coelho, Ana V.; Freire, Ana Ponces; Cordeiro, Carlos			Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease	PLOS ONE			English	Article							DOMINO LIVER-TRANSPLANTATION; RESONANCE MASS-SPECTROMETRY; ALZHEIMERS-DISEASE; EXTRACELLULAR CHAPERONE; QUANTITATIVE-ANALYSIS; PROTEOMIC ANALYSIS; MONOZYGOTIC TWINS; PLASMA-PROTEINS; 2 PAIRS; POLYNEUROPATHY	Transthyretin amyloidosis is a conformational pathology characterized by the extracellular formation of amyloid deposits and the progressive impairment of the peripheral nervous system. Point mutations in this tetrameric plasma protein decrease its stability and are linked to disease onset and progression. Since non-mutated transthyretin also forms amyloid in systemic senile amyloidosis and some mutation bearers are asymptomatic throughout their lives, non-genetic factors must also be involved in transthyretin amyloidosis. We discovered, using a differential proteomics approach, that extracellular chaperones such as fibrinogen, clusterin, haptoglobin, alpha-1-anti-trypsin and 2-macroglobulin are overrepresented in transthyretin amyloidosis. Our data shows that a complex network of extracellular chaperones are over represented in human plasma and we speculate that they act synergistically to cope with amyloid prone proteins. Proteostasis may thus be as important as point mutations in transthyretin amyloidosis.	[da Costa, Goncalo; Ribeiro-Silva, Cristina; Ribeiro, Raquel; Gilberto, Samuel; Ferreira, Antonio; Freire, Ana Ponces; Cordeiro, Carlos] FCUL, Ctr Quim Bioquim, Lisbon, Portugal; [Gomes, Ricardo A.; Coelho, Ana V.] Inst Tecnol Quim & Biol, Oeiras, Portugal; [Mateus, Elia; Barroso, Eduardo] Hosp Curry Cabral, Unidade Transplantacao, Lisbon, Portugal	Universidade de Lisboa	da Costa, G (corresponding author), FCUL, Ctr Quim Bioquim, Lisbon, Portugal.	gmcosta@fc.ul.pt; cacordeiro@fc.ul.pt	FT-ICR-MS, Lisboa/T-5273-2018; Ferreira, António EN/E-6488-2012; Coelho, Ana V Varela/O-3977-2014; Ferreira, Antonio/GXH-7620-2022; Costa, Goncalo/G-9100-2014; Coelho, Ana V/H-8885-2012; Gomes, Ricardo/E-8379-2012	Ferreira, António EN/0000-0002-9625-8115; Coelho, Ana V Varela/0000-0002-6143-4203; Ferreira, Antonio/0000-0001-5239-8020; Costa, Goncalo/0000-0001-8732-4478; Coelho, Ana V/0000-0002-6143-4203; Gomes, Ricardo/0000-0001-7155-0059; Mateus, Elia/0000-0001-8632-3983; Ponces-Freire, Ana/0000-0003-2280-8193; /0000-0002-2102-1949; Barroso, Eduardo/0000-0001-9059-7362; Cordeiro, Carlos/0000-0001-6327-8606	Fundacao para a Ciencia e a Tecnologia [SFRH/BPD/41037/2007, SFRH/BPD/73779/2010, IF/00359/2014, PEst-OE/QUI/UI0612/2011, PTDC/QUI/123060/2010, REDE/1501/REM/2005]; amyloidosis foundation	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); amyloidosis foundation	Work was supported by grants SFRH/BPD/41037/2007 (R.A.G.) and SFRH/BPD/73779/2010 and IF/00359/2014 (G.C), PEst-OE/QUI/UI0612/2011, PTDC/QUI/123060/2010 and REDE/1501/REM/2005 from the Fundacao para a Ciencia e a Tecnologia, and also by the 2011 Junior Research grant from the amyloidosis foundation.	ANDRADE C, 1952, BRAIN, V75, P408, DOI 10.1093/brain/75.3.408; Azoulay D, 1999, J AM COLL SURGEONS, V189, P584, DOI 10.1016/S1072-7515(99)00208-2; Baskakov IV, 2005, BIOCHEMISTRY-US, V44, P2339, DOI 10.1021/bi048322t; Bohrmann B, 1999, J BIOL CHEM, V274, P15990, DOI 10.1074/jbc.274.23.15990; Campos A, 2009, EUR J PLANT PATHOL, V125, P603, DOI 10.1007/s10658-009-9509-0; Da Costa G, 2009, AMYLOID, V16, P201, DOI 10.3109/13506120903421561; da Costa G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024850; da Costa G, 2010, PROTEOM CLIN APPL, V4, P674, DOI 10.1002/prca.200900118; Donners MMPC, 2005, J PATHOL, V206, P39, DOI 10.1002/path.1749; Fountoulakis M, 2004, AMINO ACIDS, V27, P249, DOI 10.1007/s00726-004-0141-1; French K, 2008, BIOCHEMISTRY-US, V47, P1176, DOI 10.1021/bi701976f; Furtado A, 1997, TRANSPL P, V29, P467, DOI 10.1016/S0041-1345(96)00206-0; GOLLIN PA, 1992, NEUROREPORT, V3, P201, DOI 10.1097/00001756-199202000-00020; Greene MJ, 2011, AM J PATHOL, V178, P61, DOI 10.1016/j.ajpath.2010.11.015; Guerreiro A, 2012, AMYLOID, V19, P74, DOI 10.3109/13506129.2012.668500; Holmgren G, 2005, J MED GENET, V42, P953, DOI 10.1136/jmg.2005.033720; Holmgren G, 2004, J INTERN MED, V256, P453, DOI 10.1111/j.1365-2796.2004.01399.x; Howlett GJ, 2006, CURR OPIN LIPIDOL, V17, P541, DOI 10.1097/01.mol.0000245260.63505.4f; Hyung SJ, 2010, ACS CHEM BIOL, V5, P1137, DOI 10.1021/cb100144v; Ihse E, 2013, AMYLOID, V20, P142, DOI 10.3109/13506129.2013.797890; IKEDA S, 1992, EUR NEUROL, V32, P308, DOI 10.1159/000116850; JANCIAUSKIENE S, 1995, BIOL CHEM H-S, V376, P415, DOI 10.1515/bchm3.1995.376.7.415; Karsan A, 2005, CLIN CHEM, V51, P1525, DOI 10.1373/clinchem.2005.050708; Kitchens WH, 2011, TRANSPLANT REV-ORLAN, V25, P167, DOI 10.1016/j.trre.2011.04.002; Kume H, 2014, MOL CELL PROTEOMICS, V13, P1471, DOI 10.1074/mcp.M113.037093; Lamy E, 2011, J ANIM PHYSIOL AN N, V95, P304, DOI 10.1111/j.1439-0396.2010.01055.x; Lamy E, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-65; Liao PC, 2007, PROTEOM CLIN APPL, V1, P506, DOI 10.1002/prca.200600684; Lim A, 2003, PROTEIN SCI, V12, P1775, DOI 10.1110/ps.0349703; Liz MA, 2004, J BIOL CHEM, V279, P21431, DOI 10.1074/jbc.M402212200; Macario AJL, 2007, ANN NY ACAD SCI, V1113, P178, DOI 10.1196/annals.1391.009; Magalhaes J, 2011, J NEUROPATH EXP NEUR, V70, P1097, DOI 10.1097/NEN.0b013e31823a44f4; Marin-Gomez LM, 2010, TRANSPL P, V42, P644, DOI 10.1016/j.transproceed.2010.02.012; MAY PC, 1990, NEURON, V5, P831, DOI 10.1016/0896-6273(90)90342-D; Monteiro E, 2004, J HEPATOL, V41, P188, DOI 10.1016/j.jhep.2004.06.004; Mullan GM, 2013, CURR ALZHEIMER RES, V10, P973; Munar-Ques M, 1999, J MED GENET, V36, P629; Narayan P, 2012, NAT STRUCT MOL BIOL, V19, P79, DOI 10.1038/nsmb.2191; Nepomuceno AI, 2004, CLIN CHEM, V50, P1535, DOI 10.1373/clinchem.2004.033274; Nilselid AM, 2006, NEUROCHEM INT, V48, P718, DOI 10.1016/j.neuint.2005.12.005; Purkey HE, 2001, P NATL ACAD SCI USA, V98, P5566, DOI 10.1073/pnas.091431798; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; Rabbani G, 2012, CELL BIOCHEM BIOPHYS, V62, P487, DOI 10.1007/s12013-011-9335-9; Rabbani G, 2011, CELL BIOCHEM BIOPHYS, V61, P551, DOI 10.1007/s12013-011-9237-x; Ribeiro-Silva C, 2011, AMYLOID, V18, P191, DOI 10.3109/13506129.2011.614295; ROSENBLUM BB, 1983, P NATL ACAD SCI-BIOL, V80, P5002, DOI 10.1073/pnas.80.16.5002; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; SARAIVA MJM, 1984, J CLIN INVEST, V74, P104, DOI 10.1172/JCI111390; Sixt SU, 2008, BBA-MOL BASIS DIS, V1782, P817, DOI 10.1016/j.bbadis.2008.06.005; Sorgjerd K, 2008, BIOCHEM BIOPH RES CO, V377, P1072, DOI 10.1016/j.bbrc.2008.10.121; Sousa MM, 2004, LAB INVEST, V84, P865, DOI 10.1038/labinvest.3700107; Stangou AJ, 2005, NEW ENGL J MED, V352, P2356, DOI 10.1056/NEJM200506023522219; Tang HD, 2009, BIOCHEMISTRY-US, V48, P3967, DOI 10.1021/bi900015n; Tang HD, 2009, BIOCHEM BIOPH RES CO, V378, P662, DOI 10.1016/j.bbrc.2008.11.112; Teixeira AC, 2013, J CELL MOL MED, V17, P429, DOI 10.1111/jcmm.12024; Torricelli C, 2004, J MOL ENDOCRINOL, V33, P335, DOI 10.1677/jme.1.01530; van Oijen M, 2005, STROKE, V36, P2637, DOI 10.1161/01.STR.0000189721.31432.26; Varshney A, 2010, AMINO ACIDS, V39, P899, DOI 10.1007/s00726-010-0524-4; Weiss Walter, 2009, Methods Mol Biol, V564, P13, DOI 10.1007/978-1-60761-157-8_2; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Wyatt A, 2009, ADV CANCER RES, V104, P89, DOI 10.1016/S0065-230X(09)04006-8; Yerbury JJ, 2005, BIOCHEMISTRY-US, V44, P10914, DOI 10.1021/bi050764x; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200; Zsila F, 2010, BIOCHEM BIOPH RES CO, V393, P242, DOI 10.1016/j.bbrc.2010.01.110	65	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0125392	10.1371/journal.pone.0125392	http://dx.doi.org/10.1371/journal.pone.0125392			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147092	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600007
J	George, SD; Baldigo, BP				George, Scott Daniel; Baldigo, Barry Paul			Didymosphenia geminata in the Upper Esopus Creek: Current Status, Variability, and Controlling Factors	PLOS ONE			English	Article							FRESH-WATER DIATOM; COMMUNITIES; CHALLENGES; INVASION; STALKS	In May of 2009, the bloom-forming diatom Didymosphenia geminata was first identified in the Upper Esopus Creek, a key tributary to the New York City water-supply and a popular recreational stream. The Upper Esopus receives supplemental flows from the Shandaken Portal, an underground aqueduct delivering waters from a nearby basin. The presence of D. geminata is a concern for the local economy, water supply, and aquatic ecosystem because nuisance blooms have been linked to degraded stream condition in other regions. Here we ascertain the extent and severity of the D. geminata invasion, determine the impact of supplemental flows from the Portal on D. geminata, and identify potential factors that may limit D. geminata in the watershed. Stream temperature, discharge, and water quality were characterized at select sites and periphyton samples were collected five times at 6 to 20 study sites between 2009 and 2010 to assess standing crop, diatom community structure, and density of D. geminata and all diatoms. Density of D. geminata ranged from 0-12 cells cm(-2)at tributary sites, 0-781 cells cm(-2) at sites upstream of the Portal, and 0-2,574 cells cm(-2) at sites downstream of the Portal. Survey period and Portal (upstream or downstream) each significantly affected D. geminata cell density. In general, D. geminata was most abundant during the November 2009 and June 2010 surveys and at sites immediately downstream of the Portal. We found that D. geminata did not reach nuisance levels or strongly affect the periphyton community. Similarly, companion studies showed that local macroinvertebrate and fish communities were generally unaffected. A number of abiotic factors including variable flows and moderate levels of phosphorous and suspended sediment may limit blooms of D. geminata in this watershed.	[George, Scott Daniel; Baldigo, Barry Paul] US Geol Survey, New York Water Sci Ctr, Troy, NY 12180 USA	United States Department of the Interior; United States Geological Survey	George, SD (corresponding author), US Geol Survey, New York Water Sci Ctr, Troy, NY 12180 USA.	sgeorge@usgs.gov	Baldigo, Barry P/C-4095-2013	Baldigo, Barry P/0000-0002-9862-9119	New York State Department of Environmental Conservation; U.S. Geological Survey [06E4NY24570025]	New York State Department of Environmental Conservation; U.S. Geological Survey(United States Geological Survey)	This research was funded by the New York State Department of Environmental Conservation (http://www.dec.ny.gov/) and U.S. Geological Survey (http://www.usgs.gov/) under agreement number 06E4NY24570025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboal M, 2012, HYDROBIOLOGIA, V695, P17, DOI 10.1007/s10750-012-1193-y; Anderson MJ, 2008, PERMANOVA PRIMER GUI; APHA, 2012, 3120 APHA, V22nd; Baldigo BP, NE NAT IN PRESS; Barbour M.T., 1999, EPA 841 B 99 002; Beville ST, 2012, ECOL ECON, V82, P1, DOI 10.1016/j.ecolecon.2012.08.004; Biggs B.J.F., 2000, NZ PERIPHYTON GUIDEL; Bothwell M, 2008, P 2007 INT WORKSH DI, V2795; Bothwell ML, 2011, FRESHWATER BIOL, V56, P565, DOI 10.1111/j.1365-2427.2010.02524.x; Bothwell ML, 2014, DIATOM RES, V29, P1; Carey MP, 2012, FRONT ECOL ENVIRON, V10, P373, DOI 10.1890/110060; CCE, 2007, UPP ES CREEK MAN PLA, VI; CCE, 2007, UPP ES CREEK MAN PLA, VIII; Clarke K.R., 2006, PRIMER V6 USER MANUA; Clarke K. R., 2001, CHANGES MARINE COMMU; Cullis JDS, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001891; Cullis JDS, 2011, THESIS U COLORADO; CUMMINS KENNETH W., 1962, AMER MIDLAND NAT, V67, P477, DOI 10.2307/2422722; Duffy BT, 2011, UPPER ESOPUS CREEK B; Ellwood NTW, 2007, HYDROBIOLOGIA, V592, P121, DOI 10.1007/s10750-007-0728-0; Floder S, 2009, BIODIVERS CONSERV, V18, P3809, DOI 10.1007/s10531-009-9681-8; Francoeur SN, 2006, HYDROBIOLOGIA, V561, P59, DOI 10.1007/s10750-005-1604-4; Gillis CA, 2010, HYDROBIOLOGIA, V647, P63, DOI 10.1007/s10750-009-9832-7; James D, 2010, P WILD TROUT 10 S CO; Kilroy C, 2009, FRESHWATER BIOL, V54, P1990, DOI 10.1111/j.1365-2427.2009.02247.x; Kilroy C, 2007, ASLO AQ SCI M SANT F; Kilroy C, 2011, AQUAT INVASIONS, V6, P249, DOI 10.3391/ai.2011.6.3.02; Kilroy C, 2012, FRESHWATER BIOL, V57, P641, DOI 10.1111/j.1365-2427.2011.02727.x; Kilroy C, 2011, J PHYCOL, V47, P981, DOI 10.1111/j.1529-8817.2011.01029.x; Kirkwood AE, 2007, CAN J FISH AQUAT SCI, V64, P1703, DOI 10.1139/F07-152; Kirkwood AE, 2009, FRESHWATER BIOL, V54, P1856, DOI 10.1111/j.1365-2427.2009.02231.x; Krammer K, 2007, SUSSWASSERFLORA MITT, V2/1; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kumar S, 2009, FRONT ECOL ENVIRON, V7, P415, DOI 10.1890/080054; Lagerstedt MA, 2007, THESIS U CANTERBURY; Larned S, 2006, CHC2006086 NIWA; Larson AM, 2008, P 2007 INT WORKSH DI, V2795; LindstrOm E.-A., 2008, P 2007 INT WORKSH DI, V2795, P35; Lohman KE, 1939, 189H US GEOL SURV; McHale MR, 2014, 20145200 US GEOL SUR; Miller MP, 2009, HYDROBIOLOGIA, V630, P207, DOI 10.1007/s10750-009-9793-x; NEWCOMBE C P, 1991, North American Journal of Fisheries Management, V11, P72, DOI 10.1577/1548-8675(1991)011<0072:EOSSOA>2.3.CO;2; Palmer PM, 2008, SCI TOTAL ENVIRON, V394, P90, DOI 10.1016/j.scitotenv.2008.01.011; Pickle J, 2008, ANALYZINGDIGITALIMAG; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Reid BL, 2012, CONSERV LETT, V5, P432, DOI 10.1111/j.1755-263X.2012.00264.x; Rejmanek M., 2011, ENCY BIOL INVASIONS, P203; Richardson DC, 2014, AQUAT SCI, V76, P553, DOI 10.1007/s00027-014-0354-7; Ross T, 2012, THESIS CORNELL U ITA; Schweiger W, 2011, PARK SCI, V28; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P125, DOI 10.1007/BF02289630; Smith AJ, 2008, UPPER ESOPUS CREEK B; Smith AJ, 2013, UPPER ESOPUS CREEK B; Smith AJ, 2007, ECOL INDIC, V7, P371, DOI 10.1016/j.ecolind.2006.03.001; Spaulding S, 2008, P 2007 INT WORKSH DI, V2795; Spaulding SA, 2007, 20071425 OFR US GEOL; Steinman Alan D., 2007, P357, DOI 10.1016/B978-012332908-0.50024-3; Sundareshwar PV, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046599; Sutherland S, 2007, SOUTHLAND FISH GAME; USGS, 2010, WAT YEAR 2010 WAT DA; USGS, 2009, WAT YEAR 2009 WAT DA; Whitton BA, 2009, HYDROBIOLOGIA, V630, P1, DOI 10.1007/s10750-009-9753-5; Woolman L, 1894, ANN REPORT STATE GEO	63	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130558	10.1371/journal.pone.0130558	http://dx.doi.org/10.1371/journal.pone.0130558			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148184	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600040
J	Giopanou, I; Lilis, I; Papaleonidopoulos, V; Marazioti, A; Spella, M; Vreka, M; Papadaki, H; Stathopoulos, GT				Giopanou, Ioanna; Lilis, Ioannis; Papaleonidopoulos, Vassilios; Marazioti, Antonia; Spella, Magda; Vreka, Malamati; Papadaki, Helen; Stathopoulos, Georgios T.			Comprehensive Evaluation of Nuclear Factor-kappa B Expression Patterns in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; PANCREATIC-CANCER; PROSTATE-CANCER; TARGET GENES; IKK-BETA; ACTIVATION; CARCINOMA; SURVIVAL; INFLAMMATION; ANGIOGENESIS	Nuclear factor (NF)-kappa B signalling is required for lung adenocarcinoma development in mice, and both of its subunits RelA and RelB were independently reported to be highly expressed in human non-small cell lung cancer (NSCLC). To comprehensively examine NF-kappa B expression in NSCLC, we analyzed serial sections of primary tumor samples from 77 well-documented patients (36 adenocarcinomas, 40 squamous cell carcinomas and 3 large cell carcinomas) for immunoreactivity of RelA, RelB, P50, and P52/P100. Tumor and intratumoral stroma areas were discriminated based on proliferating cell nuclear antigen immunoreactivity and inflammatory infiltration was assessed in intratumoral stroma areas. NF-kappa B immunoreactivity was quantified by intensity, extent, and nuclear localization and was cross-examined with tumor cell proliferation, inflammatory infiltration, and clinical-pathologic data. We found that the expression of the different NF-kappa B subunits was not concordant, warranting our integral approach. Overall, RelA, RelB, and P50 were expressed at higher levels compared with P52/P100. However, RelA and P50 were predominantly expressed in intratumoral stroma, but RelB in tumor cells. Importantly, tumor area RelA expression was correlated with the intensity of inflammatory infiltration, whereas RelB expression was identified in proliferating tumor cells. Using multiple logistic regression, we identified that tumor RelB expression was an independent predictor of lymph node metastasis, and tumor P50 was an independent predictor of TNM6 stage IIB or higher, whereas tumor RelA was an independent predictor of inflammatory infiltration. We conclude that pathologic studies of NF-kappa B expression in cancer should include multiple pathway components. Utilizing such an approach, we identified intriguing associations between distinct NF-kappa B subunits and clinical and pathologic features of NSCLC.	[Giopanou, Ioanna; Lilis, Ioannis; Papaleonidopoulos, Vassilios; Marazioti, Antonia; Spella, Magda; Vreka, Malamati; Stathopoulos, Georgios T.] Univ Patras, Fac Med, Dept Physiol, Lab Mol Resp Carcinogenesis, Rion, Achaia, Greece; [Papadaki, Helen] Univ Patras, Fac Med, Dept Anat, Rion, Achaia, Greece; [Stathopoulos, Georgios T.] Univ Munich, Univ Hosp, Comprehens Pneumol Ctr, Munich, Germany; [Stathopoulos, Georgios T.] Helmholtz Zentrum Munchen, Munich, Germany	University of Patras; University of Patras; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Stathopoulos, GT (corresponding author), Univ Patras, Fac Med, Dept Physiol, Lab Mol Resp Carcinogenesis, Rion, Achaia, Greece.	gstathop@upatras.gr	Stathopoulos, Georgios/AAE-6884-2020; Stathopoulos, Georgios/D-6576-2013	MARAZIOTI, ANTONIA/0000-0002-1978-1121; Giopanou, Ioanna/0000-0003-4393-7517; Stathopoulos, Georgios/0000-0002-9215-6461	European Research Council [260524]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by a European Research Council 2010 Starting Independent Investigator Grant (grant number #260524 to G.T.S.; http://erc.europa.eu/kras-mutation-interactions-host-immunity-malignant-pleural-effusion). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2007, CHEST, V132, p29S, DOI 10.1378/chest.07-1347; Basseres DS, 2010, CANCER RES, V70, P3537, DOI 10.1158/0008-5472.CAN-09-4290; Chen F, 1999, CLIN CHEM, V45, P7; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Darb-Esfahani S, 2010, HISTOPATHOLOGY, V56, P727, DOI 10.1111/j.1365-2559.2010.03544.x; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Deng JO, 2010, CANCER PREV RES, V3, P424, DOI 10.1158/1940-6207.CAPR-10-0032; Dimitrakopoulos FID, 2012, VIRCHOWS ARCH, V460, P515, DOI 10.1007/s00428-012-1230-2; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Fanucchi MP, 2006, J CLIN ONCOL, V24, P5025, DOI 10.1200/JCO.2006.06.1853; Fusco AJ, 2009, EMBO REP, V10, P152, DOI 10.1038/embor.2008.227; Gasparian AV, 2002, J CELL SCI, V115, P141; Gilmore T.D., 2006, ONCOGENE, V25; Guo QQ, 2009, PANCREAS, V38, pE75, DOI 10.1097/MPA.0b013e3181987d86; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Hu PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108062; Ismail H, 2004, PROSTATE, V58, P308, DOI 10.1002/pros.10335; Jacque E, 2013, ONCOGENE, V32, P2661, DOI 10.1038/onc.2012.282; Karabela SP, 2012, CARCINOGENESIS, V33, P859, DOI 10.1093/carcin/bgs024; Karst AM, 2009, INT J CANCER, V124, P494, DOI 10.1002/ijc.23973; Lessard L, 2005, BRIT J CANCER, V93, P1019, DOI 10.1038/sj.bjc.6602796; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021816; Li ZP, 2005, J IMMUNOL, V174, P205, DOI 10.4049/jimmunol.174.1.205; Maity PC, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.8; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Nair A, 2003, ONCOGENE, V22, P50, DOI 10.1038/sj.onc.1206043; Nemeth J, 2009, HEPATOLOGY, V50, P1251, DOI 10.1002/hep.23099; Nottingham LK, 2014, ONCOGENE, V33, P1135, DOI 10.1038/onc.2013.49; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Sakamoto K, 2009, CLIN CANCER RES, V15, P2248, DOI 10.1158/1078-0432.CCR-08-1383; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Shen A, 2009, NEUROSURGERY, V65; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Smith SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106966; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Starczynowski DT, 2011, J CLIN INVEST, V121, P4095, DOI 10.1172/JCI58818; Stathopoulos GT, 2007, P NATL ACAD SCI USA, V104, P18514, DOI 10.1073/pnas.0705316104; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Tang XM, 2006, CANCER, V107, P2637, DOI 10.1002/cncr.22315; Travis William D, 2011, Proc Am Thorac Soc, V8, P381, DOI 10.1513/pats.201107-042ST; Umemura N, 2012, CANCER RES, V72, P45, DOI 10.1158/0008-5472.CAN-11-1484; Van der Watt PJ, 2009, INT J CANCER, V124, P1829, DOI 10.1002/ijc.24146; Weichert W, 2007, BRIT J CANCER, V97, P523, DOI 10.1038/sj.bjc.6603878; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yu LL, 2004, WORLD J GASTROENTERO, V10, P3255, DOI 10.3748/wjg.v10.i22.3255; Zhou SN, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-288	51	23	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132527	10.1371/journal.pone.0132527	http://dx.doi.org/10.1371/journal.pone.0132527			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147201	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600296
J	Gould, B; McCouch, S; Geber, M				Gould, Billie; McCouch, Susan; Geber, Monica			De Novo Transcriptome Assembly and Identification of Gene Candidates for Rapid Evolution of Soil Al Tolerance in Anthoxanthum odoratum at the Long-Term Park Grass Experiment	PLOS ONE			English	Article							ADJACENT PLANT-POPULATIONS; ALUMINUM TOLERANCE; MOSAIC ENVIRONMENT; PHYSIOLOGICAL DIFFERENCES; DIFFERENTIAL GENE; METAL TOLERANCE; RESISTANCE; TRANSPORTER; EXPRESSION; ELONGATION	Studies of adaptation in the wild grass Anthoxanthum odoratum at the Park Grass Experiment (PGE) provided one of the earliest examples of rapid evolution in plants. Anthoxanthum has become locally adapted to differences in soil Al toxicity, which have developed there due to soil acidification from long-term experimental fertilizer treatments. In this study, we used transcriptome sequencing to identify Al stress responsive genes in Anthoxanhum and identify candidates among them for further molecular study of rapid Al tolerance evolution at the PGE. We examined the Al content of Anthoxanthum tissues and conducted RNA-sequencing of root tips, the primary site of Al induced damage. We found that despite its high tolerance Anthoxanthum is not an Al accumulating species. Genes similar to those involved in organic acid exudation (TaALMT1, ZmMATE), cell wall modification (OsSTAR1), and internal Al detoxification (OsNRAT1) in cultivated grasses were responsive to Al exposure. Expression of a large suite of novel loci was also triggered by early exposure to Al stress in roots. Three-hundred forty five transcripts were significantly more up- or down-regulated in tolerant vs. sensitive Anthoxanthum genotypes, providing important targets for future study of rapid evolution at the PGE.	[Gould, Billie] Michigan State Univ, Dept Plant Biol, Plant Biol Labs, E Lansing, MI 48824 USA; [McCouch, Susan] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Geber, Monica] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY 14853 USA	Michigan State University; Cornell University; Cornell University	Gould, B (corresponding author), Michigan State Univ, Dept Plant Biol, Plant Biol Labs, E Lansing, MI 48824 USA.	bag59@cornell.edu			Cornell Center for Comparative Genomics, Cornell chapter of Sigma Xi, NSF IGERT [0221658]; BBSRC [BBS/E/C/00005189] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005189] Funding Source: researchfish	Cornell Center for Comparative Genomics, Cornell chapter of Sigma Xi, NSF IGERT; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Cornell Center for Comparative Genomics, Cornell chapter of Sigma Xi, NSF IGERT #0221658. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2012, ANAL RNA SEQ DATA DE; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Antonovics J, 2006, HEREDITY, V97, P33, DOI 10.1038/sj.hdy.6800835; ANTONOVICS J, 1970, HEREDITY, V25, P349, DOI 10.1038/hdy.1970.36; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chandran D, 2008, PLANTA, V228, P151, DOI 10.1007/s00425-008-0726-0; Chen ZC, 2013, PLANT J, V76, P10, DOI 10.1111/tpj.12266; Chen ZC, 2012, PLANT PHYSIOL, V159, P1624, DOI 10.1104/pp.112.199778; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DAVIES MS, 1973, J APPL ECOL, V10, P33, DOI 10.2307/2404713; DAVIES MS, 1973, J APPL ECOL, V10, P47, DOI 10.2307/2404714; DAVIES MS, 1976, HEREDITY, V36, P59, DOI 10.1038/hdy.1976.6; Delhaize E, 2012, TRENDS PLANT SCI, V17, P341, DOI 10.1016/j.tplants.2012.02.008; Eticha D, 2010, ANN BOT-LONDON, V105, P1119, DOI 10.1093/aob/mcq049; Famoso AN, 2010, PLANT PHYSIOL, V153, P1678, DOI 10.1104/pp.110.156794; FOY CD, 1988, COMMUN SOIL SCI PLAN, V19, P959, DOI 10.1080/00103628809367988; Freeland JR, 2010, J EVOLUTION BIOL, V23, P776, DOI 10.1111/j.1420-9101.2010.01947.x; Freeland JR, 2012, J HERED, V103, P28, DOI 10.1093/jhered/esr111; Furukawa J, 2007, PLANT CELL PHYSIOL, V48, P1081, DOI 10.1093/pcp/pcm091; Gould B, 2013, DEV CULTIVATION ASSA; Gould BA, 2013, DEV CULTIVATION ASSA, P47; Gould B, 2014, MOL ECOL, V23, P6058, DOI 10.1111/mec.12893; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grisel N, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-185; Horst WJ, 2010, ANN BOT-LONDON, V106, P185, DOI 10.1093/aob/mcq053; Houde M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-400; Huang CF, 2009, PLANT CELL, V21, P655, DOI 10.1105/tpc.108.064543; Huang CF, 2012, PLANT J, V69, P857, DOI 10.1111/j.1365-313X.2011.04837.x; Iuchi S, 2007, P NATL ACAD SCI USA, V104, P9900, DOI 10.1073/pnas.0700117104; Jansen S, 2002, BOT REV, V68, P235, DOI 10.1663/0006-8101(2002)068[0235:AHIAAR]2.0.CO;2; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Kumari M, 2008, MOL GENET GENOMICS, V279, P339, DOI 10.1007/s00438-007-0316-z; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Liu JP, 2009, PLANT J, V57, P389, DOI 10.1111/j.1365-313X.2008.03696.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Ma JF, 2007, INT REV CYTOL, V264, P225, DOI 10.1016/S0074-7696(07)64005-4; MACNAIR MR, 1993, NEW PHYTOL, V124, P541, DOI 10.1111/j.1469-8137.1993.tb03846.x; MACNAIR MR, 1987, TRENDS ECOL EVOL, V2, P354, DOI 10.1016/0169-5347(87)90135-2; Magalhaes JV, 2007, NAT GENET, V39, P1156, DOI 10.1038/ng2074; Maron LG, 2008, NEW PHYTOL, V179, P116, DOI 10.1111/j.1469-8137.2008.02440.x; Maron LG, 2013, P NATL ACAD SCI USA, V110, P5241, DOI 10.1073/pnas.1220766110; Metali F, 2011, NEW PHYTOL, V193, P1; Negishi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043189; Raman H, 2008, THEOR APPL GENET, V116, P343, DOI 10.1007/s00122-007-0672-4; RAO IM, 1993, BIOSCIENCE, V43, P454, DOI 10.2307/1311905; Rengel Z., 2003, HDB SOIL ACIDITY; Ryan PR, 2010, FUNCT PLANT BIOL, V37, P275, DOI 10.1071/FP09261; Sasaki T, 2004, PLANT J, V37, P645, DOI 10.1111/j.1365-313X.2003.01991.x; Sasaki T, 2006, PLANT CELL PHYSIOL, V47, P1343, DOI 10.1093/pcp/pcl002; SCHAEDLE M, 1989, TREE PHYSIOL, V5, P337, DOI 10.1093/treephys/5.3.337; Schopfer P, 2001, PLANT J, V28, P679, DOI 10.1046/j.1365-313x.2001.01187.x; Shaff JE, 2010, PLANT SOIL, V330, P207, DOI 10.1007/s11104-009-0193-9; Silvertown J, 2005, HEREDITY, V95, P198, DOI 10.1038/sj.hdy.6800710; Silvertown J, 2006, J ECOL, V94, P801, DOI 10.1111/j.1365-2745.2006.01145.x; SNAYDON RW, 1976, HEREDITY, V37, P9, DOI 10.1038/hdy.1976.62; SNAYDON RW, 1970, EVOLUTION, V24, P257, DOI [10.2307/2406802, 10.1111/j.1558-5646.1970.tb01759.x]; SNAYDON RW, 1972, EVOLUTION, V26, P390, DOI [10.2307/2407014, 10.1111/j.1558-5646.1972.tb01944.x]; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; WHEELER DM, 1995, J PLANT NUTR, V18, P2305, DOI 10.1080/01904169509365066; WHEELER DM, 1992, PLANT SOIL, V146, P61, DOI 10.1007/BF00011996; Wright KM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001497; Xia JX, 2010, P NATL ACAD SCI USA, V107, P18381, DOI 10.1073/pnas.1004949107; Yamaji N, 2009, PLANT CELL, V21, P3339, DOI 10.1105/tpc.109.070771; Yang JL, 2008, PLANT PHYSIOL, V146, P602, DOI 10.1104/pp.107.111989; Yang JL, 2011, PLANT PHYSIOL, V155, P1885, DOI 10.1104/pp.111.172221; Zheng Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-453; Zhu XF, 2013, PLANT PHYSIOL, V162, P1947, DOI 10.1104/pp.113.219147	70	9	9	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0124424	10.1371/journal.pone.0124424	http://dx.doi.org/10.1371/journal.pone.0124424			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148203	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600004
J	Howard, JK; Klausmeyer, KR; Fesenmyer, KA; Furnish, J; Gardali, T; Grantham, T; Katz, JVE; Kupferberg, S; McIntyre, P; Moyle, PB; Ode, PR; Peek, R; Quinones, RM; Rehn, AC; Santos, N; Schoenig, S; Serpa, L; Shedd, JD; Slusark, J; Viers, JH; Wright, A; Morrison, SA				Howard, Jeanette K.; Klausmeyer, Kirk R.; Fesenmyer, Kurt A.; Furnish, Joseph; Gardali, Thomas; Grantham, Ted; Katz, Jacob V. E.; Kupferberg, Sarah; McIntyre, Patrick; Moyle, Peter B.; Ode, Peter R.; Peek, Ryan; Quinones, Rebecca M.; Rehn, Andrew C.; Santos, Nick; Schoenig, Steve; Serpa, Larry; Shedd, Jackson D.; Slusark, Joe; Viers, Joshua H.; Wright, Amber; Morrison, Scott A.			Patterns of Freshwater Species Richness, Endemism, and Vulnerability in California	PLOS ONE			English	Article							GLOBAL DECLINE; UNITED-STATES; CONSERVATION; BIODIVERSITY; EXTINCTIONS; CHALLENGES; THREATS	The ranges and abundances of species that depend on freshwater habitats are declining worldwide. Efforts to counteract those trends are often hampered by a lack of information about species distribution and conservation status and are often strongly biased toward a few well-studied groups. We identified the 3,906 vascular plants, macroinvertebrates, and vertebrates native to California, USA, that depend on fresh water for at least one stage of their life history. We evaluated the conservation status for these taxa using existing government and non-governmental organization assessments (e.g., endangered species act, NatureServe), created a spatial database of locality observations or distribution information from similar to 400 data sources, and mapped patterns of richness, endemism, and vulnerability. Although nearly half of all taxa with conservation status (n = 1,939) are vulnerable to extinction, only 114 (6%) of those vulnerable taxa have a legal mandate for protection in the form of formal inclusion on a state or federal endangered species list. Endemic taxa are at greater risk than non-endemics, with 90% of the 927 endemic taxa vulnerable to extinction. Records with spatial data were available for a total of 2,276 species (61%). The patterns of species richness differ depending on the taxonomic group analyzed, but are similar across taxonomic level. No particular taxonomic group represents an umbrella for all species, but hotspots of high richness for listed species cover 40% of the hotspots for all other species and 58% of the hotspots for vulnerable freshwater species. By mapping freshwater species hotspots we show locations that represent the top priority for conservation action in the state. This study identifies opportunities to fill gaps in the evaluation of conservation status for freshwater taxa in California, to address the lack of occurrence information for nearly 40% of freshwater taxa and nearly 40% of watersheds in the state, and to implement adequate protections for freshwater taxa where they are currently lacking.	[Howard, Jeanette K.; Klausmeyer, Kirk R.; Serpa, Larry; Shedd, Jackson D.; Morrison, Scott A.] Nature Conservancy, San Francisco, CA 94123 USA; [Fesenmyer, Kurt A.] Trout Unltd, Boise, ID USA; [Furnish, Joseph] US Forest Serv, USDA, Vallejo, CA USA; [Gardali, Thomas] Point Blue Conservat Sci, Petaluma, CA USA; [Grantham, Ted; Katz, Jacob V. E.; Moyle, Peter B.; Peek, Ryan; Quinones, Rebecca M.; Santos, Nick] Univ Calif Davis, Ctr Watershed Sci, Davis, CA 95616 USA; [Grantham, Ted; Katz, Jacob V. E.; Moyle, Peter B.; Peek, Ryan; Quinones, Rebecca M.; Santos, Nick] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Kupferberg, Sarah] Univ Calif Berkeley, Integrat Biol, Berkeley, CA 94720 USA; [McIntyre, Patrick; Rehn, Andrew C.; Schoenig, Steve; Slusark, Joe] Calif Dept Fish & Wildlife, Biogeog Data Branch, Sacramento, CA USA; [Ode, Peter R.] Calif Dept Fish & Wildlife, Aquat Bioassessment Lab, Rancho Cordova, CA USA; [Viers, Joshua H.] Univ Calif Merced, Sch Engn, Merced, CA USA; [Wright, Amber] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA	Nature Conservancy; United States Department of Agriculture (USDA); United States Forest Service; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Berkeley; University of California System; University of California Merced; University of Hawaii System; University of Hawaii Manoa	Howard, JK (corresponding author), Nature Conservancy, San Francisco, CA 94123 USA.	jeanette_howard@tnc.org	Kupferberg, Sarah J/L-5084-2013; Viers, Joshua/ABC-1851-2020; Peek, Ryan/H-4906-2015	Viers, Joshua/0000-0001-7957-7942; Peek, Ryan/0000-0002-9577-6885; Santos, Nicholas/0000-0001-5853-402X; Wright, Amber/0000-0002-9078-0324; Kupferberg, Sarah/0000-0002-7273-712X; McIntyre, Patrick/0000-0002-7800-6416	U. S. Bureau of Land Management	U. S. Bureau of Land Management	We thank The Nature Conservancy for supporting development of this database and this research, with additional support from the U. S. Bureau of Land Management. With the exception of the authors, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2002, CONSERV BIOL, V16, P1435, DOI 10.1046/j.1523-1739.2002.01532.x; Abell R, 2007, BIOL CONSERV, V134, P48, DOI 10.1016/j.biocon.2006.08.017; Amphibian and Reptile Species of Special Concern (ARSSC), 2009, CAL AMPH REPT SPEC S; Baldwin B.G., 2012, JEPSON MANUAL VASCUL, V2nd ed.; California Department of Fish and Wildlife, 2014, STAT FED LIST END TH; California Native Plant Society, 2010, CNPS INV RAR END PLA; Collen B, 2014, GLOBAL ECOL BIOGEOGR, V23, P40, DOI 10.1111/geb.12096; Comrack L., 2008, 200803 CAL DEP FISH; Darwall WRT, 2011, CONSERV LETT, V4, P474, DOI 10.1111/j.1755-263X.2011.00202.x; Department of Water Resources (DWR), 2013, DWR B, V160-09; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Faber Langendoen DJ, 2012, NATURESERVE CONSERVA; Gardali T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029507; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Grantham TE, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/8/084012; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hanak E., 2011, MANAGING CALIFORNIAS; Hermoso V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059662; Johnson PD, 2013, FISHERIES, V38, P247, DOI 10.1080/03632415.2013.785396; Lund J.R., 2010, COMP FUTURES SACRAME; Lydeard C, 2004, BIOSCIENCE, V54, P321, DOI 10.1641/0006-3568(2004)054[0321:TGDONM]2.0.CO;2; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Moyle P.B., 2002, INLAND FISHES CALIFO; Moyle PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063883; Moyle PB, 2011, BIOL CONSERV, V144, P2414, DOI 10.1016/j.biocon.2011.06.002; Regnier C, 2009, CONSERV BIOL, V23, P1214, DOI 10.1111/j.1523-1739.2009.01245.x; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; Sabo JL, 2010, P NATL ACAD SCI USA, V107, P21263, DOI 10.1073/pnas.1009734108; Santos NR, 2014, ENVIRON MODELL SOFTW, V53, P13, DOI 10.1016/j.envsoft.2013.10.024; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; The Nature Conservancy, 2014, CAL FRESHW SPEC DAT; Turak E, 2011, FRESHWATER BIOL, V56, P1, DOI 10.1111/j.1365-2427.2010.02515.x; U.S. Army Corps of Engineers, 2014, NAT WETL PLANT LIST; U.S. Department of the Interior Bureau of Land Management, 2013, SPEC STAT SPEC; U.S. Fish and Wildlife Service, 2008, BIRDS CONS CONC; U.S. Fish and Wildlife Service, 2013, SPEC OF CONC; UC Davis Center for Watershed Sciences, 2014, DATABASE; US Fish and Wildlife Service, 2014, END SPEC; USDA Forest Service, 2008, WAT FISH WILDL AIR R; USDA Natural Resources Conservation Service, 2009, WAT BOUND DAT; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Wilcove DS, 2005, FRONT ECOL ENVIRON, V3, P414, DOI 10.2307/3868657; WILLIAMS JD, 1993, FISHERIES, V18, P6, DOI 10.1577/1548-8446(1993)018<0006:CSOFMO>2.0.CO;2; World Wildlife Fund, 2014, LIVING PLANET REPORT; Xenopoulos MA, 2005, GLOBAL CHANGE BIOL, V11, P1557, DOI 10.1111/j.1365-2486.2005.001008.x	45	11	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130710	10.1371/journal.pone.0130710	http://dx.doi.org/10.1371/journal.pone.0130710			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147215	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600044
J	Iseki, Y; Shibutani, M; Maeda, K; Nagahara, H; Ohtani, H; Sugano, K; Ikeya, T; Muguruma, K; Tanaka, H; Toyokawa, T; Sakurai, K; Hirakawa, K				Iseki, Yasuhito; Shibutani, Masatsune; Maeda, Kiyoshi; Nagahara, Hisashi; Ohtani, Hiroshi; Sugano, Kenji; Ikeya, Tetsuro; Muguruma, Kazuya; Tanaka, Hiroaki; Toyokawa, Takahiro; Sakurai, Katsunobu; Hirakawa, Kosei			Impact of the Preoperative Controlling Nutritional Status (CONUT) Score on the Survival after Curative Surgery for Colorectal Cancer	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN-RECEPTOR; CLINICAL UNDERNUTRITION; CHOLESTEROL LEVELS; SERUM-CHOLESTEROL; TUMOR; RESECTION; ALBUMIN; LYMPHOCYTES; CARCINOMAS; EXPRESSION	Background Recently, the preoperative immune-nutritional status has been reported to correlate with the survival rate in patients with colorectal cancer (CRC). However, there have been no reports on the relationship between the controlling nutritional status (CONUT) score and the clinical outcome after curative surgery for CRC. We herein evaluated the prognostic significance of the CONUT score in patients with CRC, and then compared the accuracy of the CONUT score and the prognostic nutritional index (PNI) as a predictor of survival. Methods We retrospectively reviewed a database of 204 patients who underwent curative surgery for Stage II/ III CRC. Patients were divided into two groups according to the CONUT score and the PNI. Results The five-year cancer-specific survival (CSS) rate was significantly higher at 92.7% in the low CONUT group, compared to a rate of 81.0% in the high CONUT group (p=0.0016). The five-year CSS was 71.2% in the low PNI group and 92.3% in the high PNI group, which showed a significant difference (p=0.0155). A multivariate analysis showed that lymph node metastasis and the CONUT score were independent risk factors for CSS. Conclusion This study suggested that the CONUT score is a strong independent predictor of the survival among CRC patients.	[Iseki, Yasuhito; Shibutani, Masatsune; Maeda, Kiyoshi; Nagahara, Hisashi; Ohtani, Hiroshi; Sugano, Kenji; Ikeya, Tetsuro; Muguruma, Kazuya; Tanaka, Hiroaki; Toyokawa, Takahiro; Sakurai, Katsunobu; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 558, Japan	Osaka Metropolitan University	Shibutani, M (corresponding author), Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 558, Japan.	fbxbj429@ybb.ne.jp	Tanaka, Hiroaki/V-8501-2019					Ali AA, 2004, EJSO-EUR J SURG ONC, V30, P292, DOI 10.1016/j.ejso.2003.11.018; Boonpipattanapong T, 2006, J CLIN GASTROENTEROL, V40, P592, DOI 10.1097/00004836-200608000-00006; Cengiz O, 2006, MED SCI MONITOR, V12, pCR240; Cubiella J, 1999, AM J GASTROENTEROL, V94, P1271, DOI 10.1111/j.1572-0241.1999.01018.x; Perez JID, 2014, NUTR HOSP, V29, P797, DOI 10.3305/nh.2014.29.4.7275; Delmore G, 1997, SUPPORT CARE CANCER, V5, P376, DOI 10.1007/s005200050095; DEULIBARRI JI, 2005, NUTR HOSP, V20, P38; Dolcetti R, 1999, AM J PATHOL, V154, P1805, DOI 10.1016/S0002-9440(10)65436-3; Ferlay J., 2013, CANCER INCIDENCE AND, V11; Gonzalez-Madrono A, 2012, NUTR HOSP, V27, P564, DOI [10.3305/nh.2012.27.2.5630, 10.1590/S0212-16112012000200033]; Gupta D, 2005, EUR J CLIN NUTR, V59, P35, DOI 10.1038/sj.ejcn.1602029; Heys SD, 1998, J ROY COLL SURG EDIN, V43, P163; Ikeya T, 2014, J CANCER RES CLIN ON; Ko K, 2013, BJU INT, V112, P775, DOI 10.1111/bju.12275; Koike Y, 2008, J SURG ONCOL, V98, P540, DOI 10.1002/jso.21154; KRITCHEVSKY SB, 1992, ANNU REV NUTR, V12, P391, DOI 10.1146/annurev.nu.12.070192.002135; Maeda K, 2014, WORLD J SURG, V38, P1217, DOI 10.1007/s00268-013-2386-x; Mauricio SF, 2013, NUTRITION, V29, P625, DOI 10.1016/j.nut.2012.09.016; McArdle CS, 2002, BRIT J CANCER, V86, P331, DOI 10.1038/sj.bjc.6600120; McMillan DC, 2003, BRIT J SURG, V90, P215, DOI 10.1002/bjs.4038; Menges T, 1999, CRIT CARE MED, V27, P733, DOI 10.1097/00003246-199904000-00026; Mohri Y, 2013, WORLD J SURG, V37, P2688, DOI 10.1007/s00268-013-2156-9; NIENDORF A, 1995, INT J CANCER, V61, P461, DOI 10.1002/ijc.2910610405; Notarnicola M, 2005, ONCOLOGY-BASEL, V68, P371, DOI 10.1159/000086977; Nozoe T, 2012, SURG TODAY, V42, P532, DOI 10.1007/s00595-011-0061-0; OLIVER MF, 1981, LANCET, V2, P1090; Onodera T, 1984, Nihon Geka Gakkai Zasshi, V85, P1001; Ropponen KM, 1997, J PATHOL, V182, P318, DOI 10.1002/(SICI)1096-9896(199707)182:3<318::AID-PATH862>3.0.CO;2-6; Sobin LH, 2009, TNM CLASSIFICATION M, P73; VITOLS S, 1994, BLOOD, V84, P2689; VITOLS S, 1985, LANCET, V2, P1150; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Yeun J Y, 1998, Am J Kidney Dis, V32, pS118, DOI 10.1016/S0272-6386(98)70174-X	33	142	144	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132488	10.1371/journal.pone.0132488	http://dx.doi.org/10.1371/journal.pone.0132488			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147805	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600285
J	Kasai, S; Ito, A; Shindo, K; Toyoshi, T; Bando, M				Kasai, Shunji; Ito, Akemi; Shindo, Kaori; Toyoshi, Tohru; Bando, Masahiro			High-Dose alpha-Tocopherol Supplementation Does Not Induce Bone Loss in Normal Rats	PLOS ONE			English	Article							VITAMIN-E; OVARIECTOMIZED RATS; OXIDATIVE STRESS; MINERAL DENSITY; SERUM CONCENTRATIONS; PREDICT MORTALITY; HIP FRACTURE; ELDERLY-MEN; WOMEN; OSTEOPOROSIS	Oxidative stress affects bone turnover. Preventative effects of antioxidants such as vitamin E on reduced bone mineral density and fractures associated with aging, osteoporosis, and smoking have been examined in animals and humans. The effects of vitamin E (alpha-tocopherol; alpha T) on bone health have yielded conflicting and inconclusive results from animal studies. In this study, to determine the bone effects of alpha T, we investigated the in vivo effects of alpha T on the bone mineral density, bone mass, bone microstructure, bone resorption, and osteogenesis through peripheral quantitative computed tomography (pQCT) measurements, micro-computed tomography (micro-CT) analyses, and bone histomorphometry of lumbar vertebrae and femurs in normal female Wistar rats fed diets containing alpha T in different quantities (0, 30, 120, or 600 mg/kg diet) for 8 weeks. To validate our hypotheses regarding bone changes, we examined ovariectomized rats as an osteoporosis model and control sham-operated rats in parallel. As expected, ovariectomized rats had reduced bone mineral density in lumbar vertebrae and the distal metaphyses of their femurs, reduced bone mass and deteriorated microstructure of cancellous bones in the vertebral body and distal femur metaphyses, and reduced bone mass due to resorption-dominant enhanced bone turnover in secondary cancellous bones in these sites. In comparison, alpha T administered to normal rats, even at the highest dose, did not induce reduced bone mineral density of lumbar vertebrae and femurs or a reduced bone mass or fragile microstructure of cancellous bones of the vertebral body and distal femur metaphyses. Instead, alpha T-fed rats showed a tendency for an osteogenesis-dominant bone mass increase in secondary cancellous bones in the vertebral body, in which active bone remodeling occurs. Thus, alpha T consumption may have beneficial effects on bone health.	[Kasai, Shunji] Eisai & Co Ltd, Customer Joy Dept, Vitamin Informat & Technol Sect E, Tokyo, Japan; [Ito, Akemi] Ito Bone Histomorphometry Inst, Niigata, Japan; [Shindo, Kaori] Canon Lifecare Solut Inc, Tokyo, Japan; [Toyoshi, Tohru] Nihon Biores Inc, Study Dept, Gifu, Japan; [Bando, Masahiro] Eisai & Co Ltd, Eisai Prod Creat Syst, Tsukuba, Ibaraki, Japan	Eisai Co Ltd; Nihon Bioresearch Inc; Eisai Co Ltd	Kasai, S (corresponding author), Eisai & Co Ltd, Customer Joy Dept, Vitamin Informat & Technol Sect E, Tokyo, Japan.	s-kasai@hhc.eisai.co.jp			Eisai Co., Ltd.; Ito Bone Histomorphometry Institute; Canon Lifecare Solutions Inc.; Nihon Bioresearch Inc.	Eisai Co., Ltd.(Eisai Co Ltd); Ito Bone Histomorphometry Institute; Canon Lifecare Solutions Inc.; Nihon Bioresearch Inc.	This study was financially supported by Eisai Co., Ltd. Ito Bone Histomorphometry Institute, Canon Lifecare Solutions Inc., and Nihon Bioresearch Inc. did support in the form of salaries to authors (IS, KS, and TT) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Basu S, 2001, BIOCHEM BIOPH RES CO, V288, P275, DOI 10.1006/bbrc.2001.5747; BLACK D, 1989, CALCIFIED TISSUE INT, V44, P343, DOI 10.1007/BF02556315; Ensrud KE, 2000, J AM GERIATR SOC, V48, P241, DOI 10.1111/j.1532-5415.2000.tb02641.x; Erben RG, 1996, ANAT REC, V246, P39, DOI 10.1002/(SICI)1097-0185(199609)246:1<39::AID-AR5>3.0.CO;2-A; Fujita K, 2012, NAT MED, V18, P589, DOI 10.1038/nm.2659; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; Hermizi H, 2009, CALCIFIED TISSUE INT, V84, P65, DOI 10.1007/s00223-008-9190-x; Holvik K, 2014, OSTEOPOROSIS INT, V25, P2545, DOI 10.1007/s00198-014-2802-6; IOM, 2000, DIET REF INT VIT C V; Iwaniec UT, 2008, OSTEOPOROSIS, VOLS I AND II, 3RD EDITION, P985; Iwaniec UT, 2013, FREE RADICAL BIO MED, V65, P1209, DOI 10.1016/j.freeradbiomed.2013.09.004; KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Lelovas PP, 2008, COMPARATIVE MED, V58, P424; Maggio D, 2003, J CLIN ENDOCR METAB, V88, P1523, DOI 10.1210/jc.2002-021496; Mata-Granados JM, 2013, J BONE MINER METAB, V31, P455, DOI 10.1007/s00774-013-0432-2; Mehat MZ, 2010, J BONE MINER METAB, V28, P503, DOI 10.1007/s00774-010-0159-2; Melhus H, 1999, J BONE MINER RES, V14, P129, DOI 10.1359/jbmr.1999.14.1.129; Michaelsson K, 2014, AM J CLIN NUTR, V99, P107, DOI 10.3945/ajcn.113.064691; Mody N, 2001, FREE RADICAL BIO MED, V31, P509, DOI 10.1016/S0891-5849(01)00610-4; Muhammad N, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/161527; Nguyen ND, 2007, J BONE MINER RES, V22, P1147, DOI [10.1359/jbmr.070412, 10.1359/JBMR.070412]; Norazlina M, 2000, EXP CLIN ENDOCR DIAB, V108, P305, DOI 10.1055/s-2000-7758; Ostman B, 2009, FREE RADICAL BIO MED, V47, P668, DOI 10.1016/j.freeradbiomed.2009.05.031; Otomo H, 2004, J BONE MINER METAB, V22, P404, DOI 10.1007/s00774-004-0502-6; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; SEEDOR JG, 1991, J BONE MINER RES, V6, P339; Shiraishi A, 2002, CALCIFIED TISSUE INT, V71, P69, DOI 10.1007/s00223-001-2090-y; Shuid AN, 2010, J BONE MINER METAB, V28, P149, DOI 10.1007/s00774-009-0122-2; SUDA N, 1993, BIOCHIM BIOPHYS ACTA, V1157, P318, DOI 10.1016/0304-4165(93)90116-P; Suzuki T, 2010, OSTEOPOROSIS INT, V21, P71, DOI 10.1007/s00198-009-0970-6; TURNER RT, 1987, J BONE MINER RES, V2, P115; VILLANUEVA AR, 1989, STAIN TECHNOL, V64, P129, DOI 10.3109/10520298909106985; WRONSKI TJ, 1986, BONE, V7, P119, DOI 10.1016/8756-3282(86)90683-6; WRONSKI TJ, 1989, CALCIFIED TISSUE INT, V45, P360, DOI 10.1007/BF02556007; WRONSKI TJ, 1989, BONE, V10, P295, DOI 10.1016/8756-3282(89)90067-7; WRONSKI TJ, 1988, CALCIFIED TISSUE INT, V43, P179, DOI 10.1007/BF02571317; Wronski TJ, 1992, CELLS MAT S1, P69; Zhang JJ, 2006, AM J EPIDEMIOL, V163, P9, DOI 10.1093/aje/kwj005	39	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132059	10.1371/journal.pone.0132059	http://dx.doi.org/10.1371/journal.pone.0132059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147575	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600192
J	Kim, JS; Cho, H; Choi, JY; Lee, SH; Ryu, YH; Lyoo, CH; Lee, MS				Kim, Jin Su; Cho, Hanna; Choi, Jae Yong; Lee, Seung Ha; Ryu, Young Hoon; Lyoo, Chul Hyoung; Lee, Myung Sik			Feasibility of Computed Tomography-Guided Methods for Spatial Normalization of Dopamine Transporter Positron Emission Tomography Image	PLOS ONE			English	Article							PARKINSONS-DISEASE; QUANTITATIVE-ANALYSIS; HUMAN BRAIN; PET; TEMPLATE; SEGMENTATION; DYSFUNCTION	Background Spatial normalization is a prerequisite step for analyzing positron emission tomography (PET) images both by using volume-of-interest (VOI) template and voxel-based analysis. Magnetic resonance (MR) or ligand-specific PET templates are currently used for spatial normalization of PET images. We used computed tomography (CT) images acquired with PET/CT scanner for the spatial normalization for [F-18]-N-3-fluoropropyl-2-betacarboxymethoxy-3-beta-(4-iodophenyl) nortropane (FP-CIT) PET images and compared target-to-cerebellar standardized uptake value ratio (SUVR) values with those obtained from MR-or PET-guided spatial normalization method in healthy controls and patients with Parkinson's disease (PD). Methods We included 71 healthy controls and 56 patients with PD who underwent [F-18]-FP-CIT PET scans with a PET/CT scanner and T1-weighted MR scans. Spatial normalization of MR images was done with a conventional spatial normalization tool (cvMR) and with DARTEL toolbox (dtMR) in statistical parametric mapping software. The CT images were modified in two ways, skull-stripping (ssCT) and intensity transformation (itCT). We normalized PET images with cvMR-, dtMR-, ssCT-, itCT-, and PET-guided methods by using specific templates for each modality and measured striatal SUVR with a VOI template. The SUVR values measured with FreeSurfer-generated VOIs (FSVOI) overlaid on original PET images were also used as a gold standard for comparison. Results The SUVR values derived from all four structure-guided spatial normalization methods were highly correlated with those measured with FSVOI (P < 0.0001). Putaminal SUVR values were highly effective for discriminating PD patients from controls. However, the PET-guided method excessively overestimated striatal SUVR values in the PD patients by more than 30% in caudate and putamen, and thereby spoiled the linearity between the striatal SUVR values in all subjects and showed lower disease discrimination ability. Two CT-guided methods showed comparable capability with the MR-guided methods in separating PD patients from controls and showed better correlation between putaminal SUVR values and the parkinsonian motor severity than the PET-guided method. Conclusion CT-guided spatial normalization methods provided reliable striatal SUVR values comparable to those obtained with MR-guided methods. CT-guided methods can be useful for analyzing dopamine transporter PET images when MR images are unavailable.	[Kim, Jin Su] Korea Inst Radiol & Med Sci, Mol Imaging Res Ctr, Seoul, South Korea; [Cho, Hanna; Lee, Seung Ha; Lyoo, Chul Hyoung; Lee, Myung Sik] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Neurol, Seoul, South Korea; [Choi, Jae Yong; Ryu, Young Hoon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Nucl Med, Seoul, South Korea	Korea Institute of Radiological & Medical Sciences; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lyoo, CH (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Neurol, Seoul, South Korea.	lyoochel@yuhs.ac	KIM, JIN SU/U-2112-2019	KIM, JIN SU/0000-0001-8965-9538; Cho, Hanna/0000-0001-5936-1546; Lyoo, Chul Hyoung/0000-0003-2231-672X; Lee, Myung Sik/0000-0002-8413-1854; RYU, YOUNG HOON/0000-0002-9000-5563	Yonsei University College of Medicine [6-2014-0123]	Yonsei University College of Medicine(General Electric)	This study was supported by a faculty research grant of Yonsei University College of Medicine (grant number 6-2014-0123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Cabronero J, 2008, NEUROIMAGE, V39, P1654, DOI 10.1016/j.neuroimage.2007.10.051; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Brooks DJ, 2010, J NUCL MED, V51, P596, DOI 10.2967/jnumed.108.059998; Cho H, 2014, KOREAN J RADIOL, V15, P862, DOI 10.3348/kjr.2014.15.6.862; Edison P, 2013, NEUROIMAGE, V70, P423, DOI 10.1016/j.neuroimage.2012.12.014; Eggers C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096629; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fein G, 2006, NEUROIMAGE, V30, P1187, DOI 10.1016/j.neuroimage.2005.10.054; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischmeister FPS, 2013, NEUROIMAGE-CLIN, V3, P369, DOI 10.1016/j.nicl.2013.09.007; Gispert JD, 2003, NEUROIMAGE, V19, P601, DOI 10.1016/S1053-8119(03)00072-7; Hughes A, 1992, J NEUROL NEUROSUR PS, V66, P181, DOI DOI 10.1136/JNNP.55.3.181; Jeong E, 2013, NUCL MED MOLEC IMAG, V47, P73, DOI 10.1007/s13139-013-0196-6; Kuhn FP, 2014, EJNMMI RES, V4, DOI 10.1186/2191-219X-4-7; Lyoo CH, 2012, ACTA NEUROL SCAND, V126, P344, DOI 10.1111/j.1600-0404.2012.01657.x; Ma Y, 2002, SYNAPSE, V45, P125, DOI 10.1002/syn.10090; Mawlawi O, 2001, J CEREBR BLOOD F MET, V21, P1034, DOI 10.1097/00004647-200109000-00002; Meyer JH, 1999, NEUROIMAGE, V9, P545, DOI 10.1006/nimg.1999.0431; Oh M, 2012, J NUCL MED, V53, P399, DOI 10.2967/jnumed.111.095224; Pavese N, 2011, NEUROIMAGE, V56, P1463, DOI 10.1016/j.neuroimage.2011.03.012; Ravina B, 2005, NEUROLOGY, V64, P208, DOI 10.1212/01.WNL.0000149403.14458.7F; Rorden C, 2012, NEUROIMAGE, V61, P957, DOI 10.1016/j.neuroimage.2012.03.020; Rostomian AH, 2011, J NUCL MED, V52, P173, DOI 10.2967/jnumed.110.082057; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Yasuno F, 2002, NEUROIMAGE, V16, P577, DOI 10.1006/nimg.2002.1120	26	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132585	10.1371/journal.pone.0132585	http://dx.doi.org/10.1371/journal.pone.0132585			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147749	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600303
J	Lima, CX; Souza, DG; Amaral, FA; Fagundes, CT; Rodrigues, IPS; Alves, JC; Kosco-Vilbois, M; Ferlin, W; Shang, LM; Elson, G; Teixeira, MM				Lima, Cristiano Xavier; Souza, Danielle Gloria; Amaral, Flavio Almeida; Fagundes, Caio Tavares; Stopa Rodrigues, Irla Paula; Alves-Filho, Jose Carlos; Kosco-Vilbois, Marie; Ferlin, Walter; Shang, Limin; Elson, Greg; Teixeira, Mauro Martins			Therapeutic Effects of Treatment with Anti-TLR2 and Anti-TLR4 Monoclonal Antibodies in Polymicrobial Sepsis	PLOS ONE			English	Article							SEPTIC SHOCK; NEUTROPHIL MIGRATION; ATTENUATES SEPSIS; RECEPTOR; MORTALITY; HYDROCORTISONE; DYSFUNCTION; ANTAGONIST; PROTECTION; INFECTION	Introduction Toll-like receptors (TLRs) play an important role in the recognition of microbial products and in host defense against infection. However, the massive release of inflammatory mediators into the bloodstream following TLR activation following sepsis is thought to contribute to disease pathogenesis. Methods Here, we evaluated the effects of preventive or therapeutic administration of monoclonal antibodies (mAbs) targeting either TLR2 or TLR4 in a model of severe polymicrobial sepsis induced by cecal ligation and puncture in mice. Results Pre-treatment with anti-TLR2 or anti-TLR4 mAb alone showed significant protection from sepsis-associated death. Protective effects were observed even when the administration of either anti-TLR2 or anti-TLR4 alone was delayed (i.e., 3 h after sepsis induction). Delayed administration of either mAb in combination with antibiotics resulted in additive protection. Conclusion Although attempts to translate preclinical findings to clinical sepsis have failed so far, our preclinical experiments strongly suggest that there is a sufficient therapeutic window within which patients with ongoing sepsis could benefit from combined antibiotic plus anti-TLR2 or anti-TLR4 mAb treatment.	[Lima, Cristiano Xavier; Teixeira, Mauro Martins] Univ Fed Minas Gerais, Fac Med, BR-30130100 Belo Horizonte, MG, Brazil; [Souza, Danielle Gloria; Amaral, Flavio Almeida; Fagundes, Caio Tavares; Stopa Rodrigues, Irla Paula; Teixeira, Mauro Martins] Univ Fed Minas Gerais, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil; [Alves-Filho, Jose Carlos] Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil; [Kosco-Vilbois, Marie; Ferlin, Walter; Shang, Limin; Elson, Greg] NovImmune SA, CH-1228 Geneva, Switzerland	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; NovImmune SA	Lima, CX (corresponding author), Univ Fed Minas Gerais, Fac Med, Ave Prof Alfredo Balena 190,Sala 203, BR-30130100 Belo Horizonte, MG, Brazil.	cristianoxlima@gmail.com	LIMA, CRISTIANO/AAH-9402-2021; Amaral, Flávio Almeida/C-3768-2018; Alves-Filho, Jose Carlos/B-5814-2008; Lima, Cristiano/B-1874-2013; Teixeira, Mauro M/A-4587-2008; Fagundes, Caio/AAK-9336-2020	Amaral, Flávio Almeida/0000-0002-1695-0612; Alves-Filho, Jose Carlos/0000-0002-9918-8714; Teixeira, Mauro M/0000-0002-6944-3008; Fagundes, Caio/0000-0002-6747-5233; XAVIER LIMA, CRISTIANO/0000-0001-7724-890X	National Research Council of Brazil (CNPq, Brazil); Fundacao do Amparo a Pesquisas de Minas Gerais (FAPEMIG); European Community Seventh Framework Programme [FP72007-2013, HEALTH-F4-2011-281608]; NovImmune	National Research Council of Brazil (CNPq, Brazil); Fundacao do Amparo a Pesquisas de Minas Gerais (FAPEMIG); European Community Seventh Framework Programme(European Commission); NovImmune	This work received financial support from the National Research Council of Brazil (CNPq, Brazil), Fundacao do Amparo a Pesquisas de Minas Gerais (FAPEMIG), and from the European Community Seventh Framework Programme [FP72007-2013] under grant agreement number HEALTH-F4-2011-281608. NovImmune provided support in the form of salaries for some authors (MKV, WF, LS, GE), but had no role in study design, data collection and	Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; Abraham E, 2007, CRIT CARE MED, V35, P2408, DOI 10.1097/01.CCM.0000282072.56245.91; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alves JC, 2006, CRIT CARE MED, V34, P461, DOI 10.1097/01.CCM.0000198527.71819.E1; Alves JC, 2010, SHOCK, V34, P15, DOI 10.1097/SHK.0b013e3181e7e61b; Alves JC, 2010, NAT MED, V16, P708, DOI 10.1038/nm.2156; Alves JC, 2009, P NATL ACAD SCI USA, V106, P4018, DOI 10.1073/pnas.0900196106; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Casserly B, 2012, CRIT CARE MED, V40, P1417, DOI 10.1097/CCM.0b013e31823e9f45; Cohen J, 2012, LANCET INFECT DIS, V12, P503, DOI 10.1016/S1473-3099(12)70136-6; Daubeuf B, 2007, J IMMUNOL, V179, P6107, DOI 10.4049/jimmunol.179.9.6107; Dejager L, 2011, TRENDS MICROBIOL, V19, P198, DOI 10.1016/j.tim.2011.01.001; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Finfer S, 2008, INTENS CARE MED, V34, P1935, DOI 10.1007/s00134-008-1266-6; Freitas A, 2009, J IMMUNOL, V182, P7846, DOI 10.4049/jimmunol.0803039; Garcia CC, 2010, DISCOV MED, V10, P479; Hotchkiss RS, 2015, SCIENCE, V347, P1201, DOI 10.1126/science.aaa8334; Ishii Ken J, 2004, Curr Infect Dis Rep, V6, P361, DOI 10.1007/s11908-004-0034-1; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kimmoun A, 2011, SHOCK, V36, P633, DOI 10.1097/SHK.0b013e318237a37b; Maier S, 2004, SHOCK, V21, P505, DOI 10.1097/01.shk.0000126906.52367.dd; Martin EL, 2010, AM J RESP CRIT CARE, V182, P762, DOI 10.1164/rccm.201001-0088OC; Meng GX, 2004, J CLIN INVEST, V113, P1473, DOI 10.1172/JCI200420762; Opal SM, 2013, JAMA-J AM MED ASSOC, V309, P1154, DOI 10.1001/jama.2013.2194; Peck-Palmer OM, 2008, J LEUKOCYTE BIOL, V83, P1009, DOI 10.1189/jlb.0807528; Plitas G, 2008, J EXP MED, V205, P1277, DOI 10.1084/jem.20080162; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Roger T, 2009, P NATL ACAD SCI USA, V106, P2348, DOI 10.1073/pnas.0808146106; Spiller S, 2008, J EXP MED, V205, P1747, DOI 10.1084/jem.20071990; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Williams DL, 2003, CRIT CARE MED, V31, P1808, DOI 10.1097/01.CCM.0000069343.27691.F3	32	34	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132336	10.1371/journal.pone.0132336	http://dx.doi.org/10.1371/journal.pone.0132336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147469	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600245
J	Moritsugu, K; Koike, R; Yamada, K; Kato, H; Kidera, A				Moritsugu, Kei; Koike, Ryotaro; Yamada, Kouki; Kato, Hiroaki; Kidera, Akinori			Motion Tree Delineates Hierarchical Structure of Protein Dynamics Observed in Molecular Dynamics Simulation	PLOS ONE			English	Article							NORMAL-MODE ANALYSIS; ADENYLATE KINASE; FORCE-FIELD; DOMAIN MOTIONS; CONFORMATIONAL-CHANGE; LYSOZYME; MECHANISM; GENOMES; BINDING	Molecular dynamics (MD) simulations of proteins provide important information to understand their functional mechanisms, which are, however, likely to be hidden behind their complicated motions with a wide range of spatial and temporal scales. A straightforward and intuitive analysis of protein dynamics observed in MD simulation trajectories is therefore of growing significance with the large increase in both the simulation time and system size. In this study, we propose a novel description of protein motions based on the hierarchical clustering of fluctuations in the inter-atomic distances calculated from an MD trajectory, which constructs a single tree diagram, named a "Motion Tree", to determine a set of rigid-domain pairs hierarchically along with associated inter-domain fluctuations. The method was first applied to the MD trajectory of substrate-free adenylate kinase to clarify the usefulness of the Motion Tree, which illustrated a clear-cut dynamics picture of the inter-domain motions involving the ATP/AMP lid and the core domain together with the associated amplitudes and correlations. The comparison of two Motion Trees calculated from MD simulations of ligand-free and -bound glutamine binding proteins clarified changes in inherent dynamics upon ligand binding appeared in both large domains and a small loop that stabilized ligand molecule. Another application to a huge protein, a multidrug ATP binding cassette (ABC) transporter, captured significant increases of fluctuations upon binding a drug molecule observed in both large scale inter-subunit motions and a motion localized at a transmembrane helix, which may be a trigger to the subsequent structural change from inward-open to outward-open states to transport the drug molecule. These applications demonstrated the capabilities of Motion Trees to provide an at-a-glance view of various sizes of functional motions inherent in the complicated MD trajectory.	[Moritsugu, Kei; Yamada, Kouki; Kidera, Akinori] Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, Yokohama, Kanagawa 232, Japan; [Koike, Ryotaro] Nagoya Univ, Grad Sch Informat Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Kato, Hiroaki] Kyoto Univ, Dept Biol Struct, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto, Japan; [Kato, Hiroaki] SPring 8, RIKEN Harima Inst, Sayo, Hyogo, Japan	Yokohama City University; Nagoya University; Kyoto University; Japan Synchrotron Radiation Research Institute; RIKEN	Moritsugu, K (corresponding author), Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 232, Japan.	moritugu@tsurumi.yokohama-cu.ac.jp	Moritsugu, Kei/AAU-1502-2021	Kato, Hiroaki/0000-0002-5993-4532	MEXT [15K18520, 23247027]; MEXT creation of innovation centers; platform for drug discovery, informatics, and structural life science	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT creation of innovation centers; platform for drug discovery, informatics, and structural life science	K. M. was supported by MEXT Grant-in-Aid for Young Scientists (B), 15K18520, and A. K. by MEXT Grant-in-Aid for Scientific Research (A), 23247027. This work was also partly supported by a fund from MEXT creation of innovation centers for advanced interdisciplinary research areas program in the project for developing innovation systems, and a fund from platform for drug discovery, informatics, and structural life science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora K, 2007, P NATL ACAD SCI USA, V104, P18496, DOI 10.1073/pnas.0706443104; Beckstein O, 2009, J MOL BIOL, V394, P160, DOI 10.1016/j.jmb.2009.09.009; Bernhard S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010491; Berry MB, 2006, PROTEINS, V62, P555, DOI 10.1002/prot.20699; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hayward S, 1997, PROTEINS, V27, P425, DOI 10.1002/(SICI)1097-0134(199703)27:3<425::AID-PROT10>3.0.CO;2-N; Hery S, 1998, J MOL BIOL, V279, P303, DOI 10.1006/jmbi.1998.1754; Hinsen K, 1999, PROTEINS, V34, P369, DOI 10.1002/(SICI)1097-0134(19990215)34:3<369::AID-PROT9>3.0.CO;2-F; Ikeguchi M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.078102; Ikeguchi M, 2004, J COMPUT CHEM, V25, P529, DOI 10.1002/jcc.10402; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JUFFER AH, 1991, J COMPUT PHYS, V97, P144, DOI 10.1016/0021-9991(91)90043-K; Kenn M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/731325; Kodan A, 2014, P NATL ACAD SCI USA, V111, P4049, DOI 10.1073/pnas.1321562111; Koike R, 2014, J MOL BIOL, V426, P752, DOI 10.1016/j.jmb.2013.10.034; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kubitzki MB, 2008, STRUCTURE, V16, P1175, DOI 10.1016/j.str.2008.04.013; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Ma JP, 2005, STRUCTURE, V13, P373, DOI 10.1016/j.str.2005.02.002; MacKerell AD, 2000, J COMPUT CHEM, V21, P105, DOI 10.1002/(SICI)1096-987X(20000130)21:2<105::AID-JCC3>3.0.CO;2-P; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maragakis P, 2005, J MOL BIOL, V352, P807, DOI 10.1016/j.jmb.2005.07.031; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Menor SA, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036017; Muller CW, 1996, STRUCTURE, V4, P147, DOI 10.1016/S0969-2126(96)00018-4; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sun YJ, 1998, J MOL BIOL, V278, P219, DOI 10.1006/jmbi.1998.1675; Vaiana AC, 2003, J COMPUT CHEM, V24, P632, DOI 10.1002/jcc.10190; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wriggers W, 1997, PROTEINS, V29, P1; Yesylevskyy SO, 2006, BIOPHYS CHEM, V119, P84, DOI 10.1016/j.bpc.2005.07.004	35	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131583	10.1371/journal.pone.0131583	http://dx.doi.org/10.1371/journal.pone.0131583			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148295	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600112
J	Mucker, EM; Chapman, J; Huzella, LM; Huggins, JW; Shamblin, J; Robinson, CG; Hensley, LE				Mucker, Eric M.; Chapman, Jennifer; Huzella, Louis M.; Huggins, John W.; Shamblin, Joshua; Robinson, Camenzind G.; Hensley, Lisa E.			Susceptibility of Marmosets (Callithrix jacchus) to Monkeypox Virus: A Low Dose Prospective Model for Monkeypox and Smallpox Disease	PLOS ONE			English	Article							NONHUMAN PRIMATE MODEL; VACCINIA VIRUS; POXVIRUS INFECTION; IN-VITRO; PROTECTION; COMPLEMENT; PATHOLOGY; VARIOLA; ST-246; VACCINATION	Although current nonhuman primate models of monkeypox and smallpox diseases provide some insight into disease pathogenesis, they require a high titer inoculum, use an unnatural route of infection, and/or do not accurately represent the entire disease course. This is a concern when developing smallpox and/or monkeypox countermeasures or trying to understand host pathogen relationships. In our studies, we altered half of the test system by using a New World nonhuman primate host, the common marmoset. Based on dose finding studies, we found that marmosets are susceptible to monkeypox virus infection, produce a high viremia, and have pathological features consistent with smallpox and monkeypox in humans. The low dose (48 plaque forming units) required to elicit a uniformly lethal disease and the extended incubation (preclinical signs) are unique features among nonhuman primate models utilizing monkeypox virus. The uniform lethality, hemorrhagic rash, high viremia, decrease in platelets, pathology, and abbreviated acute phase are reflective of early-type hemorrhagic smallpox.	[Mucker, Eric M.; Huggins, John W.; Shamblin, Joshua] US Army Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21701 USA; [Chapman, Jennifer] Joint Pathol Ctr, Silver Spring, MD USA; [Huzella, Louis M.; Hensley, Lisa E.] NIAID, Integrated Res Facil, Ft Detrick, MD USA; [Robinson, Camenzind G.] US Army Med Res Inst Infect Dis, Div Pathol, Ft Detrick, MD USA; [Mucker, Eric M.] Tulane Univ, Sch Med, New Orleans, LA 70112 USA	United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; Tulane University	Mucker, EM (corresponding author), US Army Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21701 USA.	eric.m.mucker.ctr@mail.mil	Robinson, Camenzind G/O-5097-2018	Robinson, Camenzind G/0000-0002-7277-692X; Mucker, Eric/0000-0002-4656-5379; Hensley, Lisa/0000-0003-1188-4342	United States Army Medical Research Institute of Infectious Diseases	United States Army Medical Research Institute of Infectious Diseases	This work was internally funded by the United States Army Medical Research Institute of Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AP, 2008, J VIROL, V82, P9035, DOI 10.1128/JVI.00674-08; Benhnia MREI, 2009, J VIROL, V83, P1201, DOI 10.1128/JVI.01797-08; Bright H, 2004, J VIROL, V78, P2062, DOI 10.1128/JVI.78.4.2062-2071.2004; Carrion R, 2007, J VIROL, V81, P6482, DOI 10.1128/JVI.02876-06; Carrion R, 2011, VIROLOGY, V420, P117, DOI 10.1016/j.virol.2011.08.022; Chen ZC, 2006, P NATL ACAD SCI USA, V103, P1882, DOI 10.1073/pnas.0510598103; Chen ZC, 2007, J VIROL, V81, P8989, DOI 10.1128/JVI.00906-07; Councilman WT, 1904, J MED RES, V11, P12; Earl PL, 2008, P NATL ACAD SCI USA, V105, P10889, DOI 10.1073/pnas.0804985105; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; FDA, 2013, APPR NEW DRUGS HUM E; FDA, 2009, GUID IND AN IN PRESS; FDA, 2013, APPR BIOL PROD HUM E; Fenner F, 1988, SMALLPOX ITS ERADICA, Vxvi; GISPEN R, 1967, ARCH GES VIRUSFORSCH, V21, P205, DOI 10.1007/BF01241445; Goff AJ, 2011, J VIROL, V85, P4898, DOI 10.1128/JVI.02525-10; GOUGH AW, 1982, LAB ANIM SCI, V32, P87; Hooper JW, 2004, J VIROL, V78, P4433, DOI 10.1128/JVI.78.9.4433-4443.2004; Huggins J, 2009, ANTIMICROB AGENTS CH, V53, P2620, DOI 10.1128/AAC.00021-09; JEZEK Z, 1987, J INFECT DIS, V156, P293, DOI 10.1093/infdis/156.2.293; Johnson RF, 2011, J VIROL, V85, P2112, DOI 10.1128/JVI.01931-10; JOHNSONDELANEY CA, 1994, VET CLIN N AM-SMALL, V24, P121, DOI 10.1016/S0195-5616(94)50007-X; Jordan R, 2009, ANTIMICROB AGENTS CH, V53, P1817, DOI 10.1128/AAC.01596-08; Kramski M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010412; Kulesh DA, 2004, J CLIN MICROBIOL, V42, P601, DOI 10.1128/JCM.42.2.601-609.2004; Lustig S, 2004, VIROLOGY, V328, P30, DOI 10.1016/j.virol.2004.07.024; Matz-Rensing K, 2012, J COMP PATHOL, V146, P230, DOI 10.1016/j.jcpa.2011.06.003; Mansfield K, 2003, COMPARATIVE MED, V53, P383; Matz-Rensing K, 2006, VET PATHOL, V43, P212, DOI 10.1354/vp.43-2-212; Moncla LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078750; Mucker EM, 2013, ANTIMICROB AGENTS CH, V57, P6246, DOI 10.1128/AAC.00977-13; Nalca A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012880; Omatsu T, 2011, J GEN VIROL, V92, P2272, DOI 10.1099/vir.0.031229-0; Parker S, 2013, FUTURE VIROL, V8, P129, DOI 10.2217/FVL.12.130; Peters J. C., 1966, International zoo yearbook, V6, P274, DOI 10.1111/j.1748-1090.1966.tb01794.x; Prophet E. B., 1992, LAB METHODS HISTOTEC; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Reynolds MG, 2012, TRENDS MICROBIOL, V20, P80, DOI 10.1016/j.tim.2011.12.001; Rimoin AW, 2010, P NATL ACAD SCI USA, V107, P16262, DOI 10.1073/pnas.1005769107; Sejvar JJ, 2004, J INFECT DIS, V190, P1833, DOI 10.1086/425039; Shchelkunov SN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003756; Smith DR, 2012, J VIROL, V86, P2109, DOI 10.1128/JVI.06190-11; Stittelaar KJ, 2005, J VIROL, V79, P7845, DOI 10.1128/JVI.79.12.7845-7851.2005; Vanderplasschen A, 1998, P NATL ACAD SCI USA, V95, P7544, DOI 10.1073/pnas.95.13.7544; Wahl-Jensen V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024832; Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373	46	24	24	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131742	10.1371/journal.pone.0131742	http://dx.doi.org/10.1371/journal.pone.0131742			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147658	Green Submitted, gold, Green Published			2022-12-27	WOS:000358157600139
J	Sahu, DK; Panda, SP; Meher, PK; Das, P; Routray, P; Sundaray, JK; Jayasankar, P; Nandi, S				Sahu, Dinesh Kumar; Panda, Soumya Prasad; Meher, Prem Kumar; Das, Paramananda; Routray, Padmanav; Sundaray, Jitendra Kumar; Jayasankar, Pallipuram; Nandi, Samiran			Construction, De-Novo Assembly and Analysis of Transcriptome for Identification of Reproduction-Related Genes and Pathways from Rohu, Labeo rohita (Hamilton)	PLOS ONE			English	Article							INDIAN MAJOR CARP; RAINBOW-TROUT; DEVELOPMENTAL EXPRESSION; VITELLOGENIN RECEPTOR; TISSUE-DISTRIBUTION; CIRRHINUS-MRIGALA; CHANNEL CATFISH; SPLICE VARIANTS; OOCYTE; HORMONE	Rohu is a leading candidate species for freshwater aquaculture in South-East Asia. Unlike common carp the monsoon breeding habit of rohu restricts its seed production beyond season indicating strong genetic control over spawning. Genetic information is limited in this regard. The problem is exacerbated by the lack of genomic-resources. We identified 182 reproduction-related genes previously by Sanger-sequencing which were less to address the issue of seasonal spawning behaviour of this important carp. Therefore, the present work was taken up to generate transcriptome profile by mRNAseq. 16GB, 72bp paired end (PE) data was generated from the pooled-RNA of twelve-tissues from pre-spawning rohu using IlluminaGA-II-platform. There were 64.97 million high-quality reads producing 62,283 contigs and 88,612 numbers of transcripts using velvet and oases programs, respectively. Gene ontology annotation identified 940 reproduction-related genes consisting of 184 mainly associated with reproduction, 223 related to hormone-activity and receptor-binding, 178 receptor-activity and 355 embryonic-development related-proteins. The important reproduction-relevant pathways found in KEGG analysis were GnRH-signaling, oocyte-meiosis, steroid-biosynthesis, steroid-hormone biosynthesis, progesterone-mediated oocyte-maturation, retinol-metabolism, neuroactive-ligand-receptor interaction, neurotrophin-signaling and photo-transduction. Twenty nine simple sequence repeat containing sequences were also found out of which 12 repeat loci were polymorphic with mean expected-&-observed heterozygosity of 0.471 and 0.983 respectively. Quantitative RT-PCR analyses of 13-known and 6-unknown transcripts revealed differences in expression level between preparatory and post-spawning phase. These transcriptomic sequences have significantly increased the genetic-&- genomic resources for reproduction-research in Labeo rohita.	[Sahu, Dinesh Kumar; Panda, Soumya Prasad; Meher, Prem Kumar; Das, Paramananda; Sundaray, Jitendra Kumar; Jayasankar, Pallipuram; Nandi, Samiran] ICAR Cent Inst Freshwater Aquaculture, Fish Genet & Biotechnol Div, Bhubaneswar, Orissa, India; [Routray, Padmanav] ICAR Cent Inst Freshwater Aquaculture, Aquaculture Prod & Environm Div, Bhubaneswar, Orissa, India	Indian Council of Agricultural Research (ICAR); ICAR - Central Institute of Freshwater Aquaculture; Indian Council of Agricultural Research (ICAR); ICAR - Central Institute of Freshwater Aquaculture	Nandi, S (corresponding author), ICAR Cent Inst Freshwater Aquaculture, Fish Genet & Biotechnol Div, Bhubaneswar, Orissa, India.	eurekhain@yahoo.co.in	Sundaray, Jitendra/AAO-6523-2020; Pallipuram, Jayasankar/L-9422-2019; Sahu, Dr Dinesh Kumar/GQQ-4158-2022; Meher, Prem/W-3700-2019; sundaray, Jitendra Kumar/A-4800-2009	Sahu, Dr Dinesh Kumar/0000-0002-5040-2046; Meher, Prem/0000-0001-7969-2916; Panda, Soumya Prasad/0000-0002-0513-1101; SUNDARAY, JITENDRA/0000-0001-9311-0636	Department of Biotechnology, Government of India [BT/PR9916/AAQ/03/360/2007]; ICAR-CIFA [I-59n]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); ICAR-CIFA	This work was supported by Department of Biotechnology, Government of India (Project reference No.-BT/PR9916/AAQ/03/360/2007) and ICAR-CIFA (I-59n).	Aegerter S, 2005, MOL REPROD DEV, V72, P377, DOI 10.1002/mrd.20361; Alderman SL, 2012, J ENDOCRINOL, V215, P393, DOI 10.1530/JOE-12-0379; Alsop D, 2008, GEN COMP ENDOCR, V156, P51, DOI 10.1016/j.ygcen.2007.11.008; [Anonymous], 2012, WORLD REV FISH AQ ST; Bhattacharya S, 1999, CURR SCI INDIA, V76, P342; Callander DC, 2007, DEV DYNAM, V236, P2918, DOI 10.1002/dvdy.21315; Cameron RA, 1999, DEV BIOL, V208, P255, DOI 10.1006/dbio.1999.9224; Cerda J, 2008, REV FISH SCI, V16, P56, DOI 10.1080/10641260802324685; CHAKRABORTI P, 1984, GEN COMP ENDOCR, V53, P179, DOI 10.1016/0016-6480(84)90240-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chu SL, 2006, AQUACULTURE, V251, P537, DOI 10.1016/j.aquaculture.2005.05.040; Dal-Pra S, 2006, DEV BIOL, V298, P514, DOI 10.1016/j.ydbio.2006.07.002; Das P, 2005, MOL ECOL NOTES, V5, P231, DOI 10.1111/j.1471-8286.2005.00905.x; Das S, 2014, MOL BIOL REP, V41, P7361, DOI 10.1007/s11033-014-3625-4; Dominguez GA, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099812; FIGUEROA J, 1994, COMP BIOCHEM PHYS B, V108, P551, DOI 10.1016/0305-0491(94)90109-0; Fish RJ, 2012, THROMB HAEMOSTASIS, V107, P158, DOI 10.1160/TH11-04-0221; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Goetz FW, 2006, ICES J MAR SCI, V63, P393, DOI 10.1016/j.icesjms.2005.10.006; Gohin M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-18; Greene MW, 1999, GEN COMP ENDOCR, V115, P254, DOI 10.1006/gcen.1999.7293; Gupta Satya Dev, 1995, Veterinarski Arhiv, V65, P143; Gupta SD, 1990, CARP SEED PROD TECHN; Haccard O, 2012, MOL CELL ENDOCRINOL, V362, P110, DOI 10.1016/j.mce.2012.05.019; Ikuta K, 2010, J MOL BIOL, V397, P375, DOI 10.1016/j.jmb.2010.01.026; Ji P, 2012, PLOS ONE, V7, P351; Johns SM, 2009, ENVIRON TOXICOL CHEM, V28, P873, DOI 10.1897/08-213R.1; Kasai A, 2006, ZOOL SCI, V23, P815, DOI 10.2108/zsj.23.815; Kazeto Y, 2005, J MOL ENDOCRINOL, V34, P781, DOI 10.1677/jme.1.01721; Khan HA, 1995, FAO FISHERIES SYNOPS; Lecce L, 2011, MOL REPROD DEV, V78, P318, DOI 10.1002/mrd.21307; Leong JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-279; Levi L, 2012, AM J PHYSIOL-ENDOC M, V302, pE626, DOI 10.1152/ajpendo.00310.2011; Li AQ, 2010, ELECTRON J BIOTECHN, V13, DOI 10.2225/vol13-issue5-fulltext-5; Li C, 2012, FISH SHELLFISH IMMUN, V32, P816, DOI 10.1016/j.fsi.2012.02.004; Liu J, 2013, UROL INT, V90, P449, DOI 10.1159/000345629; Luckenbach JA, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-2; Mahapatra KD., 2006, DEV AQUATIC ANIMAL G, V73, P34; Maitra S. K., 2006, Journal of Endocrinology and Reproduction, V10, P73; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; Mommens Maren, 2010, BMC Research Notes, V3, DOI 10.1186/1756-0500-3-138; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Nagler JJ, 2012, GEN COMP ENDOCR, V178, P556, DOI 10.1016/j.ygcen.2012.06.010; Nandi S, 2001, REPROD NUTR DEV, V41, P365, DOI 10.1051/rnd:2001137; NATH P, 1992, Indian Journal of Experimental Biology, V30, P464; Nath P, 2001, GEN COMP ENDOCR, V124, P30, DOI 10.1006/gcen.2001.7686; Patel A, 2009, INDIAN J FISH, V56, P65; Patra BC, 2011, INT J CURRENT RES, V3, P259; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinto PIS, 2012, GENE, V503, P18, DOI 10.1016/j.gene.2012.04.081; Pousis C, 2012, ANIM REPROD SCI, V132, P101, DOI 10.1016/j.anireprosci.2012.03.014; Quasim S. Z., 1962, INDIAN J FISH, V8, P24; Reid SJ, 2009, BRAIN RES, V1268, P190, DOI 10.1016/j.brainres.2009.03.004; Robinson N, 2011, MARINE BIOTECHNOLOGY, V10126, P9433; Robinson N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-541; Routray P, 2007, FISH PHYSIOL BIOCHEM, V33, P413, DOI 10.1007/s10695-007-9159-0; Sahoo L, 2014, J GENETICS IN PRESS; Sahu DK, 2013, GENE, V524, P1, DOI 10.1016/j.gene.2013.03.111; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Sandoval-Guzman T, 2012, FASEB J, V26, P4966, DOI 10.1096/fj.11-199059; Sarkar SK, 2010, CURR SCI INDIA, V99, P960; Schmitt A, 2002, J CELL SCI, V115, P2457; Senetar MA, 2005, GENE, V362, P141, DOI 10.1016/j.gene.2005.08.012; Smith THL, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-23; Song CL, 2010, GEN COMP ENDOCR, V166, P211, DOI 10.1016/j.ygcen.2009.08.007; Sreenivasan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001791; SUNDARARAJ BI, 1976, J FISH RES BOARD CAN, V33, P959, DOI 10.1139/f76-123; Tada MN, 2004, GENE, V340, P197, DOI 10.1016/j.gene.2004.07.014; Takayama S, 2008, GEN COMP ENDOCR, V155, P176, DOI 10.1016/j.ygcen.2007.04.012; Teng KK, 2004, CELL MOL LIFE SCI, V61, P35, DOI 10.1007/s00018-003-3099-3; Toyoshima Y, 2008, ENDOCRINOLOGY, V149, P5996, DOI 10.1210/en.2008-0329; Vesterlund L, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-30; von Schalburg KR, 2005, BIOL REPROD, V72, P687, DOI 10.1095/biolreprod.104.034967; Weber GM, 1999, COMP BIOCHEM PHYS C, V124, P323, DOI 10.1016/S0742-8413(99)00081-X; Weltzien FA, 2004, COMP BIOCHEM PHYS A, V137, P447, DOI 10.1016/j.cbpb.2003.11.007; WIKLER KC, 1994, P NATL ACAD SCI USA, V91, P6534, DOI 10.1073/pnas.91.14.6534	76	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132450	10.1371/journal.pone.0132450	http://dx.doi.org/10.1371/journal.pone.0132450			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148098	Green Published, gold, Green Submitted			2022-12-27	WOS:000358157600273
J	Shu, Y; Mei, QC; Fernandez, J; Li, ZY; Feng, N; Gu, YD				Shu, Yang; Mei, Qichang; Fernandez, Justin; Li, Zhiyong; Feng, Neng; Gu, Yaodong			Foot Morphological Difference between Habitually Shod and Unshod Runners	PLOS ONE			English	Article							1ST ATTEMPT; BAREFOOT; KINEMATICS; PATTERN; BIOMECHANICS; SHAPE; SIZE; CLASSIFICATION; FOOTPRINTS; STATURE	Foot morphology and function has received increasing attention from both biomechanics researchers and footwear manufacturers. In this study, 168 habitually unshod runners (90 males whose age, weight & height were 23 +/- 2.4years, 66 +/- 7.1kg & 1.68 +/- 0.13m and 78 females whose age, weight & height were 22 +/- 1.8years, 55 +/- 4.7kg & 1.6 +/- 0.11m) (Indians) and 196 shod runners (130 males whose age, weight & height were 24 +/- 2.6years, 66 +/- 8.2kg & 1.72 +/- 0.18m and 66 females whose age, weight & height were 23 +/- 1.5years, 54 +/- 5.6kg & 1.62 +/- 0.15m)(Chinese) participated in a foot scanning test using the easy-foot-scan (a three-dimensional foot scanning system) to obtain 3D foot surface data and 2D footprint imaging. Foot length, foot width, hallux angle and minimal distance from hallux to second toe were calculated to analyze foot morphological differences. This study found that significant differences exist between groups (shod Chinese and unshod Indians) for foot length (female p = 0.001), width (female p = 0.001), hallux angle (male and female p = 0.001) and the minimal distance (male and female p = 0.001) from hallux to second toe. This study suggests that significant differences in morphology between different ethnicities could be considered for future investigation of locomotion biomechanics characteristics between ethnicities and inform last shape and design so as to reduce injury risks and poor performance from mal-fit shoes.	[Shu, Yang; Mei, Qichang; Gu, Yaodong] Ningbo Univ, Fac Sports Sci, Ningbo 315211, Zhejiang, Peoples R China; [Fernandez, Justin] Univ Auckland, Dept Engn Sci, Auckland, New Zealand; [Fernandez, Justin] Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand; [Li, Zhiyong] Southeast Univ, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China; [Feng, Neng] Ningbo Ninth Hosp, Rehabil Ctr, Ningbo, Zhejiang, Peoples R China	Ningbo University; University of Auckland; University of Auckland; Southeast University - China	Gu, YD (corresponding author), Ningbo Univ, Fac Sports Sci, Ningbo 315211, Zhejiang, Peoples R China.	guyaodong@hotmail.com	Mei, Qichang/AAN-4052-2020; Mei, Qichang/AAF-2467-2019; Gu, Yaodong/AAJ-4148-2020; Gu, Yaodong/AAH-7551-2020; Li, Zhi-Yong/G-9701-2011	Mei, Qichang/0000-0003-1113-877X; Li, Zhi-Yong/0000-0002-6814-9165; gu, yaodong/0000-0003-2187-9440	National Natural Science Foundation of China [81301600]; K.C. Wong Magna Fund in Ningbo University; Ningbo Natural Science Foundation [2013A610262]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); K.C. Wong Magna Fund in Ningbo University; Ningbo Natural Science Foundation	The study sponsored by National Natural Science Foundation of China (81301600), K.C. Wong Magna Fund in Ningbo University, and Ningbo Natural Science Foundation (2013A610262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn AN, 2014, J SPORT HEALTH SCI, V3, P102, DOI 10.1016/j.jshs.2014.03.007; Altman AR, 2012, GAIT POSTURE, V35, P298, DOI 10.1016/j.gaitpost.2011.09.104; Ashizawa K, 1997, ANN HUM BIOL, V24, P117, DOI 10.1080/03014469700004862; Aurichio TR, 2011, ARCH GERONTOL GERIAT, V52, pE89, DOI 10.1016/j.archger.2010.06.014; AYDOG ST, 2005, BRIT J SPORT MED, V39, DOI DOI 10.1136/bjsm.2003.011478; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; Bonacci J, 2013, BRIT J SPORT MED, V47, P387, DOI 10.1136/bjsports-2012-091837; Bosch K, 2010, GAIT POSTURE, V32, P564, DOI 10.1016/j.gaitpost.2010.08.003; Cain LE, 2007, J SCI MED SPORT, V10, P311, DOI 10.1016/j.jsams.2006.07.012; Cheng FT, 1999, INT J IND ERGONOM, V25, P171, DOI 10.1016/S0169-8141(98)00098-5; Cheung RTH, 2014, HUM MOVEMENT SCI, V34, P120, DOI 10.1016/j.humov.2014.01.006; Clifton P, 2011, PROCEDIA ENGINEER, V13, P100, DOI 10.1016/j.proeng.2011.05.058; Cronin NJ, 2013, GAIT POSTURE, V38, P528, DOI 10.1016/j.gaitpost.2013.01.027; D'Aout K, 2009, FOOTWEAR SCI, V1, P81, DOI 10.1080/19424280903386411; Dingwall HL, 2013, J HUM EVOL, V64, P556, DOI 10.1016/j.jhevol.2013.02.004; Freedman BR, 2014, J BIOMECH, V47, P2028, DOI 10.1016/j.jbiomech.2013.10.054; Grouios G., 2004, FOOT, V14, P175, DOI DOI 10.1016/J.FOOT.2004.07.005; Gu YD, 2014, J MECH MED BIOL, V14, DOI 10.1142/S0219519414500080; Guiotto A, 2013, GAIT POSTURE, V37, P603, DOI 10.1016/j.gaitpost.2012.09.024; Gurney JK, 2012, GAIT POSTURE, V36, P157, DOI 10.1016/j.gaitpost.2012.01.013; Gurney JK, 2009, APPL ERGON, V40, P554, DOI 10.1016/j.apergo.2008.11.001; Hall JPL, 2013, SPORTS MED, V43, P1335, DOI 10.1007/s40279-013-0084-3; Hamill J, 1999, CLIN BIOMECH, V14, P297, DOI 10.1016/S0268-0033(98)90092-4; Hillstrom HJ, 2013, GAIT POSTURE, V37, P445, DOI 10.1016/j.gaitpost.2012.09.007; Hoffmann P., 1905, J BONE JT SURG AM, V2, P105; Houston VL, 2006, J AM PODIAT MED ASSN, V96, P330, DOI 10.7547/0960330; Kadambande S., 2006, FOOT, V16, P188, DOI DOI 10.1016/J.FOOT.2006.06.001; Lambrinudi C, 1932, Postgrad Med J, V8, P459; Li FL, 2014, INT J BIOMED ENG TEC, V15, P59, DOI 10.1504/IJBET.2014.060991; Lieberman D., 2013, STORY HUMAN BODY EVO; Lieberman DE, 2012, EXERC SPORT SCI REV, V40, P63, DOI 10.1097/JES.0b013e31824ab210; Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; Lin SC, 2013, GAIT POSTURE, V37, P235, DOI 10.1016/j.gaitpost.2012.07.010; Liu X, 2004, REAL-TIME IMAGING, V10, P217, DOI 10.1016/j.rti.2004.05.009; Lohman EB, 2011, PHYS THER SPORT, V12, P151, DOI 10.1016/j.ptsp.2011.09.004; Ma JB, 2013, INT J BIOMED ENG TEC, V13, P147, DOI 10.1504/IJBET.2013.057927; Mall NA, 2007, J BIOMECH, V40, P1171, DOI 10.1016/j.jbiomech.2006.04.021; Mauch M, 2009, ERGONOMICS, V52, P999, DOI 10.1080/00140130902803549; Mei QC, 2014, INT J BIOMED ENG TEC, V14, P181, DOI 10.1504/IJBET.2014.059668; Moore IS, 2014, FOOTWEAR SCI, V6, P1, DOI 10.1080/19424280.2013.873487; Mootanah R, 2013, GAIT POSTURE, V37, P452, DOI 10.1016/j.gaitpost.2012.09.008; Novak B, 2014, GAIT POSTURE, V40, P87, DOI 10.1016/j.gaitpost.2014.02.015; Olin ED, 2013, HUM MOVEMENT SCI, V32, P343, DOI 10.1016/j.humov.2012.11.005; Putti A B, 2010, Foot Ankle Surg, V16, P195, DOI 10.1016/j.fas.2009.11.004; Razeghi M, 2002, GAIT POSTURE, V15, P282, DOI 10.1016/S0966-6362(01)00151-5; Schutte KH, 2013, S AFR J RES SPORT PH, V35, P153; Shih Y, 2013, GAIT POSTURE, V38, P490, DOI 10.1016/j.gaitpost.2013.01.030; Sinclair J, 2013, FOOTWEAR SCI, V5, P45, DOI 10.1080/19424280.2012.693543; Squadrone R, 2009, J SPORT MED PHYS FIT, V49, P6; Stavlas Panagiotis, 2005, J Foot Ankle Surg, V44, P424, DOI 10.1053/j.jfas.2005.07.023; Tam N, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-092404; Telfer S, 2010, J FOOT ANKLE RES, V3, DOI 10.1186/1757-1146-3-19; Tsung BYS, 2003, J REHABIL RES DEV, V40, P517, DOI 10.1682/JRRD.2003.11.0517; Willson JD, 2014, PM&R, V6, P34, DOI 10.1016/j.pmrj.2013.08.602; Witana CP, 2006, INT J IND ERGONOM, V36, P789, DOI 10.1016/j.ergon.2006.06.004; Wong CK, 2012, PHYSIOTHER CAN, V64, P280, DOI 10.3138/ptc.2011-40; World Health Organization, 1997, OB PREV MAN GLOB EP; Xiong SP, 2009, ANTHROPOL SCI, V117, P77, DOI 10.1537/ase.070915; Yan AF, 2013, GAIT POSTURE, V38, P175, DOI 10.1016/j.gaitpost.2012.11.017; Yeow CH, 2011, KNEE, V18, P407, DOI 10.1016/j.knee.2010.07.011; Zhao J, 2008, COMPUT IND ENG, V54, P359, DOI 10.1016/j.cie.2007.07.015	61	29	29	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131385	10.1371/journal.pone.0131385	http://dx.doi.org/10.1371/journal.pone.0131385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148059	gold, Green Published, Green Submitted			2022-12-27	WOS:000358157600093
J	Geng, YQ; Zhang, JJ; Yan, YD; Yu, BW; Geng, L; Sun, T				Geng, Yanquan; Zhang, Junjie; Yan, Yongda; Yu, Bowen; Geng, Lin; Sun, Tao			Experimental and Theoretical Investigation of Crystallographic Orientation Dependence of Nanoscratching of Single Crystalline Copper	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; INDUCED DEFORMATION; SIMULATION; NANOINDENTATION; NANOSTRUCTURE; SCRATCH; FABRICATION; MICROSCOPY; EVOLUTION; ALUMINUM	In the present work, we perform experiments and molecular dynamics simulations to elucidate the underlying deformation mechanisms of single crystalline copper under the load-controlled multi-passes nanoscratching using a triangular pyramidal probe. The correlation of microscopic deformation behavior of the material with macroscopically-observed machining results is revealed. Moreover, the influence of crystallographic orientation on the nanoscratching of single crystalline copper is examined. Our simulation results indicate that the plastic deformation of single crystalline Cu under the nanoscratching is exclusively governed by dislocation mechanisms. However, there is no glissile dislocation structure formed due to the probe oscillation under the load-controlled mode. Both experiments and MD simulations demonstrate that the machined surface morphologies in terms of groove depth and surface pile-up exhibit strong crystallographic orientation dependence, because of different geometries of activated slip planes cutting with free surfaces and strain hardening abilities associated with different crystallographic orientations.	[Geng, Yanquan; Yan, Yongda] Harbin Inst Technol, Inst Robot, State Key Lab Robot & Syst, Harbin 150008, Heilongjiang, Peoples R China; [Geng, Yanquan; Zhang, Junjie; Yan, Yongda; Yu, Bowen; Sun, Tao] Harbin Inst Technol, Ctr Precis Engn, Harbin 150001, Heilongjiang, Peoples R China; [Zhang, Junjie; Geng, Lin] Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Heilongjiang, Peoples R China	Harbin Institute of Technology; Harbin Institute of Technology; Harbin Institute of Technology	Zhang, JJ (corresponding author), Harbin Inst Technol, Ctr Precis Engn, Harbin 150001, Heilongjiang, Peoples R China.	zhjj505@gmail.com; yanyongda@hit.edu.cn	Yan, Yongda/M-7315-2017; Geng, Yanquan/AAD-9914-2020; Geng, Yanquan/Q-1119-2015; Feng, Li/GQQ-3764-2022; SUN, TAO/HGA-0197-2022; Lin, Geng/AAS-4901-2020; Wang, Xin/AAN-8435-2021; Wang, Xin/GYU-1129-2022	Yan, Yongda/0000-0002-9290-5362; Wang, Xin/0000-0002-4457-7376; Geng, Yanquan/0000-0003-3499-0551; Zhang, Junjie/0000-0002-9636-5551; Geng, Yanquan/0000-0003-0958-0999	National Natural Science Foundation of China [51222504, 51275114, 51405106]; Author of National Excellent Doctoral Dissertation of PR China [201031]; Program for New Century Excellent Talents in University [NCET-11-0812]; China Postdoctoral Science Foundation [2012M511463, 2013T60358]; Heilongjiang Postdoctoral Fund [LBH-Z11143]; National Program for Support of Top-notch Young Professors	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Heilongjiang Postdoctoral Fund; National Program for Support of Top-notch Young Professors	The authors gratefully acknowledge financial supports of the National Natural Science Foundation of China (51222504, 51275114 and 51405106), the Author of National Excellent Doctoral Dissertation of PR China (201031), the Program for New Century Excellent Talents in University (NCET-11-0812), the China Postdoctoral Science Foundation (2012M511463 and 2013T60358), the Heilongjiang Postdoctoral Fund (LBH-Z11143) and the the National Program for Support of Top-notch Young Professors.	Ciesielski PN, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-47; Dongmo LS, 2000, ULTRAMICROSCOPY, V85, P141, DOI 10.1016/S0304-3991(00)00051-6; Fanzio P, 2012, SCI REP-UK, V2, DOI 10.1038/srep00791; FOILES SM, 1986, PHYS REV B, V33, P7983, DOI 10.1103/PhysRevB.33.7983; Geng YQ, 2013, J VAC SCI TECHNOL B, V31, DOI 10.1116/1.4825405; Gregory JG, 2010, J MATER RES, V25, P921; HONEYCUTT JD, 1987, J PHYS CHEM-US, V91, P4950, DOI 10.1021/j100303a014; Ju SP, 2007, MOL SIMULAT, V33, P905, DOI 10.1080/08927020701392954; Komanduri R, 2000, WEAR, V240, P113, DOI 10.1016/S0043-1648(00)00358-6; Lin YC, 2014, MOL PHYS, V112, P1115, DOI 10.1080/00268976.2013.833657; Liu H, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/17/175301; Lu C, 2009, WEAR, V267, P1961, DOI 10.1016/j.wear.2009.05.006; Meyers MA, 2006, PROG MATER SCI, V51, P427, DOI 10.1016/j.pmatsci.2005.08.003; Nazirizadeh Y, 2013, OPT EXPRESS, V21, P18661, DOI 10.1364/OE.21.018661; Pitchuka SB, 2014, J THERM SPRAY TECHN, V23, P502, DOI 10.1007/s11666-013-0021-x; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Podymova NB, 2014, LASER PHYS, V24, DOI 10.1088/1054-660X/24/8/086003; Salehinia I, 2014, INT J PLASTICITY, V52, P133, DOI 10.1016/j.ijplas.2013.04.010; Salehinia I, 2013, MAT SCI ENG A-STRUCT, V588, P340, DOI 10.1016/j.msea.2013.09.059; Singh A, 2011, ACTA MATER, V59, P7311, DOI 10.1016/j.actamat.2011.08.014; Stukowski A, 2010, MODEL SIMUL MATER SC, V18, DOI 10.1088/0965-0393/18/1/015012; Suchowski H, 2013, SCIENCE, V342, P1223, DOI 10.1126/science.1244303; Tak M, 2014, BIOSENS BIOELECTRON, V59, P200, DOI 10.1016/j.bios.2014.03.036; Tschopp MA, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2715137; Tseng AA, 2011, J VAC SCI TECHNOL B, V29, DOI 10.1116/1.3609921; Tseng AA, 2010, J VAC SCI TECHNOL B, V28, P202, DOI 10.1116/1.3292944; Tseng AA, 2009, J APPL PHYS, V106, DOI 10.1063/1.3197313; Wang Y, 2004, ACTA MATER, V52, P2229, DOI 10.1016/j.actamat.2004.01.016; Wu B, 2006, NANO LETT, V6, P468, DOI 10.1021/nl052427f; Wu SL, 2013, ACS APPL MATER INTER, V5, P4769, DOI 10.1021/am400092w; Yan YD, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-212; Zhang JJ, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/19/195301; Zhang JJ, 2013, MODEL SIMUL MATER SC, V21, DOI 10.1088/0965-0393/21/6/065001; Zhang JJ, 2012, COMP MATER SCI, V59, P14, DOI 10.1016/j.commatsci.2012.02.024; Zhang JJ, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.054109; Zhang JJ, 2009, APPL PHYS A-MATER, V94, P593, DOI 10.1007/s00339-008-4903-6; Zhang P, 2013, APPL SURF SCI, V280, P751, DOI 10.1016/j.apsusc.2013.05.056; Zheng YG, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2839581	38	62	73	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131886	10.1371/journal.pone.0131886	http://dx.doi.org/10.1371/journal.pone.0131886			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147506	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600156
J	Geng, YF; Guo, DH; Li, CQ; Wang, EY; Wei, S; Wang, ZH; Yao, S; Zhao, XW; Su, MJ; Wang, XY; Wang, JF; Wu, R; Feng, L; Sun, DB				Geng, Yufei; Guo, Donghua; Li, Chunqiu; Wang, Enyu; Wei, Shan; Wang, Zhihui; Yao, Shuang; Zhao, Xiwen; Su, Mingjun; Wang, Xinyu; Wang, Jianfa; Wu, Rui; Feng, Li; Sun, Dongbo			Co-Circulation of the Rare CPV-2c with Unique Gln370Arg Substitution, New CPV-2b with Unique Thr440Ala Substitution, and New CPV-2a with High Prevalence and Variation in Heilongjiang Province, Northeast China	PLOS ONE			English	Article							CANINE PARVOVIRUS STRAINS; GENETIC-ANALYSIS; VP2 GENE; MOLECULAR CHARACTERIZATION; PHYLOGENETIC ANALYSIS; DOGS; EMERGENCE; EVOLUTION; RECOMBINATION; REVEALS	To trace evolution of canine parvovirus-2 (CPV-2), a total of 201 stool samples were collected from dogs with diarrhea in Heilongjiang province of northeast China from May 2014 to April 2015. The presence of CPV-2 in the samples was determined by PCR amplification of the VP2 gene (568 bp) of CPV-2. The results revealed that 95 samples (47.26%) were positive for CPV-2, and they showed 98.8%-100% nucleotide identity and 97.6%-100% amino acid identity. Of 95 CPV-2-positive samples, types new2a (Ser297Ala), new2b (Ser297Ala), and 2c accounted for 64.21%, 21.05%, and 14.74%, respectively. The positive rate of CPV-2 and the distribution of the new2a, new2b and 2c types exhibited differences among regions, seasons, and ages. Immunized dogs accounted for 48.42% of 95 CPV-2-positive samples. Coinfections with canine coronavirus, canine kobuvirus, and canine bocavirus were identified. Phylogenetic analysis revealed that the identified new2a, new2b, and CPV-2c strains in our study exhibited a close relationship with most of the CPV-2 strains from China; type new2a strains exhibited high variability, forming three subgroups; type new2b and CPV-2c strains formed one group with reference strains from China. Of 95 CPV-2 strains, Tyr324Ile and Thr440Ala substitutions accounted for 100% and 64.21%, respectively; all type new2b strains exhibited the Thr440Ala substitution, while the unique Gln370Arg substitution was found in all type 2c strains. Recombination analysis using entire VP2 gene indicated possible recombination events between the identified CPV-2 strains and reference strains from China. Our data revealed the co-circulation of new CPV-2a, new CPV-2b, and rare CPV-2c, as well as potential recombination events among Chinese CPV-2 strains.	[Geng, Yufei; Guo, Donghua; Li, Chunqiu; Wang, Enyu; Wei, Shan; Wang, Zhihui; Yao, Shuang; Zhao, Xiwen; Su, Mingjun; Wang, Xinyu; Wang, Jianfa; Wu, Rui; Sun, Dongbo] Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, Daqing 163319, Peoples R China; [Feng, Li] Chinese Acad Agr Sci, Harbin Vet Res Inst, Natl Key Lab Vet Biotechnol, Harbin 150001, Peoples R China	Heilongjiang Bayi Agricultural University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Sun, DB (corresponding author), Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, 2 Xinyang Rd, Daqing 163319, Peoples R China.	dongbosun@126.com	Yan, Yongda/M-7315-2017; Geng, Yanquan/AAD-9914-2020; Geng, Yanquan/Q-1119-2015; Feng, Li/GQQ-3764-2022; SUN, TAO/HGA-0197-2022; Lin, Geng/AAS-4901-2020; Wang, Xin/AAN-8435-2021; Wang, Xin/GYU-1129-2022	Yan, Yongda/0000-0002-9290-5362; Wang, Xin/0000-0002-4457-7376; Geng, Yanquan/0000-0003-3499-0551; Zhang, Junjie/0000-0002-9636-5551; Geng, Yanquan/0000-0003-0958-0999	Program for New Century Excellent Talents in Heilongjiang Provincial University [1252-NCET-016]	Program for New Century Excellent Talents in Heilongjiang Provincial University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the Program for New Century Excellent Talents in Heilongjiang Provincial University (grant no. 1252-NCET-016).	Bodewes R, 2014, VET MICROBIOL, V174, P1, DOI 10.1016/j.vetmic.2014.08.025; Buonavoglia C, 2001, J GEN VIROL, V82, P3021, DOI 10.1099/0022-1317-82-12-3021; Cavalli A, 2014, J VET DIAGN INVEST, V26, P563, DOI 10.1177/1040638714538965; Costa EM, 2014, VET MICROBIOL, V168, P8, DOI 10.1016/j.vetmic.2013.10.002; Csagola A, 2014, ARCH VIROL, V159, P2441, DOI 10.1007/s00705-014-2068-5; Decaro N, 2009, VIROLOGY, V385, P5, DOI 10.1016/j.virol.2008.12.016; Decaro N, 2007, EMERG INFECT DIS, V13, P1222, DOI 10.3201/eid1308.070505; Decaro N, 2012, VET MICROBIOL, V155, P1, DOI 10.1016/j.vetmic.2011.09.007; Decaro N, 2011, VET J, V187, P195, DOI 10.1016/j.tvjl.2009.10.027; Di Martino B, 2013, VET MICROBIOL, V166, P246, DOI 10.1016/j.vetmic.2013.05.007; Dogonyaro BB, 2013, VET MICROBIOL, V165, P460, DOI 10.1016/j.vetmic.2013.04.022; Calderon MG, 2009, J VIROL METHODS, V159, P141, DOI 10.1016/j.jviromet.2009.03.013; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gomez MM, 2011, J MED VIROL, V83, P1093, DOI 10.1002/jmv.22071; Grellet A, 2012, VET MICROBIOL, V157, P214, DOI 10.1016/j.vetmic.2011.11.012; Han SC, 2015, ARCH MICROBIOL, V197, P621, DOI 10.1007/s00203-015-1093-4; Hoelzer K, 2008, J GEN VIROL, V89, P2280, DOI 10.1099/vir.0.2008/002055-0; Hong C, 2007, J VET DIAGN INVEST, V19, P535, DOI 10.1177/104063870701900512; Hueffer K, 2003, J VIROL, V77, P1718, DOI 10.1128/JVI.77.3.1718-1726.2003; Ikeda Y, 2000, VIROLOGY, V278, P13, DOI 10.1006/viro.2000.0653; Jeoung SY, 2008, J VET MED SCI, V70, P719, DOI 10.1292/jvms.70.719; Kapil S, 2007, J CLIN MICROBIOL, V45, P4044, DOI 10.1128/JCM.01300-07; KELLY WR, 1978, AUST VET J, V54, P593, DOI 10.1111/j.1751-0813.1978.tb02426.x; Lau SKP, 2012, J GEN VIROL, V93, P1573, DOI 10.1099/vir.0.042531-0; Lin CN, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-39; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Maya L, 2013, ARCH VIROL, V158, P1133, DOI 10.1007/s00705-012-1591-5; Meers J, 2007, AUST VET J, V85, P392, DOI 10.1111/j.1751-0813.2007.00206.x; Mesquita JR, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-107; Mittal M, 2014, INFECT GENET EVOL, V23, P1, DOI 10.1016/j.meegid.2014.01.015; Mukhopadhyay HK, 2014, VIRUS GENES, V48, P89, DOI 10.1007/s11262-013-1000-5; Nandi S, 2010, RES VET SCI, V88, P169, DOI 10.1016/j.rvsc.2009.05.018; Nelson CDS, 2007, VIROLOGY, V361, P283, DOI 10.1016/j.virol.2006.11.032; Ohshima T, 2008, J VET MED SCI, V70, P769, DOI 10.1292/jvms.70.769; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; PARRISH CR, 1991, J VIROL, V65, P6544, DOI 10.1128/JVI.65.12.6544-6552.1991; PARRISH CR, 1985, SCIENCE, V230, P1046, DOI 10.1126/science.4059921; Pedroza-Roldan C, 2015, J VET DIAGN INVEST, V27, P107, DOI 10.1177/1040638714559969; Pereira CAD, 2007, INFECT GENET EVOL, V7, P399, DOI 10.1016/j.meegid.2006.03.007; Perez R, 2007, VET MICROBIOL, V124, P147, DOI 10.1016/j.vetmic.2007.04.028; Perez R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111779; Phromnoi S, 2010, VIRUS GENES, V41, P23, DOI 10.1007/s11262-010-0475-6; Pinto LD, 2012, VIRUS RES, V165, P29, DOI 10.1016/j.virusres.2012.01.001; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Raj JM, 2010, INFECT GENET EVOL, V10, P1237, DOI 10.1016/j.meegid.2010.08.005; SMITH JM, 1992, J MOL EVOL, V34, P126; Soma T, 2013, RES VET SCI, V94, P368, DOI 10.1016/j.rvsc.2012.09.013; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timurkan MO, 2015, VET ITAL, V51, P39, DOI 10.12834/VetIt.263.908.3; Xu J, 2015, TRANSBOUND EMERG DIS, V62, P91, DOI 10.1111/tbed.12078; Yi L, 2016, TRANSBOUND EMERG DIS, V63, pE262, DOI 10.1111/tbed.12268; Zhang RZ, 2010, VIRUS GENES, V40, P397, DOI 10.1007/s11262-010-0466-7; Zhao YB, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-272; Zhong ZJ, 2014, INT J MOL SCI, V15, P12166, DOI 10.3390/ijms150712166	55	62	73	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137288	10.1371/journal.pone.0137288	http://dx.doi.org/10.1371/journal.pone.0137288			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26147506	Green Submitted, Green Published, gold			2022-12-27	WOS:000360897600031
